>EGEFANNL_00001 hypothetical protein
MKLSRILEGCHQGDIQELVRIMNLNVVLKKEVLTIKEAALYTGYEESYLRKLNSQSTNLP
SYSCENGNKLFFKRTELDTWMTKRRKNNFIEHQKEVDAYFSRKSA
>EGEFANNL_00002 hypothetical protein
MCFNYKILTKFCFFFIVLSVNSQVTIGSLNEPVKGSILDIKQFNPDNKNITAKAGILLPR
VELKSPTELSFSDFTISDDLDEGGQKLKHTGMIVYNVNETLPFKKGIYVWSGSEWLLQE
>EGEFANNL_00003 hypothetical protein
MKIAYYYFISIFFLFSLKFNSQVTIGSLSKPVKGSILDLKAQEPDANNITAKGGLVLPRV
ELVDANELTFSDFSIADADNGGNQKLIHTGLTVYNVSEVDPFCKGIYSWNGEEWIPLKKC
ANGEFGTGPISVYPDTLYVPSGQDKRGITKMTFVVTWKNEKATLQLQNVENSALYNKVDY
QPVDLSIYKAPVAIIELMPTSMAPEDVKDEKPGNPFKTNLSNYIFSVSDGSTTQTAFKPV
IVNQTNKALTVEGKYLHKQKTIASPAVGESISVVSNIHSNAKWKVTNISSPEIVKGLQVD
SKVVVLDETIFGSEREDDKANINPLQITLENPSGMSTSASVVLKDAENPPRFNDLTLSYY
LCSPNASRTLFQWVEFLGFKGVKSKTDWLALATLEERTAADTAAGIDIPQEISGIAWHRD
QDGNIFLSGSFVANDPLSNDNRWMITNLAATKYDPKRSDGTVVSATNPIFNVKSATVNAP
YISYPADTGDNNNAQDKKNFNNDERIGLLYNWNAATMGRINSNVNEMTKDISKVQGICPY
GWHLPSSLEYAQLVGITDIAGTNIIGEISKNYSIYSRIENNSPANIVGLAVKETCLNLGT
DYAGQSNPISPTERVGFNFLYAGYSFATVLGGTFANFGTFGFIWTSSTASPKDGVKQSYG
RNGYYSVSSNNIYTKAYSLDKKFSVRCKKDPPASSL
>EGEFANNL_00004 3-methylitaconate isomerase
MRGGTSKGGCFLESDLSKDLTEQDKELTNIYGGNDPSGREINGLGGGTSTTSKAVIISKR
TEGVNAINYTFAQVDTKSTLIDRKGNCGNMSTVVGPFAIEKKLVDSIKEPITLVNIYNTN
TNKKIVAHVPVKDGKVVYEGDYSISGVPGTASKIQLDFLDPGGAVTGKLLPTGNVVDILD
VVGLGQFRVSMVDASNPLVFVKAEDLGIIGVELPEDIDDNKELLDKMLAIRETAAVYMGI
AKNLEEAKQIPAIPKFCFVSKPETYTTVNNSKIDKKDYHLSARMLSMGKLHPTYAITGGI
CTAIAAKIPGTIVNEIVKDESVKEEIIIGHCNGTLSVDSEIQMDKEDIKAIRGTVFRTAK
VLIRGEVEVDL
>EGEFANNL_00005 D-lactate dehydrogenase
MKISFFSTQPYDIKFFKECNEKFKFELEFFESNLDEHTVNIIEDSEAICVFVNDVVNDKV
INKLVKKGIKYIALRNAGFNNVDLESAKRNGLKVCRVPAYSPEAVAEHTLAMLLTLNRKT
HKAYNRVREQNFSLNGLLGTTIHGKTVGVIGTGNIGKVFAKTIKSLGTHVLLYDPFPNDE
LISEGFNYVSLEELLKQSNIISLHCPLTPETHHIINKDTISVMKQGVYLINTSRGGLIDT
RAIIEGLKSKRIGALGIDVYEQEDKLFFRDLSETIIEDETIQLLLSFPNVLVTAHQAFFT
EEALSQIALVTLDNLKQLKEFNSIENKSAELV
>EGEFANNL_00006 Putative 3-methyladenine DNA glycosylase
MDRVGKDYFYQDALVVAESLLGKKIVRVFETKEIHEYVITETEAYVGEEDMACHASKGRT
KRTEILYHDGGKIYVYLIYGKYWMLNFVTGKAENPQAVLIRSVQDCIGPGRLGKKLQLDH
SFYGENINNSKRIWVKNYKTFKNIKKTPRIGIDYAEEPWKSICWRFTI
>EGEFANNL_00007 Bifunctional NAD(P)H-hydrate repair enzyme Nnr
MKIFKKEQLRLCDEHTIKNRNLRSIDLMEVAATNCYKWITERYTKDYSFYVVCGKGNNGG
DGLALARMLVEGDYEVEVLMLQSKDDLTEDTQINFDRFPKSVQFIDNDSFEIENFNSTIL
IDALFGIGLNRSLDGIEKKIIDKINQISAIKISIDIPSGLPSDELPKENQTIFKADETLT
FGFIKRSFLHKEGAEYTGNVHIIDLDLDQDFVKNEATDNFIISNNYIKNNIRKRQKFEHK
GDFGKALLIGGSYGQVGSIALSTNAALRVGTGIVHTLAPECGYQILQTLAPEAIFHGAGQ
KIVETIELLVNDYTLGIGPGLGSDNITKGAFEQLLKNENKPLVLDADALNIIATDKKLLK
SIPENSILTPHPKEFERIFGKTNSSLEQCELARKKAIEFKIHIVLKGHYTTILTPLGICY
YNPTGNAGMAKGGSGDVLTGIITGLLAQSYSPTDAAIIGCYLHGKAGDIAALKKSQEAMT
AQDIINYLSEVFVTLNK
>EGEFANNL_00008 Fosmidomycin resistance protein
MISKKTNLTILTSISGSHLLNDMMQSILVAIYPILQSDFSLTFSQIGLITFTYQCTASFL
QPLIGIYTDKNPKPFSLPIGMLITMVGFIVLAFATNFHIILLAASMIGIGSAIFHPESSR
VARLASGGRYGFAQSFFQVGGNLGTSLGPLLAALIITPYGKQNMGYFSLCALLGAIILFR
VSKWYTAQNKNKKSNNDQVSETKKLSRKVVVISLVILLALVFSKAFYLSSITSYYTFYLM
HKFSVTEQDSQIYLFIFLFSVAAGTFMGGPIGDRIGRKYVIWISILGVAPFTLLLPYANL
SWTIALSILIGLILSSAFSAILVFAQELVPGKVGTVSGLFFGFSFGMGGLGAAILGKVAD
KTSIEYVYTLCSYLPLIGLLTVFLPGKKALKG
>EGEFANNL_00009 Phosphorylated carbohydrates phosphatase
MDGVVANTEVQYDIFLQSFIEEYNLSETFLSEVKGVRWPDIIKRYFKNSSEVEIQKILDK
VYEFEANDLIYENIPGVVPFINKLKLNNYKLGLVTSSLKPKTEIALRKMNLENIFDVVVT
GSDVKKGKPDPECYLLAAKKLNSLPSECLVFEDSFAGIEAGLKAGMEVVALSTTNSEISL
KEKVNKVYPNFIHLPIEDLV
>EGEFANNL_00010 hypothetical protein
MKLKYLFLYSVGIFFLFSCSQNKQQERTSIIPAEDIINVSVAKKAKAKITGERMAINIGN
SDSDVWTIVYTDDQGNIHSTILRKNSDNLNQIGDSITIYYDDSTPQSLPIFESQYLKLAK
>EGEFANNL_00011 Cysteine--tRNA ligase
MRTYKNNKIKLYNSLHKQKEDFVPVHDGFVGMYVCGPTVYNKVHLGNCRTFLSFDIINRY
LRHLGYKVRYVRNITDAGHLLDNEEDKISKQSVLEKLEPMEIVQKYTLNFHKVLELLNLL
PPDIEPTATGHIIEQIELIKKLIEKEYAYVSEGSVYFNVKKYDDDGGNYGELSKRKIEDM
AANTRELDGQDEKESPQDFALWKKASPEHIMRWSSPWSEGFPGWHLECTAMSTKYLGEEF
DIHGGGLDLKFPHHECEIAQSKGCFNKEPVRYWLHANMLTLNGQKMSKSTGNTILPEELI
SGDNSFFEKPIHPMVIRFFFLQAHYRSVLDLSNDAMMAAEKGFLRLTSAIDKLRTIKPSS
TSSFNVYEWVDSCYDALNDDFNTPVLISHLFDAVKLINSLDLKNETLSESDLHIFTQAIH
NFFYDVLGLELLTDRLNDNDKLDQTIKVLIDLRNKARLEKDWSLSDEIRDRLAAKGIVLK
DGKEGTTYEIE
>EGEFANNL_00012 GTP cyclohydrolase 1
MFNTDDEEQDHFSPTEYTPLREDAFTISPEKKQELIQHHFTEIMKILGLDMKDDSLKDTP
KRVAKMYVNEIFGGLLPENKPAISTFDNNYKYKQMLIEKDITVYSTCEHHFLPIIGKAHV
AYISNQKVIGLSKINRIVNYYARRPQVQERLTRQIVEALKEALNTKNVACVIDAKHLCVN
SRGIKDTNSSTVTAELSGSFQTNPTTRKEFLHYIGIDSHFKI
>EGEFANNL_00013 hypothetical protein
MKNQREMGIDNLRFAMVVLVIALHAAMTFMDYVPEWWYVINPKRSLGFTYLVIILDTFPM
TVLFFLSGYFAPNSLKKRGTLSFIRNKTIHIAIPWMLGVLFVAPFFSRLTMSAYGYPSIP
FISFYLNDFLGVFYQQAHYWFLGVLFLFFIIYAWASPKKIKLLNIATSRMIFFTIFLTAV
AYFLSTRYYKPANGWTNVGYLLYFQPARFMGYFLMFFLGIYAQNKHWFKVDGWKPSLKIF
FPSSFISMVGVIIIQMNLFNPITDGKKQIAEAIFYSLASVSITFLLITLCMRIHGSVQKI
IHFFSPYSYGIYWLHQIILMLILQFLLNTNIPIFIKWFLSIVITVFITTILTKYVLKKLP
ILKKMF
>EGEFANNL_00014 hypothetical protein
MNIYIQYIFILAIVIFSVIYLIRLFKDTFLPNKKGKCGEEKCKCGNH
>EGEFANNL_00015 hypothetical protein
MKLKKLIGIIFTHRRFVSKFPDLYRMLRASLMGHYKPGIKNIFISLFVIVYVISPLDLIP
GFLVGIGILDDITLTFLALSKLFKEVDKFREWEKQKESIIVIK
>EGEFANNL_00016 tRNA dimethylallyltransferase
MSSNKKLISIVGPTAIGKTSLSIQIAQYLNTEIISCDSRQFYKEMKVGTASPSDEELDMV
PHHFIQNLSIKQDYSVGDFESEAIEVINFLFQKHDQLVMVGGSGLYEKAINEGLDEFPDV
DPEIRNSLVSELNEIGIGFLVSELKKVDPEYYAIADHQNPMRVIRALEVFRSTGKPFSSF
RKNNLKSRDFSTIKIGLEAPREIIYNRINLRVDQMMQNGLLEEVKTLLPYRHVNALQTVG
YKELFSYLDGDISLDKAIEEIKKNSRRYAKRQLTWYRKDISVHWFPYNDKDAVIQFIKNL
LEK
>EGEFANNL_00017 Endolytic peptidoglycan transglycosylase RlpA
MRLSKFILLATLFLFLFSCGTNYTPTYKNATVSWYGKPFHGRTTANGEKYNMHKLTAAHK
KLPFGTKVLLINPENNKKVIVRINDRGPFVAGREFDLSKKAFSKLAPNQRGILKVKYKIL
K
>EGEFANNL_00018 Protein YceI
MAQWTIDNSHSEVFFKVKHMVISTVTGEFTSFKSSIVSETDDFTNAKFEFSADIDSINTK
ITDRDNHLKSADFFDAEQYPTLSFHSISGLQNNSIKGNLTIKNVTKEITLEVDFGGVIND
PWNNQRAGFEMTGKISRKEFGLTWNQLTEAGGMVVGDTVKLIINAEYISQK
>EGEFANNL_00019 Protein YceI
MKNILITITLVLTTILIPAQKLTLDPNHAKLKFDVTHMTISTIDGEFKKFWVDLDFNNPD
FSDVKFTVISDINSIDTGIEARDKHLKSADFFDAEKYPKLKFISTSIIKEKKDNYELKGN
LTLHGITKPVSLKVKYNGSILNPMTNLKTYGFTISGRFKRSDFEIGNNFPENIVSDYVNI
YSNLEFTAN
>EGEFANNL_00020 DNA processing protein DprA
MEKEILYLLALYNCPKIGEKFIKKMIHKFGSAKNAWFADPKDLLTIPNLGKSNIQFIGDE
NYFSQAEKQLQECTSNNINIVHLWESHYPFLLKQCPDAPIFLFYKGNINFNLPSISIVGT
RKMTSYGKLFTENLIECLSTKKINIISGLALGIDGCAHKKAVEVNIPTIGVLAHGLNQLY
PPLHETLAMNMLKNGGLISEYPVHTKPERTHFIQRNRIIAGLSSITIIIESAYGGGAIST
AKFANSYNREVFALPGRITDISSQGCNQLIRNLEAQIITQPKDILSFLGDSINKIKQPEL
FPNLLEDEEIIYKYLKTNGNTSIDTLAVELSLSTFQLMPILLNLELKNIIRSNPGKYFEI
A
>EGEFANNL_00021 hypothetical protein
MKKYGWVLFILILHSLHLYSFYSPVHDSTKIIRNEKLIIKKKKGNYGVVNEYENKVIIPI
LYDKIKAINDDGFAAYKEDQWIIYSKEGIIISSPYTFEKIHVPIENFNENKIIIIGKPDK
KSESVVVLVSNKNDYTSYKYDKILSISPSYYHVQKNGLYGTLSIDGKEVIPPLYKSIEYM
RPSRKEDPYLAKVFDSHNFVGMININTGKVIIPVVWNEIIPLGKSFFKVKNGDKWGLINY
NNEEILPINYTNIVALSSKFIKVQEEDGQIFFVSLDNSRGLGEDYLLSQNSYSIKQENMK
FGVVKNDGTLLVPFQYDHIEDTPQRVFIATIEKRSKLLNLNGEELTENYLNIEFNELTQN
FLAQDSKKRWKIINYKGEVLFSTEITNKKKLLELLNQTVEEEFTDYEGMSIKNDKDRKGW
ASGILAGIGTAFVYLAYALGYVTVILININYY
>EGEFANNL_00022 putative tRNA-dihydrouridine synthase
MIKIGKINFPEFPFLLAPMEDVSDPPFRRLCKMEGADLMYSEFISSEGLIRDAIKSKKKL
EIFDYERPIGIQIFGGDEEAMSLSAKIVETVQPDLLDINFGCPVKKVACKGAGAGVLKDI
DLMVKLTKAVVNSTKLPVTVKTRLGWDEKSINIDEVAERLQDVGIQALTIHARTRSQMYK
GHSDWNYIARVKNNPRIQIPIFGNGDIDSPEKALEFKNKYGVDGIMIGRAAIGNPWIFKQ
IKHFFKTGELLPPPTLKERIEAVKKHALWSTEWKGERTGLLEMRQHYSNYFRGIADFKPY
KSQLLSTLSIDELNSIFDTILTEKDIH
>EGEFANNL_00023 hypothetical protein
MNFLTAEWRKLVMINFIIPPDIISDFVPKGTKIDLWNGNCYVSLVGFMFLNTRVLGIPIP
FHINFEEVNLRFYVKREESNLVKRGVVFIKEIVPKNAITFVANTLYKENYKTLPMSHQWN
LEDDLAIKYNWKFKNKNYFMEAIASSKKEQLGIGTEAEFIAEHYWGYTKVNPLKTTEYEV
THPKWEKYQIKDYNYSIDFGELYGERFSLLNELKPSSVFLVEGSEIAVQTFRTIH
>EGEFANNL_00024 hypothetical protein
MELQEAKEKYIQTWGTLASQWGTNRTMAQIHALLLISPKALSTEEIMDELKISRGNANTN
IRALLDWDLITKELVPGDRKEYFKAEKDILEMFKRIVKERKKRELESIISTMNELKEVND
STNEGKEFKKVIAEIYKVTKKSNRIINSILKLENSWFFDKISKLLN
>EGEFANNL_00025 Acetyl-CoA acetyltransferase
MKEVVIVSAVRTPIGSFLGSLSSLSATELGAIAIEGALKKINLGPSQIQEVFMGNVLQAN
VGQAPARQAALKAGLSSTIPCTTINKVCASGLKSVILGAQTIKAGDNTTVIAGGMESMSQ
VPYYITNGRIGSKFGDQKMLDGLIKDGLTDVYDQKHMGCFADICAKEYGISRVEQDEFAI
ASYTRAKEAWEEGRFKDEIVSVPVPQRKQDPIVISEDEEYKKINFDKLKSLSAVFSKEGT
VTAANASTLNDGASALVLMSMEKAQELNLQPLAKIIGYADASYEPSKFTVAPSKAIPLAL
EKANLSLDQIDYFEFNEAFSVVGLANAKILNLSLDKINVNGGAVSLGHPLGNSGSRILVT
LINVLKQKNGKYGAAAICNGGGGASAIIIERI
>EGEFANNL_00026 hypothetical protein
MEKRKFTVITDYLSILLPKTKYEYLVLLFSLILYYPIGVYLSLTTDIIDKDGRVDMYFGF
DNSICLKYGSMFEVTHPINGILYFPIICLNYIINAVGYSPKIYTLIVVFLCAFFVSYSNL
FVYKYLTKILKLNIKETLIIIFPYTFYTCNLLLSFTPETFTFSLFLLSLNIFLVSYFISN
NKKIHTLYYVFIGTLIGGQTITNTPKAMIPILFENKLSKKNYVNVFKKLFISSLLIALII
LASLRFRVLEFLGVNMERAEMFAFLKNLKHGIHEYFISQFFGGNILFPKVYLSKTNVWGT
ENLGGIYSYFYDSWTQYLCIFAIIIIMLIGIFKNYKSRLIWIPVISFGVDFFLHMILKLG
LFESIIYGGHFIFIVPILLGWSFYRNSSKKYYNILCIVLSILGLYIIYNNTFEIIEFVRL
AQIEFPH
>EGEFANNL_00027 hypothetical protein
MNAVLIAVLIMLILSGLRVHVLISLLVGSITAGILANMSLSHTMEAFNEGIKNGASIALS
YALLGVFAISISKSGLPHALSNIIINSLTHGGSKTKIKWLLITVIGLVSISSQNILPIHI
AFIPILIPPLLFVMAKLNLDRRMMACIISFGLVTPYMFLPIGFGNIFLNEILMANISKAG
MDVSNVNVMEAMSIPALGMLFGLLFSIFISYRKPRKYSEGKIKNTEKLEIKLNKRSIYIC
LIAIVVAFAVQLYSNSMILGALAGFLLFVGTGIIKRKEVDDTFVEGVKMMAMIGFVMITA
QGFAEVLNETGEIPSLVNASISLFSENKIVASFFMLLVGLIITMGIGSSFSTIPVIAAIY
VPLCIKMGFSPMATVCLIGAAGAIGDTGSPASDSSLSVTAGLNIDGQHDHIKDTVIPTFI
HYNIPLFLAGWIASLML
>EGEFANNL_00028 Lysine-sensitive aspartokinase 3
MLVLKFGGTSVGSAERIKNLAKLTENFSPKLVVLSAMSGTTNALVEISNALYEKNSAKAN
DLIEDLEKKYQIELANLYKNPSILDKAKEFINTHFNYLRSFLKYPLFTEKEEKVILAEGE
LLSTTMFHYYLSEIGEKSILLPALDFMRITRENEPDMVYIENHIKEEIKKYPDIDFFITQ
GYICRNAQGDIDNLQRGGSDYTACIIGSVLDAKEIQIWTDIDGMHNNDPRFVEKTHPIQE
LSFDEAAELAYFGAKILHPTCILPAQKRGIPVALKNTMQPEAPGTLIGNLKTPDGIRAVA
AKDNIFVITIKSGRMLLAHGFLKTIFEIFEKYKTSIDVITTSEVAVSLTIDNSNHLEAIV
HELSKIAQVDVVKDQTIIAIVGNIAKNKAGYGVQILEAFKEIPLHMISYGGSEHNVTVVI
DSEYKKEALKALNHKLFGY
>EGEFANNL_00029 hypothetical protein
MSTLKFKTNIDCGGCVKAVTPSLSKVEGITKWEVDTTNPEKILTVEGSNEIEEEVVKAVK
KAGFTIKKME
>EGEFANNL_00030 hypothetical protein
MGALLKEIKENRGLRFMNIGAVNFQNLSFNIISIINSCQSHLFNYKKECNKDFIIDVLNL
LEIAKSLIPHGEFELLDRLDKISEN
>EGEFANNL_00031 hypothetical protein
MNLDTTHKRVHQGRNIKRLREMLGVKQETLAIELDVTQATVSKLEAKEELEKDMLERIAK
VLKIPVEAIENFNDEGALNFVANNFHTSDTATGLTITFNPIDKIVELYTEKEALYERMIK
EKNDLIERLLEK
>EGEFANNL_00032 hypothetical protein
MNLKKLLKIAIAFVILLLVIIVLADWAVSRLSKKYLYDSTEQIPANRVAMVLGTSKKLQS
GQNNLYFVYRIKAAADLYHAGKATIFVVSGDNSQKDYNESQDMKDDLVKAGVPADSIFLD
NAGLRTLDSVIRMKEIFGQNKFTIVSQKFHNERAITLARHYDIEAVGYNAQDVTAYYGFK
TMLREKLARVKMFIDLILNKQPKFLGEKIKLP
>EGEFANNL_00033 hypothetical protein
MNSNIFRLAAILYADNNYEVSTKTINRKIIESVFLDNNNEIHPIHKLIEVIQDKYEFIFM
VDEIREIVSCNEYFIISPCKTNELNISLTLNRFEFLKKKVSSNNIDYFISQFHQINKVEQ
LNINDLKQIIYRFLYEVFQTNITSFSKLINPNIKIEDIININNLEFNQIEIDIINSFLNW
ENDEKNKVVFDISSLALEYCLISNKKGNNFKLENLRNKIFYLDTNIIFRAIGINGENRQK
QTITFLEKFKDADEHLYISTFTIEELKSTINYYVKSLNKVNSIKINSDIFMQYSKNSDFL
LYFHKWKKNRSNANLDLFQSHILSEIEMLKNKYCIQTNYKTHFDFKDEKIQELILDKASQ
INTYKSQKKDWSNYYESSIFDAKNIYLIDTLRKGLYVNIFDCKYFMISSDQYLRRWDYIS
NKSTPIVLLPSQWMSILLRYLNRTNDDFKSFVSFLNIHNSEKQISNENLQLILQGISEIT
SDFSQQNSIISEMINIKFNGILKKSFNEEQIIENSKTFAKTKLEQDLEAIQKELKRNIKK
FERYQENTSNAIDNLKQQKDNEKLEKDKTEEENNKIKQELLNLKVKDGLRKYKLRAYWAF
FILVMCLFYIYFSFFFTDKNWNIISIYKNHVNKLNDGSIEKDINKYIFLIPLTIIMFLIK
FIYNRLFNKEKIEERKQKLIERYTK
>EGEFANNL_00035 putative copper-transporting ATPase PacS
MSVENNISLKKVSLAIVNLNNKHEIQIISDGVNHLDGVKNLKIDLNTKNISFEIDKGEDQ
AEVIWDVFNNLKDLGFKIQTTKKNYPVLQLSCASCANSSQNVLRLQPGVISASVNYANEE
ATIEYIPSLITPEDFKKSLQEIGYDLLIDESEEGQEALEDIQKKNFHQLKFKTIASLLFS
IPLVVIAMVPKLMHQPWANFAMWILATPVIFIFGRNFFIGAYKQAKHRSANMDTLVACST
GVAYIYSVFNTLFPHFWENKGLSAHVYFEASAVVISFVLLGKILEEKAKGNTSLAIKKLV
GLQPKVVTVIYEDGKQAQLPIKSIQKGMKVLVKPGEKIAVDGKVISGSSFVNESMISGEP
LAVEKIKDSNVYAGTLNEKGSFVYQAEKVGSETLLSQIIKSVKEAQGSKAPVQKVVDKIA
GIFVPIVFGIAFFTFFIWLFFGGTHGFIYGLQCLVTVLVIACPCALGLATPTAIMVGIGK
GAELGILIKDAESLEAAKNIDVVVLDKTGTITEGKPKVYDSKWFVPKDQYLVNLLYSMEK
SSDHPLANSVVKNLETDSPKFISNVHLENIVGKGIQITYENINYFVGSLALMKEKQVLIS
NDVEEWMLEQLKQIRTVIFFGSESKILSAYSISDAIKPSSSKAIACLKQMGIEVVMLTGD
NEHTAKEVSKSVGIEKYKAEVSPKDKIDYVKNLQSIQAHSGKNTVVAMIGDGINDSAALA
QSDVSIAMGNGSDVAIEVAKMTIISGDLLKVPQAIKLSQRTVKTIQQNLFWAFIYNLIGI
PIAAGILYPINGFLLNPMIAGAAMALSSLSVVGNSLLLKYRS
>EGEFANNL_00036 hypothetical protein
MHHTIAFYNVENLYDIVKDKNKLDDDYTYYGKKSWTLNRYKHKLIKIAKTISLIGEEETS
RLPTFFGLCEIENKKVIEELLKEFPFRANYGYVHTDSLDERGIDTAFFYNKEFFTLEKYD
FIRIPVYNNQGVRDYTRDITYAQGKFVGKDIHFFVLHLPSKRENDSNKPKRIVLLHKLRE
RIDEIFNNECDAQIIIMGDLNENPTAEYLTKELHCKKYESDLNSTDFYNPYENLYSERKY
STYHHKKGLLFDQILLSASFFKKESQLIYKKAEIFNKSYLQNKERGKLGTPWRTYTGSRY
LGGYSDHYPVYVVIETANQG
>EGEFANNL_00037 hypothetical protein
MNTKTKFTIDRLVEFMDFKCLNDNQITKIAGLSIGLIGRARKNKSGLHTDTIEKILITFP
ELNPTWLLTGKGKMLIMDNQSVDDNNKYSETSNSEESKDKDFLFEVFSAQKEIIHSLKKK
FFKTEESLKK
>EGEFANNL_00038 hypothetical protein
MIKQDLLDNIIDVFQKDVHFEYIDFKINIIQDTLNITSLINPEHYIMFQDKNHFKEEKDE
YEIYGECVPGRYSSYDSFTLNKKTDVYEKIKIWLESLWNEISLKSPLKIIEEEQEEINKI
CEKFNDYENDYFTTEEILKAKEELNKLRRILGIEIMNIVDEEQEQKKEFEMLYSHFDSLE
KMLPSLRRKGWARSLTGRVFHNVKRVLEQRQKKILENANLNFEL
>EGEFANNL_00039 Trigger factor
MNVTQNKIDNLNTVVSITIKPEDYKPKVEKALKDYQKKLNMPGFRKGKAPMGIIKKQYEG
AVTFEEINKVLNDSLSNFISENKLNILGQPLPKTNDNLDVNANELTFDFELGLAPEFSVD
LSKAKIDYYKIEASEKEINETIEKMQTQLGQIIDVDQIENGGHFSAQVEEIDENNQSIEE
GIKTNITFIVDDLKNKDLFIGKKSGEIVEINAQDIFNDPHQLQHFLGLSHEQAHDFNGKL
KITIEKPSKRTKAEVNQELFDKVYGKDKVSSEQELRDKIKEELEGYYKRESDNKFMNDSV
EWLFENINFDLPEEFLKKYIKNSSKEPLNDDEVNSEYEKSEKSLRYQLIEGQILSDNKIS
IQYNDLVEFTRDQMKQQFAMYGYNDIPEAELNKYVANAMKNEEQVRQASNNLIQQNLFNI
FDKQIGKVEKIVPLEEFNSMIKEENAKSKN
>EGEFANNL_00040 Methionine--tRNA ligase
MSRYTITTALPYANGPLHIGHLAGVYIPADVYARFLRRKGHDVILIGGSDEHGIPITIRA
KKEGITPQDVVDRYHELMKKTFYDLGISYDNYSRTTSDIHRETAQEFFTKLYKDNKFIAK
DIEQYYDEKSREFLADRYIVGTCPKCGNTNAYGDQCEKCGSTLSPEELIEPHSMLSGEKP
VLKKTKHWYLPLENYQEFLTHWILQNHKSDWKPNVYGQVKSWLDDGLKARAMTRDLDWGI
PVPLKDEDGKVLYVWFEAPIGYISSTKEWAKNNEKDWEPYWKDKDTKLVHFIAKDNIVFH
CIIFPAILEAHGEYILPDNVPANEFLNLENDKISTSRNWAVWAHEYLQDFPNKQDTLRYV
LLSNAPETKDNNFTWKDFQTKNNSELVGIFGNFINRVSVLMQKYYEGIIPEVTISNNFPE
IKEISQIAKEITSYLEKYEFRNGLNSLMKIARLGNKFFQDQEPWKQIKENPEKAKESLYI
SAQIAAYLAQLSEPFIPFTSKKIMDGLNLNYVSWNDLEEGKILLPSGHKINTIDLLFSPI
EDDEIKAQIEKLENSKKINQMTNKNSEPSKEIISFEDFEKIDLRVGTILEAKKVEKADKL
LQFKVDTGVDIRTIVSGIAESFTPDELIGKQVTVLLNLATRKIRGIESQGMLLLAKDEEG
KHVFLTPDKFLSNGLSIK
>EGEFANNL_00041 hypothetical protein
MKILNKKISLTPTKLLSSLIIQYFIYQILMMGINPTGGNWYFTILLKIKYSFNTFFGNFK
LSIGDCFYILLGILFIYSLFKIIIFLSKKEKSKAIKHSIFILFTINFLYGWFMLSFGLLY
SQKPFTNYQQNKGHNYLDDYKIVANHLLNECIELREKLPSTKSGELYIGNDIIKELYQEQ
SAVYGIPLQKSNVKNSLFSLWLTKIGVLGYYNPFTGEAQTINGLPPTSYLFTIAHEMGHQ
AGIAREDDANFYAFYMGESSSIQSFQYSVKYKALQYILREIYVDDSTFVHRIINNYSTLM
KKDREIEIKYYSLISDLGSDAFSVLNNAYLRSNSQNEGIVAYNQVSNMIVNFYKGQYPSL
FTNEALIKGK
>EGEFANNL_00042 Lipoprotein-releasing system transmembrane protein LolE
MNFTWFISKKIAFSKSNKKNLSQIIIRIGQTAVAIGIIVSVITLAIGIGSKKAIKQKMAD
FNGHITIKSYDSNNSYNSSKLNKENVEIDKIKSNPYVSEVYQYATKSGVIRTEKNFAGVI
LKGVSNDFDRNRFKEFIIRGEIPKYSEDSVNNEVLLPEKIAKEMQLDVDSSFVMFFVREN
DSPIYRRFKVKGIYRTDIKQIDDVFVIGDIKHIQKLNGWSPNEIGGYDIFIDDIEMLNEV
FPSIEEAVGFNNYAEKATTTFSQINDWIQIFDTNIFIILTIMMVVVIINLIMVLIILIIE
RTNSIGMLKTLGASNNQIRKIFINYTLIIMVPGLVIGNIIAIILLYIQKIFKIIKLNPDN
YYVSSVPVYINFWHIGIISVLAIVISGIVLLFPSYLISKISPIKALKFQ
>EGEFANNL_00043 O-acetyltransferase OatA
MKKLIIDMNESKRIFGLDILRTIAIIFVLLGHSSTFLPKKVAHYSNKILYDGVGIFFVLS
GFLIGGILMQLLENYKINVKLLLYFWKKRWYRTLPNYYFVLIILILSDSLYNKNFNFMYY
LKYFFFCQNIFSINLTFFGDSWSLAIEEWFYLITPIIIYILIAIFNIKPKSAILLSAIFV
ISFFTLYRIIYTLNLDTLNYENIINVRYTIFGRSDSIMFGILGAYLLYYKTYFWNNYKNI
FLFLGIFLSAFYYLFPISNNFYSLTLSFTITSLSVLFMLPFFYNIKRGRGIFYRMITFIS
LISYSLYLVNMQISKFIRFIVDNKADNFIEFYHINISNNYAWSILFAICFISFWVLTFLI
SIVLYKYIEVPFMRYRDKYIKFNLAKI
>EGEFANNL_00044 ATP-dependent DNA helicase PcrA
MKDLFKDLNEIQKQAVSTTEGPLMIIAGAGSGKTRVLTYRIAHLIEKGIDSFNILALTFT
NKAAREMKERISSLIGGTEAKNLWMGTFHSVFARILRAEAHKLGFPSNFTIYDSQDSVNV
IKKLISEMQLDSDIYKPKQVLGRISSYKNNLITVRAYFNNPELIEADQAAMKPKIGEIYK
AYVERCFKSGAMDFDDLLLRTNELLTRFPEVLAKYQDRFRYIMVDEYQDTNHSQYLIVKA
LASRFENICVVGDDAQSIYAFRGANIRNILDFQKDYSDAKIIPLEQNYRSTQIIVEAANE
VIAKNRDQLEKNVWTQNNEGDKIPLYRALSDADEANYVAAEIFNLKLTQQKRNKDFAILY
RTNAQSRAIEEALRKKNIAYQVYGGLSFYQRKEIKDLLAYLRVLVNPRDQEALLRIINYP
ARGIGNTTLNKLIVGADQQDQSINEILENIELLGQAIGLNKPTIEKLANFWTMIKSFQVL
LKTEDVYEVAMKVAITSGILKTLKEDDTPEGISRVENVQELMNSLQGFVDEQRQLEDGDP
SLNYFLENIALASDLDNGNEEDDKVSLMTIHLAKGLEFPVVFIVGLEENLFPSQMSLNTR
QELEEERRLFYVALTRAEKKAYFTYATTRFRWGKIVDGEPSRFLEEINNKHLEILNIEFK
GSTKNRSGLDSDLFDGDFSPRYPKGPNPKYQNKQEPPRSPQNLKPISNAKLTHPVGGSLS
DLKLGDHVLHDRFGKGIVKSIEGDPENAKALIDFENEGEKKLLLKFAKLKILN
>EGEFANNL_00045 NADP-dependent malic enzyme
MPKDSKLKEEALLYHSSKPEGKIEVIPTKPHSTQKDLALAYSPGVAEPCLAINKNPIDSY
KYTGKGNLVAVISNGTAVLGLGNIGPDASKPVMEGKGLLFKIFAGINVFDIEVDEKDPEK
FIQVVKAIAPTFGGINLEDIKAPEAFEIERRLKAELRIPVMHDDQHGTAIISAAALLNAL
EISGKKISEVKIVVSGAGAAAISCTRLYKALGASAENILMCDSKGVIYKGRTDLNEEKLE
FAVETSDRTLEDAMKGSDVFMGLSKGNIVSPEMLLSMNGHPIVFAMANPDPEIDYNLAIE
TRNDVIMATGRSDYPNQVNNVLGFPYIFRGALDVHATDINQEMQLAAVRALAELAKEPVP
EDVKQAYNIQDLKFGKDYIIPKPFDKRLITKVSMAVAKAAIESGVSRKAISDWKAYEKEL
EERLNITPKNS
>EGEFANNL_00046 Holliday junction ATP-dependent DNA helicase RuvA
MITHLSGNVYELSPSSVVIDCNGVGYFATISLQTYTALQNQSKVHLYIQEIVREDAYLLY
GFSTKAERELFNLLISVNGLGPASAIMMLSSMSSSEIASAISNGNNLALQKIKGIGAKTA
QRIILDLRDKIIHLDYSDSLEKVSGNKTKIEALNALEVLGISKKISEKLMDKILDSNPDI
DLEDLIKQTLKNL
>EGEFANNL_00047 hypothetical protein
MKKIHYCLFFFIFLSLGINFLWSQENNDKSISDQDQSLKLEDPINYEAYYDYKTGGYILY
PKVGGVVVGTPITMTSDEYTQYVIQKKLDDYYKDRTRQQDEIGRAQKENRKSENKSFIPQ
LTVRSKLFEKIFGGNKIELRPSGYASFDLGILYQKIENPQLLPQNRQNFTIDIKQRIQLS
LQGSVGNNVHLGVNYDTQAGFDFENRINLAWKPGGINGGEDNIVRNIEFGNVSMPLSTSL
ITGAQSLFGVKGEFQFGNTSLTTVFSEQQSEARNITVQGGGIINTFNIKVLDYEENQHYF
LTHYFRNQYDKSLENYPVIGSTIDITRMEVWRIDLGNSNLQEQHPILALRDLGESNSLME
MPDNSNQGVYTSITALGNSIRDVSTVYNAVNGVALPDYQGNLVNYASGENFVTNRRVKKL
AESEFTYDKQLGYISLNQKLNNDQLLAVAFQYTDSRTPGKIYKVGEFSTEQSGVLVVKLL
KPNQVVSTQSPMWDLMMKNIYSLEANQITPEDFRLNVHFKDPSQGKINYIPDPKVQNQTL
IHLLNWDRLNQNNDLTPNGIGDGIFDYVEGITINSEKGKLIFTKIEPFGNYLQSKSVASQ
YVFKELYSNLKNSAVVTANPLANRYTIEGQFKGTIGSGISLGAFNVPRGSVTVTANGQTL
AEGADYVVDYQMGTVTIINETYKNSGVPINISLENQYAFNLQKKRFMGLNVEHKFSEELL
VGATYLNYKERPLTSKVQYGSEPVNNSMVGLNLMFNKEMPFLTKLANLFPGVKTEAKSNL
SLKVEGAALLPGENSTIGDQSYIDDFETTSSKISLKDPAYWGIASKPELYGEFSPALMND
IRNGDGRALTSWYNIDPRFYGVGGGQPKGINTDALSLHLQRRVSYREIFTNRDYIAGNET
YLNTFDISFYPQQRGPYNYNPSELGAFTNYETRWGGLMRPITVTNFIESNIEYLEFWMMD
PYADSKFPESNPLGDHPELLIHLGNVSEDVLKDGYMFYENGIVEDESQLTYSKLGRQPKN
YPLLYTFDTEGEARRRQDVGYDGLMSSEEAAFYESIGVDIGDYANYINPITNLLDPAADD
FVFYLDSNWDSAADGKSIIERYRYYRNLENNSPSNSVDAATAIPDSEDLNRDFNLDETED
YNQYKLSLTNSDLRDPNNKYIADKKVWESTLPNGKKGVNTWYLVRIPVSDFGSTGREEIL
NNVRYIRMMMKGFTNTATLRFATLDLVRSDWRLYDRDISDLSGASGEANQEGTISAAPID
NVIISSVNLEENSTARPPYVMPPGVNREVLGSITGTQMQNEASLKLQVKNLQESEPRGIY
KNVSLDMRRYKMLKMYVHAEDMLNTSSNIYDKDTKFFIRLGSDLSDNYYEYEISLKYTPA
SSSANPLEIWPIENTIELALSDLVAAKSEKDKLYPYNSNIRYRSTITGEDNKIIYVKGRP
SVGQISSIMMGVRSTSGGSKNVILWLNELRLTDIDNEGGYAANASLMFNLADFAQVSATG
TYQSVGFGALDSKPSERSQDETKQYMVNASVNVDKMLPEKWGLKIPVSVSIAETYIEPKY
NPLDNDVELKNDPRKNELKKIVGTYSTQRNVSVTNLRKEKVNRSKSKFYDIENFALSFSY
SVDYRRDIYTSYYINKDLQASLNYNFTPKGKYYQPFKKLAIVQDTSRFAKYLKLLKETNF
NPIPVRVSFRTDIARTYNEFQYRDINAYLNGSSNNYQPSFANNFLFGWQYNIGFNLTKSL
KIDYSSATRTILDEMGGGMPDQNMIWNNILNSGRPINYNQKLQVNYKVPIHLLPYMDFTS
LEVGYTGQYDWQTGSTAYLEYDLNNADPRKRSLGNTAQNAQTINIMGSVDFNKFYNYFPA
YKSFEERKRKRQSEIDSLNNVYTTNFSLKKPKPFRSYKLKNKYKPTDYLWMIAGGFKRGQ
VQVNENRGTILPGLLSSPNFFGVGSYAGSTNGPTFGFLFGSQFDLRNKAVTEGWVSLNEY
MTNPYVRTENSQITANLQLEPINRLQIDLNIMRNHQKTLSQSGYNLVDPITGQRLNTYES
QSAMFSSTIISISTAFKSSDYVYNKMIENSKIISGRVAASQGRPMIDSNNDGYIDGYGLS
NSAVLMPSFVSAFTGKNPNQQGLGYKRGGIPVPNWALSYGGLKNIPFINYWFQEFRINHS
YISNYTINGVQTNPDYYANQSVSAGTNISNLYNYYNYGTVVMSEGFSPLIGFDVTMRNNI
QIRLSYNKDRIFSLGLTNYTLQEDYGNEVVFGLGYIVKNLKLNMRYRGNTKSIVGDLNIR
GDISLRDNKTVVRRILDEDSQITGGQNLVSIKFSTDYNFTKNFNLKFFYEQMITKYKIST
AYPLSTIRAGLSATFTFGN
>EGEFANNL_00048 Glycine cleavage system H protein
MNNLKDLWFTDQHQWIRIDDNIAYIGITDYAQKQLGDIVYVDIDTVGKVLNPGDVYGTVE
AVKTVSDLFMPIEGKILEINNEIENSPELINSDSYGKAWIIKVELTKLSSTEGLLNAEEY
KSLVA
>EGEFANNL_00049 hypothetical protein
MLKNIRVWLHRNQTFLRIVLYSYFLLLTWLLLRGNSQIDNISIKIISTFYNDKVIHTIVF
FILFILGRFAYPHKKPIIFLVLFSLYGILIEILQEFMNLGRTFEYLDMLADFIGCLFGLL
IARLIIGFR
>EGEFANNL_00050 hypothetical protein
MNIFISNLNYRLTSDDLHDLFSEYGDVQSAKIINDRETGRSRGFGFVEMSDDEANTAIEE
LNQREIDGKVINVAEARPKDDRPRNNFRRNY
>EGEFANNL_00051 Bifunctional purine biosynthesis protein PurH
MKRALISVSDKTNLIEFSLFLVSNNYEIISTGGTFNYLKNNNIQVTDINKVTNFPEMLDG
RVKTLHPNIHGGLLALRDNDEHLKTIQEHNIKPIDLVVVNLYPFFDKLNTGLAENEMIEF
IDIGGPSMLRSAAKNFKFVTVISEINDYKLVEEEISSNGETSLKTRKLLAGKVFNLTSAY
DAAISNYILEDSYPEYLNLSYKKIHDLRYGENPHQKAALYVDMTKEGSMKNLEQIQGKEL
SFNNFRDMDMAYKVVKEFSEIACCAVKHSTPCGVALADSVKNAYQKAYDCDPVSIFGGIV
AFNREVDAETAEVILPLFLEIVIAPSFTEDALKIFSNKKNLRIIKVNHPLVDEVEYIKVD
GGLLVQDTDRENATNFENVTNASPSDEQMEDLIFAQKIAKHAKSNAIVVAANKQAVGIGA
GQTNRIWAAEQAIQRAIEKNKENLVLASDAFFPFKDVVDVAAKNGIKAIIQPGGSIRDKE
SIEACNEYNIPMIFTGLRHFKH
>EGEFANNL_00052 hypothetical protein
MRKILNVFLFILFLLIIAGCILPYFLPKNIEISASKKLINPISEVFLEFNDLENFGSWGL
LTEQDSINTRINYFSPYKGKGASLTWKNKKNYEIGNGEFKILESIINKKIKAQIIFVNYG
ILCSEDIYFKSLKEGTYIKVSLKTQDFSYFKRIFAYLNAENLQEILDESLNRLELKLNKK
NIPQQLKLGESDFIDKKNVQLLAVKNETTTDSEEISKNLHKSFHTVNQYMVDSLNYSLLD
IKNPIVYYTNFDTINKSATYYAGYPVNNLDIIPNDNIKFISIPSGKAIFTPIKTTNLNLL
NSKYTLDSYAKENGIKLKNQFWQEFNDFPISNDDEIRGNAFYLIIE
>EGEFANNL_00053 hypothetical protein
MKKIILSTFFIFGAIALSNAQQLKIVNYNNNIVEYGNVEKGSEGKRILKIENTGDKPLII
SNIKTSCGCTVPSWTTTPIAPGKKGEIVVTYNTSIVGNFNKTMVISSNDVENPVLNVTVQ
GKVN
>EGEFANNL_00054 hypothetical protein
MKKLVYIFLLCNFSFLIAQSISLDKDVIDYGDVRLNSDGHKSFTITNKGNKPLIISNVKS
SCDCSIVSWTKTPILPGKTGQVNISYNTKIKGKFLKSIEIYSNGLDSPRKVVKIKGNVL
>EGEFANNL_00055 Endonuclease MutS2
MQIARDTLKELEYYKILEEIAVYCYSDYGKEKVINLHPLKKEKIKDALNCVNEYLSSFMN
ENFIPFNGFECIDTELKMLQIDNFTLEAKSFLKIRDLSKLINSLIVHFEKFKEYFPTLHK
QISHIEYNKNIISLINNVFNRFGEIKNEASSSLKIIREQLQITRRNIQQNFDKSLSYYAQ
SGYLDEIKESVIDDQRVLAVKSNLKKSVKGRVLGFSKTGSICFILPESVTNLNIKLIELS
NQEKNEILKILADLTREIYEFYPLLFNYQKYIYELDVVQAKARYAESIHGILPHISNDQE
IQIIEAYHPILLLNNVKEKKQTIPQTLSINKDTRIICISGPNAGGKSITLKTVGLIQLMI
QSGILVPVHPNSKVGFFNKILTDIGDNQSIENQLSTYSSRLKKMHTIIKQVDNSTLLLID
EFGTGSDPELGGALAEAFLEYFYEKKSYGIITTHYTNIKLRVEELKHTQNASMLFNEKTL
KPIYKLEIGQVGSSFTFEVAEKNNIPSEIIQLARKKIETNKIDLDKTIVRLQQEKYNIER
LKGSLNKQIDHSSEKNKQLSDTINFYKQKLINFQKLYEDESRLNFLGEKIQKFIDAYANG
KSKRDIFKDFSKLLEQEKFKNSQITEVDKIITKRHRNKVKLELKKEDIKEQLQTAKIQEI
KTTVDRVKQWMKENRKVKIKGSTSAATIDKIEGEMAFLNYGLFTTKISIYELEKV
>EGEFANNL_00057 hypothetical protein
MPVVDFIIPDYFTRIVTWKVSETNEDLLRILKLSKDRLSTYNLLTPKRKREYLGLRACLM
ALGLDNNVKYTDKGKPYVEGTYNISISHSHGMVCVGASSFQIGVDIELERNKKIENIKEK
FVREDEFSFIPKDNQKDYLHIIWGLKEALYKIHQGNLWSFLNHYRVEPFKLNMDKNIICW
ITDNISSSKYFANYKKINNYYMAYVLNYGFGSSK
>EGEFANNL_00058 hypothetical protein
MKNKILIIQNKFIGDVLVSSVLAKNIKLENKEAEIHFFCYDKAKGILENNPYIDKVITFN
NEELKKISVLLAYSKLIRNQKYDILIDPYAKLQSRIMTLFSTAKIKISYDKPFFKYLYTK
THREESLPKVIQCTSIENRCLLLSSILKRPFRNLDFQTEIFLTQEEKDISKKIMYENGVD
FKKPVLIIGVLGSSLKKSWPLNYMAELINSILSSYDVNLLFNYIPEQFKEVENLLDKIVE
KEKIFTSILGNNIREFAAILSNCDALIANEGGSVNIAKALNIPTYSIFSPHKFRKDWGCY
ENLAIHQSFHLTDLFPEIYKLYSIKEILNNPEPFYKLMYTNKVIPKIHEFITETLKIEQK
SNLELILNSSNKISAVCITYNEENNVNKFLKDIDFADEIIVVDSYSTDSTKELVEKSNKV
KFLQRKFDNFTNQKNYAIDQVSNEWVIFFDLDERIPMDLKMEILMTINDPHAKDAYWVYR
NFYFKNKHIKNSGWKNDKVIRLFKKNKCKYKVSKLVHEEMIYNSEPGFLKNKIDHYSLAS
VKSYEDKLDHYSQLKAKELFEKGKKANFFHRYIKPLYRFFHHYIIQYGILDGKEGFIISK
IYARYVYNRYKYLDKFWDEKKSF
>EGEFANNL_00059 Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha
MEYLDFELPIKDLEEQLSKCIALGKESGINIDSAYKEIEEKIIKTKHNIYDKLTPWQTVQ
LSRHPSRPYSLDYCMSITDNTFIELHGDRNYADDKAMIGGIGKIDGKSFMIIGQQKGKNT
KERQFRRFGMPNPDGYRKALRLMKMAEKFNIPILTLIDTPGAYPGLEAEERGQGEAIANN
IRQMCSIEVPIISVVIGEGASGGALGIGVGNKVYMMEYSWYSVISPESCSSILFRSWEYK
EVAAESLKLTPKHSYELGIIDGIIKEPLGGAHYQPQEAFNSLKSKILDAYNELEKLSPEE
LVEHRQNKFINIGDYNG
>EGEFANNL_00060 Ribosome maturation factor RimM
MLLKDCYYVGTITKTHGLKGHLVAKLDTDEPEVYENLESVFININGMPIPFFLVECQLLN
KNSLRIKFENTSLNSQELIGKDIYLPLEFLPQLSGKQFYYHEVINFNILDQNNISVGKII
EINDQSPQSLFSIELLNSKNIYIPIINDWIIEVNRKEQYIKMNLPEGILDI
>EGEFANNL_00061 30S ribosomal protein S16
MAVKIRLQRHGKKGKPVYHIVVADSRSKRDGKNIEKLGIYVPTTNPATIELNLDKAVDWL
EKGAQPSDTAKSILSFKGALLKKHLNGGVKKGAFSAEDAEKKFQDWLEHKEKSILTKKEK
LVSSKEQAKKEKFEAEKKINEARIAAQQKALEEENQEIANDAEAPVTEENTSADTEENKN
EETNA
>EGEFANNL_00062 Thiamine-monophosphate kinase
MFDNKNLFKTPISEYGEFGLIEHLTKNLSLFNSSTLKSIGDDACVLDSKNKEVLVSSDTL
VENIHFNLTYTPLKHLGYKAVVVGISDIIAMNAIPEQILISIAISNRFPVEALDEIYAGI
STACNFYKIDLVGGDTTSSNLGLVINITAIGYAKKEDIVYRNGAKPNDLLVVTGDLGGAY
FGLQVLERENVAFKANPNLQPDLNDYTYLLERQLKPEARVEIKNLLEEMQVHPTSMIDIS
DGLASEILHLSQKSNVGFSIYEDKIPMDNQVISTASEFGINPVTGVLNGGEDYEILFTIP
VSEHDKIKHNPNFSIIGHATQNNKNFLVTKGQNEIIPLRAQGWEAYLKN
>EGEFANNL_00063 hypothetical protein
MIKKNINLFLFFLIFSLFTHCTNGDKTISCFPNTSINVALDLGLPSNQNLASINGYVYVP
AGPLSGTRGLIVINTSQGFVAYDRNAPHICPSESSTLEVVDDFYILCPDDGAQWLFNGQP
IGDKAAGRPPKSYPAQLIGNMVYINYN
>EGEFANNL_00064 Transcription elongation factor GreA
MSYVTKEGLGKLRKELEQLEQIERPKITQQIAEARDKGDLSENAEYDAAKEAQGMLEMRI
AKLKDIISNSKVIDQSQLDTSKVAILCSVKIKNKANGQELKYTLVPDTETDLKANKISVH
TPIAKGLLGKEVGETAQITLPNGNQIDFEILEISLE
>EGEFANNL_00065 putative HIT-like protein
MSSIFSKIIIGEIPCYKIAEDDKFIAILDAFPVVQGHVLVIPKKETDQLFKLPREEYNEL
MSYTYNIAQAVKKAIPCERVGMVVQGLEIPHVHVHLIPLNEPSDLQFEKKLKLTVNEFET
IANKIKSYL
>EGEFANNL_00066 ATP-dependent Clp protease proteolytic subunit
MNLGKEFQKYAVKDRGISSLTMDQYFNSMTPYITEERKLNVAQMDVFSRLMMDRIIFLGT
AIDDHIANIVTAQLLFLESADSSKDIQIYVNSPGGGVYAGLGIYDTMQIIKPDVATICTG
MAASMGAVLLTAGAPGKRSALKHSRIMIHQPLGGAQGQASDMEITLKEILKLKNELYEIL
ASHSGQSFEKIEKDSDRDYWMISSEAKEYGLIDEVLEKR
>EGEFANNL_00067 hypothetical protein
MLKKILFVSVLLQTLVMIAQVKISGVVINQDIQRPISGVRISFSNHPQAEILTNTDGTFH
LESNTTNDSLVIIALGYKKKIIPLHSQEDSNIIVKFSSNDLEKDSPVHPLVQEYVKVTGT
LKDLENQEPITNARIFFKDSHVQTYSDSNGFFEIINRKFSDSIFIDANKYPIKSVPLSKG
DNLNLEINFSNSNSNPNSEYIVSNETNLKEKIDHDSLIIHTDSISYYKANGHLYNMDKNE
PIADATIFFEGTQNFTNSDENGYFEIQDDSNVNRLAIYTNDFDVKYVTLDKGNNSNLIVE
FSNKIEEKEKREVIKSDKLEGVVVKGFPPKRIPKKENPAYRIMQEVWKRKKTNGLKNFNN
YQYNEYEKIEFDLNNIDSAFISKKIFKKLDITVQDIDTSAFLGKTYLPVFLNESITQVVG
ENKPSKREKSFLRGNRSVGVPSDNDIIANTVKNLYKDVNIYDNVLNFFNKGFTSPVATIG
FSVYDYMLVDTVMVDSVKCYYLKYKPRRANELTFKGDLYITYDTYAVKHATLQAASGINV
NFVKDIYMELDYKNVNDSVFLPLKYYTNLDMSLITKKDKSKGMFAKRTLIYDNYLFDEPS
SKIDTLLDEQWEPISGGAYKQNDQFWEEHRLEKLTDDDLKANEVITKVSKTKLYRDITNL
VQILSSGYVNVGKAIDIGNLYQFIGYNDVEGLRLRLGARTYFTPNDMWRLEGYTAYGFKD
EQVKYGAEGRLMFNKFNRFTIGLGTKRDISQLGVSLTEGESIMSRSFASSSIISRGSNEF
LSSVNKTNAFVSIEPWKNVQLRLDGTYQFIKSANPEKFDIGYYDKFGNIKQDLYDTHLTF
SVEARPGAKYSRYGLDRFEHTTLAPTFILKYVRGIKGAFNSGFNYDKVQFMYSQPILWGP
IGRTDITTEFGKTFNKLPVSLLGVIPGNQSYGIIPNTFALLNYYDFVTDVYATMHLEHHF
NGRIFSYIPLLKKLQLREVLIFRGAWGDISDGSKSMNASNIEYVAPNKDIYYEYGFGIEN
IGFGNLRIFRVDFNWRGNYLDIKKVNKFGIKFGMQYSF
>EGEFANNL_00068 Diadenosine hexaphosphate hydrolase
MYKISVNEKFLSLGKKKVKGAINLPYSPTSFQTSFELLYNSKEVRYVNIFSKNKKKTWAK
FQEFALPIYAAGGIVHNQLNEFLFIKRNGIWDLPKGHVEKGESFEETALREVEEECGIKN
LELKNYLKTTYHVYYSKDQYYLKVVQWFSLFYLENKSPKPQIEEGIEMVKFASKKEVSTF
MKNTYRTIYGLCNKYILK
>EGEFANNL_00069 hypothetical protein
MNIKGDKIVVHKSAEEVYKQAENPSEFKSFMPENTEKFEVTEDGFVFALKGMPEIALKFK
EKEPFSKIILTSAKETLNFDLSLRIENINEQSCHVQFSFDGKFNMFISAMVEKPLKNLIK
SLTEGISEN
>EGEFANNL_00070 Thermophilic serine proteinase
MKKILLSLGIIFTITSASLTGQVVSQPVDSTYLKNWYHQSYEKTSVFGVGTNEALDFLKS
KGLKPSPIIVGVIDSGVQIDHPDLKNNIWVNIKEIEKNGKDDDGNGYIDDVYGWSFIGNK
NGKDVDHDTTESTRIVVKYEKLFETGDPKTNESNRKKYSKEFKEYQRAKAKYDEDYAEAQ
QNLNQINSQKAMIGQMTYALQEALGDKPLTVANVKAATFPNDQIKQAFLHMSEDEEISGK
NADEIKKMFDEQIKDAVDYYSNKLNYMLNKEYDPRGIVGDNYEDVTEKFYGNNQVEGPDA
LHGTHVSGIIAAERNNHIGMDGIAGDVAKILVVRAVPDGDERDKDVANAIIYAVDNGAKI
INMSFGKPFSPNKEVVWKAMKYAEKKGVLLVHAAGNDNMNVDTEYNFPTNFKDNEHKSFV
NNWITVGASTKDSLKLKASFSNYGKERVDIFAPGSEIYSTVTGSKYKFLQGTSMASPVVA
GCAALLWSYFPGLTAEQVKEILLKTANVSTVATTAGGESDNSPKITVPFNELSMSGGVVD
VYKAVKYAYEHYPSKETKKSSKK
>EGEFANNL_00071 hypothetical protein
MVLLPCFYFAPISYYNVWGLHKDKAIERWENFPKQTYRNRCIIQGANGKLPLIIPIEHSG
ARIIKDIKISYSSAWQKIHWKSLQSSYQSSPYFEYYEDSLSKIFEKKETFLFDLNLSTLE
WACKILDLDNNFIYTQEYIQKSEITDFRMSFNAKKNDEYKNPYYIQVFSDRFEFMNNLSI
LDLVFNVGPKSANYIKTF
>EGEFANNL_00072 hypothetical protein
MINLRTALITKLTLQSVGNKLREEKNVYAGDLFHLSEKEEEELQPFFITPFKNQSEYYQF
THYTQDINFNVLYTLCKDIFDEDKDFVEFSDKVLDHLLERSNHPQIKKGEVFIALLEGID
VGQESKVKGIGIFKLENKNKFLRFRESDIVEMAIQKGYRLKSSLDKGCVILNVQKESGYL
VLTHDDAQVESEYWKKSFLDVDYIKDDAYQTKNYIHLLSDFSQQYILEEKGKKVQTEFIG
NCLQVFNENETISQELLEKELLDNYGVTEEFKNYKKEYSETSALQFSEIFDVSTVALNRE
KRKIKTDIKLDTHIQIKLDINSPESSEDFMEQGYDEEKKMFYYKVYYNSEL
>EGEFANNL_00073 Phosphate-binding protein PstS
MKKNIFLLFTALIALVACNSGGEKKGTKLSGAGATFPAPFYTLVFKDFTKKTGNEVTYGA
TGSGSGIRSLKDRTVDFGATDVYLSEEEIKEMGGNILHIPTAMGAVVLSYNLPGIDKINL
TSSIISDIYLGNIKNWNDPKIKEINPEINFPDLEITPVYRSDGSGTTFVFTDYMSKVNQQ
WKDKIGAGKSLEFPKGIAAKGNPGIAGIISKTKGAIGYIGSEYALAQNIPFAALQNSSGK
FIEANSKSISASANVDLPDDTRIMISNSSSPDAYPISTFTWIIVYQEQDYNNRGEEKARA
LKNLLNFIVSPESQEGASRLNYAPIPEKAVERVHAILNTMTYNGKPVAE
>EGEFANNL_00074 Phosphate transport system permease protein PstC
MKDRLFKVLLYLSSIIILLITTGIVYALVIQSLKAFSEIGIFKFISSDQWDPKNEQYGAL
SFISGTLLTSILALVFCVFFSFPIAVFNGEYFKGSKLSSIVSSIVDLLAGIPSIVYGLWG
FYVICPVLVSLGVNSSGFGILAASLVLSIMIIPYASSLSTEFISMVPNDLKEAAYSLGAT
RIEVITKVSLPFSGSGIFTSYILALGRALGETMAVTMLIGNTNLIPTSIGDTGNTMASII
ANQFGEASGLKLSSLIAIGLLLFLITAIINFIAKYSMRVINPVNKSKS
>EGEFANNL_00075 Phosphate transport system permease protein PstA
MITSNLTYRKIKSKIFFYIICIISFISMIPLFLILWELIKKGYKQFNFSLFTEIAPTSMD
AMLAKMSNDLIPGGILNGITGSLLILAMAILISIPVGIFTGIFLAEKKNNFYVQLIRSLT
DLLQGIPSIVIGVIVYIWVVKPMHSYSALAGSVALAIMMLPMIIRSTEESVKMLPITLKE
AALALGGSYTNVIFKVLLPSAFGGIFTGSLLAVSRVMGETAPLLVTALGASTINWNVAEP
TSAIPLLIWEFYNDPNLSDLVWSSSLLLLLVILFINVIAKSISKKWKIQ
>EGEFANNL_00076 Phosphate import ATP-binding protein PstB
MENSIEKNIKQPILEFKDLSISYTPGKNAVEKVNATINENTITAIMGPSGCGKSTLLRAI
NRMHELYPNIKISGEILLKNNNILSIDPILVRRKIGMVFQRPNPFPNMSIFENVLAGYGL
NGIKLKKSQKKEIVEENLRNVGLWEEVKDSVNKKGTFLSGGQQQRLCIARALALKPEVLL
MDEPTSALDPISTNRIEELILDLKKDYTILVVTHNMSQAARISDNSMFMYLGELVEYDST
RQMFTKPSNKRTEDYLTGVFS
>EGEFANNL_00077 Phosphate-specific transport system accessory protein PhoU 
MLPIKIKQLEILLNDFELISKTVLTQLQITQKLLTNNCIDELYMEFNENEIIIDRLEMKI
REEVVFTIFTFNPLAADLRRIIAYQDSTTNLERIGDQLLNIVNLLRKVDVSNSYFQKECK
QLLAMLDLVNQMVRDTLIAFKTEDTELAYQVIKEDKQVNQLFYNLNNNLELVLIEKKFND
NDLKSIFPLGYINQNLERIGDAATNIAEAVVYLTEGKDIRHKII
>EGEFANNL_00078 Transcriptional regulatory protein SrrA
MTDAKIHLLIVDDEIDIREILQFNLENEGYLVDLADSAEQALEKIQNSTYHLILLDVMMG
GISGYKMAEKLRKNNNDIPIIFLTAKNTENDVLTGFSIGADDFITKPFSVKEVIARVKSI
LKRTGKVDDSIINKSSIIIVKNLSIDIDRKEVCIDDQSVNLTKTEFEILLLLLKNQNKLF
SRNDILTKVWHEDEYVLERTVDVHIARLRKKIGDYGKFIINKTGYGYCFSH
>EGEFANNL_00079 Sensor histidine kinase WalK
MKLSYKHKIFFTFLIIFALYSFVLVFFQQKEEKKFKTEALENSLANYTQIIHNYVQQEHL
LKNNLEISKVNHLADLLPKDIRITLIARDGKVLYDNDVQNIQKLENHLNRPEIKQTLYLR
DRGINIRKSVSTQHEYMYYAQLFDNYFVRVALPYNIQTQKFFKTDNAFIYLTIIIFILVL
ILLNAVANRFNKSIVQLKLLVSQVKEGKHLSAQVTFQDDDLGEVGEELQEIFQQKLESEK
QLKQEQEKIIFHFQHVEEGVGIFNSDNSVIYYNSQLIQYINLLTDQPSLELKEIFKQDFF
RPVTEFLSKTDENLNHTSITIYKEDKVWLIEAIKFKDNSFEIQIKDITKAERTRLIKQEM
SNNITHELRTPVTSIRAYLETLNEQTLPLDKQQLFINKAYQQSIRLSDLVEDIGLISKLE
EAKEQFKKEPVSIYQLIQEVRINLSDRLIANKIQLNLLVDKALTLQGNYTLLFSVFQNLM
ENSINYGGENIEIIIDNYKEDESYLYFSYSDTGKGLDEKYFNRLFERFYRAQEGRTRNNG
GTGLGLSIVKNAIQLHGGEIFIKKNIPSGLTFLFTLKKS
>EGEFANNL_00080 Colicin I receptor
MKFYLSLVNFLFLTQLIHSQTYTDSLNYLKNEVDELDKVIITSKKKDIKKSESPIPTTIV
SSELFKKSGATNFFDGMGMINGIQSQVNCNVCNTGDIHINGMDGPYTLILIDGTPIVSGL
STVYGLNGIPTSMIDRVEIIKGPASAQYGAEAMGGVINIITKNPKKAPLLSTDLSGSSWG
EINTDLTLKIKAGKKVSSLLGLNYFYYDNPIDKNHDGFTDLTLQNRISVFNKWSFRRNEN
RWADFALRWINEDRWGGQMNWNKKYRGGDEVYGESIYTKRLEVLGTYQLPIKEKVYTQFS
YNWHNQNSWYGNKPFMATQQILFAQTYWNKNIHSHNLMLGATFRYTYYDDNTPATASSDG
LKNKPSHRYLPGFFVEDNWNFNDKNNLLIGYRYDNDNIHGSINSPRIAYKYKLDSKNTFR
MSLGNGFRVVNIFTEDHAALTGARDVIIKNTLKPEKSYNSNINYTTNLTTNHFNLNLDIT
GFYSYFTNKIVADLDTDPKKIIYNNLDGHAISNGISLDTDWTFTFPLKITTGITYMNVYT
REKNENGDFEQKNQLYSPKWSGNLILNYSFKNKLSIDLTGNWKGPMRLPIQPNDYRKEYS
PWQWIANIQITKGFTNGFEIYGGIKNLLNIKPKNPLMRPFDPFDKTADDPINNPFGYTFD
TAYNYASMQGIRGFLGVRYTVF
>EGEFANNL_00081 Iron-dependent repressor IdeR
MYSSIEENYLKALYLLADEKEEVSSLALSQALDIKMPTVNSMMKKFADKELIYYKNYKPF
KLTKKGKKEAALILRKHRLTEMFLVEKMGFGWEDVHEIAEQIEHIHSEKFFNKMDEILGN
PKFDPHGSPIPDLDGNMQWVNFKKLSESKEGQVVVLSAIINGSKEFLEYLNSKKLSLNLE
LEIESVDNFDGNMKIRILKTNETVILSRMVTDKLLIQ
>EGEFANNL_00082 Tyrosine-protein phosphatase
MKAILFKIGLLCLSLTAITSCSNDDQAAEKLPSSSSFKSINSLVSLNYDKATQKNILEVK
KDGNWKLSKYPDVGTNNLLLSHNKAGKYYIDNDLFNLFTFEWNGHEKNIIGLRQLPLNTV
KNVRDLGGFPTQDGKFVKWGTVFRSGAYNGLSQRDIIYLNSIPLVTTVDFRTQEEKDKTK
NSYIPSVKNRIEIPIGFGNMSTEYITQILTTGTPEQAKEFMINGNRAFLKDFQPEYKKFF
ALLMDPKNTPLMFNCTAGKDRTGFASALFLSALGVDRETIINDYLSSNKFMEVTMESMKN
LYGDTPLAENFYYVSSVQKEYIETAFSTIETEYGSVENYLRNQLDVDINLLRSLYLY
>EGEFANNL_00084 hypothetical protein
MNDVIDNIILLKQRLINLENVEFGIKGDIPDLKSEDINVITNVWEYIDDIFSPESGGTIY
KEDINNFISQNICLTIKTGDIPNYYENFNDFLSGNKIKCSNINFYIEKLNYRDGKTVPIP
TIINHYKSNLEIISLLDKIADYKKEQGNRLELFFYKSENGVSLNINYNEKDLQSLKANRI
LDLRTQLLNNIDSNERKQLFVNELISELNKNGNLYKNLLENWDSIVNNYERSFRLYLSGF
SFDKIKTSSVEYFQKLTDRIYETISKVSGYIFGIPIGYILLLNNFDFTGKSIEKNIALLF
LGVLFFILMWFVFFKNIDESISAIEKDISKFKDKIEGRDELKEILNDLKDLESKSIKKQK
NKLLLVKILTIVVLVVTIVVLAFIYKNILSTKLCDLYFWLKSVINCA
>EGEFANNL_00085 Nucleoid-associated protein YejK
MDLKNIILHQITREGDELPTLNYSDHNLLVDETVIEFVKKLIKNYSSKNPTFGTFEEDIT
NYPFQTKVKQYIQNLDFVTFSTESMNILKKEIQVPKATGGYIVFVHYEERHEDFIITAML
DKSTQFAVDDTNLGIEKLKTLDIEKVARANRINISKWNRGDSLYLSFIKGTRNVSNYFQK
FIGSTDITSAKYNVKLLDNAINMYLRKNNVTGGKKDLIKENISNYFESQYKNKEDITLSS
IASIINPEQPSLFSDFLSSQNIELSGNFSLSKRDDFNIFKKSVVKEKGYTFGFEKELIKN
GKIERVGNDILIKNVPAEQLDSAFNI
>EGEFANNL_00086 Peptidoglycan L-alanyl-D-glutamate endopeptidase CwlK
MAIFSKRSKNNLKGIHPNLVKVMNEAIKNTPIDFTITDGIRTTEQQKELYAKGRTNPGKI
VTNADGVRNKSNHQPKADGYGYAVDLYPYYNGSVQVNDDIRLRTIASHILNTAKSLGIRI
EWGGHWKFRDYPHFELK
>EGEFANNL_00087 hypothetical protein
MSEYMQILIESDESGHDYIFPISLKDQWEVLKKRIENTEEYSDDWYDAIDDFSDVFE
>EGEFANNL_00088 hypothetical protein
MKIAIKFFLSLFLVIMLFFFFSCNTRKKTVTKESIKTIHDTLIKRDSIFIEREKVIYLPS
SNSSVIPNPCNEKGKLNPINENIKTPFGNVHVSSDEKGNLKIKATTDSIQSVYEKQYHDQ
NKKQLQRITELERESRNKEYIPFYGWVLFISSVFLNIILIKRYFFNTI
>EGEFANNL_00089 hypothetical protein
MAKKADSNIEELKSKAPSQNIIEVPSSYSIVKNFFNFLNTVKGFITAISIIITFFIGIYS
FGYKMGKSENDKIYKDSIKNMNINFKFILINEKEKWKSENEDRLTIEEMKLFFKNYNNEK
K
>EGEFANNL_00090 hypothetical protein
MKKNKSAYICILLIIFNACFIIVLSILNYQAEEYNAHLENQILLKDSLITQIQKNDSIRD
AIDSSKNEILNLVFKKGKSEKNISLDEMIKYINGLNDSLDFYRTFYKFSKNDANYSVKKE
KNMMIYSYSKKGIPLNIYKYALQKYDIKILESKNKYAISAPKLDLALDFYNCHKIKNDSI
KK
>EGEFANNL_00091 Thermonuclease
MKALFIYSFFFISSLLIAQNLIGKVIKVADGDTVTIITDENEQIKIRLFGIDYPEKGQDY
SSKATAFTSSFCFGKIVKVTQKGLDRHGRVLGIILIGKKNLNEELLKNGLAWHYKYFDKT
QKYSDLEQEAKKNKFNIWSMNNPTAPWDFRKAKKEKTPYKYFDNN
>EGEFANNL_00092 hypothetical protein
MKKLWFLFACLFCFLNSYGKEEGKALKKLPTIQKAWVDAGYFEWRTERNSEPYDDWVEGE
VGLKITELGKEQEYLPDVSDGGQLTSARKMFRFATKLKKIPSFNTQNITDFSYMFEGCES
IITIPLLNTSKGVNFRYMLSDCLSLTSIPLIDTSNGKNFSLMFYVCPSLVSIPLLDTSKG
IYFNAMFWGCESLDAIPKLDTSNGVNFSGMFVYCTSLTTIPFLNTSRGTDFSSMFFGASS
LTIIPLLDTSNGIDFSYMFLECFSLNSLPKLDTSKGTNFNGMFNSCKSLTKKPQLNLSKA
IDITDMFKDTLFEEKG
>EGEFANNL_00093 Tyrosine recombinase XerC
MRKKILLPNGCSCSTPSVYPSNCKIGGKSLLKKKWYINYYFYDPEFPKPKQVVIKGMNEY
SNLEDRRNATKLIYEDELKALKELGYNPFTKRNFCEIEKPKNELHKDLNIIEAFRLSHDK
LKKSVSKDYFNEIRIAINRFEKGARELRMLNIKIKDFKRSELKTILEYLNLTDHYFNKFR
SYLSSLFNELVEYDCCEHNLTRDIRKRKIIKKVRETLEIEHLKQIAEYLKEEQPYFYRYM
MIFFYSGARSSELLRIKKCDVNIEKQEYKVIIEKGRQHTETIKIILPDALPFWIELINQA
KTNDYLFSIKLKPGSTTIDPVQITRRWNYHIKSKMVIHNNQIIEKSNLKKDEKGIPVTAD
FYSLKHLFLDKVDASSENYENISSRLASHTTPNITNSVYLINKKKREREKLKNLKIDFLE
ERA
>EGEFANNL_00094 hypothetical protein
MVFLCIKVRTMKQKNIPFQLGMEYENWEFDLEILPDRLEGYDSYLYIGKEFNYFMNYPTD
KTELIFILDRLVAVILTFLNIKVNDFKQFYDRLQIEFKNNNLSQNNEAIKTLLIADNENT
IYFLYGVSNLIYAVFPLHNKAYF
>EGEFANNL_00095 hypothetical protein
MKQISILFLLLNSFLINAQEIRQFTENFTRFSTIKDGELGIIQKGNVTIIFNYGENNNIK
IYFANGNNKTYYRVSEVEKGNTKDRIEFQYMKLLDEKGEEYYFVKYEDGEVKLLYLDSFT
YTGGYGIALLP
>EGEFANNL_00096 hypothetical protein
MKILCILSVIIFHLPLTLYKDTIRRFQRMEKYNPDKALIYNQYNGNLSEISLSVILYFLS
SLLFSLFPLIEGLEINWLIAIILNLGLAFYVIPFIGFIFYPSDMIFNKNTLKIIGSICII
LGFILFTIGMSDIAE
>EGEFANNL_00097 hypothetical protein
MEKDKILKIIGKRIKQVRESKGFSQLELVGKMLGDIDPTNISRIESGRTNPTIYTLYRIA
EALEVSLEELVSIEISN
>EGEFANNL_00098 hypothetical protein
MKASEIKVSYTNKNEKKIKLENSEQLYHLALSIWNKNTLELQEEVKVLYLNQANIVLGYY
SLAKGGISACYVDIRLILSTALKTNASAIIVVHNHPSGNNKPSLKDKELTKKIKQACSLL
ELVLLDHIIIAKEHYYSFADQGNL
>EGEFANNL_00099 hypothetical protein
MISTLTNLENFGYRELALVIELLTLYNEYKIPESFIKQEVTIMFNHCSGMLFLTNADYQV
LMVYNGNLELFHTTPYKGIEGFKEELLEMLSDKQITHPEDIDFILSLEQEEN
>EGEFANNL_00100 hypothetical protein
MVTIINYKKRQKDNQDFFILEISGGIEMIQSKTTGKFYATAKKAYLPSTFDEPTCQALIG
TQIQGKIEKVECEPYSYTIKDTEEIILLSHSYEYVPENNSAISPNQSTTQNHSSYVQREL
AENHSFQTNEELVV
>EGEFANNL_00101 hypothetical protein
MYIYTSFFIFNNVVMGEWSKSIGEKGENIVKFVFEDILNFNSLIENESINCIKGSKHKDK
KAKSNRTTHGIDGLISYQSPLEDYSLDIGIISSKYVVDEYLKYPISLFKAHLRDLAQSIE
CFNHSKLKNNINRNFAGINKTEIFGILVWLSNTSDLNFDLVSKVDNILIDSDLVFDKIIL
LDNNKINFLYESIFRNKEVFGAEKVDFVYHNSGLNFLASQNNYYGKIFPLNYLYSDIIPL
RIEDSNKIILSIFINDDYQEEQLSQILHFAKSFDHLNAVDKVTIKYRSYDSLINEKSVKE
KLIKFPNYKLNQNLELKKFPSDFRNS
>EGEFANNL_00102 hypothetical protein
MKKELLPQGDYIRQLLIKSNVSNSNINQMLREKGVFLGHNEKNNSVPLLMKSIISPRDYE
ILYNTQKTKEETIKYRTSSIKCSSDFDFTDLLEGNIDLHNLIIERHTYKPNYKIIGNPSF
YFENENTAIFEYNIERENILSDWTNNKTYHSGAITLNKISDVDIQISVQQNSTSKETLEV
NNILMNILKEKMQQKSIITSNEDIITVKFNHFNNTSRVKFFYSFLSDFNIYLEFKSITDI
DLYLDESIVSHEDVKIFLDEIDNLKLNGKGLQNHLLLRDEKYFPKLIFGSIKLKYKINYK
SIEGGAIIDLGFPDYVKNKDENSEFQFSIDLILNKQDRQSSIENKIRKKLLDLFEIKKVE
SYERLKII
>EGEFANNL_00103 hypothetical protein
MGFIHYDNHRFFKWWPFRIILFNENYNPYISQYTTSGKIFIAICIIIAIVILLLIFVLYH
FIFKVISYIFYFILKNYFKLCLYLNPQKPLKPFVIIIELLTIIFIPIFSLL
>EGEFANNL_00104 hypothetical protein
MSKSYISKDTYVVCTYQENTDPKKLIPTRNKVSVFYKKDKALLTVEDKNTNEKFICKKPM
NLWMAIAGLAVGLILASNPIGWAVAGICAVVLIAGATITIVTHDCSSPLKEGKWINYKTT
VYFNGYEAITQESMLTCKSGGVLQPMISYDVASQAAKSIAYENIKETAIITAGAIASGYL
LGKPIASTSGSGLQFFTNSMRKIFGAFGSPYTYAGIATTYAMSSVQSSIMRGNDNYANNE
IYQRINEAEKKDCSNMVTIGEETYNTLKDNASTLAPPTLEDAVVLYKTGQVVIQDEVLLA
KFRELVSMSRQQLNSETARNLWSEIQTNPNYQHVYDSMRRNSIYNQNRITPTMRDNGISH
IDDKLYNNKWSLENENSLAQKSSAIALFFVPLASGYFSENARRKLAETAIQDATNSISVI
AKD
>EGEFANNL_00105 hypothetical protein
MNKQKNTLIIIVILAGLVGIFCYYFNKEEKSHETPNFKFAELGISEVEVKKNAGEPIYEI
TNKEEIVKELFEYKYKFEEFIKTYKKSSDGEIEKKLDVLNNVLRNNPQDKNLKKVVYKII
QTDDEGYTYDYQKSIYYLDKKLIYF
>EGEFANNL_00106 hypothetical protein
MEYKIYTVYEEEKLSSIAEKFNISPEDIKSLNPNVRFFKVPFGSTYVGYGQQIKVPITKK
IKTEQENNNLLENFTQKARYRCNQNNLVTVDGKPHFSCEIKTQYLLSSLEKDSKKYFKIN
LEDYITSIEPDGIGEAFELIKQVEFLRKKIIFTQNNLGKISQIYNLKELKKNWDFFSNNE
VKNIPFFQELEKRSPDTIKNFIKNGNKEFSNNEEISNILDKNLFYHILLKANLEDELNDY
IIEQQSQIYPTVKLKIKVINTKVSEDDLSTTYRLVGTLVKENLDEAILIKYYNEMYKPLI
KYSFTEFDYIYRITYVIENKTGLMIHATASISEQIKNNYATVTKYELKKVEL
>EGEFANNL_00107 hypothetical protein
MIVLYPYFQKDNEKTIAHQKFIEITQECISKIFSCHNLEIPEIRVSHPIKGRITEAIHKN
AKDLLDHEKTIYYERMAFIIRIPSITEDIQENPLELTIGGVRAYNQENLYNRKFMEKFKF
FIGFQNLVCCNLCVNSDGYVENMRVSSYQELQNSILQVLQKYEAEKHLNQMKQLPEYSLT
EQQFAQLLGKTRLYQHLPKKEKENLQISELTFNDSQFTNIAKDYYQDESFCRDSVGDINL
WKAYNLFTQSNKSSYIDRFLERNVNALNFIKSIQKTMIDKSYHWFLS
>EGEFANNL_00108 hypothetical protein
MQLRPSERKIAKIKMALQGSAGSGKTYSSLLLAQGLTNGNFFKVAIIDTENGSADLYAHL
GNYNVLSLTPPFTPEKYIEAIEVCEKATMEVIIIDSISHAWGELLDFHSRLAGNSFTNWT
KVTPRQKAFINKILQCNAHVIATMRTKQDYVLNQKGGKYIPEKVGLKAVQRDGLDYEFTL
VFDVDIKHFAVSSKDRTGLFKGKPEFVINTYTGKRILEWCNQGSLPVKSSPYTKLSENEV
YQKIESCTSLSDLSELYKEYPEYQNNLNHVFMEKKKLLSQLTNPQNFSTNGHTQNH
>EGEFANNL_00109 hypothetical protein
MKKVNKKNQFIDYQHNTFFVLKYLIVIIINEKYLIIFALFLYEKASS
>EGEFANNL_00110 hypothetical protein
MQTKVVAHTVIQNHAGELHRINPDLTVQVNTEIPKSLTLYIPENFDMDDLVKKSPPNFKY
HRDCFIYIIHLLTDTPSRNKDEEMYYVPLYSTLLQRKVRDYRKYLDYLVANGVFYENRQY
LKGEKSRSFRFTKKYQTPVKPVIITKYTLIKSILTYINVKTSDNDNNDCCIEYNLLDYLS
YWFSTGKLTVDFKNAEKYLWDLYEKDKKNQFNIFSSEGKKINPMARFNCRYIVLLKLYKQ
QFLSTVDSTAGRFHTVLTQLKSDLRQFVSYNGQKLVAIDIVNSQPYLSCVFFNKQKFMSN
EVLQKIQSYNKSYNKKNLCNSLIDKVENAHKLKSVNQFIEIVKSGKLYEKFGELLLEKGI
LKDRDNIRIQAKKIVFSSFFSPNQSIAYNNAIVIFKEHFPDVYEIYRAIKQSRHRTLACT
LQNLEANLVLHKACKIISEQRPEIPLFTLHDAIITTEGNEEYVKEILYDILLNAVGIPPT
LKFERWEKVA
>EGEFANNL_00111 Tyrosine recombinase XerD
MNNSKLYILFVLDKINTNSKGVAPLRCRITFQSKRKIFSIGIFINPNNWNSKQQKVHPPN
EINNFINIQISLIKQKINQAFLFLQIQEKNYEVEDIYLQYIGKPIKEDKTILKLFQEHND
KMGKLIGKDYSIGTLWKFKQSFELLKGFIKFQFNKNDYPFKNLDLQFIQDYEFFLKTEKN
LALATINKTIQRFRKIIKIAISQGILDKNPFSDYKVKHIKKQVIYLNTEELSKLENYHFK
AVRLQQVADMFIFCCYTGLAYQEMSTLESKHIIKGFDGNKWIKMYRQKTQKEISIPLLPK
STNIIEKYNSDVNTYLLPRISNQKFNSYLKEIADIIGINKNLTHHIARKTFATTVLLYND
VPMEIVSELLGHSKITITQEHYAKVVQKKVSEHILKLKGKLNEK
>EGEFANNL_00113 Dihydrolipoyl dehydrogenase
MNYDIIVIGSGPGGYVTAIRASQLGFKTAVIERENLGGICLNWGCIPTKALIKSAHVFDY
IKHAEEYGLNKVEGSYEFSNIIKRSRGVADKMNKGIGFLMKKNKIDVILGNAKVKAGKKV
DVTDSEGKVSEYSASHIIIATGARSRVLPNLPQDGKKIIGYREALTLPKQPKSMIVVGSG
AIGIEFAYVYASLGTKVTVVEYLPTIVPVEDEEVSKHLEKSLKKQGIDIMTNASVEKVED
HGEGVRASIKTSQGEITLEAEIVLSAVGITANIENLGLENVGIATDKGRILVDDFYKTNV
PGYYAIGDVIPGPALAHVASAEGILCVEKIKGLKVEPIDYGNIPGCTYCSPEIASVGMTE
KKAKEAGYELKVGKFPFVASGKATANGDTDGFIKVIYDAKYGELLGCHMVGNGVTDMIAE
AVAIRRLEATAHEVLTTIHPHPTISEAFKGATEAAYGEAIDL
>EGEFANNL_00114 hypothetical protein
MNNLVVLIISVIVIVSNWKLYEKSGHKGWKAIIPIYNLYVLFHEINKRPAWWIILLLVPI
VNIAVLIIVYMDWALKFGKSKAFGVGMALLPFVFLPMLAFSDATYNDGIKNDILDSLGEI
GKQDQ
>EGEFANNL_00115 Septum formation protein Maf
MKIPYNIILASQSPRRQELLRSLNISFVCKPVLVEETYPAGLVANEITEYLAKKKSSHFG
NVKSKDLLITADTIVWNKDHPLEKPKNIEEAKNFLREISNTDHTVYTSVGFTTSEGTKIF
TDSAKIYLSELSDEEIDFYITNYRPLDKAGSYGIQDWIGLSKIYKIEGSYYTIMGLPTHI
VYEYLKSIK
>EGEFANNL_00116 Fumarate hydratase class II
MNYRIEKDTMGEVKVPEDKYWGAQTERSRNNFKIGPEGSMPVEIVHAFAILKKAAAYANE
SLGVLSSEKRDLIASVCDEILDNKLNEQFPLVIWQTGSGTQSNMNVNEVISNRAWVLKGG
KLGEKSCIHPNDDVNKSQSSNDTYPTAMHIAAYKKVVEHTLPAVKKLRDTLQLKAESFKE
VIKIGRTHLMDATPLTLGQEFSGYVAQLNYAIKAIENTLPHLSELALGGTAVGTGLNTPK
GYDVKVAEYISKFTGLPFVTATNKFEALASHDAIVETHGALKQLAVSLFKIAQDIRLMAS
GPRSGIGELFIPENEPGSSIMPGKVNPTQNEAMTMVCAQVLGNDTAITFSGTQGNYELNV
FKPVMAYNFLQSAQLLGDACLSFDAHCATGIEPNHKRIKELLDNSLMLVTALNTHIGYEK
AAIIAKTAHKNGTTLKEEAINLGFVTSDEFDKWVRPEDMVGSLK
>EGEFANNL_00117 Membrane protein insertase YidC
MQQKSNFDKNQIIGFILIGIILIGFLVYSSKQQQKTILEDQKVEKQTIASENKIEQSTVT
TKPIQLDSIEEAKVQLIPFSNEQLDIKISTQGAQLRGVRLKKWTAYDEANESHKKDLFLV
NEENTDFNISFKDKTGKIINTRDLVFTPQVGKDEATFTANLANGSYIQFIYKLYGEYSLN
FNVKTQGLSQITSGKNATLDWQQNAIALEKGRSQELIYTEYRYSLNDYKQTDYDTNGFTE
DKDKIDWISVKQQFFATILEAKNGFHNSKGEQTKDEDTSKYLKKFTFTSIVPIHQGEINE
NYTWNFLPLNYDLLKSYKADNNEISKQFSYNIPFGWMKWLCIFYLWIYQFLEKFGIPAGW
IIFLMTIVVKLVTSPIMYKQYIQGAKMRILKPELDEINEKNKNADPLKKQQATMELYRKA
GVNPLAGCLPALIQIPIFYSLFRFFPNNIAMRGKSFLWANDLTAYDSIYQWNTHIPILSS
FYGNHISLFTLLYCIALLIYTKMSTSTMQPPKQEGMPDMRFMMYLMPVMFIFWLNSYAAG
LSWYYLVSNVINILLIILIKNYFIDEKKIHAKMQENKLKPAKKKSKWQQKMQQMMEQAQQ
QQAKNKK
>EGEFANNL_00118 CTP synthase
MSDPLTPKYIFVTGGVTSSLGKGIVAASLGMLLKARGYRVTIQKLDPYINIDPGTLNPYE
HGECYVTEDGAETDLDLGHYERFLNTPTSRNNNVTTGKIYQTVIEKERKGDFLGKTVQVI
PHITNEIKRRIKILGKSGDFDIIITEIGGTVGDIESLPYIETVRQLRWELGYQNSIVVHL
TLVPYLAASGELKTKPSQHSVRQLMENGLQTNFLVCRTEHDIPKDVRSKLALFCNLNIDH
VIESKDLSTIYEVPLYLKKQNFDTLVLKELGFNEDNKEPDLTQWNDFLTKYKNPKNKLEI
ALVGKYVSLQDSYKSIVEALIHAGASNETKVNIRWIYSGDILPENISDKLKGIDGIIIAP
GFGDRAIAGKITACQYARVHKIPLLGICLGMQIAVIEFARNVLGYEDADSVEFNVQSENP
VICLMEEQKNITNKGGTMRLGAWDCKIKENSLAEKIYGNLSIKERHRHRYEFNSEYKEQF
EKNGLEAIGSNPETGLVEIIQVKDHPFYIGVQYHPEYKSTVATPHPLFLALIKAAQDYQN
YNKIKNATKKQF
>EGEFANNL_00119 hypothetical protein
MDLNCIPLEPIKKGKLPASHRYNRLPLLRSHPGGFTGAGCAGLATAKIEIFVKYPK
>EGEFANNL_00120 ATP synthase gamma chain
MATLKEIRNRITSVNSTMQITSAMMMVSSAKLKRAQNSIQKLRPYSEKMQELLTHITSSI
DEDYGSEYKDREEIKKVLLVVITSNRGLAGAFNSTVVKAVKKLIDTTYKGIQVDILTIGK
KGNDLLSKTCSINENHSELWDSLNFKNTSEISEKLIDKFIQGEYDKIDLVYNSFKNVVVQ
LLKVEQFLPLQLDKEEISAKIHSDYIFESSKKEILEKLIPNTLKIQLYKAVLDSNAAEHG
ARMSAMQSATDNAKSLKNQLVISYNKARQASITNELIEIVSGAQALES
>EGEFANNL_00121 ATP synthase subunit alpha
MANINPAEVSAILKQQLSNFDKDVSLDEVGTVLQVGDGIARIYGLSKAEQGELVRFSNGL
EGMVQNLEEDNVGVMLFGKSTGIKEGDIVKRTKTIASINVGEGMIGRVVDTLGQPIDGKG
PISGELYEMPLERKAPGVVFRQPVNEPLQTGIISIDSMIPIGRGQRELIIGDRQTGKSTV
AIDTILNQKEFYDRGEPVYCIYVAIAQKASTVAQIVKTLEDKGAMAYTVVVAANASDPAP
MQVYAPFAGASIGEFFRDTGRSALIVYDDLSKQAVAYREVSLLLKRPPGREAYPGDVFYL
HSRLLERAAKVIANDEVASKMNDLPESLKNIVKGGGSLTALPIIETQAGDVSAYIPTNVI
SITDGQIFLESDLFNSGVRPAINVGISVSRVGGAAQIKSMKKVSGTLKIDQAQYRELEAF
AKFGSDLDAATAAVIAKGERNVEILKQSVNSPMPVEEQVAIIYAGTKNLLKNVPVNKVQN
FKDNLTDILRTKYSDTLKDIKKGKIDNSVTDILDSVISEVAKMYS
>EGEFANNL_00122 ATP synthase subunit delta, sodium ion specific
MRISRLAKRYALGLWNYAISENQERVVIEELQVATENIEQNKQFQLFLKSPIIETSKKIE
ISKEIFKSFTKTFQHFIILVLKHKRENILLDIFRETLKLNDEYLGTQRVEIVSAISLEEE
TIAKILKSTPKINFEKSIVKNIVDESLLGGYILRMEDFQVDASVKTKLFNIKKKLSEKVY
>EGEFANNL_00123 ATP synthase subunit b
MDLLTPNIGLVFWTTISFIILLILLKKFAWKPILKALEDRENSIQKSLDEAKNARDEMAK
LTAQNDKILKEARLERESILKEAREVKDKIISEAKEIANSESEKIITSAKESINRERVMA
INQIKSEVADLSVAIAKEVLKKELSSTDEQKKLVDTLVNQSKLN
>EGEFANNL_00124 ATP synthase subunit c
MELSVIGAGLAVIGAGFGIGIIGAKAMEAIARQPEAQSKIQSSALILAALIEAVALFAIV
VSLIK
>EGEFANNL_00125 ATP synthase subunit a
MKRLIVFFLTMLLFVCNFSHLHAKASENSDEFNPTEVAMHHIKDSHQFDIWGNNVLFLPI
ILWTENGLVTFSSKDFHCDDSGQVVVEKKGMKFIKFHEKIYYAYTQKNANGEYISNTPNI
VNLDENHHPMNQAPWDFSVTKNVFSMWMSLLVLILIFITAGNYYKSNKYNGVPKGIASVV
EPVIVFIRDQVAIPNIGLKNYRKYMPYLLTVFFFIWLNNLMGIIPFFPFGANVTGNIAVT
FTLAIITLIITTISGNKNYWKHIFWAPGVPVPMKIFLAPIEVIGMFTKPFSLMVRLFANI
TAGHIIIISLVSLIFIFKTYMVAPASIVAVVFISMIEILVTALQAYIFTTLSALYFGNAT
EEHHEQHHENH
>EGEFANNL_00126 hypothetical protein
MSKLVINYIMMNVIIAIFIIIFSFFINSEFLKFNLVSLVIICSSSAFVFFIVYLLNHIGK
DNSFFIYLLGTIIKNAVLLGFCIKFRELVSDRILYLLFLYMIFMFIEIFYIHKLIKE
>EGEFANNL_00127 hypothetical protein
MDKLSNYDISLHSLKLGNNAINLVISQHFFDLFDFNQEFSDPNVNVNINIVKHSSFFELN
MDTIGTVILRCDISDDEYEQQIKNSIKILVKFGEEFNDENEEILVLPHGSHSLNIAQFAY
EAILLSIPMKRIHPRYLNGHEDKYTELLDKYSLPNDSISNN
>EGEFANNL_00128 50S ribosomal protein L32
MAHPKRRQSTTRRDKRRTHYKATVPQLAKCSATGELHLFHRAYWHEGKLYYRGKVVMEKA
TEEVED
>EGEFANNL_00129 Biotin carboxyl carrier protein of acetyl-CoA carboxylase
MDIKDIQNLIKFVSKSDVAEVTYKTDEFEISIKTNKDAVIYNTNMPHASHAMNIAPTNTI
NSHTTAPTTSETEISNDTSKLITIKSPMIGTFYRKPAPDKDYFVNVGDNINIGNTVCVIE
AMKLFNEIESEISGKIVKILAEDGSPVEFDQPLFLVDPS
>EGEFANNL_00130 Biotin carboxylase
MFKKILIANRGEIAMRILRSAKEMGIETVAVYSTADANSLHLRFADEAVCIGPHSSKDSY
LKQINILTAAEITNSDAIHPGYGFLSENANFSRSCQKMGIKFIGATPENIEKMGDKATAK
ETMKKAGVPTVPGSDGLIPSYEEAAKIAEEIGYPVMIKATAGGGGKGMRAIWKKEELEKN
WEAAVQEAQAAFGDGGMYMEKLIEEPRHIEIQIAGDRFGNAIHLSERDCSIQRRHQKLAE
ETPSPFLSDELRKKMGDAAIKAAKYIGYEGLGTIEFLVDKHQNFYFMEMNTRIQVEHPIT
EQVTGLDLLKLQIEIAYGKKVPSTNFYPKNHSIECRINAEDVYNQFLPSPGKITNLNIPG
GIGVRVDTNVYPHYSIPPFYDSMIAKLIVDAPTRKEAIDKMKRALDEFYIEGVKTTIPLH
RQLMEDPNFIEGNYTTKFMEDFVLDKKYEYDL
>EGEFANNL_00131 hypothetical protein
MIYKVRVILETEEDVFRDIEIKGTQTLWNLYEGIKSAFSLQGEELASFYKSDEKWSQGEE
IPLEDMSEDGDGETMSDVYVKEALAKIGDRLLFVYDFIKMWSFYVELTEIIEKKPVVNYP
LTVYRFGKMPLKAPDKKFASSTNIEDFGDVVAVDDVSIKFDADEADSYEDEEEDDTYGDL
YEDEEDEK
>EGEFANNL_00132 Multifunctional CCA protein
MNLSQALQNPIFREISKLADLKKQKTYVIGGFVRDFLLERNNPKDIDVVTEGSGIDLAEA
LSLELSPKPKVSFFKRFGTAMIKLKDYDLEFVGARKESYSPDSRKPFIEEGTLEDDQNRR
DFTINALAISLNQEDYGALIDPFDGLQDLRNKILRTPLNPDITYSDDPLRMIRAIRFATQ
LNFEIEKNSFQSIINNAHRFDIISKERIADEFNKILMSPQPSIGLKLLYEAELLQRFLPE
LTNLQGIEEIEGQKHKDNFFHTLEVVDNISKYTDHLWLRWAALLHDIGKAPTKRFDKKIG
WTFHSHEFVGSKMVVTIFKRLKLPLGEPLKYVQKLVKFSSRPISLVTDDASDSALRRLLF
DMGDELEDLFLLCNADITTKNKKKQEKFKKNFDYVERKIKEVEDKDKVRNFQPPITGNII
MDNYEIQEGKQIGIIKEKIKEAILEGIIKNDYESSFQYMKELAKNLNLKQK
>EGEFANNL_00133 Threonylcarbamoyl-AMP synthase
MEQEEIQKAVQVMQDGGIILYPTDTIWGIGCDATNEKAVEKIFKIKQRTKEKNLILLVES
ERRLQEYVEVPTLAWDLMDYSEKPLTIVYENPKKLPKSIISEDNTVGIRLTKDFFCKKLI
SKLNKPLVSTSANLSGEKSPKNFSAINHKILEDVDYIINLRHEDDCIYSGSSIIKLTPNN
KVTVIRQ
>EGEFANNL_00134 hypothetical protein
MKGKGLVKFFAIALAIICLIELLPTIYVNLLESRAEKNSKGDETKRKAEIEKLAKDTLNL
GIVKMDYQSAKEKEIKLGLDLKGGLNLLLEISEKDLLVDLADNTENTVFNKAIEIASSEA
STSNNTFTQNFFKAFQKAKQELGQPDLKLSSPEIFGTKELSGVIQHNTSDSEVEKYITSS
IESKVSNAIDIIRTRITKLKIDEPNISRVPGTGRILVELPGVTDTDRVKNLLQTSARLEF
WEVVEKSSAWNMLTYINLKAADKQLMGKLIQAPNSTAVALAKLSDTATINRIINSDKAKN
ILRYNKLLWSSEPDSNNLLELYAIKGTRNNKAPLVGAVSDAQLTFDQFNRIQIAMQMGPE
SSIEWKKLTEKNAPKPGEPSGKPIAVVLDDIVYTAPVVNSVIPNGQSVISGNYSEQKASD
LVDVLKAGNLPAKANILQSEVVGPTLGQQSITNGLISILVSYIFILIWMVFYYGKAGIYA
NIALVINLFYLIGIMASWGSVLTLPGIAGIVLSMAMAVDANIIIFERIKEELRKGKPLKQ
AFIEGQKHALAAIIDGNLTTLIVGCVLLFSTGPIKGFAVTLVIGIFCTLFTAIFITGMLI
YGAMEKGQQFSLTTKFTKNWFTNVNYKWMEKRKLAYIFSLILMVVALISIFTKGFDKGVD
YTGGRTYVIKLNKEIHPEVVSESLEKIFTVGGESSNINAKQYGGKDQLRITTKYGLGDNN
PNIDLSIREKLYTGLKEYLPKGYSKEEFINGSPYGIQSSSEVGPTVASGIVKNGIIAVSI
ALAGIFIYILVRFKNWQMSTGAVVALFHDAVIVMGAFSVLSWLKIIPFSVEIDQSFIAAI
LTIIGYSINDTVIVFDRIRENKNLNLARSMTLEELYNDAINHTLGRTINTGISTIMVTVI
IFLFGGESLQGFMFALFLGFTFGMYSSIYIASSLSYDLTRRTYDQAKAKLKESVL
>EGEFANNL_00135 Sec-independent protein translocase protein TatA
MSFGEILVILLIAVLIFGPDKIPEIARGLGQGVRAMKDATDSIKKEVMSHVDTDDSFKEI
EEEIKDTKKTIDDSIKEANKNVNDFFDDTFDGPIKRT
>EGEFANNL_00136 hypothetical protein
MDRIVYWDEKLFLYLNHLGSSSYDKFWLFLTDEYYWIPVYIILIIIIFEKFGLKKSIIIL
ITIGLMIASTDNIASLFKYWVQRPRPCRNPELDGLFRLVIENCKGNYCFFSAHAASTFAL
AFYLSKLFYAKHKYTPYLFFLWAILVSYSRIYVGVHFPLDIITGAIFGLLIGWFYNKILT
YIFTKYRLN
>EGEFANNL_00137 HTH-type transcriptional regulatory protein GabR
MLRPWKLQLDIKSQSKKAIYLQIADAIISDIRSGRLKEGTALPGTRKLAEDLKLNRNTIV
EAYNVLLSEEWLVTQDRKGTFVNSKLPILQKGNINSVSKDIGGLPKHTLNISFEGGYPDR
DIAPINELARAYRQIFNSQSRWQIMGYESELGSNEFRNEIASMLNFQRGMQVNDKNICIT
RGSQMALYLVSQCMLKKGDIVAIENPGYPLAWKTFKNAGAKLLSIEVDKQGMNVESLKRN
LENGIKVKAVFVTSHHQFPTTVSLSLERRLSLIQLSNQYSFTIIEDDYDHEFHFDYRPLL
PLSSYKELKNFVYIGTMSKIISPALRIGYLVSNHLKLISKVGELRKIIDIQGDSIMEQAV
LQLIQEGTIRRYLKKAISYYKNKRDFTEYLLNKYLKDKITFDTPNGGLAYWIIPLKNINW
KELDIHLQQRGIKIITPDHYGYNTIVNGIRLSYGTISKSQLEEGIKIFSKLI
>EGEFANNL_00138 Pyridoxal 5'-phosphate synthase subunit PdxS
MTESRLELNKNLAQMLKGGVIMDVSTPEQAKIAEACGACAVMALERIPADIRAVGGVSRM
SDPKMIKGIQNAVSIPVMAKIRIGHFVEAQILEALEIDYIDESEVLTPADDKYHVNKTKF
QVPFVCGAKNLGEALRRIQEGAAMIRSKGEPGTGDVVQAVRHLRAMNEEIRLIKGMQEDE
LFHKAKELQVSYDLVKYVHENGKLPVVNFAAGGVATPADAALMMQLGAEGVFVGSGIFKS
GDPEKRAQAIVKAVTNYNDPKVLLEISEDLGEAMVGINEAEIELLMAERGK
>EGEFANNL_00139 Pyridoxal 5'-phosphate synthase subunit PdxT
MKIGVLALQGAFLEHKQKLSEINIESFEIRNKKDLQQDMQGIILPGGESTAIGKLLKDLN
MFDSLKGLISDGLPAFGTCAGLILLAKKIEGCENSHLGLMDITAKRNAYGRQLGSFYTES
EFEGIGKIPMTFIRAPYISKVGPKTNILSVVNNKIVAAKEDNMLVTSFHPEITSSNSVHN
YFIQNFCKS
>EGEFANNL_00140 NADH-quinone oxidoreductase subunit N
MSVIVIIFLSAIVSLYLGIFKAGKYSQHIAILGLLLALATTFLGEYPFFSRYSHMLNFDQ
TAKVFTQIAIFITILIFLLGNYALKLIDHHQSEIYCLLMFVLCGGIVLFSYQNLITLFLG
IEILSIPLYVLAGSNKHDLRSNEASVKYFLLGAFATGFLLFGIALIYGVTNSFSIDVIRQ
YSINTTDYPSIYMTGIILLLIGLLFKISVAPFHFWAPDVYEGSPSVITAFMSSVVKISGF
VALFKLMEYVFVGQLNEWQYIVFYVAIITLLTANIVGILQNNVKRMLAYSSISHAGYLLL
IYFNTGIESVYTLAFYLLAYSLATVGAFASIIYIERITNGITDIKAFNGLAKTQPILAIS
TTVSLLSMAGIPLTSGFIAKFMLFNQAIKTQPLLVIIAILGSAISIAYYLKLIIAMYFKP
SHDEIINAKNPPLIYNILAIFIFILIIVLGIYPQPVFTCLAFIK
>EGEFANNL_00141 Peptide methionine sulfoxide reductase MsrA
MKQYIIFFVSVFLFFIVSCQTTRKKESYSDYTSGKMENITIGGGCFWCLSPCFEMLKGVY
KVTSGYSGGSTENPSYEEVCTGETGHAEVIQIEYNPEEISLSELLDAFWYLHDPTQLNRQ
GNDVGTQYRSIILYNSQGQKILAEESMLKSQNTDLWKDKYVTEIKPLTKFYPAELYHQDY
FKQNPTQPYCSMVISLKVKKFRDRFYYKIKSEFK
>EGEFANNL_00142 Ferric uptake regulation protein
MSAETLNKNIETVKDVLKKYLEERGHRKTPERFAIIEEIYSTDEHFNIDWLYMKMKEKNY
RVSRATIYNTIEILLDANLVRKHQFGEGQQSLYEKSYYAKQHDHILLLDTGEVIEFCDPR
IQTIKDSLQEIFNIDIESHSLYFYARKKK
>EGEFANNL_00143 LPS-assembly protein LptD
MQEKKNNIKVYLTIFFLLFILGFYHTQVNPPVPIKNNKPIPIKLINADLEEVNEKVFNGN
MVYSGNVIAEHETSSLKADSIIYFQDRNFIEARGNINFKDKDTYLVCKRLTYDANTKTAV
AYDDVKLTSPDQIIETQELIYDANSDVAYFDNWGTIYKGENITKTKIGKYFVKDKRIELG
ANSTLESPDYTILGTDIKYNTQSGLAIFKNFTEIINKKDLTIYIIGTQGTYNTKTKESFL
KKDGVVHYQGKILSADDLYFNEITGYGKGIKNVKLEEPKEKRYLMGEYGEVFQFKDSAIV
TGRPYMVKAFTKDSLYMHSDTIIAIQDKNKQSTIRGYHNGRLFKSNMSGKSDSLVYHEDA
SRLDFYKRPIFWATGGRQLISDTLSVYLNPQTQAIDSVYGRENAFVISKVDSLSPKFEFN
QAKGRKLYAYFENDKIHFIDLKGNAESIAYVEEESKKTGKKERTGIAISICGILQGEFVN
EELDIVSCQLDAQSKIYPESKLPENQRYLPQFNWRGKERLRKWNDIFPDVFPDQGIDSVD
NIDVSIQKSEVEPISN
>EGEFANNL_00144 DNA-3-methyladenine glycosylase 1
MAIQRCDWVGKEEIYIKYHDLEWGKPVYEDSTLFEFLVLEGFQAGLSWITILKKRENFRK
AFDNFDYTLISKYDQKKLDELLVCDGIIRNKLKINSIVTNSIHFMNIQKEFDSFSNYIWS
YVNYQPIVNGWEDINDVPTSTPLSDLISKDLKQRGFKFVGTTIVYSFLQAIGIVNDHLKK
CICYKNLALTK
>EGEFANNL_00145 GTPase HflX
MLEKKETHYEKAILVGLITPLQDEEKLKEYMDELEFLANTAGAEVYKRFTQKLEQPNPRT
FVGSGKMEEILEYANENEIDTIIFDDELSPSQLKNLEKELEKKIIDRTNLILDIFAQRAQ
TSYARTQVELAQYEYLLPRLTRMWTHLERQKGGIGLRGPGETEIETDRRIIRDRISLLKD
KLKVIDKQMATQRNNRGKLVRVALVGYTNVGKSTLMNVLSKSEVFAENKLFATLDTTVRK
VVIGNLPFLLTDTVGFIRKLPTQLVESFKSTLDEVREADLLVHVVDISHPSFEDHIQSVN
SILADINCSDKPMIMLFNKIDNFTFEKKDEDDLTPITQKNYSLDDWKKTWMAKSQHPTIF
ISALTKENYSDMKKLIYEQVKDIHTQRFPYNDFLFEYFDEEGNHLN
>EGEFANNL_00146 Lysozyme M1
MGSILLLILIILLALYTGCLRFNYPSKTEYPIRGIDISRHQNNIQWDLIDTTEVHFVYIK
ATEGSDFIDRKFSYNWKKAWERNIPVGAYHFFTFCKSGNDQANNFINTVPKLSEMLPPVI
DLEYGGNCKTSHSKNEILKEIKIFEEKIHNYYGKKPILYVTQEFYEDFLMDKFHDNPLWY
RNIYHSPKIKGDRNWLFWQYSN
>EGEFANNL_00147 Glucose-6-phosphate isomerase
MALSKINPKETKSWKLLEEHYNNVKDKHLRDWFKEDPNRFNKFSIQLDDLLFDYSKNRIE
EKTIELLLQLAEETNLKEAIEKQFTGDKINGTENRAVLHTALRNRDNTPIFVDGEDVMPK
VNKVLSQMEKFSNDIISGNWKGYTGKEITDVVNIGIGGSDLGPLMAVEALKHYKTRLNIH
FVSNIDGTHIAETLKPLNPETTLFIVASKTFTTQETMINAHTAREWFLKQAKSEAEIAKH
FVALSTNEKEVTKFGIDKSNMFEFWDWVGGRYSLWSAIGLSICLGIGFKHYTELLEGGHE
IDLHFRKTEFNKNIPVILALLGIWYNNFFNAESVALLPYEQYLHRFAAYFQQGDMESNGK
YVDRNGKKVSIQTGPIIWGEPGTNGQHAFYQLIHQGTKLIPCDLLVGANSLNKVSNQHEI
LVSNFLAQTEALAFGKTEEQVVEELTKQGKTSEEIEALKPYKIFEGNRPTNSIMYNVLSP
KLLGKLIAMYEQKIFVQGVIWNIYSFDQWGVELGKQLAVKVQPELANDEEITSHDSSTNG
LINAYKKMRK
>EGEFANNL_00148 hypothetical protein
MNIKMVGGTNPFGYAGTAHFIFHKEDPGGFSSELEYYTPYELAYFNIKLCENDSTKFYGV
L
>EGEFANNL_00149 hypothetical protein
MIKICKFLILFIPIEVFTQTSIEKSAKDFIPAGYNIYETVFGDLNKDGLEDCVLIIKGTD
KNQIIQDEFRGELDRNRRGIIVLFNKEDHYEPVLTNYNCFSSENEDGGIYFPPELYVNVN
KGNLYIDYYYGRYGYWTYTFRYQNSDFELIGYDITSGGVVKNYISSINFSTKKKFEKINT
NEEAVGGDEVFKNVWKDIYIDKLLRLSEIKDFDGLEIPYKVLN
>EGEFANNL_00150 Nicotinate phosphoribosyltransferase 2
MIIKYFTDNDLYKFSVMHAIQRLYPWAYVRYDFINRGNNEFPIGFAERLRDEINQMSSIK
MTKEEKKFILKRCYFLDPFFVDFLEGYQYNPDEVHISQEGGKLNLYVEGFWYRTVLWEVP
LMALISELYFKMIGTEPKDVEEKAINKALSLKNLQADYSEFGTRRRYSLDVQDAVVKLLK
ENSGEFFKGTSNMYLAMKHDCIPIGTMPHEWFMYHGALFGYRAANNKALEAWVEVFQGSL
GITLTDTYTTDSFFKSFNLKLAKLFDGVRCDSGDPLEFTEKTINFYKDHRIDPTSKTIVY
SDSLNLNEIEKIKHHINGRIHDTYGIGTYLSNDVGVKPLNMVIKLTKVKENPKYDYIGAV
KLSDVLGKNTGDEKEINLSKLTLGLD
>EGEFANNL_00151 hypothetical protein
MEYLWIIFYSLNQSIKEILIKKNEYEIDKVLFLNN
>EGEFANNL_00152 Enolase
MSLIAQIHARQILDSRGNPTVEVDVITEYGTLGRAAVPSGASTGEYEAVELRDGGNEYQG
KGVLKAVENVNEIIAPELIGSDVFEQALIDKTMIDLDGTPNKGKLGANAILGVSLAVAQA
AAKELGLPLYRYVGGVNGKVLPVPMMNIVNAGAHSDAPIAFQEFMVMPVVADSYTTAIRM
GTEIFHSLKKVLHGRGLSTAVGDEGGFAPNFSGIEDALDTILDAIQKAGYTPGKDVMLAL
DCASSEFCKDGKYDYSIFEGEGGKVRSSEEQAEYLAELAAKYPIISIEDGMDENDWAGWK
ILTDKIGDKVQLVGDDLFVTNVKKLSDGIQQGVGNSILIKVNQIGTLTETIDAVQMAQNA
GYTAVMSHRSGETEDNTIADLAVALNCGQIKTGSASRSDRMAKYNQLLRIEESLGEVAVY
PQFNAFKISK
>EGEFANNL_00153 Citrate synthase 1
MNDKVKLLYNGKEYEYPIVESVLGDKGINISKLRDETGLITLDVGFKNTGSTQSKITYLD
GDLGKLYYRGYPIEQIAEKSTFTEVMYLLLEGELPTQEQLNKFEADIKKNSLVSVEMEQI
LKAFPRSAHPMGVLSTLTSSLTAFNPKAVNIKFEKDLYNAYTLLLGKFPVLCAWTYRLKL
GLPLNYSDNRLDYPHNFYQMMFKMPTEDLEVQEVVVDAINKLLILHAEHEQNCSASTVRM
VGSAHTGLFASISAGVSALWGPLHGGANQAVIEMLEMIQKDGGDLQKWVDKAKSKNDDFR
LMGFGHRVYKNFDPRARVIKKVADNIFNKLGIQDETLEIAKKLEEVALNDPYFIEKKLYP
NVDFYSGIIYRALGFPTEMFTVMFALGRLPGWIAQWKEMRINNDPINRPRQIYIGNPKRD
YIDINLRN
>EGEFANNL_00154 hypothetical protein
MFTYYKIKTSINHIEVFNFLYNFNYTEIIPMINEKFLHYVWQFKRFNFLNLKTTDGESLE
IINTGIYNNNQGPDFKCAQIKINDLLWNGNVEIHLKSSDWNKHKHEGDDFYKSIVLHVVY
EHDQQISSLKNQSVSTLELKSYIDKVLIDNYVKLIQQNYTFIPCEKFCNSDLLSKLSFSY
ESLYLDKLQSKCEQIYNLYKSKKNNWEAVLASILAYTMGLKINAESFEEIFNSIDFKIIQ
KNSYNSLLLESLFFGLTHQLSDYSDEYPRNLKKEFDFLRVKFNITDIKILLNFFRLRPGN
FPTIRLSQLASLLTQYQNLFSYVVGAKNIQQYYVLLDEVQASSYWNNHFTFDKISTLHSV
KKLTSSQKELIIMNCFLPVKFAYSKSIGQSMDEEIISLISELKAEKNSIIDNFEKLGLNF
KNALETQAILYLYKEKCSKVKCLECSIGYHLLQ
>EGEFANNL_00155 hypothetical protein
MDIVSIGIIILTILFSIKGFKDVNFFDRYKFNTAAILKGNQWDRMLASAFLHGDVIHLFF
NMYSFFFFSTKLINDYGGIFFFVVYISSILAGNFLALFIHRNNSYYSAIGASGGVSGLIF
AAVILDSTMSLQMMFIPIPIPGCIFGIIYLAYSIYGMKTQLGNIGHDAHLGGAFMGLLMG
LIYVIMYKDSNYNINFELKYLLLMLVPLIYLIYLVIKEKK
>EGEFANNL_00156 tRNA 5-methylaminomethyl-2-thiouridine biosynthesis bifunctional protein MnmC
MLDYLIIGQGLAGTCLAHQLIKDNKSFKIIDKITNSASVISSGIYNPVVLKRFTPVWNAQ
IEIDKLINEFTQFENLLQIPLIKRCDLFRVLANEDEVKTWSKKSLRNENLIPFLDSEIIS
NSNPQVKASFGLGRVKQTGRIRVNDLLSQFRNFLIAKNQLIDETLDFSLLEPKENCISYK
QIEAKKIVFCDGYSLKKNPYFSYLPMEGLKGETMLIHAEKLDLTSIVKSKVFIMPTDHEN
YYYIGATYHYRTINDLVTTEGRDELINNLNKFIETEYKIVRQFAGIRPTVIDRRPLIGNH
PKYRNMFLFNGLGSRGVMLAPKMAEELYNYMEYKVELQKEIDINRFNS
>EGEFANNL_00157 hypothetical protein
MKYLVVCLTTLMSVGVYAQNILNAKSPQELREMRSEMYDIVNGGQDTISTAPIPLPYGNI
QDKDILWSRVVWEIIDLNEKLNQPYYYSHDEVTANYVSLYDALFNGINAGEITEVYDDDN
FTSKVDPENLKSKIQAVRESDWLQDKRASGETITEQDIMEGTDHFKVDTKSVKLIKIKGM
WYIDKRLGQMKYRLLGIAPMGPDPQVLGLNDAAALGYEGEDEMIDLFWVFYPGARDVLSR
YTVFNPRNGSSSITYDDVLNARRFSSIIYKSQSEYGDGEISHYIPGDAKSQLEESNRIKN
EILQKENNMWNY
>EGEFANNL_00158 hypothetical protein
MAAGKQSARQKMINLMYLVFIAMLAMNVDREVLRSFEGVNESLQLSTTLTEKNNITFYES
IESKKNDGDQGYVVISQKATEIKNQAQQAFAAIEKVKSLLKEQADYTTPQPGEETNYNSL
QNTDVVNKVFFLEDTKPTPEVQDMIAKVTNFTQYILKGANKSTQDRINQLFDFSDKNNKS
WLTNQFYDQPMIAALTNLTKLESNIRTEEGNIVRDLLANKLETEIEIKAFMPIVSSPKFV
RAGEKFDVTIGFGAYDNTLKGTINLGGRNIPLSSGKAVVSMVGEGTGLKHVSGSITYETP
QGPKTEKFDETYEVVADVVSKVDGNATLMADNMNVVYRGVVNPLSAAISGISGAVSLSAS
SGSVSSRGANKWNYSPGAGGQVVFTVSGKTSSGKPISQKFTYRIKNVPKAQGTIRGSNVV
SMPSSSVSNQTISAAIPDFEFPVSFTVTGFKVKKPGTSARAFSGNSLRAAAGYLEGLKSG
DQVLVFDISAQASGVSQQNISPVLINVQ
>EGEFANNL_00159 hypothetical protein
MAVKTKSKDRVLNMVYSLGAAVVILGALFKINHWSLGPVDGSSILAIGLIVEAFIFVVFA
FDPPAGDYEWEKAFPELLDGKPVERKQKLVETPQQIKEVEVSLSSKLDQMFSQAKLDVNM
LEKLRSGIENFGQAVEGINKTVDANLSVQKYNDQLSKASSHLENLNALYQVQLDSGKKFT
EDLVKAGEHSTEFKDQLNTLTTNLNNLNKVYGGMLNAMKS
>EGEFANNL_00160 Serine/threonine-protein kinase pkn1
MRKVLLLLLATATLASCKSSKKGKAGKPGVQGEIVATQQSQKWNNKKPYGMVPIPGGAFV
LGQADMDFSGSVGKAPLTTVTVSAFYMDDTEVTNAEYREFIKYVKDSIARTRLAERADQE
GEEGIGRYAFLNKKSESEQNAYQQMLEERGGREGYDESKKLDWSVPLEWRTANYPDVAYA
EVMESMYYPPEERFNNERVIDPRKLIYQFTWIDQLEAVKKKGRGESFLKREEIAIYPDTT
VWLRDFNYSFNEPLFEQYFWHKAYSKYPVVGVTWDQARAFCAYSTKSKNDYNQSRKKKIE
KVFPYRLPSEVEWEYAARGGLENASYPWGGPYLIDDRGCYLANFKPKRGDYMEGEKGFLY
TAPVKSFQKNGFGLYDMAGNVSEWTVSAFNNSSYIISSTLNPYLGNRIEDPRKVIKGGSW
KDIGYMLMVSERDWEHKDSARSYIGFRRVQTIPEGSNVKFPKIKKLQ
>EGEFANNL_00161 Formimidoylglutamase
MSSIHKFLHPVDESLLHSIPNSIGSKIKFYFNEKINENSLVIVGCPYLKGASQNIEFSNL
RVVREEFYKLIWNGWEFDIYDLGNIVIENNEISQEDALKQVIEELLEKKLFPIILGGSMS
LNYSVYRALESLRKPLNYTAVDSHIHAKINIENETTEENYLSKIIMEEPNLLFNFSNLGY
QTYLVSPTTLKTLLNTLDFEAIRLGSLINHIEDSEPVFRSSDFVGVNLNSIESLTGSLST
ESSVNGFTNREICSLAKYIGLSKQIKVVGLYNFLGYSNNKIDAKLVSQILWYIIEGKNNQ
QFYENTDYIKYTVVYEDKELIFLKDKKIDKWWLSIDFITEDENFLIPCTSRDYQDALMGK
IPDKYWKTIKKFL
>EGEFANNL_00162 DNA topoisomerase 1
MNLVIVESPAKAKTIKKFLGDGFEVESSYGHITDLAKKDMGIDKTTLEPIYQVSSDKKDV
VKKLKSLAQKADTIWLASDEDREGEAIAWHLYNELKLKPENTKRIVFHEITQKAIQNAIE
NPRDIDINLVNAQQARRVLDRLVGFEMSPILWSKVKAGLSAGRVQSVAVRLICERENEIK
SFIPVPAYKIQANFINQSQQLVKSKLNIDFEEYPKALNFIQKIKGKEFSVSSIEIKPGKR
SPSAPFTTSTLQQEASKLGFSVSRTMMLAQQLYEAGHITYMRTDSVNLSEEAINSAKQII
SDKFGKEYLQTRQYVTKNKSAQEAHEAIRPTNFNLQQAGEDDAQKKLYHLIWRRTLASQM
SDAKLERTVVDIQTSGMDEKFVARGEVLRFDGFLKLYHIEQDEDTLNEEVEGLLPKLTQG
ESVTLEFAIAEEKFSRPSARYNEASLVRKLEELGIGRPSTYAPTISTIQKRQYVEVSDLE
PKQRNVRKIELKGEEIIETIEVENYGADRRKLIPTDIGLVVNEFLTDHFPNILDYGFTAK
VEEDFDSIAGGSENWKEMLTNFYKDFHPHVEEVKENADRATGERLLGQDPVSGKNIYARI
GRFGPMVQIGETEDEEKPRFAGLMKGQKINSITLDEALKLFDLPRNLGNYEDKKVEVNTG
RFGPYVRHDGKFVSLKPKEGDEVFSITLDRAVELIEAKRESDRNKFIKSFEEEDPMIEIL
NGRWGPYIKQGKENYKIPKDTDAQKLTLEEVKKLIKGTDTKSKAKAKPKTKTKKTTTTKK
KS
>EGEFANNL_00163 Metalloregulation DNA-binding stress protein
MANKIKIGEANIGISEENKQIVSDHLNRLLANEFFLYTKTRKFHWNVEGSHFKSLHLLFE
DQYNEIAETIDAVAERIRKLGHYALGSFKQFSAVTDLIEHDGEEPTDAKTMLLELCDDHE
TIIRILRNELIPIAEKYKDLGTNDFLTGVMEMHETMAWMLRATAK
>EGEFANNL_00164 Cyclopentanol dehydrogenase
MSKTIVITGTSSGVGLALGNYFHSRGYLVIGLSRSIPENSNFITIPTDITKEAEVELAFQ
QIVKVTNRIDILINNAGRGMVGPATDATEEEILSLFNLNLVSVVRIIKRMVPLMSNKRGK
IFNISSIGSLMGLPFRGYYSASKSALDMVTESLRYELARFNIQVCTVNLGDVRTNIAEGR
IKSTVSIDYQKDYNKVYEAMNMDVDKGFEPNKLAPFLEKLIKQKSKIKPHYYFGTFIQKL
SVLLKAILPQTTFEKIIASYSGMGHTNKKRGK
>EGEFANNL_00165 hypothetical protein
MILLVDSGATKADWVAIDKDGTRLFSSQTKGLSPESVDKDEMLIRLNERFDISQNRNNVE
KIFFYGAGCATDNLKSIVISALKEFFPKVQTVVVEEDIYGVVYSTTPIGTEAIVCILGTG
SNCSYYDGEKLHQKIISLGYLLMDDCSGNKLGAELVRAYNFKKLPPELSEKLVKEYKMDI
DFIKENLYKKSNPNAYLATFAKFIIQNKDHQFIKEIINRQMQFFIDYYIKQYPNCYDVPI
NFNGSICFYLKDELEKKLAENNLKLGTVIRRPIDGLIDYVCKHKLKD
>EGEFANNL_00166 30S ribosomal protein S1
MSEETKNFNEEQEVLKNANVAPEQFDWDSFESGLDAEDRKEKSELEKMYDTSLQELDENQ
VFKGRVVRLTDKEAIVDINFKSEGVISLNEFRYNPSLKEGDEVEVMVAQREDKTGQLQLS
HRKARMLKAWDRVNELHETGEIVEGFVKSRTKGGMIVDVFGIEAFLPGSQIDVKPIRDYD
QFVGKTMEFKIVKINHEFKNVVVSHKALIEADIEDQKKEIIGQLEKGQVLEGVVKNITSY
GVFIDLGGVDGLIHITDLSWSRINHPSEVVQLDQKVNVVILDFDDQKSRIQLGMKQLEPH
PWEALDANLQVGDKIKGKVVVLADYGAFVEVAPGVEGLIHVSEMSWSTHLRSAQDFVKIG
DEVECVVLTLDKEERKMSLGMKQLTPDPWTDITAKYPVDSQHKGTVRNFTNFGVFLELEA
GVDGLIYISDLSWTKKIKHPSEFCSVGDVLDVVVLELDTEARRLSLGHKQLTENPWDQYE
AKYAEGTIHNGKIVQSFDKGATVKFEDEEVEGFCPARLLEKEDGSKLKKGDDANFKVIEF
NKEFKRVVVSHTGTFREEENREETEKQVKSQNQNVEKSTLGDLDQLQELKRKMEEGN
>EGEFANNL_00167 Alpha-ketoglutarate permease
MGNDLTKKNSYTKDQKRKSIVAILSASSGNLVEWFDFYVYAFTSIYFAHLFFPEGDTTSK
LLKTAGVFAAGFLMRPIGGWIFGRIADKHGRKKSMVTSILMMAFGSLLIACLPTYSSIGV
FAPLLLLIARLIQGLSVGGEYGATATYMSEVALPNKRGFYSSFQYVTLIGGQLLAALAIL
ILESTVSENDMNTWAWRIPFFLGAIAALVSLYLRKHLKETAPKKSVENKKAGSLVELFKN
HTPAFLTVLGYTSGGSLIFYTFSTYMQKYLVNTAGFETKTATQIMTACLFIFMIVQPIFG
SISDKIGRRTCMMLFGGLGALITCPVIFGLTQINLNPFFAFLLISLALCVTSFYTSIGGI
VKAEMFPPEIRALGVGLSYAIANAIFGGSAEFVALSFKDINMESGFYIYVTVMLIITFLV
STRLPKKATYLNDNH
>EGEFANNL_00168 Transketolase
MNSNEIQIKAANNIRILAASMVEKAKSGHPGGAMGGADFINLLYTEFLEYDPQNPRWESR
DRFFMDPGHMSPMLYSTLALAGKYNMGDLEQFRQWGSVTPGHPELDVERGVENTSGPLGQ
GHAYAVGAAIAAKFLKAKVGDIMDQTIYAFISDGGIQEEVSQGAGRIAGHLGLDNLIMFY
DSNGIQLSTKVKEVDEEDVAAKYVAWGWKVISVKGNDIDELRKALTEAKAEKQKPTLIIG
HTIMGKGAVTADGKSFEDQVSTHGQPLTAAGASIEKTIENLGGDPNHPFMIFPEVKELYA
KRAEELSKIVADKKAKKEQWVSSNPELAKKLEFWFSGQTPSIDWSKIEQKSNNATRNASA
IVLETLAQQVENMVVSSADLSNSDKTDGFLKHTKAMKKGDFSGAFLQAGVAEFTMACLCV
GMSLHGGVIPACATFFVFSDYMKPVVRVAALMEQPVKFIWTHDAFRVGEDGPTHEPVEQE
AQIRLLEKLQNHKGHNSMLVLRPADAQETTVAWKLAMENTKTPTGLILSRQNIKDLPAQS
NRYEEALKSSKGAYIVQDDANYEVILLASGSEVSTLVEGAELLKKDGIRTRIVSVPSEGL
FRSQSKEYQESILPNDKKKFGLTAGLPVNLLGLVGDKGKIWGLESFGFSAPASVLDEKLG
FTADNVYKQVKEYLG
>EGEFANNL_00169 Ribulokinase
MVQPDKYIIGVDFGTLSVRSTVVRVSDGFEKGTASEVYKHGVMDTHLTASKGEVLPPDFA
LQVPADYLEAFQKSVREAVSNSGVVVRHIIGIGIDFTSSTVLATDDKGIPLCEYPEFTHR
PHAYAKLWKHHGGNEQAHRLLKVAQERNESWLPRYGGLLSSELLLPKVLETFEKDREVYD
KASFFVNALDWINWLLTGKLVYAGADSGFKRHYQDDKYPDAEYLEAVSPGFGNVYKDKMS
GPIQPLGSKAGELTPKMAEWLGINPGISVSVGNIDAHVTAAAIQAVKPGIMTAILGTSAC
YIVSGPEFKEVPGMLGITYGGIADGLWCFEAGQSAFGDILAWFIKNGVTEEYKKEAEEQG
LSLHNYLTKKAAVQEIGQHGLIALDWHNGNRSILCDHNLSGMILGQTLTTRPEDIYRALM
ESCAFGARKIIETMKVHGVEIKEIVAAGGLLKNKWLMQLLSDVTRIPLSITEATMVGALG
SAIYGAVAAGCYETIEEASEAMGSKVPNVYKPHESRSLKYDQLYKEYLILHDYFGTGENQ
VMSRLKKIKEEAVKDKF
>EGEFANNL_00170 Glycerol-3-phosphate dehydrogenase [NAD(P)+]
MKEKETINMNKSKIAVLGSGIMATALTFPLAENGHEVHLVGTHLDRDIIDSIKKTGIHPN
LGLKIPSTVKAYQLEEIEEAFEGADVAMSGVNSFGVDWVGEQLAKVVKPGMMVLSITKGM
QADEDGNLYILPDIIKKYFTKDLVDSVTWSAVVGPSIAGEVAVKRDTCVVFCGEDQESLD
KLAHMFRTDYYHVWTSTDFVGMEVAAATKNIYAFAAGFNEGIRDKNKEENDRYVRFNYGS
AVFAQGQVELTQFMQLLSDNKTLSPRHLLVGSGDMFVTSMGGRNVKAGRYVGAGIPFSEV
RDNYMKGVTMEGVAAIRVIGGAMEPLTKRGIIKESDFPLLRHLYDIIVNDQPLNMPWEKF
FDGEK
>EGEFANNL_00171 Glycerol kinase
MNSKKSTEGPLVISIDSSTTSTKAIVVDVTGYVWETSKRNIQLHTPAMDFYEHNPIRWWE
TTKACVGEVLSKLSTKDRDRVSAIGITHQRESFAPFDKDGKPLRNGILWLDGRATKQIRA
YGSAHIHDLSGKPPGVTPGIYKMAWVKENETEIFKEAYKVVDVLSYITWNLTGRWASSVA
AADSLGLLDIRNFDYSDELLAIAGVRRDQMAELVPPAEVIEMLKPELVAEWNLSKSIPII
AGLGDGQAAGIGAAAVSPDVAFLNMGTAVNAGVESPIYKCDPVFRTHVSGIKGNFVFEVL
QSSGSYLAGWFRQSLGDPKLLGEPDLKLDQEASKIPPGCEGLVTLPYWNAVQSPYWDPVA
RGAVVGWRGTHSRAHMYRSILESIGFEMKLNLESIQKGTGIRLQSVRAMGGGTRSKLWRQ
IMADIIGIPITVCLEDEISALGAAVLAMAGIKAHGSHDVANAAKHMANFGDTIEPNLEQS
QIYNEVAGIQRQLYPQLKDVFEQLHALSEKYPSATKPESPKAEL
>EGEFANNL_00172 Xylulose kinase
MNSEGPLVIAIDSSTTATKAIIVDASGQVLQTAKNNIQLHTPAIDFYEHNPIRWWETTRD
SIAEAVSKLSPKDRERIQAIGITHQRESFACFDKEGKPIRNGILWLDARATKQIQKYGSD
HIHNLSGKPPGEPPAIYKLAWLKENEPETLEKAYKIVDVHGYITWNMTGEWISSEACADT
LGLFDIRKRTFSDELMNIAGVNREQMSDLKAPGEVMGMLKQELVSAWGLSKSIPVIAGAG
DGMAAGIGAAVVTPNIAYLNLGTAVVAGVQSAEYKYSPVFRNYVAGIPGNFIFEVVQHSG
AYLAGWFRQALGDPKLLGEPDIRLDEKAEKIPPGCEGLVTLPYWNAVQSPYWDPVARGAV
VGWRGTHSRAHMYRSILEAITYEIQMNLSYLQKETGVSLTSLRIMGGGTRSKLWRQMVAD
ITGIPITICLEDEISALGAAIQAMAHTGVFGTQDIAVASKKMARFGDTLEPNLEKNKIYL
EVAEVQRQLYPQLKDIFKQLNVLSEKYPGVKPESPKSEL
>EGEFANNL_00173 Glycerol-3-phosphate dehydrogenase [NAD(P)+]
MAKITILGAGAMGSGICTPLINAGWEVRLWGTWLDDHLLDACEAGKPHPRTNVPLAKGVK
LYRSADLNKALDGSDVVVMSVASGGVPKVTEMALEGISKAKALWLTSKGFCPDENGKIQL
LPEAIRTIAKQKGVTIPPIVAIAGPVKANECAEGKPTATIFGCKDLDVSRKYAREARTEV
YCIEATDDETGVEICAPMKNVYAIALGIADGLEEGTGFPHHNLKAATFNQAVKEMSLLGQ
ALGAKPETAYGLAGVGDLEVTGLSGRNKVYGVRIGRGETAKDALAEMERLEQTVEGVPAA
GLATTFVEQSAPQIKDQLPLLRAVHEILAGSSLSVVKILSEAVLPKMP
>EGEFANNL_00175 hypothetical protein
MIENNYIQLYCYQAECGDAFRIRYIGDDNKFHNIFVDSGYERTYRHILQSEIEAISKANE
AIDLWIVSHIHDDHIGGIIKYIKAIRDDEIIDIVKEWYYNPPRNYAPSRQQNTISSASSI
NQGDFLYEYLCQIGKQPLFDLVNDLEGIDFYGLKIEILSPSTENLQKLRDKYKKDIPLER
NEYDEISSAKSSSNNDYHIPLGAFSLNSAKEDKSKENGSSIAFIATYKGSKILFLADSHP
SVITSCLKGKGYTNKKPLTCNYVIVSHHGSEGNNNSDLYSLIRCNNYIFSTNGEKHNLPN
KSVLAQILRNSHRNSKELYNIYSPYDTDILCDIFLIDGEEVYTKWNFEIHLCNNKVLILD
K
>EGEFANNL_00176 hypothetical protein
MDAQYDSFISQITVRLKNKDNSVVGTGVIYYHDNLEDKVYILTASHCLFEDGDSFSKQRD
LIIIDIYNTKTATYNSIDKNIDSSLLYKDGNKDVALLIFDKDDILPMIGLDNIPSILVIQ
ERHSFSNFVTKGFPRATQGKELETLYLKYPRGMTEVNKFQLETTSSYTDSNMEGFSGSGV
FLLADNEMYLYGIFTRYRNNPDEKGRVAYCQYIEPLNEILNNKHLPAISYTYIGENGLTR
DFFQTHIEKSVSNLGGRFNQKLNFRLPIGQVFNALSYNNLFKSLFLKIWDDWLTARYQSY
NLEGDALKDIKEQLYLIRKNKIKWVSEIKFDYRQELEVKAYKNEIQGFDTAIRNKIDELS
KLESKEKNDYQKYQNERSWLIDILQINQQLLKELDSIHIELVNKPILIIKGDAGSGKSHL
LGDIANERIKNNLPTLLLLGQHFHSAKTIEENILSLLHLGCTFTELLINLDKISDQIGSR
VLILIDAINEGAGSDLWNNQIAGFISSIKKYKGVGIALSIRSTYFDDIISADFIEAESPH
IIEHKGFKGNEYEALKLFCEYYSLKLPSFPILAPEFSNPLFLHLICNTVKEMPDKTFPKG
FNGLNRLYQLYIDSLNKRFENKNKEYKLRSIVSESIEIFATSILNSEFNSITIQEAVKLF
DEKFPNHKTLLTDLIDENILIRNKVYSGYNKYHDAVYFAYQRLGDYFMAQKLLNGCASKK
DVLDALMNPDGLGVICSDYDWKYRGIIEALSIILPEEHNLEIFEISDYFISDADKEEEWK
TQHIYEWISRVELDSLKWRKVESINDEKITSWLRSGKALISDHEWFLCLTELSSIIDHPF
NSNRLTQILKKYTMAERDSFWQEFIIYFNGYDDNEIAFPIQRLIDWAWMPNISTLSDDET
AKLVSQTLAWILSTTNTKLRDQTTKALVNLLEQKPNVLIGLLKTFQDVDDLYILERLYAV
TYGCVLRTEKDESVKLIAEYVYNTIFKNGNPPTHVLLRDYACNTIEYAIHKCLLEEVDIQ
LIRPPYNSKMNFTPLTNEELDERYEPKKDRGHWGKAEWGVSAILRSMVTEYGRGTGGYGD
FGRYTFQSAISNFDLPRQMNVNLLSNLAVEWIFEKYGYSTKLHGKYDDYIATKGDRHESK
IERIGKKYQWIAFYEIVGIIADNYKMKCYWEDEYVYFKGTWQLYLRDIDPATTTINNKEE
DSENSILEDYILKKEWWMDRMFSNWSGEDSHWVSTSNDLVHPYSILRKKDDLGNYWLHLH
HYIEWVEPKKMGIEKYAGQKKQIWYIFNAYLVKKEDKNKIVEYLSQKNFDGRWMPEANEG
FSQLINREKFWSPAYQDENQESKEELWDTINGTDYKVIVADTEANGNIEQDKSGTSAVYR
IPCEFIFEGMELQYAPKDGDLKNKEGEIIVTNINPNGVMIREKDLLEFLDKNDLDLIWTL
LGEKFSFSHDRLNESFFKTMSGVFYLEEDKMKGEMKMYDRE
>EGEFANNL_00177 Tyrosine recombinase XerC
MNFIDYLQTQYPYSERTLQDKQSQIENWKNQCLKNQTLENLTSKEVLKLIEIQKKKYKIQ
TLNNQIQTLEQYYNYLVETKKRKDHPIRHFRIKPETKPIIQGLLTEQELTEIYEQYPSDK
PIKRLEPYRQRNKVILGLIIYQALDNTTLSKLEIQDIDIKKRHIKVPKVNSYKRNKRTLK
LNPNQIPALANYLTQTRKEILRQVKTQETTKKLFPTSEKTKFSSITKAINKQIKIEKQLT
LRYSRISLWIKQSNLIQAQYNAGYRSIKSLEKLDLTHLEKLKQDLAKYHPL
>EGEFANNL_00178 Tyrosine recombinase XerD
MPEERIQNYKKYLEIKGYQSSTIRGLLRTAKNHINQKNSQQQLTNNTQQLYYYQKKVYIN
YLNQVENQNIHLSPEHYKKTLSKIEVLTLEEIRELEQGCKTLREQVVIHCLYSLGLRLSE
ASNLELEDLDLTKNIVLIRKSKTKKQRQIPINKKTQQIITHYINQERPINKGRKLLQGLK
GDLIPDGIYQNLKRIVKRTTIKKRIYPHLLRHSIASHLLQRGMDIEQIGKYLGHTSIEST
QRYTHLAEINRNE
>EGEFANNL_00179 DNA primase
MTIQEIKQNLTIRQVLEHYQIQVKNNSCCCPFHDDKTPSMQIFPDTHTVRCYSGNCQQSN
KVIDVIDFIMYKENLTKHEALLKASQLTDLSHKIQRSKEYQEIPLDRLEELFYKMKSNLR
QSKTARTYTQQRALDYQKLEIGYNGRTYKGLVNCIVFPLKDPNHKIVSLYGRSIKAEAEN
KHFYLKNRQGLYPCYPDPETKILILTESIIDTASLLPIPLALNTYSLLSCYGVNGFTQEH
RQAIKELQHLEEIIIIYDNDQAGQQASHKLAQELLKIQPKSTITQVDLPSKDINEVLQLH
NPEIFTQLLEQRKELILSIEKQEAREQSEQETTNQNSPKTEHLSLDQINHLIGKSGIIGE
ENTRLLLFIIASSYKTQSPLHAIVQGSSGSGKTHLISKIAQLIPQEDVLKFTRITESSLY
NWGEWDLVGKLMVIEDLDGLKEEALYSLRELISNQQLSSSVSIKDKKGNIKSTHKKVRGV
FSSLSATTKADVYEDNISRSFILAVDESTQQSKKIIEYQNQKYAGEVSQTQEKQAKEKLQ
NYLRNLQQVEVINPYATKLELPEEVHKIRRLNQMYQSIIRQITYLNQKNRTYKDGKIYTE
IEDLEQATQILFESILLKIDELDGSLRQFYERLKKYLKDKNQEFYLREVRQTLNISKTQM
FRYIQNLKELDYIKPIGGHERVGIKYKILYWDDYQKLRKNIKEQLQKQIEKLKMEQ
>EGEFANNL_00180 HTH-type transcriptional regulator Xre
MSVSTRIKDLRGKNNLTQSELAQRVGLTYIQIGRYEKGKSSPSADVLQKLADALNTSTDF
LMNGSSEMVDAQLADKELLKQFKEVEAMNEQDKHLVKTFLDAFITKKKIQKLAL
>EGEFANNL_00181 hypothetical protein
MQTENVQNKNENLNNDFSNENKNLNPKDFLKSLENFPFIETYQELGFTLKSLCKVTQTAL
MMDGSYPNLSVHKPWDIYNILNLIHSLIPDSEWELLDRLNKKD
>EGEFANNL_00182 hypothetical protein
MKVLREWTDHDFNELNFHDNIIYSVSFPDEEPLFSIRLDYILEWNLDRSQGLYSFLVSPA
IIVFENISKLKIDLNYENNIGMIMSAFVRDNQRLAPNKEVYLWDYVIYTDRGNISLSASR
FSLKLLDDPISSHSQKYPKSFEIE
>EGEFANNL_00183 hypothetical protein
MIKGNSQLIVIVIFFIMFFCNCESKKNAFQSNSLDFFEISQNEIELKKKTVDIQQVSKER
IKGVFLNNPYKFIEKDYILLYANGKLVYRGNFTSSFVFDIDDKITSIRRGLVNFSFEIIK
GDKIAKISNKSVVKWDDKNKFLYIAFFPTNQNTEQIVFIPVENSLM
>EGEFANNL_00184 tRNA nuclease WapA
MRLSAKKARYISYFLLFIMAIQSFTPYVPHVVKEKKENSDEKNTFSSEGKTSKAKVKEET
EDLKNEHSFFKPSKSLEAGSTLYSSDLNEGEIGFLFNHYFDNPQDNVFTLYVDHKPEKGQ
KAYIVYELYGVEDKNSVTKSINDRLATGGYLVKTNTEWTKQKEEINSDWLREGVNHIFFS
VPNNATYGYKIKNLKIEVENTTSTVEELHWNSYAYENGDTYVKGYFLDGKDREIQIQGQL
VKSFQGEFETVLSGHFPQVELSIEGKRQTQTSNLLKGKPKFVFKETFVPNQSQEWFSKQK
ESNEINFLGASLTIAGKDLWSNQLIRIQNLRYTDIPTLDMGMQNVTAKSVAFRFLPHGEH
FSKPAIVKLPYDRTKIPNGYTEQDIKTYYFDLNTKHWVSLERDSVDTQNQVIISKTTHFT
DMINGVIQAPESPETSGFTPTTLSDIKVADPLAKVNQVAPPQANNRGSAGMGYSFEMPPA
RNGMSPSLGIQYNSDGGSGLLGEGWDLNTPSISIETRWGVPRYDVNLETETYVMDGSQLV
TQGPDGKSSVAHRGEKIARQADRFFFPRKEGSFAKIQRKGNSPSNYTWEVTDRKGTKYTY
GGNNGVLKGTFTNIKGEKQEVISEWKLSRVEELHGDWIEYYYDQVEEPVRGGLTSKSLYL
REVQAGNKGEKAHTVVKLTRGKTKQKQTNNARYGYLTSQNQLLTNVEIDFEGRKLREYSF
EYKEGAFFTDLLNKVIHKDDQGAQFTYNTFDYYNTVEEQGGYYQPSETWNTHNDGLSAGF
VNPLSALQTTGDFSDKPTALGGSKTKNKSGSIYVGIGLEDGKPSKIRTIGASLNYSYSES
KGVSTLIDINGDGMPDKVFVDDLVGGMHYRPGHRDGTFGEPIRIQGASQFSTSYSNATSF
GAKAIVGKGQAEGEPKEKTATIGTDFQQSKSKTSRYFTDVNGDGLVDLVVGSKVYFNHIE
KDAQGNLVPTFTLSSADTPSPIKGGGVIDDSDTQVDPEEQAELIANNPLQDAVRVWLAPY
DGSINVSGTATLLAPQAGYDPESFAKADGVRVAMQKNQSEIKSFVINRDDYSPKDIATAN
LSVKAGDRIYFRVQSGIQENSNGDFDRVEWNPTIKYNNINGGTDANAYPTIYTAATETLN
YYDGYTVVPGVDSLTIKGNFTKPVTSDVVTLKVFMGEEKALAYEKTFQATETHQGEWVIP
ISNPSLKDVMQIEMESPSYLAWETISFQPVVYFTRTIETPEGTPQTIEQTQLASVKVNAT
YESLVHPGTVQTVATKGKGKLKIEITPKVGITPEIKNKINGSFQVKAKNEKGVFYTGNLQ
MANGSLGEGAEQDLDLPQGPVWVELYSADANREGLQNLATVKVILTDSLNAQTNALASVY
RNWDLQGFGPLHRQWGHFSYNSMEGRANQPIKENLLVLPQSENDPNVDPRKMVFIPMHLD
AVNKTYWQGNDAEVGIHQKIMTASRLGQKDVILDNPLSGLSGVGNLEGTCITGSGGIGVR
QESKSESKSVMIEAGGSLKGTLSTAEGADQTLLAFQDLNGDGYPDIISKRQVQLTNTQGG
FDGEIVTSKNGYAGFHNSESKSASVGLGGNPTHASSIASKAARLESATANIKGSFKGKTL
FDKIASLVKAVKEADDAEISLNNAKNTPYLIPGGDKNFNEDEAIDSFTDVNGDGLPDKIL
RNKQIRLNLGYEFTEPLDWDISEIRSGKGSNNSLSLGFAIDEGSWSGGIGLSNNKTHTNF
ALMDLNGDGLVDKVRLEGSKIHVSLNKGNSFADEILWEGLSEINNSSSVSESINSALTFK
MTLPTLPPLKLALNPSVNIGQSMSRTLEDLQDIDGDGFLDVVTSDREDRLQVQRSTIGKT
NKLKTVYNPIGGSFTLDYNRSEATYDHPAGKWVLSAVETNDGINDDGANTRVEYRYSQGK
QDRHEREFLGFGRVETLSVDTENSNALYRKSIQEYDVNNYYTAGNTLRSWVEDAQGKKYA
ETLNVYYAYEVKQNGANAYAITTTELCSDNQSAYTPLKYTKSMAYEGQDLGIVTSESFYQ
YDITQQYGEILAYKYSDQGNLGENGTGGYNYQTKITYTSNPAKNIYGLPVQVQVIGSDGK
QYREVKATYDTNYANHLTQVSQKLNDEGEVATTDIVYDKYGNITQKTLPANANGERMWYK
YRYDRDYHMYLERIDDAYGYTSELENYDYRYGMPLSTKDYNGYYMATTLDNLGRVQTITG
PNEMEQGLPYTIKFEYHPVAEIDSNGEIKNPAYAITKHYDPQHKGNDIETVSFVDGVGRA
LQVKKEGVITETDASGSNPKEKEVWIVSGRNSLDPYGRVSASYYPVTEDLSQKLIFNRNF
DKVTPTRTRYDVMDRAVQTLLPDKSSSSVAYGIDASTRTLVTTVTDAMGGKQTTYTNGSG
LTLKTDQLSGPSGTISTQFGYDRINQLLEVTDTEGQKTTSVYDLAGRRTQVTHPSAGTVS
LTYDALGNVTTRQTSNLAEAGQKIEYKYFYTRLTNINYPQNPQNNVTYHYGNKNAKENRV
GRVVLQEDATGAQEFKYGSLGEITEVRRTLVIPNQAIATYVTQTKYDSWNRIEHIIYPDQ
EKVEYKYNTAGQLVQLKGSKAYSYNYVEKIGYDKFEQRNYLKYCNGSETSYTYDPQRRRL
TNLQVWSNPKSPQASGGKRQIMNNQYTYDAVSNVLSVTNATALPANGQSLAGGPMKHEYS
YDGLYRLVQAQGTYTGADQKTASYTLEMGYDNLHNIVTKKQHLSQKNIMFNGGLKAGYDL
AYTYDKIKRNQISEIEDINYRTEENKPEEKRNERKAYSYDANGNLVYINTALAKKDGRET
THTNERKLRWDEENRLVALDDNGYISNYWYDASGERVVKTSGESEHVYVNSLFAGGRTQT
ASFSAYVNPYLVVNQAGKYTKHYYIGSQRVVSKLGDLQSYGADPRRIQYAGANLDGISID
WKGKYQQTIQDIKDSYAYFEVPYNGKDNDDYVNGQGFCCSDNDAVGISPLEAGIGNGNVD
YERMQYFYHADHLGSSSYITNLDGAVVQHIEYVPFGEVFLEERNNQWNSPYLFNGKELDE
ETGLYYYGARYYNPRESVWLSVDPLAEKYPNITPYAYCENNPIVSIDPDGREKIIISGGE
YDGKRYKYNFIEPAIKQLSVYKASAGSEQITWVVMNAGYSTKAINKMQRIAKREGAEFLL
LNSADELTNYINSKSPSSSNLSNDRNSDKITEMAVFGHGYVGSMEFAHGQEDHDIFSFSF
AHVAKLKSEAFNNAIIDIYTCNSFTPTGYNDISTSLGYDMAEQTNSKVLGFYGKSDYAKI
NEGESVIYKGIRKANGFNIFGSRNLPVGGNKNDGETPSEKYYHDKRK
>EGEFANNL_00185 hypothetical protein
MNKFYLFSIISFIFLNLNSQKLDSIAPGGVQGTVLWMKTVPWDQNADLHAGYQWKDFSGD
FSKVKYYNEDSEYIVSRTWFARFFNFNPALRFINSQLSKEFEIVNSNLSTSTLIGAFAEY
EFANEYSFQKPSFILAMNGVEGKGFIIDKDKIVNSTESKRGLLEYGDEYGYDLMFHPGKS
PESNIVKYKERTLRSLTYYRTSRPITSVWGEKNNAIVSFGEKFYSFNKYNNSTFDLNTFN
PNDIFTGYIPELFIYNRILTPLERVKAESYLAIKYGFMLENSFLGSDGHLLWDVISQKNY
NHRVAGLFRDDQSGLNQRISSTSYEEAPYFSYLPEGDSYDNANTYNLSNRNKLLVIEKFP
ASHLNDKEYLIWGDNNKSLQASEQIEELLGFNTMSRKWKVSTNMGNLNADPMGMKWEASP
NTEMVLDDYKISFIKKRNTYEQANISSENPLPSYEGHVTFTLNSPSSGTIVKFGTKNNFE
QAGTHDYGIYINGNGDIYPIIEGSTRWANRWSLKAYPNSIIRIDKTKEYIIISLDGNPKQ
QSGQPLPQIFIAKNDIDKDFYVTLRLDANNIDASIKNFRVGGFMEMGNRIELAYRDTRAS
DFANYATNGQSYLIIDRSGTGNFKREDIELFPSDEYDLTRNKIIFNNIFFDTDKNQEDVF
TFGYRPSNIIAKINKTNPSCNPNLETSSQDGKIEIQIEQGDPGFEYQLVNSENKQVVKEG
VFYEDKFTIDSLSQGNYTLKLKELGGFNFISDSTEAEPKAYAHQIISRGANDGGLFEFTV
RDLNPSFQVGMNPISGIMPTTYIQYGFEVKDGLVYLINNRVKSVTPMPGIKIKEGDKIQL
YRQNTYSYPYTIYYRINGISFYSQPVSLSFCFFMIQLNDRIGGFYNVKNGKPGYVATPLN
WNYSGIQPQPATKLLSETSIEHSISLMADCNKKEEESQVLPITLTSNENLTTYYKDFRNQ
SEITAYIKLDQPSPITLSIFDFSANMIYSQDITESKKEHTVDINGLNKGVYILKVFSQQG
EFSKKITIN
>EGEFANNL_00186 GTPase Der
MYLTNSFSVNSELVKLITFVKNDYMANIIALVGRPNVGKSTFFNRLLQKREAIVDSVSGV
TRDRHYGKSDWNGVDFSVIDTGGYIKGSDDIFEDEIRKQVELAIDEASAIIFLVDVTEGV
VDMDQEVAQLLRKTKKPVFLVVNKVDNSMLETSAMEFYSLGFDKYYTISGMTGSGTGDLL
DDVVATFEEENYVDPFEGLPRITIVGRPNVGKSTLTNALLEDKRNIVTDIAGTTRDSIET
LYDKFGYKFVLVDTAGMRKKSKVSEDLEFYSVMRSIRSIEDSDVVILMIDATIGWEKQDM
NILYLAQKSRKGIVIVVNKWDLIDKESNTLKQFENYIKDKIAPFTDTPIVFTSSTTKQRV
FKTVETSMKVYENRNRRVKTSKLNEVMLPIIEATPPPSIKGKYIKIKYCTQLPTKTPQFA
FFANLPQYVKEPYKRFVENQLRKNFDFTGVPIEVYFRQK
>EGEFANNL_00187 hypothetical protein
MRRIKLFLPMLAMTFGLGNLAQAQIQKGNLMVGGSITDMDFGLKKGQSWGIGITPKLGYF
IKDNLAVGGYVNVDISKQGQGSTTRTGYGVGAFGRYYANKEDINNLLKNGRFFFEVNAGL
EGANQKGEPTTNGFGFGLGPGYSYFITPNIGLEALVKYNGLTGGGNEGYQHDLSFNVGFQ
IYLPTSKVKNRLNNL
>EGEFANNL_00188 hypothetical protein
MRYIFSSRLKLTSIVLIIIGLISFGIGYYQNSHVDHDRVVTILEHNEEIAHAQPMNSIYK
NDVPLSKEHIEHAEIQIHNRPWAAFMVPLMLFFGIAATSLFFSAVQHAGNAGWSIVVIRV
MEGIASFIPVGGIMVVIFIILSSYGCLNGGGLNHLYHWMDPSLTDPNSSHFDLLIKSKQP
FLNRPFFVVRTVIYIIGSIFFLYKIKSLTRKLDETKAISDYNRVYNWNVGFIVFFALASA
CWAWDWLMSIDPHWYSTLYMWYTMISCLVSAVAVMLIISIYLKKKGSLPDFNDNHMHDLT
KFLFGFSLLWSYLWFAQFMLYWYANVPEETNYFFGRYKLYSQTYFTMLIPNLVLPFLVLV
SSKIKRNYTIVPLMACVVIFGHYMDFFNIIMPGTVGAFWGFGFLEIGAFLFMLGIFIFTV
MTSISKLNLQAKGNPYYHESKTFEYPF
>EGEFANNL_00189 Cytochrome c6
MKKLTKYILIGTVALSLISCSKKKPALVYFPDMYYPVAYDPYEEAVLAYGEQTTTVPLFK
KHDGRTALDPVPGSIAQNPEGILPMDLPATPEGYEASKNVVSPLNPENKEKDLARGKLLF
DRTCAVCHGTAGDGQGNIVQSGAYSGVPNYKDRQITVGSVYYVMLHGRNAMGSYAGQLLP
GDMWRVAEYVIHEFKPEVENSSKVATIKTTTETSEQ
>EGEFANNL_00190 hypothetical protein
MSTTKTKIYGLYGDDDLLLDGVKQLREKGIQIDEIYTPFPVHGLDKAMGLKESRLSEFAF
VYGAIGLTVACLLTWYTMNHDWPQNIGAKPSFTWGQNMPAFVPIMFELTVLFAAHLMSIT
YLALNKHYPGQKAQNPDPRTTDDKFLIEISNQNFDYVKEILIATGVEEITVKKLEDEKIN
>EGEFANNL_00191 hypothetical protein
MSGHYEAPIREPLILGDKSYHQITEDIAKPIETKAGKLWWYAFYIALVAFIYGVGCIAYT
VGTGIGVWGLNRTTNWGWDITNFVWWVGIGHAGTLISAVLLLFRQRWRMSINRSAEAMTI
FAVVQAALFPVIHMGRPWLMYFVFPIPNQFGSLWPNFNSPLLWDVFAISTYFSVSVVFWY
IGLIPDFAMVRDRAVKPVTKKIYSILSFGWGGKAKHWQRFEEVSLVLAGLATPLVFSVHT
IVSFDFATSVIKGWHSTVYPPYFVAGAIFSGFAMVQTLLSVVRKVCHLEDYITLKHIEYM
NIVIVVTGGMVTVAYITEFFIGWYSGSRYEDFTYFSIGAATGPYWWAFWLLIICNVLIPA
SLWVRRLRRNFLWTFIVSIVINIGMWFERFDIIVINLSRDYLPSSWTMFQPSFVDVGIFA
GTIGFFSVLYLLYARTFPVIAQAELKTIVKTSSEGYKKHHSEHEHH
>EGEFANNL_00192 Menaquinone reductase, iron-sulfur cluster-binding subunit
MASKDKITFRSLEELKDPSLTEKIASNEFAEELPIDEFLGDEKAMFSTKTTRRNFLKFLG
FGTAAATLAACEAPVVKSVPYIVKPEGIVPGVPDYYASTLFNGFDLASVLVKTREGRPIK
VDSNKNAKLFSGSTARSQASVLSLYDNNRAKGPKLNNQNTDWKSLDAFVSKGLQSTLTSG
KKVVILTPSFPSPSTKKIIADFKTVYPTTEHIVYDSVSYSSALDASQEVYGSRILPLYDL
SKAELLVSFGADFLNDWNGGHLEESYSKAKVPGKNMLKHIQIESNLSLSGANADERMPLK
PSAVQKLLAEVYKALDGNSANKVAVKIAKELKEKGPKAVVFADGDKSSYVLAYLINQKIG
SQVADSQRVVLMKESDDSKFSELIHWLDAGNVEVLLNFNTNPVHSYSEGDKLATLLKKVP
YSVSLSEYENETALVSKALAPVPHWLESWGDINPATGVYLLVQPTIQRIFDTRQFQDSLL
VWKRNKNKVNTNSNEEEANNADESSISPSIETTEFNSTYTNSTATPPQTDSYYNFLKEFW
KSQLASTVGYSFNQALYNGYNESKEVAVLTVVGGDSAKALNSIQSIKEGDLELNLYLKTS
IGDGTQANNPWLQELPDPISRLTWDNYITISEEDASKLKLRNEVNGRMQLDGSLVDVTVN
GKTIKDVPVFIQPGQAKGSIGLALGYGQKTGKVGKTGVNAYPAYNNSNFNQYNISLKDTG
KMHEFASMQMQGTLMGRYEIAREIPLETYLNEKSEVWNPALKMGTYVGEMPIGKIGLWTE
FDSKDGPHFNLSVDLNSCTGCGACIIACQAENNVPVVGKEEVRMSRDMFWLRIDRYYSAK
KKIDQREEILENLDQVPMYKELIKPDATNPDVIFQPVMCQHCNHAPCETVCPVAATSHGK
QGQNQMAYNRCVGTRYCANNCPYKVRRFNWFNYALNDKFDYNMNNDVERMVLNPDVVVRS
RGVMEKCSLCIQMTQATILNAKKEGRRVKDGEFQVACSQACSTGAIQFGDVNDPESEILK
LSNDKRKYVLLEDIGTKPNVFYQYKVRNRTK
>EGEFANNL_00193 Menaquinone reductase, multiheme cytochrome c subunit
MLVLFTGVSVFGQDLSGDSKKGETLFKANCTACHALDKKLVGPALKGIYTTLSSEGVSKE
WIMKWIMNNEALRKSGDKRANDIYKEYSEAAMDVFEGRLSDQDIEDILTYVNNPPEPKVE
EAQVEVPVKQNTDTDSSKLLLVSFVIIGIILIITLFKINTLVKLSTKGTELSSLESHKIK
NLSEFYRKYQGFSYFIISILLIISLYGVWAWLMGIGVDKGYEPDQPIYFSHKIHAGENKI
DCQVCHSGAKYGKVSEIPSLSVCMNCHRNISEYNGKYIEPGKSKEFYTGEIKKIYKHIGW
DEENQKYTGKQTPVKWTRIHNMPDFVYFNHSQHVVVGEKTIIAGYNKKNPNQQIDVVCKA
CHGPVDTMNVVRMSNDFTMGWCIDCHRTTEVDMTNGYNAAYFDKLHEKLKLEYGQDKSTI
TVDAIGGIECGKCHY
>EGEFANNL_00194 DNA polymerase III subunit tau
MCYLCYMKWDQIIGQETLKNKLRDSIIENRISHAQLLVGKSGYGALALALAYASEIICVN
SETCYKRLNQFQHPDLHLSFPTINNSTEKREAVSADYASQFRDFLQKSVYQELDQWYEFL
NEEKKQGFISVKEIENIINNLSLKSFEGGYKVQIIWGVEAMRTEAANKLLKILEEPPAKT
LFLLIADDEKKILPTILSRCQKILIPRIEETCIQQSLQNLYSLENNESNIIAKRSQGDWA
LALNLLNSSKVNEEFEKFFIQWNRAAVMAPKKVEFLKEIVEWSIIIAGWGREKQKRFLQF
CSETFRQALLENYSANKLVNASLSYNNFNWKSFSFFVHGNNIQDILEEINSAYYHIERNG
NARIIFLDMGVKLTRFLARKRE
>EGEFANNL_00195 Replicative DNA helicase
MITFEVIMEPLDYQKKNSIKSNKIVTLEKGKLPPQAIDLEEAVLGAMMIDKKGLDEVIDI
LSPEVFYKKEHQFIYEAIEDLFKETEPIDILTISNKLRSQGKLDAAGGDFYLIQLSNKVS
SSAHIEYHSRIILEKFILRKLIEISSNMIEKSYDETSDVFDLLDYSESQLYEITNGTLKR
TFNEAKNLVSNALKKIKSLESKQGMSGIPSGFKNVDKITAGWQPSDLIIIAARPGMGKTA
FILSMARNIAINAETPIGIFSLEMSAEQLMMRMISSETGLESEKLRKANLSELEWQQLYS
RVNKLEKAPIFIDDSPGISVFDLRAKARRLVSQHGVRIIMIDYLQLMTAGGKGIGNREQE
IATISRSLKAIAKELEIPVIALSQLSRSVETRGGSKKPLLSDLRESGAIEQDADIVTFIY
RPEYYKLDTWEDGTPCAGQGEFIIAKHRNGALEDVRLKFTSSQAKFSDLDDYFYNDSNSN
DLSTTFESKINEVGTSFESSLNIPTINPSDSFGIDENMDEEDSNMPF
>EGEFANNL_00196 hypothetical protein
MSKSINNKFFLNLKKWIKKMHLWLGLFIGILILIISLTGALYVFKDEIENYNRKEFIYHQ
EQDVENKEVLPIRSLEKLIDNQVNEKFPLHWVEIPLDKKKSYKFFWYEHNTHAWNYFDEF
PVYKLAYVNPYNGQILKIYDEKNGFFNIVKMIHWSFLLKMDWGKYVVGIPVLIYIIMLIS
GIVLWWPKNKSARKQRIWFRWKKIKNWKRKNYDLHNIFGFYTSIFGLLFAITGLFYSYLL
VGQIIYAIFTLGSDPAPNFSNITTQAPIEIRTDQTLDKIIAKVNNLYLNAESFSFDLGHP
HIDNHEHPNFQIYVKHFPGVYYKNSLLIFDENSGELLKNYDPEDKNLGEKVIAANYDIHV
GSIGGLPTKILAFVVSLLIASMPVTGFLIWKGRKNRKLKS
>EGEFANNL_00197 Ferric-pseudobactin 358 receptor
MTHKLLFLPFFLGSLLSQSQKLDSIQPRFVEIDSIPKDTIILNHGSINNSRDSLQGVIVI
GSAKKKYLNKNISSSLRLDEEIIKIPQNINIISNAALEDQQVTTLSDGVLRNVAGTQRLE
HWADQYTHVNMRGSRASAFLNGVNITSNWGPLSEDMSYVDRIEFVKGPAGFLMSNGEPSG
IYNIITKKPTGKELNGYARFTLGSFDLYRAEVDLDSKINDKISIRLNLMGQNKNSFRKYE
FNDRYVMNPSIKINLTDQTTITAEYIYQKAKMSNIGSAYVFSYEGYGTKPVDYTLSDPGL
APTNIDSHLFNINLQHIINPYWKLTAQLTYLNEYTMGSSLWPSSFNPDGTMIRRVTLSQS
SNIMKFGQVYLNGNMKTGVISHKILAGLDLGSKKYMADWNQWQDLDTEEHPFNTNSLNYQ
YPSNGYPVFNTSVPLVTRANPAGTIEQNYSGIYLQDVLGFFDDNLRLTIAGRYTDVKQND
YGVEKNAKKFTPRLGLSYSINENLSVYALYDQSFVPQAGFLRSGKHPKPVTGNNMELGLK
KDWFNGKWNTVLSLYKIIKKDELTADPLSDPNEKYSIVLGKTRAEGIEFDLKGEIFKGFN
IIVNYAFTENKVIESNTPEYPKGSRIAGYAKHTANAWLNYTINQGSLKGVGFTFGGTYLG
DRSSWSWGGEGQIPMNDYLKFDAGISWEHSNMKLNLNVFNVFNRYLYSGSSFASYYYYQA
EAPRNWRLSVGYKF
>EGEFANNL_00198 50S ribosomal protein L20
MPRSVNSVASRARRKRVLKLAKGYFGRRKNVWTVAKNAVEKALQYAYVGRKQKKRNFRAL
WIQRINAGTREHGLSYSKFIGLLKQNNIELNRKVLADLAMNHPAAFKAIVDSVKK
>EGEFANNL_00199 50S ribosomal protein L35
MPKLKTKSGAKKRFSITGSGKIKRKHAFKSHILTKKATKQKRNLTQTALVASVDEPSVKR
QLLLK
>EGEFANNL_00200 Translation initiation factor IF-3
MITESATPPVCRVVDYKKFLYEQKKKQKELKSKQTKVVVKEIRFGPQTDEHDYEFKKKHA
QKFLEEGSKLKAYVFFKGRSIIFKDQGQILLLKLAQELEEWGKVEQMPKLEGKRMIMMMA
PKK
>EGEFANNL_00201 Threonine--tRNA ligase
MIKITLPDGSVKEFQSSITPLDVAKSISEGLARNTISALVNGKQVEVTTPITEDSTVQIL
TWNDDFGKKAFWHSSAHLLAQAILEYYPNAKLTIGPAIESGFYYDVDFGDQVFSEKDFEK
IEKKILENAKKNSTFRLYPVSKKEALEKFKGNEFKEELIANLEDGSITFVTHDNFTDLCR
GGHIPSTGIVKAVKILNAAGAYWRGNEKNKQLVRVYGITFPKQKELIEYLERIEEAKKRD
HRKLGKELQLFTFSERVGAGLPLWLPKGAKLRQKLIDFLGAAQQKAGYEIVATPHIGHKD
LYVTSGHYEKYGADSFQPIKTPNEGEEFLLKPMNCPHHCEIYRSAPWSYKDLPKRFAEFG
TVYRYEQSGELHGLTRVRGFTQDDAHIFCTPDQLIGEFENVIDLVLYTFKSLGFSDFTAQ
VSLRDKDNHSKYIGSDENWEKAESAIKKAALEKGLPTVIEYGEAAFYGPKLDFMVKDALG
RSWQLGTIQVDYNLPERFDLHYIGSDNEKHRPVMIHRAPFGSLERFVAILLEHTGGELPL
WLSPEPFILLPISEKHIDYAKKVLKLMENSDICGRLDERNEKTGKKIRDAEMNKIPYMFI
VGDKEAESNTLSIRKRGGEDLGSFSLEDALSFIKKETSKP
>EGEFANNL_00202 3-dehydroquinate dehydratase
MQILIINGPNLNLLGKREPEIYGSQTFEDYFQQLKTDFTSVELEYFQSNHEGAIIDKIHE
VGFHYKGIVINPGAFTHYSYAIYDALKSVTTPAIEVHISDIENREPFRRISVIQEACLQQ
IKGKGLAGYDEAINFFVNRSLKS
>EGEFANNL_00204 hypothetical protein
MDTAPKKVHQGRNIKRLREMLGIKQESLAIDLNITQAGVSKLENKEIIEEETLEKIAKFL
NLPVEAIKNFNDETTVSFISNTFNNTHGFMYSTYTDCAFNPIEKIIELYNEKEALYERML
KEKNALLEKFLK
>EGEFANNL_00205 hypothetical protein
MTIEQIRKKLEVGDYILASKMLKITPENARIRFARNKEDVKSVILLIINNREKLIENFHK
SLNSKN
>EGEFANNL_00206 hypothetical protein
MIDNKLQIFLEKELLSKWDKRLVFTPDMKLHKDFGLVGDDVDDFLIHFIKEFNISVSNDF
NFDERFYPEAYTLNAIFKVIFNKAKSLFLQKTIQEPELKDLSIAELQEAIKIGVLK
>EGEFANNL_00207 hypothetical protein
MQGSAKGTSIASKYLSKALPYEMPFKFYTINLKTKVISSTSNLGRGLGRLVTYAGWALLA
IDVIQLLIEVYEVDKKNNKVTFHGFGGGASGYW
>EGEFANNL_00208 hypothetical protein
MGHNDLSDYDILNIIEKARKSSELGISYKK
>EGEFANNL_00209 hypothetical protein
MRNHTIEELVCQFQVSGSSLYELNEIIILLYKQNNNDALNLVLKLAMSDYGGITFKAELQ
IIAMLGTLHWGIKGLEKLGKSTIKNDCFRAINNVTRLLSHISSKSLNDFFFANSNLPCIK
RLNLENEKYKTEEWITNAKKVLIEVVKSVEKNDIFPLGLIQNLIYPFNISAQEHMFAALM
IRWFNFNSNNVYKYLELIESTTKKEIIYHNFLKNNPYILEPFHAQIWSKPKFGENLIPDF
LIRSMDDAYTVIEIEEPNTSIMTKSGELSAKTTHAKKQALDFRDWAINNNLYASRKYQNI
YRPFCLVVIGRESELTEVQKQRLKQENESTQGILKIVGFDKKTFRKTIS
>EGEFANNL_00210 hypothetical protein
MENVFKQNQKIISFGKKAIIIATKKDPYRPKIDPYNRKELYPKKDYLIMFFKEIDKNGRE
KYEGREDIHQNQIESPHW
>EGEFANNL_00211 hypothetical protein
MKILIDTNILINLEDNKAFSNIFPKFYRLAISNNCKIIYHLQAIPSDLKRDLNTIRKEIT
ISKLQKYEILINYSIPSENFNKIFEVKKENDRIDNKQLF
>EGEFANNL_00212 hypothetical protein
MLGLIDVSKSKEDFQRLKSYWNTFHCQSKIISSKNRIYGKYCKNRFCTVCSAIRKADIIH
RYYPTLKTWKEPHFLTLTVRAVKIKSLNKWINGMFRAFSLILDRYKKRFQRGKGIPLIGI
KSLECNFNPQRKTYNPHFHIITANLEIAEILKKEWLQIWKYKDNPNQIVVSSKAQFIRKV
ENLERDLIEVIKYGSKIFTEPDIKKKI
>EGEFANNL_00213 hypothetical protein
MIYIQALDAIFRAMKGKRIFERFGFNLPKQERPQPDSKLVFEFESWNFNLKVNDWVNPET
GECLTGYKSPAELAYLLEEGMNSSFL
>EGEFANNL_00214 hypothetical protein
MKKYCLLYFFIIFRISLYGQELPTYYKDLIYSIKENNFTDFKTLFAKVDNINRFIPENLE
KESYNKLTLLGFACSYKRNKIVEFLLEKKADLNLGVEDDYYVYDALYSIYQKDSLKKKSS
AIGKLLLKKGANPNTVYGDNTRSILHIACSKGDYAMVKLLLDNGADPNNSGNSGIEYKYY
PLIEAVKNSDYRIIKLLLDAGADISVKDEYNKTALDYAILSKNKKIINLLNKRITLI
>EGEFANNL_00215 hypothetical protein
MKKLLYLILLSIFILLFIGIINYDTEFGNDFRLFIKYPPSLKFYIECPPDTLFERNPTSY
LILEYEKYLSRYNQLKIWNNFIPFLLIQLFLITLFFNTKRIYQHNYLFIDIPLFIFSYFI
LMCTFYLSFGLNFDFLLLFVIFILSIVIANYFIWIRLRFRLLKLNKIM
>EGEFANNL_00216 hypothetical protein
MSHPLTENTKLKCNKGTKETPLKVTSHSGLKINSLLKATEKDKEANTNIIPFGQCKLKPT
SGGYLPCTPVIKQWEKTSPFSLNGMKKLTTDSFCMCATGGKVSPLTPPETFINVIEKSTS
FSHLKDLNDNYPIEINGLEGPTKVELFDIAEYKVTSFTKEPKFIHKTNISWRYADNKTNL
YKLNGKTVKLSLFIGEIDDLNKDISIYAYLYEISENIKITSRVINTVKIISRAEWGARKP
DPKKGLYEKIMEPLDKFYDTIVVHHSGNEVDYPTVKQVQDKHMDSKSDSRADIGYHYAID
KDGKIYEGRDIKFKGSHVNKANTGKIGIVLLADLSTDDAGMGWRSTFEWSNGELTNKLER
SLLKLCKFLDDLYGIEILAGHMEINTDRYCPGNLTMAKINNWRKLLKMKKP
>EGEFANNL_00217 Protein YceI
MSIIALTLSFQSCNNDSKEAKITNQAKQEAVSSKEANTYKVDTLASKITWEGGTLASKHL
GTIILQSGELKLKDSKIESGSFTANMNTISTTDIPDPEKAKLLNNHLKNEDFFDVSKFPS
SKFVITLVKPIESGEYNVELEGNLEVKGITKNLSVKANVKAEGDKVTLKTEKFTINRQEF
NITYSNGEPQDKLIKDLLDISVDIVANKEAN
>EGEFANNL_00218 DNA repair protein RadA
MSKNTKTSFFCQNCGAQYSQWMGQCKACGEWNTIVEEIIEKRTKRNFPSNKSISSNIIKI
HDIETVHEDRIISGDSELDFLLGGGIVPGSVILIGGEPGIGKSTLLLQLSLQINKKVLYV
SGEESAIQIKMRGDRIKYSNSDCYILTETSIEKIIKKSIELKPELLIIDSIQTLSSSYID
SSPGSISQIRECASELIKYAKSSSTPIFLVGHITKDGTIAGPKILEHMVDVVLQFEGDRN
YMFRLLRSHKNRYGSTSELGIYEMFQDGLRQVKNPSEILISKKDENLSGNAIAVTLEGLR
PMLVEIQALVSTAVYGTPQRATTGFDIKRLNILLAVLEKRAGFHLGSKDVFLNITGGIKI
DDPAVDLGVICAILSSNENVSLPDNCLFAGEVGLSGEIRAINRIEQRILEAEKLGYDVIF
ISKYNKIDIDKFNIKIELVGKVDDVYKMLF
>EGEFANNL_00219 Murein DD-endopeptidase MepM
MSKSNYSTVIITDKNSHETKVYSIKQKHIENIILYKRILLFSTICVVILLAGLSSYIGYV
YYQKRDLRNKILNLQSKLDDKQLDYLINNLSEAGETLELIEKYLKEREVKTLSSSRDLDS
NNDVGGEYYAVDDMNVDVVNSEKERIENLLKNIQSIPMGLPHIGRLSSDFGVRGNPMSGR
GSEFHPGLDLAGKIGDPIKVTANGVITYASVRGGYGNCIIVKHSHGYETLYGHLSEINVK
VGQKVKSGDIIGKLGNTGRSTGPHVHYEIIHNNIKVNPKNFLQIK
>EGEFANNL_00220 hypothetical protein
MFNKKNNSSNGFDSQNITTVLAEDCIIEGSITSKAFIKLDGKVTGNIDSAGGVILGQKGF
INGDIKTKLLTVYGSIEGDVFTDELIIKSTGKLTGNIHAKSIELEKGGIYNGNINMKETS
VTDNINSDLKGKK
>EGEFANNL_00221 NADH dehydrogenase-like protein
MKKIVLVGGGFAGINFLKKLKNNKNFHITLVDKNNYNFFPPLIYQVGSSVLEPAAISYPF
RRFIRYKSNVSFRQGELLEVKPNENKIILSNGELDFDILIFATGTQSNYFGMQNLEKYSV
PMKTLNDALLLRNTLLLRMEEASQEINLEKQKELLSIVIVGGGPAGVEIAGVTREIFNTL
QPLDYKELKSKVQIHLVEGSPNLLGSMSEKSHKEAYKALNKLGVNIILNQHVKDCDENFI
YLGSGDKIATKTIIWTAGVTSRVFAGISKDVYSRGRRMQVDEFNKVISYENIYALGDTSL
MISDPNFPDGHPQLAQVAIQQGINLARNLKRELRGQNKRKFSYVDKGSMAVIGKNKAVAD
LMNNKVFFKGFFAWLIWSCIHIISLVSIGNRLNTFYRWLTIYFSKGSSLGIAYEIGDKKN
K
>EGEFANNL_00222 hypothetical protein
MIQIDDTLISLDLIQKEFVCNLNKCKGICCVEGDSGAPLDEDELSILDDVYDDVKPYLRE
EGRASIEKQGKYVVDLDGDYVTPLIDDNECAYVIYDDKGIAKCAIEKAYEDGKINYKKPI
SCHLYPVRLQKLKSYLAVNYDQWYICSDACTFGKELKVKVFQFLKEPLIRKFGKDWYLQL
EDAEKLFNAE
>EGEFANNL_00223 Thiamine pyrophosphokinase
MNKALFFINGEEPSKIPQNINEYSLIACTDGAYSRYVYKFQLKIDFISGDFDSLIQEQVP
QGITLISTPDQNKTDFHKALELLVERRITQVDVYGATGRESDHFIGNLSTALYFKNKLKI
TFYDDYSKFFFSNHKTHLTNVKGKIISLIPFFKAENIQTQGLQYPLNNEPLCLPERIGTR
NKAIDECVTIEYSNGELLIYISNS
>EGEFANNL_00224 Cob(I)yrinic acid a,c-diamide adenosyltransferase
MKIYTKSGDDGTTSLYGGKRVSKNITRIKAYGDVDELNSYIGLIRSYNKDINIDKQLHTI
QNSLFDLGAELATPPEKMVLANGKPRLTCIIKVQQIEQIESWIDAMQEVLPKLKEFILPT
GSILTSTTHIARTVCRRAEREVVTLNEVEEVRNICLNYLNRLSDYLFVLARYFGCLDKNI
ETPWTPNE
>EGEFANNL_00225 hypothetical protein
MNYIKKSTYNPTENLIYTNAHLSTIVAGAIKKYPIPPYNRERLELEDGDFLLLDWWRNEN
TNKLIILSHGLEGHSRRTYINSCADYFHQAGYSILAWNQRSCGGEMNRLPSLYHVGMIHD
LEKVVTYSITQGYSEVYLIGYSMGGAVSLNYTGRMKIPKELKACIAFSSPLDFVSNAETF
RKPANYIYLKNFINDFKKKLKYKSKQYPDIFDINLIRSINSFDEFDEYVTVPLFGFKNKE
DYYKKVSPINILDNINIPTLIVNAKNDPFLSPESFLKENQMSNVNIYFEMPKYGGHIGFM
LPKSKFSWVEIRAKEFIEDIKVK
>EGEFANNL_00226 hypothetical protein
MSWNIHINDKWKDKQEDLLTIINNFDALGEVIFKERNTLKKIQIENLGTLAVKSFKIPHL
LNQYVYSGIRRSKAYRSYHHAEILLNKRIKTPNPIAFFEERIGGKIQRSYYISEFCSYDF
TFRELIERKENFKDWNNILESFTEFIYTIHQQEILFKDLSPGNVLVEKINESYVFSLIDL
NRMQFKKLTLNQRIQNFIKLSLTDEMIPIIGEKYAKLVNESLSKIIQILDHKNHVYINKK
TRKQRLKKLLGKI
>EGEFANNL_00227 Deoxyribodipyrimidine photo-lyase
MKEKINIFWFRRDLRLHDNPGLYKALGANNVYLIFIFDTHILNQLSEVDDARVSLIYDQL
QNINNQLKPYHTQIRFFKGKPIQVFKEIIKSYEVGSVFCNEDYEPYGQERDKKIKDLLAT
EQITFYQEQDHVICHPSEVFKADHSPYTVYTPYSKKWKEVVSKKTLPYYPSEKFLNNTKQ
VVGEPLSMKEIGFTKSTIVPPSFNISQIQINNYKETRDYPSLAGTSHISTYLRFGILSIR
EVYKNTEVNSSIFINELIWREFFISILYHFPPVVNHSFKKKYDNIVWRNNEEEFQLWKLG
KTGYPIVDAGMRELNFTGLMHNRVRMIVASFLCKHLLIDWRWGEAYFATKLLDFELASNN
GNWQWASGSGCDSVPYFRIFNPTLQMKRFDPQNKYTKQWVPEFDTKNYMPPMVEHTFARK
RALEVYSKALKI
>EGEFANNL_00228 23S rRNA (uridine(2479)-2'-O)-methyltransferase
MLSANRIKLIQSLANKKYRQKYNLFIVEGIKNIKEFIYSDFTLSKIYTIEPIEILSEDKY
VIISKKELNKISFLKNPSNALAIVEIPKPELKKIEGKQLVLESIQDPGNMGTLIRLADWF
GIEQIICSEDTVDIFNPKVVQASMGSLARVNVVYTNLEIFFRDNQHLPIYATDMDGESIY
QVELEQEAFLIMGNEGNGISDSIKNTCSKTISIPRFGEKKKTESLNVAMSAGIILGEFFS
QKEKNERKN
>EGEFANNL_00229 hypothetical protein
MKIQYNITLKILIFSLLFLIFSCRTNKVPENSHLFTGNTYKYLDAKGKPYADELDNYVKQ
KPNKKIFFYVPLKLWLYDLSNAKFDSVYKDYYLVDKEQRSLKLLDSLYLKYNLDSYVGKS
RWLDRFIYSKGEPPVLVDSAMANSSAKNLNQYFINRGWRKSQVIDTILTSGKKATVQYNI
KLGEPMIIDTIIYDVSEEINANIYNGYLRFKNRVNPKKLKKNYTKEEILQNFYQKLSLLK
KGDRLDAYLMGDEITQLDNQFKNMGYFGFNDLKDEVIFYVDTANNINHVPVTLSIKKSPY
TLPSPTSASGDSLQGSNDSISKDRAKPVFKKFKYEKINVTLLNNQTDDNKESIVDSSYFV
NKKKFIRFENGKKVKSYIEDTVAFIINKSDGRYRDRVLADMLAIGMGKTYRLNAETETRR
NIYKVNNFNLLGFNTSPEKGSDSTLISNIILMPMNKYSYEIGLEAFTSSVANFGITPNLT
FTAKNLFRGAENLNVTFGGSLGNIESKKNNNRLFNASEFNTQVSLSFPRFLAPFGLRDKI
PKSWGPSSAISVGYNAQFNIGLDKRSYNAGFLYNFSPTRSTNHQISLWNLQYTQFLNPDN
YYNIYTTDWAGVNGMREIYFTVNPSMREEYESGKITNEQLQHIIANDPNFRTEVEQKAPQ
YWDQYNLLESRRYRFTQNILISSFQYSFTYDQRLKYFPPKHPFYLRAQMELAGNMLSIFN
KSFKDFETSNNKVVKEIFGVPYSQFVKFDFDLRKYWNLSSKKSIDARFFMGIGLPYGNSF
SMPFDRSYSVGGPNDIRAWRAFGFGPGASKLSGKNGYELIAIDNFKLLTSVEYRFPLPSN
GFFGALFVDAGNIWGINNDSPYKFKFDSFYKELGIGGGWGIRWDISNFIIRFDFAYKFYN
PQRDLGDRWYFKHINILQPQFNFAIGYPF
>EGEFANNL_00230 Sporulation kinase D
MNLYGNIRLSNWIGYISALLVAIFFIVFMNKKVNQLKKDESIRISNYAKTIELLNTEINI
PPHTQTYLVGTIEQNTSIPVILVDSKGVYIDSKNIDTHIVNNPQTLEKELNNMRKQYPPI
SIILPFGKQYVYYKNSIFLNQLEYFPIVIFLVIGLFIWFSYWYFSTLKKTEQSLLWAGMA
KETAHQIGTPLSSIIGWLEILKLENIDKKPIQNIERDVNRLQDITERFSKIGSIPSLENE
NVVKISKHAFYYLKNRVSKKIIFEFSAPEYPIFIKLNKHLFNWVIENIIKNAVDAMKGEG
TIQLKIIDHKKNIYIDISDEGSGITKNNIPKIFKPGFSTKKRGWGLGLSLVRRIIEDYHF
GRIFVLNSEINKGTTFRIILKKEL
>EGEFANNL_00231 Lipopolysaccharide export system ATP-binding protein LptB
MILKGEHLVKSYGNKRVVKDVSLNVKRGEIVGLLGPNGAGKTTTFYMIVGLIKPTQGNIL
IDSLDITHDAMYKRAQKGIGYLAQEASIFRKLTVEDNILGVLQMTKLSKKEQKIKTDSLI
EEFSLEHVRKNRGDLLSGGERRRCEIARCLATDPKFILLDEPFAGVDPIAVEDIQKIVRS
LVNKNIGILITDHNVQQTLAITNRTYIMFEGNILKEGYPEDLAGDPMVRQVYLGENFRYE
KY
>EGEFANNL_00232 hypothetical protein
MKIKNISTDNFVFFTSTGAITIISFLFLGLSSIALGIISVMFTYIIYSAKPKSGKYIYTF
FWLSMILFGCYLGILFKLSIEFYIFLFLLSNYYYIAYNHDPISDRAIPYFIIYSSLGTTL
KDLSYHTAIAYLLGSIITLTMIAIVNRRKLEFINFQSSEFTQTLFTHPFQNFVNSLIFSS
FLFLTLYLPEQLKLERSYWAVMTFVVLLKPKDQGILTNTIKRFLGNLAGSIVVLIIMNID
SKYRIFHFLVILLCVFFLPTFLNFKYFLKTFGLTVFILILLESAEFWKDPNYSLPFARIY
ETFLGGLLALLGSFIMKKMHQTILKET
>EGEFANNL_00233 hypothetical protein
MPDESFPNSSYSPLNSSDSSEIIYQSSGLGQSFITYARVSAQGKDISKKDHIKVKITQKM
LTYNRYDLLCPSEVFADKNVYPLQNSKYLLGARVLIELIQFGKTASSFEAMVTGVEYVNE
NQYPFIRLICSAPSVLLDQGARSRSFTNLSLKQIVERVASGYNDQRLNFLIAPFSEEVLP
YTCQINESDFDFLKRLAVRFGEFFYHNG
>EGEFANNL_00234 Actin cross-linking toxin VgrG1
MEKMVERKKLSKENLASIETQTDSPFLRLGDIMSMQAWDKEKQKALPIESYRILEIVHVY
SAECYYNLPIGMPREHPIAPYFDEKAFPRADSQYGVVVNNNDPWALNRVKVRLVWQRDSQ
ETTPWISMLQAHSGDGQGAHVLPEVGHSVLVDFLGGNAEAPVVVGTVFNGNQKSGFHTPN
NDLKSFQTRSGTKRVANDAEGSILEEDSAGSFFKLEGDGNVTLHVVKNLNIRVGENLSVS
VGKDMVSRIDGNKSESVIGDSVYSAQNVTATVSENYRGSVGKVFYQSSVSLEVQTLNGEL
KLSAATLAIVKGLEDVKVSKG
>EGEFANNL_00235 hypothetical protein
MMLGLIDVSKSKEDFQRLKSYWNTFHCQSKIISSKNRIYGKYCKNRFCTLCSAIRKADII
HRYYPTLKTWKEPHFLTLTVKAVKINSLSKWINGMFRAFSLIMAKYKKRYQRGESIQLVG
IKSLECNFNPQRKTYNPHFHIITDNQEIAEILRQEWLQIWKYKDNPEKIVVSSRAQFIRK
VENLERDLIEVIKYGSKIFTEPDIKNKSKKQKSNLAPMIYIQALDAIFTAMKGKRIFERF
GFNLPKRERPQPKSKRTYEFDNWNFNLKVNDWVNTETGECLTGYKTPVELAYLLEEGVNK
RLY
>EGEFANNL_00236 hypothetical protein
MVKYLFLFLGIVLSVQVCAQSKTDQQITKEIMKTIELPQQYKKEPFYYCNIYSANIKWEL
FINDVQMFSHYQGKITSPIVPLNYNILNSGKQKITLRIYPANEQSKLGEYATFKMRLFYN
ENFRDKNDPELDILNFELPREKTKELPYFEKTFEFDAQVPYELVGWTKSKDLTKVPNLET
KVLTKIEELHKILENRDTESYIKAIMPRSKEKYICLYATKEEIENDINETSLDNGFILGN
FKEVQILPVRNYALVLEPNNRIVKIRQKDSDNLVDGIIFKGIDKEDGEEVTGDFLFRFHI
PEGSEELEVIR
>EGEFANNL_00237 hypothetical protein
MVKYLFLFLGIVLSVQACAQKKKNTTMIEEYKKLQDSLPSYPVEKQITYIAHLNSKTPYE
LYLDDILVDRNITSGFSKSVELNPYLLGNGTHKLKIRFFPPENSEDGRIKPKDIVYDQDV
KWNLYFIKLQKDPNDPLGYAGSIDYRNSELPIVAPPTEVPVWEQEFEVEVKDLPYQLKGW
SEGEDLSKLDPKELEKEVVAYYNQLRDLLNKGDIIDFMRLNAINDYETSVSIYNTKKRFE
EAYQENIDVLNQKCVGNMLPITDYVVKLYAKGKIVALEIPEGEYKYWSALFSDSKKYGQS
GWGIMIYRPQGSKEFKIIRN
>EGEFANNL_00238 hypothetical protein
MVKYLFLLLGIVLSVQACAQNNKSVKELEKRLLAVKDSLPTYPVEKQITYIAHLNSKTPY
ELYLDDILIDWEREDNFSKSVELNPYLLGNGTHKLKIRFFPPENSEDGLIKPKDIVYDQD
VKWNLYFIKLQKDPNDPLGYAGSIDYRNSELPIVAPPTEVPVWEQEFEVEVKDLPYQLKG
WSEGEDLSKLDPKELEKEVVAYYNQLRNLLNKGEITKYMQLNKTKHYEVSVSIYDTPQQY
EKDYYDNVDLLSQECIGNMLPITNYTVKLYAKGKIAALEIPEGKYRHWSVLFSDSKKYGQ
SEWGIKVYRPQGSKEFVIIRK
>EGEFANNL_00239 hypothetical protein
MKKIFLLTLILLTGLQACSQEKKNMKNKENTTMIEEYKKLQDSLPSYPVEKQITYIAHLN
SKTPYELYLDDILIDWEREDNFSKSVELNPYLLGNGTHKLKIRFFPPENSEDGRIKPKDI
VYDQDVKWNLYFIKLQKDPNDPLGYAGSIDYRNSELPIVAPPTEVPVWEQEFEVEVKDLP
YQLKGWSEGEDLSKLDPKELEKEVVAYYNQLRNLLNKGDIIDFMRLNAINDYETSVSIYN
TKKRFEEAYHENIDVLNQECIGNMLPITNYVVKLYAKGKIVALEIPEGKYKHWSALFSDS
KKYGKSSWGIMIYRPQGSKEFKIIRN
>EGEFANNL_00240 hypothetical protein
MTARYQDRKSKGLPIKITVDRPSFSGGMYARFLRSSTQPNKIGYAYSLNFAASPLFKVTG
KLDLLFYAQFIPYIGQALKAINKVVEGINFLTLGAVKIEYYLNIATSLAVDLDWTGMEYH
RIDGWNTSKRIGMKTEIKFWLEAGVNLRADFKGIASEEAEGAMTGTSTIDITITYDNVRQ
KADAEVDFKGLEVKIWLKAKIDMKKKRGEGPPPEPNTKPDYIKPLIKGMKQPWKINIM
>EGEFANNL_00241 hypothetical protein
MKKIITGVLASMFLLSCAQKSRERILPQNDQIKKITIYQEPKNMNDTLKPYLFAPSLSGR
NDTIKNKAYYAFVNTGNSQLEFSVGDVPVSLNLFWGEITGKDGRKTGTNIPLNSCILKSG
KYKVTGRIYPRYGQSALEFHSYLMMEGYYQEATDWDHTYPMFTIETPDRYHKNGEIYNPI
TGYPYFELQTEIEVEVPYELEGWSNSVNLKEQEEESLKKELQERYNQIRTLLAKKDTASL
RQLVQEREDLLGTVYYLPEQEKEKRLQEFLDLVANDEFDIAPYPSEAQILFFAHGKMVTM
VDPINREGVIRLVNKKDPKDIISLEFRFHRKKLGEKLSVI
>EGEFANNL_00242 hypothetical protein
MPRGITEILFSQEDIDNNQVVHLPQTLLGCKVYGIRANNQKVFMRVEMYTETLEKIKKLE
QEGHKYSGVKWVYGKVNSLEDKQIAWSSWYKDLNNNEKYEPYLGEAPHNFPPLEKILNSK
VKDIYEIKSSYNVSNTISAKFDKQTNFMPTLYWIEPFLIYPELYKAKNPKGVFILPVQPP
GPINAYIYCDDFILADENSNLIDYFLSTNKSESEANPFYYGNTIQINIDTQLIPHGGTLL
VQILEEGTNRVLYQTKTTVDDASKKTDETSELHTYLNKHLYGVALAELTLSIDQKPAEQK
KEQDRTFILKISYIDYHPTSDGVYRALKDFVMDLNYRSIEGYITIRYKDTQDYLQKTEKE
VNQVVQKPAKIKAAPGCEPCYYSQIVAQRYKSNDFSKTDGESLLVFDENKRVKGDSQPRV
DIIAGDTSPAYLKLKADLHTQGKCHPDKHTHGGKSVFSFERREDGVYIPAEKQNIKVIGD
IKDKEINLSLPYIYIKDQQIGGVVSTFPFNYFWLTQKDAQAHVVLIETCRYQNDVLINVF
PDISWELAFTFALENPLAYTHSGKKPGYIFYEAQEKARKSGYDKYQLSQGGAVPFEFSLS
LKNAYNGETVKNEYALKYAKKLNDTLSIFTKLKNMADKVKNATGGAAKKISGMPFSFEIQ
SPVLGAMLSWKNEEQDGRVANTGTLSFSADPLIGAEFTIDLLAAGSNLHPVVKVIERGVR
VGLDILGGYFILEAKFYGNLAITIEAFKFGYQGLAFSQQPAKIEGKMGIILLLKLKVAGK
IEALGYEVEMSFNAEADADAYFGGTAKLGYDKDGIYADCVGKFSGLLFSAKIEVVIGKYT
RKVELKSEPIWASDEVPLGKVYFNKK
>EGEFANNL_00243 hypothetical protein
MGIKYIVQGAICQCQFGSATDEVVVKTQSSLYLNDLQSAKKLAVTTTDIGATFKKNCFGS
CTKKNNDPCTVTVTQWSNPEVQKVEGAGNLLTENSQATCPIGGTNCISIVHHGQQAEPSQ
QNVKNTSEEVRSQINPWTEPEELSQPEKTEVKLKASSHA
>EGEFANNL_00244 hypothetical protein
MEESRFFIEEVNPQPKPEIKEEPDFIVSSGDPIQLAPHNRIPVKPIIERTYRLNITYPHT
QHQVDYEIKVQGMVFSQDAAEFRFTKDQYFVDGYAPTKVLDELDIAISKILYPMNLNINY
KTQKVTLTNLNEIQKRWLSKKEELRQDYQGEFFEKYLKQIDKIIKDSYNFTQKLVKKDLF
FSLFTHAIYKEYNRALKIPAHWTFLPSGEKYRQVFTGEQRVEPVYNHLNGIFIYMQAITA
DKKYQIKAEYNLDAEDYTLKDIVAQLYKKEQENKEILIRCKIHQLREKEPVKYKPTAKDL
EEEQRKKEEEEKNYQKYLQSKKSWFDRLFGF
>EGEFANNL_00245 hypothetical protein
MRSLLIIISCCFYTLLLQAQTYIDKKGVGEESAINYKQLVVYK
>EGEFANNL_00246 hypothetical protein
MRSLLIIISCCFYTLLLQAQTYIDKKGVERFDKENYKNRNNGEYYYRGRGTFIRISDSAR
IDFYEGKYISQIVTVPFKPNIFYKEEKKFYPTGILKSKEVYFGPGYEIKTGKSQYYDKKG
KLIEEVDEDAKFGAIKPQDIINFLDREGYINKQTGEIGINSEGEKYDFIEFEFNPASKLW
DIYIEGGREYTPREIERIEELSTIENEDGSLGYANNLFPDSYTYAYKIDGETGKVLSNNL
ALDPRDVFKTYQGKEYTRRQWRYYRNQHHNQLLEEGEYFGDKEKPYPVQKRKETP
>EGEFANNL_00247 hypothetical protein
MRSLLIIISCFFYTLLLQAQTYIDKKGVERLDKENYKNRKNGEYYHQKDGDYIRIKDSTK
ISFYLNSFQIREIPPKPNIFYREEKKFYPTGILKSKEVYFGPGYKVKIGKSQYYNKKGKL
IKEVDEDAKFGAIKPQDIINFLDREGYINKQTGEIGINSEGEKYDFIEFEFNPASKLWDI
YIEGGREYTPREIEKIEELSTIKNEDGSLGYDNYLFPDSYTYTYEIDGETGKVLSNNLAL
DPRDVFKTYQGKEYTRRQWRYYRNQHHNQLLEEGEYFGDKEEPYPVQKRKETP
>EGEFANNL_00248 hypothetical protein
MKPIYLLIFLFIIKISYSQPVEALSPIIKLNREEYQKISGSSYIKKDGTKATFIGMLGYG
ALSLRIEEYPPVPNILLQVKKVYYNNDILESEKKYFSKVLIGRSRYYDENGKLIKEVDED
AKFGAIKPQDIIDFLDREGYINKQTGEIGINKEGSKYSFIKIEFNPESNLWFIYIEGGRE
YTPREIEKIEELSTIKNEDGSLGYDNYLFPDSYTYTYEIDGETGKVLSNNLALDPRDVFK
TYQGKEYTWRQWDYYRDHHRNQLLEEGEYFGDKEEPYPVQKRKETP
>EGEFANNL_00249 hypothetical protein
MLRIKVGGKITKTADGGIYNYAKGNISFNSATEVIETAPEIIYGKAEAHPPTPMKTTCMV
EFRPGEDYRAEFGFDWFRDGGCFWDSNQRDFKQVVGKYYTDSTYTQVFAGGNKISPYFKP
DEEMFTRLENSFNRYYNPFFKKLYKVPMLSLRKGKTALLDIINYRQGEEALSLSLEFANP
EAKNYLEAEFLNLPETSPTDEQGRLEPQKVRIYCKEEFSQIQKLQVKSKDAQGSTEVCGE
LLIHPNSPEYQKEVKFLFVAVQTNLNGEVKQTEFKEKDKAFFEDLLGQALIYPKIEIRTL
DCTDPVFTEELKKKGHIAHGKYKKKIKNPDRVIDAEGWYIQKIRKIHDLLNQQAELQDLK
KEFPPKEYYYMYFFAEDYTPGVEGYSYYNSNFTVCLTFEKTTAAHEYGHAVGLPHTFDAS
SKNSLYTYSQKRTYNLMDYGGDKNFFLYHWQWKLINPNLLKLDI
>EGEFANNL_00250 Actin cross-linking toxin VgrG1
MGEDYNHISGKIIEDSGLYHRSSFGDSFLPFAKVTINGKELSKKHHIQVNVYQEVLTHNK
YELLIPSEAFSDHDTYPLQNSKYLLGQQFSIQLIQFKKTTLVFEGMITHVEYLSENKYPY
IKLIGLANSLLLDGNKRTRSFENKSLKDIVKKVTSDYNDNRLNFLIEPETEEIIPYTVQY
SETDFEFLKRLAIRYGEYFYHNGEYLIFGNGDLKRTELSEGRDFQKYSLDMQSHPQHFIT
QQYDLNQDELYTINSKSLHYPDIVNLFQFQAVNASEKAYAKNFTDMHIPALLNEGDHAMY
RAVERKRKSNQSTLWLNTETNHPALRLGDAMKMNAWDKTKQKHTPIETYKILKIQHQYSC
DGYLNRAQGVPIQQKVAPYLDERAFPKADNQVAKVVDNNDPLSLNRVRVQFKWQEASNEK
SPWIPLVQGHSGSGTGAHVVPEIDHTVYVEFISGNAEVPLVIGSLYNGSQKSGYHTAKND
LKVFQTRSGTQRIANDAEGSILEKDAAGSYLKLEGDGNATLHIEKNLTINVGENCIFTVG
KNMQTRIGNEYTCRVLGNAKWVVTGSADYDIKGDYTTHTDKGEHSTSEGEINYRSKNVIQ
NNSQKQVKNNSGETSNLF
>EGEFANNL_00251 hypothetical protein
MGSFMSKLELDGEIYTILECNYGFEKRTDSTSKPSGETLGGEIELTIESRGKMNLVEWVL
SPDKEKSGVIIFYRRDGMSKLFDIHFDKAYCIKFHEKFNSTGNEPMQITLTIAAKTLKFN
NHIGYTRDWVII
>EGEFANNL_00252 hypothetical protein
MYRINYLNRNVLITPDEVLSHAATDQEINARLIQSNIINAEERFIAPALCDEFYEDFINQ
KNRIVTEENRAEIIESINSSSSVKVKGLPLGTIVNALEFVENEWYLKLWHRFLWKLTAES
VDMMCIVPSWLRHTSAGQMLNNPKTIGGNEGGANSGDLKDIQFKLDIAIQDRIDPLMEQM
KAWLCRNKTHFPLFCHPCDECGCNGNKDHKGVAHIRKTNLITNLYDD
>EGEFANNL_00253 hypothetical protein
MASLASKKVQPQKKVVSNSVSLDVRNPIPFEPTGQSSAFLLTRTDRKYLPFLEPKDNFFQ
LLLEAKLLSPTNNACVNSKANFCIGKGIYFKDHEQKDKEFLQWVKRVNHKGQNLNKVFKS
VFSNDLNVGNNFVEVIRGKIGTKRFIRVINRNFLDCRLSVPNDNDICETVFISKKFRQRN
VWSLKEEEAVELPIYYGDPNMHWYVNEKQKTEHCIIHVKNEFSGYDYYGIPDNVSSLPWQ
ILEYEGARYNIDIFENNLVSGGVVCLDGTVSQDEAKVIGQNIINAYTGKGKRGRIAVVAG
AKGVTNSFFQPFNVQNDGSYLKLDESVESKIIDSNNWDSALYGQHKTSGIGNGGFAYLSS
IFNTKLKTVIEPMQDRINQDLLYPLLEICDSWMGTSWSDFDLGFKTVSPVSFIGDINVNS
VLTKNEGREFLGLPSLENTEVGEQLIEIKNNTIHV
>EGEFANNL_00254 hypothetical protein
MALKVKEEYKNKVIGFNGRSLPLGQRKDLDKLAELAVKSGDLSLLNLLEEIPSIQEIEEK
KGKKLMEEIKKK
>EGEFANNL_00255 hypothetical protein
MLCVDLISYSAPCGATSGGVSDIWIYDPSDFNFIQEKETGKGANPYSAISLVDGATKEGG
ARMFRVKFKRKEAEFNFTHSSEGCSVTYEFELSAKLPNLSNDLTNFLSSLDAAGCCCGLG
IIIFLNSGKILVLGEKNVNSEVIPYFEVVMNGTKGGSGKTFKDFNGADVMLKGEYSRMAR
EFVGGVQAIIDLE
>EGEFANNL_00256 hypothetical protein
MNFKKLTISPASYYDLLIKPNFADLIPGGQYTGTLSEFTVMDDVSSKRKIIDILGARNIL
KRRDASCNITFSPVGKASIRTIETDPIYGATQQCDNEFYQGCLEDFRNSNPKFTDFILDF
FLKAIKVDINSNMYFGDITRPNDATGNWNWNTFDGIFKHYFDFINKGIIPANQTTAFNSG
AITPQDGYDFLHWAWGRQDIFLRHLPNEMKAFYVSQSIFDAYEEFLILTGGANNIQYYIN
GIPKLKFKGIDVLVETTWDPILNILNGGNDAHACILTIRGNFVFATDKTYGERTDTGVEA
LSVWYDRNSYSWKYVNFLRAGTGIAYPEHSVIGLTNF
>EGEFANNL_00257 hypothetical protein
MTAIEKEILQGGLCANCECSGFNAKLNYELDLSTKKIKVTDASEFDSTDALKIVLVHVHD
KEGEALHDKIEAQGGNVEIDVSALNLKDLSLLVTVVSTNGCKADLSIYNLGNTALNGEFE
NKADQGNRNNI
>EGEFANNL_00258 ATP-dependent Clp protease proteolytic subunit
MDAFNNIMYYHSLFLSPLYKGIKMNKLCVFNYHITNENSDRLEVYIDGGIVDAESQEFYK
TWYNDETSVSFKSFRNEILSSGKKNIRITLNSFGGQIGDAMAMHDFIKQLENEGYEVETL
GMGMICSAATYPLSASKNSKITPNSWYMIHNVSGYAFGDINEIEKSAKNLRKFNNDIRDF
YVNLTGKSQEQIESWMNEEKWFTGKQAVENGFVKSLALEEKEEFKPINHKEWSFKNTHVL
NAYNSFSSPKPININNKIDMNELVQKIVNAFKGNNLVVTENTPKPENLTVENLTKALNEA
TKDLKLEPSEEQIKHSVVNLFKDGLPENISKQLEEVVKNATKDLPSNEKLEELKKEIEAI
RENLVNSKGGVPVNQAENSSKYNHEGISFVE
>EGEFANNL_00259 hypothetical protein
MGSLIILLGFLGMPLCFKNQYNVDDKYVERIELKIYKGNDMKKEKASYKNSTEVIMKIFN
TIDLLLKVGNLGDG
>EGEFANNL_00260 hypothetical protein
MSEDLKKYKHEALEMAIQDFEQFCKYAGVNIKQLKVCIERSKGYSVRKISMQLNIPRSTV
DKIGRKCFKKEKAPINDA
>EGEFANNL_00261 hypothetical protein
MTFEEFRKELIQRVRKTSLNQFIHLYIKAKDWGDILRAFKKTEFYEWSFNQNIIDFDLLN
EIPEEEREKENYYNRKAEIKDFKGVLVLLNEAEIVLNQKEDLRCQVVMFGNSKLTAEITD
RSMVELEQYHNSDANIEIKNDAFLYATQKNESKSKLISSDFATVRLILDNGSLSEVSILD
ESFLNSTTLWFSQLVINNPIQVLSFSNLKKTMNNHKVITKDKSQIIYKNE
>EGEFANNL_00262 hypothetical protein
MSNITKIYTLKLTGQKDLVSSMQSVNKSFEDSKKRFLELKAQLGKSGLDNLEIKTIRLEM
EQTRLEMLKLKKEQLVLTNEGKAYTNVIKIQREEERQARAEKKLTLSEYQKLSKQHVELR
NFAKEVAVVFGEESKEFKQAAQEANLLDIQLKKIDSSLGQYQRKVGNYPKDINITGISKN
AFNQLNSAGLGDILGNQINNTKSRVKELDNEFLRLKSRITEARNSGVNDLNSMEKEIIQN
RIEADKMNQEISKSTTHLNGLGSVGTGVFGRLNTDIKSLVLGYVGFTAVMSQTQDLFKRS
IQIDSMNSALEAVSEKTGDLAVNQQFLEETTERLGLKTIDTTQSFKSFYAASTEAGISGE
KTREIYEAAAESSAVLKLSQEQVNGVILAFGQIASKGKVQAEELRGQIGERIPGAFGIAA
RAMGVTTQELDKMMSNGKLLSNDFLPKFAAELKKTFGNGGKEIKGLNAELNRLDNIKTKI
ASNQSFLKLLNLTITIISFLAETILNVPWKVWIGFVTLLTLAYLDNIKALIANIAQQTIY
IARMAAGNVLLAAARVITIAQTVAVFALNVAYRALNATMLLLGTIIPGIRTAWLLLNSTF
LATPLGWVMAGLLALGAATIAFGKNIDKSTQSLEKQGKALKESAVQLKANNEITKSIGQS
TQQTLSKIDSLTKTIKNSNLSLEARKQALQKLIDINPQYLKGLNLENIEHEKGIKILEDY
KNKLIEIAKAKAVQKLFDAQSEKIIDSVLKLDQVKDSAKKERELLNDPTRFFKKDYWGMV
YEKGKQTIGFGEGTNMDQAINAYNSKKEAEEVQNYLSVKYKDYLEMMIDETFGGLSSSNS
DNKTKTGTYKGSELNGQQRHYLKDVDAVRDTLLANNEKAYTKAEITEKEYLSAIFKINDE
AWTKKLNYIQGVNAEERKQRAQWQNEQAKLEKETQEKLFKIDSDALKKKLELDKAKLDNN
LRNITENPYSTDLEKTEAQQIYYEDLLKITTDYNSSMDTLEKQYNQNIIESANARATELE
EIERKINNTSYKLTEERFQNIKNIVNNAVDSTINEKNINAELEKQKVLLNSNLTTRQKEN
EINRISFLNEADETEAELERIRDLINLYNQKLINSTLTVDQQKELNNLLGKESELITRNI
ENKTKQNKIGFGVGKIDAPSDSNTQSLIKEKILNDLNLDEDAFGSMVGTAISQSWDLAST
AMNGYFDAEEARINRSKELAYERIDLEKEQLLAQAQSQAERDSLEKQATEKKKQADNVAA
AQLKKSKKAELQITLATELANIAASAASNPLNGITFGGAGLAMYATMAGLALARYYVNLS
NVNKTQFKKGGLFSPKKFARGGRLIGPSHNQGGIPAINPTTGEQVAELEGEEGIINKRSM
KDNSIYSVTGTPSQIASRINAIGGGVDWMGGATMQKFMKGGTYLGSNLQPPVFKSYYDSI
IQKENENYNAERLDRIEKNLEKTAQSLNREVNRKTIVSSRELSRVQKENNKQSQIATL
>EGEFANNL_00263 hypothetical protein
MQNISVIIDGLELDIDSSSDFPITIDYQLEDSQDFQEKKSSQSIGLTLPATLNNQKILNT
FHNPSVNDLTKEAIYTNIRQISMETDGFEIFVGKAIPKKAIKKGGIPILYEMNCFGNNAD
WIIDLKELTLYDILKHIEFTFNENTIINSWQFDGQNANLPYVFAPVKYGEWMDPDYNNGE
GKPKGSDKNYSIKTMRPSLSLYWIFYWGFKSIGYKIKSEFFNTNYFKRLVIPWSFGGFLT
SENTKYEIHKFLARTNGEEKWFDYRGSNFVDLDVKDNLDGCYDNNNTLVSGDYTGSNGAI
NGGGTEMIWKYNPPHYGPLEVMMKMSLYYDYLLQDNNPVESTDMSLDLYWYHKDASTGVI
TEFIEHIRDDEITTGQKQESGLRNIYRMFTVKPNDEIICKVWLRLFPGKGSNQCRCKLRV
DEYTTDYFRIPVGGNISFDAYLSLQKENFLDVVRGTADLFNLSIQTDPVNKEVLIEPTHS
YSITNNKNQLLEGYFTDNILNWGEKEDISQESTLELYDDNAREYVFKFKEDSNDGALKVV
QDRYKITIGSGKYVFNKRFKAEKKEFENRYFSPTMHYLVDDFQGITGIAPQMICLVPENI
SNTSSSEAQNTFNPKIAYYKGLVLGAGGWIFNGKTYMNYPYLFSVNYKPGGENDPILSYT
DEKIGNNGTFKIGRGLLKRFFWQRLAIMNNGQWLTTNFELNNTDIINWYHRERIALDGEL
WELLSIKGYSSIKGESTECVLRKWVPITQREDDNTYPSEKSILTDAVKVDQEITSSSTEI
DKVFDNQYSRAICLYKDIPR
>EGEFANNL_00264 hypothetical protein
MNVLYIPEGIENLKNLFSIDFKNVKSWKVRLLTENDEFICTSRNNIAQNCNEIRIHFINS
LGEIDSIDFNKTKITQETKSESWKKSQGYPFERFKGGTYRKNIISNESYEAVTRSYSEHE
QYWLKELMNSPKAWLEMQLPNGFLPSEEKAYIPIVITDSELTEKKVEQRYEYIVTIKFSM
SNENINLR
>EGEFANNL_00265 hypothetical protein
MPIISITQQPEVSSLNAAYKPIVFKVLATENNSSNKPPVVYCDVYIDDVYYKTFSKTINI
GINGGSFEYLFDIQDIKELLEYNLPTINGNTIQQMTNTLRKVFVKFRNAYKDNNGFIISE
QKAPIQGTSNKKPISGEGLISNTFYILNSLIQQEEKQDLSELLNSYKTDEWDINTFPLTK
RPKNIYLKKTESSFFPIITDKTPYKICIEVTYFDNTTGVECIKVENMNIDEIVGKIKKLE
DLTSILKKGTILLFNKTAKEIPDGWEEYTPLRGRSPIGLDPNDPDFNTIGQPVGSKTHTL
KKENLPPMSLSLKDIQLWGVGAGSSHSVLRQTIGSQFPIEGGGGISKEINHLDPHRIVTF
IIYKGE
>EGEFANNL_00266 hypothetical protein
MNPVIIFAKAQKIINNSLIAELNNQGHYLTGALNRSITTTSSIISKPNETSLNGYALKYA
QDLETGKNATQLGNINTHTKNLITYFLKRGLKKGEAVRAAIATAKRHQKEGVPTLASKRF
SKTGERKGFITRAWKENEQKVDSVMDLGMDSIFNEEFNKQKSEKL
>EGEFANNL_00267 hypothetical protein
MSSIKEIAKKIPNNVRSQILITEEDIIHKAIPVNGNKEMQILNKIWHEFIEPNKELTNCP
VCLNNILTSFKQMKESLIELELEYQKLNAL
>EGEFANNL_00268 hypothetical protein
MNELNLYQLFRDIITNSKKMNRFVVAPQYGIELNKNNVGEILKDIVGGISDGVKYPICLM
FPPVEIIDSILGENEWSRYSCKLFFLTTPYSDEGGIQLQNLDNNLSEHTIPMTWKDMHQC
AIDFRKVFEMVTERNFNKGIRSTEETTVIERFSDIGNDRLAGVGISFIIDLFLNCEILDY
EIKDIDNIKLNIEDLHNH
>EGEFANNL_00269 hypothetical protein
MNLLHIAEGWYKSKIHADEKSIILSKERLKECIKCSHAVDKKFLKLINGKSVNEKTKACK
LCGCPIVEKSLVKEEQCKIGKWNE
>EGEFANNL_00270 hypothetical protein
MKWFNIYLKKGSFIKLQADKMVIYDNRSLLMRNGEVLASIPISILVTETAPPIDL
>EGEFANNL_00271 hypothetical protein
MKNQIRLGCAVLFLAALFFTGVGILIGKYWL
>EGEFANNL_00272 hypothetical protein
MNQQKFNPEKFEKLFKEELESNKFDIPQENLSNLIPVWVKVLEVNSLEKLNCDFDIYSSI
LNELLKDKPTFNLYQASYLINGLTRSSARDLGLRATEYSRVLFYSIELSKTWNEKVIPIR
EKLMDKLKRETALVMPGKNRLVNPNIRK
>EGEFANNL_00273 hypothetical protein
MTYIAKEGTIFYKQNGKSNLDNIKETKAYDVLLWASEQDDQKEIINAYYNNLSKK
>EGEFANNL_00274 hypothetical protein
MNFIYKNKNYCIPSSLSEITLKQRIDFDKIYLSEIEKRKEDLYKVDEEGNVIKPDEVDEM
IFNIKIASMNFSFFSGIPLDEVEKNIPLEDVLAVYHSCFKQIYEEQTNLNLQENYLFHNE
IWKIETPMLTFESKITFNEFIVSKQIIKQMDELGAGNWEAMLYLSAIFLKRENEVFQEEW
LSSNSERLKLMETLPMDIAIAVAFFLQTSMIIYLKTSPYSAKEVMEKDPI
>EGEFANNL_00275 hypothetical protein
MENTELVKITITDIDEFKKVLLDRHQNNTNLCIRLESVFTQLNNSLKAGLGEMREVTNSR
FTPTPLKKVMGQSVEFKESKKVELPKFDNDDKEAFKERVNKAYESFLDRDAQDLITSLEE
IEIRGVAKIAKIANYKEASIDVPFIEKIKQAIKEKQEADKKKEEERVKFEQEEKDKQEQA
IKEKQEADKKVNTKK
>EGEFANNL_00276 hypothetical protein
MFSVGPLFEANYNCPTKVAVNQGGTSSGKTYTIMQVLFTIAVKEPRVVITVAGQDIPNLK
AGPIRDAKNIVMNSPALQPFIKTYNKSERTYEFLNGSIIEFKSYDDEQDAKSGKRDYLFI
NEANGIDYLIYWQLSIRTQKKVFIDYNPTSKFWVHEKLIGGKDTTLFISDHRHNPFLSQE
LHDEIENIEDEELFKVYARGLTGKITGLIYPHYKLCENIPDFLDTCYGLDFGYNHPSAMV
EVGDWLEENALYWDEILYESYLTTGDLIERFNLLGVDKNKIMYCDSARPDAISELKMAGY
NAQPADKDVLEGIRHVRYKKLLITKRSHNLIKEANAYKWKEKNGVSLDEPVKLKDDGMDA
GRYATYSNRNNKSKIVSWSSSSSNSYLDYLD
>EGEFANNL_00277 hypothetical protein
MAAPKGNSYWKLAKGFAVGKERAYKPNDLWVKSLEYMEWLEKNPLKEEKVFANGQRMSIN
KMRAATITGFCLYAGICTSTFDNYSKDKAYLDIIKKIKDLFFSQKFEGAAADLLNPNIIA
RDLSLADVNKIQGDAENPLQHEVKINVIQAEAKICNSEEEVDY
>EGEFANNL_00278 hypothetical protein
MKVIKSKRMNYSDIAPEIKKKFLEYYLNNSNNSIPTMQKKFKLSYPFINRIIEEGRKDKS
ISN
>EGEFANNL_00279 hypothetical protein
MAKYVNAKPRHLESKLQQACVSWFNIQYPKETIFAIPNGGKRNALEAKIMKGEGVLAGVS
DLFIMKPSKNYSGFFIEMKIGKGKLSEYQKEFLKKAQNKGYKTAVCYSLDDFTKEVNNYM
K
>EGEFANNL_00280 hypothetical protein
MKDLNKKAKEIYQDNIEKGFHDKKYSIQHMAMLVITELSEAVEAFRKNKWSDVDYYKQIA
EKNNEFDSTLFSMYIKDTVEDELADTYIRLLDLAGLKRLELTIDSNTSWKLVSEYEVRMD
EKSFIEKIIFIVSAVSSFNDRNISYYIINTLVWIEIICEEMNIDLNFHVQEKLKFNKTRP
FKHGKIC
>EGEFANNL_00281 hypothetical protein
MYFKAIIRVVKSIRGDFGATEILREPLIDAENKQEVKEILLKKYPQFFQNNKIYERESKD
TAQFFYVVIYPLLKYELDQIKEGSWECSYCGQIHKNKYEFKPKYDYLLLGENKMFCRSEG
NICMENFKKEKFKGLDMLPFEEYYINKDSANYIYKCTHKYTGKCYIGKTKNIPFFRWYNH
LTYSYSPFGLFLKSTTLDQWTFEVLEVLPSNMTDTEVFKKESEYILKYDSINNGFNEILS
YKK
>EGEFANNL_00282 hypothetical protein
MEIYSKYYIGEIVYLKCDNEQKEHYIVRIIVLPNNLIMYELRGECQQNEYFEFEITNKKD
TLKAIL
>EGEFANNL_00283 hypothetical protein
MENTVKNKKMKDLNELAKYLFEYKKVKFEGRSFEELVLEVIVELSYLHNNVNSLKSRLPV
AYIKLLEIAGYYKFDMNRIATQHIVNNKKSFEENIYAIIREIASFKYTKEEAVNYTLLEI
KEFAKIMNIELEVEVNTILYLRNILK
>EGEFANNL_00284 hypothetical protein
MKKIYIAGKVTGLTYSQAYNNFKKIEDQLQANGFQVVNPMNIVPKETTSWHEAMKICIKA
LMECDGIYLLSNWKESSGAKLESELASKLALNFITQKDLK
>EGEFANNL_00285 hypothetical protein
MTTAQLVDIAIIVTLGMLSITLFLITILIIKEIKNKVS
>EGEFANNL_00286 hypothetical protein
MILPFSTKINGRPNYFIEKIWLGLLFSGKYGNYMYNIYNKCYSDKFGESWDDKIGLLPKI
HTIRLDNYNRWKEGNKMHLVINNRTDNEFHFTPQILCTSVQKIEITHENYPILKIDGIAI
GFSKLQRLSSNEGFESVEDFFNYFKEDFEGKIIHWTNFKY
>EGEFANNL_00287 hypothetical protein
MEKRKNIQEPEELKLYQGMNGAWFVKKGEVLRGGFHDKTDAEKFYNLLLEVNKMEEIKNN
QP
>EGEFANNL_00288 hypothetical protein
MKIGITKEECKKGRRVYYYSYYDLATGEHSEPKESIIVDGEIYLISGIPCCFIKNVSGVV
ALSHLELINN
>EGEFANNL_00289 hypothetical protein
MKTTEQISSEKQRQLDRAKAIKALEKGKALEKLQILKGKKYKRIDNKF
>EGEFANNL_00290 hypothetical protein
MLKLEICYNPITIQEVVSENGLINKICRLFGVSSEVASPETQKEWTQWILTSPFKTLTEK
EILNAHKMAINGELLDEDQKHFKIFPMLTPIQSGAILRQYVEFKRNNEVYWKAKQNLKKL
AEPKKTQQELEKEKEENFNTYCNIIFNEIKQDGFTKKATHYYSKIAQKIDLKLVVAKRLY
RLELNKFLKNFKTIRGLKETKEFEISFFQTNESLAEIKNKIKHGEAVPSVQQNCRDIIVN
HYLRKSKSLNDLKQKIKELEG
>EGEFANNL_00291 hypothetical protein
MRDSIIFYRSFYEAIDELPLEMQAKVYKAIFEYSLNFNEVVLEGIPKTIFTLIKPQLDAN
NKRFENGKKGGRKSTEKNQELTKDEPNKNQEPIKIETNNNNNVNNNNNVNDFLLEKETKE
REGKFPDDILLKNSLKPPEETSKRKKVAPKKEKVSFSPPSLQEVQEYCDERQNGISSESF
VNFYQSKNWMIGKNKMVDWKAAIRTWEQKRKDQTNGKSNTEYSRFSPPKGRRIAQCDPEK
MAELLARDAETGNLL
>EGEFANNL_00292 hypothetical protein
MRKKIKGRPSNYRKGLQNDDKWQEVRRKIKIRDKHKCRICGNKLELEVHHITYCIDGEST
RGIEIFNLEWLITLCHSCHHFVHQNKNHKLNPNNPNKISANYF
>EGEFANNL_00293 hypothetical protein
MKIVETQPFIHEFNITGNENNLPEILKHFNTPEECHEYFSSNLIAEHTKLYVDRVYTEEE
ITEFEDNILDIVKNQMPDAENKISDAEYSLQVAKKNKEKAVESYNALNTEIKDYRNEILK
GTTELEIEAQRVFRFPYKGYYYHYVYLDNGMVVLAKITLMNEEERNELFSSSDKNEKFIN
SLLNEEKNKRKTK
>EGEFANNL_00294 hypothetical protein
MIYDTSIPEKRKLAIDRINHLLKKKAKIEIVEKRRNRTYSQNNYLHLILSWFALNYGETL
EYIKQIIFKRQVNKDLFLIEGVDKKTGEVIKYCKSTTTLNTKELTTAIERFRNFSAKEFE
LYLPEPKDLNHLEEIQNEIELNKEYL
>EGEFANNL_00295 hypothetical protein
MELKSENLPNLFLADTSNEIDSFEQWLNQRNGRFTASEIYRILTYQEKPDYISAGALSYI
EEKALEVLTNGKSRKTFFNLSMKHGKTFELEAIAKAEEKLIIKFEKTGKDQEFIEYGSHA
GCTPDGLSEKLGIEVKCPDCKTHFKYLKIKNQEDLKRTEPKYYWQIQKGMLCTGLKQWYF
VSYDPRFTNEKNQLLTLLIHENDKDIEFLKQRLKLAISKKIELINQ
>EGEFANNL_00296 hypothetical protein
MSTEITTKNNSIQSFDLTENVPNLQEAIVLQADLTSEYWTPEREGEFKLVFFQEIKHSTY
TDEQTGETIELPCVVFVEQKQTGELKTVRNGSKRLVASIEDALNGNIIRTGTPLRIEFLG
KQKNSTNQFQSDRWSIKPLVFK
>EGEFANNL_00297 hypothetical protein
MNAQIQLQGLINIHDEALNNNNSIMAFHAKNLITRIKDKALLDNIKNLEFLCFDYFGIVL
KNTKTNKTYCLPAGDVIGWYFRKGRTLSLIHTPNDSFILEILEKRSKRLKPSHEEIQAIC
IEYRYNLYEIYINLK
>EGEFANNL_00298 hypothetical protein
MTMIGAKVLQKEELTKEKINSAIQKGIDKFCKDYHEEDKYQYEIIEISNDIIEVDFSLEI
EDEIEEYYYWVKRQEATHKYKVYERLTIELDENEDLEEKLESIFGATELFIYDLNQKY
>EGEFANNL_00299 hypothetical protein
MTAQTVTDLFNILPKREQEVFLKMNGFKKVIEEPKRKIGRKSKEEELKEALNSPLNRKVD
RFLSKIK
>EGEFANNL_00300 hypothetical protein
MKLTNEVIEKIRTDISLRYAISEKVGRSERGIYNMAYRVSDTLPLIVKSSIRIIEKHTGL
KESEIFEKEKLKNR
>EGEFANNL_00301 hypothetical protein
MSDNDGVKNRIKQYIEYLNIPISAFEKNCGLSNGYVSSIRKGIGHKALEQISEKYSEINK
SWLLTGEGEMLKNVQFKDTEAKKVFMNIIQIPVVSQYAYAGYLGGFDDPGYMESLPTHPI
PMDRELKGKYLFFEIKGDSMEDGSMESYREGDLALAREVYQEYWKYKLHIKRWDFVIVHK
TEGIIIKRIINHDVENGTITVHSLNSFYEDRILKLSDVAQLFNVVQIVRKF
>EGEFANNL_00302 hypothetical protein
MQEIISFIGLVALIMFAFIVCICITRWVFGISSIIKQSENQTKLLEKIAEKQGVTKEEIN
EIIGCKK
>EGEFANNL_00303 hypothetical protein
MKKLLFLFGLLFIITCSSDDNNDGCKETWNITRYYEFPPDCNNEAPIPSTYDKDFDCSNV
KDVKKGDVRLDTKLSSCGAVYIRFNKKVN
>EGEFANNL_00304 hypothetical protein
MLTSDKKILELIELLKESGGIRFKKEFYDAIGLQKQNVFWVKNQNKQEKQSYHFTAEHIE
KICKTYSINANWIFGMEKNIFLSSKTHMNKEKIN
>EGEFANNL_00305 hypothetical protein
MSNLLITIEEVRNIGQLSIHCDKSKIILGITQAQNHDMKKLLQDFWYIVLENKDNEIFHT
LLFGGKYEVQSGGYKYHEGLKNVLAHYAYARYVMLNEYNDTPVGNMDFQSSFYSSKSSSS
IKMQYDYYRNLAHALFKDVDTYLCFSKNIFPEYNSSECGPCLNNTEKNSSSVTPYGIKSS
VITKKITPLW
>EGEFANNL_00306 hypothetical protein
MGVRASFIELFSRVVKVLHNDEKIYINGANNLYPNEIERIINSSPTAKRCVNVMMSYIYG
KGIDEGADILINKRKNYTLSTILKKVIKSYTYQGGAFIHIGYGWENGKIVIKSLDVLDYT
KCRISKEDDKDSKGKIYYDNYEKKWSYLSGYSQERKWYYPFNNNQEVLKAQLLNDFSLNK
RNKKDTFSLERAISDFRGQVYFFNPSDYVYPLSFIDPAYNDADSEHRISIYTNTQSRLAF
LGKLIMVCAGLEKEEKEKIQNDFSRFLGSENSGGVYRLDVEAGQNLEDAVKFIQLDAQYD
DKLFENTDKRIIRNILGVFKNLPEGLAFSSDAIFSNSGESYREMQRFYNQQTFWDRDEIE
KTFKVLGFELKINPLIDE
>EGEFANNL_00307 hypothetical protein
MTREELIHIGKQEVRKNESLLLSYIDLFEKQFGFKPNCMSCSFNSDWDLFVKSTKNNNSS
NLKMKNNKYKINRLLSQKIFTYIKDRRTYRIYGNQMTDEFAENYLKYGTEQELEARKKEF
ETLVETEKSEEDSKKKKISTKNTKVEDKKVEDLNLDSISVNKTKEEVENKEEKVSKKKTE
EDIK
>EGEFANNL_00308 hypothetical protein
MAVTSLCAEIQRGQDLACTSLDKRYYQQAIIINKNDIATYNITIDSKTGKYHVKFSLKEG
KKGYLYRAMESGSSFSGSFDKSTTDQGMVQYLHKTNMIIQTADAEGKLAQHELDRGSFVV
AMQFKTGGIEIYGMDYGLSSADYTNDLQANNGVNAIVLQSLETAQENSLPLIYESETPGG
ETADFDSLFENKAA
>EGEFANNL_00309 hypothetical protein
MNTTFESNFNEFAETIQGIVAGNSSTISKAIFTKSYGVSNLTTSHYIQTGVKTGEKIQII
TSEADYTSNSYMDENNCEYNSCSLDLNYSSKEWRLKQFGCQYEFCTKKFDDEFAAFYGTF
KIYNPQENDKGIIYMAFLINKIKENLLAAQWRNAYLADESKKAPYLNKQNGYLVQAQAGG
GLKVDINENLATSYKDQLMTGEKVFDTLNNLIDSVSDEPWYDPSNQLIKMSNYMAKPFVN
WLNEKTDRAAGYCEKIYDTKLIQHVPLWNKENISFRGVKIIVHREIDTAIKQIPELNGGG
GNNPRENPNFALLTSRENLRIGTSQKDDLNYFKVVFDNVNDKLIVKTNSTMEAKLVTDEY
AIAI
>EGEFANNL_00310 ATP-dependent Clp protease proteolytic subunit
MAFEIKIYGGISDYQSENTFTLKDLQRRLEEYNGEPDVLVRIKTDGGYVDEGFAIYGELR
RFAKEKNIKITTRADGFVASIGTVIFLAGDKRILNPYILPFIHEAYSPMGEDSEFVNESL
AKFYTEHTLMSEQQARELMQQETYIPLDQALDMKFGTEVDEVYKPEFLNKIMHKMEEKNN
KETWLKKRFNAFTKAFKANNKIEFDASNNELLFSEVQESEEVKIGDTASYNGEPAKGEVT
MSDGTIYVFENGALKDIKKNSAEPEPKDPPIETDPKDTKIQELEKQLNKEKEEKEILIKD
LQKFKNEAERSSKILNKFTELESSMADEQAKKDKYEGGSINYLEKLKNLNI
>EGEFANNL_00311 hypothetical protein
MDLSNNDLLSLIERTRKESEFGISYRTPFLVNESLKRNLTKNIGLYNNNNSSPYYLKTGI
TSIKEVVQQHNYSKSILGTGMFFIGFPMIKKRFVTKGSVEGTSIASKFLSNKLSYNMPFK
IYSINLYGKLKTTTNLGRGFGRVIPNIGVALLIIDAIELLIEVYEYDKNNNKVIFKGFGN
GGSFGGGGASAIW
>EGEFANNL_00312 hypothetical protein
MIDNKLQLFLEKELLTKWSKKIIFTPQMKLYKDFGLEGEDAEDFLLHFTKEFKVNFDDKF
NFRDRFYLEFEEGFIKNLFAPFISIFSFVTNKKAPKLKDLSIGELQEAINTGVLK
>EGEFANNL_00313 hypothetical protein
MKKINLFVLILVLQISCQEHKQLTHPTISTPIEIISTRSKINTQPMAFIDPEKVKNWSFE
QIKEKYKPITEEEYLLNEAIISEFRIELYNYFNEKERDQPILIKEVTWEKDNDTNFTIWY
KKDADKWVFINSFIWEKDWMF
>EGEFANNL_00314 hypothetical protein
MSTTKRTDRMDIFIEEGRNIILIQERWQYNWLTKVTPWTITERRKFHELADQRIWKIWGG
HFKLKVQGTSSFAEKHKNTTFTVNFDIKWALINPHWKVNLTKIAPGGFQTSYVNWNSKII
SLDTEDTKIVTRYAGRSKYKQYPVAHEFGHAIGNVPIRGISHSDEYHDSYRLNGGFKLDY
LSIMNIGNNLRNRHLDYVLIQLNSMFANTTFYIV
>EGEFANNL_00315 hypothetical protein
MYRIKEICRNKGLMLKDLAEKIGITEVGLSKSLNGNPTISRLQDISKALDVDFIELFVPI
DNVTKGYIEHKGKIYKINSISDIERMLEEIKEKNK
>EGEFANNL_00316 hypothetical protein
MKDIFESKQDLYKRIVELFEKYLKDNGLTTDGIDPDKHFISRRQFFYLKNIAKGKEAPDI
GEGKLNSLLNMLNLKLETSVFYKLSEK
>EGEFANNL_00317 hypothetical protein
MIEAWKFFRTTGKEFSECLKQAWRNFKLVQAMKKGIVKFYFTKVNGEVREAWGTLNEKFL
PVVSGIDKRKKNEFVQIYFDTEKQEYRCFKKLNLI
>EGEFANNL_00318 hypothetical protein
MKTISISYEQRLNINGKIGYVDFIGEDVIVLVNDNRIA
>EGEFANNL_00319 hypothetical protein
MQELVKITEKNGKQAVSARELHTFLEAKERFGNWIKRMFKYGFIENTDYVGCKQFNTLAN
QELSDFALTLDCAKEISMIQRSEKGKQARQYFIDCEKKLKEVRQIGDGEDLKNIEAKIMV
ARFYLEVCNPNENSKLMLMHSIANPVGLDLPDYTTSKDVLRSASELLKINNIGMNTRQLN
QLLLQEGILTENSRSSNSKTAKDGKSYFKTLTEKGLEYGENQSSIHNPKETQPLYYENKF
MDLLKLLNLL
>EGEFANNL_00320 hypothetical protein
MKKISLFFLLTLCVFCFGQKLKEVETFNYNEFSDSNFRNKYSNNCIVGTYITEDGNSIKK
GDTLKLGIPSNKQGTGGDFSFLIFGTLNGTLLRGIDYVNGTLTGNYITIEEIQIFRSMGT
YGIKLQTQPVQGQKIPLTKYITVLNFDQAYNTGEILLTNAKITKEQAIKLLKEKKDLLDL
GIITQEEFDRAKEELTPTIIQ
>EGEFANNL_00321 hypothetical protein
MSNYFPKDTKIKVYELCKQGVSYFDNFYTEIEDEGNSYSDLVAAIRIIEDTSNLLLRPKG
QFRKLQTSNSPYKLYEAKKGIIRIYLFHEEHKGRVMVLGGKKDNQKKDIDLFQKIIKEYY
EEQNKK
>EGEFANNL_00322 hypothetical protein
MKNKIKNNKQKLEKILETPSYWVEAINGELYNSIVEYMKKNNMNQTQLAEYFNISKGRIS
QILNDGDINFKIEKIIEIALKVDKFPIIKLEDKEIYLESKTQINNIIPLTYNYNNVLYSE
VKDDNIEISKGTEEGYLRFEKSDTDVFKLAIS
>EGEFANNL_00323 hypothetical protein
MDKKDFLGYKVDNIYTSFFQLKDLKKEEVKELFTIKDRLELTIRIAFIADYNNGTMNVGV
VIMLTDREKHESVLHHVVNTTFGILGLNTILDTETQELKIPKEMMLSLLSISFSHARAVS
ITSLGNTPLNGYFVLPVVGVNTLKESLETGQMNFK
>EGEFANNL_00324 hypothetical protein
MECVGELINKNKGVFKRMVRGGLISCSVVNHYEMYKFYKGVDNSLSKMEKYQLTAEEFRV
DIKTIIRAIKKMER
>EGEFANNL_00325 hypothetical protein
MERVSSIIKKVKTISKNGIEPVQQGINNFNIPDETIEELAKKRAEICAGCEFMKMEPISF
LRVKDTRIPLISEQYCVKCGCELPYKLRQSIEKCEKWNV
>EGEFANNL_00326 Chromosome partition protein Smc
MAEKISIAELDWDTSLLEKSIQNYTQKLQIVKKEQDGVILSLNTMTSEYEKLSKVVNLFT
TSDKSMNVELEKNKKQMDELKASMRVQAETIANLQAQVAQLNKERTRANEILEMTKQKEK
ANSDASQKNAQATIISLQKVNKELEKTQNAKVTTVDLNVDSFLSKAAEARKQVEILKGEV
KFFTDAIKENEKTILEDSEVLSSLARQGKSNSDEYKERARLIKELQDKNKGLRNELELNA
SALRKEQQELRNSQRQVDAFNKTLVDEYEVIIKTDGSINQLSQALANNRKIYRDLTAEQR
NNIEVGGRLLNIIQAQDNEYKELQKSTGVNQVEVGNYRGQLEGLFETLQGGATPVQALTG
EFKGLYSQALALGSNPIGAFLIALAGVAKLTKMWYDYNVEMSKSTRLVQQFTSLSGDALT
DLTVKVRTLSKESGESEKQTLNAVNAVANSMGISYEDAFNKVTNGFIRSGESAEDFFDNT
SEYVSHFKNMGYSADEFFSIMEEGAKAGTYKDKLVDTIKEFSIRFNDLNKAGKESLDNTF
GKAFIDNLIKQYKAGEVQGREVLDKLIKKGKELGLSFKDTGAVVANVMGSMGEDTGGYVH
IVKALNNGLENTHRELTEIEKARQIEIKSTEALNQKWAQLFNTSGGTFEMMKAQGKSWVN
GTLIKMIDGIIEFANGFIETYNSSMLLRGAIGSIGTIFQVQMSIATSALKLLWNNLKSSA
RLIKSLLTLDLDGIKDSLKDGFVGMKDIAISGAKDIKNAYESAINTTVNGKLNKIEFSSS
ALKDEGGEANSTKPTAVKPPSQNTKKSGPSKKDNESLKQAQEQLKALQAISNSSLAIMKA
ELDEFIRTSESKLDESKRTNEKLLQLEAERLKEIENKQKEFLDQEAKNQIEQARQTIKNE
QEKNAKILEITTKLGHEKIKLESETDKKIKENKDKYNAQILAEQKQAKALEFKQKIEALI
SSGASEYLIKSEQIKNEYQQNEERIKLENELEEIKTQEQALKMADIYYEIDQATLERKAY
LNSALYNMDYEYKNALIQLQQEAKFAELEAYAQIAQGVAQIMGEQTMAGKAAAIAATTID
TYSAIVKTLEAFAGKPIPGYAIAQAIATGVFGFAQVAKIAGLEVSSAVEGLQNVGKGVVT
AMQVSPLNKNEPSQGYFKGGYTGGSSIYEERGAVHGKEVVFNHKDVEAYGGWQNIELLRP
TSDMFQGFPVNTQMILASSQNSNNIDLSSLSSSIKQGAYEGALNGSKIGSQQGSQIGSQI
GSQIGSLQGSQAGSQKGISQLTKNQRISDGAGF
>EGEFANNL_00327 hypothetical protein
MYDFRFQLDNGRCSNTSLNNSVGENSVGIDKKIYLPLEWFDHEDHILIKLTIPLEYISTT
NTLDFIVSNYQYVGVGFGYKKDPIVSICVLDNK
>EGEFANNL_00328 hypothetical protein
MRSYHNNICELNNLLGWKVKAGTELLLEKEKPSQEKLQEIEERQEEQKIQEFKEERESHE
GSHFLVHGAKCICNKGSNLATLKVISNRYTPFNNNREGAYAATEEGVQFEEGSFCFGSCK
LRKNDPCIFSPAGKWQKPYNYVKIYDMKTLTELSYLNCTQVGKITVHYHGQKIKIGFMHL
QRADTETLNMILPGLELQEYMEEQDTDQYYI
>EGEFANNL_00329 hypothetical protein
MAKVLKGIKGERFPKIGEKVMYSISLVDGVKPESISDTEIKWQLYQANEYSEYEIVNFSG
QKIGKEVPYTFLTPLLNRHMKLIVSYKEDSTEMLVIPTQGEAKIVDVFFLDNTGKQLKKI
PSYGESIILRVYTVKLNDKKLNFTIYDIVEGKEVEVGKNLKPLKVIQSNGVVKSDLITLN
IGMPIRAKQDMSAEVHKYKVKVTCEDPALSYEEELKVKNEQVNVSIIPPDVQTPTTVGTA
PKKEEEKKEENKKCFCNRDLTVEEVKSFYNSKMLFSAKNCPLPENKKTYEEFVKALNIAM
KEYNINTCLRKAHFLAQIEVESDRLNTTLEYAEGWDYDHTTHQGNYDKYKLYLSDKDKYR
QYNDTKIKRGYNRYKNSFQQTISQPFVAPVIRLPLGLFMFTLFISTPEPIVFFPFFFRIR
TYFCLFVKNIIVKPIF
>EGEFANNL_00330 Putative deoxyribonuclease RhsC
MLQERLTALSNEKGEKYQFSRNQRGDIVREVSFDGINRYYKRDKAGKVVRIKRGADRFTE
YEYDKGGRITRAEYHDGSWETFSYDQAVRLIEARNSKTAVSFKRNRDGKILQEKQGEHLL
DYLYDKDGNLVEVKSSLGANINYTRDAFGQISGIQAGDKENLWIAKIKRNMLGLEVERSL
PGGVKSSWSYDENNLPLSQKVESYKFKSGLHKNYQWNASQQLQQITNALTHGETTFAYDA
FGSLASARYEDGSFDYKLPDEIGNLFRETAKQDRKYGRGGKLIQLQDQYLFYDTEGNLIL
KSKRKNPNIEVLDNSETKMSF
>EGEFANNL_00331 Putative deoxyribonuclease RhsC
MIKILENNRIEIYDGLESKELYNKIIIENIKLKDILENDFLNLKDKLVKETDEEGLETLH
NYDELGNLTKTTLPDESTYTFAYDSESRLILATDPSGNHTKWTYYNNRLHSTESDGKSTR
FLYNEQNLISTIRNHWEEETHLQYDSQYNLVELTNPLKKTTRWKYNSLGECTEVINPLGN
KQQFEYNRLGRLSKVKLPNSEIIDLKYDAYDSILRVNSLHSKINYTYTPLGSIRSREEKG
VKVFFEYDVTRKVNCTKQ
>EGEFANNL_00332 hypothetical protein
MKNSIKKISIRGRMYFCLVCLQNAFKQNNINNGESNLIINIIKEFLESNNLSDWEELANN
IQPINILDEKFNINDFSFEHKLVLKLKIFYEHIPAYLTEMIDYTLDVGLNNLYGGTGEYS
PLTLEPVLKIIDLCKENSIEFPDINNFLQYSYQDDDGWGFPIQLN
>EGEFANNL_00333 hypothetical protein
MGQTAEFIEELVVGSKGAGAVIKSAKGSAVAASATEKLSIAITTINEFVKTTKLGKIAKS
IKGIFKVGKKIYKGSAKIEAYKYAQELLDTLSNNKMPRAVSVIVDKKTGKIYKGTSKGID
DITKLDKNVADKLPKPSKEKWPAENCAEVDAYNKAIKDGVNPKDMEMHTVSIDKKSRSYK
DFERCENCKVTTKDIGYVTSD
>EGEFANNL_00334 hypothetical protein
MKKIKEKELIYGGSDQGIILDMVVINSKNIRFIDIIENNPFQNLKEKISTENFNFIKKDL
HILHGTETKRFREAKNLGLIEKVGIESFNYYKIESDNLSLYYYKVDNYIYIYIYIYMVLE
KHNLVYINYIWKEFMNYNKKEDI
>EGEFANNL_00335 hypothetical protein
MKKLRITLEDNFFPVQAYFNSIPDRSFLKVLQDFSKNIGSGFEETSIGFPEEAEEWGEEP
FKGVAFGIIEKEIIIYNTDFI
>EGEFANNL_00336 Endonuclease V
MKLAIDVYYYDNKAKAVGILFKNWEQEVPDQIITSFITDVAEYQPGSFYKRELPCILDLL
KQVNLSEIEVIIIDGFVYLDNQEKPGLGKHLYDSLNKKLPVIGVAKTPFFQNEKLVKEVL
RGESTKPLYITTVGISLDESAENIKNMHGKFRFPTLLKLLDQETKNKL
>EGEFANNL_00337 hypothetical protein
MELNYNIKLLEEDPSLSCVNDVNSGLLIYYLGENKKELFTGAIYEKFNNKIISEYEVKDG
KKNGIQRDYFQDGKLEEISEWKENFKYGINKEYNDEGILKGVSIVWNNDYIKIMDIEKQK
VIEKKIIKKEGIPKRILYLLNLSDRKLLDYSFDMKNSSDLEEYYMNGFNSLEDHHTTRNI
NL
>EGEFANNL_00338 hypothetical protein
MKTNKINKNNLRLSEEAPSLFSDDDPATGLLIYYLGEDKEELFTGELYEIFQEHIVSEYE
VKNGKKEGIQIDYFRNGSKDSINENSQNMQFGVYKEFDEHEKLKVVSVIWFNLNIKSIEF
SENTITITEKKIDKKYIIPKRIESLLNLSNEELINYSFPPMVNGGFTEEDKRNVTARAFY
FQNKTIYIYENNTLTKVISTINSESTFYGWKIEKEIKDGIINKILLESEEETLREVLWNG
GKLSKDDRIIPEEELPTNIIQLLNLSPEKLLSFPFEATELEQNEFLNKNIIL
>EGEFANNL_00339 hypothetical protein
MKIQELILKELEQIKSIDFWEDCLIFDYERTILNQEAPIKEDIFNYLLDNIYEINGDNKY
VTGFILDLLTLPNFDSKPHFIKLLEKLSESNQDFIYEKLIDNLRDWELSKDEKEKLFSLK
NKIINKSSLVFKIIENK
>EGEFANNL_00340 hypothetical protein
MAVDDLFIPDGVYLKCDQGATVVNLKVNFKKHKLYGEIIATEKDHTPLVNIPSFGACSST
GSACTPTDTYWVNVHEGGTLVQKQKPLLETSFCKCMKGGNIKIFFSEAEAIAGLEADKNE
RVDKIPYIDAILGKATLGPLNPLFLFTDTEPSDVGRGVRKGIKSTYHGLKQMILHPIDTA
KGLGKLAMTGVAGYVPPMTSASFGGIPTESEIKMQQDWFDKTPEQRIADFDKDMGTDLTS
THEGIKAAASEFYDQKIVHGTNAERGVLMGQTAEFIGELVIGSKGAGAVIKSAKGSAVVA
SASEKLSIAIATINEFVKATKLGKLAKSIKGIFKVGRRHIFLSTDVFEKIIWGERVLPGN
RLIGGHSGKISNLHPNYAVEELGYSSVNSNCRRIKFVTQYPDGKLSKIKSSTLFPDNWSS
SKIKNAIENIANDNSIPMTTQGTGTSYKIGTYQGVKIQVTYDNAGKITGGFPL
>EGEFANNL_00341 hypothetical protein
MGFLRNLFRNEVSSVSAIPEVQGRFKKTYNYVYERRQWLRGQSMKHKVEGIIQAAISPYS
KNYTKWEIYFKDVNLRKTSNFVLEYYILWDFVRRANFYMSTNGKITTHEFDVFGQKEIFK
EKQEKIYQYLREGSRRDAIEKVIKGVNQNSILLARTLKANPIIQLLAKEFSFFQENLLQN
THQLPVFSFYSNEVMEDYFGAGKHLPLKKFSSLNLSFKDAIVGCAVNGWNKEEIGTGNFF
RFMKQLAGKIQIGRELLVDSSEYYKYAPTNFFNDRKLLEAESYTQTVVAEAWFLEEQTSL
TLIEEDYGS
>EGEFANNL_00342 Actin cross-linking toxin VgrG1
MSRIRVQFPWQKAYGGQSPWIRSITPYAGSGKGMHVVPEIGEEVIVSFENGNAEKPVSLG
AMFNGKGKSGHGGAGNFIKGLQTPTGNKIQFNDKEGSALLTDNGGASMKFDGAGNAVTNA
AAMQTLNVGGGGKDSSGETIPPQSVLKMDKDGNIKLDGKTNITLMVGENTLVIDANGLTL
TNKDGNKVAITPEGIVQTASVGDISSTAETGDIKLDSSASKITLNASTQIEATAGSTIDL
SAPEVNSN
>EGEFANNL_00343 Tyrosine recombinase XerD
MDSETILKTLHDRLQVQRYANNTIKSYCGYAQIFLEYMSKYRTLNEIPIAEIEGFINEKV
FQDNISASYQRSLVGAIKKIYKLVNNQSIELNYLYPKRKSTQLPTFFSQEEVRKILNTTE
NLKHKAILTTIYSCGLRLSELINLKLTDVKSDSNLLLIQQSKGNKDRLVALPDKLLSLLR
EYYIEYKPKIFLFEGTNDEQYSERSVQLVLKKSMKKANIATKGSVHTLRHSYATHLIKSG
IDIRVVQELLGHSDIRTTMIYTHITDVDKKSTPSPLDFL
>EGEFANNL_00344 Aminoglycoside 6-adenylyltransferase
MKVREEKLRTIIEWSEKNEDVRVLLLTSSLVNPLALVDEFSDLDIEFVFEDNTNYISDKS
WTLKFGNPIAMIEEDESCFNHKHAMKMLLYEDGVKVDFKLYSKSKFIKETQEKELPEDWD
IGYKILIDKDGITKQMLKPTYQISIIKKPSEKEFQNLINDFWWDTTYVAKCLVRDEIFYA
KFMSETVIRTEYLIPLIEWHIASEHNWNITTNKYGRLFKKYLNQEMWAKTEQTFSGSDIK
ENWTALFSMTDLVSEIGTELSKKLEYKYPDKLENDIRKYLAGLKPKT
>EGEFANNL_00345 hypothetical protein
MKYKNIREEELKNKVGADWFKQFDTTEILGNIDFTVFPKQDSLFGRTPLLWAEAKTGNFD
IPTMFVQLILTIGKARTFDKTLPPAFLGAFDFKKIAFVDYVNIQDIFYLNDFNWNVTPSN
HETKEFQLIKERIEAVLKSKTYVFDYQKDEKLLNTFIKNNVAKATTKSKIKIDKNNFIPI
YLRWIEIVKPIIEVNWEDLKKANIFDSDFYLADIFVDDKGTETLDDDFTIRDGLFVVFQN
QGYKIAKENIKQMFDATINIRHKDAYSQFWKLYKRPPIKEFQDYIIERRDLLAPQDIRER
KGAFFTPRIWVELSQKYLTDYLGEDWQDDYYIWDCAAGTGNLLAGLTNKYNIYASTLDQA
DINVMHERIDHGANLLKNHVFQFDFLNDDFTKLPESLRDIINDEEKRKKLIIYINPPYAE
VSSVGEKGKAGVNQSKTHTKYNEILGTAGREIYAQFLIRIYAEIPDVLIAEFSKLKLLQG
SAFISLRNFLRAKVEKMFIAPAYTFDNVKGKFPIGFKIWNTQIKEVFSSASTDIYNEKGD
FIGTKGLYSIGKSYYINKWISSFKVNDGFIGFLAGTNGNDFQQNGIVYILNKKEQMANPR
GMWISSLNLIPVSIYYSVRKCLDQTWINDRDQFVVPNSNWSQDFEFHNDCLCYTIFNTNI
QEKFGLNHWIPFTEQEVNAQNRFESNFMTDFINGKIKTENETNLFGVKENQNEKREFSEE
AKSVFDAGRELWKYYHSKPNVNVNASLYDIREYFQGRNDKGRMNSKSDDERYMELIGELR
NKLDFLADKIKPKIYEYEFLKE
>EGEFANNL_00346 Kynurenine 3-monooxygenase
MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTL
DLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDL
RAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTD
TEVEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFK
TPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKS
KRPLPITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFIY
GKEAQEESTQNEIEMFKPDFTFQQLLNV
>EGEFANNL_00347 Aminoglycoside 6-adenylyltransferase
MKVREEKLRTIIEWSEKNEDVRVLLLTSSLVNPLALVDEFSDLDIEFVFEDNTNYISDKS
WTLKFGNPIAMIEEDESCFNHKHAMKMLLYEDGVKVDFKLYSKSKFIKETQEKELPEDWD
IGYKILIDKDGITKQMLKPTYQISIIKKPSEKEFQNLINDFWWDTTYVAKCLVRDEIFYA
KFMSETVIRTEYLIPLIEWHIASEHNWNITTNKYGRLFKKYLNQEMWAKTEQTFSGSDIK
ENWTALFSMTDLVSEIGTELSKKLEYKYPDKLENDIRKYLAGLKPKT
>EGEFANNL_00348 hypothetical protein
MKIYIFTILALIFFACSTDKKQTTENSNSMLKLYKLIDDQLHYWETWDKDVKTAIVHWGI
VGQTGQDKEVKSGLFSNFRKTVQKEIDEKLKDGYAEFDEDNYAFLEIEYKIDGFGTEQDL
DKRHRLEEKMDEVLGWAGLGHTDGGSIGSGTMEVGCIVVDFDIAKKVIEEKLKDTEFGDY
SRIFKMDNE
>EGEFANNL_00349 Bis(5'-nucleosyl)-tetraphosphatase, symmetrical
MKRRPPIKKIFRIITYGILSLIGFIFLFLLIVGFNVEHKDGTRDKWSGLRALFEKDRDFG
IFLNYQEKYNLNGIDGPYIIDNQLYEVTKENKLLSKNINRKEKLNVIVNNSDNDQFELQL
KDSITSEPDSFELPEKLVVISDIEGNFDGFSSFLINNGVIDKNFNWTFGNGHLLLNGDFV
DRGENVTQVLWLIYKLEQEALNQNGKVHYILGNHEIMNFQGNAHYANKRYKRVAQLISKN
DSLKIATQYLYSDKTELGKWLRSKNIIEKIGNYIFVHAGISPEIIKYNVSLSDINQIARN
NWDKNLYNEDEKNKVENFITGRKGIYWYRGLAQDYKYYGKIKENELKEVLNFYQADKIVF
GHSVVEDITKDFNGKTINTDVKHGQEKNSEKTKGLLIENGVEYKLDGKGTKTKF
>EGEFANNL_00350 hypothetical protein
MKVTNSLKLNIYIHQSCEKIWDVLTKEELFCDCFKFLKIKCNNWQIGGKITFKSQNSNII
DFAIITELQTFKKLAYKYHKMNSNDFQLIVFDIYSIENNYSKICITGKNFRDKDEYNHSK
TAWNLMLETLKIYLETDKKL
>EGEFANNL_00351 hypothetical protein
MRFSLAVILIQKEIFLNIFKYITNMKNLIIIILLILISSSCCKDDDFIGKECVNDFYYFD
SEKIYLDNLNGNYLIIGFKKETDDLTISTFINSLDYLEVEDILNDNYKFRLIKLQNEKTC
VEIDSEIYKLNKKEIVLYANKAYNTDFFGYYGPYNLMFTTDQINVKLKDNIEKSQLENLI
AEIKNVSIIAENNNFPNVFLISNTSKERNTIQTSTLLYETGLFEYSEPNFSYIQFL
>EGEFANNL_00352 Proline iminopeptidase
MKLNIKILHLIIVLFLSLNLASCQKLTNGSYYEKIGDLKLNYTIRGKGPIMIVGHLSSGK
IGYELTLKPLEEYFTMVYYEPRGTGKSEVPKTIEEYNQTFIVEEIENLRKKLNANKIWIF
GHSDQSSVALEYALRFPKQTSGLILTGTGFIGTQQETYDRRAKYEKERAKESPWFAQVLK
DWDYMIEHKTSTDENGKDLSDAPIKWWCYNEESSQKVIPIVKEITKAGRRKPINNQFSFE
TENERQKYLDYQKQFPTIETKILIVNGKYDTNNQPKYAEELQRALPNSKLVLIEKSGHFP
WIENSEKTFQEIENWLQTVKK
>EGEFANNL_00353 hypothetical protein
MKFFFPLIFLFSLNAMSQNIKYKHTRPELRPKVSNRNQIFKGLVKEVRSKTEYFNKDHSE
IPSYTNWKFDQIGNLTYYSYTIRGNNGDRYVHIFDKKDNLISTEWYNETTNELYTTTKYK
YDDLNRLEFKEVFNKMGELRQKKKYLYKNSDKPYEIHIYEDNLIDLRKPIGYFIQELSEI
NKLEYDQRGNLIKIEKLNGNNELESTIKLVFDGKDRCIEEAIYVPEPGYAFLYEFNDEDN
SVTFFNSRNGLKEILHYDKYLDGKLISISTFGNSKVINEKVYKYDDKGNLLSMITLEDGN
KSSKMENVYTFDKFSNPITIDVFVDDIKIESKTLEFEYY
>EGEFANNL_00354 hypothetical protein
MIAFSNTGTGFKGAISYVLKEHEKHLPIHKQPIVIEQNNVWGTSTEMARQMRFIADSNSK
SSRPVLHIAFSFHKDERLPLRKSLEAMHLALNEIHFHKDKNQYLVVKHNDTDVEHYHWII
NKVNLDAKNLDTSYIKNRLQVACDKVEKQLRLRPTPGRTIVYDSESEKGYRFTKKETPRN
KVFREKSANISDTKQFVYDELVHVLSFLSDVKDLETQLSKKGIACKTTFNKNGLSGVSFR
YNKQAYKGSQIGIKAKDIVNAVEKNQSLDIKQQITTLSAFDKNIQNALSAIVKDYENGNP
YPDFTEHFKKHEIVLDPERLLYKGFRISNQPIERFRQKAETYVLGTLKDFEYKTHYYHNL
MNQEPEKVPLLFGRDKVLSENKRLLKQQQNAVEPKLQIKINQAIIPDYSIAFMKSIQEYK
RKLAELIKEETKVEKDVGIEKTNKILQNQQEIKRGR
>EGEFANNL_00355 hypothetical protein
MIVIRVSVLEKKQIQKRAEKYHLSISDLARQFLLNGHAWAKEINAFSEPILDRKTLIGLS
NNLNQLTRYAHQKKELPVIMELLQKINKIFDP
>EGEFANNL_00356 DNA primase
MNCETAKNIKLSSILDQIGACKIRTFNHEIWYLSPFRKEQTASFKIDLRKNLFYDFGEGF
GGNVLDFVMRYYKCDIPNALKILREDFNSFSFQQQPTAVLDEETEQKKSYEITTVQTLSN
PVLLDYLKSRKLNLELCRNYLCQVHYQLNGKNYFGVGFKNDQNGFEIRNKYVKICLGKKW
FTHLKNESKSVVILESWSDFMALLTLYPKMEKENDFVILNSLVLSSKIDSIMERYECVFL
TLDSDEAGTKVTQKLLEKGNGKCTDFRKIYSNSKDLNEFLIKKSPVKNNRRL
>EGEFANNL_00357 hypothetical protein
MTLDIPYIRVGTSYFKIIDKPLISGDKVKVMVRWNRETIISDHGKSFLNNVLKLDGFCCI
PNHFGYEQIVGDFYNMYNELPVKPINKEFSLEELEKLIPNSLHFMNHIFGEQTALGLDYI
KLLYEKPTQTLPILCLVSKERSTGKSSFIKWMKAIFGMNMTYIKGDSFGSQFNSDWASML
IVAIDEVFFDKKEITERLKYLSTTDKDKVEAKGKDRQEIEFFAKFILCSNNEDNFIQIDE
EEIRFWIRKIRPISTEDVFFLKKLHKEIPYFLKYLQMRTFFSEQKTRMWFQPEQIMTASL
LKLVNRNKSELLILELLHECFEKMDEEELKVAPNDLYLLLRKQNNRISISANEIRNILKR
WNFVPEDNTKSYQGIELLSHGEYVKVDRRGRFYTIKKFLFYKLFDALMQNEDKAL
>EGEFANNL_00358 hypothetical protein
MYLGNLKEKPVWQMTGEELIQLLKTSTEKESKERIDSHTNDLSNKRYVYGIRGIANLFGC
SISTANKIKKEGKIKEAIIQHGRKIIVDADLALKLFSRK
>EGEFANNL_00359 hypothetical protein
MNTVDAYLEISLQLTDTTIMMWEQELNTSGNSFNFDSQDIYRQYLTNVFLFDFKDRVESN
KTTTNRVEKLKKLKENLELMIKIYEKNSNFFTQLDRNALRLTKFREITKSTLSDNDLQLD
LYRKIELPERKAYLESDFYTEVGFLNYDYHYEIYIHSKKLLEDVKTNFDNYEIYDNDYLF
INNKPLFRMKLIGELHDFLNNLVIEDISEYDFYKEINILHTVNKIKISKDHVVVFYYIIH
CLSNTIKDKEIKKKWLSRILQEFGIKRKSYDSKYRHIASSDANVTLKEYCTQIDSVFK
>EGEFANNL_00360 Tyrosine recombinase XerC
MNIKRKITIAIEKRKKDGVLITENVPIRARVVYNGGRVEFFTGYRIDSSKWDEAKEKVRN
GCTNKLKQSSSEINTAIQELTAIIERVFKKFELKNEVPSFQVLRDEVKRSSDKQIISATE
KNLFAAFDDFVKNNGRKNDWTEATYSKFKTVKSHLFTFRSNFQFSDLSEKLLLEYVSFLR
DQKKMRNSTIEKQISFLKWFLKWCKNNNYIVEYGFENFRPKLKETSKRIIFLTQEEVSKI
KAADLSSKPYLDRVRDILLFCCFTGLRHSDVYNLCKHDIKDNIIEFVTKKTNDLLRVELN
KHSKAILDKYRKIPIENNKALPVISNQKMNEYLKELGEIAEINEPTRETYYIGNERIDDV
KPKYEHLSTHVGRRTFICTALSLGIPAQVVMKWTGHSDYKSMKPYIDVADTIKANAMSKF
DML
>EGEFANNL_00361 hypothetical protein
MRILIDTNILINLEGHKIVKDNFSQFYRIAITNNCKVLYHPRAIPFDLDRDSNLERKEIT
ISKLKKYEPLEDFAYPTEKFKSLFIVKKVNDEIDILQLFQLFKEYVDYFITEDRGIHNNA
KKIGLQSKVLYVSEIQELLEELFTIKIPSHPILKEHSLREIEDKFNSPFFDSLKEDYGKE
AFSNWLMKCIKKNRKCYSLIVKDELQALLIYNLEKIEQHQLKDIYSDVLKICTFKVSDTV
FGIKLGELFLNKMFEYCINQKIQYLYLTVYEKQTHLIKLLNRFGFYKNIFINKQGLSEVQ
MIKCLNKNLVSKKYNCINLHPFYYDNSTISKYVIPIKPKYYSKLFKDGSLRHPTLFDFSQ
DSINEIQGNTIVKAYISNSRIITPKQGDILLFYASNTDKAIEPVGILESIEIVDNFDKLW
KLVSKKTVFSQEELIFKLQDKGKLNVITFRLITYLNKKIRLSKIKKLNSFKNKIQTITKI
SESDYLELRNEEYFDKRYIIN
>EGEFANNL_00362 hypothetical protein
MKNTLTNVILSIKPTYANAILSGLKKVEFRKKIFKKPVDKIFIYSSSPQKMIIGYFTFSE
IMEDTPKNIWDKFNKVGGIGKKDFFEYFKGVEKGYSIIINSYEKFKIEIDPIEFIEEFSA
PQSYIYLDDKSSLEIALTKLKKIK
>EGEFANNL_00363 hypothetical protein
MKRKEIDLLENSKDYFTSLSKMNIESYKELGFTLQSIIRICQSAILAKEKNVHLYTDLDI
YNLLSLMKKLIPDSELEFLDEVHSLND
>EGEFANNL_00364 hypothetical protein
MSSHLPERKTYVVCTNQLGSGHRKLLADPDRRKVSVFYQKEFALLTTADKKLDKDFTCKS
AWNKGLSGGAFGAGAGIAVAPLATPVVSGLLSAAGAVSVVPYAGWIVGGALAITAVGYAL
YSALTAPKCSGALGHISSQWKLYHPSVYYNKHNALLSRSVLQCGEGGVLLPFLSINVAYK
VSESIARNNKWDVGIGVIVSGLGGFGMAKLLLAGNISALGISLIIGNYIIPPSAEWAGDA
YADVYRDQRYKEIEEAIGQKKEENKTYMDYIMASANPIDDTQTIIKNSNEIIANIKAHGA
SKEAIAEFEKSVAEAKRTGTFTNEKSSKVLADIKEGKYGEKAQNIFKNKNGTTTGMHTEK
SYDKAIREEQMKMGLNKVNSLKSFGNGSITILGIAQPFMSAIFNKRSILLAKEAQEKELE
IENSNAISVVSSNY
>EGEFANNL_00365 hypothetical protein
MEEFNNYTFRATTIPKIILTMLIWIVLTIVVSIPIQNFFHYEDIKNPTILINIKVFGTTV
FISSIIILIISQYIISSRYHFDFKNSYIEIYKNNKLDKIVELSNINSFSSTITPFLSGIE
ITFNDKKKYHFCIGFIFNFKKEVNIFSLFLIKELNPFLLEKNFVLNIKLETTKMKSFKFI
SKS
>EGEFANNL_00366 hypothetical protein
MEEFSNYTFRALTRNHAILIFILIFPVFITIYLLMDKFIFYDVKVYNVFSNMKVIGIPMI
LTYFLLAITANYILGNKYWINIKDNEITIYRNNKIFHSIELNQVHKIVFFFSSKQNNGYL
LFNCNNIKLFMFMGVLLTKKKDFIMIQNYFNTILYPYLLKNNFTEIIQEQKGITIYTLIK
KK
>EGEFANNL_00367 hypothetical protein
MEKLEEFNNYTFKAITRKGAILIFILILPIFISIYLLMDIFIFYDIKVYNVFTNMKVIGI
PMILTYLLITITSNYIIADKYLLETNDNKITIYRNNKYFYLIELYQIKKIICTINSKFKG
GSIHIESHNNKLYIITGFFFTKKNNFPIFQEFSNIFFSSLEKKEFSKEKKQKKELITYIL
TNKN
>EGEFANNL_00368 hypothetical protein
MEYENYIIEREEKLSSIANKFNTTPKEIKACNPNMRTFGGGVWGAEYASYGQRIRIPVQP
LEPIRLQTDFISDIPIPSIAFNSKARYRCEQINETRVLETLTTYTNQKTQYLLEQNLEEG
YAKIKLEEFLYEVIPPLLSDSFELIKSTEFIKNKAIFKLSEKGKIEQILNAKEISNQWKT
FKEKELKNLPFIESLQDNTEAIHNINKAGDIEFNSPKVKEYQRNLFNFLCFDQHLYQPIE
ELEKEEFQYASSLLAPVIIPLEFKYNKVSEDNKFITFKKIADVHLTDSLVQKLKQKYDEV
LKPVIKYSFTEYKLFFSCTLDWNKETKLLEKASVHLKETIADNIQNVCTFSLNQLKNYTP
>EGEFANNL_00369 hypothetical protein
MKSPQTLKTKPLNTHSLILLEGEGTDQSDIKSLKGRAKRKLITQKMMLNLIDVCKTKEDS
QRQKSYWNTYYCQSKIISSKNRIYGKYCKNRFCTVCSAIRKADIIHRYYPTLKTWKEPHF
LTLTVKAVKINSLNKWINGMYRAFSLILNRYKKRYQRGKAIQLIGIKSLECNFNPQRKTY
NPHFHIITANHKIAEILKQEWLQIWKFKNQPQKIVVSPKAQFIRKVENLERDLIEVIKYG
SKIFTEPDIKKKTQKQNSNLAPMIYIQALDAIFTAMKGKRIFERFGFNLPKQPRPQPKSK
LTYEFENWNFDLKVNDWVNPETGECLTGYKTPVELNFLLEESVNTQLS
>EGEFANNL_00370 hypothetical protein
MVHPQIFISLTQEELQILIKEAVQTALKQQPLNTATQPSPEKYYTRKQTAEKLHISLGTL
DNYTQTGLLTAYKIGHRILYKPQDINHCLNQKQGIPTNKRKQRKQLQASDKNPNP
>EGEFANNL_00371 hypothetical protein
MEERKYYIYSMPPNIPIYIQELIEKEDEESLYKLLYSIIAEYIHEVRIHTYRLKLKTKEA
QKIYPLINQTEEEKTNYFIKELCNKYIEYRRLPPNSGKYTEEEFRKQCLDKIVNLIYNQQ
HVNETEIKSILYFLNLIVKSNFNENYFSSIEYKYSHTLLKYLIYLCNTEHIKDKPQPKKI
IDQIIHQFIINYEIAIGDTSVYQQINTLFENKLLQLFRSDFFPAKKLYIKRLLDILTQIN
QEEGFQDLWTKDLLTLLQDLIQSDKDFQQEARQNPLPPSQQKEPTDYSDTNNVEKIIFLH
KLGVLEYLRNQEPFNHSTNLLAEYLSAVTGIKATTVQSYINPIINKNAQQNKSALHNPNT
VNKVEQKLIKIGCKAKDLLT
>EGEFANNL_00372 Tyrosine recombinase XerC
MASVTFVLKSPLSKERTSIILLFRYDNQRIKIYTKQTIEPLYWDKDKHRVKNTVKITNSH
SINNQLQQMETLIFTQFDKFIENYQRKPLPVELKEIFEKEYFEKIPQFTKTKTKTFFDYF
DEYIQNKKIEYPSTKTHEKYQQVKNTLLDFQSYTKTTLIVENIDLQFRNQYIQYLQETKG
YAQSTIHRHLKFLKTILLYIENHGHKLHPQLKSKGKNSFIPQDEISEKIALSEKELAELE
NLDLSRSPRLEQVRDRFLIGCYTGLRFSDFIRLNKNNLEDDKYILIRQQKTQKPLTLPLF
PPVKNIFEKYNYELPKPISEVNFNLYLKEIGKLCNTLQQTYETTKTQAGKRIKIQTPRYE
QVSTHTARRTFVTLNHAKGVELDTLMLATGHGNIKTIRNYVKLNDKQNADLLARRIEEAS
KKRDKKNETKIIPIKTAHK
>EGEFANNL_00373 Tyrosine recombinase XerC
MSLKLFNFKKVPLTVPLMKPYTIKIYDAKGDVSKDWYIRWFLRDKESGKLVRQTNIKAGC
NRLKTANERYTHLRKIIMLMEYKLNKVLNEKEEVKKIDESILDELHKTNYSLEEAFNYFI
SIKTSSWSNVTLRDYKSVYKIFSTFLEKNKVDTSNVNNITRKYIIVFLNERHKETSARTR
NNNQINLKAFWEFLKNEEICNKNILDGIPKVKTTAQTHKIYTPEQFDSIISEIEKIDNQL
ALYIKFVAYLFVRPVENCRILIGNIDMKHRTIVYKSKTKDQKVKYIIDLIYKDLEKIHIN
KYDKDFNLFTPDGKPSLWIGKEESKRQYFTELYKDIIKSNPKLISLGLTDNHDMYSFRHT
GIMILYRSYRKKLSPFEVKSKLMLITGHTTMSALEKYLRTIEAELPEDYSKDFLS
>EGEFANNL_00374 hypothetical protein
MGNNKILDVITRISTNNLNCVLNLEDDVIVNNTSGYIEHIGAEEIAINSEGKIVVFKIKD
IVSLRIL
>EGEFANNL_00375 hypothetical protein
MFEKILICEDFESYSISVKKVLEEFKATNIEQVYYCDDTFFKIQVAEKQKEPYTLLIVDL
SFNDGEKKQELKGGEDLIKKIREENINIKIIVFSIENRASKINFLFEKYNIDAFVTKGRE
DVTDLKEALTKVMNDGIYIPKSVKLSQNNLIDIDEYSLIILKLLSKGMTTIEISNQLKKD
KIEPNSESSVKKRLMALRDFMDVTNTKQLISICKDMGII
>EGEFANNL_00376 hypothetical protein
MNKDYIIKERHRVAEVIKARREDLSMTQEELAQKSGMSRITINRIENCVFSPNADQLYTI
CKALNIEIKLIPLINSMSNKTL
>EGEFANNL_00377 hypothetical protein
MKSPVYNVKAVPIEKIRANSYNPNAVAPPEMKLLELSIWEDGYTMPCVCYYIPEEDIYEI
VDGYHRYTVLKTSKRIFEREKGLLPVVVIEKDISNRMASTIRHNRARGTHSIDLMVEIVS
ELTKAGMSDAWILKNIGMDADELLRLKQISGLTELFKNKDFSNSEEYE
>EGEFANNL_00378 tRNA(Ile)-lysidine synthase
MNVYEASLKRLDLIFSEFDNVYVSFSGGKDSGVLLNLCIDYIRKNKLNRKLGVFHMDYEA
QYEMTTQYVDEVLHSNKDILEVYHICMPFKVTCATSMQQGYWRPWEDSLKEVWVRDRPID
SINIDNHCFDFWNDALWDYDFQGKFSHWFHHEKKAKKTCCLVGIRTQESLNRWRAIHSER
NYKNYSGLGWTKEMYPEVYNAYPIYDWNTQDVWIANAKNGWSYNPLYDLYYQAGLNIDQM
RVASPFIDTAIESLKLYKAIDPNMWAKMVGRVNGVNFSSIYGGTTAMGWKNIKLPKGHTW
KSYMFFLLDTLPNDVKENYLNKLNTSIKFWKEKGGVLSKETIEELKGLGISLEVGKTTNY
NTDKLPVRMDYLDEIDSKDFKLIPSYKRMCICIMKNDHLCKYMGFTLTKNENERRKNIME
KYNNIL
>EGEFANNL_00379 hypothetical protein
MKVEVFMGTDPRVYEIIGPFAMDLNFIKANGYPLTTSSLHKWFVGIEDGEILCFCSVKYA
LTTKTMQLGNFFNLRGNKQRQLITKVIKTFTKEKQLGLNAFSNNDNLEFFYKLGFVMQTE
NKEWHNLKYEPKKEEE
>EGEFANNL_00380 hypothetical protein
MRPLLFQQKAAKGHLSAWKCGALFMEPGTSKTRIAVELVNRINNLDLVVWIAPLRLIEPL
GNLPSTKDEIQKWGGFHCKNVIYIGVETISLSQVKYINLYQRIKNAKRVFIVVDESSKIK
NLSAVRTQRVLSLGEMTPFKLILNGTPFSKNILDVYSQMNFLSPKILNMTAADFENIFCR
KKRIIKYLGKWKQRKIYDREFITGFENIDLLYSMTRHYVYEYDLNLQIKQYWNNYNYVIG
EQEKEEYYYLKNKYLDNERLLMLNNNIFLEMTQKMQHSYCISESKFEVLDRHFQSYPIDQ
HIIFCKYIKSREECLKRYPKATVLNYQSESMGLNLQHLPLVIFFDKIWDYALRVQGSRRS
YRVGQEKDCRYFDLTGDVGLEKLINDNIAKKGVQMEYFKKLSKNELKEIL
>EGEFANNL_00381 hypothetical protein
MWTKVYFNQQSIQRETPRSVLIKMPNHSKYKGYCFWHPAKLVREEGGKGYHLSFSFSDDF
NFNVIKYGQGRYNSNEIISEYELDAEDMKEVWQVVDRSIQVSVSDEIQKKKDENHLEIIV
EEIIPKKESPLDSNEIDDLRL
>EGEFANNL_00382 hypothetical protein
MENFKILTVQIAEQLIGKKIEWHAPNLYANQPYSGISIITKIDLSNRNPISCINIEGHGL
EYAFLYTFKEDNSIIFSYSDYYNFVTFQVIENVD
>EGEFANNL_00383 Thermonuclease
MLSFLVSTFLLSQTLSGRVIKVADGDTVTILTDENEQIKIRLYGIDCPEKGQDFSSKATA
FTSSFCFGKIVKVTQKGLDRYGRVLGIILIGKKNLNEELLKNGLAWHYKYFDKTQKYVDL
EQEAKNNKLNIWSMNNPIAPWDFRKKPKKR
>EGEFANNL_00384 hypothetical protein
MEREKIVLLPSINTDVINSPCDSTGKLKVIERTIKIPYGEVKVNSNGDNLKIQVNTDSIS
SLYEKVYRERNSSQLTEINELRIENEKLKITPFNWWKWIGYLSIGLNIVLILKYLIKYKL
SFKIL
>EGEFANNL_00385 hypothetical protein
MSVEKLYPETGHNLPGKGVKEDPGAVANGYKENELTILFMDTVLEEFRKLGGDFQRDDDQ
VSLASNIATIRKTIKHSDLIYSVHFNAATSKATGTETIVSNYAGVTSQEIAKEISEVTSR
VLGIANRGVKKEKDTPRRKLAILNLKGTAVLHEVCFITNPNDMEKFFKNYKTLAKEIAVI
LKYYDDLLNK
>EGEFANNL_00386 hypothetical protein
MRIRDPFPFEYSSFPPAKIGLIPCFRLYIASLVAIPMSKT
>EGEFANNL_00387 hypothetical protein
MNYKEVNTKKEYNLLILKVKKETEKLFYKYPEITIYKIILDQLIDIISSLKSNKKFTDNE
IYKRYNLGAIAVKNFDCDEDLYGRELQDIFGGLFDYHQMPDK
>EGEFANNL_00388 hypothetical protein
MIEISKGTELYHYTKVNSEGISYRGDYYTANLNHTPNELGISDKYNVREGRNYTDEIKTV
NQEKIIIKQEVEGLKSTSAPINDTWS
>EGEFANNL_00389 Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase
MNYYQLVQEARQFSILAHKEQKYGAYPYDIHLGHVVEVLITNAVGFYSEEDYTLLAVAWL
HDILEDTNTSKEQLNIRFNINIAEIVYSLTDGKGNTRKEKKEEVYKKIIYNQEAIIVKLA
DRIANVEFSLIHGNIEKIKKYYTEQKDLENYIKPNISTNLGKILFEYLEKIFTNNIYLIK
>EGEFANNL_00390 hypothetical protein
MIDYNYIYYKKNINGEDTLFRIPKNGIKFHEQIQNIQVLDKKKWTTNHLKITSFLNDYMT
GWIDEDDYLSSEEVQRILNENM
>EGEFANNL_00391 hypothetical protein
MRSAVHKAIEFRDKLKAQKKGDGAFEKSAEQIKAEELIDQAKIAEAELTDLLIKLAEENE
GKMEGLDFRLKSIESLTRKLQTDGLNAEMKDVLRYTTIFENSKLTSRTKTMLDALKQNGY
KEVAIKNTFKDGAIYKGINTNFETPNGQVFELQFHTPESFNVKQNINHILYEEARLPSTE
VARQIELKNIMIENSSKIPNPQGVSSIK
>EGEFANNL_00392 hypothetical protein
MTKKIEIENILNKIASLHIEDDYAFNKYFDKILELLKNNESEAIHILTTLSEKDIDWLTP
MFEDLSAEFQSYKFILCLEEIKKKYPNIHLIDESIQWAKDAMDE
>EGEFANNL_00393 hypothetical protein
MEYNYQYMDKISKLIILRMASLKTIESSYQFNKIFMHIGSIASATRLLDELEQEKLISHE
GIYDKDPSFYKKIKITEEGENYLQENLKNISFSNTEFNEHRIDLLNKIFGLS
>EGEFANNL_00394 hypothetical protein
MIERLRAIERGELEATNQDKAYLTHELREYELMDKGMSYGEAHAQTCKEYGITAEMERKT
NGEHPFYTKEAEIADLKESGF
>EGEFANNL_00395 hypothetical protein
MQSTSFINCIESIGEKYPNIPYIQDDIQDATKTNLANSVERVKNNMRSAVHKSIEFRDKL
RAQKKGDGAFEKSTGGKSPFDTIAEDGYRGGLEHIKQIQDQ
>EGEFANNL_00396 hypothetical protein
MEKNIETLKIINQISCSSAVNLRSIDMRVMIKYSEIIYNKELLPIINSLIDKSYLKWVKE
NSSVIITKEGIECLINEGENLNS
>EGEFANNL_00397 hypothetical protein
MNVKYKIIKIIKNHNEGRPVGVPIIDRIMTKYGVFGGILKVELDNYVKDNLIVWTDSLSL
SITEKGIEYLMDEDKI
>EGEFANNL_00398 hypothetical protein
MANEIFNESHYFMCEGGLKPASLKTSQENVLLENNKYYLTEYSLKCKGIDFSCRWVALLV
AIIAAAIALLMSCPAGWVLLAAIAGAAGGALLAGKICGDKAAIVRVWLVIKDDVVFGEHK
AVSNHKPQHLNCRAFGYNIVYKPNVTSEFEAICIFGGNVLMTGLEAFMYVYAFRGGGTLL
TKPMTFFRNFGVNYLKTISKYGMLGRGVFGVWGGANAYYMSDTEGFNANEVAKASAQSFF
FAETAAYHAVTERDPQSIALLLSMGGIPAGGKTGQRNSLGMEKVADATKADLANSVEGVK
NNMRSAVNKAIEFRDKLKSQKKGDGAFEKYLGGRGINSQFGDTMGEYSGREFFKDKCGGK
ILDLDYKNTTITKEGIETVKEHTSRFGEDHANQKMIERLEAIERGELEITEYDKRYYTHE
IRESQRYDNMGVEKGEKGSFEQWNDAHTATLEDYKINEIEQPLYHPEALNE
>EGEFANNL_00399 hypothetical protein
MKNLIFFLEDDEKPSDFKKLTRQLQEEFKQKQREEKKEKDEIKAKALKRFGFRKKGIQKY
QVRLEGEMQVNSMNVKTVVENKYILQLKEIYENSVLIDLVSYDKEMVETSNPTFKEMFMV
TRQLEKLYDEFTARVSHEGEILEIKNLSALQEKWLRIKKELVPYFNEGTNIEEFFSLNDQ
TMKSPDIWKQLLNEQEFLFLFFKLAGYGKKLNFSDTLVKENAYRSGKIAWDIQGYTPIEF
FSEVLNLSISGSFKPSTGWLDKAYGKMPFMNEISFQPSYQLQADYQIDSESGFIRKAHVY
WEEIAHPSLVFHKMKFTITQIS
>EGEFANNL_00400 Actin cross-linking toxin VgrG1
MSRIRVQFPWQKAYGGQSPWIRSITPYAGSGKGMHVVPEIGEEVIVAFENGNAEKPVSLG
AMFNGKGKSGHGGAGNYIKGLQTPSGNKIQFNDKEGSALLTDNGGASMKFDGAGNAVTNA
AVTHIINVGGKDNDAGPSNVTMDQSGNITIKGDANVTIITGNSMIELTPDKISLSASEIN
INGEKIEVKGPGQWQGGKIKIN
>EGEFANNL_00401 hypothetical protein
MAQMQQEVEVNNSQRVQGQVMADIVIWKNEKKDKLENINSVIVLECKEEHITIQEEDYF
>EGEFANNL_00402 hypothetical protein
MANSFIEKIIQQLLDSYKDLSSIHLVLPGKRPIIFFKKFLIDHGYQGFLPTFYTIEDFIE
KYSKLTRIENIPLWLEAYKIQKNYINPEEKLDDFLKWIPTLLKDFNDIELFSENPIRVLE
HLASIERMENWAEKLDSKNEEKLYHKNLKFWENNLILYQELKKSLFNQGLGTSGMLLSTV
VDNLERLSIKPEDIFVFAGFNALTPKEEKLIKYFISHSTTLLFWDTDEYYMNQSTQEAGF
FLRKNILWNYYANREFLWKENQFSKKKNIQVIGTSQEVAQAKYTHNILENIPQHEWEHTA
LVLCDETLLPSVIESLPQEIQKVNITMGYSLKNSLVASFFKQIFGLHIFREKNKTQGFYY
KDVLAILQHPLLEYNQEIADFCKEIQENNLVFISDSLLYKKLNTWNLLFVFKEYKDPLQL
VKIMSDYCYQKFWNYNEDEGILKENFLKFKNIFSLLYTQLSEQSLVDTFSLLQSLYQHIL
NNEKIDFIGEPLQGLQIMGVLETRLLGFKNLIMLGVNEGIIPEGKKDNSFIPFDVKKNYN
IHTFLENDAIYAYHFYRLLQHAEQIYLLYNNFTEGLYSGEKSRFISQLEFESPHQIQEIT
VSYSGSVQQQPEFKIDKTPALVKTIQQWLKKPISPTHLTSYHYNPINFYLQKLVQLEENT
EVEEEISPLNYGNLIHHTLEALYTPLKGQYLTEDALKNCLSDYKVHLQEYIKKELNPDLF
ERGQNYLQKLLAEKTLEKIILRDLTDIQQGNSIYLQDIEKSISSKTNLENLGKIQLKGFV
DRWDVFNGQDRIIDYKTSTVGSLAFNSDKRDKIQENTNFKFFIQLVFYAYMILNEKTTNS
VQIGIWSFKKPFRGLEVLSYDKQTLITSPMAIDLFKEVETIIQEIANPHIPFIEKTYVKF
R
>EGEFANNL_00403 hypothetical protein
MQFTGNLNHHLEKSNLKTLPQVFKKLIKVGTRYILFPALLVIIWFLFHNFFIIKEGINNG
TSPAEVGVIFGSKNQENGSLSASLLERLNIGLNLYRKKQIEKIIVTGGMANKGLCEADLM
RKYLSDHGVPLKDIITDDKALNTQENVENSLEIIKKHKFKSVAIVSEYYHIARIKLMFNK
HNYDFNNIETVSSYGNPLKKYHLDVYLREFLAYYYYLLFK
>EGEFANNL_00404 hypothetical protein
MIKDLNIFDIKSEDEFNHLSLKVFNYQYLSVPIYKKFVDLLSINPNEISNYKDIPFLPIE
FFKTHSVLDKNYNYKFYFQSSGTTSTHLSKHFIVNEQIYEQSILKSFTTFFGNPAEYIFL
GLLPSYLERENSSLIYMVNYLMKLSNHKENNFYLHNFSELDQIIKKTEQENKKVILFGVS
YALLDFVEAFPQKLEHTMVIETGGMKGRKEEITKEELLNELKNSFQTHKIYSEYSMTELL
SQAYSLGQNIYECPSWMRILIRDIEDPFCYKNHEKTGAINIIDLANIHSCSFISTQDLGK
TYSNNSFEVLGRIDNSDIRGCSLLVI
>EGEFANNL_00405 Protein GrpE
MTDHTKNSFDEELEGNDAMTNESVENPENMSENCKDQPNLEDKLKEEKDRYIRLFAEFDN
YKKRVTKERQDLLRYSNKDILESLLPVLDDFDRAMEELEKDPNSSAVLEGVKLIYNKLYN
NLKDNGLQLIEVNPGDDFDLDFHEAITQVPAPDESLKGKIIDVVQKGYQLHEKVIRYAKV
VTGK
>EGEFANNL_00406 Chaperone protein DnaJ
MSKRDYYEVLEVTKTVTEVELKKAYRKKAIKYHPDKNPGDKEAEEKFKEAAEAYEVLSDP
QKRARYDQFGHAGVGGAAGGGFDGGGMNMEDIFSHFGDIFGGAFGGGGFGGFSSRPKQAQ
GSNLRIRLSLSLSEIVNGVEKTVKVKRLKLAEGATSKNCPTCQGSGQSRRVMNTPFGQMQ
TQTVCSTCGGTGKVADHIPPGANNQGLIKVEEEVSIKIPAGVREGIQLQVRNKGNDAPFG
GVPGDLIVVIDEIEDEELKREGDNLHYELYVSVPEAVLGTKKEIPTVTGKVKISVEPGTQ
SGKILRLKGKGLPQMQGYGHGDLFIHVNVWTPNPSKLNKEQKEFFESMLNNEQFHPKPTK
NDKTFFEKIKEMFS
>EGEFANNL_00407 hypothetical protein
MKLYSTILFIVFCTTYLNSQITTDTLDLSEIAIRITLPNQINETSGVAYYKNALYTFNDS
GGNAEIYKLDINDGKILQTIKIREATNVDWEEITLKDDTLYIGDFGNNLGNRRDLTIYSI
KLPYDSISKNLEVPLINKFYFTFEDQKDFENQGYQKTNFDCEAFVYDQGKLHLFTKQWGN
NQTTHYLLNIPKKNGSTAIAKKMESFNTECVITGASLYKNELFFIGYTPNGLAYLWKFKD
FKNGYFFNGKAKKILLGLTAELSQTEGIEVHENNVYITGEEMNYSLFQTPPTLYILNKSE
L
>EGEFANNL_00408 Cysteine synthase
MKVNSILDVIGNTPHVRLKNLFPNHEVYIKLEKQNPGGSIKDRIALAMIEDAEQKGHLKS
GGTIIEPTSGNTGVGLSYVGKVKGYKVIIVMPESMSVERRRLMVAYGAELVLTPREKGMK
GAIEKADELQKETPNSIVLQQFKNQANPEIHATKTAQEIVADFPGGIDALITGVGTGGHI
TGVGKVLKEKFPSTKVFAVEPTDSPVISGGSPGPHAIQGIGAGFIPDTLNVDVLDGSIQI
SKDEAFEYAKKLANTEGILGGISTGASIAAVAKKIQELPEGSTVLTFNYDTGERYFSVEG
LF
>EGEFANNL_00409 Serine acetyltransferase
MNKKIDNYIDLISSHPICLSINKKDLETAVDLFFSQMYPICEKTENLDTKRIQITTIYKI
LSDNISKLLNSKSKADEIIDQFFQKLPEIQDLLYKDAQAFLDHDPAAESLEEVVITYPGF
YALTIHRIAHEFYKLNVPIIPRLFSEYAHSKVGVDIHPGAQIGERFFLDHGTGTVIGETT
SIGNNVKIYQGVTLGALYVTKNLTKTKRHPTVEDNVVIYAGATILGGETTIGHDSTIGGN
VWITNSIQPYTLVYYSSQMKLKTIKEFKEPINYVI
>EGEFANNL_00410 3-dehydroquinate synthase
MSLINPIYYKKEGVNQINSFIKKYHPSKIVFLVDENTHQYCLPKVIPEIEDNSEIEIIEI
ESGEINKNLNTCKNLWEALTDLKIDRKGLIINLGGGVLTDMGGFVAHCYKRGIKFINIPT
TLLAMVDASIGGKTGVDLGSHKNQVGIFVLPELVYIQPSFISTLSHEQKLSGFAEIIKHG
LIADQEYWNKVSSYKVIPFNDFEEIEELIHTSIEIKKKVVSEDFSESGIRKILNFGHTIG
HAVESFFLEKETPILHGEGVALGMIVESYISVKKGLLQESDYLSIKEFLSVFYPKISLHK
EYLGEILTFMYNDKKNSNKEIKFVLLEKIGKAIFDVSVEEDLIKEALLKYIN
>EGEFANNL_00411 hypothetical protein
MVYDPIYLMITGAIFIISMIVQNRLKSKFTKYSKTTLSNGMSGKEIAEKMLRDHGIMDVQ
VISTPGMLTDHYNPANKTVNLSEGVYNQRSTAAAAVAAHECGHAVQHAVGYSMLQLRSKL
VPIVSISSNLVQWVLMAGLALMAFSNNTTVLAIGIVMFAITTIFAFVTLPVEYDASNRAL
AWLEGNHIVQSNEYEECKDALKWAARTYLVAALGSLAQLMYFVMILLGNRRSN
>EGEFANNL_00412 hypothetical protein
MSQIEIKKVTTKIDLKKFILYPNELYKDNPYYVPALISEEMEVFNEDKNPVFQFSICEKY
LAYKNDVIVGRIAIIINRKEVEDLGIKKIRFGWFDAIDDISVTKALIDKAYELAQKNNFK
RIEGPVGFTNLDKAGFLSKGYDKLATMIGIYNFPYYHKHFEKLGFSKANEWVEFYIEVVD
HLPDKVIRFSKLLKEKYNLKALQFKSKKELIAYGDQIFKLLDDTYKVLPTYVPFSEKQIQ
YYKKKYLPFINKDYVICIADENNDLVGFAITMPSYSKALQKAKGKLFPLGWYYLFQASRS
NEWVNFYLIGIHPSFQKKGITSIVLKEFYELFTSKGIKYLETNPELEDNKSIQLLWKDFN
PINHKRRKTYFKEI
>EGEFANNL_00413 hypothetical protein
MTFFIFLENALFTFTINFSTNYRKYLIHLMKINFSLYIFIFFISMVKSQHIIYKNSEHFN
NKIGNRNLHDSETKISYSKDKMSLTTDSLSLNELNTKVNNPNGTINLDTSRTINVDNNND
TNYSNNIGKSRDRSRDLRRDLKRDKNRERNKDRQTVINKYKGYKIKLKIKNS
>EGEFANNL_00414 Fumarate reductase iron-sulfur subunit
MAGKLLNLKLKVWRQAKKDQKGSFEEYKLEGVSTESSFLEMLDMLNEQLVEQDKEPVAFD
HDCREGICGMCSLYINGRAHGPDRGITTCQLHMRMFNDGDTIVIEPWRSAGFPVIKDLIV
DRTAFDRIQHAGGFISVDTSGNTIDANAIPIEKEKADKAFAAAACIGCGACVATCKNGSA
MLFVSAKVSQFALLPQGKIESTRRVLNMVKKMDEEGFGNCTNTGACEIECPKGISLENIA
RMNREFLHASIVNDIKYE
>EGEFANNL_00415 Fumarate reductase flavoprotein subunit
MSIKLDSKIPEGDIHEKWKNHKDHMRLVAPNNRGKIDVIIVGTGLAGGSAAASLAEMGYN
VKAFCYQDSPRRAHSIAAQGGINAAKNYKNDGDSIYRLFYDTIKGGDYRAREANVYRLAE
VSNAIIDQCVAQGVPFAREYGGLLDNRSFGGTQVQRTFYAAGQTGQQLLLGAYSAMNRQI
GKGRLQMYNRHEMLDLVVVDGKARGIISRNLITGEIERHSAHAVVIASGGYGNVFFLSTN
AMGSNATSVWKIHKKGAAFANPCFTQIHPTCIPVHGEQQSKLTLMSESLRNDGRIWVPKK
KEDAEAIRAGKLKATEIAEDDRDYYLERRYPAFGNLVPRDVASRAAKERCDAGFGIENNA
TGEGVFLDFSASFVKYGKEKANELDMHNPSQEEIIKLGKKVVEAKYGNLFTMYEKITGDN
PYETPMKIYPAVHYTMGGIWVDYNLMSSIPGCFVTGEANFSDHGANRLGASALMQGLADG
YFVLPYTIADYLADEIRTGSISTDLPEFEQAENEVKNTLNHFLNNPGTKSVDYFHKKLGK
VMWNKVGMARNAEGLKEAIQEIEEIRKEFWKDVKVPGSQDTINMELEKAGRVADFLELGQ
LMALDALKRNESCGGHFRTEYQTEEGETLRDDENYSYVAAWEYNGEDINKEILHKEDLNY
KYIKIAARNYK
>EGEFANNL_00416 hypothetical protein
MTRFFSSSIGRKFMMALTGFFLMIFLLVHLGINLTLFAGNTDCAGELLPKEEVIFNQASH
FMATNLLIQVMQYVLALGFIYHILLGVVLTHKNQKARGKERYAVNHYAANTPFNSRTMIY
TGLLILVFLLLHLWNYFIPIKFSEVPDDYLLVTSLFKSYGYTLIYVIAFIFLGTHLSHGF
ASSFQSVGFNHRIYTPLIKALGKIYFILISVGFASIAIYFCLKGNGLI
>EGEFANNL_00417 hypothetical protein
MTDNHKKKSLDDIIFENKNKEYGAYELRKSGKKYLTIAFFIGFLFFLTLISSIFIYLKLK
DDTPPPVKYKEEIVAVLPPTPEKVPEEIPEKVPEEKIYTIEDNNKGSERSTVEKTPKQDE
VAQKKYFETKVDNSKEEQTTPKQSELEGKNIGEEDKEGKKTRTDDTNRSGEKNDGTSNAN
NVKGDPNSIVKNPQKKAKFNGGDWGSFLRKILVYPSKAEFNETQGTVMVQFVVDKKGNIS
DLKIISKRLGNGLEEEAMRVLKKSSGLWSPGEINGEPVNSYYTQSITFQLE
>EGEFANNL_00418 hypothetical protein
MSAGVDTNNNKNKNKTRVKKSAFRIDMAPMCDLGFLLITFFMFTTTFSKPKILQLNMPSK
ALIDPSNIPTVKNINSLTIILGKDNKIYYHQQELASLNPSNLIETDYSKNGIRTVIYDAK
KNADQDKFTVIIKPTNDSNYKNLVDLLDEMQITNSERFSVGKITKQETDVYKQKQNN
>EGEFANNL_00419 hypothetical protein
MARVKPQRQGIHIDMTPMSDLAWLLLTFFILTTEFRPPDILNIDTPSSISSKKMKDIGTM
KISIPENGKYYFSMEEEKYRVPLLNAMGEKYNISFNAKEQNEFKKISEFGVPIQQLKQYL
SFNDSQREKLEKSGGIPGIPSDSLRPQIVEWVFEARKLAEQNNDSLELKIKGDQNVKYER
IKNLLDRLQDRNLNKFKLITVYNAGK
>EGEFANNL_00420 Biopolymer transport protein ExbB
MENNQLNQPKKTNNTGLNPLLTILLLLIISVLTYIFILGDDSNFVRLNKSDIINDLSANE
GTPSNVLGIIYKGGFIVPILMTFALMVIVFSIERFFILSKAAGTKSISQFTTEIKTALEK
NEINYAIELCDQQKGSVGNVVKESLLSYKNLGVDQTLSQEQKLNALNQTIEEAVTLEMPS
LEKNMNILSTIASVATLVALMGTVMGMIKSFFALGNSGGAPDAAQLSNGIAEALINTALG
IGASALAIIAYNYFTSKIDNLIFKIEEIGFIIQKSFKSKH
>EGEFANNL_00421 Phosphopantetheine adenylyltransferase
MEKIAVFPGSFDPITLGHLDIIERAAPLFDKIIVAIGNNSNKNYMFSLQKRMEWIIETVK
TFSNIEVDHFDCLTVDFCIKKNAPYIIRGLRNPADFEFEKAITHTNRTLAKKSIETVFFL
TSSEKSFISSSIVREIMRYKGDYSSLVPNTVRI
>EGEFANNL_00422 Vancomycin C-type resistance protein VanC
MLTIGIVMGGYSGESVVSLKSGEYIYSQIDQNKYKNVFNIHILNDGWNVVIDDLKYPINK
ENFSFILNDKKINFDVLVNTIHGTPGENGILQAYWELLNIPYTGCYFYNSALTFNKKDTL
AVLSKYGVAMAKSFYLNKGDEINSHDIITNIGLPCFVKPNQSGSSLGVSKVKVIEELPKA
IEDAFKEDHSILIESFLDGKEVSVGVMKYKGKIVVVGTTEIKTDNDFFDYEAKYLGASEE
ITPANLTSVEEKNIRDAAKHIYKCLNMNGFSRLDFIIMNNTPYFLEINTNPGCSPASIFP
QQVRYAGYNFSELLDNEINQAIENSKK
>EGEFANNL_00423 hypothetical protein
MKFLKLVASWQFWVSVVLAIALVFGLIKGTFLWLDKYTNHEIQIEVPDLSSLNLDEAIQK
LQNSELEFELDTTKYDPKFKPYQILDVYPLAGTNVKRGRRIFIRANAKTWKPVVVPNIIG
KYKYLAFNQLDLVGLKVIDTLYEPSLATNTVIRLLYKGKEVQPGVNLPRFSPLTIVLAKG
LAKNVSVPNFLGLDEETAKRMITEKMFSVGTITYDDPDNKENTRVYYQVPSPSANYDQGQ
SIDIYLSSKPLEELRTKIRDLDATFNPNSSAGYLGETYEDEKFYRPDSNDDDIISSSNSI
NAGSTNIPSNTNIDKSSQMQGNSSSISDQVKENQKQLKPTADKDQKRKVNRIIVE
>EGEFANNL_00424 Ribosomal large subunit pseudouridine synthase D
MKVVEGNSQINESDGDEMYEHFKIVVDKGQSSIRIDKYLVNLIENSTRNKLQQAAIAGNI
LVNGKPVKSNYKVKPNDSVSIVLAHPPRDTTIVPQNIPIDIVFEDEDLLVVNKAPGMVVH
PGFGNFEGTLVNALAYHFQQLPFFQTDLDKRPGLVHRIDKDTSGLLVIAKNEYSMNHLAK
QFFNKTTKRIYNALVWGNIEEEEGTIVGHIGRSLKDRMQMTVFEDGAYGKHAVTHYKVLE
RFRYITLIECRLETGRTHQIRAHMKYKGHTLFNDERYGGNQILKGTTFTKYKQFVENCFS
ILPRQALHAKTLGFIHPQTKKEMFFEIELPEDMQQVIQKWRIYINAVQEID
>EGEFANNL_00425 30S ribosomal protein S6
MNHYETVFILTPVLSDSQVEEAVKSFEKLLKENNATIVNQENWGLKKLAYSIQLKRNGFY
HLIEFQAPGEIVNALELAFKRDERVLRFLTVKLDKHGVEWARKREEKVKSLKK
>EGEFANNL_00426 30S ribosomal protein S18
MAIDDLAKQAAGGNTSEVKFLSQLDIDTKVEKKYCRFKKYGIKYVDYKDPDFLLKFVNEQ
GKILPRRLTGTSLKFQRKVSQAIKRARHLALLPYVGDQLKP
>EGEFANNL_00427 50S ribosomal protein L9
MEVILKQDVENLGLEFDVVNVKPGYARNFLIPRGWALLATPKNKATLEATLKEREAEEAA
LIKSANDIVNKLKSATVSILAKVGSGDRLFGSINNQDLAEALAKAGVHIEKKYIKIPGNT
IKRLGKYTAKIRLHRTVEYDYTFEVVSDGVSAE
>EGEFANNL_00428 GTP cyclohydrolase 1 type 2 
MRILDAINVLRNLAPEEYAEDFDNVGVITGDVSNKISGILITLDCLESVVDEAIANQYNL
IVTFHPIIFSGLKSITGKNYVERAVIKAIKNNIVIYAIHTNLDIAKEGVNFEICNRLQIK
NSKPLIAKKNVIKKLQTYVPLESLNKVQKALFDGGAGEIGKYKKCSFKLEGKGSFLPGEG
ANPFLGIKKEFNEVKEIMLSVIFQDYKEINVLKALRQSHPYEEISYEIYTLDNENQEIGM
GRVGELDQEVSEKDFLKFLKTSLPTLCIRHSEFRNKPVKKIAVLGGSGSFAIQKAIQSSA
DVFITADLKYHDFFKAEGKIILTDIGHYESEQFTTKLIFRYLNENLNDLRIRISKVKTNP
VRYFM
>EGEFANNL_00429 RNA polymerase sigma-54 factor
MLKQDLKLKQLLKLSPQQIQLMKLVQLPTLAFEEAVKQELEENPALEDISNEDYYDASES
LEASNDYDESSDNEIIDAPDINIDEYLSDDEIPSYRTQSNNYSDEEDETEMPYAQYISFQ
EHLISQLHTFRLNEEEIEITDFIVGNLHDDGYLRRDLSAIVDDLAFTQGIYTDEETVEKL
LVNYIQKLDPTGVGARDLQECLLLQLKAKNQTEFTELAYKIIDEAFDAFTKKHYSKLQQK
FSITDDELKEAINEIEKLNPKPGKSFTNNSKNTEQIIPDFTIRIVDGKLELLLNGRNAPE
LKVSREYSEMLDTYKNTEKKSREQKDAVMFVKQKLDSAKWFIDAVKQRQQTLYITMKSIM
DYQKNYFLSGDEEQIKPMILKDISEITGLDISTISRVANSKYVNTPYGTLLIKDLFSESL
TNSEGDEVSTREIKTILQDVINNEDPKKPLTDDNLMKILNEKGYNIARRTIAKYRDQLNI
PVARLRKKI
>EGEFANNL_00430 Thymidylate synthase
MKAYLDLLQHILDNGVEKDDRTGTGTISTFGYQMRIDLQKGFPLLTTKKLHLRSIIYELL
WFLKGDTNIKYLSDNKVKIWDEWADENGDLGPVYGHQWRSWGTLNGKPIDQISEVIDQIK
NNPDSRRMIVSAWNVADLPSMALAPCHALFQFYVSKGKLSLQLYQRSADVFLGVPFNIAS
YALLLHMMAQVCKLDVGEFIHTFGDVHIYKNHIEQVQLQLSRQPFILPKLLLNPKINNIF
DFKFEDFAIENYEAHPHIKGEVAI
>EGEFANNL_00431 Riboflavin biosynthesis protein RibD
MKNKYDIAYLRMALEWGKLSYCKRKQVGSLIVKDRMIISDGYNGTPTGFENCCEDENGYT
KWYVLHAEANAILKVAASTQSCQGATLYVTLSPCKECSKLIYQAGIIRVVYIDNYSDTSG
IDFLEQAGIKVDYIPYDQII
>EGEFANNL_00432 hypothetical protein
MTYMRKFIMIFECFYENVYKILNMQKILKQNKLHLKKS
>EGEFANNL_00433 Asparagine--tRNA ligase
MNLYSIKELLKKGTQCLNEKVTVQGWIRSFRSNQFIALNDGSGQKNLQIVLDYNNFNTDL
LKQLTNATSIKVNGVVAESKGAGQEIEVIAEEIEIYGYANPEEVQETILQPKKHSLEKLR
EQAHLRFRTNTFSAIMRVRNALSFAIHKYFNENNFCYINTPIITGSDAEGAGEMFTVTNF
NLNNIPKNDNGDIDFTKDFFSKKTSLTVSGQLEGEAAAMGLGKIYTFGPTFRAENSNTTR
HLAEFWMVEPEIAFYDLDKTMWLAEDFLKYCIKYAIDHCKDDLVFLNQRFEDEQKQKPKE
EKTEHNLLEKLDFVLNNSFVKLSYSKAIEILKKSKPNQKGKFKYPIEKWGADLQSEHERY
LVEKHFKSPVILYDYPAKIKAFYMRLNEDGKTVRAMDVLFPGIGEIIGGSQREERLDILK
NKIEDFNIDEKELWWYLDTRKYGTVPHSGFGLGLERLVLFVTGMGNIRDVIPFPRTPNNA
EF
>EGEFANNL_00434 hypothetical protein
MKKITTNQPINITSYFLFEENKVSYLVKSDQNFSDKKIFYLDHSNFIDKKYFNDKLKKFN
FFQASYNFIDVSIVNDTFTLIPLEYFDEETAEIFLNNTVIFNINMGVRFNLLPEYGLAIV
FYYPEDIDNLLIESVNKIRVTHTGFKFLSKIFNSFKNDEGVYINIYDKCFEVAVIEKKGL
LIYNVFSYNSFSDILYYLQVISDTSKINIFNKTLFCFGVKKDSEEYINGFEKHFIDSYKG
YEDEFVRDNFTILDL
>EGEFANNL_00435 Ribosomal RNA small subunit methyltransferase D
MIRIISGEFKGKRIHAPKNFDVRPTTDFAKEALFSILSNRYSFSNINILDLFAGIGSITL
EFASRGCQNITSIDNNNKHIKFIQDTVNTLNINDRIHLIKHDVITFLSKKSNQSYDLIFA
DPPFNTDTELYNKIINLIFQNKFLKSQGEFILEHESRKDLSELPFFSDSRKYGNVRFSFF
NNSKVL
>EGEFANNL_00436 hypothetical protein
MEKINLFLFIVFINISVDAQVGINQDSPTSTLDIVVNPNNEYALKVYNSKKDLVFNINRD
GNIGFDVENSNVLLGLNPDDGAIGIGNSYLTASEAGSGAIKYSKTDQLLYYSDGLTWSSI
SSKVLPLYTVANIENSTVVFPTDIKTQVTGFVVQYENNNAFVDGVFTAPRDGSYIFSYNL
GFNLTSVLAGSYIEMELSILPSSNDTGVPRMLSLKSRKTYYVTANNMEPFAAITTTATLK
AGEKVIPYVYHNLGSTISLNPSACSISIVEN
>EGEFANNL_00437 hypothetical protein
MFKKLFITHIFIISSILNAQIGVGINTNSPEATLHIKMKENINYSNAISVRSLDQSLKFN
LDGLGLLKFGEENSPVPVDVRINSNSSVIKVGNTSLSAEEAQAGALRYKFESEIFECSNG
EQWLVLNYDTPPDHLIAVNNFKKVLIPNNVYTKLTGWEVKYESRVGDFINDTYTVPVTGM
YILSFSVFTNMIQQPSSSYFKGEWVKIEGGVETPIIQAKNNFLSSGVYMLGISCTGTVRL
NEGDKIQARVIHNSGDGRYLRVDVNNNAVAERNFNSLSIIRVSE
>EGEFANNL_00438 hypothetical protein
MINFNKHIMKNNRIFATLLILLFNLNLFSQIAINSNDPTDFESIQSASLSVYSKNPEYPI
LKISDFLNNNIFIINENGYVGLGKNVTPKVRLDLRGDSEGTIAVGNSNLDAVTAGAGAIR
YNPLTSLIEYSNGLTWITMKKAPPKTNVLAVARPAGFTLIVPSDQPIKGWTIIRDITNSF
NPTTGVFTAPDNGIYAVTARLLIKTINTPADASCELNIFYTDNGVAQGVKSVYPIIAPTS
GIDIPVFNKTFLYLKAGDKVHVSFYSYLLNSPSISENDQLNYINIVKV
>EGEFANNL_00439 Ribosomal RNA large subunit methyltransferase L
MDLNINSFVMQAKTFYGLEEVLAQELRQLGATNVHIKNRAVEFQGDLGFLYKANYSLRCA
LKILVPIYKFKANNDTIFEKYISKFNWENYFFNSQTFAIDSTVYSEEFKHSQYIMLKMKD
AIVDRFRNKFGKRPNIDAKHPDIKFHLHISNNDITISLDSSGDALFKRGYRSTFFEAPIN
EVLAAGMLHLAGWEGKGNFLDPMCGSGTLLIEAAMIALNIPPQLHRKRFGFENWKNFDLN
LFNKIKETRLNRIKDFNGKIVGFDIDKKAVETALKNVKSADLTDFIEIYQKDFFTTQKEL
FPTLLIFNPPYNERLNIEQDNFYQSIGNTLKTSYKNTLAWFITSDLEAYKKIGLRPSRKI
KLFNGKLECRFFNYDIYEGSKKNNHNG
>EGEFANNL_00440 hypothetical protein
MRFINNKIEKNNPKILSAWIFYDWANSVYSLVITSTIFPIYYSILTTERNTKNYNEYRNV
WYDTPIRSIIQIFGQKYEPDALFSYSFTISFIMVVISTFLLSSLADVTGNKKNFLKFFCY
LGAFSCIGLFFFIEKSQILYGLFLNITASVGFWGSMVFYNSYLPDIATEDRQDQVSAKGY
MLGYLGSMLLLILCLFLIEVVAPEDEKLLYIRICFALTGMWWLGFAQYTFKFLPKNHKQE
GIRRKTVIINSFKTFYLLYRRIIKNKNLSFFLLSFYFYSVGVQTIFLIAALFGTNEINLE
SYKLIISILLIQLIAILGAYLCSQFSKVIGNKVVLIICISIWVVICLGGYLLDKTDPNIE
YYYYIAAAMVGLVMGGIQSLSRSTYSKMLPEEDKDITATYFSFYDILEKLAIILGTFISG
YLINKTGNMSNSIFAMSLFFFVGLFFMILVKIKK
>EGEFANNL_00441 Polyphosphate kinase
MLKKNHKYINREISWLKFNSRVLQEAMDKKNPLLERLRFLGIYSNNLDEFYKVRYAYIAR
MIQFQRKYNNIIEDQKDVDLLDEINQTVAFQQKKYDLLYEQIIKELAKENTLLVDNDHLP
ESLIPYVQDFFQNKLSHNLTVLYWMEGDKVLNLKDNIFYLIVTMKKKNGNQQYALIEVPT
DRFSRFLVLPDINEKHYVIFLEDIIRFHLKDIFQFFKFETIEAKSIKLTKDADLSVDNDV
QISYMESVAGALKERQKGLPVRLVYDKTIDSKTLVFLKKMLNLDEYDSLSPGGKYHNKKD
FMKFPTLGRKDLEYKKIAPIIPKILREEKNYFKAFAKEDTLIYTPYYDYSVFLKFLRGAA
IDPKVTKIKITIYRVANNSQIISALINAAKNGKQVTAVLELRARFDEEQNIKWSQQLQDE
GVNVIFGVPGLKVHSKIGIVEREYQRGAATRYAFISTGNFHEGTAKIYTDFTLFTVNESI
VNQVNDVFNFFNANYLVKNYKDLAVSPWGIRRKLILGIKREIKNKKSGLVAQINLKVNSL
CDKEIIDHLYDASKNGVEVRILVRGICSIIPGIKDLSENIKVISVVDKFLEHPRLYWFKN
AGEDAIFISSADIMSRNLDHRVEVACPITNPKNKEEIMKIFNLGLEDNVKGRLIKEGLEE
PYQRNRRRKNRSQETIYQFIKEFNQ
>EGEFANNL_00442 Guanosine-5'-triphosphate,3'-diphosphate pyrophosphatase
MNISTYAAIDIGSNAVRLLINNIYETTDSVTFNKASLVRVPIRLGQDVFTDGKISEHSKE
RLAQAMQAYKLLMDIYNVQKFRAFATSAMRESQNATDVIDYVKNVSGIEIEVISGEEEAE
IIFSSELKNYIESNEFYLFIDVGGGSTEISLLNKGKVINSQSFPIGTVRLLDGKVNEEYL
FETIKPWVKNITRDLSVEAVGSGGNINYIFKNSEKKEGKSLTVSYLVNQYKILKELTYNE
RIEKYNMKPDRADVIVPALLIYSSVMKFANAKQIFVPKIGAADGMINLMYKRSKEKK
>EGEFANNL_00443 DNA polymerase I
MTTQNCDKKLFLLDAYALIFRAYYAFIKNPRINSKGINTSAIFGFTNTLFDLMKREKPTH
LAVVFDVGETFRHKEYSEYKANREETPEAIRIAVPYIQKILEALEIPCMWKEGFEADDVI
GTLAKKAEKEGYTTYMMTSDKDYAQLVSEKIFVYKPATRGNDIEIWDIEKVKEKFEVEEP
AQVIDFLGMMGDSVDNIPGIPGVGEKTAKQFIKEYGSMENLFSHASELKGKMKEKIEANQ
EIGLLSKRLATIETEVPIEFHYENFTVDKPNEEKVVELFEELEFRNMIVNFKKTYNLISE
KEITAGTSNKKNSDSAQKSLFDSVQEDNANIEESDHWKTLENTEHFYQLVDTPTAIKLLK
QKLLKQKVVCFDTETTSTNSLEAELVGISFSYEKGKGYYVPLDPDDKQKTNEILDVLLSF
FNSEEIVKVGQNLKYDCKVLRRYNVEVKGTLFDTMIAHYLINPDGRHGMDIMAETLLQYK
PLSIETLIGKKGKNQKLFSTVPLEQQKEYAVEDSDITLQLKEKLQPQLEKDNLKKLFEEI
EMPLMKVLADMEWEGINLDLHALKEMSKELDTNLSHLEKEIFTQAGEEFNINSPKQLGDI
IFDKLKLGNKPKKTKTGQYATGEDVLLKLAHKHKIIDQLLEYRQLQKLKNTYVDALPNEV
NPQTGRVHTTFAQTVAATGRLASNNPNLQNIPIRTSRGQEVRKAFVAKDAQHKIISADYS
QIELRIIAAMSKDPAMIQSFNEGEDFHRSTASKVFHVPMGEVSREQRSHAKTVNFGIIYG
VSSFGLSEQTGLSRSESKQLIDAYYEAYPLLKQYMMEQVEIARKNGYVETLLGRRRYLPD
IQSANSIVRSHAERNAVNAPIQGTAADIIKIAMIQIHQQMIEKKMHTKLLLQVHDELVFD
SPDEEIEEASSLIKNTMEAAIQIEVPLLVEVGVGKNWLEAH
>EGEFANNL_00444 hypothetical protein
MKALHLLLSFLVLLGITSCSNDDNFNSQIQAPPLKSSNVTYILNEGSFGSNNSTLSYFNN
DTGELINDYFQKINPSKGGLGDTGNDLKIYGSKMYAVMNASNSVEVMNSKTGVSEGKITI
PNARYIAFDKGFAYVSSYASATYGNGEALGIVFKIDTTNLQIISEVNVGRQPDGLAVVHN
KLYVANSGGYTTTGDYETTVSVVDLNSFQVTKNIEVAPNLNKVKVDQNQKVWVTSRGNYG
NISSSISVLDPTTDLVIQKLNLPVSDFDFYGDTMYYIGTEYDNNNKSSNVYGRLNINSLS
KGSSFVNENIKSQIESPYGLAVNQKNGDIYLADAKNYMVTGNVFCLTNGGDLKWVNATGI
IPGHFAFLK
>EGEFANNL_00445 Vitamin B12 transporter BtuB
MKKIFFSIKKLLILYFILFFYFIQAQKNSDSISIESLQDVVTFGKKKSLEVIPHQQISKE
ELDKVNGLSVADAVRLFSGVQLKDYGGVGGIKTVNIRGMGSQHVGVFYDGVSLGNAQNGT
VDLGKFSLDNMESISLYNGQKSEILQSAKDFATASSIYLKSKKPIFLENKKNNIGIQFRT
GSFALINPSVLWEQKISPTLSSSLNLEYLNSNGKYKFRYRKNGLDTIAIRTNGNISAFRA
EWNLNGIIKNGTWSLKNYYYDSDRQIPGAVIKNSYQRYQFEKQWDRNYFVQGTLEKDINP
RYKVLIHAKYANDYTHYYDHTVLGDYVSKHFDNVYKQQEFYISLAQQYKLFDFWNIALAT
DYQFNHLTTNFYKNRNPKRNAEWVALSSNFNWNRLKFQTSVLGSFIQDQVADQSTEANSR
NEFTPSFFASYKLLKNINFTFHAFYKQIFRMPTFNDLCYTEIGSSNLKPEYVSQYDIGLH
ISHKFSEGILTNISATVDGYYNEVKDKIVAFPRGQQFRWAMFNIGEVKIRGIEISTQSTW
QLMEHMQMYTHINYTFESAQDVTGGLTGQSTYKNQIPYIPKNSGNLLVGSTFKTWDLSYS
LVYTGSRYSSSENIKSNYLPEWITHDINFTKLIPMKNMNLKAGIEVSNLFNKQYEIVLNY
PMPGRSYRISLRAEL
>EGEFANNL_00446 hypothetical protein
MEENKEIKTEESTISKKEIDKKTSSKAIIINRWHLILGLCFLVILGLLGYIVFSPKAIEE
VKINDDKQNDKVLAVEPEKVKEDSVKVTKVEKKFDEYGEEIDPYTKAYIIANSAYLRTSP
DKSNNAVETLHFGEVLYVKDFYENRSGPYVEVYKTKPREGDSYPSRYYIATSTLVEEYSF
DEFKKAFSLSPFSKLDSKTKKIILDNDYYDQTRYKPTQNADRATQCVAYGDFDNDGLQDV
AVILDNTQRQSSYLLVICTNKVTKEPYVAYSKDFNGYYRINSFKKGAKIFKNSSNLVPSP
IDGLILQYGSYNKNALLMDTNTKDYDLYPQYSYGDEEN
>EGEFANNL_00447 HTH-type transcriptional regulator ZntR
MDIQLPEKLYYSIGEVAKAFNVNASLIRFWEKEFDILTPKKNKKGDRFFTPKDVENLKVI
YHLVKEKGYTLDGAKTALRVQPNTPKKVEVISRLQMIRAELVKLKELLDE
>EGEFANNL_00448 hypothetical protein
MKLPKFLMADNSNYPEDLFVVHTEFPRFILNVEEEDVEWLDTIEESDEDATNEINSLIEK
AFAFCDEEIEKYEEEDEE
>EGEFANNL_00449 Carbon starvation protein A
MESINGINALTLVFVSLLVFAIAYRFYGIFIANKVLRLNSKNVTPAVEFADGHDYVATNK
NVLFGHHFAAIAAAGPLVGPVLAAQFGYLPGTLWILIGCVLGGGVHDMVVLFASVRHKGQ
SLATIASKEIGPVTGTIAGFAILFILILTLAGLSLACISAMHEASWSLFTVLITMPIAIV
MGLLMRYRKNSVTLASILGVFLLIIGIVGGHNLMQNETINHIFHWDIKTISIAIPIYGFI
ASVLPVWLLLVPRDYLSTYLKIGTILMLAVGIIFVHPTIQMPSLTSFINGGGPVIGGPVL
PFIFIVIACGAISGFHAIIATGTTPKMIGDEREILFVGYGAMLVEGFVALMALIAACTLM
PGDYFAINTPVDTYNSFLQAHPSLHAVDLQYFIDHIGIDLHGRTGGAVSLAVGMAHIFNN
IPYMDRLMAYWYNFAIMFEAVFILTAIDAGTRVGRFFLQEMLGNVIPKFNDKNWLPGIII
SSTLFTFAWGYLVYTGNVSSIWPLFGISNQLLAACGLIVCTTMLIRMNRKKYALCAAIPG
VFMAVITFWAGYIQVVDIYYPNEQYLLATLATIAMLLMLVVFIGTFKRWLELLNMKTLVT
DKYGDSVKQLVER
>EGEFANNL_00450 Xaa-Pro aminopeptidase
MKTKYNTIDKNLFIKNRQKFVQRMRPQSIAIFNSNDIFPIGADSTLPFQQNRDLFYLTGI
DQEETILVLCPYAHLEEYREILFIRETNKHIAIWEGEKYSQEQANDISGIKSVFWLKDLN
KIISQLIPQMENIYININEHSRAERVVETREDRFIKKLQKQYRGHNYLRSNPILQHLRSI
KEPEEIDILQHACNITEKGFRRVLPFIKPGVFENEIEAEYIHEFIRNKSKGFAYSPIIAS
GNNNNILHYIQNNKECKDGQLILMDVGAEYANYSSDMTRTVPVSGKFSQRQKQIYQAVLN
IKKESTKLLVTGNNWLNYNEEVGKIVTQELLNLNLLSLNDVKNEDPKWPAYKKYFMHGNS
HHLGLDTHDYGILTEPFVPNMVLTVEPGIYLPEEGFGIRLEDNYVIQSNGEPYNLMRNIP
IDYEEIEDLMNA
>EGEFANNL_00451 hypothetical protein
MFNYIEIERVEKISKEDFYNNFYKKQKPVVIEKITQNWAAFTKWDFEYIKQVAGDKIVPL
YNNDPVSADKKVNEPDARMKMADYIDLLHKGPTDLRIFLFNLLKQVPEMQKDFEFPDLGL
NLFKSMPMLFFGGAGSNVFMHFDIDLANILHFHFSGKKQCILVSPEDTKFMYKVPYSTIC
REDINFDQPDFEKFPALKRIKPFRADLSHGEMLYMPEGWWHYMKYITPGFSMSLRSLAKR
PSNFTQAILNIFVKRHYDNYMRKKKGQEWIDYKNELAIKNTHRELSMFE
>EGEFANNL_00452 hypothetical protein
MKIFYKVILLSILLVSTLLFSQKKYPSLLWEISGNGLKEKSYLYGTMHVSEKVAFNLSDD
FYEKLFSVKQIALESDPELWLNEIYSKLNTDNFYQKNDYSYQSLYINNTSIDIYKQSLRA
KDMLANGILYRRYPEMQNFQENTYIDMFIYRAAKKLNKKFVGLENIQESEDLVQKSEVSN
GYINNSDIKNIKIKKLLKTKSLYELMFDAYRKQDLDLIDEISLATSTFNSRKYLLYIRNE
NMVKTMDSLMKKGSLFSAVGAAHLPGTYGIIEKLRNLGYTVQPITGLYTEKGRLKKEQLE
HLVYNHKLKNYKSKTGLTIQSPEKFFNYSSSQDIDYLVSLDIPNGAFLSITKFNNYNFLK
NNLSKVSLESIDSLLYENIPGKILNKKNISLDGFSGIELISKIEQDEYISMQIFVTPLQT
YIVSLFGSKPYQDKYKSKIFKSLKLDNYTSTFSNFEPKYGGYTIKMPDYRVVTDTLYGHT
NVIGYDNNTKSYYFMKSQVWENISSEKEIYELERIPYEIGKNLNAEIITTSINKENEIPY
SESIIQWKNREKLYLKTMINSSYYHVAGIQTSNEDQKKDFFNSLIITDFKRLKKTEKFTN
KTAGYSIIVPSESIKTKPKIDIEKSVNDSGDELDTSINIDDHEQNNTEEMNEGDVQEQTS
FILDNGQTLSIFNYNYIPTSDSLSLDQVIKEYVDDQYPSDSCNHRKIKFLVHGITENKNS
FSDYLLKEDTKAQAYRLRYFYENYRIYEIKYIVNAHKEFRNPSIEDIINNIQFLPFADDQ
VNVDNIENLDVNKEPTEITSTQLVDNDEFFKFNDEFSSSDVNSYSLEQDSLLWKPDIFID
KKILNQLKLFSNNSNKVEEFVLELNEQFLNQKLLEKVIKILDFHENTKPEFYLNLFTKFK
NNGNAQFIILQKIIALDKDKQLNKDIIELIQRNQPIPLSESAIPNLMNNLELYDQSEDYM
LPTLLSLLGVEEYQNTLIDYLTRLNDDHKLKAYHIKKYRDFFYKETDKEIKRILSYESGN
SMNNPYLENNYSIIKLKKYLEILSIFNDTEYKHLIKSIRETKNIGLIELLISLKEPIDLT
KEEYLFVKKQAIPSKKMNESYKEKFGEDLFNPAKDLTAELAKKELMKNILQNHTYDYEKV
DSLAFKEEQNYSYEGKDYKIFYFTVYKNNIVSELDKNINAKEDEQDFHEYKEKDDNIQEV
NIGIIAFDLMTSNKNNDTCYEENNQDGFTNESDYVWNSESDFMALTLFNSIDLYYKDLNE
WEKLKDKFIDYLKSLSHPRSTSKFLDEVYTIEYPY
>EGEFANNL_00453 hypothetical protein
MITILYIGFWPFAKFVGFVLFLIIASMAFWCLTFLLSILPYWLTFGIAENSGKINADVKP
DDVRRKILTEQEGVELVYTK
>EGEFANNL_00454 Acetate kinase
MLILVINAGSSSIKYQLLNMETTTVVSKGLVERIGTTGGQLTHRYLNGNSLEKKTINQEF
PDHTGGMKLIIDLLTDTEIGVIKSLSEINAVGHRIVQGGGDFNAPVLITDEVKKKIEEMN
PLAPLHNPANLLGIEVAQQFFPNIPQVAVFDTAFHQTMPPRAYRYAIPEKFYTENKIRSY
GAHGTSHKYVREQAAKYLNNEHAKVITIHLGNGSSITAINEKGESIDTSMGFTPLNGLVM
GTRCGDIDPSVLIYMVRECGVKFEELDDLLNKKSGMLGMTGHSDARDIENLYKAGDEKAT
LCLDLYSYRVKKYIGAYMAALNGADAIVFTAGIGENDFQLRSLICKNMDYLGIQMDDSKN
KEYNSPDEIKEVQSSDSKLKILLIPTNEELEIANNTLEIISKK
>EGEFANNL_00455 Adenosylhomocysteinase
MNTEYVPYKVKDISLADWGRLEIQLAEAEMPGLMSLRKEYKDEQPLKGARIAGCLHMTIQ
TAVLIETLKELGAEVTWSSCNIFSTQDHAAAAIAAKGIPVYAWKGMTEDEFNWCIEQTLF
FGDDKKPLNMILDDGGDLTNMVLDKYPELVSGIKGLSEETTTGVHRLHERVKNGTLLIPA
ININDSVTKSKFDNKYGCKESAVDAVRRATDLMIAGKVVVVAGYGDVGKGSAASFRGAGA
RVIVTEIDPICALQAAMDGYEVRKMDNAISRADIVITCTGNRDIIQGKHFEMMKDKTVVC
NIGHFDNEIDMAWLNNNYGNTKVVIKPQVDKYTLNGKDVIVLAEGRLVNLGCATGHPSFV
MSNSFCNQTLAQIELWQNPGKYENKVYTLPKHLDEKVARLHLEKIGVELDILTKEQADYI
GVTVEGPFKTDEYRY
>EGEFANNL_00456 Fe/S biogenesis protein NfuA
MNNSITDKVNKALEEVRPFLVADGGDVELIDIQDHVVTIKFTGACSDCSINQSTLKLGIE
STIKKHVPEILEVISIVE
>EGEFANNL_00457 Iron-sulfur cluster carrier protein
MISKKDIIEFLKEIEVEDLVKNVQLMGDTAIIDMLSHSPAMHEKKRMEVAMHAAFEDKFG
KDLKLKLNISVEVPEKQEIKGKNIPGIKNIIAIASGKGGVGKSTVASNLAISLKKLGFKV
GLLDADIYGPSIPVMFDVENAKPTSKDHKMVPIESYGIQLLSLGFFSGANQAVVWRGAMA
SKAIHQLIHDADWGELDFLLIDLPPGTGDIHLSIVQEVPVTGSVIVSTPQHVALADVKKG
VAMFQMPEINVPVLGIIENMAYFVPKELPENKYYIFGKKGAQKLAESLDLPLLGEIPIIQ
SIREASDYGRPAALQEDELIPNIYIEIAKNMIESLVSRNKNLPPTEAVRITTMAGCSSK
>EGEFANNL_00458 hypothetical protein
MGLRTVNVTRYISPLREGGSLPALAEADDDFKYVVKFKGAGHGSKALIAELIGGEIARLL
SLKIPELVFINLEEAFGRMEPDEEIQDLLRASKGLNLGLHYLSSATTFDPIAFKVDSALA
SKIVWLDAFLTNIDRTVKNTNMLVWHKELWLIDQGASLYFHHSWVNWEKLSITPFSQVKD
HVLLPLATQLEDADIFAKKYINEESLKKIVNLIPEEWINLEDFDENIDQVKSIYLEYLLR
RLNHTQIFIKEAQNARKTLI
>EGEFANNL_00459 hypothetical protein
MQEKHLYEYAIIRLVPKIEREEFINIGLILFSKHARYINLKYEINERKIKCLFNNMEELD
IENIHSILTAFENICKGKNNGGEIGEFDIPERFRWLTAMRSTIIQTSRPHPGISTDLNKT
FSALWEELVM
>EGEFANNL_00460 hypothetical protein
MKRILFLFACFSFIIAQSQKITSISTDFKLDSLLFPDMVTPAKIYTQLDNGNINNLSVIT
NPSLICSLFKVDCKNVKKIYLENYQDRNSGSESGVLVAEYKDIKSLDTALNKLLANKQKG
YLTKENYLIQVWSNDPKQGEEEIIKMENFYQNKIMAKLYVAEEIYPTEVLPGE
>EGEFANNL_00461 putative sugar kinase YdjH
MKLLAVGTVAYDAIETPFGKTDKILGGAATYIGLAASKLGTEVNIISVVGGDFQQKYLDL
LENHKIGIQGIEKVEDGKTFFWSGIYHEDMNSRDTLVTELNVLESFNPVIPEDLKNSEVL
MLGNLHPAVQLSVIEQMSEKPKLIVLDTMDFWMNSTLDLLLKVIAKVDVITINDSEARQL
SGEFSLVKAAKKIQQLGPKFVVIKKGEHGALLFHKEQVFFAPAMPLEEILDPTGAGDSFA
GGMTGYLAKSEDFAFENLKKAIIVGSALASYTVEKFGVERLVELTQQEFESRLESFKTLT
SYDYNI
>EGEFANNL_00462 Ferrochelatase
MKGILLVNLGSPKSTSVEDVRIYLREFLMDKRVIDVPWIIRKLIVELAILPKRPKESAKA
YQSIWWDEGSPLVVISERITQKIKKSINNPVALAMRYQQPSIEKGLKELEEQGVTETLVI
PLYPQYAMSTTETVVEKAKEIQKKRFPKMHLSFLPPFYKDEEYLDLLTKNIKTKLPKNFD
LLIFSYHGLPERHIFKTDITKTCRLDNSCCFEKELPSHSYCYRHQCYYVTEQIKKRLGLE
DSKVMQTFQSRLGKDPWLKPYTDYTLKNLSSKGIKKIAIVAPAFVSDCLETLEELAVENK
EYFIENGGIEYNYLECLNEDDNWIQWLINKINNYTNN
>EGEFANNL_00463 Lipid A biosynthesis myristoyltransferase 2
MRVLANITIKIISFFPLKLLYGISSILYFIIYYILRYRKKIVRHNINIAFPNKNIKEKQI
IEKNFYKNFTDFIIEFIKIFSMTQQDFNKHISIKNLEILEKSKKENKDVILLAGHLFNWE
WLIGVSKQLPQNEAYAVYKKVANGFFDFEVFQARSKFGTIPLSVKDATRKMIGLPNDGTH
AYLFVADQSPYKTRIHYELEFFNRLTPVFNGYDKIARKKNYHVFYLEMNKIYRGKYEVVI
KSILPDQQNFRENEIVEKFYQNLNHNIIKHSALWLWSHKRWKYTSGIDYKL
>EGEFANNL_00464 N-acetylglucosaminyl-diphospho-decaprenol L-rhamnosyltransferase
MEIYQRNRLQTLAIVILNFNGTQWFKKFLSGIVNFSQGYPIYVIDNHSTDDSLNYLQVNY
PEIGVIKNPKNLGYAGGYNHGLKEVKEEIYCLLNSDVQVTPNWIDPILKLFQEDGEIVAV
QPKILSYKEKNKFEFAGAAGGFLDNLGYPFCRGRVFFSTEEDISQYNNTCEIFWATGACL
FIRKKSFWEQNGFDEDFFAHMEEIDLCWRLKNSGKKIFYCAESQVYHVGGGTLNPYNPTK
TFLNFRNNHLMLLKNLPSYKIFPIIFFRLILDGLAGIKFIFTDGWKHCWAVIRAHFAFYY
LIPKFLKKRNPGIKNYGHKKFIVFQYFFYKRKTYKKLR
>EGEFANNL_00465 Diaminopimelate decarboxylase
MELARIQQLEELAKQYGNPLYIYDGDIIKSQYKKLSEAFNNVKEVTFNYACKANTNLNIL
KLMKKLGTGLDAVSLQEIQIGLKAGFTPQEIIFTPSGVSFDEVRKAVDLGVNIHIDNFPF
LKYFAEEFRNYPIGIRINPHIKAGGNEKISTGHVNSKFGISIEQIDDLLELKNQIPLNVQ
GLHIHTGSDIVDIDIFLKGAEVIFDVAEKFPNLKYLDFGSGFKVPYKEGDKQTDIELLGE
KLGEIFNQFIEKYGKTLRLIFEPGKFLVSQSGYFLAEVNVVKETPYNTFAFVNSGFNHLI
RPMFYNAYHHIINLTNPNAQKKNYNVVGYICETDTFASEREISEIREGDLLCFLNAGAYS
FSMSSNYNSRLKPAEILIMNGEPHLIRRREVLEDILMTTEEINL
>EGEFANNL_00467 Inner membrane protein YjdF
MIYSKNYYVLFYLLIFSITAVCSIYKPYELSLWILESGFCFLGIIILLFSYRRFRFTNIT
YIFILIHFIILFIGAHYSYARVPYFDLFTNSGRNNYDKLGHFAQGFVPALISREILIRLK
IVQNKNWIPFLVICICLAISAFYEFLEWCISIFSYGGTEDFLGIQGFIWDTQSDMFCAFI
GSITMLLTLSKIQNRQILQLKYKKAYHP
>EGEFANNL_00468 5'-nucleotidase SurE
MSKPIILVTNDDGIAAPGIRELILIMKEIGTVYVVAPDKPQSGMGHAVTINSTLRVEEIY
SDNSSFEWACSGTPADCVKLAVNKILPKKPDLCVSGINHGSNSSINILYSGTMSAAIEAG
IEGIPAIGFSLCDYSHNANFKAASNYIKSIALNVLKEGLPKDIVLNVNIPKADEKEIQGV
KICKQARAYWEEEFLKRVDPRGQNYYWLTGSWKNKNYENGTDEEALSENYISIVPVQFDL
TAYSFIDTIKNWNFSI
>EGEFANNL_00469 Tail-specific protease
MFNFRKTWIFLSLCSMSLLAFCFNASSKDDNEKEIFKRVRETLLYASYSPKNLNEQYSKD
VYKKYMEDLDPFKRYFLKADINEFKKHEGKMSDMLINEDVSFYHLTIDRLYKRINESENY
VNEIFKEPLSLNEDEFFLTDDKKRDFPANEKEAKDYWRKYIKYRVLQEIFNAQKQKDSVN
DSIKISKLENKEKTKPQTKEEIEADAIKKVKENLGEYFRQVKLRKKSDLFSIFINAYTEV
FDVHTTYFSPKDKDNFNSSMSGKIIGIGATLQDIKGYPTIKELVIGGPAWKSKEIEAGDK
IIKVQQGKKGEPVSVVGMLLDDAIRLIRGEEKSTVVLTVEKKDGSTKNVTLVREEIEIQE
TFVRSAIITDEKGNKFGILYLPEFYVNLEGNSKGGRDCSDDIKREINELKKQGITGLIMD
VRNNGGGSLSEVLDITGLFVGSGPVVQVKDSNGKIKVLETKEKEIVWDGPLVVMTNELSA
SASEILAGALQDYKRAVIVGPEQTYGKGTVQTIYPLDRFSMGDDKYGALKVTIQKFYRIN
GSSTQLRGVNSDIVIPDILTYSDIFEKSQKFALPWDQISTTQYTTWQGTPKIDYTYIKEK
SKERLKGSSYISSIEAIGNWTKELDKIDKISLSYDKFMDEMEKRSQQGKKYEKDITFDAK
IKVEAPSYELVKFKQDTVLKAKREDWYKGMKKDFNLRESINVLNDIIKK
>EGEFANNL_00470 hypothetical protein
MNNFFIIEVYFIKNYVILLQTFYIIIMKKNKLLISILLIIIIKALFLLTKHIQEDAFITW
RVAQNILDYGVYGFNGDERISSSTTHLYVFISIIFKLIFSENFIYPLIIFNSIIYTWGTK
ILSDILTGNDNVKILFIFFANFLPPAIKISILGMEFGLIFFLYVLFLKYAVLLRRNWAFL
LLPILISWTRLDAAMFLLINFFYDLFRYRKPNYFFILSGILSVITILGFNYFYFHEIINN
TIVAKRLAYANEADNFMSKFIGMLNNTNYYSMLKIPLNILKINIFLIITIFLSIFSFYKI
SKNLNREQKYILSIIYTYAWVRMVVFGFANSWFDWYYWIPQIFMFIPIILYFIQDLNKTK
IITYIVIFFIPLVAYQTVHSIATGHGEWYYNRKVGLYLDSIEPDKSKTVFLEPAGYIPYF
SKLKAIDYVGLVDKRVLEEFKIKGNNVAESVIKKYQPDYILEDNKPMFKGDISIEESSKY
KLIKEFHILQNAKSDNFILDKIYKLKPSGRDYYLYKRIN
>EGEFANNL_00471 Competence protein ComM
MLVKTYGSAVYGVNAQIITVEVNIDKGVGYQLVGMPDLAIKESAHRISAALKNCGYKMPG
KKITVNMAPADLRKEGSAYDLTIAMGILAASEQIKYSSLEKYLIMGELSLDGSLQPVKGV
LPIAIQAREDGFKGFFLPIQNAKEAAIVNNLEVYGISHISEIINFFDKKVDLKPVILNTR
EEFNKNCNHYPYDFSEVKGQENIKRALEIAAAGGHNVLLIGPPGSGKTMLAKRIPSILPP
LTLSEALETTKIHSVAGKLGQESSLMTTRPYRNPHHTISSVALVGGGSYPQPGEISLSHN
GVLFLDELPEFNRQVLEVMRQPLEDRVVTISRAKFTLTYPASFMLIASMNPSPSGYFPND
PKNTSSLTEMQRYMNKISGPLLDRIDIHIEVSPVPFDNLSDKRKGEPSEKIRKRVIEARN
IQTFRYKENSYLHYNAQMGPKELDKYCALDEKSTQLIKNAIEKLGLSARAYDRILRVSRT
IADLDKSENINSNHIAEAIQYRSLDREGWGT
>EGEFANNL_00472 Endolytic peptidoglycan transglycosylase RlpA
MKKVTFVAILLVSLSFTAFQTKTVFFDESDKFELPLDTIVADTLQKNNKLILKDSLTDSL
SINKEDNLENDNVAIVEESKKLSAGKVSWYGGKFHGRLTSSGERYDMNAYTAAHKSLPFG
TKVKIINPKNGKEVIVRITDRGPFVPKREFDLSKAAFAELASLNSGVLNVQYVVL
>EGEFANNL_00473 hypothetical protein
MRKFLLLLFAGFLLMSCTIKQDKNIKIIHDFYNVFSERKDIHKLMDFYSAHSIWEDGLLN
STLEGKDQIKSMYGWEDTNFKKHPNYSELVSLKSILANDSVVAVSGQYNPYYYNGNLIPE
TPFTSWFYLNEEGKIEKQIEWIQYSLNDLQEMINFKTNAKIH
>EGEFANNL_00474 Alanine--tRNA ligase
MTSKDIRKTFLDFFESKQHTIVPSAPIVLKDDPTLMFSNSGMTQFKDFFLGYKEPKSFRI
ADTQKCLRVSGKHNDLDDVGKDTYHHTMFEMLGNWSFGDYFKKEAIAWAWELLTQVYKIP
KEWIYVTIFEGDSIENLNKDVEAYNFWKEHITEDRILLGNKKDNFWEMGDTGPCGPCSEI
HVDIRPLNEKEKIDGKKLVNQDHPQVIEVWNLVFMEYLRKADKTLEKLPKQNVDTGMGFE
RLCMILQGKTSNYDTDVFMPLIAKLEQISGYKYGANSNTDVAFRVLADHVRAIAFSIADG
QLPSNSGAGYVIRRILRRAVGYAFRILNMKEPLLYQLVPILNTQMGEYFLELSKQAEHIA
LVIKEEESSFLRTIDQGLVRMNSFIENNPTIKTIPGEIIFELYDTYGFPSDLSRIIAEEK
GLSIDEEGFEVEMSKQKERSKSAGKFRTYDWVVLHEDLQEEFVGYDYLDTQVKVTRYRKI
ENKEGEFYQLVFQLTPFYAQSGGQVGDTGYIMNDNEKIDILNTKKENNLIVHIVKELPKY
IEFPFQAVVDQARRESISQNHSATHLLHAALRKVLGNHVEQKGSYVGPDYLRFDFSHFSK
MTEEEIEQVEIEINKKVMERILLNENRSVPFAKALDMGAMALFGEKYGDIVRVIKFGDSV
ELCGGTHVKNTQEIIICKIISESSSSAGVRRIEAITGKKALDFLKQEFNSYEQVKSLLKN
EEPIKSIEKLITENEELKKQIEQLVREKAKNEKLLWENSIKEINRVQYIGLITELNNATV
KDLIFQLKKEIENLFIVVGTKTDNKPTLSIGISDDLVNSKKLNAGAIVRELAKEIQGGGG
GQPSFATAGGKNLSGLERAIDKSIQYID
>EGEFANNL_00475 hypothetical protein
MRLGDIKFNLKFFLIDKLYYEFQNKDNDEIVEIIRDNHKKYLHANKNNIQIVKPSLEFYE
EKDFKYYTYCYNNPKNLGYWKLFLPYELAKKQNFEILEFSFVLFIIYKSNIYCVIGGSGI
TVIKKYIDPYFGIDLYQHFAKPNEDISLVIDTRGITGNLSQKSNTYNFNQSVNDSLDYSE
IPKKIKIKVRAELRNGIFKKYHLDDESIMEVGSYFNLRKKISFEELRLLIIDIHNIREDK
SKYTQLTLFKKITEEQLLHSLDEFLKEKIVDDVNLHITPDELNRLNNDIIEIVNFNKLEK
FYECDEFRIRFRRKRKTNDKIINNRNKLYFECTQFIYNNTDNINDRLSIKQKLYELGIIG
TINGKESTSGTFYSHIIAEIIYSEKKYFRIDNQWFYLEDRFIKQIKQEAINYYKQYKLNK
TILNTWDEDMDEDTYNTSHKSSNHYILDKVLKENIELCDILYLENDSIYFIHVKDGFNTQ
MRNLSSQVILSAKRLWNDINSNSGSNYFINTIKKHNRKSPTKILEGKALFNQIINNDLKI
HFVMAYNNRAYKNENSIKKIELSESNIALYSLVQTVKEILNYKLFNIQLIDISEI
>EGEFANNL_00476 DNA gyrase subunit A
MQEPNQENLKPSEQVEQTQKVSGMYKTWFLDYASYVILERAIPSIFDGLKPVQRRILHSM
RELEDGRYNKVANVVGNTMKYHPHGDAAITDAIVQIGQKDILIDTQGNWGNIYTGDGAAA
ARYIESRLTPFALEVVFNPKTTVWQSSYDGRNKEPENLPVKFPLLLSQGVEGIAVGLSTK
ILPHNFVELIDASIAYLKNKPFTLYPDFQTGGLIDVSNYNDGERGGKIRARARISNPEKG
LLLINEIPYGTNTSSLIDSIIKANDKGKIKIKKIEDNTAAEVEILVYLTNDVSPDKMIDA
LYAFTDCEVSISPNACVIDIDKPIFTTVSNILKSNTDHTVDLLKKELEIELEELQEQWHF
SSLERIFIENRIYHKIEELETWEEVIDTIDKALKPFTSHLIREVTVEDITRLTEIRIKRI
TRFDLGKAEEHILALEGKIEEVKYHLGNLISYAIDYFTNIKKKYSKGKERKTEIRTFDTI
DAAKVAVANIKFYVNKEEGFIGYSLKKDEYLFDCSDIDDIIVFRKDGTMLVTKADAKTFV
GKNIIHVGIWKKNDKRTVYNLIYRVGKMGPWFMKRFPVTSITRDKEYQLISEDKYSEIQY
FTANPNGEAEVVTIYLKLSQRLKKLKFDLDFSELSIKGRSSKGNLVTKYPIKRIELKESG
ISTLAPRKIWFDDSILRLNVDGRGTYLGAFKGTDKVLTLSSKGFAKLHTFDLLNHFDDDI
IVIEKWDPEKPICCIYYDGEKSIYFIKRFLLEDTLNPQIFFQSENPKSFIEWVGTGGKLI
AEINFGKDKETETIDLEEFISIKGIKAQGNQLSKEKIRNIKVEEIKPEEEILEEENHLEE
DNLDANGEQINLF
>EGEFANNL_00477 hypothetical protein
MKIQNKETQNKLKIVNILTLIVCVSSIIFIYLDIRSLQYRDDLVFILSLLILLYLTYLGC
PFFKYDGEGETLIFQNKRSLASSVFVKELQSDFPKRKLKKFNIKKSYFFKKTLEIYISSN
RVSGGLSKLRFDISYLSSKQIRNLKISLDKVVKENKLSDTQINKS
>EGEFANNL_00478 DNA gyrase subunit B
MTPSKYTEDNIKTLDWQEHIRIRPGMYIGKLGDGSSPDDGIYILLKEIIDNSIDEFVMGE
GKKIKIFLNENNIKIRDYGRGIPLGKMVDAVSKMNTGGKYDSRAFKKSVGLNGVGTKAVN
ALSSYFKVQATREHLTRYAEFSKGILTFESDEIESKETNGTEIIFEPDPSIFGNFKFRKE
YIDKMLKNYVYLNPGLKIYLNGEEFYSENGLQDLLEENIEGDTVYPIIHLKGEDIEVAIT
HGERSQSESYFSFVNGQHTTQGGTHLNAFKEAYVKTIREFYNKNYEASDIRKSIIAAVSI
KVIEPVFESQTKTKLGSNEMGPNLPSIRAFTTEFLKSNLDNFLHKNSEIAESLQRKIIIS
EKERKELSGIQKLARERAKKVSLHNKKLRDCRQHYNDQKSPRKLESTIFITEGDSASGSI
TKSRDVETQAVFSLRGKPLNSYGLTKKIVYENEEFNLLQAALNIEISLEDLRYNNVVIAT
DADVDGMHIRLLLITFFLQFFPELVKNGHLYILQTPLFRVRNKKETRYCYSEEERINALN
ELGKNPEITRFKGLGEISPDEFKNFIGRDIRLEPVMLSKDTSIETLLEFYMGKNTPNRQE
FIIDNLVIEAIK
>EGEFANNL_00479 hypothetical protein
MDIDHIKKYWITQDNNKNYSQDELISMLNKTSRNTVKYIVAISIIEFAVMILSLIISLTT
DRTIVFNSLDVNGQKTFIKEMQISDALTYLNIIISIFFIYNLYKSYKDINILSSTKELIN
KILGFRKRINTLLAINIILGFIILYYTSFYDFMHIIKSRHSYYEQGIFKSLYIPFSSPKY
IIIYIIICIIFIAILMVYYGLIYGILLKKLKKNLEEIKKLDIE
>EGEFANNL_00480 ECF RNA polymerase sigma-E factor
MKKNNELEFSALIEGNQGIIHKVCRLYTNNDEDSQDLFQEIVLQLWKSYKTFKGNSKFTT
WMYRVALNTAITLFRKSSRKIETQEIDHSLYKISDDNDFSIKQEQINFLYESIKKLSEIE
RAIILLYLEDLPYKEISETLGITEVNARVKINRIKVKLKDIMSKNE
>EGEFANNL_00481 Hemin transport system permease protein HmuU
MYKIIKNKTFKIIYICSVFSNKFIILLVVLVLFCTSLIFINLLTGYENISLCDLFLSEDE
TKRLIISYRFNKIFAVVLAGISLPVSGFLLQELFKNPLAESSILGISSASALSVSLIIFF
GGSYWLLEYPLLSNWMLAIGAFLGALIVSIFLLLTIKKIKNISMFIIIGFLISSFCGSII
SMLQFYSQSEKLKQYVFWSFGSFEGLTSMQLIIYALFIVLGLFLALMSVKNLTGFLLGEE
YAKVLGVSVISMKACIILSVCFLSGSTTAMLGPIVFIGIIIPHFCRQIWNPASLWNQLIL
NMGVGVAFMLTVSLIMSYTQLPVNILSSLIGVPTIFFMIFKTQLKNNLY
>EGEFANNL_00482 Iron(3+)-hydroxamate import ATP-binding protein FhuC
MKELKLLNKLQINNLSIGYKSPLLSNINMEAKSGEVILLIGRNGTGKTTFLKTLLKELAP
LKGKIEINGKDLKFLSATEISMLISVVLSKINVSPFLKVYDLVALGRFPYKKWYQNLSLQ
EKKTIEEILNLLNLTQYQHYYIHQLSDGNLQKAMIARALIQDTPFLIMDEPTSHLDIANK
LEVMKIIHSLAKEKGKIVLFTSHDLSLGLSIADQVALIRKDKFKIGFTEDLAKNENILDH
FAGKDITFNYISNEYEFISVKNKREISLVGDSQSLYWLKKALIRKGFYIVPQGELLIREE
NSKFIVQKHEQDYSFSTVEEVIRFLS
>EGEFANNL_00483 Acyl carrier protein
MGLDIVELLVEVEKKFNIEIADHEAERVLTISDFVNVIYLKTKITKKDKDIFKNIYYKLK
NIFLRLNVPEKLITVNTEITSLIPQSELELFWNQLTLKTGLKLPNSKIIKYTEKIEKEDV
KFLGLKIYTKTKRLRNHTLSQLVDYIVSLNYESLIDLNKVHSKYEIERTICMITSEKSGV
EIHEIELFHAFTYDLGME
>EGEFANNL_00484 Cystathionine beta-lyase PatB
MRRYNFDEVIDRKNTDCLKYDALKERFGSVDLIPLWVADMDFQSPPELIEALVERTQQGV
FGYPYPPKEYYQSIINWQQKHHGWEVKKEEISYIPGIVKGIAFALDVFSKEGDQIIIQPP
VYHPFRIISKLHNREIVTNPLVLERTQYQMDLEGLEKLITEKSKILMLSNPHNPGGRVWT
KEELTQLAEICYKHKVLVISDEIHSDLVLTGNKHIPFASVSEKAEQNSITFNAPSKTFNI
AGIVTSYSIIKNEEIRKKYHHYLVSSELNEGTIYAYLALQTVYEKCEDWMIELKEYIEAN
IEFVDDFLKKNIPQIKAMKPEASFLLWLDCRELNLSQKELTSLFINKSHLALNDGSMFGK
EGTGFMRMNVGCPRITLEKALNQLKSIL
>EGEFANNL_00485 hypothetical protein
MKKLLFSFMVLFLTLGIAQSQKQEEPLELEFRSGNTTSNYKGVKIGEYYWMDASLYEPVL
HYTTQNFINKHMDGWAVPYDMPAESFNRYYGQFYGPMEVPSGDMYENGVVDKNWKLPNRA
AFYQLMAMCGTGSYQDIKEYLGAKTNDNPMAVNLTASGDISSGHWFAPNKNVYGFSLMPG
GGRMNGPWQELAQGDFYAMYKHAKLRVDDWSVFTVDNLEKTASFSGVLYHWINIRWAKRI
PDEQLGYKLYIKESDYKKYEYSELIPNFDINSVDIKKLSLDHVVPNGYIELPNGWIRGFY
IQKNGTQPIKKMPELTTHLRILTDDNKYVFRENDQVKFYLRTDAKSQTELENLNFGLYNP
KNGDFRGPIKILSVDGYVYTCELPDNYIGNFMLIPYFSDKEEKIALKREVSTPWIDRLPI
SIEYKLSRGYIVSKDFQATSFMQVNIPEGGVNRLFQIELEKPFKVSMPTSDPASVRIGLF
YTNGDFYTDITNSVKGSIYTCSLPNSVQAGDYILMPYTKEDGKIKVVERNDETFYMDRLP
IVALEEDIWGDSFSAFSVEELLTPYTQNNNTLYIKGLSSTANLSIIDINGTVKKQMNNIT
QNTAIPISDLKSGVYFIKVNTSEGKVENLKFIKQ
>EGEFANNL_00486 hypothetical protein
MKLDGRRSSKNVEDRRGKSVGKATLGIGGTIVVGLIVWLMGGNPMDVITQQLSNTSSTQQ
TYKPNAEDEKSAEFVKKILAGTEDIWTEIFKENGMTYVPPKLIMFSGATTSGCGGASSST
GPFYCPADQTIYIDLSFFKQMKNELNAGGDFAYAYVIAHEVGHHVQNLLGTLGKVNQEQQ
RLSKKESNRMSVRTELQADFYAGVWAYHDNKNFNSIEPGDIEEGLNAATQIGDDRLQMQA
QGYTVPDAFNHGTSAQRKRWLNKGLQTGDITQGNTFNVPFSNL
>EGEFANNL_00487 hypothetical protein
MNILKFKYSYLAFVTITYLVACNNTNEHLEKDSNTNVITHNQHPSELKVDVLKKGDHVPS
NKVCMVNDEYMGKEQLEVPLDGKMYYGCCEMCKNRIPQDEKVRYSIDPLTNKKVDKALAY
IVLASDNGQVYYFENESNYLKFNNKN
>EGEFANNL_00488 Nicotinamide riboside transporter PnuC
MEIFNSYLISIIEQFYGITWLEFIGVFFAVLQVLFAKANKVWLYPCGIISICITSYLYFE
IQLYAEILLQLYYLIMSIYGWMLWKNKKGEGSEISLSSNSEKRKSILIVIGTFFFLYFIL
IKHTNSDVPLWDAMVSAFAWAGMWLLAKRKIENWIYLNISNLISIPLLLHKGLILYTLLT
LFLFIIAIFGYLDWKKILKNKELLT
>EGEFANNL_00489 hypothetical protein
MTWTIIIGILAGFLAGILMRGKGFGCLVNLIIGVVGSVLGTKIFKILNISVNENSRIGDL
SMSLVGAIVLLAIVSIFRKIK
>EGEFANNL_00490 Superoxide dismutase [Mn]
MAFELPKLPYAYEALEPHIDAKTMDVHYNKHHATYTTNLNNAIKGTELESLPIEEIIVKG
FNQTPIRNNGGGYLNHCLFWEWLTPEGQGKPSRELAEAIDATFGSFDSFKDEFSKAAASR
FGSGWAWLVVKDGKLSIGSTANQDNPLMPEVGVSGYPILGLDVWEHAYYLNYQNRRPDYI
NAFFNVVNWDKVSELYKKHK
>EGEFANNL_00491 Aspartate--ammonia ligase
MSNLIIPEGYKPILNLRETELAIKQIKDFFQLNLSSELHLRRVTAPLFVLKGTGINDDLA
GNERAVNFPIKDMQEQKAEIVHSLAKWKRLTLADLQIENGYGIYTDMNAIRADEDMDNIH
SIYVDQWDWERVISAEDRKISFLKEIVTNIYDSIRRTEYMAYEIYPKLIPQLPKNIYFIH
SEELLQKYPDLTPKEREHKIAKEHGAVFIMGIGDKLSNGEAHDVRSPDYDDWTSLSESPY
SGLNGDIIVWNQVLNQSLELSSMGIRVNKESLIKQLQLTDKEERKELYFHQRLLNDELPL
SIGGGIGQSRLCMFLLRKAHVGEVQSSIWPNKMKESCYNAGIPLLI
>EGEFANNL_00492 hypothetical protein
MSNDYNNNTGLIILNNIPDPIKPGWGCFLLFYFNSYIDHVPYCIKRLQKIAVNPTDWSKA
KDIGENILKFSKENPFFVPSSYLTLAHNIAKMIDRIANPSSSSSDRREEWKIPFLAMETA
IYFKDSVLENDIESTLSLFTRVPELKNTIKNSKDFVLFKRINDILWINWYSDLEHDLNPT
YKYQNYLPDIFILKKSNASIESIANRILQIEKDIIKLPGDQENCKIVASAIYNLKY
>EGEFANNL_00493 hypothetical protein
MDFILSLLYKIRYVEIIEFLGTFAFAISGIRGAATKNCDWFGAYVLGFVTAVGGGTLRDL
LLNQTPFWLHNGFYALCSFFALIFYIFLREHLNHLNRFFFWSDSIGLGLFVFVGAQKAMV
AGYSFWVVITMGTITGIMGGIMRDTLLNRIPVIFKRELYAFSCIVGGSTFVILNWLRFEL
PLISLLTVGIVVFIRFVADRWNLQFPRLKSETIRQREN
>EGEFANNL_00494 Glutathione peroxidase  BsaA
MKKIIITCGILGLLQLTLINCNAKTEVKQESNSSENNLSKKDSISTIYSFEVTDIDGKPF
KMDSLKGKKIMIVNTASKCGNTPQYADLEKLYNTYKDKNFVILGFPANDFLGQEPGSNEE
IKKFCTANFNVSFPMMSKISVKGDEIAPIYKWLTKKSENGVMDSEVEWNFQKYLIDENGK
LVDVVPPKESILSDKVKNWIENKK
>EGEFANNL_00495 hypothetical protein
MKKILILVIFMVSSIYLNSQTYKKINGFSDEINEKLKQFLVSSLTIKDRKVAVFDCDGTL
LGQVPYYLSEEAIFTYAKMKYDGKNDSISIEKMNYLFHILKPIDENDYVQNTLNFLSGMT
VKEIEHLGTSTFDSKYKNKFYGEMKELLTNLKKFNFEIWIISASPELLYQEIIHRELGIP
KERIIGMKAVISENNLATNLLVNPYPMNQGKAEAINTFIKVPPLIVGGNSRGDMEMMNAS
TGLKIIVNPNDSHIENNINSGDMFGYTVKKYWEKDPSCIEIFLKDEAFNNQTFISNQYGL
MPNY
>EGEFANNL_00496 hypothetical protein
MKNIYYRFALFLFIVQCSPYKKAESQLNKGDYAQAFETSINVYTKNYSQDKKEKQLILLQ
NAYLNANKKEEEELKILKSNLIPDYKRIYLVTKSLSNRYAKISPLLPLYNNGKELKFPTK
DLQQALALAKENYLNSYYNKGVSLLERNNKASARDAYEYFQEIKEVDANYRDISFKLKEA
YNQGLNIILVGVKNNSGTYLPSDLPQTLLFNINNYNKNFWTLFTLDFNEPHDEEVVVNIN
GAFVNYGNERIFTHNYEKDIIDGWEYLKDSRGFNIKDADGNYIKVDRYVKLQAQVTEVIK
QRDAVINATFQLYNSFTGNLINTYPVTSRSEFKSAYGILNGNREALDIYALELINAPRVP
YPNDRQMLTDCGIDLRNQLINFLNSL
>EGEFANNL_00497 Thioredoxin reductase
MSENNILDTLIIGSGPSGFTAAIYAARAEMNPILISGMELGGQLTTTTEVENFPGYPEGI
TGPEMMVQLQKQAERFGTKVIIDTVVQVDFGNQLGDTHTVKTSSGNDYKAKTLIISTGAS
AKYLGKEFEEKYRGGGVSACATCDGFFYRGRNVVVVGGGDTAAEEATYLAKICKTVYMVV
RKDYLKASKIMQERVESTSNIVLMYNHEVVDLKGENNLVAQAVVKNNITNKESILEVDGY
FVAIGHSPNTKIFEGKLDLDETGYVNVQPFSTQTNIPGVFAAGDVVDKKYRQAITAAGSG
CMAALDAERYLSQITH
>EGEFANNL_00498 Recombination protein RecR
MNFPSKILEKSVEEISQLPGIGKRTALRLALHLLEVPKNQADNLANSISQLVHNIKHCKE
CNNLSDTEVCIICGNSFRDDKTICVVEDVRDVMAIENTHQYQGKYHVLGGRISPMEGISA
SDLCIFPLLERIKEKQVVEIIFALSATIEGDTTMFYLYKLMKDLKIKFTTIARGIGVGDE
LEYTDELTLIRSLQNRVPYSQDLI
>EGEFANNL_00499 Inner membrane protein YbjJ
MNENISSCSSKFSNKQIRLGIFAFYICQGICFSSWASRIPDIKNYFHVGDGEWGNVLLMI
PIGQILGMVLSGFLISRLGSKKVLLLALPLHVLGLIAVGLSSSLLTLMLSLVAFGFFGNF
VNISVNTQGIIIENIYKKPIMSSFHGGWSLAGFFGSLIGLLMINLGLTPLQHYIFILFIV
GILIIFNCKYLQPDKKSVSLESNEKTVQSIQETNNKSYKKKTYPEMFLYLLGITAFCGMA
SEGAMFDWSGIYFEEVVHVSKNWAPLGFAAFMIMMATGRFIADYAAQKWGKQRIIQVCGL
SISIGLFIAVLFPHIIITTLSFMLIGLGVSSIIPTIYSLAGQKTKINTGMALTIVSSIGF
VGFLLGPPIIGYISHAFNLRYSFALIGIFGICIFLLSTYLKVFKQKD
>EGEFANNL_00500 2-aminoethylphosphonate--pyruvate transaminase
MVHFALNPPIGSVLRPQDKLLIVANGAYGKRMAEIATYYKINHLLVSLNETEIIDPIQVK
NLLNENKDITHFSMVHCETTTGILNPLKEISDVVKNYPVTFIVDAMSSFGGIPIDIKDLG
IDFLISSSNKCIQGVLRFGFVIALKDKLKECKGIARSLSLDLYDQWITMEEGNGKWRFTS
PTHVVIAFFQALKELEEEGGIESRYLRYKENNKLLIEGMKSLGFKPLLPMNVQSPIITSF
LYPFSNFSFIDFYNQLKSKGYVIYPGKISMADTFRMGNIGNIYPKDIENLIESIKNS
>EGEFANNL_00501 2-aminoethylphosphonate--pyruvate transaminase
MKEYLLLTPGPLTTTDSVKNSMLKDWCTWDKDYNENIVMSIRNQLVHLAKATPNEYTSVL
MQGSGTFCVESTYWICVTPPR
>EGEFANNL_00502 Phosphonoacetaldehyde hydrolase
MYNYGLAGIAIDYGCFAPLHAFLKVFSDEKKINITYRQDRERMGLLKIDHIKSILSMPEV
NDKFHEVYNRNWSMEDVHKMYQSFEKHLFTSLSDFTTPIPKVIETLNSLRNEGILIGSTT
GYTQALMDIVRPEAEKKGYYVDHLVTPNDVPAGRPAPYMIYKNMIDLAIPSVEQVVKVGD
TIADIQEGINAKVKSVGIIVGSNEMGLTELEYNQLPDSEKEILKNKVRERMLNAGADAVL
DNITELPSYIDSINQL
>EGEFANNL_00503 hypothetical protein
MVACGDLFFSYLEGRKLTDILASFMGVSMVISSGTAKSVGLYMMNVLKINEFWMPALIGG
IALPILILLIYILNRLPEPNGEDIESKSKREPLNNIDRIKLVKNFALLLIVLFIANVVLT
ITRDIKKDFLVKIVNTSEHSNWLFAQIDTVVTIIVLVTFCLVYLIKNNLSALKILLFVLI
VGMCLMAITSLNYNQLKLDTVLWLFIQSLCLYFAFLAFQTIFFEMFIACFKIKGNVGFFI
VLNDFLGYIGTVLVLFIKEFFGSNIHWLTFYNQLSGYTGIFCCLAFIYALFYLQFRAKKE
KNKLELQKYNEEGNINTNSSYTI
>EGEFANNL_00504 hypothetical protein
MLKINNFKNYSSRLLFILWAGGAALLSYSLVYALRKPYTSATFEGIQVFGVDYKVVVTII
QILGYAISKFIGIKLISDLKRKNRFKFIIGSMVIAEMALILFELLNSPYNLIPMFINGLS
FGCMWGFIF
>EGEFANNL_00505 hypothetical protein
MKKFSTGIIILVIAIFLIGFYIVTSNKMVVLNNDVKLKWGAVETAYQRRADLITQLAATV
KKATNYERETLTAVVEARARATSVQIDPSNLTPEKLAEFQKAQAGLNSALSRLLVSVEKY
PDLKANQSILAFQSQLEGTENRIKIDRDNYNISVTEYNNYITKLPYSIISSIKGLKEKTL
FKSFEGSDKSPDVDLLLNGEK
>EGEFANNL_00506 hypothetical protein
MLFTNNQEKHIINAIQQVEKFTTGEIRVYVDMLLQGDPLAEAQRLFYKLEMQKTKNKNGV
LIYVSENKKKVAVVGDENIHSFVNQSFWNNLIEEILHSFKNKQFDIGILTAIKKIGEQLI
KYFPSTTENFGINQIPNEIIYNK
>EGEFANNL_00507 hypothetical protein
MRLYTINSLWRILLVLLLNTSIFSAQKEFQIPDKPAKIYPVNDYAGVLTQAQKNLLEKKL
IAYNDSTSTEILLCIVKTLTGDDINYVAARWGERWKIGKQSKNNGILILIATEDRQLSIQ
NGRGTEDAMTDFISHQIINDYMIPYLKNGDYYGASNSGIDQIFNVLQGKFKSSSKDQPLD
LVSSLVFIIVLIILFIYISQILKGKRKGTYYNKNGKNKDDDFWGPGGGFFGGGFGGFGGG
FSGRSGGGFGGFGGGGSFGGGGASGRW
>EGEFANNL_00508 Thioredoxin 1
MKSIIFIAIIFSLTLNSCERKDKTDNKQIEKKVSMKTIPLNIEDFKVKIMDYQNNPDQWK
FLGNKPAIIDFYADWCGPCKMVAPILEELAAEYEGKIDVYKVDTEKEQELAAMFGIRSIP
SLLFIPMDGEPQMVQGAISKKDFENIIKEIIFK
>EGEFANNL_00509 hypothetical protein
MYWTLELASYLSDAPWPATKDELIDYAIRTGAPLEVVENLQAIEDEGEIYDSIEEIWTDY
PTDDDFLWNEDEY
>EGEFANNL_00510 Protein translocase subunit SecA
MNILNSILKLFVGDKHKKDLELLNKYLEKIKNEEEQIATLSIDQLRYKTIEFKEKINEAT
QEIRTKINDLKQKTQTTEDVEEKEKYYAEIEKLEKESYEIEEKVLEEILPQAYAVIKETA
KRFTENSTIEASVTDFDKELANAKEYVTINGEKSIWKNNWNAAGKDVQWDMIHYDVQYIG
GTVLHKGKIAEMATGEGKTLVGTLPMYLNALTGRGVHVVTVNDYLAKRDSAWMAPIFEFH
GLKVDCIDNHQPNSESRRQAYLSDIVYGTNNEFGFDYLRDNMANSPSDLVQRELNYAIVD
EVDSVLIDDARTPLIIAGPVPQGDKQEYQILKPVVESIFTVQKNELTKIFQEAKQLLANG
DKKLGGQKLYQVFRGLPKFKPLIKFLSEEGNKAILLKAEAYFISDNNRMMPEADKDLYFA
IDEKNNQVELTDKGIEFLSKGNEDPHFFMLEDLGSAIADIESKNLPKEEEHKEKEEFLRE
FAIKSERIHSLNQLLKAYTLFEKDIEYVVMDGQVKIVDEQTGRIMEGRRYSDGLHQALEA
KENVKIEAATQTFATITLQNYFRMYNKLAGMTGTAETEAGEFWEIYKLDVVAIPTNKPVV
RKDHQDLVYKTNREKFNAVLNEVIRLSQEEKRPVLVGTTSVEVSELLSKALKMRKIPHNV
LNAKLHKKEAEVVAEAGKPGVVTIATNMAGRGTDIKLIDEVKDAGGLAIIGTERHDSRRV
DRQLRGRAGRQGDPGSSQFYVSLEDNLMRLFGSDRIAKMMDRLGHKEGDVIQHSMISNSI
ERAQKKVEENNFGIRKRLLEYDDVMNKQREVIYSRRKNALFGEKLSIDIANMIFDTAALI
VKENKSNRDFKNFEFELATTFAMDTPMDSSEFNSLNEADITQKVFEQAEALYKEKLENTA
EQLYPTVSNVFLSPNRSYKNISVPFTDGSKVINVTTNLEEAYNSGGKALLKDFEKSITLA
IIDENWKDHLREMDELRKSAQSAVWEQKDPLVIYKQESFKLFRDMLDKTNKEIISFLFKG
GLPIEANNTTIHEAKEVKQKMVESRNFEESQEGEVKDKEIQEPLRVNKIGRNELVTIRNL
RTGEVKNLKFKQAQPYIDEGWMVED
>EGEFANNL_00511 hypothetical protein
MRINIYAYLLFILLIISCDNKNIKKEEFYVYGTSEFVEKEKGMKISLEEATQIYAEYIYH
LQKNKKDTINCNLDIIYKDYYIFSPFLYNAKTGNYNLSGIWVNGNTGQIKKIKTEKNLHI
ILKIPKNYYKKEIYLK
>EGEFANNL_00512 hypothetical protein
MKQILFMSILSLLLSIMGCNRENQYLKDHKVILCYELNKKKLTKEAKDFSNNSILGIEEA
GNIYKEFLVNKKELDSSKSNLNLSIHPKIIIDSNYVFSFYNMKQMKIAVFGIWINANTGK
ITYNKDELWLNEREIGV
>EGEFANNL_00513 hypothetical protein
MVIYTKKKNYYIGYNSNLYKRNLKTAPLYFLAEINSETGEIMTDKN
>EGEFANNL_00514 hypothetical protein
MKKILFMSILTLLLSIMGCNREKQYLKNHKVIYYGTSEFNIFENNVQINKKEAYKLGLAY
AKKNDLVMGNNLFFVIDNYYAFTNHYIPKMPAASTKGIWINANTGEVKYIKEGIMLRPKF
FPEKKIKDEN
>EGEFANNL_00515 hypothetical protein
MKKFKCYSLIFYSLFILVSCSYTKDKKIYIFGTYEFKEKEKELKLSLEEATQIYANYIFK
QDTQKTRIKCILDVIYNDNYIFTDSPLNFNSKTGYNISGIWVNGHTGEIKEKHSSKYVKI
PNELKNINAIIPFQKEIIKKSR
>EGEFANNL_00516 hypothetical protein
MAKFKTLSLIFYSLFILISCSGTKNKIEFVPVNRKDKKSISSFDGDLKRYIYIYTEDFLI
KNPPTDLEELKKIMIDYRNKKGVPLDKLDTDLYSMGFYRYTDDTSYFLTHESYDTWEGQT
KYLGSQEQDFLGFIFSKRCPADTTQWQTNILWTIPDQEKLKKDGFYELKQENIIPCPKPK
DPCLI
>EGEFANNL_00517 hypothetical protein
MVKLKTLSLIFYSLFILISCSGTQNKIEFVPVNRKDKKSISSFDGDLHRDIYVYRERILI
KNPPTDLEELKKVMIDYRNKKGVPLDKLDTDEYSMNFYRYTDDTSYFLNHISYDTWDGQT
KYLGSQRQDFLGFVFSERCPSDSTHWRTDLLWYIPNKEKLE
>EGEFANNL_00518 hypothetical protein
MWEHFGLDLPDMEKLFNILPQASEIFAHWFILQHLYGYRPFVTQAVIEREFSGNIYYTRQ
ENIKAQQAEQAAKQNEAQDAQQKVNLNNLPKW
>EGEFANNL_00519 hypothetical protein
MSGFKKLTVFLIGGIIILSYNFISCQKKQSQMEWKYIDFDQIPEEKNSNDEYYSYFVYLN
KYDFKHILNYNKNIFFLLGNDNRRTFNDSTNSVIYATYDFGDTWHKTSLGKGTVEFGCFS
GEKMFVLVQEVEFTRSEWKSAIYSSEDLGKTWKEELKSEQGKQITDMVFYSDKVRLLAIL
HYTPYNDSWVYEYQYTEDGGKNWKKINFNGQFNSVGNRDYCIFNSDSTVLYVDKNTQLIE
FNLKTEQKKTLKTWNIPEDMKLMDIIRDPKTKEIIVEYSSKKVTEDKSALYYVERAEYVA
LPDNYFLATYGDLYYGLVFDQPFSTYVWSTDRGKTWNKEKLDYVMIYSNWPKSYYGEGYM
YMQASLFRREDEHLGRGNRFCIAHPFFNQRTNK
>EGEFANNL_00520 hypothetical protein
MHTKKIIAFLFIGIITLNYNFISCQKKQSQMEWKYIDFDQIPEEKNSNHEYYSLFNQLTK
YRFNYILNYNKDIFFLLGNDDQRKLNDSTNSVIYATYDFGDTWHKTTLGKGTVEFGCFSG
EKMFVLVQEVEFPRSEWKSAIYSSEDLGKTWKEELKSEQGNQIMTMMFYSDKVRLLAILH
YTPYNDSWVYEYQYTEDGGKNWKKINFNSDFNPEGYQRGYCIFNSDSTILYVDKNTQLIE
FNLKTEQKKTLKTWNIPEDMKFSNIIRDPKTNEIILKYASKKVTEDKSALYYVEREEYVV
LPDNYFLATYGDLYYGLVFDQPLSTYVWSTDRGKTWNKEKLDYVMIYSNWPKSYYGEGYM
YMQASLFRREDEHLGRGNRFCIAHPILNQKTTK
>EGEFANNL_00521 hypothetical protein
MAGGKITIRAGKKITKTSEKYSIYTDRLTLNSNGPIKLTSDQEIVYGVPKQYGHKASCNY
TPKSVSLGGKDYYIRRVMDFFDRHKSCMHFPPVYYYGDFRIFGTLTSSEETEVRRARISE
SRYPNVSREKVEKIRANRARKDALNPKFTKLKKNSFMIYSGTPENSYGYKYCDAFTKLRP
NLTEGGKKWLDKTMNLLQELMESGVVNKNYIAKYNEDYNKNNGFYDQYGMLLSENIKNFY
TNIELNGGHFQDFAFATHPDAYNPLEMQDLPAHDLVRICLTPELKEWMGPKTWEQAWIVA
KNISYTEIGKNTWEKVKKDTKEGAGKLKKYWDEIFKL
>EGEFANNL_00522 Actin cross-linking toxin VgrG1
MLENSRKILGKRISFIFYQFGKAQQIFTGIVSRVSSGMNEGVKKIVLTGACPSVLMENGA
HCESFENRTLEEIMNGIASHYPQNLVQFRINANFKDKISYVSQYNESDYSFIRRLAAQFG
EYFYYDGEQFVFSAWGSKIVELMEGEDIYDYDLSMQMGAQAFGLTGYDPQQGESLVVESS
SKRVQYSENPFQQYANNVSEDLYASHIPTAHYGHSNLREGRMALDMDLERGIRKKRELVR
LEARGNNPSLRVGDIAKLKVWMPGHQIFKNGKVPAESYKVLEIVHSFEDGLGYEHRFVGV
PKDSVVPACYNSRSFPRADVQHAVVTQNQDPQKMGRVRVQFTWQKAKNSQTPWVQIIQPH
AGSGKGTYFTPEVGETVLVAFQGGNPDAPVVLGTAYNGGEIARYYTEGNDLKVIETRSGT
KIVFNDAEGKGSILVEDPSGNRWFMDGKGSISVDAPKDFSVTAGENINLSAGKNMNFSAG
QNQTTSVGMNATTQVGMQYSLFAGDIDMDSVGSVNMKSKELQELSEEYQSSTETTTNFHA
QETFHNNSGEKSNLF
>EGEFANNL_00523 Chorismate synthase
MFNEFGKIIKLTTFGESHGTAIGGIVDGFPAGLPVDLEAVQKELDRRKPGQSKIVTQRKE
DDKVEFFSGLLEGKTTGQSIGFLIPNTNQKSKDYEHNVQVFRPSHADFTYTQKYGIRDHR
GGGRTSARETANWVVGGALCKQLIPEIKIQAYVSSIGEIQLNKHYTELDLSQVESNIVRC
PEAPTAEKMIDLVSRIKKEGDTIGGTVTCVVQNMPIGLGEPIFDKLSARLAQAMMGINAA
KGFEIGSGFEGTRCRGSEHNDIFIEGGKTLTNHSGGIQGGISNGMDVVFKVAFKPVATIM
KEQSTINERGEVSTIHGRGRHDPCVVPRAVPIVEALTAMVLADFTLLNKLRKI
>EGEFANNL_00524 hypothetical protein
MAKPIPKNYNSIKVMAQTIDLKYYWEQAVSYDSYKEIIEKQAQEGINNEEDKNIQKLAEY
TRLNLSRIHRNDKTLVLEESVLTILNKLNKKVNILAISEGWCGDASQIVPVVQKLAESSP
NIDFKLFFRDADEKLIQQYLTNGGKAIPIILFIDAETFEEMAHWGPRPQSCAPFLKKYKE
NPETYTHDDFAKDIQGFYNKDKGHEIANELTQIISKI
>EGEFANNL_00525 Sporulation thiol-disulfide oxidoreductase A
MKIKPIYVVNIVFIALIIALLFTPLRGYLQKIQSSTAESKYAKISQLTPEQYNIELKGVN
TPDVNFKDFKGKKIFLNFWATWCPICKSEMPDIQTLYNTSKQDYQFVLIYMKDDRKKVED
FLKENSYTFPVYEAVSPIETSLLPTEYPTTFLIKENGEIQEKVIGARDWKNLKF
>EGEFANNL_00526 4-hydroxy-tetrahydrodipicolinate synthase
MKLLQGLGVALITPFNEDETVDFSSLEKLVNYNIEGGVDYLVVLGTTAESATLKAEEKRE
IIECIKQTNNHRLPLILGIGGNHTAEIIRQLQTTDLEAFSAILSVSPYYNKPSQEGIFQH
YKALAKNSPKPIIIYNVPGRTSSNIEATTTLRMANEIENLLGIKEASGNFLQSTDILKNK
PQDFILTSGDDEYALPVTLAGGDGVISVLGQALPEKVSQMIRLGLENKVQDAYQIHYQIQ
SLIRLIFAEGNPTGIKALLALQGIIKTSNTRLPLVKATQQLMDKLSSELKKL
>EGEFANNL_00527 L-fucose-proton symporter
MNKDSINSSNSQKLMLIPLVLIISLFFLWGMANNLNDILISQFKKAFQLTDFQSGLVQSA
FYLGYFFFALPASMVLRKYNYKTGIIIGLLLFSLGAFLFYPAAQNATYGFFLFALFVIAS
GLAFLETAANPYVTILGSPQTAAFRLNLAQAFNPIGCITGILVGQYFIFSGVEHDEATLS
QMSPSAIEAYYKSEIHAVETPYLVISTVALLFSILFALVKFPKIQEQKSGKKDSLISSLS
HLCKIKHFKLAVITQFFYMGAQVCIWSFMIRYAKFSINGISDFDAAHYLTFSLIALTVGR
FAGTFFMKYIKPNKLLAIYAIINIVLVFIGISSPNLTGVWALVVSSFFMSIMYPTIFSLG
LNQLGNETKTASSILVMAIVGGAILTAVMGFVSDITSISMAMIVPLVCFVLIALYGLYGY
KVKNSIKL
>EGEFANNL_00528 D-psicose 3-epimerase
MIKARIGASILSWIPPSWKADAGLYAIQQASKSGFDVIEILLPNSMDFDAHTVKKQLKDN
HIEAVCGLNLSKPYHIPTHPKEAIKLIQQAIDKAAILEVDYLGGVLHSAIGVFSGKPRTS
EEETILLEVWGESAKYAEKFNINIGIEPINRYESYICNQAEDTLQLIKRVKATNLFLHLD
TFHMNIEETSFYDPVKNSGKWLKHIHMTENDRGMLGEGLVRWDDLFKGLNEINFEGNLVL
ENFSSSVAGMAEAVSLWRPSKYKANELANKSLSFIREKMEEFNRE
>EGEFANNL_00529 Outer membrane protein assembly factor BamD
MKKIIFILTASTLLLNVSCEKKLNRALKSSDKGYVLKIAEEYEQKKKYPQAISLYEYANK
LVVGTDDAPEIAYRNAQLNYLDGNYRLAAHQFKTFLSTYPQDKRAEEAAYMSAFCYYKDS
PDYNLDQANTKNALKELQSYINRYPNSDKIVECNRMMDELTHKLEKKAFENAVTLYKITE
YKGSIVAFNNVLDEFPDTNLREEIQIYLLRAKTELAVNSVHRLKNDRLNDAVLSYTNFVK
NFPQSEYVNEAQRLKNRLENAREDFDSKEKNIEESKNKKDSDKERKKII
>EGEFANNL_00530 hypothetical protein
MNLKELKAPSNTITFNKENIENKVGNIYEAIVIIGKRAEQINTIIKNDLNQKLDEFASNS
DSMDEIFENREQIEVSKYYEKLPKPTLIAIQEWLDNEVYFRKTDE
>EGEFANNL_00531 Coenzyme A biosynthesis bifunctional protein CoaBC
MSVLIGKKALLIVTAGIAAYKTAFLVRLFIKKGVDVQVIMTPEAHSFITPLTLGTLSKNE
VYTEFFSTSTGKWNNHVDLALKSDFIIVAPATTNTLSKMANALADNLALATYLSAKCPIF
FAPAMDLDMYLNPSNQKNIKTLQEKGDILIPPNCGELASGLEGEGRMAEPEEIVTFIEES
FKKNSIFNHKRILITAGPTYEAIDPVRFIGNHSSGKMGFDLAKEAEKLGAEVILISGPSH
ETIPLSSSIKLINVTSAQEMFESVFQYYDEVDIAIMSAAVSDYRVEKVSTTKIKKVEETL
QLNLVKNKDILFTMGEKKKNQILVGFALETNDEEVNALHKLKKKNLDIIILNSLQDPGAG
FKSSTNKITIFDKNKNKTSFNLKSKEEVAKDILNYIFSKI
>EGEFANNL_00532 hypothetical protein
MKKILSFFIVFIASLSTYSQELYADVIVNYDKIAGSNTQVFNTLKKDLKDFINNTKWTDG
GTLSLQERIKCTIGITIQEKVSNEFKATIFIQSGRPVYNSNYITPLLNFQDTQFKFTYNE
SENLIFNENKFSGKNLTDVISFYVYMILGYDADSFSRRGGTKYFEKAKKIADNSINQGYD
GWNTFEGPKTRGSIITDLINNKSNTLRDVFYQYHRLGLDLMANNEQLAKNNIAENLLSLK
AYTNNYQFYPLDNFFIAKREEIKNIFSAGLPTTKVNLAELKTLLETINPINSKDYWNQIK
N
>EGEFANNL_00533 DNA repair protein RecN
MLKHLSIRNYALIDHLNLDLPNGMITITGETGAGKSIMLGALKLVLGERADLKSLKNSDE
KCIIEADFLIKKNNFLSFFIEHDLEFDDNTIIRREILPSGKSRAFINDSPVTLDILQKLT
SRLLDIHSQFETAQLLNEKFQLDLLDHFSSLQEDKNEYEKIFTQYHLENRKLQELKDKLL
TGSKDQEYSKYLLEELEKAELDELQFDELQSNFNLMKNSEFLAQILSESKQIIDNEDVGL
LQQIQVIISRMDKASQVSIDVEKLLERINGVKAELQDISFESENLLEKLEFDPIKFEEYN
QKINLIHSLLYKHKVSDIKELITVRDDLAQNHLDLEQLESLIYESEKKIEEYTEILSKQA
KILSSKRIKNAPILEKNILKILSNLGMDKSQIEIKVDPLKDFTPSGIDKISILFSANVGM
PIQPIVKAISGGERSRVMLAIKKIMAENVELPTLILDEIDTGVSGRIANEMGKLMRDMSK
SMQIITITHLPQVAAKGKVQLKVEKQELHGKTTTGVRKLSEEERIEEIAQLISGSDVTES
ARQQAIELFK
>EGEFANNL_00534 hypothetical protein
MKRFFIPVIFLFSIVSFSQEIYSGEYNTKFYLFLGSYQGVDMKMLDTMHKTVQWINIDSA
NLNQVGILSPVDFIKTILSNQLYFQVNSIEQSPWTAQIKDNSFYINDLQNNFTKEIPIHI
NFNDPTIYLSFEDDNKNLKGSIKRISQEESNSLCSSEEIPLWKTTFTFNNRTYEGCTYIK
NN
>EGEFANNL_00535 2-oxoglutarate dehydrogenase E1 component
MDQFSFLNAIHSEYIEELYQKYLSYPDSLEPSWKAFFQGFDFANTSYEGKQIIDEEKKQF
IVDNHTGISEDVVREFKVINLINEYRMRGHFFTKTNPVRQRRTYTPTLDIENFGLTTEDL
SVKFNGKIIGLDQYYTLAEIIQLLNKVYCNSIGIEYMYIQSPIEIRWIQEWLKKGFNQPQ
LNVEEKKRILKKLSHAVAFENFLHTKFVGQKRFSLEGGETLIPALDEIINNSSELGVEEI
VIGMAHRGRLNVLANIFNKSYSQIFTEFEGKDYVENIFSGDVKYHLGSCNKYNTKKGKVV
NISLAPNPSHLETVDAVVEGIARAKADHNFNEDYSKVLPILIHGDAAIAAQGIVYEVLQM
MKLDGYKTGGTIHIVINNQIGFTTNYLDARSSSYCTDIAKTVRCPVLHVNADDAEAVIHA
VRFASEYRSIFHKDVFIDLLGYRKYGHNEGDEPRFTQPKLYKLIAKHPNPREIYKAKLEQ
EDVITPELIAESEEQYKQLLDKNLEDSRSMDTTKVELFMQQEWKNFDRVGEKELLNPTDT
SFPIDELRQIAKVITQVPENKNLFNKIQRLLNQRKEMVEVSNSIDWGMAELLAYGTLLME
GHTVRLSGEDVERGTFSHRHAVIKTEDTEEEIITLNQLNTQAKFYIYNSLLSEYGVLGFE
YGYAMTTPYSLTIWEAQFGDFANGAQIVIDQYLSAAEDKWKMQNGLVMLLPHGFEGQGAE
HSSARIERFLSLCANGNMYVINSTTPANFYHAIRRQLKPNFRKPLIVFSPKSLLRHPKVT
STLEELTEGSFHEVIDDPSSNVAKVTRLVFCSGKIYYDLLNKKEELMDEKVALVRIEQLY
PLHWEKIYHILDKYENKKEFYWVQEEPENMGAWWYILKEFRKFDIDVISPKASSSPSPGS
HDRYIKIQKSLINSVFNNIK
>EGEFANNL_00536 Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex
MILEMKVPSPGESITEVEIATWLVKSGDYVEKDQAIAEVDSDKATLDLPAEASGIITLKA
EEGDTVQVGQVICLIDTDAEKTNETPEKSIEVSQEKLNENTKSVSHSVPNPEPIYNSYAT
GEASPAAKKILEEKNIAPSTIQGTGKDGRITKEDAMKAVVPSMGTSTGNGARTAQSVKLS
ALRRKVAERLVSVKNETAMLTTFNEVDMSEIYRLRNEFKEEFKNKHGVGLGFMSFFTLAV
VRALKLYPDVNSMIDGNYKTSYDYQDISIAVSGPKGLMVPVLRNAETMTFRGVEQNIKEL
ALKVRDGKITVDEMTGGTFTITNGGVFGSMLSTPIINPPQSAILGMHNIVDRPIVKNKQI
TIAPMMYVALSYDHRIIDGRESVGFLVAVKEAVENPLEFLMDNNPQKALEL
>EGEFANNL_00537 Phenylalanine--tRNA ligase alpha subunit
MIDNIKNYLKEVQEFNPKNPEELENFRIKFLGKKGILNDLFQKFKEVPNDTKKEFGQQIN
HLKQLVNDKINSLKDHYNFSKQPTSDRLDLTRPGYPFNLGTRHPISVVKNKIISIFKKIG
FSVADGPEIEDDWHNFTALNMSEHHPARDMQDTFFIDKNPDLVLRTHTSSVQIRYMEKNE
PPIRILSPGRVYRNEDISSRSHCMFHQIEGLYVDTNVSFADLKQTLQFFTSELFGKSEIR
MRPSYFPFTEPSAEVDVYWGLETETDYRITKGTGWLEILGCGMIDPNVLKNVNINPEKYS
GFAFGMGIERIVMLMYQIGDIRMFTENDIRMLKQFSTEY
>EGEFANNL_00538 Glutaminase
MKKLFYILFLLVLVPKSGFAQGSKIDQLLFSTLIESKAYIDKGKVADYIPELSKANKNLV
GVALVDSLGNLHTKGDTKSKFTMQSISKVIALMLAVEERGEKYVFERMGYYGTDKPFNSF
EALEYRHKPLNPMMNAGAIVTTALIKGKDDEAYKKILERVRYITKNEDININEAVYQSEK
ETGNRNRGMFYLLKNFGLFDAENEESLNNYFRQCSIEVNAEDLAKIGYFFAHNGTRFDGD
KTFYNPEISKLIKSIMLTAGMYDYSGEYSSKIGIPSKSGVGGGIMASVPGKIGIGTFNPS
LDEQGNSVPGLYIMEKLSKELNLSIF
>EGEFANNL_00539 hypothetical protein
MDKIIEKLEKETGLTKDQAEKALTIIKEAFKAGQLTENVKNSVEGKSNDFKNSISSFFDK
ISDKASEITSKISDKVSEFTDSAEDKADDLKDKGKDLIDSAKDKVEDLKDKGKDLLDSAE
DKAEDLKDKTKEQANCALNKAEDELKDLKKNIQ
>EGEFANNL_00540 hypothetical protein
MNELDKINYIKTFVKNRLYNEYSGHDYWHIVRVVNNAQKIMLNESADNLKVIIASWLHDI
GDYKLHNGIDKTKEIVFPLLKSMEFNNKFIDDILKIISEVSYNGGFNQPPSSIEAKIVQD
ADRLDAMGAIGIARAFAYGGNKGREIYNPDDNLNIYNSKEEYKNNNSSSIMHFYEKLLKL
KNLMNTDTAKFIAHRRHEFMILFLNEFMDEIKN
>EGEFANNL_00541 hypothetical protein
MKILHYLFNYKSTIFISLIVLIITILCLNIYPIKKEHSLIENAIFTGSIISPVIFLFITI
GLFKGLFCKNTPTPSNKNYGLTVIPNNCLDKILYWILSSIILVAIYSTIDNHFHIAIFLF
IIMLYWIFFKSLSIVLKNSLKCKKNLGLSMIYGLTYTLLFNLWFYTITFMMYRIK
>EGEFANNL_00542 Primosomal protein N'
MEFVNVILPLPIKGVFTYHVPKVLENSLQIGQRVVVPFGGKKLYTGIILEIHKIKPELYK
TKEIFTILENEAFVTINQLNFWKWISEYYLCTLGDVYRNAFPSALKLESETYIRKTGHEI
IWEELDEREIFVMQNLEVKTSIDLKEIESFISKKHIVPTIKSLFEKNLVELDEQIIEKYK
PKQMVYLDLNPDFKNSEIFKRALLEIDRAPKQREAFLVFIQWQQQRTSHIGKRELVDRFS
PAVVKGLIDRNFLIEFQLQIDRIEDYDDNIEDFNELSEAQNQAFHEIRNQFSKYNTVLLQ
GVTSSGKTEIYFHLIDEQLKLGKNCLLLLPEISITTQLVTKIQKRFGNEVGVYHSKLNQN
ERVEVWKNTLNNKYKILIGARSIIFLPIQNIGLIIVDEEHDSSYKQSDTLPLYNARDCVQ
ILAHQFKAKVLLGSATPSMESYYNCDQGKFGFVELNQRFGEIKLPEVDLVSLRTPTITPN
ISYELYEQIKICLENKKQVILFHNRRGFSPILECNQCGHSPTCPNCDVSLTYHKVSSTLR
CHYCGNTRALPQTCPSCHSHSLETKGIGTQQIEEEIIHLFPEARVARMDVDTMKRKHAYE
ILFEKMHLHEIDILIGTQMVTKGLDFDSIQLVGVIRADSLLNFPNFRAEERTLQLLTQVS
GRAGRREAGKVLIQTFDPENPLYLFIQENNYHLAKDTILQERKEFLYPPYYRLIEITFKH
KKQDKAKKTATFVVEYLRNFIQEPFILGPEEGLIPRINNYYIYKVLLKHPANKSTKNLKF
FIEQSLTKVESVQAYRSVKITIDVDPL
>EGEFANNL_00543 Pyridoxine/pyridoxamine 5'-phosphate oxidase
MEDLSNLRKIYNSGKLLELDLKDNPMELFRDWYLLAKSHDLILEPNAMSVSTIEDSKNPR
TRMVLLKKFTWEGFIFFTNFESRKGTAIEENNNVCLNFYWDRLEKQIIINGCAERLSANL
SDGYFHSRPRGSQLGAIVSQQSKVIPNREFLEEKLRVLEEETKSLNELERPNNWGGYLVR
PKQIEFWQGRPNRLHDRILYTLLDNFEWKIERLAP
>EGEFANNL_00544 hypothetical protein
MSYKGNLLIAKPGLNDEYFSKSVIYLTGDDPFKGSVGVVLNKLYEKKLNEIIPEIDLDMD
VYMGGPVNQDHLFVIHSRPDLISKGTYIGKDYYWSGNYKEITLALKNKWIENDEIRFFIG
YTGWKYKQLRSELNNKDWMVLPDKDLNILKWEDNLWKNKLIKADKRNIIWVNYPTNPLYN
>EGEFANNL_00545 hypothetical protein
MLLKSITKILIIVNLFIISSCHSTNIMNMNKVEKHTLKEKIDHYQFTGIVINNEKSISKG
NKQLDILKIQITSSVNENLQPNTIIYAVVDRNNLLKLEINREYVFNGNGSYTSKLGKHYI
KIIKIQDLI
>EGEFANNL_00546 hypothetical protein
MNILESVKQYLKRIKISSINGISLYEILQIYFQGITKGAIGYRAAAASWNVFMSFFPFLI
FFLLLISYLPYYDEIQHLIYDFLLKKLLPPNIFDIVNGYMNDRILLVNNHLNRPNIYLLL
LSVLLFIILSSNGIRSLITGFKSVNNHDPIEFKGFRSFFLSIFIILFFSIFLIVSLLLFY
VSEIVLRLFQYSISFNIIEFRTIINIFNYIISSIIFFFGTCFLYYWGRTARLKFKEVIPG
ALLTTLLFPICTYIFGYYITHFTRFNVLYGSIGSMLMLMIWVNLSVTFILIGYELNIAIR
KAKFNRSFIKDKV
>EGEFANNL_00547 hypothetical protein
MARYKLLFFIIIFTSILSCKKNSVHESTIALDSLNSIQKKDKNISNLDVITGTYNGVISC
DDCENVQLTLKNNGEYSLLIHLADEEDSRKNTTLLNGRYIWNSKDSIISLDQNHFKFLKQ
KNKLYFLFDNSLNIAEDEVLVKE
>EGEFANNL_00548 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MSEYKITLPPMGEGIIEATITRWVKNEGDFINEDEIIVEIATDKVDSDVPTPRAGKLIKK
LKDVNEVCDIGEAFAILEVEDDSSSNSNNISSNTLIESSEEEIIAQLESPLVHKTSSIEN
TEKKKDNYYSPLVRAICEQENISESERQSIVGTGLNGRITKEDILTYLKNRSEISSTEKV
SIIESKIISRDCETPSDSLINDLSTKTIVSSSESDEIFEMDRMRKLIAENMLRSKQIAPH
VTSFVETDVTNIVLWRNKFKDLFYKKEGEKLTYTPIFIQAVVKAIKDFPMINISVKGSTI
IKKKNINIGMATALPNGNLIVPVIKNADQLSLSGLARKINDLANRARTNKLNPEDTQGGT
YTVSNIGGFGNIAGTPIINQPQVAILAIGSIVKKPAVIETPQGDLIGIRHKMILSHTFDH
RVVDGALGGMFIKRISDYLEDFDLNTEI
>EGEFANNL_00549 Heat shock protein 15
MRIDKFLWCIRVYKTRAIATEECKKNRISLNENVVKPSKEVNSGEIYTIRKNQIDYKIQV
IQIPTNRVGAKLVSLYCKDLTEPEQLELLQTRLSTQNYYRQKGIGRPTKKDRRDLESYTS
DDLSEEN
>EGEFANNL_00550 Shikimate kinase
MNISLIGYMGCGKSTIGKEISDITGLKFIDLDSYISSKEQMSINEIFSKKGEVYFRKIEK
KYLHEILNLESIVLSLGGGTPVYYDNIETINNKSCSFYLKLSPKELAHRLMKEKEHRPLI
SRIEDQNLEEFIAKHIFERFPYYERAKYKINGNQDVPTIVNEIIDITKPS
>EGEFANNL_00554 hypothetical protein
MENILNLLTSGLGSQIINGISEKTNTSVEQTSSVVSSAIPALLGALQNNASTEEGAQGIL
NAVTSKHDGSILDNISGFLGNGGNEQEGKGILGNIFGNQLGDIQNGISQKTGVSASSVGS
ILSLLAPIIMGYLGKQAQSSNISDGGGISNLLSSLLGGNSGSSILSSILDQNGDGKLGLD
DLAGLVSGNKSSKGNGLLGNLLGKFLGK
>EGEFANNL_00555 Protein-L-isoaspartate O-methyltransferase
MALDTLKHKGKRNKLIQLLRSKGIGDEMVLEAMNQVPRHLFIDSIFEDLAYEDKAFPILS
GQTISHPYTVAFQTQLLHVQRGEKILEIGTGSGYQTAVLVALGAQVFTIERQKELFEFSK
KILKKIHFPPKYQTFGDGYQGISSFAPFDKIIVTAGAPNVPKMLLQQLAIGGIMVIPIGD
EAQKMYTILKLDINTFETMEFGDYQFVPMLENKEL
>EGEFANNL_00556 hypothetical protein
MNLSYIKSLLYVCLAASSYGLVATFVRLAYNHGYTTGEVVISQMLIGLISLIFIHKIIYR
KEQIKHSTKDKYKLIICGTSFGLTSTFYYLAVHYKIPVSICIVLLMQAVWMGAFIDFIVN
KKKPSLIEIISIFLILIGTVLATNLINDNQVKLNPIGLSFGILAAISYTCSMYSSNKIGT
QMSPTLRSVYLFMGSTILVSLIWGKSILQGTFNFTIFYQWGIICALFGAILPTILFTKGM
PVVGIGIGSILASLELPISVLMAKFILNENVYFLQWIGIVLILISIVLLNLSFLLPKNTK
L
>EGEFANNL_00557 Transcriptional regulatory protein SrrA
MSVKILWIDDEIEMLEPHIIFLKNKGYEVLEVNNATDGYDIIINEPIQAVLLDENMPGIG
GLEALQRIKELKPRLPVIMVTKNEAEDIMEEAIGEQITDYILKPVNPNQVLLSLKKILKS
DEIIEKQTVKNYQQEFGKISMDLMYARSCEDWIQLYHKLILWELRFDKLSDVEMNKILQN
QKDEANSLFAKFIENNYYNWLHENSNPTLSHTAFKDVIYPVVKNSSKTLLLMIDNLRYDQ
WKMIEPLFKKYFSSSKEQTYLSILPSATQYARNSFFAGLMPSEIEKNYPQYWTQETEDGH
KNQFEEELLKIQLQRLGLSNIKLKYYKILNAEFEKKVYDEFKSNLKFDFISIVYNFIDIL
SHAKTNNNIVNELIRDDKTFRSLTYTWFENSSILKTIQLASEEGFKVIITTDHGTIYVKK
PSKVIGDRESSTNLRYKLGKNLQYDSKDVFAISNPEDYFLPKVNVNSKYIFAKENKFFAY
PKNYNHFVNYYKNTYQHGGISLEEMILPITILE
>EGEFANNL_00558 hypothetical protein
MNQGKNIKKKIFNDPVLGFITISDSLILKLIEHPYFQRLKRISQTGLTYYVYPGSTHTRF
LHALGATHLMQLTLQVLKQKGVKISKDEERAASVAILLHDIGHGPFSHALESTLMDNIHH
ESLSITFMNLLNNEYNGELSLALEIFRDKYPRKFFHQLISSQIDLDRLDYLKRDSFFTGV
SEGNINSERIITMMNVVHDELVIDEKGIYSIEQYLTSRLFMYWQVYFHKTSVTAEVYLIQ
ALKRAKDLIKDCKKIPSTSTLSYFLNKSDFSQLNAEDIMYFSRLDDTDIITALKDWQFVD
DEILKILSQSIIQRKLPFSRISSHPKSDEEIRKLKSKVEEKYNLKDGKYFVHQNKLNIFL
YEGKTQAIKLLLKTGEIVKLQDLGNPVFNNESNKYICRYHLCFPRDILLKL
>EGEFANNL_00559 UDP-3-O-acylglucosamine N-acyltransferase
MEFSAEQIADLVNGIVIGDPTVIVSYISKIEDGTPGTLTFLGGEKYQNYLKDTKASIVLI
SENFIPKDTSELPTMIVVKDAYASFNQLLRYYNDLRTHKTGIEDPVFISKSAILGQDLYV
GAFSYIGNNVKINDHTKIFPQAYIGDNVTIGENCYIGPGAKIYNDCTIGNRCVIHAGTVV
GGDGFGFEPLAEGYQKVPQLGNVIIEDDVEVGSNCTIDRATIGSTIIRKGVKLDNLIQVA
HNVEIGEHTVVAAQTGIAGSTKIGNWVMIGGQAGIAGHLKIGDRVIIQGQSGVMADVENH
KRLFGYPAIDYLKYQKSFIYFKDLPKLVSRLKKIEEKLDK
>EGEFANNL_00560 UDP-3-O-acyl-N-acetylglucosamine deacetylase
MSEKQKTLKQEFVLKGKGLHTGKEVIMTIKPAPVNTGFVFVRVDLEGQPTIEADAAYVTS
TERGTVLEKKGVKIHTCEHILAALTGMDLDNVYIELNNSEPPIMDGSSKFFVEAIEKAGV
VEQEAVREYFTIKEIISYTDPETGSEITAIPSDHFEVMTMVDFGTKVLGTQNATMKNISE
FKDEFSNSRTFSFLHELETLLDAGLIKGGDINNAIVYVDKELSEETLEKLKAVFNQPEVS
VRPNGILDNVNLYYPNEAARHKLLDVVGDLTLVGVKLKAKIIANKPGHHSNTQFAKKLNK
LYKLFKRKNIPEFNIDQPPVYNINDIMRMLPHRPPFLLVDKIMEIDDKHIIGVKNVTINE
PFFVGHFPSEPVMPGVLQIEAMAQTGGIFVLENVEDPQNYSTYLIKLDKVKHKKKVVPGD
TLILKIDLLEPIRRGIVHMQGYGYCNGQMVVEAEMMAQVVKTKD
>EGEFANNL_00561 Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase
MNQKLLISLDPKAKIAENVTIEPFTTISGDVHIGEGTWIGSNVTIMDGARIGENCKIFPG
TVISAPPQDLKYKGEQTITEIGNNTTIRECVTINRGTLDKMKTSIGNNCLVMAYSHIAHD
CTVGDHCIFSNNTTLAGHITVGDFVVMAGMTAVHQFCSIGSHAFVTGGSLVRKDIPPYVK
AARDPLSYVGINSVGLRRRGFTSEKIAEIQSIYRVIFQKKLNISQALSVVEAEFEATPER
DEIIQFIQSSMRGVMKGFNAIKNMD
>EGEFANNL_00562 Elongation factor P
MASMGDIKKGLCINFNDDIFKIIEFLHVKPGKGPAFVRTKMKSLTSGKVIENTFSAGSKI
EEVKVITRKFQYLYDDDHGFHFMNNDDFSQIYIDKNLIENSQFMKAGEEVMIILKEEDET
PLSAELPASVIMEVIEAEPGVKGNTATNAQKNAVIETGARILVPLFIEAGERIKINTEDG
SYIERVK
>EGEFANNL_00563 UDP-3-O-acylglucosamine N-acyltransferase
MKFPKIFTLKEIASIIKAEFIGDENFPIYGTNEIHRVKKGEIVFVDHPKYYEKALNSNAT
TILINKKVDCPEGKSLLISDDPFRDFNAINGYFRDFSLKNQMIATDLDIGDNTIIQPGVF
IGNQVKIGKNCIIFPNVVIHDFTTIGDNVIIQSGSVIGGDAFYYKNRGYSFDRLKSVGNV
IINDNVEIGSNCTIDRGVTDSTIIGEGSKLDNLIQIGHDTVIGKKCLIASQVGIAGCCII
EDEVTIWGQVGVASSITIRSKAVILAQSGVSKNLEGNKTYFGYPADEAKSKLKELATLKK
LVK
>EGEFANNL_00564 Succinate--CoA ligase [ADP-forming] subunit alpha
MSVLINKNSKVIVQGFTGKEGTFHAEQMIEYGTNIVGGVTPGKGGSVHLDKPVFNTVKEA
VDKVQANTSIIFVPPAFASDSIMEAAEAGIKVIVCITEGIPIEDMVKVKNYLKSYDCTLI
GPNCPGVISAEESKVGIMPGFVFKKGRVGIVSKSGTLTYEAADQVVKSGYGVSTAIGIGG
DPIIGTTTKEAIELLINDEDTDCIVMIGEIGGQLEADAAHWYKSIGSPKPIIGFIAGQTA
PKGRTMGHAGAIVGGENDTAQAKMKIMSECGIVVVNSPADIGKTVANLLK
>EGEFANNL_00565 hypothetical protein
MKNYFSKVVFLLLLLFITRLHSQEQISIGIRGTVHTSNVSEIHVDSKALIGGSLGGSVKF
PLGYDNQFYINAELAYSMQGEKDGSIKYAQNYVNIPIYFRAYFSEADSEFFGEIGPQIGI
LVSQKNKELDEAYYGDKPQTLDLSIGAGMGYSFSRKFEIFARYNYGLTDVYKKYQGQQRT
SILGFGVTYYFNSY
>EGEFANNL_00566 Chaperone protein DnaJ
MKDLYSILNLTPSASSIEIRKSYRTLALKYHPDRNRDNVDYRKFFIEINEAYHILSNSEL
KKKYDLKYFTQKNKVVTPEIFLNKFIEIRKFLNSRNRNKISKKALYSALQKLLDNRNLHY
LHTNCSQNIKEQIIKEVLDCLKYLSSNDKLNIIKQLIILADSKSNLIDIIHSYIKSMNRN
INLMNVLINIKRQIDQFLNKS
>EGEFANNL_00567 hypothetical protein
MKHLLIVLITVIYSISINSINAQKIANQSPTVKRPALIYGPISKGKIKDLFFTKDGFKLP
KKISEINTIARYTSFESINGAGNIYTWDFTNGFQISSISEPEGKDVNEDKILLVSFNYGG
INAFELFDGITLHKSTLSEIQKNYSNRLIKFKTSELPTYKLKTNSVYATFYFNKDNVLTS
LSLSNYDLEI
>EGEFANNL_00568 Long-chain-fatty-acid--CoA ligase FadD15
MNFVHSILENQKLNSKKALNYKEDGVWKSYSWKEFHDLVLQTANALSKLGANPQDNIAIY
ADNMPQWVIMNFAILSLGATTVPIFATLPEDQVKHIVNDANVKFILVGNQKQYDTILKIQ
DKNELIKHIILAKDSIELKTNDSYHFNSIIKNESANFKVYNKNKDDTASIIYTSGTTGIS
KGVMLTHGNFHTICKSHQNFFEYDFSNENSLVFLPLSHIFEKGWSSFVLYSGGQLSFCEN
PKEIISYLKEVKPTAMCSVPRLFQKVYNTINEKIQSSSNLAQNFFKWSIGIGKQVSELKR
LKKSIPIDLRFKYFLAHQLAFKKVKNQLGGNLWFIPVGGASITSNITEFFDAIGLHLTVG
YGLTETSATVTLFPFQNYVYGTVGKPINGVDVKIGENDEILVKGNSVFKGYYKNDEETKK
VFTEDGWFKTGDAGKFDIDGNLIIIDRIKDLMKTSNGKYISPQPLENLLTNDNFIQQAVL
IGDNRSYVTALLVPDFENLEKYAKSSNIIYESKQDLINKKEIIDFYSNKIKSIQTNLASF
EQIKKFKILPKDFSIDTGEITPTLKVKRRVILEKYHSIIETMYGE
>EGEFANNL_00569 hypothetical protein
MKEITNSLIQWYVRKRVKQMQFFFENPIDVQKNVLSKLLKAAKDTEYGKKYKFNDIISYR
EFKDQVPLVYYEDFEPYITRSRKGEKNLIWPGSIEWYAKSSGTTNAKSKFIPITKSSLND
CHYKAGKDLFSIYAYNNPETKIFNCKNLRLGGTREDYEDFNSKYGDLSAVLIDNLPFWAE
WKSTPNKQVSLLKDWEIKMPAIINQVVNQNVGSLTGVPSWMMVLLRNILENNHIKYIDEI
WPNLECFFHGGISFTPYVEQYKNIFKKSINYYEIYNASEGYFAMQDTNSSKDMILMLDYG
IFYEFIPMDEFYSENPTIVCLEDIQLNINYALVISTNGGLWRYIIGDTVRFVSKKPYRIK
VTGRTKFYINAFGEELMVENAEQALKVAQDKTKAIISEYTAGPVFMDGKEKGAHEWVIEF
ECQPDSMEEFTRILDLELQKLNSDYEAKRYNNMTLNPPKVHSAKKNLFYEWMKLRGKLGG
QNKIPRLANDREYLNALLEMNNEL
>EGEFANNL_00570 Lipoprotein NlpE
MLKKIFILSLFSLTLLNCTKRNSETLVSKENSNSIDSIKVNNNESPIIDNSTPQNSLDYL
GIYEGIIPCADCEGIKVTVELKEGNQFIFTSDYLGEKDKSKPTVIEGNYTWNNNGTIITI
VQNSTKQSFKVQEDRLVWLDQEGNEITGDISAHYILKKQ
>EGEFANNL_00571 Ferrous-iron efflux pump FieF
MNSVAKENYSFQKSIVIIGVILFVIKLAAWFFTRSVAILTDALESTINVIAGLFSLYSLY
ISGKPKDRDHPYGHGKIEFISAGIEGGLITIAGIIIIYESVKNILYPNTISKLDYGIVLI
AVTGIGNYVLGELAIRKGKKNNSLALVSGGEHLKSDTYSTIGLVLGLIIIYFTHIYWLDS
IIALIFSGIIIFTGVKIIRKSLAGIMDEADQELIKKLVCTLEENRNPNWIDIHNVRFIKY
GSSLHLDCHLTMPWFFNIKETKRESDKLEKIIQDNFGNSFEMFVYVEGCEDFSCKICKKN
ECPYRKHFFEKEITWTVDNIEIDKHHTLKSSTHE
>EGEFANNL_00572 hypothetical protein
MKYLKIEKKIFSSLGRLGYIIIFLSILLFIMLVIDFLLHSFVDNYFTSKFLFTGEISLKD
WFHLMRISYSLPIFKFVLFGIIFLLLGIFRTNKLKNLLA
>EGEFANNL_00573 Multidrug resistance protein NorM
MTIKEHFKANSKLAIPVLITQLGQVSVNFIDIIIIAGLGEKAVASASLATSVFIVFLVFL
LGFSFSMSPLISSSVARGNNERVGRIFTHGFTMNVLLALISIAILEIGSPLLYYTKQDPS
VIPDAIRFLNISAYSLLPLMIFQSYRQFSEGISMTILVTIATIISNITNIILNFGLIYGK
WGLPNMGVEGSAMATLIARILMMLIIITVLHINKKSAFYLNMIQWKSLKAVYYRKLISIG
LPSSLQSLFEICSFAISAFIAGAGINKYLDTSAHSVTTNLASMTFQICMGFGIAATVRVA
GFYGLKNRIDLRKAGLTNLYLVIAFMTFAGIIFVTFRNYIPLIYFKKEQVEVIKLASHLI
IIAAIFQIFDGIQVVMLGALRGMRDVKIPTIICFIAYIIIAIPIGYYLCIEKEMGAFGMW
IGLCLGLIFASILLLLRFNTLTRKNSDF
>EGEFANNL_00574 Deoxyadenosine/deoxycytidine kinase
MHIAITGNIGAGKTTLTKLMANHYKWLAHFEDTEDNPYLDDFYYNMAQWSFNLQIYFLSS
RFKQIQEIRKSKNNFVQDRTIYEDAYIFASNLYEMNLMQTRDYNNYLTLFNLMKEYVQAP
DLLIYLRASVPTLVNQIKKRGRECESSISLDYLNRLNDKYEKWIGGYKEGELLIVDVDSI
DFVDQSKDFEHIIHLVDTKIRI
>EGEFANNL_00575 Chromosome partition protein Smc
MATNKKADTTTVEDKLRALYDLQIIDSRLDELKNLRGELPIEVEDLENEIVGLEKRIEKI
EDEVVNLSNDIKVKNELNKNSESQIKKYKTQQENVRNNREFEALAKEIEYQELEIQLQNK
KIKEINAKIDFKKNQIEEQQSKLASLNNHLNHKKSELSNLIKETENEENFLLEKSKELST
KIDERLLNSYHKIRKSSKNGLAITSIDRGAVVGSFFTVPPQKQVEIASRKKIILDEHSGK
ILVDEYLAKEELEKMKEFLGK
>EGEFANNL_00576 hypothetical protein
MKLVTLSKVVLASTLVLSLQSCDTQTISVNNKGVGVNAIKQLLTSTTNKSFSILENSESF
LTNSLIDAAMPSQLKQINSTLENLGLNSLVEKEKKYIADAASTSVTVAKPIIASAIQDIT
LTDAISIVKGGKGAGVEYLKNKTQDKLIAAIQPKVEQQLNANGVTSLIENATGNNSKIQN
TLNLIIGNKNTSSAQSLKNSISKYASEQIVNGMFDIAKDYEVSQSNISSKIINSVLNGN
>EGEFANNL_00577 UvrABC system protein C
MSIELQLKTLPNQPGVYQFFDDKKVVIYVGKAKNLKKRVTSYFFKEHTGKTKVLVSKIRN
IKTTIVDTEYDALLLENNLIKEFQPRYNIRLKDDKTYPWICIKNEPFPRVFLTRKLIHDG
SEYYGPYTSVIIARALLELVKSIYPLRSCSLDLKKEKILLNKFSVCLEFHIHNCLGPCED
KQSSEDYLENIQGVKNIIKGNISEPLALLKKKMFTYSKKMEFEQAQKIKDKLDLLEKYQA
KSTIISPSISDVDVFGFTSDESAAYINYFKIIKGRIIQSYTTEIRKLLDETQEELLEKAI
IDIRKKFQSISKEIFVPFKIDIEIPSVNFYIPKIGDKKKILDLSEKNAKEYRLEKMKQIK
IMDPERHSNRIMSEMKQLLHLPKEPRLIEGFDNSNIQGTNPVSACVVFRNGKPSKGEYRI
FNVKTVEGPNDFATMEEVIYRRYKRQLEEDNELPQLILIDGGKGQLSSAYKSLELLGLAG
KIPIIGIAKRLEEIYFPHDSVPLYLDKTSETLKVLQQVRDEAHRYGITRHRNKRSKKTFT
SELENINGIGEKSIQLLLNTFKSVQKIKEAPLEEIESIIGNKRALIIMDYFKKES
>EGEFANNL_00578 putative transport protein HsrA
MEEEIKVSKWLPWVAAIAFFMQSLDGTILNTALPSIAHDLNKSPLKMQPIIIAYVLTLAL
LIPVSGWLSDKFGSRNIFTFAVGIFTLGSLACVFCTSLEALVYMRILQAIGGSMMVPVSR
LALLYTYPKDKLLKVINFITIPGLIGPVIGPTLGGWLVHVASWHWIFLINIPIGVAGMIL
AWKFIPNYKRTEGKFDFIGFLLLSLGLVLISLSLEFAGNRIISLNTVFLVLFVGIILIVL
YIVYSQKVSKPLINLKLFKIRTLRIGIIGNIITRLGVGGIPLMLPLLLQVGFGKNSVISG
AMLIFSAIATILAKSSAIPLIKHFGYKKLLIYNTIILGVAITLFMFPNENTPLVWLIPIL
IAYGAFNSIQMSAMNSISLADLTPKDASGGNTMFSVTQQLSMSFGISLSAMLFNSYEIFE
NNHVITAFKLTFLTLGIITILSAFTFAFLKNDDGTSMSGN
>EGEFANNL_00579 hypothetical protein
MKSILCYTFILISLIGNSQGTKNYFKSGAKVDPSLVNEEVGDRAKKVNHIFHFRNDNKSH
FIKIMNLEGKTYAQSISEFVILDFNSKKGGDLHRKVEKLANITIDGNNFISDQLKASYIL
LKEKGTNYENINEIPIKLMVCSKDKFGNTNCRINDDEVEITPEEFPGKYPQTGFTRLGDE
DLRNKKPKELEIMRNEIYARYGYRFSEPSVADYFFSQNWYEPLVDNKLVELNDLELDNVA
MIDLYRGKVAYHDLNLKSYSQVLPLETSSNSTYGENILKSMKYMKQDTLGGSKCVYTEYN
KKGIATFQQDCMINKDKFVNYFNKDLLVEHVDGANDTYFYYDFNGLPLKTVKLDYTAGTT
EETFFTYDSNQNITQKDIYQNNNFNESIYYDYDYDGNLVKEYYKDKEGNEEMVTEYFFEN
RDNLNTGYLKNKETGCNYEYNDTQDLLLSKNCFKIVKDKEYPFYRLNRDVKEVVRGKNSR
LSSVKLVEEENYKYYISILEYQYY
>EGEFANNL_00580 Putative agmatine deiminase
MDKTKYIKNKTSDINNYTPKELEYFFPAEFYPHKATWLSWPHRESSWPGKIDKIYQPYSK
FIAEVSKGELVNINVVNLEMKDFALKYLKQTDANFEHINFYIHPTNDAWCRDHGPAFLIN
PLAKDYKKVIVNWEFNAWGGKYPPFDLDNRIPLLIANELKLPVFNPKIIMEGGSVDFNGK
GTVITSKSCLLNKNRNPNLSQEQIENYLMNFYGVQQVLWVNDGIVGDDTDGHIDDTVRFV
NEDTVITVTETDPNDENYEILQTNLEQLKNMKLIGGKHLNVIELPMPKPVIYDGIRLPAS
YANFYIANEVVIVPIFNCVNDEIALNIIQKCFKDRKVIGIDSTDIVWGLGSFHCLSQQEP
AI
>EGEFANNL_00581 hypothetical protein
MITAIKKHKKQIILFFIAGFISAIIEISLMKILSLPQMLPSLFSFENKAHAYPLSNIIST
AGGIMSNYFFSIRYVFERGKHSKRKEFALFLLLSIITMLMSWGVFAFFHSFIHEPISIFH
IITVGDIVVCKAAAILLVSVINYVAKKKIVFSN
>EGEFANNL_00582 Murein tetrapeptide carboxypeptidase
MHSLKKNDKILIVAPAGAVTKEHIQPAIKIIEDHGWNYEIGKNTFNSYSFGYNYSGTPKE
RLNDLQWALDHPEAKAIWFARGGYGAVQIVDLLNLNKFIKHSKWLIGYSDNTVFHQHFNR
RGFPTLHATVCKPLADGHSDETFTSLINALQKNKLNYSFNVHPLNKGNSLEGTVTGGNLS
ILYSLIGSNSLDFFDDKILFIEDWYENFYHIDRMLIGLKRAGVLNKVKGFLIGGFTRMDS
KEDNINYNNPFDNEAYLVIDERLKSFDVPKIYEFPAGHIHDCRAIIMNGKISIKIENNKI
LFSNSIS
>EGEFANNL_00583 hypothetical protein
MGIMKKKLLIALAILLAIQLFRIDKTNKPINKKLDYVSLTHAPKNIEKILEKSCYNCHSN
QTIYPWYANVAPISWLVKSHINEGKKFINFSEYGLYNVYQKDHINKGLYEVIKNGRMPLS
SYLLLHQEDNLSNEQRQELLNWFSIILNKKNSIK
>EGEFANNL_00584 hypothetical protein
MQRFVYIFCLTYLFTSCARMSMPEGGPKDINPPKFLGSNPKMFATNVDVNTKDLTLDFDE
YMLVKDVDKQVVVSPPPQTSLVITPTSSAQKKLTVRFSEPLEKNTTYTINFGSSIQDNNE
GNQLKNFSYIFSTGDYIDSLELSGKVQKSLNKDWDPSTVIGLYKVVKDSLGNDSINLKNK
PYYITKIDSAGNFSLKNLHEGNYRLFAFTDLSSNLILDTKNEAAGFYPDIINPQLSSAYS
ITLSPIKQLYKAEKISQEAQGILKVNFKGNPKEVTIQPLDSNFPSYDIDHKPFSDSLYLY
FNNKKFIDKEKKFKLEFLVESSNNKDTLSLVYDNSKESPLKLAQSHKEVTPTQSLTLESN
NYIKTIDTNLIKVFKDSDTLDFLAVIDSTDTKKINLNFPVSYDSNYKIEINKNAIEDFLG
HKNEDSIVYSLKTKKQNELGNLNIEIQNKPTSNFFFQLLDDKGKIIENIYGNNDSFNFKN
LIPGTYSIRILVDENNNGFWDLLDLENLIPAEKTYLYPKAIEVRPYWDLNETWVL
>EGEFANNL_00585 hypothetical protein
MEEKIEKILSSNEERNFLLSLLRVGRKDFENSIEFIDFLTETIKNNPIIKEKFNERLKPI
FRGIRMQRFITDFGIFSDDKIIPLLFRELGNKILPQISDDQTLLSLTNEVLYSRENHNFV
KLIPVDRWANFYEALFNNDNLICNREYVKKQIREGALILIDRIVGGAADTEIFKMGTIKS
IEENPFQKLDRNLIKILQDHDIIDIEKVEGIIRQIQVCSVYLDSIIDQKEVKGISLKITI
KITLLKQQLERIKILVNALHLLDDSTISCAMANITKNWLGFYSTKSKVSNTFQSTLYVVA
SLITWHNKQTGEKYITSTTKEYMKMLYSAMGGGLLVAILCFIKTQMGMGIHTPFFQALLY
SLNYAWGFTAIYLMHWSLATKQPAMTAAALAHALSQDEKSDSDYKEFGIIFSRLFRSQFI
AFIGNVLAVFVVAIILFYALSFFTNLELINNHKANDAINELVNLDPKIFWFAAIAGLFLF
LSGLVTGITDNYTRYNNIPERLYNHPLLKRFVKETKRRKWSNWYKNNIGGISGNVIFGFC
LGSSFLIGNFLGIPFDIRHITFSAGNYAIALAHFNFEITWQYFILGCIGIFGIGALNFLV
SFSLSLWLAMKSVNVPTREIGKILYSALKLFLKNPVQFFIPIRSKKNN
>EGEFANNL_00586 Proline/betaine transporter
MLANLLLNLKFMQDIKSNSVRKLSTQDYKILGLSALGGALEFYDFIIYVFFSKAIETLFF
PSDIPQWLSQVQTFGIFAAGYLARPFGGIIMAHFGDRLGRKKMFAFSILLMSLPTLFIGL
LPTYQNIGIFAPLLLLFMRICQGAAVGGEIPGAWVFVSEHVPEKRIGLACGILTGGLVTG
ILLGSIIATLINRNYSETQILTIGWRLAFIIGGVFGLISMFLRRWLKETPIFSEMEKRKK
LDKDIPVKIVVSKHKHSVIICMLLTWVLSAGIMVVILLAPSYLHNIYNYSILKSQEANSV
AILMNGIGCLFFGMLSDKIGFSKTLIIGCILCILTTIFFYTSLETHPEILFITYGLAGFG
VGIVGSFAHYMVKSFPANIRYSGVSFSFNMAYAIAGGLTPLLLSLLTNLVSHKAPAYYVI
LLFTMGLLLGFYLLRTKTRDESFAKN
>EGEFANNL_00587 Ribulose-phosphate 3-epimerase
MILLAPSILSADFGNLNKDIEMINQSEADWFHVDIMDGVFVPNISFGFPILEALNKKATK
FKDVHLMIAHADEYIQTFKKLGADSLTVHYEACLHLNRTIQAIKSEGLKAGVALNPHSNI
HLLDDIIEELDLVLIMSVNPGFGGQKFIENTYKKIANTKDLIIQKNSSARIQVDGGVNTN
NIKKLADTGADVLVAGSAIFNSENPLETIKSFKSLAV
>EGEFANNL_00588 Diacylglycerol kinase
MINQNKIIYFIVNPISGGGKGKLIVELIKSKFSDYYPHIHVTKQKGDAHAFTKLAIENNA
SCVVSCGGDGTLNEVASALVGSYIPLAIVPIGSGNGLARHLKIPLSYTKALDLILNSKKI
IETIDVGKVNENYFFSNAGIGFDAETIRSYSNQKTRKLMGYLKSMVLNIRTFKPVNATIK
PPYQQHSGEIMLLNISNSNCMGYNFSICPKASLKDGWLDVNIVKKSNWLAFLWIGIGYLL
HLDLGKNRIQLKVKELELNTSSNVMQIDGEYLSLNSSLLKINIIPKALKILVG
>EGEFANNL_00589 Succinate-semialdehyde dehydrogenase [NADP(+)] 1
MKTSSIKTVNPATGKIEKEFQEMSEEQINQILDMAVYAFQQWKITSFEDRTEIIHTTASL
MREKKEELAKLCAKEMGKILEEGIAEVKLCANILDYYADKSKEFLADKPIDTPQGKAFIS
YEPIGVILSVQPWNFPFYQLVRSSAPNIMAGNTMVMKHASNVPQCAEMMEKLFLDAGLPK
GVYTNLFIPGSKVSNLAADNRIKGVALTGSEPAGASLASVAGKNIKKSTLELGGSDPFIV
LEDADIDSAVEVAAYGRLWNAGQVCVSPKRIIVMESFADQFIQKSKEIYERVTVGDPLDP
NTNLAPLSSQKALEEVISQVEKTVSQGAKLVFGGKKIKGEGTYMEPTILTGIKKGMLAYS
DEIFGPVLCIYAVKNEAEAIELANDTEFGLGATIFSKDINQAVEVARKIDTGMVFINELT
GTSPELPFGGTKQSGYGKELSVLGIYEFVNEKLIRIAK
>EGEFANNL_00590 hypothetical protein
MINKDFNSIIDLINAFPNEQTCIDHLEQLRWNVNVVSSFDSTSKVYKCKDNKYRCKNTDK
YFNVKTNTLFDNTKIELCKWFLAIYIATSHKKGISSI
>EGEFANNL_00591 hypothetical protein
MLQRIRNCFCISNNEKFDNEVEIDETFVGGKNKNRHTSKKVENSQGRSYKDKTPVLGVLE
RKGNLIAKVVEDTKAETLTPEVIKAVKDTVSVIIDELLGYKSLKRFYDHAFVEHKEGEYV
NGRIYTNTIEGFWSLLKRGIIDIYHFTTRKHLQKYVDEFVFIYNSHDDSTRNRFNTLLHN
LENRITYKELIYG
>EGEFANNL_00592 hypothetical protein
MDNEIKKVIHEGKIVLGSFAIPCYVLEDGTRVLSSNAMQNALKLQDESENSSGTRLARYM
NQTSLKPFIYKNKLPGHYNPIICYQGNKKINGYEATVLADICDAFLEARKTINLSSRQRI
IADQCEILIRGFARVGIIALIDEATGYQYDRERLELQKILNAYISDEILKWQLTFTDEFY
KEIYRLWGLPFIPKYIKNKPSFIGKLTTKYIYDQLPRGVVDKIKEKSEKTEKGNWKYKWH
QSLTPDIGREHLKKQIIEVSTLMSISQTKEQFDALFQQKYNTSPVQLQLEFNEDIEANKK
LSKHNKS
>EGEFANNL_00593 putative transporter
MEIKNQPKLTNSILWLMTISTGLVVANNYYNQPLLGLMAKDFNVKESQISTITMCTQIGY
AFGLFFFIPLGDRFKRKKLILIDFIFVIMSLLAMAVSKSVVLLFPISFVIGFTSVIPQLF
VPMAASLAKPEERPKVVGIVMGGLLVGILGSRVLSGYVGDVWGWRTMYYIAAIIMIILFV
LIYFKLPEVYPKFKGTYKQLMKSLFELFKKDPDLRMASLRGALAFGSLSAFWTPLVFHLE
KNFQLSNGAASNISGKFGLVGACGAIVAVFIGKVIPKYNKNTLLTLFSALTLLSWFIFYW
GGFSYLGLIVGVILVDIGVQATHITNQSIIFSSNPEASNRVNTIYMTSYFIGGSIGTALA
ANAFQYYNWFGVVFTGGFIALLLMIFHFYNIKSQK
>EGEFANNL_00594 hypothetical protein
MENNFDKEFRDFIYNLDDIVDSFVKKLNQLSFSIDFTKTSINTLENYLLDKHVTIKDDDF
YDASCYLGELFKKNYGGDWEIDKNENSKYYKKPVIKNFDPVGMIFSPFSILKETLATREK
GALMKILKSSLDDENETEKLNADTKTDKDNYRNRSFIDDLDTNNSIEEEKQSVKKKEEYQ
AEVNPNQPYKIFKGKAFTKEEWLKFEEEEYQRFSMKNHQHKTNEKPPQSGGGFFLDERES
DW
>EGEFANNL_00595 Epoxyqueuosine reductase
MNKEQLTQFIKQKSQELSFLDCGISKSGFLEEEAPRLEKWLKEGNQGKMSYLENHFDKRL
NPSLLVDGAKSVISFSYNYYPSETQKSDTYKIAKYAYGEDYHIVIREKLEFLIHLIKEKV
GDFSYRVFTDSAPVMERAWAKKSGLGWIGKNSLLLSKQKGSFFFLAEIICDLELEYDSPF
KTNHCGSCTRCIDACPTQAIISEKVIDSRKCISYLTIELKDEIGEEFKGKMKDWIFGCDI
CQDVCPWNRFSKPNTESRFQPSSDLLDFTYKDWEDLEEETFRKIFKHSAIKRAKYSGLKG
NINFIKKK
>EGEFANNL_00596 hypothetical protein
MELLKILNILSFKIKNYKFISGGDINQTYYLDTDQGKMFLKYNLKSHYPNLFQCEYNGLK
VIEESQTFKIPTIIECSEEDHLQFLILKWIEKGTPQEKTWEIFGSNLAKMHSIPQPYYGF
TEDNYLGTLVQKKPQCISWKDLYSNFRILPLAEKLFNDKKFNSKDLLSTEKFCNSINEIF
PTENPSLLHGDLWSGNFIISNTQEIYFIDPAVYYGHREMDLGMSKLFGGFSPLFYESYNE
VFPLENGWKARLPYTQLYPLMFHAYEFGGFYIDEVKNILKNFY
>EGEFANNL_00597 Penicillin-binding protein 4*
MIISKYTGFILLIFIVFCNTLISCNKSEKINKNSNHSLQNPPIPSYSGINFQSIFTESDN
YSADDNRIKVILNKYYKDVWETAKLSGGILVARGNNILLEKYSGYSNYDLKTSITATTPM
HVASISKILTSLVILKLVEVGEINLNQKVNTILKNFPYSELTIQDLLTHRSGLPNYAYLT
DKNTDRTTLLSNQDILNLFSNTQPELLFKRDTQFLYSNTNFVLLALIAEKITNTSFPSLV
NYMIFKPLGMDHSYILQEKYVPYSTLSYYANGKPYNFEYLDLIYGDKNLYTTPDDLFRLS
KAMFAPNFLPKNLLEKMFTPYSNEKKGIKNYGLGMRLMVFENGKKIVYHTGWWHGSNAIF
IHLLDEKVTIIAIGNKYSRAIYSAINLTALFGDYPLNMEDLH
>EGEFANNL_00598 Cystathionine gamma-lyase
MKLQTKLVHISKPDELTGAISTPIYQTSSYIQESPDVHKGFAYSRTANPTRKVVEQAIAE
LEGGVSGFAFSSGLAATDCVLKLLNQGDEVVAGNDIYGGTYRILSTVYNRFGITSKFIDT
TDVKNVANAISDKTKVIWIETPTNPTLKVSDIKEIAKIAKSIGAWLIVDNTFLSPALQRP
IELGADIVVHSGTKYLSGHGDVLSGFVVVKSEEVAEQLKYIQNTSGAVLSPFDSWLTLRG
IQTLALRLQKHSSNAQKIAEYLLTNPKIDKVYYPGLKNHKNHEIALKQQDAFGGMVSFSL
KEDTLEAATRFLTKTKIFILAENLGDVRSLASHPATMTHKSTPSQIRRETGIQDSLIRLS
VGIEDPEDLIKDIEQALC
>EGEFANNL_00599 Homoserine dehydrogenase
MKRNRLKLGIFGFGCVGTGLYKVLEETGSVEANIKKICIKHANKSRPIDAKYFTTQKDDL
LNDPEINVIVELIDDAEAAFEIVSEAMRKGKDVVSANKKMIAEHLPELLELEKKYQVSFL
YEASVCASIPIIRNLEEYYDNDLLTSVSGIFNGSTNYILTQMIDDNIPYPEALKEAQNKG
FAETDPTLDVEGIDPKYKLCIILFHAFGLSTKPENIFNFGISRINDFDLNFATQRNYAIK
LIASCKKNGNEISGLVAPSFIENKDPLAYVKYEYNGVVLESAFSENQLMIGKGAGDKPTG
SAVLSDISALTYGYRYENKKYLHVDPSLKLESTGKYRVYVRYYDDFDSFDDFLSIEEKFI
SPQGNYFIGIITLDKIINSKWIKDNKINVIFCNQNIE
>EGEFANNL_00600 Valine--tRNA ligase
MSEIESKYSPNQIESKWYQFWMDHKFFHSEPNDKKPYTIVIPPPNVTGVLHMGHMLNNTI
QDVLIRRARMLGFNACWVPGTDHASIATEAKVVDKLKEEGINKHEIGREKFLEHAWEWTH
KHGGIILEQLKKLGCSCDWDRTKFTLDEDLNTSVIKSFVDLYRRGYIYKGNKMINWDPEA
QTNISDEEVIYKEQNGKLFYLKYKVVGEDRFITVATTRPETIFGDSALCINPNDERYTFL
KGKKVVVPIVNREVPVIEDAYVDIEFGTGALKVTPAHDVNDYQLGLKHNLEVIDIFEKNA
TLNDKGLHYQGKDRFIVRKEVVKELKEKNLLEKEEDHLNKVGTSERTGAVIEPRLSIQWF
MKMGDFSKSALDVVLKDELKLYPEKFKTTYKNWLEHVHDWNISRQLWWGHRIPAFYYGTD
EDDFVVAETLEEALILAQQKNPNIKAENLTQEDDVLDTWFSSWLWPISVFNGINEPQNKE
INYYYPTQDLVTGPDIIFFWVARMVMAGYAFRNEKPFSNVYFTGIVRDKQRRKMSKQLGN
SPDPIDLIKQYGADGVRVGVLLSSSAGNDLMFDEDLCLQGRNFANKIWNSYRLVKSWEIA
SDKVLPIENKEAIVWLKNKISKTIDQTNLDYKKYKISEALMSLYKLVWDDYCSWYLEIIK
PPFGEKIDKESYNETLSILEDLLKLLHPYMPFITEEIWQNMKNRDINESLIISTYPENIP
YDDNLIAKFEKSKEIVTAVRNFRSGKGISPKEAFELYIGSEESIDNLESVKKLANLSTIY
CNKNTDLPAYKFLIDKTEFSIPFAETINIEDEKKKLQEEINYYQGFLKGVMAKLSNEKFM
NGAPEKVIEIERKKQADALQKIEILNKQLLSL
>EGEFANNL_00601 Putative glycosyltransferase EpsH
MKLLVIIPVYNEAEFLLSCLESFENQTYDKITWVIVNDASTDKSPEIIQNFIKDKPNFQY
LSLNHRSEHSPGAKVVRTFYSGLNTVDYSQYDAIAKLDADIILPPDYYKIMINTLKANSR
VGMVGGLVYTKQNGVWAHEGVANKNHIRGAIKTYRRQCFEDIGGLRETLGWDNLDVLLSH
MKGWEVRVIKDIWVKLLKPTAHVYKDTKAEKLGKYYYNIGLDYGLAFISSAKAAWIDKSV
KNFFISYRTYVKMSVKKTKREITPEEIKFIRKFRWYETLQKIGL
>EGEFANNL_00602 hypothetical protein
MKNVAILEFETHSHLLYLWDRILQDQNSYQYHFFVSKNINKQLRDITSTKITVIEHFIDL
NNKLFSYDLVIINTLHRNFEKYALIFENYKTLLLVHNSNFYFKSANYKFIYLFKNFNVQL
NYYYLKLIYKEKIYKNRSIINRAGGFGVLSEEILNYNSNQYKNKYYVPLFYNKSVEISPN
QSQIKIVIPGNISQRRRDYDLIFKILPELAPKANLCFVFLGKPENIKMQKKLENFSKSKF
SNRIQIKYYSQWISQKEFDAEMFSSHYLLCPLHKETSFYLQKEIYGKTKISGNETDCIYY
GKIGIFPEFYKMKNWDNLYYKNQQDLINILENITFEKYIEDTKGLLKNAKLFSQSNASKH
MINVFDKLINV
>EGEFANNL_00603 2-O-methyltransferase NoeI
MTKFREKLIEFTYKYLPYLYKKRFFKKLNHLTKINIEERNVEYEFLYLSEYLKPNNVFFD
VGSNVGSYLYYVEKIIGSNHIYGFEPNPYLFKRTKHLFPSVHLEHLALCNTQGTLTFKVP
SINNEEISTRGTLKTEYVEDNETSFKLLGVPADTLDNYVNNNHIKKIDFLKIDVEGAEMD
VIAGGINAIQKFKPILIVEVEERHHNQESVWKVIQPILKLGYDPYFWDKNSFQLKNFTSM
VDTNQKNSDIQNKKQYLNNFIFLPKN
>EGEFANNL_00604 hypothetical protein
MGIVARQGIKYSIVSYLSFLLGTFSTIVIYPADTEFLGKIRFIQPSAEIIFPFMVFGLSY
ANIKYHQKFKAKNQQIDFLLFSIKFIFLSFIILSLIFWLLATYYSGISSSDFWKMKQYIL
PAALFLAITQLFSKYVSNFKRVAITGIFENFFPKLGSLVGFVFCVYIGFSSSASLSIFVF
FFAIAMLGMVLYFFKLNKDKRSNRLDILKDKPFRTEVFYFCFFSVLGSLGNQLALRIDNL
MISELIDYKQNGIYSILMSIIGFLTIPLAGIFAISGPIIVEKIENHKFEELGIFYKNISK
YLFLFGTVLLTCILSGMEYLFLLMKNGKDLLDAKAIIYILGVSTLFDLATGFNSHIITYS
KYYRFNIYTMLFLAGLTICTNWIFIKHLNLGIEGVAIATAISLTIYNIVKLWFNYAKFKI
HPFTIQYLYILIVGIIAYGIALIIPESTINFINLITKPLTVLITFSLSNLLFKFVPLDKI
CNKNWKTFLTGVNKK
>EGEFANNL_00605 hypothetical protein
MNIYKKYLSISFILIYSCFTYSQERLLKGKVYFFDTSSEESVADIYVKNINTGYTTITDL
TGNFVIPAQAEDKIQFTSYHTEERIVTVTPTMYEEKKMRIQLDISTGTVLESVTVVVLKS
YGSLELDVKRIPMKNKTNELMNKLGELMPTQKMDGSTDLDSQLARLAPMKFSIDNMLGAL
SGETKKKEKLYIYEDRMNVLQDIRDYLGDQYFIDQGLNKDQINEFLLFTYLNYNLRYFYD
HQNYYVILSIFNKSIENYKSKKNESK
>EGEFANNL_00606 Cysteine desulfurase SufS
MSIDTKHIQTQFPILGEKVNNHTIVYLDNAATTQKPNIVLDAEINYYRTINSNVHRGIHT
LSQLATMEMEESRKVVQSFINAKKDYEIIFTKGTTEGINLVASGLERLLKAGDEIIISQL
EHHSNIVPWQLLANRKDLILKIIPVDEHGDLILEDYKNLLTEKTKLVAVNHVSNALGVVN
PIESIIQLAHQAGAYVLIDGAQSIPHLKVDVQELDADFYVFSAHKMYGPTGVGILYGKEH
LLEVMDPYQGGGEMIKEVTFEKTTFAELPFKFEAGTPNIAGNIVLRKSIEFIQSLGLKNI
QHHEDELLKYATQKLEEIENLTIYSKNAKQRAGLISFNLDIANTNSSDVGFILDKHGIAV
RTGHHCAQPIMKRFEIPGTIRASFAVYNTLEDIDLLVNGIQEAKKMLL
>EGEFANNL_00607 hypothetical protein
MTIENPTPKNIHQGRNIKRFREMLGIKQEALAWELGEDWNQKKISLLEQKEQVEDKVLEK
IAEILKVPSEAIKNFDDELAINVISNTINNNDNATMTNPAVLNYQPSFNPVDKMVELYER
MLQQQKEMIEKLEKLIERK
>EGEFANNL_00608 hypothetical protein
MIRVFKDSKFKISENFSLHFINIETYSSDLINLIKSEIVKVWDGDLSEYELSLVKNQIKR
FFKEKTENQNYGFVAEFICHLYLRYIGFQQYSVLKNLEEIKAPKKGFDGLYEKDGIVWLI
ESKSASPNRKTFVTHKNKVAEAYRDLKDKLEKNTSDENKNNPWENAKSHFLYTQKKDDSI
FKHINRLSISYEKQDIMKIDDFNVIPCSTIYLDKDYCEINNVELEKSLKSLLNRYKAKNM
SVLCINKKDIKCFINFIYE
>EGEFANNL_00609 hypothetical protein
MSKDLNAISNLYNDLNFRNIFKKLCLEEILTSDEKEFILASSLLLFDFYNRDNRSKAYFR
LGYYILLKYGNIYKDYKPLYEISLQLGLYPLVDYVIKKKDTQLYEIDTSNRILDVFSYTS
YKKNFRSPEKYIETFEQKQSREKLIESTSNQLAFIAPTSYGKSSIIKQFIIKKNFQRIVI
IVPTKSLLAQTYKDISSSIKGYKLILHEEMFNQEQNFIGVLTQERAIRLLVKNPELFFEI
LFIDEAHKLLDRNSRSFLLSRVMQLNYKRNNNQKIVYLSPLIEDVSSLKTKKSNIGNVFS
QKIELDLKSFEVFLFDNNKSFFFDKYLNKEYNIDTNIEYFEYINKYSLSKNFIFNSRPKK
VEEFALELINNIKKIKEDCNIQRIINTLSKEVHKSFYMINCIQKGVIYIHAKIPNIIKEY
LEYCYKKYPSINYVVANTVILEGINLPIETIFITSNGSGNKNEKLKIKDLVNLVGRANRL
NYVFSSEKKDLESLISKIHFLNHSYYQGNNDIRTSIKNLREYSFKDLIFNPLLENYNIED
IKFNGKKDTLIEIKEKHKIEDSKINDYTDFMLAVPNTALDKIKKYFIENSLYKFFSDLDS
LINQIEINIKNYSFKEDDILLDILYKIFFYNTEDYICDFELERLKNKSARKFYNYFLLVT
QKQHLNERINSTVKYLERKSITDDPYLYIGSSYGEIPRLTEKYNNNHFNYNVYIDLRKKP
KEELVNLAIVKLKIEEDFVNYKLISLIVFLRDFKIIPEKYYFNYIYGTTDEKVISLVRFG
INISIINKLKNDDKLFYLDFDIYGNLKIKDKDKFNQYLKKQPELFKFEINKYIN
>EGEFANNL_00610 Carbonic anhydrase
MRRLIISLGVTFLLFSCKNNLEDPLTIVTNDEIISNKIITKEDQEKLTPDQVIQDLKEGN
KDFVDDKLTIRNNSERVREASLGQYPEAVVLSCLDSRVPVEDVFHKGIGDIFVTRVAGNI
VNDDILGSLEYACKVSGSKVVLVLGHEHCGAIKSSIKGVELGHITHLLDKIKPAVLEAKE
TFKGEQSAKNPEFVDAVCKYNVELSIKEIRERSPILRDMEEKGEIKIIGGIYDMKEGKVE
FL
>EGEFANNL_00611 putative HTH-type transcriptional regulator YybR
MYYIENKKYPCSTSLTMSYIGGKWKSVILIHLKEKKRYNELRKNIPVITERTLSLQLKEL
EADGLVLRTVHTQKPPLKVDYELTDFGKTLIPLLEAISEWGKMAAKYNQKI
>EGEFANNL_00612 Oxygen-insensitive NAD(P)H nitroreductase
MNFLELARNRYTTKQYDTTKKVSDEDIEKLKEILQLGPSSINSQPWKFTIVSNEELKKKF
AKSSFINESRVNQASHLVIFSCIDNLSVFEESMKDYLDEGSINYYNQMIKTKPETTIKEW
LHNQVYISLGYFLSACAAMGIDSTPMEGIVKEEYDELLKIKDYTTMFAVAIGYRDPEDKN
QPNITPKSRKDQEQIIEFR
>EGEFANNL_00613 hypothetical protein
MKSKEKNLRNIKVKKVYDIGFERMRHSCVYYPEIRLAGKWLQDFGFKAGDILTLECNKNQ
IVIKKV
>EGEFANNL_00614 hypothetical protein
MNVEATQPKNVHQGRNIKRFREMLGIKQEALAFELGEDWNQKKISLLEQKEEIEPTLLQQ
ISGVLKIPVEAFQSFDEEKAINIIANTFHDSAVANTFSDSAQVNFKCTFNPFDKVMELFE
RLLESEKEKTKLMKDILDKMG
>EGEFANNL_00615 hypothetical protein
MLDMDNDLKFELWYLFQIFCCMENLDKFIHRFHSALLNLITSIKIHM
>EGEFANNL_00616 putative HTH-type transcriptional regulator YgaV
MSTEKKYTQEQEQLARFAKAMGHPVRIAILQLLASQSCCYHGDLSEVLPIAKSTLSQHLK
ELKEAGLIQGEINPPSIRYCVDRKNIERLKTLFDQLFTEIGKQNESC
>EGEFANNL_00617 Arsenical resistance operon trans-acting repressor ArsD
MKTIEIFDPSLCCSTGVCGPSVDTDLMRIASSLDKLKKQGATILRHNLNTDPQAYIDHPL
VNEQLTKFGVDILPITVVDGDIVLTKKYPTDAQLENWTGLTI
>EGEFANNL_00618 Arsenical pump-driving ATPase
MLEMQNYDLTKINFTTYLFFTGKGGVGKTSLACATAVGLADQGKKVLLISTDPASNLQDV
FNQELNIHGKNIEEVPGLTVANLDPELAAAEYKESVVAAYRGKLPATVIQNMEEQLSGSC
TVEIAAFNEFCTFLTDDAKQDEFDHIIFDTAPTGHTLRMLQLPSAWNTFINDSTHGASCL
GQLSGLQEKKNIYKQAVEILSDIRLTQLILVTRPEESPLKEASRSSQELKLLGLKNQVLV
VNGLLDKANITDEISQFMFHRQQLALENLPNNLKNIESYKVSLRSYHLSNINSIRKMLHE
EISTKLEAFENISFSKNKLEDLINDLYLTHKRVIFTMGKGGVGKTTLATQIAQGLAKKGL
KVHLTTTDPANHLNSDLINSSFLTLSHIDEKKALNEYKKEVLDKARETLSDEDIAYIEED
LRSPCTQEIAVFKAFAQIVEKADDEIVVIDTAPTGHTLLLLDASESYHKEVERSRGDIPN
SVKNLLPRLRDSNVTEVVIVTLPEATPVLEAERLQKDLKRANIFNKWWIVNSCLSLTNTN
NPFLMSKAHSEIDWIAKVDKLSHGNVALVPWMDH
>EGEFANNL_00619 hypothetical protein
MNVEVTQPKKVHQGRNIKRFREMLGIKQEALALELGEEWNQKKISLLEQKEEIEPTLLQQ
ISGVLKIPVEAFQNFDDEKAVNVIANTYSFQDFKDNAVASGFSYQPTFNPVDKVMELFER
LLESEKEKTKLMKDILDKMG
>EGEFANNL_00620 6,7-dimethyl-8-ribityllumazine synthase
MNIAIVKALWNQDINDLLENSCEQELLKQGAKISKYTVSGAVELPVLAKQIIEKKKVDAV
ICIGTIIKRETDHYTFVAYQASYGCQKVAVETGTPVIFGVLTTNNKEQALARANGEHSFS
GKEWAEAAVQLVNTIKSL
>EGEFANNL_00621 Riboflavin biosynthesis protein RibBA
MSNTVLKALESLKLGRPIIIADSKDRENEGDLVASARMVTDGTVNFMVQHSSGVLCLVMT
EERMKELKLTKLRTEDHQRDKFMTNFGETFEAAEGITTGISAKDRAFSVRLAADPSTTYK
DIISPGHVFTLAAHKDLLKGRRGHTEASATACELAGLGQSAVIVEVASPSGGIMTGNELT
NFANTYNIDIVTIDELDEFYDNPSRVIKYSESNLPTQFGEFKISVWKNTSGEEIIAVAKG
DLQGEGVPVRFHSQCLTGEVFHSLKCDCEEQLDRFLQFMQENNQGLLLYLNQEGRGIGIA
DKIKAYSLQDQGRNTIEANLEIGKPIDARNWDFALEVLKQYPLKSIKLVTNNPDKVKAVS
EIINQVEVIHLPSTVNKYNQGYLETKIKQLNHNIKINKDKN
>EGEFANNL_00622 Riboflavin synthase
MFTGIIKHQSKIISLEKSEDIIKLTVESDQLFQNAAVDDSIAVNGVCLTITQLQENKASF
DVLPETIERTNLSLLKVGDVVNTEDSMTASTRIGGHFVQGHVDTTSTITKVEEDGEAYDI
YFTCDQKYQNMLVEKAYIALDGMSLTVTAVTPEFFKVMIIPHTFSQTIVKNYWKVGYQVN
TEIDILNKSIYKYINDIQK
>EGEFANNL_00623 Riboflavin biosynthesis protein RibD
MQITEDTYMQRALELAAQAGGYCCPNPKVGCVIVKDGKIISEGYHRKYGEYHAERMAILN
SKESVENSEVYVTLEPCSHTGKQPPCADLLIESKVKRVIIANVDPDTKVNGKGIEKLKDA
GIEVHLGILNEKAYQLNEDYFYHRINHIPYVVGKIATSIDGKTSTFNKKSQWITNEKSRQ
YSHYLRSRYQAIMVGASTFNEDNPKLNVRINDGKDYYNPIKIIVTSSGKINLNHDLFKER
SNNIIICTTPKIDFQQETKLNQMGCTVLKIPENDQGQVDIKLMLKELGKRNIVSIYLEGG
SALLESFIKLDLLQKLLVFMGNQILGGLNNGIINSNIYPEISNSPSFVLNQVRTFENNVM
LDYYTQNYYKKLKKQLCLPV
>EGEFANNL_00624 Spermidine/spermine N(1)-acetyltransferase
MEKICIKNITSKDVHILQTIAKQTFIDTFEEFSSPEDMELYCKNSFSLEQLNQELNNTNS
QFYIAENENEIVLGYLKINFKEAQTELKDNSSLEIQRIYVLKDYQKQKVGQALLEKAMQI
AIHDNLEYVWLGVWEENHKAISFYKKNGFIPFDKHVFRLGNEDQTDILMKKEIKTSNTIH
LQPSLENDKILLSPLLKEDFLSLYKVALDPEIWEQHPNQDRWKKEIFEVFFNGAIESKGA
FKILDKETNQIIGSTRYYNFNPIENSICIGYTFFSKAYWGKGINPKVKNLMLNYIFKYVT
IVYFHVGSENKRSQIAIERLGAKKIDEKEITYYGEKPKLNFIYKIDKSEWSNS
>EGEFANNL_00625 hypothetical protein
MRSAFVNLCLLFYIMSPSQVGINTRNPEATLDVRQSNLVLDDIFSIKDSQGNQIFTIKND
GRVQTKGVNNSPLLFDLRGGEEGDVLAVGNTTLSYEDAGEGVIKYEIDSNKYYLSTDSAW
KEINLKPLRVLVSARPQEGFTIENDLTKKFINWKILSDDYQSMDLTSGYFKAPHSGNYAF
YLNITFQKSMVNANTYFETNFLTSDGKKNKCLDTYAVSSTNYPTIQCSGSFLLDKDETFY
VEIFQNTGYSQTIIQEYSFFSIVEL
>EGEFANNL_00626 hypothetical protein
MKLKILCILTLNYLCFYSQNLGISITNEVTDVEIQPTPNDLNDKLLKITNSDGKEIFNVT
TEGNVGVGVAEPKAGIDLRSDHKIPLLGIGSTNLSPEILGDGVIRYVPGISELQVSVNNS
WYRFTSNLERPFLVAANNYIAGTYPNDQSTVLDGFTVIKDSYNAFDINNSTYTIPMDGVY
VFSFTISFAYGQILADSYIEASWIASNGYVVKSIQYFPVQGNGMGSITCSGSMKLLKGYT
LTPKIYHNLGTEKKLRVYGSTPSQPESDLNYNNLYIFAQ
>EGEFANNL_00627 hypothetical protein
MKLFYIFLIYYVFFLSTGNLKIYAQVGINTKNPTAVLDIVTNSTNDINKIFNVKNSKGLS
LFSINKKGYIDIVENSNSLVKLDLRDKSPNQFNRSLGIGYSDIDPSLVGSGVLRYNPTFK
ALEFSNGSNWIQLSSEKKRVFVLAENTSGSNYIVSFGSINQVLNNWTVVSDDTKSFDPVS
GLFTAPRDGVYRISASAVFNNVQIRSGSISSYELSLIQLLDDYLAIDYQGAKSVVTYFGG
TGSITMSNTCKNLFYLKKGESVYIAVNIINIIRSAQLSPDGASNVLTIVEM
>EGEFANNL_00628 Thioredoxin 1
MQKLFLSLTLIIGGILSSQTNHVLNSEEFSKKFTEEGVVILDVRTPEEYNTGHLENAIDI
DYRNPSFKEKIQKLDKNKTYMVYCRTGVRSAAAIDSLKSLGFKNLYDLQGGITEWKKQNR
PVVGEMPDKISYDEFNKLLKSDDIVLVDFYAPWCGPCVQMTPMFERLSDKYKNKLTLVKI
NADENKNLSKPYIEKGFPILIAYKNGKIQWEQIGLLDEDSLTKLIEDLIN
>EGEFANNL_00629 Cytosol non-specific dipeptidase
MSSNQLIREQEPKKLWNFFADINAIPRPSKKEKKIRILIQEFAKSLNLEVKEDSVGNILI
KKEASEGYENRKKVVLQAHLDMACQKNTDTDFNFDTQGIQMKIEGEWVQAKDTTLGADNG
IGVATILAILASKDIKHPAIEALFTVDEETGMTGAFGLDKNFLSGDILLNLDTEEDNEID
IGCAGGVDVTAEISYKVENITSEMIGFKIELTGLHGGHSGIEIHKGLGNANKLLNRFLYE
FLDFKIQLISFIGGGLRNAIPREAISYFIIPKNYKAELEICFKSLKKEIIEEFKSLEENV
LITLSPIEIENEKSLGFKQSKQIIEAIQTAHDGVYKMSPDIENLVEASNNLARVEIGKGK
ASIYCLTRSSVESSKKWVSTSLKAAFELAGMKVSFSGSYPGWKPNPNSEILKIALDIYEK
QNNEKPFVVACHAGLECGIIGEKFPDMDMISFGPTIKGAHSPKERVSIPSVQKFWKYTLD
LLENIPLK
>EGEFANNL_00630 putative oxidoreductase
MENNIKEKVVVITGASSGFGKISAEHLSNLGATVVLGARSTDKIEKISEEINSKGGKSLA
VTTDVTKVEQVKNLVDSAINKFGKIDVLLNNAGLMPLSPLEYLKVEDWNRCIDVNIKGVL
YGIAAALPYMKEQKFGQIISVSSVAGHTIRPGGAIYSASKYAVRVISEALRQEVKPYNIR
TAVISPGAVETNLPNSVTATDISKNIHEYYSKHAISVDSFARCLEFIINQPEDMDVNEIL
FRPTIQQL
>EGEFANNL_00631 hypothetical protein
MLVNSQSYKQNKMGNKINLDNKQQLVVNISAFTAVGNMDSLTIELGRGLEAGLTINKIKE
ILVHLYAYTGFPRSLNALAAFMQVIEEAKKQGKEYIEGENTSPLPENTDILKLGTQVQTE
LVGQPVSGGVMEFAPAIDRYLKTHLFGDIFAGDVLTYQQRELVTVSALAAMTGLESQLQS
HLVIAMNTGLTENQLLEVMDQIEQNINKEQADIGRKILSKLKEYK
>EGEFANNL_00632 hypothetical protein
MSASIFILCITCSPLKQYNKMQTKNSNISNFPIGEENTLYQQYFSGKSWLAPLTKNKDLN
VPMNNVTFEPGCRNNWHSHTGGQILIAVGGVGYYQERGKEAQRLELGDVVEIAPNIEHWH
GAAPDSWFSHIAIECNPQTNNNKWLDPVSDEEYAEAVGKK
>EGEFANNL_00633 HTH-type transcriptional activator RhaS
MEKIEQLNKISDYNDLLGVETLHPLVSVIDFSKCKPVNHGSLNFGFYAIFLKDVKCGDIK
YGKEYYDYQEGTLVFFAPGQIMKIENNGIKVIPKGFALLFHPDLLNRTSLAKEMNNFSFF
SYDAHEALHISTRERKVVLECLEKIEDEIGQRIDKHSSKLVVSNIELFLNYCTRFYDRQF
ITRDTINRGILEKFEILLNNYLYSDLLQKEGHPKVNYFAEELHLSANYFGDLVKKETGKS
AQEYIHLKLMKLSKEKIFDNSKTINEIAYELGFKYPQHFSRMFKKETGFTPNEYRNLN
>EGEFANNL_00634 Replication-associated recombination protein A
MNLPPLAERMRPQKLNEYLYQKHLVGEGASIERMVKNDSIASMILWGPPGTGKTTLAEII
AKESGREYYTLSAINSGVKEVREVIEQAKKQNLFKGKSPILFIDEIHRFNKSQQDSLLQA
VEKGWIILIGATTENPSFEVVSALLSRCQVYTLKPLDREALSNLIQRAIQEDKLLSQKKI
IIKEEEALIQYSGGDARKLLNGLELVVQQINTTEEILITNEEVQKVIQKNMALYDKNGEQ
HYDIISAFIKSIRGSDPNAAVYWLARMLEGGEDIKFIARRLIILASEDIGMANPTALILA
NNTFQAINVIGNPESRILLSQCAVYLATSPKSNSSYLAINEAINYVRETGDLSVPLHLRN
APTKLMKELNYGTHYKYSHDYPGHFAFQEFLPEEASNNSFYKPADNPKENKLKEYLKNLW
GDKYNM
>EGEFANNL_00635 hypothetical protein
MTFNILELDKTFELESNFNCRYLSPTKLHHFLIEYHNKNIDKIGCSELGKPIYKLTLGNG
FKNILLWSQMHGNETTGTLSCLDVIKFLAEDSAISKKILEAFTLDFILMLNPDGAEIWTR
RNILGIDINRDFLTSSSTEMQLLKKVASSKKYDLAFNLHDQRTIFGVTGKKEPATLAFLS
PSESENREITETRKKSMGLIADIYKEISQLIPNKISRFTDEFYPRSVGDNFQKLGIPTIL
FEGGHYPKDYLRQNTRRYFSLALITALYYATVKNNWEENYEVYETIPKNSTFFYDIIYRN
VQLSSINDTKADLGIQYSEEIRKGDNEIIFVAKIEDIGDLSLMNAHKEIDAEGRYLSLPD
GKLPKIGILADFKLDEWIISNGKKLEHWV
>EGEFANNL_00636 hypothetical protein
MDIDKRIITLIELLGLSPGEFADKINVQRSSISHITSARNKPSLDFLERTLSVFPEINSD
WLILGKGKPLKNKEEEIDKKKNILKNNIIEQPTLFTTVVDNSESKKNYKSNSYNLVDIDE
EKNNVNSKNDSTPKEDLPRFSQLNSKKKINRILFFYEDGTFEVYES
>EGEFANNL_00637 50S ribosomal protein L19
MYTIDQPLAKDVYCCSILINIFIYIMEPLIKYVQEKYIAKKEFPKFGAGDTLTVYYEIKE
GNKTRTQFFKGVVIQVRGTGATKTFTIRKMSGDVGVERVFPVNMPALQKIEVNRKGKVRR
ARIYYFRKLRGKKARIKDANTFN
>EGEFANNL_00638 Metalloprotease LoiP
MKKIILTISFACLVASGMTAQIKIGKTSIGKGKIEAAQKAAKALTVSDAEMAEMAAKSIK
WMDENNPVCTTKDKDKKKKAYAERLEKIFGPYKNYDGLNLNYKVYYVTDINAFASPDGSV
RVFSSLMDIMTDDELLGIIGHEIGHVKLGHSKKAYKQALLTAAATQYAGETGGSVGSLVN
SANIGDFAQALVEAQFSQTQETAADEYSYTFLVSNGKDPKALISAFKKLADLGSGKDSFK
DKILSSHPGSEKRAQNIEKKIEKDSKKKK
>EGEFANNL_00639 Ribosome-binding ATPase YchF
MKCGIVGLPNVGKSTLFNCLSNAKAQSANYPFCTIEPNVGTVSVPDPRLNKLEKLVVPER
VLPAVVEIVDIAGLVKGASKGEGLGNQFLANIRETNAIIHVLRCFQNENITHVEGTIDPV
RDKEIIDIELQLKDLDTIEKKIEKSKKAAKAGNKEDQLIVSVLDKLKSFMEEGNNAREFE
TDEISFPVISDLQLLTFKPILYVCNVDEKSAKSGNEYVEKVKEKVKNENAQVLVLAAQIE
ADISELETYEERQVFLEELGLDEPGVNRLIRQAYQLLNLQTYFTAGVKEVRAWTIQKGWT
APQAAGVIHSDFEKGFIRAEVIAYEDFIKYGSEQKVKEAGKLSVEGKEYIVKDGDVMHFR
FNV
>EGEFANNL_00640 ATP-dependent Clp protease adapter protein ClpS
MNYSNSPLWEEKEELDTLLEEEQSHTIVLHNDEVNTFDYVINCLIEICEHTLEQAQQCTY
LVHYKGKCEVKSGSIDYLIPINNALLKKGLSSEIV
>EGEFANNL_00641 Ribosomal protein L11 methyltransferase
MKYKEYQFNIEPLEPWREILIAYLAELPFESFVESELGLLAYIKDEYDKENLIEDLPLFS
NKEVKISFTKQGSPDINWNEEWEKNFPPVLVENKIYLHTDFHPKKDEIPHQILIEPKMSF
GTGHHETTYNMLNAMLEIDFKNKDVLDMGTGTGVLAIFAKMLDANYVDAIDIDHWSYQNA
IDNAKKNNMHINVQLGDASLLGQQNYDIILANINKNILLQDFGAYVKNLKPKGFLLVSGI
YEHDFNDIIKKANLHGLNFIKKWSKNNWISILLNYEL
>EGEFANNL_00642 hypothetical protein
MKENLKYAVKLSAVAIKSFIKVNFLGGISTILFTILGLLLLIKDMGNVQTGHVNPTIAFV
ILFTHRPTATILIVLGIISSPFIFFTLGNKYIISKLSNKIINDKAENFIYPFIDKILNIF
QKNQPKIIQNAADFSMNKLKIIQTIKENKETNKWIRRIVAFGMNKVHLSDIDFNHGNQNF
NEILKNKTLQSLKNISEPSLKFVWIAIAIQWIIILYIWLF
>EGEFANNL_00643 Uracil phosphoribosyltransferase
MIIHDFTHKRSILNHFVGELRDVNIQKDRMRFRRNLERIGEVLGYELSKTLDYYPVNINS
PLGIKPSEYISKQPVLCTILRAGLPLHQGMMNFFDQAETTFVSAFRNHSKNSKEFEVVVE
YLATPSLDNKTLIISDPMLATGESLANVYEVLLKYGSPKKVHIVAAIGSKPGIDYIKEKL
PESTELWIASVDEILNEKQYIVPGLGDAGDLAFGKKLH
>EGEFANNL_00644 hypothetical protein
MKNKILTYIFLLIGAFSLGQEIDLEKIKNNTQDKDSKYYYDKLVEEFMQSNQSLLADKEK
LQNLYYGKLFSPYYKESSQMKSDYLKFMKLVGAKKIKKYLKAIELGENILKKDPINLMVI
MNLINSYTNTKDNEYRLKELKSQSELLMSAIAASGDGTSKETAFKVITLADEITLLNYLG
INMGKYNRNSKIINKYTVLDLWTKHNNYNEEHRDQIFIEVFNNGNKIKL
>EGEFANNL_00645 UvrABC system protein A
MNQDYIKIYGAREHNLKDISIEIPRKKLVVITGLSGSGKSSLAFDTIFAEGQRRYIETFS
AYARQFLGNLERPDVDKIDGLSPVIAIEQKTTSKNPRSTVGTVTELYDFLRLLYARASDA
FSYNTGEKMVKYSEDQIVELIYKDFNQEKVILLAPIIRSRKGHYRELFASLAKKGFLQVR
VDGEILDIQTDMKLDRYKIHDIEVVIDKLVIDTEDHSQRILSSIRLAMQYGEGTIMLLKQ
GENLGKLFSKNLMCPTTGLSYPMPEPNTFSFNSPKGACNTCNGLGKINEIEINKLIPNPK
LSFKKNVIPIFEELKHTGWLISQIEVILKKNDFNLTTPWEEISEKTQNEILYGVNEKVTL
DLDYAQIKKTYKISFEGVIQYLTRLAKGNEEGESQKFKTLIFEDKICPNCKGKRLKKESL
FFKLDHKDISEISNLPLKQLEKWLKELPKHLSENQKIIATELLQEISKRLSFLLDVGLDY
LSLNRPSQTLSGGESQRIRLATQIGSQLVNVLYILDEPSIGLHQRDNVKLIDSLKKLRDL
GNSVLVVEHDKDMILNADYVIDLGPYAGKNGGEIVWQGDPKDIIKANTLTSKYIIGELKI
AVPQKRRTGNDHYLKLTGCTGNNLKNVTLKIPLGVLTCITGVSGSGKSSLITNTLYPILN
KHFYRAEKEPLPYKKIEGLEHLDKIVDVDQSPIGRTPRSNPATYTGVFTEIRNLFANLPE
SKIRGYKLGRFSFNVKGGRCEVCQGSGLRLIEMNFLPDIYVNCETCHGKRFNRETLEVRY
KGKSISDILEMSIDEAVDFFQPIPKIYQKVKTLQEVGLGYITLGQQSTTLSGGEAQRVKL
ATELSKKQTGNTIYILDEPTTGLHFEDIRILMEVINRLVDLGNTVLIIEHNLDVIKASDY
VIDIGLEGGEKGGRIIVEGSPEQVAQNKISYTAKFLKEELI
>EGEFANNL_00646 hypothetical protein
MNVYKERSYTFDNLKFLLILLVIFGHIIEYYIFFNHNYKSIYLFIYSFHMPLFIFISGYF
SKNICLDKLKHTSKKLIYIYIIFQIIYTIIDYIIFNKFSGLNLLFVPNFSLWYLISLICW
RYTFIFLKKKFSLKFVFILSIISSIVISYSDFHQFYLAVGRTLYFFPFFILGILCNYKTL
KYIKSIPKYITLIIFITCFSIYFLNDIYSFKNVQFILYEMSSLIDMQPFVFKATFFRFLF
IIVGVFICVSIINLVPNKKKYFISEEGKNTLVYYVFHGILVKVIFFYVFLYNIKYSFTFI
ILIFISIVWICYLLTKNKLVKKLIL
>EGEFANNL_00647 hypothetical protein
MLKPLAIFVPKTNILMNAKFYIFLLIVSVGNSLFAQNQEDFIKFYKSPHTGNTEDQFPEI
KPILLRANENNNIAKDQFGNSMVIDTNGDGEISYNEALAVYELDFSDVEEYDARQSVIFM
TYETTEGLQYFKNLKKFVCDVNFALYAVDVSRLESIEELSVSGGYKLYNNVVFGYHPYLK
KIDISGNKFSGLGRITSENIPNLESLIFSDNIKLKNFEIKDFKNLKQLNFDRNCFENGVL
SNLPLTSFTYKDLEGTGKNCQKEYYNFTLEHLPNIDTLNIQGVSSITLFLKDIPNLSQLT
LNGKQFFGSVNFLNDFPKIKKIVIKGYVDLETKYLPNLEYLQAQLNNNSSSDLSKNPKLS
TLILDNTIGISGELDLTKNTKLKHLSLINTAFDSVNLSKNSELQYLDIELTTMKNINLSK
NRNLDTLHAGPYYLTDLDLSKNAKIRSFKFMNKYYNSNFRNLNIKNGVKDYWLHEDFFHN
NYYLNSMGFDSLCVDKSEFEIANKSIQKLVQKIKETYGENLEEVLETGPVKLPVVTTECN
SSFESEENNDEIIQEETTQPEEEESKDNLEINLTNHKFRIYPNPVNHELYISSEQPVRKI
EIFDSTGKLILSNTGDLKKLNVSSLSKGIYYIIIHTNNGKIKDRFIKL
>EGEFANNL_00648 Leucine--tRNA ligase
MQYNFKEIEKKWQKKWLDQKTFATSQDPSKPKYYVLDMFPYPSGAGLHVGHPLGYIASDI
YARYKRHQGFNVLHPIGYDSFGLPAEQYAIQTGQHPATTTKVNIDGGLDKKGDKITGYSN
QLKKLGFSFDWDRELRTSDSEYYRWTQWIFIQLFHSYYCKNSNKALPINHLMEIFSKEGN
ANVNACTTQKNIFTANDWNNYSDNEKQDILSKYRLTYRAEATVNWCPALGTVLANDEVIN
GVSERGGYPVYQKKMMQWSMRITAYAERLLSGLDKIEWSEPIKESQKNWIGKSQGAEIDF
EIANSNKKIKIFTTRPDTIYGSTFIVLAPEHPLVDEITTEEFIMAVNQYKEDSSKRSERE
RIADAKTISGQFTGAYGIHPFTKKNIPIYIADYVLMGYGTGAIMAVPAHDDRDHRFAKHF
QIPIVEVIQGGTDVQEEAFTSKDGICINSELINGLKVKDAQQVIISEIEKINIGHGTINY
RLRDAVFSRQRYWGEPIPIYYKDDIAYTLPETALPLVLPEVEKYLPTEDGDPPLGRASIW
AWDIEKEQVVSKERINHTTVFPLDLNTMPGWAGSSWYYLRYTDPKNGSKLADPECIKFWE
NVDLYIGGSEHATGHLLYSRFWNKFLKDLGYVNKEEPFHKLINQGMILGQSAFVYRMDGT
QNYISRNLIEPQHKITPIHVDVNLLIGASDEIDIDKLRNWRDEFKEAEFILENGKYFCGR
EIEKMSKSKFNVLNPDDVCEEYGADTLRLYEMFLGPLEQSKPWNTQGLVGVHNFVKKLWK
LYHSGPNDSFLVSEDKPSKEELKILHQLIKKVTDDLENFSFNTTVSSFMIAVNEWSKLKC
TKREILESLLLIFSPYAPHIAEELWEKLGHSESIEYVAMPAFNPLYLVSDSFEYPVSFNG
KVRFKIELPANLSSKEVEIAVLEHEKTPKYLDGKNPKKIIVIPNRIVNIVL
>EGEFANNL_00649 dTDP-4-amino-4,6-dideoxy-D-glucose transaminase
MIPVTKPQLPPLEEFNEYLIKIWDKQWLTNNGPLHQELEEELCKYLGVKYISLFANGTMA
LITAIQALNLSGEVITTPYSFVATTHSLWWNNIKPVFVDIEPTYLNIDPNKIEAAITPKT
TGILPVHVYGNPCEVDKIEKIAETYGLKVLYDAAHAFGTKINNNSILNYGDLSILSFHAT
KVYSTIEGGAIISHTKKEKDRIDKLKNFGFEDEITVLSPGINAKLNEIQAAYGLLQLKYV
DQMIKNRENIDLLYRKNLANIKGIHLLPSKSNVSKPYSYFPILIDKSEYGKTRDELYEIF
KSKEIFCRRYFYPLISNFPTYKGLESSSFSNLSIANKIANEVLCLPMFSELELREVEKIT
QIIKEYS
>EGEFANNL_00650 Polyol:NADP oxidoreductase
MEFIKSNFESSTINCGILHIGVGNFHRAHQAYYINQLLEFKDQNQWGICGVGLLPSDKKL
MDALHSQNLAYTLTVCGRNGDKKVYEINSIQELIWGIENPEAVLNKIADENIQIISLTIT
EGGYNIDKENGNFDINEEQIKHDLENPQNPRTIFGFISEGLRRRKEKCNKGLTILSCDNL
QHNGNTARKAFLTFIQAQDSELAPWVEQKVTFPNSMVDRITPITTVEDISKLNNLSGMED
KAPVYCEDFIQWVIEDNFAEGRPNLERVGVEFTQEVDIYENMKLSLLNASHTLLSYPAFL
KGFRKVDEAMHDEDILEYVKEFMNEDITPYVPAPPNTNLEDYKKILIERFSNHAVSDQVS
RLCADGVSKFPVYIVPNLIKMIEDRKDLKRIAFLVASYRHYLKYKVDDKGNSYEINEPWL
SNEDQKNIESSNVLDFLNISPFKSCNLIEKDSFIDSYIIYAENINKNGMSIELKKLIHKQ
>EGEFANNL_00651 hypothetical protein
MSFLKSKIANAWASFYVKKDYKWIENPVDYQNLWFKKLIKDAENTTFGKAHYFSEINNIK
DFQERVTLQDYESLVPYIDKIKKGEKDILYCNKPQYLAKTSGTTSGTKYIPVTEKSMTFQ
VEGVKGALMHYIHKFGNSNFINGKMIFLQGSPKLEELNGLKIGRLSGISAHFVPKYLQRN
RLPSWETNCIEDWETKVDKIVDETINQNMTLIGGIPPWLVMYFEKLIERSGKPIKHLFPN
LQLLVTGGVNYNPYQEKIEDLMGQKIDTIQTYPASEGFIGFQDDVNSNDLLLMVNHGIFY
EFVPAEEIGKNNPTRLTLKEVELNKDYAIILTTNAGLWAYEIGDLIRFVHLKPYKIIVSG
RTKHFTSAFGEHVISCEVEESMQEATNQSQIIVTEFTLAPQVNPKEGLPYHEWFIEFENY
PTNLDEFALELDNAMRKRNSYYDDLISGNILRTLKITPIQKNGFNEYMKEIGKLGAQNKL
PRLSNDRKIADKLIKYML
>EGEFANNL_00652 Electron transfer flavoprotein subunit alpha
MIYIYIETLNKIFKNSAFELATYAKKIADSTQDKVCAIVINSEDNPEKLLDYGVSLVHKI
NDEKLKDFNPKVYASAISQIANGNLILFSHSSESLSIAPYVVKDKKAAYITNVVSLPLSL
SPFTVKKRVFSGKADVIVETDNKCKVLTISNYSIGALQSPVEGTIEQSTVQINPDSNYVV
LDQEISTGSISIENAKIVIGGGKGIESPENWNMLENLANVLDGTTACSRAVSDLGWRPDS
EHVGQTGKSIAPNLYIAVGISGAIQHLAGVINSKTIVVINKDPEAPFFKTADYGVVGDLF
EVVPQLIEKLQAFKKQSNL
>EGEFANNL_00653 Electron transfer flavoprotein subunit beta
MKILVAISAVPDTTSKMNFIDNDTKFDKNGVQFIINPLDEYCVNKALQFQENHQAEVSLI
TVGEPSVESVMRKALALGINEAIRVNTEPKDSEIVAHEIAAIAKKNNYDLLLLGKESLDF
NGAAVPGLTAALLGYNFVNDVISINILDNNKISVVRELDNGVETIELKLPVVLAGKKGLV
KDNEIKIPTMRGIMAARAKKIIVEEAQNIPSKLKSIKFEKAKARSEVRLIDPNHLDELVN
LLHDEAKVI
>EGEFANNL_00654 Cytochrome c biogenesis protein CcsA
MKKFINLLFSTKTTAIMLALYAISMAWATLVENNYGTPVAKALIYNSTWFEIIMLILILN
FIGNIQRYQLWSIKKWPVLIFHISFIFLFVGGAITRYISYEGQMHIRENETTNQVTSEGT
FLKTQITNDKGIVKAYNDIPFIFTPENIPFLLKPFQKKINSKYDYLGKIVQLESTGFIPW
AQDSIQPLPNGKKILKLITTSEEGRKTEFIEEGTSKQIQNALVAFNVQNPDSTAIHITSS
PEDELTISSPLMGRRMVMTTQQELTVQGENKAQPLQLASLYQFPNLTFVVPTAPERGKIV
HYAGDKNKNSSDPDLIFMKVSSGNDSKEFSFYGKKGWTGLQKQVMVDGLLVSVGYGSKIY
KTEPFYLKLNKFIMEHYPGSNSPSAYESEVSIIDEGKEIPYKIYMNHILNYKGYRFFQSS
FDPDLKGTILSVNHDFWGTTITYIGYALLILGMFTTLFWKGTRFWKLNDQLKKIAKNKKM
MVLLLFLSSLITYSQNIDMHGTEDGSIKKETIVEGVHEGQKIHENSDNSSSSIFSFKNSI
PKQPLDPKIFSETIKIPKEHADKFGEMLVQSFDGRIQPTNTLALEILRKLHKSDKFYDLD
ANQFLISISLDPLTWSQVPLIKVGNKGGEDLKKLTRANEDGYTTLMNLFPPGPDGVPYFV
LDSEYKKSFAKKPAERSNYDKEIIELNDKLRALQAVISGLYLRFIPIQNDPKNTWTSWAT
PDFKTDSIATRFIGGYFRAVMDAEKTGNWKLADEQLNRISEYQYKWGKQVIPSETKIHWE
IRYNHWNIFFKIMIVYALLGTVLLTIAFVKLFLDKSSIITFLERSLLLLVIITFIIHGFG
LGIRWYISGHEPWSNGYEAVMFISWISVLSGFILYRNRNGFIPAAGCLVAVILMGFAHGG
DQMNPQITPLVPVLKSYWLMIHVAIITSSYGFFGLSALIGTVVLLLFTLNNKKISLKVED
SIRELTIVNEISLTIGIFLLTVGTFLGGVWANESWGRYWSWDPKETWAFISVIIYAVVLH
IRLVPGWRGKYIFNLLSLLSFSSVIMTYFGVNYYLSGLHSYAQGDPVPVPNWVYIVIAIV
TLLAISSYFAHKRKFNK
>EGEFANNL_00655 Peptidyl-tRNA hydrolase ArfB
MQDFQSEIRFRTSRSSGKGGQNVNKVETMVEAVWNVNDSIFFSEDEKLRINFKLKNRINK
EGELLVKCSENRSQIANKNLVLKRITDLVSRSLYIPKHRIATRRSKSSIERRLKEKKKNS
EIKKLRNNSIL
>EGEFANNL_00656 hypothetical protein
MKKFIFPILLAIGLISCEQKRFKDSTLDESIESMAIESTLKQTNKQFIHKSHIDGEVKDV
LKSTLNIEKSVIDLGGYITTSKINSELKSKTIEPISADSAKEIKIFKTVAEIHVNVPQIY
LSQFLANVNAEIEYLNTRVIEATDITYQGQELSLDEKRLIQTQKKLDTVNIPNKNKQRLI
KQQDHIQYNLDHTKLAQAILSDKIKFSTVSINLIGKDTFQENIVPNTDHYQLYNNNHLFY
RLKTAFVSGWIILQTIIVTLCYLWPIVILALIGFIIYKKYKNKLEKVNKMSK
>EGEFANNL_00657 Adenine permease AdeQ
MKQFLYNFFQLKENQTTIKKELLAGIITFLTMSYVLIVNPNILSETGMDREALFTTTALA
TILATLLMAFLAKLPIAQGPGMGLNSFFAFSVVLGLGYSWQFALTAVFIEGVIFILLTFF
NIREIIIKSIPNVLKDAIPAGIGLFIALIGFKVSGIVVSNPNTLVSLGDFSQHNVWIAFA
GLIVTAIFFARNVNGAILIGIIVSTIFAFILGDITLPEGSFMSIPPSISPIFGKAIEPML
TAEGWKQIFSVDMLIIVFTFLFVNLFDTVGTLIGVVSKMGITDKDGNFPRMKKALFSDAI
GTTAGAILGTSTITAYVESAAGVASGGKTGLTSVGTALMFLLALFFAPLFLMVPTAATAP
ALIIIGLFMISSVAKINFSDFTEGLPAFLTIAFMPFTYSIAEGIVFGMLSFMILKVFSGR
HKEVSMTVYLVSVLFLLKIVLDALHILG
>EGEFANNL_00658 Adenylate kinase
MKKNLNILLLVGPPGSGKSTFAKYFLRTEENWMRVSRDDFRMMNFTQGNLSDKQENLITE
MVDASISALLNKNINVLIDATHCKKEYIDNYIKKYNSRADISFKLFDIEKNELLKRCETR
YKETGKYIPEKVLNKMYSQFEILKNEFDFSIRSKIENLPVEIRQQKADLPKAIICDLDGT
LALIHGRNPFDASKCNDDHLNEPIGNLLKNYAQLGYKILLVSGREDRFKEPTLEFLNKYK
IPFNELWMRKTLDKRKDAIVKEEIFETHINNNYYIEFVLDDRNQVVDMWRKNLKITCFQV
NYGDF
>EGEFANNL_00659 hypothetical protein
MMEKTDELSKLKNRIDWFCENKVNAFSPTISPAPKSMERNEIESPYEAIQYYLKNGIEEL
IVQKKYMGSYCDIYLHKDLNKTYFVSRNGYIIEHIDLDKAKQAFKELHSRLDWNGIEYII
IQSELMPWSVLGKGLIENEFGGYLYIHENHFEVLKNSEVYKKIEALKQSSDYKNYIQFRN
NHSSKEIKEKYPEHIVRQYNSLENFWVKNLDHYKNAIDIYSKQISHFGKEEDIYFKPFNI
LKIVKEDESEIFVNDNLSYQDVNDDYFLHISIKTEKDKKIAEEKIYHWFNDLSNENEEGI
IIKPRKAFIKGVAPALKVRNDHYLTMIYGINFLEDYPYYLNKRKINKKLECSIKDWMINW
DLLKVPYIQINKENYYFKNLVYDRIMGERVEGTLDLRL
>EGEFANNL_00660 hypothetical protein
MRKSVLGLHHNNKVMFIKIKSENEYLLDILYKNPQTDLGLYFKPLKKGIIVGNVVNSNEY
EIIFQDSKYSYLPESSNQIDFQSYCSPLVILDISKELFSHLLKEKNEYKNKSIHWLNISQ
GEADVKECTIEIPTFFIDSNWYKNDEFLLSRYFTGVEISHKSGKIFSLKITAKSVFEALN
LLNLIALFVHITNNYGVFTYITDDFAEKYVRILTNIDEVPYFVFYLFIKRAVKSEKQFLN
FKPIFENYLNKYHIKANLTWYSTHADRINFITSQLDINTPIVDIGCGEFIYYKRMMNKNF
TASYIAIDKDEKFSSMAGKMAERFKTGNLHFYTSLD
>EGEFANNL_00661 2-dehydro-3-deoxyphosphooctonate aldolase
MKNSLYHIPKIKNTDKNNFVLIAGPCIIEGEQMALDIAGKVIEITDKLGIPYIFKGSFKK
ANRSRVDSFTSIGEEKSLEILKKVGETYNIPTTTDIHENEHAALAAKYVDVLQIPAFLIR
QTDLLVAAAKTGKYITLKKGQFLSPEAMQFAAQKIKDSGNENYAIIDRGSSFGYHDLIVD
YRGIPTMKQYAPVILDVTHSLQQPNQTSGVTGGRPDMIETIAKAGIAVGADGIFIETHPQ
PSKALSDGANMLNINLLEDLLGKLVKIRKAIL
>EGEFANNL_00662 Oxygen-independent coproporphyrinogen III oxidase
MMQNNLIQKYNVPGPRYTSYPTVPYWDLDTFTQNKWIDSLQKSFIESNKKEGISLYIHLP
FCESLCTFCACNKRITKQHNVELPYIQALIKEWKLYLSILPEKPVIREIHLGGGTPSFFS
PKNLYYLLNTILSSSIIHPNKEFSFEGHPNNTSQEHLQTLYDLGFRRVSFGVQDYDTEVQ
KAIHRFQPLENVKKVTEWARNIGYESISHDLVFGLPFQNLSKVLNTIEITKQLHPDRIAF
YSYAHVPWVKGVGQRGFKDEDLPSGEEKRELYKKGKEKLEEMGYFEIGMDHFSLKTDSLY
QSMMDKNIHRNFMGYTSSSTQVMIGLGVSSISDSWYSFAQNVKTLEEYYDKINNQELPVF
KGHILNEEDLSIRKHILNLMCLLETHWDAEDLIHHHPDIFERLQEFEQDKLISLTSNSIK
VNEKGRPYIRNICMAFDLRMMRKLPQTQLFSMTV
>EGEFANNL_00663 Magnesium and cobalt efflux protein CorC
MDDLPLSILFTVLNVTDTISLPKLFLTIFLVLLNGFFVAAEFAIVKVRSSQIVVESSQSP
RKAKAAKTIVNNLDSYLAATQLGITLASLGLGWVGESSLTPVIYKTFTFIGFIGNEYAEI
ARKISFPIAFIIITMLHIVFGELAPKSLAIQFPTKTTFAVAWPLKLFYAVFKPVIFIMNG
LASIILKIFGIRPIHGSDIHTEEELKMIISESQEGGAIKETERELIQNVFDFDNRRVGYI
MMPKKNVSAINIDSPIEEIIKYTLAEGYSRYPVYEHSIENIKGILYTKDLFKAYTSYQKN
LKIKEILRIPLFVSETALIKNVLKTFQQKHSQLAIVTNELGEFSGLVTLEDILEELVGEI
QDEYDNEEPIVVNVSKDIYIVNSHNKISDINKFIPYPFEENEHYETLAGYISEKYNEREL
KVNDIIDLDEYKGKILKMYRNSVESIQLKIIEDLNNDSNTTEAG
>EGEFANNL_00664 Putative cysteine ligase BshC
MENQINISEIPSINKLVKDYLNKESFVRSFYHQDFNYQNLINQSKEKINNYLHRETLVYE
LSEQLSKIHLSDKQKLNLEKLSLKNTVTITTGHQLNLMSGPLFFIYKILHVIKLCDFMNK
NQKEIYFVPMFWMATEDHDFEEINHFYFNNKKIEWKDQFKDYVGEIPTTSLEDVLHPFHE
KLKYFPKGRQLREIIENSYFTSENLAEATQKFVHRLFKDYGLLFIDGNSRNLKKLFVPFI
KDDIKYQKSFHEISKTINLLKDNYKIQVNPRNINFFYRDNQERKRIEPVGNKYKIVDTKK
TFSSDEIVKELDLFPEKFSPNALLRPVYQEVILPNVAYIGGNAEIAYWLELKKYFDEQNL
IYPILIPRNSVLLLNSIQEKKMQKLDWKGINIFESKKKIIDSLVNQLSTNKFDLKKYENQ
LKNIFNDLIHESINTDSTWRDMILAQQKKQLNGLNKINERFHKAERLKYNEYISNFEKLY
MEIFPYNQWQERIINFSEYYANMGTDFFDLIYSNINEFESVISIVNIDK
>EGEFANNL_00665 hypothetical protein
MKKFFILLSILLLFNAFIFGQKKQHIVEAKETLYGISKKYNISIEDLKRENPKLLERTPQ
IGEKLSIPENNTSNKVSNSKNVELEENSNNKISEIGSSKGNKTNSENISKDDIIDNIVRQ
NLNEPNYIYITIEPKETLYSLSKKYNVSIETIQKLNPTMDIHGPKIGEVLKLPNKNSKLK
ERKVIKSDTILNESKNTSLPSDYYSKDAINVVMILPFQSKSNKEKELALDFYSGAKLALD
SLSNNGKRFNLSLIDNSDGTNFVDMINSYDFSTTNLIIGPLFKSDLINVAKINKNIPIIS
PFTSSDELDDYSNIVMYNTKEQTLIEKLADELLKKYDGEKTYILYDENNYQNALYLQSLI
LSRKNNAEVILTQNAQEIKTEQNLVTDETEDIYAVLISDKESLTQQYLDQLLELNQSNVF
PISLNYSYLFDLPKYSNQLLQMGLLYSDTNYVNENGFNEEKTLNSYKKKFCESLNKYSVS
GFDVTYDILNRIDSKGNLADHSMKIERKQLSNKYYFNRVKKSGAWTNQGVRIIKLM
>EGEFANNL_00666 Malonyl CoA-acyl carrier protein transacylase
MNSLVFPGQGSQFPGMGKDIYDSSSDIKKLMDSANEILGFDILDIMFHGTKEQLVQTNVT
QPAIFIYSVAISKTINNSNINMVAGHSLGEFSALVNNGVLTFENGLKLVYQRALAMQEAC
EKNPSTMAAILGLSDQVVEDICKEISKPDYIVVPANYNCPGQLVISGHVEAVQEACEKLK
EAGAKRALVIPVGGAFHSPLMKPAQDQLEKAINNTTFSSPTIPIYQNTTNTSVTKVEEIK
ENLIQQLTSPVNWTKLVNQMILDGCLTFKETGPGKVLQGLIKKINNSVEVNSL
>EGEFANNL_00667 putative ABC transporter ATP-binding protein YknY
MNLISLKNVHKYYNTGNNNLHVLKGINLEIKESEMVAIMGSSGSGKSTLLNILGILDYAD
EGEYFLNQVKIDNHLSESKAADYRNKFLGFVFQSFNLINFKNAMENVALPLYYQGVKRSQ
RNSIALDYLKRVGLYDRATHMPNELSGGQKQRVAIARALVTHPKVILADEPTGALDSKTT
YEVMKFFQEINMEGKTILIVTHEPEVAAQCKRIVHLKDGIIEKDEIIDQIKL
>EGEFANNL_00668 Macrolide export ATP-binding/permease protein MacB
MFNLDRWHEIFYSIKQNKLRTFLSGLTISLGLFIFILLSGIGNGLKNGFSLQFILDSPNL
ISYIPGITSRAYAGLQEYRTIILKNEDLDLINKNYSNQLKYKTSTSSSSENVFYKNESGN
YSIIATYPEKKYIEKIIITSGRYLNNYDLQNESKFAVIGRLVQKDLFKNENPLGKYINIG
NTNYKVIGVFNNKDGDNYERIIYIPIRTHQNQKSNTDIINQIDVVYNDNISPTKAIELGE
NIKTTLKTKLKISKEDNNGLIVRNKAENMEKPLAFFNVISFLVLFIGFGTIMAGIIGISN
IMVFIVKERTKEIGVRKALGAHPWNIIGLILQESIFITLISGIFGALVGILVLNLIKDRY
VEILIINPSVSWKLILYATLALVIFGAIAGFIPARNAAKIKPVEALKD
>EGEFANNL_00669 Macrolide export ATP-binding/permease protein MacB
MLILNREIWSEIYYTLSKNKLRTILTMIGVAWGMFLYVFLLGAAKGVENGFNKIFDGFAT
NSIFLWGESTSEPYHGLPKYRPIDLNLEDINYLKTEVEEIETIAPRSVASSEQGIINRHK
ITKRYSVFGDYPIANQLVKKEIIRGRLLNEEDINHNRKVVVIGKEIAEQFFSKNENPIGE
YIKINNTYFKVIGVYKNPNGSNTSDNQLFIPFNTYQQIYNRGNKIGWMVIVIKPQYDVKK
AEIKIKNILKQRHKVSPTDEKAFAGFNFAEGYKKLVRFLEGMQLLTWIVGGLTILAGVIA
ISNILLITVKERTLEIGIKRALGAKPKEIRYQILMESVFLTIFSGLIGFIGGILFLFFIN
QMIVNNPNIPFYNPSLSMWNVLAALSLMVSLGLSIGLIPAQQAVRIKPIEALRAE
>EGEFANNL_00670 putative peptidyl-prolyl cis-trans isomerase
MIQKIIIFLLVSLTLINCKTLETIDNQTYDHLENGLYANIKTNQGNILVKFFDKESPVTV
ANFIGLAEGNIPNSAKKNGEPFYDGIIFHRVIKDFMIQTGDPEGTGMGGPGYRFEDEKNN
LKHSGGGILSMANSGPNTNGSQFFITEVPTPWLDGKHTIFAEVIKGIDVVNTIAAAKTGA
QDRPLESIIIEKVSILKKGDEYKNYDAAKFFEENKDLISERNKKFIDEKEKESTLKLEQL
KSEMIQTPSGLYYKISHEGSGSMAKVGDKVSVHYEGSLLNGNIFDSSFARNEPIDFPLGK
GMVIQGWEEGISLLKEGSRATLLIPPALGYGSQGAGGVIPPNAWLLFEVELVKVNN
>EGEFANNL_00671 DNA-binding protein HU
MNKSELIDAIAADAGLSKADAKKALDAFTSNVTKTLSKGDKISLIGFGTFSVTERSAREG
INPQTKEKIKIAAKKVAKFKPGAELSDAVN
>EGEFANNL_00672 hypothetical protein
MKITEKEFISEDNYTLIEKGEVSHKCPSNIALVKYWGKYENQIPANPSLSYTLTDSFTET
KIEFNKSDKFKVEVYLDGRFQESFTEKIKKYFLSLKKYLLFIDQYHYKIYTENNFPHSSG
IASSASGFGALAKCLMEMSKILSDDKLSEEFKLKKTSFIARLGSGSACRSLYNGLVLWGE
HPDIIESSNLYAVPYPLEINSVFETFIDTVLLLDEGVKEVSSSVGHQLMNEHPYASVRFN
EATKNITKLISILKEGDLESFGYIVENESLSLHSMMMTSKPSFILLKPSTLLVIDKIWKF
RKNCKAHLYFSIDAGANIHLLYPEKDKGIVSSFIQNDLIKFTENGNLITNQISFLN
>EGEFANNL_00673 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase
MILVTGGTGLLGTYVVLKLAKENQNLKVLIRDENLKENILYIFKIYEPINYQELFNSIHW
VKGDILDIYSLEPALEGVTKIYHIAGKISFQEKDKKELYKVNVEGTRNLVNLSIEKNINK
FCYISSIATLDPEIDQNDIYENSEWNFKTYHSSYACSKFAAEMEVWRGSQEGLNVIIICP
GVILGSGNWNRSSGMLFDMAISNKVYSTKGLTGFVDAEDVANIIVKLMESDVINEKYIVV
SENASYKQVFSILRRHINQSEPIVISNFLIKSLALLTKVLPTQKKLSRSVVNALINTTTY
SNQKIISKINYKFKSLEDSLLFHFNNFIKHKNL
>EGEFANNL_00674 hypothetical protein
MTLNKQLLLLVTIYLLSLINIKSQNNLNRRVVWSLEECLEYAIANNITVKKAILSKNSSD
LNLKQSKNNRLPNLNANINGGMTNGSSIDPITSSFQNEFYKSVNGNISTSVALYNGNKLT
NTIEQNQLLVNQNSLYIEQAENNIILSILEAYVQALYTQEAIEIAKNSAKSTEDLLKQGQ
IKFSNGALSRSDLADLEAQNATNQYNIVSAQTQYAQQVLALKQLLELDPKIDFQIEIPEL
SDSKDFLIPNKEIIFEQAVNKLPDTKIYDLEKQINEKDLEIAKAGYLPTLNLSGSLSTGY
SSTRDYIDFGRQLDGNKSQNVSLSLNIPIFSKFQNKTNVALAKINIQQSELNKIQANKDL
YQKIEMAWLNATTNQAESKSSKTLRDTSKLSYDLSIKKYEFGGSTTTDLLVSQTNYLNAE
QKYLQTKYMGLLYQQLLQYYQGQPIKIQ
>EGEFANNL_00675 Macrolide export protein MacA
MKTNKIKILVIAIISIVSIFFIYKYFFSASKPTLSVETVKVEKGNVSEAITATGTVNPVN
EVTVGTQVSGIIEKIYVDYNSPVKKGQLIAQIDRTNLLATLTDAQATYSSALNQLSYQQQ
NFNRQKNMYNAQVISKADFETASFSLNDAKESVKQAKSTLQKAQTNLGYANIYSPIDGVI
VTKEVEEGQTVAASMSTPTLFTIAQDLTKMQVEANVDEADIGNVQVGQRVTFTVDAYPSI
TFNGTVNQVRLGATVTSNVVTYTVIIVTDNSNLKLKPGLTATVTIYTKELNDIITLPAKA
LNFTMDPKILEIYNKEHQLNTKISTINKSNDDDKYVWIRNKQGILEQKLVKIGESDGINV
EVISGLKVGDEVVYSMKNKQDGTSSNKQESSPFMPKRPGASKKK
>EGEFANNL_00676 putative ABC transporter ATP-binding protein YknY
MSKPIIHIENLKREFKMGSEIVQALKGINLTVQEGEFLTIMGSSGSGKSTLLNILGCLDQ
PSEGTYELDGVRVKNLSKDQLARIRNEKIGFVFQAYNLLPRTTCIDNAELPLMYNSTVSS
KERRERAVTALKRVGLESRLTHVPSQLSGGQQQRVAIARALVNHPVILLADEATGNLDTK
TSYEVMALFQELNEQGITIAFVTHEPDIALFSHRTIVLKDGFIIKDEAIKNRLNASDELQ
KLSNKTD
>EGEFANNL_00677 Macrolide export ATP-binding/permease protein MacB
MPRMNYKNYPTKPIKMNLSNLFKISFRAILLNKMRTLLTMLGIIIGVASVIAMLAIGEGS
KQSIKDSLSSMGSNIITIRPGAGRQGGVRLDMSASQTLTLKDLNFLSKNANLITEISPVV
NGSGQSIHGANNWPTTLYGVTPEYLSIRNLEILDGSMFTTQEVNSYSKVCILGKTVIDNL
FPNGENPIGQIIRFNKIPLKVIGTLSPKGENAFGQDQDNIILAPFTTIQKRVLAITYLNS
IVASAVSEEQASNAVDQLTTLMRESHQLNSSDPDNFNISSQQEILSTMNSTSEMLTILLV
AIASISLLVGGIGIMNIMYVSVKERTREIGLRMAVGAKGKDILMQFLIESILISFTGGAI
GVLIGLISTYSIKTFAGWPVSITLFSIFISFAVCTVTGIFFGWYPAKKASDLDPIDALRY
E
>EGEFANNL_00678 Sensor histidine kinase YehU
MNKFRLLQNKKLVYFLHFVVWGVLFISPYLFSYGQEELSFVARRSWVSLLIYAFLFYINY
LWLIKKFIFNNKILIFITINVIVIALLVILKHELIFKLLTEDPHFRIPSRPSRSFFIYFD
SISMIIPMVFALAFRISERWVKTESEKNEVENYKLQAELQHLKYQIQPHFFFNSLNNIYS
LVDISPEKAKETIHSLSKLMRYLLYESNTETVRLEKEIEFLNKYIELMKLRLTEKTQVKV
NFPKISSSIQIPPLLFISIIENAFKHGVSATQTSVIEFSMKLWEDRISLFSKNHNFQKSI
TDKSGSGIGIQNLKKRLDLLYPNQYEYSSEICGNEFIVNLEIKLKTNEFQ
>EGEFANNL_00679 Transcriptional regulatory protein YehT
MNSNKISCIIVDDEPMALQLIENYVNQTAYLELIGKFNNAIEVLDFINKQKVDLIFLDIQ
MPELNGLQLAETIKDHTKIIFTTAFDQYALEGYKVNALDYLLKPFDYKEFILATNKAKEW
FELIHAKEQKELDKKQSPEYFFVKSEYRQIKISFHKILYIEGLKDYVKIWLKDEPKPILT
LMSLKKLEEELPKDRFMRVHRSFIISLEHIQSIEKNQVIIHQQYITISDQHKESFYKFIQ
SNSIN
>EGEFANNL_00680 Pyridoxal kinase PdxY
MLPKIKVNLRMKNILSIQSHVVFGHAGNSAAEFPMQRCGVGVWSLNTVQFSNHTQYGKWT
GEVMPAHHLLEIVEGIDNIQQLNKCNAILNGYIGSPEQGKAILEIVKKIKSINPNAIYFC
DPVMGHPEKGCIVAEGVSDFFKNEAIQVSDIMAPNLLELEILTGLTINHMDDVLQGIKIL
HQKGVNIVLVKHLSKAAKSSDQFEMILSTKDEVWHIARPLFDFGTRQPVGVGDLTSGLLL
THLLLGKNGKEALEATTAAVYAVMLETYKRGEYELQLVAAQEEIANPSQHFEAIKI
>EGEFANNL_00681 Periplasmic pH-dependent serine endoprotease DegQ
MNNKKSKFQIKKVASYILMGVAGAALSVGVFSAMKKNTNLSDFEIFKKDQNEKGYFQSAS
YSTASYNPPDLTVAAEKTINAVVSVKNYSSYSPQQQRQQFIDPFDFFFGDPFNNSPRRSQ
PQQPKDTPNGLGSGVIISSDGYIVTNNHVIDGADKIEITLNNQKTYTATLVGTDPNSDIA
LLKIEEKGLPFLNFYDSDNVKVGEWVLAVGNPFGLTSTVTAGIISAKGRSLDILRSNSKN
PIESFIQTDAAVNPGNSGGALVNTNGDLIGINTAIASHSGAGTFEGYSFAVPSNIAKKIV
EDIRKYGLVQRGYLGIGALDMSDDSAVKQYNAKNKTSYKSQQGVLVTEVQEDGGAKDAGI
KKGDIITQIDGVTIRNFPTLSGIIGEKRPGDNVSVTIMRDGSLKSFKVKVKDAQGGTSVK
TKADLSVTEKLGGEFTSLTEQEKVNYGLESGVVVTNVDANGKLRSIGINEGFIIMEINDK
PVNSDKDIERLLKNYNGTVSVKYVDPYGRFYRRGFKMN
>EGEFANNL_00682 CRISPR-associated endoribonuclease Cas2
MSFSRYNAYRIMWVLVLFDLPTETKKQRSQASRFRKDLLDDGFTMFQFSIYLRNCPSKEN
ADVHIKRVKNKLPQYGKVGIISITDKQFSQMEIFFSKQASNLPLAPQQLEMF
>EGEFANNL_00683 CRISPR-associated endonuclease Cas1
MLKRTIYVGNPAYLKLKDHQLNVEDPATGTINGTVPVEDMGFLVLDHSQITLTHPLMVAL
QQNNVGIISCDAYHLPISLMLPLAGHVEHSRRLREQTSLSEPLRKQLWKQTVETKIYQQK
CLLQKLGHSFEPMLEYMNEVKSGDTTNREGIAAQYYWKQMFENFTRERKGETPNQFLNYG
YSLLRSMVARALVSSGLNPTLGLFHKNKYNPYGLADDVMEPYRPFVDEMVVEWLQQNRQE
EKLSKSAKLHFLQLATRDVRLEGSKKPLLVALSSTTSSLYKCIIGENRIIRYPEFV
>EGEFANNL_00684 CRISPR-associated endonuclease Cas9
MKHILGLDLGTTSIGWALVKEAEDTNEKSSIVKVGVRVNPLTVDEQTNFEKGKPITTNAV
RAQARSARRNLQRYKLRRENLIQLLTENHFIVSSTILAENGKNTTFQICELRAKAAQEVL
SLTDFARVLLAINKKRGYKSSRKVNITEDGQLIDGMEIAKKLYEDHLTPGQYVYQNSLHK
NFSIPEFYRSDLENEFLRVWEFQKQFYSEILTDELKENIKGRNKTQTWAILKEPLQLVGI
KRDKKGKELRLENYQWRNEALAQQLNLETLAIVLQEINGQIAGSSGYLGAISDRSKELYF
NKQTVGQYLYSQLQKNKHARLRGQVFYRQDYLDEFEKIWEVQAQQHQELTSELKEKIRDV
IIFYQRKLKSKKNLISLCEFEQREIKDKNGKARTVGLRVAPKSSPLFQEVKIWQQLHNVK
LKHKKTGEELDLCQEDKNLLFEELNLKGCMSAEQVLNILGKGKEYKLNYKVLEGNLTNEQ
LYNKYLDILDLSGYDLRKNFKVSTGKEEVNLKDIKLDAHEIKNTVQAIFEDLGIDTEILN
FHSEWEGEQFQKQPAYQLWHLLYSYNEDDIPPEIKKESRTGMEYLYVQLHKKFGFTLEQA
KRLGTVVFKDDYGSLSTKALKKIAVYIKENDYAQACALAGYRHSKNSLTQEELAQRKLKD
RLENLPKNSLRNPVVEKILNQMVNVVNTILDSENDRLEAQGLERNFKLDEIRVELARELK
KNAKEREELSKQVESAHKYHQKIIEILQQAPFHIKNPSRNDIIRYKLYQELKINSYKDLY
TNQYIEPQQLFSNLYDIDHILPKALLFDDSFSNKTLSPKKINREKSASTAYDYILNNYGP
QRLEDFIARVENLYKAKEGGITEAKYKKLLKKATEIGDGFIERDLRDTQYIAKKAKDLLF
QITPTVVSTTGSVTQKLREDWGLLNVMKELNLPKYRQAGLTEIIDNKKGEQIIDWTKRND
HRHHAMDALTVAFTKPSHIQYLNYKNARTNENHPFHPIITAIEDKELIKVKSKSGKNKSL
FKEPLPNFRQQAREHLETVLISHKNKNKVVTKNKNKIAGNSKIQDTLTPRGQMHKETIYG
KIKQYVYKEYRINASFDEPTILKICNSLHRNLLLKRLKENNNDPKKAFTGKNSLSKNPIY
LDDDKKETLPNKVKLRELEEKFTIRKNVDPDLNIEKVVDQGIKRILKQRLLDYGNNPKIA
FSNLEENPIWLNKEKNKALRRVTIFGVANAEPLHTKKDHLGKEILNEKGHPIPVDYISKG
NNHHVAIYRDEKGNLQEKVVSFMEAVERKNQNLLVIDKTYQQDLGWTFLFTLKQNEMFVF
PSEDFHPAEINLLDKKNYQLISKHLFRVQKIATKDYFFRHHLETNVETHAKTKDLTWKRV
RLSEIENIVKVRINHLGEIVQIGEY
>EGEFANNL_00685 hypothetical protein
MEGIKTKTGLEFQKLKIISIKKDELPRLKCFHNGIILIVSPFTANIDKFF
>EGEFANNL_00686 hypothetical protein
MELTFRKANKEDIEVIWEILQQAIARRKAEGSKQWQDGYPNPQVIEKDIDSNAGYVLVND
GKVVGYCALFINDEPAYSNIVGNWLSNGDFVAFHRVAISENYLGKGLAKKMMSFIKEFAI
NNNIQSIKADTNFDNAGMLAIFNKLGYKFCGEVTFRGASRKAFEKLLILEN
>EGEFANNL_00687 Toxin-antitoxin biofilm protein TabA
MIIDTIHNISKYSALHPMFTKAFDYIQNLDMNNLKMGTFPIQNQDIFAIINESAMGTIEN
THLEAHNQYIDIQVPFSKTEMFGWAPRSILRNPLTEYDEIEDIQYFKDHYSFTFELQPEN
FVIFFPLDAHAPCLGEGNILKLVIKIKVIP
>EGEFANNL_00688 Uracil permease
MKEKNPRVVLQINERPKFLQWILLSIQHLFAMFGSTVLVPALTGMSPAVALVSSGIATLT
FIVITRGKVPSYLGSSFAFINPILVAKSLATDPNSGVGSGDFLVGCFFVGLTYACVALVI
SKVGTQWLMKLLPPIVVGPVIMVIGLGLASTAVGMVTNNIDTQGYDLKYVAVGFVTLTIT
ILVAVFTKGFLSVIPVLIGIVGGYIFSSLLGLVNFTTVLQADWFEVPPFTFPFIDYTPGI
STRILLLMIPVSIVPIAEHIGHQLVLSKVVDKDLIKDPGLDKSMLGDGVATMFAALLGGP
PNTTYGENIGVLAITRAYSIYLFIGAAIFAILFGFCGKIAAVLSTIPTPVMGGVSILLFG
IIASSGLRMLVENKVDFSLKRNLIIASVILVIGIGGAAIHVGDLFSLEGMALASIIGIVL
NQILPGKESIDFKQMFKE
>EGEFANNL_00689 Nicotinamidase
MKALIIVDMQNDFLPDGSLAVENGNAIIPKINSIQAKYDLVVATQDWHPKNHKSFATQHP
ENKIFDQIILEGLYQTLWPEHCVQGTQGAEFSSLLNQNLIEAIFRKGMDENIDSYSGFFD
NGKKKSTGLEEYLKAKKIKEIHVCGLAADFCVYYTAKDALDLGFKTSIIENATIAINPLN
FNEIKINFQEKGGEIIQL
>EGEFANNL_00690 hypothetical protein
MQYNDNFYSDSEFDQLNSTPILPNTHMPLAIIATFISCCSFNCLSLILGIIAIVYANQVK
DKFILQDYLGAKRSSQTAKILSLIAIGLFAIGLIINIIFPIFFNTIKGILNLD
>EGEFANNL_00691 hypothetical protein
MKKGFKFLIWLIFLFSLLFLVLFYYYINPEETNLGFTCSFKEFTGLNCPGCGGQRAFHFL
LHGEFWKALQYNIFIYFIPLFIYLLYVIIEVYLFKNKKFQQGFIFSKRLGQIVLIVIILY
TILRNIPCKPFIFLSPPK
>EGEFANNL_00692 Triosephosphate isomerase
MRKKIVAGNWKMNKTLSEANTLLAEIDSYVKTNDPKCEVVVGIPYLYLANAKEKYENLNI
YAEDVSEHQSGAYTGEISAEMLKSVHVDGAIIGHSERRQYHKETDEQIGAKVKIALENGL
TPIFCNGELLEERKSGKHFEVVKKQTEVALFQLSPEEIKKVVIAYEPVWAIGTGETATPE
QAQEIHAYIRSLIAEKYGKEIADEISILYGGSVKPANAKEIFSKPDVDGGLIGGASLNIK
DFGALIQTYSDL
>EGEFANNL_00693 hypothetical protein
MKYITHLVRIIVGIIFIISGFVKTIDPIGFSYKLEEYFGPGVFNIPILENFALPLSILFV
ILEVLVGVLLLLGMWKRLTVYLLLTLIVFFTFLTFYSAYFNKVTDCGCFGDALKLTPWMS
FIKDIILLVMIIFLVRQIRFIKPFLKYKTNKIIVILSLILCIVVAYQGIAHLPIIDFRPY
AVGKDLKKGMQDGSPQVESIVYTLENLKNKEEKRMTSDEYINSNIWADTLTWKIKNSDIK
IIKEGVLPSVHDFIIDCGGQDRTESILEENKIVVITVPYAEKMSLLEKAKLKKIISDLKV
KRLKYVLMANDPQKLRIPNACISDQTTIKTINRSNPGFMVLKKGIVVAKYHGDDFPSLKK
IEKL
>EGEFANNL_00694 hypothetical protein
MSQTSHEFDTIINNCQTLFKNKMLDYGAAWRILRLPSLTDQIYIKANRIRTIQEKGEQKV
EENIDNEFIAIVNYSIMSLIQLEKGVANQPDLSVEQALEWYVKKAEEAKNLMLAKNHDYG
EAWRDLRISSITDLILQKLLRVKQIEDNMGKTIVSEGLEANYFDIVNYAVFALILLNNQG
NNK
>EGEFANNL_00695 hypothetical protein
MDIYRLLLDSYFYCFPVKKSENTFLMNNKDDIFILAEYNKSKLNSKFSYSKLKNQGIYGL
YNFIFYNDSTIYFFEDQGRFIPNKNQEATLVLFNSEKLIFISDSTKYPYIYLNPSKLKYI
KYNELDSFLVEKVNLLPMKIKDNPGYRTRVSISIFKDSLQNKNFNKIFNKFKTFGKLNVR
NFTTEEQLVAYVKFYNKTYNPKLYNWKKILTISQ
>EGEFANNL_00696 hypothetical protein
MNKSWVLLNLSNLLIVSFLGIILRFFQLFHTKYLYGNYLHTHSHVAILGWMFLSFFIAIY
YFFIPKNNGNLKKFKTLYIISQISVWGMLLSFPFQGYGSISIAFSTIHILCAYAFVWLIW
KNINLKEYDQKFLKTSLIFMVISTLGIWGLGGVISIVGKNSFLYHLAIQFFLHFQIQGWF
LFALWACLFKLIKNKLSIYPNYSKAFFNLNLIAVIFSFSLPILKYQENQIPYLNIFLHLS
SILNFIALLIYLKHIHPKIKTIINSEPAYCSMAYHTFLLSYILKIIVPIFLLISNSINEI
IIINNFYIGFIHLTVLGVYSFFIFFLMSLKIEKRNLNKFTLGLGLVIIAFIITELLLMIQ
GFFIYFNLGSLKFYYPLIISSSILFPIGIVLILLNFLPQRINKFK
>EGEFANNL_00697 Iron-sulfur cluster repair protein YtfE
METMFKKATVGEIVAENYKTAAVFSKHKIDFCCKGDRTLEQVCEKKSVDYSTLVNELNEV
IKDKSSGEDFNTWPLDQLSDYIVRTYHEYIREKIPPLTQFLTKVDKVHGDGHPELHEILA
IFLESAEDLQTHLRKEEMILFPFIKQMTQAKNNGQPLPTPPFGSVENPIEMMKDDHSIEG
DRFRKISELSNNYTPPEGACNTYKVSLAMLQEFEEKLHEHIHLENNILFPKAIQLESTF
>EGEFANNL_00698 HTH-type transcriptional regulator IscR
MFSKSCEYAIRSCLFIAIKSSNNYKVGIREISNEINSPIAFTAKILQKLGKNHLIKSLKG
PKGGFYLEGKDLENIKLSHVVSAIDGESVYKGCALGLPKCSETQPCPVHFKFKSIREELS
KMLLSTSLKDLIDGLDRGETFLKIK
>EGEFANNL_00699 Putative aminopeptidase YsdC
MKDFEINKKSIKFLEKYLNTPSPTGAESEGQKVWIDYIKPFVDEVRTDNYGTAYGIVNPT
ADYKVVIEAHADEISWFVNYITEDGLIYVVRNGGSDHMIAPSKRVNIHTSKGIVEGVFGW
PAIHTRNYTAAEEAPKVETLWVDCGATSKKEVEKLGIHVGCIITYPDEFFILNDNYFVCR
ALDNRVGGFMIAEVARLLKENKDELGYGLYVTNSVQEEVGLRGAEMITQTIKPNVAIVTD
VTHDTSTPMIEKKKHGEIKCGEGPVISYAPAIQNNLRDLIIHTSEKNKIPFQRQASSRFT
GTDTDAFAYSNGGVPSALISLPLRYMHTTVEMVNKKDVENVIKLIYQTLKNIKPNHSFKY
I
>EGEFANNL_00700 Ribosomal protein S12 methylthiotransferase RimO
MRTKSIGKKKINIITLGCSKNVYDSEVLINQLKANNKEVVHEQKGDIVVINTCGFIDNAK
EESINTILECVEQKEQGLIEKVFVTGCLSERYKPDLEKEIPNVDQYFGTRELPLLLKALG
ADYKHELVGERLVTTPRHYAYLKIAEGCDRPCSFCAIPLMRGKHISTPIEKLVQEAQALA
KGGTKELILIAQDLTYYGLDLYKKRALADLLKELVRVEGIEWIRLHYAFPTGFPHDVLEL
MKVETKICNYLDIPLQHISDSILASMKRGTNKEKTNRLLNEFRTIVPDMAIRTTLIVGYP
GETKENFEELKEWVREQRFDRLGCFTYSHEENTTAYQLDDSISDEEKMERVNQIMDIQSQ
ISWELNQEKIGKNFKCIIDRKEGDYFVGRTEYDSPDVDNEVLITANDLYLSPGSFVNVKI
TKAEDFDLYGELL
>EGEFANNL_00701 hypothetical protein
MKKKILIVSYYWPPAGGPGVQRWLKFTKYLPEYGFEPFVYIPENPSYPILDDSLEKEISS
KVKILKNRIWEPYQIAEKISKKNKNYKAGQFETEKKESLISQLSVFIRGNFFIPDARKYW
IQPSINFLEKFLNNHEIDYLVTTGPPHSMHMIGLGLKERFPLLKWIADFRDPWTQISYYS
QLKLTSWADKKHKFLEKKVLQKADLILSTSYTDKVNFEKLGAKKVSCITNGFDSESQINL
PSSSLFILSYVGMLETLRNPTNLWEVLQDLLLNNENFKKDFQLRFVGKIADSILEKIKHS
SLKDHTTILGYVSHEEAIQEMNQSNLLLITNFPEEKSKGIIPGKLFEYLASNKTILSLGY
PDSDVKKILQETQAGEHFTFDDYDKLKSFILDEYLKWKNNLPTNKVYSTQKFHRKELTKK
LVECLEGL
>EGEFANNL_00702 hypothetical protein
MKKNNLFPILGCLVLFAIISFAYFTPLLSNKYISQPDIIHYKGGAHELEEYRKIHGEDTY
WSNSMFGGMPTYQMGANYPSDIIKSIDRILRYFPTPASYLFLLLSGFFLLGMVWLKNWKY
ALLGSAMFAFSTYFFIIIGAGHNAKVHTIAYFAPFVAGVYLLYQKKYVWGFILSTLFLSL
QIAANHPQMTYYLFLALGIFAVVEIIQTIKYKTYKSFAISTALLIVGLFLAVGMNSSRLL
STYEYSKETTRGKSELTINQNPTSSVKGLDTDYITHWSYGILETANLFVPNFMGGGNNEK
GFKPDHLQSALQQSIKSEEEYQQFQKAFNGSYWGEQPGTSGPAYQGAVVIFLATLALFYY
KGKYKWWLVSATLLSFLLAWGKNFGIFTNFMIEYFPFYTKFRAVSSALVIAEFTIPLLAL
LGLYAYFNDKTLKLAYKKKVLLVSSGVIILGLLILYLFGLYLFSFHTKLEGEYINTSILE
AIKEDRFSLFQKDVLRTLIFVIFTGGILYVSLLNKLKSDYLVLSLAILSLIDLWGVNKRY
LNDENFVEKSLYKNPFPTQASEQQIQRAEQDPSLARILNVIPVNQVLEEIKEKDPSNYRI
YNLLLSPFNETNTSYFHQSIGGYHGAKLRRYQDVIDFYLTDSLNFPILDMLNTKYIITAD
SIIRPIPNPNNNGNAWFVNDLVFVNNADEEITQLVKINNKKQAIVNRKYQQELNISKPKD
SLKGTITLEKYQPNQLTYKSYNPNEQLGIFSEIYYPYGWTATIDDKPATIYPANYLLRAL
KIPKGTHTIVFTFDPPVIHKGKTITQISFIIFILLSAGFLFWDSWKNKKHSVQS
>EGEFANNL_00703 hypothetical protein
MAKLFEFIFFVVVAYFVFKFLNQFFTKTTIKTNHRNTNNQTKSQYKQQNQKSKTSDINWD
AETIDYEEIDSNENEKK
>EGEFANNL_00704 hypothetical protein
MKKSLTVLSVISALVLTIVSCKNKEESKLIDTSVQNSNTTKGDSLTHFNSPATPLINVLE
QPSTENLTGIYQSTDGAYHLVYNLEKGKTYNFNIREVNTQTQTLSASGKDENGEKKTVNE
TSKPLVQESIEPLSFTVSDFTDGVYTLQVKMGGRKLIMKADGKQQTILDTNGKQPTNPEQ
ARLWKMYKAISELSFIIKMNVNGSILQVSGFESIYDKAKNAVKNDLKGKELTEFINDFKK
GVNENVFKAQFENSLMKFPSEGIKVGGKWNNDPAMKGKGYNQLVSVDANTAVVKLFADIP
SQSQSDKKDGVSLKASLTGSQSGKIILDIKSGWVSKGTLTTSVTESQTASKDGDYQKMTN
KVVTNIYIN
>EGEFANNL_00705 hypothetical protein
MDEINLLDKKVQEYIYEHINADLVELRMKKSPFKNISSLQLVQQIQGKRIAQKKFPILFN
NDQIIYPPHLNLEQASSQSTALFKQKIIEGKIGTDLTGGMGIDTLFLSENRDKFYYVEPN
LNLFNITKHNFKVLKKDNIVLENCSAEEFISKQKTGLDFIFMDPSRRDENKNKKILLEDL
CPNVMEIKEQLFKLAPCVYIKLSPLLDIKRSIELLPIQKIYILSVKNEVKELIFKLHIDS
FSNNPEIHCINLESNQPSFNFNYNEENRCLCSKLSVPKKYLYMPNASILKSGAFKLLGNS
YQLDKLDNNTHIYTLDIKLENFPGRIFKVIDLNFQPNNYDVKKFNIITKNYPLNIDEIKK
KYKLLEGGNLYLIFLKAKNKTYKIVCSLV
>EGEFANNL_00706 hypothetical protein
MKIKYIFLLLIVSIAGILFYTNPSKPVVDNFIKQKFISVFNDKVSQEISQSNDPKLRLLA
NLGKNLLPLAGDQWINEKIDSRIRNKNYYLLTVIELNYRDQWNPIGIGIFNRVFLFPKVE
EEINNFDFKEEFNKLLH
>EGEFANNL_00707 putative amino acid permease YhdG
MLFKRKPIENIIEESGTKSNLKRSLGPIALIALGVGAIVGAGLFSVTGKAAGDYAGPGVM
ISFLIAAIGCAFAGLCYAEFASMIPVAGSAYTYSYATMGEFIAWIIGWDLVLEYSVASAA
VASSWTGYFNQFLLSFNIHFPVELLKTPFEGGIINLPAAFIVIAMSLVLMRGTKGSASFN
NFIVILKVSIVLIFIALGFKYINPENLTPLVPPNTTGKFGDFGWSGILRAAGIMFFAYIG
FDAVSTAAQEAKNPKKNMPIGILGSLLICTILYITFAYVMTGIVNYTEFSNAGTESLAPV
VIAINQMGNIGADGTIIPAYPWLNIFIVFSVLLGFSSIILVMLLGQSRVFFSMSQDGLIP
KIFSQTHSKFKTPVKSNFIFMVFISACAGFIPGSVISEMTSIGTLFAFVLVCIGVIVLRK
KNPNAPRGFKTPLVPLIPILGVLTCFGLMVSLPLDTWIRLVIWMILGFDIYLWYGIKKSI
MAVKDTDNDRRKSYTITSYCGIFVSIILMILTYLHHKLSDGNDQILIYFSVIFCVINLLI
FIYYIYKSKFNSK
>EGEFANNL_00708 6-phosphogluconolactonase
MIKENIQIFNTSDELSENFTKFLQNLLSVYPHINISLSGGSTPKQLFNYWSQNNKQNLKL
DWGRISFYWGDERCVPPDNEMSNYGMTEKYLFKNIHQIQTQNIHRIQGENDPTIEAQRYA
KLLNSNLAVYKNTPCFELILLGMGDDGHTASIFPDQMNLWNSENDCVVAKHPETGMQRIS
LSGKVINNAQHVAFLVTGKDKAEKVSEIIKNRSASETLYPAAKVNPSNGFLYWFLDKESA
KLL
>EGEFANNL_00709 Glucose-6-phosphate 1-dehydrogenase
MPTNKIANQILIIFGASGDLTYRKLIPAIFDLYKQNSLPEKFSVLGVSRTPFTDDSFREK
MKEGILKFSGLKPENEDELNKFCNILHYLPINTAESKDYSQLTLRLKEIDKNENTQGNYI
FYLSTPPSLYGVIPKYLAAEGLNIENNCFRRIIIEKPFGTDLKSAIELNSILKEDYKEEQ
IYRIDHYLGKETVQNLLVTRFANGIYEPLWNRNYIHHVEITAAESIGIENRGGYYDHSGA
LRDMVQNHLMQLLALVAMEPPMSIDATSIRNEKLKVFQALRPMKDDDLFKNVVRGQYLPS
NTNGNYYKGYREEKDVAKDSRTETYVALKLFIDNWRWADVPFYIRTGKRLPTRVSEIVIH
FRPAPQNLFPGQEIHKNNDNQLILRIQPDEGVSFQTKMKIPGSGYRVKNVNMDFHYSQLH
NVYLPDAYERLLLDCMMGDPTLYIDSGALEATWKFVQPLLDFWKNNTEAPLYGYPAGSWG
PENADRLIEGENKSFRYPCKNLSNDENYCEL
>EGEFANNL_00710 6-phosphogluconate dehydrogenase, NAD(+)-dependent, decarboxylating
MKIGFIGLGKMGGKMVERLLNQDHEVVAYNLTQKEIDDVCKKGAIPANSVKDLVDKLEGR
KLVWLMVPAGKPVDENIDELLTLLDQGDIIVDGGNSFWKDSIRRGKKLKEKGIYYLDCGT
SGGVWGLQNGYCLMYGGEKEPCDFAEPIFKSLAPENGYLRCGEVGSGHMVKMIHNGIEYG
MMQAYAEGFEIMKNSPYNVDLEKVSRVWMQGSVVRSWLLELIGNALDGNENLDGIKDYVQ
DSGEGRWTVEAAMEFNVPAHVITSSLFTRFASRQESSFAMKLLAAMRNQFGGHEIKKD
>EGEFANNL_00711 Adenylosuccinate synthetase
MSTYVVVGLQWGDEGKGKITDVLAEKSDYVVRYQGGNNAGHTVYVGENKFVLHLLPSGVL
QCKGKCIIGNGVVVNPEAFLDEISQIEKKGLSADHVFISSRAHIIMPYHILLDTYREEAV
GNTPIGTTKRGIGPCYEDKVARVGIRAIDLLNKDILKEKIKQNLIVKNALFEKLFDKEPL
SFQEIYDQYLDFSEKLKPRIIDCEYELNTAICENKNVLFEGAQALMLDVDFGTYPYVTSS
SPTTGGVSIGTGVPPTRLKNLIGVSKAYCTRVGNGPFPTELEDETGEQMRKVGHEYGAST
GRPRRCGWLDLVALRYSCMINGITHLVITKLDVLSGFDNIKVCTSYKTPEGDNIDKFPST
TEELSKYNATYTDLEGWKEDISKIKKFEDLPLAAQNYLQFIEDFLGIKIHLISVGPERSQ
NIIKTELD
>EGEFANNL_00712 O-acetyltransferase WecH
MAKILKNNYHIIWIENLRAIATLAVVLLHVASQMFYNFGKVSDMHWWASNLYINLGRFSV
PCFIMITGALILGRNYNWKNFIKKRFLRILCPFIFWSIIYIIYNLVRIIYKDSSKLNLNF
ILEYIQNKLAYGASYQMWYIYMLIGIYLIFPIFNKWIINSNRKEQQYFLLICLLNYLIQY
LPIDFLKTDVNISFFSESLGYLVLGYYLTNNKFNFDGKKRFYFLILISVFLISYLTICID
TYYSSIIKNSPIQKIKPWDLLQTISIFLLFLYIPYLNKKIRLLSIVNNYSFGIYLIHVLI
MDLLAKAGLAYYSFNPYLSIPITFICTIFFSILVLYLLSKVPYGKYITR
>EGEFANNL_00713 Amidophosphoribosyltransferase
MDKNYYQRNRFRKSENILFDSPEEECGVFGVYSTKNIDTFSLVQFGLFALQHRGQEACGF
SVLKEGTIYTVKQSGLVLDAFKSVEDTENYQGNAAIGHNRYTTAGDKKRYNYQPLFAKNE
YDRTILSIVHNGNLVGIDELRNRLEKEGVNFLATSDTEVMLRLLQKHLSNGLENAIKESA
KYLKGAFSVLTLTKEKLVAFRDPNGIRPLCIGVIDENTYVFASESCALDGVGAQYLRDVM
PGEMVIVDKNGLRSEMIYENPIRRICSFEYIYFARPDSIIENIEVYKVREKSGEKLYEQS
PVEADLVIGVPDSGIPAAIGYSKASKIPFMPVLIKNRYIGRSFIVPTQEMRERVVNLKLN
PIESEIKGKRIIIIDDSIVRGTTSKRLVKILQEAGATEIHFRSASPAIIAPCYLGIDTPD
KTHLISSQKSKEELKNYLNVNSLDFLSLENLYEILGSKNHCFGCFTEKYPVSKD
>EGEFANNL_00714 Phosphoribosylaminoimidazole-succinocarboxamide synthase
MEKKEFLYEGKAKQIYATEHTDKVVVHYKDDATAFNAQKKGSITDKGVINNEITTLLFEY
LQKKGIPTHFIKKLSDREQLVQKVSIIPLEVIIRNYIAGSMAKRLAIEEGTKSPVIITEI
CYKKDELEDPLINNDHAVSLGVVTYNELDEIFRITYKINDLIKDLFDKINIILVDFKIEF
GKNSKGEIILADEISPDTCRLWDKDTLEKLDKDRFRRDLGKVEDAYHEILNRLKTVL
>EGEFANNL_00715 Phosphoribosylformylglycinamidine synthase
MNKRIFIEKKNDFDFESQKLFTEIKDIYSINYLKVYLIYDIFNVTDKEYTQILNTIFSDK
ITDICYENIPVQEDYFAVEYMPGQYDQRADSAQQLISILTGNINCKVKTGKLYCIKGSFD
LQFIKKYLINPVDSREKDLTVLQDSYSQPPSNVKIYENFIQLDQQDLERFYNENNFAFDL
DDLKFIQNYFHQIDRNPTETELKVLDTYWSDHCRHTTFMTELKNISFVGNFKNTLESIFS
KYLSLRSELGRDNKPITLMDLATIAGRYFLKNGKLDDLVVSEEINACTIKVDVDVNGKKE
PWYLLFKNETHNHPTEIEPFGGASTCIGGAIRDPLSGRAFVYQAMRISGSGNPLEAFDNT
LPDKLPQKKITQGAANGYSSYGNQIGLATSHISEIYEEGYKAKRMEVGMVVGAVPQNWVR
REKPVEGDKIIVLGGKTGRDGVGGATGSSKVHDETSIHTLSAEVQKGDAVQERKIQRFFR
NKEVTQLIKKCNDFGAGGVSVAIGELADGLEINLDALPVKYEGLNGTELAISESQERMAV
VVEAKDVDKFIHLAQQENLLAVEAAKVTSDHTLTMIWRGQKIVELSRTFLDSNGTTKENQ
VSVNINEKIFDNEIINFTEEYFENELKSLNHCSQKGLIEKFDSTVGRTTVLMPLGGKNQI
TPAEGSVHTFPLLKGKTTTVSLATWGFSPEISKKSTLHGGAYAVVESVAKIVALGEDYKN
IRFSFQEYFERLGNNPEKWGKPFASLLGALQAQLAFECPAIGGKDSMSGTFKDINVPPTL
ISFACSVGSKENIISSELKNEGNYIYLFDHIANEDEMPNYEQLKNVYSFIHQQVIQGNVK
AIKTIKNSHPVIELAKMAFGNDLGFKVEIPNKKCIVGSLLIESKNEINHPNLTKIGVVTS
GDIFSVNSILYNISKLKKSYEKTLEPIFISNKSQDKNFEEIKIQNLNSEKSIQSNSISIQ
PKVVIPIFPGTNCEYESIQVFQEEGASVSSVIINNLNLNLLRESILNFETQLKDTHILML
PGGFSAGDEPDGSAKFMVSILKDESIKNAVHRLLERGGLILGICNGFQALIKSGLLPYGR
IQDVDENSPTLTHNFIGRHVSQMVTVKVHSDRSPWLKGMKDQTFTIPVSHGEGRFYANDK
TIKNLLENDQIATQYIDSNGKPSLQMPFNPNGSTYAIEGITSKCGQIYGRMGHPERFNSG
LIKNIPGSNYHNIFKNGVNYFKNNKK
>EGEFANNL_00716 hypothetical protein
MKNKFILLNLFVISFFNVKSQAQNRFGVKTNLQFTNVTNVHEDSKIRNFGLGIGFFSQVP
MNDYNDRFFLRPELFYSQQGGEQNKDNHLIKFYQNYLNINLLLKYYFPDQIFMSRQGCAC
HMKTNHEFFIEAGPQFGYILSENNKYLDDLEFGGSTKFDLSLGIGAGISIRRKFEFSLRY
NYGLTDTYRFYPKQNSTTNLAFSISYFFGREA
>EGEFANNL_00717 Putative esterase
MKNSEIINQLNQISKNTLIETLGIKFISFTEDSLIAELEVCSKVLQPMNFLHGGTSLALA
ETIGSCLSMTTTNLDENYVFGSEVNGYHLKPVKEGKIIAIATFIHKGRSTQVIEINIFNE
IEGKKFKNCFVTMINRIVKKDRIK
>EGEFANNL_00718 Isochorismate synthase MenF
MYKLPFAIIRLPKCSKYFLIENDKNGSNLYKFNSFNNSKQYILSYHNLIELHKPEFKNLN
FSLSKSEEVKILNKNDYITLVNKTIDYIKNSNALKIVISRNLWLSRSNINPINSFLALCD
ANPNSFCHLSVWNNDEIWIGSTPEILGYYDNSIFKTMALAGTLPNKNSYHWSEKEIYEQK
LVSDYIYQILNIYCDNISILGPETYGLNHIKHLVTHFSSQIKNDKSIYELINALHPTPAV
CGLPLNLSKKFIDENEGYDRDFYAGFIGLEDISFKKYFVNLRCGKLFSNGALLFVGGGIT
AQSNPEKEWYETEMKSKIIVECLK
>EGEFANNL_00719 hypothetical protein
MKRICHLIFLILLLNLINSCSNEDDLEGNRENSYSPKKETYYFYVTFGTMPSLYASLHAL
SHNNPTYFSCERINTFDVNLFPSNITFLYGDNNPNKISARDMMKNRIMEINRMEPNSVFE
FFVDDLRSRLGYDWFVAQGIDSSKVKVTLLSDGTATYNNFFDYFYNPSQGNAKWDDVASE
INNLKWNSVDKLITPKLAEYQSHDWPYYMSTLPNYTYFKQDKNLLETQSSYIKSQVMNMK
VKNISPLDLLNSLPLEKQNLFYNLTKFDKQKFSELFKKSPKKNLIIIGTTNSSAQEQYIS
QVYNEYSNEYDIFYKPHPADKDYLDYEKTYPGLILLPAQMPFEVFVWSLIDEIDVIGGNQ
STVFMTVPVNKIKFLFAKDSESLFKPLNLIFKDADIEWIQ
>EGEFANNL_00720 DNA gyrase subunit A
MTGEGEKLIPINIEDEMKSSYIDYSMSVIVSRALPDVRDGLKPVHRRVLFGMHELGVTSS
SSYKKSARIVGEVMGKYHPHGDSSVYDTMVRLAQEWSMRYQLVDGQGNYGSIDGDPPAAM
RYTEARLKKISEDILSDIDKDTVDTQLNFDDTLEEPKVMPTRIPNLLINGASGIAVGMAT
NMAPHNLSESIDAICAYIENREITIEDLIQYIKAPDFPTGGIIYGYEGVKSAFETGRGRI
VLRGRANFEEVHGREAIIVTEIPYQVNKADMIARTAELIKEDKLQGISEIRDESDRKGMR
VVYILKNDAIPNVVLNLLYKYTALQTSFSVNNIALVKGRPVQLNLKDIIHHFVEHRHDVV
VRRTNYLLRKAQERAHILEGFMKVIATQDSLDLAIKIIRNSSNPSEAKSGLIQEFELSEI
QAQAVLDLRLARLTGMELDKIREEYEAIMKEIEYLNNILNDEGLRFQIIKEELQEIKKKY
GDERRTEINFAGGEMSIEDIIPDEKVVLTISKMGYIKRTSLSEYKTQSRGGIGNKAASTR
DEDFLEYVVSATAHQYMLFFTEKGKCFWLRVYEVPEGSKASKGRPIQNLINIESNDKVKA
YILTHDLKNEEYTRNTFVVMVTQKGTIKKTSLEAYSRPRSNGINAINVRDGETLISASLT
SGNDEIMLATLYGKALRFPQEKLRSIGRNASGVRGITLGDDKDEVIGMVIISDSEKDTVL
VVSEKGYGKRTHADAYRITNRGGKGVITLNITEKTGGLIAIQKVSDDNDLMIINKSGVAI
RMSVEELRVMSRNTQGVRLINLRKNDEIAAITKIEKEEGVEIEEDIKDTENYSDLVNE
>EGEFANNL_00721 hypothetical protein
MKKIIFIFFTVSSYFSIGQVNSDECRKFTIGEFNNINNENLTLNSVIIRNKNKQLEIVNG
IKSNKNIRWLNDCDYILFFDKKEAKKDPFKKFINDNGGISISPEKIEGNTLYYKSYYFDG
KRGVKGSGKLIKTSSNPEFR
>EGEFANNL_00722 Signal peptidase I
MNLLQYYLIFGIITNILYFLTTWKLFQKAGRKAWESLIPVYNLLVTIKIIHRPWWWIFIV
FIPIVGPIMTIIILVDFISHYNRRSWMDALFVVLFSFIFLAYVNYSPQTKYIGKIERKET
LISAVLFAVIFATVIHTFIIQPFTIPTGSMERTLLVGDFLFVNKIKYGIRLPMTPVALPF
LQNKIPLGDSSKPQHQTNSYIDNIRLPYFRLPGWTDVKRGDIVVFNYPTDSLHTAIDRKD
PYVKRAVGVPGDILEIKDANLYVNGKPENIKKDEEQQRKYNIYTNESGISPKKIDDLLGY
APYFETQSEIRDKRKYTFEGLTTENLNLIKNLNTVDSVAQDIAKVGVQDLRINAYGKIDS
AQSIFPITKHWNRSQYGPIQIPRKGDVIHLNHENIEQYRDIITRYENNDLKIVGNQFYIN
GTPTDNYTIKQNYYWMMGDNRDNSLDSRYFGYVPENHIIGSPVFTWLSIQGLFENTFKTP
SGEKVDGYGHKAKFKIRWDRMFKIPNTDTLPKDKTSYLPYFIVLLIAYFSYDYFKKKKKK
KLKNQ
>EGEFANNL_00723 4-hydroxy-tetrahydrodipicolinate reductase
MKIALVGYGKMGKAIETIAEAQGDQIVARLEEKPTKENINEADVAIEFSTPQTAYDNVVA
CLELGIPVVCGTTAWLDRLPEVEKICSQVNGAFIYASNYSLGVNLFFEINKRIAQLMKNH
PDYTISLEEIHHTEKKDAPSGTAITLAEEIIPIYHMDGWKLSSESSSNQLAIEAKREKDV
PGTHTVLYNSEVDQIEIKHIAHSRKGFASGALVAAKWLVGKKGIFTMKDVLGL
>EGEFANNL_00724 hypothetical protein
MIKIILLIFSFLTISIVKSQHSKQDSLISVQEDLIIKNTNRIDSLTQSLTRSPLKASLYS
AILPGLGQMYNRKYIKAPIVLGVIATGVGFIKHYDDRYNKYHKAYLAQLSGKPHEFSGVQ
GIDARVLANAQDTERRNRDYAIVLTTLAYLLNIVDAAVDAHLSIFDKDKDLAIKPVILED
PNTVLYNQKLGLAFSFNF
>EGEFANNL_00725 putative chromosome-partitioning protein ParB
MSGDKKRAMGRGLSAILSENSKKVNSAEEKGAEELVGNIVEISLEDIITNPNQPRSNFEE
KALKELSISIQQLGLIQPITVRKNGSKYDLISGERRYRASKMAGLKKLPAFIRLANDQEL
LEMALVENIQRRDLDPIEVALSFEKLIEEIQITQEDLSHRVGKDRSTITNYLRLLKLSPI
IQTGIRDNIISMGHGRALISLEDHGQQIFVYEKVVKEQLSVRQTEALIRTIKNPKEKKDK
KVRELSNSLKKGLKTFEDFFETDKVEIKASDKGKGKIIINFNSEEEFQRIQKFLEN
>EGEFANNL_00726 Sporulation initiation inhibitor protein Soj
MGKIIAIANQKGGVGKTTTAVNLAAAIGVLEKKVLLIDADPQANASSGLGIDVDQVEVGT
YEVLEHSAQAKDAIQNTTSPNVKLIPAHIDLVAAEIELVDKEKREYMLREALQDIKSDFD
YIIIDCAPSLGLITLNALTAADSVIVPIQCEYFALEGLGKLLNTINSVQKLHNPTLTIEG
LLLTMYDARLRLSNQVVEEVKTHFPNMVFESLIQRNVRLSEAPSFGESILKYDAESKGAI
NYILLAEEVLNKNKEEVK
>EGEFANNL_00727 30S ribosomal protein S10
MSQKIRIKLKSYDYNLVDKSAEKIVKTVKATGAVVNGPIPLPTHKRIFTVLRSPHVNKKS
REQFQLNSHKRLMDIYSSSSKTVDALMKLELPSGVEVEIKV
>EGEFANNL_00728 Elongation factor G
MSRDLKYTRNIGIAAHIDAGKTTTTERILFYTGVNHKIGEVHDGASTMDWMAQEAERGIT
IQSAATTCSWNFPLTDDGKKVADTHAYHFNIIDTPGHVDFTVEVNRSLRVLDGLVFLFSA
VDGVEPQSETNWRLADNYKVPRMGFVNKMDRQGADFLNVCRQVKDMLGSNAVPIVLPIGS
EEDFKGIVDLVKNRAVVWHNDNFGSTFDIVEIPEDMKEEVQEYRQFLIEAVAEYDEGLME
KFFEDPDSISEEEIHEALRKATIDISIIPMVCGSSFKNKGVQFMLDAVCRYLPSPIDKEA
IEGTDPKTDEPISRKPSAKEPFAALAFKIATDPYVGRLAFFRAYSGHLDAGSYVLNTRSG
DKERISRIYQMHANKQNPIEYIEAGDIGAAVGFKDIKTGDTLCDEKAPIVLESMVFPDPV
IGIAVEPKTKADVDKLGLALSKLAEEDPTFQVKTDETTGQTVISGMGELHLDIIVDRLKR
EFKVEVNQGQPQVEYKEALMQSADHREVYKKQTGGRGKFADIVFQLSPADEGKVGLEFVN
EIKGGNIPREFVPSVEKGFKEAMKNGPLAGYEIDGMKVILKDGSFHPVDSDQLSFELAAK
LGFKEAARKAKPVIMEPIMKLEVLTPEEYMGDIVGDLNRRRATVNGMDDRNNAKVIKAFV
PLSEMFGYVTSLRTLSSGRATSTMEFDHYEAAPQNVADDVIAKAKGTNA
>EGEFANNL_00729 30S ribosomal protein S7
MRKTKAKKRPLLPDPKFNDQLVTRFVNNLMKDGKKSIAFKIFYDALDIVESKKEDQEKTS
LEIWKDALENVMPHVEVRSRRVGGANFQIPMPIRPDRKISMAMKWLIKYSRDRNEKSMAQ
RLAAEVIAAAKEEGAAVKKKTDTHRMAEANKAFSHFKF
>EGEFANNL_00730 30S ribosomal protein S12
MPTIQQLVRKGRATLTKKSKSAALDSCPQRRGVCTRVYTTTPKKPNSALRKVARVRLTNG
KEVNAYIPGEGHNLQEHSIVLVRGGRVKDLPGVRYHIVRGALDTAGVQGRLQRRSKYGAK
RPKDKK
>EGEFANNL_00731 hypothetical protein
MKNKNLLLLALFLCLFLVSSLALYHKNMYKDAYAYLKVKLFKSINKDIVHLKLKPDNLAD
KSKEAYQFIQNNGYDTTHAILIDFSIHSGKNRFYVWDYNENKAIIKGLVAHGYGNENFRS
TQEKIVFSNVPNSYTSSLGKYKIGVRAPSQWGTKIHYKMHGLEKTNNKAFSRIIVLHSYS
QMPDHEIYPEHIPLGYSQGCPVIDNKTMEKMDSLLKNKTKPVLLWIYN
>EGEFANNL_00732 hypothetical protein
MDLQDQLKKLFPDHKIENNEEDCLSNDNELFFQDDPIICKYEKKGRNGKPVTILEGYQGD
DDDFKKLAKEIKSILGVGGSAKEGIIILQGNYRDKVMDILKNKGFKVKRVGG
>EGEFANNL_00733 Alkaline phosphatase PafA
MKKKFLSVFLIIFSLAFSQNQKPKLVIGIVVDQMRTEFLFRYSSLFSDNGFKRLLNDGFF
YSNLHYNYVPTFTAPGHASIYTGTTPVNHGIVANEWFHRGLKRDVYCTEDFSVVSLGNPD
KNKEGQMSPKNLQSSTITDELKLATNFKSKVYGISMKDRGAILPAGHFANRAYWISDNGN
FISSNFYGNEFPSWVTSFNESKRYMKYIQEGWKLFKDISYYKDCLPDDNPYESTGLKIHK
KAVFPYLLTEDFAQTGPKVIKSTPFTNNLIVEFAEELIENEKLGNGDVTDFLTLSFSATD
IITHLTGPRSIETLDTYLRLDDLLGKFLTFLDKKVGKGNYLLFLTADHSGSENPKHLKDH
GYDISSLNAKEMENKLRAYSIEKYGKDLILSYSNQNIYIDDALISPSKKFNEIVKDFANF
IESFPEVKRAYTEDEILNISAVDEHGSMIFRGYDKKQNGQIYVLLKPGYIEYKPQGATHG
SSYTYDTHVPLIFYGWKTPHGTSSEKHYITEIAPTIAQKISITFPNSTNSQILSEVIKY
>EGEFANNL_00734 Aromatic amino acid transport protein AroP
MEEENKNLNKGELKRSLSNRHIQLIALGGAIGTGLFLGIGPAAVLAGPSVIIGYAIAGFI
AFMIMRQLGEMVVQEPISGSFSQFAYKYWSPFTGFASGWNYWLLYILVSMAELTAIGTYV
QFWWPEIPLWASSLFFFVIINTINLANVKIYGEAEFWFSIIKVVAIVAMIIFGIYLLLSG
SGGPKANISNLWSDGGLFPKGFFTSDGSGGYQGLLSSLAFIMFSFGGLELIGIAAAETDH
PEKTIPKATNQVIYRILIFYVGALIILFSLSPWREITIKTSPFVTIFNSLSGFQFDLFGT
TISFTKIIANALNLVVLTAALSVYNSSVYSNSRMLYGLSKQGNAPKFLSKLNKNHVPIMA
ILVSAIFAAICVIVNKIMPEEALEYLMSLVVSCLVLNWIIITITHFYFKKALKNQGIIKT
KFPSLWYPIGNYICLFFLIAILIIMWFTGMKLSVELIPVWLIVLFICFHLLKYKKIKKGS
>EGEFANNL_00735 hypothetical protein
MTVEVLYEGSLHTEATHIQSGTKISTDAPKDNHGKGESFSPTDMVASALASCMLTVMGIK
ASSMGIDIKGTKAEVTKIMNAEPRRIGEIKVIIFFPLLNLEDKQKTILERVAYTCPVGAT
LSPEVKQTIQFNW
>EGEFANNL_00736 Chaperone protein HtpG
MAKGNINVSVENIFPLIKKFLYSDHEIFLRELISNATDATLKLKHLTNTGEAKVEYGNPM
IEVKINKENKTLQIIDQGIGMTEEEVQKYINEVAFSGAEDFISKHKDAEKEGIIGHFGLG
FYSAFMVADKVEIITKSYTDAPAVQWVCDGSPQFELGPSDKKDRGTEIVLHIAEDSQEFL
EEYKIRELLQKYNRFMPIPIKFGTKEETLPLPEGADKDATPEKVIVDDIINNPNPAWTKA
PSELKEEDYKAFYHELYPMQFDEPLFHIHLNVDYPFHLTGILFFPKLGNNLNIDKDKIQL
YQNQVFVTDEVKGIVPDFLMLLRGVIDSPDIPLNVSRSYLQADGAVKKISSYITKKVADK
MVSLMNDNREDYEKKWNDIKVVIEYGMISEEKFYEKSDKFALYPTVDGKYLTFEELKDKI
KDNQTDKDGKLIILYASNIDEQDQYIQTAKEKGYEVLLLDSPIVPHLIQKLETTKENISF
VRVDADHINNLIKKDENIASILTDEEKETLKKDLEETIDSKTYTIALENLSKDDAPFILT
QPEFMRRMKDMQQTGGGMFGMMGGFPESYNLVVNTNSALASDILKKENKDEKATIIKQAL
DLAKLSQNILKGKDLTNFIKRSFDLIK
>EGEFANNL_00737 Foldase protein PrsA 1
MNRILLILTFFASLYTYSQERKLDGIVAVVGDEIITDTDIFDAENYAKSEGQQITDRCDF
LENMMKEKIILYKAKQDTLISVSKDEVNREVDSRLDGYKNYFKTDQELLLNFKFKTMAEL
RSVLETMVRNQMYTQRKMFEITKNVDISPEYLRAFYQAHENEFPYLNDEIEYAQILMYPQ
LTDAHKQELINQLKDIKKQIQEGASFAEMAKTYSEDPGSAPNGGQILNVRRGIMVKEFDA
VAFSLGEGEISEPFETEYGYHIIYLEKKRGQIIDLRHILLQSKPNQEEIAAALDKLKKIR
EEIISDKITFNEAVTKYSDDKLTKYNGGLLSNQKTGDNRFERSKLARKDSYNLLGLSKGD
VSEAFEDDLNNRTGVKLLKITEVIPSHKMNLETDYNRIKGFAEKTKQNEVVEKWVETQIP
STYIKVQDSYKNCKFSNHWLKN
>EGEFANNL_00738 hypothetical protein
MNKLAFFLGLFTTTSLYSQSVLITINKDTIYTQNFLEEYSKSLDILGTDTTIDNFIDYQL
IKQYGLSKGVDKSVSYLKELSNKHQMIQDSLYYPQEILKPLLQDYFNKLQLEKKVQIFIF
NKDNFKDKSVDQQKLFIDKTIRSIKNNTKLFEKAANEYSVESKWIEPKYLDVFSINKNLL
DAIYDAPIGKVVIYKDEEGNNYLILVSEEREWLGQVRLEEIKIDDPTDNGKLIIEAIYKQ
LKNGDKLENVKQKYSKVTDKTILLKHFENKEIYNYIISQKNKLPLHREYSKPIKTNEGYV
IYKLVFLDEFKDYNLASSKIFYELKQNNLLEELDRKLIDILKKKPFFNSNSIAINNFINN
LPNNFKEFSNYSENRIIDLIKIGNENNEDYILTNQKLLDQLKYQLTSYNYINRKFIVDEL
INNWQDTKLIEFYKENFYDMDDVKKRLKLEEDQLLVKYTVSLLTNQSYADDEGQQQFLND
HKSKYIWKERIDGTFYYCLNQEVEKELLSLLKNNQSVDDIKNFYKAKMDHENNPLVIIEQ
GKFPAKFLGFSSDTKLSKGIKVLDSKNRRLVMDIKNIIKDEPLSLEDFKKYYIKDYVDYK
IHENIKQMKNNAVINKNIIEINTLKKKYN
>EGEFANNL_00739 hypothetical protein
MNEMKRWSKIENFMKIKFNQDETPDLNTIIFLIGLQEFGGGYRRYKKDDKMNLIHIAVCR
LLEPFGYYKFDRFDDDGWPHYITLEELPDLKSNEQMLLIKKAIIQYFEDEKLIEDF
>EGEFANNL_00740 Adenylosuccinate lyase
MNKYQNPLESRYCSDEMLYNFSPEKKFTTWRKLWIALAEIEKELGLDITDEQIKELKDNI
SPIDFAKANEYEKKFRHDVMAHVHTYGDVAPKARPIIHLGATSAFVGDNTDLIQIKDGLE
LVKKKLINVIKGLHDFALKYKDLPTLGFTHYQPAQLTTVGKRATLWLQSALLDLEELDFR
IETLRFRGVKGTTGTAASFKELFDGDFNKVKELDRKLSKRFGFTHVFKVSGQTYDRKIDA
QALNILSNIAQSAHKFTNDLRLLQNLKEIEEPFEKNQIGSSAMAYKRNPMRSERIASLAK
FVISLASSPAMVASTQWFERTLDDSANKRLSLPQAFLAIDAILIIWNNILDGIVVYPKMI
EKHIQEELPFMATEYIIMEGVKNGGDRQELHEIIRTHSMEAGKQVKIEGKNNDLIERIIA
DSRVNIDKDKLLNLLNPSNFIGFAPEQTEEFLDGEVNPILNKYKDLLGIDTDLKV
>EGEFANNL_00741 Ribosomal RNA large subunit methyltransferase H
MKITLLAIGKTNSKELINLIKSLEKRLPSFIKFERKELPDIKNAKNLSENELKNAEADLI
ISQLEPNDVVYLLDEKGVEYTSMEFSLLMDQHMNNSVKHLVFCIGGAWGFSQKMYSLNPH
KIALSKMTFTHQMVRLFFVEQLYRAFSILQGKPYHNE
>EGEFANNL_00742 hypothetical protein
MNNYLKLNGYEIALYLIIFFIGGNLIGAILGGVALFLNINTYVVIPIATLLSYGLVYFSY
SNFKKQSKKEIFKINYSLKNFKYFPLILIIFIGQFFISEFISSLIPTEGKIFGKLYQTMS
YGLLGNFEKYPWITFFSICILAPFLEEIFFRGFLLKGMLNNQVKPYKAIIISALLFGGIH
FYPWQIVGGFFAGIVLGLSFYKTGSLLICTLLHFLNNFLGFLLFMKYHQLEMPTLGLNEY
LTFFIGILIVIFFGYIYLKQTKNYEWRSF
>EGEFANNL_00743 Non-canonical purine NTP pyrophosphatase
MEILLATQNEHKKEEIINILPQNFNLKTFNDYNFKGEIEESGKTFEENAYIKAKFGFDFT
NIPCFADDSGLVIEALNGEPGIYSARYAGTGSFNDNIAKVLKNLEAHSNRNAYFISVICW
VFKNEVQYFEGKIHGTISENIRGENGFGYDPIFIPNGYDISFSEFPPAQKNLISHRAIAL
NKFTNFLNQKLGINK
>EGEFANNL_00744 D-erythrulose-4-phosphate isomerase 1
MNKKKIAIGCDEAAYDLKVVLKDHLEKLGYEVKDFGANKGEVVLYPDVAASVAKAVAAGE
FERAVLTCGTGIGMAITANKIPGVRAAVCHDSFSAQRARKSNDAQIICFGERVIGVELAK
NLLDIWLESEFSGGGSAPKVQRICDYEAEYNK
>EGEFANNL_00745 hypothetical protein
MTDILNCPKCSQENVYFDGTSNVCPDCFFEWSGEENEVSSIPLDSNGAELKDGDAVTVIK
DLKVKGSSMVIKRGTKVKSIRLTENSDEVDCKIDGSSIVLKTCFLKK
>EGEFANNL_00746 Glutamate 5-kinase
MKGRIVIKIGSQILTKKDGTLNVTQMSSLVDQLAQLHKDNYEIILVSSGAVAAGKSEIQP
KFKLDSVSSRQLFSTIGQVKLIQRYYDLFKQYNIVCGQILATKDDFSTRKHYLNQRNCMK
VMIDNGIIPIVNENDAISVNELMFTDNDELSGLVATMMNCSKLIILSNIDGIYTGNPSNP
ESSLIEKIYPGDDHIKQYIQTTKSSAGRGGMKSKYNIAKKVAEEGVEVIIANGETSNILI
DLLNNNAIKSTTFITSKKSTSNIKKWIAHSEDFSKGKIYINAGAKDALLGNKAISILPVG
VVKITGEFEEGDIVEILDENENSIGVGCSSYTSNKAKNCIGLNNLKPIIHYDYLYIGK
>EGEFANNL_00747 Gamma-glutamyl phosphate reductase
MKENFNHIFKNSVQASKELSLLCESTINEILNLLAKETENNIDYILSENKKDTDKMPITN
PKYDRLLLNQSRIENIIEDLKNVAKLPYPVGYNFFEKKLNNGLIISKVSVPFGVVGIIYE
ARPNVSFDVFSLCLKSGNACLLKGGSDAYHSNQSIVNIIKKVLEKTNVNSDVCTLLPTDR
SATDALLNANRYVDLVIPRGGKELIEYVRKNSLVPVIETGAGVCHTYFHEDGKVEFGEKI
IHNAKTRKVSVCNSLDCLIIDESRINDLPKLCESLVNEKVIIYADDASYKALLNTYPQSL
LTNADEQSFGTEFLDYKMSIKTVKGLDEAIEHINMYSSKHSETIISENLEAIHKFETLVD
SACIYSNASTAFTDGAQFDLGAEIGISTQKMHARGPMALKELCTYKWIIKGNGQIR
>EGEFANNL_00748 hypothetical protein
MMRKNLIYFIVALFSVSAYSQTQNSLDEKDFTIKRNKYYENEEGVKVPLRYGQKYSKKTM
KVSDENLDESYDQIETNQESSILIAINEDPQIFAERIIKSSKSKYSYLEKRSKEGAESFT
FRYIPKNATNKEEYHAKKTCADCMDIEFRKNPSDSSYTFSNVWGNFNDLFSVWKKIFKKD
AKESDYQVTADNLLAEWTTFYGGREVAFGRLGEVWYIIMK
>EGEFANNL_00749 RecBCD enzyme subunit RecD
MEKTIDENKNLEQELAYKLICYTHKNIFITGKAGTGKTTFLKNLKEKSEKNTVIAAPTGI
ASINAGGVTLHSLFLLPLTSFIPVNHVNEDRNIAITKQEAFQHFKYNKEKRKLLTELELL
IIDEVSMLRADILDAINWALQSVRKSLQPFGGVQIVMIGDMYQLPPVIKEEQWKILKNYY
KSLFFFDALVLQNNQPICIEFKKIYRQADPVFINLLNAIRYQDYDSIDFNLLQKRYNPNF
NPEHFGYITLTTHNHLADSINQKALEKIENPIHYFDAIIDGTFPENSYPTEAELILKEGT
QIMFIRNDSSGERRYFNGKIGIIEKIEDFDIYIRFENQKDLLKLEHEVWKNIRYIVDNET
GKIKEEELGSFSQFPIRLAWAITIHKSQGLTFDKVIIDAGKSFASGQVYVALSRCRTLEG
IILKSLIQNSNIIQDIKIKEFQEQMWNLNELEETLEKEKYAYALDNLFKTISLKELTTEI
NEWKKITIEKNIPEKESVLELISSIDETLNYLQIVLYKFETTIYQWFNKYKDLSLKIEIW
NKIKTRSISAVEFFIEELFTKVWKPILSHYLEYKNKSRITQYLRFVEEIEESLKNKIKQI
SIAKLIDDRLSYKDIIFISDSGKTVSKEKNNTVEITLELLNQGKSIDEIAKERNLSISTI
SNHVSRLISQNKVSVFNFISKEKYEKIENEIKKMENIELKLLKEILGDNYSYDEIKYVRS
NLSK
>EGEFANNL_00750 putative lipoprotein YiaD
MRKIKLKRLALLNFGALALVLTTVSCKCDKNTNHSATATSSTTSKSDSLSSEQLLVKETI
VGKLDSAGNFIYDTGEISAITLPNNIKLEGVGNNSTESKLFNFLSDSSISVDETDKTKGW
ITLDRVYFNTGSATLTNESSKQVKNIAEILKAFPNAIVKVGGYTDNTGSEEINNKVSAER
AKKVEDELVKLGISTSQVSSEGYGPQHPVCPSNDTPECKAKNRRVDIRVTKK
>EGEFANNL_00751 Ribosomal RNA small subunit methyltransferase B
MDNKKIKTHRNLIQGLEQAIKTSFFEPDKYADKVLERLLKLNKKWGSKDRGFVSESFYEI
IRWKRQLEFYANREMKDDNIYFIIATYLLLNKQEIPPFPEFEKIYIKKIKERFKKPFPSR
AVEFSIPDWLQSRMENELGSSWIYEMKALNIPASTIIRVNTLKTHADELQKSLEEEKVAT
NFIQGYKDALVLERKQNIFKTKAFQDGLFEVQDASSQLVGEFLEVKPGMRVIDSCAGAGG
KTLHLAALMENKGQILALDIHEWKLQTLKQRARRNGAHNIQTKAVTDSKILKRLENTADR
VLIDAPCSGLGVLRRNPDAKWKLNNEFIYRIIDEQKQILQNNSKLVKKNGYLVYATCSIL
PSENSHQVENFLSKNPDFELIDEKKIMPSTSNFDGFYMAKIVRK
>EGEFANNL_00752 Dephospho-CoA kinase
MFIVGLTGGMGVGKSTVANIFNEQGYPVYNSDSNAKILMIQDCQLKSKIIDLLGPNAYIG
DDLNRKFIADQIFSNPELLRKQNLIVHEAVKNDFAKWISTQESKICIKESAILFESGSYL
GCDATIAVIASEKIRLKRIMQRDGWSLREINDRLKNQWSQEKIKNLTNFCIVNDADLENL
KSQVQNTIEKLKTYFKLNV
>EGEFANNL_00753 hypothetical protein
MKLIKLNRNKEEILNTISHAAGVLFGIFGLIYLLFKNKKNTDFSTISIWIYGVSMIALFL
SSTFYHYLESGKLKNRARILDHMSIFLLIAGTYTPVCLITLEKSSGWLLFTIVWSIAALG
IILKIFLTGKVDKLSLLLYLSMGWLIIFDIRNIIDLMSLQALIFLIIGGLLYSLGTIFYV
IEKIPYSHFIWHLFVLGGSISHFFMVDSLV
>EGEFANNL_00754 N-carbamoyl-D-amino acid hydrolase
MAKIKIGLVQSSCSNNIENNINKAIEGIKMAAKDGAQIVCLQELFSSLYFCDIEDYDNFK
LAEPIPGPTTDKLTQIAKELKVVIIASLFEKRSQGLYHNTTAVLDADGTYLGKYRKMHIP
DDPAFYEKFYFTPGDLGYKVFHTKYAKIGVLICWDQWYPEASRITSLMGADILFYPTAIG
WASTQDEGTNTEQYNAWQTIQRSHAIANGVHTVSVNRVGYEQEGAMKFWGGSFVSNPLGS
ILYQASHDHEEVKVIEIDTEKSDSYRVHWPFLRDRRIDSYQPICKRFIDED
>EGEFANNL_00755 hypothetical protein
MLKFLIINPIPRPSIDDNLINYIVLSSLFILVLSRIVLLPKKESFFRFKALMGEDENFTL
FTSICALLYLIFLSLVLVPFFKIHIPFNNSQLAKISLIFTFLCIYHVTSHVLGNSFIYIL
GKKEEYKVNNINNFRFTFIKLVISILLCFIIYYTNIPRFYALNIAIFTLGIILTLEWIYL
MFFIKKNINIPNYYDFLYLCAFKILPTLCLIKIAFLGEEL
>EGEFANNL_00756 hypothetical protein
MKIKSVLVSQPEPIGDSSPYFDLQKKHKIKIDFCPFIEIEGANAKEVRIQKIDFSNFTAI
IFTSRNAIDHFFRLAEEMRFTVPDSMKYVCQSEAIALYLQRYIVYRKRKIYFGEKNIQSI
IPLLKKNQKEKYLLPTSDMLNQDIPDALDKAEVDWTRAILFRTVSSNVVSNIKDIYDYDA
LIFFSPYGIKSLFDNYKDFKQGNIHIGTFGASTKFTAEEAGLKVSLFAPTKESPSMTKAL
DDFLQ
>EGEFANNL_00757 Phosphoribosylformylglycinamidine cyclo-ligase
MTTYKDSGVDKEEGYQTVSKIKDEVSQTHNPNVLNNIGSFGAFYELSGYKNPILVSGTDG
VGTKLRIALDSEIYDTIGIDCFAMCANDILCHGAKPLFFLDYLACGNLDSDIASKIILGI
VKACKETKTALIGGETAEMPGMYKKGDYDVAGFCVGVVEKEDIIDGTQIKKDQVIISLPS
SGFHSNGYSLIRKIFTDINENFEGQPLYKTLLTPTRLYQNDIFKILEKYPVYGIAHITGG
GIIENLPRIIPNGLCANISVSSIHVPSIMKELQKRGKISNDEMFGTFNMGVGMCIIVDEE
NSLPILNLIEGSSIIGNIINNSKKIILNF
>EGEFANNL_00758 hypothetical protein
MKRIIKKSPIFLIFCLLIIILFPLKINAEYSPEKQMNEGSKHSILFPKVSNAKVIHEIIE
IDVVPYFNDPKDYFVNYNITYHIESDHEQILPLIFIASNFKNSPINILINGKEVNTNSIL
DNQNLIFSIFPYIKSDGNENVCIIDTKNNVNLFNIKELVYFNSLLKKGKNEIHLNYKGNL
ESNNYGFLKNYNLDYYLFPYKFWNSFGPIFVKLNTPPNYKIKQSSIGNPSQKLSKNLYFW
RLNKINKKEFKISLSPKISTLSYFLLLLKPVGITLTFGLLISLIHIYFIKKFRKKDNHSI
NYYLILGNIINPPLFYLTYCLSFKLIEWSLGSIALKNYEYIISPILYLPLIYVLYDYTMW
FLDISLKNNTSLKNT
>EGEFANNL_00759 Phosphoribosylglycinamide formyltransferase
MNIAVFVSGGGTNLQNIQDAINTGILENVKIELVIADRNCYALERALDNDITTYLVDRGN
EISTQIDEILSSYSIDFIVLGGFLSILDSNFCNKWANKIINIHPSLLPKYGGKGMYGEKV
HQAVLDAGETESGSTVHFVTSEVDEGKIILQKSFQINENDSAKDLQKKIQVIEKEILIKS
IQMLCQS
>EGEFANNL_00760 Organic hydroperoxide resistance transcriptional regulator
MVSVDSSNELSQITENEKTGFLLWKVNNYWLRSFKKRFKDLDITHSQLLLLLSIFWSKTN
ELNLTQKELSYKSGIDAMTTSTALRTLQKKGLIIRNINNKDTRTHLIEITEKGKTIVEKA
NDIIKNFNNSFFSCLKDQQKQFQENLINLLLSDENSKQHLLKYYQKELEKFNITVENK
>EGEFANNL_00761 Efflux pump periplasmic linker BepF
MKIKKIKIILALFIITSLQLTSCKNDSKTGAAASMQQNAVKPYPVQVLSEQPTTLYVDYP
ATIKGTQDIEIRPMLEGFIKTIEVDEGSTVRKGQVLFTLDAPQYEQNKLNALAAIKTAEA
DLNNAKMEVRKVTPLVEKGIVSKYQLEAAKYALEAKQAALNQAYTTLANAETNVSYTRIV
SPVNGSIGSIPYRLGSLVNSSTTLTTVANTADVYVYFSINEKQLLDLLKTLPGKSQNEKL
KHIEPVKLILSTGNEYIDSGRIDAISGIINTGTAAANMRAIFPNTQGILKSGLSGTVRIT
NTIKNALIIPQKATYEIQGITFVYVVQNDNKVKQVSIKVTPTPDGKSYVVDSGLKANDKI
VINGIQNLKDGMEIKPQL
>EGEFANNL_00762 Efflux pump membrane transporter BepE
MFKIFIERPILSTVISIIILILGGIGMVTLPVAQYPEIAPPTVQVTANYPGASADVVLKS
VVIPLEEQINGVDNMTYMTSTASNDGSATITIYFKQDANPDIAAVNVQNLAARANSLLPA
EVTKNGVIVQKTQSSNILFMGLISKNPNFDQKFLQNYANINILPEIKRINGVGDAQARGG
NTYAMRIWINPDKMAIYGITPSDISAVLAEQNLEAAAGSFGDNSNQTFEYPLRYTGRLTD
AKQFQNIVLKSLPSGDILRLKDVADVEIGAESYQVTSTIDGYPSTIISVSQTAGSNARKI
IEEVEVTMKEAAKSYPSGIETVFMMNANDFLNASIDKVIHTLIEAFILVFIVVLVFLQDL
RSTIIPAISVIVAIVGTFFFLLLLGFTINILTLFALILAIGIVVDDAIVVVEAVHSKLEN
GMKDSKKASIHAMTDIAGAIVAITLVMASVFVPVSFIGGTAGVFYKQFGLTLAISIVISA
VNALTLSPALCAIFLKPHSDDKHKTTFITRLKDGFNVAFKKTTNKYKRILILTSKAKWSV
FAIILVFSGLLYYLMKTTPTDFVPQEDSGFILSDISLPPGSTMEQSTKIGDEVNKIASKI
NGVEHIAQLNGLSFLSGAGGNYSVVLVKLKPWSERPNINIKDVVKELFIKTAHIQGARII
FFGAPTLQGFGNSNGFELQLQDKTGGSLSNFYEVSQQFLGALNKRPEIQYATSSFDPNFP
QYEMSLNIAEIKRAGLKATDILGALQGYVGGIYASNYNQFGKQYKVYIQSHPSARKNLTD
LDGMYVRNASGDMAPIGGFVTIKPTNGPQTLQRFNLYQSIPVSGSPNQGYSAGDAVNVIN
EVAAQTLPQGYSFEYSGMTREQVKNSGSQTVYIFILCLVFVYFLLSALYESYILPISIII
SLPIGIAGAFLFAKLFGITNNIYLQICLIMLIGLLAKNSILIVEYALERRLHGLSIIDAA
IEGAEARFRPILMTSFAFILGLLPLMFASGAGAEGNRSIGTAAVGGMLIGTIVGLVVTPM
LYVIFQTIQEKITKIKPATTVKEDLEDDDL
>EGEFANNL_00763 Outer membrane protein OprM
MKIQPIQYITILALAGSLTSCVTAKYETPEIIDNKLYRDMNSKDSTTIADIPWSNFFKDI
NLQNLIKEGLQNNLDLQIAVTRIKQSEASLRSAKLGYLPTLSAEASYSNSKLNEVKGSGF
RTHSEIPQLSATASWEADIWGKIASTKRSALASYYQSDAYRLVTQTSLIANIANSYFNLL
AYDEQLKIMKNTIKLLEDNVQTMQYLKEANIVTGAAVEQSKALLYSTKLNVPDLESNIKT
LENSISLLLGKEPGPIVRSKIEEQVIPTELEYGVPVQLLSKRPDVMMYEYAYRASFENTN
IAKASLYPSLTLTGNVGYSTYQNLNNFFDYSSMFANIVGGLTQPIFNQGKLKSQLRISQA
KQEEAFLNFKKAVLNSGMEVSNALYSYEKAKSKDTGRNLQIEALQKSVDFTKELLIYSNA
NYTEVLTAEQNLLSAKLNQVNDRLQQLQSAINLYKALGGGVN
>EGEFANNL_00764 Small ribosomal subunit biogenesis GTPase RsgA
MKQATIIKSTGSWYLLKDKITSTIYEARIRGKFKKEKISTTNPLAVGDEVDYELHEDGVA
WITTIHPRKNYIIRKSVNLSKSTHILASNIDLACIIFTIKNPQTSLGFLNRLLITCEAYH
IPVLIVINKIDLLINEEDLKEIKEVTHIYKKIGYDILEISANKNINIDILKYLLKNKVSL
FLGHSGSGKSSTINALQPDLDLKTSVISNSNDKGKHTTTFAQMYDWSFGGSIIDIPGIKE
FELVEISKEELQNFFPEIYKFRSWCKFHNCLHLNEPNCAVIKAVDEDEISQRRYSNYLKI
LKDL
>EGEFANNL_00765 Phospho-2-dehydro-3-deoxyheptonate aldolase
MSIRDINQDWINQFDKPLIIAGPCSAESEKQVMEIAERLDKDYVQVYRAGIWKPRTKPGS
FEGVGAIGLNWLRRVKEEFGMLTATEIANASHAKLALEFDIDYLWIGARSTVNPFAMQEI
AESLRDTDKVVLVKNPVNPDLDLWIGGLERLAAQGIKKLGVIHRGFSSNNKSKYRNNPQW
QIALELKDRFPNIPIICDPSHIGGTRELISEIAQQAFNLEYNGLMIETHCNPDEAWSDAK
QQITPERLKEILVDLTIRKKNDLSDDFSSKLNRYRGEIDELDNQLLGLLASRMDVAKKIG
ILKKDHNVAIFQPDRWNVLKKLAIRNGSRMGLSEEFLDHLLISIHKESVDLQNKIMDDI
>EGEFANNL_00766 hypothetical protein
MNFDELKLFLDEKFEEYNHHRFIETDPIQIPHQFTSKEDIEIIGFLIATIAWGNRKSILK
SSEKMVNYLEGEPYNFILNHTENDLKKIEGCVHRTFNSEDLIYFIKSLQNIYKNRGGLEK
IFSTHKNESNTFYAIERFRKVFFEILPLQRTQKHVSSPLKNSSSKRINMYLRWMVRKDNK
GVDFGLWQSISPSQLMCPLDIHSGNTARTLKLLNRNQNDWKSVVELTNNLKKFDKDDPVK
YDYSLFGLGVFENFVNKFK
>EGEFANNL_00767 ATP-dependent RNA helicase RhlE
MTFEKLNLVEPILRALKDQNYINPTPIQAQAIPILLEGKDLLGVAQTGTGKTAAFSIPII
QQLHQNLTKNRGRNIKALILTPTRELAIQIEENIKEYSKYTNLCHTVIFGGVPQKKQTDT
LRSGVDILIATPGRLLDLINQKFINLKTLEYFVLDEADQMLDMGFIHDIKKILPLLPNKR
QSLFFSATMPPEIEKLANNILNHPSRIEVTPVSSTVDKIEQSLYYVEKTNKIKLLIELLQ
NKNLESILVFAKTKHGSDKISKQLNQVGIRTEAIHGNKSQNARQNALKNFKDKSTRVLIA
TDIAARGIDVDHLSHVFNYDLPNVPETYVHRIGRTGRAGRNGVAIAFCDHDELPLLKDIH
KLIKKDITIVKEHTYRNDDIESSFLNNFKKKENNFKRNFKPKNKKRSLKV
>EGEFANNL_00768 Inner membrane protein YedI
MASGIFAILDDIAALMDDVAVTTKLATGKTAGILGDDLAVNAEKATGFVSSRELPVLWKI
TKGSLINKIIIVPIAIALNLFFPVVIQYILILGGFYLAYEGVEKIFEYFFHKNQHIKKED
VTNLENDPIAEKKKIKSAIFTDFILSIEIVIIALGTVVNQPLWIEIFTVSIVAFIATVGV
YGIVALIVRLDDMGNFLILKSKGKGILTAIGKLLIKSLPIIIKVLSIVGTIALLMVSGGI
FDHNIHFVHHISLQPEILKQIILGLIAGSIILLLVSGIKQLVKMVKS
>EGEFANNL_00769 Rhodocoxin
MSEVKITIIDRKGTKHQVVAPTDMSMNLMEVIRAYEIEPEGTIGICGGMAMCASCQVYIL
NKEDCLLPKSDEEDAMLSEAFNVKENSRLGCQIPIQQNIDGLEIQIAQE
>EGEFANNL_00770 Ferredoxin--NADP reductase
MIETDILIIGAGPTGLFTVFEAGLLKLRCHIIDSLPNPGGQLVELYPKKPIFDIPGFPTI
QAAELIQNLQEQIKQFEPGFTLNEVAQTIDKQEDGTFIVTTDKGTQHKAKAIAIAAGLGS
FEPRKPLIENIEKYEGKGVEYFIKNPELYRNKKLVIAGGGDSALDWSIFLSDIAEEVTLV
HRRNEFRGALDSVEKVQDLKNKGKIKLITPAEVIGIHGDGKLESLIIEKENKKIEIFTDY
FIPLFGLTPKLGPIAEWGLEIEKNAIKVNNALDYQTNIEGIYAIGDINIYPGKLKLILCG
FHEATLMCQSIYNRINPNKKYVLKYTTVGGIQGFDGTVKEAEKAVVKSIE
>EGEFANNL_00771 Hydrogen peroxide-inducible genes activator
MTLIQLQYVLTVAQYKNFTVAAEKAFVSQPTLSMQIQKLEKALGVELFDRTTNPIKITSI
GEKIISQARIILQEADKLPKIVEEDKKSMNGIVKIGIIPTIIPTLVPLFFKIFKNKHPES
ELIIKELKTEDILKSLKNDEIDFAIVSTPLNNDYPIIERPIYREPLVAYISPQDDLYKED
LLEIDKLDFNNLLMLEEGHCFRDHVLDLCKYKDSIHSNIKLESGSFSTIVSLVNEGFGFT
ILPLLESENLSETDKKNLRYFKNSPSREISLIYSSNQIRLTFADKFIELIKSILRGKLFL
EEKIDNKPQLKIV
>EGEFANNL_00772 RNA polymerase sigma factor SigA
MRQLKITKQVTNRETASLDKYLQEIGKVDLITADEEVDLAQRIKAGDRVALEKLTKANLR
FVVSVAKQYQNQGLSLPDLINEGNLGLIKAAKRFDETRGFKFISYAVWWIRQSILQALAE
QSRIVRLPLNKIGSINKINKAYAHLEQEHERAPSAAELSEVLDMSEEDIKESMKNSGRHL
SMDAPLVEGEDSNLYDVLRSGESPSPDKDLMLESLQTEIERSLSTLTPREADLIRLYFGL
SGQHPMTLEEIGETFDLTRERVRQIKEKAIRRLKHTSRSKILKSYLGK
>EGEFANNL_00773 hypothetical protein
MIEIIISVVFNVAVSIILKIYSTKNNSKNLLFQIITYNYLFSAILCYFIFKPDVFTINFT
KIPWGIYILMSMLMPSLFLLIGQSIKYIGIAKTDIAQRISLLLTIIASFVFFNESFHLNK
VFGLCIGFISIFFIFYEKINRNKTKPSMLNKWYLPLLIFLGMGMVSILYKIIAIQNSNIS
FITSTFIIFIGSFIFSVILIIYRKQKFNLSAIFWGLGVGIFNFGNVLFYLRAHQTLRDNP
SIVFATMNLGVIVFGSIVGIIFFKEKMSKLNYWGLLLALISIVLISKI
>EGEFANNL_00774 Sec-independent protein translocase protein TatCy
MANKNKNTANMPFLSHVGELRKHILRCLLAVCLGALLVGWKIHFVMDHIIFGPVNKNFIT
FRIMNFVSQLFGSQDVFVMPDHFPIQVRRIFEQLNTAFYIAVAGGLILVFPYIIYEMWKF
IAPGLKPREKKNSLSFFIATYFLFIIGCSFGYFLVTPLTMHFGYFFNISDTIKVNIDLSS
YISILLQTILGMGFVFLLPIIVYVLTSLGILTPKFLKTYRRHAVIIILIIAGFITPGDIP
SMLVASCPLYLLYEASILVSTVVYKRNNVRENSIIAK
>EGEFANNL_00775 Arabinose 5-phosphate isomerase KdsD
MEKHKILELGKNTLSLEIKELNSLNDRLGEDFVEAVNLILGCEGKIIFCGVGKSAHIANK
LVATFNSTGTPAQFLHAAEAKHGDLGVIRSEDITICISNSGTSMEIQEVVPYLKKYSSRL
IAMTSNKNCLLAEQADVILDTKVDKEADPNNLAPTTSTIVQLALGDALAITLLQVKGFKS
EDFAKFHPGGALGKNLLWKVEQFVKQIHKPQICLNSHLKEVINSLTSSSHGITVIVDNEK
VVGVITDGDLRRVLSKDVDYNKITAKEIMSVHPKTIQKDELASVAFTLFKDNQIGQLVVL
DGEKYFGIIDLHVLLENGYK
>EGEFANNL_00776 ATP-dependent DNA helicase RecQ
MNSLEKDLSKSLKKYFGFSTFKKPQEEIITSLLEGNNVFVLMPTGGGKSLCYQLPALISN
GTAIVVSPLIALMKNQVDAIRGISSNEGVAHVLNSSQNKTEIKKVKDDIISGVTKLLYVA
PESLIKEEYVEFLKSIEISFFAIDEAHCISEWGHDFRPEYRNLRAIIEKIGKVPIIALTA
TATPKVQDDIQKNLGMTDAKVFKSSFNRPNLFYEVRSKINPEKQIIKYIKENPNKSGIIY
CLSRKKVEELAELLKINGINALPYHAGLESKLRACHQDKFLMEEVDVICATIAFGMGIDK
PDVRFVFHYDIPKSLESYYQETGRAGRDGGEGKCIAFYDYKDIEKLEKFLASKSVSEREI
GMQLLQEVVGYAETSMSRRKYLLHYFGEVFDEVNGLGAKMDDNSLNPKPLTEVSKEIQQM
LSIVEKTKEKLKIKDLVHIATGKETAIIKSYKISSENYFGFGKDKTENFWKSIVRQAIVH
NFLAKDIETYGVLKLTDLGKSFISNPTSIQMAEDWDYNQEIENSNTIVQPSGNNNAIDKT
LFEDLKNIRKKVAKKFNIPPFAVFQDPSLEDMALQYPTSLVEMGNIFGVGEGKAKKFGKE
FIDYIAKYIEDHDIIKPDDLVIKQIANKSSHKVFIIQNTDRKLDFEDIAKAKDLSMSELL
DEMESIVYQGTKLNINYYVDELLDEDQQQEIIDFLMESESDKMSVLLEEFGEDYSDEELR
IMRIKFISDVAN
>EGEFANNL_00777 hypothetical protein
MKKNYLWLLLILFFQLNAQQIDSLSIANPLYSEYKSLSFIPTYKFSKISKLLAKSGIKNI
SNNGSENKIVPVILSDEDFNQLSFKEKFTYVMAYPENLNKNIILNTSLDRNDKINAHLPY
HDQDIIWSIREIDFLRNNRNEVLKLIKENSLKQPNIGLNFKLILRELNATEMIPFLISSF
KKSDKKDYEILTLLMLLVKDNNYFPFMKSNICYHLYIQNKDSNEMYLDILESNVGYILST
AKNYYSQLPKPNKTL
>EGEFANNL_00778 8-amino-3,8-dideoxy-alpha-D-manno-octulosonate transaminase
MPGYELWGEEEKKHLNDVIESGILMRYNFETLRNNHWKAKELEQAIQKKMNVSYAQLTTS
GTTALITALNSAGIGAGDEVILPTFTFVASFEAVLSVGAIPVLVDIDDTLTMDPKSVEKA
ISPRTKVIMPVHMCGEMADLTSLKELAKKHNILLIEDACQAFGGTYKGKYLGTIGDLGCF
SFDFVKTITCGEGGAVVTNNHDYYIHADQYTDHGHDHVGNNRGAENHPYLGLNYRISELN
AAVGLAQFEKLDKILSIQRNNKQVFKDALKDIEGVEFRRILDEKGDNASFLSIFLPTKEK
AKEASQLLVSKGIGNAYWFDNNWHYIKKWDHLKLLKTLAPLYKEHKELLPNYANADYTQS
DNILSRTITIPISLLWTEEELAKKAQILRSSILEIIQ
>EGEFANNL_00779 Putative acetyltransferase YjbC
MRLQKLNMDDKREITFIENLYEESFPKNERRPKERMLNVYKDEPKFQILLAWSENNPVGF
FNYWDLGTFIFVEHFAVCSKHRNKGYGSKILNSIKSKVSKPIILEVELPIEEMAKRRIIF
YEREGFTLWDKVNYNQPSYYNDGKSYPMKLMALGKLSENSDSQNIINLIHTIPYKH
>EGEFANNL_00780 hypothetical protein
MKVKITIIVVLFFWVVGKAQDIENITYTDKDNKEVPAFSFSLPVCNKETVLSVWKNFIKK
QGGKARGGVINKLNGVNLKFDPKGDLWNGTLVYEYVDDKNMNIFTSFQDSEGIYINDKLN
EKSLALPVLNDFKNNMNLTCTQQDLVGAKNYNLSLEKERIRNTDRILFLEKGIQQTNNRI
EVLNSQTSDIDEAKVSKLKEDIQNYQKEISQLKEQNLSLEKEIEAQKIVIQHFQDRLDGL
EGNGNNNDPKILSNEWDQKESINDNSNNSLNDSQSTEKLDNIDQVESLDDSLELDFNQ
>EGEFANNL_00781 tRNA (guanosine(18)-2'-O)-methyltransferase
MYKGIENNLELYEYLKEFLTEDKLKKIENLVNFRTEFVVPVIEDIYQFRNAAAIVRSMEA
FGFQSLYALQNRNEFSPETTVSRGADKWIDINYMSSGLESLIKIKEKGYQMVAVSPEKNA
IPIHDFIIDKPTALIFGTEFKGVTKETFNFADYSLSIPMKGFTESLNVSVAAGICFYEFR
KQLERSKLDWKISDERKINLKTQWAINSISSGKEIAEYYLKKINK
>EGEFANNL_00782 Ammonia channel
MNIDVINNGNVSFMVLTTVLVFLMIPGLAFFYGGLVPKKNSLTMMMYTFISMGIVTILWT
FGGFSLVFGKDIGGVVGSPTEYFMLHGVDFNVNPRYGSSIPFLMFFMYQLMFAIITAPLM
TGAIASRITIMGWVKVLILWMILIYFPVAHWIWGGGFLSKWGFVDFAGGTVIHATAGFSA
LVGVLFFGKRYYKTSEDYGNINLVILGAAILLFGWFGFNSGGALVSGEHAAIAFTNTGIA
AGFSTIVWVIICYLRDKKFSFIELTTGAVAGLATITPCSGYVSPQSSVLIGIIAAFVCYG
CLQLSIKLKLDDALGVWGVHGMGGVTGSILVGIFAASNLDGVSGGFHQFIIQLLGVSIVI
VYSCIVCWAIFKICDLTGSIRVPKDVQEKGLDQKYMTEIVDFKSSN
>EGEFANNL_00783 Phosphoserine phosphatase SerB2
MQNSEIILVNITGVDKPGITTALTHILGKYNAEILDIGQANIHHSLSLAIIFKSENGSSG
DILKEMLFKANSLNVNIRFSPLTTEDYTHWVQVQGKNRFIIHILGKELGANQISEVANIL
VEFNLNIERIIRLTQRIPLNKKTDRTCFELAVRGNITDVKEIQNRLLALSSQLNIDIALQ
EENGYRRMRRLICFDMDSTLIQTEVIDELADRAGVGEEVRAITESAMNGEIDFTESFKRR
IKLLKGLDESVLKEIAEKLPITEGLERLMKILKKSGYKTAIISGGFTYFGEYLKRRFGFD
YVFANKLEIIDGKLTGNYLDDIVDGNKKAEYLRLLAKLENIDIQQTVAVGDGANDLPMLS
IAGLGVAFHAKPKVKESANHSLSTVGLDGILYFLGFKDSAENTEMMNIS
>EGEFANNL_00784 Dihydropteroate synthase
MKYYIQGEKVNLNKPKVAGILNLTEDSFFDGGCYDTEKKALLQVEKLISEGADFLDIGGQ
STRPGSKFITADEELKRVIPIIKIIKKEYPKIKLSIDTFWSKVANESVQEGVCMINDVSG
GTLDPQMLPTIGRLKVPYVLMHMRGTPQTMNQYTKYENLVENVVQYFEEKINEAKNFGIE
NLFLDPGFGFSKTLEQNYELLNQLNQLKKFNLPIYIGISRKKMIYETLNISVDEALVGTS
ALHLYALLQGANVLRVHDVKEAKQMINLAKQIKSN
>EGEFANNL_00785 Vitamin B12-dependent ribonucleoside-diphosphate reductase
MNEKLWWKNSESEQILNRGYLLKGETVEGAIDRITTAASQRLYKPELKQPFQELIERGWM
SLSSPIWANMGTERGLPISCFNVHITDSIEGITHKLGEVIMQTKIGGGTSGYFGELRERG
SAVSDNGKSSGAVSFMKLFDTAMDTISQGGVRRGAFAAYLDIDHPDIEEFLTIKDIGNPI
QNLFYGVCVPDYWMQEMIDGDISKRKVWAKVLESRQQKGLPYIFFSDNINKNKPQVYKDK
GLIIKSSNLCSEIMLPSTEEESFICCLSSMNLELYEEWKDTEAVKLAIFFLDAVLQEFIA
KTEGNYYLTAAHNFAKRHRALGLGVLGWHSYLQRNRIPFEGIQAKQKTVEIFKHIHDKSN
KATEDLARIYGEPELLKGYGRRNTTLMAIAPTTSSSAILGQTSPGIEPFSSNYYKAGLSK
GNFMRKNKYLDELLTEKGINNEDTWRSIMLNGGSVQHLSELTYEEKQVFKTFKEISQLEI
VQQAAIRQKYVDQSQSLNLNIPSDLPVKDVNRLIIEAWKLGIKTLYYQRSQSVAKELVLN
LVSCSSCES
>EGEFANNL_00786 Ribonucleoside-diphosphate reductase subunit beta
MSVFDRRINYKPFEYPEILQFTDAINKAFWVHSEVDFTADVQDFHSHLDEKERNAIKNSL
LAIAQIEVAVKSFWGNLYQHFPKPEFNGLGSTFAECEFRHSEAYSRLLEVLGYNNQFEKL
LDIPVIRERIEYLDEALKDAKSEDNKKYVVSLILFSILIENVSLFSQFAIILSFTRFKGL
MKNVSNIIGWTSVDEQIHANAGIYLVNKIKEEYPDFFDTDTIESIRKIVNHSIKVEGKIL
EWIFELGSIETISKENLINFMKFRVDESLKQIGIEQLYYISAEQYKPMAWFEEEVFANSL
DDFFAKRPTEYTKHDKSITENDLF
>EGEFANNL_00787 NAD kinase
MKVGIYGQVVKEEDKDLLKTFFNELETRGIEVYIYELYKQELQKILGYENPNFQTLSKRK
KLPKDLQLLFTFGGDGTILSTISIIKDLKIPIVGVNTGRLGFLATLQKTEVLRELPRILE
GNYEISERSVLEIKSLSGNVNSYAINEIAVIRNETTSMINIDAYVNEVFLNTFWADGLIV
STPTGSTGYSLSCGGPIIYPKAEIVVLTPIAPHNLNVRPLILQDNIQIKLKVNSRSDIYF
MSLDSRYYKMNIEDEILISKANFKINIVNYKDYSYYQNLRDKLQWGVDSRN
>EGEFANNL_00788 hypothetical protein
MIITEYISKNFQTINLKSSIEKAKSLMFEQQVNHLPVVNEGKLLGNLNASLVSKINPEDT
IDKYIVELEDFYLHNTVLIFDSLKSFSDNETNVLPILNDKEEYLGVVLEETIIDEFSSLP
FISDYGWFIGITTPIKKYSISEISNIVESNNGQILGLTVVKTDLETTQILLKIKAENISS
IGDTFERFGYIITNRYFEDIKKELLKDRYNQLQKFMEV
>EGEFANNL_00789 Oxygen-independent coproporphyrinogen-III oxidase-like protein
MMGNELELRKNEMQTPIKTIYFGGGTPSLLNEDEILFLFHKIYSFYNTSELIEVTLECNP
NDLSYDFLNFLKKETPVNRLSIGIQSFFDVDLKFMNRSHHSMQGEECIKMAQEVGFKNIT
IDLIYGGETTSDEQWIKNLEKAISLGVPHISAYALTVEPKTALENNIRKGKLPPADEDKQ
AKQFHILRNLLSKKDFIQYEFSNFGKQGFFSKHNISYWENLPYLGIGPSAHSYNGKDKRC
WNISNNVKYINALEKNKLPLEIENISDKDRFNETIMLGLRTYQGISLKILNENFSSSFLA
IFNNEAQKLINDKKLICKDNYLTVNPEYLFLTDGIISQLFLID
>EGEFANNL_00790 Glutamate racemase 1
MKDDNRPIGIFDSGVGGLTTAKEIQRLLPKENLIYFGDSKHLPYGDKSKEVIIEYSTQIT
RFLLSKNCKAIVIACNTATANALQEVRKLASEKNVRVYDVISPVAEKVAFTFNQNVGVIA
TKSTISSHIYKKYIRKNNKHIAVHELATPLLVPVIEEGFTNHQISEVILKTYLNNKKLSN
IDSLILGCTHYPIILNEVKNFYQNKIQVIDSPLIVASHIQQDLEKRKILSNSSNSTYEFY
VSDLTPTFSKLAKKFFGAKIHLKVENIF
>EGEFANNL_00791 5'-fluoro-5'-deoxy-adenosine synthase
MPIITLTTDFGLNDFHVPALKGCIYSQLPEVVIVDISHEIMPFDLLETAFVVRNSYQSFP
RGTVHIIGVDALSSPHVKSMAAEIHGHYFICNDNGILSLITEGGVIHEMYEITINPYEDI
NYLLKDLFIPVACHLARGGKLELIGRKTSDYRVLTEYKPLEKADENSLIGMIIYIDNYGN
AVTNIKKERFYQFGKKRDFVISIRNVEFTEIKTKYTDVLGDDPDENKYHGKALAIFNSSE
YLQISMYKSNLKTVGGASSLMGLSIGTQIKIVFQ
>EGEFANNL_00792 PhoH-like protein
MNQINLILDEVDLKLFYGEYNQNFNLLTNHFPKLKITGRDQNIKATGNEEDLLEFEKKVK
SIVAYINRYNKLNEIALNGILHISKDINNVEKLEDVIVHGIGGKIIYAKTENLKKLVNCV
DTHDMVFAIGPAGTGKTYTSVALAVRALKNKEVKRIVLTRPAVEAGESLGFLPGDLKEKL
DPYLQPLYDALRDMISPEKLASYLEKGIIEIAPLAFMRGRTLDGAFVILDEAQNTTHLQM
KMFLTRMGANAKFIITGDPGQIDLPKQQKSGLKEAMRILQGVKDIGFVKLTEIDVVRHRL
VKKILEAYRKQEEE
>EGEFANNL_00793 hypothetical protein
MGGYNLTYVSALMDSDSLYIPQNIDFEADLCKSNLDIIKIYEPLDKWMDFYKKYYSKEFK
NYQVVIPVKYVSLTQGSMFPEKDKYYLFKISIGYNKNADLEIVKEIIEGIKEEREIISN
>EGEFANNL_00794 hypothetical protein
MKKHLIGISFFLTTLMIGQVQESSINMVDKFKVAVYQSIINSKEFKSNKSCHIVGIKPIA
LTMDYSIGSTLGDLFYNVKETSDTVTIKELRKKKKKKLGFLKNRMNLYWEDII
>EGEFANNL_00795 hypothetical protein
MDRAKIDFVKTEIYKALLLSDEVKKEKEFHLVSIQTLDLDINPNSNFFQIFIKEKKDSIS
VDKLNQKMPYNYKIYKELKEEKFMDSNLQRVNLYQAFSEYNEWKPVNYSYIRIYEPLDKW
ANLYLYISDLIGGNPYEIIPVFYTQIKNKQELKQEYKLYKIVYSKQGKIESINTIN
>EGEFANNL_00796 hypothetical protein
MKPLILASFYLFSCLIFAQKDSLNKADLDLITQFKTRLFIEIVSSQEFQNKVQCKIVTIP
SFALEIKKKYEYLEPRKDKDTLTLGRLRDILPSNYWVFLVESDLEYIFKGEEIIEHYIKE
YPVYSSNKISENMEGRKNPFTSAIGFFFNYCDNEYDIIKIYEPFDKWGNLYSYMFSRYST
DQEIVIPVKYEHSEQFSGKENYMLFKFKVNIQDNRIISKEVISD
>EGEFANNL_00797 hypothetical protein
MKKYLIGISFFLTTLMIGQVQESSINMVDKFKVAVYQSIINSKEFKSNKNCHIVGIKPIA
LTMDYSIGSTLGDLFYNVKEISDTLSIKELRKNKKKKTWIFKEPDNFLLAGYDLEYISSL
KDSDSLYIPQNIDFEADLCKSNLDIIKIYEPLDKWMDFYKKYYSKEFKNYQVVIPVKYVS
LTQGSMFPEKDKYYLFKISIGYNKNADLEIVKEIIEGIKEEREIISD
>EGEFANNL_00798 hypothetical protein
MKSGKIVRIIGGESIKKAKRTITLTSTEGDLTFSSPKQVIMIGKKGGVQFLNDYQPPEPL
RVVELNGPLDEDGKKLEIVEKGKSYKFKITRFNREIKSPMELKNIKWAVQHNNDSPIPIA
QVMGKQEVTMDISETETSGKITVYAYIQNLKEEGKAESILNLKKGGINTRFYDEKGQQVF
EIPAKLHKAFNEEYGIKLAYHKDDEMLYYDGECKPAYEKTSLTAINHWKKELDPNQISKG
KLLFGYNFGYELVAEPLENTSYNYYTDYSLNDFDREGNVLHLKKEKGNVAGGVVPGVPKA
DIQDWDDKKRKQGKRGTIPRHTSIGDIAFIDLADFTDELNQNGFIYEYTFQRKYELLNEP
LPSVNRYFNLSRLLEHEFLGHAILKLTDDKYNFNSVEYLNEGPVEVEAKFCNLIRREIRI
T
>EGEFANNL_00799 GTP pyrophosphokinase
MQELEDIKTKKENEEIAKRYKDMLRNTYRVLNDEDKILIRKAFDLAKEAHKDQRRKTGEP
YIYHPLAVAKIVADEIGLGATSIVCALLHDVVEDTAYTVEDIEKLFNLKIAKIIEGLTKI
SQIDHQDLSLQSENYRKLLLTLSKDVRVILVKIADRLHNMRTLDSMKVAKQKKIASETTY
IYAPLAHRMGLYTIKSELEDLSLKYTDPDSYNFIVKKLEETDRDRQRYIDEFSKIISERL
REENLNFLLKGRHKSIFSIYKKMRKQNVDFEEVYDLFAIRIIYKSDHKNEKFLAWKIYSI
VTDEFVPNPNRMRDWISTPRSTGYESLHVTVIGPESKWVEVQIRSERMDEVAEKGIAAHY
KYKEGYKVDEDNQIESWISQVREMLESQGTVTTKELLDDFKLNLYTKDIFIFTPKGDLKV
LSVGATALDFAYSIHSNIGDHCLGAKVNSKLVPLSHKLKSGDQVEILTSSNQKPKIDWLD
FVATSKAKSRIKSALNSEKRKYTEEGKELLIRKLRHFKINYSEAELNAIQKFFGAKTSHD
IFYQVASGIIDTKELKKYVDSKGVFNNLLSRLRKRPNIPFIHSKETDEVKEEGKLDMIVF
GEEEEKLDYQMALCCNPIPGDKIFGFVTIGKGIKVHKEICPNAVDMRANYDYRVIQAKWV
NSSHRNFLVHILIDGIDRIGLISDISNILSNLMKVDIKKMNFNSEDGIFTSQITLQVKNT
FQLDEILKNLQKVENISKVKRIEKKS
>EGEFANNL_00800 hypothetical protein
MKILIIYLFSFIFILNGCANNQRQNNVNHSPIMEEFEFEQSVPFTIAENYFSKEDLNSFI
TILSQSEFDQYIGMATTMGKHGQPTPIDFKKQWVIAVALPSTDINTQLIPISLKKDGKGK
IIFTFKAVEGNKLSYKIKPFLAIIVDRKYLGEIQVIKI
>EGEFANNL_00801 Phosphomannomutase/phosphoglucomutase
MSLIKSISGIRGTIGGKVNENLTPVDAVKFASAYGTWLKRKSNQENVTVVLGRDARISGS
MLSQLVSSTLVGTGIHVIDLGLSTTPTVELMVPYLKADGGIILTASHNPKEWNALKLLNE
KGEFISGKDGEELLRIAKNDDFDYVDVDHLGSYVENKEGIDYHIQQILELPLVDVDAIRN
ANFKVVLDAVNSTGGISVVPLLKKLGVEVVEMYCEPNGHFPHNPEPLEKNLTDIMRKVPE
VKADLGIVVDPDVDRLALITEEGAMFGEEYTLVAVADYILSKTPSSTVSNLSSSRALKDV
TQKYNQSYHASAVGEVNVVTLMKEVGAKIGGEGNGGIIYPELHYGRDSLVGIALFLTHLA
QKQMTCGELRKTYPSYFMGKKKIDLSPEINTDDILEKLTLKYKHENLSTVDGLKIDFPMH
WVHLRKSNTEPIIRIYTEASTQDEAERIADQMIQEIKELI
>EGEFANNL_00802 Thiol-disulfide oxidoreductase ResA
MKKYFYIAMLAATILSCKEKNGGSNTDTKTSISDSLKTNPTDSKVEINDAVETVENTTYK
EAQKLYHLDSDTVYVTNYWATWCGPCVQEIPDFVALQEENKDKKVKIIFMNVDESNTQNE
VEPFVAKNKMKNVYHISIQDLAENIGKINPDLTQGIPVTVVQKGKHIEGLIGNQSKEFMT
SKIQEYSNK
>EGEFANNL_00803 hypothetical protein
MTTKVFTTIGLLILSNTFMNMAWYGHLKVFGKDNHTSIFFIILISWGLAFFEYLFQVPAN
KFGFIENGGPFSLVQLKVLQEAITLIVFMIFSKLVFNNIQFTMNHFIGFALLVGAVYFIF
KK
>EGEFANNL_00804 hypothetical protein
MKNQTVKSLLVLTLATGLATETFAQKIHQKKSPLRTEVLQKINPISGNVKEWVFNQDFVY
DGFYLETNAEKYLVKFPIHLGAELRNSISNNPIVVQGVVKYSPLGEKEIELVSLKTPNKV
IYNLPPETPTNVLEKKFVNNSGKIKEVQINEMGDPIGFILEDRTVLRLPKHLSKQLSNLA
PQGSTISYTGIEKSKDNGEAYYNNYSVVRCNTITIGEDQYLIK
>EGEFANNL_00805 hypothetical protein
MIKRMPKKTEYINQLKHFLGLQLPSNLKNNGEDPNPKSHTILKTLPKESITLTGKVLEFL
VNPMEDIDKILLSTEEKNVAVHFPPHKAQAILEKIQIGQFVHLSVCKSKKMIFKSFPLYD
LIHLQEPFLNLDSFKPQKSKGGAISVQGFISNFRYNDRNFVSAFFLENYLVDIPPHFGEI
ITPVLSADKEVIIQGHLRQNNMGFVNKSGLEIIRPYALNVDGTNYLL
>EGEFANNL_00806 Transcriptional regulatory protein CusR
MKILIIEDEPSLGRFLEKGLQQAGYSITLSKDGIEGQNLAASGNFDLILLDLMLPGMNGF
DILSNLRAFSISTPVIICSALSSTEQVVQGLDMGAVDYIKKPFDWDELLARIRVIQKKIT
HQESSILTINDLSLDIIGRKVSRGGKEIKLTAKEFILLEYLARNVNRIVSKNQIMEHVWD
LDFDPGSNLVEVHMYQLRKKIDKEFEYPLIETVIGLGYTLKGIKS
>EGEFANNL_00807 Sensor kinase CusS
MPRRLALLYTFLYIILCILLSAFLLVWFKDTFLKSYSFSYIFSAFSILLIIGSLFTYLLS
YWLTLLLLSPIHQLIEQVNHINIYKEITLFNEPKEEGTIKELIVSFNHMLLRIKEQYEQQ
NAFFSSASHELKTPLTVMLTQLQILLNNKNLSQEVRDVYQMQFQETKRLSQLVQDFLLMG
EINNQQIQLHSKECDLTDILYHLIEPLKSKLDERNTPIKISYHPIEADYSFISDEGKLNI
ILSNLLNNATKYSKENTKILIHISKREGSIFINIINTIREDIHPEVTDLNQKFYHSKPLH
GEGFGLGLWICKQLSDLLELELFFAIKDQTSFEATLVI
>EGEFANNL_00808 hypothetical protein
MKKNILVVTLFSLIAFSCKAPGGNKEIFPENILENQKSDSLKAENTSLPQKDAKEKAVTS
NNDSIQVKNDSTSTSLVTDSTKSK
>EGEFANNL_00809 hypothetical protein
MNKKNFLSSLLLSSILIISCGENNQNSTVQSESDKVSTEASVNEKISSYKNNLEWEAYKT
ERKEGVKGTFTKINLYDTQESLKFPESLVGSKFSIDGLSVSSGDVARDANLNSFFFKRLA
SPEITGTFEKFENGKATIKISLNGKEAVKEFNYTLNDNEITIKGSIDILNDFDAQKSFKA
LHGACSDLHEGKTWTDVNLTIKIAK
>EGEFANNL_00810 Phosphoglucomutase
MNYSERAKSWLRDPFDKDVQKEVQYLIENNPEELEDAFYKDLEFGTGGMRGIMGVGTNRL
NRYTYGQATQGLANYLIKEYLGKKISVAIAYDVRHNSDVFAKIVADVLTANGIHVYLFKE
FRPTPELSFAVRELNCEAGIVLTASHNPPEYNGFKVYGKDGAQIVPPEDEAIIREVRKVN
YSEIKFNGDDSKLTYLGEDLDQKFIDTVTKHASFLTGKKDLKIVYTPLHGTSIQVLPQVL
KKAGYENVFIVPEQQNPDGNFSTVKSPNPEEPEALSIALKYAEEQEADIVFGTDPDADRL
GIAVRGLDGKMVLLNGNQANTILTDFVLKKRKENGKINGKQFIGTTIVTSDIFYPLAKAY
GVECRTVLTGFKWIADLIKKSEGKEQFICGGEESFGFMLGDYVRDKDSISSILLACEVAQ
EAKNKGKTLFNILLEIYHKVGYYYEELISIVKKGKDGALEISSMMEQFRTNPPKELIGEK
VVQLDDYKNSTSLNPNTGKKINLDLPKSNVLIFYTDKGTKLACRPSGTEPKIKFYFSVNT
SINNDQEYKNKLNEAKSKIDKLKEFVQ
>EGEFANNL_00811 hypothetical protein
MKKVIFYSFIALYSLCLVSCSFSVKGEGETGEKEIKISNINEVEAKGNYRLIYLYDNTNP
RIVVETYKNLLDNLKIKTSGSKLTISESKKVEGTDLYNVYIYGPQIETFDVTDSINVDIN
SQLRVSQLNINLSKSAKLLASNVVVDVLKVDLSGKAKASIQGTGNKLLLNASDESDFTSP
FLELSEANVNISNVATAELYVKSKLLGKITNNSRLSIIGNPSKDIKTIDLAELKFINSDS
IRK
>EGEFANNL_00812 Dodecaprenyl-phosphate galacturonate synthase
MQLSVVIPLLNEEESLNELLERIQAVCTQRNISYEIIFVDDGSTDQSWEIISTFSQNHPQ
VKGIKFARNYGKSQALNAAFKMVQGEVVITMDADLQDFPEEIPALMKLIVEDGYDLVSGW
KKKRYDNVLTKNLPSKLFNWAAKVISGVKLHDFNNGLKAYKKEVVKSIDVHGDMHRYIPV
LAKNEGFTKITEKEAPHQARLYGKSKFGTNRFVRGFLDLITVWFMSSFGSRPMHFFGFMG
TLMFLIGFLSTAWLGIHKLIKVWNKVPAQLVTNDPLFYIALTMMILGTLLFIAGFLGELI
VQLKRKRTDDYIVTQYLNIK
>EGEFANNL_00813 hypothetical protein
MKNSSVHYGVLLGFLTLVLFFLVYFLFIGQSYYILSLRVNFFILPALYTLVAVILLYKKT
SIQKLSFADCFSISFSTMFIGGTISFIIISLFLNYVDKGANEIFGHQLYTTWREGLDQEF
STLVHPSSEDIQRYHQYQKLLNWMITEEKYFFNLRMTVIILGMLYTFYLIISVFLSMFFR
LRNPHATIRSNTSS
>EGEFANNL_00814 D-alanyl-D-alanine carboxypeptidase DacB
MSRNKIIFFLWMIGSLNLFAQNSFLDNHFNSEFYSNQWVGFSLYNPQEKIELYNYQSNKY
FIPASNVKILTLYTGLKLMPDSVPSLQYLKKNDTLYIKGTGDPTLLESYFKENKVIHFLK
NSQLPIALYIENWNDTAYAPGCSWDDFVEDYSPERSPFPIYGNLVTLQSQKIVPKYFANR
VLFQKKQSVRDLNNNIFYYAGNKKIQIPFIISKELIKNLLEEETNQKIFLTNNFPKGTVE
TLYSIPSDELFKRMMLVSDNFIAEQILLMSSLNISEMLNSQSTIQYILKTYLNEFPQKPR
WVDGSGLSRYNNLSPKDLVYVLNQLYEEISTERLLSLFAVGGVNGTLKNSYPGNPPYVYA
KTGSMGQVYNLSGYLKTKSGKILTFSFMNNNFQVPTSQLKVEMKKVLEYVRDYY
>EGEFANNL_00815 Release factor glutamine methyltransferase
MKSLAQLRKEYIEVLSSRYTQKEIDTIFYTLAEAYLHKKKSILQLGLNELYEESEIKSLL
FQHSLFQLSQGVPYQYIVGNTEFYGCKILVNPNVLIPRPETEELVDWVIQENKQKFDPIN
IIDLCTGSGCIAIALAKNLKHSKVSALEVSSSAVELAKKNAELNQVDINFIFGDLLDATV
EDIPNLDVIVSNPPYIRNSEIDAMEDTVVQNEPALALFVSDNNPLIFYQAIIDYAYKNLK
PSGSVYVEINQDLAEETQELFSKNFILVELKKDLSGKNRLIKAKGIR
>EGEFANNL_00816 Aspartate racemase
MLFRNKKYRYKEVIFSMQKIAVIGGLGTLAGGDLFFKLLKNKQVLKNQSNFHFGFEQKPY
TQMDLPLYQEKDIKSRKFYTYSICKNFEAKNFTKILIPCFASHSFINELQKEISIPIVNL
YEALKNFVKKRFPKGSRIGILSSDYVKDLKITKEYFQDYTLIYPENQNLLMESIYSKLGI
KNGYLEGIALENIYSSCVNLIENGCDFVIPLITEISLIADQIRKRGIQILDVNQIYADYA
LQNESLEPLKPFKLGILGGVGPAATVDFMNKVIQNTPAYKDQEHIKMIVEQNPQIPDRTA
HLIHKDTDPTISMFSTCKRLEVEGANAIAIPCNTAHAFVDSIQPHLNIPIINMITETAKY
ILENWGENVNVGLLATTGTIQTNVYTNEFYKFKLNAIVPDHEHQEFVMESIYGAQGVKAG
FTEGLCKENLLKAIDYLIKKDVEVIVLGCTELPLMFKNYKEYKYKQAIIIDPTEILAKKI
VQLSKSEGNT
>EGEFANNL_00817 hypothetical protein
MKKLFILGSLVLTSLVAQAQEGLKGRLFLGGSIGYTHDKVGAADIKSDNFNVSPLIGYFI
TPTIAVGGQIGYEYGKVTTPISTPFGTFDSEVKTNTFVIQPLARKYWGIGEKVYFFGQLD
VPVKLGNTKVGDSKSNFVDWGVNLRPGFDLFLTKNWSVETTVGRFGYGTHNPDGVKHDDN
SAFGLNFNDVNFGVKYVF
>EGEFANNL_00818 hypothetical protein
MGWKFTLSIPLEKFKKCVLVCAPHTSNWDFYYCIACFWSLGVPYKIMIKDDYTKPWYGFI
FKSLGCLGVNRKSRNNLVEYSAKLIKESKSMALINTPEATRSWSEKWKKGFYYIALEAQV
PIVLAYADYKNKEAGISKIIGVENNSIQEIFSEIENFYNPEMAKYPEKYNPKIF
>EGEFANNL_00819 Putative glycosyltransferase EpsE
MNPAISVVMAAYNAETYISASIQSILNQSFQNFEFIIINDGSTDKTKSILEEFAKKDPRI
QVVHNTCNQFVIKSRNIGLKIAKGKYIAIMDSDDNALPCRLETQWNYLEENPEVFLLGSS
AKIIDENGIHVGNYNAVTNYPDIQEDILNHNLFYHSSIMFRNEHLLYREKMLYCEDYDFI
LMLLSNQKIVINLPQPLIEYRSTTNSLSKSKNYLVHWMFLNLAKQFYLERLNSKGQDSYD
SFHPETFTNLLDIDYPISKKSLEMALKIAFYEANIDHLQILLNKYSKNKFPVSKKFIFYK
LLSCNHFLFSIIHQIYNKL
>EGEFANNL_00820 hypothetical protein
MDILIKSFNRPFYLDRCIQSIYLNVKGDFNLKVLDDGTPNKYLEKIQNKYPKIKIFTSKN
YKEKTEAIEENLKSGKDINGFKIPTDLWIDTVKKSSQYFFITEDDVWFTREIDLNSLEQS
MQLEKIYLLKLGWLGNATYKDNCIIKALNAEIIATKPQLYTAPNFIMKALFKNKFKCFSL
LYRMGWVDHNTIGKYWILNSMLMGIYHRDYWLSIWQDANGRVNEIHQLINATNFYRKNKK
NENFIAHLNQEALKTTFISSATNSYHKYEVDFDVNRFNYILNESWYDDKFNSFDNYPKDF
SYEVISNLLLEANHPKARFAEWKKWSDLFKAQYKQQGCEVE
>EGEFANNL_00821 ATP-dependent RecD-like DNA helicase
MEHYKKITKYWRDSLVDKQFSKGKYKLSDLAKKFLLNNRSSFFRINSKNILQSLFLFEDG
TIDTLYVPFSFKKVTSHSKHEKDYCPEVIFPIIFKVQVSENGFIYPTGNPIIPRDLLLPL
DKEDFYIGNMDDYDLFTTQYNVPSFEFEKNSEWEVYFLKNIESEYREGLISCLFEQNLID
SDQSKEDFKKLIKSLSKSKASKKEFTSIFNRYNEDWDILIEDKLANDKEFNKSIESYLTK
WHEYFKYVERLLDRVITSNEILEGYEKIVSAYFTNGELDISSKITAVYEDLYTRKEELQL
NLLRNYTTIEQENETSIIDSDTFFSKRLGHNNDKYPLTDAQRTAVSALLDEKNGEILAVN
GPPGTGKTTMLLSIVACLWVESAIKASEPPVIIANSTNNQAVTNIIDSFAKDFSTGKGDF
SGRWMDGINSFGSYFVSSMRGLNAREKGYLTEEVVKEMETEGFYVTAKKSFLEKSKKAFN
LREITVEESVNKLHSLLLEKKSLLSNIEEAYRNYHNFGKEFSILLNIDYKNEEEITVLGK
TLNQDKKEIEVIENKWEKYLDSESIFLSLFSFLPFVKQKRNYKAKVFANENNFKHHLQIE
DMDVNILQSNIQSKKEHIYANIEKFKKFTEVWNNCKIVLNKLDNDICPNLNFIEIDKKAD
TKIRFEMFLIATHYWEGRWLLEMEKMIDKGHLKNIDWKYKNIRENNWKRRMKITPCAVMT
SYMLPSYFSFSRKIHDNLIKEDYLYDFIDLLIIDEAGQVSPEVAGAGFSLANKALVIGDT
LQIPPISKLTKSIDIGNLHKVNLISKDLKVDEIDKTYKKLQRVGIASDGGSVMKISQNRS
KYYPEKKLERGLYLYEHRRCYDSIIRFCNELCYKGILKPMRGDAPDNALLPSMGYLNIEG
KCQNAHGSKKNELEAKIIAGWIISNYKNLREAYNGKEIKDIIAVVTPFREQSYRIAEYLR
SPKDKSLKEELSLITVGTVHSLQGAEREVILFSPTYSRDNKGGFIDNDRSMLNVAVSRAK
DSFLVFGDMSLFNRESVSPTGILSKYLLENENNELSYIHQYSKLFVREDLISKKHALEIL
TNYEEHDVFLKKIFSEATQRIIIISPWLIYSTIEENGYDQLLLNKSIKVTIYVDEKFNTH
TQNKLDKEKEHVFHSTINKLNELGVEVKVVNNIHSKIVIKDDDCLCIGSFNWFSAQRGGK
YANTEHSIAYYGENTKDEIDSILKELN
>EGEFANNL_00822 hypothetical protein
MTKNNRDHSIYSYHTGRIKHSYMQKRERAMSITKKTLST
>EGEFANNL_00823 putative type I restriction enzymeP M protein
MDLDLIQKGIKENLIKLDEENHSITYIQPNKKRNFSNPEEKVQAEAYLKLILNYGYKPER
IKLFVSVTMGSGTKEADIIVYNDDDCEEPYILVECKKEDVSEPEFAQAINQAYSYAYALP
NDVKFIWVTSGLKNEYFEVNKQKDSKISHPDIPQFGVKKLANYKFVYKADTLQSEAGKQK
FSDIKIVSEEELTRQFKKAHDALWGGGHLNPSEAFDELDKLIFCKIWDERKARKAGKPYD
FQIITVEKEEIKNYKKLSEKELENAIRIEENSRLAARIKNLYGEGRVKDPEVFRDDIRLT
HERIRTVVGYLQEINLGETDLDSKGRAFETFMGSFFRGNFGQYFTPRPIVKFITDVLPIT
HESLVLDTSCGSGGFLLYALNKVRNQATEFYPEYETNPSDNNKHYKHWHDFAEKNLYGIE
INEQISRAAKMNMIIHDDGHTNVITSDGLLLPEEIEKNTKNRGFTYNRFDFIITNPPFGS
TVRQTEKAYLKEYKLGKKEADWLAVVEKPETNRENQSTEVLFIEQNYKFLKEGGYLAIVI
PDGILTNSSLQYVRDSLEEMFRIVAVVSMPQTAFTATGAGVKSSVLFLKKHTLETTEKIK
EIKTSTQFNLLSAYGYKEKVTQYEKDKKQDIKKLEKEYKEKYPELDKKAFNELIKDEKTE
IQNAYTEKLNNLKEELQEAFTKERQSKLPDYPIFMAIAEDIGYDATGKPTNNNELDIIGK
ELTKFINSLD
>EGEFANNL_00824 Type-1 restriction enzyme EcoKI specificity protein
METYKVPSHIDPDKIFLVNRSELEERLEPKFYTSIYLQNKFRLTNSLYPLVTIKNITSLV
SDGTHFTPNYIDEGIKFISVKDVRKSEINLNNSKFISEKEAHILDKRCKPIKGDILLTKI
GTIGLAAVVNTDEKFQIFVSLALLRPKNNILSHFLEIVLNSNLSYLQYDRIVKGSGVPDL
HLEDIRKLKIPLPPLEIQQQIVDLYQEAYQQKQQKEAEAKTLLESIDTYLLHELGITLPQ
KENSLENRMFTTPFSEVSGGRLDPRYFSLYFKLFDKMIDCKYPAKTIKSISLKINSGATP
KSGGNDYTTKEKGVPFIRVTNLKNNTIDFSDCIFIKRHIHEGSLKRTQLKKDNILLSMAG
TIGLSIVVPKVLEANINQALAQIELKKDINPFFISEILNSSIGKIQMDRLSRPAVQANIN
FEEIKSIKIPLPPIEKQNEIAEHIQGIRAQAKELQEQAQKILEEAKQEVEKMILGD
>EGEFANNL_00825 hypothetical protein
MLVFTQDKKQLTKLKEKAFKLEKDIKTLFEANLEKILGLQFIKSEFKIKSSFIDTLAYDK
ETKAFVIIEYKRGKNDGVVDQGISYLNLMLENKADFIVEYNETQPEPLKRNEIEWTQSRV
IFVSPHFNDYQKQSSNFKDLGIELWEIKQYENGLIILNPIKKSKSAPSIKQIQNNENSEI
SKVAQQIIVYTEEDHLQSKPEEIKELYETYKNAILNLPASIELEPKKLYLAFKENKTNIA
DIVILKKGLKLFINKKKGELDDPKHLMKDISSIGHWGNGDYELVVNDTKNIEYIMSLIKQ
TLSNYLL
>EGEFANNL_00826 hypothetical protein
MNKEPNTDIQNWIEELKKDRVFRFMNTGASSYKQLGFIILSLLNTCQTHLFSLENKAPTK
EQVQELRIDIYNLLEMAKNLLPHIELEFLDKVLNSEDL
>EGEFANNL_00827 hypothetical protein
MYTHIEPKKVHQGRNIKRLREMLGVKQDTLATELNITQATMSKLEAKEEIDKNTLEKVAQ
ILKIPVEAIENFNDEGALNFIANTANSYDSSVSHQFYFNFNPIDKIVELYSEKEALYERM
IQEKNELIEKLLSK
>EGEFANNL_00828 hypothetical protein
MNNSKLNILFVLDKINTNSKGVTPLRCRITYLKERKIFSTGLFINLKNWEHKKQNSKSPN
KENIRIKI
>EGEFANNL_00829 hypothetical protein
MNQLAKTNKRYTYNDFLVQKKVLKEEISGMENSLSPKNLSNQLGLLGSSFTNFTKKSLGF
TNSSSSNFTSLILDWIIRKGGNKIINKFIGKRQGPLKKIILMASSYFLPWAVVKVKNFIS
KKIQNKNKKYID
>EGEFANNL_00830 hypothetical protein
MFGFVKNYVNKRVNLIKLELTENVSLLISNLIVGFFILVICFLFLLLLSIGISIYIGIKF
ADIGLGFVTFSAFYLILLIILICFYSKLSKAVMKKIIEFQLNKKQDESISENE
>EGEFANNL_00831 hypothetical protein
MGRKTTSNILASVIFGAAAGLLAGILIAPDKGKITRKKIKDRANDLNENLKDTYHKFKDD
FIDGIDKCKHEIHKKKEELVEKITSDTDPLKRS
>EGEFANNL_00832 Aspartate aminotransferase
MPIISFRGLNMPESPIRKLAPYARKAKDKGLKVYHLNIGQPDIKSPQAAIQALKNIDLDI
FEYAPSEGILEYRKTLATYYNSLSIGLKDLSYENFLISNGGSESLSIAISCICDERDEII
VPEPFYANYYSFAEALGVKIVPVVSTIDDGFSLPKIKKFEELITPRTKAILITNPSNPTG
YLYSKEELQTLADIVVKNNIFLISDEVYREYVYDGFKHYSVLEFQELKDNAIVIDSESKR
YSLCGIRCGFMVSRNQEFLQMALKFAQARLSPPLIGQLIANAAHSEPQKYIDDVRNEYQQ
RRDLLVQLLREIPGVKCPVPRGAFYCTIELPIDDAEHFCLWLLKDFQYEGGTVMLAPAQG
FYSDHELGKNQVRMAYVINQEDLKSAIHIIKKGLEVYNSTQ
>EGEFANNL_00833 UDP-N-acetylenolpyruvoylglucosamine reductase
MITLQENIDIKEFTTFKVPSICKYFTEIKTIDELQEAIDFSRKKKLPLMPLGGGSNILFV
KPFNGLVVKINLKGIAETFKNEDYVYVSAYAGENWDDFVQSCVSKNYGGLENLSLIPGNA
GTSPLQNIGAYGVEIKDCFFSLKALHIESGKLETFTHESCNFGYRESYFKNEGKDKYIIL
EVTFLLTRRNHKLHMEYGAIQEELIKKNISNPTIQDVREVVMQIRRSKLPDPKVYGNAGS
FFKNPVISNEKFELLQKDYPTIPHYQLENHTVKIPAGWLIEQVGWKGRNQKQAAVHNKQA
LVLINLGNATGNEVYDLSFAIINDVKDKFGIDLTREVNIIS
>EGEFANNL_00834 Tetraacyldisaccharide 4'-kinase
MKIILLPFSGLYWLGTFIRNKFFDWGILQSKKYKKPVITVGNLSVGGTGKSPFVIYLIDL
LKDKYLMGILSRGYGRQTKGYQFANYETTFEDIGDEPMQFFERFRNKIVVGVDEKRIRGI
KNMLKDFNPDLFILDDAFQHRYVKAGLNILLTDYSKPYYEDEVLPAGRLREGKYAAKRAQ
IVIVTKCPDSFTEKERDRIQSKLNLQPSQALFFSRIVYENRVISSNYSFKLENLVNFHVL
LITGIAKYNEILSFSEQNFEIVTHLNFKDHHNFTNADIQVIEKKYKEISGNKMILTTEKD
YMRLKHFQQIKNYLFYLPISIEIDRAEDFEKLILNYINKN
>EGEFANNL_00835 50S ribosomal protein L21
MNKKTLFWIFLILGIAWILGISYWYLWIENLSLAYIDWEGNFYSKDLNTQAFFKAVSLLI
VPLVITALLFYIIGLLFAKRTIQNISNVENENKQLKTELAQSLDKIETMKVLYTGGKIKR
KLPIKKEKQSVESKLEAEIQTHKDDLKIIDGIGERIEFFLNDNGIYTWKQLSQRSEEELR
NILEMYGGVSYRIHNPSHWPKQAQLASEGKWEELKQLKEKLKHN
>EGEFANNL_00836 hypothetical protein
MNATRFKTIINSKDKFIKYVEKRAKIEHAIIQNINFKDFKVNWSEFSIYNCIIVDCELSK
EDLSYLFQQGVFVYPKFKKLPYLPIRKELYNWRELMEIEKTKAPKTKDEVIYQHFNQTRF
NPPMDEALTQRLHDYSIDSCLRELLKFNDEGMTEKKAVGFMGGHSALRTSESYIKTATAA
YLIAQEGYYVVTGGGPGIMEAANFGAYMSAYPQKDFMNALALLQETGTNHIHPEYLSENY
LEQAQKILQIYPNGNENLAIPTWFYGHEPSNIFASHIAKYFSNSLREDILLSVCLYGVVY
SPGSAGTTQEIFQEATQNHYGTYGYYSPMIFFSKKRYVEDTALYSTLHQLAKGMKYKDLL
FLTDEPEEVVRLIKTHPPVKKI
>EGEFANNL_00838 HTH-type transcriptional regulator ImmR
MISFGKKIAILRKELSLSQTELAKKLNTSVSVISRYERDEMTPSIETAKKLANLLNSTVG
YLLGEMEDDNILKEPEILNRFKEINNLDDIDKERVFFTLDALIHEINNRKRYANS
>EGEFANNL_00839 DNA primase
MSIPEIKQKLSIQEVLEHYQIPVKNQMCRCPFHEDQTPSMQIFNDSNTVRCYSGNCPQSN
QVIDVIDFIMYKEQISKAQAIAKASQWIGLATKSSYKEYQELPMDRLEEIFYKMKQNLRQ
SKKANEYTLSRNLTPEQLEIGYNGRTYKGIVNCIVFPLKDHHNKIVSFYGRSIKDQNHYY
LKNRSGLYPGYPPKETKNLILTESIIDSASLLQIQEIREKYSVLACYGTNGFTQEHKQAI
QELQHLEEIIIIFDNDQAGKQATEKLAKQIQELNPQLQLTTLELPNKDINETHQLHTPEI
FTELIEKRKTIERSPEKHSIEDPPKKESNLTLNQINQLIQQSGIIGEENTRLLLFIIASS
YKTPKPLHAIVQGSSGSGKTHLISKIADLMPPEDVLRFTRITESSLYNWGEWDLVGKSMV
IEDLDGLKEEALYSLRELISSQKLSSSVSVKDKKGNIKSTHKKVRGIFSSLSATTKGEIY
EDNMSRSFVLAVDESIEQSQKIIAYQNKKYAGEIRKETENKARKHLQEYVRSLQDLEVIN
PYATQLQLPQEVHKIRRLNQMYQSIIQQVTYLNQKNRKINQGKIITEKEDLQQATEVLFE
SIILKIDELDGSLRQFFERLKNHLKTKDKEFTQREIRQAFNLSKSQTQRYIHSLLELEYL
KQSGGFINKGLKYKIDYWDNFQKLRKQIKEQLQTQIQNL
>EGEFANNL_00840 hypothetical protein
MQAQQIRITYKKTLLIKQLNFLLEQITDNTKTLIEDPYYKSLLEQIETNKKELVYHLIHN
LTKINRLYRIETNQKTLISTEEDILVALDLTKELINPSSILEPKDREYLRLLEAHFITKT
FKAREASALFQLKKTQTWRILVKLIIAGILQRNGNPNKGYIYQFPIDPIELPILD
>EGEFANNL_00841 putative deoxyribonuclease RhsB
MKKYLYFILLVLSICFNWNRVEAKSIHSREEKVSAELDYNRFRYYNPETGQYISKDPIGL
EGNNPNMYAYVYDSNTEVDLFGLNAKPEVAKDFEARIAKMSPSERVIAVNGKVSKVAKKN
GWEKDSKLSRTNNRNVYKDADGNLFAADTQHGRIEYTDKRGIHLGEYDIDGNKTKPADAS
GGHNLKCK
>EGEFANNL_00842 hypothetical protein
MKNIKLEDLKENIERGVILRCKGQYPYEEYVDFMVIEQQDQYALLVISGYKAGLIFVYLP
KESIPQDNNGYAIDLEWLKSNWNEWGYSDCPINDVHIIYKDSPTSFSDR
>EGEFANNL_00843 hypothetical protein
MKSNIKLNEKECTEISTKLSFVIGSIDRVGSGFYGDEETALALLLCFKENKMLDILSNIR
RIFDISLEKHLSEDEFEKFMEKEIEVWKPPYNATKEELLKLLQEC
>EGEFANNL_00844 Riboflavin biosynthesis protein
MKYAGKKKIIFFFSPDHFLSQWYPCKFVINNINFFSAEQWMMYSKALLFQDMDNAQNILS
VKSSKIQKRIGQSIVNFNSDIWDENKKNIVYKGNYAKFSQNEHLKKLLLSTKDKILAEAS
PYDKIWGIGLGINSDMRFNISKWKGKNLLGEVLMQVREDLKKE
>EGEFANNL_00845 hypothetical protein
MDLADNIKLIREGKNLMQKEVALHIGVDKSTYSKIEKGIREITVIELNKMAQLFDMTTDQ
IINFDGAIPKEITIGDKNEVEQIRLINQLDEEDKSIIFKLIDKMLTTKKFKDFFNKNVAS
L
>EGEFANNL_00846 hypothetical protein
MYFLFLFNFIFISAQQSVEKSLKRQLEFGSSIYNNVTDIAYYKYDKNDVDASFEVISKIL
NQNGYKQLSVDSFTKKVKNIFGDLKQFGNILFLSKQYKCLKPTEIQYFDEDGFSLNIYFD
LKNGLMVEQYKLPELIDYQKEYPEISKIENTLKTKKVVNGDSVFIQRWKDVPDLAQQRRF
NKQLLVSRNKYLFNDDKSQFVWLTNNDEYFMRSLVTTFGYTEDKKLLNWVIENTDLDLYS
LKNKGKFNYEEFGSLFWTKKCNGVLKLHPNTFKLLQELYKPNDNSTMRFLLDNIKEYLNY
LFNDKIYNGILTKEERLKIGANLVYFAEQYKYNTDYNSNERMMGRLRYFLDDDSVGILMK
NNYYNLPKFKQWWDKALYDQDYVIECEYDGVCGRDNPGPDPRDPKYKNSF
>EGEFANNL_00847 hypothetical protein
MERGDVQHLSCPRCKAPVTKDELKKIFPKANDETLTIVATSYTKYMEDLQMDTCWNKAHF
FEQAKVEGGEKIELKKGESMDYSAEDLYKGRWNPKENKYVTLFSAFKGNYEDSYNYGRSS
RNNYTANQKMIANIAYSNRKELGNLGGDDGWNFRGKGLIQLTGRDNYSKANVFTKKYENV
DILANSDLVAHDLKIAVLSSMAFFVFRKINIKANGTKNVINDICPLVGNNVTLAGGKTNH
KEKQDAFDKYTSVVFQVDKCLWGKLDNALKYMDGRAPWMKIVLDEAKNYGGYNEGSNKNQ
TKLTKRIKNAYFSIKNEAASSSSDPSSISWCACFASWCLQQAGYGNPSSCRALEFDPNYI
HEGPGNPEKKPAHMRKISEPVYGCIIVWKNNKKAGGHVAFYFGKTKEGNVIPIGGNQGQS
LQFSNRNPNGDYGQKIVGYYLPDDYEENPKDKFTDDELKLDPVKLNKSDLLAKNGFVSGA
T
>EGEFANNL_00848 hypothetical protein
MFKIKSIFYLIFIIPLNIKCQSKIDKNTNEVMGNNDSINSYTENILWKQLKQCFDYYYIE
SGVEGSDEYNKDDLQAAIYKIEQMLFNNNFNFIDKNLFNKKIKNIFGRTIDVSSNSEYLY
VNFFNKCNKNIVYHPNDIDYQGIFIIKNKNFIMDFYLLPRIIDYQKEYPKLYEKEKRLTE
ISNREFGIAKVRYWKDMFSLNEKNKNVLTLVSRNKYLFNDDKSQFAWLINNDSFFMENLV
TNFGYTEDKKLLNWVMEKNKSNAVEFVKNNIFVKNCQGDLEIREGILKYIEENTNENDNT
YYTALESFGYNIGDDNNFNKNEKVKIIAYIANSLSPLFYKYTQLNGNAIWNSATMLYNLS
VRNEYIISEIEKNNYFNLSNLKEVIENLDVEAPPLPAE
>EGEFANNL_00849 hypothetical protein
MLFQLWSSEIKNFSIEDVENNLWARQAGLDDKSLARSVNEFNLAFTNMVLILVCKKLFFW
R
>EGEFANNL_00850 hypothetical protein
MQKIVFLALGYAETRFKLLGEEISSFNSSKSIYKGREFHQLTGTRDGNGFYNSPGPYENY
AKAVGNQNIISHPDLICKNIHYAIDSAGWFWTDPNWGKKVPLWSSSSNVKYIKFRADYFS
KALGKPLNEVSHLVEDDEKYFWLQAKLLNGYPKGEKLEIDPNGWKTRKNAFDILKNNVFE
FNIRCKGNEQLNFNTEGRAPWMKIAWEEESKKLVETGSNKEIQKFFNGTPYEKSMKDGST
NESISWCGAFVNWVMTKYGYAGLSKNQDQYDTVRALKWSEWSEGKNIGKPVYGAIAVKKR
SGGGHVGFVAGKVGDKIVILGGNQGNALKCSKYNITDYFAYMIPNNYPITEIDYNLPEYI
GNPSEKESEV
>EGEFANNL_00851 hypothetical protein
MKKFFFVFFINILSISKFNSQKMFTKNDSIYNILMEQVKYGKPSYDNYYNGYLFSEKDYQ
IIEPYIESILLSNGYKKPDKIQFKHKIQNIFNRIIDYDNKKELFYINFLDKCNRNIVYGN
NDIIFYFGIYVNKKNLFLSDFYSIPQIIDYQIEFPKIKEYENTLSAFQSDDNNDNIVKLT
LWKDLPDLARQRRFNQQLLISRNKYLFNDDKSQFPWLINNDEYFMENLVTTFGYTEDKKL
LKWAFEKQGFTYQSYPPDDILQKFGKFLWTKLCNGEVKIHQNSLNLIKDLSNPSVNQEDY
ILLVAEYINYLTLEEKITGLTFEQKARIIATLLEFGEQYKYDKAYGFNQMFLGKFIFYQD
FDKLYKKEFEKNNYYNLPNLKHWYLLAEKEKDMFVNDMTLSDVPQPRDYLFRATYYTHH
>EGEFANNL_00852 hypothetical protein
MEIDIQENLTTKVGNNISTTAGKEISQYSGKKTLLHSSQSMEVEAMNYLDLYGKQKLITY
TKGNAEMGAMGQMHVHGTTALYSAKSTLDYKAPNMGRMAQPENFLYGKEKAILDIYVMDK
NMEKRLEEVPYGEESHVFVQTRNYEEGEIVTVIGKPFDEETEEKCILKGVVDKEGIAKME
KTFYFKKNLIKQEGNSVIEGNEIEEDAIYKTYKGKDYTYQQWQDFEQKQWEYYQSKQKRN
RFWD
>EGEFANNL_00853 hypothetical protein
MPGGDEDKCIEIGINCPPPQKQDGGLKGTSDGNQKRQDIINRRHGQYSWEVDGHTNKESK
IIIKVVDEPIQAWVAENPDTKVNALVVGYKKGKKDYFDVNSYGMVELPADNPNALNGQYT
FDKKVIYEFYQRNDVPNRVKDQWGKAEYIANMINSILEYNKTYSDIISIGDMRSPSDGPT
YASSSKTHHANSGAFDIRFLGKNGTIKGGGTPSQVNLEKTQFFMDCLGKHSFTRIILSHK
LKNKGFKVSGTLGILWDPSTVHDNHYHVDMGTKFSLKPE
>EGEFANNL_00854 hypothetical protein
MKNYYFLLLLFYLFSCKINEEKTKICPPKTEDIQYLQYGSTDFTSNMLNSTYLFNNSFKN
SYKVSSSTNLYKKLKENLNFDDLYYYSYIDTKDSFETLVLFYYSDYVKSFLLVTIKNNKI
IDILDISSSTGHVEDNGFENYDKESDYNYTTKDFFSSFNDRYLAISCPIDTTTYYKKGRT
RIWIDEKGKIHEDTLEVKRNFITTEKNLDCE
>EGEFANNL_00855 hypothetical protein
MLFFNYTFIFGQFSNNRVCKGIKEEDIISIKFMDENYENELESLVFGKKINIVVQTCNYK
KGEEVTIIVNYSYDIEGEEIKTGIEHKFIGIVGKKGIAKIENIILKKISDEEFIIEKK
>EGEFANNL_00856 hypothetical protein
MTFPINQDTQLECSEGTEPTPIQVTSQNFVSLAGKLQATEQDKEANTNIIPFGLCKLKPI
PGGYLPCQPALIKWQNTSVFTIDGKQELTTDSFCICSTGGKITPQTNANSSFENIK
>EGEFANNL_00857 hypothetical protein
MERKKEGLLESSGDYLTSLSKMDMESYKELGFILKSIVRVSQSAILAKESNIHLHRDWDI
YNLLTLIEKLIPDSELEFLDKVYNSGY
>EGEFANNL_00858 hypothetical protein
MNTDTASKKIHQGRNIKRLREMLGIKQESLAFDLGVTQSTVSDYEQKEQLEDKILEKVSQ
ALKVPVEAIKNMNEETTNNYINTFYENKGDGFFSNNCTFNPLDKVVELYERMIKDRDELI
EKLSKK
>EGEFANNL_00863 hypothetical protein
MNTTELKKRIKKNVDQADERMLRLINAMFESEQSSSPVPQWVYDEIEEQKEQIQNGEIKL
SEWKEVKQRLKEKYAI
>EGEFANNL_00864 hypothetical protein
MQYKLLLTPFAERDLDEALQWYNTQQEKLGFRFIATVEDYFIRILQYPKSYPIKSNSNRE
AYIKKFPYVIIYGLKESTQEIVIYRIFNTHQNPEKKPK
>EGEFANNL_00865 putative deoxyribonuclease RhsB
MKKYLYFILLVLSICFNWNRVEAKSIHSREAKGSAELDYNRFRYYSPQTGQYISKDPIGL
AGNNPNMYAYTHDSNTMVDLFGLDLITVYRFDTRSPSEIKAGGGFVAYKPDANVDLLTYA
KKNPQSQYISTSYSLQSAKDFSKYHSGEGYIYKIEIDDSKGVNVNEVLGAKSPYPKENEF
AVFKEIPNENIKGHTHAKDITDINDIKWLCPY
>EGEFANNL_00866 hypothetical protein
MLKILQILMILNGFVLTNACNLRKMNTQENFQSFNIECLNSKDSRIKAIINIWTNKEINP
TIVDIDTKKPYTYQGIFEVTYIEYKDSENVSFLTKDIRKFEAFYKLYKQTENKNIRMLIK
GCSIENYMVKFLVNTLFTMKLEMGVRVDYSTPTIGIFEEEEDVNQIATVQEQKAYYHRWL
KSIEGLPY
>EGEFANNL_00867 hypothetical protein
MKKYIILLVLLISLIACSQKNKLPSFSSENELISIPEDTLIKDRLIIEKLSKDIQAYQDF
KEWGCSLCYEKYSQDSTEINFVNTFIDLFNSCEPITPRTRTSPIGVDSVKCRVLVRLVDE
KRNKAKSFFENYIQKESKGEKLSLKSCKELFDKKELKNYYLFFINNKTTFMERVSYEDDY
LNFGYAKVYTE
>EGEFANNL_00868 hypothetical protein
MKKTAFYIGIFLFSTNLSFSRKTDKIKELKSFALSVCIQDNYKKLNPEFDSKDYTNSFIV
GDIVTISTPNLEILSMITQKIFINQFLLVLPMKIIMLIWYVIIV
>EGEFANNL_00869 hypothetical protein
MKKYIILLVLLTSLTACSQKNKLSTFSSENELISIPEDTLIKDRLIIEKLSKDIQAYQDF
RELGCSLCYDKYSKDSTEINFGNTFIDLFNFCEPITPRIRRTPIGVDSVKCRVLIRFIGI
EKRNKAKSFFEDYIQKESKGEKLSLKSCKELFDKKELRNYYLFFINNKTTFMERVSEEDD
YLNFGYAKVYTE
>EGEFANNL_00870 hypothetical protein
MAIIVSAQGFESPPINPIRPKWSDVYKNYPKKSATEDMFGPNVYKSMYGDDYDLNTHLLD
NKHELYNACAAKVSIALVLSGVELRRISGIGIDFIARQGPMKDKGFISTASKMKLWLEKT
WGGPYCQWKTSETCPNYSIGEFGLTVENRKEIYVMLAKNPTDFGAGGHVTLWIGGNQKVF
GGNHYDKSAKAMYFWELK
>EGEFANNL_00871 hypothetical protein
MSDVDILAHKRIIGYSKGITEFGAMKNMHVYGGNSLITALNKIEYKAPDMNEVTEPGKFI
HDDSPQIVEMFWSYGDDFIRLNEKSRFYVDMNLHALTRNYKPGESIDFVLKNEDDTPLAK
ELDILELSGVVDEDNQIILKDVFKDYTLNLTKEDPQQEEEDFKI
>EGEFANNL_00872 hypothetical protein
MPQTITETATLQCNQGTAESKLSVSSQNFFFIGDHAIATEADKQTGVNIKPFGLCKLKPI
PGGYLPCTPVPTNWAETTKKDELNGNKILLDCSVCPCTTGGTISVKEKGHGEEQEG
>EGEFANNL_00873 hypothetical protein
MKKSILFFSLLSIVCSCQKQETSTSIETISSTPIQPKDSLIGKFNIQEFNKHQKNNEWEY
TKDNKDFFLRDVQDEYWMEVSEKNNPFILRINYYLNGNRKLKALSFHANGFTKGLVVEYN
EKGNITKQTDYDAPYKDYPWEKVKVWMESKNIDLLDPLTRVWREIDNDKPIWYISWDTKK
LDKYSNQIIQNVEINGKTGEIIKEYTSSFGEEIPEKYR
>EGEFANNL_00874 hypothetical protein
MKFLAIFLFTLLLSSCQRQETSTSIETIFSTPIQPKDSLMGNFNIQKFNKHQKNDEWEYI
DKDGNEIRETYIEGDGYVVDINYLKYPFSTYKFFNTKGIIKTKGNYFHGNGFNKGIWTDY
DEKGNIIKQTDYDAPYKDYPWEKVRVWMESKNIDLMDPLTSVGRNNDNDKPIWYISWSIP
LNEVGTQTTYNVEIDGKTGKIIKESSETFDREG
>EGEFANNL_00875 hypothetical protein
MKKYLFFILVIPVCISCQKQETSKPIKTISSTPVQPKDSLMEKFNIQEFNKHQKNDEWEY
IDKDGNEIRNIKDGNEGYIIKITNNKNIFDINKYFYPNGNIAQKSFQFHGNAFIRGVMTD
YDEKGNIIKQTDYDAPYKDYPWEKVKVWMESKNIDLLDPLTRVWREIDNDKPIWYISWDT
KKLDKYSNQIIQNVEINGKTGEIIKEYTSSFGEEIPEKYR
>EGEFANNL_00876 Actin cross-linking toxin VgrG1
MDHTNSPYVYHRKGNGDFSDTSAVVTLNGKEISLRNSIEVKISQEMLSHTTYHLICPSEA
FGDKDAYPLSNSKQLLGSNLSIQFRKKGETIALYTGVVTRVNYKKKNKYPFIVIEAKSFS
VLLDTQKRCRSYLNQSLKEILNKAFSEYSGDRVEFICEPNYSSLIPYTVSYNETIFAFMQ
RLAIRYGEYFFWNGSQLIFGRGNQRRTPIYEGQDYLEYEISTGVAPQHSIRENYYPSAAS
VQSLNSKTFAPSNSLYLVNPFLHHAVTEAKKIYPSSETSFYFDALSEDQDIEQQNKLKIQ
QSALENLVWVEAKTTQPGLRLGDIAKMLAHIPEIQTFENGKKVPIESYLIQKIEHTYDTH
GYRNEFSAIPREQLIAPYWDENAYPRADDQSAVVAEVDDPLKMNRVRLRFFWQKGESELT
PWVRLVQGYAGQDRGLHLMPEKGEEVLVSFRRGNAEFPVVTGSLNNGSQISNYQTEDNRF
KVLKTKQGEKLEFEELKNIVLADRKGNQLHIEIDKDTLTLRALDIINILAPYINIEAEKN
LTLRAGQKMLSEAFEKMLVNTPFMQQLVSDYYHTQAGKALINSQNEIKLESPETYVQGGQ
KLFLHSDELATLNSKGIAEFRGETKNALSNKADVYTPQQYKIEAKCTVQFRPHNNWDGEF
GFDWMRLGDTGRNPGDTKAYKDIVGKNRDGGKISNNNYGNNIVPDSAEYTKLLKKYNVLS
VPFTKDFYIVPWASLFKDKTAKFSLKLHIEEPPKKLEFKYDKTLFQLNKTEITTKTKGKH
TLPDYLTVKCIKTFNADQYIDVYADEKLAGRLKIHKNGKVDRRKIDIVLAPVKTNIINKS
KTGETGKITGEEAKLKKYLGQALITPNIIIDNSVDLRNNRIFERTFIRGGQLVYGHDSSG
RGKLHTYMISNYNLAGKYPGAFIIYIFDLPCPGTGGEVFEIPSYFALVYKYASRKPTCLV
HELLHGLGLYHTFDNDSTFTFPKKTENIMDYTATRYATWKWQWDLIRKHSQVKPE
>EGEFANNL_00877 hypothetical protein
MSSFLAKLFLDGETYTILKCKYQFDKLTDPTFKPSGEVVGGKIKLTIESRGHVGLLEWIL
ARDKEKEGYVEFYRRDGMSRQLRIEFKKAFCIRYKEKFNSVGNVPMHISFVIVAQKLKFN
HLEFHNDWVI
>EGEFANNL_00878 hypothetical protein
MNTDIAPKKVHQGRNIKRLREMLGIKQESLALDLGVTQSTVSDYEQKEQLEDKILEKVSQ
ALKVPVEAIKNMNDEATINYINTFNDKVESFNSYNCTFNPLDKVVELYERMIKDRDELIE
KLSK
>EGEFANNL_00882 N-acetylmuramoyl-L-alanine amidase AmiD
MKFILKLLICTFVLTLIITSCSTQEKVIVKTKTVHDTIYVTDVDPKYHFVEQANLKDYII
SKKNFPSVASNHRVKFIVLHYTVSDYPTSVKILAKKGNVSSHYLVNDLPNDSIDLLVSEN
QRAWHAGISSWGNAVNLNDTSIGIEIVNSGYKKIGDSMVFQPFPNYQIKKVISLVKNIAE
RYDIDPVNIIGHSDIAPLRKQDPGPAFPWEKLYKEHQLGAWYDEKDKLYFLNMYEPDIAP
YNSVLEFQKALKKYGYSVNLTGVYDKNTKLVTRAFQWHFRPQKGDGIIDAETWAILQALN
KKYRTK
>EGEFANNL_00883 GTPase Era
MTEVPFKSGFVNIIGKPNVGKSTLINLLMGEKLSIVTSKAQTTRHRIFGIWNDANVQIIF
SDTPGIIQKPAYELQEKMNEFVKDSFHDADILLYLTELRDEKNPSEYLLNKINSSKVPIL
VLLNKVDNSKDSEQISQAVEILHEQIPTAEILPISALHSLNTDLIIPKIISLLPESPPYY
DKDQFTTLSERFFVNECIREKILLHYKKEIPYSVEVVTESFKEEDNMIRIESVIYVERET
QKGILIGHKGEKIQKVGIEARLDLEKFFDSRIFLNLFVKVKKDWRSNDKDLKAFGYSNS
>EGEFANNL_00884 hypothetical protein
MARIFSSYFAILLFLVFSCRSSNNNPNTSEKKTFLLQQQLIKHKITEDIPYRIEVDYSKD
SILINNIFNDEKIISYKLHSRNKEYYINNSFSNGKSYLFLKNQGPDSCYSLTLAKDEKLN
YEYYSKSNEIDLCFSNLKQGNFSTTIRLNPYGSISHNEIFFYNKHYKFYKIALRLNNQIY
WYLP
>EGEFANNL_00885 hypothetical protein
MNKYIKLVIAVAIIGLGIYLMFNRNIGLGIVMILLSAIPILLFFRNEYILLAFWKLRKQD
LAGARSWLNKITNTKGQLVRKQLGYYNYLMGITEAEKNPAKAEGFMRAALDYGLSFKHDR
ALATLNIAAGAMMRGNKLEAERLLNEAKKLDSSNMLGDQIKMMKEQMKRVNVSRSNMINP
NMRSRSKFMR
>EGEFANNL_00886 Allantoinase
MILIKNATLINEGKSLLGSVLLKDNIISAIYFSEEIPEQIINQSQIIDAEGLWLLPGVID
DQVHFREPGLVHKGNIESESKAAIAGGVTSFMEMPNTNPQTVTIDALNYKFELASQKSYA
NYSFFMGATNDNIKELKKVNPKEVCGIKIFMGSSTGNMLVDNKKALETIFSEIEMLIATH
CESEEIIKSNIQKYKLKFGENIPISYHPLIRSAEACYASSSEAVELAHKCGTRLHILHLS
TEKELSLFENKPLSQKKVTGEACVHHLWFTDAEYETLGSKIKWNPAVKTKQDREAILEAV
KQGRLDVIATDHAPHLVDEKEGGCLQAASGGPLIQHSLQIMLELVKQNKITKEVIVEKMC
HAPAELFQIYKRGYIRKGYYADLVLVNPNKPYTVTQENILSKCKWSPLEGKTFTTSIEKT
FLNGKLAFDNGTINQVRGEALSFER
>EGEFANNL_00887 Multidrug transporter EmrE
MKSYLYLLMAICFEVAATSTLPKTEGFTKWKPSIIFFLLFFVALFALNKAIKTIPIGIAY
AIWAGIGIVLISGAGFVLYKQKLDTPAIIGILFIIIGVVIINLFSKTAGH
>EGEFANNL_00888 Holliday junction ATP-dependent DNA helicase RuvB
MSDLLDPDKNKYTGEELAQEEQVRPKNFFEFTGQTHIMDNLEIFVKAAKLRNESLDHVLL
HGPPGLGKTTLANIIANELGVGIKITSGPVLDKPGDLAGLLTGLEENDVLFIDEIHRLSP
VVEEYLYSAMEDYRIDIMIESGPNARSVQINLNPFTLIGATTRSGLLTAPLRARFGINFR
FEYYNTELLSTIVERSSRIMNMPIEQQAAIEIASRSRGTPRIANALLRRIRDFAQIKGNG
KIDLKIADIGLEALKVDQHGLDEMDNKILSSIIEKFKGGPVGLTTIATSVGENPGTLEEV
YEPFLIQEGYLMRTPRGREVTEKAYKHLGKKVKFKGDQSELF
>EGEFANNL_00889 Multidrug resistance protein YkkD
MNWIILIVGGLFEVGFTYSLGQARESQGNSSYLWYTIFVICLFASMGLLMKATQTLPLGT
AYAVWTGIGAVGSVLMGILVFKEPATFWRIFFVTTLIASIIGLKVVSNH
>EGEFANNL_00890 hypothetical protein
MHLSTIITSIYNIPNASLDKIVQLSEEIKYPKKYLISEEGTIKNSTYFLSKGLVRAFSTI
NGKETTFWIGTEGHVICSMRNYVENKPSYESIETLENCLLYKINNLSLEKLFLEDIHIAN
WGRKFIEKEIIKTENQLIFQLFHSGRERYQYLLKNHPELLQRVPLGIIASYLGMSQVSLS
RIRANK
>EGEFANNL_00891 Bifunctional aspartokinase/homoserine dehydrogenase 1
MFKNTHKFKTNFHIFSLENKNSLKLYLNEENLMKVVKFGGTSMESSQSIRRIIDILQHKY
SQGEKFIVVSSAMSGVTNLLTQLSEQAATGINFKDELKDLEKRHFTVIKDLIEVKYQNPV
LTQIKIYINELEDLLQAVLNLRELSLQSKDFILSYGEKCSTFLLSQIAKQYFPNSLFVDT
STLIKTDDYFGNAKVDFPETEKRIQEFYTNNKDKILFATGFIASTKDNRITTLGRGGSDY
TAAILAASIDADEIELWSDVDGMLTADPKIVKKAFPLAEVSYTEAMELSYFGAKVIYPPA
MIPAISKKIPITLKNTFNVDFKGTQIKETVQKNSYPIKGISSIDHVSLVNVTGSGMIGKV
GFSGKLFSLLARENINVILITQSSSEHSITFAIEPQDISKAQEVFNREFELEIETHKLNP
LTVEENLSILAIVGENMKQTPGISGKFFHALGRNGINIHAIAQGSSEYNISVIIKNKNIS
KALNAVHDVFFIELTKTLHVFNVGTGNIGSTLFKQIEKQSKYLRENNDIEVKIVGISNSR
KMFINEDGIDLENWKNILEESGEKVTLEKFTEKIKQLNLSNCVFIDNTASPETSKFYQQL
FQSNVSVVTCNKIANSSSFDEYNLLRNTARKRGVDFFYETNVGAGLPIIRTLKDLMTSGD
QIIKIEAILSGTISYIFNNFKGDATFHDVVKKAQELGFTEPDPRDDLSGKDFMRKMMILS
RELGNPTEERDIKLGEILPESCIKAPTVEAFYEELKKSEDYFNQIKKQAENNNQVLRYIG
KLENGEATVRLEMVDCNHPFYNLTGSDNIISFTTERYKSNPLVIKGPGAGAEVTAAGVFA
DLINVGAN
>EGEFANNL_00892 Homoserine kinase
MKEKDSIHVFAPATSANFICGYDILGLALEEPGDEVKLTRVNTPGVVIKKITGDEGLLPT
DPKKNTVGACIEMVLQHLNREDLGIEIELNKKMPIGSGLGSSAASTIAGLFAINQLLGEP
LTRQELLPFALKGEELACGYGHADNVAPSLLGGITLIKSYHPLEVINLPTPKELCCSIIF
PHVEVPTRAARQILRTQIELKNAVHQWGNIAGLISGLFLEDYGLISRSLEDKLIEPIRSI
LIPEFDQMKEIAKELGALGFGISGSGPSVVAFTKGLGKAKEITEALQLQLKNKQIGSNGY
SSRINTHGAIVIK
>EGEFANNL_00893 Threonine synthase
MKLYSTNNKDLRVSFKEAVFNSFPIDKGLYMPVEIPQLSSDFINNIDRYNFQEIAFLVTQ
AFLGNEIPEEDLKKIIEEVINFEAPVVPLSNELGVLELFHGPSLAFKDFGARFMSRIMAY
LSDKNDKTLDILVATSGDTGGAVAQGFLGVEGTRVTILFPKGKVSEIQKLQLTTNGQNIR
ALEVDGTFDDCQSMVKEAFNDPELNEHFNLTSANSINISRLIPQTFYYFHAYAQALRQNK
KSINFVVPSGNFGNIGAGLLAYKMGLPVQHFIAATNINDTVPRYLQSGVFTPKPSIQTLS
NAMDVGNPSNWVRIMELFNNDLQKIKEIVSSASFTDEETLSGIQELYQQYNYIACPHTAV
AYLGAKEICNAQEFTIFLSTAHPCKFIDVYSDNLKNEIQIPTQVKELENKTSLAKPIKND
FIELKKFLLNN
>EGEFANNL_00894 Sodium/glutamate symporter
MGNFELNSYFTLIIASMVLLIGNFMTKKISFLKKFNIPIPVAGGLLVAFLLTVLHYTSNV
SITIDTSLQEGLMLMFFASIGLGADFSRLKEGGKPFLVLTIVVAVFILLQDLVGVSIASL
LGVDPRLGLVAGSITLTGGHGTAAGWGTTLENLGVSGATTLGIACATFGLVLGGLIGGGL
AERLIKTKKLIPLKKDHLSNDGKEANTVDTTFEHPETPRLITVNSTLEAITMFAICIGFA
FLMSQFMIKNYPDFFIKIPNFVWALGCGVIVRNILSHLFKVDVFDRCIDVIGNVSLSLFL
AMALVSLKLWELIDLAIPILIILGAQTLLMITYAYFVTFRALGKDYDAAVIAAGHCGFGM
GATPTAVANMQAITSKYMNSHKAFLIVPLVGAFFVDLINASVISSFVSFLSR
>EGEFANNL_00896 hypothetical protein
MPHPIIQDTQLECSQGTKPTPIQITSQSFVCIAGKLQATEADKEANTNIIPFGLCKLKPI
SGGYLPCQPALIKWQNTSVFTIDGKQELTTDSFCMCSTGGKVTPKTDINSSFENIQ
>EGEFANNL_00897 hypothetical protein
MKIIILLLTILILYSCNMKNQICKTEDNRYEIWGTTPFDVTKRIEEEGCRCLSHTLLWNP
KPKFFDYKQLKEIREKLPNWLSENASDFSKQDKEEFIQELARMTDGELLQKLIYQYSFFR
TSQYEEIYVFTLKIANIQAYCINYNEVYSNYNNKDIYPEGDEFYDRLKKYYPIIENEAWA
ENEFGDSGIIPVNNKSNKQPTSKFLLEN
>EGEFANNL_00898 hypothetical protein
MNLFCKGVVYSLLFFLFITYSPPLVETIDPCSATPSYEYSNTIFIIIFYTILFLILGSFY
TSHIVKKKYILLILVFLLPIISFFFSYIIISYLIHSEFLSNNNIINYIRTYDECYNNKEV
KEIPLNILCSIILFISSYLTLKKR
>EGEFANNL_00899 hypothetical protein
MGENKILKATITKATIGSKSKPLNEHLGNTNLYSYIIVIGLQAHAGDWKKNAVAPFYGGY
VGEGSKLMFVHQALRRMKLNNGDIKYEVLLCNSIVPTHYYSKNQVTKITEAVRGYGGILI
EVKNADEIINYINKGDIKKSSTKKRNNFIKQLIFYSHGLVGELALGMPPLGNSTSLSIKE
EEVNKMNKIAFSSACNIYSFACRTGLGNHKVDKSVYINPKGNKKDPNNKYNLLSSESLAQ
KLADKTGATVFAYLCRSDYAETLFTKDELCFKDYYQAREKKKTRVENARCGDTYKHLLNQ
NYKLTEAEKARIKEWKEIESNMIMIDKAWFDPDGARHPVKGGTTPEGTPNDMKTYKPKY
>EGEFANNL_00900 Actin cross-linking toxin VgrG1
MGNGYTNEFIAMPCDQFIPPYYNEKAYPKAEKQRALVTDNNDSLGLGRVRVRFDWMKPEQ
QSPWLRIVFPYAGAGKGHYFLPEIEEEVMIDFENDNMEKPFVIGTLYNGNQKSNYYNSKN
QLKALHTKHGHVLEFDEREESIGITIKDKNNNYIHLNTKENNLEMEALETIRMKAKNMEI
DIQESINTKAGKDIKTTAGEEIYQHSGKKTLLHSSQNMEVEAMNHLDLYGKQKLITYTQG
NAEMGALGQMHVHGTSALYSAKITLDYKAPNMGRISEEGDFLYSKEGEIIMVKWVNKKGD
KIITDLSENKRASIWIQTRNIKEGETITINVEEKDIQGNINNIEYSGIINSNGEALLSSI
FSFKKDL
>EGEFANNL_00901 hypothetical protein
MGILFCERIVKFFVLYPIILILKVQIEFIENLVLNFIYKIKNKYFIFNSSKKVNHILILL
YLYEIKLNYYQLFMMSRTYSSVPDGKGSIIACTIKIDGKEVLHQSGSYHLEMKQSMCEHS
TFRLLCPADAFETSRDFPLTNSKNLFGKKIYISFKQFGETTFIFQGIITQLNWKIEDNNP
QLELIGQSPTILLEQGELCKSYENQTLEQIVTQTCEGLPRDIFELKVKPKYKNKIPYNVQ
YQETNFQYLQRLAKRYGELLYWNGEQLVFGGYGGRKIPKQEGEDAQYLQLQMKAQPQKLN
LYAYQSEYDILHQLDSDQLQKKG
>EGEFANNL_00902 hypothetical protein
MILEQLKNAPESIEFNEVIAYIDNHYNFTPTSFKNGDINNESGQNNGSCKVFSFAKLHQV
SKEKTLFLFGKFYREDVLKNPEGTDHANIRNFMKYGWEGMGFKDQALKKKVA
>EGEFANNL_00903 putative MFS-type transporter YhjX
MVVSAVSMHLSIGSVYAYSVMVKPVSEIFNVNGSVINWAFKLAILLLGFSAAFMGRWVEK
VGPKKSGTVAGIFYGVGIIGSGLAIYLHSLPLFLFCYGVIGGIGLGIAYITPVSTLVKWF
PDKRGLATGMAIMGFGFSALIFGPLMQILFEKVGVTYTFFILGVVYLAMILLAASYIERP
PENYLPHGFNPGEGATLKKDLSNIDAKAALKTARFYYIWIMMFINITCGIALIAAASPMT
QEKLGYTPLQAAALVGVIGVFNGLGRIMWSSLSDYLGRANTFILFFSFQILAYYFLPQIT
IEIVFLVILFTVITMYGGGFATLPAFLGDLFGTKQLGAIHGMVLTSWALAGVAGPSIYDY
VKETTGSLTITLQVFSAMFIIAWIISLLMKRSINKLKRSLNNA
>EGEFANNL_00904 4'-phosphopantetheinyl transferase sfp
MKIFYSFIPDQSLENTLLSYLKILPTGIQSKIYGFKNTEDALRLLLGYALLINGAKYFGY
SSSFVVQNMIYNPYKKPYLKNNPIFFNISHSKELAVCIINSTNEVGIDVEAIVPIEIEDY
QECFTSSEWHQIFQNNNSLKNFYELWTEKEAVLKAESSGLNISLNSFEIINQNCFMDGNN
YSIHMVDIHEDYVCKFAIKNPSKPMNYQALHIPFK
>EGEFANNL_00905 Tyrocidine synthase 3
MTEKSRVKLTPFQSLFYYEWLKNPLRNDYNMVMDSFVNGDLCVKKCEAAFLKLVNEHFVF
FHNPRVYEGTFYWKLRNKAKKVIDYFPAKLTEDEIYNYISKPFNLEKDLQLRLGIVKLEK
SKYRILLVISHLVIDGITTNQIYEKWAAIYNGIGYTTFSFEKQMEMHNQLNEYFDSILIK
NKEEIHGFWKKHLENLTGIDLNFLKNNLSSQKSPKRLVSEIVFTYDGTIYNQLNSLKHLY
KITPYVFGQLVLAILLHKVSGADNIPISYPIAILEGTDFIYGAHVNTMIVDYRFHEKTTL
EETIQNVLQFFKDLKTSKAKYLPTSQIVQYAENSNILDIGFAQTFLRDFEPNLDGITFEE
INHEYQIDLVNQLLFEQELHNKNINYRVKYDKDLLDENLVKNFIQLYQKLFLEILNDLIS
ENKNREITTYKLLNEKEPEYFKIVNKWNQTYVHKNTAPTIHEIFEKKVKQNPLNKALIFQ
DVEYTYSELNERANKYAKYLKEKYQIRKGDIIVLVLDRNEHIITTILSMLKLGAIYVPLD
PLLPDSRIEYVVKDTHSKLIITNKNYFERIFKIISEVEIIDKEELWDKTLIHYSSDNLVN
LTNPEDIAYIIYTSGTTGNPKGVMVMHKNVTNLVFNADYVSIDNTDRILSLSNYQFDGSV
YDFFTALLHGIPLVLADKEDLINSALLNKKIKKYKITNVLITTALFNMLVDEDLSGFRNL
KYILIGGEAASVVHVSKFVKKYQNVTLINAYGPTETTTFSTCFLINPQKIYNIIPIGKPI
PNVTNYILDKERNPVPVGVVGELYIGGDGVSKGYLNNLPLTSERFIINPFQTEKEKELNY
NSTIYKTGDLVRYLPDGNIEYIGRNDFQVKIRGLRIELGEIESAFNSIEGIKNSIALVKD
NGEGAKYIVCYYSSSHEMGENLLRNDLGNKLPDYMIPSVIVPLKGFALTVNGKIDRNQLQ
EPTFTIKQNYEAPENEVENKILGIFSSILNIDSSNIGVNDEFYKLGGNSIQIIKLSAQIN
NNFQIKVPVSELFDHLTIKKLANYLYKYKGYKDINIQKYYFKNVEDQCLSFAQQRLWFID
YFEEGTYAYNIPLLFKLKEQVNIDLLKQSITKIIDRHEVLRSLIKTDQWGNGYQYVKDLK
DRPLIINTTNFKSQEELDELMSKDVWHIFKLEEEYPIKVQIFQNERDLYLSVVVHHIAFD
GWSTDIFIKELIYNYEYFKLIKSENPIHAEKYLLPDLKVQYKDYAIFQRNYLKQELYNKQ
YAFWKKQLQGYERLNLSTDHKRPLKMDYKGEDIEFHLDEFTSKRLVSLAKEMNISLYNLL
LSGYYLLLSAYSNQDDILIGSPVAGRNHSQIVDNIGFFVNLLVLRQIINDQQSLYNFILE
VSRNSTEAQNNQDLPFDHLVDAFGGEKDRSRNPIVQVVFGVQAFAKEVEDKEKNILEFYQ
GSFSRNFNIAKFDIMTMLDDSGDSIKGVFNYATSLFNKATIENYISTYITILKQFADLGL
QEIKNKKIENIKYLNKTQFDKIIYTFNHTKQIYDSNKTLVQLFEEQVLKNPDKVAIIFEN
KNFTYTEINQKANQFANFLISKYKIKIGDRISMYLNKSEKQIYTILGILKTGSAYVPMEP
VMAEERLSYIVDNIKAKLVITEKAYKSNLEKLINNPAQSILVIDDHSYEQEINISNPVQN
LDLNISSEEIAYIIYTSGTTGSPKGVKIKHKNTNNLVSNAKLLSMNETDIVLSLSSYQFD
ASIYDYFLTLLSGATVVLTSKEIFLNLEKLDELIAKYTITNIFVTTSLFNVLVDEGIKNL
DSVKCIVFGGESASYTHISRMQKSFPKIKLINGYGPTETTTFATINTIDTLLEDNTPSVY
IGKPLNNYTTYILNKNLKPLPLGSIGELYIGGDGVSDGYLNNLNLTKEKFLNNPFQTEEE
KKENYNQIIYKTGDLAKYLQDGQIEYIGRNDFQVKIRGYRIELGEIETTICKYPKIKKAT
VVVNQTSSEIKSLVAYYEADKEVKEDELKDFLSKSLPDYMIPNHFIHLSAFPTNSNGKLD
RKALPEITKINQTTCIKPHTDNERKLIKIYSEILNLNSTEISTEDDFFSLGGSSILAIKV
MNAIKKECNVSIDVASIFTNRTIKKLAQKINEGQNTFTQVKKITVDHPEDQLLSFAQERL
WFIESYAGGSDAYNIPLILKFKNEVNYKIVEKAFIRLLYRHEVLRTLIKTTHEGIAYQQV
IKDLPQPFIIKKATVDSKMELHKLIQTDIHKKFKLEKEFPFTVGLYTLDNELYLSLVVHH
ITSDGWSLDVFMRDLMNNYLFEEKNQNSLELKNDKPLTNQENLLQYKDYALWQRQFLQGD
ELKKQLDYWKKHLENYETLNLPTDRIRPSLIDYKGAYVNFSLEAELSNSLRLKAKELKVS
LYSLLLSGYYLMLSAFSNQEDIVVGTPVAGRHYEGIKDLIGLFVNTLVLRQKINASQSIA
CFISEVGENVNNALMHQDLPFEKLVDELKLEKDSSRNPIFQVMFGVQSFGKDQREEYENI
FTLYEDLEGLGYSPAKFDLTTMLDDSEDKISGIFNYAVSLFDKDTIQNYIHVYLKILEQI
ATVSIETKKLNQISYINDDEQYKIINQWNHTYADFPLEKTMHQKFEEQVTRTPDQCAVKY
NNEELSYKELNEKANAFAQFLITTYKIKPDELIPICMSRSTNLMVALLGILKSGAAYVPI
DPKAPQDRISYILNDTKPKLVVTDDGTKIEKIQTTSLDIITLNFEFIYQLKSTYSVLNPE
VEITSKHLAYVIYTSGTTGNPKGVMVEHKGVINRMEWMQNYHPILPSDIVLQKTNYTFDV
SVWELFGANWYGATLILADSEEYKDNLYLIELIRKEKITMIHFVPSMLASFVETLNNYPD
KQSHVYTLQTLYCSGEALGLEEVKQFQKLVPQCNIYNLYGPTETTIEVLYYECNTKNLSK
VLIGKPIANTSVYVLDKHLRPLPVGAIGELCIGGVHVTRGYLNQEELTKEKFLDNPFHNF
QITEHYENKRIYKSGDLVKYHKDGNLEYLGRNDFQVKIRGFRIELGEIEASMLTHPQISQ
AVVVAKEHDSGEKYLAGYYVSEMPIEQSELSKHLLNNLPDYMVPSIFIHMFEFPLSTSGK
LDRKQLPSPKFTGDKTYIAPKTEEEKKLCALFAEILKIDIKEISVEDSFYRLGGSSIKAT
QLTHKINNLFGSKIKLIDLLKAPSIRELALLVQDIKLYCPIVELNNSQNKPLFMIHPGVG
GCEVYESLATKLNPYYHCYGIDSFNLYNVNKILELSKLAEYYLLSMDEIQKSKTSYNLLG
WSLGGQIALEIAVQLERRGVKDIKVYLLDTWINFKLRHGLDHAVDRFISRFGKDIMEREK
ILELMEVDNIIQSQPLSGLLQHTKVILFKALVPIEGLEDDRMVICPYNNIETSVKNFDQL
RAVNLETDHFSILDKEFDIMNNMIG
>EGEFANNL_00906 putative oxidoreductase
MAKDNNTENLESKDPKDENPYNLTGKLKVSDPEKKAAGFTAVKVSLENLIDEKTLLRGGK
ALFSMNQFTGFDCPSCAWPDPDDERSSLGEYCENGAKALAAEATSKKLDPEFFQENSVYE
LSKLDDLKIGKLGRLTHPLYLPPGGTHYQAIEWQDAFNKIANHLNELDSPDQAAFYTSGR
TSNEASFVYQLFCKEFGTNNMPDCSNMCHETSGTALSPTIGIGKGTVKLEDLYEAEIIIS
IGHNPGTNAPRMLSALEKCKSNGGKIISINPLPEAGLFGFKNPQKIKGMLGGGVKLTDVY
LPVKINGDMALLKALEILLFEFEKQSPGKVLDKSFIQEKTVGFEEFSKQFSKYKLEDLSV
ECGISVQQLREVAEMLAFKNRIIICWGMGITQQPNGVDMVKEMLNILLMKGSIGKKGAGV
CPVRGHSNVQGNRTMLVNHKPTDEQLDTLEEVYGFKMPRSHGYDVVHTIKAMHEDKVKVL
FCMGGNLLSAAPDTNFTSNAIKKLNLLVTVSTKLNRGHLVHGKESIILPTYSRSDMDIMN
DEVQIISTENSMGVVQASKGVLKPVSNNLINEMQIVCRMAIATFGEKSKVNWKRFHDSYD
AVRDDIAKCIPGFENYNERVRVKGGFYLPNGARDKQQFSSSYNYKAPFTISDVPENKLED
DEYLMGTTRTHDQFNTTIYGMDDRYRGVHNERRVIFMNDDDIQKAGLKNGDKVDLFNYDN
NVERIAPLFIVVSYNIPKKNTMTYFPETNVLVPIDNTVRGSNMPASKYVKIKIKKHDPKI
YDRIEV
>EGEFANNL_00907 Sulfurtransferase FdhD
MINSLLNKKSINQLDTVKVKQGRFVNFTDSVSVEEPLEIRILFGSTGNKTEKNISITMRT
PGNDVELAIGFLFTEGIINSYKEIKTVKSTEEGTPLLQENRVIVELSDGYNPEIGNSDRN
FYTTSSCGVCGKSSIQAIKTVNKYQNIKKKSLKINTEIFYALAEVLKKTQSNFEITGGIH
ASAIFDLEGNLNAMREDVGRHNALDKLIGYFLINNHLPLNDKILLLSGRASFELIQKASM
AGVSLIASIGAPSSLAVSIAKEFDMTLIGFLKKDSMNIYHKSLKHSFY
>EGEFANNL_00908 hypothetical protein
MSLISIKDLQYVLKLKKFGFLGKSVAWLLMYILRLNKVNEVYDKVKDLSAQEAYQRILDE
LKVTYKIHEEDLKRIPESGPFIIVSNHPLGALDGIILMKIISERRSDFKIMSNFLLKKIE
PLKDIIIPVNPFETRKDVFDNKMPIMEALRYLKQDHCIAMFPAGEVSHYNRKTKKYEDRE
WLEGSLKLMKMAKVPIIPIYFHAKNSNFFYKMYDIHPDLQTAMLPVEMVRKRKKPIQIRI
GKSISVKQQNDYPTIKEYGNFIRSKVYMLKSFYTVNKDPFKNLRFLSVATMMKSANSAKQ
KPIIDETPKECILKEIELLREFNCDLFTNYQYEVFFAKPEKIPNILREIGRLREITFREV
GEGTNEAFDLDEFDQFYRHLFLWDSGKQAIVGSYRMGMGEEIYKKHGIKGFYTASLFEYD
HEIQPFFRKSIEMGRAFIMNEFQQKPMPLFLLWKGIVHVCLRNPYYKYLIGGVSISNQFS
NFSKSIMVEFMRSHYYDAYVAQFVHPKNEFKVKLNDTEKDLFFGAAENDLNKFDKLIDEL
EPSLRLPVLIKKYFKQNARVIAFNVDPKFNDAIDGLMYIRISDIPSDTIKPVLDELQKEM
DKEKISS
>EGEFANNL_00909 Fructose-1,6-bisphosphatase class 1
MTNTKTKNPQTLGEFIIEKQADFQYSSGELSRLLSSIKLAAKVVNQQVNKAGLVDIVGAM
GNHNIQGEEQQKLDVFANETFIAALNNREVVCGIASEENEDYIKVHAKNNINLSKYVVLI
DPLDGSSNIDVNVNVGTIFSIYRRTSLEGSVQAEDFLQPGKNQVAAGYIVYGSSTMLVYT
TGNGVNGFTLDPSLGTFYLSHPNIQIPKNGKIYSINEGNYIKFPQGIKKYIKYCQEENED
RPYTSRYIGSLVADFHRNLLKGGIYIYPSYSNAPKGKLRLLYECNPIALLTEQAGGKASD
GFHRILDITPSELHERTPFICGSKEMVEKVEYFIKNAK
>EGEFANNL_00910 Acetyltransferase
MQNKSEEISLKIKRFNELSITELYHLLKLRSEVFIIEQNSIYQDLDDKDLEAYHMLIYIK
NELGAYSRILPKNISFTEASIGRVVVKNKFRSIGLGKILMNKSIENLYNLLGKQPIKISA
QFYATNFYKKLGFEEIGKIYLEDGIEHIKMLKK
>EGEFANNL_00911 hypothetical protein
MKKYFIFFLLFLLPFAGKSQSKINVIFQIVDAKTKKCLSNDLNKEITFQYKYDSLFKDVK
TFTTNKCFNSYTISKKTGRFKILISVSGYQTQEIIFDVKEKTLGPLYLGKVYVNLPNNQQ
MLKKNKFNKNQGIVVSGKKEYLKPKEIPKQNQDKIGDKDSTVGIQYTKSIGEDSISTLPS
LKSSTLKPTPFNNNDDNIYLYDKDKLLSSNPNTKWNVDNHSNKYKPLSSFPILNKNETSN
VYTPIDNSIKNHESEEKPLESNVHINNESTLNLIFKIVDSKTNACLADDLNKEIKFQYKY
DSLYKDVKTFNTAKCYNSYTISKIPGKFRILVSTIGHQTQSIDFDVVESLPDTLLIGNVY
MNNIGNIGEVPDTLSNSEITNMEGVVVVGGKKEMIKVEANKTTYSVKDNELLSGGNAEEA
LTKIPGVIKGYGGELTVNGKSMAIYIDNSPTGLSGSDLEGLLQGMPASSIEKIEIISNPG
ASYEANTGGGIINIVTNGRASLGLNGTATVNYRFNKLNIVSPSISLNTRRGSVGLQLNSG
FSYRENETFTSNNREFTSFSPSILMIQNNNNSSYNRFYYFRPSANIRLNERSNILINYNF
NYSHDNNSNLGVLLGMDNTGNLNLINNFNSKNDNTNHEIIAKYRTEIDSLGKVFDITAYY
SNFNKNLQNRGIQNNLGIYDYSINEIDSKSDNFYLKSNIEIPIHELDLTINAGGKFSLNS
STSKGRYNLLNSSPLIFENPNYNTFMDFKYDENQYALYTELSKNFNKLSITAGLRYENLE
YTSKVKESLQKSKHSLEKFYPSFSLLYRLNSTINFNASYRKSISLPSYTSLDPNITGYYD
EYNTTTGNLFLEPNYYDNYEASISAFNYLRLGFQYTHSKSINLMSYENAQNSLVVNQTTK
TYNGVNSYNISLGVPVPFGLITKGKKFFDEPMNVNKMSFLYFYTMYNYYKVDDYPYMDKV
KPMWFYALYTQIVLPKEIKLTGFYLFSSKDGYFQIYKSQQPINYSNIELSRSFYNNNLKV
SLGMNNVFSPTKLKAQITNPNLLTNFYQRNQNQLYYIKLSYNFGKLKNMKKENTEIETDK
TKESNQLIPTPLNP
>EGEFANNL_00912 hypothetical protein
MNNNNLDKYFKLVCYAEGFSCFLLFLVAMPLKYMFNTPIIMIPAGIIHGFFFTAYLILAI
YARKLYKWDDEDFVFALMSAFFPFATIWVEKKLTKPN
>EGEFANNL_00913 hypothetical protein
MVDKISKKTIHQVLFIVILLLLFTLIFSQLVIFLPSLLGAITLYTLSRDLFLKLTEEKKW
NKWLTVFLIFILAFILISAPVYLIIELTYSKVSTAIAYSKNLNDSILKIMHDLQTKYNFD
LLSKENLLKVSSWAGKFIPQILNSTINVGVVFVFSFLIFFFMIMNIRKLESTLTQWSPLK
LENTLKLGNRLKRMILANSIGIPAVALIQGIIATIGYIIIGLDNLWFWFAVTIFAAMIPL
VGATLAYLPIGIILFTSGQTWQPIFIVLYGFIIVGSSDNIARFTLLKKLDNVHPLITIFG
VIFGMKIFGFLGLIFGPILLSTFFLLLNVYNDEFTNR
>EGEFANNL_00914 Transcription termination factor Rho
MFEEQKLKAMKVAELQEIVNKLGIKTSGLKKADLIESILSKQKNEKNIDNSESHNSTSEL
STNHKKVLEEDKSQRKRIVSKQSQDKPSNPKQVEINVEDNIKSSSIEEKKDRIPEEIIVE
SQQARRSQVILKKNSGSTHFQKPTVEKEERKTTDDVEKNNFQKKRKPNDYNKPNNHHSNK
YRSSEYEFEGIITAEGVLEITQDGYGFLRSSDFNYLSSPDDVYVSLSQIKLFGLKTGDTV
TGEVRPPKEGEKFFPLVKIIEINGREPSYVRDRVSFEHLTPLFPEEKFKLAGVGATLSTR
VVDLFSPIGKGQRGMIVAQPKTGKTLLLKDIANVISMNHPEVYMIVLLIDERPEEVTDMR
RSVKGEVIASTFDESAEKHVKVANIVLSKAQRMVECGHDVVILLDSITRLARAYNTVSPA
SGKVLSGGVDANALHKPKRFFGAARNIEGGGSLTIIATALIDTGSKMDEVIFEEFKGTGN
MELQLDRKIANKRIYPAIDLVSSSTRRDDILLDPVTQQRMWILRNHLADMNSLEAMEFLK
NRLSKSISNEEFLLTMNK
>EGEFANNL_00915 hypothetical protein
MIQRIQSIFLTITGILSLVAGFITDLIPDDWIDMCLLFLIGILSFFSLFSFKKRKIQMKI
NYLNIIINVMLISYMVYHLLSSPGGVLSPMKGVEFFVPVLLIILLAMANKYINKDEKLIK
SVDRFR
>EGEFANNL_00916 hypothetical protein
MITALSVFLGLANHQIDLNKQLILFFSSLAAYNFICFYEIWKTKTLNHRSLYIFILSIGT
VVYLFFKQNNLYTLIAHTIILSVLVLMYNSRILKLHFRSISLLKIFIISFVWTYAIFWMG
NAIDFSIGLFISVYLFVFGITIPFDVYDIREDKILTIPKWIGIKKSKCISYFSLVVSCII
LIYSLNSYIYTAYKISWGISCLIAMVMVYFTNCKQAYLYTRFWVEACSSFPLFLLYIFK
>EGEFANNL_00917 Crossover junction endodeoxyribonuclease RuvC
MEKIIIGIDPGTNVMGYGVIRVLNKKMDLVCIDELILNKIDSHALKLKKIFDKTLALIDT
YHPDELAIEEPFYAKNVQSMLKLGRAQGVAMSAGLLREVPITEYLPKKVKMAITGNGNAS
KEQVAGMLKTLLKLKEFPTKYLDASDGLALAVCHFLNSGTSSLANKKSYTGWEAFVKNNP
KKVSK
>EGEFANNL_00918 Orotate phosphoribosyltransferase
MIDKENFLLKSYELGIIKFGEFTLKSGIQSPFYIDLRPLASSPSLLKELSELLLEEIQEP
NYQLICGVPYAALPMATAMSLKSEIPLIIKRKENKGYGTKKMLEGIFTVGQTCLLVEDVI
TSGKSLFETIEEVEREGLKVKDIVVVLDREQGGIELLNEKGYKVHKLFSIQNVIDILYKN
NLLKEKEVLKIKDFLNGNSLAISKKPRLKYEEKKELQEHPVAKKLLSIAIEKKSNLIASL
DVTQTSEILDLAKKIGDYVVAIKLHTDILTDFSVDYINELKSIAQEKNFLLFEDRKFGDI
GNTQQLQFELGIYKISDWADLITSHVIAGENSLNVFSENIGVVTIAEMSSKGTLTDVTYK
QKAIQISEKNSKVIGCVAQSSLPDSLLLFTPGVNLDSKGDSKGQQFNTPEKVFREYYTDF
IIVGRGIYKSANPVEEAQKYREEGWRSYEATL
>EGEFANNL_00919 hypothetical protein
MKAIVNKLIIGTVLLMVAIGCKDSNKISISTNFDQLSDKGLHMGDKLPLEISSEDGTIDS
YTVKLNGKDYESNNIVLDSTNSSLGANTLVVNINYNGNHKKEIETVFNIYSNVKEKEFSY
SIIQEYPHNPELFTQGFTYKNGVITESSGLYEKSKLVRYNLGETAFKQSISLAPQFFAEG
FAVLNNKLYLLTWREKTLLIYNQATFELEKQQPYPNNLSEGWGATTIGDDIVVSDGSSKL
KFYDQNFNLKRIISAIGYNQIYSNLNELEYANGLIYANIFEQPIILAIDPKTGVVVAKAD
FSDLAKKNQTNADAVLNGIAHVEENHFLITGKLWSKIYKVIFQD
>EGEFANNL_00920 Prolipoprotein diacylglyceryl transferase
MNQLLHIIWDPSIGIQIGNFTLRYYSLMYVIAFSIGFYLMSKIFKKDNEDQKLLDPLFIY
MFLAVIIGARLGHVLFYQKELFIEDPLAVFLPFRTKPEFQFTGFSGLASHGAAIGIVISL
YFYNKKYLKRNLLWILDRIVIPVAIGGMFVRLGNFFNSEILGKPSDLPWSVLFNQQDVHE
YGERVSRHPAQLYEAFGYLILFFSLVFIYFKTNKKKFLGWIFGYFLIILFGIRFIVEFFK
EPQGEEYINWFGLNTGQWLSIPFILVGIYILLTSKNRIYITK
>EGEFANNL_00921 Chaperone SurA
MAILGQIRKRNGLLIGFVAVALLLFLLGGIDWSRLGGKDPNVIGKVNNQVITRQEYNNQL
NFIQNQYQGQVPLNFLEGQVWNTLVQNTLIKQKFNSSGFILTDDMIWNAARNSNIFNSPQ
YKDKNGNINVQLIKQQFEQLEQNQNANSELSQMYQQFLELKNNLSVQAMYRQYFGSYGAG
LLTNANEVDILLGNRVNSANIEYVKVDYNAYQSKHPVKVTDQDLQNYINAHKTLFKIDEN
RTLDYVYFPGTASSSDKKQILDQLNKLLTNTIIDGDTIQAFGSVKNDSLYISKLSSDQLI
DNDFNPIYRAEQQLPQAIKNWVKTAAIGQVSSVYEDGGAYVYSKLIGKKNVDSIQGKNIL
ISFTDSGSQLKPKTPRTKEQAKAQADQLVQQLNANPNDFSKLVVQYSDDPGVSSNGGVIK
LTTAQDFKGEYKGLQRVLESSPLGKYEVVEIPEGYFVIAITDRKPVGTVYKLADIAKNIE
PSEATVDLVRKQANTFIQNINGKSSQEFHNVAKAQKFNAKQQRGILRFGTMLEGLGTDKD
SDIIAWAFNSKRNLGDTELFITGDQGYIVARVSSLFSGGLADPSIVRKQIETTVRNELLG
KIIADKINSSNQSLDQLAKDFQTTKEQANITFDNPSIGGSFEPKVGGAAFGIKPNEKSKA
IEGKAGVYVIITKSITKGDSGDKKTFKEQLMSIYSQQMPNLLLQTLYQEAKIDDYRADIL
NSNPRN
>EGEFANNL_00922 hypothetical protein
MKLPVIKHLTQFIEKNDEDYVNETIETLEDLTESPGLKDEEIDVIGELISNMYGAIEVHK
MVQEGMDQKEALNAFMKRVLGSIDK
>EGEFANNL_00923 Thioredoxin-like protein
MVQELDQDNLQEIVQSSPIVLVQYAATWCGNCKIMKPKFKKIAAENENIPFVIADAEKFP
ESRKLANVTNLPTFAAFKDGKLVNQIQTNKIEPLQELVNEVTGN
>EGEFANNL_00924 putative peroxiredoxin
MSLVGKKFPNISVDAMDHMGDDLKINVFEEATKKNKKVLLFWYPKDFTFVCPTELHAFQE
ALSEFEKRNTLVVGASCDTNEVHFAWLNTPKDNGGIEGVTYPILADTTRNLSNILGILDI
QSSSYDEDHDTVIIEGSNVTYRATFLIDEEGKVFHESVNDMPLGRNVQEYLRLIDAYAHV
QKYGEVCPANWEEGKEAMHADRKGVADYLSSH
>EGEFANNL_00925 7-carboxy-7-deazaguanine synthase
MKSMNEQSDLDLGLSLPIMEHFYTIQGEGRHTGTSAYFIRIGGCDVGCHWCDVKESWNPD
LHPVSSAEEIAKMAVKHSKTIVLTGGEPLMWNLSPLTSILKELGCTIHIETSGAYPMSGT
IDWICLSPKKNSLPLKEIYEKTHELKMIIYNQHDFIFAEEQAEKVNNEALLYLQPEWSNR
EKMTPKIIDYVMKNPKWKISLQTHKYLNIP
>EGEFANNL_00926 Nicotinate-nucleotide adenylyltransferase
MNKIGLFFGSFNPVHIGHLILANSIVENTDLDKVWFVVTPHNPFKNKSTLLEDHHRLEMV
NLAIEKYSKFESSNVEFSLPKPSYTIDTLVALQETHPNKKFVLLMGEDNWIHFPKWKNYE
EILKRYEVYVYPRSHEYTTIPLEHPKMSKIAAPKIEISSTLIREYIKNKKNIRPLLPPEV
YKYIDGSNLYK
>EGEFANNL_00927 Single-stranded-DNA-specific exonuclease RecJ
MQNRWVLRSKSDKDQINTLAEELNFPVEIACLLLQRKIDTFDKTKLFFKPSLDELHDPFL
MKDMEIATERILLAIEKKEKILIYGDYDVDGTTSVAMFYMFLHSFYEKVEYYIPDRYQEG
YGVSYQGVDYAIENNFSLIITLDCGIKEVEKVLYAKENQIDFIVCDHHLPGEILPPAVAN
LDPQRPDCEYPCKHLSGCGVGFKLMQALSQKKNISSPDIYSYLDLVAISIAADIVPLIEE
NRILTYFGLRQLIEKPRVGLKFFLPKEVRETFSVSNIVFGIAPKINAAGRISHAHNAVEL
LISQNEIEARRIYSQINELNNERRELDANITTEAILEIKKTGQTENYSTVVYNKNWHKGV
IGIVASRLIEEYYRPTLVFTEGKNDDLVASARSVVGFDIYSALERTSEYLEQFGGHMYAA
GLTLKKENFIPFKEKFETIVKETIKENQRTPVIEIDEEISLKSINKRFFKLIHYFEPFGP
GNLRPVFLAKNVSFGGYFTLMGREKEHLKMTVFQDNLKNSFEVIAFKMGHLIHKFEKYPF
DMVFSLYENFWQGKTFYQLQIKDVLFKEE
>EGEFANNL_00928 N5-carboxyaminoimidazole ribonucleotide mutase
MSSALVGIIMGSDSDLPVMEQAVEILNEMEIPYELTIVSAHRTPDRMVEYSKSAYARGLK
VIIAGAGGAAHLPGMVASQTTLPVIGVPIKSSNSIDGWDSILSILQMPNGIPVATVALNA
AKNAGILAAQMLSPFSEEITKKLEQFRKVNEIKVLQAVEKVKKRFPNDYDG
>EGEFANNL_00929 N5-carboxyaminoimidazole ribonucleotide synthase
MKIGILGGGQLGRMFMQNAINYPYTIGFLEPDAEASCSIFKNSFTVGDFKDYTSVLNFGK
DKDVISIEIENVNVEALKELRNQGKKIIPSPECLELIKDKGLQKEFYKENHLPSSDFYTV
QNRNELLNHPQLKYPFVQKLRVGGYDGKGVQIIKNAEDLQQVWDEPSVIENVVPIKKELS
VIISKNENGQSCVFDVVEMVFDETLNLVDYLLSPAEIEDKIKEVAKDISIQAIEALNTPG
IFCVELFLLEDDSVIINEIAPRVHNSGHPTIEANSSSQYDQMLRVLANLPLGDVCIRECS
AMVNVIGDPKQEGEAEYVGIEDLISLPQTYLHLYGKRITKPGRKMGHVTVLGKNKEEIVE
KINFIKSKFKVIAQ
>EGEFANNL_00930 hypothetical protein
MKKFFCLLFMASVVTSCSTKKTGVTSRTYHRITSWYNTIFNGNVTLEENLKSKREAYRDN
FSEIIKVDPIDPFEESSLEEEMTMYSIPKQNNTLSNFNSILGVGNNITTESPKTQGLNRV
IEKGKNAIENHSMLIKGKEYNSMLGEAYLLLARAYYYKQEPFEALNYLNIMNGSLVKNRQ
EKEAKIYLALAQEQAGNTFEADEVYTQLLKEKLKKQDRKLLYNSYAQYLLNQERYPEAIT
SLETAKKFNKGKYTKGRYSFIQGQLSEKLNKEEDAINYYQMAYKKKPSPELEIKSQIALS
GLLKGDSTDYQQRIKFLKKLTRQGLYQSRKNELYYAMAVAAHKQKRDEEAKEFYIQSLKE
KESDPQIRGLVYRSLGDLYFSKPDYVYAGAYYDSAVAKIMDPEMKRKLMVKNKTLKEVIQ
KYYLIKKNDSILSVANMNPDEQRNYFQKHIDRLKEEEEKNRIALEKELESENTTVFETEF
MGAGTTQVVTATPTTGNKWYFYNNSLKQNGISDFKKNWGDRSLMDNWRMYRKSSVNLDEV
KEQLLGKKDAKNSRRFEIDYYLEKLPKNKEDLEALKQQRDTAELSLGLMYYDRFNDVSSA
VFALDHLVSTPPKEDEVKVKALYNLYRINKEKNPQLASRYSDRVIAEFPNTKYAESILNP
SIDIFKLNSTEATAFYEEVYKKYEEGKYKEVKALANEALQKFPSDVMIGKFSLLAAFSDA
KLGNKQAFLESLERISIAFEGKEEGKKAKELLNYFTKKELEEKAKQSQKPKTEKIPPSVP
>EGEFANNL_00931 hypothetical protein
MVENFDSYSEILGNPERNVIKKIPFQEGYIAIKSFKKPHWVNKIAYKYLRKSKARRSYEH
GLQLLQLGILNPEPMAYIENSDFFGITSSYYICQYTPYDFTIREIYDQPDAFLAVQAYAR
FSAYVHSKGVYIKDNTPGNTLVQRNNQEYNMYLVDLNRMEFHENLSFEVKMKSLSNNIKE
QPFLDIFMEEYSKVSGYPLSEVRERMFHYQQIFNRKIESKARLKKRLKKLMGKKI
>EGEFANNL_00932 hypothetical protein
MSILDPNLNKGANLSKPNLSSKNIVESAADVSGLNNKLSNLEDQLADKLTELTAPAQETI
DKAKKATETAKEITHQAQEIKKIIPGDLTSLPNGLITPEQFAEFKGVNSLIATYGGDPET
NLANSHIVYSKITIGRERVLADSHFVVEIEQKATEHDTFTIKCSAEAIDGPNAYPLEKAR
SFLGKRTTIQFIQYGAPAQVYTGIITHIKNKRENGESQLILTGKSPTILLENGLDSQSFE
NADLENIIRKATAEYPQDLVQWKIQPLQKEKIPYTVQYRESDWNFIKRLATRYGEWLYYD
GQQIVFGPYAGKTWELVEEQDVYDCSLKMELVPQKFNYISYDPKQAQAHNVDSESVSLSR
RLVNPFQQYAIQASETIYSKVPTSLTTA
>EGEFANNL_00933 Actin cross-linking toxin VgrG1
MEGGEYELKQAVKRQKQKRQNVFFMEAKTNNPNLKVGDNVKLKAWMPGHPIFKNGEVPLE
TYRIIEIYHFQDVTEAYYNQIVAIPKDNEVPPYMDEDAFPVCEEHSATVIDNNDPEGMSR
IRVQFPWQKAFGGQSPWIRSITPYAGEGKGMHVIPEIGEEVIVSFENGNAEKPVSLGAMF
NGKGKSGHGGAGNFIKGLQTASGNKLLMNDQAGSVILEDHGQTSMNFDGAGNSSLGTSAS
HTITVGATKESPDGQAKFSMTNTGEITLNGTKSLKINVGASTFEMFSDGTIHINGNKITA
TGVETKVIGSELTEVGKPGADPGIKIDKNVNIQGEEVDIN
>EGEFANNL_00934 hypothetical protein
MSEEYKLHWVEGEEKLSAIAQKYNISIEELKKANPEMRTFYSGFFGGAEYASAMQKIRIP
VVEEIVIKPTVPTMPSYHFEPLARYRCEQLNISRIKQEIITFSAHINTEYLFSADKEDKK
ILQILLEDYQLSVEPIHFKGAFEFAKKIEELKKKISFSQNNKGEIREILNLGELRQEWDN
FKNKVLPTDALYQSLKEQTPKQAQDVIDTGNKEFSSSQLLGSTLGKNLFFHILLRANVGD
ELKDYTLKQFSQLFPNLELTIPVVKSKVKEDNFTTTYRLVGTLDRTHILEEELEKMYNEW
YKPLIKYSYTEFSYVYRITYTIENKNNHLLEAKAALCEKIKNNFEAMTEFTIKQVEL
>EGEFANNL_00935 hypothetical protein
MKKVIIKAVKLKVVFLWLILILPITYGIYIIAGWLKQTVNQTYFIIFSLTTFLILAYSLL
RKQMIEVTFSFKDNEIEIIEEKMISKNKRTYSIYYPTIKNYNLYHLILKKMGYIVRIEAD
KNYLYVVDWISWNKDHIIKQDDYLKLTNNFNKKNINRGKILIDYFILFLFYVPLIIIFLS
IIVVVISLYLYNK
>EGEFANNL_00936 hypothetical protein
MNKKIQLRTINSKVFFIGFIFVAMVFGIFSYLISEYIHNTTYITGAVIGLCYLVGGIYAI
IVEKSTKLITFEFTENSLNIYKEDKQKLSFPYSNIKNYNLYYVSFKKREYLIRFQADKNY
FYWVCPKNFFKKQTTDDDDHIKIYKFLNLSPLYKKKIFWDKIILLWKPLFWSLLILSLLC
LLTFFIWLIFFL
>EGEFANNL_00937 hypothetical protein
MMNKKIQLRVLDNKVYLISIPIIFLAIILMAKLAENIQNTSNQTMFIICFGSIITGAGYF
WIKRMAKLFTFTFSSDSLIINSEEDKVYYIPYNQIKNYNIYYLVIKKMGFMIRIKSNKNH
YYWICPKNFDNRQNSDDQDFIKIYKYFNMLLLNKKETYQDTFLKF
>EGEFANNL_00938 hypothetical protein
MMNKKIQLRTINFKIFIISIVVLIFSLTLVMNISSRFNYDRIYFIIFSLIVIVGSLIALE
QKSTKFFNLIFKENQLLIDGKENKIFLYSDILNFNLFPLFPKKKLGYVLRINHKKDNFYF
WITTNNKNMKWSGDDYSNIALLKNSFIQKVTKKQIFLDYIIYSIALIPFLLILSAFLFVL
IILFSLLTGNTGWFQHLEFISNYLNY
>EGEFANNL_00939 hypothetical protein
MGTSYLSKDEVFSVCTYQLGTNPKKFSHSRDKPSVFHGKSSGEKVLLTIQDRNLNEAFTC
KSPWALASSFLAFAAGLALVASGPIGWIAVGVTATIGVCYLVKAASHKCTDPLGGGKWFL
VHGSVRFNGYTAVTRSSILKCGNGGVLTPFFSEATAKKAAEAIASNNRWELGLNTAASFG
AGFFLPSAFASVGSATTLGGKFMAGSIITGKFAAGFVAFSAIFYAERAGIRTWNENIGDL
KDNATYDAMNNYKETQVVNGKEQETNIDKNTFWPSVEKPDDVTQDVSDIAKVGVDANGKY
NIIYLENLIQGTKNLPHTLKDAELNIKLAKHKGKSRPVLNRDPEAQKLLEELNNGKYSKQ
VRDMENYNPRRINPTMVKDGAEATKTRLTTTAQGVLFVMPFISTLFSEASRSDLARAAAK
DLKVAGTHIVANTPID
>EGEFANNL_00940 hypothetical protein
MEKKVLNKFLAKPKEKHKVADFSSNYTADITKEEAETLLQNNILEMRKLQDRLYAQDQHS
VLLIFQAMDAAGKDGTIKHVMSGINPQGCQVFSFKQPSQEELDHDFLWRIHKAIPEKGRM
GIFNRSHYEDVLITKVHPSILLGSKLPHIQSLKDVNEDFWNRRYKHINDFENYLVDNGTL
ILKFFLNVSKDEQKNRFLSRLEDETKNWKFSISDLKERAYWDDYMKVYSDLLTETSTEVA
PWYVIPADNKWFMRYVVSQIICDKMRELNVQYPTLTQEDKENLEKAKLLLQEEEKKKEDK
KDDKPKVEPTLKDKKKDKKKAKKKN
>EGEFANNL_00941 hypothetical protein
MKYTSKLLIILSFYCSTINCVKGQNTFGNVRSESIFKDFPYTKFVDIAYSPSTSSDYRIK
QEGSKIETGKLHEEKMRINFLVPVYKKPGKFEILAGGSYKYQTYHFTEVENDKTNPSFFN
LNSKEETHYFSGNLTGIYYAKIMNKLVVLNANLLVDGSNQGYERTIASFTATLPLYKSDK
TYFALGAYFTTSHSRLLPLMPTLIYQHKIKDGPWYIDAVLPKSLYLRRMINEKSRFSAGF
WLDPSASFIYPDQKGFKQVYVFNKVEVKLDVKYEQNLNENFGFQIQGGISQPYKGVFRET
NSSRNFADLYQDMNFYLNAGIFYKLKK
>EGEFANNL_00942 hypothetical protein
MLSVILSLYCMKKNLFFTLLYSLLLISLPAQAETIENDTPVIEQQSSTKSKLYPNPARDY
IQIKNSSSLPIKNISILSMVGSSMLNKDLGNQLEEQPINVSRLPSGRYFVKISYHNGSQE
ILNLIKI
>EGEFANNL_00943 Lon protease 2
MINLDILSLNQAIQGENEIIPLLTQDEEDKMMNEEFPTVLPLLTVRNVVLFPGVVVPITA
GRSKSKSLLLEAQKKDKIIAVITQKDTNIDEPGINDLYKVGTIGKIIKLLKMPDGSSMAI
LQGMRKFSLNSIVQEEPYFKAEISLLNDKKVSQKNSEHFNVLVESLRETAIKTIHENPAI
PSEASFALKNIEGTTLLINFIASNLNLSVKEKQELLEINNLESRASETLKHLNLELQKIT
LKNSIQDKVNSDLNKQQRDYFLQQQIKTIQEELGGVSHEEEAEEMRKKASKKKWSKEVNE
HFEKELNRLVRMNPQTPDYGVQRNYLELMLELPWEHFSKDNFDIVHAEKILNRDHFGLTD
VKERILEYLAVLKLKGDMKSPIICLYGPPGVGKTSLGKSVASALGRKYIRIALGGLHDES
EIRGHRKTYIGAMPGRIIQSIKKAGTSNPVIVLDEIDKIGTSGHGDPSSSLLEVLDPEQN
NKFHDNFLDIDYDLSKVLFIATANNLATIQPALLDRMEIIDLSGYTIEEKIEISAKYLLP
KQISEHGLAKKDLTIGKKELEFIIQAYTRESGVRNLERKIAKIVRHIALLITRETEYTKK
INKAKIEEILGPPMMPEESEENKVPGVVTGLAWTQVGGDILFIESILSKGKGTLSMTGNL
GNVMKESATIALEYIKAHSKDLGIDTDTIENNNVHIHVPEGATPKDGPSAGIAMLTSLVS
SFTHKKVKSKWAMTGEITLRGKVLPVGGIKEKILAAKRAGITDVILCKENRKDVEKINPE
YIKGLNVHYVSEMSEVLNLALEV
>EGEFANNL_00944 hypothetical protein
MWQTFLSSLFPLRCFGCGLIIPTHQKYLCEKCLGRMPYTHWRLDSENCMYEKINSLVNIE
SASALLFFDKDNLTQKLIHFLKYKNYPELGSWMADLWFENHKNQTFLKDIKSVVPVPIHR
KRLKLRGYNQVVPCAQRLAHLLNCEYNDSTLERTLHKKSQTTLNKFDRIAKMKNTFTRIN
NHSSHYLIVDDVFTTGSTIVSCAEELLKNPQSKVSVFTLAIA
>EGEFANNL_00945 hypothetical protein
MIRLTKIFTFETAHALWGYDGKCKNIHGHSYKLYVTIKGNPLEDLNHKKNGMVMDFGDLK
SIIKKLIIDPLDHAILLNVNSKHKDLGEKLLLEGHKVVFTPYQPTCENMLLDFASKISSQ
LPEPIVLTKLKLFETETSYGEWILEDQ
>EGEFANNL_00946 UDP-2,3-diacylglucosamine hydrolase
MDIGRSINIELLEGKKVYFASDQHFGAPNEYSSKKREKIFIEFLNKISNDAQVLFLLGDL
FDFWHEYKTVVPKGFIRVLGKLAELSDRGIQIYFFTGNHDLWMNDYLQEELQVILFTKEQ
EFIINGKSFFVAHGDGLGPGDLGYKRMKKLFTNPIARFLFQWLHPDIGVALGNYLSRKNK
LISGAEDIKFLGEDNEWLILFSKEKLKEKFYDYFIFGHRHLPMNLSLSSTMESRYVNLGD
WIVYFTYAVFDGQNLELLNYKES
>EGEFANNL_00947 hypothetical protein
MYHLFMEIITCILSLLDKNKEVVVPTFGKFSLNFSSVTEDHSTGKVLPPQKYVAFEQPHK
LNDIYLVKELQAYLNINQDEAEKIMLEEIVKWKNTLKNSNSLTLKGLGSFTLDKERITYE
VSKDCIFNYRNYGLPELYVSLKDIKA
>EGEFANNL_00948 Endonuclease MutS2
MSIEHIEKSYNEIINKEKENIHSLQKKILIVACLRMSCILLGIIFCYRFWENTYLTFTLF
LFFLISFILLLKVHEKLFYKKKYSLALIHLAENELKGLNNNFSSFDGAPEEINPEHSFSF
DLDIFGDQSLFQSINRTIGSLGKNILIEYFVTPSTNKDEIINRQKAIQELKNKPKLMNHF
RVSGTIDKKEDICIEKFSKSFKPNQIYFYKNKLWSLFIYLVPITYLIGLILALTGIISSY
WLGLLWIITFTISTLQIKTVNKILDIFDKKTDVLSSYSYLFKIIEDENFASELLKTNQNL
LLVHKEKASRIIYKLSRYCSNLNMGLAYPIVLFFNPVFLWNVRYAYLIEKWLTNYHSSIF
PWMQALGRFDAFVSLGTFSYNHPEYIIPNPTNEQFILEGKEIGHPLLSRNTCVKNNITIN
KKSFFMVITGANMAGKSTYLRTIGTNYLLACLGAPVYAEDFLFTPSNLVTNLRTSDSLVN
NESYFFSELKRLKMIIDRLKSGEHLFIILDEILKGTNSEDKQKGSIALLQQLIHLKSNGM
IATHDLELGKLEVQYPSHIENYCFESHIIDNKLSFSYKMQRGIAENMNATFLMKQMGITG
L
>EGEFANNL_00949 hypothetical protein
MNLKELKQKMEIGDYILASKMLKITPENVRIRFSREKKDVLEVLKLIIDNREKLIKKFQE
NEN
>EGEFANNL_00950 hypothetical protein
MENTINEKYNIMKHSIKKFQLYFNISQDSSKNLLK
>EGEFANNL_00951 Malate dehydrogenase
MKVTVVGAGAVGATCADNIARKEIVDELVIVDIKEGVAEGKALDLTQTTSILGFDTSIIG
STNDYSKTAGTNVAVITSGIPRKPGMTREDLIGTNAGIVKDVASNILKYSPDAILVIISN
PMDTMTYLALKSLGLNKNRIIGMGGALDSSRFKTYLSLASGVSQNDIQATVIGGHGDTTM
IPLTRLATCQGINFSKLLSSEQLQKVAEDTMVGGATLTKLLGTSAWYAPGAAGMAVVESI
IRDEKKIIPCSVYLDGEYGESDICIGVPVVLGKNGVEKIIELDLNEIEKEKFKASAQAVR
NMNQVLFDMNVL
>EGEFANNL_00952 Undecaprenyl-phosphate 4-deoxy-4-formamido-L-arabinose transferase
MEYELTVIIPVYNEEENLLRVKEEMERFIKSAKKKSKVLFVNDGSKDNSLNIIKKICQNN
TDFSYISFDKNYGLSPAIKAGFDHVQTPWVGYIDADLQTSPMDFNLLLPYADDYQLITGV
RANRKDSITKNLSSKIANGIRRTFTHDGMDDTGCPLKILQTKYAKRIPMFKGLHRFLPAM
ILLQNGKIIQTPIEHFERVAGKSKFHFWNRLIGPFSDCFAYLWMKKKYINYKVEEKKI
>EGEFANNL_00953 hypothetical protein
MTFTLLDISSTPHNLIYYLTLGLGFTAQILFSSRMIIQWISAEKNKKVTSDLIFWQVSLV
ASFFLFIYGYLRHDFSIMLGQLITYYIYIRNIQLHNAWKKYPVVFRFFIYFFPILSISLG
LWNGTIDIFKLFSKEIMPLWLLIAGTVGQLLFTMRFIYQWLYSEKLKKSELPMGFWILSL
AGSLIIFIYSIIRRDPVLFAGHCMGIIVYTRNIIILTKNNEI
>EGEFANNL_00954 Undecaprenyl phosphate-alpha-4-amino-4-deoxy-L-arabinose arabinosyl transferase
MKSNKATYTLIFIVSAIILLANLSIIPINIMEARNFITAREMVEDGNWLLTTMNGMPRYE
KPPLPTWITAAFGFVLDFETTTFLRLPSAIITMIMVFYIYKFSLKLNLSKKSSLNNALIL
ITSFYIYFAGRDNQWDIYCHSFMIVSIYYLWNLLQSDSKPLKNTLLGGIFLAFSILSKGP
ISLYALLLPFIIAYGFTYKFNLRNKQVNKSILIYIIIGVIIGSSWSIYIHFKDPEPLAAM
TKIETSRWISDYNSKPFYYYWDFFLQSGIWSISSLISLQYFYLKNKVSNKKAYTFTLLWT
VSSLILLSIIPEKKVRYLLPTLIPLALNTGFFIEYLINGKKNKKDRILGMFNFILLGIVG
VLYPLVLFLGFYEKISSQLNWAIISSLFMFFTGCLIIYFSLKKNFKQGFYTLIAYQCIIM
VFVFPLAKSFTHNTNFKSAKDLRTLIKTNIELYSYKYMTPEIVWDYGKKIPTITDDGLKE
MLPHMKDKHIGLICIPQEIKHLQKEYGNKFNVKKVSYIDLNIVSPDNENYNDRLYKTFVI
MYQK
>EGEFANNL_00955 2-isopropylmalate synthase
MEKLFIFDTTLRDGEQVPGCQLNTIEKIEVAKALEELGVDVIEAGFPVSSPGDFNSVVEI
SKAVTWPTICALTRAVEKDIEVAAEALKYAKNKRIHTGIGTSDLHIKYKFNSTQEEILNR
AVAAVSYAKKFVEDVEFYAEDAGRTNNEYLAKVVQAVVNAGATVINIPDTTGYCLPTEYG
EKIKYLVEHVDMKNAILSTHCHQDLGMATANSIMGVINGARQVEVTINGIGERAGNTSLE
EVVMAIKSHKELNIETNINTQKIYPLSKMVSNLMNMPIQPNKAIVGRNAFAHSSGIHQDG
VLKNLSTYEIIDPKEVGIKDNSIVLTARSGRHALKSRLNLLDIKVDVDELSQIYTKFLEL
ADRKKDINDEDLLILCGRELNSTNRIKLEYLQISSGKGMKSVAVVTLNIAGEKFTNSSFG
NGPVDAAIKAVREIIKRQVTIQEFLIQAINKGSDDLGKVHMQIEYNDVVYYGFSANTDIT
TASVEAFIDAINKIPV
>EGEFANNL_00956 3-isopropylmalate dehydratase large subunit
MKTLFDKIWDAHTVSEIPEGPTQIYIDRHFCHEVTSPQAFNGLRERGLKVFRPNQTTLTA
DHNTPTCNQDQPVKDPISKKQLDTLSKNAEEFGLTLYALGNERNGVVHIIGPENGYTQPG
MTIVCGDSHTSTHGAFGAIAFGIGTSEVEMVLATQCILQSRPKTMRITFNGKLQKGVTAK
DLALYMISQLTTGGATGYFVEYAGEAIRNLNMEERMTLCNLSIEMGARGGLIAPDETTFE
YIKGKDFAPKGEAYEKAVEYWKTLKTDEGAKFDSEYVFDAGKIEPMVTYGTNPGMGVSIT
GNIPTLEGLDETGRISFQKSLNYMGFEAGDKMEGKPIDYVFLGSCTNGRIEDFRTFANFV
KGKKKAENVTAWLVPGSHRVEKQLKEEGLYQILVDAGFEVRQPGCSACLAMNDDKVPAGK
YSVSTTNRNFEGRQGPGARTILASPLVAAAAAVTGKITDPRKLN
>EGEFANNL_00957 3-isopropylmalate dehydratase small subunit
MEKFQTITSTCVPLPIENVDTDQIIPARFLKATDKEGFGDNLFADWRYNKDGSPKPDFVL
NNPTYSGKILVAGKNFGSGSSREHAAWAVSGYGFRAVVSSYFADIFRNNSLNNGVLPVVV
SPEFLSELFESIHADPKNTITIDLDKQIITNNHTGEGESFEINAYKKECLQKGLDDIDYL
LSKKDKIEEYEKNRVYSY
>EGEFANNL_00958 2-isopropylmalate synthase
MSTIEIMDTTLRDGEQTSGVSFSTQEKLSITRLLTEMGVNRLEIASAKVSEGEFNTVQKI
ANWAKNSGHLDKLEILGFVDNGISLEWIKKSGCKTINLLTKGSLNHVTNQLRKTPEQHLY
DIKKNVELANSMNILVNVYLEDWSNGMIHSPEYVYQMLDELKDTSIKRFMLPDTLGILNP
NTTKKFCKDVITKYPKLHFDYHAHNDYDLAVANVMAAVEAGVQGIHVTMNGLGERAGNAP
LPSVVAVLHDQMKIKTSIKESLLNKVSRVVETYSGLNISSNQPIIGENVFTQTAGIHADG
DNKNNLYYNDLYPDRFGRVREYALGKLSGKSNIKKNLEALGIELDNDEMIKVTNRVIELG
DRKEIITQEDLPFIISDVLNTNENEKKVKIKSYALVLSKGLHPTASIQVEINDKIYEQTS
SGDGQYDAFFKAVALIYQKLNKTKPILTNYKVIIPPGGHTDALVQTVISWKYNNHEFKTR
GLDADQTEAAIQATEKMLNIIEKM
>EGEFANNL_00959 3-isopropylmalate dehydrogenase
MKLNIAVLPGDGIGPEIVTQALEVTKAICSKFNHELSYKEALVGAIAIDKTGVPYPQETH
ELCMASDAVLFGAIGDPKYDNNPSAKVRPEQGLLKMRKDLGLYANLRPINTFPSLIHKSP
LRAELVDGADFMCVRELTGGLYFGRPQGRSEDGNTAYDTCVYTREEIERIVRLSYKLAEQ
RNKKLTIVDKANVLCTSRLWRQVAQEIEKEFPHIETEYMFVDNAAMQIIQWPKRFDVLVT
ENLFGDILTDEASVITGSLGMLPSASIGIHTSVFEPIHGSYPQAAGKNIANPLATILSAA
LMLEYAFDLKEEGALIRKAVDASMDAKVVTEDIASGEKAYSTSEVGEWIINFIKNN
>EGEFANNL_00960 Thiosulfate sulfurtransferase PspE
MEIDKIIKEPTVTFLDVREKEELINEGEVKGAILIPMREVPERLDEIKLFSKPLVVFCRS
GNRSENVVNFLKDQGLTEVYNGGGFNEVNVLLNDH
>EGEFANNL_00961 hypothetical protein
MKINIVVATEEHYKYAEEICETIYQSAIVRGTGIAKRTPEYIQNKMDQRQAIIALDGEKF
AGFCYIEKWQNGQFVVHSGLIVQPDYRSIGLAKKIKKFVFDYTRKTFPEAKIFGITTGLA
VMKINSELGYKPVPFSELTEDPEFWNGCKTCTNFNILQSKQNKMCLCTGMLFDPKTETKS
STQEKKNSFDKKILNRLKKIKESLLLK
>EGEFANNL_00962 Argininosuccinate synthase
MKKAVLAYSGGLDTSYCLVNLSREQNMEIHTVIVNTGGFSEEELKNIEKRAYQLGSKHHE
TIDITEKFYKECLRYLIFGNILKNNTYPLSVSAERMFQSIAIAEYSKKINAEYIIHGSTG
AGNDQIRFDLAFAIISPQSKIITPIRDEKLSRQQEVEYLQNQGIDMNWEKAKYSINKGIW
GTSVGGVETLTSNQALPEEAYPTQLSENNPLQIELEFEKGEPIGLNGERLEPVSLIQKLN
DIGGKYAIGRDIHIGDTILGIKGRVGFEAPAPVLLIKAHHLLEKHTLSRWQLLHKDSLAN
WYGTLLHEAQYLDPIMRDIEKFLESSQNHVTGKVHIELNPYYFKMIGIESPYDMMQSKVA
IYGEENDAWDSRDAKGFIKIFGNQLKIYHNLKDKN
>EGEFANNL_00963 N-acetyl-gamma-glutamyl-phosphate reductase
MKKLKVSIVGGAGYTAGELLRILIHHPRVEIKSVYSTTNAGNPITQIHTDLLGETKLVFT
NTLDYESDVVFLCLGHGNSKKFLEENPFSTNTKIIDLSNDFRLQPNHTFQKKVFTYGLPE
LHKEKIKEAQHIANPGCFATAIQLALLPLAYKKIINSDIHINAVTGSTGAGQSLSPTTHF
SWRNNNASFYKEFSHQHEAEISQSIYQLGQNKHQLYFLPMRGDFPRGILAGVYIKSDLSR
EEAIDIYNEYYEEHPFTFVSDQPLSMKQVLNTNKCLLEIQKHKDVLLITSVIDNLTKGAS
GQAVQNMNLLFGFNEMEGLHLKSIGF
>EGEFANNL_00964 Pyrroline-5-carboxylate reductase
MKIAIIGAGNLGLSIAKGIIKSDLYKSLYITKRNINTIKELKTSDKIHFTRDNQEAIINS
DVIIFAIQPYQLEEILIQNKNLFTNEKTIISVVLGYTTENIEKIIGFQHPIIRAMPNTAI
AVGQSMTCICSNKSGVERMKLALNIFNSLGHTLEITEKHMSAATVICGSGIAFWMRMLRA
TTEGAVEMGLEADEALDMAIHSCLGAAKLLKSTNNNPEQEIDKVTTPGGCTITGLNEMEH
HGLSSSIIKGLIASFHKVNHITDK
>EGEFANNL_00965 Acetylornithine aminotransferase
MSLFDVYPLYNITPEKAKGATVWDKKGIPYLDFYGGHGVISIGHSHPTYVNYLTEQVNKI
GFYSNSIINPLQEKLGLILPEFSGYPDYSLFLCNSGAEANENALKLASFHTQKSRVIAFK
NSFHGRTSAAVAATDNTKIVAPINAQQKVTFLELNDIDSLKKELEKGDVSSVIIEAIQGV
GGLEEGTTDFFRELEKLCKQNQVVLILDEIQCGYGRSGKFFAHQYHDIKADIISLAKGMG
NGFPVGGILISPEFKASYGLLGTTFGGNHLACAAALAVLEVMKNEKILDNVNEQSQYFIE
KFKTIPQIKRIKGKGLMLGLEFDFEIADLRKKLIYEKNIFTGNSNNKKLLRILPPLTIKN
QEIDTLFESLKSCVQ
>EGEFANNL_00966 N-acetylornithine carbamoyltransferase
MKKYTSVDDIENLDQILQLAKKIKENPFDYKELGKNKTLGLLFFNPSLRTRLSTQKAAQN
LGMECIVMNLNSEGWTLEFEDGAIMNGSSSEHIKEAAKVISQYCDLIGIRSFPSLKDKEK
DAAESIISSFVKHSTVPVISLEGSTEHPLQALADALTIEEYKTTKRPKVVLSWAPHPKAL
PQSVPNSFIKMMKKMDVDFVITHPEGYELNPEITKGVSIEYNQDEAFKNADFIYGKNWSN
YIHYGEITNNDPTWTIGSRQMNLTNNAKFMHCLPVRRNVVVTDEILDSDSSIVIPQANNR
TYSAQTIITSLLNNLE
>EGEFANNL_00967 hypothetical protein
MKKGLFVFFIFISLLSYSQEKDTLLISKKDLQDLIRTEVQKELNIQKKELKTQQSDSSPN
LSFLKGKIIFSGKSTLRVGEWDFNQNSLNPTNGVKIKDHTRFWSRFNFHLMTDVALSPNF
DFHARIRTGNKQYSFINFGGNSDERFNIILDELWLDWKFSKNQFRLGRQNASRIWTNQQG
VLFDVPTHDGISFKSSYLLGSLTLNPKFALFIENYKGNTSFKEQGKIYGGAINIQQKKEN
ISWTFETGLLIANELPTKYTKDWNNNGNNLYMDGDLAPDYMIWTNHWALTLPKLQYLTFA
FDYFYNMKNYKRNPISSYIYNASGYNSFSNSKEFNSETAPNFTKQRNGFIGTVSLGNSSI
PKNIFFGISYLYMEKYAAMDYFAQYDFVPWASTNIQGPEFAISYRLNKFLEFKSRLFFME
QIKGLYGIDPSYKKSSNRLRFDININF
>EGEFANNL_00968 Acetylglutamate kinase
MNSEKLSIVKIGGNVIDDSKILSSFLQDFSNLEGYKILVHGGGKEATRLASKLGIETIMM
DGRRVTDKDMLDVTVMTYAGLCNKKIVAKLQALGTPSMGLTGADGNSILSKKRENSNIDY
GFVGDVISVNSSWIKSLLEIGTTPVFCAITHDKKGQLLNTNADTIAQSLATGLAHLFNVS
LTYCFEKRGVLLNIDDENSVIESLNFNYFQELKTKNIIHSGMLPKLENCFQALQLGVKEI
RIANPEIIKNPNLPHTYISM
>EGEFANNL_00969 Acetylornithine deacetylase
MKSIQKLTEKAIILLQNLIETPSFSGEEDKTALLIEAWFIHHQIPFQREKNNVWALNKHF
DSSKPTLLLNSHQDTVRPNKGYTHDPFEALEKDGKIFGLGSNDAGGCLVSLLATFTYFYS
REDLNYNLVIAASAEEENSGKYGLRSILELLPKLDCAIVGEPTLMNLAIAERGLLVLDII
IKGTSSHAAHTNIDNAIYNSINIIQWFQTFEFEKKSEVLGPVKMSVTQINSGQQHNLVPD
ECKIVVDIRVNDCYTNEDILSTIVNNIGSDKVIITPRSLHLKSSFIPKEHPLVQAGIKLG
RETYGSPTISDQSVLYCPSLKMGPGDSLRSHTANEFIYRKEIEEAIPLYIELLNHTLTIS
>EGEFANNL_00970 Argininosuccinate lyase
MKLWEKGISTDKQIDFFTVGNDRELDLVLAKYDVLGNIAQAKMLCKVGLITEKEKENLLK
ALNEILNEIEVGNFSIEEDFEDIHSKVEFLLTEKIGDAGKKIHTARSRNDQVLVDMNLYL
KDELNLIKDSTKELFDLLMEAAEKYKNVLLPGYTHFQIAMPSSFGLWFSAYAESLIDDVI
FLNAALEVVDQNPLGSAAGYGSSFPIDRSYTTQELGFKTLKYNSVAAQMSRGKSEKSTSF
ALSSLASTLAKLSMDVTLYMSQNFNFVSLPAHLTTGSSIMPHKKNPDVFELIRGKCNKVQ
ALPYELTLITNNLPSGYHRDLQLLKEGLIPAIQTIKSCLEMAHYSLKDIQVKDNILDDPK
YDYLFTVDSLNELVNQGIPFRDAYKIIGEQVEKGTFTSPKKTTHTHEGSINNLCLEEIKK
KMSKII
>EGEFANNL_00971 putative methyltransferase YcgJ
MKPAKSNKFYDRISNFYYFIEPFFKSQNNLLIDKVNSLPKGKLLEIGIGNGKTLEFYKNH
KITGIDTSMAMLNKAKMYLRCYEHIELICMNGENLLFKDDRFDYVILPHVIAVVDNPNLL
LSEVYRVLKPGGTLIILNHFTPNNFIKYIDRIFNPIAKLLHFQSIFYESELTALSKFKKI
DNISCDVFGYFKLLLFLKL
>EGEFANNL_00972 hypothetical protein
MKKIDLSALIVLTFCLFIYIFYRTEKTVINQLLTQFYSSKSFVEMQQCVRRILPLNKFII
YSLPEGLWVFSATIFSYPFYINIKKYYFYCVYIPIIYPILLEIFQYFNWIHGTFDLIDII
ICLFFWLIAFLYVKNKFKRENIITSSLTIKKVLFFSIYGIVYLSHVCK
>EGEFANNL_00973 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MQIEVREEKINLFSKIDNVSILHLSDFHIKLSSKMLEEIKKIILDKSPDVIALTGDYYDL
PQGATLFRLFILELSTLFPIVFIHGNHDTWYGKKIFNSLINIPNCFYLKDYIFTFTTKNG
SRINFTSWENRKNLSSTESDKNILLIHNPEKIRVDELINIHVILAGHLHGGQIILFKTIN
NTFFPGNLLYKYCLDRKEIKNTCILVSKGLGDLLPLRYNCPKEILYIRIE
>EGEFANNL_00974 hypothetical protein
MRIYILILSFLITFINLKAQIVKVDSLQFPEKKEGNDRNVMLNAASTSEPREIQIGLPDA
GTYVRENSLPAVYYTNPQALSTNWRSDLSLEKVGLVNVAENAITTGNIGYGINSIDKLGG
DQFQGAFKYFGNQYNMQQFDVNVSGPLLKSKGLYYSASIFQSYDPGSFNIKFTDFQDQIN
MYKIALTKVFNNNKGKITFLYKNAEDYRLTLVTQNAPFIYVGNGNVKQYKNFKLGTSSYA
PVDGSMTYMNIRNGRMETTNLRDASLNRTNEYNLLTDINLSDNYKLKINAKYMRSMASMV
YQTPMGLTYENQIPSDMQYYYEDTNVPYVGDVQSRMSALNRGFIDTFLLTSELSAKTKNH
NWRIGLNEWYYNIDYSSNTTMYNQEVAKNPRRLRTQNLATGESFTYYDYNRNASEYYKGF
ENRLALYGTDNWAISDRFNLYYGLRLEYYKLKGKNLPYERYTGFHLGDTHTYGPDQTETI
QEQSFDFNWLNTVATVTANYVLMPHFGLTGEFTYNTQRPHIDNFAGFSNPSTKQIKVPMA
RVGIYLNNDWIQLTSMFTWIQKTNNYTRLNLINPANESEIVAKSLNFDIETLAWTTDLVT
YPFKNFDLHFLFTYQKPKYKKYETSAFGKSYNFTGNIVTEIPQVLIELDPKYQITPKLSL
WASFRYFSKTYANLSNALYFNGRWETFGGINWDVNKHLMLNATVVNFLNQTGAKGTISGS
ELKTKEEIEANPQAYKNVLMTGSYIRPLTIEFSATIKF
>EGEFANNL_00975 Levanase
MKKNLIILLCSLPLLSITTLHGQNKKSGKEAFIVVDDFESGNFKNWKVEGEAFGNSPVTK
ENSGIRDVNGYLGNYFVSSLSEGDDSRGTLTSSPFKIKSNYINFLIGGGTSPDLYIELVI
DGKTIYKNSPFSEGSQLEWMTWDVSKYLGKQAYLRIVDNDRGKWGHILIDQIEMGNIPKS
DYMVDKRLSIKSDKKYIMLPIEDKAPEVKVFLEIDGIKQIPHSNIRLAQNKIDYWVPLNI
EGYKGKDINLLLPIFKRNGIGYSKINTSNTFNFKYDEPFRPLYHYSPFFGWTNDPNGMVY
KDGEYHLFYQYNPYGSVWGNMTWGHAVSKDLINWEHKTPGILPDSEGTIFSGSAVIDKFN
TAGFGKDAMVAIYTNDGDRQTQNLAYSLDNGKTFIKYKGNPVLTDPNIVDFRDPKVFWDK
DSKQWIMSLATTQTITFYGSKNLKNWEKLSEFGEGIGAHGGVWECPDLFPLTYNGKTKWV
LLVSINPGGPNSGSATQYFIGDFDGKKFTPDPLPYPLWIDNGRDNYAGVTWNNEPNGKTI
FIGWMSNWDYANQVPSVNFKNAMTLPRELKLVNNGKHLVLANPPIETVKELRKETNTYEN
VSVNDTYTIKNLLSGNEGAYEIEMDIKPEKSNEFSFILSNNNNQQVSFIFDLTKEELSLD
RTQSGDTDFAINFSSVIHSPIVKRNMYKIRLLVDKASIELFLNDGETAVTSLIFPKESYN
NLTFKSLDKQPIQFNNINIYKLGL
>EGEFANNL_00976 Type III pantothenate kinase
MGTDLYANAYYAYKHYKGIKIIVDFGTALTLTCVDTHGEIKGVIIAPGVITSLNSLIGST
AQLSDIEMRVPKTVLGKNTEECMQSGVFFGFLSMVEGLIDKIKEELQEKVYVIATGGTGH
IFSELTHKIDVYDRYHTIKGLRELYYKYKQENL
>EGEFANNL_00977 O-acetyltransferase OatA
MHLKYRPDIDGLRALAVISVIVYHLNNHWLPGGFIGVDVFFVISGFLITKIIYREIISNQ
FSFKNFYQRRINRILPVFFSVMLCTSFVAWYLLLPDEFMLFLRSLKSTTYFWENMFFAKN
TGGYWDSSAEQMPILHTWSLAVEEQFYILLPLILLLLLKIRFQTENKLLRLNINTILLIL
FVIAIISFALAQISPKYSFLNKYNYYSLFTGRAGELLIGSIVGILQIKIDEHSPKKNYLH
SFIFTNIFTIIGSIALIFSFLFISKKYLFPSIWTLIPTLGTALILYFYHPKSIITRIFSL
IPLVYIGKISYSLYLWHWPIIVLAKKYLFIEHLVTFKHYAYITITCIILSILSFYFIEKP
CRKNNKSFKFSLIIYYILPSLLILSIYYIHKKNRSLDFRFEKRIKLYNLQKQFLDPQSNF
CHNVINDNCIFGDTSKEPSILLIGDSNAAHYGPYLDEAGKYYHFSVKIITNDRHVCAVLP
DERAILSLKEFENECTEFIKYLNKAIDKARIIIFTNRQENLYYNIKTRFILSNSLPKFID
FLNKKGKKVIFLAQVPMLNANEYDKYYYYFLINKTFDTHNMLSHIEEKSNNFVYNIIKNK
ALYFNPLNDLDENSKKSWPIYNSLLAYSKDNNHLNEYVTRQWAKEVLPKQKAFWERIARI
ANKSN
>EGEFANNL_00978 Type III pantothenate kinase
MLLVVNIGNSNIRFGFFEGEECVNSWVMNTKPHKTEDELFSQIKLTYQNYGINIKEIKEI
VVGSVVPHLTYPVRRSLHLLHGIKSILVSREIPTELTGISSRMGTDLYANAYYAYKHYKG
IKIIVDFGTALTLTCVDTHGEIKGVIIAPGVITSLNSLIGSTAQLSDIEMRVPKTVLGKN
TEECMQSGVFFGFLSMVEGLIDKIKEELQEKVYVIATGGTGHIFSELTHKIDVYDRYHTI
KGLRELYLKYKKEN
>EGEFANNL_00979 hypothetical protein
MKKLLILLVVITTSILKSQITPYYQQQANYNIEVDVDTKNFKYNGKQQINYINNSPDTLS
IVYFHLYWNAFQPNSMMDQQLIQLGKNADQRMVTPEGESRISKLKPSEIGYQKIISLKQE
NVPLNYTIEETIVKVKLDKPILPNTTTVFTMDWEGQIPLMIRRAGRNNNEGIDFTMTQWY
PKLAEYDYEGWHISDYIAREFQGVFGNYEVKINIDKNYVVGAGGVLVNPKEVKGYDLDIK
PKARNNKVTWHFKAENIHDFAWAADPDYSVQTLQVPQGPKVYLVFQKSEKTKYWEDIKPF
IIKYFQIMKENFGAYPYPTYTFIQGGDGGMEYGMCSMVMGNAGSLYDLAKLMFHEASHSW
FQQVLATNESMRAWMDEGFTSYAENLVLGELFPETIENYPNSHLETVSTYVNFAKSGQEE
VMGLLADHYHANNGYSVASYIKGEMFLVMLEYIVGKDNFTKIMKEYFQTWKFKHPTDKDF
MHIAQKVSAMDLKWYWNYMTNTTRTIDYMIKKVEELQGETKITLQNSGSFPMPVDVFIVY
TNGNKEIYNIPLNLMHNSKKQEFGIPQKTLPYWKWTHKEYSFILPIPLDKIDLIMLDASQ
RLGDIDYQNNLYQNK
>EGEFANNL_00980 hypothetical protein
MILSAIILGLVLSLILIGPVFFLLIETSLTRGVKPALALEAGVVMADLLCIYIAHRGSTG
LSNFIKEHPSIYMLAGFIIFVYGLYNYFSKVKVNFKSEVDKIATSGYLKTFLNGFLLNLV
NIGVIVFWLTTVVLISTQYPKSKDFYIYIIFMMSTMILIDFLKIFLANRFQNKLTGTIVF
KLKRIVGIALIVCGIIIFTRSFIKTDGENSFEIIENRLNHTFE
>EGEFANNL_00981 Penicillin-binding protein 1A
MNLNKNIKNKHKFPRKKSIVKRFLLWFWALFFTGILAIFLIFILTIYGVFGEMPDVRDLE
NPEIFVASEIISSDGVVLQKFEKEKRIPVEFKELPQPLIYALMAKEDERFPYHSGVDSKA
LLRAVVFLGKRGGGSTITQQLAKLLFTQREKENGNFSYNGVAKSKFQRVIQKLQEMVIAV
QLERLYTKDEIIALYLNKFDFLYNANGVATASKVYFNKNIKDLDLSQSATLIAMLENPVV
NNPKINPENARKRRDVVLGLMKEQGYITDAEYNTVVDTPIELDYKPIKDIGEGYSAYFKY
ALKKEVTTILNDYEKQTGKKYNLYKDGLKIYVTLDSRMQRYAEDAIEKHVKYLQNSFFRE
QKGRKYAPFYNYPGDPKIEVLYNKLMTDAMKRTPRYKFLKNRGMTDEEIIVEFKKPIELQ
IFTWKGDRDTLMSPWDSIRYHKHIVQAGLMAIDPTNGNIKAWVGGVNWKHFQYDHVKQAR
RQVGSTFKPFVYATAIKNLGYTPCTQVSNATYKKGNWTIAGNGAIMPLKTALAYSKNAVT
ARLIDATGPDAVIQMAKDLGVESPIPRNNTIALGSADLSIYEMVGAYGTFANFGNYTKPE
MIWRIEDKNGKVIKEYEPQVREVMNEIYAYTMIELMKGVVDIGTGKRLRGMGIKADVAGK
TGTTNKNADGWFIGITPKLASGVWVGWEDRYAHFVSTGMGQGASTALPIWGYFMQKVYAD
PKLKISQSDKFSKPESMKNDFSCDDLAAYGSYGSDYTSSGGTTTDIIEESVDIDEVTHTD
DNINKSLKEKDDIDFDK
>EGEFANNL_00982 Gliding motility lipoprotein GldH
MKKIVSFFILVTFLSQCKNNYEFSEVKNINNTWLKTDTLKFNVKIKNPQEKKNINFIVRN
NNEYPFMNIYFFVQIKKGDTIIQKMDTVNYNLSDVTGKWLGKGMGEVKEIYYRYKENFSF
PKEGDYTISIVQGMRKDTLVGIEDFGVSIE
>EGEFANNL_00983 hypothetical protein
MGTCGSCSSNGIPKGCKNNGACGTGSCNTKLSVFDWLSGINPPTSKIHNQYIEVRFKNDR
KDFYIVNPDHPLTIGDIVAVEASGGHDIGIVSLTGELVKIQMKKKKVKLEELNKVYRKAS
QKDIDIWTNYRDKENNVMLEARKIARRLNLEMKICDVEYQGDGSKVTLYYTAEGRIDFRQ
LIKDYAVAFRTKIDMRQIGYRQESAKVGGIGSCGRELCCSTWLTDFRSVNTAAARYQQLS
INPQKLAGQCGKLKCCLNFELDTYVDALVDFPSSQTILETEKGRAFCIKVDVFRHQMWFT
YANNSISWYPIDVDELKKLIALNAKGIPTKPLDELKEKNNLKVDLIEENNLNRFEKKHRS
TNKKRNKNTKPQQPKNPKKIESKQNSKSRRIKKD
>EGEFANNL_00984 Protein SprT
MHLKKLPDFSCLSKYISVDAIFYIKKWLSPYWFQLHIKNPRDSKLGDYRFPKSNEPHKIS
VNAGMHPSLFFFTLTHEIAHLIAFNTYSVKIAPHGKEWKKIFSEMILESINVYEDDLQPL
LIRFAKNPKASYYSSPCISEYFNKKLSPNIFLLKDLDNGDEFIIKNKVFLKLQKIKTRYI
CVEKKSNKKYLISGSAPIEKIGYNLHEK
>EGEFANNL_00985 Mannose-1-phosphate guanylyltransferase 1
MAGGIGSRFWPMSTPKLPKQFHDILGTGKTLIQQTFHRISKIIPIENIYIITNEEYVNLT
LEQLPEISKSQVIGEPKMMNTSACNIYMAEKIYNLNPDSCIIVAPSDHLILNEDEFSREV
LIAFKKAEKQDILVTLGITPHRPDTGYGYIEFSENEKSTEAYKVKSFKEKPDLETAKSFL
KSKNFLWNSGIFIWSSKSILNSFQLLLPEMYEKFQSIKTSYNTPNENIKIREVYNQIEKV
SIDYGILEKSSNVWVIPSSFGWNDLGTWNALYENLSKDNEGNAIYGKNIHAYNSSNNILK
TTQIDKTIIIDGLKDYIVVDTDDALLVCPRESDQEIKNYLKKIRTID
>EGEFANNL_00986 putative ribonucleotide transport ATP-binding protein mkl
MITASNITKSFDGVQVLKGISVTFEKGKTNLIIGQSGSGKTVFLKCMLGLFEPTTGEILY
ERTNASKLTTSDRQKLRSEIGTVFQGSALFDSMTVEQNVKFPLEMFANMTEKQMRDRVDE
VLERVNLTNARKKYPSEISGGMQKRVAIARAIVNNPKYLFCDEPNSGLDPQTSQLIDKLI
HEITQEYNTTTIINTHDMNSVLEIGEKIVYLKNGYKEWEGDKNSIIVAENKPLQDFVFSS
PIFKKAREAMLYEINNFKNKN
>EGEFANNL_00987 putative phospholipid ABC transporter permease protein MlaE
MGMISNIGMYSLLMVRVFKKPQRRRIFLKSLMREINDLGLNSVGLVVFTSFFVGAVVAIQ
MYNNFQTSSFPIPDYYVGYATKVVLILEFCPTIISIVLAGKVGSFIASSIGTMRVTEQID
ALEIMGVNTPSYLILPKVVASLFFNIILIMISVIMGIWGGYFAGDLSGSWASADYIQGLQ
MESPSFYIYYCFIKTIVFSFMIATVPSFYGYYVKGGSLEVGRSSTQAVVWTTVLIIITNL
VLTQLLLN
>EGEFANNL_00988 hypothetical protein
MEIGIYVYALTLGLLSGTHCIGMCGPIAFSLGLEANNKVKYYTQNFLYQLGRISTYSILG
GILGIVGKSFNIAGYQQYVSIFAGVLLLLMVLLPGKNFELGGNLKFLNHFMIKVKMFLGK
YIQKKDNTSRYLTGVLNGFLPCGVVYASLAASIAAGGIIQGMLFMAIFGLGTFPFMFITV
LAGNFIGIKAKTKVTKVFPYFLALLGIIFILRGLEIGIPYLSPPKKALKIEKMDDKSKSC
CH
>EGEFANNL_00989 hypothetical protein
MKFKFTWAHGIILALVSFIVFICSMVFSLEFSENTFDLVSDDYYQDEIYYQKEIDAANNA
MNLLEKPQIFVDKEVGIEIQFPKEFSSINTMGRFQLYRPNSKMLDINKNTLDFEMGNKII
IPKKVLEIGNYILKLYWKKNNINYKMEIPVEWK
>EGEFANNL_00990 hypothetical protein
MSQEEKIKPELEGESFRENLATAEESGKRKWVFPRKTHGKYTTYRNIVSAILLILLFVIP
FIKTSKGNPLFQFDFLNRQFYLFGAYFSPSDFYLFSIGFVTTIVFIILFTVVYGRIFCGW
ICPQTIFMEHVFRKIEYLIEGDRNKQIRLDKQDWDSEKIRKRLLKWTIFALISFIFSNIL
FSYIFGIDEMIKMIKEGPANNVGLFVALIIFSALFYLVFAWFREQVCSFVCPYGRLQGVL
IDKDTINITYDFIRGEGEKGRSKWKKNEDRKLSGKGDCIDCQQCVVVCPAGIDIRNGSQL
ECINCTACIDACDEVMTKVGLPTGLIRYASENMIEKRTTFKFNARVIAYTLILFILIAVC
TSLLFVRSSVESKFLKVVGTQFTIQDKNIVDEYQFSFINKTSEIQNLNIKIISPKSAEIE
LVGYGNKITIKPKELLKGTAVIKIPEADLSKTKQEVVIGVFDNKGAKIDEYKTNFIGPTK
ELF
>EGEFANNL_00991 Cbb3-type cytochrome c oxidase subunit CcoP
MKPRTPVGIIIIIAVCLITGAFLMLLQNFKFINNPIYLGTIVISIVLLLINNSIDSLIDA
GKFKNLSEEEKNRYLELLKTPYFTRLWRDAFKRSKEEELGEIAILDHGYDGIQELDNQLP
KWYIGLFAITITCGVIYFFAYIFTDFAHPIAEYDAEYKTQLAEIAEYEKTVPQATIETAQ
YNPEAIKEGKEIYNNLCITCHGEGATGGSGPNQTDDYWLNIVENDEFKNIVSVVWNGSKT
NPTMRSFINSGELKGNDIVKVASYLVHLNETTKKNPDGSSAGKAPQGDIAPWVKNPQAIV
EAAKKEGKEVKVVTEVSGN
>EGEFANNL_00992 hypothetical protein
MLKFYSKIIAGIDSATIYQSLALVIFFIFFVGLIYMVMSKPKNYYSEISSMPLDEENKQD
KDQNTVN
>EGEFANNL_00993 Cytochrome c oxidase subunit 1 , bacteroid
METQKFSYDNKITKAFAFATIFWSVVAFIVGLTVAALLFIPTLPDFIFGVEPSQLAKSQG
FIGFGRLRMLHTSAAIYAFVGNGFFAGFYYSIQRLLKTRTNDTLSWIHFWGWQLIIVLVA
ITFLMGINTSKEYAEHEWPIDIFVAIIWVLFGIIMFITIAKRRVSHMYVAIWFYIATWIG
ITLLWVFNNLEVPIDWNIVHSKSYSAYAGVQDAMVQWWFGHNAVAFFLTTPVLGLMYYFM
PKAANRPVFSYKLSIIHFWSLIFVYMWAGPHHLLYTSLPGWAQMLGTVFSIMLIAPSWGG
MLNGLLTLRGAWDKVREDPILKMFVVAITCYGMATFEGPLLATKSLNKIGHFTDWVIGHV
HIGTLGWNGFMTFGMLYYIIPRIYRTKLYSVKLANWHFWLGTLGIVLYAVPMYMSGFTQG
LMWKQFNPDGTLVYKNFLETVTALRGFYITRFIGGVFYLAGAALMVVNIFVTVRKGNLLA
NEPAEAPALKISSKKGENEKKHTWLERTPIYFSILTLVALAIGGAIEVLPTVFVKSNIPT
ISSVKPYSPLELEGRDLYIREGCNACHSQMIRPFRDEVVRYGEYSKAGEYIYDRPFLWGS
KRTGPDLHREGGKNPDSWHFTHMLNPRDTSPGSIMPAYPWLIYNKLDVSKTKEKLDVMKN
WFNIPYDQELMDNYQKSMSDQAKEIVTSIFTDRPDYKERFEATAAKDGENFVPLEQREII
ALIAYLQRLGTDIKNTEVKTASN
>EGEFANNL_00994 hypothetical protein
MEILYLMILCSVSLAAIFLGLFIYAIKKGQFDDDESPAVRMLIDSNEVQHAEGEELKNNE
EKIK
>EGEFANNL_00995 putative copper-transporting ATPase PacS
MDKKCFHCGQEIVSEEVNFDDKVFCCNGCKTVYEILSQNHLNNFYELNKQAGIKPDGDKN
YFEFLDTPEIFNKIIDYSEDGTTLVTLKIPVIHCTSCVWLLESLKNINSKILYSTVHFTN
KTVQIAYKSSTYKLSELANFLSSLGYKPIINLETAEKKKPENVDRTLIIKIGIAGFAFGN
VMLLAFPEFLEGNKDVWLKQYNQLFRVLMFLLSLPVVLYCASDYYKSAWSALRYKRLNLD
MPIVIGIFALFFRSCYEAYWGISNGYFDSLCGLLFFMLLGKFFQQRTYKSLAFDRDYKSF
YPIAVTKIDPDNQQKNILISKLKIGDRILIRNGEIIPADAILIKGEAFIDNSFITGESHL
IEKKSGQKIFAGGKQRGTMLELEIIKEVNQSYLTRLWNNEAFKKENSILDTITNSVSKYF
VFVILIITLISGCYWYFIEKNTSQMYQVITAILIVACPCALALSVPFTLGNIMRILGRNK
FYVKDSTTVEKMSKVNHIVFDKTGTLTMNKANHIAYEGKPLTVAELEELKAILKNSNHPL
SRSLYEYLDCPDKSLLVRNYKEIIGKGIGANVNGNTYKIGSSSFVKYKGEPIQETSVFIS
INGENIGRYIFKNQYRKYVPEVVKKISLKNKISLLSGDNNSEEEFLKQLFPTSTILKFNQ
SPQDKLEYIEKLQKKGDLVMMVGDGLNDAGALKQSNVGVAIADDINSFTPSSDAILDGSR
ITSLSSYLKISKIAIRIVYICFMISFFYNIIGLSFAVSGRLKPLVAAILMPVSSITIVFI
STILTQISGYIVFKKDLKS
>EGEFANNL_00996 Fumarate and nitrate reduction regulatory protein
MYFRPKNRAMYSDSVELIISELKNNDVLKEFSKDEIKILNNEIIEVTYHKGQEIIHEGCK
PTGIYGILKGTAKLYQNGFNGKEQILRFVKRGDIIGYRSLLCGESFSASCTAIDDELVAI
YIPEIIFNRLLKVSSKVSFDILKKISLDLGEAGKTITLLAQKTVRERLAEVLLFLEKKLG
IDQEGFINITLTREEMANLIGTATESAIRLISEFKGDKLIKVSGRKIKILDHKMLTRLGH
VTL
>EGEFANNL_00997 ABC transporter ATP-binding protein uup
MNYLSVKNISKSFGIRTLFKDVSFHVNEGEQIALVAKNGSGKSTLLKILAGKENLDDGEI
LFNKDVKVIMFEQSDSFNDDSKAEDYIFNHSNPILDVVHQYDKLIKEDPSNPELMNLIEK
MDLYDGWKVEPLIQEIISQLKIDFLFKKIKDLSGGQKKRISLAKFLIDITLEKGYILLIL
DEPTNHLDIEMVEWLEYFLNKENKTLILVTHDRYFLDAICTKILELEDEMIYTHNGDYET
YVTNKALRIENQASQIDKAKNLYKKELEWMRRQPKARTSKSKSRISDFYKTEETANIKLD
NSNLQLDMQMTRLGKKIIEMESVSKKFGNKIILDSFTHTFLRGARIGIVGKNGAGKTTFL
KILENQEPIDSGSIEWGDTLNIGHFKQEGIIFKEEQRVIDYVKEIADYFPLSNGKQLFAS
QFLEMFLFKPETQYTPIGKLSGGEKKRLQLLSILFKNPNFLILDEPTNDLDLPTLTVLEN
FLNDYQGCLLIVSHDRYFMDKVVDELMIFEGEGKITNFIGNYTKYYLEKKSKTSVNQEEI
NQSEEKIAADKGHEEPVKKNKKLSFKEKRELEILEDEIAKLEKKKDELSSQLTLENLEFK
KIQELGDELNLLIQELEEKEMRWMELSDL
>EGEFANNL_00999 hypothetical protein
MKLYLFPLLCLIILSNGLHAQQTSTSPYSSIGLGDEKFSTDITVSSMGGIGTSYISDFNN
EANFNNPAANRNLRYTSFNVSVNTDFINEKTSSQSSDRSTTYLSNISVAFPAGEKSRIGF
NLRPYSTLGYNMDLSNNSNGITQNSSLKGRGGLNMFGGFYSYNITQDLSVAAKINYIWGQ
LKKEEETSIQGANLKSGTFNRKDYGYFDYTLALAYRKKFTNDHLLKLGATYTFGRDVNTD
VNSLYSTYYYNSLNEKQSIDTLSYSRGTYNSKIPFSYSLGVAYGKEFKWSLGLDFKYINQ
SKLEIPQENYTYNNRYRVALGGWFLPNINGFKSYFEKIIYRYGIYYEETGIELNNQSINQ
YGITAGLSLPIGKTGKQDPSTLNLGLELGQRGTTSEGLIKENFVNFRIGFNFDDLWFRKR
QFD
>EGEFANNL_01000 hypothetical protein
MREQNKLRKKTFSLYMRKIITLLVFITSYTLLNAQFRSKDVMDRYDDIDHQQFSWGYYLG
INYFSFKLHPEAEGLNSRGKFLVNVDSKAGFTVGLIGKMRINEYLDLRLEPAMHFVQRDL
IFRNIQNIINQEVEEGKEPTYTDLDAIRNVKSTYIDIPVFINFHGNKWNNTRPYVQAGLS
YLMNLQGSEKKEQDNLEQVFRMKDNNFSYQLEAGIEIYLKRFKLTPSVRGIFFINDELVK
DNPGTPPVWAGAIKSMSTRAIVFSLKFE
>EGEFANNL_01001 Demethylmenaquinone methyltransferase
MTPENIKPYNKTDNKKKQVEEMFDNISENYDFLNRLLSLKIDVYWRNQLEKRVVALNPGK
ILDVATGTADLAIEHAKKTNALVTGLDLSQRMLDYGQIKINKQGLKERIKLIKGEAENLP
FHDEEFDVVTASFGVRNFENLEKGISEMQRVLKKGGKLFILEFSKPTGIFAPFFMLYFKY
ILPTIGKIISGDSKAYTYLPDSVSKMPYGKEMEEILLKNGFKQSTSKTFTFGVVSIYEGT
K
>EGEFANNL_01002 hypothetical protein
MKNNSLKGLIIALAFCLFSVSVYLLFLKKEDVFLLDNPTDSSIKVVLNNKKYLLGPGQTA
EVSIQLGNNAISAKREDSVVLLKDTFFSIENNTRGLINPTLSNYYTFKRYYGYVKNRDSL
YNSHQIDIEGKEYKGEIKKYNDLVLQGFSININQDYPKLKKKSDSLTGITKLFRKNQFVE
YYETISE
>EGEFANNL_01003 Outer membrane protein TolC
MKIYSTILAFLILRILSAQKIWSFNDCLSYAKENNLQVLAAILNEKVQEGNYDIAKKNKL
PNLTGTVGNSFSFGPDASKDFSYNEGYQNNLALESSIILYNNGSLDITQEKNKLLIDQYK
FTTEKIRNDISLQIVGNYLTVLLNKELMLVNGNLLNTQIQDAERNEKLYNAGSIPLSTLY
ESKANMAKAKQTFENSKIDVNRALMNLAMLLQMDYRDFEIEDVKVSDQIDLPLINIDNII
NHAYTNQPEIKSSELSVEVAKKDIELAKAALYPTITGGYKASTYYQDYFDRSVKNLKDQW
HDNNSQIITLGVSVPIFNKGITKAKIEQSKIAQLIQENQLDQNKLNLKQTIQSSYFDVNS
SYQTYTSAKELVESTKISYEFAEKSFNAGKINVYDLNIARTNYFNAQSQMLQAKYSYLFK
LKILEFYMGKPLEISSDENINTNNTLTTSISQSIHNTEISLNETNSNESLNVNTNNDNNI
IANEPKEVNILQKNSEIVDLEDNLKSESINKKTIEKNIPINESEKIISNDHTETANIPKK
DQINQNSQTIANSSLNEEDLKREALIKERRAKLSQGSSTNIFKNEAEREEMIKKKREEMK
KN
>EGEFANNL_01004 Chaperone protein ClpB
MDINKLTIKSQEALQQAQNYTQELGNQAIEPAHLLKALLTSEASVITFIVKKQNSNLAYI
NSELQNILNSLPKVSGGQLYLSHNANKVLTDAQTEANKMKDEFISLEHLFLAILSVGDAT
SQLLKNQGVTRDGVLKAIEEIRKGERVTSQTAEDNYNSLNKYAKNLNELALEGKLDPVIG
RDEEIRRVLQILSRRTKNNPILIGEPGVGKTAIAEGIAHRIINGDVPENLKDKTIFSLDM
GALIAGAKYKGEFEERLKSVVKEVTSSEGNIILFIDEIHTLVGAGGGEGAMDAANILKPA
LARGELRSIGATTLNEYQKYFEKDKALERRFQKVMVEEPGVEDAIAILRGIKEKYEAHHK
VRIKDEAVIAAAELSNRYISDRFLPDKAIDLIDEASSKLRMEMNSKPEELDALDRKKMQL
EIELEAVKRETESPTSNEAIKLSNEKKLENVKQELAQLNEKRDELSASWKAEKERAERVQ
EIRKNIEELKLEADKAERAGDYGKVAELRYGKIKEKEEALIQAEEELSEDKPRLIKEEVD
SEDIAEVVAKWTGIPVTKLVQSEREKLLNLEQVLHKRVVGQEEAIEAVADAIRRNRAGLN
DERKPIGSFLFLGTTGVGKTELAKALAEFLFDDENSMTRIDMSEYQEKHSVSRLVGAPPG
YVGYDEGGQLTEAVRRKPYSVVLLDEIEKAHPDVFNVLLQVLDDGRLTDNKGRMVNFKNT
IIVMTSNLGSHLIQENFEKLQENNYKEILELTKKEVLELLRKTLRPEFLNRIDETIIFKP
LNKNEIRGIIDIQLDSLNKILAKKGINMRMTEEAKDYIMSKGYDPSFGARPLKRIIQHEI
LNQLSKEILGGKINDNENIIADYFPETGLVFRKDN
>EGEFANNL_01005 Alkaline phosphatase synthesis sensor protein PhoR
MKEKFIPILSSLMTISLVVFVGLQVFWLKQSIDAGEQDFSSRVYKALNNSAQKINSIEIN
KFYKPFTNFYQNINNQKDSSTIQTAMSVIDSQSVKYIMYKKTIVNRKPLIIPFSKKDTLK
ITNLLTDEGVLKIKKDSNDSNLKPIEQSIENSFVSPKFTLDEFARLSINQMSLESRVNIQ
LIDSVVNIELRKQNIDTKFESGVLNNKFEITKIHSKDFVLSKQPKENYNVILFSDGKDIA
NYYLSVYFPSKQYSVLNPIFGAIGLTIASTLVIIAIYSVSIYYMYRQKKISEIKTDFINN
MSHEFKTPIATINIAADALKSEKVQANTEKILFYSSLIKQENERMKKQVEMVLRMSKLER
NSLELIRKETNIREILKNSVKTIRLQVEQRGGKITENYTAINYIANVDGFHLTNAFVNIL
DNANKYSPNEPDITLKTYNKNNDYIIEITDKGKGMSENVVKKIFEKFYREESGNIHNVKG
HGLGLTYVKNIIKLHNGGIKVVSKPNKGTTFIINLPLNHN
>EGEFANNL_01006 Transcriptional regulatory protein BaeR
MEKKIKLLLVEDDPSFGSVLKDYLTLNDYDVTLAIDGEDGLEKFKADTFDVCLSDVMMPK
KDGFTLAKEIIDLNPDIPLIFLTAKNMREDILTGYKLGANDYITKPFDSEVLLYKINAVL
QRNSNSTINSENDVKEVYEISNFKFNTKLRQLEINGKMHKLSPKENELLKLLCKYKNDLM
PREEALTKIWHNDNYFTSRSMDVYIAKIRKLLKEDDNIEIANIHGEGFRLLVKE
>EGEFANNL_01007 Multidrug export protein MepA
MDNLKKVHNIYDLENKKISSLLWEYAIPGIIGTVAVALYSIIDSIYIGNNKYLGDHANGG
LGILLPIMNFLSGIGMLIGAGAAARTSIFLGKKDNISAEKIVGNSIILSIVLTLFPVIYI
YIYIDKILFLLGTTSETLPFAKEFLKYYLPGNIFLILNFSLNNIMRSSGYPKKAMYTMLI
GVGANIILAPIFIFILNLGMKGAAIATNLSIFLGLCFVLTHFFQHKNTLTLKWKRLKPDF
RIIWAIISIGFAPFFILIAASLIVFIINHRLVSYGGSIAIEAYTLANRILMVFIMIIVGL
TQGMQPIIGYNYGAKRLDRVKQTLKYTLKVGFIIGLIGCISGVIFPHIIIKMFNPSPYLA
KHAERALHILTLTLPLSGIQMVISSYFQCIGKAIKAFFLSMTRQFLILIPALYILPKYFE
LNGIWYSVTISDTISTLIAIIMFILQIKTFKYIK
>EGEFANNL_01008 Phenolphthiocerol synthesis polyketide synthase type I Pks15/1
MKNKEVLIVSPFEIPNVRLALQTLKSGAFPILHLGRNKKIAINKLKELSEKTSEKFGISG
CSYILSEIEIPTNVSKVITPYISNIKLDYTIDILYQVFSFEEAELAIKNGVKSIIIKGNE
GSGKVSYESSFILFQNILKKYPNPDFNIYVQGGFGVHTSAAALALGAHGVIFDSQVALFP
ESNTPENLKNILSKLSGSETIVVENYRFLSRKNSPKLPESPTFKDVEPFIGGLDIESNLI
PLGQDIALAVDYLEKYKKLDNFVFAVKEATYGHLLQAQKLNSIGKNSPLAKELKIKYPIA
QGPMARVSDIPEFAEKVANEGAIPFIAMSLMIGKAAKNAVKNTYDLLKDKPWGVGILGFA
PSQIREEQMKYILENKPPVVIIAGGRPSLAKPYEKEGIKAFLHVPSVSLLDLFLKEGAKN
FIFEGRESGGHVGPLASLVLWEKQIFRLLKEEQPSLINIFFAGGIHDSFSSAFVSIMSAS
LAAKGVKIGILMGSSYLFTKEAVDTGAISKVYQQESINLDKTILLEAAAGQETRALPTPF
TEEFLNEKKRLIAQGLDSKEVWLKLEEMNLGRQRISAKGIERKGDKLVELNHKEQLQKGV
FMIGAIASLRNKAVSIKDLHKEVAIDNNTLISNLSEISKPANKQKNTKLAIVGMAGIFPK
AKDLDEYWKNILLGEDCITEVPDDRWNKDLFYNPNTRDTDYISSKWGGFIPTIDFDPLEF
GIPPQSLASIEPVQLLSLLVAKRAFEDAGYDMKNFDGENTSVIIGAEGATDLASSYGFRG
YAKQVFGELPEELKKALPKLNEDSFPGVLSNVVAGRITNRLNLGGCNYTVDAACASSLAA
MDIACQELQSNRSDIVLVGGADLHNGLNDFLMFSATHALSRKGKCASFDADSDGIALGEG
IAMLVLKRLEDAEQDGDRIYAVIRGTGGSSDGKSLGMTAPNKKGQMKALQRAYKNAGVLP
SEVGLIEAHGTGTVVGDRTELNALTDMFLESGAQVGQTHLGSVKTQIGHTKCSAGIAGVI
KAALSTYYGIKPPTINLKKPNTYYNQELSPFVFNTQAGLWNDDKRISGISAFGFGGTNFH
VVIENYQSDIKKASPLNSWPSELFIFRGDHKEEALLLAKKIKTLLNTNKSLKIKDIAYSL
ATYNQKEIQFSIIAQNIEELDLKIDNVLLNKEDQNIYLRKEIDGKVAFLFSGQGSQRVNM
ARDLFVAFPSMRKLLNQNREYEKILFPHTVFDNGSKIQQNKIITDTRNAQPTLGIVDLAI
AEFLNSLGITPDVVAGHSYGELPALCFAGVFDSEKLVYLSKERAESILKAIKEDKGKMIV
TSANEEQLSSLLKDENEIWAVNYNSQKQIILAGSTSAVAKFIEKAKENKISCKELTVDCA
FHSPLLKDAEKFYSKILKDIKFKEPKIPVWSNTTAEEYPSQETKIKERLSEHLIKPVLFT
QEVNNLYNNNVKIFIETGPGRVLTNLVQTILGKEDIVTIQTEEKGKEGISFLLQGIAQYI
STGRNINLEKLFEDREVAKLKIDEPEFYKNKPTNWLINGHYAVPSIGELPANGALPIVQP
LNLLGKLSSQNYNSENLTESDHIMLEYLGNMKSMIQNQRDVMLGYLGQEIHINPRVETKD
IFQKNTIQYKSSNGSSDIIESPQNNAQDLAPAKSSPSISLEIIQNTLLDTVSEKTGYPVD
MLGLDLDLEADLSIDSIKRMEIIGALKEKLNITADFEESEDAIEKMASIKTLSGVIGWVE
ELVKEEQNSKHIIDSSNSNHGITQSNQGKESISLEIIKSTLLDTVSEKTGYPVDMLGLDL
DLEADLSIDSIKRMEIIGALKEKLNITADFEESEDAIEKMASIKTLNGVIGWVEELVNED
LKKETKVITTQANSSISTISFDAETIAELESDLNENNIENEPILRTFFELKNYPIDSKEK
LEITNKYFALTDQGDNLSKNVKKLLEEKGAFVDFITGNENDLSKYDGLLIFKTNKSSIDY
TIEDVFHMIKKLNMDKVQWIYLIEDIMAGLEKKQSISEFKILPGYSGFIKSLAREYSKIN
CRIISSLTDFNEYLPTLIYQELEISDISAEVFYKNKDRYRLNLIPEKIQTQKNSKLELDT
DSVVLVLGGAQGITAELTEQLSTEYPCNYILVGRSKKPTDDDNKYISLNNKNEIRKFLIS
NEGMKIPAEIEKKAQMIDKTNQIIKTISQIESSGSKVTYFSLDVTNDNEFKKLIKNIYKQ
YGKIDGVIHAAGILEDKLFSQKTYESFEKVYTTKIKPLHVLLDELKDNLKFMVFFSSIAS
VYGNRGQIDYAAANGIFDRISLLAKNIKDIRILTINWGPWKGTGMVSSALEAEFKKRGVG
MIPLKQGGKEFVNELKYGTHSQVLVMGGSEDDVKQFFGI
>EGEFANNL_01009 Phthiocerol/phenolphthiocerol synthesis polyketide synthase type I PpsC
MKNIDIAIVGMSCLFPDAKNIQEFWNNLISGKNSITEAPNSKFDILVKNTTNCLTSIKGG
FIPSINLDFESLNLTKSEIQNVDIDNLLAFKLVVDALEDASISRNDLSNSCVIIGKENNI
SSSNINAIDTFHTKEQLIQIIRNILPNLTEDQIAEIEKEYLKNRNADRIISTNIASFISN
KLNINGAAYSLDSSYSSSLLALEHAIKELTSNRVEIGIVGGINFTLNSTNLGIYSKKGIL
NNNPNDQIFNNSGEIFLGEGAGFVILKKLDQAILDNNKIYATIQGISSNSISDIEIGQKE
AIKNAWKQAQISPKDIDYIEASASSMNKEDQTEIKVLSNLFKDKNITVGTLKPNIGNTLS
ASGIASIIKVVLSLYNQEIPSTLNGKICNEELKDTPINIPTQNIQNMNLMYAGINSFGLE
GMNVHTIIKVHDKNSKLKSLSSVRFTDEVIAVTANSKEELIKALDEENFSIANNTGKYRL
VLFNPVKERIEKAKKLISKDKPWKGRQDIWFTNEPLLNENGKIVFLFPGFDPSSHLEIES
IAPYFDLKNSYNQNLKEDDQRLLNQSFKQSYACEISNKALKDIGVLPDMNAGHSLGEWFA
ANAAGLFSDNTTSDLLKSMDPEKFEIEGIYFIAVGAGAEKINPILENIPDLYLSNDNCPS
QVLLCGTEKAKDTLINYLKSKQIFYQVLTFQSGFHSPFIKDKLYLLDEALEHIKLKKNTI
PVWSATTLEQYSHNEKEFKELTIKHLTEPVLFRELIQKLYSQEKARIFIQVGGGSLIGFV
DDILKEKDYSAISSLVPNRKSLEQLRRILALLFIEGKSINIDFLGLKNSKTQNCIEISLN
EKSTIVKELHTLQALVKNTQENSTHTPNKIDDFLIKSNHPVIQALNDNTLEILHMQKEFS
EIIRKRNENIYYNKRNIPIHHLKKVETNKPLSNQPLPRKDSSFKENLYISLEDHPYIIDH
SLFKQPKYWKDLEDINPVIPMTMSLELLMETALKQAPDKKILCLGPVSVFQWMKVSKPFQ
QIIEGTWKNKSNISLKIKNFANAEVTLGNKFYNPEPYYTQDFDLGKDIASIPYPNTIYSS
HMFHGPAYQGIQEIKNITQKGLRAIIKKSTGKGSLLDNIGQLFGLYLQLTLGEESNVSFP
VKIEEINFYQEFTDQEGTFECICLPTSITEKIATSDIIIKRDNKIWCIIKGWKNQIFEGF
DKNLWNMTMNPSENIISKNIEENNIYFFNNIYKRAVNWDFLMNIYLNKEEKEHYNSLMLN
KKKDFLISRICLKDNVRKYISNKFGKNYYPIEISVQHDLNNKPYVRGVSEAEKIEISLAH
KDSNSVSIVSDKPIGIDIELIQSREQGFLDLSFTENELKLIKDKDLSEWSTRLWVAKEAY
GKKLGLGLQGNPKKYEVENIEDSILTINKTKIKTIKLNNYIIGWTQ
>EGEFANNL_01010 hypothetical protein
MDPIEKQKEEVYEQLKKYIIEIIGEDIAEELDISPKSIFTKDLEMDSIEIVSLAEKVKTK
YGDVIDFNGWLSEMEMEQLIKLSIEDIVNLIVDALNKDK
>EGEFANNL_01011 Tropinesterase
MPLIKINNKNVNVLELNPEGKSTIVMIHGMFTNSSIFYFNIAPILAKEYRIIMYDLKSHG
LSEKVDHGYDLKTLSKDFIDLLEKFKLEKVSIVGYSFGGLIALYIAIYYPEKIERIAIID
SPLTNRDEETDKVLEKYGNEFLELYMKNYSISTNIKPNHKQLEKNRRLYNFLLHETTLPK
DLITDEHFTSKENMEKVKHETLLLYGNQSDCLPDGEFLNNSIPKSKFFIGNGDHNIPIQN
HVWINEKLSTFFNI
>EGEFANNL_01012 Demethyllactenocin mycarosyltransferase
MAKYAFIVPPLTGHINPTLSLGSELLDRNHSVSWICLDPELNKQLPKGGELLIPPIEASN
EEKSKLIAYAKELQKKKVYGIDSLKFLYEEVLTPMNSLMIQGIEKILQKYKPDVIIHDHQ
IYAGSVAALKYNIPYATSVTAPASIKVNANFPKIYEWEGEQIIKFQNNNGILKNERLDCS
SLLTLVYTSKIFFGENNLPSNFKFIGPAIATRHLNIEFDWKKFEIIGNNRPKILVSIGTN
FDYKQKIEFFNKIIEAFEDQEVAVVLISDPNLFKKIPKNFIIQNKIPQLEIIPHIQLVIC
HGGNNTVCEALSEGIPLVVIPIAYDQSFISTCVVENGVGIRLNFNRFKVEHLKNAVTTIL
NENSFKENAHFIQKSFKEAGGIKKGADYLEQLLN
>EGEFANNL_01013 4'-demethylrebeccamycin synthase
MSKIIFVVPPFFGHINPSLSIGKTLLERGHEVIWTGLTELNKELIPNGGTYYILKKSFQQ
YQKEIENIIHLQDKGANMPALEALKLGLQDTYIPLAKIMFDEFNQLVKSFEPDIIINDCI
TFVGGLVAHLNKIPLATITPITPNAIHDPGTAPKVSKWVHDSIKDLQYYVGIEEDEELVL
SKKLNLFYTSQKFVGYKNDEIPPYMKFIGALTGRPDNTPFDWEKLNNEKRPIIYISLGTV
LVDIRKEFFSKMVEALGDKNFTVVAATNPTILNHWPDNFIVQSYVPQLKLLKHVDVVIGH
GGLNTVCDTYMNGIPMLVIPMAFDQSHTGALIEQYGCGIRLKYKRLRTIDIENAIEELLN
NPKYKKSAKEIQESFIEAGGNDSAANLIENLIKN
>EGEFANNL_01014 hypothetical protein
MFKINITSKKNISDVNMYILLLIYVIITLFACSKMSPLYVTNEWADPNVYFNVAKGMVNG
KVLYTEIFDHKGPFIFFIYAIGYLISNNTFLGMFFIEIISWFFLAISLYKISKIYFSRNS
SSILTMLFFIPFVKIIKAGGSAEEFILCLEGVSLYLFLQYFNKNSCLHKPKYMFIHGMIV
SIVLLTKINLIIFWFFPLLFIYINIFLHKKFKNLINNILLFLIGSLIIALPIIGYLYCNN
ALEEAYNIYIKLNSAYAKIGSLKKTTILLTLRILYLFIEPLSLFIFATIGIFIFPLKHIK
NPLGKYSILLTGISLYIIIFMGKFQYYYPIPYLIFSFLGLLQIANYLKEKNTNTNVYLSI
KDMYLITLIIVFANISVSKMSNTRVEEWFFPKDTYASTTVMTNKLRVEIMKEKNPTLLNL
GFGLANNLFTTCNIVPNVKYFITPNLSYSFYPQLRQEQFKYIKNKKTDFIIIQEYITGSD
YYKKQNPVDRPSYLKELPILNENYKLILADTLTNYIDENSDEIYYLYKKNP
>EGEFANNL_01015 hypothetical protein
MTEKLVQELNDLELKILSLKKENSELKKINKYLENSLSIKEDKFIQKEKLYKEIEEQNRR
LKVVNALSGSEEYKKVMKLQMNRLIKEMDICISDLKGF
>EGEFANNL_01016 hypothetical protein
MSLKVNLKIAGRTYPLVVQDDEEEILRNATKRIQKYVSTFDKDYNINDKQDSLAMSALQL
ASELENLLKNIDREHKEILLKVKNIKALITDS
>EGEFANNL_01017 Ribonuclease Y
MEITIISELIATLLIGGIIGFFLSKSSLNKFRNNKIKEAQNKASLIIKEAVSKAETVKQE
KMLQAKEKFLELKVQHEEQINQREKKIIDTEKRIKDKESKLNDDLHQNNIQKKQLDQAIK
DNQSKADILLKKEEELKNLHQQQVQILEKISGFSAEEAKAELIDALKHEAKTKAQAQIQS
IIEEANLNAKAEAKKVIIQTIQRIGTEVAIENSVSVFNIESDEIKGRIIGREGRNIRALE
AMTGVEIIVDDTPESILLSCFDPVRREVARLSLHKLVTDGRIHPARIEEVVAKTQQQIEE
EIIEIGKKTILDLGIHGLNPELVKIVGRMKYRSSYGQNLLQHSREVANIAGILASELGVN
PKIAKRAGLLHDIGKVPEEESELPHAILGMQWAEKYGENSTVVNAIGAHHDEIEMKSLIA
PIVQVADAISGARPGARRQVIESYIQRLKDLEDAALSFDGVNTAYAIQAGRELRVMVQSE
KIDDQKASQLSFEISEKIQNELTYPGQVKVTVIRETRAVNVAR
>EGEFANNL_01018 4-hydroxythreonine-4-phosphate dehydrogenase
MSLNNKLKVGISLGNPNDIGIEIILKTFQKREMLEFFTPVIFGSTKLLSQKKKKLGYNSI
FFQGIASASEIVHKKINVVNVWKDSADNNNENLIEEFARLANISFTSGIESLKQGQIDLL
IIDSWSNSFLDGVQLLEVLKNDLGGSPYDMILNENLRISFVNRGGKLNDFSQSLKKEDLS
KYIKLINKTLVQDFCIEKPKIAVLGVNNFSQDVTLIGKEELKIIEPSVKECFERGILAFG
PYSADSFFENFEYTSFDAVLAMNEQQVLAHCDISFKENNFSFVGGTPYIVFRSNQNFSDV
SNIEIEVNTNNSFEQAIFSGIKIYKDRKEYIDLKTNSLKKVKIDGIDMSLDEDLPDEE
>EGEFANNL_01019 Lysozyme M1
MIKIYNDFLKDSNNNHNLLNSRKISEEKKINSILKEYQNCLFGIDISKHQGKINWDSIHS
INSNYPITFVFVRATQGIYKKDNFFDSNWNNLKAKKFIKGAYHYYNPDQNSSEQAKNFIK
AVHLEKGDLPPVLDIEELPKNQSIDLLKKGIMNWLRLVENEYKIKPIIYSNDAYFIHHIK
DLDLENYPIWVANYNPIKYPLHTRWSFWQFSEKGIIPGITYNFVDLNVFNGDINKLNTLR
VK
>EGEFANNL_01020 hypothetical protein
MNIKILSLSLLLSVFLFSFSCSSNNVSVEKNMRVEKINPVNAQIQENQVWVLQKIDGEDA
KNVFDNLPTLSFDVLKKRVSGNSGCNRYSGSYLLDEENHLDISQVITTRMFCDNKNNESG
FVTNLDQANLVKIENNTLTFLKDDDALLEFKLQ
>EGEFANNL_01021 S-adenosylmethionine:tRNA ribosyltransferase-isomerase
MKTSDFDFKLPPELLAERPSENRDESRLMVVHKNSGQIEHKLFKDVIDYFDEGDVFILNN
TKVFPARLYGNKEKTGAQIEVFLLRELDAESRIWDVLVDPARKIRIGNKLFFTDDDSLVA
EVIDNTTSRGRTLRFLFDGSYEEFRIKLKELGETPLPKYIKRKPDAEDIERYQTIYAKNE
GAVAAPTAGLHFSKHLLKRLEIKGIDFAEITLHVGLGTFASVEVEDLSKHKMESEQVSIS
EKTCEIVNHAIENKRRVCAVGTTSMRAIETSVSANNRLNPYDGWTNKFIFPPYDFGIANC
MITNFHTPKSTLMMMISAFAGYDLVMKAYKEAVNEGYKFYSYGDAMLII
>EGEFANNL_01022 putative dual-specificity RNA methyltransferase RlmN
MDIKKKDIRALSLEELKAYFSSIKEPAFRAIQVYDWLWNKNTHSLSEMTNLSKSLREKLE
SNFIINSAKVHSFQKSVDGTIKNAVKLYDGNIVESVLIPTSKRTTACISSQVGCSLDCTF
CATAQLERMRNLTASEIVDQVNLINKQSNEYHHKPLSNIVFMGMGEPLLNYNSVINAIQK
ITDLKGLGMSPRRITLSTSGIPKMIVKLADENLKIKLALSLHSAIEEKRNKLMPFSLKFP
LKDILESLKYWYAQTKSRITFEYIIWAGINDSDEDIKALVMFCKQVPSKVNLIQYNSIDD
GIYSQASNLAVEKYIQHLEKNNIIAKIRKSRGQDIDAACGQLANKH
>EGEFANNL_01023 hypothetical protein
MSFKARLEVGGKKYNILNINYSLSQETDPTGRPSSQTRGGRIEITIESTGDTDIFEWMTN
SFERKDGSVIFIKRDSDATLKQLDFTDGYVVKYRENFDSIGRSPLKETFLISAKTIKVGT
GEHVNDWV
>EGEFANNL_01024 Guanylate kinase
MGLVYHKPGNDALDLTQLLPGKKVEGKLIILSAPSGAGKTTIVKYLLSIIPDLSFSVSCT
TREKRDNEKEGEDYYFISKDEFERKIENNEFIEYEEVYNNQFYGTLNSEIERLWSLGKHV
IFDIDVKGGINLKNEFKNKALAIFIAPPSLKVLEERLRLRNTENEESLKKRIQKADEELL
YAKNFDSLVINDNLEKSKFKTEQLVKSFISSPIKAI
>EGEFANNL_01025 hypothetical protein
MTGYGKSEVSEGNCKISTEIKTLNSKTLDLYVKIPTRYKCKELEIRKIIADHVFRGKVDF
SMNIENADEDSNPKLNINTIKNYIKDLETLQMEVSQAEYLKMAVRMPEVFLNREELEISE
DEWEQVVISIKTALLKLDDFRKEEGQSLNEILNIYILNILNSVKEIEKYEKERIEIVTQK
LIKQLDEIKVQYDEQRFHQELVYYIEKLDISEEKVRLQQHCKYFMEMLNEKDPIGKKLGF
IAQEMGREINTIGSKANHSIIQKLVVLMKDELEKIKEQTNNIL
>EGEFANNL_01026 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MKNFLAVLTIFLLIVEYYSYQGIKVLFKNKKIQYVCTIISFILFLVIAISFYQINRNNKF
QIQFLIGLFIIIYIPKLLFAFILFLEDIFRILKFLVNQFYLNVKNFKEQSSIKYLPQRRK
AVSLIGLGIASIPFLGVIEGIIWGKFDYRIRRKIIYFDDLPEEFDGYKVAQLSDIHMGSF
NIEDYKKIERGIQMLNEENPDIFFFTGDSVNNYAEELKPWLPLLKKIKAKDGKISILGNH
DYGIYAYGVDNVKKQQENINKIQEFHEEINWQLLKNESLQIKKGKSYINIIGVKNWGEGN
FPKDGDLEMASKNIKDGDFNILLSHDPSHFDAHVKKFSKKIHLTLSGHTHGMQFGVEIPG
IAKWSPVKYRYPKWADLYKEKDRYLYVNRGFGYLGFSGRVGIWPEITIIELKKTV
>EGEFANNL_01027 3-oxoacyl-[acyl-carrier-protein] synthase 3
MLQSIITGSGSYLPNKIVPNSSFEQITFFDENREPLVKSTSEIIQKFADITEITERRYIE
DDSVMNSDLAAEAGKLAIENAGIDKEELDYIIVAHNFGNIDSDERQVRITPSISALTKQK
LGIKNTQCKPYDMVFGCPGWNEGVILADQFIKAGIAKKILVIGSETLSRSVDPFDRNCMI
FSDGAAGVVLEGREKSDEPIGILNHYTRSDNGEEVFYLTTDKSLNPEYVGSKANIRMRGR
KIYEYALKYVPQAIKKVIDDAGYTITDINKVLLHQANAKMDHAMLQRLFRLYGLPISSIP
EGIAPMTIQKFGNSSVATIPTMYDMMAKGNFLNQTFKSKDLVIFASVGAGMNINAILYRM
P
>EGEFANNL_01028 Protein RecA
MAEKENKDNNSSEAKKKALNLILDKLDKTYGKGAVMRMGDKPVEEVDVIPTGSFGIDLAL
GVGGYPRGRVIEIFGPESSGKTTLTLHAIAEAQKKGGVAAFIDAEHAFDPTYAQKLGVNL
DELIISQPDDGEQALEIADNLIRSGAIDIVVVDSVAALTPRAEIEGEMGDSKMGLHARLM
SQALRKLTGTISKTKCTVIFINQLREKIGVMFGNPETTTGGNALKFYASVRMDIRKSGSP
IKDGDNAIGSRVKVKVVKNKVAPPFRQAEFDVMYGEGISKVGEVLDLGVEMGIVGKSGSW
FSYQDTKLGQGRDAVKQLLKDNPELLEEIENKIKEKL
>EGEFANNL_01029 hypothetical protein
MIGSISISKIEVKVIRELLMRFIMDMILITKEIIR
>EGEFANNL_01030 Putative peroxiredoxin bcp
MLEIGDKVPDFVGIDQEGKQIKYSDYQGKKLVVYFYPKANTPGCTAESCSLRDNYQALQA
KGYEIIGISADPVEKQKSFHEKFSFPFPLIADTDKKIIQAFGAWGKKKIMGREYDGILRY
TFLIDEEGQIKDVITKVKTKEHAEQILKAI
>EGEFANNL_01031 Copper resistance protein A
MKIIEKLVLINFILISITNIKAQKIVKYDLYVTDTITHIGGKKKKALAVNGQIPMPTLHF
TEGDTAVISVHNKLKNKETLMHWHGLLLPNQYDGVDHLTSPPIKAGETMVYKFPIIQNGT
YWYHSHTGLQEQDGLYGAFIIDKKDKIDNLPEYTVLLSDWTNSRSKGVLRRLYFHDDWAA
IQKNKVQKGVTQSYSEAIAQGYLGTKLKNEWKRMTAMDVSDVYYDQVHINGKEEDFFKEY
KGNKVKLRIINGGSSSYFWVQYSGGKMQVIAADGKDVHPVEVDRFIIGNGETYDVIIEIP
EVDTSYELLATTEDRIRTASLWIGNGNHKQSMKRLEPLKYFEGMKMMNDMMKMNGNLDNM
GMKMSYQTMDMNQVMYPEIQNLKHHDPSMHMKEKEVSKENQDMHKEEDHSSHMNMPESSH
NGQHDHQSHMHMKKDFEEQSPKDQGQYSSITTMTEHEHISHSMSIDKLEKNNSQNPVTLN
YSMLKSTEPTNLKEGPVREMYLELNGNMERYVWSFNNRNLSETDKIVVKKGEKLRITFVN
NSMMRHPLHLHGHFFRILNGQGEYSPLKHTMDIMPMEKNVIEFEADETGDWIFHCHILYH
MMSGMGRVFSTQDSTQVSRSHGGEHDWKMFSKMMGNMERLAVMNEISNKGNTGKLRIENS
RWALLQAEWKLAYKDNPGYEVEARVGRYIGKMQWFMPYIGYSFSYTTAGREKNIFGQKYN
KETINNLAIGFRYLLPMRVLLDASVSPVNGEFKIKLEKEDIVLTPRTRLDLSLDSHLGFT
TRARYIISKNFSIAAYYDSEWKWGAGLAFRY
>EGEFANNL_01032 hypothetical protein
MIGKKIIVILITIGVLFQTPHLLAHGIHGLNKNFSNNSKTHSCCRDKCNHHNKQNCKETK
NKKNCCDILCAPSFIKLQLFFNEPSIEKYNLNKTYLPLIKFNTFFTYQSYTSVNWVPPQF
I
>EGEFANNL_01033 hypothetical protein
MDSIKTFKSRGKLLLTGEYAVLDGALALAVPTQVGQTLQIHPVTKGNNQITWLAYKHNGE
LWFNCILDIYTEQVVKTNQPDIALKLLKIFLEVKKLGSKTFQENSSFECETHLEFPENWG
LGTSSTLINNIAKWTKVDPYKLLSQTFGGSGYDIACANAENPITYRLQKEKEPMVRDVYF
PSEISDRIIFVYLNNKQNSREGIQHYRQKEKSQALVEAISEITEQIITSKITFEEFAYQI
IQHENYISKFIEIPTIKEKLFSDYPGFIKSLGAWGGDFIMAEKTDNSEQYFRGKGYKVVK
NYDELLI
>EGEFANNL_01034 Putative esterase
MNSSIFQLEMKVRDYECDAQGIVNNANYQHYYEVARHEFLEKEGLNFYELHTQGTDLVLI
SIFVKYITSLQGGNQFICTIESLEKQGIRYFFNQKIIRKSDLKLCSEARAEVVSVVKGKV
SIPKILDDSFSKYL
>EGEFANNL_01035 hypothetical protein
MIKIKLLLLVASLLITSLIYSQREEQAIDISINKSSDPAKIDTLKNLNPTIYSYQYWTED
TPKSIFDTVLTIDKYYKNRMYNHKDDFGTIPFSNIGEAFNPLLYNTKINSSISLIPQGKS
YNLLDVDQVRYYDVKTPMTEFQYNNGYKQGHSLSTMFTHNINSQFNYSIQYKGLRSEGKY
LDQLASNNTFLVTTNYHTKNLRYKFWAHYLITNANNEENGGIQNPKNFEDGDSRFTSRNR
LQVNLTDAYSKYEQRRFYLAQQFGLVPSKENTYVASIKNIFSYETMHYTYEELKTLNTYY
SSVENMYGGSNLVEHYNTKEFRKFSNQTMAVLDLSDRLYLEAGVKYEHLEFNFDRLMDPA
TTTIPEKIKDDRIGVAGNLTFNWNKGIVLTSQGEALTGNQFNNSYYIDNRLTLQPFKGYF
IEANLGVKSQIPSINVLYNQSFYKQFNYFIENPENETTIQMGGALRMKPFNTRFTVQFFN
IDNYTYLDDEYAPKQSGTSVNLAQIGLKNSFQYKKFHLETALAYQNVTRNKEILPLPEFI
GRATLYYQSKIFKEKAEVQAGMNAYYFSKFKSRMFFPVTNEFKLQSETENYRIGEYPLLD
LFIHFKVKRMLFIIEAQHFNSSLSGYDFYSTPLNPYTDFRLNIGILWYLFT
>EGEFANNL_01036 Subtilisin BPN'
MNKYILLFTLLFVYTYSFSQTEKDRSSITNSYDQKEIEKVKSELKRKEQIRQEILDKYLN
KNSRRVMSDSLEETGLPISINDNGEIIYLKTFNEGSAKTINERTLISELAVDGKNMYAGV
WDEALPRTTHQDFKNAQGEVRIEKGSDNVQKVSKHSTHVTGTIIGGGYSPAADNLPQGYS
KGMAPNAHVKSFDYSNDLSEMTEFAQKGYLVSNHSYGISALNAKGRPVFELNSWVFGAYD
FTSYKLDQLAYLNKYYQMVIAAGNDRENYLKINPEKDGYELILNYGVAKNVLTIGAVEEI
INYNDPKNVKISTFSNFGPTDDGRIKPNIVAKGVSVYSTGNLSDNSYIFLNGTSMATPSI
TGSILLLQQYNHKLNSKYLTSASIRGLLQHSAKEAGSYDGPDYIYGWGLADIGAAAQIIT
DKNKKSILEENQLNNRSTYIKKIKASGAIPLQISISWTDPENKNYNGDILGLSTGKFIAG
VKDPDQVNLVNDLDIKVTQINNEGQVIVTYYPWRLNKFQPSLPAKNDGTNDVDNFERIDI
PNPNGEYLITISHKGNLTNNSQDYTLIVTGPSMETVETVEEEFKLQETKVYPIPSKDYVY
IYVMKNSTYKVYGTSGNLYLTGTLIEGENKIDTSSLSSGIYFVRINDGKNNETKKIIVQ
>EGEFANNL_01037 SusD-like protein
MKVKIIFISFFLVLMSCSEDKLNTEPSTEVPLDVIIKTEEGLINAKNGIYYYLARPGGLG
CNVVLLGDLISDNSFVNTSNTGRFLNLNNMSYNPELNFDGIEGEGPPLNRLYDAYALAST
VINAPISLNDEIKQAKAEAYAARALAMFFIVNIYSPSVALGYNQEFGMPIYNKSYNPQIK
HSRATIPEVYTQIENDLLQSLELFQSESSTKTHLGPTAVKLLLSRVYLYQQKWALAYEYA
QQVESQSGGSFDFIQKENYVDYFSLNSAPETVFEIGYNQSNSLGINSLSSFYSITGTYFQ
NEFRKDLYNLYEDSDIRKNLLKLDVTNKGNNPTGEEGYYTLKYPVTMNLDSNVKILRMSE
SKLNKIEALYHLGNQEEALKQLNSFVSTRGDYQYNSKDNQLLKDILKERRLEFVGEGHQF
FDLKRNRLPIVKKTNCKLNCEVSASDKLFVYPLPQIEIQTNPNIKQYPGY
>EGEFANNL_01038 TonB-dependent receptor SusC
MIKAYNKIILVLCLLLYQSVFGQIKGIIKWEDDSFAKNVEVELLNKNQITQTDNHGYFSF
TNSDKGDTLVIARGIKQIILQETDTLINISLERTKLDKIVVLGFINTPYKGAYSIIRDNE
LESMPQASIDDKLGVIPGVSYSGSGGQPGSATSVIIRGVSSFTGSSNPLYVIDGVPIGKG
LDSSSLLDSYSSFSPISNLNPNSIESIVVLKDIAAASMYGAAGANGVILIKTKKGKYNQK
TKFNFISEIGFQDIAFDKHQWMNSEQYMDWGAMVYAGKEYIGGRTDAFLNLASYKQQFIE
NMKKNGWDGETSTNWMKEVQRNKSVVKQYSLNITGGEKNFLFYLGGSYYNNEPLVKGSTF
QRYSFNLGLGYRLTEKINLNFNGSITNLNTHTYTQGGSFSSPWSSSWTLLPIYPVYNPDG
SFNIQNLGGNQWYNPVELLNSDYLEGDNTTWRSSMSVMYKLNKEIKITSDFGMQYQNLLE
KSWWNQNSGNGKSRNGLFQQNKNRVIDYSWTNFMNYKKYLFDKHDLSVDLGISFEEHKRD
DQYTSKFDYPEYSKPNLSNGTNILQSLGSDETWRQISYIGRINYTIDKKYTFIAGIRRDG
NSTFGKNNKWGNFWDTGFVWNLSNENFINVEKTKINDLKLRLNYGIAGNTPMTEWGKLYY
YKTLLKAESYGSGESALYFQSAGNDNLKWEESHQLGIGLYFGIFNNKITGSFDYYNKKTN
DLISIVPLPYTVGGANAYYANVGSIRNRGFELVLKSEVINKNKLIWNIEASASYNKSKIL
RLNIETSDGINLEGYSKALKVGKQAGEYYTWTWAGVDSNTGYGMWYVNDIELETRFKEGK
LTASEQAFVNDGKLYYDSKGKLVTTDKSIAKKEFQGSTALPIWQASLYNQLSYKGFTFSI
LLTGSFDYKVMDAFTNVWMSDGAYAGNRNQESDLLDSWTPQNPNAENPLQIGDLTSTNSM
SSRFLRRADHIRLKEVKLSYTFTQNIIKTIGVESITLFIRGTNLFTWAFDKKLKSDPDIY
STGALNEGYPDFYGRGYYDFTSPIMKIYSFGISVNF
>EGEFANNL_01039 Translation initiation factor IF-2
MSGIRLSKVLKDLNISLDRAVEYLSSQSVEIERNPNVKLDQKAHQLLVTEFSEDKLKKDA
SLDVVINKIPEKKKEEKPVVTEVVKGKAKEISKPKTLGKIDLEGQRTKYSKPVEETSEKN
HTNEANQDSSNQESEVVEEKAKSKGIKIIGKLSVDDLKKAQESTYPVKKAKEKEAKAEKL
EKVDKIEEKKEIIVPKEEVVVEKKEETDEPEKLETQYQKLDGPKMTGQIIDLSQFQKPKK
ASVSKDNNADKKKRKRIVKDSKVDVNAIAKTINTDKKAASQDKNKSFNNRKPIVNNGQNK
KFGNRNVNTRPVELTDEQVKNQIKETLEKLTSKGGKSKSSKFRRDKRIQRREYEAELQEK
EQRDNTLKVTEFITVNELASLMNVSPTEVISACFSLGVMVTMNQRLDADTLVLVADEFGY
KIEFTDTEIDAAAVEEEIDLEETLEARAPIVTVMGHVDHGKTSLLDYIRKTNVIAGESGG
ITQHIGAYNVKLANGEKITFLDTPGHEAFTAMRARGAQVTDLAIIVVAADDNVMPQTKEA
ISHAQAAGVPMIFAINKIDKPNSNPDKIKEELSQMNLLVEDWGGNIQSQEISAKFGNNVD
VLLEKVLLEAEILDLKANPNRVANGVVIEAALDKGRGYVSTILVQKGTLRVGDYLLAGKN
HGKVRAMLDERGKPMKEAGPSTPVTILGLDGAPTAGDKFKVFEDEREAKQIANKREQLMR
EQSIRTQKHITLDEIGRRIALGDFKELNIILKGDVDGSVEALTDSLQKLSNDQIQINIIH
KAVGQITESDVLLAAASDAILIGFNVRPNISARDLAEKEEIEIRSYSIIYDVINDIKEAM
EGMLSPEIKEQIIGNVEIRETFKISKVGTIAGCMVLDGKINRGSKIRIIREGIVIHTGEL
ESLKRFKDDVKEVTKGYECGLNIKNYNDIQIGDLLEVFEEIEVKKKLKI
>EGEFANNL_01040 Transcription termination/antitermination protein NusA
MDSIELIESFGDFKDEKNIDRITLMAIVEESMKTVLRKRYGSDEHFDVIVNPDKGDLEIY
LNRKIVEDEMSEDDLLEIEISEVRKIDPSFEVGEEYTQKIELNELGRRNILAFKQVLNTK
IAEYDNSNLYEKFRSIEGEIVSGEVHHIRHRQVILMDEDQNDMILPKENQIPSDFFRKGE
TVRAVVQEVGLKGGKPQIVLSRTSPKFLEKLFEFEIPEIYDGLITIKKTVRIPGEKAKIA
VESYDDRIDPVGACVGMKGSRIHSVVRELKNENIDVINYTTNQQLFIQRALSPAKISSMD
IDEENKNVVVYLRSEEVSKAIGKGGQNIKLASWLTGYEIDVRRDEPEEDIELVEFSDEID
SWVIDELRKIGLDTARSVLEKDLEDLLKITDLEEETILDVVRILKEEFAK
>EGEFANNL_01041 Ribosome maturation factor RimP
MFLKDKVESLIEKFLQERTDIFLISCKISADNKIEVIIDGDEGISIQDCLQCSRAIENNL
DREEEDFALSVYSAGVTNPLILPRQYKKNLGRELKVFLEGGKEINGVLEQVKDDKITLTW
KERIPKEKGKGKVTVELREEIEIQNIQKATINIKI
>EGEFANNL_01042 CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase
MIKQLPNFLTLLNLLCGSLACIFTITNSAIEYILILLLFSLIFDFFDGFVARAVNASGSL
GKELDSLADVISFGLLPGILMFNLLDGDVFLSTIKGLTTLDFNFNSFYFLIDSLFIKNAS
IIGLIITLASAYRLAKFNLDEDQTFYFKGLPTPANTLFIFSLYWLIHKNPESFWSNTYLL
IFISIFSSVILVSNLPLFALKFKNLKWNDNYLVFSYVICSILLFIFFNLSSIPFLIILYI
LLSILFRKKIISNEP
>EGEFANNL_01043 DNA polymerase III PolC-type
MNLKLHKPLCFFDLETTGVSISKDRIVEISILKVNPNHSEESKTWRINPQIPIPKACSLI
HGIYDKDVADAPIFKDIAPHILEMIKDSDLAGYNSNRFDIPLLAEELLRNGFEFDIHKHR
PIDVQVIFHKMEQRTLSAAYKFYCNKELINAHTAAADTLATYEVLKAQVEKYDAIDNDVK
FLHAFTTQNKYADLAGFIGLDKNDEEIFNFGKYKGKKLTEVFLTDVGYYSWLMNADFPLY
SKKIFTKVKLKNAL
>EGEFANNL_01044 hypothetical protein
MDILTYSNLLKNIGIYDISDVYFAQMEKNGAITAFTNNFDNYAVLLVIEGKINFSYLDGI
GKDEDWLKDALKKEGYDNIEKIFIAQWSPEKFLIIPNSKEHKVKLV
>EGEFANNL_01045 hypothetical protein
MYCVDYLQQNLNFKENLQIGFKLVVALFAVLIYIKIIGRTILNHVSGLDLVQNIILGGLA
GGIIYNPNVSILKFAFVLFIWTFIISFVAYVCRKNGKLRRLFEGQIIPLVRKGKMNE
>EGEFANNL_01046 Ureidoglycolate lyase
MKFICVGRNYADHAKELNNEIPKDVVLFLKPDTALIKSKDEVYIPEFTNNLHHEVEILIK
ICKTGKYIQPEFSENYYTEIGLGIDFTARDIQEELKIKGLPWEKAKAFDGSAFISNFVSK
ENFDLENLEFSLIKNGILQQVGNTSNMIFSINKLVSYISQFFTLKVGDIIFTGTPAGVSK
VKGNDILEGYIKNDKFFEVKII
>EGEFANNL_01047 hypothetical protein
MKNLQNLTNQELKEINGGGLAADLANNVQGIVSNAIDKNWSDMAKSIVETSTTGLKLVGS
FFGKFFGR
>EGEFANNL_01048 Lactococcin-G-processing and transport ATP-binding protein LagD
MRKLKVKQHDLRDCGAACLASIGAYYNINLPIARIRQYASTDKKGTNVLGLIQAAEKMGL
TAKGVKGNLDAISQIPLPAIAHVILGEKQLLHYVVIYKVAKNFIEVMDPLDGEMTRYSYS
DFEKIWSGVIVLFSPNENFKESNEKISNFKRFWNLVQPHRSILIQCLFGAIIYTVLGLST
SIFIEKITDYVLVDHNKNLLHLLGVCMLVILVVQVYIGTQKNFFVLKTGQLIDAQLILNY
YKHLLRLPQRFFDTMRIGEIISRVNDALKIRVFINDVAIDFIVNIFIVVFSFILMFAYYW
KLALIVTLVIPLYITIYLIINKLNKKIERRVMEDGADLETQLVESVNNVRTIKEFGIEDY
TNKKIEYSFIKLLFSNYKSGLNTIFSGTSSQFIASLFTVILLWIGSLFVIENKITPGELF
SFYALIGYFTSPIASLVSMNKTIQNALIASDRLFEIMDLEREKTDNKFEIKLEDLGDIRF
ENVYFSYGTRTDVFKGFNAVFKKNKTTAVVGESGSGKTTLISLLQNIYPIQKGKIYIGNY
DLNYISYQSLRNIMGVIPQQLSLFSGDIIENIALGCDEPDMHRIIDLSQKLGISDFVEKL
PQGFQSPVGENGTMLSGGQKQRIAIARALYKEPQILLLDEATSALDTHSERIVQNVINDF
KTQNKTVIVIAHRLSTISNADEIFVMDNGLIVEQGDHHSLLSLKGKYFKLWKDQIS
>EGEFANNL_01049 Leukotoxin export protein LtxD
MSKYSNIKYTIENLYYKNKVKNFNIYTLVIVVLLVFFILLPIIKVDISTQSRGLVRTESE
NVPISSVVSGRILFINISNNKNVKIGDTLLVLQASTLEAERQSNISIQGDLNLVLEDLDN
LCKGHVGSLKTSEIQKEYQSYLQKKQEATANLVLAKKSYARNKKLYQEGVISASEFEKYE
YELKSAETYLKNLEQQQYALWQTHRREILQQIKSYQGSINQINASKDNYILTSPINGSIM
NFIGIQKGSFLNDSQIIAEISAQDGLKVEMYVSANDIGLIQKGQKVNFQIDAYNYNQWGM
ARGNVMDIDQNITLRSDGSSYFKVWCNLDKDYLTLKNGYKGEIKKGMTLTGRFIINRRSL
WNLLYDKVDNWLNPKIIN
>EGEFANNL_01050 5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase
MQTHNLGYPRIGSDRELKKACESYWAGKISINDLVKVGKTIRNQNWETQKNLGMDWIPSN
DFSFYDHVLDTSLMLGAIPKRYNKILENQSNSELDLYFAMARGVQKDGIDVRAMEMTKWF
NTNYHYIVPEFEENQKFSFFSTKIVDEFLEAKNAGINAKPVIIGPVSYLLLGKEVDKSFN
KIDLIKNLLPVYIEILNKLKEAGVEWIQFDEPFLVMDLEPKAKEALRYVYNEIDKQFPSI
KKMIATYFGSIGDNLELAYSLPVQALHIDCVHGFKQLDGALELAPKEMILSLGVVDGRNI
WKNDFDKSLDVIQKAVTKIGEDKIFIAPSCSLIHTPVDLDLETDEKTLTPEIKDWLSFAK
QKVEEIATIKALAIGSKDSEILDKKQRNSNSIKNRKESALTHNKEVRQRMEQLQSISDKR
ISAFSERKKKQLEALQLPLYATTTIGSFPQTKEVRSWRSKNKKGIISDSEYQKLLEEETQ
RAIRIQEEIGLDVLVHGEFERNDMVEYFGEQLEGITFSKKGWVQSYGSRCVKPPIIFGDV
YRPEPMTVEWTSYAQSLTDKPVKGMLTGPVTILQWSFVRDDQPRRDTCYQIALAIRDEVH
DLEEAGINLIQIDEPAIREGLPLRKNDWQDYLQWAIKAFRISSCGVKDETQIHTHMCYSE
FNDMIQEIADMDADVITIECSRSNMDLLEVFSKFKYPNDIGPGVYDIHSPRVPTQEEMVF
LLKKAKESIPVEQLWVNPDCGLKTRGWDETKKALEYMVAAALQMRQEV
>EGEFANNL_01051 Fructose-bisphosphate aldolase class 2
MSRKFPAGVATGSLVKEIFDYAKEKQFALPACNVIGSSNINAALETAVRVNAPIIIQFSN
GGAQFNAGKGYKNSNLRSDVLGAIAGAKHIHTLAEAYGATVILHTDHCAKKLLPWIDGLL
EANEDFYKKEGKTLYSSHMLDLSEESLEENLAISSKYFERMAKIGMTLEVEIGITGGEED
GVDNSDVDSSKLYTQPEDVYKTYQALNAISPNFTIAAAFGNVHGVYKPGNVKLEPKILHN
SQEYVQKQIGGSDKPINFVFHGGSGSSLLEIREAISYGVIKMNIDTDLQFAYLEGVRDYV
ENNIEYLKSQVGNPTGEDSPNKKFYDPRVWVRKSEESFSKRLEKAFEDLNNINTL
>EGEFANNL_01052 Ribosomal RNA small subunit methyltransferase E
MRLFIGNITPEYVILNQEEEHHIIKVLRMNDGEEIYVTDGLGSLVRGKISIMGKKISINV
LEIIKTKQTEIDNKGLHIAIAPTKNIDRFDFFLEKSIELGISTITPVLCANSERKHLNYE
KVLKQAYGACKQCLRTVFPIINPLTNLQDFLKNSAENIYVAHCYNEFEKKSINQVLKNRK
DLTILIGPEGDFSKKEIEHLYSYGATGISLGENRLRTETAGIFVTSCYYYSNFD
>EGEFANNL_01053 FeS cluster assembly protein SufB
MSRDKYTEEELRIDLETKEYQHGWETNLEYEDFPTGLNEDIIKEISKRKNEPEWMLEWRL
ESFKIWKQMSIVNWANVSFEEPDFNAIKYYAAPKNKKEISSLDEVDPELLKTFEKLGISL
NEQKRLTGVAVDAVIDSISVKTTFSETLAEKGIIFCSISEAIQKHPDLVKKYLGKVVPRT
DNFYAALNSAVFSDGSFCYIPKGIRCPMELSTYFRINQSGTGQFERTLLIADEGSYVSYL
EGCTAPQRDENQLHAAVVELIALDGAEIKYSTVQNWYPGDKEGKGGVYNFVTKRAVCEKD
AKVSWTQVETGSSITWKYPSCILKGDNSVGEFYSIAVTNNYQQADTGTKMIHIGKNTKST
IISKGISAGKSQNSYRGLVKVMPGANNARNFSQCDSLLMGNQCGAHTFPYIEIKNETAQL
EHEATTSKIGEDQIFYCNQRGLDTETAIALIVNGFGREVLDKLPMEFAVEAKKLLEISLE
GSVG
>EGEFANNL_01054 hypothetical protein
MVNHKLRNSLIIKTVGVEFLDQHNELLRYVFQVTNKILEDSGYEEGEIIRTKRPILERAD
VIGWFNKDQLISQISIYPCKVNIHGKTYKMGGLTGVGTYPEYANLGLMNDLIKVGLENMK
SKGQTISYLYPYSVPYYKRKGWEIMSDHLTYVIKDSQLPKPVDLPGYVERLPVNHKDIII
TYNQFAKTNHGALIRGSFEWEEYWRWENEEERHAAVYYDQQSQPKGYVLYWISGDVFNIK
EMIYLNMESQKGLWNFISAHYSMVNTVKGNIYKNDPLAFLMEDSQITQTIRPYFMARIVD
VKAFLLKYPFQYSSTQPFHFKITDPLAEWNNGIFGIRWVNKDKFQVLNDPIGDSVEVDIR
TLTAMLMSYRSPSYFYKIERLKTTLDTLRILEDIIPEEQPYFSDYF
>EGEFANNL_01055 hypothetical protein
MPKIKIFIMKKILLSLSLVGLIAFNSCKDEKTTTGNENKTDTTAIIDSSANNTQTEAPTT
EATSAELPKFEDKEVQEFVDSYSKFIKENEALLKDSTKIAEMKPKLEEWAQKSLPIFTKL
ANNPEELKKFTEYFEKTSK
>EGEFANNL_01056 hypothetical protein
MKNSLFYAKILLFGEYGIIENSRGLTLPYNAYKGTLQFSSSLSESQLKSNKSLYNFLIYL
KKIELPSRFKLNLKSLEKDIDNGMFFDSNIPQGYGVGSSGALVAAIFDKYSGHKVSPDTI
SKNDLKDLKIIFGKMESFFHGKSSGIDPLICYMNIPLLIQPDAEVDKAKISENNEGKGAV
FLINSGIPGETEPMVKIFFEKLKNDGFRKTLKEEFIKYNNECIDSFLNKDMKSFFKSLKH
LSSWALNNFTPMIPSDFLKIWEKGISSNTYYLKLCGSGGGGYILGFTEDYETTQELLKDY
NKEIVYRF
>EGEFANNL_01057 hypothetical protein
MNYLDKNIWLFNLSLLLRVRIVNIVMLFCSMYISAIFLFGENKGVIENLKSIKLHGIIFS
SILSAMAGYIINFFYDQDKDKIYRPITTKLQRFIKQSTALRIYILLNSISLIIAALLSYR
IFIFFLFYQFIIWLYSHKFSKIVFINNFINSILMLFPFLALFLFYENFSKHILYLAIFLF
LLMLIKDICKDLDSYKFDNIFNYHTLPNTIGVFYTKAILDILLVFLSLTSIFLAFQKYLY
EIRLYYLLTAFLCLNSGIFIWFIKTSKINSLILMIKFWIFLGTISLLFINGNPLPLHILE
>EGEFANNL_01058 Ribosomal large subunit pseudouridine synthase B
MNNNKSPNRRGAGRNEKSFKKSFQNESNKKPSPSKFNKDLKDKKKFNTSPSFLRKKNTKP
IEKKEGIRLNKYIANSGICSRREADLFIQNGVVKVNGKIITEFGYQVMPGDEVFFDGRYI
RPEKNVYVLLNKPKSYISTTKDEKARKTVMDLVANASPYRLYPVGRLDRQTTGVLLLTND
GDLTKKLTHPSHEVKKIYHVTLNKKVSVSDFDQLLEGIRFEEGIAKVDKVSYIEGSPKNE
VGVEIHIGWNRIVRRMFEKLGYEVEKLDRVMFAGLTKKNLKRGYWRILTELEVNNLKML
>EGEFANNL_01059 hypothetical protein
MKLNLLSRYRTQLMGVAILWVMFFHSHLPTEFSGILDFFKKMGYGGVDIFILVSGFGVYY
SISKDGSTKNFYFRRAIRILPYYLPIVLIVTIIANIAGFWKPIAFFYNLTTLGFWLNVGL
MNIYDWFIPALISIYLFTPLFYKFFKINKTISTLVVILGAYIFSYLSVGTFDYLYNFTFR
IPLYVMGFWLADYLKNHKDYKLSKNMISLITVIFIFGILLLCYLYYFTSVFSIYGNYLLP
FIFITLPLCVYLCYIFSLFPNYKFPILTFLGSHSLTLFIFHEKILFYCSLFIKTILSDII
AFIVTVILAYYWQKFVDRIIERYMLKKNKQTI
>EGEFANNL_01060 Endolytic murein transglycosylase
MNKKKIIPLFYLILIIIAFLIGKTYYKNSYSSNVKNDALLYIPTNATFEDVKVLINPYLK
NIQSFENKAISSDYPNKIKAGRFKIEKGETNKEVINRLLLGKQEEVHLRIRNYDDIYELA
SDLGKNLEADSIIFLNYFKKEALEKGFPDVEELKIYFTPETYFVNWNTSPEKLFARFEKN
HNNFWTEERLNKAKKLNLSKLEVYTLASIVQREYMKKEELPIISSLYLNRLNKGMKLQSD
PTVIYAERKKQGFKVMMKRVKNISIDSPYNTYKYKGLPPLPICIPNDIVVDAVLNPANTN
YLFMCAIKNTGMHAFTADDKEHMLNAKKYRQWLDSIGIK
>EGEFANNL_01061 Shikimate dehydrogenase (NADP(+))
MKLGLLGKNISYSFSQKYFNDKFKVLGLKDYSYEIFDIQDKDSLEQLFTIPKLNGFNVTI
PYKQDIVEYLDELSPEANKIGAVNTVLIAQGKKIGFNTDAIGFKNSLSPLLEPHHHSALI
LGSGGASKAVSYVLNQLGIKSKIISRNGENNYSKLNENMVFYHPLIINTTPLGTFPNIDH
IPPFPTKFLTPNHLVYDLIYNPEETKLLQLAKEKGAKTKNGLEMLHLQAEAAWDIWNSMF
>EGEFANNL_01062 putative oxidoreductase
MIQTVLITGASSGIGLATARKFAECGINLVLCGRRKEKLEELKKELKEKVEVTLLSFDVS
NRKEVFTAIESLTEECKQNINILVNNAGNAHGLDTFQDASLDDFDSMINSNIKGILNVTK
ALLPYLIKNKSGHIVNLSSIAGKETYPKGSVYCATKHAVESISKGMRMDLLPLGIKVTNI
APGAVETEFSLVRFKGDKNKADAVYTGFEPLVADDIADAIYYAISRPDHVQIADMTILPR
AQASGTVFNKK
>EGEFANNL_01063 Endonuclease YhcR
MIIVTFALFFVPLSCVHDDDYQSPIINYPNLTANYTIPQLKAEATETSTLLHKDSIIEGF
VVSSDEGGNIYKNLYITTSDGKSGIQLNINQSNIYNYYPAGRKVYVKLKGLYLAKQYDIA
QLGGEKYGSSIVGQAEWNSAKSLILLAEDKVDEETLVQHYTNIENAIKNENLATLIELDS
VQFQEKYLNKTYYDSDNTSGSYIEDKQGNILNVRVSSYAKFANNILPSGSGRIKGILTKY
KSTWQLMLRTIQDVNLDQSRWNKEEEKGDTEGTKENPFTISQAMNNQGQTGKWVKGYIVG
SVTGQSIVEGAQFNAPFTTQSNILIAASPNETDYTKCIPVQLPYDATGVNTVRPNLNLAT
NPVNFKREVMVYGDLTTYFNQAGIKNTSDYVLGKEDNSSNTLPEDGEENSQTSNILVFPG
GDFEDYNAFIRSLNSFGIKPYANLSNQTGINNSNSLHLKTDGTSANEYVFTVLAQKKLLQ
QPKKIQFYIKGKSDKTISISLFKTDQISYYAFNLGDVSEDKVITASSNNSYSGIIDTNGQ
WALITLDISGLSDLNLNQLSNNFFGLKVGKLASYNIFMDEFRIY
>EGEFANNL_01064 hypothetical protein
MKLTLKFLFTVIIGQHLLSQTTVSGYIKDTNQNPIGWAIVSLEKDLNNTITTDPKGYFEF
QNVTQGEFTIVISKEGFMPQVINLSIIPSEDIKNLGDITLEYQPLEAENLISLTDEELTT
DDGGSLGQVGIGLLQSSRDVFSRVAAYELGAYWFNIRGTDNRYNNIMIDGVPMAKNHSGR
PDFSNWGGLNNSFRYTHELAETNNVSDYSFSNLGGTAYYDTRASSYRKGLNLSYSLTNKT
YQHRLMVSYATGMLPSGWAFAFNASRRWIEEGVIDGTFNDSYAYFVSVEKKISENHRLNF
TTFGTPTRRSGASPNTQEVYDLRGKNYNSYWGWQEGQRRNERIKKMFEPVFMLTHDWNIN
KNTKITTTASYQTGYQKSSRLNWYNSTNPSPTYYRNLPSYIQYLIAKANGSPTESLEAAY
QEILNRWQEIDTSITQINWGSLYEANYNAPFVTYLYSGEQGRRASYFLVNDVIKDRTFNA
SAHLQTQFADHWKFYINLNYQNLVSDNYREVEDLLGADFALNRSSFLQGDAGDYNILKPN
SIAKEGDKLEYNYKLHKQAVTANATTRLYVDHWNLAASLLLGWNESYRNGIFQNGLYADN
SYGRSSKENFIDVGLRGGITYKIDGRNFIILNSGYFLVSPTLNEIFANPRLNNMVTPDLT
NQKVGTSDITYTLRSPKIKLRATAYYTRIKDAVEISRFYAQGLDLSQYLPSQGSVSQDAT
SSNVFLSEILTGVDKEYMGTELGLELKISPTITTFAVASVGQYVYKNNPNLKILTDNYEG
MPDLGSANIKNYKIVGSPQKGYSLGFRYNSPKYWWIGVSGNLLQDIYSDISALSRTENFI
INPESQQPYANATNQSVKSLLKQKKYEDAWVFNANIGKSFRIGKCYMEVSLSVNNIFNER
GLVSGSFEQGRYANYEQLSFDHSLTTPLFGDKLFYDRGRSYFVNISFKL
>EGEFANNL_01065 hypothetical protein
MKFHTFYIFIILLVFIPKRINAQNNYKSATIMFYNVENLYDTIKSADVINGKLSPEDSLY
QISIPEDSALASGLKIYRGELSFDKLKGKHVIRKQILTNEFYYKGTKVWNSKKYNEKIGN
LTKVISETGREETKSMPSIIGLAEIENEHVLQDLCESLGKKGTKYNYAHFNSFDARGVDV
GLLYNEKRFTLIHKKRIVIDLPPENGYKNYTRDILLVEGLLDGEKVYFLVNHWPSRRGGE
QKSLPKRIRAAEIMKTAMDSILNIHPNAKILAMGDFNDDPTSPSIKKILNTVYKKDQVKS
GTFFNPAEKLFKKGMGTLAYNDSFNFFDQQIMSPGFINNTSEGYTYYKTMVFSPFYLISQ
EGTWKGYPFRSFSGDNYTGGYSDHFPIYTILVKKIKTND
>EGEFANNL_01066 hypothetical protein
MKIQIKEVTNIKDLKKFISFPLHLYKNCPNYVPSLIKEELEVLDKNKNPVFEHAQATYYL
AYKEGKIVGRIAAIINTYEVEKLHKKKVRFGWFDVIDDIAVTQALIEKVKAVGLENNLHY
MEGPVGFSNMEKAGLLTEGFDRLSTMITLYNHSYYKNHLESLGFKEEKVWVENFFKVPEE
LPEKVTRFSKLLQENKNFKPLRFSNKKEMEPFVRPMFNLLIETYSALESFVPFSEKQINF
YTQKYLQILNPNFVTCILDENQEICAFAVTSPSYAKGLQKSRGKLFPWGWYHLLKASKNF
DTAEYILIGVHPKYQKKGITAIIFTEIFHTLKKYNIRFVETNPQLVDNLNVQLLWSDYNP
ITHKKRKTYIKTIC
>EGEFANNL_01067 Lipoprotein-releasing system ATP-binding protein LolD
MKALLVKNINKYFYEPKKFQVLKNVNLEVEKGEFLSIIGKSGSGKSTLLYLLSTMDTEYE
GEIYINETKVTGLSQNKLSDFRNKHIGFVFQFHYLLPEFSVLDNVMIPALKLNLKSKEEI
KERAIELLQMLDIKENETKLASKLSGGQQQRVAIARALINEPTIIMGDEPTGNLDSKNTE
IVFDIFQKLANKGQTIITVTHDDEFAAKCNRIIEFSDGEIIN
>EGEFANNL_01068 Macrolide export ATP-binding/permease protein MacB
MGVNKKISWVHLTSKIRQLLVATLSVTFGISVYIFMNGFMTGVNDSQSEITFSSIPHIRV
YNDISPDLPVLLPEKEDHQIVMVSNNKNISYTEGIKNAVPIIENISKIQEVAGVTQQINE
NVFIKNGVTQNNANLSGVEVQNEDLLFKTSHYMISGDFYDLNKRSDGIILGSKLAQNLGV
RTGNNVTVITSGGVSKAFKVIGIIETGSSNADKTRAIVSINQTRQLFSKNKNYATDVYIN
LKDYNQATKLSEKIKNYTQYKVESWQESNPQLESANKVRGSIGTAMSLTILIVAGFGIYN
IMNMTVNEKIKEIAILKAIGFNGKDIVQIFLTQSIAIGMIGGILGMILGYTISIIVHSIP
FKIATYDTLPVDFSLITYIKGFVFGLLVSAIAGYMPARKAAKVDPVSILRS
>EGEFANNL_01069 Macrolide export protein MacA
MKFIINYKIVVISCLLFLACSKRETTAPERKNLQEAVFGNGYIKQEDEYTISSTINGLIT
EVNIKEGDLITPQNLLVRIKSDVPNVQLQDAYVVNNDAIRNTANNSPQILQIQAQINQAR
QQLILDQNNYDRYKKLKQTNSVSQLDLEKAESQYIASKENLRALEESLAQIKNQLNLAAQ
RSKIQIENHKAQLEDYNVIGEKEGQVIEVYKKKGELVKIGDPIAKIGSGKYLIRLYISED
DITQIEVGQKLVVNLNTYPNHGFSASISKIYPGFNKDEQSYIVEAEFDKLPEKLFSGTQL
QANIKVGERKNVLVIPTDYLVKGRFVTLKDGTEKAVLIGKQNKDWTEILSGITEKDIITK
KK
>EGEFANNL_01070 hypothetical protein
MKKRIFFLPICIFLGIHTIGQVQFKSLKEVFNYADANAYEIKDAEIQQNITKSKKIQSQS
SLYPNISFGSGYNDNLTLMSTLIPAKIFNPNASEGTFEKMTFGKQHTYNIGLQAQWDILN
FQKIFAAKAAGIQEESSLIQTEKIRYNLYNQLASTYYSILLAQKSIDIYNKNVEVSTKLL
GNAKEKFNKGLISELELNKAKIQQLQNFKNLQNAKDNLQQLQVQLQSQLNLGEDIDINGD
IEEALINNTDITTENPEILWQKTQIKAFEYNVKQGKALYYPLLSLQYQYTYNWATDGFLN
FSNVSHLPSQVLGFKLSVPLFTGFNNKQSLNEMKLQLQQQKMKLDNLQLVKSKEDENFKL
QYEQALNNLNRDKEILDLQEKNDLHYERRYENGIISLDDRLDKYNDLLTAQFNYLNSLAD
YSIAQYQVFIRQMNYQLLDFNNIEP
>EGEFANNL_01071 Zinc-transporting ATPase
MSKACCNTQIYSHKTQLKFLKSFLPAIVSLLILIVGSILNSSDQSWFKGWIKFAYYIVAY
IPVGFPVIKEAWESIKKGQFFSEFLLMSIATLGAFAIGEYPEGVTVMLFYSVGEALQDLA
VSKAKNNIKSLLDQRPDSVTVVEKENLHVIPAKEVKAGSIIQLKPGEKLALDGQLLSEKA
LLDTSSLTGESAPQIKYKLDSVFAGMINLNTVIQVCVTSTYDHTKLSKILELVQSATSKK
APTELFIRKFAKIYTPMVVFLAISICFLPIFFTSDYQFKEWLYKALIFLVISCPCALVIS
IPLGYFGGIGAASRHGILFKGSSYLDKIAGIQNIVLDKTGTITEGSFKVQEVNINPKFNL
SKIIQYVNAIENLSTHPIATAIKEYAGEVNMGISVQKVEEFPGMGIKAEIEEAEILVGNF
KLLDKFNIYYDAENLNLRNTIIAIAYKNEFVGYISISDQIKADAAQTIKELIHLGIKVTM
LSGDKSSVVKEVANALNIEEAYGNLYPEEKVKKLEEIINFKESVAFVGDGVNDAPALALS
DVGIAMGGLGSDAAIEIADVVIQDDKPSKIPVAIKIGKKTKQIVWQNIILAFTIKIAVLI
LGAGGFANMWEAIFADVGVALLAIANAIRIQRMNF
>EGEFANNL_01072 hypothetical protein
MDKAKIEDKLNYKNVKPTNMRILVYNFLKNKKVALSLTEIENYFEYADRITIYRTLKTFE
EKGLVHSIQENNTSKYILCKEDCDEQLHNDWHLHLSCKICGETTCREEVVIPEILNVKFR
IEEIHFSAKGICERCLQELQ
>EGEFANNL_01074 hypothetical protein
MKENIITDTVLMIEPMAFGFNKQTAIDNLFQKNDSVSPKIIQEHASKEFNGMVNELIKSG
IEVIQIKDTHEPHTPDSIFPNNWVSFHSDGTIVLYPMYAENRRDERREDILKSIENKGFY
INQIIDYTQAEKENLYLEGTGSMVLDRENKIAYASLSERTNEFLFLEFCEEMRYTPITFH
ALQEIGDKKFPIYHTNVMMGVCKGFCLICLETIHNEEEKRKVVNSLKSTGKEIIPISIHQ
MKQFLGNHLQLKSKIDGTRYLVVSQTAYQSITQEQLKKIKNYTEIIVCNIPTIEKYGGGG
VRCMLAEIFLPKAIDKDCKFFA
>EGEFANNL_01075 Arginine deiminase
MQLNITNETSLLQTVVIGQPYSIGKQPKLDEAYDAKSYQSIKDKIYPSESKIVNEMLCLE
KILKKYGVEVLQPKILKEYNQVFARDVAFVIDDKIVISNMIADREEEQEAYEEIFKSINF
KNIYNLPKKANVEGGDIVLTDEVVFCGVYKGSDFSQIKTARTNPYAIEYLKELYPNKIFK
ELQLKKNDKDPRKGVLHLDCTFMPIGKNKAILYKESFANEEDYHFLVDYFGIENIFELTE
SEVFYINSNVFSISPEVVISEEKFIRLNQFLENEWNFKVEKIPYYEISKMGGLLRCSTLP
LVRKK
>EGEFANNL_01076 Fructokinase
MEREIDTRPIVSFGEILWDIFESGKKIGGAPFNVAYHINKMGATGKMISCVGKDELGAEL
LGKVKEANISTDYCQVTQEQETGTVLAEIDENNEAHYTIKEPVAWDFIQWQDSYKELLRN
SQALVFGSLGSRNSTSKETLHKLIEIAPYKVFDVNLRPPFIFQDNILKLLEKSDLVKMNK
SELRQVLQWLGEEYTSEESAIKYIRNHFNLDGLIVTKGSKGAVYCDHKEYLFLKAVEVEI
KDTVGSGDSFLAGFLSKRAKGATVEEAMKEAVYLGAFITNHQGACPEYSIEEFEKFKQDR
EIG
>EGEFANNL_01077 HTH-type transcriptional repressor CytR
MKKASIKDVALKAEVSTALVSYVMNNKHINRISKETAERVRQAAKELNYRPNKIAQSLKS
NKTNTIALLVADISNPFASQIARIIEDETSKRGYAVLIGSSDENPEKLQQLIEVFLNRQV
DGFIIIPVINSENSIKELIKTKIPVVLIDRYFNDVQVPVITTNNYGISYQSIEYLIKTGK
KNIGILVYDVELAHLKERIKGYRRALEDRGLPFRDENIKFINEKNIQAEVEKAMDELLKS
NNNSIDAIFFTTNKLAIAGLKNIVKRDIKIPQEIAILTFDESEAFEVFNPPLTYIKQPLQ
EISKESVEILMQIIENKNLNHKPRVFNSKLMIRQST
>EGEFANNL_01078 D-xylose-proton symporter
MSQGNNKYLYWITFVAVNGGLLFGLNMAGIAGANELIKKDFNLSDSGLGTIASFLMLGCL
IGALFTGKFTDTYGRRKVMIGTALLFIISSLGCAFSTGFYSLTFFRVLSGFAVGATSVVG
PMYIAEISPAKKRGTLVSFNQFAITIGIFLAYVFDYFLINLGDNSWRYMLAIPALFGVIY
FIYLLGNFPESPRWLLANNYKDKAIKILRKTSESSDLENELREIEESIKQETSKEKIKFS
ELFKGKTGKVVLIGTLIAAFQQITGINAVLVFAPDIFKSAGVGADQALLQSMIVGLVNVL
MTIVALKLVDSKGRKTLLLWGALGMTVCLAYLTYAFSKEEKSAIAVLLALLGYISFFAAS
FAPVMWVIISEIYSNRIKGVAMSFSTAVSWGCTFLTVYFTPIIRQNFGNSFLFAIFGFFS
IVAYIFVKFYIPETKGKSLEQIEKELGLK
>EGEFANNL_01079 hypothetical protein
MKKYIIPFLMFILLTSCQTQNGAIDYDTQYNFSKIKTYDYYIDNVVQSNSIDSASIMKNL
NYVLETKGLTRNTQNPDVYIALQVSKRDETQVSNVVNLGVGGGGPWFGLGTNIGIPIRNK
VTAYFIQVSMDDANTNNLIWTGQTIENLPYGSKPETKSRFFKSSIESLFKKFPPKVRKTK
KQMKKNYYN
>EGEFANNL_01080 Inner membrane protein YjjP
MPDSPNHIKSVSLLLSDLAITLIMNGANTSRTLKNTLRISNQLGFKTDFFFSLSSVILTV
SDIKGNESHTIVRSIPHISVNFDIISEISLLSWRVVDENLSVYDIEKSLREIKEIKQYSK
IYICIFVGLAGAGLCRILGGSWLEFIFCFFATVIGLLTRILLTKKGFNIFIVFSASSFAA
VSTICAFRLIFNDSLNSALASCVLFLIPGVPLINSFIDILEGYISQGIARGILGTMLILS
IAIGLFLSLFIFGYGFN
>EGEFANNL_01081 hypothetical protein
MDLISLFTAADISTAEKIFWSMWVSIGFAVLFTTPKRSMLVVAILGGLGFSCRTFLLYIW
ENQIVFASFISACLVGILGIYCAHKVHTPPIVFTIPAIINIIPGKSGYEFMVSLIQAITL
KEGEVLQINFLMGILDKGIKTGFTLLSLAFGVVFPILIFKARSVKKTTLHSLLAKSKK
>EGEFANNL_01082 Aliphatic amidase
MRHGDISSSPDTVGIAVVNYKMPRLHDKEEIKQNCEFISQFIAGVKQGIPGLDIIVFPEY
STHGIMYDRDEMMNNATTVPGFETEIFSKACKDNNVWGVFSLTGERHEEHPKKVPYNTLI
LINNKGEIVQKYRKMMPWTPIEGWYPGNQTYVSEGPKGMKISLIICDDGNYPEIWRDCAM
KGAELIIRSQGYMYPAKRAEVNIAQCMAWCNNVYVAVANATGFDGVYTYFGHSSIIGFDG
RTLGECETEEMGIQYAQLSVSEIRDSRANDQSENHLYKLLHRGYTGTINSGEERFGEPKC
QYSFYQDWINNPEAVQKRVEDMTRSKPGVKSAPIDGIPFE
>EGEFANNL_01083 hypothetical protein
MNTFVEPRKSITNHWWVLLLLGIIFLLGGIIVLSKPAPTLIFISTFFAISFLLTGIFEIF
FSLSNTKNSSWGWYLAGGIFDLLIGIVLLRSSIITRLDILAFFIGFWILFKGVSLTGYSL
DIKKLGSNNWGWLLFFGILEIIFSLIILVVPSIGLATLLVWISVSIIFIGIYYIFLSLTL
KSI
>EGEFANNL_01084 ECF RNA polymerase sigma factor SigW
MELYDLIEKAKTSKQQAQSRLVNLFWDDVKRYIYSLVKDENNAEELTIETFTKVLQKLNL
YNIDFDFKTWILSIAHNTCIDFLRKNNKILSNFSTDNYHDIKDSDPSPEQLFINKQNIET
VQKMLNKLPEKYSILIQLRYLDEKKLNEIVNDTGLTLANVKVSLMRAKKLLFEMKDENL
>EGEFANNL_01085 hypothetical protein
MPTKAECSAIVFSEASAYGLPILTYDTGGIPNYVINGQNGYRLNLKCGGKEFAEKILEII
HLKELNKLREGSFAIYKQKLNWECWKAKFMNVINEIKESN
>EGEFANNL_01086 hypothetical protein
MGILSKIFFKNKSEHLIFYSKILAKDINHHLINEVDIIFAPSGAVNIAYLKIKKPIIYLT
D
>EGEFANNL_01087 hypothetical protein
MKILLSPAKMMSVDASSQWKKRSQPNFLDKSVELQNILKEYSPSDLENLLDISPKLSKEN
WERNQEWKSNPTKEESLQAIFAFKGEVYRGLKAETLNEKELEYLQNNLLIISGLYGLLQP
SDEVMLYRLEMGKKLKTEKANNLYMFWKEILTSYLSKQLKKEEPILNLASKEYFKVINTK
NLQNRIIEVDFKDYKNGSLKSIMMYFKNARGKMTRWCAENNIQDIEKLKVYNEDGYEFSE
DLSKENNLVFIR
>EGEFANNL_01088 FeS cluster assembly protein SufD
MNILNNTEIKNKASLAQAELKNLKFPSKKEEDWKYTKISPLNPELYVQAEKHEVDQEIIN
RNKIEGLDSFKIVYIDGVFVPEFSNYPKDKFIVLPFSEALQNEFYTNVIEDKYGKLVPNE
YFSVLNTANVKEGTFIYMPKNTVEERPVEILYINTEQNKKASQYLRNLFVVDDNSQILIT
TKIQTFSNLDFLTNLVTEVFVGKNSNFSLYKIQNDSYTTHLLDSTYIEQERDSQASIYTF
SLGGKVTRNELIFDQRGENINSILKGISLIGEGQEVGNHTLVNHNQPNCESHELYRGIYT
ENAHGIFNGKIKVDQIAQKTNAFQQNNNVLLSNKASIDTKPQLEIFADDVKCSHGCTVGQ
LDNDALFYMKQRGIHENEAKALLMFAFCADVMETVAIPQLKDIVNKIVAKKLHADIDFDF
>EGEFANNL_01089 putative ATP-dependent transporter SufC
MLSIKNLHAGIEGKEILKGINLEIKAGEVHAIMGPNGGGKSTLSNVITGREDYEVTGGSI
LFEGKELLDLAPEERANDGIFMSFQYPVEIPGVSVSNFLKASINANRKAKGLEDISAREF
LDKVKEKSELLEIKKDFLSRSLNEGFSGGEKKRNEIFQMAMLEPKLAILDETDSGLDIDA
LRIVSNGVNKLKSKDNAVLVITHYQRLLDYIIPDFVHVLMDGKIVKSGTKELALELEEKG
YDWI
>EGEFANNL_01090 Colicin I receptor
MRIKTLLTFFLSMLFFTLYYSQITDSLYIDSTNMETVVVTGQYSQQSIDKSIYQVEVISQ
EEIKNRAANTIADILNYHLNFSTSSNSKTGDSEATLFGLDNQYFKVLVDNIPLVSDHGMG
GSVDLTKINLDNVERIEIVKGSMGVDYGSNSFTGVINIITKKKVLSDWKISGYVQEESVG
TEYNLKNKGRHIQAIDLAHNISDHWMFSMNMYRNDFKGYFGDMKGKKYYENDNKRGYEWL
PKDQWNTSALINYKSNNFSAFYKLEYLNELINYYSPTTRYAPLQENGLYTYSATEKDFKT
TRFINHLFVNARIFNQINFKGDLSYQKQNRESRDYIYNIGNREIFEKKGNYQSYSKTKAW
YIRGTFNDFITNSIFNFQVGYEFNIMEGYRAANSTSVQGINISGYNEDVKKHLNNYDAFT
SGELKVSQNLSLRGGFRASFNTKFENLYSYSFLAKYNLSKNSTIRGEIATSSRTPNFDEL
YTYYVNTNHNIQGNPNLTPEKGYSTAIYWDTKINTNSGLRAKFEVSSMYLHLNDKIALAT
VSSLPLEYKYMNIDKYQSWGIQSGNNLRYENFDFHLGLSLFGVYQKMDNNINGTIISTPD
NKYLYTFQLNSNISYSIKKWDTTLSLYYKYTGQQSQYFLDANTNSYYLGKQEDYHLLDAS
VRKYILKRNVELTVGARNLFNVKTINTNSINSNASNAHGNSNISSINLFYGRSYFVKLGF
NLNL
>EGEFANNL_01091 hypothetical protein
MKNIFLLFITFLILIGCNEDNSPIEVPQPMGAILDPWVGGTTEPNQVWIDLDMQKMTVTP
RIAWDFGFYSGKEFRVILNTSISMAAGKLETTDINAVTEAHVASMKPLVAVATFQPSNIQ
YVDDIKGNYLERTAIDEISANDKDNKVYLINMGNYMYTGNSTDLKISGDSRGWKKIRILR
NGTNGYRIQYANISDTTFKEYTVNKDTAYNFNFLSLDNGPVSIQPTKNNWDLCFTVFVNE
INGSGTYIYSDFVITNTMDHVGAYQVLTSEINYEAFTKANVDPSKFIYDDQRVIGANWRT
TFGGAKTYTDRFYILKDHLGTLYKIRFLKLTNSENLRGYPQFEYDVLN
>EGEFANNL_01092 hypothetical protein
MDKFEIIKKNKAPKDLRFANYLIDNFIFLLLYIFIGVLFFIKDEMYMNSIFYNNEIVIGF
YYVLYMFLLEVLFKGRSLGKFITRTKVITLHGGVPTKRQYLARSLIRIIPFEPFSFFREV
GGSHDLWTNTRVVKAQSFDQDIEYFISIDSIGEKKHQRDSL
>EGEFANNL_01093 hypothetical protein
MKNQQIVANHLAPRTLRFLSYAIDIIVFYILIFSTGILSPILNARGWIYLLGSNPLIDRL
FAMVLFVIYFFLLESLLKGKTIGKLITGTRVVTEEGEKPSIITSLKRNLIRIVPFDTLSF
FGEIGWHDRWSKTRVVKAKNFDREFYDQTSIDDLGK
>EGEFANNL_01094 60 kDa chaperonin
MAKDIKFNLESRDALKKGVDALANAVKVTLGPKGRNVVIQKSFGAPHVTKDGVTVAKEVE
LEDPVENLGAQMVKEVASKTNDIAGDGTTTATVLAQAIVREGLKNVAAGANPMDLKRGID
KAVDAVVEELKKQSQVVGSDSEKIKQVASISANNDETIGSLIAEAFGKVGKEGVITVEEA
KGTDTYVDVVEGMQFDRGYQSPYFVTNTEKMITDLENPYILLCDKKISSMKDLLPVLEPV
AQQGKSLLIISEEVDGEALATLVVNKLRGSLKIAAVKAPGFGDRRKAMLEDIAILTGGTV
ISEEAGLTLEGATVEMLGTAEKVTIDKDNTTIVNGAGSEENIKLRVQQIKAQIENTTSDY
DKEKLQERLAKLAGGVAVLYVGAASEVEMKEKKDRVDDALHATRAAVEEGIVSGGGVALV
RAIDGASKVKGINQDEETGIKIVTRAIEEPLRQIVANAGGEGSVVVNKVKEGKDDFGYNA
KTEQYENMLSAGIIDPTKVTRVALENAASVAGMLLTTECVITDIKKDEPAGMPPMGGGMP
GMM
>EGEFANNL_01095 10 kDa chaperonin
MSQLSIKPLADRVVIEPAVAETKTASGIIIPDSAKEKPQEGIVVAAGAGKKDEPLTVKVG
DKVLYGKYSGTELKLEGKDYLIMRESDILAII
>EGEFANNL_01096 putative ABC transporter ATP-binding protein
MKRDQEKSIQSKGAITRLLKLGRKHTLWFYSTILTALFLAFISSYRPVLISQAIDIDILQ
NKNFSGLYLSLLYIFILLVLEVSLQFLLSYISSFLAQNVIYNLRIKLYKKLIYFKTAFFD
QTPLGALVTRVISDIETISTIYTDGILMVLGDILRIVFVIIMMYSINWKLATVALFIFPI
MILITRIFQKAIKKAFSQERTQTSIQNSFLQERLSGMMIVQVFNQRSKEYKNFFKINQEL
EKAYLKTVFYFSLFFPVVDIITGIAIGVMIWFSGHEALSQQGISPGIVIAFTTSYINMLV
RPMRQIADRFNSIQRGIVGAERVFTILDSKEEMPNTGTTKKDHLQGSIVFDRVNFSYTED
QPILKNLSFSVQPGEKIAIVGATGAGKSTIINLLSRFYDISSGHIYIDGINLQDYELNNL
RSHIAVVLQDVFLFNQTIFQNITLGNPKITYEQIREAAKKIQIDDFIMSLPNGYFYEVSE
RGSSISQGQRQLISFLRAYVYNPSILVLDEATSSIDSKSEGLIQVATEQITQNRTSIIIA
HRLSTIHNADKILVLDHGQIKEIGSHNELMDKDGHYRKLYEAQFSKK
>EGEFANNL_01097 hypothetical protein
MLFEVRTYRFLYHYSIKPIKQCTKLFHFFLIISIGFKKFLSIRNTHKKLRSINFLVLFKI
LEPYINLSYTCIIHKNFLATFNFFLEIIIVSFTRYYNNKNLNLSLSTILLISLKFI
>EGEFANNL_01098 Glutamine synthetase
MSKLRFYALKKLPYLQPRRIEIPKKLSELYCEHVFSESTMREYLTKEAYQSISDAMKYGK
KITREIADQVAVAMKDWAMSKGATHYTHWFQPLTGETAEKHDSFFSPIGEGRAIERFSGS
LLIQQEPDASSFPNGGIRNTFEARGYTAWDPTSPAFVIDTTLCIPSVFVSYTGETLDYKT
PLLRALQAVDEAATAVCQSYFDKNVTKVSSTLGWEQEYFLVDSSLYQTRPDLVLTGRTLL
GHAPAKGQQLEDHYFGSIPTRVRNFMKELEIDCIKLGIPTTTRHNEVAPNQFELAPLFEE
ANLAVDHNSLLMDVMKKVSRRHGLNILFHEKPFEGVNGSGKHNNWSLSTDTGENLLSPGK
NPKKNLQFLTFFINTIKAVHDYADLLRTSIATAGNDHRLGANEAPPAIISIFIGSQLTAV
LDELEKVTQGKLSPDEKTDLKLNIVGKIPELLLDNTDRNRTSPFAFTGNKFEFRAVGSQA
NCGEPMTVLNTIMAYQLIKFKKEVDALVGKGLKKDEAIFNILRDYIKASRNILFEGDGYS
DDWVKEAEKRGLKNKKTTPEALKLELEKNLMEPFEALGVLSSKEIEARNDIKLEKYSKMI
SIEAKVLGDIARNHVVPVAVDYQSKLIENAKGIKEIFGESEMKNMCSEQLNLIKEISLHI
TEIKSHVDQLFTERDKAIEIENPQKQAEAFCNRVKPIFSVIREHSDALEMLIDNEMWPLT
KYRELLFTIR
>EGEFANNL_01099 hypothetical protein
MKKLYYMLDFSAFQCFFQIRVNDVEIFSFNVEGQTSIDIPINQGILESGECTVEVKVFPL
QGKTELHEKAYAKYKVTVFDLSSGDFVFVEQFEEQRTPPAQKAIPFTQVSSLFYAEVLYK
IDAWQNGINLKDVNFNLKEKLLQEYQKILNRIAEKQYSEIEELYRKKEENTATVMYLNEE
EKKERMSKLFNDFSSGFEPVPLSKDSFVEYSAYGKEYV
>EGEFANNL_01100 hypothetical protein
MNNILQPFYLIDYTFSIYNFEITILESFNMAYPKKEKK
>EGEFANNL_01101 hypothetical protein
MKNIFYYIIFMLILAVITCNCYSNNTNIIGIWKGCIIDYHTKKPIDSLKMEFKKDNLLNY
KIGFGKNEQTINLRFRIDKQFIYTRELNSNEEDKAKYSIENDSLILNFEGLSIKLLKYNE
>EGEFANNL_01102 hypothetical protein
MGRIIIYLILISLMISCKGQNLDLATIDFNESADRYSLETFNFFEKEEQKGHWKINHIKD
SISLKLEDNGERVISYSFIGDDNAAKNINYEKLLIDPILGVSISVYDNRVVYMGVNIQHE
ETFKLLTYLLEKLGNPTEIIENTTTAISAEGWNLLEKNIPQYVKQGKSDWGSDIVYYPQY
FIWVKDGIIYQLTLMPVAQFVSNNLVIISKKAIKDRIILGYHVGDRDILLGKYLK
>EGEFANNL_01103 hypothetical protein
MKKILTLLLSSLFFISCQSQTDLEALKFGTDISTLLNKLEDQHKDSNYNIPRYGYSTKQL
DHFTIGSIALNTYSFDNYYNTRDNELYLAVDSYKNNQYVGFSALIQDPEKEQELTDYFLS
QMGEPIKKYINEKKEKGYLDAKYLWDDPKNDRLVYIDRHHTRNKKGNTEEEIRFVETIFL
IVERGLIFVPNKGTNPETIKKYLEENPKGFEMIEVLKSRFPN
>EGEFANNL_01104 hypothetical protein
MKKLLSFLFCIFLMVSCQSQIDLEGLTPGEDISTLAKNLKETREDREPNYGLLGYRTENL
DQYKFGEVSFSKYELPEGHLLDYSRSYLFVDNFKKNRYLGFRLTLVNEKEGNQLLDYLRK
QYGEPEVHEASNNGQAYVWYVKDQWILFSQDHISIDKKGNPFLTTNLIVVKQGTRVVNST
DPKVFTILESFNMAYPKKEKE
>EGEFANNL_01105 hypothetical protein
MKKLCTLLLSCLLMVSCQSQTDLEALKFGTDISTLLNKLEDQHKDSNYNIPRYGYSTQQL
DHFMIGNIALNTYSFDNYYNTLDNELYLAVDSYKNNQYVGFSALIQDPEKEQELTDYFLS
QMGEPIKKYINEKKEKGYLDAKYLWDDLKKNRLVYIYRHHTRDKRGNTEEEMKFVYTYFL
IVKRDLEGKPDKNNNPENVKKLLEENPRAFAVLEILKSRFPN
>EGEFANNL_01106 hypothetical protein
MVVTVKADVYFEASGSGESSITFGHTINYDDKGLYYRPQLGFDGLNAKYIIYVSVGLAMK
IAKDKNKVETERKGNQWEIARGNYDDVIPKFDVIEELETLLNIDANIPLIKNK
>EGEFANNL_01107 hypothetical protein
MNNILQPFYLVDFTSSICNFEIYINDMPVFLHYDEGSLSTHYPINHFILESGIQNIRIRV
IPLKEENFLRKEASLRIKIYFYDNYDNSYQNLIQVFEFITPDLSEQEMPLLEFKGNFQAE
VPYELIGWKKSIILAEDKLQIKQAMNFYKKIYSLFENKNYQEINALQNKKYKEIDTALYI
KNADNLLEWMQVIEEINISKMLLQEFPLSLVPIFYAEGKVINLTRKDGSPILHFKNENNE
EFSFPTLIHKKSMDSEFEIIR
>EGEFANNL_01108 hypothetical protein
MKNIFYYIIIMLILATITCNCNSNNTNNKIIGTWKGYVIDYQTKKPIDSLKMEFKKDNLL
NYKIGFGKNEQTINLRFRIDEQFIYTRELNSNEEDKAKYSIENDSLILDFEGLSIKLLKI
Q
>EGEFANNL_01109 hypothetical protein
MAQYFGLSLNAEWNRGTNLPQKIEIGQEFGLRIAKTLGIINKIKQTVQGISNSPLAKGKV
MFEIKSPVIAFSAQWYLAKAKKESSKVATIVVIGVDAKPFVEAEFTINVFKLFIESVGNA
VCPGAGNVISWVLDKLKKNAGIHFLIIFSGGIYANGRVNINTLYPEETSGEVKVTGKIQI
TVEFKAWAGAEIGYIGVDGVIKANVETSVTGGIKVGADNQGIYASPIAEFAGIKANFVAI
GTIKFGIFKKTYSYEEEAIFVEPDQIPFDKSYIN
>EGEFANNL_01110 hypothetical protein
MPELTAVLQYAIQYKSQLKITGFASSEENLEYNNKIALQRAEAIRDFFVANGINKNQITL
FYKIQKTEWKEQARKAEITFKLFNFSNTTLTYATVAPSTTPNNLTIKVNDFNTLTCFIEK
NNVQTPHSRKIWTKYNLEKSAEGDSIVLPLTSKLSTYNVAPLFQYIWPGSTHCYKYTEVH
IHSCAFYSDTTQPTLALHVYPDIKWTLEFK
>EGEFANNL_01111 hypothetical protein
MPRGVAKISYIDPSKTGNVSNIQKVIPYSNRIEVKISTFQSVEIPFFVVQWLNDTKNSDK
LKPVTWLEQTENRKNIISTTKIRSGFHFFFTIKRKYCGLKSHYIEASLSGYQDFNRETGI
YVRGICDFKITDCTWSLFKYGPDIRAEHKCFYGEKIWLRLQTEGMNGYKNVKIEVYRALK
KLENTPKDPLVATFTASVINGEINTEVKTTAWYNIIDRQPEEYFYLRVRNPENKISHVVD
INGKYFTG
>EGEFANNL_01112 hypothetical protein
MSEKFAVVQGAICSCQFGSASDQLKVNSHQKEYANDPEGAEKLIATTKELGTATFENNSF
GSCSQMGNPPPPCKVNVTQWQGFYEKVTLSNGGKVLLEDSKAICAIAGTPCISIEWHGQI
MELAEQNFKNVNTDIHSQLNPLVDLNELMQDEEESWIDNDNNK
>EGEFANNL_01113 hypothetical protein
MNREEKEYKVTENAKLDCSSEACYGRFLENPEDEFGFWVDNYPAVTEIHTLLSGFSFCAY
TRETCNFSPVGTWKTSLIGIIMHTKTILSTGACLLCKQRDTMIIKEFEQKGEGSYIKF
>EGEFANNL_01114 hypothetical protein
MEYEKYKVSRGDTLESIAKELNLSVAQLREFHNRHCELPYLLGSGKIPSSVKEILYLPLQ
EIEEQAQHKITNQSFYQLRLRHPTAEQIYQVKIKFFEEGKENSLSYIIKILWLEKNTIKI
HREELFIDGKEPNFLVDELATQISSVLYPMEFYLDAQGCFYKVKNLSQIKERWNQLKPQI
EKLYKGNCVTKYLYNFQKILFQPYLFNKAMKQEVFLTAYFTHLYGQYNTRGEVEEMLIRF
PVIPTLAPVQYVIKNRIEWLEEAKQKLIKIERKGELADPRSLNNFLNAMDIPLKKDTTNE
HEEEKAKGAYRSNYFLHPGTGIIDSLYLECNLETERNKKIYLTASRLNQDPPLNKTIKEE
GIIEIGGPRAQSPQRQNFFE
>EGEFANNL_01115 hypothetical protein
MKYFLNIMFVLFIAVIIFNASKINYSVSLTSDPNDQFFYSGLVAVIGILVVFIVRQLRTI
FHNHKA
>EGEFANNL_01116 hypothetical protein
MVTKKFILFFSILWLSIVGTQAQITFEAIPQKTVVTYQEPVKIQYRLSITPSNKEVGRMD
IPAYTNAQIIERKASSNIFIENGNSTMEYVEEITLLPIKVGRLNIESATVSVAGKKYKTK
SFHIKVKEQTEDQADDHKEQENHLLILKVSTLSPYVNEGTVVQLKFYTKQFEFLNSLTHL
SPPNFKGWFVQPIKEKNNSYQQETINGEAYFSRVVASYVVFPSQPGNITLDPFTLTLALS
NNFFEEYEINIKSNPVHLFVKSLPTGAPKNFYGLVGQFTMKATTDKVKLNTHQVANLKVS
VAGTGNLSLVKIPSVGVPEAIEEYKPVIKQQFTPTLQGLKGTLEASYVLVPQEGGNYQLK
VEPFSYFDPVERRYKTITPDPIELKISSESKRVNKKNKDSLVVEDKPEKKMEFLDYSQNS
QSKPEENSVVVNKSNFLYGALFVVVLLGLFLFFILRKKKNSKKKVLNEDPIDKEDKNPKT
VEKTKGKKNLEPALFKLKKIATRGEDKNSFYTWVEEILLEVVNAKIDQADQYLSLLDLEE
KVTQIYGEELADEWKELLLKSQIERYSNLTDQDSLLEIYDRVEELIQKMT
>EGEFANNL_01117 Photosystem I assembly protein Ycf3
MFSKIKLILVLIIIFSLSFSLFSQNKSRKYRLEGNQAYEKKFYDEAAANYLRAIQEGDNS
YKSNFNLGNALFKLQKYQDAIQQYEKSIKFTENKIEKSRAYFNIGDAYYQKKQYQKAADS
FKQALKLNPVDESARYNYALAKQKLKKEKEKQKEKNTGEGQNNQNQKDPKSSPNQQENQT
QNPSQPPTADKRNQQGQSGGFQNDQKVQGNEKQDQGEKERDNHSSPEKEEILETAQNQEF
YNGILGAMQEQEKRAQQKIINKRVSQPTSKKEKDW
>EGEFANNL_01118 hypothetical protein
MGWEFEKTSYFYLLLIIPVLIGRILYLHQWKTKSINRWVEPKLRQRILGKVNLKKFIIDN
VLIIFAVLSLMVGLVNVLGGIEKKEIKREGIDVVFVIDVSKSMDAQDIIPSRIEKAKKIL
DDILNGLDGGRVGIVIFAGHSYSVMPLSNDYAAAELYLNSVDTGLITQQGTNIADAILET
SKMLSDVSNTSKAIVLVSDGEIHEGELNSSIQAAKKEKITIFSIGIGTTQGAPIPMHTTG
NDLDFKKDRNGEIVLTKLDDNSLKKLASETGGAYFHGDYSSSEISKEVLKSIDSLKKKEQ
SSSYTYDHKQYFQIFISIALILLIIVSLTNYKNDFNI
>EGEFANNL_01119 hypothetical protein
MIMRTNLEFANSWVLILLLIVPLFILLKYRKRKKQNSIFIPNLSKFRSEKTIFERLRPVC
FWLRLCTIFLLIVALARPRKVHVSETLNNNKGIDIMLTVDVSLSMLAKDLDPDRLTALKK
VAKNFVKNRPVDRIGLIAYAGEALSLVPLTIDRNILIQQMDALQTQTLEGDTAIGVGLAT
AVSHLKDSKTKSKVVILMTDGVDNDGFIKPLMAADIAKKYGIKVYTIGVGSNGLALYPTS
MNPYSGEIFFEQQKVEIDEDLLKEIAQKTGGKYFRATDAQSLQDIYDQINRLEKSEINNR
KHYNYTEKYRLFLIPAFIILLIELLLRGFVYKSIA
>EGEFANNL_01120 hypothetical protein
MRLIVVIFCFSLFSVFVNSQNPLTSSISSKKIKYGEEVVLKLEVKASKNEAIVFPEIKDT
LSYHLEILENKRDTLFKEGIYTYIDSIKFSAYEPGIFTVPSQKVQINSKEYFSPEYKLII
DSMVVDSTKQPLYDIYPIVQEPKIFQDYVKQYWVYILMAFIMIVVILIVMVLYFIEIKKK
KIKGDKILYPYKLALNKLNKLEKSDYLSKGLSKKYYSEMVLILKEYIEQRWKVGATQLFS
EDLILYLEKNFKIKEEQKNDLKNIFQAADLAKFAKSKPTIKETVQHTQMAKKFISESNTD
FLMDKDDHAY
>EGEFANNL_01121 hypothetical protein
MTAEEVLKKIKLIELKSKRRLNSSFLGEYNSSFKGVGMTFSELRPYQFGDDVRKIDWNKT
AHFHEPLVKIFEEEREMTSILLIDVSGSMNFGTRKQFKNETAAEISAILAFSAIKNNDKV
GLILFSDKIEAFIPPKKGNAQVIHIIKTILDIKSINKSANLNLCIDFLLKTIKRKASIFL
ISDFDIGDYEKKLCILSKKHQVTGIRIYDRVELNFPDIGWAHLKDLETGDLKWVNTSNKS
IREQYSKEYKKLLLQTKNVFTKCGSGFINIATDQDYIKELFNYFKERH
>EGEFANNL_01122 hypothetical protein
MNYLTASEDIKILIEKVQEKSKDFSFLIKEVNQVIVGQKYMITRLLIGLLANGHILLEGV
PGLAKTLAIKTLSDALDGEFSRIQFTPDLLPADVIGTLIYNIKDNDFKVKKGPIFANFIL
ADEINRAPAKVQSALLEAMQEKQVTIGDETFQLQDPFLVLATQNPIDQEGTYVLPEAQVD
RFMLKCVINYPEFEEERTILRQNMSKDKYQVREILNVEKIFEARELVKSIYMDEKIESYI
LDLTFATRYPKKYELENLSPYIMYGASPRGSISMAMAAKAHAFLNQRGFVIPEDVKAVAK
DVLRHRVGVSYEAEAENITSENLIDEILAAIVAP
>EGEFANNL_01123 hypothetical protein
MKNTLLLYFFSIPLLLISQVGIETDKPEATLDINGDLIIRKAEYAIDYHDKGFYNIVTDS
TGKIYKDDFIPSSYSYYLGFDPMASNHTEELPTPLVPGYITTIYGVSVGACHGNVVEFTL
TYKGIDLLSANIHRFSAENRDGTEVVVNGGSVIIEGINESKLYSNSLENLPTPPSGCGDD
YGHKLSATIVDGVKKLSVTYLDLPVYYPDAGTFTVTNVSRIKYIPTNLKK
>EGEFANNL_01124 Regulatory protein PchR
MDLKNTFKSRIRENKISDKLYLAQIDNYTDVTDTISKPVEKEFVQMYFCIKGTATFHFAR
NEIYFMEKESTLLIFHPKQNVPINISLAKKSNLIIIVIKIQELEKIFSEYTYKLPFYENA
EYKCLFREKLLGIRERQILSQLKDFIIDEEFKNIYLKTKIIEIFLFYFSDNENNLIKNQS
ISQENIVSKIQEIKECILENIASPPTLKELSNQVHLSEYKIKEGFKKIIGKSFSTYILDT
KLEIGKEKLDLKLKSVKEIAYDLGYTNPSHFIEAFKKKYGITPKQWMLK
>EGEFANNL_01125 Glutamyl-tRNA reductase
MYLSNCINNFFVVSLSYEKANSKVRGKFSFDSNTTQQFCEKISLIDPYTRVFVLSTCNRT
EIYVQTEKIQELIKIFCKHIYASSDEFLSYSCIYQGEKAIKHFFRVASGLESQIIGDFEI
ISQIKKSFNSFKKFKLTNAFLERLVNTGIQISKKIKNSTALSSGATSVSYAAVYYLIHNV
PEISSKKIILVGTGKIGRNTCENLIKHLKYPNNLTLINRTRANAQDLADSFHLNVKDYKD
LHTEINQSDIVIVATGANKTIFNKEDLTNNSKSITFLDLSVPNNVCPSLKESKNVKLLNV
DDLSGIINQTFKQRIQEIPKAEGIIQEIMQEFILWCNNRRYVPLIQAFKSDLEKIKNIQK
KSLDKNLSITSKIEDELSNQLIQKITNRLADYLINNPDKSEIATDLFKDMFKLQITR
>EGEFANNL_01126 Porphobilinogen deaminase
MKPLRIGTRKSPLALWQAKEVEKKLNQLNIPTEIIPITSIGDKNLIQPLYEMNIVGVFTR
DLDLALLNNEIDIAVHSLKDVPTILPKGIVLSAVLKRDYEADILVRNPKTNSTLKKFDGL
HIGTGSLRRRAFWNAKYPNVNFHNLRGNLQTRLSKLETENLDGTIFSLAGIKRLNLNIDY
EVLDFIIPAPGQGVVAISSLESNKEITNLMDTINHKETQICTEIERDFLNSLEGGCTAPI
AAYAKIENESIIFKGGIVSLDGSKKLILEKKVPINKYSDLGKTLGKEAFEQGGNEIIKEF
KTKN
>EGEFANNL_01127 hypothetical protein
MKKDLSIKDKKISFLFLLISSSMVLSCNSKSKREPINVNDTISETISLDPIPQDSIVLSQ
TDTLQKDTLVNPTVQTIVETQVMPETNSNVVSKEGISSNNTNVNKSSSYKVEEKSRPVAK
NDLVEEMNDVGEYFYMNKEGNFETLKEKVITNNQPVSLKKEKKVSTSASEEPKTTTLEVP
KAKEVEVVEESTSVSTDNNNSTVQEKIIEIKEN
>EGEFANNL_01128 Alanine racemase
MYTVGELASLTNGKVIGDSNKKISEIFYDSRSIVSPKEGIFFALTGNSNGHDYIEEVFTK
SIRIFVCSYIPVKHEQATYILVDNPLEALQKWAKEHLKKYPVKTIGITGSNGKTIVKEWL
FHALNSELKVYRSTKSYNSQLGLAISILQMKPGYDLGIFEVGISYPGEMEKQEKVLSPKI
GVLTNVLEAHSANFKDKEDLIVEKIKLFKHSEAILCNDQPKIRTIIKQVYPDKKIIFFGK
DADSDIQLLNVVKQNKSTCLNVKINSKEESFTIPFSDEASIQNALCLLAILFYLNMDVAL
IKKKFLQLYGISMRLELIHGDNDSVVINDTFNSDIKSLEIALQQLYQQNKPKKILILSDI
LQSSSKEEELWNQVSTLVNAYPLDQLLLIGEKGAKYKQWFKHATYIFSTTQEVITFIKKS
PPKDSAILLKGARDFGLERISKFLQSQSHDTILEVNLNALRFNVKYFKSLLKPKTKMIAM
VKASSYGIGGYEVAETLQLHHMDYLAVAYSDEGVFLRKKGIYLPIMVMNPELNSYQAIID
NDLEPEVYSFRVLEKFTERLKELSIAKKYPIHIKIDTGMCRLGFNPQEIEKLAFQLKENP
WIEVKSIFTHLAVSDVPEEKDFTQRQAKLLTSAYDQLVETLGYKPMLHCCNSAGIVNYPE
FHFDAVRLGIGMYGYIDHKETLKNLENVVTLQTVISNIHTIQEGGTVSYGRRFRAKKTTR
IATLPIGYADGIKRLAGNGRGYVRVNGAIAPIVGSICMDMMMVDVTEILCQEGDEVIVLG
ESPSLLEYATWCETIPYEILTSISPRVKRIFYKE
>EGEFANNL_01129 Thymidine kinase
MFLENTINSKSQTGWIEIICGSMFSGKTEELIRRLRRAQLAKQRIKVFKPTLDIRYQEDQ
INTHNQWFLEAISVDSPKEIPVRVEDCEVVGIDEAQFFDESIVEICNLLANQGKRVIVAG
LDMDFRGRPFGSMPNLMAIAEYVTKVRAICAKTGALANYSHRITTNQHLIDLGEKDKYEP
LSRSEFWKILDLEKRKK
>EGEFANNL_01130 hypothetical protein
MNARESFQKEILEEIKLIAKELSNIQNLYGLLTYQQKIQNLYEKFIFLKQLNTSKYQQIL
ENHSEVAPKTEEPRDFYSNVVNEPPIEPVISTTETPKDSVVVEETEPNLTPTTEELVSSS
DESVFKTNKLKPLDIEIADIAPLINKDEKTYSENLSASKINLPPVSPSFGDSITFISQLF
KGSKAAMDTEFKLLNQTQSLEEAKKWIEQMFVKYDWKNKGLHVERLSQLIVERFNSLKN
>EGEFANNL_01131 Ribosomal RNA small subunit methyltransferase I
MSGKLFLVPTPIGNLEDLTFRGLRILKEVDLILAEDTRTSGKLCKHYNIETPMQSFHLHN
EHQKTEHFINEIVNGKNLALITDAGTPGISDPGYLLVKSCIENSIVVECLPGATAFVPAL
VVSGLPSHEFLFVGFLPQKKGRQTKLEKLSKEERTVIMYESPHKILSTLEQIIKIFGAER
KVSLSREISKLYEETIRGTAEEVFKQISDKPIKGEIVLLIEGL
>EGEFANNL_01132 Putative HTH-type transcriptional regulator
MISNRCKYALKALIYIARQEMGKSVLSSEIAKDEHIPKKFLENILRDLKNAQFLTSKRGA
KGGYKLNKGAEEITLIDIIRLMDGPIALIPCVSIMYNQTCDTCKNDYFCTIKETFAEVRD
ATLKIYEKTTLASLARKEKNTNFVI
>EGEFANNL_01134 hypothetical protein
MNKVIFSNGNSIFRGVISSQSSYRASLQRGNSLLTYEVQLEQKGNSVQIEAKNFLINNNP
PDLMAEQLAHKAGQALYPLCLSLNRQGDISYISNYEEIKTRWQKIYTKLLEYYVDAYSVH
YINQTHRSYTLHSLLKEKLEENYFFFLYFGGIYNQTLGDDFYREYTLRYKGVDFLFSQWV
DMETNENNCFGLYREGLQEERDERIELRYLLENKHKSIEEASFSFFKSEKIDFLFTIEKL
EETASFSTGETPTEERMQFWLDEKPENLNH
>EGEFANNL_01135 hypothetical protein
MEEKHVTCQGAICQCTYGSTTDKLKVYTQTKHYINDKNKDYKLVATHKELGTTFENNSFG
SCSLRNRNPCTVSVTGWNGFYEKVTLEENGGKALLEDSTADCPTGGKGCIKIIFHGQQAE
LCKANFHKVDSSICNAMNPTGEMEATQEMEEEIYDAE
>EGEFANNL_01136 hypothetical protein
MPEYILHKVKKGDTVWGISRQYGVEEHKIVQANPEIKLRKQGKNYTPLIYEGDTLRIPQG
EGKENYRIEGKTSLGMGETATYKLVTSEGIAPHYPSTKIVWLFFVDEGTENWRQLRLEKE
KTGQEFSIVFKNQKLKAKKIRMEAYVQWSKEREKLAEFFMALDGQDVPEIKELTLLDANR
NKIKRKVSYSETIFARALCTGMEGETLYFSLWEDDAKGAGHSEENKDNFIETKTAIVTDG
KAEVAFRLLYATMAPIANRKVPVGQKNEGAYHEYYVTATRYEKTEGEKASENIDVKNPDY
TPPPPKPKPKPKATPKKETTKPKIIHKAPVDAPAKGRDKLPAPAWKEPNIIRVYIRDTQG
KVWNRRPKYGEKIRVYIDSENMINRKIQLKIYDKDVVYNDLLHEEDRTITANTNFTTIHL
TAAMQEKGGDISYQNLFAEVYLYDTQQTVKSEVVNVDKTNFSALPPEGITPTTVASSPQK
KEENKNKCVCEERVRAYMRMLRVGEGTGELIKSYDQKLKKIVYIEKDPQKGYTTAFGGNK
ILDLSKHPEKNYGGSTAAGAYQIMRYTWWSLSGWELDKNYAKTGKYIEKNDLLKKYNITD
YYPESQDKICVIIFKHKRSGILNLITKGEIERATREYGSLEWASLPNKGDNSKYSYKGKP
QPATPMKDVLAHFEEFYKEELNEISNLHLKKGFLKSFNHTCNCQNKDVTIIENKNNICNT
CNEEHYNLADGSKWQTQFDSIFGNKQKQNVACWRACKVILSNYGVTGGDNINPIQMVSQN
GTSDLILKKVKEGKSYLDKELKSNRVVLVGVDDGRTAVYNSDKTTEHFIVIIGKGCDNGK
IFYRYFDVGTAHKDKGTNSNNKLYLQSNGIIQGKSPGGTKTYTIAQVRKNTIKN
>EGEFANNL_01137 hypothetical protein
MKYLSIITIILFTYSCKGHETKVDKIESLNSDSTKYSLVGIWNKLTINKKDTIIYQPCDA
NNTSIKVTRDSVIIDYGQEILAYFILEKNNYNNKHIEFKLSGTNNKLECIINNKTTAFWI
INGTKNLFTKSDISKFKTIEQPCIECWEEDECNNQKDNNLEIQNLKNSFIDLAEKDFKKR
LPEILKLNHSEGIDITENYTGDLTNDNIDDLVIYYSLVPGTEENNEFNRGIIIYKNDNGY
PKMIKQIEPDYLFNVIGIQNNILQIEKLEYNEYDSRCCPSKKTKINIQAE
>EGEFANNL_01138 hypothetical protein
MEDKYFTKTESGLDGKDIVILAKELGYTNTCNCLETTKIAQQEKTEEECYDCDLKFRKIA
PIILEHEGGYVDHPNDSGGPTNKGITIGTWEAYAKIDLGIDPTLENLKKITNEQATKIYR
KRYWEPKGFCKINNDKIGLMVYDWTITSGGAGKEIQKLLVNEFSQSITIDGVIGTNTIKA
MNNVQDQNKLLNRIAEIRKQYYTNLAYDKNGKPTKNYIFLNGWLTRVDKCLNYNL
>EGEFANNL_01139 hypothetical protein
MKIIKVYISLFIILFFSSCKKINAQKDNSFRYKSELLGEWESKENLNNTFSINFGEIKGD
SIFGQYCAVAREGRKIDCDTDEIFNIKGIIKDNIIKISFTSFFNAKNGKAKIIITDSLLR
WVITKYPEGESYAPKESTLTKSEKKELNFYSLLNDTPSIILPINYSELDKFQWNENNYKL
IENMDLFLRLPNYNDFKIAILLNDNGDDEIYKLITIKNNNIIDSKDIGYAIDNYPESNFR
ELVQFSIDKNFLITLFFKQLKQNKLILKKIKKYKINNSGKFEEIKE
>EGEFANNL_01140 hypothetical protein
MKIFSFILISIIIISCTRNNNFNFLSKDTSLASNYKVLNLKNISPDFPLDSLEMLTSEYG
NFKFYSENTLRGEGVIALSINSEIEILNLDKSYFGSISLNKEMESYNINLPKVTIAREII
PDSEYQIFNFDSEQPNKNKDFLIIYLNKEPKLIQKNKTQYSFSSWDEYIKKSFIKLTPQV
DNRAPEEEYLYKAIKIKEDSMLIKSVPKSACDYVEKYKNITKWIKWKSNNCKLIKFNFCY
>EGEFANNL_01141 hypothetical protein
MKNQLICFICFFLVFSCKGEEIKQVSQNNVITKDKNILGGDTIQGINTLKEFYLTFYGDD
NAYKNKKSKEQYISDRVLKRIDSLSGPEEVTLDYDPFIQAQDYFGNIIRKTIEVKPLKNK
NEYKVSFLLFGEKNEKRTEIDLLLKKDSKGNFLIDAILNDEYLNFKKNLNTSEKKSSIPI
SGNYSPNYELSFDNIKYNEDSLITNLTINIKNKKNNQLQTISYSPEYCSSIPSKAVALKA
NSKGIIDSDNTLEDNIPIIFADFNFDGKEDFAIINDQANNVGTQYSYFLQDERGNFSINE
FLTEKIGLFPTEINNNNKTITLINPIGCCNISTRIFQKEKTNWKLIQSKTEKMN
>EGEFANNL_01142 hypothetical protein
MKNLLIYFSCFLLICSCKAEKKKTIEEKKNNIVLEDSITNNLNRNQENGVWHFYDISDSP
VLDLKGIDREKLKTEIEKYTIKLTENHITISNSCSDIEYVNLREKSLSYFTNQDNLERYS
NALSNKGIKFSDSINIIRSTLPDEECDYPFGEIIKINDFLIVLYEGYLVFFSKEVPSDNF
ISEYNKLSNISLPIDYDLIDSIEDSKFIPISDKYKYFLKLDHLSNYKGIKLPVINQNIKT
ILISAYQESGEQNLYIYNLSEEGKVLDKLVLFSIEGETEQGNNIGNNTFNIDKYYKIKIT
RILENDTKIIKYYRINKNGKFEEINNK
>EGEFANNL_01143 hypothetical protein
MKHFKIKNIILFLLLIFTINCKGNKCQEREHFFTKKETSDTIKILDNITGDIKALSKWRK
EQINLDNSCIALSKEELPYNKTIDLDNITYSLLNCNIKGVENWLCGESSLRYIPFPKKDN
IEVILVPMDCGDFEYRYYMLTIKNNTVMDQLYVEGEWYEPGSNEENTIENTSFSIDKNYI
ISVVTKKLKEKSIIQKYKINNSGKFEEINNK
>EGEFANNL_01144 Glycerol-3-phosphate dehydrogenase 2
MKRNEQLSNLNTTTEWDAIIIGGGASGLGAAVDASTRGYKTLLLEAHDFAKATSSRATKL
LHGGVRYLAQGDIALVKEALRERGLLERNASHLAKKQVFVIPNYKWIDGPFYTIGLKFYD
MLSKKLSLGKSKHINKQKTLEMLPTVEPKSLCGGVIYYDGQFDDSRLAVNLAQTAVENGG
TVINYMKVIGLLKNDAGQICGVKAKDLINGNEYEIKGKAVFNATGVFTNEILNMNDPNHK
KTVVPSQGIHLVLDKSFLPGDNALMIPKTSDGRVLFAVPWHNRLVVGTTDVLVEKPSLEP
RALEKEIEFVLATASQYLTKKPTRKDVLSIFAGQRPLAAPDKDGGSTKEVSRSHKILVSD
SGLMSIIGGKWTTFRQMAEDFIDKAIELGKLPSKECKTVNLSIHGNVPASQVDRSKHNYI
YGSDIPAIQKLEQENPDLAQKIHPNHNYTKAEIVWAVREEMAEKVEDILARRVRLLFIDA
RAAIDCAEEVARIMAKELGHDADWVAKETEEFKTLAKGYLLVNY
>EGEFANNL_01145 Queuine tRNA-ribosyltransferase
MNAFFNIFVSMFFTISETDKSSKARAGILKTDHGDIQTPIFMPVGTVGTVKSVHQRELKD
DIKAQIILGNTYHLYLRPGTEILHKAGGLHKFINWDSPILTDSGGYQVFSLSQTRKIQED
GVKFKSHIDGSYHFFSPERSMEIQRYIGGDIFMAFDECTPYPCDYSYAKNSLEITHKWLK
RCVKWCDENPELYGYKQHLFPIVQGSTYGDLRKQSAEFISSINADGNAIGGLSVGEPEEE
MYRITDIVTDILPKNKPRYLMGVGTPWNILESISLGIDMMDCVMPTRNARNGMLFTWNGV
INIKNKKWQDDFSPLDEDGTAFVDKEYSKAYLRHLFAANEFLGKQIASIHNLAFYLDLVT
VARKHILEGDFNSWKNSTIPKLRTRL
>EGEFANNL_01146 hypothetical protein
MINIIDRYIIRNFIGTLFFMLILLVVIFVIIDIQSHFQEFNENGFTITDALRLYYPYYVI
WAVNIFASILIFISVIYFTSRMANNTEIVAIISSGASFFRFSRPYLIVSIAIASVSLLTN
HFFLPWANIKKNEFSVKILTGNKKDTYNANQSIASQISPGEYLFIYSYNRQMKSGAGFKY
EKFNKDRILLHELRANNIYWSESDNSYMLSNFYEKIMDSTGRVIYLNNGPQLKKKFNFTP
DELLPESYVAETMNTFELNKFIEKEKMKGAGNINIYLNEYHQRTSSSIAIIILTFLALSL
SSAKKRGGLGVNLAIGITCAFLYIFSFEALKIFSSTGILPSWLAVWLPNLIFGIITTILF
YKRAYS
>EGEFANNL_01147 hypothetical protein
MKKKTLINLIAIGIGIYFIYRGIVWYNSTTDENQPNKFIGFIYMGLGILAILVQVFANYR
STKRKDK
>EGEFANNL_01148 tRNA threonylcarbamoyladenosine biosynthesis protein TsaB
MSIHILSLECSTKNCSVSIGTNGDNNCLCEELSPDFKHSENLHTFIQWALEGAELELNNM
HAIAVGKGPGSYTGLRIGLAAAKGLCVGLDIPLISIDSLEILAYPFFESDYDYIIPVMDA
RRMEVYTTVFDKMGNKLEITKPHILQEDSFYAYKNKTVLFVGDASEKTEKFLKENSLTYT
DSFSFITSYPSAENMNPLSHKKFNNKSFEDIAYFDPLYLKEWK
>EGEFANNL_01149 Iron-sulfur cluster carrier protein
MAFTDEQVQDLGNKIVEKLKTVYDPEIPVDIYELGLIYDVQVSTDGEVHILMTLTTPNCP
VAETLPMEVEEKIKSIDGVSKAEVQITFEPSWEKDMMSEEAKFELGML
>EGEFANNL_01150 hypothetical protein
MYPEEMVMPMKAALTDRGFQDLNTPEKVKEALQQSGTTLLIINSVCGCAAGSARPSVLLS
IEGEGKKPNHLTTTFAGFDVEAVKTAREYLVPFPPSSPSIALFKDGELVHFLERHHIEGN
SAEIIAENLKQAYEEYC
>EGEFANNL_01151 Ribonuclease P protein component
MNQKYSRNEHLKNYKQIQYLFENGIWVNKYPLKLICCPNLDQATNFHKFGVSVSKRNYKR
AVDRNYIKRLLRECFRLNKEQLYSAFSQPHLFMLLYVGKEIITYKDLEDTYKNLLNKCSF
KEQA
>EGEFANNL_01152 Glycerol-3-phosphate transporter
MIFFKTNKMFNFLSPPKPTNKKNNIETDSYYKKLRFQVFIGIYFGYAAYYLVRKNLTLAM
PFLEKDFGYTKASLGAALACNGLGYGISKFVMGGISDRSDARKFLPLGLILASLTIIIAG
SNMVISNVLTIGIFQFLIGWFGGMGWPPCGRVMAHWFSPTERGTKMSIWNTAHNLGGMLI
GPITAFATGYLALLNFKNFWQIGMFTVPAIIAILVALFAYILIRDNPQACGLPPIEEYKN
DYPANYSKKAEEVLSAKEIFFKYVLNNKILWIVAIANAFVYLVRYGVLDWAPTYLKEVKG
YDIKQVGWAYFAYEFAAIPGTIICGWISDKIFKGKRAVTTIIFMLLVMIAVLVYWKNEGS
MTIDIIALISIGFLIYGPVMLIGVHALDLAPKNAAGASAGLTGLFGYLVGTAILSNLLMG
YIAEHYGWGAGFELLIVACILASVLMLLTIPDENRKYRNRKKLAQS
>EGEFANNL_01153 Glycerophosphodiester phosphodiesterase
MKLVQNYVPENAVIAHRGTTYWAPESTESAYRWVRNMGADYLEADLQITKDGVVLVMHDA
HMKEKTDIQILSQDPLSIFYGKADAPTSEFTYEELMQLNAAYPFMEKNLGTGRDRPSFNT
QHQYISTLEDLMNFAIGKRIKRDSNGKRVWSKSKEGIYKFEYEDDPYDNGNRPGIYLELN
PGLEEAMGKLLAEHQWDISITPSTDTNQFKLEKVNVGNTNGKVVLQTFLLSSLKKLNNIY
HGNLPMAYLVSKGLMAQTSGSSDEPLVYAQFINDGVSNGAQFFGPSISGAPNNYDELLNP
WQAHMIRRSEMKIHPWTFDTEEQMMRYYEGIGFTNLNDYKSPPYCDAMFTNRADLTIQYY
KKKGVRNDGPDYQDPNNILNNLGY
>EGEFANNL_01154 hypothetical protein
MKQIFIALFITGCTLMNAQKLAHSGSDYTLKKVIPVEGRQGIAVDKDYYYVSSSTALYKY
DKQGSLITKNEKPFENFEKKVNHFGDIDIHNGEIYTGVEYFNSGNVENIQIAVYDAKDLK
YKYSIEFGEIEQPEVSGITIDRKNNIAWMSDWTEGWYLYKYDLKNKKYLGKVHLQPSPQW
QQGVYYIDGKILITSDDGDSDLNEPDNIYIANVSNPLQTTTNVEKFRSIPEFKKAGEIEG
LSIDPTNNDLIILNNRGAIIKKGMPSGFYPGYDKEIHELYIFEKSK
>EGEFANNL_01155 hypothetical protein
MNLKSTLLITFASIFLSSVYGQNSKKEPELQDSIKKISFVERMTSDSSHLAQGIKLKFIN
DLVGANENSFVPTLKYGIGFVLETLYQEIPKEARGHREGSSRYNFQPAAFKIGFLHTDMQ
ITPKLGAGITYNLHANKISDVFINYDFNPLLSVKIGRFKGSGNRAANETSAYDLDLADFT
YTSENQSIDQGAPDLRHYGINLSGFITKYVKYGFFWHNSDSNRDRYWSAANDGPSAGQGN
HGLEFKSWDASLRIYPIKNIEFGGHIGAVNLPGMGYKQTWAYSGYAYYVNPKKFKFKFDY
GTNKQVRFLNPSTGDYNLTASPGGNMDYSKYDYKTVNKLGYSFLVGVNVSPRFEPVARFE
YYNQGNKEFSGFNYTDLYLYTAGVNFYVYPNSPRMAKITAFYQHRAESGGPSIANDWFGI
NYQIVLYNNTKGNF
>EGEFANNL_01156 Glycerol kinase
MQKKLILALDQGTTSSRAILFNHHGEIVSVSQKDYTQYFPKPGWVEHDPEEIWSSQISVA
AEVTAKQGISGLDIAAIGITNQRETTIVWDRETSTPIYNAIVWQDRRTAKYCDELKAQGL
TDSIREKTGLILDAYFSGTKVKWILDNVPGAREKAEQGKLCFGTVDTWLIWKLTRGKMHI
TDVSNASRTLLYNIHKQEWDEDLLKLFNIPKAILPEVKQSSEVYGETATTLFSTKIPISG
IAGDQQAALFGQLCTEPGMAKNTYGTGCFLLMNTGEQAVLSKNNLLTTIAWKINGKVHYA
LEGSVFVGGAAVQWLRDGVKIVKSSPESERLAQSVPDNGGVYFVPALTGLGAPYWDPYAR
GGILGITRGTTEAHIARATLEGIAYQVYDLVKAMEADSGVKDLELRVDGGACANDLMMQF
QSDIFRFNVVRPKTLETTALGAAYLAGLAVGYWNSIEELQQQRSIDQIFQPKMDLVQAEK
YIKDWRKAVGRVRNWVDEEDK
>EGEFANNL_01157 hypothetical protein
MKKFLLLLASISFLNFSYSQEIDKLDFNLNLETSHIWNGIIVSKAPAAGIDINYAFDKKN
NLKLGVWGGVGLSDANGKHYQEVDYYFKYNTARWGLGIWDVFNNTDLTGKADEIFNYDNK
TTGHRLDLRGYYVLSENFPLKLDVVTSFYGNDRNAKGDQTFSTYTGLTYSVLRDKKVDLD
VFFGTAFNLGKGYNFYGDGTKDFDVVNFGLTVSKDVPVLGYKLPVSATAMWNPSRKEGII
HLSTQLF
>EGEFANNL_01158 hypothetical protein
MILTLKYKLITVLLIFLISTEFIKAQIDIKVINIENNQPIINASVFDKLNNFLGVTNEDG
IFKVLDTKKYERIIIKIPGFEEKIVAIGKLNKSVYLFRKGLKLKNDLKATKILKKMWDNR
NLNSPDHLDSYEFDSYVKFSIEAPSDSVSYIPNPKTKLDSLNNKFKSLLDKSMLFLGERT
MTYKYDKKFGRKAIVTAYKAGGFSDPELFNATITLSLVNEIPKILTPKELQHNTSLLVDS
IDLNGRKTYIIYTFKGKSQSENYRSLTVFIDAKSYALVKLIGNTSKISDIYYEITYAENN
GIWYAENEYIQTKLLSKNFIEKMNKLLPKSLFFFTRLSTTATIESNFLNFKSLIVFDPKE
FNGYEYAISKTINTDKNLTLYNLRTDSLSNKESNTYHELNRLSKKYNVEPKISFLRSLSS
GVLPIGFFNFDIFNLVSNNMYESFRYQVGGRTNWKLSNNFSIGGYIAKGTKDKDTKGGGE
VTFYINKKKGGELTLKLETDVLPVGRTKIKYQTAKDILEAKPNNIYNDKYFSYRTIDLSY
KQNFFKNIDFTFLLNYQKQRVDFDYKFKNYNVDTWFNFVTTSVMMRYAPNVKYIESISGK
RTTLKDIPPYYYLTYSKSWNLFNNSTATHRIYLSTLYILNTRLGSTEILGNMGASFGETP
LMNTYEGVGVAKGGRSLWGRFSVKGYQSFETMEPSTFFSDKFASFQLLHHLPSIRLNQSK
SLYFTLVYKGLIGGMSHKEDHQLFVFEVPKDYYQEIGIEANKLLLGFLGIGVYSRIGAYK
VGNLDRNLYIKLTLDL
>EGEFANNL_01159 N-acetylgalactosamine-N,N'-diacetylbacillosaminyl-diphospho-undecaprenol 4-alpha-N-acetylgalactosaminyltransferase
MIKLLFVNTDLRGGGAEKVLVNLLNRLDFTKYEVTLFTVFKEGVNRENLRPEVKQKWFFN
NLFKGYSRIALIFPPRILFKFFIKEKYDIIISYLEGFPSRIVSGCEDPNTKIVSWIHLEL
YKNTVSYEFRNLKEAEKTYNKFDKIVCVAESVKKCLQESINIRPNKFKVIYNSLDIEDII
HKSKENVLPIKNKLRLCTVGRLNPQKGYDRLLRIVSRLKNEDNIDFELLILGTGPLENEL
KKYVKENKLIDTVQFLGYNKNPYAYIKSSDLFVCSSYKEGYSTVVTESIVLGTPVISTNC
SGMSEILDEGRCGVIVNNDEESLYLGLKNILLNNQLIEHYKEKAIERSLFLKERNELQNF
DHLISELIN
>EGEFANNL_01160 Serine acetyltransferase
MSDSKIKKDYFRIYGSYPKKFIFKSLLNPNFRYLYILRKASYHKKKSILGIFYRLLLYRY
QIKYGFQIYPETLIDEGFYLGHWGTVIINPKVKIGKNCNIAAGVTIGQTNRGKNKGTPII
GNEVWIGTNAVIVGNITVGTNVLIAPNAYVTEDIPDHSIVIGNPAKYSYNIDATKGYIEN
KI
>EGEFANNL_01161 N-acetylgalactosamine-N,N'-diacetylbacillosaminyl-diphospho-undecaprenol 4-alpha-N-acetylgalactosaminyltransferase
MIKKKKILIRIGSLRHGGAEKVLVTFLKNIPEKKYEIDLLLNLKSGKYLPEVPNWINIYH
LHEGEMITTNKPWEIPVKVYRRSKEEILKIFPNLLYKYILKKKDYDVEIIANHTLLEEVL
KSPVKESKKIVWVHSDLFNIPKYSKDKLNKFFKADQILAISDNIKNGFDNLACSKEEKDK
IIKIYNPIDSNEILQKADDKKDLDFKFGQEKIFVAIGTVYPAKGFDRLINVHIKLLNEGL
KHKICIVGDGYDFNNLNNFVKLHKLEDTIHMIGYRNNPYPYLKKSDFFILSSRYEGYPTV
LFEALALKKPIIATDVSGVREMLQEGELGKIVENSEEGIYEGMKEFLSDIKVPDTYIQKL
EKEDLPFTLENSVKKMMDVIDKN
>EGEFANNL_01162 Serine acetyltransferase
MTKIQADLYRYTGNKNSSIFWNFFKIRAFRYQYYYRMSCKKNNFFIKIILKILSHRIISK
YGFILETTDQIGPGLMVLSTSLLGVNAGSKVGKNCTLSQGVYLGVANRGKLKGCPKLGDN
VWIGPYSMIVGNIKIGNNVWIGPNSYINIDIPDNSRVFGNPPQIIPDESAVKDYIINPIE
>EGEFANNL_01163 Maltose O-acetyltransferase
MKTSIQKDYYRHTSKWINHPWIKTIFNIDFRYTYLFRKISEKKTPIIFNFFLKSYYKFLS
KQINYHIDLKATIGDGFYIIHAHRLYVGPRVIIGKNCNFSHCTTIGQTKGRDNIIIGNKV
WIGTYCVLDGNITIGNNVLIAPLTYVNFNVPDNSIVIGNPAKIIKRENATEDYINNTI
>EGEFANNL_01164 GalNAc(5)-diNAcBac-PP-undecaprenol beta-1,3-glucosyltransferase
MTSDSIHISVITPTYNRSHTLHRVFNSLKQQTLQNFEWIIIDDGSTDNTKVVVDEFTKEE
KFPIVYYQQKNKHKFLSIFKGIDLAKGKYIAFVDSDDKILPNAFDTFYREIIKLPENNKY
YGVIGLCTYEDGNIAGDKFPISPLDTSIFDMRYKYKVKGDKWGLSIKKAYQEINFDISAY
ENKGFIPETVLLYLFDKEGYKTRYINVASLIYVSDAEDNKSLANNFYSSKNSFGLCENYK
TFITCYRNRFLNYPLVYFKNFIAYILFGIKNHRSLNDLLKIDGILIKIFIIFFYPLVYLF
KDKTIRG
>EGEFANNL_01165 N,N'-diacetylbacillosaminyl-diphospho-undecaprenol alpha-1,3-N-acetylgalactosaminyltransferase
MKKKVLFFIHTMRGGGVENVLLNIVNNEQFKDLNITILLIRKEGDFLEFIPNGVNLKFLA
LGNEFLSKNSIINFFQKSFRYLKLNFLLKFPFFIRKFYIPEVYDVENAFLSDLIPILDKI
KRKNTYNIGWIHGDIYANKAEITLKNKVLKSSLNLDKVIYVSKKSLKSGILWNPNLKKNA
QVIYNPINKEEILKKSLQPIDFNFKNFVFVCIGRLSGVKGYEDLIEVHKKLISNNIIHDI
VVVGKGEDENILKTKILNYKIENTFHLLGHKQNPYPYLKNADAYLLNSKSEGYPLAVKEA
LLLGKPMIVTNVGGVSEIVNNSNAILIDFNQDQLYEAIKKMIVDNDFRNQLRINNEKHYE
NYNKNIIYNSYRELFFYKKNK
>EGEFANNL_01166 putative NTE family protein
MEYSKKYIIFLVLIISHLSFAQVNESISNINIDSLNRKPKVGLVLSGGGAKGFAHIEVLE
AIEKAGIKIDYISGTSMGAIIGSLYAAGYSPSEIKNAIESVDFTELFIQNKQRDYIPLFN
KSYGEKHIISLPLKNFKLTFPSAISDGQGPLLLLTKLLYNVHDVHDYSRLPIPFLCIATD
LETGEEIQMESGFLPLSVLASGAYPSLIEPVKINGKTLVDGGIVNNFPAKALKDKGMDIV
IGVDLGSGLQSAKEINSILNIINQIVSYRINLKTDYERDFVDLLIKPDLNDFSVTDFDKK
DSILSKGKIVAEKYFPQLKKIAELQNYDSLSRPRINELPEDKYLFITNFSIEGNSDDDSI
FIKRKIGLHIPMNSSITKLNQGVSNLYSTGNYNQVYYKIKYDSTKNSQKITLHLDEKSNN
FIKLGLHYDDVYKASFLTNITLNKLFLKNSTLSLDIIFSNNFRTNLNYYIDNGIMPSFGL
NTSYTNFNFNYSDIKNDEYPFDRIRNFNQQIYIQSTLMEKYALGAGLEYNYIYTLPFYLN
NIDYKKDENYFFNTYLYLKADTQDNANFPSRGFKLDVSARFNLFSNAEKERFTMLKGNLN
FTIPITKRLFIENQLFLGVSFESPSLQYKYYLGGYFKQDFNNFKSFLGLPFGYVFNDQIL
TLYSSLNYRLLKNHYLKTYINLANLENDFDNINYFKYKYTSFGIGYGYDSPFGPINLMYS
YSANQNKGVLSVGLGYWF
>EGEFANNL_01167 Endoribonuclease YbeY
MINYFSNNNFKLKNKQKIRNWLNKAISMENHVVGNINYIFCSDEQLLEINIKYLDHDYYT
DIITFDYKENNRVSGDLYLSTDRIIDNAKLNNISFDEEIIRVLIHGILHIIGYNDKSPNE
SKLMRAKENFYINLYKN
>EGEFANNL_01168 tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG
MILDKYDVIVVGGGHAGSEAAAASANLGSKTLLITMNLQTIGQMSCNPAMGGIAKGQIVR
EIDALGGLSGIVTDKTMIQFKMLNLSKGPAMWSPRAQSDRMRFSEEWRLQLESIPNLDFF
QDMVTNIITEKSKLIGVKTYMGATIYTKSLILTNGTFLNGLIHIGDKQFGGGRMGEKSAF
GITENLVELGFESGRMKTGTPPRVDGRSIDFSKMEEQKGDENPLKFSYTKTSKLINQRSC
YITYTNTQVHETLKEGFERSPLFNGTIKSTGPRYCPSIEDKINRFAERERHQIFAEPEGW
KTIEYYINGFSTSLPDDIQIKALRLIPGFEEAKLFRPGYAIEYDYFPPTQLKNTLETKII
EQLYFAGQINGTTGYEEAAAQGLIAGINASLKVQNKDPLILRRNQAYIGVLIDDLITKGT
EEPYRMFTSRAEYRMSLRQDNADERLTPLGHSIGLASNERIISLEKKLKETNELIQFIKT
TSIHKEQTNPILEYNNSTLINQTVKAESILLRPNIRLKDLEQIPQIEDFIKQNNYSEDVL
EQTEIKIKYKGYIDKELENVEKLNRLENIKIPSNFDYNKLNSISTEAKQKFIKFKPETIG
QANRISGVSPSDINILLIYLGR
>EGEFANNL_01169 Ubiquinone biosynthesis O-methyltransferase
MKIIDYFLTHETFELIKTNYDGVLKTNNIPIDLNKYYNSEKYLSHTKNNTLKSKVYQFIQ
KLNEYYKLKIISKYKSSGKILDYGCGDGSFLKFLKNNDFSILGLEPNTKASEIAISKIGT
DNIINSLDSIEKNSLDIITLWHVLEHISNPEEILSKLKTKLKKDGYLIIALPNHKSYDAK
FYKERWAAWDVPRHIFHYSKEGAIQFFNINNFNVLHTYPLPFDSFYISLISESYSKNPFG
IFRFPFIASLSNLKGMINGNFSSVIYILSEKK
>EGEFANNL_01170 Narbonolide/10-deoxymethynolide synthase PikA2, modules 3 and 4
MKKEIKIYLRNLSIFIDKILIKIKAFGLNRADLGQIYGNYPSPEGITSILGMEFSGVVIN
SFKGCIFQSGDRVMRLVSGGAYAEYIYVSEDEIINIPDSLSFIQAASLPEAWCTVLLNLK
LIGNIQKGQRVLLHSAKGSVGSVAIQYAKYCGCYVVATTRSAEKLDYLRDQGADITFLLS
ELGNSCKKIINERGIDLVLDPVGKNTFEFDQKVLNKDGIIIIIGIMSGKEINLDLGTLLI
KRQKL
>EGEFANNL_01171 hypothetical protein
MKNIFKINNPEYFLILFFGLSYYIFILYDNHISLKFNYQYFLYDYSFGFIKRGLLGQILN
ILPISITEQVFVGIATLLIIILGILFVKIIDEINFKNKFLSYFLICLLLISPSLLKNLWY
DLGRLDILGILYCLLFLLPFSQKIIHILFILSPIVLFIHEGFLLLWLPTYFICWFIINDM
KINKVFLFFCITSIASIFFNIYFGKLEVDFEIFKNYLINKSSGEVYIENTVITDSLYSQI
YNSMVLNFTHVKFWFLGFINLFTFIYIIKIFFKILNINKLYYKFIFIPIPFTFIMFFLGS
DALRWFSNICFSLYIILIAILAKNKNEIREYKFEGEDFNYLCFMIFILLIMLPFTKLGVL
WW
>EGEFANNL_01172 Phosphoglycerate kinase
MKTVNDFNFNGKKALIRVDFNVPQDDNLKVTDNTRIVSAKDTIDKVLKDGGSAILMTHLG
RPKGEASEKYSLKFIVDEVSNVLGCSVKFVDECVGDKAEKAVSELKSGEVLLLENLRFHK
EEEQGDVNFAKQLAKLGDIYVNDAFGTAHRAHASTAVIAQFFPNNKCFGLLMAKELEAIQ
KVLKTGEKPVTAILGGSKVSSKITIIENILPVVDNLIIGGGMTYTFVKANGGNIGISICE
DDKLDLALEILRKAAENNVKVYIPEDSVVADNFSNDANRKVVDTKEIPDGWEGLDIGPKT
IKTFSEVILNSKTILWNGPLGVFEMPNFAVGTKAMGDAIGEATKGGAFSLVGGGDSVAFV
KQNNYTNKVSYVSTGGGAMLESLEGKELPGVAAILEN
>EGEFANNL_01173 Serine/threonine-protein phosphatase 1
MERILVVGDIHGGFKALTQVFKIANVSNNDQLIFLGDYVDGWSESPQVLDFLINLKHTNS
CIFIRGNHDVYLLNYLKHGDLDPTWLIHGGSATVNSYEKILKKTIFKHIQFLEELESYYL
DHDNRLFLHAGFTHMRGVDFERYNESFYWDRTLWETAVALNTNINKDSDLYPKRFKLYNE
IYIGHTPTTHICSTIPTQKANIWNIDTGAAFNGKLSILNINNKEFWQSNSLPNLYPNEKG
RNH
>EGEFANNL_01174 Putative O-methyltransferase/MSMEI_4947
MELNPLLEKYIEENSEQENSILRQIRKETHLKTTQPHMLSGVLQGRILSMISKMINPKFI
LEIGTFTGYSTLCLAEGLSSSGKILTLDKNLETAYIPKKYFEISEFKDQIEFKIENALIY
IPKIIETIDLVFLDADKENYSNYLDLVKPKLKKGGIILADNILWKGKVIDHKGDKKTEII
KDFNNKVNTDKELEVVILPIRDGLSIIRKK
>EGEFANNL_01175 Gamma-D-glutamyl-L-lysine endopeptidase
MNKSVVQVSVAPVRKEPSDAAEMVTQLLFGELCEVLDTNKQWNKIKVEYDNYEGWVDSKQ
ILNLELDKFSLFSQKTSYIIEPFNLLIYKNQPFPVTIGAEIHHLSENNIFELSPNHKFIV
EENLNNQKLDKNKLLEIAFKYINTPYLWGGKSPYGIDCSGLTQMVYKIAGYQLPRDAYQQ
AEVGQVLSFIEESEPGDLAFFENEEGKIVHVGIILPSQKILHAHGRVRIDSLDYTGIFNL
DLNRYTHQLRLMRRII
>EGEFANNL_01176 hypothetical protein
MRKILLLSDTHSYIDDKILDYASQADEVWHAGDIGDVNVSDALKKVSLSFKAVYGNIDGS
EIRKEFPLNHRFMCESIDVWMTHIGGYPGKYAPVVKDQIKENPPKLFICGHSHILKVMND
KKFNLLHMNPGAIGIYGFHKVRTMLRFLIDGEDVRDLEVVEFSR
>EGEFANNL_01177 tRNA pseudouridine synthase A
MRYFIEFSYDGTNYFGYQKQPNQITVQEVLEDRLSKILRTEIKTVGAGRTDTGVHASKMF
AHFDYADDLTEKFIDKMNSFLPQDILIKKFIKVAENAHARFDAVKRTYKYSITTTKNPFK
REFHAQYLNYNLDLIKMNNAAKILFKYLDFTSFSKLHADNKTNDCVVKQAKWEEKNDEFI
FTISANRFLRNMVRAIVGTLIDVGRGKISEQEFELIIQKKNRSFASTSAPAKGLILIDIE
YPPEIFK
>EGEFANNL_01178 Low conductance mechanosensitive channel YnaI
MEFITSFFNQYHTQIIATIITLVVIFLIKLIVNRIIKKYSAHANIKEIRIKIIIKYFNVL
INIIGFVLLITIWGVTPQWLFASFASFFAIVGVAFFAQWSILSNVTAGFIIYFTSPFKIG
DTIKILDKDMGIEAKVEDIKAFYVILLSKEGLPIMIPNNLILQKAIYTISREE
>EGEFANNL_01179 Fluoroacetate dehalogenase
MLFYKDKGKGKSIVLLHGFLENLKMWEHFQEKLSKNYRVITIDLPGHGKSSDLSEEIYTM
EYMAEKVNEVLEFLKIDNFTIIGHSMGGYVALALVDLYKSKIDGLGLFYSTTLPDDEEKK
EQRLRAAELAIKNPKDFFSLAIPNLFADSNSIKSKIYIEIATSWANETTLKGISASLKGM
RLRENRTNIIKEFHKPVFILLGTYDKAIINIDLKNNLEGLDHISFYELPTGHMGSLEAPN
ESLEIIETWLKTKF
>EGEFANNL_01180 hypothetical protein
MKKIKTLLASLAIVGMLASTTISCKSGPKDQDIKTQISNILPENISIDVNKGVATLSGEF
KDDQSKQETLKAINAIPGVKSVVDNATVKSVEISADATLRTNVDQILKNYPGVTATINDG
VVTLTGEFKKTELPKLLQAVNSLKPKKVENQLTLK
>EGEFANNL_01181 hypothetical protein
MALQDKYADLINLANSLGTNDLAVREQDQVLYIDGIVSNGEIKDQLWAEYDKIDPDFRSG
DLVLNINVSPDAPSSEYKVTTQSSNLNIRKGPGTDQPILGKAAHHSIVTFLSKYNEEWYL
IRSAEGIEGYCNTEYLTKV
>EGEFANNL_01182 Iron-sulfur cluster insertion protein ErpA
MIKVSPEAEKKIIELMKEDNFDHLKDFVRVGVESGGCSGLSYKLTFDHQQKPEDKLFEDK
GIKILVDKKSFLYLIGTTLEYSGGLNGKGFVFNNPNAQRTCGCGESFSV
>EGEFANNL_01183 Endonuclease III
MKQKDKVEYLIKELGKLYPHPEPPLNHKDIFTLLISVLLSAQTTDKKVNEVTPELFKVAP
DAFKMAQIPDWEIKEYIREIGLSNTKSKNIYKLSNILVEKYNGEVPESFEELESLPGVGH
KTASVVMSQGFGHPAFPVDTHIHRLMKLWKFTKGKSVEETEKDAKRLFPKKLWNDLHLQI
IYYGREYSPARGWSLEKDYITKYFIEN
>EGEFANNL_01184 hypothetical protein
MKSVTLIFGTLYGLTSVILGAFGAHAFKKILSPDKLESFETGVKYQMYHALALLIIGLSL
SFSTSLEKWGAWGLIIGTFLFSFSIYFLSFSDFWKMNLKFLGPITPLGGFFMILGWACLL
LYFIKCR
>EGEFANNL_01185 Lipopolysaccharide core heptosyltransferase RfaQ
MKVLLIQYNHAGDVLISSVIPNNLKKIYPDIKIDFLCNKEYMGVLQKNPSIDRIIAIDNK
HIKSVLSLYKYMKLVRSERYDFLIDLSQNFSSIFLTFFSKAQKKLSYNTPILNKFYTNRL
VKVNKLNTQTCNLLENRLAVLDQFLNDQSISIDPVAKIFLSQEEILEAKTTMLNAGIKFT
RPIIMLGIFGTEKHTTWTIGSMAKLIDFIWSNYRADLLLNYLPNQHKELNELLSLLNSNT
KVFVQPVGKSIREYASLMKNCTLFIGNNSRFLAITKALQKPTFGIYAPFVYKQDIACYEN
IDFHKSIHLSDILPRLYENFYPNELKKESSKFYLMLSSEFVIIKIKPFLKSYLSTFNKI
>EGEFANNL_01186 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase
MKNLQHTIESIWDNRELLSEENNKNSIREVIELLDSGELRVAEPLENGEWKVNEWVKKAV
VLYFPIQKMQTIEVGIFEYHDKIPLKKDYESKGIRVVPNAVARKGAYISSGVILMPSYVN
IGAYVDEGTMVDTWATVGSCAQIGKNVHLSGGVGIGGVLEPLQAAPVIIGDNCFIGSRCI
IVEGVHVGNEAVIGANVTLTASTKIIDVSGDKPVEYKGYVPPRSVVIPGSITKKFPAGEY
NVNCALIIGQRKESTDKKTSLNDALRDNNVSV
>EGEFANNL_01187 hypothetical protein
MKKIYLLLILVSFITYSSCSDDLNDSVSIPSDLPRGKVVNRTGSIDGVNYSLKNLEINPN
LIKINSENAKILSSSEELNLGTIRLDVISTEIGNQLISGNVLFIQTGDHTYFKRITSVIQ
NNNSFTIETVNANLGDIFEDGTLDLSMDIKESTSDQQSLPLVSAKSINDFDHNYSLFNFD
FIKEFTRDGITLNPNTSVKSAVHLSLSFKKNLPLPKQIEVYYVLNSNISPYFSFLGGINK
KVAYNLADNIPDNILELIKKVSIDIKIPTNEFLGELPAKVSIKSINIPTEIEANLGKKSL
LAYNTSGSLKIGFAYYNNVPGKTSHPIYENSMQFKGINDTEIIGEIASDMRVSITPKIEL
FDTNLLDVSGDVVFGINSYSIGNGSTTQSSNFLSNGNFYSSATFYFKTLGVTAYTTELFK
ENKELWNLGSFNKSIEFSNLSLGKASTFPCSGLNSFSINASLDYKYPIYGKKLSGKLEMS
YDVYADNGSFLETKKISINPSNISSNNFNFSLCIPFRKINFFQTAKTSYLRNIIIKDDRG
FTANGIKNPKTGEILSEIKVSR
>EGEFANNL_01188 Photosystem I P700 chlorophyll a apoprotein A2
MKIVKIALLCTIGAFATSCVSKKQYDQAKIDYASCLERNVDKDKTIATLQERNKALEEQI
KLVNRQNDALQQNLADCMVTGKSGNANINKLIGQINESNAYIKKLTEARAKNDSLNLVLS
NKLKRSLDNLNDNDVNVQVQKGVVFISLSDNMLYKSGSYEVLPSAEEVLAKVAKIINDYK
DYDVQVQGFADNDQFKSSTSCIRDNWDLSVMRATSVVKLLQTKFDVDPARMLAGGHGEYQ
PKVPNDSPTNKAINRRTEIIILPKLDQFMDLMNQKIAD
>EGEFANNL_01189 hypothetical protein
MEIVGKIKLISEIQTFDSGFRKREVVITTEEQYPQHILVELLGDRVDIINSFSVGEDVKI
SINLRGREWVNPQGETKYFNSITGWRVEKLMTTPSNYNSPVPPSFQNTEIPSSPTAMIQE
DEDDDLPF
>EGEFANNL_01190 Leucyl/phenylalanyl-tRNA--protein transferase
MIFLTDKLEFPEVSKANSNGLLAIGGDLSADRLLLAYKSGIFPWYNKDEIIQWWSPDPRF
VLYPNKLKISKSTKKILEQEYFQFTENKCFKKVVSHCASASRKGQSGTWITNEMIDSYVI
LNQKGLAKSFEVWRENLLVGGFYGVDLGDIFCGESMFSIVSNASKCGFTNFVNKYANKYK
FIDCQVYSSYLEQLGAMEIPRNKFINYLNSETIKNLHFTQ
>EGEFANNL_01191 hypothetical protein
MSKEKYETKEILDTLNSTASKSEKFLQKYAKPIGIFFGVLILAILGYVIYDNYVVVPKNV
EAADLMVNAENLYDEGKTKEALGGGSSGILGFSDIAEDFSNTKSGKLANLYAGSIEFKKG
NYQQALDLFLKFDSQDKDLKAVKYGAIADSYVELKNTDDAIKFMEKAANESSTPATAYHF
GKKAGLLAMSLNQNEKALGFFQSIHDKYPDVDQSGEIEAYIERLKYATGKQ
>EGEFANNL_01192 Succinate--CoA ligase [ADP-forming] subunit beta
MNLHEYQGKEILSSFGVRVQRGIVATTADEAFKAAQEMTDKTGTNWWVVKAQIHAGGRGK
GGGVKLAKSLDEVKEKASEIIGMNLITPQTSKEGKKVHQVFIAEDMYYPGETEVEEFYMS
VLLDRGKGKNIIVYSTEGGMDIETVAEKTPERIFTEEIDPAVGLQSFQARKIAFNLGLSG
AAFKDMVKFVDSLYKAYIESDATLFEINPVLKTSDNKIAAVDAKVSIDDNSLFRHPDYLK
LRDVREEDPTEVEAGEAGLNFVKLDGNVGCMVNGAGLAMATMDIIKLSGGNPANFLDVGG
TADAERVEKAFRIILKDESVKAILVNIFGGIVRCDRVAQGILDAYKNMGDSIKVPIIVRL
QGTNAEIAKKMIDDSGLKVFSAITLEDAANEVTKALA
>EGEFANNL_01193 Methionine import ATP-binding protein MetN
MIELKNITKIFQEKTLRHVALSEVSLTVKKGEIVGVIGESGAGKSTLIRCVNLLERPTSG
EVWVDGKNLMLLNSSQLIEARTNIGMIFQNFNLLSSRTVFENIAFPLELRKTPNSEIKKR
VQELVDLIGLTDKIHNYPASLSGGQKQRVAIARTLATNPQVLLSDEATSALDPTTTQSIL
ALLKDINKELGITILLITHEMEVVKEICDQIAVINEGKLIEKGSVSEIFSHPKTELTQRF
ISSSLRIDIPIDYQKRLVLEPQLNKHPLLKLQITGNSVDEPILSEIARKFNINSNIISAQ
MDYAGGIKFGVMLTEFIGDAEQELLAMEYLKNKNIKVTLLGYV
>EGEFANNL_01194 D-methionine transport system permease protein MetI
MYDIIIKLAEGTWETIVMTFVSGFFGFLLGLPLGILLFITRKGQIKENLVFNQIISILVN
IFRAIPFIILIVWMIPFTRMIVGTSIGVSAALVPLSVGAAPFIARMVENSLLEVPQGLIE
ASKSMGANSLQIIKKVLLPEALPSLINSASIILITLVGYSAMGGAVGAGGLGKIGYQDGY
VNKDTTIMNFVLILLVLLVFIIQFVGDYLSKKVDHR
>EGEFANNL_01195 D-methionine-binding lipoprotein MetQ
MKRLTILALLSVAVLAISCKTEKKNNPNFIKVGVESGPEFVVAQAAQKVAKDKYGLEVEL
VEFNDYIVPNTALNDGDIDANAIQHKPFLDNIIEQRKYNLVPVGNTFIYPLAGYSKKIKS
LNELKDGSTIAIPNDATNRGRALLLLQKQGLIKLKDENALISGISDIVSNPKNLKILDID
GPQLPTVLDDKEVAIAVINNTFAGKAGLTLEDGIFVEDKNSPYMNIIVSREDNKDAENVK
KFVQAYQSDEVEETAKKEFKGGAIKGW
>EGEFANNL_01196 Biosynthetic peptidoglycan transglycosylase
MKFFLKWVKRIIIGFFVSSIIVVIVYKWIPVPFTELMIERYIFNASSIKKKWVPIEKISN
TIQLAVVSSEDQNFIKHNGFDFEEIKKILEKEGEPKRGGSTISQQTAKNVFLWNGRNFIR
KGLEAYFTCLIEFIWGKERIMEVYLNVAEFGDGVYGVEEASQKYFHKSAKNLTKPEAATL
AALLPNPRRYGKNINGNYVQKRKKWILRQMANLGGELKYTQN
>EGEFANNL_01197 hypothetical protein
MIKYSIIFFLIAQWCFAQNAVEKIYNPSVNGIQIFNYQTNDETPFFKMGDTFQLSFDMLD
QNYQTLYYSIKHFDRNWEDDNLFESEYIVGYPMSQIYNYKSSFNTQQNYTHYSIEFPNND
MQPKISGNYLITVYDQNQKPIFSKKIAFYETQVSVGVNYERYISSSNQEYNQRVMAEVLV
NNTSNIMVNQFSLTLLQNNNWNTAITNIKPQFTSANTFTFTQLDNTFIGGNQFYSFDTKN
ISVPGYGVYQVNRQANFYETLLYPVIPYPTDYVYKPDVYGAYYFRRFDLNQERNATYEGD
YTPVTFSVNLTNPLENKDLYVVGMFNNYQLTDSNKMEYDEEEGYYAKTILLKQGYYNYTI
ATVDRNTQKMDLGEIPGSFWQTMNLYQGLAYYTPFGGTYDALIGYGELRMTQ
>EGEFANNL_01198 hypothetical protein
MYPIIKDIHHYVGMATLVFIFLLTVVAFIYYIQGRVISGQVRKVSTLALILTHTQVLIGI
VLLITYFSTSQVSFDMKNAFLRRNYMEHPLTMIIVAILITIVNTKIKKINDMKFWMVLVL
AISLALVIGMIPRAFWNTLFI
>EGEFANNL_01199 Aspartate-semialdehyde dehydrogenase
MKIAIVGVSGAVGQELLKVLDQRNFPLTDLVLFGSKRSAGQTYAFKGKEYKVNELQHNDD
FKDVDIALVSAGGGTSLDYAETITKHGAIMIDNSSAFRMDDQVPLVVPEVNAEDALNTPK
NIIANPNCTTIQMVVSLKPIEKLSHIKRVHVSSYQSASGAGASAMAELEQQIKEVAEGKP
VNVEKFAYQLALNLIPQIDVFTENGYTKEEMKMYNETQKIMHSDIEVSATCVRVPVMRAH
SESIWVETEKELTVEEVREAFQNFEGIIVQDNPEEKQYPMPLFLSGRDEVFVGRIRKDLS
NPKGIAFWSVSDQIRKGAALNAVQIAEYLIKDKK
>EGEFANNL_01200 putative multidrug resistance ABC transporter ATP-binding/permease protein YheI
MSSLKSLNPYFYKHKKLLIIGIIFIILANILTIYPIKFVGKAVNIIAETISNPKNLDKNE
LYRQLIVYGSIIILAPILTGIMRFYMRQTIIVASRRIEFDLKNNIYKHYQTLSYTFLKNS
KVGDLMNRISEDVVNVRQYLGPGVMYSINTLILLIIILGCMLATDPIMTLYAFIPLPFLS
YFVYNQSIVINKKTKKSQEKQSELSSFVQDSFSGIRVIKSFTKEKFIISQYVEKSKDYKE
KSISLATTEAFFSPIMVFMIGLSNVFILYIGGQRYIHGKIDVGTITDFFLYLNILIWPFT
ALGWVTSIIRRAEASMERINDFMKVKQEIKNINHDNYSIKGDITFDNVSYTYPNTGIKAL
DSVSFHIYAGETIVIMGKSGSGKTTVALLLLRLIEPDSGNIYLDGKLLKDHNLELIRSKF
GYVPQENFLFSDTIFNNISYGIQNATQQIVETYAKKAEIHSNILKFKNQYQTHIGERGVT
LSGGQKQRISIARALIKDPIIYVFDDSLSAVDTETESKILINISKEIKVKTTIIISHRIS
TTKYSDKIIVLEKGEINQIGSHYELISKPGYYLEIINQSK
>EGEFANNL_01201 hypothetical protein
MMNDFENVEKKENEIFSKVLRAGKRTYFFDVRETKAGDYYLTITESKKNVSEEGSLGFKK
FKIYLYKEDFKNFKDILEETTSFIIKETGEKVISERHRDDFNLLTEDDNNKHNVNNKNIS
NYTNISFEDI
>EGEFANNL_01202 Murein DD-endopeptidase MepS/Murein LD-carboxypeptidase
MKSFIKIFLVSITITLSTTSCVSSYVARNDGYLTTEALLAHRTNYSKSSIEAESKNFNEN
SSAVFEEETSEKSYSQEAYKLIGEAKTYLGTPYRYGGTTRSGIDCSSFVQHAFNALNISL
PRTSILQSNEGKIVKKDQLKKGDLIFFAQSPKSRISHVGIVERVEPDGEIYFIHASSSKG
VTISSLEGEYWKKRYRTAKRILESNNNLDNIETQNIHSDLAKVSS
>EGEFANNL_01203 hypothetical protein
MKKRDYLFIMSCLTGFICVQSQEKQDSITNLSNVVILGKVPISKEQVKKNQIEKKNLGQD
VPYLLKNNLSVVSSSDTGNGVGYTNMRIRGNDQTRINLTLNGVPVNNAESQGPFWINMPD
LASSMSSITIQRGVGTTTEGVGSFGASINVKTQEPSNNPYFQTDQSIGSFNTHKHTFGIG
TGNLLNDQLKIDARVSFIKSDGYVDRAYSDLFSYYTHAVFKKNKTRIGALVFGGKEQTYQ
AWNGIDEETLKKRRTFNTSGAIYGSNGEIVRFYDNQIDHYLQNHYHLYLDQEINSIWQLK
STLFYTKGKGYFEEYGQNSKLNDYKLAPININGITINETDLIRQQWLNNDFYGIVNSLLG
FYKRWTIELGLGANVYQGQHYGKVIWAQNFSDQINGHEYYRNKAKKEDLSTYAKAIYKLN
KKWEFFGDIQYRFINYEGHDVQGGESLYKNGGELNFDKNYNFLNPKVGTTYKLEKEDIYF
TYGIAQREPTRDDILNNKDIKHELMHNVEVGLRKNTLPFSYTVNWYGMYYLNQLVLSGAV
NDVGSFIRENSGKSYRTGIELSASYLVNTKLLLSANSTVSINKNINYKKEEGLYTVDLGN
TDLAFSPNYIGNLIIEWKPIKNLSATLSNQYVSSQYLTNENQKNAKLDGYFTSDIVIQYS
PTLPKLKDFSLKLALNNIFNATYINNGYYYDHVAYYYPQAGFNILTGISLRL
>EGEFANNL_01204 putative protease YdcP
MTKTGKIELMAPAGNFESMQAALENGADSIYFGVEQLNMRARSSVNFTLDDLDEVSRRCS
EKGVRTYLTLNTIIYDHDLSIIKTLLDRAKSANITAVIAMDQAVISYARQIDMEVHISTQ
INITNIETVKFYSLFADTMVLSRELSLSQVKKITALIEKEQIKGPNGNLVEIEIFGHGAL
CMAVSGKCYLSLHSHNSSANRGACKQNCRKKYTVIDQESGFEIEIDNEYMMSPKDLCTID
FLDQVVDSGVKVLKIEGRGRAPEYVATVTKCYREAIDSIEEHTYSKEKIENWMKKLETVY
HRGFWSGYYLGQKLGEWSENPGSNATQKKIYIGKGRHYYPKTKIAEFEIEAYNLNIGDKI
LVQGPTTGSQETDVKSMRVEDISVQEAKKGDILTLPLEFKVRPSDKLYKIVKTEFSN
>EGEFANNL_01205 hypothetical protein
MIIITLQREKCIGCNYCAEFDPENFRMSKKDGKSVLLRSQEKKGFHTIKIPDESIYESAD
KAAKACPVKIISVKKI
>EGEFANNL_01206 5-formyltetrahydrofolate cyclo-ligase
MTKQEARKYFLNQRNLLSENTIQEYSLAIIDQIKNSTILRSNTFHIFLSIQEKKEVDTNE
IIKFLWKNNKKVYVSKVEGNILRHYKFLPETKLKKSKWGILEPYNENPITIDHLECIFLP
LLAYDLRGNRVGYGKGYYDRFVKNYPKAEKIGLSFFNPVTKIEDLHMEDVPMDSIITQNR
YSGFPMYEK
>EGEFANNL_01207 hypothetical protein
MKINHVLQILLGLIIIIVISCNKAKYYDGDIDPVKTKGYKNENYYSSEKMDSLAVISHIN
QQKLQEVYDLAILTSEYKSNKDIDTLLLSQLQGYFPSGDTLYYSRIIHNLDSLRAKYVKI
ELDNFVSNDSLNIIHKDSLQINKSDSIIGKVLFNANFYDKNKRYIYTEKNQANYILKKNP
KKFKLEFKFYFSYIGKPE
>EGEFANNL_01208 hypothetical protein
MTNQDKILFENLKKEVAKIFLDDFPSVNPDISKWKGLDIVYFQESLRQKVKGNVSEKWFY
TYFKSEFEKLPRIDMLNLLSQYAGYKRGWTEFLEYQKNDTSKTNANTSSKNKNSKHNIQE
EIIENSLENNNDKSNVNNSKRNLYVLISVFSLLLILFGLYKYYFYYKSNYTFCFYDSDRS
SLIKSDLEVIIEKPGISPEYYKISEGCFSYRSTIDTLKMIVGSPYYKKDSFIVSLKQIRE
KGEENHRNFKLRPNDYAVMLYYYSTSLNSIDESKKAQFINQRKEELDKLIDNNALIYQVY
DSEVFGVEVLDKKKYIDFMTTPTTSLKNYVLIASQVNKNNKISLIKFKIQKNEN
>EGEFANNL_01209 hypothetical protein
MTNNNMKKNIKITVFLVAIAGSLLACENKKTNSEASVGDSLVGGLNSQPVQEVNPATPYT
NDSLANETKNENPLVGGMDGQLQQEVNDSVKNK
>EGEFANNL_01210 hypothetical protein
MKRLFLNIAVFSAITTTTFIACDKKKSESDAANIDSIATSPDSLNVVEEQLTETITEQPA
SVSNDSTAVSTDSTKLEKVDQIESKSK
>EGEFANNL_01211 hypothetical protein
MKKIALNLVALALVVTTSFVACDKKNTTATDNKDSLNAAINDTVNSTLNQADNAIDSLKG
EAKDAVEDAKDKTSDLVGDAKEGLKDAASNVKEGTQNLKEGIKETAKDAADAVKNAADDV
KKEIK
>EGEFANNL_01212 Modulator of FtsH protease HflK
MQIFGSLVSVFLFIIVCGFILTFLGAFFTVKQQTTAVIERFGKFNCIRQAGFNLKIPIID
KVVGRVNLKIQQLDVMIETKTKDNVFVKIKVSVQYMVMENAVYDAFYKLQNPHSQITSYV
FDVVRAEVPKLRLDDVFERKDDIAIAVKGELQEAMLSYGYSIVKTLVTDIDPDEQVKHAM
NRINSAEREKIAAEYEAEAERIKIVAKARAEAESKQLQGKGIADQRREIAKGLEESVKVL
NGVNINSQEASSLIVVTQHYDTLSTIGSNSRSNLILLPNTPNAASDMLTNMISSFYATQN
INDESKIDK
>EGEFANNL_01213 Peptide chain release factor 2
MRFLISFVNFEDMITLDNIKDIELRIHHLYEYLDIEKKQIEILNEEEKSSDPSFWNDPKK
AEIFLKQLKSKKKWVDVYMELKSLHEDLQVLFDFYKSKEISEEELNLNYLQTVGLLEDIE
FKNMLSSEGDDFSAVLQITSGAGGTESCDWASMLMRMYIMWAESHNYRIKELNYQSGDVA
GIKTVTLEIEGEYAFGYLKGENGVHRLVRISPFDSNAKRHTSFASVYVYPLADDSIQVQV
NQAALSWDTFRSSGAGGQNVNKVETGVRLRYKHKDEDSGVESDIIIENTESRSQLQNKEK
ALQLLKSRLFEMELEKRNAKRDEIEASKMKIEWGSQIRNYVMHPYRLVKDVRTGTETSDV
DSVMNGNIDDFLKSYLMLMGQKENNV
>EGEFANNL_01214 hypothetical protein
MKSKFFIVLTIFLLVKVPSQNNQGTREYNELEKENINNKEKIYFLKAYSLNYCLYTNYRN
IDLDTTLAYNDFSSLKLGDESGRNDKLLYDLRKYITSKTDSFYIKGSTYYSERGIPNLIF
YDCYQFYESKELKKYIKNLLKEESNL
>EGEFANNL_01215 hypothetical protein
MKNCIILLVLLVSFINCSQKNKLSSFNSENKIKSIPKDTLVRDSLIIDKLSKDKQAYQDF
KEWGCSLCYEKYSTDSAKINFENTSIDLFNSCEQITPKKTSIGVDSVKCHVFPRLIDEKT
ENIKYFFENYIKKESANRKLTLETCKDLFNDSKLKRQYEIFINNRSNFMRNIYYENDYLN
FGYAKVYTE
>EGEFANNL_01216 hypothetical protein
MAIIALAEGVESPPINPIRPKWSDVYKNYPKKSATEDMFGPDLYKSMYGDDYDMSTHLLD
KKYYLYNACAAKVSMALVLSGVELKMIDNIGRDFVARQGVMKNKGFISTASKMKLWLEKA
WGDVFCSWETGKSCPSYTVKEFGLSVGNRKGIYVMLAKNPTDFGAGGHVTLWVGGSQGAF
AGKHYDKSAKAMYFWELK
>EGEFANNL_01217 hypothetical protein
MEVEAMNYLDLYGKQKLITYTKGNAEMGALGQMHVHGTSALYSAKTTLDYKAPNMGRMAQ
PENFLYGKEKQIVEMYWSYGDDYTRLTNKSRFYVDMNLHVLTRNYEPGESIKLTLKNVDE
SPLAKELDTLELSGVVDNGNQIIFKDVFKDYTLNLTKEDPQDEEDFKAEEEENKKQAEWK
KWEEEQWKKYQNKKRNKGFFNF
>EGEFANNL_01218 ADP-ribosyl-[dinitrogen reductase] glycohydrolase
MLLIKDKDIEEIYFKLQNHISNFLLEQKIPSKEIKKFDRLLQNRIFDLKEEDIQSSGYVI
DTLEASIWCLFKTQNYKDSILKAVNLGEDTDTTGAVTGGLAGLLYSHESIPQEWLLKLAR
KKEIDNMINKLE
>EGEFANNL_01219 hypothetical protein
MKLGDNLKRLREGKGYTQQQMAELIHTHRTGYSKMENNQQDIPVDALIYISKHFGISVDD
IIFYNEKNEIPQEISIKDAEALEQLKLINELEPEEKNILLKLIETFISKKRFKDYLQNNI
ASL
>EGEFANNL_01220 hypothetical protein
MSEKIPEYISNKEIQDFLDSCIKGDIYLSISEEYLNKNIHSFYENHFFDWKTGERTYTDE
DLKKVVKKDFLGMLFAENKDFQPMQEAFKKSYPGIYSLLFEIKQEFPYQSLSYLLFQVES
YVMLELLARDFNNKNRGRLPFFTFHDCLVVQESKEQMLEDYMKVRLAEIYKKPPHFKFKK
W
>EGEFANNL_01221 hypothetical protein
MKPFLITLFVLFFLSGKSQVNLNLTLNFYFSSNYDYDLDRNTSYPIKFNSIILFDIVDGK
GKVIIYYSGKKQIFQVLSCEKNKNYIKFFYSTGGTSSLIWEEKYYVLFTLDDPRNNTAVL
FHN
>EGEFANNL_01222 Arginine--tRNA ligase
MNPKSLLKEICIKAIKRIFGLEIDTIEIQKTKDEFEGDYTLVVFPLVKYLQQKPEQIANT
IGNSLLEEKEIIHSYNVVKGFLNITLQDKLFINFLNNNYSNPEFGIKKELGNKIMVEYSS
PNTNKPIHLGHIRNNLLGYSISKILKAAGNEVITSQIINDRGIHICKSMLAWQKYGEGET
PESSKLKGDHLVGKYYVIFDKEYQKQVNELVTKGYEKEEAKKKAPILLEAQEMLRKWEEG
DTEIRELWHTMNHWVYQGFEMTYKQLGVSFDIIQYESNTYLLGKDIVEKGLEKGILLQKE
DGSIWADLTEEGLDQKLLLRADGTSVYMTQDLGTAVERFAKYKLDQLIYTVGNEQDYHFQ
VLFLVLKKLGYTWADHMYHLSYGMVDLPSGKMKSREGTVVDADELMQEMIETAEQISIER
GKLDEFTQEEKSKINESVGLGALKYYILKVDPKKRILFNPEESVEFNGNTGPFIQYTYAR
IQSILRKEQPQDTVNNDNKLNEVEKNLIIQLSYFPEAIEKSAHDLNPSIIANYVYEVVKE
FNHLYQNYPILNSESIEQKHLRLELAQFTGQVIALSLYLLGIESPNRM
>EGEFANNL_01223 UDP-2-acetamido-2-deoxy-3-oxo-D-glucuronate aminotransferase
MVDLISQYKCIEAEIQKGFDQVLNTASFINGQQVTQFANNLENYLQVKNVIPCANGTDAL
QIALMALDLKPGDEVITADFTFAATVEVINLLNLKSVLVDVDYNTFTIHPEAIKKAITPK
TKAIIPVHLFGQCANMEEILKIAQEHNLYIIEDNAQAIGADYIFSDGTTKKSGTIGTIGT
TSFFPSKNLGCYGDGGAIYTNDENLAHKIRGIVNHGMYKRYYHDEIGVNSRLDTLQAVVL
NAKLPHLDEYNKKRMNAADYYDKEFANHPNLQVPTRAEYSTHVFHQYTLKIVNSNRDELQ
KYLLEKEIPAMIYYPVPLRKQKAYFSDDYKDQDFIITDQLINQVISLPMHSELEDEQLKY
ISDNILMYFNTKN
>EGEFANNL_01224 putative FKBP-type peptidyl-prolyl cis-trans isomerase FkpA
MIKKVFLLAVVGMAVVSCDKKSGNSASVSTLKTNDEKASYIIGSNMAQNLKAQGFDKTIN
WDVFMQGIKDKLEGKKSLFPEDSIQSFMTTYIPDHAEKVKKSNAEEGKKFLEENKKKSGV
KTTPSGLQYKVEKEGTGANPTSEDIVSVNYVLKTIDGYVADDSKKINGKPVDIPLNQVVP
GWQEGVKLMNKGSKYTLYVPSELAYGENGPVGPNQTLIFEVELVDFKPDSKKDQQAIPQG
GIKQMDEEQNKDLNVQSQQPKK
>EGEFANNL_01225 putative FKBP-type peptidyl-prolyl cis-trans isomerase FkpA
MKKNIIAVALCVYALPAFAQKTTKITTDKEKLSYSIGVNIAENLKAQDLSEDIDVTVLGQ
GMNDVFAEKPLLFTQDSINVFMQKFGQKKMAELQQKREILGKKNKEEGLAFLAANKKKKG
VITTASGLQYEVLSKGTGKETPNATDKVKVKYTGKLLDGKVFDSSDKSNNGQPVEFILDK
VIPGWTEGVKLMNKGSKYRFYIPSELGYGENGAGSEIGPNSVLIFDVDLVDFQAQPQDAQ
EVQGIQNNK
>EGEFANNL_01226 putative FKBP-type peptidyl-prolyl cis-trans isomerase FkpA
MENSKNIYGQPVDIPLNQVVSGWQEGVKIMDKGSKNTLYVHAKLAYGENSFVGHNQTLIF
EVELVDFISMTKPEEQIVPTKNAELIQQYEEQIELYRK
>EGEFANNL_01227 hypothetical protein
MTTYIPDHAEKVKKSNAEEVKKFLEENKKKSGIKTTPSGL
>EGEFANNL_01228 hypothetical protein
MSNTNSLLSIKNILETTEEKIDKNLSLDTTQKPKDEFNEEQVILFWNDYLEKLKLEEPIL
FNALNSAKCNLKDKYLISFEFPSNSSYEEFETLREDFFQKLKYKLNNFSIEFTYQIKQST
VNISLSEKDKYQKMLKENPWLEKLRNDFRLDF
>EGEFANNL_01229 DNA polymerase III subunit tau
MDNFVVSARKYRPLEFDSVVGQSHITDTLEHAIENNQLAQALLFCGPRGVGKTTCARILA
RKINEKFGETDENDFAFNIFELDAASNNSVDDIRNLIEQVRYAPQVGKYKVYIIDEVHML
SNAAFNAFLKTLEEPPAHAIFILATTEKQKIIPTILSRCQIYDFKRIEVIDIKEHLQKIA
IKEKINYEEDALHIIAQKADGGLRDALSIFDRLVTFTQKNLTLSAVTENLSILDYDCFFR
ITDMALNNDIPNLLLVFNEIEKKGFDPQSFIASLGSHFRDLMVAQNPQTISLLEVGESTK
KKYIEQAQVCKPKFLINAIEICHQADINYRSSKNSRLSIEIALMQLASITTDEFTSSKKK
SLE
>EGEFANNL_01230 50S ribosomal protein L34
MKRTFQPSERKRRNKHGFRERMSTPNGRKVLARRRAKGRKQLSVSDYRAKR
>EGEFANNL_01231 hypothetical protein
MKFNHILIYSISFLLLSCNSNNKDSSPADLSSKEITSSNSLSDEVDWENDFKPFENNHNI
SAEKKSQIAILKKELGFKMKAIGMDPKLSGYEKGVEKRKLKSQYLSEINKLINGEQSGLN
SAFYDNPELAQQYQKFNELELQLDKLENEYDLQKDQLERQENSLSKNKYKKRKEELKSNY
KRKKDYLKMKMDSIILISTNK
>EGEFANNL_01232 tRNA pseudouridine synthase B
MYTLEQLQEGIIYLIDKPLDWTSFDVVNKIKWRIKRHFNVKKIKVGHAGTLDPKATGLLI
VCVGKYTKKIQEIQNASKVYTGTIKLGVQTPSYDSETNEINPKDYSYLNKLSINDATKSF
IGLQINQTPPLYSALKKEGKRYYEIARKGESIDISARKINIYDFTITEIQLPFIKFKVHC
SKGTYIRSLAHDFGNLLGCGGYLTELHREKIGDFDVENANNLILVKEDYFS
>EGEFANNL_01233 Glucitol operon repressor
MRSPNNINNIRQQEILDELKYNNYVSVADLCRKLNVSAVTIRKDLTHLEKIGKLYRTHGG
ATRESFIVQERNINKKETLQVEEKTKIAKAALSLIEENDFITISSGTTTQMIAQVIGSQY
EKLTILTSSLKPALSLYGNPNFNVIQLGGDVRTKSGSVMGPYAELMISNYSCNKLFLGAD
GVDFDFGLSTSSTMEAKLNQMMIENSEKVIVLADSTKISKRGFGKIVELEKIHVLITDDG
ISTTDLQRLEDIGIEVIIAK
>EGEFANNL_01234 putative glycerol uptake facilitator protein
MDSVLTTKFIGELLGSFTLIALGCGINMNLTLKKSYGEGNTSSVTGPLAWGFAVAMAVIV
SSPFDTGGHFNPAVTIGQWAAGVFPKEWILTYLTAQFIGCFLGALAVSFIYKGHLDQTAS
EPAKLLGVYATNASIRENKIQNFSSELLATFFLILIGLCMGANHAGVIIENSTGIPQFTH
SVVGFGSLGAIPAGFMIFAIGMAFGGITGWSLNPARDLMPRLVHQILPLKGKGDSDWGYG
IVYASIAPMIGCLLAAGIYLIIKPYFG
>EGEFANNL_01235 Transaldolase
MKFFIDTADLDQIKKAQDLGVLDGVTTNPSIMAKVGITGKDQIHAHYKAICDIVDGDVSA
EVLSVDYDGIIKEGEELAKIDNQITVKVPMIYDGVKAIKYLSSKGIKTNCTLVFSPGQAL
LAAKAGATYVSPFLGRLDDISTEGLNLIEDIRTIYDNYGYTTEILAASIRSPMHIINCAK
IGADVITSPLASIINLLKHPLTDSGLAQFIEDAKKL
>EGEFANNL_01236 Glycerol-1-phosphate dehydrogenase [NAD(P)+]
MSKESIASALKQATETKFLEIESGILNQVPKIFSEQFPGKKGIIIADPNTYRVAGEEIHE
ELKKAGLEGESPYILDDPNLYADYIFVEKIRDYLKDKDVTPIAVGSGVINDLVKRASSEL
KRKYMCVATAASMDGYSSAGASITNKGAKITHACEAPQVLVADIDIIAAAPPLMTASGYA
DLYAKVVSGADWLIAAELYDEKNPKKGIEPLTSAWHTVQDGLAESLSDPEGAKNGNAKAI
ELLTEGLMLGGFAMQSMESWGAGVSRPASGAEHQFSHLWDMEHHTFQGEMAKRFGLYPNQ
DEQAPSHGFKVGIGTLAITALYEVLLKTPIENLDIEAAVEKWPTLEDQLSEINEMFGGTE
ILPFAINQTTDKYVTKEELREQLTKIKNNWPSLKEKIQKQIIPFNETKRRLSAVGAPVEP
EEIGITRDRLKKSFYRAHKIRSRYTILDFAYRAGYLDQWVDELFNSGVLKG
>EGEFANNL_01237 Glycerol-1-phosphate dehydrogenase [NAD(P)+]
MNSQNRIDKALSKATETKFLLIEAGAINKVAEIFKIQFPDKKAIIIADPTTYAIAGEKIT
KDLEKENLLGENTYILKDPNLFGDYVYVEELREHLKGKGLIIVAVGSGVINDICKRAASE
LETPYMVVATAASMDGYSSSGAALTNKGSKTTHPCEAPQVIVADLNIISKAPSLMTASGY
VDLYAKVPAGADWILASELYDKNNPLEGIEPITEAWHTVQDGLAEALADPEGAKRGEHKA
IQLLVEGLMLGGFAMQEMKEWGLGVSRPASGAEHLFSHIWEMEHHTFQGEMAKKFGIYPH
KDNQSPSHGFKVGIGILATLAFYELLFQTPVENLDIEKAVENWPSLEQQNLEIEKLFKGS
DILPTALKQTKSKYVSKEILREQLTKIKNNWPKIKERLQNQLISFEETVERFKQVGAPTK
PEEIGLTKEDLKLCFYKAHKLRARYTILDFAYRAGYFEDWVEHLFTKGIFK
>EGEFANNL_01238 Ribulokinase
MGKDQYIVGIDFGTLSVRSSVIRVRDGFERGTAVSEYKHQVMDQNLTASENEPLPPDFAL
QNPTDYIESLIESVNQAVKDSGVVVKHIIGIGVDFTSPTVLATNSMGVPLCNFPEFKNRP
HAYAKLWKHHAADDQAKRLLKEAQDRKEDWLSFYGGGLSAENTVCKIMETYEKDRELYDQ
ATNFVNAVDWIVWQLTDQLIFSSADTGFKKNYQNGKYPSYDYLESVSKGFGNMYKEKMNA
PIQAIGTEAGKLSKVMAEKLGLYPEISVAVGLNDGHVTPAAVKAVRPGILSAILGTSGCY
FINSEKFKEVPGMLGIVYEGVVENLWCFEAGQTSFGDTFAWFTKNFVPSEYQEEAKKLNL
NLHEYLTRKCSTQKIGQHGLIALDWNNGNRSILCDASLSGLLIGYTLTTKPEDIYRALME
ACAFGARKIIETMNQYELEINEIVVAGGMLKNKFFMQMLSDITRLPISITKSNAIGALGS
AIYGAVAAGCYPNITTASDAMGNKVPNVFKPNEEKAAAYDLLYEQYTALYTLFGEKQPEI
MHQLKKIQKNSTLTINNKN
>EGEFANNL_01239 Ribonucleotide monophosphatase NagD
MKNHITDIKTVPQEILEKIQKIKHVALDMDGTIYNGSTLFPYTISFLNQLKQLGVTYSFL
TNNPSKSISDYLKKLEHLGIPATEEEMYSSAVATIDYLKNNHPEVKKLFLLGTPSMIEQF
ENAGYISTKDSADDEPDALVVAFDMSLTYERLCRAAWWAKQGKLYLATNPDRVCPTDQPV
VLVDCASIYACIETATGRKPDLVLGKPQKEMLDGILESKKLKPEEVAMVGDRIYTDMMMA
YNAGAFGVLVLTGEATLDDAKNANPELDIILPSIKELGNLIEITHSK
>EGEFANNL_01240 L-ribulose-5-phosphate 4-epimerase UlaF
MSKYNRIKEEAYHGNLQLSKLGLVLFTWGNVSVADHSEKVFAIKPSGVPYENLTVEEMVI
VDFEGNVIEGKLRPSSDTPTHAVLYKHWNDVNSIVHTHSTYATAWAQSQLDIPILGTTHA
DHNTSDIPCAPPMSDEMIKGNYEYETGFQILNILKEKKLSHTEMEMVLIGNHAPFTWGKS
AEKAVYNSAVLENVAKMAYLTKQINPNAPRLKDALINKHYERKHGTNAYYGQN
>EGEFANNL_01241 Ribulokinase
MSISNHLVIGVDYGSDSARAILIDAESGKELALSVKEYTRWKKGMYCDPVNYQFRQHPLD
YIESLEFIINDVINKVPGSRDRVKALAIDVTCSTPIVVDKEGTPLSLKPDFAENPNGMFI
LWKDHTGIEECDYINEFSQKWHTDYTKYAGGGGNYSAEHFWAKALHVFKTDPDVRKVGHS
FVDACDWLSNVIVGINKPEELKRNICTAGFKVLWNKEWGGYPPNEYFKALDPVLDGLVNT
FSKEVYTCVEPIGHLTEEWAKRLGLTTNVIVAAGNIDAHAGGIGAGVKNKAIVQIIGTST
CDIIVGPKSNGDRLIPGISGQADDSIIPGMIGYEAGQSVYGDYYAWFKKVLMWPLREIFA
KTSLVDEETKQKVIDEVYAEMIPTLAEQAKLIPTKDSHIIATDWINGRRTPNVDYTQKGT
ITGLALSSSTPLIYKAIVEATAYGSRAIVEQFINNGIEIEEIIAVGGISQKSPYVMQVLS
DVLGMPIKVIATREACALGVAMCASVAAGIYPKLEIAQEKMGMGISTVYTPNPDNHAHYN
NEYKKYKKLDSVKELTQ
>EGEFANNL_01242 Ribulokinase
MKLSDNLVIGLDYGTDSGRAMLMDAETGKELALSIKEYPRWKKGMYCDPIKSQFRQHPLD
YIEVLEFIVKDVLERVPGAAEKVKAISVDMTGSTPVAVDKNGTPLSLLEGFEENPDAMFI
LWKDHTGQKENDYINDFSKKWHLDYTKSSGCGDYSTEHFWTKALHIFKIPEIKSVAHSFV
ESSDWLPAVLCGITKPEDIKRGMGIAGSRVMWNKDWGGYPPNEFFKALDPVLDGLVDTFN
KQAYTCDQEAGTITAEWADRLGLPKNVKIAVGNLDCHAGAIGAGVKDKSMVEIVGTSTCA
ITVGPKSLGNKLVPGIPQQADDIILPGLVGYEAGQSAFGDLYAWFKKLLMWPLDNIMLNS
NISDAETRKELRDEVYAEMIPALAKVAKTIPPKDSHIIATDWINGRRSPNVDYELKGTIT
GLALSSIAPLVYKSLVEATAYGAKNIIDRFINNGVELNEIIAVGGISQKSPYVMQVMADV
IGMPIKVIATREACALGVAMCASVVAGIYKNIEEAQQKMGMEISTIYYPNQEHHEHYKIE
FDKYLQLEKIKDIIH
>EGEFANNL_01243 hypothetical protein
MMYKLKFYKSPIHSYIFNKKQLNTKLKSRHYNYLTFE
>EGEFANNL_01244 Anaerobic C4-dicarboxylate transporter DcuB
MKTKLLSCFSLIIFLLLFTLPSKTYSLTPQTIVSIQNVSSINTDTNKQETIKTATSSKEE
ISKNSINHEIPKNAPIKFVVQVIFLLVIIYFGIKKGGVSLGLLGGFGVAILVFVFRDIPG
MPPIDVMLIILAVVTTSSTLEATGALGMLVKFAEKILRKNPKYIVYLAPMSTFLLTMLVG
TGHAVYPLLPVIYDIAYKQKIRPERPMAVASIASQMGITASPIAAASAAMISVALASGVT
ISLLSILIVTIPSCFIGMILAATWSLNRGKDLDKDPVYLEKMKDPEQRAYIVGNLEQTSN
GTPSKDAKVSLSLFFLGILFIIIIALFPDSILPKNNGKPLAMTSVLQFVMLGVGAVIVFC
TKVKAKAISDTKVFNAGMIAVIMIFGIAWMSETVIKNNESYLLSLISDAVRARPWTFAIA
MFCVSMFLKSQAATILVMMPLGFMLNIPIATLIGCIPASYAYFFFAFYPSDLATINFDRT
GTTHIGKYILNHSFMVPGLIGVISATIIALSLSNIYN
>EGEFANNL_01245 hypothetical protein
MRKFLVLFITFFIFQGCMVSQSKKIKNISFQVLDSGSYSNVADKSIKLVNDQKEFDLLFS
KIYGTGIKVPFDYSIECSYIFIFFKEQASGGLNYKVTNVTQNNDSINIYLDVVKNDDIPT
ISTMAISHPFIVLKIGKSQANDINVLLTND
>EGEFANNL_01246 Cysteine desulfurase IscS
MATKKIYLDNAASTPMDPRVIETVWESMKENFGNPSASHSFGQTSKSKIEIARKIIAKEL
NAQPSEIIFTSCGTEANNLILRSCIENLAIQRIITTKIEHKSVGETVKYLKNKPNFDIIY
LPVNYKGEWQLSDLENLLQDGTPTLVTLMHANNEIGNLIDLKSVANLCKKYNAWFHSDTV
QSMGHYSMNFSDVPIDFASCSAHKFHGPQGIGFAYIRKSTGIKAIQTGGGQERGMRSGTE
NIAGIVGLGKAFQLAMIELEERKKIIEELKLYAITQLKKYIPNIKFNGKSDDLNQSIYTL
ISILLPFSNSMIGFQLDMKGIAVSQGSACSSGAVSPSSTIQELLTVEELSSCSILRISFS
HFNTKEDIEHLVMALKNIYEQDKSNARVHKS
>EGEFANNL_01247 Endonuclease MutS2
MKLSVGNKVSIVDEQEYYTVKKIYSDKVIVVDTYGFEHVYPKHKLLNIENNANLYYETLN
NDSITCKDSSESKEIYKNILKKEVQVREIDLHIGHLIDNIKDIPPHKMLQRQINQAIIEI
EKARKDDLNKLILIHGKGKGILKKEIYELLKTIPKIEFLEADIVKYRFGAVEIRFKK
>EGEFANNL_01248 Hercynine oxygenase
MKIGKFILLLATVSPLLLTLASCGGGSGRSKPGGGTRNTQSLSGWKPNDKNGWFFSNKKK
TEKGWTGMVFVEGGTFTMGLVKDDVMHDWNNTPTRMQVRSFFIGETEVTNYEYREYVTWL
KYVYSPTDQNYKDIYFGALPDTLVWQNKLSRNDIYSEDYFRAPQFNNYPVVGVSWLQAQR
YCDWLTDRANERELMNQGIIPKDYYSNPENNVGSNSFNVEKYKYNDPSLEGIVNQEKVAK
RSGITNKNERIISVNKSAQGNLVQKFRLPTEAEWEYAALAEADNRQYNLVEGKDVMINRL
RGKKGRNRGQFLENFKSGGRGDYSGIGGFGNDGNAITSDVRAYPSNSFGLYGMYGNVAEW
TQDVYRPLIDTDYNDFNYFRGNVYQQFINDESGEAGRFKKVDDGSIQYDTLADGRLVYKN
LPGKFETEVVEDARNFRDGDLQSSLEAGAGISNEGGSYNFYNSPIRNWVVDEKGRVVLQK
DTKSRTSQISNDLRVIKGGSWNDTAYWLDPGQRRYMSENESAVWVGFRVAQDHKGKESSS
TRTQRGSKNKIPK
>EGEFANNL_01249 hypothetical protein
MKKKLLFLSLLSVSSLFQAQNRNYAIVTGAPFLRISPDARSGGMGDQGVATSPDAFSQYW
NPSKYSFNTSYSGLGVSYTPYMNKLTNDVFLLNGTFYTFLGEEERSTLSASVYYFNMGEI
QLNELMGNNIVEKGISKPNEFSIDVAYGLKLADVYSMAVTARYIRSDLFNNVDNSYAQTK
AANTFAVDVTGYFQSEKGSSFSGYEGRWRAGWGIFNMGPKLDYSNSSQNSSYLPTQLRLG
GGYDLYFDEDNKLGLTVEASKLLVPAPEKMTDPDGAIYYQIPDKSFLSGMFSSFGNKDVG
KEITYSIGAEYTFKNAFAFRTGYFHESPEKGARQYITLGAGLKYQSFGIDFSYLITTASI
NNALDNTLRFGLTWDFGGESSNATENY
>EGEFANNL_01250 Bifunctional oligoribonuclease and PAP phosphatase NrnA
MFSQEELSKINKLINTSKNILILSHHNPDGDAIGSSLALNLLLSNLGVHSTIIVPNEFPK
FLKWLPGAKNIVIAEQRLKFTEIAFENADLIFCLDFNSASRINHLKDKLSQSKAIKILID
HHQQPDVFDYVYSDTSQPATCQMIFKFIEALGENSLIDKNIATCIYTGILTDTGSFRFRN
TTAETHMIIANLIEKGIYPDEIASNVLDNNTPEKIKLLGTVLDSLQIIPEKNTAILSLTR
NQLKLFGYQKGDTEGFVNYGLSIIGIKFVAFFMEDIHNNFIKISFRSKGDFDVNQFSRKY
FSGGGHMNAAGGRSDLDMKDTLQKFKNIINTEIDEIS
>EGEFANNL_01251 hypothetical protein
MKSLNLLTFLLILLCFSCHKKEAFQPIKSKSASEFINISKEYSKQREEKERNFLQDWINN
QKDSLGIAYMPTASGFWIRFITKNNNPRALKNNFVKYSAEIKTLTGETIYNSQEFGFKEG
VMGKFKDIRGIESSLYLMGKGETVELVLPSFTAYGFFGDENKIGANVPLLVLLTLDDVKT
LPFK
>EGEFANNL_01252 hypothetical protein
MEKEILSNLLKAYDLAILEYNDWILVNEQLPAIRANTQGYKEFDQGVSIRLDISVLLADK
KVINESYPGIGKDKKAAIQNAFQNFISNSFYIFLASFWEIREDDQVGIENWNINNNNWNI
YIGNFTCKGDFNIPSNLFKTIEEVVKNECLTDDIYWFRFYYAHLNTGEIMIEALKNNEDW
NDLKDSVKNEVQWEDSDKFYSLRSFILIKKV
>EGEFANNL_01253 Isopentenyl-diphosphate Delta-isomerase
MEHVILVNNRDEVIGEMEKQEAHIQGVLHRAFSVFIFNSNQELLLQQRASTKYHSPLKWT
NTCCSHPRKGESYLKAAHRRLHEELNFDCDLYEKFYFIYKADVGDGLIEHEFDRVFIGEY
SGKINFNRNEVASVKWMSLLDLKNDLKLNPNHYTEWFKIIFNQYEYQIQYHKF
>EGEFANNL_01254 putative lipoprotein YiaD
MKTLYSKITLFILSISILLVSCNANNTQKGAGLGAVAGGVLGAVIGNNIGNKNNAALGAV
IGAAVGGTTGGVIGHKMDQQARQIQQSIPGASVERVGEGIKVVLNENAIRFDFDKSTLTS
SAQQNLDKIITVFKQYPDTNIGIYGYTDSKGADQYNLNLSERRAKSVADYLIAHGIASNR
LSTKGFGKEDPIGDNNTDAGRALNRRVEFSITANDKMIRDAQTNQ
>EGEFANNL_01255 hypothetical protein
MKKFILLGVLSMLFFYSCSTSNNDAVNRSSQRIVRGTWNLDKVTYSENMVKVKAFDEFDA
QCLTNSTWYFVSNNYTGNFTLQGGNNCPSGVQSFSWYINNQDALVLKLLNDGDKARKVTT
GTIYQFQSSSENEFTLNQVINGVKISYHFTRLSTGKL
>EGEFANNL_01256 hypothetical protein
MKKKYLSKAILILLPLIFLSFYKLNSDQFHTSITKVEYIQGNKTLKLSTKINTLDIEKIL
GVKASTNTFGSSLSKYLQQNVKISVNDVPVSFNFSSYNPDGNVIWVYYEATNLEGLINSI
TIKNSILINNFPDQQNFISFLVNGKRKSLVCKKGSETGRVNF
>EGEFANNL_01257 LOG family protein YvdD
MDESNTNFISTNFNQKNWNEIKTKDSWMLFKIMAEFTNGFETMTKIGPCVSIFGSARTPA
DNNYYKLTEEIAYKLTEIGFGIITGGGPGIMEAGNKGAKAAGGKSIGLNIELPFETGSNP
YVDHKLSMDFNYFFVRKVMFLKYSQGFVVMPGGFGTLDELFEALTLIQTKKTSKFPIVLV
GAKYWKGLLNWLKDTMLVEKNINEQDFSLFKVADSADEVVNHIRDFYDKYSIKQNF
>EGEFANNL_01258 Carboxylesterase 2
MIDYLVREPKSAIENPSLFLLLHGYGSNEKDLFSFADELPDDAYVISLRAIKKLPMGGYC
WYELDLSKNVRILDIEQTQKSQDIILKFIDQIHDKYPFDKNNISLIGFSQGAILSFSLAL
HNPHKFKKILCLSGYPDPDLLADVDMGSDFSDLEFYFSHGIEDPIIPVQWARQFKSIAEE
LDLHFEYHEYHQGHGINSENYYDLLNFIQ
>EGEFANNL_01259 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MKIGIVCYPTYGGSGIVATQLGMEMASQGDEAHFISYSLPAKLDITLPNIYFHQVNVKPY
PLFEYQPFSLALSTTIVNIVETYKLDLLHVHYAIPHAYAAYFAKQILKEKGIELPVITTL
HGTDITLVGQHPIYKSAVEFSINQSDYITSVSDSLRKETYHQFNIHKEIEVIPNFINNAE
INENSHCLKKNFVSNDEKLLVHVSNLRKVKRIDDVMKIFNLVQKEVKSKLLIVGEGPEAE
TIDRYTYKFKLGEKVKNFGKIQDVQNVLRITDLFLLPSEQESFGLAALEAMACGVPVISS
NAGGITEVNKDGYSGFVSPIGDVESMAKNAIRLLKDEDLLLKFKKQAKNEALLFDNSTII
PKYKELYNRALNQKLKPNI
>EGEFANNL_01260 Lipid A export ATP-binding/permease protein MsbA
MKSLKRILKQFASPYKKDFILGITFNILYSLFSIVSVVSIMPILDMLLGGSVKQKETLDH
VKEQAENGFFSELKYQIYLFLQNNIHNMGEKKFLSILCVSVILLFFLRNVFRYLAQYFIV
LLRSGVSKDLRSALYNKILTLPVSFFTEKKKGDIMVRLSNDVTEIEGNTLNAILELWRTP
FSLIFTLITLLIISPSLTLIALIVLPFMAWIISSIGKSLKKDARKGLTESGNVLSIIDET
LNGAKIIKIFNAEESMKNRFQKSVSNLRKLSISMMKKYELASPSSEFLGSVAMIFITWYG
GVLILDGNKGLDLASFLVYIALFFQLLEPAKTLSTSISNLHKGSASTDRLVETLDTNIQI
HEPENPIKLTGLKDSISFNNIFFQYQEDHPILTNVSIEIKKGKTVAIVGQSGSGKTTLVN
LLARFYDVDSGSILIDGHNLKSLDLKEYRKLLGMVTQENILFNDSVINNIRLSNPNATME
EVVSAAKAANALEFIEQLPEGFETSVGEGGMKLSGGQRQRITIARAILKNPPIMILDEAT
ASLDTKSERVVQEAFENLMSNRTSIVIAHRLSTIVKADIIIVMEHGKIMEQGTHQELLAI
DGIYKKLIDMQNFS
>EGEFANNL_01261 hypothetical protein
MKNNFYKIFIYSLVIIIFNSCSKEESKEQYYKKGKVDLSVDPSFYELALSLNQVFNTVYP
KAIIDVQPQAEALAINNFINGNATVIMVGRNLTDEEANFIFNRTKKKYKSAQIACDGVIF
ITSKKNNISELSIQTLKTDIVSENSKYVFDGIYTSNYNTLKNILKFKFKEGEKINSFKDA
QELINYIDNNPSYIGITGLSTLNYSNDENFKKILNNIKILPIRSKDGEIISPNLESFKSN
KYPFTRRIYLLNAENGFGIGSSFLRFSTSQRGQLIVSKEGYQPYYLYERNINITK
>EGEFANNL_01262 hypothetical protein
MKFKWDYKTLSLLIGISYIVIGGLVLLYKKFFLPLSNQGSLALGLLLVIYGLYRAYRALK
YMKNNEE
>EGEFANNL_01263 tRNA threonylcarbamoyladenosine biosynthesis protein TsaE
MNKLIHNLNELEQVAESIITNSKFKIFTLQGNLGAGKTTLVKFLCKYLNCEDNITSPTFS
LVNEYTCPTSKIYHFDLYRIEHIEELLNIGFHEYINSGNYCFIEWPEISENELAEHHKIS
LNLEGQTRQLSFS
>EGEFANNL_01264 Alanine dehydrogenase 2
MGIYSPFTANELIPQEEKIEVVKKGGKISIGIPKDDEVYENRIALTPDAVSTLTCNGIEV
IIEQGAGEGAHFTDIQYSNAGAKVSQNPKEVFSQPIILKTAPPTLEQIDLLQVNSYLISS
VQINTQTKEFFEKLSSKKITALGFEYIKDNHNEFPIVRILGEIAGMASILIAAELLSSTA
NGNGLLLGGIAGVRPTNVVIIGAGNVGINAARSALGLGATIKIFDNSIKRLRRCQEILGT
KIYTSTLDPKELRKALLRCDVVIGCLRGENRSPIIVTESMVKQMKSGAVIIDVCIDNGGI
FETSQIKKTNGQSYTEHEVIHYCNPNITSKYARTTSKALSNFFLSYFLDLTNQGGFETIF
TKNRGLYKGIYMYKGRITNQQISQWFALPYQDINLLITEL
>EGEFANNL_01265 hypothetical protein
MNFFKRLRLYLSGVFLGLIFLLFMYGDKVFSWSYLPNDRVLAEIKLKKISFSPQSESYLI
KNNLSTSFILDTVLVKGSIDFNESNAQNKPCPYYTLYHNNIKVTFTKCKDSVIINSLKHK
>EGEFANNL_01266 Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta
MGWFTRSKKNINTSEKMDVPKGLWYKTPSGKIIETDQLKANFYVSPEDDFHVRIGSKQYF
EILFDKGKFKELDEKVTSKDPLNFTDTKSYKDRLKEATSKTKLQDAIRNAVGKINGMEIC
ISCMDFSFIAGSLGSVMGEKIRRAIDYCLENKLAYVIICQSGGARMQEAGISLMQMAKVE
AKLAQLSKAKLPYISVLTDPSYGGVMASFGSTGDLIIAEPGALIGFAGPRVIKETIGKDL
PQGFQSAEFLLEKGFVDIISHRRDLKDTIYKCVDMLTNTK
>EGEFANNL_01267 Spore maturation protein B
MALNYIWIAFFVLSFIVGLIKLIFLGDTLIFKEMVDGLFSTTKQSVMEIALPLAGMMTFW
LGIMKIGENAGAIRFLSKLVGPFLSKLFPSIPKNHPAIGNMMMNFSANLLGLDNAATPLG
LKAMDSLQTLNPKKDTATDAQIMFLVLHTSGLTLIPTSIMLYRYLNGAQNPTDIFIPCIV
ATFCTTLFGIIIVSLKQKINLFSRNIILGLGLSLLFIISMSFYIKKTSATYEAKASEYVN
KITPDLINYKINNTEDLKNLYPSSFQKEFEKNHKEESLTPELIAKSNREYINFESATASR
VLSNILLLLIPVTFISGAFVKKVNVFESFIDGAKDGFNVAVKIIPYLIAMLASISLLRTS
GIMDYLLDGVAYLFYTLKLNTEFIPALPTAFMKPLSGSGSRALMIEAMQNYGADSFVGRL
ACIFQGSADTTFYIIALYFGSVGIKKIRYALSAGLLTDLLGIITSILITYYFF
>EGEFANNL_01268 putative membrane protein
MNNFDWSQFTWGQLVNPEFYIKLGGLYLVLFIIFAETGLFAGFFLPGDSLLFLSGIYSKE
LIQEFVSIDSDFLNVFLLSSLVATAGIIGNEIGYWFGKKSGPYLFQKKDTFLFKKKYLFQ
AKEFYDKHGGMAIILARFLPILRTFAPIIAGIVQMSKGKYFLYNVIGSVAWSFSLIFAGH
YLNHFFLKEFNFDLKQHIEMIVLIMVLVTTAPVLYKIFFKKETKKGEMNLND
>EGEFANNL_01269 ECF RNA polymerase sigma-E factor
MVKKTDCQLVNAYMNGHEKALETLLYRHKLKIYNYINKKVNNSELAEDLFQDVFIKVILT
LKEKKYNEEGKFLPWVLRISHNLIVDHFRVSGKTKLVNESVGNDDYNIFDFVKISELSIE
DLMISEQTKIDLKRLIELLPDDQKEVLKLRFYKELSFKEIAEETKVGINTALGRMRYAII
NLRRLIENKNLTFS
>EGEFANNL_01270 hypothetical protein
MNKNKYQLEFDMKCSTTLLFEYIGTSSGMSEWLADDVIERGDEFTFIWGDQSEIANLIKY
KEESFVRFRWEEDEGTKYYWELAIHVDEVTNDVALVVTDFADESDLEHSKLYWENLIDDL
KKIIGS
>EGEFANNL_01271 hypothetical protein
MAIIFNEEYLEESPDFFDNTKKSIFSGYYVNSFCWLFQGNLIFWEDTYFQFMASLRKMRM
EIPISFTPEMFKNQVLLLSEKLSLMNGLAKISAFRDDSKNEKLSFIIELIDKNFLTSCKE
GEIDFFKEILIYPNLLSAIEIFHPINEVASQYAKENEMVDVILLNNEKRIARSIKGNIFL
IKENIIYSPPISEGAMISSIRKNFIPFLREKTNYIYKEEAMSPFTVQSSDEVFILGDKTG
TISILKSRKNSFSIHQTELLMKKFIGYAVSNKEE
>EGEFANNL_01272 Ribosomal RNA small subunit methyltransferase I
MAVLYLLPAYLGENSSSEIFSQQLKNTLKEIKFFASENEKTARKFIKFICPDIDQKSLSF
SILNKRTTDEEILQLTEPLEKGIDMGLISEAGLPCIADPGNKLVMWCHQNKIKVVPINGP
SSILLALISSGLNGQNFSFHGYLPIENNDKKKEIIKLETLSRKDGSAHIFMETPYRNQKM
FEDLLKYLSPLTMLCIATNLTLPDEAIQTLSCKQWKTVKPDIHKKPTIFIIQS
>EGEFANNL_01273 hypothetical protein
MRFIKNNIIVLILMFIGILLASGVYYKRYDLTSDQRYTLSEATRNVLEKIDKPMEIDVYL
EGDFPADFKQLQLETLTLLDEFKRINPNISYQLIDPVKQKISQDTLEAMGMSPSALQVEK
EGISTQIILFPYATIKYKGYGQTVPLITQQTGINAEEQMAKSMEGLEFGFINSIDKLSNK
HLKNVGILVNQAELNKLEMFSLANRIVQNYNFGPIFPKDEQSLKIQDLPTLKKFDAIIIA
KPRKAFTDEEKVVIDQYIMNGGKTLWAIDQVNAEMDTLLKSSKILAYPYDLNLTDLLFSY
GIRVNSSVVKDLQRPDYINLQVGSVQGNPQNRRVPWVYFPLAFPQKFSHPITKNLNPVRF
EFPSPIDTLSTPGIKKTVLYQSSPYSGVQGIPSYISLEEAKISNKDSVNVNLYNKGPQIL
AVLLEGEFSSAYKDRIESSQVEHFKNQSKNNKMIVISDGDVARNPIIKGQPLPLGFNIST
GNMDYGNEEFLINSLNYLLDDSGLMSLRNRSVELRMLDKQTIVMDKSYWQWLNLLLPLVG
IFMIGGVLIFLRRKKFR
>EGEFANNL_01274 hypothetical protein
MFSILKKELWAYFGTLGAYIVAVAYILISSLFLWFFDSKFDTFNIFNVGLASLNNFFVLS
PWLFIFLIPALSMKSIAEEEQTGTLVWLFSKPLSIESIIAGKFLAISILVIFTLFPTLIY
VFTIYNISMPEGNIDLGAIYSGYVGLIFLSTAFISIGIFASSLVKNQVLSYIVGVFLCFF
CFYGFENLASYNLLGNYDYWLQRMGFYQHYTSFTKGIIDTRDIGYFLFITTLFVFASIQL
VKLKK
>EGEFANNL_01275 hypothetical protein
MHIPDIPSYYALKSIHIIFMVSYFAGIFYLIRLFVYYIETKEKPELEKQILQKQYIYMIS
RLWDIIIIPAGIIMTLTGLFMVANTRGDIPFYILTQKWFHIKIVFLIGLAFYHYWSWKSI
KKIKNDQFTTTSIKLRMMNEVATIILFAVVFIVMFKQFFMGMWVSLLISFIVLVLTIMLV
VKFVNRNKKK
>EGEFANNL_01276 Inner membrane protein YagU
MNGKIDPSRIRLKVAIWVGIISGIVGAIIKFGWEVPFPPRTPQRDLTNPPQQLLEQLGMP
YDLSHAVYYFNENPRPIMSFIVHFLFAIFFAVVYCVVAEYYPKIKLWQGTLYGIFLNFLF
HIILMPALGTIPAPWNQPLEEHFSELFGHILWTWVIEIFRRDLRNRITKEPDVEIPLTSS
FR
>EGEFANNL_01277 Histidine--tRNA ligase
MTPSIAKGTRDFSSEEIYKRRYIISVLQSNFEKFGFNPLETPSFEKLQTLTGKYGEEGDR
LIFKILNSGDFLDNVKEKDSEVSTWNSKNIIPLISEKALRYDLTVPFARYVAMNHGKLTF
PFKRYQIQPVWRADRPQKGRFREFFQCDADVVGSESLWYEVNFILLYDSVFTELQLPVEI
HLNNRKLLAAIAEYAEIEDQLIEFTIALDKLDKIGLDKILEEMASKGISQKSLDKLVPII
NLSGSFEEKLIQLKEIFQDVEIGLEGIKELEFIYNSTMQIGLQTADLQFNLTLARGLDYY
TGTIYEIKSKNVVMGSIGGGGRYDNLTEIFGVKNMSGVGISFGLDRIYLVMEELNLFPKS
TQKNKQILFFNFGDHESIHALMLIQKIRLMGFACDLYPEKTKLQKQFSFAEKNNFEYVVF
YGEEEIKNQTITIKNIITGKQENIATDQLSDYLND
>EGEFANNL_01278 Extended-spectrum beta-lactamase PER-1
MKKFITLLFLLSINLFFSQKILIDSIQNVIKDKQATVGVGVIYHNNDTLSINNQYLYPTM
SVYKFHQALAILNYLEKNKLSLNTSYFIKKEDLDPNTYSPLFKERPEGNFNISIKDLLYY
SLCLSDNNVSNYLFNYLVSPVQTEDYIKSLGTDEISIKGTEKEMSQNHDNQYLNWTRPLA
TAILFNKILNKKIFKDEYQDFLIETLIKTNTGENKIKGLLPKDLIVGHKTGNSYRDNGIK
VADNDAGFVLLPNGKKYTLAIFIMNSKETDEVNASMIAKISRLIYNYYSKL
>EGEFANNL_01279 hypothetical protein
METINKKLLLQIDNSPLIIFRIFFGFLLSAETFGAILTGWVKENLMIPKVFFPFIGFEWL
HPLPGFGMYIYFFTMGILGILVMIGYRYRLSLLLFTFLWTAQYLMQKTSYNNHYYFLLLV
CIIMLLLPANAYASYDVKQKRTLKSYTMPQWCSYVMIFQVSILYFFATVAKLYPDWLNGT
FTQILYANKSHLPIIGEWFKEKWFYIPIAYLGLMFDGLVVPFLLWKKTRTFALIASLIFH
LSNSLILQVGIFPYFALSFIVFFYSPETIRKIFFKKHLKIEPQEYVKSIPYFTKYFFALF
FTLQILLPLRHYLIKGNVFWTEEGHRLSWRMMLRQRSGSTYFKIVDKKTKEIISYNLSDL
FTPKQISRINAYPDFIWQAARYIKDDLAKKGHEVEIYANSYVSVNNHSPKMFINKQVDLT
QAHWNYFSHSPWILLEEDYRD
>EGEFANNL_01280 Tryptophan--tRNA ligase
MRVLTGIQSTGTPHLGNLLGAIMPAIELSKDPKNESFFFIANLHSMTQIKDADILKQNTY
EIAASWLACGLDPERTYFYKQSDIPEVTELMWYLLCYFPYSRLALAHGFKDKADRLEDVN
SGLFTYPMLMAADILLYEAQIVPVGKDQLQHLEMTRDVAQKFNQIHPDLLVIPEAKIQEN
TMYIPGLDGNKMSKSRNNTIQIFAPEKILKKQIMSIVTDSTPLEEPKNPETCNAFNIYKL
VAKEHEIDNMREQYLAGGYGYGNAKKELLNVILREFSEIREKYDYYMNHLNILDEILSEG
ANKTRKIASQNLHKIRTSLKFS
>EGEFANNL_01281 Glycine betaine transport ATP-binding protein OpuAA
MSKIKVKDLYLIFGFAKNQAMKMLKKGKSKKEIHSKTKCTVAVNNANLEIQEGEIFVIMG
LSGSGKSSLLRCFNMLNTPTSGSILVDGEDITKMDRKQLLNLRRKKIGMVFQHFGLLPHK
TILDNVAFGLEIQNIPLQERYAKAKEVLNLVGLNGYENSYPDQLSGGMQQRVGIARAIAA
DSEVLLMDEAFSALDPLIRTQMQDDLLEIQQKLKKTIIFITHDLDEALKLGNTIVIMKDG
VIVQQGAPEDILLNPANDYVKDFIGNVDMSKVITASSIAEPFRVKITIGKEGPALIYRLM
ERLNTRLLPVISNDKEFLGYIRKKDVLNLILSKSTDLNSILIEIPRIREDMSVSDTLPLF
INQNYPLTVVNENNYPLGYISYSDVVSLVTGYDEEEVKTIIENAN
>EGEFANNL_01282 Glycine betaine transport system permease protein OpuAB
MEKLDLGKYIEKFVDVVSIKGAPIFKQITIIIENCIDVLQGILLSLPFYIIILLMVLLSF
ALKNKGFKNIKFTPSNARKLLELPLFSLLGLVLIYWMGFWKEAMDTLVLVIVSTFIILII
GIPLGIICARNKKVNLLVRPLLDFMQTMPAFVYLIPAILFFSVGNVPGVIATVIFSLPPA
VRMTALGIRDVPKETVEASIAFGCTKTQTLFKVQLPLAKPTILAGVNQVIMLALSMVVIA
SMVGAGGLGESVYAAIQQADVALGFEAGLCIVILAIILDRMTQSLGNKK
>EGEFANNL_01283 Glycine betaine-binding protein OpuAC
MFKYKYILLSIVLALGFTSCKRVKKYDVSLLYPNWADGIAITYLAKNIIEDKGYKVSMKR
LEPGPIFASIARGDEDIYMDAWLPYTHKNYWDRFGDRVDLLGSVFDDGSTGLVVPEYVTI
QDIEELNKYKDKFNNKIYGISSGAGIFANTNKAIKEYRLEYSQLPSSETSMVAALKKAIN
EKEWIVITGWKPHFMWSQFHLKLLKDSKNIFPTDKISIISRKGFDKDEPELTEFFKNFNL
NEDMLNELISTVSEYNDPNIGAKKFYQKYKSSLSQWLKPNPKNAN
>EGEFANNL_01284 UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase
MTIEELYSIYLQSSGVTTDTRKITSKSIYFALKGENFNGNLFANEAIELGALAAVVDDKN
LSNPSKGIFYFENSLLCLQNLARYHREQLNIPIIGLTGSNGKTTTKELMASVLKEKFNVW
YTQGNLNNHIGVPLTLLSINQNHEIAIVEMGANHLKEIELLSGICQPTIGYITNFGKAHL
EGFGGMEGVYRGKSELYSFLRENHKKVIVNTDDTKQMELSNGIDSISFGTEGDYTYSYQE
NSNHTISLIYQNCLINSQLTGKYNYTNLCAAATLGLYFGIEIGKIKVGIENYLPQNQRSQ
IVKLGNKTLVLDTYNANPSSMEASLKNFSVFEGSKTIILGDMFELGKESAYEHSKIVSLA
LNTNFDNIFLVGENFYSTTIDDFKIKKFKSTEEAKNYFKEHSIVTKNLLLKGSRGMALEK
LLNVIKE
>EGEFANNL_01285 hypothetical protein
MKKITLVVMLSAFVGIFQLAKAQTGDASKIAYINSMELLNSMPEKKAADEQLKKLADQKK
EGIKKQEEALAAKYNKIQEDLSKKSQTELDSMKDQLQKYEQELQSDQQNLATLREDAANA
LDKKQAELYDPIMKKAQEAVDAVAKEKGYLYVFDTSQPSLIYAAGPNILASVKAKLGL
>EGEFANNL_01286 Chaperone protein Skp
MKKLLTYIFLFLLFYSGTAQKMAYVDTKYILNQMPQYQQAQQRLDNEIKKWQTEIQKEQS
KLDQLRVEYENEKILLTDDQQKNRLSIIDSSEIKIRNFIDKKFGSEGDSFRLRMNFVKPL
QDQIWNAINTVASRDKYGLIFDKSSDLIMVFTDPKYDITDKVLKQMGLDAKQSKKKESQT
NSNSPSKISKTEDIIQESNEDNNEINVKEKSNKKDQTKSGYGSKYVPKKKKQAVEIQENG
DKEIDKTNNKSKENKLNNNKEVTDTAEAEVEKPKENPEVKKATTAQPNKGYGSKYVPKKK
TANSNK
>EGEFANNL_01287 Outer membrane protein assembly factor BamA
MKKLLASVLGILHIFIFGQIKDSIQTPPSISDTVTIDNDTLKEETSYLEPQENSYLIKEV
NVTGTTQYTKNQIMRYTGLYEGEYVEIPGMQINMAVKKLWDSKLFSDVEIYLSKIEGKSV
YLRINLRALPDLGNVKFYGISKSKGEKLIKQNNLKTKTKITDDLRSKLQNSLKEEYTEKG
YPFPIIQIKEQPNKSDASLINWNVMVNKGPRVKVGKIIIEGNEVLKPSKIKSKAFKNTKE
KKFFRFWKKSKYVPKKYEDDLKKVIETFQSFGYRDAKIVSDTVYRKDDKDFEIKVDIEEG
KRYYLGDVTFSGNSKYSSELLSKILGYKKGDPYDAVGINKKVTGSEKNDDIATLYYNNGY
VFSNVVPIEKAVRNDTIDVEVKIREGEQAYWDKVTFTGNTKTHDHVVQRSLRTVPGNLFS
KEEVQRTMMELAQMQYFEAQTLVPEITPNPETKTVDVNYKLEEKGTNSQIELQGGYGGNR
FIGTLGLTFGNFSFNDFFKKKAWKPIPTGDGQSVSLRAQAGSNYQNYSISFTEPWITGKR
PTSLSVSFYTTFLNYRDYYQEGKNRLDIYGAQVGLTTRLNWPDDYFRLSYGINYQLYSFH
NYPFNVSNTTWSNGQSNNFSFYASIGRYSAGLDPIFPTMGSEFELSLKATPPYSLFNNED
YRNKTDNEKYKWLEYFKVKLKAYWYQELVGKAVLKAGGELGFLSDYNSKVGIPPFERFYL
GGTGMYGNRYDGREIIPLRGYRDPTAFGGQPNEDITPLGGGTSYARFLMELRYPLLLGGA
TKIYALAFVEAGNVWSNNNSFNPFELKRSAGVGFRIFMPQFGILGFDFAKGFDPAINSTG
ASGWQTHFVFGQQL
>EGEFANNL_01288 Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)
MFKKKEKEIDITKTEMPRHVAIIMDGNGRWAKKKGMIRSFGHQSAIKSVRDSIEFCQDMK
IPYLTLYAFSSENWNRPTFEVNALMSLLVNTIKKETKTLIEKGVRIKVIGNITKLPKDVY
NELESLIRITENLQNGTLILALSYGAKEEIIEATKKIALDFASNKITEDQINEDLFSSYL
YTKDIPDVDLLIRTSGECRISNFLLWQIAYSELYFTDVLWPDFNKGDFLEAIKYYATRER
RFGKTSEQLKVK
>EGEFANNL_01289 hypothetical protein
MKNKFLLVLLIFMSLNAWTNAQRHEIGISLGQPNLIADIGKTNFIQFKADGANTPISIGM
LYRYNLNNRQSLRFNLSYNKVFFDDNEASEGYRIDRKLSGMNNIIEASLLFEYYFFDINN
IQNFASSPYIFAGLGVFTHKNPKYTINHQLIKNSDGTYKPPMNSSDFESSIEKSTSTKLD
VSIPFGIGYKFKFNYNWLLGFEIGARYTTQNNLDYSNLADKNFTSNIDPRLLQQGNLSSS
IQEEINKRNSDIKESYQTGNTFKSNDWYLVWGVNLTYTFGRPPCLCN
>EGEFANNL_01290 All-trans-nonaprenyl-diphosphate synthase (geranyl-diphosphate specific)
MSKIAEQIKIPIAEEMLLFEKRFYQSMKSKVPLLDRITQFIVRRKGKQMRPMFVFLTAKL
TGEISDKTYRAASLIELIHTATLVHDDVVDESYMRRGFFSINALWKNKIAVLVGDYLLSK
SVLLATDNKDFDLLSIISRVIRDMAEGELLQLEKSRKLDITEEVYFNIIKQKTAVLISAC
CESGACSTNADDETIHKLRLFGEYTGIAFQIKDDLFDYNSKSFIGKPVGIDIKERKMTLP
LIYAINNADTTKKKWLLNSIKNHNKDKKRISEIIAYVIESGGLKYATSQMNEYKEKALNI
LYSFPKNSSRDSLELLLNYVIHRNN
>EGEFANNL_01291 hypothetical protein
MYKKKIKLILLTLLWGGTFSQSLLSQVIITSSNVNADSKTTSKSADLILNSPDKSFLPNR
VALSSLNSPLPLAEDLTEIQNGTIVYNTTTNLGFSSGLYLWQDNKWNVLLTSHGKKQDFS
NLVYKQTKKGELYQLPYVSSNGSGIEIPTFTEKFVAPKDGTILISTLIYTQMSADASTFA
QIGNTFFTIQITDITPGTAEQGTVTKFYAGCTPLSMRPIPGSSSIGINNNPTSATAFTSM
RVIANHNYEVKVLGEEGWNQAATVYAGNFEWNIYEANSALKIDFQSDDY
>EGEFANNL_01292 hypothetical protein
MLLNFNLSIKHITIFNLLFFMSQLLQSQITIGDKDIKPNSSTDLTLTSPNKGFLPNRVSL
KSLTDSQTVPNVKEGAVVYNIQETADLGKGLYVWNGTQWDRLLMEYGKKQNYQTLVYKET
GPSDVVAFRKMTPNPTEIKALQTSFVAPWDGIIYISTLIYAYASFIDTPTYKYSTVANTF
FTITTTEVETGKVTTFYSGCSPVIMYDVEAKVFKGNFPSTASSISTMRVVKDYNYSVKIT
GIEGWNADMIINAGTYNKNNSSTLKIDFISDPH
>EGEFANNL_01293 hypothetical protein
MFFKKNIFLKKKSFLLLFSTLPIINSAQVGINTLNPDSSTDLTLGSNNKGFLPNQVNLVS
IDNSAPLSSTDIKEGTTIYNTNATLNKGIYVWDGTQWNTILFNDGTREEFINLVNKQTGT
DPSEELYILTTTNGIEIKSLGDTLTAPRDGKFYISTVFYSKNTTGVAYDLITTKTFYRIE
LTDLTDSTIPPVNFNSVCTNVIASIPGSINGYGSAGSNPGSVSSDFIATAKGGHQYKIRV
IATRSPDDINNINYINSYTGTYIWTNPMNNNKYMLFSNLKVDFLSDSFIQ
>EGEFANNL_01294 hypothetical protein
MCRKKFSLVLFSVFWGLISPTLFSQIIINSSTKDDLKISQSNSADLILNSLDKSFMPNRV
ALISLDSPLPLAQDLTGIQEGTIVYNISDAPGLSAGLHVWQDSRWNILLTKLGKRQDYSN
LVYLQTGSGDNVGADDITTIPYVNTTSPGVELAKFTSNFTVPKNGNIMINALIYVQMYVQ
TYGVSQVANTFFTIQVTDITPNSPDQGKIQKFYTGCTPISMRQTPGASVAGINNNPTSAI
VFSTMRVTEGHSYEVKVLGQEGWNSAAEIKAGTFQWRPSASLVYNANSVLKIDFQSDPY
>EGEFANNL_01295 hypothetical protein
MFIKLYKNKKQLFLLNIFIFISQTFNCQVAIGTPNVKPYPSTDLTLTSNNKGFVPNRVSL
TGLNDIQTIPNIKEGGVVYNTNITSELGNGLYVWDGTQWNRLLMDPGKRQDYQTLVYKQT
GPTDITSLTKDIPQEISSLTTNFQAPLDGLVYISTLIYAYANVITPPNYNFSSIGNTFFT
INTTEIETGKVTTFYSGCTPLIIYNPTTNLFVGNFPVTAPSISKLEVKKDYNYEIKITGV
EGWNQFIQVNVGTFNNNSSPLNNLYSTVKVDFISNPH
>EGEFANNL_01296 hypothetical protein
MYLKKNILLRLIILLGFILMPTIYKTQVGINTENPEINADLTLGSNNKGFLTNKVSLLKP
DDPSPLSNLDIMEGTLIFNTNPNTLLKKGLYIWDGTNWNTIIYNNDGLQQDFINLVNNKT
NDNTSTTQTYDQKNVVLLNSIDQEIVPLGTIVQAPKDGKFYISTVIYSKITIGPISDFTA
VSTFYTIQITDLTDGTPPTNFYSGSSNVAASISIPGGGTGSASNNPALVSSDFIYSVKEN
HQYQIKVFGKSDGNGNSSLQILAGTYAWRNPINSNIYQLYSTLKVDFLSNAYTQ
>EGEFANNL_01297 D-aminoacyl-tRNA deacylase
MRVVLQRVREASVEVENRIVGEINQGLLVLLGVEDKDTEEDVEWLVRKIINLRIFNDPQG
VMNLSVEDIQGGILVVSQFTLFASTKKGNRPSYQRASSNEFAYQMYLTFLQKLEHSFTGL
VSSGRFGEDMKVSLMNDGPVTILIDSQNRE
>EGEFANNL_01298 putative lipoprotein YiaD
MKKIGISLFVLVLLTACVPQAKYKDLEKKYYAALQGESKNKQEIEAREADLKALTDQFSS
LQAQQEALAQKKVQLDNEYADLQIEYTNKLKDLEDLKNKNSQISETALKEKQKIEGELAQ
AQGQLNQKIQRINELEGLINQQKESVSLLKKNLQTALKSYEGKGISVEEKDGYIYISMDN
KLLFPSASWTVEPQGLKALHELSKVLAKDKNLNIIIQGHTDSDKYIGNGNIKDNWDLSVM
RATAITKILQSEGISPEKMTASGRSQYAPIASNSNPTSKALNRRVDIIIAPNLSEINKLL
NQL
>EGEFANNL_01299 Exodeoxyribonuclease
MYYTYICSMKLLSYNLNGIRAALNKDFITWLRATNPDILCLQEVKANIDQFDVSQFEELG
YHSYWFPAEKKGYSGVAILSKIAPNSIKYGCDNEFYDKEGRVIQVNFENFSVLSVYVPSA
TNIDRLGFKMDFCEYFLTYVKELKKEFPNLIINGDFNICHTPIDINDPVRNSKVSGFLPE
EREWLDRFLQECKLVDSLRLFNQEPFQYSWWTYRVKTARANNKGWRIDYNFVTRTLEKKL
QRAYILTQAIHSDHAPVGIEFEL
>EGEFANNL_01300 hypothetical protein
MQKLITIGLLSLGFILIACKNLKGIEFPSDKTNYVGTWICQDPEIVLSIKKNGSVKYSFK
DGSLSKSIEAPIQQFDSNDFVVGALGITTKFKVSKTPYQENGKWKIVVDERILTKVDKVN
DDF
>EGEFANNL_01301 hypothetical protein
MKITLLLPMKEEKEKMLEAFQQYSSLRHIYEIIETGVGRENMAKGFLEKKESDLTVLVGF
TAITGIEKTLPIELKKGKLVEVTSTSIYGYKGEIFENGSIKLTNSRTSLPCLSSLTTDQF
IRSTDLPIGTLINMEDYTFMCLKKPKDLIIRVISDFLPHNKEIDFFKEIEDIEFYSVVEL
LEKLY
>EGEFANNL_01302 Quercetin 2,3-dioxygenase
MNTILFPSDSRGHANHGWLNTYHSFSFANYFHPDRINFGALRVLNDDSIAGGKGFGSHPH
SNMEIITIPLSGSIQHQDSMGHTEVIKPGEVQVMSAGKGIVHSEFNADNVNELKLFQIWI
LPNEKDVVPRYDQKSFNFSVKNEWISIVSPKNFKDANLWIHQEAWLHLGYFDKDFNVEYY
LNKSDNGIYLMVIEGSFSVNGQNLNARDAIGIWEAGFVTIQATSKNSRILLIEVPMISIN
>EGEFANNL_01303 Curved DNA-binding protein
MAFIDYYKVLGLDKNASADDIKKAYRKLARKHHPDLNPNDKEAQKKFQQVNEANEVLSDP
EKRKKYDQYGENWKHAEQFEQAQQQQGGNGQYYYENAGNPFDGFSQGFGTEDFSDFFGDL
FGAKAGNNQRSRTSQFKGQDYTTELHLSLRDAATTHKQTLNINGKQIRITIPAGVSNGQQ
IKLKGQGGEGLNSGPKGDLYITFIISEDSNFKRLNDDLNTTVEIDLYTAVLGGETMVDTL
DGKVKLKVSPGTQNDTKVRLKGKGFPVYKKENQWGDLFVTYKVKIPTQLTPKQKELFEEL
AKS
>EGEFANNL_01304 Chaperone modulatory protein CbpM
MEHELINLKEYCFHYKVESSFIHELEEMGLIRVFKQEEERFISMDSLKELESYSRMHYDL
EINTAGIDAIKNLLNKIEVLENEMNNLRNRLNLYE
>EGEFANNL_01305 Vitamin B12 transporter BtuB
MKYIVNFYTLPKLINVVAFNLFFISLTYAQKTGELSKVIVTGRKTSLSLENISQNIQTIE
KKEIQNSPASTIEELLSYYSGIDIRQRGAHGIQADISIRGSSFEQVLVLVNGIPMNDSQT
AHNMLSLPLNLASVQKIEIVKGPAARRFGLNAYAGVVNIITQPSTENKLGISIYGGDYGT
YSLSANANLNGEKFSQFIQIGNAQSDGYRYNTDFTKKNIWYQNRYILDKGELWFQSGFFE
KKFGANGFYSSSQAKEQYEEIQTSLVSLGWNQQFSNFKLQSHVFWRRSQDEYIFNRKNPS
AYRNLHLGNTIGAKAEASYLYSLGIAKVGADVRREFINSTNLEDKNRTISLFFLEHRFLL
FNNALDISPGISFVNYSDQGNFWYPGIDIGYKINSKNIIFLNVGKTYRIPSYTDLFYTDP
LNNGNPDLKPEMAWSYEIGYQANLNKLSSEISLFRREANNLIDWVRENEDSKWTPENIAR
VNTNGVEVKLNYDFGYKLFSSINIGYTYLDNKLENSTANFSKYLLDNLKHQLVVKFEQRL
FKNWTNQWIYRYNDRLTLDSYQLLDARLSFKNRRLESYLQVNNIFNTQYTETNLVPMPGR
WLEVGLTFNNFFINNK
>EGEFANNL_01306 HTH-type transcriptional regulatory protein GabR
MDSPDTIPFQSFIQIDRKSNTAIYLQIVTQMINAIQRQYLYKGMKLPGTRVLSKILNVNR
NTLVLVYEELASLGWIEIIPNKGTFILAKEENVVNRIKNTTPVRYTTYPNSTGFRFKKSM
ILDSPFETPTYSFILNDGIPDLRLLPIQPLAKLYSTSLKRKKNIDWAFHESKDFFKSHLS
NFLNLTRGLHITKKNMLVARSIETCLYISSEILISPGDKVIVGELSYFLPNMIFQKAGAQ
LLTIPIDKEGILIEPLKHLCKKNKIRMLYLTPHHHYPTTVTLSAERRIALLELSTQYGFI
ILEDDYDYDFNYTNSRTLPLASADKDGMVVYIGSFGRSLAPGFRSGFIIAPQNLIHEMNK
LLGIIDRQGDVFMDLSLGEMIEEGEIYRHLKKSTYIYKERRNSLTHLLSHHFKNEIRFTP
PSGGLATWIEWNFPINLMQIRENCKKENIFIPKSLLYQSKKVTALRMGFGNFSTNELEMI
VEKLKFCTCK
>EGEFANNL_01307 dTDP-3-amino-3,4,6-trideoxy-alpha-D-glucopyranose
MDWFAKWFNTPYYHILYKNRNEEEAQEFIINLIKYLSLPIDSKILDLACGKGRHSIFLNK
LGYNVTGVDLATKSIEEAKIQENEKLHFFVGDMRETNFPNEFNAILNLFTSFGYFSDDAD
NLKVYQSVYEQLKPQGIFVMDFMNASLAETNLVEKEDKEVDGILFHLQRKTENDFIIKDI
HFSDNGEDFHFQERVKAFKLDYFENLAKIVGFKLKRVFGDYQLNEFDSKRSPRLILIFEK
>EGEFANNL_01308 Zinc transporter ZupT
MEYVVLIVAVIIGAFIAYFFQNNHRFSKKLLMFSAGLLLAITVLDMFPTLYSSHEKVNAG
LWVIVGVFLQLLLEGLSKGIEHGHVHTHSHGQVDSIVPLSVMLGLFIHSFLEGAPIEAHH
HGHSHEHSNILWALSIHKISETIVLSTFVFSLKIKNLYKFLILILFAISAPIGTLVGSII
PNKYFPEIIGIVSGIFLHTSSVIIFESNEKHNLNFQKLFLVFMGMLVGYLITLG
>EGEFANNL_01309 tRNA(Ile)-lysidine synthase
MQKSINQLEIKKSYLLAISGGIDSMVLLHLFQQTSLSFSVAHCNFNLRGEDSLKDEAFIR
EYCEKHKIKLHVKSFDTLKIKQKKESIEMVARDLRYHFFLELIKKYNYNYLVTAHHLNDH
IETFFINLFRGAGLKGLSGIKKKRDYIIRPLLNFSRKEILEYAQNNVIIWREDYTNQSTD
FLRNKIRHTIIPNLEDIKPNFIYLAKKSLSIIDESQKFIQKQVNLLKDDVTLKIDSNISV
IDLNKLLNAESLLVYLLLAEFGFINKKDCENILKSKTGSIFLSKTHKLWVNRNEILVEAL
QNRTIYESEINLKINSIPWEIDHPLHVSLYTSKKHEKSESHEILDLNTISFPLYFRNWKS
GDFFYPINGNGKKKVSKFLKDLKISNYEKNKTFVLCDGLDRIIWLVGYRLDDRFKISNNT
TDLLNLRLHKNLTSY
>EGEFANNL_01310 hypothetical protein
MIVYLPFIFIGSFQGMAIFPFIFVRYKHMLYDKRLINHEKIHLRQQIELLWIFFFLWYLT
EYLYNVVKYKNLQLAYKKISFEKEAYANDLNFTYLKTRKMWNFLSYYKRV
>EGEFANNL_01311 hypothetical protein
MKKIILIHAHKNLDHLNRLIDALDYPTFTIYVNIDKKSSININKISSKAVLIKKRVSVVW
GEYSQVESTLNSLRQIVEEQKDFSHVIFISGQDYPIKSNFDIDEFFNNNLSNNFLEYFLV
TENNKYHEYLYRVDRKHYPSHRIIERKFHTAFKLMYKFLTKKEYKIKMINNYTCYWGSNW
WNLSKEVIEFLLQVAEDKKIINFFKTTWCSDEVFFQVVLLNSHFKEKIINNNLRYIDWTN
CINNPRNLDPNDFEKIINSEALFCRKMEIGLSDSLVNLLEKHRNK
>EGEFANNL_01312 Transcription-repair-coupling factor
MKTNLIKSLLSSHLKGTLLDEEIHLLSENKILKLSVKGAVGSFINLFCSYLHAATDKSIF
LYFADKEEAIYALNEIESLFGKEKVLFYPSSHLNPYQVEEVQNANVVLRTEVLNSILNHN
KSKFIISYSEALSEKVLSKKSLENVTQKISVGNKLNPDFLNEVLFSFNFQRTDFVTQPGE
FSLRGGILDIFSFSDEKPYRIGFFGNEIESIRKFNIETQLSEESVTEFTIVPNIDTSYHN
SESKINFLEYLPEDIIFIAKDLDISLSVIDKKFQKAEEVYSSLTSIINREKPKDLFIDSN
DILKIIEKFSFIEFSSLPHFLNFKTIQLNQSEQPSFHKQFHLLGEDLLSKEKNGFVNYIA
FQSEKQEDRLKEIFSTIEHEVPFKGIHVNISKGFIDYDSKFLIYTDHQIFERYHRYQVRN
SFSKSESLTLKELTDLKVGDYVTHVDHGIGKFMGLVKIKNDDKIQETIKLVYKNNDILYV
NIHSLHKISRFSGKDGVEISLNQLGSPAWKNLKNKAKKKVKEVAFDLIKLYAERRTKEGF
AFSPDGYLQNELEASFMYEDTPDQEKAIQEVKMDMEKPIAMDRLVCGDVGFGKTEVAIRA
AFKAATDGKQTAIMVPTTVLALQHYKTFSKRLKDFPVRVEYLNRFKTAKQKKEIIHDLGE
GKIDIVIGTQQLVGKDIVFKDLGLLIIDEEHKFGVSVKDKLKTLKTTVDTLTLTATPIPR
TLQFSLMAARDLSVIKTPPPNRQPVQTQLMGFNEEMIRDAVMYELNRGGQVFFINNRVES
LAVLAGMIQRLVPMARVITGHGQMEGKKLEQIMVDFMEGEYDVLISTTIIESGLDVPNAN
TIFINDAQRFGLADLHQMRGRVGRSDRKAFCYLITPPIDVLTSEARKRLQAVEQFSDLGS
GFNIAMKDLEIRGAGDLLGAEQSGFFNEIGFETYQQILNEAIEELKENEFAELFENENKT
KDFVSEVQIDTDFELLIPDEYVNKVEERFSLYQKLSELENESQLEIFSQELIDRFGELPN
PTKDLLESIRLKWLAKSLGFEKLVIKNNILLAYFPTNSQSKYYQSNFFKGILEYLNKNSE
EGIFKQKNTNDGSILYFKKENIYCINTILNFFNQIKNFISHI
>EGEFANNL_01313 hypothetical protein
MRNILKCNIFNKVLIIASILALLPFLLLCLFTQPTLDDFGYALNLSDKSFIETQINIYMN
WSSRYTATGLLILNPIQWGFWSGYKLISLGMIVLFVIATFYMFYKISTNNAITIILSCSF
IFCYLFMVPEIVSSFYWLAGSATYHFANILLIFFVGLSISYYNQKSLIKILMLFLLVFLI
IGCNEISMIYLDIYIFIIFIYSYLKKKKLNYSWLFLLVWAGFLTLLILLSPGNAKRSSSI
IHHIPLLESFFMAVKKSIVIIFRYGIIVFIINLLVFYNCRNDLKKYNFLILNFPFYFYII
ALFIFLFLGSFPSLLSIGSYPPQRTVNVIFLPLLIFSMIISFKMVVSTYIYNLKISPNKL
SFILLFIIFSYSFIVGNKEFLSVHNNLYLAYYDLISGKAYKYNKEIEARYKKIECSNNEN
IVLSPLKYRPRSIFISDLSPDPSYFYNQSMANFFSKKTISIIEK
>EGEFANNL_01314 Polyprenol monophosphomannose synthase
MTKNCVIIPCYNEELRLPISEFEENLTSQNSLYFCFVNDGSSDGTLNILNKIKSRYPNQI
YVIDKKKNAGKASAIYTGINEMLKLNYFDVVGYLDADLATSIQEYERICTYIHPPIEFVF
GSRIKRIGSHINRKLHRHLIGRVFATLSSTMLNLPVYDTQCGAKAFTSKTAKQIFNEPFI
SDWSFDVEIFFKFIHLVGKDKVEEKAKEIPLESWRDVGDSKVKLSYSLKLPFELLRIKRY
YKKKFK
>EGEFANNL_01315 Peptidyl-tRNA hydrolase
MNKFLIVGLGNIGEEYIYTRHNIGFLISDYLAENLNATFKPSNFGQLCETSFKGRKTFIL
KPNTFMNLSGNAVKFWLAKEKIQLENCLVICDDLSIPFGHIRLKPKGSSAGHNGLKSIEN
NIQSQQYPRLRFGIGNDFLKGQQIDYVLGKWTEEEYTKLNTRINVGVAAIRSFIFSGINN
TMNEFNANKEGL
>EGEFANNL_01316 hypothetical protein
MSNNEINSKDINNKNSEEFYDKLKIQLDESNTLPGKYMFKFIVPTESSKIAKIQKIFEFA
SPTFSMRESKNNKYTSISVNIYAVDSTSIINYYKEVSLIEGVMML
>EGEFANNL_01317 hypothetical protein
MIKYFFSIITLIAFYSCSTSFNNGFTNGNSEKLNQRNISQLNGTYEIFASGKYNENGRFT
AVSTNKKKYSFYNKIENKLPNMKVKDLGDIGNILKNPPIDSIPSLTSNYEAFEVKIKPDG
YLTFNFLKNDQIATSLTYKGNIKDGFIYLPKEKNCTKIYSSKNCVISQRRIGLAEDGSII
LQESNKVDASSQTTSVLLSLFEGNGENAYKYKKIN
>EGEFANNL_01318 Long-chain-fatty-acid--CoA ligase FadD15
MNVSRLFDIPYFQLVNAPQESSLVTKHAGKWVVISTQELVQLINQVSRGLLRLEVKKGDH
IAILSPNNSTEWLIIDFAIQQIGAVTIPIYPNLSDPDLKFILKHSNSKFCFVSGMELVNK
IQRINLDSIHLKNIFTFENLDHLISLDSIKELGNDLSNQKEVEKIKQNIHPEHLATIIYT
SGTTGSPKGVMLSHKNLLSDALNTHERVIIENSGIIKMLSFLPICHVLERMVVYLAMYRS
YNIYFAESIEKVPEHLKEIKPHIMTVVPRVIEKLYSTIYQKGTSSGWIQKHIFLWALKIG
HNFQPFTSTSLSYKIVNQLVFKKWREGLGGEIKTIISGGAPLSKNLNKIFFAAGLPILEG
YGLTETSPVIAVNGKDKNLFKFGTVGPLLKDMKVKIAEDGEILTQGPNVFMGYYNEEDKT
KEAFTDDGWFKTGDIGEMDGIFLKITDRKKEIFKTSGGKFITPQITENLLKQSRFIEQAM
VVGAGEKMPCALIQPNFLFIQKYLVRKNLIENKREFSNQELIENVTIKDRIWKEVEKVNM
TLGNWEQIKKIELTPCIWSMEGGELTPTLKLKRKFIKEKYIDLYNKMYEKNL
>EGEFANNL_01319 hypothetical protein
MRLNELDAKMRCFEISNDFEILPEIYMIARLDGRGFTKLTKEIHPYKKPFDLEFSNLMVE
TSKHLMNCGFHILYAYTQSDEISLLFHKKETAFSRKTRKYISILAGEASAKFSLLLGSTG
VFDCRISQLPHRELVMDYFRWRSEDALRNSLNAYCYWKLREENKTATQAFDFVKGMSISN
KNEFLFKRGINFNDLPLWQKRGIGIYWKTFEKKWINKDISKEVITKQRELIINQELPMKE
KYFNLLNDIIPFT
>EGEFANNL_01320 Serine hydroxymethyltransferase
MDNKIVFDLIEKEKQRQLKGIELIASENFVSEDVMRAAGSVLTNKYAEGYPGRRYYGGCE
IVDQIEQLAIDRAKKLFGAAYVNVQPHSGAQANAAVFLACLKPGDKVMGLDLSHGGHLTH
GSPVNFSGLTYSPVFYRVKKEDGRIDYEEMEALARKEKPKMIIVGASAYSRDLDYAKFRE
VADEVGAILMADISHPSGLIAKGILKDPIPYCDIVTTTTHKTLRGTRGGIIMLGKDFENP
FGHKTPKGEIKLMSQVIDGAVFPGIQGGPLEHIIAAKAITFEEALSDGYFKYILQVLKNA
QALSTALMDRGFEIISGGTDNHLMLIDLHNKNITGKAAEKALEKADITCNKNMIPYDDRS
PFVTSGIRFGTAAITTRGLKEEEMVKIADYVQEVVADPENEKVLARVKDEVNALMSSRPL
FQW
>EGEFANNL_01321 UDP-glucose 4-epimerase
MNKIKILVTGGLGYIGSHTVVELINSGFEPIIVDDLSNSELFILDNIYKVSGQKPKFYKS
DICDINSLKSIFEENKDLKACIHFAAKKAVGESMEKPLLYYRENLVSLLNVLDLMKEYKI
HNFVFSSSATVYGEPEHLPVQETFPIKKALSSYGSTKQMAEDILEKVAATRWLNALALRY
FNPVGAHLSGLLGELPKGIPSNLMPFITQTAIGIREVLTIFGKDYNTPDGTCIRDYIHVV
DLAKAHVYACNFLLNGKGNLPYDVFNIGTGEGYSVLDMVETFERVNRVKIKYKFGERRNG
DVASIYASSQKANEILGWKTELSLDDMVKDSWNWEKNYRNQ
>EGEFANNL_01322 Low affinity potassium transport system protein kup
MQTNNVNTSKLSIIGMIVTVGVVFGDIGTSPLYVMRAIVAANHMPHISEEFIIGALSCII
WTLTLQTTIKYVIIALRADNKGEGGILALYSLVKKMKKKWLYLVAILGAATLVSDGVITP
SMTIVSAIEGLKNYNPNTQVVPITIFILIALFVIQQFGTQSIGKFYGPIMTLWFIMLGVL
GLIEFLPHLYVIKAFNPYYAIHLMMDVSSNAGSVTEGKHMILLIMGAVFLCTTGAEALYS
DLGHCGIKNIRISWIFAKVCLILNYLGQGAWILANPEQAQSGGNPFFMMMPETFLIIGVI
MATLAAIIASQALITGSYTIFSEAMSLNFWPRQRVEYPTHEKGQMYIPAINWGLLVSCIF
VVLHFKESAKMEAAYGLAITITMLMTTILLVFYLKLKKVHALLIVLFGAVYLIIEGGFFY
ANVLKFAEGGWITMFLAGLIAVCMYVWFNGRKLKNKYVQYVDLKPCLPIIKDMKVDTSLS
KYATNLVYISRSNSPNEIEAKIIFSIINKNPKRADYYWFLKVENDLNPYTFEYDVMELIP
DTLYQVKFRLGFKVEPLINIYFAQVLEDLKVSGKINLISKYPSLRKHDIPADFKFILIDR
VFNQEYLLSIKERFILRFYNMVKYMGISDTSALGLDSYNVEVEQVPMLTDVIYKNRIKRV
RIY
>EGEFANNL_01323 hypothetical protein
MIFIKRRKSSYIYLIIHSIVAILLVSVYVNRFITPKDFPYFGIVALIFPILVLLHLLFTF
VWLIKKEMIFIPFLVLTFLLLFPVKKYIHFGNQKNLSLLNESDKKEELKVLTYNLRYANG
NRDLESLEKFIKSKDVDVAFFQEIYTRQWRSKEVFLVDRYNAVFDLVGISSKYPIIDKQK
IILPDQGYACMADILKGSDTIRCINIYLEPMYLNKSLFKFSKIDEAKDQTKIVTEKLVNG
FKKHQKQLELLTKYIRESPHPTIVCGDMNSVPLSYEYFTMLNENLIDVFETKGQGLGLSF
YDYFYPIRIDYIFTNNKFMPISCYVDRTVHFSDHYPVFATMKLNP
>EGEFANNL_01324 hypothetical protein
MMDKLFYYYKTGTEGVKIIYFSVIASVVYWILEFIFQKIFNVSVGSFFLLSSHAFIPNIW
TFLTFPIFYVKFMDLLFGCVMIYYTEKIFRLYFNGESFLKFFILGNWVGGILFLLFGYAT
STYGYLSGSILGVYSCLFAIISYNPKMKVTLFLLPIEFPLYILGIVIVGLDLLQLSAQPG
GGGFLISRVSAAIFGYLYMRAFQSGNDFLGKFIPSFHSLMKVKNLFKLRQKSHLKKEKGG
GKTNTFDGRRPMSDEEFNRNKVQEQNEINAILDKISERGYENLTKEEKDILFKFKK
>EGEFANNL_01325 Rhomboid protease GlpG
MNRYIPPVTKNLLILNTIFFVGKFLLLMQGIDLDVVLGAFFPASPNFKWYQIISHMFMHG
NFMHFVFNMFALWMFGSAVEKALGIKKYLILYFVCGLGAFVLYNLVNFYEYKKIYEVLIE
QGAPLGELYSYTKLSPIEAKNITITEVKEWLNAMPSGVNVQLLFELFRGWRTPMIGASGA
IYGVLVAFGMMYPNTVLMLLFPPIPMKAKFFIPIMIILELFFGFQNQPGDNVAHFAHLGG
AIFGFFLVRHWLKNRYRWN
>EGEFANNL_01326 DNA mismatch repair protein MutL
MPDIIRLLPDNVSNQIAAGEVVQRPSSVAKELLENAIDANAKQIQLMVKEAGRNLIQVVD
NGMGMSATDARMSFERHATSKIANTEDIFHIKTKGFRGEALASIAAVSQVELRTKKEEEE
VGTQIIIEGGQLISQEVIHTPTGSSFQIKNLFYNVPARRKFLKSNSVEFRHVLDEFHRVA
LAHEDIQFQLYNNGEELLRLRSGSLLQRISDIFGRKIQNLLIPISEELEWVRLSGFVGKP
ESAKKTRGEQFLFVNHRFFKSTYFNKAVQDAFEGLIPQRYLPSFFLYIEIDIERIDVNIH
PSKTEIKFEDESSIYALLRTAIKKSLGVYHVAPSLDFEQNQDWVFSIPKKDSPIEEPKIK
INPAYNPFKENSKPFTKAEKLNVTEFYSSFRNDDITSDLFDAPSANNEENFLRLMNGRWM
IEHKGQLWCIDPYRIHQTILYNKYIKSIKNHALSQQLLFPLERPVYDLEKEKLISIQSKL
FAQGFDMQIEDDLLTITAIPSDILQEKVLDIIEELLYQLTEHSEEEFSVFFSKSVSKVSA
KKRNEFIQSSQIRPIWEEFKNLEMPYLNPLNKKNYEIISIPNFE
>EGEFANNL_01327 hypothetical protein
MCKSFLIPIFFIVSYVCLGQTEVIKNVGDFTSLRVFDKIPVILIRSESPRIEILGNKSED
VQVINKNGELKVRMSTLNLLSGDDTVVKIYYSEINNIETSEGSSVKSEEEIESQTLTLNA
KEGAAITLTLNVEQLNIRVNSGGVINASGNTIDQNILITSGGKYLAKNLNSDNANINLTA
GGNSVIYASKSVIATTRAGGNIDIYGSAEVQQKTILGGTITVH
>EGEFANNL_01328 Regulatory protein RecX
MYTVSDIKKKLASYCAYQDRCHWEVEEKLKEYYFLDDEEKGGILVWLIQNDFLNEERFAL
SYTRGKFNLKKWGKIKIRQKLKQKKIPERLILLSFEEIDEQDYMKSLEKIAENKWNSLKN
ESSLIKKKKLISYLIQKGYEFELIQNAIDSLVNKE
>EGEFANNL_01329 putative protein kinase UbiB
MQDNRKKIHRSARLIYILTKYGFDELVIKSGISKLIPESWQSKEEGTIKVAKGKTIYERI
RMAMEELGPTYVKLGQVLSTIDLFPEELIQEFRKLQDRVEAENINIIYKLEEELGEDPKE
YFEVINPNPIAAASISQVYFAILKNGEKVVLKVKRSNIHKVIESDLLLMKDLSVILENNY
DWAKRINLVYIIDTYEKSILQELSFLKELENIEKFSKNFENNPHIHVPRTYKEYSNNNIL
CMEFIEGIKISDKEELIKQGFDLKELAIRGIDLYLKQIIEYGFFHADPHSGNIFVLQNRK
IVYIDFGTMGMLMPSDQEQIENMLIHVIKKDVPKIITSIKSIAIKYSIPDEKQLERDIYE
LLNFIDQNSLKDIDLKALIEKLLNILNKNEILMPSHIYLLGKGVLLMEGIGRNLSLDFNI
IESIEPYVLKIIRKRLNPNHLLSKGIHRLQEISSDILSIPNELKIFIKNANEGKFKILYD
FENNNSFIKTIHCLTLSLIVLSLLVSSAILSLSPLPPFLLGIPALSFFLMSLGLIILLYL
LYTIKKGK
>EGEFANNL_01330 L-amino acid-D/L-Glu epimerase
MEASFHSYDLQFKTPAGTSRGVLKSKTTYLLHVKYFEKEYIGECALFKGLSADSELEYED
KLHWVCKHINEDKDYLIDSCKEFPSIQFGLEQVFLQIENKKSGLFFESDFIHGNTGIQIN
GLIWMGDLDFMREQIQNKIEQKFDCIKLKIGVNWEGEYSILKSLRKEFPAHKLEIRVDAN
GGFTFDEAPKILEQLAGLQIHSIEQPIKAGQIEPMAELCKISPTPIALDEELIGKFSLTD
KEILLKKLNPQFIILKPALVGGFKGSNEWINLAKNYKIGWWITSALESNLGLNAIAQWTA
TLNNPLPQGLGTGGLYTNNFPSNLEVRGDRLYYNL
>EGEFANNL_01331 2-succinylbenzoate--CoA ligase
MCNIELDFSKEIHLNKIPTHEAWLNNIVSFLTEWYDNSDIIKTNTSGSTGIPKTIELTKE
AMVKSAEMTGKFLNLKENDSALLCMPALFIAGKMMLVRAIVWKLKLRCIQPSSNPLKNIK
NEISFSAMTPMQVEHSLDKLHLIKKLIIGGAQIPTPLSKQLNQFSTSIYESFGMTETISH
IALKKVSKNPEERFKLLPNTKIDLDDRGCLTIKTPFSNEEIITNDLVKMHSENEFEWLGR
LDNVINSGGIKIYPEKVEKQLKTIIPNEFIISSQPDPILGNKVILVIEGCILTHIEELIQ
NFNFNHKYEKPREIYFIEKFQRTPTGKIVRRNISLSFK
>EGEFANNL_01332 Thiol:disulfide interchange protein DsbD
MKKILWIFILITGFIQAQIENPIHWKSEIKHLKDKEYVAIFTANIENHWHLYSADAEEGI
VIPTTFKFIPNPNIKLIGKTQEVGQKIKEYSQAFKANIVYYKNKVEYHQKFEILKDIPLN
LEADVDYQLCNDKICLSPDGESFILKIEPEKNFAISKQSNKEVNEIVTPSKSIVKDTLSS
KNNPEIEEVKNISNTPDSENKNIIIANLDVDNPINKECGDKIIQNEGYLWIFIFGFLGGL
IALLTPCVYPMIPLTISYFTKNSNKNGKRDALIYAFFILFIFIIFTLPFHLINGINSDIF
NQISTNVWLNLAFFVVFIVFAFSFFGFYDITLPSWMANKSDRASESGGILGLFFMALTLV
IVSFSCTGPVLGSILAQSIQNPTQLTMAFSGCGLAWALVFGGFALFPNLLKSMPKSGGWM
NTIKVVLGFVELALAFKFLSKADLVAKTFLLKREIFIAIWIIIAFATALYLLGLIKFPHD
SKKSKIGTSRKVWSCLFILIGIYLIPGLFPSQKPNLKLLSGLTPPLNVSIYKKDKEQGIL
GLSIQHDYFEALKIAKEQNKPILVDFTGFGCENCRKMEEFVWSEADIWQILNNDVIIASL
YVDDSESLPEEEQIVVQLKDGRNRKIKTIGNKWSVFQKENFNSNSQPFYVLVTPDNQILN
YPVAGYMKKEDFKNFLHCGIQTFKNLKK
>EGEFANNL_01333 NAD-dependent protein deacylase
MKSKLVVLTGAGMSAESGLSTFRDSNGLWNNYKVEDVASIEGWYRNPDLVQDFYNKRRAE
LKNHKPNQGHFLLQELEKNFEVTIITQNVDNFHERAGSSNIIHLHGELTKIRSVQDENLI
YETSEDILMGDLAEDGAQLRPHIVWFGESVPLMETAIKITQEAHIFLIIGTSLQVYPAAS
LIEYAPKNCKIIVIDPKPIDQLWNKEIIYINKGASEGLEYFKQNYL
>EGEFANNL_01334 Methylglyoxal synthase
MEIAIIAHDGRKADMVAFLMSHLEVLQQHNVHLIATGTTGTFVESAGLKVQKFKSGPLGG
DAQIAARVVDGFTQMVIFFRDPLGKHPHEPDVNMLLRLCDVHNVPLATNRATAEILINSL
GIVKK
>EGEFANNL_01335 hypothetical protein
MNVILFDEEERNNLLPLTFTKPVAELRMGGLSFTERWKRILETTNVSFLSEEYLSKKYPA
KIKDLNLFINPAYFPNQELIFKIKNLQQGEALYQNEKLIAANCNYEDFKFSNCKKNYIDD
ISFHIQYPWDLFTYNSLAITYDFQLITQNRKSYPLSETVRVIGDTSKIFLEEGAVAEHVI
INTKEGEIYLDKNSEVMEGSMIRGGLMLGEGSKINMGAKIYGGTTIGPYSKVGGEVSNSI
FSGYSNKGHEGFLGNSILGEWCNLGADTNSSNMKNNYSEVKFWNYHSSKFIDSKLQFAGL
IMGDHSKSAINTQFNTGTVVGVSSNIFLPGFPPKLIDSFSWGGKKDSPLFQLEKVYDVME
KVMLRRNKQPTQEDKDIIKYLYSNCLQKNAL
>EGEFANNL_01336 Putative cystathionine beta-synthase
MAGTYNNVLELINNTPLVRLNKVTEGMKGKFFAKLECYNPGHSTKDRIALHIIENAERKG
LLKPGATIVETTSGNTGFSIAMVSIVKGYKCILAVSDKTKPEKISFLRAMGAKVYLCPAN
VPADDPRSYYEVAKKIAAETPNSIYINQYFNKENTKSHYLTTGPEIWEQTQGKITHLIGC
TGTGGTLTGAAEYLKEKNPNIKIIGVDAVGSVLKKYFETGEIDPNEIKPYQIEGLGKNLI
PEALDFSVIDKYVKVSDEPSAYATREIALKEAMMVGYTSGASLTATRKIAEDFTDESVVV
LIFPDHGSRYMTKVFSDEWMQSQGFVKSRLNGLESHATIETVQ
>EGEFANNL_01337 4-hydroxy-2,2'-bipyrrole-5-methanol synthase PigH
MDIFDRIKNHPGPLEKYAEYAEGEYIFPVLEGEISPRMKFKGKEMIVWSINDYLGLANHP
EVRKADADAGVKYGMAYPMGARAMSGQTPQHAELERQLAEFVNKESAYLLNFGYQGMLSI
IDTLVSKNDVIVYDVDSHACIVDGVRLHFGKRFTYQHNDIESLEKNLQRATKNAAESHGG
ILVITEGVFGMRGEQGKLKEIIELKKKYNFRLLVDDAHGFGTLGKTGAGAGEEQGCQDGI
DVYFSTFAKSMAGIGAFVAGDKEIIKYLKYNLRSQIFAKSLPMPMVMGALKRLELLKTKP
ELKAKLWYNVNKLQGGLKDRGFNIGSTNTCVTPVYLQGDPLEATLLIKDLREFYGIFTSV
VVYPVIPKGMILLRLIPTASHSDEEIDATLAAFEAVRGKLMDGTYKKGSENLDLGI
>EGEFANNL_01338 Inner membrane protein alx
MEDNMFNHPLLITIFSISILVMLILDLGILNKKTHSISNKEAATWSLVWISLAMIFSGVI
FLVFKEADGYKFALEKFSQFQSAYWIEKALSVDNLFVFIMVFSFFKIPKEYQHKILFWGI
IGALIFRGIFIFLGVEMINRTYLPPFSIGNFHFVLDHHTEYSNTTSNEFYRPNIILTIFG
VFLIYAGIHSWFSKEEDNDSKKDLNESLGARIVKKFFKVTKDFDKDKFFTVSNGIKMATP
LFTALIIIEITDLIFAVDSIPAIFAIAPNDPFILYTSNIFAILGLRSLYFLLANFMHMFS
KLKYGLAIILSFIGIKMLMAPFIHISSLSSLGVVAGVLILSVLLSLIFPNKKEQIQ
>EGEFANNL_01339 Deoxyhypusine synthase-like protein
MSKPISEFIEKYFLHFNAASLVDAAKGYTAHLKDGGKMMITMGGAMSTAELGKILAEMIR
QDKVAIISCTGANLEEDIMNLVAHSHYKRIPNYRDLTPEQERELLDNHLNRVTDTCIPEE
EAFRRLQQHIEKIWKDADAKGERYFPHEYMYQLLLSGVLEQYYEIDPRNSWMLAAAEKNL
PIVVPGWEDSTMGNIFTSYVIKEEVKASTMKSGIEYMAYLTEWYRNNSQGKGVGFFQIGG
GISGDFPICVVPMMYQDLEWEDVPFWSYFCQISDSTTSYGSYSGAVPNEKITWGKLDVNT
PKFIIESDATIVAPLVFAYVLDM
>EGEFANNL_01340 NAD(P)-specific glutamate dehydrogenase
MKTQQVLDSLKRRFPNEPEYHQAVHEVLESIEEVYNQHPEFEKSNLIERLCIPERIFTFR
VTWVDDKGQVQTNMGYRVQHNNAIGPYKGGLRFHSSVNVSILKFLAFEQTFKNALTTLPM
GGGKGGSDFNPKGKSNNEIMRFCQAFVTELWRHIGPDTDVPAGDIGVGGREVGYLFGMYK
KLAREFTGTFTGKGLTFGGSLIRPEATGYGNVYFLLEMLKTKGIDIKGKKCLVSGSGNVA
QYTCEKLIELGAIPVTLSDSAGYIYDPEGITTEKLEYVKELKELYRGRIKEYAEKYGCKY
VDGGRPWSEKADIALPSATQNELNGEDAEILIKNGIIAVSEGANMPSTPDAVKAFIEAKI
LYAPGKAANAGGVAVSGLEMSQNSERLSWSLETVDQKLKEIMQDIHNNCVKYGKDADGFV
NYVNGANIAGFMKVARAMMAQGIL
>EGEFANNL_01341 hypothetical protein
MQNAAQSLRNFQFKDISFSNLMNKRIYNVLLIATKYDLFILEEDGRIDEQIFDEYTALNL
RYPPRFTQVSTEEEALELLQENHYELVIFMPNMDEVHMFSTAEKIKKLYSEIPLVVLTAF
SKEVSKRLSAVDLSFVDYVFSWLGNSKLLLAIIKLIEDSMNVEHDVQTAGVQVILLVEDS
VRFYSSALPSLFKIVMNESKNFAKEALNEHQQMLRMRGRPKILLARSFEEASEIYKLYTK
NLLGIITDMSYLHNGVKEKLAGYNLAKWIKESNKFLPIIFNSSDPNNKKYATELNCDFID
KNSKSYSYELRQRIIQQFGFGDFIIIDPETKKELYRIRNLKGLQKVIKIIPDDSLAYHVS
QNHFSRFLYSIAIFPIAEMLKNIDAKDISLQEVRQLIYDSIIEYRKMKNTGVIAVFEKDR
FDEYSEYARIGEGSLGGKGRGLAFLGNIIKTHPELNQHNNFPVTIPKTIVLCTDIFDEFM
EENHLYSIALSDAEDHEILNAFLKGNFPERLDEDFISLFHTIKSPLAIRSSSLLEDSYYQ
PFAGIYSTYMIPCIENKLQMLSWLKDAIKSVYASVFFRDSKAYMEATHNVIDEEKMGIVI
QEVVGRSYEERFYPAISGVTRSLNFYPIDYEKPEEGIVNLAMGLGKYIVDGGITLRFSPY
HPHNILQMSTLDFALRETQRQFYALNMKGIDESFSINDSFNLLKLNVNEVLKDSSLKYIV
STYEPREQIIYDGFYEGGRKIISFTNILQHELFPLIDTLQKVLKITKEEMGRDIEIEFAI
DIENKEKATFYLLQIRPIVLNKEDMNEDLSLIPVEETLLTSNNALGNGIIDDVYHIIYVK
SKDFNPANNQMIAYEIEKINKKFKEGDGGYVLVGPGRWGSSDSWLGIPVKWSYITNARLL
VESGLKDYRIEPSQGTHFFQNLTSFGVAYYTINSFQEGEGTFDEEYLNHLPSIEETDYLR
VVKFEKPIVIKTNGRKKQGAVFKSSN
>EGEFANNL_01342 Magnesium-transporting ATPase, P-type 1
MNTNRSKKHSNIEINSTTKLQMVSRNTSNLFYAMLESSEKGLSLPTVEEKIKKFGYNEIE
QDKVPSWYKQFVMAFINPFIAVLVILVIISAIMDVWIVSPEERDFKTIIVVGSMIIISSI
LRFWQEYNSNRAAENLKNMVKTTATVFRRNQGKVEVNIREIVPGDIVHLSAGDMIPADLR
IIKSKDLFVSQAILTGESHPLEKRDEVIVNAENKSPLELENLCFMGTNVVSGTAIAIVVT
TGNQTYLGSIGKAISGKKGETSFDRGVNKVSWLLIRYMLVMVPLVFLINGLTKGDWLQAL
LFAVAIAVGLTPEMLPMIVTANLAKGAKSMSKQKVIVKKLNAIQNIGAMDILCTDKTGTL
TLDKIFLERHLNVLGHEDDEVLKWAYLNSFHQTGLKNLLDIAILEHVEVHDYLKVEEDYI
KVDEIPFDFQRRRMSVILEQKNKKQLLICKGAVEEMLDLCTHAFYPGENSKMHAEKDSIV
ALDAQMKKTVLNTSRKLNEDGLRVLLVAIKEYNNPKIDYNVEDESNLILTGFIGFLDPAK
PSAKPALEKLQKLGIQVKVLTGDNEIVTRKICKDVGIPFQNIVLGADIEFLNDDELSMKI
KDISIFAKLNPVQKSRIVTLLQKQNFTVGFMGDGINDAPALRKADVGISVDTAVDIAKES
ADIILLEKDLRVLQKGVVYGRRTFGNIIKYIKMTTSSNFGNMFSMIGASIFLPFLPMLPI
HLLIQNLLYDISQTSIPWDKMDQEFMESPQKWDANGISRFMIYIGPISSFFDYITFAVMF
FVFKANTPEHQNLFQTGWFVEGLLSQTLVVHMIRTRKVPFIQSWATAPVVALTSLIMLIG
ILLPFTSLAESIHLQPLPLSYFPWLIAILFSYCLLTQFIKNRFIKKFHQWL
>EGEFANNL_01343 hypothetical protein
MLPITEFALRLILAFVLGMAIGIERQWQQKSAGLRTNTLVAVGSAAFILISMSVSGSHGD
PSRVAAQIVSGIGFLGAGVIMKDGLTVRGLNTAATIWCSAAVGSLAGIGLYAQAALTALT
VIIIHITLRPLGSKMNKISFKQKDHTATTEYQILIHCKNNIENHIRVLLIQQLGNNEKLL
LRSLSSKDDSDGESTLITADITANGIQDYLMEQMVSRLTIEQEVIKVSWEFVGQQSDV
>EGEFANNL_01344 hypothetical protein
MQLLIYKLLKDSCLNYTNSRKVGVKNQLYVNGTEKNGKLFIFINKINYNVTNH
>EGEFANNL_01345 Inner membrane protein YbaN
MKIVWIIFGTISLLLGIIGAFLPILPTTPFLLLTAYCYGKGSEKFHSRLVSSKIYKKYIK
DCVQERAMTLKQKLILLVFVSFLSIIFMIIYQNILIKSILSLVILGHVIFFGFYVKTKKN
KSFIFLELLRK
>EGEFANNL_01346 Methionine synthase
MLIFENIMQNTLKLSGLEEFTLLPNSNFINIGERTNVTGSKKFLNLIKNERYEEALSVAR
DQVEGGAQIIDICMDEGLIDGVKTMTTFLRLIASEPDIARVPIVIDSSNWEVIEAGLKNI
QGKGIVNSISLKEGEEEFIKKAKIIKRYGAAIIVMAFDEEGQADNLEKRKTIAQRSYDIL
VHQLNINPSDIIFDLNIFPVGTGMQEHRRNALDFFEATKWVKENLPGCYVSGGVSNVSFS
FRGNNKVRESINAAFLYHAIQYGMDMGIVNPTQVEIYEEIEPELLRKIEDVLFDRSEDAT
ENLIEYAETITQEKGAKEQKVEEWRNYSIEKRLEYALIKGNADYIEQDVEEARLQARRPL
DVIEGPLMEGMNTVGELFGAGKMFLPQVVKTARVMKKAVAYLQPFIEAEKTEESRTNGKI
LMATVKGDVHDIGKNIVGVVLACNNYEIIDLGVMVPKEKIIETALKENVDIIGLSGLITP
SLDEMISVVDELEKRKLSIPVMIGGATTSKIHTALKIEPKYSHTVIHVLDASKSVAVASS
LLSNQHETFKAKIKEEYKYLRESYLSRSSEKDYLTIAEARKNKFKIDKKSFTPYKPKQIG
TQVFDAIPLSELKEYIDWQPFFRAWQITGKFPNLLTDKIVGEEATNLYKDAQALLDKIIS
ENLLQPKAVIGLFAANATEQDDIEIYDSKGQHINTFRTLRQQTKKSEGVANFALSDFILP
KNKENIQDYIGCFAVTIFGAEELAKKYELENDDYSAIMVKAISDRFAEALAEYLHAKVRT
EIWGYASDENLNKDEIIKEKYLGIRPAPGYPACPDHLEKITIWELLDVKESIGCILTESL
AMYPASSVSGYYFANPQAKYFGLGKITKDQVEDYANRKEIKLEDAKYWLQSNLA
>EGEFANNL_01347 Beta-barrel assembly-enhancing protease
MKLLNLLFILFTGSLWAQNYIPIDTADRAKRDLAAASFKNSGDEFIKFVKTSYPKKVGKI
MALSYEEFYKDFEKQIKDGSFVYDVRFSSYIDKILNQLKQGNPNIPKDLRVLISKDPSLN
AYCLPNGTFVLNMGLFYWLDNDDEVASVLAHELSHNILKHSLKRGEAMANDELSSNNKNQ
IKSIQKQKYNKSRAALELYRNKLYTSGDLRKKNEFQADSLGLIIMKNSPFNEGAFVDALE
LMEEYDSIKPSGLKEDIYRKIFSLPNQPFKDDWLKREDFSNYDYSLYKEKIDKDSIATHP
EIEDRINKLRTYFPGMKENDIELKPSKELEELQKIAKYEQVPSLYFFEQYGAGIYICLYY
LQKDPENQFYKEWLGKCFEKIYEGRKTYRLNRYLDRIEPKDQSESYQQFLSFMWNLSLDE
IKNISEFYNSKKAPE
>EGEFANNL_01348 hypothetical protein
MKRKLYFYLLCLFIYSTTWAQTAKLAKLSEGKLVYYTPLLDAYSEKELGLYGYFFIFNKD
RTQRTEYNYEYVLLDKNLNKVFSGEFSEQYNKGINTRKYFEGWYINKQVLLNVYEDGDKM
KNRNRWQRLIDLKTNKVSDPFYVNDSQSNFPIDIGKNSNAFYYSLFPYSQTGFFYNNFKW
PYPLCFYKELKPGEPTWCLKNSKQNKQTLKKYTDFWLSPVNEEIGLLEEKNIKETSSKKI
LDLRYKLINMKDGSTITTLSIPDPEKKDSIINGLNKNLQFHFNTYGNIEDNLLKVSKTNF
SDRVINPDPFKIIVKEYYSLDTGKKVKTDIFNLKDLSSFMNYTPDYKVMNNGKKWELKLI
EHLKLINNNSILIFEETNQNSEKSEFGNLYFVELNKDLKVIKFTKTNIKSRIFTKKEDQQ
EIIENTRKKLSDLGISISVSESWLKKLPLEDIEFTKQIEDGTIVIFYKQKNEEGKINTLS
SLSYKDGKIKQLPDFPIKTEEGSKISFLPAKNGYLLLYEEFEDENKMPELRLEKINY
>EGEFANNL_01349 hypothetical protein
MKKLLLFLLLSISGFISAQMQDLATLASGKLVYSQILLDTEDQVYGYIYFFNQENIDEDH
IQMEYVLLDKNLNRVANHSFKMHQYNKMLVTRYFRDCSLINNNQLLLRLSHQPMNALPIE
SFSILSIKEKTISPEFWYYNDAIEEIPKSYPEYEKKAFYFKNTGIAIPDKNHNGFYIKEQ
PYTKVGTNKFLKFYDLKNQLQWSYEYNTSTKNKEQNTIYINNNKSETIYLLESNSLKKDK
IVAINSQNGKIEFRYTFDNNLTKIYHDFNSKVINNQFIITGNYYKYEGYTDSYNLNMSLG
FYRIIIDKNGNKINEKYIPWEDLNEQININKNGKVDKKYFLRPNGFYIFEDGSVCFLTDK
YQPNSSSSDFVLFFMDPDFKLKKIETIAKEPFKGTQYNYLFSQFSKEKNEYTFFYKNYIT
SNKEWVLGVVTLNKEGIIKEDKIPMSSKDEKFTILPIPAKEGYILLREYNENDEKYNQLR
LEKLN
>EGEFANNL_01350 hypothetical protein
MKRLFLALFLSLVGFISAQIQDLATLASGKLVYNTILYDTDNQVYGYIYFFNQGDVDKEN
TQMEYVLLDKNLNKVANNTFTFKNYNIKINSYFSFCNYLNNNEIALGMRYTTKNKPSIYS
FRTIKINEKTVSPEYWYRNGNIEEVPTDYKEYKKIIKEVNNTGFFSTNKKNNGFFVKELY
NKKFGTNKFIKFYNTNKELQWEYEYNPNAKSNNFNTISIQHSSENTIYLLQSQNNGRYAT
EYKIVALNSKNGEKKYEYVFENNNSNYSHSLITKEINNQLVIVGNYSKYNKEKTFDLDKN
LGFYTIILDEKGNKIKEKYTQWEDFKGLIDIDEKGRVEKNYRLRPTEFYIFNNGSIAILT
EKFKQAKNGIGNFIPIPIINVIVDEATKREQKIDDFVLFLMDTNFNVKNVKTIEKDLTKG
YSYNYLFSQYSKNRNEVAFFYQNYLISDKEWVLGVNTINSKGELKEDRIPMTSKEEKYTL
SPIPAKEGYILLREYNEKDDKYNQLRLEKLN
>EGEFANNL_01351 DNA mismatch repair protein MutS
MSKTKETPLMKQYNSIKARYPDALLLFRVGDFYETFGEDAIKASKILGIVLTKRANGQAS
HIELAGFPHHSLDVYLPKLVRSGLRVAICDQLEDPATAKGIVKRGVTELVTPGVTFNDKV
LEGKNNNFLLSVHQEKENYGIVLLDVSTGEFFMTEGNSHKLKQLVDNFKPTEIIYQRKKN
LPFEISSYSFQLEDWAYQFDYAYEKLTQHFKTNSLKGFGVDDLRLGIVAAGAVFSYLVDD
THHKLLDHISGIQRLPQDTFVEMDQFTIKNLEIIAGANNSSVSLLNILDQSLTHMGGRMI
RRWLLMPLKDIKVINRRLSLVRYFLNNPKVTTPLKEELKGISDVERLLGKLAGERISPKE
FGYLRDSLVKYLKIEQILLSEKNIDLKSLGEFKDTRETVNLLINQLNEDLPVALAKGNVI
KEGVSEELDRLRSLKENGKEYLENLCLKESEKSGIPSLKIDFNNVFGYYLEVRNTHKDKV
PQEWVRKQTLVNAERYITEELKEYESQILGAEEKISVLESELYKKLNAEVKKSLLEIQHN
TRIIATIDSLISFAEVAQENYYTQPHLDESKTIEITEGRHPVIEKQLPLGEVYVSNSVYL
DDKTQQILMITGPNMAGKSALLRQTALIVLMAQIGSFVPAKNAKIGIVDKIFTRVGASDN
LSKGESTFMVEMNETASILNNISERSLILLDEIGRGTSTYDGVSIAWAIAEYLHEHPTCP
KTLFATHYHELNEMTGSFKRIKNFNVSIKELKDSIVFLRKLVAGGSEHSFGIHVAKLAGM
PVSLTQRAEQILKTLENKDVRKDLKNRTKMLTEENMQLSFFQLDDPVLENIREEILKTDL
NTLTPIEALMKLNHIKKMIGG
>EGEFANNL_01352 hypothetical protein
MCNLLLQHFRSRIPISDHEFNLLLSYMDHFQVKKKHKILCSREVCNSTFYVNQGLLYSYS
TDSNGLENVVNFAMEDYWIGDMYSFINKTPSNQTIVAIENSDIYQLSNDALEILFDKIPA
LEKFYRILYQNAYTHTLQRLDCSLNVSAQERYLKIVNENPKLLQRVPLHLIASYLGITPE
SLSRIRKKIYL
>EGEFANNL_01353 hypothetical protein
MYSNSPFKNYFLIVISLIAVVFLWFIGYFRIQERIEQAYLLQVIFISALSFTLNVFIIFN
INSQKKRKIIPLAIYIVLFGAFFKEFYSINMGVVYLLCTLVLLLVLDVLSISSSFKYFNI
GALITISSLLYFPIIVMVPLFFFITLLYYKKKINISQYIAGVFVASILILEVTFLTGNFS
YIEHWIQNLHVPKFHIEYQIPIIIIIFIITIYGWIYQYTNQTINNSIEQSSKYTILVFYL
FAWILIYALFMGDNYHLLIFVSLPVSLILPKSI
>EGEFANNL_01354 hypothetical protein
MTDLIIGIGKLFTWSFKILPIIGHFADWIFVVILCLVLLYWMKRIVDFGQKDKEYDGDRI
>EGEFANNL_01355 hypothetical protein
MGYKFLKSWLWGNSVALSWLWGLGLFFSVQMTFLFGLTGLFSFAFLNALGLFLFGYGTQK
IASRDKGSESLERFFKRWSKPFRLSLYLYQLIALTLTIFAIIKYLVMPLLVSFWPDWETQ
GTILQVFLLLLVAALIISAACLIGEEFTIKTIKYWHLFAGILILLSVISILCFFSPSELV
QYSAWIKIETCKPIFWGYLIPILIGFFVGPWLDLQQWQRAIEMRKENVNISVSYMWGGLI
FFFFLIFHGFLASLVFNNPWFSPNMTFVGLGGLEYGHDLIVKYMLHFQSIFPWWIPTSYF
IFITLAIITTLDSGYIATKWFLKENSKSSNSPILSMIPEGIINSPIPTFILAGFIAVFGV
LINCEIEYFMVFFATFFVAYAALGIARCFVPNSQHSLPQVKLFSIGAFSLVIFACGYFLQ
VAWLMILGSILPILYVCWLVLNTDLLRVVKEKVEEVMDVASEIPVLKSISKATQTALNGK
IKEVSTGSHFEDKWFVHSFMATYADTNSVGNVYFGVYALWVGKTRELFFNYVLPDFDLKD
TKYLILTRSFEHKYINETREFEKISVKIRVSEYNRKFATLSHQVYDSAGNLLGKGKQQLI
FVSPENYKILDIPAEVLKAFMPFM
>EGEFANNL_01356 hypothetical protein
MATNIKDCLYSNLRISVSLGYTLMKNTIFYIKGMKAFNTSAGMSNIL
>EGEFANNL_01357 hypothetical protein
MAMTIDILFLRYPSEVSLIVSKNSRSLFHNNVWFIYTEQGACTFKDENGNFYAYAPGKVT
LGEYNNHQDIPYNEACTLQSGNLLTKMIDKNQIIQIARQYFKPLSVQKDNVEALVSLRDD
DMGFYLS
>EGEFANNL_01358 hypothetical protein
MRRFSYGFIVIFILFLSIFSCREDLDYQTASHPLRFSKDTILLDTVFSTIRSQTYVLKVY
NQQNEDVTIPLIYLDKGINSQFKINVDGTPGTHENNNRFVNVPIKAKDKISIFIEVAPKS
IDSTSLVADEDLIFNTLGNSQKVKLLTLIEDADFYYSAGGNIKINSDLVWDKSKPKVIYG
NLEIDNGSKLTIEEGSQIYFHKDASLIINNKSKLFVNGTLNSKVTFRSDRRNARYDSLAG
NWKQIKLMPQAEATINYSLLKGGENAFYLEEGSKLNITNTEIYNFLYSGIYSEGGNVVGQ
NLAMNNFGLAALFVENGGNYNFTHCTFANYWNLTTGTTYSVYLSNKQQNSAENIYKDLSV
TFNNNIFWGRSANNLYLDNKNLKLFNYKFNTNLIRNSNLNINTDSNFNNTILDKDPLFNK
TSYSNTVLSLKPNSPAKNNGNPNFSVTVPLDILGVDRALNPSLGAYQ
>EGEFANNL_01359 hypothetical protein
MRKSLVTLILFLFWTLTFAQVDLGIKGGMAFGYDGTLKQTITNIKESKAKNNIGWHIGFY
SRIHLLSWYLQPELYFSSMKNNFESSTEGSFTTHSNRLDIPVLVGKKILSIGRIYAGPLF
STSVNEGISLKRISKTKSDDFSLGGQIGVGVDISKLTLDARYEFGFNKSNTNFVNKVTHQ
EFTIEKKQNSLLLSVGYKF
>EGEFANNL_01360 hypothetical protein
MEITYYGHACFAFKTSAESFIIDPFITENELAKHIDINSIKADYIFLSHAHYDHILDAET
IAKNNNATILANAEIATHYSKKGIKVLPMNIGGVKKFGFGKVKMVNAIHSSSFPDGTYGG
LAAGFLMKVDEKVVYFSGDTALCTDMKLLPFVYGHIHIAILPIGNTYTMGVYDAVVASKF
VQAQNVIACHYDTFPAIKINNKEKAKQLFSAEEKKLTFMEIGSTKDANDFKLNLY
>EGEFANNL_01361 Oligopeptidase A
MNDNTLLNSYNTPFESIPFEKIKQEEFKSAIEEGILIAKQELNKIIENSEKPTFENTMVA
LESVGKKLNIISSTFFNLNSAETNDFLQNLATEVSPLLTEYANDIIFNDRLFNKIKEVYT
NRDPSNLTPEEFRLLEKTYQDFSRNGALLNQQDKQKLREISNELAILSVKFGQNVLKETN
DYFLHLTEENQIEGIPASIKEMAELEAKKRNLEGWVFTLQYPSYIPFLTYAKNRDLRKEI
YTASMQRAFKNNEFNNEEIIHKIVTLRDKKAQLLGFNTYADFILVERMANTPTLVYEFLD
DLLSKARPFAENEINELMHLAEKDGIIELMPYDHAYYSEKLREEKFSFSEEELKPYFPLN
QVLEAAFKAAKKLYGVSFLERKDIQKYHSEVITYEVLNENNEHLALFYADFHPREGKRAG
AWMTSYRGQYKQGKENIRPHISIVCNFSRPNGNTPSLLTFNEVTTLFHEFGHALHGILAD
TVFESLSGTNVYWDFVELPSQFMENFVYEKDFLKTFAIHYQTGEVLSDEKIDKIVESANF
MQGYQTLRQIGLGLLDMGYHTNKLKPEDSIENFEQEQTKKAQLYPHIEKTCISTSFSHIF
QGGYAAGYYSYKWAEILDADAFELFKEKGIFDKETAKKFKTLLSKGGTQNPMDLYIDFRG
RKPMPEALLKRAGLLK
>EGEFANNL_01362 hypothetical protein
MNIKSLAEEERPREKLLVKGKQALTDTELLAIVLGSGTRQESVIRLSQRILSSVNYNWNE
LAKLSISDLCKFNGIGKVKAIEIITALEIGRRKSLQEALKIVSISSSEDAFQLIHPLLSD
LIIEEFWVIFLNKSNGMLGKEKISQGGITGTVVDVRLIFKRALELNAVSIIVFHNHPSGS
LKPSEEDVRITKEIKEAGNLLKIMLLDHLVVNQTSYFSFADEGFI
>EGEFANNL_01363 hypothetical protein
MEYNFLLMFIVSLILVVGAFIYLFNRFIHTENQRRNFELRMKNSENVLPNKLQAYERMVL
FLERIRPSSMIRRTPDAHNISDLEMLLIETVQVEFDHNLSQQIYIRPETWKVILAAKNAT
QIMIKNVFHSLESTATVQEAREALLNQAINQEESSSSTAILYLQKDIQGII
>EGEFANNL_01364 Dihydrolipoyl dehydrogenase
MNTFDVIVIGSGPGGYVAAIRCAQLGFKTAIIEKYSTLGGTCLNVGCIPSKALLDSSEHY
YNAVHNFENLGIDIQQPKANLNRMAQRKNEVVDQTTKGINYLMDKNKIVVYQGVGSFISE
KQIAVKKSGGETEVLESKYFIIATGSKPVNLPFAPVDKERIITSTEALNLKEIPKHLIVI
GGGVIGLELGSVYKRLGAEVTVIEYLDSLIPTMDGALSKELQRVLKKQGMKFSLSTKVTS
IKRTGGEIEVHCEAKDGEKLSFQGDYCLVSVGRKPYTDGLGLENINLGVDEKGRIKVNAY
LQTQVPNIYAIGDVVEGPMLAHKAEEEGVFVAEILAGQKPHINYHLIPGVVYTWPEVSGV
GYTEEQLKEKGKQYKVGQFPMRALGRARASGDIEGFVKILADKKTDEVLGVHIIAARAAD
LIADAVTLMEYRASAEDIARMCHAHPTYSEALKEAALDATDKRAIHM
>EGEFANNL_01365 hypothetical protein
MKLQENLYSYTIGAEDYLIHQLFSATNNENFKKQRKKGLLIWTLLFGILALVFFIQKNFL
LTIYFIIFGIIFFFVYPYYSSWVYKRYFKRIVQRNFPNDKEAVTLKISSKNFILSNQKEQ
GEIAIADLESINEIATHLFLRFKDGKNIIIPMLEVENKNLLLNQMSSLAQENSFSYYKNL
NWKWK
>EGEFANNL_01366 Glycine--tRNA ligase
MKSQEDALKKVVAHAKEYGFVFPSSELYDGLSAIYDYGQNGVELKNNLKQYWWKAMVQLN
DNITGIDSAIFMHPTIWKASGHVDAFNDPLIDNKDSKKRFRADVLVEDFAEKFEEKAKKE
IEKAKKRFGEDFDQEQFESTHPKVLEYRKQKQEILDRLAKTLETDLSKTKELIEELGIGD
PETGSKNWTEVRQFNLMFGTKLGSTVDSATDLYLRPETAQGIFVNYLNVQKTGRKKLPFG
IAQIGKAFRNEIVARQFIFRMREFEQMEMQFFVAPGSELSFFEEWKNKRLNWHLALGLGK
ENYRFHDHEKLAHYANAATDIEFQFPFGFKELEGIHSRTDFDLSAHEKFSGKKIQYFDPE
LNKNYVPYVVETSVGLDRLFLAVISNSYKEESLEDGTTRTVLALPPAIAPTKLAIFPLVK
KDGLPEYAQKIFNDLKYDYNIMYEDKDAIGKRYRRQDAIGTPYCITVDHNTLKDNTVTIR
DRDTMTQERVSVDSLREIIDPKVNMKSLLKIL
>EGEFANNL_01367 ATP phosphoribosyltransferase
MDKLKIAIQKSGRLSEKSLELLRECGIKISKGSQTLKTNSSNFPIEVLFLRDDDIPQYIE
QNVADIGILGENEVWEKNRKVETIRKLGFGNCRLSLAIPKDENYTGISYFNNKKVATSYP
KILSEFCAENNLYVEIEEISGSVEIAPSIGLAHGIFDIVSTGSTLLMNGLKEVETVTKSE
AILIKSENLSHEKQKILEKLLFRIQAVIYSRENKYILLNAPNTAISAIIEVLPGMKSPTV
LPLAKEGWSSIHSVIKEDEFWDIIDRLKNLGAESILVVPIEKMIL
>EGEFANNL_01368 Histidinol dehydrogenase
MKTIKYPAKSDWQDLILRPEREKESLLDTVKSVFNDIKISGDSALKLYTEKFDNVNLTQL
KVSKEEIDDSTNKISMALQEAIVRAKNNIEKFHSSQKEHPKLIDIEPGVICWRESRPIEK
VGLYIPGGTAPLFSTVLMLGIPAKLAGCKEIILCTPPDSEGDIHPAILFAAKTVGITEIY
KVGGIQAIAALSLGTESIPAVYKIFGPGNQYVTAAKKYAQEFNISIDLPAGPSEVLIIAD
EQANPSFVAADLLSQAEHGTDSQVIFLTTDEAILEKTLKEIENQLKQLPRKEIAAKALDH
STAILFNSIDECIQFSNQYAPEHLILAIKDFVNYVNKIENAGSVFLGNYSCESAGDYASG
TNHTLPTNGYARNYSGVSLDSFVKKITFQELTQEGIQNLGPTIELMAEAEELLGHKNAVS
LRLK
>EGEFANNL_01369 Histidinol-phosphate aminotransferase
MNIDIKKLARTNILNMQPYSSARDESGGIQGVFLDANENPFGENNRYPDPYQQKLKQKIS
EIKKIEPNQIFIGNGSDEIIDHIYRVFCRPGKDKVLFFNPTFGMYQVAAELNEVEIIDIP
LTPDFQINLEEAKKYFSDENLKVVVICTPNNPTGNHINSKDIDFILENFKGIVAIDEAYL
EFSTQKSYLNQINNYPNLIVFQTLSKAWGIAGVRIGMAYANPEIIQLLNKVKHPYNISVL
NQKAALEVLHNQEEFEKRVKMILSEKEKMKEEFKNIPIITKVYPSDTNFFLVEFTDANKV
FQELLEQKIIVRNQSSKIKNSLRITVGSPEENEKLIQALKNIS
>EGEFANNL_01370 Histidine biosynthesis bifunctional protein HisB
MKKVLFIDRDGTLVIEPPVDYQLDSLEKLEFYPGVFQNLAKIAREMDYALVMVTNQDGLG
TDSFPEHTFWPAHNKIIQAFENEGIKFSEILIDKSFEHENLPTRKPGIGMLTHYIKGNYD
LNNSYVIGDRLTDVQLAKNLGSKSIYMGDEKKNEATFSTKNWAEIYQYLKKEPRKAKVVR
NTNETKISVEINLDGSGKSKIHTGLGFYDHMLEQIAKHGNMDLFIEVDGDLNVDEHHTIE
DTGIALGEAVLQALGSKKGIERYGFLLPMDDCLAQVGIDFGGRPWMVWDAEFKREKIGEL
PTEMFYHFFKSFSDNAKCNLNIKAEGENEHHKIEAIFKAFAKAIKMAVKQTDANFAIPST
KGSL
>EGEFANNL_01371 hypothetical protein
MKQEDIKEKVDLYLKNREHKKRYASFDYCFNYFKTSDINKDLEKSCLVLATYLASWGMFR
GSSFLLQEKSLAHFIPTIQYINKLKNDRPEIWDIDVHNYNDQNINTILDIYKEIQERFTE
NHTHLTLVTKILLGVFGFIPAFDRNFRSTFSRFFIDDKNCGFTKVDKNSLKYIKIFYEEN
KEQIDDLSNKIYTIDFFDGKSTQTHYPKSKIIDMYGFQKGIEIELQKKNKFQP
>EGEFANNL_01372 Imidazole glycerol phosphate synthase subunit HisH
MLAIIKYNAGNIKSVQNALSRLGVESLVTDDKETILQADKVIFPGVGEAETAMNYLRERN
MDVFLKSLTQPFLGICLGQQLMCKHSEEGNTDCLHIFDAEVKKFPPKELVPHMGWNNIYD
LQGNLFQNIEENSDVYFIHSYYVELCKETSATCNYILPYSAALQKDNFYATQFHPEKSAD
IGEQILKNFIEL
>EGEFANNL_01373 hypothetical protein
MINKEDQSKEITPTTLPSFFKDWNWEDRKEKKSKSNKCEEVIDFFISWTLRCAEEKYKDI
SPSVNDYAKKVLSKLLFDDENHLKDKVVTSVDVWRQWKYIDLITKIKINDEWYLLAFENK
MYSPVDLDQLKSMYDKVKKYHDEKDFPNANRKYVLLRPDYCFIEDDTKVLAKLKEIIVET
EYKKFIYTNIEEIRDKIGISKTDNALFDEFWFNW
>EGEFANNL_01374 1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino)methylideneamino] imidazole-4-carboxamide isomerase
MRIIPAIDIINGKCVRLTKGDYSTEKIYREDPLDAAKEFEDAGINYLHLVDLDGAKSSRI
INYDTLYKIATETNLKIDFGGGLKSDEDLRIAFENGASQITGGSIAVKNPDIFQSWIEKY
GADRIILGADCKDRKIATQGWLESSSLEVVDFIQEYQKKGITYVICTDISKDGMLEGTSN
ELYHEILEKTQVKLIASGGVSSVEDLYRLKEMGCEGAIIGKAFYEGRISLEELSNF
>EGEFANNL_01375 Imidazole glycerol phosphate synthase subunit HisF
MLKKRIIPCLDIKNGRTVKGVNFVSLMDAGDPVELAKAYAKQGADELVFLDITATIENRS
TLIHLVERIAHEVNIPFTVGGGINSVEDVAALVKAGADKISINSSAVRRPELISEIAGQF
GSQCVVVAIDTKNEENGWMVYTHGGRTPTPIFTLDWAKQAEQLGAGELLLTSMNNDGTKN
GFALDITGEVANLVNIPVIASGGAGTKEHFSDIFLKTKTSAALAASIFHFNEIPIPELKN
YLSEQNIPMR
>EGEFANNL_01376 hypothetical protein
MNIEDFRDYCLSIKGATESFPFDENTLVFKVMGKMFAYGSISPKDGKLSFSMKCDPDKSI
DLREKYIGITKGKHTTSNLWNAVYLESDVPNLLIKELVQHSVDEIIKKLPKVKQTEYNNL
NNE
>EGEFANNL_01377 Phosphoribosyl-AMP cyclohydrolase
MKIDFNKNNDGLVPVIIQDYLTLQVLMLGYMNEEAFEKTKKEEKVTFFSRSKNRLWTKGE
TSNHYLWVKDIQIDCDRDTILILASPEGPTCHTGSYSCFGKKKSLGFIYELQQIINQRID
EKVKDSYTYKLFERGMNKVAQKVGEEAVEVVIEAKDNNENLFKNEAADLLYHYLILLKAK
GYRLEDIEEVLMERNR
>EGEFANNL_01378 2-(5''-triphosphoribosyl)-3'-dephosphocoenzyme-A synthase
MEFLFSEFISPNSLVGQEPSLMEVLNSREKKQFLQQECLKKYSCSLLSISLISPGGVKKN
LLQEYLFFRALETVDSYLLEEKITIHERLIKDEDTGLYALISLDEDPMELKLRMIKLEES
LPLARLWDLDVLDKQGNIISRKQTQQAELRKCLLCEQKAKICARKRLHSIDEIYKRIQQL
VIEDFLSQKVSEMAYQSMFEEINLTPKPGLVDAENSGSHRDMNQQTFLKSAEAIKPFFAS
FTLMGIHNSHESPELVFKNIRSLGLQAEKAMFSATSNINTHKGTIFSLGLVATAVGYLYK
NQRKINSDSIGEFVINATAGILEEFYGMEDREESIGIQLFKKYHLTGARGEAAEGFKTVR
MNSLPVLYRYPRLNKEHRLLLALLKLISVNNDTNVVHRGGLEALEWMKNYAQNLLQDMLI
YEDFNFLEKQMKIFDKLCIEKNLSPGGSADLLALTWFFFELENNFLK
>EGEFANNL_01379 Citrate lyase alpha chain
MNQKERISTYLESKEAIHAGEYKKICKLDLLETIANDRKICKSIEQAIDKCGLKDGMTIS
FHHAFRNGDYVINMVMEVIANKGFKNLTLAASSLNSCNSPLVQYIKDGVITKIYTSGIRG
ELAEEISAGIMNEPVNIHSHGGRVHLVKTGEIKIDVAFLGVPVCDEYGNASGVGFCGSLG
YAKVDAANADKVILLTEKFEEYPFTPASIAQDEVDYIVKVDQVGDPNKIGADATRMTSNP
RELLIARRASEVIAKSGFFKDGFSLQTGSGGAALAVTRFLENKMRSKNIKAGFALGGITS
SMVKLHEAGLIKKLLDVQSFDKDAAQSLKVNPNHLEISANQYANYSSKGASVERLDVVVL
SALEIDVNFNVNVLTGSDGVIRGASGGHSDTAASAQLAIIVAPLVRGRLPTVVDQVLTCV
TPGENIDVLVTDHGIAVNPERPNLKRRLEDAGVSLVSIEELKNRALELTGIPKPIEFTDK
PVAVVRYRDGRVIDVVYQVKHHG
>EGEFANNL_01380 Citrate lyase subunit beta
MLFVPGANAAMISNSFIYKPDSIMFDLEDSVALKEKDGARMLVVQALKHPFYREIEKIVR
VNSLTSEYGKEDVKAVVSAGVNVVRLPKTDSAQDVLDMEQEIESAEKYFGIEVGRTKMLA
AVESALGILNAKEIAFSTKRLIGIALGAEDYVRDIKTERSPDGIELLFARSSILHAARAA
GIMAFDTVFSDANNEEGFLREATLIKQLGFDGKSLVNPRQIELIHNLYAPTQKEVDFAKQ
VIEAAEEALKKGSGVVSLNGKMVDNPIIERAKLVLQKAELSGIRE
>EGEFANNL_01381 Citrate lyase acyl carrier protein
MEIVQKAVAGTLESSDIMIRVSPSDELDIVINSTVEAQFGDEILKTVKEILSKLNIDKIK
ILIDDKGALDCVLRARLITALIRSTKDQTLWEKIQ
>EGEFANNL_01382 [Citrate [pro-3S]-lyase] ligase
MMDIDTIYKVREVDAGQDKLIAEIEKFLNNNDLKLGKDVIKYLTISIGGEIVASAGIAEG
GIIKCTAIHPNYRGEGLVLKLFTELTYLCFDLGFKDLFIYTKPENEKIFRNCGFFPIEIA
SKVILMENSKTRLTNYCKDLQKINSRINATKIGSVVLNANPFTLGHQFLVESAASLCDWL
HVFVVKEDASYFSWEDRFELVNKGISHLKNVTLHEGSRYIISRVTFPTYFLKDEKIADEN
YAELDLRIFRHYIAPSLNITHRFVGTEPTSPITNKYNSEMNYWLEEAPLAYPPIKTTIIE
RKTVNSQPISASKVRELYLADKMEELKLYVPPTTYEFLEKNKNVKNK
>EGEFANNL_01383 Inner membrane protein YbhI
MDKSKIYKLGLLALVIVITCMTPNPEGLNPLAWKLFGVYLAAILGLIMKPYKEPVILLSA
LAISALIIGVYNKFYIPKEEQVIEMKKVLGGYASTTTWLVFSAFSLSVSFVVTGLGKRIA
YLLIKLIGNSTLKLGYVNVFLELLLSPAMPSNTARAGGVVTPIFNSIALALGSDPEKSPK
KAGRYLLLNVYMVTKTTSYLFLTGMAPNALALSLLHQVNPAFNLTWIQWLLFSSVPGIIC
LFLTPIVIYLLCPPELKKVDNKKISEEGLRELGPMTVKEKILTIVFILALLGWVFGSMLG
IDSSAVAIAAMSILLITNVINWDEVLKSKGGWSTLIWYGGIIGMSGVLSQVNFFKWLGEA
LATQLSGITPTMQLGGGMVGIVIILTISIVIRYLFASGGAYVAAMVTVFGLLGVAMKVPY
ELLAIGLLFSNSYGGTTSHYGGAAAPIVMACGYNDTKSWWKIGGVIGYGTLIVHCTIGIL
WWKFLIELGVLN
>EGEFANNL_01384 hypothetical protein
MKKKKLLLSLCVFLSMLLPIHLESQVVDQESSNPQKQLENQQKQIQDLQEEMRMLKEQLY
RTQVPANVDKSSQTSPEQELKKGPVYINKGKVFARIFMDYANNLTHAGDRRQGIDISRAY
LGYDYQMTQELSARVMIDAAPEGILAQTGKSNTASLKNPVLKNAYIKYQDKENKYYIMGG
MFTTLENTGYLKYWGNRYISKGLAVDSKMDKGTDIGIAGNYRFNKLISVEASIMNGEGYK
TISKNGSFLYTLSVPLQITKNFEFKPLFSIKTGEDNHLKDKMFMSFLAGYKNKFISGGVE
FAETFNDGKDDLNKYGYSIFINGKLNEKFKLIARYDQVKNTESSKSFSGYDIYGENGAFA
GHYNLAMFGIEYKLIKNIKIAPAYMLRTLKNANQNQKDININTIYLFLECSF
>EGEFANNL_01385 3-oxoacyl-[acyl-carrier-protein] synthase 3
MFINSTGYYIPEKRIDNQYLAQINDSTEDWYVKRTGIITRARANEGETVNYMCIEAVKSA
IKNLPYDIHEVDLIIFGSYTPSDTISTTAHVIQKEFNIDKAKAFYISSACSSAVNGMEII
KSFFETNISKRALLVCADQNSQYSNDHDRESGHLWGDAAVALFFSNEKITSNDSKVIDVI
TRGLGNVGKGPDGITLNPKVGIQMLYGKDVFTNACTYMSEFTKYIVKKNNYTIDDLSYFI
GHQANKRIISFVCNELGICESKSLTNIETLGNTGCASAPLVLAQNYDNFKSNDLICLSVF
GGGYSSGTCLIRKG
>EGEFANNL_01386 hypothetical protein
MKKKILNLTSLLFIIYCLIPLNLFSQENNDFKPSGNVILRTFFDYHTDFHDHRGFDITRA
YIGYNYKFTPTLQARVIVDGASGKNSSNQLVPFLKNAYVNWNYKNWDVNAGLINSLINPT
QEKYFGLRYVIENIATLNKIGQSADLGINATYKFNKIVSVDASITNGEGYKDIEMDNTMR
YALGTNIKPVKNLLIRGYVDYYNKPSDTVNLNSKKDLMTMNVFVGYDNSKLAVGAEYIQQ
FNNKFIKENDFQGYSVFSTIKIAPKWKPFIRYDYMKSTSINDKPWNKTDGSLAILGIEYQ
PTKLLKFAANFRNYNYIKKDAEQFIYLNAEFNL
>EGEFANNL_01387 hypothetical protein
MKKIYFLHGYKTSGKKFLAIKEYYKNSKEYLPIYWEWDENLDIAKFILEKSKVLMEDEGE
KIIFADSMGANLAWHIVNHFPSMHYVMTNPVFAADQIIDQSRIQPELKSKIFKATSDSIM
NKNLHLIISKNDQTLNNKYYKIVFGDDFKTLDLDDVHELININKYMPLIHNEIEAAFKKI
I
>EGEFANNL_01388 hypothetical protein
MYKKLFSQTLIYGLSNVLVRVFPFVLTPMLVKAFGPSKYSVYADFYSAAGIISVLLTHGM
ETTFFRFFQKFKEDRSQQNMVYFTSLTSVFIVSLIFLGFGLLARVPLANVFKHPDQVNFL
VWFLFILAADAMSAVPFAKLRIENKALRFASLKIMNSIVMFFLTVLFIFVIPKQIESYGI
GSSIFSKFYNPEYGIGYAFVANLIASIVTFLALTPTMFNGKYSFNIPLWKKMLLYAWPIT
IAGLAGIINETMDRQFLKYLLPEGTAEIEMGIYSAVYKIATFITLFKTAYLLGVEPFFFS
HAGEKNSKQTYASLMKYFTIFSALILLFLVANLDWIGRLYIRNPEYWSGLKVVPILLIGS
TFLGIYLNLSIWYKLSDNTHYGAIISVIGAGITIIFNWIGLKYTNLGYWACAYATFLSYL
VMMVISYVWGQKNYPIPYNQRKLIFYIGGSSLLSILSFYTSNSIFVHIVLGNFLFFIFLY
FMIKIEQRDIKIIKEKLKNFKRKGKG
>EGEFANNL_01389 hypothetical protein
MMPDFEYFLRMRIVGEHGHTALGVYYFDLPIGFLFTYIYHYCIRNTFIDHLPNFFRKRFI
FFKQFNWNKYVEKHFFVVVYSLLLGVYSHLFWDAFTHEYGYFVQKIPILKETIFKRPIYN
ILQHLSSIVGAWLIYYSIKKMPVVCNLNVYTNNVMIYWFWVVFFTGSFTLIRFYDNMHLW
MIGNIIVTTIMNFFLALLLINFIYKTFRKNNV
>EGEFANNL_01390 1,2-phenylacetyl-CoA epoxidase, subunit E
MKFYPLTVKKVKPLTSISKSIDLQIPEELKAVFKWKPGQFVCLKFSINGEKVERDYSICN
APNNECITLAIKKTKNPYISSYLNEHIKEGMHLQVSAPLGNFGIDSRPNEKRTLVAFSSG
SGITPILSIIIDTLQKEKDVKFYLFYGNSEESDVMFKEDLDLLRSKNPDNFFVHYFYSQQ
KVNDKFYEGQLDENKLKLIINQIVDWNEVDKVMICGPTSMTVTLANAVYKQGIPKENIHY
ELYEPVDKVFMDDEVVSSSVDEVEVIFTYEGETKSIQWLNNGSTLLDALLDLGIDAPYSC
KGGVCGTCQCTKEGGDVVLGENLVLTDEDLQNHKILTCVAYPKSNKLKINMDEL
>EGEFANNL_01391 Cobalt/magnesium transport protein CorA
MPSSNVQQTHYEWIDLQNPNKDELQEIALKYNLNYYNLADSLEPNHLPKYESGEDINFLI
VRIVNINAKKEANIQSITNKIAIFYNDKVIITVHRVKIDFLLDIKLKFVDSNKAKTTLAI
IIKILSECLQSYNQALLSTMNKLESYENNLFASKNTSVSLKNIYSLKRKTSLCSKLLILS
DNVISALKPNKSEKPEFQDLKDLYTKLTTLHEQVSDDLNNLLNLYISLSSQKTNEIMKTL
TVFSIFFMPLTFIAGIYGMNFSYMPELQNRWGYPIIMIVMVVITILIYFWLKRKKWL
>EGEFANNL_01392 hypothetical protein
MELSVLNFPEKYEFQIKEKCSLWYIFDEVRKKWLILTPEEWVRQNVIKYLQKEKKIPKSA
YLIERRIQLNNQVKRLDLLILKKTEPFLLVECKAPEISISEAVFEQAARYNLEIKAPYLL
LTNGLNHLYFYYDSHKNVYSLIKDFNY
>EGEFANNL_01393 hypothetical protein
MKEYNNLVKDIKNKKFLPIYFLEGEEPFYIDKISTLLEENVLYEEEKAFNQTIVYGTETD
LDSIISLAKQFPMGAERQLIIVKEAKGLNFDKSESFENYIKNPQSSTILVINYKYKALDK
RKSLTKQLNQRGYIFSSDKLYDNQVPAWIGSLCQSSGLEIDEKSKALLAEFLGSDLSRID
NEVQKLKLILRDSKKITPEIIEKNIGISKEYNNFELRKAIVEKNATQAYKIIDYFEKNPK
ANPIVLTFGTMISFFSNLLIVHSLPVKTPQNIAKELKINPFFANEYITAIKNYPLKKTTL
CISYLRDADIKSKGVQVSSQATTKDILMEMIYKILH
>EGEFANNL_01394 Acetoin:2,6-dichlorophenolindophenol oxidoreductase subunit alpha
MAQYRKRMKEFNKEVYLKWFEDMTKWRRFEEKARSLYLKDKIRGFLHLYNGQEAVAAGFT
HAMDIKKDKVITSYRCHAHALAMGVSPEAAMSELCGKATGTSKGLGGSMHLFSKEHNVYG
GHGIVGGHIPLGAGIAFADKYFDRDGVTICYMGDGAVRQGTLHETFNMAMNWKLPVVFVC
ENNQYAMGTSVERTTNNLDIYQLGLGYEMPCAPVDGMNPEIVAEAAYEAIERARRGDGPT
FLEVRTYRYRGHSMSDAEPYRTKQEVEEHKKEDPILMVKHKILSNQWATEEELDSLDKSI
KDYMNEVGNFAENAPYPEPNVMYDYIYSEPNYPFLDKFENQ
>EGEFANNL_01395 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MAEKITMPRLSDTMTDGKVSKWNVKVGDPVKEGDVLAEIETDKAVQDFEYDGDGGVLLYQ
GVKEGESSPVDTLLAIIGQEGEDISGLIEGGVSQTSTSNTTEKKNEPQTQETSQPAASIP
EGVEIISIPRLSDTMTEGKVSKWNINVGDQVNEGDVIAEIETDKAVQDFEYDGNGGTLLY
QAVKEGDSAPIDSLLAIVGPQGTDVSGVIKNGGSVSASTTPKTSEQPENKIFPTSSNENK
NSISSDNKRIFASPLAKKIANDKGIELAQIQGSGDNGRITRKDVENFVPATSSSTPKVST
TKPSSPAVTLQVTPGVDTETPNSSMRNAIAKSLSNSLFTAPHYNLVFEINMDNAIQARKA
INSLPDTKVSFNDMVIKSVAVALRKHPQINSSWTDSKIIHHGNINIGVAVAVEDGLVVPV
IKNTDYLSLSQISSSVKDLAGRARDKKLKANEMDGSTFTISNLGMFGVESFNSIINQPNS
CILSVGAINQKPIVKDDQIVIGNTMNISLACDHRVVDGATGAQFLQTLKLYLENPVSLLA
>EGEFANNL_01396 Nucleoside diphosphate kinase
MINNKNLTLTMIKPDAVKNGYMGNIINDITNAGFTIIALRLTQLTSQDAKKFYSIHKDKP
FFKNLVEFMTSGPIVAAVLKKENAVEEFRKLIGATNPKNAEEGTLRKKYAESMERNAIHG
SDSDENARIESLFHFAEKEIYLD
>EGEFANNL_01397 5,10-methylenetetrahydrofolate reductase
MKVIEHIEQAQGKTLFSFEILPPKKGDNLQSIFSNIEPLMEFNPPFIDVTYHREEYEYKE
FSNGSIQKIVTRKRPGTVGICAAIQHRYGVDAVPHVICGGFDKEETENLLIDLNFLEIDN
ILVLRGDPIKSEGTYQAHPQGYSYANQLIHQVVDMNNGKYLHDEYANGATNFCIGVAGYP
EKHFESPNLDTDFYYLKKKIEAGADYIVTQLFYDNKKYFSFVERCREAGITIPIIPGIKP
ISIKKHLNILPKIFHIDIPQELVLAIEKCKNNKEANEIGIQWSIQQCKELIEYGVPVLHF
YSMGRSNNIQRIAKSIF
>EGEFANNL_01398 Dihydroneopterin aldolase
MEKIKLKNIRIYANHGCMAEEAKIGSFYLINLIVWMDLKMAGLSDNLTDTVNYGDLTNII
KAQMHKRSNLLENIAHRILFEINLQFPTINKAKISVEKINPPVNADLDTVKVTFKKKFN
>EGEFANNL_01400 Putative monooxygenase
MVTVIAKITAKKDKINEVEKLLQSLITPTLMEIGCKQYDLYRSITDNNIFFFHEIWNHKK
YLDIHLKTERFLKTTQEITPLLECPIEISLVNKIIN
>EGEFANNL_01401 hypothetical protein
MNCCTKNLIKGVAVGILASWVKSIVEPPLQDLGEKHFPPTPKELQLKGADVKHQPENMPP
AILAKKIYSAVTNEELQNQEAVKSMKFIHYALGAVIGVAYVTLVNSNKRLKVEEGITAGA
VVWAATHGSTVPALGLQGKVKDMPKSWWVWEFGSHLVFGVALEQSRKLLNKLF
>EGEFANNL_01402 Protease 2
MNQPKAKKIPKELKIHQDIRIDNYYWLNNRENPEVIQYLEQENKYTEEKLESTEELQRKL
FKEMKSRIKEEDESAPYQYNGYLYKTRYQKGAEYPIYVRRKDVPTASEEIMFNVNELAQG
YSYYHLGGINVSPNNQLACYSFDSLSRRIYTIRIKDLETQEILQDQLENTTGNIVWANDN
QTLFYSTQDLETLRPNKIFKHQLGTPQCEDTLIYEEKDETFNVSVAKTKSMEYLIIASGS
TVSDEYRIISADQPNGDWQIFQTRERNLEYSFDHFENHFYILTNKDKSYNFKLMKTPVNK
TQKEYWQEVIPHRENILLENFELFKNYLVTEEREKGLVRIFIESWNKKVKYFLPLNEEVY
TVGLSTNLDFNTDKLRYKYCSLTTPWSDFEFDMNTQHKTLLKQQEVLGDFNPENYETKRL
WATARDGIKIPISIVRKKTTAISNQTPLLLYGYGSYGYSIEPTFSSLRLSLLDRGFIYAI
AHVRGGEDLGRLWYEDGKMLKKKNTFFDFIDCAKFLINNEYTSPQHLYANGGSAGGLLMG
AVINIAPEIFHGVVADVPFVDVVTTMLDESIPLTTGEYDEWGNPNDLEYYEYMKSYSPYD
NIEIKDYPNLLVTTGLHDSQVQYWEPAKWVAKLRELKTDSNLLLLHTNMDAGHGGASGRF
ESLKEVALEYSFYLLLENKIA
>EGEFANNL_01403 Catalase
MNRKKLTTTAGNPISNNQKSLTAGFKGPVLLQDFKLIEKLAHQNRERIPERVVHAKGWGA
MGTFTVTHDITKYTRANIFSEIGKQTKMLARFSTVAGELGASDTERDVRGFALKFYTEEG
NWDLVGNNTPVFFVRDGYKFPDFIHTQKRHPKTNLRSNEAMWDFWSLTPESLHQVTILMS
DRGIPKTPMHMHGFGSHTYSFWNNNGERFWVKFHFKTQQGIENYTNKEAEQITGQTREKY
QEELFNAIENGNFPKWKVYIQIMGEEDALNCPFNPFDVTKVWPHADFPLIDVGVMELNEN
PSNYFQFIENAAFSPSNIVPGISFSPDKMLQARIFSYADAHRYRLGTHYEMLPPNRPISE
VNHYHKDGAMRFFENFNSNPDAYYEPNSKNGPVEDRSLEEPPLKIDGNAARYEENDTYGN
FKQPGDLFRLFTPEEKQRLFQNIKEAMQGVSKEVVERQLNLFDQADPEYGAGVRKALGI
>EGEFANNL_01404 Phosphocholine transferase AnkX
MNNQENLFQAIRLEDLNSVKEILEENKDLLNSKDHRGSTPLLLASYYGNIDIVDFLLKLK
PNLDEKDGSGNTALMGVCFKGFYDIANKLIEAGADVNVTNSNGATALFFAATFNRMEIAK
LLLEKGADTSIKDIRGNTASSQALTQGLNDIAELVK
>EGEFANNL_01405 hypothetical protein
MQLRKPIFPIKNNLLTYLDKYNKTTEISMLYEDLLRFKDYTVIEDKDGKDTLWLSVYYSQ
WEQEEIQQNLKIIYTYLHSDGDRTTLPFLKVESIEFCTFGNSKPFRIRVKNILNENYTNF
YIKKADASRIYGLELEDLLSPHRVNYLVYKDTLIEEHILGIPGDIFIERHLPLCSDLEKS
QIAKEFVKFNERCLLGLLGDMRSYNYVVVVTHDYDQIVYRIRSIDFDQQSYEGDLSFYMP
QFFKENQLMLELIDEKLEANSVEQYRKEVRSVIAKRILNSFERYSDLISIMKEDHISTDE
KINQLKLALYKLTYSYHFKHCDTMGEIVETGLNFIVKNYRKHN
>EGEFANNL_01406 hypothetical protein
MKSNKTKILLYISLLCIGIVIGIAIRHYYNLPLSVDINIIDVATLVATVFLAVYIPEVLD
RNFQEIKDKKDVILKKVEELHFLNRKINILVQNEIQPNTKSILIINNTLDLIENKLQTLK
TLVKLGNLKINFSPEINKIETLIREHKVLIFNNTKNLSNCNFNEEIKMKEEIIFNHLDHN
FCLLIFKIA
>EGEFANNL_01407 hypothetical protein
MFVLLFNFISSLCAQEYEWHSPDYDLIKKETFNEKSEFLYSNLLSRFYAFDSTLTKKDYE
YLYYGYLYQKEYKPYKKAKNETALLSILKKNSQIQEEDYEEIIKLTTESIQEYPFALDAM
AILSYIYKLKGDTENYLKIRFRLYDILEVITNSGDGSTCRNAFHVTSTDHEYVLLKMINK
KPISQELIFLKDPVAYCDLQKLHENSKGYDSVYFDVTKLFEAQAERIKKGE
>EGEFANNL_01408 Glyoxal reductase
MKITDIKGTVNLSNGVKMPYLGLGLYKAEDGQEVINSIHKALDAGYRHLDTATYYFNEEG
VGEAIKSTSIAREEIFIATKVWYTEQKYEDTKKAFYSSLNKLGLDYIDLYLIHWPHPDYY
LEAWKAMDELYKEGKIKAIGVCNCMQHHLQKIIDLGGTKPMVNQMEFHPNLVQQELLDFC
KKNNIQYEAWSPLKRGGLFEAPTLKQIAEKYEKSVAQIILRWDLQKGVVTIPKSTNPERI
LANADIFNFILTEEEIHTIDSLDNGDRTGAHPDHFLEYFAKKNKS
>EGEFANNL_01409 Poly(glycerol-phosphate) alpha-glucosyltransferase
MKIAYCVENIHNSGGIERILSTKSNYLVSHGYQVHMVVICPAPSKPFFYFDPNVKFHYLN
LDIRKDHGLRKKINFNKNKKIFLDSLSKLFSEIKPDITISTFCIFSKYIYELKDGSKKIL
ERHFAKYKRAYYYAKLDKYYLGRLITYFYRRQEYAIIQKFDKFVVLTHEDKESWGNRLSN
IEVIENALTCIPKSTSELENKKVITLGRLNQQKQLDHLIEIWSVIAKKYPDWKLEIYGSG
SQERKLKQLISKLKLTGFIKILPATPNIEKVFLESSIYAMTSKYEGFGLALAEAMSYGVP
PVSYACKCGPRDIINNNKDGYLVAFNDKKEFIEKLSLLIEDENKRKEMGKAASTNILRYS
PEAIMKKWMNLFDKLVNTN
>EGEFANNL_01410 putative amino acid permease YhdG
MNINSFLRKKNISDLQNENHSSQLNKILNLKDLTFFGIAAIIGAGIFSTIGRASYEGGPA
VSMLFLFVAIACIFTALCYAQFASMIPVSGSAYTYTYVSLGEIFAWTIGWALILEYAVSN
IVISISWSGYFVSMLQGFGIHWPEWLAVDYWNAHQAFLAQQAHETLTNNDIKLAEVYKSA
PSFGGIKVLFNLPAGLITLFVTILAYIGIKESTKVSNALVWIKLVVIVGIILIGAFYVKP
DNWTPFLPNGFEGVMGGVAAVFFSFIGFDSISTTAEECKNPRRDLPRAMILCIIICTVLY
AAIALVLTGMVNYKELRVDDPLAYVFDKIGMNFIAGIISVSAVIAMTGAILVYQVGQPRI
WMTMSRDGLLWKPFSKIHKKYHTPSFSTIIAGVFVAIPAMFIDMQVVVDLTSVGTFFAFI
LVCSGVLFLDYKGYSKQAKFKLPYINGKYIICPLFIFAMYVFLFQVNGLKMLSDKPLLYV
FWLVWLGLGIGSLKYQFSLLPILGILFNLYLMTELGWSNWIMFIVWLVIGLTIYFLYGRK
NSKLNRIFNS
>EGEFANNL_01411 hypothetical protein
MKFKILFFSAALLFFTSCATINTSYDYNKTVDFSQFKTFAFYKQGMDSLKLNDLDKNVII
STVTNQLESKGLSQSTDPSLLVNILASSQQVVNVYNNNPYWNSPWTGPWGGPWQNSWGWG
YGWGPGWIGQDTTISEDRIGQITIHLIDTRNNTLVWQGVVGGFNVSDAASKEAQIIKAIQ
QVFTNFPPK
>EGEFANNL_01412 hypothetical protein
MKRKNYHFLFFLFFLSWSLCWGQTSREYEVTAPGGLESLVSSEKHTITDLTLTGTLNAAD
FATIRSMAALQNLNLEKANLVDNTLPGGAFSGAKLLKIILPKTLDVIASYAFTNGKIVSI
DFSKSTNLTTIGGEAFSQLQLESNTLDFSNNTKLQVFGLSYYNQNGAFTGNSNHVILPKT
LKLIPSRLFSNFKGSISLPEDLETIDAYAFLSAKMPSIDFSHSPNLSTIGGEAFTGIQLE
NNVLDFTTNSKLSNFGLSYYNNNGAFTGNTSHVILPKALKIIPSKLFSNFKGSVTLPEDL
EIIDAYAFLSAKMPSIDFSHSPNLSTIGGEAFTGIQLENNVLDFTTNSKLSNFGLSYYNN
NGAFTGNTSHVILPKALKIIPSKLFSDFKGSITLSEELEIIEAYAFQRAVMPSIDFSHSP
NLSTIGGEAFSQLQLESNTLDFSNNTKLQAFGLSYYNQNGAFTGNSNHVILPKTLKLIPS
RLFSYFKGSVTLPEELEEIQNYVFAYSTIKELSLSKSLKTIGVGAFSDMKQLEKLSICAT
TPPTLGSNVFSGVPVNNVELAVPKNTISSYKKANQWSQFTQIIESNICEAAPINPYDLNV
YAPNSYIFDIEQAKSYNYGGIAIPVAKAYAMWENNEYLDYKGIPSGKLSSSVYWEDVEGL
IRSTEIDQNGSNSQINVQINQAKGKGNAVIAFHVGDTGDPKQDPVYWSWHVWVTDDPTKG
ITYDNGTLVNSFMDRNLGALSNNFLGNDWNRAGGLMYQWGRKDPFPPGVYLDGNAPIIHT
LKYGSVINTPIFHNRNYNEANSNIQESVQLPYSIITMTPEEIQDRNNHSKYAWFTNDLVG
YEQKNGRTFDLWGSNTEGYATAGIISEQKQKSSFDPCPAGWRVPSAGSDSHFYWGSPWGK
YLGSNQNSKYDFKNDSNAEKDFSGLKIYPGLGYDFTEVKGYNIGIIPASGHYYVTNRLLY
QDQGSEAQLWTATLGTQSRHGGTANMLHLVSDFLQDNFTGRYTLDFNEITAGHNSSLFAV
RCVKEALPAFDWQTIYLPNTVKEYSEGLYNPNSYLLVKSELEQKINIPVNKAFAAYNQLL
TDHEWPTGKLSENIYWTTNTQLIKSIALQGSNENGILQVTINPNQSGNAVISLHNGDQGN
SNDPVLWSWHIWVSNSDPTLNTFTHTTENKFSKEKLPLFAYNTLNGTVPLTTTFMDRNLG
ATESDISSTDRNIYENTKGLLYQWGRKDPMPVFIPFYYGIWGIHDKIYLGSTNLGNQQFP
KILDHIEQYEKQYTMTSWENTLEEVLLKSVRNPLHHLYRGNSPSWLPEVYPKLWGHANEK
SPFDPCPDGWRVPDFSASDHLGSPWYKEGMGYWYKDNNDLSIFKLSDSNRALDKIGGVTV
KNNLGTVGISLNSQQYNVGNYPAVGTRGTIDNNNPIGLEGLLYYGVNWSANMFMGSQTWL
RLLASAFSMGEVSVDPSSLFRPRSGASVRCAKDETRFTAESIANSPEYIVPINRNLRSEA
VEINSNSKLTESQVQVTPNPNSGIFKVMLTDIPEGMLRVFSFTGDEVYTKSFKAESEISI
NIQSFPAGVYVVQVQSQGQTVSKKIMKK
>EGEFANNL_01413 NADH-quinone oxidoreductase subunit 4
MSNENNQKELQHLSSLVDKYIVKEQVDGELQHINLGPTHPSTHGIFQNKILMDGERVVSS
QSTVGYIHRAFEKIAERRTYSQITTLTDRLNYCSAPINNIGWHMTMEKFLGIKVTKKIDY
MRIIIMELARIADHLVCDSVMGVDTGALTGFTYVFQDREKIYDLYEQVCGARMTTNIGRI
GGFERDFSPKFHELIKKFIKEFPARIEEFANLLERNRIFMDRTIGVGAISAEKALNYGFT
GPNLRAAGVDYDARVMNPYSSYEDFDFVVPIGTAGDAYDRFMVRLQEIRESYNLVKNAYE
NLPEGEHHVEVPDFYLPNKPEVYTSMEALIYHFKIVMGEVDIPTGEIYNSVEGGNGELGF
YMVSDGGRSPYRLHFRRPCFIYYQAYSEIIKDQMLSDAIITLGSLNVIAGELDA
>EGEFANNL_01414 NADH-quinone oxidoreductase subunit C
MEEKVIDNQYVLELISNKFEDSILRAYEPDGILTLEIKKEILLPLVQWMKEDNIKIDFLT
DICGIHYPNNHGAELGVIYHLHSLIHNFRIRLKIFFSIQNPEVDSLTPLYSSANWQERET
FDFYGIKFIGHPNLVRILNCDDMDYHPLLKQYELEDATRTDKNDAMFGR
>EGEFANNL_01415 NADH-quinone oxidoreductase subunit B
MSEKKVKIVEAPEGISGPGFFAGSLDKIIGLARSYSLWPLPFATSCCGIEFMAIQASNYD
LSRFGAENMCFSPRQADLLMICGTISKKLAPVLKQVYTQMAEPKWVMAVGACASSGGIFD
TYSVLQGIDKIIPVDVYVPGCPPRPEQIIEGFMQIQELVKNESLRRRDSEEYKNLLESYQ
IS
>EGEFANNL_01416 NAD(P)H-quinone oxidoreductase subunit 3
MSLPVDYIPVLIQVAVAFAFSVVTLIGSAMLGSRVHGKVKDDTFECGIAYEGDARSPFSI
KYFLTAILFVLFDIEIIFFYPYALNVREFGVEGFLAVLTFISIFLIGFFYVVKRGALNWE
K
>EGEFANNL_01417 Catecholate siderophore receptor Fiu
MKHIYTSFSLFFCCIITFGQNLSSIQGFILDEQGIPIENSTVYIDGNPSHKTSDSKGFFF
IEQLEKGTHSMSVFHPNYSLHNQEISLISDSLKQIFIVLKANKDSIANHNSGIEGYIFDE
DHQPVVNANLYVDGNTNSIQTDPSGYFSIYGLKEGAHNLFIQNSSLYSEHFENIFLSPNE
IRNITITLNSLAKTDKNLDEVVVYGKKKVPNGLDMVTRIPIDPQDMIQNISIIPEKIIKE
QGALSLSDATQNVAGVTLFGSYGGVRESMSIRGYRGTPVLKNGVQVDSDFRTASIASDMQ
GVESVQVLKGSAALTQGIGDGLGSPGGVINVVTKTPKFKDQGNISIRTGSWGMFRPTLDF
QTVLDKKKTAAIRINSAYERSDSYKSYINKEKFYINPSFEWRPDDKTRIVLEMDYLDSNV
TPDIGTINLAPDNIEALFKMPHNKFLGFKSDNMHNKTTTYSTRLYRDLTDQLMLRLAYAG
SSYQTESTAASLTKNKFSENGVIDYSKRYRTLNKSARDDKNQVIQLDLIGKDVKTGFMKH
TFQAGFDFKKTDLNTTSYSLLDSKGKSVKYIDVIDVYSPISNVKPAGYTFGDEKVSSSNT
SSYGFTVQDVVSFNSYIKAMLGVRYSSKISQSNSTIGKTQGNAWDPFFGVMITPIENINI
FGSYTTTSDLRSAANRDINGKEMGSAVSKQWEMGFKSSWFENRLFFNATYFNIRNSDLQY
GITDGVSNVVLYYILAGDLKRSGIELELTGKILPNLQAILGYSYLDAKYEDSPSYVDGSR
PMNAPHTTFNGWLRYAFDKGALKDLSLGAGVYYVGSRPVNEWSLVADGHGTTPGVKPFLM
PSYLTVNAQAGYKIKQFDIQVFFNNIFNELGYNSYYRGGFINQIDPSNFGIQVGYNF
>EGEFANNL_01418 hypothetical protein
MKEKNKFRKFINDIHLWLGLIAGIVLFIVCLSGSIYVFRSDIEYFVNPNKYNASDFNNNS
PYLPIEKLVATLEKTENGKVSFIEIPENREKNILFGLSKKTTPVNNKIKSKGDENIQPKR
QRPTTYYVNPYSGKIAGKDGDKASEFFMIVMKLHRFLLLDPSIGRPIIGISTLIFILLSI
SGLILWFPKKFKYWKRWNHWKPGFKIKFKARWKRINHDLHNTLGFYSLFLLLLMAITGLC
WSFEWYKNGLGKIMGSEVFAGRNEKPLTLKNTSDQTISFEEVERIVNQQLPYKGDVRINI
PKDSAHAYSISKSKSGIFAIAAPDKMNLNPYNGEIISLDLFKDKPLNVQIVSLIKPLHIG
DIMGTFSKVLYFICCLIGTSLPVTGIIIWFNKMKKKK
>EGEFANNL_01419 hypothetical protein
MQPSNKFIGKRREIFIIILFISFHLLNASSFKLKDVIAVNDFLQGEEPSLQSILNNYYKA
VAGSKEKLESIKTLESKGEITFSTTDVKANIVTKYQVPNKYISIVDFMGQKVVQGFDGLK
PISNLSALTQDKEKEMREKKGIFTELYFADENSEYLGKSILNGNEVHKIKFKDKDAETIV
YFDAKTGLKVKEEILKTGENMVKEYSDYKDFQGIKLATKIKTIVPGQIATQTVDSYTINP
VFSDKDFSL
>EGEFANNL_01420 5-amino-6-(5-phospho-D-ribitylamino)uracil phosphatase YbjI
MIDYSNVKLVVTDMDGTLLHTDYTLNPEFFDLYKQLKELQIQFVVASGRQYDSLASIFNP
IKNEIYFISENGGNVIFRDKKIFVGELSQELIYKVVDALENLPGTEILLCGVKSAYMVEE
KKEFEKFVAPYYPKRKFVSNFREPINDDQIVKIAVFNTKGSEENVYPLVEHLKEDYLVKV
SGKNWLDISIKDSNKGKALQIVQRLLGIHKEETMAFGDYLNDLEMIQESKFSFAMENSHP
YLKENANYVTKTNDEDGVLCVLKEMIKQRKDATK
>EGEFANNL_01421 Methionyl-tRNA formyltransferase
MKERNLRVVFMGTPEFAVAPLDKIIQAGYEVVAVVTVPDKPAGRGQRISESAVKKYALKN
NLNLLQPEKLKDNNFIEELTKLKPEVMVVVAFRMLPKEVWSLPSLGTFNLHASLLPQYRG
ASPINFSIINGDNETGVTTFFIDEKIDTGEILLQERIAINENENAGELHDRLQELGSHLV
VKTLQGLEDGTLKSEKQELKKDIEYKYAPRIFKKDCIINWEDSIENIHNLIRGLSPYPVA
YTHLVIDDEKFKIFKIFSGYYSRETHNYPIGKIIIEGKDILKIAIKEGFYFPKEIQLEGK
KRMNISDFINGLIDKNNIKVQ
>EGEFANNL_01422 50S ribosomal protein L21
MYAIVEIAGLQYKVEQDRKLFVNRLKANAGDEVTFDKVLLTDIDGSVTVGAPAIEGVTVV
AKVLDQVKGDKVIVFKKKRRKGYKVKNGHRQQFTQIQIVSIGGVAAPKKAAKKAAPKTEA
KEEVKSED
>EGEFANNL_01423 50S ribosomal protein L27
MAHKKGVGSSKNGRESHSKRLGVKIFGGQEAKAGNILVRQRGTTHHPGDNVGIGKDHTLF
ALIDGVVVFRKKQNDRSYVSIKPNEA
>EGEFANNL_01424 hypothetical protein
MARDKLFDSLKFLLICLVVFGHTIDTSTTKSDHILFGFLYTFHMPLFIFISGYFSKNITW
KKYKKFFIGLSITFTIFQFIYSIPSMFLGFENWLQVFIRPKGWYILGLFLWRFIYVIVKG
RISIINLLFISFLVPIILGFLPFNIEFFRLITFFPYFLLGVLSSKITMVRIRKINKFYSI
LYLIILFVFIYKNMDIRYRLSLFGEGSYLVYFQSNLVGLFYRLQAYLLAIITSIAVINLT
PQNIGKFGTKTLEIYLMHFIFEVIIYSIIFPRFSIQPNLLINIISTIIIITLCIYISNFR
IIQFIMHPLDFFNSNYNKKNR
>EGEFANNL_01425 D-aminoacyl-tRNA deacylase
MEFIDTHTHLYSEKFDEDREEAIKRAVEEGVGRFYLPSISSAYYSKMKNLQENHPDKIFL
MIGIHPCDVKPENYKQELIFVKDQLEKEKFAAIGEIGIDLYWDTSTLEIQKIAFKEQIEL
AKKYQLPIVIHVREAFEEVLEILRQEKSSDLYGIVHCFSGTLEQAKEFIDLGFSLGIGGV
VTFKNGKIDQFLNKIPLESIVLETDSPYLAPVPFRGKRNESSYIKYVADKLSDIYQINID
EIGKKTTENALKIFKL
>EGEFANNL_01426 hypothetical protein
MIFRTELEYQTNELKLDYNSKIFTIGSCFATEIAQKLIHYKFNTYHNPFGILFHPLAIEN
ALMRIYSNQEYISSEIYKYEELYISWDHSSTFDSVNAETILNQINKNIQTAHDFLRNTDL
IIITLGTSWIYKLKQFDIIVANCHKIPNSNFNKLLLTEHQIKTSLKNIVEMLNDLGKDKV
KILFTLSPVRHIKDGLVENNRSKAQLLSVIHSVVDLYDNCEYFPAYEFIMDDLRDYRFYK
EDLVHPNEVAIQYIWNKFKNSFMSNEVESIMQRIDKIKLSLQHKAQNESTIAHKKFLYNI
LKNIQDLEPLLPKGSMQLEYHLLKNRIENT
>EGEFANNL_01427 (2E,6E)-farnesyl diphosphate synthase
MNFLEKYRGLIKEEIIKNAFNTAPEELYEPMNYILDLGGKHLRPVLVLMTYHLFKEDYYK
VIKPALGIEYFHNFSLMHDDIMDKAPLRRGKPTVHKKFNENTAILSGDALLVKSFQMLED
LEPQLFKPCFQLFSETALKVCEGQQYDMNFETQNKVSFDEYIHMITGKTAVLCACSMKMG
ALLAETSSENASNLYEFGKYLGIAFQFMDDYLDVFGEQQEVGKKYAGDIYENKKTILYIL
AEENANPEEKKELQYWYEIREESQEKISNVVQLFKKLKVDRKCLELVNEYNNQAKKHLNA
INLTEEKKQPLLTLIDNLLIRKS
>EGEFANNL_01428 Putative HMP/thiamine import ATP-binding protein YkoD
MNTDLIEIKNAIPRINFFSFSTPINWKIKKGEQWAVIGANGSGKTLLIEILTGKYGLKSG
EISCKDECGKQYSIRNFVKYVAFKDIYSLTDCRNSYYQQRWNIGLEEDIPLVKDFLKQED
NQEWVNHLISTFRINDLLNKKINLLSSGELRKFLLVKSLASKPRILIIDQPFIGLDSHSR
RVLNEVFNDLIKFTDLQIILLVSDIADIPPLITHILPIIDCNILPFQNFTDFINNKDLHK
NLFKSRIDNHLFSKLPKSQIVISYNNAILFKDINISYDKRTILNHLSWTVKKGEKWALLG
PNGSGKSTLLSLIVADNPQAYANDITLFDQPRGTGESIWDIKRNIGYISPEMHLYYQKNV
CCLDVVSSGFFDTIGLYNKCSESQKEIALLWMKILGIESLHSSSFLNISTGEQRLVLLAR
IFVKDPSLLILDEPLHGLDMDNKKKIIKLLNLYCSSDKTVIFVSHYKEEIPEIINHELVL
TKH
>EGEFANNL_01429 hypothetical protein
MKRISLLIIFEIIISAIAGYLMSLMSFIGRMGINLVRTEYKVFKTWWKTALIIFSIQIVL
IFIQWIVKRGCTLSASRIVFFFLLLIGVLGLAYTYYDFSSVFEHRLMKDKFHLGGYLFWI
GWISSNLYFLVTPYTRNNKMVES
>EGEFANNL_01430 Phosphoenolpyruvate carboxylase
MDQNVSESTFRQEVENKYIVYNSLFANLPYHDMGKLGALTPMLYDLANEELNKEKNPKDI
IEFFLNKYAYLNKEEDKNELLFRIIQFIERQVVLFDSVEDASFDKIIAVNHQNGTLENLY
QVAQQQNKLKEVYEELKTFKVRVVFTAHPTQFYPNTVLRIISDLTEAIQDNDITQINNLL
QQLGRTPFINKNKLTPLEEANSIIYYLRYVYYDAIGQLHEKLFSEYYSENKDFIPIMELG
FWPGGDRDGNPYVTSSITKKVTQELRTSIMKCYYNDLKKISRRLTFRGVYEKLRELSQLI
YDNSFGVKKGLTTEIILEKALEIRRILVDDHDGIFLNELDRFIRQVQTFRMHFASLDIRQ
DSSIHQKILNAIVKRYNLSEKSYDEMDKEEKFYVLFQSNILIQESDFEEDIIKDTIRNIK
QIKQIQEENGVHAIHRYIISNSTSIFSVLEVFALFEFCGYKKEDIELDIIPLFETVEGLD
NAESIMQQLYNLPLYREHLMRREKRQTIMLGFSDGTKDGGYVKANWAIFKAKEELTKVSK
DNEIEVLFFDGRGGPPARGGGKTRQFYASQGPTIASNQIQLTIQGQTISSSYGSINQAKH
NFEQLITAGISNRVFENKQLILSPKDRYILDELSKISYKKYEELKEHPQFIAYLEERTTV
EYYGKANIGSRPSKRKKDSSGLQFKDLRAIPFVGAWSQAKQNVPGYFGFGTAIQEFKEQG
RLSELQDLYEHSLYFRTLVQNSMMSMIKCNFKLTSYMKDNDKFSDFWNILNEEFKLTYDL
LLEVSKQKVLMEKEEINRMSVLCREKIMLPLLVIQQFALQKINETENDEERIVYERMLVR
TLFGIINASRNSA
>EGEFANNL_01431 DNA replication and repair protein RecF
MTLESLKLFNFKNFEEKHFSFSNKINCLVGNNGKGKTNVLDAIYYLSLTKSYLNYSDQNN
VRFGENFFSLEGIFKNQDNQDIIKLLVQTGQKKVLKKNNKSYEKLSEHIGKYPCVMISPY
DQNLIAEGSEFRRKFMDNMICQLNPEYLHCLIRYQKVLLQRNALLKLFSVQNTFDAFSLG
IYDDELIKNGNTIYKFRIQFIQDFVSVFSKYYSILSNQEESVDIQYISDLHETTFQNLLK
ENLLKDRNSTYTSKGIHKDDLLFKLFNHPIKKIGSQGQQKSFLISLKLAQLEIIKNYSKK
NPILLMDDIFDKLDEERVEKLLKLVLDENFGQIFLSDTHKDRTESIIQNISSNYSLYNL
>EGEFANNL_01432 Pyruvate dehydrogenase E1 component subunit beta
MVEENSSMELESALSFYEFKREILKDYRLCLISRECSILGRKEALSGSAKFAILGDGKEL
PQIAMAKVFKNGDFRSGYYRDQTLAFATGEITIENFFSQMYADADPEREPQSRGRMMNAH
YATHLVDVDGNWKNLTEQKNHAADLSPTAGQIPRLFGLAYASKIYRQEKGLSKQSNFSNQ
GNEIAFGTIGDASTSEGHFWEAINAASALQIPMVLSIWDDGYGISVDSTEQRAKKQFKEL
LQGFEKKSGEKKGCKIFHVKGWNYPELIETYSKAEELARNEHVPVIIHVDELTQPQGHSS
SGSHERYKSKERLQWEKEFDCLKKFKEWILDFKVPNLDNNTSRSLISENELEELEESVKE
EVKKHQKIAWNQYRESLNSIKSEAMQLVNLLELQSSKKVFISQQKDIFLKITNPYKREIY
HFVRKILRIIRDENIAAKSDLITWFNKNLKREEDNYNTKLYSDTTKSALNIPYIAPEFDQ
ESKLVDGRLIVRDNFDKLLMKYPELIAFGEDLGKIGDVNQGFEGLQAKYGELRVSDTGIR
EATIIGQGIGMAMRGLRPIAEIQYIDYVLYGIQTMSDDLASLRYRTGGRQKAPLIIRTRG
HRLEGIWHSGSPMAGILNYLRGIYLLVPRNFVQAAGFYNTMMMSDDPCMIVECLNGYRLK
EPLPKNLGEFTTPVGQVEVTKEGKHITILTYGACWKIVTEAAKELSILGIDIEIIDAQSL
IPFDIKHQTVESLKKTNRLLIVDEDVPGGASAYLLHKVIEEQRGFQYLDSAPVTLTAKEH
RPAYGTDGDYFSKPSVDDVIEKVYNIMHEVNPTEYPPIR
>EGEFANNL_01433 hypothetical protein
MKRLILISSVVFLAIACEKKSDMLENANNLSNVKVENQLDPVCEMETSKHLGDTLTYNGK
LYGFCSSKCKTDFEKNSQQYLNK
>EGEFANNL_01434 Ribosomal RNA small subunit methyltransferase A
MKVKPKKHLGQHFLKDLNIASKIVDSLTYKNYDTILEIGPGTGVLTQFLLNKNVELFLSE
IDDESVEYLKINYPQLKSKIVDDFLKIDIHQIVPKNLSIIGNFPYNISSQIIFKVLENKE
QVVEVVGMFQKEVAERIVAEKGSKIYGILSVLTQAYYKTEYLFTVHENVFNPPPKVKSAV
IRLSRYREQIEGVESELFIKIVKAGFNQRRKTLRNALKVLGVPLSLHDHEFLNLRAEQLS
VENFIQLTQQWQNS
>EGEFANNL_01435 Cell division protein FtsX
MAIKADNLDKNRLRSSNITVVISIAMVLFLIGIIGLIIINTNSYIDYLKEQMVIEVFFKN
EKKSNPNSQSQVQYVDSLKGHPYVKSIKYITKEEATDIGKKELGVDSQVLFEENIFPASV
IVGLKPEFIDSTHIETIKKQLIKNPIVDEIKSDNSLLEKMDKSVKKITIGISVLAIIILF
IAVSLINNSIRLKIYSKRFIIKTMQLVGAKRSFIIRPFITESLTLGVLGAFIALLLLFAT
NYVITNVLHILPPIIVFKNHLILAAFILVLGILITSLSTWFATWRFLRLKSNDLYY
>EGEFANNL_01436 hypothetical protein
MKKNSENKSDLLFGKKNYIFMFIGVAVIALGFLLMTGPDANTVNGVYDPNSWNQDIFSFR
RVRLAPTLIILGFIIEGYAIMIHPNPSKTNKK
>EGEFANNL_01437 Undecaprenyl-diphosphatase
MNTLEAIIIAVIEGLTEYLPISSTAHMIFTGSLLGIEENNFVKMFEYCIQFGAILAVVVL
YWKKFFDLKKINFYLKLVCAVIPALILGKLFSDKIDDVLEKPEIIAIVLVLGGIVLLFID
RFFKNPTILKEEDISIKQAITIGFWQCLAMMPGTSRSAASIIGGMQQKLSREVAAEFSFF
LAVPTMLAVTVYSLTLKTWEEGDLKMKGYELLLSNSEHFGLFILGNIIAFVVSIFAIKFF
VGVIKKHGFKIWGWYRIIIGTLLLIYFYFFQHK
>EGEFANNL_01438 hypothetical protein
MKSFRTIIFLVLFLNFTILFAQKDSLNLTLEYLPNKNYTFNSDIQMIIEGWENNTINYTN
QIKNLYSKIISTGNLNNNKFPFSIRFNDENNIDLNKYEFKGICSPLEYPKISYVVPTIEN
KDIENFYLNYIQEAIKEIPILTKKLKLGESFTTSSPLKYTLSEFLSLDLLVLKHYTLVKI
DSNYAYFDYEMKASIKNFEYMDIKYSGKSSGKGKLVYDINNHFFISSKNNESILNLNMLH
QGKTSLLKIKTFINEDILIHEN
>EGEFANNL_01439 3-methyl-2-oxobutanoate hydroxymethyltransferase
MSVHAKINKVTVETLKKMKATENKISVLTAYDYTTATLIDQAGIDAILVGDSAANVMAGY
ETTLPITLDQMIYHAQCVGRGIEKALLIVDLPFGTYQSDARQAYHSAVRIMKETSASAIK
IEGGIEIKESVKAIVNAGIPVMGHLGLTPQSINQLGSFKLRAKEKQEAEKLISDALLLEE
LGCFSIVLEKIPSQLGEEVSKLLSIPTIGIGAGNKTDGQVLVIHDLLGLNPHFKPKFARQ
YATLHEQITNAVSCYVKDVKEETFPNQNESF
>EGEFANNL_01440 tRNA pseudouridine synthase C
MVLEDQILFEDNHLLIINKKAGQIVQGDKTGDVSLVDEVKTYIKKKYNKPGNVFAGLVHR
IDRPTSGIVIFAKTSKALSRLTEMLKKREIKKTYWAVIKKTEIPNKQRLIHFLKKNEKTN
KAIVYKTPNIGAKEAILSYESIQTSNNYMLLEINLETGRHHQIRAQLSSIKCPIKGDLKY
GFDRSNPDGSIHLLARKIEFIHPIKKEPLQIIAPVPQNDNLWKSFVN
>EGEFANNL_01441 Cell division ATP-binding protein FtsE
MSEPIIYLNNASVYQKNHPVLNNVNLSLARGNFYYLIGKTGSGKSSLLKVLYGDIPLKEG
EGKVADVFLTSLKESQIPSLRRKLGIVFQDFQLLTDRSVEKNLIFVLKATGWKDKEEMHS
RIDEVLESVGMLSKKNKKPYELSGGEQQRIAIARALLNHPELILADEPTGNLDPETSRDI
MLLLKSIVEKTRCTILMATHDYSMIKNFPAKTIKCEEGKIFHGNSEELFTK
>EGEFANNL_01442 hypothetical protein
MSFKNFLKKTIHYLLGFFFFLETIFFLDTKPESFLSGIISLACALVILPITRNFLEKILN
FNFGKGIKYSLPFIGFIFPPLFCVSTIKNDDHLNNYSNSKIFKNSINTNVNNFISQTSIN
SAYNDKKNDEVQASNLLTSASTKNSSYKKENRPTNKVKKPYAFSKKINKSSKNKVQNGLP
NRNFSSGLCGHANKSGGFCKRRVKGGGYCWQHR
>EGEFANNL_01443 Epimerase family protein
MNKFYKLIQSTKDQKMKKNVLITGANGFIAKNISKLLQENYNVRFLTRRKTNDQEYEWNI
DKQEIDVRSLKDVNHIIHLAGANIGEKRWTKERKKLILSSRIDSAKLILNTLIKENISIE
SFISASAIGYYGTLTSNKIFAETDKHGADFLSHVCLQWENIADEFKTKNIAKRVIKIRTG
VTLSEDSNGALFKIKTPIQYHLGACLGSGKQYMPWIHIKDLCSIYKYALENINLEGAYNA
VSPEHTTNKDLTYSIAKHLNKRIWLPNIPSFFIQWVMGERANLLLEGNRISAHKLLESGF
YFRYKELDDSLKSLLQ
>EGEFANNL_01444 Lactate utilization protein A
MNQPIKTMAQYIEEGKSPEVLFWVGCAGSFDERAKKVTRAFASLLQKAKVEFAILGQEEG
CTGDPAKRAGNEFLFQMQALANIEILNSYEIKQIVTACPHCFNTLKNEYPSLGGNYRVLH
HTQFLQTLLNEGRLKVEGGKYKGKRIVFHDPCYLGRGNGEYEAPRFVLEKLEAELSEMKR
CKKNGLCCGAGGAQMFKESEKGNKEINIERVEEALDVNPDIIATGCPFCSIMLTDGVKAK
ERNRTVYIKDIAEILNEE
>EGEFANNL_01445 hypothetical protein
MEYISNIIFILLAFIGIGFFLRNLFKIRRNILLGKPENRSVQPKQRFKLMLRIALGQGKM
MFKPVAGFFHILIYVGFILINIDLIEIFIDGIFDTHRYIGQLLSPYLYNYITASLDVLSY
LVLIAVVVFFSRRNFIKVPRLKSNELSGWPKKDANIILIVEFLMMLAVIFANSSEVVLQQ
KNAIHIVGYFPLSSWLISPWLSNLTIHQLTIVFSSCWWLHYIGILIFMNYLYYSKHLHIL
FAFPNTYYSNLKNKGEFNNLSSVTEEVKLMMDPNINPFTEEGSSDQISEKFGANEVTDLS
WIQLLNAYTCTECGRCTSSCPANLTGKKLSPRKIMMDVRDRVEEVGRNIDKNGEFVEDGK
QLLGDYITKEEIWACTTCNACVESCPLQIDPLSIIIDLRRYLVMEKSEVPQELNGMMSCI
ENNNAPWPFNNTDRENWSKE
>EGEFANNL_01446 hypothetical protein
MKIKKEFKAGVIVIVTLLCFWWLFQFLKGKDVFSSQKIYYVKYNKLEGLSKSKSVYINGL
KVGMVESIESIPTKNNNISFVVGLSIDKEFSFSKNSVAEIQNSLMSGAEIHLELSEDGPI
AQPGDTLKGIIIPGIMDVAGNELKPLSKNVNSVLLRLDSTLTATNKLLSNRNINTVEASL
DNLNRTIAQFNQLGKSMNSLVSQNSAALTTALTNVNTMLISTNKTVSQYGSLAEKINQSD
FEKTIKNLESTLSNVNQLTAKINSGEGSLGKLMNDKQLYTNLENASKNLNLLLVDFRENP
KRYVHFSVFGGGNKNKKNKKVDSTAQALN
>EGEFANNL_01449 hypothetical protein
MSLTTRKEDYFYDPVPCYDYVVRGSSEYKIGDQSTINHFSSLVYCKVDEYKQAVFVVSSF
SQSSKALIYLLAQDFSSCVSSLCLQLNEIGQVTKILNLEEIQAKFLNAKLSLLDKYSKVP
DISVILDNYGASLKEEGKLRKSLFYYGVYRLFFTGIKELVKDSYPQKRITRTRKLDGFIL
SLALPVIEDILIERVKDIYRVTIVGRIDFDRLDKNIFIDACRFMYGKEITFSDIVFSAKE
SYELDYNFIFLRGSYKHFFEIRGKLLKRDELSFHSKKFSFV
>EGEFANNL_01450 hypothetical protein
MSEVNKKYVPEGVFLVCDKGTMVTQLIADASRNVKIYGAKQCVDTDNKFGVNIIPFGGCA
TCGTCKFASIEWTKVKQGGVRVNKAIPLLEHSEGICSVGQGKIRIFFDEYEADLANENNN
ESAFVKESISSSILGEALTTPFGKLIDLFCEDNDKFTEGVGRGAKKGLESTWNFFTSDMW
KADTWKGMGKLAVIGASYSSPLTGTLMGDRSLELLDSQFGTDFKQTKDALVEGVKKSAGN
AWEDVKRGNMGEIGESVGQLEYAIAEALIGSKGAGLAVKGASTGAKALIGAERLAEIAAT
SAKWMGKLKTGALGLVKVGRMDWMGGKGFFSWGMDGATLRNQARLLKYPSPHYYDVLIHG
YPYMFSPAKGELINASQLYTRLIEGGYKQGTPIRLISCSTGKELDGAAQQLANLTKSKVV
APTDLTAVDNSGIIHVANDGHFKIFYPE
>EGEFANNL_01451 hypothetical protein
MKTIGFLKMYNNNVRFNNSMNLSEMIKDTRAYTDLDKIINYLESGYYFTDSPVMLQDDED
KPMFGLGYQTDGEWIWPNYFAYYLQKYSNYEIDKDFLDYLKSKDFVYTEPDESQIKKVSD
YFFANIW
>EGEFANNL_01452 hypothetical protein
MKTILKIDEIFKMSFGYTYFVGTLIGKKDFFEKGEWLLKENGHSIKKVVIVSEQMPPANK
IDKRILVSNQSFDKSTVNLDKSLILERIDKDKSEKETYPYKTYKGKNYTEEEWKLFEEKQ
YQEYLRKKGKL
>EGEFANNL_01453 hypothetical protein
MRVKKIFFLENGLNVLVVNRNEYAEYYSKNQKWELYLNGDKYKKLNDLKELSLLNQSKNL
EEIPLETTTELNKLKEINLEFNNIELKTI
>EGEFANNL_01454 hypothetical protein
MSDFSKHEQLIDFLNKTYSKDFRKFKEQNFSKDFEFLDTNDINNAVVIFTEVLNLYGGSV
GKYDLYKLMQEYLTNAEKRDAINTIIGKL
>EGEFANNL_01455 hypothetical protein
MINKYLESLDELKQIYFNSGTDLKIWKNKAISIINIIYGEGSKYEDQINQIKYIDTPSIS
FINAYEDEDKRPRLTSKSNSKECEQQAREIIENIIHILKVFGLPEKKEVLKASNGININL
NQNQSQNQNISINIILETLQNELTGRQLKEIQEILNEQNNDTQEGKKSKVISKLKSFGSD
VLSNIVANIITNPSILG
>EGEFANNL_01456 hypothetical protein
MNTKTAPKKVHQGRNIKRLREMLGIKQESLAFDLGVTQSTVSDYEQKEQLEEKVLEKVSK
ALKVPVEAIKNMNEEATVNYINTFNDSAVNHGSNTNFNCTFNPIEKIVELYTEKEELYKQ
MLKDKDILIEKLSKKN
>EGEFANNL_01457 hypothetical protein
MVNDMDILEKTKDYLTTLSPTDEGKYMLRVEIDGYKHLGFILLSILRVCESCLLARERNI
AINTDLDICNLLDLAKSLIPYSELEFLEELNSYSKENKKDT
>EGEFANNL_01458 hypothetical protein
MKESKLNTQKAFRYYCLGLTSKEIAKLLDCSYRTVQNYMSAENWKEKRNQLKPKNKVIKK
>EGEFANNL_01459 hypothetical protein
MIDGIKIYCEDLSPQTWERMPYLSFITIINEQTGEILNKKRYAQYQALYLEIKPSTIIKN
KDNCYLHGSIAKYHNNGLDNAYDYDYQAFQNTLTDLENKLKINPEKAQLKNFEFGINITL
PFPVKTALNHLKTYKSNSFSTMYTGRQNIGYIADYQQYTLKIYNKSIQAKINQPNLLRIE
IQVKKMQYVKALNIHTLADLKKPEIWKYLANHLLNLWAECLYINEKDFNYKTMSDRTQKK
FLRFIDPRYWDSLKEKKQRLRARQAYKEICNLYQNKEEKQIITTFIKEKLEKLKPKTVHQ
LTNPIPLKTVQNDKPNQKIKCPPFNPLDKELISTQNKNINKDRFLLENIKQKKPEKQTKK
HIKKCLVCHQSLKNKNTHAKYCSKQCNNQYHTRKRKKMRQKIKITQIKNLNRIIQQIPKN
NLWLTITYTNKKLTYTETLHQSEILSPAQWINKIKQIEIKGIRKNSPIIILTSLRAKKLI
KQLTLINQKHTKNTLNNQKNNRGGVLQSSP
>EGEFANNL_01460 hypothetical protein
MPYKKPVNNKEYLFILLDELVILNLHAQDIQAPNPKQAILAKIQELYTLIESYLD
>EGEFANNL_01461 hypothetical protein
MKQVNLEVNGIDFKNLKVNGVSLQELFQKLENLTHTKTQEKNATESETHLLLTRKEVAHL
LKISLPTLHDWTKKGLIKSYRIGNRVRYKQTDLYNALQKTSQQ
>EGEFANNL_01462 hypothetical protein
MAKPTVFISSTFYDLKYIRTEIDQFIENLGYQPVRNEEGDIPYGKEEALEEYCYKEIQNI
DILISIIGGRFGSESKKTKEKSISHLELKYALEENKQVYIFIEKNVNAEYETYLLNKEND
IKFKHVDDVRIYKFIEEIKLLPNNNNIKNFETSSDIINYLKDQFAGLFQRFMQNQSRIKE
ISLINKLETTSKTLDQLVNYLSDENKENTEEINRILMIHHPLVEELKNKLDIKYLFYIQE
LSDLEELLKARGYKDAGEKDDYFLWNKKIRDKIKTLGVSKSLFDIDDKLKFLKKGDWKVN
YVSVNIEEEDDDLPF
>EGEFANNL_01463 Tyrosine recombinase XerD
MKVRFYITKQKNPYSTIHLRFWHGRKYDFKTSTELVVKYEDWNNEKEVVRNKVTAKDKDF
INNTLANLRQYIIENFNTEYNSGLPISKMWLKNKVSVFFNRVDESKPEQTYYTDWVTKFI
ETASKRLYKGKPISQSTLKKYVTTRNYLVMYEEYKKTKLLHQDITMNFYYDFVDYCKTIQ
KVNLNTIGTYIGKIKFFCGQIALEGLPISNHYKNSEFMGLSEQTEDIYLTIKEIETIYNL
DLSTNPRLDNVRDLFIIGLNTGLRVSDFMRLDLTHIKDDTIRIKAQKTGKIAEIPINNHI
EQTLAKRNGNLPKAISEQKFNEYIKELGKLAGLTQQVQGAKINKETKRKEKGTYPKYELI
TSHICRRSFATNLYGQIPTPVIMSITGHATETQFLTYIKKTNAENAEVLRNFYKKSMKEK
GLKPMLKIIK
>EGEFANNL_01464 Exoenzyme S synthesis regulatory protein ExsA
MKDHLEVLNYSGIFLSCFSNNYTSCVPTLKDHTLIYLCSGEHTIIENNKKIILKPGESAF
VRKNHRLTMFKNYGENGQYKGISITFQRKFLREFYNAQWKHQKLQESITPTHQNIFKLNN
TPDLKSLFESLTPYFDSGVEPTKDLIQLKLQEGIHILLKTNMNFYPILFDFTEPWKIDIL
EFLNENYTYDLSISEIASYTGRSLATFKRDFSKISHLPPQKWLINKRLEAAYETLKSSKI
MVNDLYTEVGFKNLSHFQTAFKKKYGFTPASFHKSGSMKG
>EGEFANNL_01465 hypothetical protein
MLVYFYDKTFEGLLTAIFFSYKHKEFPDQLMQEGDIAPLFTERTYTVVTSTEKAGRVWKA
LEKKISKRACRMLMHAWLSEIEGSDEIIFRYIHKAINSYTRMETNFGDKDVLEIVQIAKK
VTRERHHLEQFVRFQKASDSIFFAPISPAHNALPLVINHFKDRFADQQWVIYDTKRKYGF
YYDLKSVQEITFSEDPQWINGKLEDHQMAEDEKRFQKLWKGYFQALTIKERINLKLQRQQ
MPKCFWKYLTEKQY
>EGEFANNL_01466 hypothetical protein
MKDVVYDKLKILAESAKYDVSCSSSGVARNNKSRGLGNTAGGMGICHSYTEDGRCVSLLK
ILLTNVCIFDCAYCINRRTNDIQRASFSVKELVELTIEFYRRNYIEGLFLSSGIIKNADY
TMERMLRVVKDLRTLHRFNGYIHMKSIPGASQELVNQAGLYVDRMSVNLEIPTEKNLKLL
APEKDHTSVFQPMKYIQQGVLENIEDRKRLRSAPRFVPAGQSTQMIVGATNEKDKDILHI
SSLLYKRPTMRRVYYSGFIPVNHYDARLPSIKQAPLVRENRLYQADWLLRFYGFKAEEIA
NDAYPDLDLEVDPKLSWALRHPEFFPVDVNRADYGMILRVPGIGVKSARLIVMSRRHGKI
TATQLRKMGIVMKKAQYFITCNELPNYTIHEATPKLLKSILMEPKKKTFKSGQLPIIFPV
>EGEFANNL_01467 Elongation factor Tu
MDRVDNFFMIITEVFNVPGRGTILTGRIGKGNVSIEDTLYLIDSFGNIISKSITIKGLDI
GFSRTRPSTAEEGMNVGLLIGEVDIEIVPGYIVRNLQTQPRKAF
>EGEFANNL_01468 hypothetical protein
MRLLTLVLASILLSFGYIQAQNKNNKNLNFKNMINSDSYTFKLSDKVTREKVTFKNRYGI
ELMGDLYIPKNHSGEMAAIAISGPFGAVKEQSSGLYANQMAERGFITLAFDPSYTGESSG
EPRRISSPDINTEDFSATVDYLGLLRDVDRQRIGIIGICGFGGFALNAAAIDKRIKAVAT
ASMYDMSRVNAKGYNDSMTKEERTQLLEQMSQQRWIDAANETLTFKETGLPDSLKGDEPL
FVKEYFDYYKTPRGYHPRSINSTGSWSFTNPATMMNMPIMTYINEISPRPILLIAGEKAH
SRYFSEDAYKAAAEPKELVLIPNGVHVDLYDRVDIIPFDKLDAFFTNSLKK
>EGEFANNL_01469 Putative acetyltransferase
MNILDRMKRGDLILESDPEYHQLLEALHRGMRITGELNASYHTPDQTRAIISELTGQELH
ESTWIVPPFRTDFGQFIRLGKKVFINSGCMFMDRGGITLEDGVFIGPNVSLITENHAEEP
HLRHNVYTKPIYIKQNAWVGAGAIILPGITIGENAIVSAGSIVTKNVADNTIVAGNPAKP
IRKIKK
>EGEFANNL_01470 hypothetical protein
MKILFLIVCLLLTTALSACRKDNHLNASIQMDNRNQQEIKLIIGTTTFNLTLENNHTSNA
FVSQLPLTIEMNDLNENEKYGNLSENLPTNPSRVNTIHKGDVMLFGSNTLVIFYKSFNTS
YDYTLIGKITHPYDLEKVFGKGKVRVKFIQ
>EGEFANNL_01471 Glutamate--tRNA ligase
MSEVRVRFAPSPTGYLHIGGVRTALYNYLFAKKNKGKFILRIEDTDQNRFVEGAEPYINE
SLKWCGIEVDESVEKGGAFGPYKQSERKEIYDQYIKQILSTDYAYIAFDTQEELEQLRAE
HEAKGKVFSYNFEIRNQLNNSLTLSDVEVQKKIEEGIPYVVRFKTPPYRTLVLSDMIRGK
FTIETNTLDDKVLVKADGIPTYHLANIIDDYTMKISHVIRGEEWLPSLPLHILLYEAFGW
NPPQFAHLPLILKPEGKGKLSKRDGDKFGFPVFPLAWKDQKEGTSSIGYKEEGYLPQAFT
NMLALLGWSPADNKEILSLDEMIQEFDLEKVHKSGARFSKEKAVWFNHEYILKSPAQNLL
PLFEEVLKENGVTPNPTFDTKIIALLKERVNFVKEIWKEGSFFWNEPKEYNEKNYKKVVK
EDTDSILSQILELLEGINFNEKEIHDCIHNFVEKSELGFGKVMQPIRLALVGALSGPDIP
VIMEILGKEESLQRIQKFINEIKN
>EGEFANNL_01472 Ribose-5-phosphate isomerase B
MKIAVAADHAGFEYKNHIFKYLTDRGFQVHDFGTYSQDSVDYPDFVHPLATAIENKEFDF
GFLFCGSGEGVSITANKHAGIRCALCWQNDIAKLSRQHNNANVMAIPTRFIAKELAQELV
DTFLSTQFEGGRHETRVEKISKW
>EGEFANNL_01473 Inner membrane protein YbhL
MENNEYRNTAENYTLKQTVASQQATFIAKVYMWMSLALAITGLAAYYTATSEPLLNLMFK
PITGAPTFLFYALIIGELALVFWLSAAINKMTLSLATAVFLFYSLVNGMTLSMIFIAYTM
SSIATTFFITAGTFAIMSAYGYFTKTDLTKMGKILFMALIGIVLATIVNIFLHNGTLNLI
ISIVGVLVFVGLIAYDTQKIKEIGATIGENGTENYSKGAIMGALSLYLDFINLFLFLLRF
LGDRR
>EGEFANNL_01474 DNA translocase SpoIIIE
MEKPSKILEKKQKKRVLITIFGLCLFIFSIALFLSFIYFFLYWKEDQSQITKFLDKNVVA
LNPMGKFGAFLGEFFIFNGIGITAFFIPFYLFCLSIKVLIGKEILKLWKLLSHAIFFIIW
LPVFLAMIFSYKWLLSGLIGYEVHDYLKSLLGSVGTVFLLLLSLAVYFILEFNLSMDHIK
EKFNSIHHKNRKRTTDNSINNEPFAEENIYEKIEDPSTIQSETILTNTKDDINDKNIISN
SDPEINIEERNIEISVQENISTSFEIDIPKAEETIEEISLTIENPEIEEIISDEELSKNI
IDKSGPYDPKLELGKYKYPPLELLKTYNIANDAITINNQELEENKNKIVTTLGNYGIGIS
SIKATIGPTVTLYEIIPEAGIRISKIKNLEDDIALSLAALGIRIIAPIPGKGTIGIEVPN
STPTMVSMRSVIASQKFQKIEMELPIVFGKTISNETFVTDLTKMPHLLMAGATGQGKSVG
LNAIVTSLLYKKHPSELKFVFVDPKKVELTLYNKIERHFLAKLPGSDESIITDTKKVINT
LNSLCEEMDSRYKLLQDAYVRNIKEYNEKFIQRRLNPEKGHRYLPYIVLVVDEFADLIMT
AGKEVELPIARLAQLARAIGIHLIIATQRPSVNVITGMIKANFPARVAFRVTSKIDSRTI
LDGNGADQLIGKGDMLFTTGNELIRMQCAFVDTPEVDQITEYIGSQQGYPDAYLLPEVYE
DKPSGFDSEAEETKRDDLFADAARVLVSAQQGSTSLIQRKLSLGYNRAGRIMDQLEAAGI
VGPFEGSKARKVLVTDLNSLEQLLENL
>EGEFANNL_01475 hypothetical protein
MLFTSSFLLWGQKIDANAKTILDNASAQLSKSSTFYIKFNYLYTVPEQKSTTEVGQIYAA
GNKYHLILPSITQISDGSKIYTISKDDKEITISNPEDGDGISPINILNLYKKGFNISSEG
SSTVNGVKCSLIKLVPTNNKSKSIVLAIANNKIVRVSENYNDGSSLILTITDFKENIIVN
KSLLSFDSSKYPDYTITNL
>EGEFANNL_01476 hypothetical protein
MVKKLDWYIIRTFFGPFLFIFSVLMFIFVIQFAFNQMDKFLGKGLTLWDITKLLYYLGLD
VIRLVLPLTILLSSIMTFGGFGERYELAAMKSAGISLARVMFPLFCFVVVMSIWLFYFSN
TVLPDNQRKARTMLTNIIKTRPALNFEEGKFIKEMNPFSIKIGKKSGDNGEIWEDVFIYK
NTFPNEDQQTIISKKGNIVSKNNYFLKLELYDGYIYQEDIKGKSPAALAKQESSVIKFDT
LTQYFDISDLIKKSLDQESGGDNYRYKSFSKLDVYIDSIQKSNQIYYKQFADYSLSFLLS
NSSPLDSIDYSNYKANLPFDWNKLDSNTQVRIVQSAIDNVKYAKSELEARTPEIKSTGKY
ISKMIIWQHKNVISFSFTCIVFFLIGAPLGSIIRKGGVGMPVIVAVIIFIIFYVLGLYME
NLAKNQIMNAYWASWIPNLVFFPLGIFLTLKSMKDSDLFDVNNYLGPLRKFFKMINGNKN
TEHKRYQ
>EGEFANNL_01477 hypothetical protein
MFRLKMIKQQRVGVLLLIVFIIALEIFLHKDKFIKKSSIIVNELPHSIKSQITEFGSSYP
KDSLKFFDPNQYTSEDWQRIGFTKKQSDVILKYKELLGGTFTSKEQIRKCFVISEEKYKE
LESYIQLPEKFRTNTAKQEIQNLQKNTYSLTLFDPNDYTLHDWVKIGFTKKQAEVILKYK
GILGGKFTSKEQIKKCFVISDEKYKELAAYIRLPEGESSIHKQLKSTLKNKIDLNKATYN
DIYAILGDAVLAKRLISFRNGLGGFVSKNQLDDVYGITSRNKDSLLNAFVVKVENIKKIN
LNKATEDELQRNIYLRKYKNKIIELRLKGENPIKAISSSDSKYQWIVQYLE
>EGEFANNL_01478 Dihydroxy-acid dehydratase
MKTQLRSHTSTQGRRMAGARALWRANGMKEEQMGKPLIAIVNSFTQFVPGHVHLHHIGQY
VKEEIEKLGCFAAEFNTIAIDDGIAMGHDGMLYSLPSRDLIADSVEYMVNAHKADAMICI
SNCDKITPGMLMAAMRLNIPTIFVSGGPMEAGNHNNQHLDLVDAMIKSADSTVSDKEVNA
IERLACPTCGSCSGMFTANSMNCLNEAIGLALPGNGTIVATHANRKKLFIDAAHHIVENA
YKYYRDGDESVLPRNIATKQAFLNAMTLDIAMGGSTNTILHLLAIANEAEVDFTMDDIDA
LSRKTPCLCKVAPNSTKYHIQDVNRAGGILNIMHELAKGHLIDISTPRVDGLTLGQAIEK
YNLCKSNVDEKVLELYKSAPGNKFNLVMGSQNSQYEELDTDRSEGCIRDVEHAYTQDGGL
AILKGNIALNGCVVKTAGVDESIFKFTGKAKIFQSQDDACEGILNGSVQSGDVVIITYEG
PKGGPGMQEMLYPTSYIKSRHLGKECALITDGRFSGGTSGLSIGHVSPEAAAGGNIGLVK
DGDIIEIDIPNRSINVKISDQELAFRREQELAKGENAFKPHRDRKISKALKAYASMVSSA
DLGAVRIIK
>EGEFANNL_01479 Acetolactate synthase large subunit
MSNNKISGSEALIRSLIAEGADTIFGYPGGAIMPVFDTLYDYKDKIKHYLVRHEQAAAHS
AQGYARVTGKAGIVLVTSGPGATNTITGIADAMIDSTPLIVIAGQVSSSLLGSDAFQEAD
IVGITKPICKWAYQVRKAEDIAWAIARAFYIANTGRKGPVVIDITKDAQQGLLEYSYKPM
NFIRSYQPVPDINLNDIQEAAKLINGAKKPLALIGQGVLLGEAENELKIFLEKADIPAAS
TILGLSALPTNHTLNMGMLGMHGNVAPNMKTNECDVLIAIGMRFDDRVTGDLNTYAKQAK
VIHFDIDPAEIDKNVKTTVKVLGDAKETLSEVTKFISENKHTEWKNSFKVFIDKEEKFVI
EEEIHPQDGGIKMGEVVRKVSEATNNEGILVTDVGQHQMMGVRYFKYKETRSVVTSGGLG
TMGFGLPAAIGAKIGNPDRTVCLFVGDGGFQMTLQELGTIMQYGIDVKIIILNNHFLGMV
RQWQELFFDERYSETIMDNPDFEAIAKAYRIEAKTINKREDLDAAIHEMIQHKGSYLLDI
QVELKGMVYPMVPAGTCVTNILLGNSEKA
>EGEFANNL_01480 Acetolactate synthase small subunit
MEQKNNNTLYTITIFSENTVGILGQVTSVFTRRFLNIETLSVSPSAIEGIHKFTITTFCN
KETVEKIVKQIDKGVDVLKSYYNTDEELIHQEIALYKLSTSEFLKIGSVENLIRKYNAQI
LEINEICVVIQKTGHYEDTQALFKELSNSIQVLQFIRSGRIAINTSKIERLSDMLSELKI
KESNEKQ
>EGEFANNL_01481 Ketol-acid reductoisomerase (NAD(+))
MAEMNFGGVVENVVTREEFPLEKAREVLKNETIAVIGYGVQGPGQALNLRDNGFNVIIGQ
RKGGKTWEKAIADGWVPGETLFDIEEAAAKGTIIQYLLSDAAQIEVWPKLKPHLTAGKAL
YFSHGFGITFNDRTGIVPPSDIDVILVAPKGSGTSLRRMFLEGRGLNSSFAIFQDATGKA
KERTIALGIGVGSGYLFETDFKREVYSDLTGERGTLMGAIQGILLAQYEVLRENGHTPSE
AFNETVEELTQSLMPLFAEKGMDWMYANCSTTAQRGALDWMGPFHDATKPVFAKLYSEVA
CGNEAQRSIDTNSKSDYREKLEDELKALRESEMWRTGAVVRKLRPENN
>EGEFANNL_01482 hypothetical protein
MLFFLFSLLSYSQKLGYDKTYGENGIVQLQPDEQDDYPYSYQTYEDGKILIASNNGIFRL
NSDYTLDTSFATNGRIKNIINAKIFLLFDKKILAITTENDNTSFKLQRFLADGTSDKNYG
TNGEVTYTNLGYIGSTIQKDDKVLVTCTDNQNKLRYLLRIGQDGYLDSSFGAQGKALIPN
IFTRLSTDIVSKSLGEIIISGSDFFSSNSFQALQFTSNGSIDKSFGTEDGLLSINDINDS
SFNAATNIKIKTLKDGNLLFFANVETVDGILKVIVQKTTPDGKKILFNKEHIQIDNFFFQ
DLLIKEITELNNGNLLFSGSTDSSMTPNISYYLLDAKGDIVENFGIKGVLSFNHSSPGSM
LNESTIGTIEKNNGDLISIGNYQTGTKRKSKLALYKFNVKGEMDSSFGTQGVLMFGSKKP
VQKLTSIILQKEDKILFSSNDSRIVRIDNQGKIDGSYFQIENEIDNYDLVSSISNDDNII
GEILPVSFVTSPVGKSGSNIILDENGNKINYYGIDGLNQTTTIIDMIKLPNGRYLTNLVY
KNGNDTGRRLLISDINGSNDKTIFNTYSNINNEKIYSLILQNEDKFLFIKSGVLSLGHEF
DSGARNQGIYRCNFNGEMDPTFQPKMSFLPDNLLVQPDYKIIGIKNNLISRWLQNGDIDA
TFGNNGTLNLNELLSEEVNVYRYTIRTDNKLIFVIENSKGALEVIRLNTDGSLDSSFANQ
GKYTVDHSKRLISLKTQSDDKLLLLYLHTDGYYEMIRLHAEGQLDTTFTNQGKISFEESL
NLQGLLLQSNDQPLVFGTQKIEEDEYITFIRISNQQFIAPKGEILEDQEVLRQNEPITFS
LQTTGEPIDYLWRFEDGSNSITSTESHPVVTFKSLGVHKIHLTVTYSDSYISDIEKNILI
EENESTEIILNPKPEPDTSISSETRVSPNPTHGVLNFKMKGNTKKVEVQILDLSGRQIAE
YSFVGEQGNINIQHLTSGVYFIKLSSEEFSNVQKIIKN
>EGEFANNL_01483 hypothetical protein
MFKISKKGFLFLNLHEFMPCRFRLINEIFTISAIDFIKFINYRISTELFTTFDLYKF
>EGEFANNL_01484 hypothetical protein
MKKIIIVLAAVASTSFIFAGISNPAVFSLQGKFQKNPYYKIIPASELPANIQETINQYLG
GMSKVTRATIDDYKYEVETQDGYRAKFKLNGSIIKVESNNQAIPLSILSKLPGNIHTYVK
SKYADWKLLEVKIKSSKIELELEKDHLEGELEFNGSGILIKEDIDS
>EGEFANNL_01485 Transcriptional regulatory protein QseB
MKLLVIEDELDLQESIELTLSAEGFSIETASDFPTAEEKIYLYEYDCIIVDLTLPGDGSG
LDLIKKLKEKESNSGIIIISARDSLDDKLKGLDIGADDYLTKPFHLSELSARIKSIIRRR
GLMGLNEYVFHEITIILEGRKAIVNGNELILTKKEYDLLLYFIMNKNKILSKEMIVEHLW
GDEVSTMADSLDFVYTHIKNLRKKLIDKGCKDYVQTVYGIGYKFSEA
>EGEFANNL_01486 putative sensor histidine kinase TcrY
MNLDQIIRKNLIKGICLVMLLGCLSHFIIFRYFTYKYNDKILYEYKKGIENYVKLHDTLQ
VYSSTMLKPSRIEEQIIKDPSHHPESVKDILLYNEVTQDYRSFRQLCFTIYYKNHWHLIK
VNQPYIESKDLLILIILSLFLIMLLLLLFIYLVLYYLRKDIGIPFYKNLRLLRNYNVKAH
SELSLVDYNVHELNDFNKVIRKMLRKINADYENSRIFIEDASHEMQTPLSIIKSRLELIL
QSNLIQDEWQTKNIQIILRATTRLSKLNRSLSLLTKINNDQFHNKESIDFKYLIINYLSE
MEELMASKDIITEVQLESFTFEIDPILADQLISNLLNNAIFHNLSNGGKIKITLEENGFL
LIENTCLPIATSENLFNRLIHGKKENSTGLGLNIVKSICDKNNISIEYKHIDTSIFQIFI
NFYKS
>EGEFANNL_01487 Excinuclease cho
MTLNDRLKNLVDSIPKNLCGVYYLLNDKNEIIYIGKSINIKKRLNQHFKSTDKKEIKLQN
LSHFVQYENTGNELIALLRESELIKKHLPIFNRAQRKINFYYALYKETNEQGYHSLLIKK
IDPALPEILTFTSLREAKNYLFKITEIYQLCQKINGLYKTQSSCFQYSIKECQGACIQKE
DPKSYNARVNKFVRTTRLPKKDFLFELQGRTESEKGIVLIEKGAYKGFGYCPIPITSKEE
MISYIETKQDNKDVRKILFRHIKKEWLN
>EGEFANNL_01488 hypothetical protein
MLQNPSTIQNKYKNFVTRVVANERLYALENNKGYATSYSNRVEDENGDPIEMICFWSDES
LAKSCIEKEWRDYQVSPLLLSEFLENWCVGMCNDGLMVGIDFDKNLFGDEIEPLKLILDI
LSLLIDLNKNISFKKYRDINELYNQAKELL
>EGEFANNL_01489 tRNA modification GTPase MnmE
MYQDTICALATPQGIGALGIIRVSGEKSVEIVNSIFKGKNLKVVQSHTLNYGYIVNEKEI
IDEVMVSVFLAPRTFTSENLVEISCHGSSYILQEILNLLVKKGCRLAIAGEFTQRAFLNG
RIDLSQAEAVADLIASENKASHDMAISQMRGGFSSLLKELRIELLDLASLLELELDFSEE
DVEFADRSQLIQLLNQILYEINPLIESFTYGNAIKNGVPVAIIGKPNAGKSTLLNALLNE
DRAIVSDIAGTTRDTIEEFININGIQFRFIDTAGLRETQDAIEAIGVAKALEKANTAAII
LYLVDIETLSWKEVEADLNRVKRENVFIILCLNKQDKNIDIENTELSKSTENKYPVIKIS
AKENINLELLKEEMYLYIEKQKASSQTIVNNTRHLNALLKAKESLELCKKGLQSGLSSEL
VAIDLRRALEALGEIIGQVSNDELLGNIFGKFCIGK
>EGEFANNL_01490 S-adenosylmethionine decarboxylase proenzyme
MVGKHFILDIFECDERSISFVKPIQELCNNLVKVLELKKVEEAYKQFQPVGVTGILLLEE
SHLSIHTWPEKRYAALDVFSCRPFDVTKVEGLVIKCFKTKILKPTLIDRG
>EGEFANNL_01491 Putative acid--amine ligase YjfC
MEDSRFKRVKSFKKAQLPPVLQWLAGQEYFVDEMIGIYSQEMESFKKLTNETFDLFVKAT
DHLIQNNHLDYLGIPKSFQSAIIHSWENRADFPFFAGRFDFNGGVDGLGLRVIEFNADTF
STLPETILWQKMQNREAQSTAFNFLEDHLITQFKQLKQFFNFEEIQMVASSLGHPEDLAN
CNTMLMQAHQAGLQVLYKDLTDIIFSEEEGLFYELGNGEFQPIDIWFKMIPWDWMFEFEP
ELAHTLIKISQDRKVIVLNPLYTTLWQNKKFLSYITEKFPNSLVAETYNNSNFLQEYVKK
PMYGRIGENIEIKTDRVEKTEGDYQNQPCVYQKYYPLPKDEEGYSYQFGMFYSDQPLAFN
VRHQNSKIINDECEFISHFII
>EGEFANNL_01492 hypothetical protein
MKKNILTLNKLSKIALGGIFIASTFMLSACKGNSNEEETISVEEVKPTKGVITEIEEGKD
GEFKIISEKTIANPDESKAIVHYADGKVDTLNSTQVKNEIEKAPSSHAGTGFLSGILMYS
LMSRFMGGGMNSNFVPNPNAYKTPEAYNQANQTNNEVNRTATRTVRTIKNPKSGFGSKSS
STSRSGFRSTRSYGG
>EGEFANNL_01493 Polyamine aminopropyltransferase
MKVKYSLSLAVFIAGLCSIVYELLISATASYFIGDSITQFSILIGIYLFSMGIGAYLSKY
FKNKPIHYFIYTELLLGIIGGLSIPILYFIFVTFPISVLQWSCYTVMLTIGLLTGMEVPL
LTFAFDSNNYKNFLSNILSLDYIGGLIATLLFPFVLLPFLGLFESSLIFGIINIALGIWV
CFCISKKLNFISLAGLISILFLAILLSFSNHLLKNWEEKIYKNPIILNKQSPYQKIVLTE
NNEKDVKLFLNRQLQFSSKDEYRYHEMLVHIPLLWVPKAEKILVLGGGENLATRELLKHP
NIKQIDVVDIDNAMFDVSKKNAEIVNINNKAAFNPKVHLIAEDAFLYLKNTKESYDLIIA
DLPDPSNDILARLYSKQFYLLVKKNLKKEGVFVTQSCDVYFTNKTFNCIVNTLGNVFQST
KPYQTFVPSFGNWGFTLAADYPLEMPKNIELAENLSYLDASLVQSSFHFPKDIPLQKTKI
NSLDNPFIIDYFLEEWKQWKENANSE
>EGEFANNL_01494 Thioredoxin-dependent 5'-adenylylsulfate reductase
MDQSIIDILNQPKSIKENLKFLNDKVEGKIVFSSSFSMEDQLITDAIFSQNLNNIEVFTL
DTGRFFQETYSVWSKTLLKYKYPIKPYYPNTESIEKFVLEKGINPFYESIELRKQCCHIR
KVEPLQRALKDATVWITGLRAEHSATRNNLNIIEWDEHYQLYKYNPILHWNTQEVEDYVK
QNKVPYNLLYDQGFVSIGCAPCTRAIQKGEDFRAGRWWWEDASKKECGLHSS
>EGEFANNL_01495 Sulfate adenylyltransferase subunit 2
MSNSKKYLNQLEDEAIYILRETAAQFEKPALLFSGGKDSIVLVHLALKAFRPGKFPFPLV
HIDTGHNFPEAIEFRDYLVNKIGEKLIVGSVEESIKKYNLKETQGRFPSRNSLQTYSLLD
TIQENGFDACIGGARRDEEKARAKERIFSVRDDFGQWDPKLQRPELWDILNGKIQKDHNI
RVFPISNWTELDVWNYILENNIELPSLYFAHDRECIVHQDKLVATSKFIQPLPEDKVIIE
KVRYRTVGDMTCTAAVPSNASTIQDIIDDIISTRISERGQTRLDDQLSEAAMEDRKKQGY
F
>EGEFANNL_01496 Bifunctional enzyme CysN/CysC
MNTLKFITAGNVDDGKSTLIGRLLYDSGSIHTDQLGVLKQQTKQEGVEVDLSLITDGLRA
EREQGITIDVAYKYFSTHKRKFIIADAPGHEQYTRNMVTGASNSDLIILLVDARKGITTQ
TKRHASIGSLMGIKKAIVTVNKIDLENYSEEVFNNIKNDFETIKDHLDYDEIIYIPISAL
NGDNIVEKSKNTPWYAGETLLNILESIEIPTQKLNDARFQVQWVIRPKDDKYHDYRGYSG
PVLSGNYKIGDRVKILPSEIETTITRIEKLQEEVEQVWAGDSTVLHLSDNIDISRGDSIV
KVEKLPTASNELKSWICWLDQNSLQTGKTYILQHRFKSVRVKIQSIDRKWEVNDWKFSEA
NEIKLNDIGQISLRTNQPIFYDSFKENPKSGNAILIDETTFNTVGALMFL
>EGEFANNL_01497 Siroheme synthase
MILEKKGKVILAGAGPGDPELISVKALKYLHAADVILTDRLVSPELIQDHARKDALIIYV
GKQCSKGIHTPQKEINHLLVKYAKQEKLVLRLKGGDASLFSNVLDELDILVAHNIPYEII
PGISAAFGAAAYSAIPLTAREYSRAVRFLTLFDLDSITIEQWKDWAKTEDTLVFYMSGKK
LNQLTNYLISHQIEDSKGLAIIQQATTPYQQTQTFSFGELKTNKLPEFEYVPTLIIIGKV
VHLHKSFAWIQEITKTESYFDNHITTLQHAN
>EGEFANNL_01498 Sulfite reductase [NADPH] flavoprotein alpha-component
MQTNHILEFKELIKKFSRDELLWINGYLSGILEGGGNPTSLEATPSTNLNSTPAPLIKPT
IIYGTETGNSKKVALQLQKLLKQNKIQSKTYDASQYPLDKLEKEKFLLIIMSTQGEGEPP
VSATNFYQSLEQSNANLDNTQFCVLGLGDSSYPLFCKAGEDIDKNLEKLGGQRIISFTPS
DVDFMPVAKSWFNQILNFIQNSASPSLSIQIETPKIATSIQKKSYTGIVKHKVILNDIGS
NKETYHIEIEPEEEVDFQPGDAIGFYPKNNENETIEIAKLLNEESRSTEFLTKNIRGLSG
KSLEKFSNLFKTEIKESKIDLIDLLKKYPNNSIHIDDVLNLLNPISPRLYSIASSPEAHD
GELHIAVSLDKFKVDGQVKTGLCSQFLANYTLNETLPFYIHKNNNFRLPSNDKDIIMIGP
GTGIAPFRSFIAHRDATGAEGRNWLFFGEQHFVKDFYYQTEIQEWLSTGVLTHLDTAFSR
DQKNKIYVQDRLKEHSKEIYDWILNGAYLYICGQKDPMSLDVNKTLIEIIEKEANISKEE
ATAFLDDLELNGRYQKDVY
>EGEFANNL_01499 Sulfite reductase [NADPH] hemoprotein beta-component
MSQEKLSPIEIIKEKSDGLRGTLKESLADNYTGTIRPDDEALIKFHGMYAQDDRDRREER
AAKKLERLFSFMIRLRIPGGLISSSQWKAIHDISEEHGTGVLKITTRQTIQLHGLLKNEL
RTTIQEFLISKLDSIAACGDVNRNVICSAHPQVSPLFKEIHAYADKISTLLLPKTQAYYE
IWIDGDKVYERSAEEDPLYKKTYLPRKFKVAIAIPPTNDIDVFANDLGLIAIVKDGVLKG
FNLSIGGGMGATHGNADTYPRLGTIIGFLDSEEKIMKAAYEIVTIQRDFGNRSDRKLSRL
KYTLDRMGVDNFIKELEKRTGFPLLPAEEFKFTERTDRFGWLENDKNEWFYTLFVEHGVI
KPYQKSFLHEVALLNICDYRFTCNQNLILGSISKENKTRIEQLIQKYKVEEQDSNLRKNS
MACVALPTCSLALAESQRYLPHLVTKIESILKKHNIENDAISIRMTGCPNGCARPYLAEI
GLVGTALGQYNLRLGGDSLGERLNLPYKEHLNESEILLELDTLLEQYVEENKEGDTFGDY
IYKKFYTS
>EGEFANNL_01500 Precorrin-2 dehydrogenase
MDNTLFPIFLKTETFRFLIVGGGYVGLEKTETLLRQNPAMNIKIIAIEISEKLHKILSKN
PHIEWEERAFEKEDLQNINFVIAATDDTKFNQELKHLANEKGILVNAADQPALCDFYLGS
IVNKGYLKIAISTNGKSPVLARRLREYLEKSIPKNVHETIENLNTYRNQQQGDLKSKLEA
LNKATSLLSNDNKEKPKSRVNYKRFAFDITFIFMATFIGYGLSSFITIEEAKSYLQDIPT
IFFIMLAVGFFAQMVDGAVGLGYGITCTTSMMLFGVSLPTISGSIHIAEMFSSGISGFSH
YKFGNVNKKLLLWLAVPGCIGAISGAILLIYLGNEYESIAYGVLAIYTMIIGIRLIFIAL
QKKILKKKIKHTGILGFAGGFFDAFGGGGWGPIVTSTLLSKGRRSKYVVGTVSLAEFFIT
LSASITFFAYLGVKHWYIVAGLIIGGTIAAPIAARLAGKLPQRTAIIAVAFLVIIFSLRI
LYKLF
>EGEFANNL_01501 Signal recognition particle receptor FtsY
MSWFKKIFGKETKETLDKGLEKSNRSFFDKIGRAVAGKSKVDDEVLDELEEILISSDVGV
ETTVKIIKMIEDRVAKDKFMSTSELDQILREEIMKLLAENKSSDSTFEIPESNKPYVIMV
VGVNGVGKTTTIGKLAHQFKQQGKKVVLGAADTFRAAAVDQLVIWSERVGVPIVKQGMGA
DPASVAFDSVQSAKAQNADVVLIDTAGRLHNKVNLMNELSKIKRVMQKVIPEAPHEILLV
LDGSTGQNAFEQAKQFTAATEVTSLAITKLDGTAKGGVVIGISDQFKIPVKYIGVGEGMN
DLQPFDKFEFVDSFFKKDE
>EGEFANNL_01502 hypothetical protein
MAKKVVATLRTESKKMTKVIKMTKSPKSGAYVFEEKIVNADSIDAFLKQK
>EGEFANNL_01503 50S ribosomal protein L33 2
MAKKGNRVQVILECTEHKESGMPGVSRYITTKNKKNTPERIELKKFNPVLKKYTIHKEIK
>EGEFANNL_01504 50S ribosomal protein L28
MARICQITGKRAMVGNNVSHANNKTKRRFEINLMEKKFYIPSEDAWVILKVSAHGLRIID
KIGIEEAVARARKEGLIKD
>EGEFANNL_01505 Apolipoprotein N-acyltransferase
MKRFIKCILCGLLLALSWPTYGFPFLLFVAFVPLLLLEHEITLKKEKHTYLKIFLFSYIS
FLIWNYGATQWLHYAKNPDGSNSWVAFLIPLFSNSLLMSITFLLFHFVKKVAGTWYGMFF
FPVIWIGFEKFHLSWEMSWPWLNLGNAFANFPQAIQWYEYTGTFGGTLWVLIVNLIIFYY
IRAYQVTHQKVYLWRPLFYSILLIGVPLAISFLIYQSYKEKSEDRTEVILVQPDLDPYEE
KYELNGEVILNDILNLADKQITTNTRFVIAPETAFPGRGSILINEFKDDPYINRIKIWLN
KHPQINFISGVSLAEYYNQQQTTSSRYVEKYNQWIDFYNSAIQINQEPEIQHYNKSKLVV
GVELFPYANYLKPILGNYMLNFGGSMESLGTQDQPEIFINHGLKIAPIICYESIYGEYVS
EFVKNGANAIFVMTNDSWWGDSEGHRQLLSYARLRAIETRRDIARSANSGISAFINQRGD
IVKDLAYLKKGSLKGDVNFNSELTFYVKYGDLISRISYLIAGILLAYTVAKLFLEKINLK
RRGKIK
>EGEFANNL_01506 Thiosulfate sulfurtransferase GlpE
MKNLLLLLFVICLLSCKTKEPVVNNTAYTTTVGELVTDLPRSRSIYSNTFTSDSDTIINH
ENIKEINHSPISNLSKRKTTISNESKSLPTNNIGSFEIKNSKGKNSPKKNKKKDKDTIEN
NKRENENVINEISSNNHESIGIETIAGIEAVDISTSNDSSDIQKNKEKNKNSTIQILDIS
KFSWEAGIRLTQIVDIRSLQEYKSGHIFDAINIDINSSSFVHLIQNLDKTSPVALYGRSE
IDELKAAKILEKKGFSIIYVLEGGIHEWIKAKKELFK
>EGEFANNL_01507 hypothetical protein
MVSQTQIKCPNCSTEINVNDLLKHQLEESIKQDYKEKLSIFQKEIQKKNLLLEKEKEEFE
AKKKKENELFQERLSKITKEKSLEIETHLKQKLEIENQERISLYEKQLKESSEKLQGLYK
MEAEISKLTREKEEMKVMIEAEAQKKLNEEISVEREKIRKQETEKNELRIKELQKQLEDQ
KRLTEEMKRKQEQGSMQLQGEVQELAMEEWLSFNFPLDTIDEIKKGVRGADCLQIVNTRE
LQNCGSIYYESKRTKEFQNNWIEKFKNDIREKKADIGVLVTEVMPSDMERMGMREGIWIC
TYDEFKGLSAVLRHSIVQFSILKHSQENKGDKMEMLYDFLTGTDFRLRIEGIVEGFSQMQ
EDLAKEKRAMMNIWTKREKQINKVIENTIAMYGSIKGIAGNAVQKIKALELDTHEEIDFE
G
>EGEFANNL_01508 Magnesium transporter MgtE
MEKNIFEGNLIEDLHPNDIADQLEELSEKDRILNFFLLPRTQKTEVFTYLDPKVQQELLE
GLGKKDIADLLNGMAPDDRTEFFIDLPDDLIKSTINLLDEKERKTALQLLGYPEDSVGRL
MTPNYIQAKKNWTVEYTLQHIKRFGRKAETLNFIYIVDEHDKLLDDIKIGKLLLANSDTK
IEELCDDNFIALKSMMNQEEAIHIFEDYDRTALPVISDTGILVGIVTVDDILDIVKERDT
EDIQKFGGVEALDIPYRDTPLLTLFQKRAGWLIILFLGEMLTASAMVHFEDELEKAVVLA
LFVPLIISSGGNSGSQAATLIIRAMALKEIGLKDWWYVMKKEIFSGLLLGLTLGIIGFTR
IVIWQGLNFYDYGPHWILIGSTVACSLLGIVLWGTLSGSMVPFILRLFKLDPATSSAPFV
ATLVDVTGLIIYFSIASLFLKEILL
>EGEFANNL_01509 Vitamin B12-binding protein
MRYYSYIILFLVVTISCKREKASEFTHTVKINEYAQNFHISSEDEGILIHSANKITHFPK
GFKINRCIITNTSSSAYIDILGKFNTIVGVSSPNYFYNSKISEGIKSGSILDIGNDANLN
YEKIIKLKPDIIITSHNSNHEKILNQLAKQGIKVLYVEEFNEQHPLGKMEYLKLFGYIFN
QNARADSIYNHIKKKYYELKNKTQNISYRPTVFTNIMYGDSWYMAGGKSFIAQIFRDAGG
KYLWEDVAKTGTIPLSFEEVFIKAKNANYWIGASNFKDKREIESSNLYYKQFKAYKNNDV
YAFNNKENSNLANDYYEMGNIYADKILADVIKVLHPELLPNYNLTYLKKIE
>EGEFANNL_01510 hypothetical protein
MILNIKKMKNSKIISLYITFLLFFVITACHEISNQKVNIADKKLKPIPIIKCDSVIVDKF
NFPDDLERLIGMNYICINSLDIEGKDEHLKYFKNLEISFSDKNYILAEMNSNTMFLKDNM
EDLMMIIKCPDGDFSGKSYGFTMIVLLDSQFNPIFSIHKGGISKYRIDNKLKKNYYTRVK
LNKKIKIDERLEKLSYDQIITIFQELKKENYKELEKEEEYFFYKEGVPLWTENVIM
>EGEFANNL_01511 hypothetical protein
MDLTINNLLEVISKDLDLDANDIDSKAFISEYIDGYPAEDLLAKISKEFNCSFDQFDFYK
YFHSEIEITRSISILNLLRLRKIRKVEKLSIEKLYEYMKNNIKP
>EGEFANNL_01512 hypothetical protein
MNKILLILLVLFISCKKENKMEYSKWKPYILINKEKVDYIELTTKQFEKIMQDSSNFQIL
KPDFSSASVYKLSSGNILVSEEGYHTLYRNVDDYRKIVDDYNEIISNHGNNIEILYGQNI
YNDKFPEKTKFLVKELLGELDIDTKSVLSIDLLREVEEKAIKSNKIYEINIINFIAIVGE
TVLKDYKGEWRMELSKDGETWNPFLLIEGKRIEITSYVYEDLMDREEPNLILSYQTIKDI
LTFDQIKPIE
>EGEFANNL_01513 hypothetical protein
MWLSVDPLAENAPGVSAYTYSFNNPIKYTDPDGRWPWPWSTEWILTSAQFFHITAQNNGI
SRTDKNYYPRLGRIFENTVVKSLRESKNNSKFYPQGSKRAVIPDIVGESVKNYMNKKNPM
RIDKRITFPNAHFIDAKFTDNLKLEQVYNPQQIRGFIDVLSEMKGGYVNGVWNPNIKPSD
YGAAALTFITPFGATIDPEILIYATAKNVKINQRFV
>EGEFANNL_01514 hypothetical protein
MILKELQENKDYQTKIADNYYNHLLESLNPDQEQLSRRLIHHITLLNKTFREKHNQEYQS
THEDIILALELVQDLIKPQSKLTPKEQSRVEELEQHYLSQGFTRQEVQKTLQISKSQTHR
FLTKLEQLNLIQKESAPKNQTHRYSFGIDNPDIAELFSDNQNIEFTDII
>EGEFANNL_01515 DNA primase
MTIADIKKNLTIGQVLEHYQIQVKNNSCCCPFHDDKKPSMQIFPDTHTVRCYSGNCSQSN
KVIDVIDFIMYKENLTKHEALIKASQLTDLSHKIQRSKEYQEIPLDRLEELFYKMKSNLR
QSKTARTYTQQRSLDYQKLEIGYNGRTYKGLVNCIVFPLKDPNHKIVSLYGRSIKAEAEN
KHFYLKDRKGLYPCYPKEETKILILTESIIDTASLLPIPLPLKSYSLLSCYGVNGFTQEH
RQAIRTLKELEEIIIAFDNDQAGKTATEKLRIEINELRKGLKISTIELPNKDINETLQLH
SPEIFKELIHNRIKIEEIRSKEEITDKKEESLPLKSYSLSQINEFIGQSGIIGEENTRLL
LFIIASSYKTQSPLHAIVQGSSGSGKTHLISKIAQLIPQEDVLKFTRITESSLYNWGEWD
LVGKHMVIEDLDGLKEEALYSLRELISNQQLSSSVSIKDKKGNIKSTHKKVRGIFSSLSA
TTKADVYEDNISRSFILAVDESTQQSKKIIQYQNQKYAGEVSQTQEKQAKEKLQNYLRNL
QHVEVINPYATKLELPEEVHKIRRLNQMYQSIIRQITYLNQRERKYQDGKIYTEIEDLEQ
ATEILFESILLKIDELDGSLRQFYERLKKYLKTKDKEFTQREIRQALNISKSQLQRYIHH
LLELDYIRQSGGHINRGLRYRIDYWDNYEKLRKRIQESLKQQIQELKKTKNHQESPKGHQ
NPH
>EGEFANNL_01516 HTH-type transcriptional regulator Xre
MKTGKIIANLRDSKNWSQTDLANHSGVSRVMIGKYERGEAIPSIDAAKKIADAFMVSLDF
LMGEGINVSFDNKTVERLKEIELLDEEDKRCVYNLLDAFIAKNKLKAILG
>EGEFANNL_01517 hypothetical protein
MTTQNKKVEFSNENKNLNPKDFLNSLENFPFVESYQELGFTLKSLCKVTQTALVMDSSYP
NLSVHKSWDIYNILNLIHSLIPHSEWELLDKLNKMA
>EGEFANNL_01518 hypothetical protein
MKEEDIVQIRFFCKDDRIAEAEYLSVEINEGLNFLNIVNLKLNKNFSLSHFICNEVIIKI
YLKGKLMLLTCNSLTYEVKDDSTIIFKLNEIYTDEIYTFNQDYLDVFYGWQNGREYTWRD
FKDKEEKESWLRCCCFWSGVPHSLGKMNNYILKDEELLKTPLDLHCLLSEVFFGKRGYFG
SEINAFIDCLINIQQNAKDNFDNIKVIINNYDDINKKMSRNIGYENYLIQISMELEKHGL
QVITN
>EGEFANNL_01519 hypothetical protein
MTPYQYAYQNPIRYIDPTGMMPSVGGDPDPNNGEISSLEAVVVTPRKDEKSWLGKMLNGL
GRGIKNSVEGLWKGLKRWPASIGLRGNDETVKAQKEITQEKLETADAVWSIVQNPEKFLN
DLSDDTEAQGELAGGILSSVGISLITRGKGGGKLIPKVINKEFTKILKGKGSANLDGLGF
QKIIENRSGVSPKWVGAKEWKAPDVPGTSLNGTRILEHPSGKWGYVINHDYTKIHEIPTS
SPIPYMNK
>EGEFANNL_01521 hypothetical protein
MNNKIIAIDFDGTIVEDNYPEIGRPLLFAFETMQKLQSKGYRLILWTYRSGKALEEAIEF
CRKNGIEFYSVNSSYEGEVFEESQSRKINADYFIDDRNLGGFPGWGEVYQIIKEKIEFGI
EGRQIIPYSKKKHRRKKSFLSKLFGS
>EGEFANNL_01522 Methionine aminopeptidase 1
MIQLKTKEEIKLMYESAQIVSKTLGILTKEISPGVSLIHLDKIAEEFIRDQGAEPGFLGL
YDFPNTLCMSPNDQVVHGIPNNYTLKEGDIISIDCGALKNGYYGDQAYTFSVGEVDSSIQ
KMMDITKQSLYAGIKKCKKGNCIGDISFAIQLICENAGYGVVRELVGHGLGKSMHEDPQV
PNYGRKGSGARIDDGLVVAIEPMINLGTHKVKFHKDGWTVTTQDHKPSCHFEHDVAVVDG
MPKLLTTYKYIYDALGVYSNEEDEFIFNP
>EGEFANNL_01523 Ubiquinone biosynthesis O-methyltransferase
MNKKIFKYFLNLFPRPILIKFSYAIAPIISIYYKGNKYTDPIDGKSYRKFLPYGYGNVRN
NVLAPGTLSLERHRLMWLYLQRDTNFFTSKLKVLSIAPEQCFLKRFKSLTNIDYITADLY
SPIVDVKADILNLPFKDNEFDVIFCNHVLEHIEDDAKAISELYRTMKPGGWGIFQVPMRS
NEKYTYEDFTITKKEDRKLHFGQYDHVRWYGLDYFKRLEKGGFQVEQVKYYQILSLEEID
KYALSRNEILPVVRKPKLVL
>EGEFANNL_01524 23S rRNA (guanosine-2'-O-)-methyltransferase RlmB
MSLEKKTEKLKLDALNRKSIEEFKTSEKIPVVVLLDNIRSMNNVGSVFRTSDAFSIKKIF
LCGITPCPPHREIQKTALGATESVDWEFYEDILQLIKNLKKEGYLLVGIEQVKDSILLQD
FTINCKNKYALILGNEVDGITDSILDEIDLFVEIPQSGTKHSLNVSVCSGIILWEWYKNF
I
>EGEFANNL_01526 N-acetyl-alpha-D-glucosaminyl L-malate deacetylase 1
MKLDILAIGAHPDDVELGCGGTLAKMISQNYKVGILDLTQGELGTRGTYQTRKSEADLAS
RILGVFYRDNLKFKDGFFTNDEFHQLEIIKIIRKYRPNIILANAIEDRHPDHGKAAKLVN
DSIFLSGLAKIETILDGNFQERWRPKHTFNYIQWKELKPDFVIDISGFLDIKVQACLAYK
TQFYDPESKELDTPITSLNFKKSIIYRAENLGRLVGCDAGEGFTSASWIGLKDFDNFI
>EGEFANNL_01527 hypothetical protein
MKKKLFIIFFALLSMITFAQDRYKYRQEIQSTNDKILLIENMVKNEFGEPSSPGIWTSNN
SDFGLMIRTKGNSFSISAWQISDNPEIKIRVERLMNKVKSIL
>EGEFANNL_01528 50S ribosomal protein L31 type B
MKKEIHPDNYRLVVFKDMSNEEMFLCRSAADTKDTIEYEGVEYPLIKMEISSTSHPFYTG
KVKLVDTAGRVDKFFNKYKSYKK
>EGEFANNL_01529 Phosphatidylserine decarboxylase proenzyme
MRFHKAGTEIITISVILFLIINLVSIYLFKYWSVIIFIITLALLAFILWFFRNPKRFIKA
NNNEIVAPVDGKVVVVKEVYEKEFLKTSCIQISIFMSPLNVHVCRYPVSGEVIYTKYHPG
KFLVAWHEKSSELNERTTVVVQNECNQQILFRQIAGAMARRIVLYPKIGDTAVAGNDYGF
IKFGSRLDVFLPLGTDILVKVGDKIPNGGEKIIARLK
>EGEFANNL_01530 Phosphatidate cytidylyltransferase
MLTRTFSGLIYIFLIFICSNNIFSDFSYTYFNIKINAGLLFYILNSLFLLCCLVECIKLL
KYSTFIYKLLTIAVVFILYYYSSIHYFNHSFYISSLYIRYLLTLLLFFLSIVTIFKYSNE
LYSDSSKLIFVLAYLGVPFGLSLALPNSYRDYTSEVFYIFLLIWVSDSFAYIIGSKFGKR
KLFPKISPNKSIEGLLGGIFFTLVAGILIEYNLKILKGNWIVISLLISIFAPIGDLAESK
LKRVFKVKDSGKLMPGHGGLLDRLDSYIICVPVVFTYYLILSKI
>EGEFANNL_01531 hypothetical protein
MGFLDKIFGKKKKEEILDWNIDNQEEDQSVIFVEKFKSAGGMFFYNDDESEALQTLKNIL
IVEDISEVLCLNPKLISMLNVLDCNNTPICNGKQDIAFINCEYLVTLDGSVMVSSDQISH
LKKSDLPNKIIVWASPDQIISSSSEGLEKIRVSKKQKLPSNITTIHGNQVQGFSGLSTTR
KLYLLLVEESYIA
>EGEFANNL_01532 ATP-dependent zinc metalloprotease FtsH
METNKNKKNNKNKKPFTFNWFYGILIVFAVLLLSQEFLFSGRDTKIDQAKFFNYLEKGFV
SRVVFLNATSEVKVYLTDEAKKNPEVVGKESQSLNPFGQISDSPQFTFVAGDKQLFEKQF
NEDVDKLGLKTKIEFENSSPWSGILLQLLIPILFFGLIWFFLFRRMAGGGAGAGGQIFSI
GKSKAKLFDENDNTKVTFKDVAGLEGAKEEVEEIVDFLKTPEKYTKLGGKIPRGALLVGP
PGTGKTLLAKAVAGEANVPFFSLSGSDFVEMFVGVGASRVRDLFKQAKDKSPAIIFIDEI
DAIGRARGKNNITGSNDERENTLNQLLTEMDGFGTHTSVIVLAATNRADILDKALLRPGR
FDRSIYVDLPDLNERREIFQVHLKPLKLDENLDIEFLAKQTPGFSGADIANVCNEAALIA
ARKGKESVGKQDFLDSVDRIIGGLEKKNKVIKPHEKKRVAFHEAGHATISWMVEHAAPLL
KVTIVPRGRSLGAAWYLPEERQLTTTEQMFDEICATLGGRAAEEVIFGDISTGALSDLEK
VTKQANAMVTIYGLSEKIGNISYYDSSGNEYGFTKPYSEVTSEIIDKEISRIIENQYERA
KEILLENKDKLTELANKLLEKEVIFKDDLEEIFGKRKFEDETFSQEIEDNNTTKENNNSS
DYHI
>EGEFANNL_01533 Ribosomal silencing factor RsfS
MINTEVDKEVLLNAIVQGIEDVKGYDITILNLTQLENRISDYFIVCTGSSNTQVSAISDS
IERNVRTSLKEKPWHVEGKDNLQWVLMDYVSIAVHIFQPEFREYYDLESLWGDVEVKKIS
VEN
>EGEFANNL_01534 Bifunctional ligase/repressor BirA
MPLDYLLHTSSTNVFLKDNLDNYKVNFSGVYTFNQTKGKGVNGSSWQCEANKNIALSFCL
NHKTMSNPIDLSLWVAVVMRDWVMDILENNDVYIKWPNDIVVNEKKICGILIEKHKEYYI
IGIGLNVKQTNFNNLYTATSLFKENNLKDYNLHQLVDQLINSFKINLSLLKAPDVLLNTY
NEYLFGKNIGREFIINEKVIKGIIKEVDRDGLLNIQFNNTIERFRMKEISFIL
>EGEFANNL_01535 Beta-barrel assembly-enhancing protease
MEDFFDNDLVNEFENLLENNKSIYFDSDEFNEIITFYLDIYDFEYANKALLIALNLYPES
LDLKIKQLEYYVGVEDLETASSFIESLKDYCFNNNDYLIASARYWSLKKLHHKSIELYLT
ALENHEEENYIYNCIGNEYLELNKPKEALEAYKSALKFNLKDDYALLSCIHCYEVSFEYN
NCITFLNDYIDNNPYSEEAWFQLGLQYLNINNYKQGLISFDYVIIINPKSIAGYSQKAFC
YEKLELWEKAIETYEESLAFDDTAAFTFLKIGLAYNKLKKHDLAMKAFYKSTKEDPQFDK
AWFEISDLFDLMNDKEEALVFIKKALEIETKEVSYWKKYAYLNVQLGNYQEASDAFEIII
DLEPDTFHNWLAYSELLINMKEYSKAIIILKNSLKTLNRAEIYYQLGNCYFLINDIEKGN
NCLKMALKLNPYINIEMKEKYSILLKIINNY
>EGEFANNL_01536 Acyl carrier protein phosphodiesterase
MNIVAHQFLSFNIPDIQIGNILGEVVRGKDYQNYPQSIATGILLHRHIDSFTDSHPIVKE
TTSIFHKSYGKFAPIITDVIYDYFLIKNWHLFYKEPFYDFKNSCYNLVNSLEILVPKNLE
VFLISLINDDWFDKYKSLEGIEWTLHNLTKRSKFKHLIQDMGYSIKEIYLQEKNIENQFL
LFFPELEEYCKEFIIRLMPNYENLVKEYSAKR
>EGEFANNL_01537 hypothetical protein
MMNSYIVFFDGICNLCNSWVKFIIKYDKKNRFKFASLQSEMGQNFLKERNLSSHSFDSII
LYQPNSAYFLKSDAVLQIFKLLGFPFSILSIFYIFPSFIRDKLYSLIAKNRYKFFGKSES
CMMPNPEWKDKFLTN
>EGEFANNL_01538 H(+)/Cl(-) exchange transporter ClcA
MRRKKKHKLFIIIFLFKRIRVEANLLARKFLLTNPQAFVYIISIIIGLTGGISAVILKNL
VSFTEELIYHRNGISYSNYWIIFLPAIGILLTVIYIKFFVKENISHGVEKVLAAISKNKS
RINIKNTYSSIVSSSLTVGFGGSSGLEAPIVYTGAAIGANVADKFNLPIKLRTLFIACGC
SAAVAGIFKAPIAAIIFSLEVIMIDLSMWSIIPILISATTGALVSYFFLGDDISFYFAVF
EPFDKSKIPFYILLGIICGFYAVYFIKFSRYIEKRFAQKKNIYLKAIIGGLSVGILIFIF
PPLFGEGYIGIQHLMSDKPNVIIENSLFNSWKDNNLFLILFLLSILFIKVIASSFTTASG
GIGGVFGPALFTGGVLGYIFEKIITKLSLIKLSEHNFTLVGMAGVMAGIMHAPITSIFLI
AEITGGYSLLFPLIITATTAYLVKYRFDKYSVYTYHLKKENQMITHNKDKEAILRMNINN
LIERDFIVVKSTMKLVDFIKEIIPKSNRNLFIVEDDNGDYLGVIQLDEIMGLLLDKEKYE
GLEVKDIVTPSSAVINSLKGDNEAIFNLFDTYDVWYLPVVKNKKYLGMLSKSKLLQKYRK
LIIDFSED
>EGEFANNL_01539 hypothetical protein
MIVDQIEKKIQYLKKNKYQLPIKEILSQTFSLFTKTLFLGIFSVLFTSSVLVLVYQFFTS
YFDLADLDGTIYQSYIVLLNTFAKGDIVKSQEALMGTRNLLFSYLSNFCVMQRFIILIFS
KIIIFPLSAGVVYCAYKKDTVGLATFKDLIQNFEGRRFLNLVILGVIYYIAIAISIVFFY
LPMLIFSPFLYLAGAFIAINNISLGKALKYSIQIAKINYGKMLMISLLSFVLSTIIGQLF
GFMLLYALSVPYTLVMVYVVYKNILGTDIINNE
>EGEFANNL_01540 hypothetical protein
MKKFLFFILLLLSIHFYNGQEKITRVDSATGGSLTIEANKEIIDLINEDQLCRKVPKSNI
PAKVSTSRSDISEIDNSKVVNTKPSSSNTNSTRTVNKENPKNICGSRRDIPGYMIKVGEA
KSEQDINTMISDFRSKFPYLRVEKTYLRPDWRLLAGDYFKKESAQADLKKIRQTYPSAMV
INWRIYCNRAK
>EGEFANNL_01541 hypothetical protein
MNNTFIYFIFFISTLVGAQNKKKYNSNAETILHGNYASKILEKVRENRNVNSVSSLESYE
YDLYQKYFIDDYLSAYIDSIDRNKNTREELILIGERVTKFKHEKNSGDKKLILADAVSGF
KEPFLELFKQADFQEEFPSILSHEYSQYNFRLIDSTWVEDKKNYIFSFTAKKKLFINGKR
GTLYIDSATYAVTKYTGVEYNEMYTRTFENLWKPYENIWYTASQSNQIKLRVIDLASFLP
RELKVSKKMVGPWIVIENSVKNLRKKENFSKQEFKGYTYELMEDYSKDSFSKLSTYRNYP
LTEKEKNTYEFSTLFHIYPIEKKINLSQNLNRGVLPVGKINLNLLSLASYNDYEGFRFQL
GGKTNFKFNPHYSWYGYLGYGTKSTDLNGGIGTEFLLNKEVERKINLQIFADVNPFSRSI
NRYPESLRDIKQELNFIQNSVFYKYRGGKISYQQDFFKKITTNLILGYEEQKSEYEYSYK
NFNKSRWFDQFTTELKIKYSPFAEYMLTPKGKITIKDKPVYLYLNYLRAWNLLGSSLEYD
KLNLSLDMSINNSWGRSNLFIESGLVFGDTPLWNVFGSFGDAKKGSNIWKRFSSFGYHAF
ETMNPEDFFADRYTALYLTHNIRNVNLFNLKKIDISFLYKGLVGNLDHTVLHRFKGSFNT
PKKYYQEIGVEFNRIIYYFGLGFYYRIGAYNEGNFDNNLFMKLTFTIF
>EGEFANNL_01542 ABC transporter ATP-binding protein NatA
MNYFIQAENITRAYEDKVALDNFSIQIPKGSIYGILGPNGAGKTTFIRILNQITKPDSGK
LYFNGEPLQPKHIAEIGYMPEERGLYKNMKIGEQALYLAQLKGMKKSEAKSKLEYWFDKL
NIEKWWSKKLSELSKGMAQKIQFIVTVLHDPKLLIFDEPFSGFDPVNANIIRDEILELKQ
KGTTILFSSHRMESVEELCDYAALINNSKKILDGSLKDIRNKFKKNKFNISLTETSENEI
KSLINEQEINNLTFSDGIYNFSIQIPTDKNSNAIINELSKKGTIISFFEEIPSMNEIFIN
AVNSK
>EGEFANNL_01543 hypothetical protein
MRNIFLIMRREFLVQARKKSFIVITVLAPILLLLAGSAISYVFKADDPISNIAIIDESQL
FNNSFKNTDKVFYEYHTSNDSNALKDSLTKTNHLDAILQISKDHKDPLLLNIEDKIKLYS
NKTLNQSLLHTLENNINKTIEYNRKLQLGISQSNIDLIKSNISLTSINLINGHTNANTTL
KEIISLSLMYIILMFTIIYGTRVMRSIMEEKNNRVVEIIISSVKPFELMLGKILGTTLVA
LTQFSIWILITLSIIFIGNYLLGDSVIVTPQQNIFHAIFSLETQLQIKEALTNLLDLNIP
LIVFIFLFYFFVGYLFYSSFFAAIGAAVDNDTETQQFLPIVVIPLLIGAYGSISIINNPD
SHVAFWLSIVPFTAPMVMVTRSFYDIPTGDLLLSMFSMIISVFIMISIAGKIYRIGILIY
GKKVTLKEIIKWIKQS
>EGEFANNL_01544 hypothetical protein
MKNFLLNKYPKIQLKVKLLVKFLFIFYCIYLIYLLFFGFGRPPLFNDTKAEYNLRPFHTL
KFFLNLDKNKHWEYFMINIAGNIFIFIPLGFWLSSKVKEFLYFSIFFIIIIFVIELLQYI
TQTGTADIDDILLNYIGGIVGFLLLNFYKKHIFEFNSTKK
>EGEFANNL_01545 Diaminopimelate epimerase
MTINSFVKTQGLGNEYIVLDENNITFPLTEKAIQTICNVNFGIGSDGILVKTHSKKADIG
LKIFNPDGSEAEKSGNGLRIFCKYVFDYKILCKKQFTVETKGGIVNATIQETHNNRASIV
TVDMGKAIFSSPLIPTLFECQEVQDQNIQIEDKNFQVNCVSLGNPHCVILKENLDVDEIK
KYGPLIENYSKFPNRINVQFAKIIDRKNVEILIWERGAGFTLASGSSSCAVASVLRKKGL
IDHLVTIHMLGGYLTIEISEEFNIRMTGEVKQICDGTFHEELINSFV
>EGEFANNL_01546 hypothetical protein
MRSILLALSITFLTYIQGWGQIGINTDVPNATLDIVNGNEAVPPGVIAPRISSEDLYSIA
HTYTKEQNGAIVYITTPYSGSDESFKLVDSPGYYYYNFSKSMWIPFGGDTEPWNNIETAT
TATSNSQNIYQLGSVAVGNSSIDKNAQLDISSSSKGVLIPRLTISERNAIKEPSNGLLIF
NNTTNCLNYFVTEISKWLSLCGDLGPANLSLLSCDAPTGPQGKYKAGTNITGNTTNTYTV
VVKVDEPGSYSILVNTTNGYSFSNSGTFTQTGEFTIVCTGQGTPLKEGQDIPTIMINGAP
SIINCKLPPISVDPASAKVTISECESLKATGNYFSEETLSSSTNFIDIPVTVIGEGAFIM
ETNSVNGFVFSSNSIIVSPATKSIRLYATGVPTNTGNYTFSINGYTCTFNILVTTNLGTF
KKPADRCSSILEKDPSSVDGYYYIKGGTNSYKTYCDMTGGGWTLVKSYSEKAVLNSGTKW
TANAGFNINDPTNVITTETGVVDLTAFRLPLSVVQSISSENKYKFLIKQDINAAPSKDLW
AVDNYLITNIISGGNPTTGDYTSPGFTSEGKLFSYSLTKPTAGNRIHIYNGKSYTNANGF
WNQGFFAGFYGANGGASSSTSESLAFTTPDGSVDYVFPYYINDLWTLYTPENQLNHHIGK
CRVANNSTSAEGPDYGGLANCSGNLNYRTPHTFNNGEGRIIQSYIK
>EGEFANNL_01547 hypothetical protein
MRLIYPSICIALLYSFQLRSQVGINTDMPNATFEVMKGEDLVPPGVIAPRISSEELSTLG
YLYTEAQSGAIVYITTPFPGTDEKFKLVNAPGYYYYNFPRSIWIPFGGDTQPWNNVDLAT
TATSNTQNIYHRGNVVIGNSVIDKNAQLEIASSSKGILIPRLTNSERNTINDPANGLIIF
NTTTNCLNYFSTDANKWLSLCGDFGPANLNLVNCDSPTGPKGSFKAGVNTTGNSGNAYTV
VINVNEPGSYSIEVNTDNGYSFRKTGTATHTGEYTIVCEAQGTPMREGSDIPTITINGVS
YTTNCSLPPITVEPASAKVTINDCSSLTPVGDYYSNELLSSSKNYIDIPVTVTGEGSVIL
KTNLENGFSFSSNSVTVNPSTNTIRLYASRAPINTGITSFTIEGYSCSFNVNVTSNLGSF
KKPADRCSSILAKNPNAADGFYFIKGGTDSYKTYCDMTGGGWTLVKSYSEKAALNSGTKW
TVNAGFNVNDPTNVITTETGEVDLTAFRLPLSVVQSIASENKYKFLIKQDINAAPSKDAW
AVDNYSINTVFSGGNPTTGDYTSVGYTTEGKLFSYSLTKPSTQNRTHIYNGTSYNNAYGF
WNQVFYAGYYGVWGGASRSTTETLTYTTPDGGTDVVYPYYINDLWTLYTPENQLNHHIGK
CRVENNSSSAEGPDYGGLSSCSGNFSYRTPHSFNNGEGRIIQSYIK
>EGEFANNL_01548 hypothetical protein
MVEKIEKLIPIETTHLVISQNILPYFIEYNLTGGRTFDVLMYRYPIDILQKKLDGIYDIH
QQSNTLNEYRAPNSIIINEDKGLKKARKIVTPHRKISELFFQKSILLNCSINIEKNITLE
KGLKVLFPGSSLARKGAFEVRKIVQEFELPLVIKKDAMETKSFWNNVYIEYADSKDIFKN
IELIIYPAYI
>EGEFANNL_01549 Vancomycin B-type resistance protein VanW
MKEHDANVLAQKHSRYKTFLFYVKTNLLCLKRNFQNKFHRIKKFPVGNQFKNLPVVSISK
SDLWTNNEKKEHRILTAGKIHNLRIASRKINGLEIPAGETFSFWKYIGKPLKSRGFVVGR
EIREGCLLPTIGGGLCQLSNALYDAAIKANFKILERHRHSLVVEGSLAEVDRDATVKWNY
IDLRFLSTQSFRIEVEMTSEKLIVTIKSYNKVNNVRRDIEDNNYLKTSIINDCYTCGNQV
CILNNPKINIKNISKTTYVIDEYSSEYENYINNYSEDNSTIILPFFKRQKIKNDNKSWTI
HKGEVITYSIIEIYQCIKCKFKKGNIFKLSLEKNRGGG
>EGEFANNL_01550 Acetylornithine aminotransferase
MEDLQKDFFKYQAKTTFFASGFEVDRAEGNYIYGKDGKAYLDFVAGVSANTLGHSHPKVI
KAIKDQVDKYLHVMVYGEYAMEKPVQICKMLAENLPDPLHTTYLVNSGTEAIEASMKLVK
RYTGRQQIISFIDAYHGNSQGSLSLAGRDTNKVPFEPLLPQIDFIRFNEEEDLQKITSKT
AGVFVETIQGAAGFLTPKNNYLKKLKSRCEEVGALLALDEIQPGFGRTGKLFAFQWYDIV
PDILVMGKGMAGGIPIGAFTTSKQMMESLADNPKLGHITTFGGNPVPAAAACAVMHELLT
TDLMDQVHEKEKLFREKLQHTCIRSINGRGLMLAVQLESPEFTLEVAKRCMKNGLIVFWQ
LYRNEYMRISPPLTITKEEIEKGCEIILASINEVLNERA
>EGEFANNL_01551 hypothetical protein
MNYQSPIRLFEYCNIDYKESLDIKKVKKIIGLEFSFAKEGYITLENLDYSKDQIFKEIER
DDFLQRFNFHLQIWENKSLLNFLERQEINLPILGKWISLCNKQNCNFKPFISPYFAYSIN
KVFKKCLSSKNFKLVNEWLDFFVFIDTLEDEFLATESLKNFLIDKTHILKNVNKNTYVTK
LPQINDWLNEPFSNFVNKLPESLNDQIDKLVTELINFSVEIQFENKKLCYQIIKELKLIQ
NINEDLKLLISENHKIYKKKNISIRNIRNIRKRDIIRFILALFIIIRFLSVINKGVFTDK
EKNSIKNFKEEVNFEKEIFIENRNKLSTIHWDSLEVVKNSKIVMHKDVKYFLILENKLNQ
KKESSVQFVNNSKYPLIISIPDNDNDLVDFKVEAGRNLSVKVNSNVMDLIFSLQNKYHEL
LHKENKNYIPILISDSLDLTLRKINFNQSGKIIDIDHPEGKDDLSVIIETDSNNRSYFYV
VGKYDWIAPKKMFMVQNKIIYNYQYLPEE
>EGEFANNL_01552 Chaperone protein DnaK
MKTVNFGIDLGTTNSLIGKYEEGKVVLYKNPIGHKDTLASVVAFRKERTLVGDKAREYIV
KDPVNVFSGFKRRMGTDDRFYVVNLDENVTPIELSAFILRELKNFIHTNEIPEAVVITIP
ASFDTMQTNATKEAGKLAGFEEVFLLQEPIAASLAYFNNSKEDKEGNWLVYDLGGGTFDI
ALVQIKEGEMKIKDHEGNNFLGGVDFDALIIEHLIVPKIVEKTGISDFAEQLMTKHGKYE
KIYYHLLYLAEEVKKELSTQAKSEIDLSMEIDGVFYDLTFPISVDDFNLLISPKIEETLE
MLQTIINRNNLQPQDIHEIILVGGSTYIPWVREQLNIKTGIPVNNSIDPTTAVAVGACFY
AASKFYTPTEKVKMVINNQESNDFLENLENFGDPQEEKPNIKLNLGFSQMSKEEEEVLLV
KVEGDYQGLNYRIMRMDGGFDTGLIPLKSKFTEFLPLLTNTLNHFIMQIYSSNGEKINSF
TEEFSINQGQFHILGQPLPKDICIEIDDQENYKTKLEVIFEKNSILPLKKTLYREVSKTV
VKGSEDSIVINLLEGDRFARAISNLPIGCIEITGKDLTSDLIKGSDIEIQISISDDRELK
VNTFLVMTQQEFTNNFSISEKHISISRLKEQYQDLEKELRKNLKDFNFNQNEIWAIELEN
LLKKLEISGKQLMTLKENDATDKRYILADTMARISQEVDKIGGKERLSNLQFKYIEIKEY
IEEILSSADENKEILSQRYTKIIEKENDILKSKNSSFLQKNIELLEDLQWEILWNTYTYI
TGRFYALQSLQPEEYKNYKAAQQLIKAGEDAIKYSHYKELKRLMIDLIYLTKQSDYYKQE
DNKKFKGTGIG
>EGEFANNL_01553 hypothetical protein
MNNSILLINQLIEIKQKAEKENLYSKIERNVNRMLSIFEDEGYKIIVPLGEKYSETRTDC
EANLVGKESTNMKITQVIKPIIYKQQNQGVTLVQKGIVLVENK
>EGEFANNL_01554 hypothetical protein
MLFTLIINFYLISCKSGDKNESTKQEEITYKKPTPPKSEGPIRVLFVGNSHTEFIISYPK
ILEALAKANDKKVEIETLLEMGVSVDKILSYNKSKAEKLFAKKDTDGNYFDYVIIQESTP
VAIDETDEYLNDSKKVIELISKNSPEVATYIYELASPFNVTDSDFNSIKDHLSKRAQEVA
KQLTNAEVLPIGTILASAYNNDKGYTAVKDGKDLLRNTDNSKHPLNDAGFLNSIVIYKFL
FGETPKIPNQLPLAKGNEPGNFILQDVDKAVSNPKALEEIAASFK
>EGEFANNL_01555 Cobalt-zinc-cadmium resistance protein CzcC
MKIIKSIFFTASFLINILHTQSQTRQEVESQIITYSEFIKQVAENNLEYAAEKFNVSLAE
AEIDVAKIIPDVELGLEGGSNNKSMGNSMEIGLGWTIELGGKRKARINLAKSEVELNKYL
LQNFYNNLRADATLLYLQTLQNKQLLDVQKRSYDMLEQLAKSDSLRYKLGVIAHIDARQS
KFEAQSMLNEIYEAETEWQNSIINLSLVMGKSQTDQWWMTEGDLNKFDRNFDLSQLITTA
QNNRADAMAGIQNVKVSEEMLKLANANRIMDLGISAGLQLNGKATNEEAPSPYHTGVVAG
LNIPLRFLNNRKGEKKIAEYTIQKSNLEYKQIELQIQTEITQAYNNYNTSQKQVKQFKDH
LLKQAEEILKGKMYSYQRGETSLLELLDAQRTHNDVQKSYYETIFNYASSLIELERVSGI
WDIEF
>EGEFANNL_01556 Cobalt-zinc-cadmium resistance protein CzcA
MYKIIVTAIDKRWVMVILFSLLAAFGYYSWKQLSIEAYPDIADVTSQVVTQVPGLAAEEV
EQQITIPIERALNGLPGMNVMRSKSTFGLSIITIVFNDGVEDYWARTRIQERLNEVELPY
SAVPELDPLTSPIGEIYRYIIESDNHDLRELTDLQNFVIIPRIKQVSGIADVTNFGGITT
QFQIELNPQKLDQYNLTLSEVTETIENNNVSAGGSVLPRGDLGYVIRGIGLVKDLSDLGK
IVVKSENGVPVLLNDIGDLKYGNIERKGILGYTDKNRNYSESIEGVVLLLKGENPSVVLE
EVHKAIHELNDETLPKGVKIHPFMDRTELVNTTLNTVSHTLLEGVTLVVIVLIVFLGSWR
GALLVAITIPLSLLIAFILMHFTNIPANLLSLGAIDFGIIVDGAIVMMETILKRREEHPN
ETFKEKTIAQRATEVAKPILFSTLIIITAYLPLFAFERVEKKLFTPMAFTVGYALFGALL
VALLLIPGLAYVIYKKPQKIYHNRWLEKLTNIYHNCIKKIMQKPKKIFIPLSIVLLVTGG
LTYIVGKDFLPPLDEGSIWLQVQLPPGISLEKSKELSDELRAKTMKYGEVTYVMVQAGRN
DDGTDPWTASHFEVSVGLKPYKEWPKGKTKYDLINELEKEYEKMPGYTVGFSQPMIDGVM
DKISGAHSELVVKVYGDDFKETRRISEDIMKTLKTVDGAVDLAIDQEPPLPQLQIVANRD
KIAQYGLNVSDVAELIEVAIGGKAISQIFIGNKVYDIICRYNEESRNSPDKIANLMLTSS
TGAKIPLSQVADIKLSTGESTITREMNKRHLTVKLNIRNRDLSELLKDAQKKIEEQVKYD
HKKYHIKWGGQFENQNRADARLAVIVPITLAIIFVMLYAAFGKFRLAALLLSIVPMALFG
GMLALNIRGMTLNVSSAVGFIALSGIAIQNGVIMVSHINVLRKEGINLLQAVIEGAKHRF
RPVLMTATVAVLGLFPASLATGIGSDVQRPLATVIVYGLLFSTIITLFALPALYYMIEKR
FDPNKTKTS
>EGEFANNL_01557 Cation efflux system protein CusB
MIKKINISILLAVVTVLFSCHKSTYEETPKNFIIEGQTLVLPEGSNIIPKIKTEKAVVGE
YSPSISTVGTVRAIPTNYAEILPPFSGRVLKSYVNLGEKVVAGAPLFSISSPDFFNAQKE
YFDSKQELALAQTNLKRQQDLFNHGVGIKRELEEAHTDVLTKKSALENAVAALKTYNVNL
SNMSLGQPLVVTSPIAGEIVTNNIIMGEYLKEDSEPIVKIAELSKVWIVGQVKEKNMSFL
HNLKKVEIKTEALPGETLYGKIYHINEMIDESTRSVEVFVESDNSDRNLKPGMYVNVLFS
DSPTSAIIVPAKAILQNSENQFVYVQVGKNKYIKKEVVTENISEDKVRIKSGLKPGDTYV
NEGGIYLLDAQ
>EGEFANNL_01558 Signal transduction histidine-protein kinase ArlS
MKIRNRLTLLFTLISVSILIFFSVIIYFTAKKNRSNEFYELLTKEAITKFNLFIDAKVPP
QILQNIYYNNSQIIDEVEVAIYDENYTLVYHDAIDIDFVKETRSMLDEIKVKGELKFYQD
QWQVIGLKHKFKNKTYIITAAAYDQFGYKELHLLLKNSIFLIVISIFFIYLTGYYFVKRI
FQPITEMTDNINEISANRLDYRLKINKNKDELTKLAQTFNQMLDRLENSFDSQKKFVSNI
SHEIRTPLAAIITEIEIALQRENTTEDYQTTLHKAWMDANKIVKLSNNLLDFAKASYDPS
QIAIKPVRIDEILLDSCEQVKRINNNYRINLSFENEFHEENEIHVNGNEYLLKVAFANLI
ENGCKFSQDHKTQVSILIVNSKIEIRFKDEGIGISRQEIKKIFKTFYRGNNKEWAQGSGI
GLSLAEKIIKLHGGEIIVSSKINLGTTFTVILSHL
>EGEFANNL_01559 Transcriptional regulatory protein CusR
MVRNTASILLIEDDIRISELIKKALDEEAFIITQAFDGIVGEELALNKDYELVITDILLP
SKNGLEICKTLKNIKPYLPIIMLTALGTTDDKVEGFDSGADDYLVKPFEIRELVVRIRAL
LKRHEKLGNNFLLKCEDLEMNLQTKIVKRGNIEIKLTPKEFKLLEFFLKNQGRVIPRLEI
AEKVWGTYFDTGTNFIDVYINYLRKKIDKGYNKKLLHTQSGMGFILKA
>EGEFANNL_01560 Aspartate--tRNA ligase
MYRTHNCGELNESNIGTTVTLCGWVQIVRDMGYVTWIDLRDRYGITQLVFDEERSNQELL
EQVRTLGREFVIQVKGEVIERSSKNPQIPTGGIEILTKTLTILNSSLVPPFTIEDKTDGG
EELRMKYRYLDIRRNPVKENLIFRSKVAQLIRNYLAQNDFIEVETPVLIKSTPEGARDFV
VPSRLNPGQFYALPQSPQTFKQLLMVGGLDKYFQIVKCFRDEDLRADRQPEFTQVDCEMS
FVNQEDIINTFEGLTKLLLKELIGVDIPKFPRITYDEAMKKYGNDKPDIRFGMEFIEFNE
ELKNSGFKIFDEAELIVGINVENCAKYTRKQLDELTEWVKRPQVGANGLIYIKYNQDGSI
KSSIDKFYTEDQLKVVLNKSNSKPGDLMLILSGISKKVRPQLSALRMEMAERLGLRNPKN
FAPLWVIDFPLLDWDEDENRYVAMHHPFTSPKEEDITLLDSDPSKARANAYDLVLNGNEI
GGGSVRIFNDELQSKMFSLLGFSQEEANNQFGFLMNAFKFGAPPHAGIALGFDRLVAILG
GQEVIRDYIAFPKNNAGRDVMIDTPSLISKEQMKELGILNKVNI
>EGEFANNL_01561 C4-dicarboxylate transport protein
MFNMKKRSLYTFLILIFLAINIIISVRHLLFGDTSLARFFISTFILVFALIYYLSKKISK
VIPIFFVFAIAMIYSYYIFFGGLSESLLFYCRWIAVVALLVYGINKKNLTTWIFVSLILG
ACIGFDFPTLGKNLEILSQIFLKLIKTLIAPLIFATLVHGIAGHSDLKQVGRMGWKSLVY
FELVTTIALFIGLAAINLTQAGVGTKHVETGHTQLPQVAHQTWQDIVLHIFPENFAKSIA
EGQVLQIVVFSIIFGIGLIMVEEKKRAFMVNFTDSLAETMFKFTNVVMYFAPLGVLGSIA
YTVAHMGLDALLPLLKLLLTLYGALIVFVLLVFIPIALLIKMPMKRFFREIGEVASIAFS
TASSEAALPKAMEAMEKLGVPRKIIAFVMPTGYTFNLDGTTLYLSLASVFVAQAAGMHMT
FEHQILMVLILIVTSKGVAGVPRASLVILMGTAASFGLPEWPILMILGIDTLMDMARTTV
NVIGNCLASAVVAKWEGEFDPYGETQNLEQEQIKS
>EGEFANNL_01562 putative membrane protein
MEFVYVLIDFILHIDAHLRDLVRDYGLWVYLILFLIIFCETGLVVTPFLPGDSLLFVAGA
LAAIEDNGLNVYLLTILLVIAAILGDSINFEIGKYFGHKLFSNPNSKIFKQSYLKKTNEF
YDKHGGKTIILARFVPIIRTFAPFVAGMGRMNYKFFVRYNIFGGVIWVSIFIFLGYFVGN
IPWIQKNLKFLIVFIIVFSLLPGIIEIIRNKLIINKK
>EGEFANNL_01563 Superoxide dismutase [Mn]
MKISNIFFISILLLSLQLSAQFSLPTLNYKYDELQPSIDSTTMRIHYSKHHAAYVKNLND
VLQKYPEYSGMTLEELIANINHLPQEIRMAVRNNGGGHYNHSLFWSVLTPQKKSKIGGPI
VKEIKKQFGSVEAFKEEFNKAAASQFGSGWAWLLIDKDGNLKISSTANQDNPLMLGVVDV
NGAPILGLDVWEHAYYLNYQNRRADYIKNYWYIINWDEVNKRYQEAIRK
>EGEFANNL_01564 Methionine synthase
MQIEDILKEKILILDGAMGTMIQQYQLKEEDFRGSQFKTWHKDIKGNNDLLSITQPEIIK
KIHLEYFIAGADIVETNTFNSNRISMADYDMQEYVRELNIESVKVANEAREEYYKKYGNK
PLFIAGSIGPTSKTASISPNVNDPAYREVDFDFLADIYKEQTLALIEGGADLLLVETIFD
TLNAKAAFFGIEDAFMEAKKSLPLMASGTITDAAGRTLSGQTTEAFLTSISHIPLLSIGL
NCALGADQLFQYLEILSNKSPFFISAHPNAGLPNPLGGYDETPEMMAEKVKVYMENQLVN
ILGGCCGTTPAHIKLFAEMAAKYKPRTL
>EGEFANNL_01565 Protein YceI
MGSDVFNQDLCIVNYNEIYSKEWGLNKLNSNFLFYVKHNGISTLEFEFFEFEATLYSPTG
NLDYLELYFTVDTSSLKSNMHFRDEHVKSPYFLNSKLFPRITFSSTSKFLGKKLIGELTI
KGITKKIIFNQTYLNGTKNSIKNSIHLEMTTSINIEDFGVNYNKINPQGISVVDKSIEIL
LDLEFDQI
>EGEFANNL_01566 Isoleucine--tRNA ligase
MSNKFQEYKGLDLNKFANEISNFWKENNIFKQSITSREGNPQYVFFEGPPSANGMPGIHH
VMARTIKDIFCRYHTLKGKQVYRKAGWDTHGLPVELGVEKELGITKEDIGKKISVEDYNK
ACKEAVMRYTSVWNQLTERIGYWVDTENPYITYDPKYMESVWWLLKQIYNKNLLYKGYTI
QPYSPKAGTGLSSHELSLPGAYKDITDTTIVAQFEVIKESTTLFNEVDGAVYLLAWTTTP
WTLPSNTALTVGKNIDYVLIQTFNPYTFKPIQVILAKSLVSKQFNNKFFETDSNTDFENF
KPEDKKIPYKILSTYKGEQLLGIRYKQLLPWATPYEDAEKAFVVISGDFVTTEDGTGIVH
TAPTFGADDAKAAKAYGVPPMLVLDENNNPVPLVNLQGKFIDLLPQPFGGRYVKNEYYME
GEAPERSTDVELAILLKTDNKAFKVEKYTHSYPHCWRTDKPILYYPLDSWFIKIPEVRDR
MVELNKSINWKPEATGAKRFGHWLENANDWNLSRSRYWGIPLPIWRTEDAKEEIIIGSLE
ELMIEIDKSVKAGFMDKNIYDGFVAGDYSEDNYKQVDLHKNIVDQIILVSESGKPMKRET
DLIDVWFDSGSMPYAQWHYPFENREMIDNKISYPANFIAEGVDQTRGWFYTLHAIGTMVF
DSLTYKNVISNGLVLDSKGNKMSKSKGNAVEPFETLDQYGPDATRWYMISNAQPWDNLKF
DLEGIDEVRRKIFGTLYNTYSFFALYANVDGFVYKEEDIIFPERNELDQWILSELNLLIE
TVDNFYADYEPTKALRAINTFVIDNLSNWYVRLSRRRFWKGEYSQDKISAYQTLYHCLLT
VAKLMSPAAPFYSDHLYRDLNSITQKENFISVHLSEFPVKVNSNINQSLLERTHLAQQIT
SMVFSLRKKENIKVRQPLQKIMIPILDENHKSDLKNIIPIIKQEVNVKEVQLLNAKEASD
LIVKAVKPNFKALGPKLGKDLKQVTQELQNLTNTQIQEFESNGNITIHGYVLTLEDVEIR
TQDITGWLVATEGRLTVALDITITPELKSEGISRELVNRIQNLRKDNGLEVTDRISLEIQ
ADQEIRAAIEQNKEYICSETLTDQFLFKDSIINGTALELDDYQVYIILKKI
>EGEFANNL_01567 General stress protein 16O
MAEDRLRYSDEELEEFRKLILDKIEIAEKDLVMLKESFVNDLNNGTDDTSPTFKAFEEGS
ETMSKESNAQLASRQEKFIRDLKNALIRINNKTYGICRVTGKLIDKERLKAVPHATLSIE
AKNMQS
>EGEFANNL_01568 Lipoprotein signal peptidase
MKKVLWITFIILFIDQASKIYIKTHFHLGEQLPIIGSWCNLTYVENPGMAYGVQLGGFLG
KIGLSILRLVLISFMAYYISKWVKKANSWYFIIPAGLIFAGAIGNLIDSIFYGVMFDTGT
TYNALSQSWSEYHGISKLDFKGYAPLFGGCVVDMFHFPIIDTHLPSWVPIWGGNRIQFFN
YIFNVADSSITIGAILLALIYFFKPNALPKEWLK
>EGEFANNL_01569 hypothetical protein
MIRNLYIDLIKGIACIGVIFIHTSFWSGVSYVPDFFRSVSLLIDVPIFFLLSGLTTSINI
KKNFIRLGKLQLSYMFFVTLIYFIHAIYTQKIDVYKLLLWWVHDYSDSFPLPVVMGSMWY
LKIYFFVAITAQLVLKFIAEKYYLPLLIILFTLINFLTWIYRYESGDIDYVVFYLFIFML
GYYFKNKNFKITYLYFTIALVSSYFIIFYILGIDIYLDNIDKFPPNIIYLLYSLFSLTAI
LYLKDKIVIHKSNFLIYIGKNAIYYYFAQGISASIIFLFVYLLRNILDWATLLPMMFITN
LILAIIFAEGIKKLDKLFFKLF
>EGEFANNL_01570 3-deoxy-D-manno-octulosonate 8-phosphate phosphatase KdsC
MKNYKEKLNSITSFVFDVDGVMTDGSIILMNKEMIRSTNTKDGFALQFALKKGYKIGIIT
GGRDASVVSRLNYLGITDIYLNSTYKWADLEDFIYKYNLKSDQVLYMGDDLPDYEVMSRV
GVGAAPKDACSEILTVADYISPLEGGKGCVRDVIEQVLRVRGDWDYLETQNDIASI
>EGEFANNL_01571 Glutamyl-tRNA reductase
MFKTVVIVGAGNVAYHLTRALLENTVNLVQIFNRTLSKAQLLAENYNISYTDKISEIKKA
DIYIICTSDDAISEISYYIPFDDCLVVHTSGSTPISALKGKYRKGVFYPLQTFTQGRSLE
YDKIPFFIEAENSSDEGALLALAERISEESYLVDYEKRMKIHMAGVWANNFTNHLYLIAE
EICKKQEIPFDALKSIIKEGVDKLVDGVSPYDAQTGPARRLDKSVIEKHLSILEATDSKL
FQIYNLLTESIIKLYHEKL
>EGEFANNL_01572 Phenylalanine--tRNA ligase beta subunit
MKISYNWLNDYIKTDLSVEKVASVLTDIGLEVEGIDKVESTQSNFNGVVVGEVIDCIKHP
NADKLKITQVKINENEILQIVCGAPNVDIGQKVPVATIGTILCDKEGNEFKIKKSKIRGE
DSFGMICSEEELGIGESHEGIMVLDSHIKLGMPIKEILTTSSDYTLEIGLTPNRTDAMSH
FGVARDLASALKSRKIKSELLPISIEEFKLEEENYNPIQVEIEDANLCPRYTGIYLKDVE
IKPSPEWLQKKLRTIGLTPINNAVDITNYILHSYGQPLHAFDADKIKGNKLKVGSVQKGT
KFVTLDNVERNLDGTELVIKDSEDQPLCLAGIYGGLESGVSSTTKNIFLESAYFNPISIR
KTSKKEGISTDSSFRFERGVDPNNTLLPLKKAAELFKELANATLVGEIIDEYPQPIKEVN
TVLRYHKIDQILGKRIHRDQIKEIVKSLDFTIISDVNDVLDLNVPTYRVDVTREIDVIEE
VARIYGYNHIDIPEKFSFTYDNNQQNEEDLLEDSITNLLKFNGFYEVLNNSITTKKMEDT
NYVELLNPLSSDLSVMRQTLLYGMLQTVSFNYNRNQKEIKLFELGKVYFKTSGNNYLENK
KLGLILSGNFQSNNWISKENRSSFFHLKGIVYQLLNSLGIQPSEKPIHSNLYDEGIELSM
NNTYLGEISIISPSQLKEFGIKNEVYFAELDWDNILDLSTKRKALKFEEISKFPGSSRDL
ALLVDKNVNYFDLYKTAFNEEKILIKSINLFDVYEGEKLPVGKKSYALNFIIQDERKTLT
DAEIDAVMNNLINIYSREFKAELRN
>EGEFANNL_01573 DNA polymerase III subunit beta
MKFIVSSGDLLKALQLISGVTGGNSSLPVLENFLFDLDEGRLTIYGSDGETTMKTSIGVQ
SEDKDRIAVPSKLLTDIIKTFSEQPLTFSKKENQLEIVDEKDNYFIALDDVDQYPSIPEI
EVEKSLKIKASVLAEAINNTIFATGNDAMRPVMTGILFQFNESESCFVATDAHRLVKYTR
RDSVSAEPIEFIMPKKPLILLKNALAAYDDEVLIDFNDTNARFTYSETQWVCRLIDGKYP
NYDAVIPKENPNVLTINRQLFLSSLKRASLFSNKSTSQVRLVLNGNLLKLSAEDLDFANK
AEMSLPCDYNGEELKIGFNSKFLNEMLNNISSEDITLEMSTSNRAGIIKPVDGKDDNEDI
LMLVMPVMLNQ
>EGEFANNL_01574 hypothetical protein
MFYHRELLRKDLVQSIGKQDLYIVDSMPLEVFKLSRSLRNSICKETYLTAPDKGYCASQG
NHYYGYKLHAVCTIDGVFTDFDLTQASIHDIHYLKNIKSMYSDCTILGDKGYLSIDYQRD
LFSNNQIKLEVPMRSNQKDYKPQTYLFRKSRKRIETLFSQLCDQFMIRRNYAKSFDKFKN
RILSKIMAITVIQLINKLNNRNINILKTIIA
>EGEFANNL_01575 hypothetical protein
MNNFTRSYEKILETLQSIESTMNFRNQIRKPKLSDIELIAIDLTSEFIGVDSERDLFRKL
PDNLNSRV
>EGEFANNL_01576 30S ribosomal protein S15
MYLTTEIKKEIFAKHGKNEKNTGSAEGQVALFTYRINHLTQHLKKNHKDFNTERALVALV
GKRKSLLDYLKKKDINRYRAIIAELGIRK
>EGEFANNL_01577 Polyribonucleotide nucleotidyltransferase
MEIPKAITEKIILDDGREIILETGKLAKQADGSVVVKCGGTMLLATVVAAKEANPGVDFL
PLTVDYRNKFSAGGRIPGGFMKREGRPTDEEILTMRLVDRVLRPLFPNDFHAEIQLMIQL
ISYDGSILPDALAGLAASAAIAITDIPFKGPISEVRIIRQDGRYTINPSLAQMNQGFDLD
IMVGASKDSIVMIEGEMSEISEKEMIEAIAHAHNAIKEQIVAQEKLASKVEKSLIKREYC
HEEHDEDLRKEITEFAFQKVYDIAKNPSDKHERSDKFHAILEGFLSKYSEEERSEKESLA
STYFHEVQKDAVRQLILNEGIRLDGRDTKTIRPIWCEVDYLPGAHGSAIFTRGETQSLTT
VTLGSSLDANRIDDVIFQHEERFYLHYNFPPFSTGEARPVRGVSRREIGHGNLAQRALKQ
MIPSDSPYTIRIVSDILESNGSSSMATVCAGTLALMDAGIQIKKPVSGIAMGLITDKESG
KWSVLSDILGDEDHLGDMDFKVTGTADGITACQMDIKIQGLSFEIMEQALNQARDGRLHI
LGKILETLPCPNSQLKPNAPKLIRLEIPKDFIGAIIGPGGKIIQQLQKDTETIITIEESD
DLGKIEISGVDQTKIDEAITRIKQIAFVPEVGTIYKAKVVSIKPFGAFVEISKGTEGLVH
ISELEWKRVEKVEDSVNLGDVIEVKYLGMDDKKKMKLSRKATLPRPERTDKKDKNEE
>EGEFANNL_01578 hypothetical protein
MNRSFLFLLAISIFLFACSKKEESQAPIKIVFFTDSTFTVKKDSIEINSLNNSLHGFVKI
YGYGGINSFEEGELKDGKHIGIWKKYFYGTTLSEYITFNQLGERDGVSLEFDSNGDTLSL
LNFRKNHPIGKQKEFYKGKLTLQYFIDSNDHLINKFLALKPNGDTLYFVDLGKKGTGYLK
KYDRYGVLNIEGYLKNGSFQDTIKEYFYDNFSNKYLYANVYFYKDDSTKVFIKKINMN
>EGEFANNL_01579 hypothetical protein
MNSKIVESTEKLAKDNIIINSYKDFYSGKGYFLTKNLLLGGSKKPFFFPIKSSFEKWWSS
GELNIVQKKYILLLSGVNEYNVNKNAYDSIKKGYDKWNSNYLVDIYGGNKGWACNLFVGE
ALFFAGINTVVSGKYLSAKQIWNGESSRMKLIDKKNLLAGDIAAFGGTHVEIVTKVHRGQ
LFFDDDFCSRGAGRGTTDFGTEKCEGMFGDTREIENSNIRFLRAQ
>EGEFANNL_01580 O-acetyl-ADP-ribose deacetylase
MKIEVCSADITNIEVDGIVNAANTSLLGGSGVDGAIHRKGGIEILEECKKIRSRQGGCKV
GEAVYTVAGNLPSNYVIHTVGPVWSGGINKEKELLSLCYTNSLKIANQLQLKSIAFPNIS
TGIYKFPKPLAAEIAISSVINFLEKENTSLIKVYFVCLDQENEQLYRDNLRGRIELTH
>EGEFANNL_01581 RNA 2'-phosphotransferase
MNLDENGWADVDDLIQKSVMNNVNFTKKDLEEIVDTNEKKRYSFNEDQTKIRANQGHSIS
INMEFKSVCPPEYLYHGTVVKFLPSINEKGIQKMSRQFVHLSVDESTALKVGCRHGKTVV
LTICSNQIYKDGIIFHCSENGVWLTDYVDIKCIFKEKY
>EGEFANNL_01582 hypothetical protein
MKTLKKIGIDEFLILLLLMIILAYFFPSLGSSEGTFSLKSLTNIGVSVIFLFYGLRLSLS
DLKAGLSNWKLHILIHLFTFIVFPLLILPLRGLFTGAENQQLWLGIFYLAALPSTVSSSV
VMVSIAKGNIPAAIFNASISSLLGVFVTPLWVGLVISGQNNSPALGHVMIQLVIQVIIPV
IIGIILNKYLGEFAKKYNKGLKKFDQAIILSIVYTAFCESFTQHAFDGFSITKLVLCGAG
MVVLFFIAYYLITLLSRLLNFNREDKITATFCGSKKSLVHGTVMSKVLFPNSMSLGVILL
PTMLYHALQLIVVSIIAQKLAKQVKDKSKLNY
>EGEFANNL_01583 Osmoregulated proline transporter OpuE
MDLYELISISLYFILMVVIGFYAYIKSTANTEEFLLGGRKMGAAVTALSAGAADMSGWLL
MGLPGAMYISGLSASWIAIGLTLGAYLNYLYIAPRLRIYTELAGNSITLPVFFENRFQDQ
SRLLRIISSVLILIFFTLYTSAGMVSGGRLFEFAFGMHYNVGLCVTSLVVVVYTFLGGFL
AVSLTDFVQGTIMVLALVTVPIVAVVILGGPIDTLEIIENKNDTYLNLFTGTTAVSILSL
LCWGLGYCGQPHILVRFMAIDSVKDLIKARRIGISWMIFTVGGALLVGLIGIAYLHKYDV
DSMMIFDSSKEKAETIFIYFARVLFHPLISGFLLSAILAAVMSTISSQLLVTSSSITEDV
YKAFINKKPTEKQAMIVSRLSVLGVAILAFILSLTPRDSILNLVGNAWAGFGATFGPLII
LSLFWKRTNVWGALAGMLTGGISVLVWVYAGLYAKTGIYEIIPSFFLSLVMIIIISLCTE
KPKKEIIDTYDKMDVELEEKYKN
>EGEFANNL_01584 hypothetical protein
MKEYKSILIVLVKFFCVYLVLIGLYYLYLNFYQNKLQTCDPYTEIVAKQSATLLNFVSVN
SMAIHINHNNFMFFAIDSKISSIVNEGCNALSVIILYIAFIIAFANTWRNTTIFLLSSVL
IIYITNLIRIAFLNYIFHTFPSYSNLAHDYIFPVIIYGIIIFFWMVWIKFFVLNKPAYVN
DKNN
>EGEFANNL_01585 hypothetical protein
MIKTIKIFGIIIFILGLILVRKYESSLFYDPFLEFFKKSNFNHLSPPNFHTIRLFISLSL
RYSLNLILSLLIIYLWFGDKKISVFSFYIFTIGFAIFCALYFVSIYTNFSLGYMPTFYIR
RILIQPIFLLILIPAIYYHKHLKKTNSPNYSR
>EGEFANNL_01586 hypothetical protein
MKSSIIIGILCLIIGGAIAYLQHNGTDPIFTFPLVIGSLFGAGLGLILGAIGGYMGKSQS
IKRKELKEKLSEKVATETNQITENSTENNLGN
>EGEFANNL_01587 Putative TrmH family tRNA/rRNA methyltransferase
MEKDFIFGIHPIIEAIEAGKVFDKVFLQNGLLGDNIRELKIKLGEAGIKAKYVPIEKLNR
LTRKNHQGVCAFLSPVQFYKLEDVIPELFEKGKMPFILMLDHLTDVRNFGAICRTAEIVG
VDAIVIPNEGSAPVNSDSIKTSAGALFNVKICKEKNLLKALEFLKLSGIKTVCATEKTDK
NIYEEKLALPIAIVLGNEEKGISRDILKNADEKLKLPMYGKTDSLNVSVACGVFLYEVVR
QNI
>EGEFANNL_01588 hypothetical protein
MWKVFKVNNPEYYIILFFSLFYYLYELKEHTPLSFNYQYFLYDYNFGFIKRGLIGQLLNL
TSISLTIETFIKISTLLLFLVAILLVKIIDTVNFKNKFLGYFLICFLVVSPSLIKNLWYD
LGRLDIFGILYCLIFLLPLNKKIIDICFIISPMVIFIHEGFLLLWLPSYFVCWLIASDSK
INKKNLSIFSVFIFFSLLSILINMFFGKLTINFQVFENYIINKSNGGVDIEKTVLSNKVY
NEMRNSMINNFSHKKFWIFGIINVITISYVIKLFFVILNINKFYFNFIFIPIFFTFLMFF
LGLDALRWFSNMCFSLYIIFLSILFKNRNKIRGYEFKTEDQNKFYFLLFILLIMIPFTKL
GYQIDF
>EGEFANNL_01589 hypothetical protein
MSIRRKEQTSNSAIKNLIKVLGIEEKLLIVEIQNLWRELMGPSIFEHTTRMFIDNEILYI
QIDSAVIRNELNFNQEKLYNEINKAIAQNRFSKIKFI
>EGEFANNL_01590 Aminopeptidase N
MYTKNALLGKKLVLLISLFTFFLVEAQDYSGYNPSSTMINDLVHTKLKVGFDIPNEKLLG
EEWVTLKPHFYPTDSLTLDAKGMEISTVKLANGKDLKYSYQNSKLKIQLDKTYKKGEEYE
IYIKYTAIPSTVTQKGSAAINSAKGLYFINPRGEEKDKPTQIWTQGETEASSCWFPTIDA
PNQKTSQEIYITVPDQYVTLSNGVLKSGIKNSDGTRTDYWKFDQKHAPYLFFMGIGDFAV
VKDKWKNIPVEYYVEKEFEPYAKQIFGDTPDMIEFFSNKLQYPYPWEKYSQMVARDYVSG
AMENTTSTLHAENAQQKPGQLIDKNSWEPVIAHELFHHWFGDLATNESWANLPLNEAFAN
YSEYLWLEHKYGKDYAEEHRAEELDGYLNGGENFTKDLIRFQYKDKEDMFDAVSYNKGGL
VLHMLRNYLGDDAFYAGMNLYLNQNKYKATEAHHLRLAWEEISGKDLNWFFNQWFFGNGH
PKLKVSYTYNDTKKSVTVTITQTQEPKFQFPLDIDIYENGKANHHQVWAKATETNTFEIP
SKTKPQLVNVNPDNILLAEITMEKTPEQYIYQYKNTPEYYSRKEAINKLADLQTSNPLAL
ETLLQAASSDPFEGLRVFAISQLDLTNPKVKQKSASVLEKIATSDKKTLVQAEAIKQLGE
LDAAKYLNLFKKSFESPSYGIKAAAIEASVKGDKALGKELADKVDDKNPGKDLELAIAKA
LIANQDNSKLDLISKNFLNLLMYAKSQQEADTYFAILRTIMSGDYPVETKNIVDSIVKIY
PQAKKYSFGDLMKQVMEASLQMKQGALNINPSNNSLKKQVSMISEGLNKMM
>EGEFANNL_01591 Dihydrofolate reductase
MDENQAIGGNNQLLWHLPSDLKHFKKLTQNHVVIMGRKTYESLGKPLPNRTNVVITSNPK
FKAVEDVIIHHSIKEALQFAKSKDDNPFIIGGGILYKETLNLVDNLEITLVETKIDQADT
YFPSIDYSQWKKTKEEFHPMDEKHSYSFRFISFEKK
>EGEFANNL_01592 hypothetical protein
MKNYKILRKCTFSLFIFSFFFLGVSCDKATLSESNAWDAVDKYLKVNPIYETVTMSLGEV
KFSPNKDSRELSAYKKLAQEGYITFEAIKQKKKFLSKDSILTYEVKLTDKAKPWVLNQKK
NQVEVKSIEYQLDKKDDPKIELTGKKSGKAILNLHKANTVFSILSEDNNPHTTFITQTFL
LNFKKDKGWEVTKSKK
>EGEFANNL_01593 hypothetical protein
MTIALKIFSKNILLLFRLKEENIDKDIDKILGDQKPPDNYLALAIISTIVCFAPIGVFSL
FYSLRVNQYWEEKKYAKSRRASILTRVICVWTIVAGIIFWVGILFGAIYNIFGNRYLVF
>EGEFANNL_01594 scyllo-inositol 2-dehydrogenase (NAD(+))
MLKVGLVGAGHLGKIHLKLLRQSSKYQLIGFHDLDMEAGESLAQEFGYKYYENFDELLNQ
IDVLDIVTPTFAHFEYAEKAIIAGKHFFIEKPITNSLEQANQLIQLAKQNNIKAQVGHVE
RFNPAFISSKPFIVNPMFMEIHRLAEFNPRGTDVPVVLDLMIHDLDIVLSVVKSKVKNIH
ASGVAVVSNTPDIANARIEFENGCVANVTTSRISMKNMRKSRFFQKDAYISIDFLEKKAE
IIKMEDAPKEIQPFDMIIENSNGDKRKIVFQYPEVQSNNAILDELESLADSIEKKLPVQI
PLEQGKEALEIAMEIMRQIDNSIKNI
>EGEFANNL_01595 hypothetical protein
MNGAQINTSQNVSIDYNLADIGERVVAKILDTLFILGYLLFCLAIFIGVAYWYEDNLEFF
IENDGAIAITIYLVMMIPVFFYSLWAPYFMQGQTFGKKIMKLKIVKVDGSEAGFSTYLIR
WLLNIIDSLFYYIVGLVVMGTTEKRQRVADLVAKTVVISTKPKMKIDQTILAQIDENYTP
TFTQVLQLSDNDIQIISKTLTRIKATSDYSMLSKLREKIESVIHESKPELTDMDYVQTVI
KDYQYFSQQ
>EGEFANNL_01596 hypothetical protein
MREAAFINKNKLQWSNFENALKNKKKLRPDELADLYLQIINDLSYSKTYYSKGNTTIYLN
DLARKAHFYIYKNKKEKSSRIITFWKYELPLLFSSYQKEFLLSLIIFLLSAAIGLFSVYK
DLDFARVILGNGYVDMTIKNIKIGDPMAVYHQTSAWTMFLTITTNNIRVGFISFLGGIFT
PIFTIYVLFQNGVMVGTFDGFLLQYGVGLRANSIIWVHGVFEIFVIIVCGAAGLILGNSI
LFPKTYTRLQSVQKGFKDGLKITFSTLPFFVCAGFLESFVTRYTLMPLPVAISIIIVSLV
IIIFYYIIYPRLLRKKFDNHEFNPKI
>EGEFANNL_01597 hypothetical protein
MNSIQKFDFVENRSLSKIITDSFRFAWLNLKSLSISLFYICFIPILIYGLTSYLYFNDYF
SSTLSFNNTEGFENLNFHNFILEIQNSGLIRSFSYLSLTYIGALLLSMFISIVSFSYIKL
YQNVSEITPSSVWKTSKKYFPKILFYNVLLILTIIIGNLICLIPLMLWKLGIIVTILLYI
IFTFLIFYLYIKILFSPLFIILEDKGVWDSIKNSFNFTKNIFWETFLFCLIFGIITSMIS
SLFKLPGTILLYISSILGIINDNDPSDNATVLSSLLIGLGGAFGFLMYSLKYIGTCFFYY
STKEKRQGYNTYKELDKIGVYEAEV
>EGEFANNL_01598 hypothetical protein
MRQRFKIRTTNLSNRFVQITVVLFLLFPTKKLPAVTDSILHDQSKISPINDLPEKPSNIY
TGKDFIYEIPQKDSDSDSNFLSKYFNWIVQKIFNFIKKLFNFNTEQNQLSSRNLLNFILL
SLLAILLIVGLLFLIKKFRKTIGRNDEDILSAEEVEKNIDTIDFEQFINKAVSDKNYRLA
IRFYYLRILKLMANKKVIEYHRNKTNYDYFYEIKNYDLKNLFQSTSKTFDYSWYGDYSPR
ESDFLLAKSKFLELQQMISKL
>EGEFANNL_01599 hypothetical protein
MNKHLKIYIGIFIIVIGGLMYLEYQKPKPVDWTETYSSKDKIPLGTYVLFQEFSKLFPQK
IVTSISETPSAYLFENEETYDSNSLYFFLNKNSTISETDLEYLNDFVNVGGDVFIISNHL
PEELEKQLNVETDIIYNSNRLKDRVKLRLVNPSFEKQEYTYNKVNPLTYFSKIDTTKSVI
LGELTQSGNRKANFIKTKYGEGNFYIHLLPEAFTNYYLLNDDTYTYAIHSLNYIDKKNIL
WDEQNKSINSVQKGILMYIFSSPALTWAWRVLILGSIIYVLFLGKRLQRIIPIVNPLKNT
TVEFTKTIGNIYFNQREHQDIINKKITYFLYFVKEKYFLNTAFIDENFSEKLHTKSGVSK
EITDKIVSLIQKNRDSKSSTENDLKLINQTIDLFYTKI
>EGEFANNL_01600 ATPase RavA
MENDKFQYTNRIDLSLLKISADKIRAELKKIIVGQEEAIDLILTAILADGHLLLEGVPGV
AKTVLAKLIAKCISAPFSRIQFTPDLMPSDVIGSSIYNEKTTNFEFRRGPIFSNIVLIDE
INRAPAKTQSALFEVMAERQITVDSQTYFFPRPFTIIATQNPVEQEGTYRLPEAQLDRFL
FKIEIDYPKLEEEINILKNHNQIESQNETDLVQAVISAEDIINFQNLVKKVHVEDSIINY
IAKVVTSTRNNANLYLGASPRASISILNTCKSYAALQGKDFVTPDDVKYLAPSVLKHRII
LTPEREMEGLTPTLVIKQIIDGIEIPR
>EGEFANNL_01601 hypothetical protein
MLKFFKSLYLTQRLFLILLGFVLAFILANFIEPLFILVKYLFLLYFLAIIADMFLLYLVK
NGIRANRLLPEKFSNGDDNPVHITFENLYNFHVSLSVIDEIPIQFQIRNFLFKVKLKKGE
CKEYTYQIHPTKRGVYKFGKLNVYAESILGLVKKRYIFEEGKDIAVYPSFLQLQKYDLLA
FTNRLHEYGVKKIRKVGNTMEFEQIRDYVYGDDIRNINWKATAKRNQLMINQFQDERSQP
VYSVIDKGRVMLMPFNGLSLLDYSINASLVISNVALQKNDKAGLFTFSRKIENKIVAERR
KSQMELILNTLYNIRTDFAESDFGRLYGNIKRTINQRSLILLFTNFENMDSMQRQLPYLK
AIAKNHLLIVIFFKNVELKKLIHQPAKNTREIYQKVIAEKFAFDKELIVKELKKNGIQSI
LTEPEKLTINTINKYLELKARGTI
>EGEFANNL_01602 putative ABC transporter ATP-binding protein YxlF
MKITTDISSFENQYKEIANFIQFEDFPLALKRIIDLTLDTEEISFYREAHDLLAWNDYNE
SNLDGKKEKYSLLLNQLYTFLVKKPIVPSTDLLEIKNLKKAYSKSSFALGPISFKLKEGE
IIGLVGENGNGKTTLLRALCGELLPTDGEINYHFHYQNNYDLRSRLVYIPQRYTSWQGAI
LDQLRFAAASYGIKGEENLLLVELVLSRLGLRNYQNLQWKNLSSGYKMRFELARMLIRKP
KLLLIDEPLANLDINAQQTVLNDFKSIAKSPFRPLGIILSSQQLYEVEKAADQVVFLKNG
EKKYTQSKINSENSTHHEFIIEFETEWQYEKLYPIFSALEITKLQFNGGSFLGYFPKTVT
MNHFLQLIIENNIPIKYLRDISNSTRRFFV
>EGEFANNL_01603 hypothetical protein
MLKKLQSNLLVNHPLLWNLKLVPILILIVIFNILFFFLGYFSTKFTFNNYTRFPYDHYNE
PNFPLYGIAILSSLLTLIVWLTFYLKNNGFKSLYPRTSFSLFKEWILSYFIIIGAFLYCF
SFYQGSLTKTRSYASLEETNKTLDLLVKINYLIPNVYLNDYNDIESGNFPNSLLSLKNYQ
YTRKDSIYSHQVHEWLIKENKDSIKSTLNSFLDLHKKHHLKTNLTTDSWIKFYYHPPEYI
LDSYLKLDNYKDNYYYFNHVYHNIFEAYNSLEPVLKFVLITFYIALVFSLIIFSIRVTHA
KAWITSFIILGLLIFTSGIFMAILDFISFGYTSQNLYTYFWLLTFLILFLHLESKILGKN
KTKGFSSISLNLVLWIFPFVPYIIFIIFMNWCKNLSPIENRSSSCIYSYFSENLDKFLWL
NLILSIVVLFFFVKQIKVWKSLPEE
>EGEFANNL_01604 Sensor protein ZraS
MYKRFPLSLRIFLVIILVVVSSMFAMGLITFYQYVRIAREYNNKKLERKEQLIVETFDYL
LSKKNTASSEVKDKIGNKIYEISDINNLDINFYSLNGNFLLGNKIPDASTKFIPKEYLKS
LSINNDRIKINKKSALTGENYATIYRYIYNNNYEPIAIINFPFLHDEFFLKKDFHTLLYR
YLVIMLIVLVVSGVFSWFFSQTLTRKIKDLAQRLSDTGALTNNRPILYNYIDEISPLVKA
YNIMLVKFKEQTDALIKSEKDSAWQQMARQVAHEIKNPLTPMRLEIQSFQLRFNPEDPEI
KDKLNKLIRSLITQIDTIASIAEAFSDFAKMSIKKDEKINVLEIAKNSLEIFPSQYIEIV
AEENIILNFDPNLLNRILTNLVKNAFQAIPENQTPEIAVKIAQDNYNVYFFVIDNGTGIP
EEIQSKIFTPQFSTKSSGSGLGLAIIKKIIEEYNGSINFTSEEGVGSVFKFEIPKGE
>EGEFANNL_01605 tRNA1(Val) (adenine(37)-N6)-methyltransferase
MNNCFKFKKFTIKQENSVFKVGTDGVLLGCLANISNAYNLLDVGTGTGLLSLISAQRNPS
ISIIAIDSEVEAASLAKENCSKSSFSKNIRVIHEDLNNYSSDFPFDYIICNPPFFKTSKQ
LHQKHPVARHQIKFSYDLLFTKAKEIIAKNGKLGLIFPIDGEKEVLSKGESNHFYPERMV
YISGIKNGRFKRIFTEFSLNKKEILTDSIYIEESPRVWSSKYKNLTTDFYL
>EGEFANNL_01606 hypothetical protein
MAIHNDFGKEAEKEAQKYLRNKGYSILETNWRFHQAEIDIIALYRSYLVIVEVKGRSGNS
LISPEEAVNVFKKKLLIDAANRYAENYPEEINVRFDIISLIRNENRWQVNHIEDAFEAIL
>EGEFANNL_01607 hypothetical protein
MKFTFSLRAFLLFLFFLLIEIVIGIYVKDSFIRPYGGDFLVVFLVFYAFKTFLPTKTLPL
IIATLLLAYLVEFTQYLRLADVLDIKNKVVRIILGTSFSWEDMIAYTFGCICCYFIEKKI
FKQK
>EGEFANNL_01608 ATP-dependent helicase/nuclease subunit A
METNYTIYNASAGAGKTFTLVKKLVTILLKDENLDTVRSVLAVTFTNKAANEMKVRILNW
LKEFSDKTKYKENIVLKLISEELGISLEILNQRAYKTLSYLLHHYSLLSVSTIDKFNLRL
MKSFTKELGLSYSFSVELDASEYLKQSIDELVYQLGTENPFAEVILNYIFWKFENESTTD
IRKELLSSSQNFLKEMHLENLESVTQKDFEDFKKLNQILVKRIKSNHDEVINIAKKIVDL
IQTHGLEASDFYQGKNGMGAAFYKIALEGNIFLNFESANYKKFCEEEKYAKAKSPKEDDI
KLIAPEMIKAFNQIKQLVNRIKIDESVRKNLITLELQSEITGFLDQKKEENDVVFLSDVN
KLISRHLKEEPVAFIYEKLGGRYNHYFIDEFQDTSQLQWDNFLPLIENAKVSDGTSITLV
GDPKQAIYRFRSGKPEILIDLISSAEEKNIQIENLQNNYRSLPNVVDFNNQYYQFLANTE
LSNPDYKDLFGNKLQQISFQKEGGRVQVSFVPPKEEEDDFMSERVVEIIEESLSNGFAFQ
DIVILVRNKNHSYSIVEKIIEKGYPILTEEALLVASSPAIQAIIYAFRWIEKPEDKVPLI
RMLYQLYKLDKIKIQDFTEEILKLQNLSFTEILKFLSEEFNLQIHNKQSNNLSFYDFAEE
FINSLNFGSKEDLYISALLDMILQFEKNSVLSLSEFLEHWEIKSKGLSIRFPEHRNAIQI
MTIHKSKGLEFPLVIYPRYEKRKSNSEEYWFPLEEDLYEGFDKYYTSSKSNLDETNEEIK
QVIDKQEFEKKIDELCIEYVATTRAVQQLFLLIEQKSEKSISSISSFLANQGHEAKGVIE
LYPNTHFTNLKPKDKDYPIEDQMIQWYSGSWNQKLKVSSEIHKFYREENKEIQYGNAIHA
ILAEIETLEDLPLILKKYIYKGVLESENLPIVKELITNLVIHKDLKIFFSEEVRIYKEQE
ILWEHKFYRPDRLVELNGEFHILDFKTGQKLSKHKKQIESYENALLSMGKRINSKQLIYL
LNSEIEIIKL
>EGEFANNL_01609 Spermidine/putrescine import ATP-binding protein PotA
MIQINLEYSFLTPNGKKNLSINTEIPEKEIIGLSGPSGAGKTTFLRILAGLETPERGKIK
VGKQVFFDSEKKMNVPPQKRKLGFMFQDYALFPNMNVEQNIDFGRSHKHNPELTHRLLKI
MDLQNLRKQRIHQLSGGQKQRVALARALATESSLFLLDEPLSALDLPMRTKLQEEILKIY
ESLQPTIFFVSHDKDEIHKLSTYILQFNNDKVELLKK
>EGEFANNL_01610 Sulfate transport system permease protein CysT
MNSDFLNTLVLTGKLAISTTIILLVISLPIGYWLTYSKFKFKAPIEAFICMPMVLPPTVM
GYYLLVAFSPENILGSFLDQYLNTRWAFSFQGILIASILAGLPFMVQPIQNGFSSLPKSY
KEASYTLGKSSWVTFYKVLVPNIKSSIITGVALTFAHCIGEFGIVLMVGGNIPGQTRIAS
IAIYDEVQALNYPAAHQYSLVLFIISFFLLVLIYSINKNFKINTL
>EGEFANNL_01611 Molybdate-binding periplasmic protein
MEVNTNFIFTSMKIKIILFISAILTIISCSPKEQKVTIAAAANLRYVLDEIKEQYIKENP
EVQLQMIYGSSGTLTQQILNGAPYNLFLSADTKFPESIVKKGMAEGLPINYCYGRLAMWS
SSIEVSKGLSILTSPQVKKIAVANPSQAPYGETAVNLLKKLNLYNQIENKIVWGENINQT
AQFASSGNAEVGFIALSLALAPQMKEKGKYYVIPENQASPIAQAAVLIKGQENNKQAKIF
LNYIISPKCSSLWEKYGYGLANKK
>EGEFANNL_01612 Cyclic pyranopterin monophosphate synthase
MVNITAKANTLRKAIAQAEVKVSRIETIQAIQENKVPKGNVFEMAKTAGLFAAKKTSDVI
PDCHPLPIEYTSISFEIKNLTIYITTEIHTIYKTGVEVEAMHASSVVALTMYDMLKPVDK
NIEIQNIRLVEKKGGKSDRKETFNPPLTASVIVCSDSISQGKKEDRAGKVIIEKLENCEV
EISDYIIIPDEVTEIQNQIKKYTEQEVNMVLITGGTGLSQRDVTPEAVKPLLEKEIPGVA
EAMRAYGQDRTPLAMLSRSVAGLIQETLVVTLPGSTNGAKESMEALFPSLLHLFKIRNGG
QH
>EGEFANNL_01613 hypothetical protein
MDLPIIQSLHIGKEASLANTGYYSAINKHEIKESQYVRKEGLILDSQADKKNHGGKDKAL
HQYAFENYSYWKQKYPNQPLLSSPAAFGENISSLGMNEDMVCIGDVYRLGSCIIEVSQAR
QPCWKLNFRFGIENMAVQVQNSLKTGWYYRVIQEGKIKAGDIFELDARPHPEYSLTRILK
VLYLEDINIPELNQMIELKPLAESWKRILKKRIDTGIIENWEKRLFYTHTNN
>EGEFANNL_01614 Molybdopterin synthase catalytic subunit
MNDKKNRKIDPFIDGAIPPEFISESIRKHSAKTNIGGHSLFLGQVREDKKGDTEVEAIHF
TAYKEMAINKLAILREEIFSKHELVCIHLYHSLGKVKKGEICLFVFTSSKHRKTAMEACE
ELVERIKKELPIWGKEIYNNQSYHWKENK
>EGEFANNL_01615 putative adenylyltransferase/sulfurtransferase MoeZ
MDLQRYNRQIILPNFGEKAQKKLWNASVLVVGAGGLGCPVLQYLATAGVGTLGVVDYDKV
EESNLHRQILFEESDIDILKAEVAKDKLEKLNSNLKVKAYPYPLTLENVFSIIDSYDIVV
DCTDNFSIRYLLSDVCYLQKKPLVYGAIYQYQGQVAVFNIEKEDRMTNYRDLFPLPPQPD
EIPNCNEAGVIGTLSGMVGTMQANEVIKLITGIGDVLIHKLLLINMLDYHTSIIKYPKSK
LNTSPQTQEELKPENYSETCKLVQDTDVKSLRELEDLLKDDQALLIDVRNEDEMPRIQLK
KCKSIPLERLKNEFQELEKYERIIFICQSGIRSQKALEITKAQYPDKKIQQVSGGIKTIL
>EGEFANNL_01616 Molybdopterin synthase sulfur carrier subunit
MKIKIFGKLTDIFKTEEYHLDKEENFVIELRNQLEKKFPQLKTSTYLIVINEEIKQDSDT
IPENAEIALLPPYSGG
>EGEFANNL_01617 putative molybdenum cofactor guanylyltransferase
MRINAVILAGGKSSRMGEDKGLKPLCNKPLIANTIQVLSQFFTSIYINTNNLKYESLGLP
LIPDIETNHGPIGGIYASLTKFKADTFFISCDMPLISTEVIGILIKSHQKGQTTIATYNQ
RLIPVLGIYSPGLLSILEQKIKQRELKMKTFLEEVSCNCIELNEIISENRFVNVNTPEEF
KYVEKILKHED
>EGEFANNL_01618 Molybdenum-pterin-binding protein MopA
MEDLRIEGHIWLETPKGLKIGRGRALLLEFIEKTGSIAAAARSTNISYRKAWGMVQEMNQ
FAPLPLVIKNVGGREGGGTFLTKEGKRLLEKFRKINQEFNQFKDKNAN
>EGEFANNL_01619 Molybdopterin molybdenumtransferase
MNFITVSQAKDIVKSEIYQGSIVKKNLEEALYHYTAEDIYAPLDVPSFDNSAMDGYAFNY
EQYKEKIPLKISYTIQAGATDLPILKKGEVARIYTGAPIPKGADTVVMQEKIKENLGELQ
IQDSKIFQGMNVRLKASQTKKGDLLVPKNTFINSGIVGFLAGFGFTQLPVYAFPKVGLIV
TGNELVEAGKPLQQGQIYESNSQALKALLQDINIQPHKIVKVLDDKDSTIETIQDFWEEV
DILIMTGGISVGDYDFVKEALEISGVEKLFYKIQQKPGKPIFFGKKKNKYVFALPGNPAS
VLINFYQYVRPFLEGIQGNLNFNKSKRTARLATAYKKENTLTLFLKAIYKQGKVCLLPTQ
ESYKMDAFTKANCLVELHGDPRLIEENEEVTLWKI
>EGEFANNL_01620 GTP 3',8-cyclase
MNNLTDTFGRKHSYLRISLTDNCNFRCIYCMPEENIHCLPSKEQLQADEIFEISKIFVDY
GVNKIRLTGGEPLVRHDFATIVEKISQLPVQIALTTNGVLLDKYESVLKDTNVLTINVSL
DSLNPEIFFKLTKRDAFHKVWRNLLTFIENGFHIKLNVVVMKGINEIEVNDFVNLTMKYP
IEVRFIEFMPFDGNHWNKKNVVSMSEMLSSIAEKHRFNKIQDQVFDTTKKYKLEGAKGTF
AFITTVSQPFCEGCNRMRLTSDGKMKNCLFGKEEFDLLGAYRNKQDIKPLIEKCIYKKHE
KVGGQLNQLKEFDPDQLNNRSMIKIGG
>EGEFANNL_01621 hypothetical protein
MKKKHKVNNPVNPSRMNTLTSAIIVIFILILALQIWLMYGALNNALDGNHGFAWATFIAS
LFLFISSLFLLKYLPASIKNKENKKSENQYE
>EGEFANNL_01622 Cytochrome b6-f complex iron-sulfur subunit
MSKDNKEPIWKSDFPVRQEESTHVSRREFAKFLCLLSGGLALGNGFIAAKSLLPSKKEVE
EEFYVCETSEVPIGQMKSFTIKENHKVPYILIHLGEDKWRCFEQKCTHLSCAVLYNHEIN
KIVCPCHQGFFNPETGDVLQGPPPRPLPQLSVIIKDGKIYVKEKV
>EGEFANNL_01623 Anaerobic dimethyl sulfoxide reductase chain B
MTTTEYNKNMEFFVDMQRCIGCHSCEMACAECETNGQESMIHIHYVDRKHTVQTTVQVCM
HCEDPVCANVCPADAITKDSFGVLHSANTARCIGCSNCVMACPFGVPKKIEEAELMMKCN
MCYDRTSAGLKPMCATVCPSGALFYGTREEIEEKRPNSTPVNKFIFGQEEVVTKVNIMMP
KGSKELKVH
>EGEFANNL_01624 Assimilatory nitrate reductase catalytic subunit
MSKIPVSDKKIIEEFGPHKQYTPKEGFKGVEEPDKLVKTHCCFCGMQCGIQLKVKDNKVV
GFEPWREFPFNEGRLCPKGVQRYLQNNHPDRILSPMKRVEGVGFQPIEWEEAMSKTVAEI
NRIQDQYGKDAFAMLSGVSLTNEKSYMVGKFARVALKTKNLDYNGRLCMVSAGTGNKKAF
GLDRASNNWSDLKHAEVIIVAGANVSETFPVLTHPLWEARDNGAKLIVVDPRMVPFARTA
DLHLDVRPGTDSALYGAMLKILVDNDWIDQEFIEKHTSSFKEAIEVVKDYTLEWAEEITG
ISAAKIYKAAEMWGKAKTSFFLHARGIEHHTKGVDNVLGVINLVLATGRIGKPYCGYATI
TGQGNGQGGREHGHKCDQLPGNRDIENPEHRKYISEVWGIEEKDLPGKGLSAYEIIDAIH
RGEIKGLISICFNPLVSLPNNNYVREALEKLEYYVAIDFFLSETARYADVVLAGSLQEEE
EGTVTTAEGRVVRINQAITPPGKARKDSDILKELAKRLGEESKFNYKNAEDIFNELRVAS
KGGTADYYGITYEKVEKNMGVFWPCPSLDHPGTPRLWEDLKFKTPDGKAHFNPVTYKESS
EMIDEDYPIILTTGRVVSQYLSGTQTRRIGKLVDQYPEPLMEIHPKLAAKYGIQDGYLTK
VITRRGEMTLPANVVDTIREDTIFIPYHWGGKHSANQLTVSSLDPLSKIPEFKVCACKIM
NTNEKAPDSQKSDAFQSLDN
>EGEFANNL_01625 hypothetical protein
MFHLFQNLNKSALLKAIIASILTIVMVFIGSRNLQNFDAALIAYLFGAVFAIFGITYRYS
IWLQRPPTKMYWKRSWQFLFSKYFVAYIGRGLRLFFQNILFQKFIYPRGRTRWIGHFLLA
TGCMLAFAITFPLTFGWIHFTLESGSLTTYEAHLFGFKMMDFQLGSFIAFLIFHALVWCS
VLVIIGSIMMMKRRMTHGGLIATQTFDGDWLPLLLLIAISVTGIGITFDYTYLEGKTNQF
MSVTHAVTVILFLVWIPFGKFFHIFQRPAQLGANIYKTEGIKNGLAKCPYTEEEFATQMH
IDDLKTVTQELGFNFKLSNGKSHLDYSPEGKRCMLAKAHLKAREEAGSFFG
>EGEFANNL_01626 Nitrate/nitrite transporter NarK
MATWLKEWNPEDSNFWELKGKKIAWRTLIITTISLTLSFIVWYLMSGIVTKLTGVGFKFT
EKELFWLASLPGLAAGTLRIVHTFLIPIYGTRHTITISTLIKLIPVVGIAFAVMDPSTPF
WVFAILAFTMGFGGGDFSSFMPSTNMFFPARLKGTALGIQAGIGNFGVSIVQFLTPALLG
VAIVGAPQILKTTNSVTQEVISKPIYLQSTALIYVPLLIVMTIVCWFGLKSIPLKSSFKE
QMGIFKQKHTWFCTITYFMTFGTFSGLAAAFPLMIKSLYGDFPGAPDPLKYAFYGPLIGS
ASRVAFGFVADKVGGAILTTITGVGFIICIGVMIFMGSVSPTSMEQFPSFLAMMLAIFFF
SGIGNAGTFRQFPIIFKSNAVHAAGVIGWTAAIAAYGPFIFSLILGSELHASELAGRKSA
NGFFWGVLIFSMIATWVNWYYYQRKGAERPS
>EGEFANNL_01627 Nitrate transporter
MPKSNLKQSHIILALNTLAFTICFACWTLNGVLVTYLVENGIFDFSVVEIGWLLGIPVLT
GSLLRLPVGIMTDKFGGKKVFIILLIFCSIPLFILPLAKSFLAFAILSFLFGIVGTSFAV
GVGYTSVWYPKEWQGRALGIFGMGNAGAAITTFLAPTLLNYLSKNNLENGWKILPLIYGF
TLIVLSILYILLAKNKKPQSSSKTMSSLLSPLKKGRVWRFGLYYLLVFGFFVAYSQWLVP
NFMNVYSTTLVMAGMFASFFSLPSGVVRAFGGYLSDKYGARKVMYWVLGSSVAFSFLLMF
PKMDIYTQGQGILSTNAGTVTHIDKDKILVNNKEYKVKNKEEEVLKDQTRFLPEKNTWQE
ILVKENQKVNKKELLAKGITGIKFEANMWMYLALVICIGISWGIGKAAVYKHIPEYFPNE
VGVVGGMVGLIGGLGGFIGPIIFGYLLNYTGLWTSSWMFIFIISLLCLICMHRVIVKMNK
EKMPEIFKDIEKK
>EGEFANNL_01628 Putative HTH-type transcriptional regulator
MFSKTSEYAIKIMIYLSSKNHKDNYSQVKEISQALETPEPFTAKILQQLAKVGLLISMKG
KNGGFALGKDSSEIKILDIVITIDGSKSVTRCVLGLSDCSNEDPCPLHHKYYKIKEQIKK
DVLETNLKDIKDRLKNLKLK
>EGEFANNL_01629 Cytochrome bd-II ubiquinol oxidase subunit 2
MFDLYVVIFFLWTAIALYLLLGGADFGVGIAELFSNKKNQERIHKIMYREMGPVWEANHM
WLIIVIVILFVGFPQIYSTLSTYLHIPLLIMLLGIIARGTAFTFRHYDAVIDNWHKVYNK
IFIYSSFITPFFLGIIAAATVSGTINTEATEFSTAYIWSWLTPFGIALGVFTSCICGYLA
CSYTISQIENEEEKKYIGKKVKIFLISVILSGGLVFACAGYQNLPLIRWIYGGVVGWAAV
LFATLSAIGAFYCIYKNKYSAIRILAGFQVIMILLAVTYGHYPDLVLLKQGSLSLLSGEN
EPKTIKMLAWALILGSIFILPGVFHLIYSFQKKR
>EGEFANNL_01630 Putative cytochrome bd menaquinol oxidase subunit I
MDDFIAARSQMALSLGFHIIFSCVGMVMPFFMAIAHCKYLKTGDKIYKGLTKAWSKGIAI
LFATGAVSGTMLSFELGQLWPKFMEHAGSIFGMPFSLEGTAFFVEAIALGFFLYGWGKLN
PWFHWFTGLLVGISGLASGILVLAANAWMNSPAGFDFVNGEYLNVNPVKAMFNDAWFSQA
LHMIIAAFIATGFAVAGVHAFMILKGKNLVFHTKAFKIAAISASIAALIQPLSGDISAKD
VSKRQPEKLAAMEAHFHTEKNADFILGGIVNENEHKVDYAIKIPGLLSFLSHGDFNAPVK
GILDFPEQDRPPVAIVHYAFQIMIMLGVALMIISILYLLAIVKKKSWLSKKWLIKLFVMA
APLGYIALEAGWVVTEVGRQPWIIYKIMRTSEAVTPMPGIAYTFYLFTLIFMSLSLIVIF
LLYRQIKMVPYLYDETDPKFIHKPTNK
>EGEFANNL_01631 putative GTP-binding protein EngB
MSIHSADFIKSSPKIEECPEPDFPEYAFIGRSNVGKSSLINMLTNKKGLAKTSSTPGKTQ
LINHFLINNSWYLADLPGYGYAKVSKKTREIFSKMIEKYILNRKNLVNVFILVDARHLPL
ENDLEFINWLGEKEIPFSVVFTKIDKVSQREFAFNFKKYMQELRKTWEEVPPIFKTSAEK
KIGQEEILSFIEDTNKYLERNKITFT
>EGEFANNL_01632 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase
MIFSLPKKNKFIYTEVGEGSPIVLLHGLMGGLSNFKYQIEYFSQKGYKVYFLQLPLYTLP
QLKTNISGLTNYVIKFLEKVVDKPAILIGNSLGGHLGLITSLKKAQYVKALVLTGSSGLY
ERSFGDSYPKRGSYEYIKKKAQDVFYDPDIATKELVDEVYETVTDRLKAIKTIQIARSAM
KNNLSEELKNIKIPTCLIWGKQDNVTPPEVAEEFNQFIPDSKLYWVDKCGHSPMMEKPEE
FNSILYEWLKSREL
>EGEFANNL_01633 Nickel and cobalt resistance protein CnrB
MNIRIYITLFLSLIIISCSKEKQENHEAVTKENTEIEITPEQIKINNIQIGKPELKSIDS
RITVSGVIHALPQNMSSVHSQVDGFIDKVNFITGEYVKKGQVLATLRNPSFIPLQKQFLE
SYYNMLLNQKDFQRKKSLLAADAISQKAYEQALALYQVSSAEYESLHSELKVLGFSPSTI
IKTKTINPILPIISPQNGFIQAEEISPGKQISTADELFKIINQDELHLELNVPSKYASQL
FAGQEVEFSLPEIKDTLKGEIHLIGRATNTENNTIQVHVDIKTKLPANDFYEGRFVNASI
INKTHPLLTIPRDAVFEENGKKYIFIKNGSKFDKKEIKTGVENSEYVEVLDLDNNQELVT
AGTYYLKAGEIESGHSH
>EGEFANNL_01634 Cobalt-zinc-cadmium resistance protein CzcA
MFKKIIEFSINNKLLIIVGTLALLIGGVYSVKDIAIDATPDITNNQVQVVTTSPTLAPQE
VEKLITFPLESQLRNIPGTTEVRSISRFGLSIITVVFKENIPTLQARQLVKEQVDIAKSE
IPDGLGDPELMPITTGLGEIYQYVLKVKPGYENQYNTEKLRTIQDWIIKRQLNGVEGIIE
ISSFGGNIREYEISIDPVALQSYNLTLEEVHTALENNNQNSGSGYIQQKHNLFYIRTEGM
IKNFQDIENIVISLNNKVPIKISDVAQVKIGSAQRFGAMTMDGQGEVVGGITLMLKGADS
YKTVQNVKQRVTEIEKNLPEGLDIYEYLDRANLIDKTISTVTKNLIEGGLIVIFVLILLL
GNLRAGLIVASVIPLSLLFALAMMDLFGVSANLLSLGAMDFGIVVDGAIIIIESVIHVLY
TSYLGKKLTQKEMDGVVTKAAGDIYKSASFGIMIIILVFVPIMTLTGIEGKMFRPMALAV
SFAILGAFILSLTYVPVMTTMFINKNIKQKITFADKIMNFLKKLYLPVLQKVLKIPYTIV
SLVVAIWLMFVFVFMKMGSEFVPTLQEGDIAMQMSIQPGSSLDESIATTTKAEKILKENF
PEVLHVVSKIGTAEVPTDPMGIEDADIMIILKEKKDWISATTQEELVNKMKEKLSVILGA
SFEFSQPIQLRFNELMTGAKADVVIKIFGEDTEELKKIADKAAESIHDIKGAADVKVEQT
EGLKQMNISYNREKIAQYGLNINSLNQIIRSTIAGQSAGVVLEGEKRFDIVLRLNENYRK
DLNLNQIYVKSPTGILIPLSEVASMNYESGPMMISREQAQRKINIGVNVRGVDVATLVKN
IQTKLDKDIKLPPGYRIQYGGAFENLQQASARLSIVIPIALITIIFLLYVAFKSLKDALI
IFTAVPLASIGGIIALWARGLPFSISAGVGFIALFGVAVLNGIVLVGELNDLKKSGKFNS
LKDLIIQGSLTRLRPVFMTAMVATLGFYPMAISSSNGSEVQHPLATVVIGGLVTSTLLTL
LIVPAIYYIVENKSFKKLLNKTNTTLGVFILGGIMSIQGQTRVALPELLQRVSTENMELQ
GDRMQIEKEQLEKKYAYTVQNTSITAGYGEYNDRKGDYQVELEQNLGNLFSYRSMQNLSD
SKINWLNSLFLLKKHTLELQVEQTYNQWLYSIEKRNLLLKMDSLYQSGLKRAEFRYQQGE
TDYMEKQFFKVELDQIIRRITSNEQEYLNVENQLYNLCKIDLNNKIIPIESFSRLENDYI
SSTPLPLFTQEFDQAMQFNNQTVMLGKSQRLPELSVGTIMHSIDQRSAYFSGVVGINIPL
FNNSYKKLKEQSYIENQFIENNKEQKVRSLELRIKQLKEQEDLFNKEIASLGENHLNELI
KMRKVALTKYKYGEIDYLQYCSLLKASVEAHLTYLDLIHDYNQVLIEIKYLTQQN
>EGEFANNL_01635 hypothetical protein
MNNYKFSLIHRLLHWSMALTIIFILITIFLRLGWMNKNIMATIIFNNLQENNIKITQKEA
VSIAKNIRGNMFNWHVYIGYVLLGLYLLRITYIIIKKGKFRTSSLIKYSLKKKFQSLVYL
IFYIGLGITLITGLLIQNAPKEYAQSLKSIHQLSLYFMLIFLVFHMIGIFIGEKSTDKGI
VSAMINGGDNISR
>EGEFANNL_01636 hypothetical protein
MKIMGKISMYLATLIVVAHMVIPHQHKAKLQTVIHECLFDNNDLLEKDDSTFIGAIADLI
KHVNLGEKHLEIFKISNYKYQINSISIFEVPEINFLSFQFKELKRSTIFPDFNLLFSHQS
HPRNLRLRAPPII
>EGEFANNL_01637 UDP-glucose:undecaprenyl-phosphate glucose-1-phosphate transferase
MKYSRYSRNLLSIQYIIDFSILVSLSLCFLNIQYVESVGYKYTLQYLIIYHYKVIILFLV
SWYFISVNVKLYVGGRFSGIIAILRKNLYQVLLFSIIVFAVSGFKTSDLFSNRLSIYFLV
TLFIVTSFVKIILFFTIKIYRSYGGNYRRVVFVDENINTYSFIKLLSKRKDYGLVNCGFF
LSSIKDNEKRKKYNFELNKFKSFLLEEKIQIIFYSLNGNFSQQIHDDLVYLVQKLHIEIS
FIPSEIYDSYSSLNLEYYDTYPILTFKKFPLDNFWNQFLKRMFDIVFSLVVIIFIISWLF
PLIGLVILLDSGSPVFYLQKRVGLRGKVFNCFKFRTMKKSVDNNIKATVKGDIRITRFGK
ILRKTSLDEFPQFINVLIGNMSVVGPRPHMIIQDEHYNDIILKYSLRHYVKPGITGLAQS
KGFRGEIATKEDIHKRVIADAYYVKNWSFLLDVIIIVRTFFNIISGDKKAF
>EGEFANNL_01638 hypothetical protein
MFRRESTNINFLLAIFYGLFLGSLIPGFALSNVMLILLGIGSIYFCVKNKKIKYDKNYIP
LLLYFLWAVLSLFWTIDEHQTVKGISKLIGFCLIPLFISQYPTIKKENIFIIFRTLSLCL
LIYFGVSIIKAYKLYSLDHNIDHFFYHDLSLIFENNAIYISVFTSFALLGSINLAKKNIY
DYIIILFLLIYLILLSSKNIIFTTFLIQLLIIIFFNKTRKQKLFIIISLLVTAIFFITLI
FLDSPLKNRYLEENKSNYKQIFKDNSFKDYYFGGTTLRLLEFRIGIEMFSKENIGIKGLG
LSSAQKLLDDYYNHYEVPRYKTYNFHNQYMQTCIELGIIGGILLFIMLIYPLVKSIKRHN
LFLFSFVIIMILLFFTESFLNRQKGILFFTFAYSILFKSQKGILNVDKKIKNEV
>EGEFANNL_01639 hypothetical protein
MKIAILGTRGVPNYHGGFEQFAEFFSIFLVEKKHEVYVYNSSLHPYKDNIFKGVNLIHCK
DPENKIGTAGQFIYDLNCILDSRKKNFDVILQLGYTSSSIWYFLLPKKPIIITNMDGLEW
KRSKYSKKVQKFLKFAEKLGANHSDFLISDSKGIQEYLKSKYNKSSQFIAYGAELFLNPK
EDKLKDYKLTPYQYNLLIARMEPENNIETIIKGIINSNDLKPLIIIGNYKNTEYGKYLYS
SYKDNTQIKFIGAIYDLEMLNNIRYYSNLYFHGHSVGGTNPSLLEAMASNCLIVAHNNIF
NKSILGEDAFYFSNEEEITQTVKKLNKQDNRIKIENNTKKIQKYYTWDIINNKYLEFIIQ
CLEEKVQI
>EGEFANNL_01640 hypothetical protein
MKNKLIYILMLIIICLFYHIKFGLETIIPTNINWIMSSRGDLAQHYLGWAFYSKESWDFP
LGRIESIYYPLGTTVSNTDSTPLFAIFFKLFNFFLPQNFQYIGLSMFLSYLLLSYYSIRI
FKLYKITGILLLLSAILLTFNPVFLFRGGGHDSLCAQWLLVASIYYYLIKTNKNNVIRIN
IYQIIILNLSIMIHPYLTFMVLLFNLILPIKNYFFDKTLTIKQLIVLPIASIFSLSVTCF
LIGIIDLKHKTSSSAWGYGHFSLNLNALYNPLQYSSILKGININEGQYEGYLYLGLGMIS
LVLISIGIGIAYLCKSKIIFSKYYVYILLFIASFAYVLLAITNIIVFNQKFFQVNLPLKI
LDSLGTFRASGRLGWIFYYVIIIFSLIYFNKIEKITKKGKAVVLSFLVILQLYDIKPLLF
ESNIKEIPMGDYHTYLTENKWNKILFNFKVIQTYPIFTQSLLKENDFSELSYLALKNNVK
ISSFYVARDARGRDKRKVIEEFNKNIEEKTLNYEYVYITTKENLSFFSDIIKDENISCEE
IDNYYLIYKKIK
>EGEFANNL_01641 hypothetical protein
MSQTVSLDKEGMKKVWNIFFNFLVYINAGFNKKIILIFEVAFILSCIITLRSIKFGKKII
DKVTTLIYMVSPIIIFICIPGALIFTENFNILPRVLVGSSIFIIFILYSFNEVMKKNWKY
LLILPYIYFFSLMYSYGASLTIYKNHKEYLISQINHDLYKLGIKNGDKLYILGSPEYPPP
VSLFISKHKFTGYFFLANNFNSNKYFINEFFILHNLKIEMFNFEKELDTYKQIKVKDEPN
INQGIYKIYRDGDEYIIWFP
>EGEFANNL_01642 hypothetical protein
MRMVLIDRIGIYSGMNHYIDAFVSELRKRKYETKIVSNYQGKQSILKNYYIGGNISEKIY
LFIISYIAYIVQIIKLRKNNYFITSFYGEVQDVIFLIPFLFFSKKKIILDVHELVGLDIK
NKIKSRAIIFFVKLISGKIIYHSSRTEEIIENIKYSGEIYYCPHLKYIYSKEYDLKNIKK
EIEELINRDKVNFLFFGNIRESKGIDLLFEVINKLEDQYLLKSNFIIAGKDPENLLISYS
DIKNIKKITRYITGEEANYLYSNADYILLPYKEISQSGVLETAIYFKKKSICSNINYFRE
IIKKYKSFGFLFNSAEEFLYTIQNLCVEKKEDINKEDYNNYLNKEEIDQFFYQLNKSLIL
>EGEFANNL_01643 hypothetical protein
MTYIILLNYNGYEDTIECLESLLKLKIINYQIIVIDNSETNTSINYFQKWAKGERESIVT
SFPSIIYPLQEKPIDCIFIEENELINFKKNKIIFTKAKENKGFAAGNNIALHYILKYGNK
DSFIWLLNNDTIVENNTLSSLIACYEKDKSVGILGAKLLYYYEPSKIQAIGGKFHPKFYY
PYLVGEGLKATINKLEEKIDYAIGASLFVSYENLNKIGVLCEDYFLYYEELDWSYRAKQE
GLKTDWCPEAIVYHKEGKSIGTSSNHKKRSILSQKHMFRSRKIFCEKYYKISFQFYTSTF
LMFFNRIRRFNFTEARIVLESMFIK
>EGEFANNL_01644 hypothetical protein
MKFLFLSIIGIVFLGILFSKGYKKLYWILFGIVFLDNGIIIYNYLAPIVRVWVLGLFLSI
LWDLYKTKSRSSAISVLDSKYTKIIFLFSISILILCLMDERHSLIKNGIRAFTYMCDYFL
ILLLSSYFIKNTNEVIKLSKFFYYLMFGCALYSIYVLFSLHNPYSLLISKVYNVNDISGH
FINRTRVAISSVITHPHKNGAFIAIAILIRFFFWVNKKNKWHFNLFQIFILVIMIISQLI
SNSRSVGWGMILGFVIFISLYKFKIKQKVVFFIVAICYLLLLNFATKLNLRYISEHFISK
YYIIKSDNKNSDVDNFKLDNKTYENSGSTISMRTMQLKKSYELMKSDVWKGNGYRWLSEN
LGFDPLRNDFILEGGYYGFESFFYIVLIEFGIIGIIAYTLLFTAILVYNYNFIKYKNQAS
FFGICNISIFSYFFLIIILNGDPGIFTITTLFLSIYTKGATLSLQKINHLK
>EGEFANNL_01645 Undecaprenyl-phosphate mannosyltransferase
MNNTIVTVIVTYNRLELLKKCIQSLKDQTLNTHILVVNNGSTDGTKNWLLEQKDIVVINQ
ENEGGAGGFYRGMKEAYERGYDWIWVMDDDAFPEKDCLNKLMLYSGEARVLAPLVIENEN
IDKLHRGRINFDRINIPIFQIPINNYDLFQDKNISITIDFISFIGLLMNRDIIEEVGYPK
KEYFIFNDDVEYSLRIKKKGIKCLLIKNTCIYHKKYEINKFELGNYKFFRKEVKNIFFYK
KFKKEKKIPYFRLLEFRNSIINVLDYSNKITTNKIFIIIYFLKQSLKSLFIFKEGKKTVF
LLYISLIQGLHRNINNKKIKDYYDK
>EGEFANNL_01646 UDP-galactopyranose mutase
MKKYLIVGCGFSGAVVAEQLTKNENCKILVIDERSHIGGNCYSERDPNTNVMVHKYGPHI
FNTSNKKVWDYINQFCEMMPFVNRVKTVYDGQIFSMPINLHTINQFFNKNFNPKEAEEFI
EKQADKSISEPKNFEEQALKFIGKDLYQAFFYGYTKKQWGCEPKDLPASILKRLPVRFNY
EDNYYSNIYQGIPRNGYTEIFRKMLSHPNIEIKLQTKFNGSFNIDNFEHIYYTGPIDAFF
NYKYGRLGYRTVYFERGEEIGDFQGNAVINYAEENVPYTRVHEHKHFTPWENHEKTIYFK
EFSKETGNNDEPYYPKRLEEDLYKLELYLKEVEELKRYTFLGRLATYRYLNMDQVIEEAL
KIINE
>EGEFANNL_01647 Putative O-antigen transporter
MNKHGLFKNIASLGVVQVANLILPLISIPIISRIIGPDKFGVVNYAATFIGYFTLLIDYG
FNLTAIRRVAKNPNNKELRDLVFSEVLYAKIFLFLISIVLFIPCVLFFEPLYLEKKVAVF
TFLTCIASLLSQNWFFQAMQDLSKVAVLNFLSKLLFTIFVLLLVRQKQDYIWMPLITSLV
AILVGWISYYWGIRKYNIILRRISLKKIFNLLNREKTIFFSTVVINLYTATNIVVLGMLQ
NEESVGYYTAAQKLILISIGVINLPLSQAFYPYIGKAFGKSKEEGLQTTHKIFPWVIILT
SISGIIMYLFAGIGINILYGNDFRPSIQVFRILTLVPLLIAISNSFGIQIMMNLNMDKLF
FRITSSGALFGLVLNVIMIKWLGYIGTAWNWLLVELYITITMYIMLKKQGINPISWKEFK
LIRLKQCIQLMFNRAK
>EGEFANNL_01648 hypothetical protein
MKCLLLLGMLLGHTLFFVYDRDLFFSKYYVDNKYFLLALVAEFLHLITFSGYFFCWGFLC
NIVYFNSSKPKQVRKKIFYSAIRMLIAYYISAFSYRFLFDPGIKKTNVINILKLKDVPGF
SEFILAYFGLMLVILIFFPWIRKISKLNGYYIILFSILLFSLSYIIPYDKIGARLGLYLG
STKYALFPILLYFPYFLLGVYFSKSKRIKQNVFVIIFLMFGTASYIVYFYKKGVPPTRFP
PRFEWLVGAMFFVYMYYVISICLDKWIVKNNNYNMKNLSNFAILLGQNTLFYLILSNIFL
FAYDSIFEKQNIFNTIIIYLIVIFVPYYLLIIARPIKRIHE
>EGEFANNL_01649 dTDP-4-dehydrorhamnose reductase
MKRILVTGGDGQLGMSLRQKIKEKPPIDCTFVFTDVQELDIMDEMFVKTYFYSNKFDYIV
NCAAYTAVDKAENDKEIAEKLNTYAVKYLAKASASQKATLIQISTDYVFSGEESTPRKED
DPVSPLGVYGLTKLEGEKMAQKYNSKHYILRTAWLYSPYGHNFVKTMLNLFDQKKEISVV
NDQIGSPTNALDLAETILTIIQNDIEAYGIYHYSNEGECSWFQFADEIKKISNSQISILP
VSTDEYKTIAKRPKYSLLDKTKIKTTFGVSIPNWKESLKNYF
>EGEFANNL_01650 dTDP-4-dehydrorhamnose 3,5-epimerase
MKVVETELKGCFIIEPKVYEDSRGFFMETYNLKSFQEQIGYKPEFVQDNLSKSSFGVIRG
LHQQLPPFAQAKLVYVLEGKVLDVAVDVRENSETYGQHIAVELSSENKKQLFIPKGFLHG
FSVLSETVIFAYKCEGFYNKESEFGINPLDETLNINWGIEKGKEILSEKDRNAISFNQLK
NRDL
>EGEFANNL_01651 hypothetical protein
MLVKEPESIHKIRFMDCDPIGHLSNIRYFDYMLNAREDHCLENYQIDNYEQSKKTGCLWV
VLQNQIAYIKEVKFNQQIKITSKIIKFSDKTNTVEILMYDKEKKMIHAVLWLTLIYFNLK
TRKSEEQPHNIINLFEDLKVNIPEDSFENRVSAFHNKNKEIQTI
>EGEFANNL_01652 30S ribosomal protein S1
MNKISFIQKKTELPTKGIENTLRLLDEEATIPFISRYRKEMTGNLDEVQIQKIAKLKTEF
EDIQKRKESILKNIDEQGALKQELNDKIVNCYDLTLLEDYYLPYKKKRKTRASVAKEQGL
EPLAKILMKQNPITDLEILANKYINKELNDVEKVLQGARDIMAEWMNENEIIRAQLRKLY
KQTAIIESAIVKNKENEEEAKKYLNYFEFSEPLKRSPSHRILAMMRGENEGFLRVKIKVD
KEQAIEIIERNILKTNQKEISKQINLAIKDSFSRLLEPALSNEILQEAKVQADKVSIQVF
SANLQQLLLQPPLGEKRILAIDPGYKSGCKIVCLSEQGELLHNDTVYPHAPQKEIKESIK
KIKSLINAYKIEAISIGNGTASRETERLIQSIAFDRPLKVFVVNEAGASVYSASKLAREE
FPNYDVTVRGAVSIGRRLSDPLAELVKIDPKSIGVGQYQHDVDQTLLKNELDIVVMSCVN
NVGVNLNTASKSLLSYVSGIGEKLAENIIKYRTEKGLFTQREELKKIPRLGDKAFQQSSA
FLRIPNAKNPLDNSAVHPESYPIVEQMAKDLGLKVENLVCNSEEIKKIKLDSYITSEVGL
PTLKDIIKELEKPGLDPRKKSQIFTFDSTLKTIEDLKIGMKVPGIINNITNFGCFVDIGI
KESGLVHISKVAKEFVTDINTVVHLNQTVEVKIIEVDIDRKRIQLSMID
>EGEFANNL_01653 hypothetical protein
MSLETKIMDAMKAAMKEKDKVALESLRAIKSQLLLLKTGGGDGEVTEEQEVLLLQRLVKQ
RKEAYEQFVANNRQELADNEIAQAKVIEQFLPEQLTPEELENEIQAIIEEVGAKDIKDLG
KVMGVASKKLQGKAEGKLISQTVKNLLA
>EGEFANNL_01654 Cell division protein FtsZ
MENNDSKKLFFELPKNRPSAIKVIGVGGGGNNAVGYMYDQGITGVDFIICNTDAQALINN
PIPNKIQLGTTITEGLGAGANPEVGEQAALESVDDIKNALGEQTKMVFVTAGMGGGTGTG
AAPIIAGIAKEMGILTVGIVTIPFSFEGKSRLEQAEKGLEKIRKSVDSLIVVKNDKLREL
YGNLGYRSGFSKSNEVLSTAAKGIAEVITKNYSINIDLRDAKTVLANSGTAIMGSAIASG
PNKAQEAIMTALDSPLLNDNKITGAKNVLLLIVSGEDEITVDEIGIINDHIQSEAGNNTN
IIMGIGEDENLGDNISVTVIATGFPVDDERNSGKEKERIIHTLTDDGLQDRVFNISKKND
IKIQQEKTDEEPRIKSYIYENETLNTNNDPFVQKIITLEEEEELTSFGISNKPEIIAPTY
SSDSDIRIISKDESKLREDLKQIKSINKEQTNIQETKTNNSFGNQSTIFTLDEVENFAQK
IESTNEGISSLVETNTIENEDNSLAELMDKKIQERRARLKKLNSKFQGLNKQNVDEVERV
PAYLRQGINLDNRIESEDESEIYFNKSSNEIKIRPNNFFHDNVD
>EGEFANNL_01655 Cell division protein FtsA
MDTNKIAVGLDIGTTKIVAIVGQKNEHGKLEILGMGRSKSLGVHRGVVNNITQTIESIKK
AVSEAEKASNYKITDVTVGIAGQHIRSLQHSDYISRSNFEDVIDDVDIDKLKDQVHKLVM
LPGEEIIHVLPQEYKVDSQSEIIEPRGFHGSRLEANFHVVIGQISLMRNIARCVKEAGLN
LIGITLEPLASSDAVLSQEEKEAGVALIDVGGGTTDIAVFKDNIIRHTAVIPFGGNVITD
DIKTGCSIIERQAEILKVKYGSAWPSENKEIEVISIPGLHGREPKEITVKKLSQIIHARV
EEIISLSYLELRNYGCEEQKKKLIAGIVMTGGGSKLKHLRQLTEYTTGMDVRIGYCNEHL
ASGQPKELASPEYATAIGLLMTGLNNLENYKNKFNYTQEKEIQPKVEIKKESVETEKKIK
EISQKEEKKKEKKKSIFSTFQEKFIKYINDTE
>EGEFANNL_01656 hypothetical protein
MFLILSLFFLMNFAIKRHDNRDINEINIQIDNSDRIQFITKDMVKQIVDQSSHNGIQANK
IKDINTIKTEESLNANPFILKNNVYIDLNGEINIHVVQKQPIARIKTNKDEFYLDNYGNS
FPLSKNFSLPCLLVNGEIQEDEYEGIANLVQVICKDNLLKNHIVGIEKVKKDLYHLILNV
PDCYIEYGKIENNKQKLTNLKEFYTKYLDYVGFSTYKKISLMYDNQIVATKR
>EGEFANNL_01657 UDP-N-acetylmuramate--L-alanine ligase
MKDIHTYKNFYFLGIGGIGMSALARYFNFSGAKVWGYDQTQTQLTIKLEEENISIIYDDN
PELLPENINKEETLIIYTPAIPNHLKIKNYFIEEGYTILKRSKVLGEITRFTQCLAIAGT
HGKTTTSTLLGHLCKYANLKATAFLGGISANYKTNFIFNGNQISVVEADEYDRSFLALSP
NMAAITSTDADHLDIYNDSSHLVDTFNEFAKLIPEEGFLLVKKGLPINVKHFTYSATEKA
DYYAENIQIENHTFTFDLVTPDLNIEGLILPIPGKHNIENAIAALGIGLKMGISPSVLRK
ALAEFKGVARRFTHHTFKNGKIYIDDYAHHPSELNATIETIRSLYPGKNLLTVFQPHLFT
RTRDFANDFAKSLEQTDQLLILDIYPARELPIEGVSSEWLNKKIQLNKKQVSTLDKALDI
IKEKDFDILLTVGAGNIDILYQPLLQWLNEAEI
>EGEFANNL_01658 UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MKSPKFLISGGGTGGHIFPAIAIADEIKRRIPHAEFLFIGAQDKMEMEKVPQAGYKIEGL
WISGLSRSSLLANLSFPIKLISSLIKAKKIIRTFKPDAAIGTGGFASGPALFTAVNAGVP
IFLQEQNSFAGITNKKLAAKSKRIFVAYEGMDKFFPNNRICLTGNPVRKSLFTNKISQKE
AKEKLGLNTEKLTILSIGGSLGSRTINNFWKQKANEVINLGAQILWQVGKSDFSSLDIEN
NFNNKEIHCTEFIKEMEIAYAAADIIVSRAGAIAISELCLAGKPTILIPFPFAADDHQTK
NAEQLVKKEAAIKVNDRDVSQELLPKIENLINNQELRESLSLNIRKLAKPNATEEIVDQI
LTEINLDF
>EGEFANNL_01659 Peptidoglycan glycosyltransferase RodA
MLRLKQYFKGDSTLWAAIILISLTSFLPVYSASSNLQYVVGQGSVLEHFAKHAGFIIVGI
GIVFIFQKFDYKYFGGFSKLLLPIVIFLLVLTLMQSNNIEGANASRWLKLPGVPFSFQTS
TFASLVLNVYIARYLDRNRNSFITFNNSFVSILLPIFLIVGLIFPANGSTGLIIFFMALA
LLFIGGYPIKIIGSILGIGIITITLFIFIVMKFPDAFTSNRVHTWISRVDNFLGEEHEES
YQVQQAKAAIVQGGMNPRGPGKSALKQTLPQSSSDFIFAIIVEEYGYAGVFICFFLYILI
LWRIIVIATRIENTFGSLLVVGVGLPVIFQAFANMAVAVNLIPVTGQPLPILSYGGTSMW
VTYMALGIIISVSRGIPNKENQNNSKLEKENYEIA
>EGEFANNL_01660 UDP-N-acetylmuramoylalanine--D-glutamate ligase
MERLVVIGGGESGVGASILAQKQGFEVFLTDLGEIKPEYKMVLNQKQISYEEKKHSEEKI
LNADWIIKSPGISKNSALIKKIKEKNIKISSEIEFASQYTGAKLIAITGSNGKTTTTSLA
YHIFKNAGYNVGLAGNIGKSFAWQVSEENFDYYILEISSFQLDDIQNFKPHISMILNLSP
DHLDEYGYNYQNYIDAKFKITKNQDPQDYFIYNEDDKMILEWFNKNNTEANRFPFSLKSE
VKNGAYMDGNNIKIQVNSERLEMKINELALSGKHNVANSMAAGIAGKLSKIKSEVIKQSL
ADFEAVEHRLEFTYKINGISFINDSKATNVNSVYYALETMNSPVIWIVGGKDKGNDYTEL
IPFVEQKVKAIVCLGLDNTKIIETFKDIVSEIVETQSMKDAVQAAYSLGKKDDVVLLSPA
CASFDLFKNYEDRGNQFKEEVKKL
>EGEFANNL_01661 Phospho-N-acetylmuramoyl-pentapeptide-transferase
MLYDIFEYLNQHFHIPGSGLYRYITFRALAAVFTSLFISLIIGKRIIKILRRKQLGETVR
ELGLTGQKEKEGTPTMGGVIIILATLIPVLLFCQLENIYVIILIVSTIWMGIIGFLDDFL
KIHKKNKDGLNGKFKVLGQVGLGVFVGLVLYMNNDIVIKEKIEGSHHIEFAKDFYPSEKS
FKTTIPFFKNNQFDYSKILTWVGVEEGEAQNLVWIVFIPIVIIIITAVSNGANLTDGIDG
LAAGSSTIIVATLALFAYVSGNIMMADYLNLMYIPESGEIVIFSAAFAGALIGFLWYNTY
PAQVFMGDTGSLTIGGIIAVLAIVLRKELLIPVLCGIFLIENLSVIMQVSYFKYTKKKYG
EGRRIFLMSPLHHHFQKKGYHESKIVTRFWIIGFMLAIVCIITLKIR
>EGEFANNL_01662 UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase
MKILSDIIYKIKVEKEIGDININISNISFDSRTIVQGDVFIAIKGYDLDGHQYIQSAIHK
GAVAIICEEIPTDVVANVTYIQVKNTSYALGIIASNYYNHPSDQITLVGVTGTNGKTTTA
TLLYNLFQNLGYRCALLSTIENRIADQKLNTRHTTPDPITINQLLSQAVEKKCEYAFMEV
SSHGIHQERLAGLNFKVGAFTNISHDHLDYHKTFANYLAAKKKFFDDLPKSAIAISNIDD
KNGLVMLQNTEAKKVTYSLKSNSMYKGKIIENRLDGMLLNFNQQEFWTSLAGKFNAYNEL
LAYSIALELGFESTEVLKALSNLNRVKGRFETYVSNDKKYIIVDYAHTPDALQNILEAIN
QIRTRNEQLITVFGCGGHRDKEKRPIMGKIATRFSDLSIITSDNPRDEEPEQIIKEIEGG
IEPQNTNKYLSITDRKQAIKTAIKISKPKDIILIAGKGHEDYQEVKDERLPFDDMLIAKE
LLTN
>EGEFANNL_01663 putative peptidoglycan D,D-transpeptidase PenA
MNKENKDILARTYLVAAMVLLFAVLVFARLIFIQTVDSEKYRNLAQTTNFRNEEIQAARG
NIYASDGILLATTITKYDIRLDMKTIRKKLYDENISSLCDSLGKMFGKSSFYFYKKLNEA
RIKDNQYLKLATGLDYEQFTRLKKFPILNKGQNKGGFIVERRLERIKTISGFGNRTLGFD
DERGKTGLEGAFTSYLKGTNGKEIQQRINQKEWKPINIEMEPIDGNDVYTTIDMRIQDIA
YSALQNQLEKSEADHGCAVVMDVKTGKIVALTNLQRTKSGEYDDLRNFAVWEASEPGSTF
KTISMLALLDDGYVEPNTTVDIGEGAWKYKNQVVRDDHGQGTITLSQVLSQSSNVGIAKT
VVKYYSKNPKDFLAKINNWHIGLKTGIDIPGEGAPYIPQYDQKWSSVTLPWMSFGYGVKL
TPLQILTFYNGVANGGKLMKPQLLDKIENKGIIIKKFSPIVLEKHMASSKAIEDLKQMLA
YAVEKGTSRSIYTPNLSMAGKTGTAQLEYWSKGKGRLYQASFCGFFPVENPEYSCIVVIN
KPKNGFYGSQVASPVFKEIAGKVYLKKPLNLPKEDETKISKNIKQFLTQNQKIQVNPKTK
NVPNVVGYYAKDAIPVLENLGLKVVYKGNGKVVQQSITGIPIKKGMTVYLKLSV
>EGEFANNL_01664 hypothetical protein
MARKRKNIKKRSISDILKGRFLVDGDAISVWRFILFIIFLSLISITSSHLVDQKVVTISK
LKEEAEEYKARYALVHSKLMKLKVESELEGMVLSDSLFALDKQPYKIIVPHVENE
>EGEFANNL_01665 Ribosomal RNA small subunit methyltransferase H
MREYHNPVLLHPSVEALVKNKEGIYVDCTFGGGGHSCLILEKLNSEGKLFAFDQDSDAYN
NQIEDPRFTLIPQNFRYLKNFLRFYKIENVDGILADLGVSSHQFDVPERGFSTRFEGPLD
MRMNIQQSLTAKEVLHTYSEEQLKEIFYLYGELQRPGKIAHLIVENREEKELETTGDLKQ
IFDKIIPQYKQNKFYAQLFQALRIEVNDELNALKELLVQSYDLLMPGGVLVFISYHSLED
RLVKKFLKTGLFEGEPERDIYGNWNKPFDLVSSKAIIPDEDEINDNPRARSAKMRIAIKR
>EGEFANNL_01666 Transcriptional regulator MraZ
MLNLIGTYECTLDSKGRMLLPSGLKKQMESLLEEGFVLKRSVFQPCLELHPISEWNLVMS
KINKLNRFVKKNNDFIRQFTAGLKNVEIDNNGRLQVNKDLIQFAKLDKNVVVAASINVIE
IWDKDLYEKAVSVNDDDFASLAEDVMGNIFEDEGIS
>EGEFANNL_01667 hypothetical protein
MNSSHLLEKYIKNFLQISILLLSVFLVVSMSIDIFRGIDTYAQNNYLKIQYWICLWFLFS
FFIEIFLSENRWKYFKSHFIFLIISIPYQNIIYLYHIQLPSEAMYLIRFIPLLRGGYALA
IVVGWFTNNKISSLFITYLSMLMATVYFSSLAFYAIEYTINPQINGYGDAIWWAFMNVTT
VGSNIVAISITGKVLTVLLAAIGMMMFPIFTIYLTNLITTKAKELGRE
>EGEFANNL_01668 Serine/threonine transporter SstT
MNIKNFILKGNLVLQIAIGLFLGVLLAVYLPTYAISVKVLGELFLTALKSAAPVLVFILV
MSAITNHKVGQKTSIQSIIILYLFGTFLAGLFAVIFSFIFPVTLTLIQQKPLEMVPPSSI
VDVLKGLLLNFVDNPVNALINGNFIGILAWAIGLGIALRHSSESTKKVVTDLSNAFTHVV
RIIIRFAPIGIFGLVASILAETGLNVLWDYIKLVSVLLGTMIFIALVINPIIVFFKIRKN
PYPLAIRCLKESGITAFFTRSSAANIPVNMELCKKLNLHEDTYSISIPLGATINMQGAAI
TISILTLAAVHSLGIEVDIFSAILLSLVSALCACGASGVAGGSLLLIPLACSLFKIPQDI
AWSIVVIGMTIGVVQDSAETALNSSTDVLFTAAACIADENKKNI
>EGEFANNL_01669 Putative bifunctional phosphatase/peptidyl-prolyl cis-trans isomerase
MVKAIFFDIDGTLVSFKTHKISIDVLEALEKLRSKGIKLFIATGRHKLEIDQFNDFIFDG
YVTLNGQYCYTPEKVLYKNPIDKDAVEKIISFSENTENAYMLFGENLVGINRINQRVEDT
LKQLKIENFKIGDLHSFIEMDVFQMISFTPSEEENTLKREFPNCDFTRWNPLFVDINPKG
GNKKAGILKILDYFNISTNEIMALGDGENDISMLELAKYSIAMGNASDLVKSKANYITDD
VDNHGVIKALQHFNIL
>EGEFANNL_01670 hypothetical protein
MKKLFKIIAYFLSSIIVFIILYFLAANILSRIVIQKEKDFSKDLAIYISTNGMHTDLILP
VKTETIDWSKEIKYTDTKGKDNIQKYIALGWGDKGFYLDVPDWDHVKPSIAFKAAFGLST
TAIHATYLKEVVEDKDCKKIMISKEQYNKLVEFIKNDFQLDGNGHIINIKTEKTYGSNDA
FYEATGTYQMFYTCNTWANTALKKSGLKSCLWTPFQEGIFRLYK
>EGEFANNL_01671 hypothetical protein
MNIMVVLILGVLGMIMLILVPIFLVAFLTSQSRKRKRKNIINTLPSNVEFYAPMRINSER
KNNAFFKFAAFECSGILYAHEGKLFFRGTKKQFELLEFNLDKVSIYWIGVQAQNGALQWF
SIKGSEEGNFYFNLDTGMTIFNFSKSGETTKSVYEKIMNMKLKENIDGIGKI
>EGEFANNL_01672 Uroporphyrinogen decarboxylase
MIKNTLFLDALKGKEVQRPPVWMMRQAGRFLPEFRAMRDQYDFFTRCQTPELAAEITLMP
IQRFPLDAAILFSDILVIPQAMGMPFEMKESVGPFLANPIASKEDVDRLQNAPVEESLDY
VFKAISITKELLKNEIPLIGFAGSPWTIFCYAVEGKGSKTFDRAKAFAFKNTELAHILLQ
KITDYTIEYLLKKVEYGVDAVQIFDSWGGLLSPKDYEEFSWKYINQIVEALAEKAPVIVF
GKGCWFALDAMSKSKASALGVDWTITPQKAREFSGGKITLQGNFDPAKLLSSPQKIYDEA
QQMVREFGVRNYIANLGHGILPNIPLENAASFVKAIVEYKA
>EGEFANNL_01673 hypothetical protein
MKKVLVTSTFTLPEENDKRLQIDYIPFIETEIYPESQIIPYLPNEVNSFIVTSGNAVQAI
KNIELEGDFYVVGKNTAKELFGQNREISFISNYAEDLLERMLETEVKKYVFFKGNLSLST
LPDSLRKNGVEVIGIECYKTTLKPTKVNEKYDALVFMSPSAVKSYLSMNQIPRDALVFVS
GKTTAKAVKDLAGDLPVYYPEETTKESLLTLIKETIND
>EGEFANNL_01674 Aminodeoxychorismate synthase component 2
MKVKIALIDNYDSFTGNLFQLFDENLNCTLEVIPNDRIQMEDLIKFDKIVLSPGPDIPKN
TPNLFSVIEEFKQTKSILGICLGHQAIVECLGGKLLNLEKVNHGIKKTIIINKQEKIFQN
LPTTIEVGLYHSWLADKDCLPLSLKVIAESIDHSIMAVSHTTWDLKGLQFHPESFMTFYG
RQIINNWIKQ
>EGEFANNL_01675 2-amino-4-deoxychorismate synthase
MKINRSAIEKMNDLGRKQIPFLFILDFSENENIILPLSKISPESILYDFEGFTNLTPNLF
HINTIPKLSYTYHPIAFAEYEKQFNLVKKEIAFGNSYLINLTTATPIDVNIDLKDIFLVS
KAKYKLWLDHQFVCFSPETFVKINNGKIYSFPMKGTIDASIPNAKKIILEDLKETSEHYT
IVDLIRNDLNLVSKKVKVDIFRYLDEINTQRGKLLQVSSQISGELEPNWQCNIGNIFHKL
LPAGSITGAPKKRTVEIINSIETFPRNFYTGVAGIFDGRSVNSMVMIRFIEETIDHKYLY
RSGGGITCFSEVQKEYNELIQKIYVPIS
>EGEFANNL_01676 hypothetical protein
MYRFLETILIKNHSFQNIAYHNQRANNTCQFFFKKKLVQDISEVISIPPELEYKETYRCR
IIYTDIIEKVEFIPYLQKPINSIQVVYNDDIEYSFKFENRSALDALKINSSADDILIVKN
NYITDTSIANILLRKYGQWYTPKHPLLHGTERQRLLDLNFIIEKDISIDSIDEYDSFCLI
NALRPFSNNHVLSCKNLIF
>EGEFANNL_01677 Carnitine transport ATP-binding protein OpuCA
MVTMLEVKNISFSYNEDKKNIEGLSFNLEQGKMLALIGESGSGKSTILKLIYGMLEWQEG
EIYYNHRKLSGMKGNLVPGEPEFKYLEQEFGLDSYATVGDNVGRFLSNIDMDEKQERIFF
LLDLVEMSSFIETKCIHLSGGQKQRVALAKVLAQTPSLLLLDEPFSQVDTFKKNILKRAV
FDFAKENNISILLATHEIEDALAYADEMVIIKDGKIVQKNKPSYLYKNPVNEYVARLFGE
INIFTKENFPELFKGIEATKILVYPHQLYAEEEGELQVKVLKSYFLGSSYLVEAIGQRKR
IWFSSEDYYAIGESCVLQIHDYQILRE
>EGEFANNL_01678 Peptidoglycan O-acetyltransferase
MLPLSNEAKELNVFQKFIQNIDAHKLIEQFYFNPLEPLIFNSGFFVFIFTFFMIGYALVH
RTHFPKVIYVILFSLYFYYRSSGYYYLVLIFCVFFDFFVGFVLYKAKNKIARQTLLFFSL
AVNLGILVHFKYTNFLIDSFNAVTHNEYKKIDIFLPVGVSFFTFQSMSYIIDIYRNKIKP
VKNLLDYGFFVSFFPQLVAGPIIRAYDFIPQLYNRPTIITKSMIGRGMFLITIGLFKKSV
ISDYIGANFVDRIFDQPQLYSGIENLFGIYGYALQIYCDFSGYSDMAIGIALLLGFHFPK
NFNSPYQAKNITEFWHRWHISLSSWLKDYLYFSLGGNRYGNFFGYFFPVLFFIGLLVWGI
VGIQNQSYWQMLIAVIFIGFFSLSILLSSNKKKAVFGSFNQMTTMLLGGLWHGASMRFIL
WGAMHGLALAIHKTYMNIFGITEKNNKKSNIWINLLAVIITFHFVCFCWIFFRVSDMQTA
WTMLGQVIYKFEPHILVQMISGYKLVFFLMLVGFILHFTPVEWEESFKTKIEKAPYLVAL
LFLFIVVILVAQVKSSDIQPFIYFQF
>EGEFANNL_01679 hypothetical protein
MKDIKITKSFYFFIVAFLFGFQYGCSQLTIENTYSFVQENKNVIHNSQELQPFFKKLDQA
SSRKINILHIGDSHLQPNQITQVPRKQLQKVFGNAGRGLIVPYKVAGTNSPDDIISTSQF
KWEGKRNCKPLIPQPTGIGGISLKSLDSASTFIFRLPHEYAFSSMTVFFENDGKSYDLFA
KDLIHGEVINLKNFIDEKNPNVSKIKFSQPTNEVEILSLKTSLEQTHTTILGINTENEEN
GIVYHSIGVNGAEYYHYDTSEYFNEETPFLNPDLIIISLGTNEAFRKNFDEEDFKSEVHK
FITNLRKYNPEVPFLITTPANSYINKKYQNPKLKRVRDILVAYCKENQLAFWDLQEITGN
AQNWKNNQLISKDLIHYNAKGYRLQGELLYNALINSYKEYVTTK
>EGEFANNL_01680 hypothetical protein
MKKDQTFYIPILCLIFLAGLIAMRYLPPINIMGYELKTIDMFSDVENEVPTVEENLPIVA
IKPQNKIQCPEGQICIEDYSEDQNYFGNLFHHLQNISLEKDKVRIAFFGDSFIEGDILSG
DFRNLLQDKFGGSGVGWVPIASEVAQFRQTIKENFKGFKNFDAVHNPKEKVPYPPFGICT
IPLTGNEASFYGTNFSSRTEYIPGFRLFYQTPNTLKIKVETDKETQEVKAEAGTLMNIVE
VNYHPAKNVNLSFSTSPNTYLYGVSFEGSSGVYVDNFSLRGNSGLSLLSSSDEMHKALNK
IQDYKLVILQYGINAVNEKTKDLSWYTRMMNKVVAEVKEAYPQAAILLVGVGDRSRKING
QYKTMPTIKLMIDAQRSVAAENKIAFWNMYEAMGGENSMVNYVKSKPPKANLDYTHLNFL
GGKEIGSSLYKSLLFEYERYKNN
>EGEFANNL_01681 hypothetical protein
MKNVFLGSFITFFFIFSCNKDNTNQHSNNINVNNSLKTKSQEYTIDTNISSVNWTGYKIE
KSLNLSHFGTLSFKKGFLKTKNNNVESGILYIDMNSIKNHDIQNSSQNNKLINTLKNKDF
FSVTKYPIAEFVLNSVQKIDGNSDFNFSLIGTLKIKGQSKNIRVKTNIRNENDKLFLNTE
KFSINRKDFNLNYQGLPNILIQDHFDLQISLVANSKNTCN
>EGEFANNL_01682 DNA topoisomerase 3
MIVCIAEKPSVAKDIAKILGAIHRKDGYFEGNGYQVTWTFGHLCTLKEPHDYNPNYKYWN
LEDLPIIPSSFGIKLIANRGIEKQFKIIETLVAKSDEVINCGDAGQEGELIQRWVLLKAK
CKAPIKRLWISSLTEQSIQEGFQNLKDSSSYENLYAAGSARAIGDWLLGINATRLFTKKF
GVNKTLLSIGRVQTPTLAMIVQRQKEIDSFVVEEYWELKTIYKDTEFNADIDRLKSQDKA
NKGLEYLKKYPLIILSFEIKEGREKNPRLFDLTSLQVEANKKYGFSAENTLKLAQSLYEE
KYITYPRVDTTYLSEDLYPKITNILSNLKPYENFINSLLNNPLPKSKNVFDDTKVTDHHA
IIPTHISPTNLSSDENKIYDLIARRFIAAFYPECKISNTLVTAKVGEVPFKTSGKQILEL
GWRELYKNERKDNNGNGEKILPIFIKGETGSHEPFIHQGKTTPPKPYTEASLLRAMETAG
KQVDDEEMRELLKDNGIGRPSTRANIIETLLKRNYIEKKKKNIYASLAGISLIDTIQNEL
LKSAELTGVWEKKLRLIEKGEYKLDIFKEELILMVKEITNEVKASNYKKISTESVSTYKR
EKNNSLPQNKKTVMNDKLLCPKCKSNTLIAGKSAFGCSDFKNCNFKIPFVIYGKKLTYKQ
LNDLVTKGKTSKIKGFKSPTENNFFEDILCLDDNFRIIFGNENLKIE
>EGEFANNL_01683 Large-conductance mechanosensitive channel
MGFFKEFKEFALRGSVIDLAIGVIIGGAFNKIVNSLVEDIITPLILDPALKAARLDNLSQ
LVIPGTTVKYGNFLSISLSFIIIAFCLFLIIKGVNKMRKDEDDKKIEPTPTKPSQEELLT
EIRDLLKNKKS
>EGEFANNL_01684 hypothetical protein
MNKKKLICGLGLLAIFQIGKAQTTQFYPNDVSDLLNLYGDNSSSSGTARSIGMGGSMGAL
GGDISAVETNPAGLGIFRNSEASLTMSVSSHKNKASMGSASNSTTNTNFNIPGVGFVLAL
GQESQPLRVNLGVNYSYQRLDNDVYFGKNKNLSYLYPGANGEMQTYSMENYDIYTNGYKS
KMKFSLGTNYMDRFYFGVGLDWQYLNVDRNSTYAQRSSVDGEYMPFNEQLTPYNQEANGF
GLSVGVIGKVTPEIRLGIAYHSPVWWSNINDYRWIYNFDESNNVIGNYVYYDRNKNTTAG
KLVLSGAYASNIINDDNSLAFNVDFLNYFNNNMNFGGGDIDYRLNNNFINLYTKNSQEYR
AGLEYRYKELKLRAGYSYMTSPVKDKTIAGSFDLNSDPVYVKNYLAGAKNKFSLGVGYDM
GPFFADFAYQYIKSDYYTSLSGDFFNPSQNTNVNFSLENPILGKVQNTQNNFVLTLGMRF
>EGEFANNL_01685 hypothetical protein
MTFVSSLSKIYELLFNYKGKIYKIIKKNIMKIVKNNIMRLGMLVSVTTLLSGVLTSCYVG
QTSYAGEDGVYYNPNKVQKKQRTNNVSQSYSYVYNDDGSKDTEQSHVRIGKKYIDTTPNA
SDLLYEDSNSNTNSNTSAYNGLNNENGWGDDGGTVVNNYYYGGYSPFYSSYWGNPYWGWN
SYGGWNSSFSIGFGWGWSNWGWGNSYWGSPYWGSSYWGYPYGGWYYRPYSNYWGGRPYYG
STWNRPGGYYNYPNYGPRSAYTSGRSSSSTNLGRSYTVSRSQQIRDIQRQSVRSNTMSSG
RTGTISGSRSGVVSGTRGSVIGNSNSRVPNNTGANSSGRVRGYTGGTINNGTRSSTGTIN
RGSRSSSIGNSGRSYGVGSRSSSPSYSSPSAGSRGSFGSGSMGGSRGGSIGGGARSGSVG
SRR
>EGEFANNL_01686 Proline--tRNA ligase
MATLTSREDDYSKWYNELVIKADLAENSGVKGCMVIKPYGFAIWEKMQKQLDQMFKDTGH
ENAYFPLFIPKSYLSKEADHVEGFAKECAVVTHYRLKNAPDGSGVIVDPDAKLEEELIVR
PTSETIIWNTYKNWVKSHRDLPILINQWANVVRWEMRTRLFLRTSEFLWQEGHTAHATKE
EAVEEAKKMQGVYADFVENFMGVPVIKGTKSPAERFAGAEDTYTIEAMMQDGKALQAGTS
HFLGQNFAKAFDVKYQSKEGKQELVWATSWGVSTRLIGALIMTHSDDHGLVLPPNIAPIQ
IVIVPIHRTEEQLEEISNLANDLKKQLNQLGISVKFDDRTEYKPGWKFNEYELKGVPVRI
AIGPKDLENKQVEIARRDTLEKHSHPIEGLVDHLKNLLNQIQENLYLKARNHRDSLITKV
DSYEEFKTALKEKGGFISAHWDGSMEVEEKIKAETKATIRCIPLNAPEEEGICIYSGNPS
KKRVLFAIAY
>EGEFANNL_01687 hypothetical protein
MKKYFKAIPISLFTILICYALGYFSIEYIDSYALTIFLFLPSLLGFLPSWIVLKQKNNSI
NVYRLSIYNLIISLLFLLIFAYEGLICIVMAFPILALLTAIGTYIAKIIYKYKFQNKSIG
IVIFFSSVLFLSFDSLNKNVTLIPVSTSVVIQAPIETVWQNVIEFDSIPTPKEFIFKTGI
AYPTHANIVGTGENAIRYCNFTTGSFVEPITHWGLLHYYNLVF
>EGEFANNL_01688 hypothetical protein
MGAPTLLQFSVLEQPTPMNELNPFWDIQPPHLNGYFLSKKGEFKLSPINQKETQLTGTTW
YEVNVKPEFYWKWWSDFIIHKIHLRVLNHIKDQSEKI
>EGEFANNL_01689 hypothetical protein
MGMKLASLFHPKAKLWIQGRKNVFTNIQSKISKNDKVIWMHASSLGKYEQGLPVLNALKY
RCPNYKFAVSFFPLRVTKW
>EGEFANNL_01690 hypothetical protein
MNLSDKSIKFYTLFSLIYIFPLLLALENYYYIDDLARSLWGFGWDHDGRILSTKVIQLIS
FGEKSIDLFPYSNILASLILALGGFFISEILKIEKNQKIKFSGLLLLTSPFMLENISYKW
DSLPMSVSIISVIIPFLFINNYKKFIITSTLGLIICLFTYQASIVIYGLITFCLIISYSI
NKTEIKEIIYLLKFTLISCILSFLLFKATILFLNIDYKNRDSTIFSSPDTFILLKNNTKN
SFRLIKKAFNLPLKNHFFTNLYFIFYFDSENIFM
>EGEFANNL_01691 hypothetical protein
MLKIIILIASSFIPLIIISILIIQKDAWFTPRTLIGFPFFIYPLLILINFYSEKLCKYIS
ITFIIISLPLMAVYANSLKNQNKFEEFLIKDIYEKIDIHHNNKNIAFYGVEPWAPEIEIP
INNFPII
>EGEFANNL_01692 hypothetical protein
MSNDWYWGGILLLKKTYSTNPKFLGIFEQKQYKELIKRKKTIPITTKTNFYYIREDQSNI
IIDFNKEED
>EGEFANNL_01693 3-deoxy-D-manno-octulosonic acid transferase
MNSTFYNLGIQLLGMGMKLASLFHPKAKLWIQGRKNVFNYIQSKISKNDKVIWMHASSLG
EYEQGLPVLNALKDRYPNYKFAASFFSPSGYEVVKDKSWADVIFYLPLDTSLNAKELIKA
LHPSCAIFVKYDFWFHLLNELSKNKIQTIFISSIFRENQIYFKPNGKWMVSILKNINHFF
VQNDKSLRLLNSIHISQATVAGDTRFDRVKMLLNLKHDLPWLAQFKQNNTLVIAGSTWKK
DDELFINYINSNTNKKLKFVIAPHNMNKEYFNDLKYKFNCKVLFYSEINPELNLSDFSVL
ILDTIGILNSVYSYGDISYVGGGFGKEGVHNVLEPAVYNQPVIFGPIYDKFIEAEELSNS
NGGIVIKNQLEFNSIISSLVLDPDYRNSLGGKAQNYILNKPNSTQIIVDYLDNQL
>EGEFANNL_01694 ComE operon protein 3
MDKNPYIFYLLFLIIGIFLGDFLLFNFYFLISILGILFTTLFFIRKNIKLRITFSILLFI
FWTVLGTTLVKINSFLPLHHYIYFKEDNAIQFISVTVKEQGNSNSKSRKYVAEVNQIANK
DKFYSTCGDVLLLVDKEKFNSVLTLGNQYDLLVELKDPIKPLNPHQFNYSQYLQQQYILQ
MADVKKILSITPHQSILYKIKNLNQRVVEKINHSNLSKGSKEFLKAYLLGDRFEMDKNTL
EAYSQSGIMHLIAISGMHIAFIFSIIFSVFHLCLGRKRRTLVIIISLFFVWLFAILVGLS
SSVFRACLMISLFYIFELLKRISNIYHSIALSAIVILLINPYEVYSIGFQLSYCAVFFLC
WLAKPLSLILKTNYKGFNQWIINPLSVTLAAQLGTLPWVIFYFHQFSLLSIPFNFIIIPY
SFIITYASIVELLFLYLPNDFHSYSAFIYDFLIKLLVNSTSWISSQNTFMYKNIPLGLVE
ALFLTFSCVSIRYIFKSPYKLKYFFPFLLSLIAFQITRLSLKIKNDYKKQVIVFHHTKTL
VGLRNGNQLLILKDSTLNLADIQKHILIPYEAGERISNTEYRNFYLDRDYFWEGKIIKAL
NYKQLSALNTNKTTIIVSSFEPSIKKSNSHSIIISDSQATKSNDLGVPSKENVWITSKQG
AYITSLP
>EGEFANNL_01695 Thiol:disulfide interchange protein DsbD
MKFISVIIISIFSLNFLISQENHLINWMNIENADSLQQKGDKRLMLIDVYADWCGPCKLM
DRNTFNNQSVAEYVNENFIPVKLNAESKDDIKFKGKYYSWVTDGRVGVQSLAYSLLNGEL
RYPSIALVDDKGQTLTVVTGYFPAQDFLEALKDLKSQIDEYYAKEGK
>EGEFANNL_01696 hypothetical protein
MRFFFTFLLSLLFSLKSLFAQEVIVPNVTINDHNGISEIINIDCAYNFYNDQPNRIKLTA
NYSDIRVTNDYTVASIEYNPVVDFGAGSLIHIERKDGIRDDAFSSKIPLPFKFCFYGKEY
SSIVISDNGVVSFNTLYANEENPYTISGSIPNSSLPIASIFGAYHDMQLVDENKASKDLV
KIYVEGTAPYRKFIINYNEIPQFSSNKKSTSQIVLYETTNVIVIYVKNKDLNSTTSKERK
ALIGITNATGSNGIAAPGRNTGEWEAKNEAWRFLPSGSSSISVKWYDSYNKLIGSNPTLV
VNPSVDTKYKVVVTYSLCTTVTKESEIEVKFLPDFPTANNVEMDQTAIPCLNEGETAEVD
LTKFQKSINSRDDLKFVYYTSLSGAENAEEKYLIADPKHFQYNSDNTTVYVRVIKEKLCY
TTSTIKLRINRKPKIQDNKTFNFCNTSSNSPLYINLISDVAHQLSGFSSSTMNIKFFNNQ
SDAASNKNEIVNLSKYPLSSSTTLYIRV
>EGEFANNL_01697 hypothetical protein
MVDNLEKLVCFLLEGQEIEIDLTQFEQELYINSDGNHTNNIVKYYTSPIYNSSYEIKNPK
SAKITLDGIVFVKITDPATSCEGTTTIHFRADGDCDGKPGGGELAGGGGGPILCDVPEGT
HEIDLIRNYFVYKLPKGLTLDDIEILDITDTNNKPVENPYTIEYTPPSYQKTFIVRYKIK
ETGIITRNTFTVLLTSKLKFKQDYFNVCNYENADSKEVIISLDKEFNELYKNTNYKLLYF
KSIEDIENYLKDPFNNQDLPITTIQLYSNKYVKVYVLMNYDRCSYNYEINLKLEKMDTVN
LDYTICDFGGDNYEKINLKLYEDDVKKLFNGTSKDIFEIVYLNVEDPKEFEMKSSPSTIS
LSVRKNNGCAYKITLNFTFTTAVALPKIINLLNVCYDDTDKKTDLSLVLSEIAENTRIIF
YSDEYAAEKGDENSEYYIGTYGNLNQPPLYQVKEETTIFIRVEDLTTGCFKIIPLPVIPI
KIEDLSSNTISICDYEEPNIENIKIIDIKNYLIQAKNYLIQANNFLKKETLDLQFYLNEK
DANENKNEIATFIQATPTTYLYLVITDSQTGCRRLFKLNFELIPPPVIQTNKEFWVCDNA
SKNSNNTTLEKINLNQFNLDFITEGTENDYSFSFSYDEYFDQPVGTSGIATISSFPITLW
VKVTNKKTNCYTISPFTLKAYPSMENKFQNKFINFCADVKTQIIDLKDLAKDMVINPKNI
ALYTITYHYTLQEAGNNLTSTISQSLIDNGITVSDKDAFYIKFTHSTTGCFIIKRLDVVI
NPTPKAQVIFPYLCDDTDGKLDGKFLIEDLNDYKQFRSQIITGELESVMDKVYDFSFYIS
LTDAENKQNKVNHKNFTLTESELTAPDTPGDPYFYQLWVRIDNKETGCFSLVSIMFNMNP
KVNLKKEVVELTECDKVGYGNSIFNLTLAKNNLTDLTDAQFSYYLSEDEARDNQAVPINN
PLTYTSRVTNDKEGIYTIDYIYVRIKDLKGNYCDQIAKIKLRTYPYIKITNIPEITICEF
QSDGKTENTINLNDETKGLLSGLDLAIQTDLEISFHTSKENATGDISIPSSEIANYKLPI
GITKIWVKFKSKTTQCYQLQEITINKLEAPKIKSVNYIFCDDNLDEIYEVPLTELEHLIL
SNHENYDIGFYENSTDAELGNHAIDKNRLYIVPFSQFPKKLAIRVIEKNTSCVTTGTLIL
NTNPKINLINKEVELVGCDEDNDGFSSFDLTLVSEEISEDSDISFSYFSTLEDAQNNQNP
ILNFTSYINKKAIEDYVYVRVEEYPASHTRCPSLAKIKLKTYYSTNPLPAEYFICPRGKG
TLDGGDYDFWEWSFNGKVISNQRYLDISETGIYTLKVSKNLNYGIACPSTFSIEIKLLRE
PVIMELKQGKDYITVIAQGPAPLEYSLDQIHWQDDNTFSNLSEGIYTVYVRSKANGCNSI
SSKGIIFGIPNVITPNGDRHNDVWRLGGLSMFNGEYSHIKIFNRYGKIVFEESSNTYFLW
DGKYLGRVLPTASYWYIITIADGRKFTGWILLRNYDDIDTYK
>EGEFANNL_01698 hypothetical protein
MKNFKLLLLFSIFFLNKNFAQQSIPFDQQYLLSDKVLINPSYTGSTDDIVFKATYHQQWN
NIESSPNTQTISLHSNIFDRVGLGIYLFRDENGPMSLTGFNLSSAYHIPLGDEDRTKSQF
SFGASVSMFSQSFDYSRLRPDDLFDPLIYNNKTVFLPYLNLGMSVYYSGFFAGVSVLDLP
LGQNKPVVNSIEPSPSWYYLNLGYDWQLPSNLFIEPSMMFTLNTNAEKMIDFNLRAKYQS
EVNLFAVGVSYRIANDSKINGPLSLTPFFQAELNKLNFSFGYNFGLTDIYKEGGDGLLVG
LGYNLDNFINSRGFRYR
>EGEFANNL_01699 putative transcriptional regulatory protein
MGRAFEYRKASKLARWDKMAKQFSRIGKEIAIAVKAGGPNPEANPALRRCLLNAKGVNMP
KDNVERAIKKASGADAEQYDEVTYEGYGPGGIAIFLECTTNNTTRTVANVRAIFNKFDGN
LGKNGELTFVFDRKGIFTLDKDSIAMDWEDFELEMIDAGAEEVDIEDNEVIITSSFEDFG
SINHKFEELKIEPKSADLQRLPNTMKTLPLDQAQTIMKMLEKFEDDDDVQHVFHNMEITE
ELQSSL
>EGEFANNL_01700 NH(3)-dependent NAD(+) synthetase
MKTQEVISYIIEWLNDYIKNSGMKGFVVGVSGGIDSAVVSTLVAATGKPVLLLEMPIHQP
IEQVSRAREHMDFLKNKFSNVLTKRVDLTNSFDVLTEALEVDEGNTNTNLSLANTRSRLR
MTTLYYYAGLYNFLVCGTGNKIEDFGVGFFTKYGDGGVDISPIADLLKSQVFELAKEMGI
SQEIQKAKPTDGLWGDDRSDEDQLGATYPELEWAMSVHKNHVSSDFSGRQKEVFEIYERL
NKAAQHKIKPIPICIIPKELM
>EGEFANNL_01701 hypothetical protein
MVKITKFLYFFLILALISNCSKKNKAEEYSKRWKIDVGGSESEVEIIDISKDFYNLNSPI
SNFKEKYPFFLDARISDQKYETQRRDTTELNIYKEIVKNVNTSQIQKDLTDLFSHIKYYY
PEFKIPKVYLYSSFLQDYLNPVTYVPEQNAIFIATDNFLGADNKYYNLFRIDKYLQKTMS
PNYLSSKVTDEIIKQLNLLPKKLNSQNFVSQMIRQGKILALKDAFLPDLPDEYKMEYTKE
QYDWAKNNEFDIWNFFVQENYLFSDDIGLSDRFLSLAPFSKFYTEVDTHSPGNIGSWVGW
QIVKKYLQENPEIKLQDFINNTNHDQIFSKSRYKPKQNETVESEK
>EGEFANNL_01702 hypothetical protein
MKETEINFAIDLDENHIPEKIIWAAPDGGVVGQETKSILLSVWDHKTKEALRIDLWTKEM
PVDEMKRFIHQVFISLGDTYQKATDEEDVAEEIRKFAEYFADRSGIKM
>EGEFANNL_01703 Delta-aminolevulinic acid dehydratase
MILHSRNRRLRSSQSIRDLMRETTLTTDDFMLPLFITEGNNIKEKISSMPGIYRQSLDLT
LKEIKELWSLGIKAVNLYVKVSDNLKDNTGKEAWNKEGLMQQAIKAIKDTVPEMIVMPDV
ALDPYSIYGHDGIVKEGKIINDETVDALVKMSLSHAEAGADFVAPSDMMDGRVSAIRKAL
EENHFHDVGIMSYTAKYASSYYGPFRDALDSAPGFGDKKTYQMDYCNSKEAINEALKDIN
EGADIIMVKPGLPYLDIVSKLNELVDVPISVYQVSGEYSMIKAAVNQGWLDNNKVIIESL
SCIKRAGASLITTYFAKEAARILNS
>EGEFANNL_01704 Lipoprotein NlpE
MKKNILLLSAISAFIFFTSCDKKAEQNQSNNDSIPVDSIEITDLTIEEIPVPDEVVGTYE
GTFPCADCEGIKTHLELNKDKTFKRTEEYLGKKKPEDKNVFETKGNYKVLNNKHVVLVPD
STEFVIGIDQLTLAPTNNNASPETNTSNYVLTKIKIKEDKEKIQQEVIDSTGQVIDKTKE
KIKVQ
>EGEFANNL_01705 Phosphate-binding protein PstS
MVGIILISIFVFTLIDNIMNFRKLTYLTLLLLTIYSCSNKNSEKIQISGAFALYPMMVKW
AEEFKHENPGVKIDISGGGAGKGMTDVLSGMVDIGMISREIHDEEIKKGAYAFTVARDAV
VATMNTQNPEWSEMKKKGLSSEKASKIWNAEYKTWGEIFNNTNQNPLNVYTRSDACGAGE
TWAAWMGEKQEDLKGRGVFGDPGIASAVQKDVNGIGYNNIAYAYDIKTMKPQENLGIIPI
DINKNGNLEGDEDFYKDLGSMIQAISNHKYPSPPARNLYLVTKNKPTNPVVIKFIEFILT
KGQSYTAENGFIKISPETAKEELKKIN
>EGEFANNL_01706 Phosphate transport system permease protein PstC
MKSLKCRILKDKLARSYMLAITLLSILLLFFMGGGLFNNSLPLLKLHSLKDLLSSSNWNP
FKNEFGFFPFIYSTLQVTLLSIVLAFPVSLLTALLISEKASSHFKKIISPVLDILAGIPS
VIYGVWGVLIIVPWISKYLAPKFSISSSGYSLLASGIVLAVMIIPILISLLTQIFTNVPE
DLKEASTSLGATQWQTIKNVVIKKSLSGIIASVVLGISKSFGETIAVVMVCGNSIQIPHS
IFESGYPLPALIANNYGEMMSIPNYESALMFAAFLLFFMILIFNLISRIILHRLQTKF
>EGEFANNL_01707 Phosphate transport system permease protein PstA
MKFKFIEERIATLFMYLAAFIVVAFLGSILWTIIKNGFPYLNWSMISKLPSGGFYIGGDG
GILNAIVGSLYIVAGATILGLLISIPVVFYLNVYLTTHSKFAQLCRLTYDVLFGIPSIVY
GAFGFTLMIYFGLRTSLLAGIIVITLLIIPIFIRSMDEAAKELPKDLMDATYSLGATRLE
ALKIFMKQIAPGIGTATFLSIGRAIGDTAGVLFTAGFTDNIPTALDEPAATLPLSIFFQL
SSPSSEVREKAYAAALLLTLIILVLSILGRIFFHKYSKNKLR
>EGEFANNL_01708 Phosphate import ATP-binding protein PstB 3
MNLTLPHKLLQTFSKDSITDTKINNSEFLPYDKFNSKKSYPDLRIKDFNLSIQGHKILKN
INTTIHNQSITCIIGPSGCGKTTLLKSINRLNENLPNVKIHGDILLDNENIYGKNVELTH
LRKKLGLLSQRPTPLPMSIYENITYGCKIHGLKNKKKLNIVVEYYLKAVGLWEEIKDRLH
TPATRLSIGQQQRLCLARGLAVEPEFILGDESTSALDPISSGTIEQLFLSLKEEYGIILV
THTLRQAKRIADYVIFMYMGEIIEQGKAQEIFENPQQELTQKYISGAFS
>EGEFANNL_01709 RNA-splicing ligase RtcB
MGKIKLKGKDLLKLGYPNNKIVNIAIEVMQKNFEKKNKAYVLSILKDIQNQPEEYKNHLM
LGQIAKEFLNLTKVEKRKLESQRAPYKIFGIEQIAEEAIQQLYTSLKLPISIRGALMPDA
HVGYGLPIGGVLATENAVIPYGVGVDIGCRMCLSILDVPTSYLEGSKDKYLNALQEHTKF
GMYEAHQNHIEHSIFEEEAFQMIPLLRRLKAKAIKQMGTSGGGNHFVEFGEVEILEEHSM
NQLPKGKYLGILSHSGS
>EGEFANNL_01710 RNA-splicing ligase RtcB
MAWLDLDSHLGIEYWTAMNLAGEYAAACHTDIHRRLMKITGGRLLARVENHHNFAWKEIH
EGKEVIVHRKGATPAADGQIGFIPGSMTSKGFIVRGKGNAEALRSASHGAGRLLSRHKAK
NVITNSEISKELKKHHVELIGGSKEEAPMAYKNINEVMNSQSDLVDILGTFKPRLVRMDK
K
>EGEFANNL_01711 Peptide chain release factor RF2
MYKKTLQLTSGRGPVECEWAAAQILKHLIQEINKEKLNYKIIERTSGTFQGTLQTACLEI
YGEKELLNQFICSWLGVIQYIGQSPFRKFHKRKNWFIEISEVSELKEINILETDIKYQAV
RSQGPGGQKVNKVNTAVRATHLPTKTSVFVMDSRSQFQNKKTARDRLIEKIKLKNYENLK
SQIQEKWNHQTDIQRGNPIRVFTHKD
>EGEFANNL_01712 hypothetical protein
MNTIQNKYYFQALDNFPYNMEDTMEALNYALSYDPNQADCLCLLARVYAEVLNDYTTAKE
YFERAMASNLHCISLYPPYIECLLWNEDFQEAEKLIHFALTVKGIDKAAIYNKKSLWYEY
QRDYKNALKAIDEARLHTYTQSFMSHLDDRAKLIKQKEKKVNKKPRNSK
>EGEFANNL_01713 DNA primase
MISKETIDKIFSTARVEEVISDFVNLKKSGSNYKGLSPFVDEKTPSFMVSPAKQIWKDFS
SGKGGNVVTFIMEQEHYTYPEALRYLAKKYHIEIEEDETELTEEQKEIQLNKESLYQLSE
VANEYFQQQLWDEEEGKTLALSYFREREIRDEIIKQFQLGYSPKSRSAFTTYALEKGYKR
EALEKSGLGIFKEDSEIGYDRFRERVIFPIHSFSGRVLGFGGRVLQNHGKTAKYLNSPES
EIYHKSQTLYGLFQAKTHIIKEDNCYLVEGYMDVITLYQNGIKNVVASSGTSLTTDQIRL
IKRLTPNITILYDGDPAGIKASFRGIDMILEQEMNVRVLLFPQGEDPDSFARKHTTEEIE
LYFKQNIKDFINFKTDVLLEETQGDPIKKASLIRDIVGSIALITNLIQQEIYIKECSRLL
DISEQVLFSELAQISQPKENKENSSSAPRPQLQAINKQSSKEVDFTYKIEEDILDLMLSY
GDFEIEIKYQDEDETYSTTVIEEIVQKLQEDDIQFSIDFYNKIFHDIIEGLENNELRTGS
YFVKSEEEEFTHFAAEKMLKKYSISKNWEAKEIFVPTLEQNLAKNTKDVILTYKSMKIIQ
MKNALALQLKEEDLTDEKRITIFKQLMNLDTLLKRIKQLENRVM
>EGEFANNL_01714 Ribosomal RNA small subunit methyltransferase G
MQTLKKYFPCLTEKQEKLFNKLPSLYKEWNKKINVISRKDIDFLGERHILHSLGIAQVLS
FQPKAKVLDIGTGGGFPGIPLAILFPETSFVLVDSIGKKIKVVQEIAEALSLTNVTALHS
RAEEIDDRFDFIVSRAVTQMPTFINWTHNKFLKKNMHSLKNGILYLKGGDLTEELKEFPK
AKIYPLSNFFEEDFFETKKVVYLEN
>EGEFANNL_01715 Glutamine--tRNA ligase
MHEEEKKTSNFLEQIIDEDLAQGFPKDKLRFRFPPEPNGFLHIGHTKAIWINFGLAQKYQ
APVNLRLDDTNPEKEEQKYVDAIKKDIEWLGYRWDQECYASDYFQQLYDWAEQLVKEGKA
YVDSQTSEEIAEQKKSPYEEGVESPYRNRSVEENLDLLRRMKAGEFEEGAHLLRAKIDMK
SPNMNLRDPAMYRIIKKSHHRTGDQWCIYPLYDWTHGESDYIEQISHSLCSLEFENHRPL
YEWFINQVYQEGTVKSKQREFARMSLAYTLTSKRKLLRLVEGNYVSGWDDPRMPTISGMR
RRGYTPEAILDFLERVGVAKRENLIDLSLLEFSVRNHLNKIAPRVMAVKNPVKIIITNYP
EGEIEYVRVENNPENPESGEREVPFSREIYIEREDFMEEAPKKFFRLTLGGEVRLKGTYI
LKAERVDKDETGEIQTIYCTYDKDSKSGSGTEASLRKVKGTLHWVSATQALPIEIRMYDR
LFKVESPDSMEGDFLDYLNPDSLQVVQGYAEPSLLNATIGSKYQFQRLGYFVVDEDSTKE
KLIFNQTVGLKDTWSKIANQK
>EGEFANNL_01716 hypothetical protein
MKKIISLTVLLLFTLFTYAQEIKAPAASLKAKVEQMVGLTDVEFEYSRPNKKGRVIFGDL
VPYNKIWRTGANENTTFQFGDDVEFYGQNLPKGKYALYTIPHKNKWDLIFYSDSENWGVP
KEWDESKVALKITVPTKQLNDTVETFTIGINNLSDNSGHLQLMWDQTLIDAKFNVPTQKI
ANSSIEGILSNPNADANAYYASANYYLRSNGDMKKALNWINRAIDLKQGESPYWYFWIKA
QIQAKLGDIKGAIESSEKSLEGAKKESNEEYIKLNTNALKGWKKVL
>EGEFANNL_01717 hypothetical protein
MSDIVNKVEKSGLITIDLEDFYPTEPRKVFDLKEFLYQELVLKEKDFRQNLKDFNWEIYK
NSYVAIHCSSEAIIPSWGYLLVATYLTDIAKHISFGSLEELERDIYTKIIQEFDVNPYKD
KKVIIKGCSGKPIPQNAYVQLVQKLKPMVFSLMYGEACSTVPIYKQKK
>EGEFANNL_01718 tRNA (guanine-N(1)-)-methyltransferase
MRIDIISVLPDLLKSPLQESIMKRAQDKNKVEIYVHNLREFAKGKHKQVDDTQYGGGAGM
VMMIEPIDLCISQLKQERYYDEIIYMTPDGDTLNQKTCNSLSLKKNLMILCGHYKGVDQR
VRDLHITKEISIGDYVLSGGELGACVLVDAIVRLLPGVLNDETSALYDSFQDNLLAPPVY
TRPEEYKNLKVPEVLLSGNFAKIEDWRHEMSLQHTQKRRPDLLE
>EGEFANNL_01719 hypothetical protein
MKEEDSIFGKRPKEYFVVKEKKSLGFLMACLYMGFMGLIPIVLAYLGFKKIYFPSAPLWF
FGINLFFGVLMILGSYWSYHFKKNGIYLFTATLILDILFHLFLGFEELDAIHGLYFFIGF
ALVPIIPRWKYFN
>EGEFANNL_01720 Regulatory protein AsnC
MKENFYIDDTDKRILKFLSVNTRMPFTEIAKKMNVSAGTIHVRVKKMEDAGVIRGTSLNI
DYSILGYGFIVYVGILLTKSSKTQSVLEKLALIPNVTTANVISGKYNIYCKISAKDPQDA
KNVIYKIDDIEDVLRTESMISLEESLNDQNRLMDALFL
>EGEFANNL_01721 Cyclic nucleotide-gated potassium channel
MKKIGRKIKLFFDGSTPDQINGSLKWKYELHEIIFESDTVKGKIFDIILLFFISLSTLII
MLESVSKINNEIGFWLYILDWWVTISFTIEYFLRLISVKNRWKYMTSFYGLIDLLTIIPT
YLSIFFIQSHYLAIIRIFRLFRVFKILKLANYIDESNTMLITLKNSKRKIFVFLYFILLI
TLILGALMYVIEGENFSSIPQSMYWAIVTLTTVGYGDIAPHTVLGKIIASGIMILGYSII
SVPAGLLSVEYRRNKIYKQNTQVCRYCMAENHEVDAIYCKRCGHLLNENLNTTDNP
>EGEFANNL_01722 tRNA-specific adenosine deaminase
MLSHEYFMKIAIEQAKIAFDKGEVPVGAVVVSNNLILAKAHNLTESLTDVTAHAEIQAIT
AASSYLGAKYLTQCTMYVTLEPCVMCAGALYWSQIDKIVVGASDEKRGFISKNISLHPKT
IYEFGILKDECSELLQKFFKLRR
>EGEFANNL_01723 Low-affinity inorganic phosphate transporter 1
MTLLITIVVLALIFDYINGFHDAANSIATIVSTKVLTPFQAVLWAAFFNFVAYFVSLYII
GEFKIGNTIAKAVHENFITLEVIFSGLIAAITWNLFTWWAGIPSSSSHTLIGGFIGAAIA
HVGGFSEAGNVVINYPVVIPIILFIFVAPLIGMIISSIITLLIMNICRKANPYKADQWFK
KLQLVSSAAFSIGHGGNDAQKVMGIIGAAFIFYEVNVVHAAEYVNLSTSERFQHFTIDYW
WVPIASFVAIGLGTMSGGWKIVKTMGTRITKVTPLEGVAAESSGAITLFLSEYLGIPVST
THTITGSIIGVGLVKRVSAVRWGITIKLLWAWILTIPVSAILAMIVYWIVKLFI
>EGEFANNL_01724 hypothetical protein
MNISAFFRLFQPKDKVFYSLFEQVADNLAAMSKDLVDGLKSEEAITEGFYKKMEDYEHAN
DKLTHNIYIELGKNFITPFDREDIHQLTSSLDDIADFIYASTKYILLYKSPVMPCYSSFA
SIINDSVLELKKAIYAMRDLKKPKEVFAHCVEINRMENMADDLFSKEISALFESNKEVLD
IIKIKSILEYLEDVTDKCEKSANIIESILVKYS
>EGEFANNL_01725 Signal transduction histidine-protein kinase ArlS
MKVQTRLSLLSSALWGIVFIVVSILIFSLYKQNIEKSVYHNLEKTAQIIAFYFFEEDEIS
FKEYEKIKKQYENLSNAYFQVYDKNNHLEFGLKTPQIPVEIIDEIRNKGKLTFNIPGFLC
YGVYYKDNQGDFVIITKDKKDEVVTNYIKPLWWILTSAFVVGMLATILLNLWISRLAYRP
IRETIKQVKNMSPNSLSLLKSSKIKDEIYDLTDTFNQLLQRISDTFKIQQNFVSYVSHEF
KTPLAAIQGNLEVFSLKDRTPEEYRELSDLLIEEIRQLEEILDILLIVSDLRKNTDIAEV
IHLDVLIEEIIRKVCEKYPSASQQIKWKKMIDAEFKDHLQINIDRTQLFMALYNLIENAV
KFSQENPVEIVLYWDNALYLSIKDHGIGIPEEHMGNIIRPFFRGKNAQNIPGKGIGLSIA
LRILEKNKVKYQINSKENEGTEFLLRFT
>EGEFANNL_01726 Transcriptional regulatory protein CusR
MELLLVEDNKKISQFMVKGLEECGFAVTLAENGVQARKLFLEKIWNVILLDIMLPDLDGL
ELLQYLRYKKIESPVLVISALGDPDDKVKALEKGADDYLSKPFHFKELVARIQALNRRAN
LNYQVPTHSLSCADLYLDLEAHKITRGDEEIILTIQEFKLLKFLMENKDKVLTRTQILSA
VWGAHYDTNTNVVDVYISYLRNKIDIEGKPKLIETVKGRGYKINSIQ
>EGEFANNL_01727 Cobalt-zinc-cadmium resistance protein CzcA
MHKFVEKCIAFSLRNSILVLFLTVLLFLGGILCYFNTPIEAYPDVTNTRVRIITQWPGRS
AEEVEKFITLPIMREMNTIPKKTDVRSTSLFGLSVVTVLFDDGVDDFFAQQYASNRMQGI
DLPEGADASIEPPSGATGEIYRYVVKSDLPIKEVAALNEWVIERELLSVPGVADINSFGG
EEKIYEIKVNPIELANYGLSPLEVYEAVENSNINVGGDVIQKGNQAYVVRGIGLLDKIED
IENILIEVKGSTPVRVKQVAEVSVSAKPRLGQVGLDNEDDVVQGIVVMLRGENPGEVIKH
LKEKITELNERILPKDVKIEPFIDRTTLVDSTVHTVMKNLIEGVILVSIVVFIFLFNWRS
TLIVATVIPLSFLFAIIMLRIQGLPANLISMGALDFGLLLEGTLVIVEIIFVSMAKRNEE
LGDQRFLKLAKGGLIKKSAGGVASHIFFAQIILVVALFPIFSFQKVEGKMFSPLAFTLGY
ALLGSLILALTYVPVMCKVLLNKPIKERTNRISRFFTTNLYRIYAFASRYRKGTILSFLA
LLILCLVRFSFWGTEFIPSMNEGAIYIRATLPNSINLDESVRITKEMKKKLRKFDEVKFV
LTQTGRPNDGTDPTGFFNIEFHAELKPEKEWKRKIKKDELINQMKDSLDIYPGTIFGFSQ
PIQDNVEEYVAGVKSALVIKIYGDDLKQLEKLADQTASAIGKVKGVEDVNVFRSIGLPEL
QIKLSESKMARYAVSMADAQAVVEMAIGGKAATNFYEGERIFDVRVRFQKEFRENEDQIG
EILIPTMDQKYVPLKEIADIQFVSGPTFIYRDGSSRYVGVGFSVRDRDLGSTIAEAQKIV
DKEIKLDHGNKMVWAGEFESQQRATHRLMIIVPCALLLILFLLYMNFHTLKDTLIAASAM
PYAFIGGFISLWATGTVFGISAGIGFIILFGITAIDSILLIALMKNTMQRTHNLKLAIDS
AVKSRVRPVLMIALMGSMGLLPAAMSNGMGSEVQKPLAIMIVGGIVVCMLLSFTVLPQVF
YFAYRKKDKSKN
>EGEFANNL_01728 Cobalt-zinc-cadmium resistance protein CzcB
MKRITILLATLYLLGACSSKLENNETVEKQTINQTFLNNLKTVRAELKPQEEDLVLTGKV
EYNPDKVVEYSPLVNGVITQTYFSLGDKVNKGQVLANVKSMEINSLHSEKSSLQAELATA
QRELKSAESMHKDSMLSDAELQEARSKVMQAQAELSRVNSDMSVTGSNKSGGFSIVAPIS
GYIVTKNIAPGTMVSPDSDPLFTIADLNQVWITANVYASNLKFVKEGMPVDMTTLSYPGD
VFVGKINQISQVFDSEERVLKARIVMDNPDLLLKPEMAMMIKLKNNTENLKVAIPMKALI
FDENKDFVVVKQGADKFVIKEVKLQGHNGDTAYILSGLKEGDEVVIKDQLLIYSQLKNK
>EGEFANNL_01729 Cobalt-zinc-cadmium resistance protein CzcC
MRKYKILILLLLIIQRISAQDSRVIKMTPEQIEAQFLDQNLELIAEKMNIDIADASIIQA
KLWENPSFELGDVNLWTTKAQRNTEELSPIIGKSLRTQFSLELSQLIQTARKRGKLINRE
KVSKEIAIQDFEDVLRGLKLELRTSIQEIIYLQNYQKILQHQEDLLKGLIQAYKNQVQQG
NIAKNELVRLQSSLLEISNELYEVKTEFNEQQKTLKTLLNFQPEVSIEIEETTEKLLKDP
QNIHLEQLLQNALENRADVKKANLQIDYSDKDLIYEKAQRVPDITFSANYDRASGVWKDY
VGFGLSFDLPLLNKNQGNIKAAQFAKKQSEFMAVQQMNLAQHELVEAYNNYEETYKLSKE
IEKEDLTKDLDFMIDAYTRNLKNRNISMVEYMDFMEAYKENKQTMLTINKNMFIQFENLQ
YAAGVELK
>EGEFANNL_01730 Ecotin
MKLFKVFLIFTFVGIILMSFTKHEKMKFNNNDPYKELGNFPVAGEGMTRYVIFLKKKSNE
NDFKIELIPGKIMNVDCNFYTLLGNMEEKNLDGWGYNYYQYTSSGEAMSTMMACPEQTKT
NKFVAGKSIWVDYNSKLPIVIYVPKGIEVNYKIWKAGKESSAEEK
>EGEFANNL_01731 Succinyl-diaminopimelate desuccinylase
MKLSKIFLGIAILALVLFLILIIKTYTYPFKKIVESQEKDKTSGTISIMDESLQRLAGGI
RIPTISTTDYEETNFKPFDEFKQYLRDSYPRVYNSLETTTINNYGLVFHWKGKNSTKKPI
LFLSHYDVVPVTGYDLDTIKNSPIIFQPKDTPIAPIQENKNSWDYSPFSGAVVDGRIYGR
GTLDMKGMLFSILEAADQLLKEGFEPEQDLWFAFGHDEEVSGKQGAVNIAQFFKSKNIEF
EAVYDEGGFIIAPHSILESIGKPMALVGVGEKGFLTLNIEVEGIGGHSSMPPEKSSLVYA
AEIIELLNSTQMDAEIIEPINNFLKNVGGEMGFTSRMAIANQWLLQPVLIKSLSKTPASN
ALVRTTTAITMAKGSDAPNVLSTTAEITVNFRILPGNTVKQVMDHVENLCKGYKVNIKTI
SSREPSKISSSQTDGFKKIESAVNKIYPGAIISPYITIGGTDAYKYQIVSNNIYRFMPIM
VNQFEQRTIHNENEHISIDNYSKMIAYFKELMQ
>EGEFANNL_01732 hypothetical protein
MITLIIYKLIIYYSDKPKNTNPKGWCFYLINSYLVCPRVPIRF
>EGEFANNL_01733 hypothetical protein
MEDNTINADELASSIENILLNKEEELSNREEINNITIKKVYAHYIHGYNVYMSIGIKEKY
LNEKDVDLFDIIFDVIDKEEIVYVNGNFILSNGENLNELIISGKEDILLKIDSFINSCLK
KYENVINDYIDYL
>EGEFANNL_01734 putative deoxyribonuclease RhsB
MKKYLYFILLVLSICFNWNRVEAKSIHSREAKGCAELDYNRFRYYNPETGQYISKDPIGL
EGNNPNAYAYVDDSNTMVDTLGLNEKLTEGIVYKMASGTPDSMTPRPGKDTTSGISFSLD
KPEGKYQAVDVAKLNGTGLEAINDHGSHVSIRPENDPDFKKLNEWASTRQIGEIHPYTES
LMNSRIICK
>EGEFANNL_01735 hypothetical protein
MSRSFVLAVDESQEQSQKIIEYQNKKYAGKLSSLQEKQAQKQLQDYIRSLQNLEVINPYA
TQLQLPDNVHKKRRLNQMFQSIIRQITYLNQKNRRISADNQIITEKEDLQIAIEVLFESI
ILKIDELDGSLRQFYENIQKHFKTQEFTRFHIMESTGLKKTQLQYYLNQLVQLEYLQQFG
HPNKGYKYKIAHNDNMQKVRKDLKDYFYNQLEKL
>EGEFANNL_01738 hypothetical protein
MTKVRNCLYETKIYVGTYKKYNEGSLFGQWLNISDYNDFEELIQAMRKLHQDEEDPEFMF
QDYECSTIIENMGLIGESYISSEIYEVLEAIEASYYREEVIEAYVDCYGTEDNIHNLIRK
VEESYTGKYNTDQEFVEELLEQTGDIPENLPSYIHIDWESTTRNIMYDYSTSNNHYFRDI
>EGEFANNL_01739 putative sugar transferase EpsL
MNNLKSLFDYSFSIVILLLSIFPLLVFSLLIIVTTKKSPFFKQQRIGRNKRKFYIYKLRT
MKGEYKSSITTSKMEITPLGRFLRKYKWDEIPQVINILKGEMSWVGPRPDVPGYADQLFG
EDEIILTVKPGITGPAQIKYRNEEELLSNHPDPIKYNDEVLWKDKVEINKKYVKDWSLGK
DLKYLFQTFFK
>EGEFANNL_01740 hypothetical protein
MKKILLINFALVALITSCTDDYNDLPITKPSASESVDQGQVGGEQEHIPVDANSNRVVDQ
AQVGGEQGHIVVKELSIDVAHGAQVGGEQGHISVKSYSNRVVDQAQVGGEQGHIPVGANS
INIPTENEK
>EGEFANNL_01741 hypothetical protein
MLKKIYIYTCATFITLLACKEKNNSIDSINKESPRILEYIYNDKNLQSAYKDILIAKKNK
NAHQLSNIYFQLGHYYLDGNISDSAFYYFNHSKEQSLIENDSSFIGRCLSNMAMIQADEA
DFLGCEETAVEALKYLSPYKMKDSIPLASVYNTLAISKTELEDYSQAIQYHELAMNFSSN
KLSNIILKNNQAVVNAKDQRYDIAINTLSTLLKNPILDKNPIEKARVLDNLAYIRWQKYG
SNNDIKNELEEALKIRIKENYPLGEMASHFHLAEYFEKDNPYEAINHASKMYKIAIKLDR
TEDQLAALQKLIFLDPKSSAKKDYFQTYLTLSDSIQKKRNHAKNQFTLIRYEVEKNKEEN
ALLKAENIQKNYQILKQRIIVFIIILIIFIIIVFFVLWYQKRRQKFNLEKNQEIEKTELK
YSKKIHDEVANGIYFLMTEIINSSDIKPSKVINDLENLYHKSRDISHDAEFKMDLKKDYN
LILRQMIQTYSSKDTNIILMGNEANIWNGISLEKKEELYYILKELLTNMRKHSRASLVTI
KFKNDKNSFTIEYIDNGIGMNLKDYNPNKHFINLKARINSINGSYFIDFTRNIGFYIKIL
INN
>EGEFANNL_01742 Transcriptional regulatory protein RcsB
MLRKILIAEDFDSYSIGIEKTISEQANVKIVDKTYYCDDAILKLRAALSKNDPYDLLITD
LSFASDYREQELEGGEDLINLIKQEQPNLKIIVFSIENRYHKINHLFEKYKINAFVTKGR
DDIKDLKKAIEAIKENKSYISDDNKISKSNLFELTEYDINLLKLLAKGFTQKEVENYLKK
EKITPNSESSIEKKLALLRITFNAKDTKHLLSLAVELGII
>EGEFANNL_01743 DNA polymerase IV
MDAFYASIEQRDNKEYRNKPLVVGSSGVRGVVAAASYEARKYGIKSAMASQKAMQLCPNI
IFVQPRFEVYKSVSKQIKEIFLKYTDKVEPLSLDEAFLDVTENYMNEPYAMEVAKKIKSD
IFKETNLTASAGVSFNKFLAKIASDYNKPNGLFIITPKKAEKFVGKLKVESFFGIGKKTS
QKLHELGIYTGWDLKQKTEDELIRYFGKQGRKFYLNAKGIDHGEVNPNRIRKSLGAENTF
RVDTNSLEFIYLELKEICKEVIERIKKVSFKGKTITLKVRYENFKIVSKSKTLSQPVTDY
SVLYKSARELLHELDLSNKVRLIGISIKNMYNIETDTTLGHQLEIPFEV
>EGEFANNL_01744 Multidrug export protein EmrB
MINRHIFRKDIPRWLMLAVAYIIMAPVMLINGAYTGSSVDISSSLGVMSEDINMAYFSTS
AGMSIAYPLIIKLRKVVTQKVIILWALLMQVFLSLLCAEVNNMVIITLCSFFIGFFKALA
LLEIIMILMPMLSPDNHRGIFYSKFYPVTLGLSQLSMVLTSELAYRYNWQYMYYFMIALL
LIAMIAVLLTFKYTELPKKIPLKDADWLSVFLCSIIYISIIYVFTYGKTFDWFNSTSIFV
CTFFIIPIAVILFIKRQLIKEDSYIDLSILKNTNTSVGYLVMFICMFYVSASVIVSSYVT
SVLRLESNRLYELYIITIPGFILGAIVCWRWFNKERRINLIIFFGFLCLVSSCAILYFTV
SPNGQYSLLYIPMFLRGTGMIVTFVVFGVYVVQGLHPDKFIYNVFFLIGIRSALSPAISS
SIYSNTIYRLQQQYVAKLSESINNTNPLAVEKYNQYYHTGVSKGFGVYEAQQYALSSINS
LVQIQALTLTLKTILGWLTLLGIFILLLVLIYPFNNHKKLKFIKWRKSMGY
>EGEFANNL_01745 putative multidrug resistance protein EmrK
MKKNEMHPHKDVTTDDSLINEPSTKKDSTTYKRNNERSNLHIELKKKKRRTIIVNTICIC
IILFGIGWVTQYFWRYYEYEITNDASIEEYITPINSRVSGYIKEVRFKEHEKVKAGDTLV
IIDDSEFKIKVLDAEASLKDAEASKNVMISNLQSSLKNVSVSEANISEAKVRMDNAYKDY
IRYENLWKEESVPQQLYDLKKADYEAYRAKYQSLINQKQANISNTEGVSKKQENADAQIL
RSKANLEMAKLNLSYTVIKAPYDGYVGRKNIEVGELVQAGQVLTNIIKNNDKWVIANYKE
KQIANIYEGQEVNIYVDAIKDKTFKGKVTAISEATGSKYSMIPTDNAAGNFVKIQQRIPV
RIDFIDLNQTERTRLRAGMMVETEAKIK
>EGEFANNL_01746 hypothetical protein
MILNTTALKYISYFILFITIMSPCKAQVAYNLTVEELFSLGLKNSLEIQEAEIHKEIYES
KENTAKTKRLPSLDVTLANGYLGTPTVYDKNLSYVKKPYMPKWKQNYAVDLKQPIYQGGR
IKNSIKYSSIEKDIATVDFEKSKSDIKLWLINNYLELFKLYKQREVFEKTIDEANKRLKN
IKNLKRQGIVTNNDVLRSEIEVSNFQLSLEEANNDISLTSQQLDIILGLNEEIILIPDST
LLDLDLFLASEETYLEQAYKKYPDLKKSNFNIEKAEIEKKISESKYIPNLNLNVGSQLIR
PITTVSPVQDLYMNSWGVTLGVTYDLFSWFDYKHTKYQSNKNVELQENRKRQIEQEIRVN
IKSAYIKHMQALNRVKVLEKTVIQAKDNYRITKNKYFNQLAILTDLLDAASVQLDAELQL
TVAKANTIYTYYSLLHTSGNL
>EGEFANNL_01747 hypothetical protein
MEFCLYLINFDKIISQMKYILNIFFILSISLINSCKNNKEVHLNNDTIINNEKITIETST
NSKSDTSASLSIIETNNNSVKDSASNFKTKNKDNLNLKNDSLNKYHIYISLDDGPQEGTR
NCWKILKECNVPATFFMIGVHNEGKSKTSLVDSIHNDPLFVIGNHSNTHAYFNKYSKFYN
DPSGSINDFILAEKNLNLNSKIARLPGRNTWSVDHIIKGELSALKTVKKLDSLGYSVFGW
DTEWHFKNGNIPVQSADEMVRTVNYILKNGKTHSKNSVVILVHDRMFQKPEHAASFKKFI
VSLKENNNYYFNTLNNYSK
>EGEFANNL_01748 Mannose-6-phosphate isomerase ManA
MSLYPLIFYPSLHYRIWGGNKLKTLGKKVSDDKIGESWEISSVPNFISKVSNGFLKDREL
TELINVYKEDLVGSDVYNKFGNNFPLLIKFLDTHEPLSVQVHPDDIYGKKHHNSWGKTEM
WYVIDADKDSEIILGFEKNMTQEKFFEKLNANDFDGVFRKVYPKKGDVFYIPAGRVHALG
KGLLIAEIQQSSDITYRIYDYDRLDKNGKKRELHIEEAKAVIDFSYIENVYSTYNPQGLN
ECLVHSPYFNVNKHNIAKNYIFKDLPTSFKIFILLEGRGSMSYNQNQSIFIEKGQSILIP
ACLKNIEIISDKDAPITLLEVHL
>EGEFANNL_01749 1-acyl-sn-glycerol-3-phosphate acyltransferase
MNYLKIIFTVIWKLWFYLVVIIDTIFIGTIIYLLSFQKNDKITYIFMRAWAYVLFFGSGF
SYSLRSKEDLAPGKNYILVSNHASMMDIALMFILHPNNPITFVGKSEIKKYPFFGRIYKK
LCILVDRSSKESRKNVFPAIKKALEENHKSVVIFAEGGVPDRDIILAPFKDGAFVSSINC
NIPIVIYAFHNLNNMFPFVFRLGYPGKIKVERLAILSPENRNKEELKQLAFHLIYEKIKD
NKINHPELK
>EGEFANNL_01750 Inner membrane protein YqaA
MLDALMQYGYVGLFIASFLSATILPFSSEAVLLGILALGGNSWICILLATLGNTLGGLTN
YFLGKMGKMVWIEKYLKVKKEKLEKMQQWLEKKGASMAFFSFLPIVGDTIPLALGYMRAN
IYIVTVFMLLGKFLRYLVVFYGYKFLQ
>EGEFANNL_01751 Inner membrane protein YccS
MSNIPKIHKKTKNFVSESTFFLFSFYFSTGLRITFAMMTPLALGVLFDQLNFGILASSGA
LIAGAGDNPGSFKVKLRTQSIGALFYLLLVVISQFLLPYREHVITFGLWVTFCGFFFSMF
FIYGARAVSVSTASLFCIVYACSFYHKSIWFNTLGIMSGVLFYGIVSLGLWRIQPYRVIE
QRLSEGIKLLSEYTELLLEYINTKEKASFKKNKLKELYSKILEKQEKVHTNQEDIRENLF
KLRINAKSFSSKGRRMTMIFSALVDLYEQLISLNIQDDKLIESLKNSHLQADFTQGLLDM
KEILEHISWAINIHKKIHRNIEISLLDKFKKRILDLEKYEEESGIEQTEVIHLLKHIRFI
FRSFYKQTLIIKSIVNGENANDSNTYQDLDIVKFTREYTYNFSTFKANLNLKSNIFRHAL
RVSTAILIAYIFCIILNISFFSLLFLTIILILKPVYGNTRTYALRRLQGTLIGASITLVI
FLFTRDPYILSIITVLSVLGAYSFLSINYKIGISFVTIFVLLLVYLEHRGGGSLSNLLIR
LGGTSIAVVIAFIFSFLFLPTWENKQLPKLIGNLIRNNLDYFSKISFNLVESNNQEMISD
TEIKLARKEVLLATSNFSSTFQRIVSEPALSKEYKSTIYSLQTQINLLSTRISSLRTYNF
TSNKDIVTELDKKIIALIKELLNGAIIMIQKDQEEIDSEADWKEIDFNLSLKKLSLTTYQ
LKEIYNLVQQIYSNIKKIKDFKEWKSAEK
>EGEFANNL_01752 hypothetical protein
MIKRILLTATIVFLTIQCQTTHSIITQKPTEVNTENKVDLSKFRFSYDQMVQIANPDFFK
HRMFYDKPSEGPDAAWFDAVKQGNLAEIKRMVKNGQNLEAKDEASLGQTALGWAAFIGYP
DIVKYLVKQGADIRATDRADVYNALKSATMGGNVEIISYLYNLLKDETDWNALEEDGETL
FMVAAVDGRTEAVKFIFENSPEPIDLNVVSEKLDRSALSGACERGFTDIANLLIEKGAIN
HKTGKSSCK
>EGEFANNL_01753 hypothetical protein
MGFGFNLFFVLVWAPFNFILLILWLFTRKKLWGKSILFFNISLIIIISISVGISSKNMIV
LLKKEDYYGDYVIYRDAYPGYQADWQYYRYKFTIKPNDQILFYETNDYGKTKIFKGKIST
IKPYSSERLVIQMDSSHHITAKNPTVYRTTQGFYLVFHSSLFKNVFFKKR
>EGEFANNL_01754 hypothetical protein
MKCLLLKRIFLVLLLFQLLSCKSSQEKQEAILSKIPDPKTLNETFVSDPDQILNPSTVYS
LNQTLKELDISGKAHIDVVIVKSIGDEVPKDIAYKLFNTWKIGRADTNNGLLIFLVLDQR
RIEFETGVGLEPVLTDMICADIQRKYMIPYLKQGNYDQAIVSAISPIIEVLNTESYNFNV
EPENLGNINVALSEPHESEHKTSNSFFNSIENIADKWLKNSNFVLVSIIIFSSLTFFSTI
ITVVKKVFFQRKKKSRLVSKFLIILFQLTIILLISSIITAVFHINFKKCVYVIIGLYLFR
GFLLHIRLLIILILAKRKDRDKRYNYLLKYKETFKYSENLYPISFIHLLYKKLCKDIKHS
RYDPYVCENCKSLMKLNKNKNLSKGQSLEEKINSVEYDSWECISCKTIKLVKYTNIYSKA
KECEKCHYRTNVLKKTYITQKATTSSSGSGYELYECKFCHEKEEIEFVIPKDSTRSSRSS
YSIGSSRSSGSSSRSSSGGYSSSSGGRSGGGGAGSSW
>EGEFANNL_01755 hypothetical protein
MLKKILILFSILFYSKGISQTTAEKEINQIFQLEEKEKIHQFFQAIEEYKQDHDYSDAMI
MDSIFAEITPPVLVNFIKSINKEKFIQEKEFTKDYEFNIFPKEYAANMPCADVVSLQFLE
EKNQFLLMVGNSFYVEDFGCTESGTSYLFKIEKGKIKIINIMEVG
>EGEFANNL_01756 hypothetical protein
MKENLSLNQICWCFTPKTYTSFDEFNKEVINYQKSIGETDEDWKPDEVAIDSPELQIQYR
AWITGPSDLLENETLIDDYKSIFDEELEEDEYPVEIIAKFKADNGKNFTTLEFLIKLHNQ
QANKELGDHVFFKGIDEPEIIHGIPTYYIACGS
>EGEFANNL_01757 hypothetical protein
MLEFLGELIGGIIIEGLGACVRYLFFLLIGKRKKFSKLLESGGYNIIVSIITYVVIFFIF
YLANL
>EGEFANNL_01758 hypothetical protein
MSNLEKKQSLTESLDSGTYEIIKKRLQTQQEELTSRLSQLNQARKEVFNSVEFVLESNQR
INTENNCIARGIIAIENLCIFAYNVHFGLRTDIQLSDVFSIYSFDGKQFTPQSLDLIKDE
TFINDYKNLYQYYRDSIFSRFRRTENYLYMIFQTGKNTEDLKAFKWLIKEGKLIYQDDRS
IHEVPKVQQYEFKWNKTTLDNRRLGVHPHISILDKVFIEAIQGDITFKIEDNTDTGKGIY
SEPVENRDQQLDDADYYYADLGNFILIRIKPYQEKFRAFVFNNRTKEVINIPKLNETGIL
LPDNQGIIFSNGYYLQSGEYKIFENGLENFEFIRKIPSANGEDYLYIFYQNESNTYVLMS
YNIIKQEVETPIICNGFALLNTGKLIYFRSEDEAIKHHVVQIWNTPYQAEIQEAPEQKNN
EIYKIGNKDIVKAMAECQEIINLINKEDSYEGLYNDIAKKAGDITDSFFWISQPSTFKLS
EPLKQIQEIAHTAIDEFAKVQEQKKSAVQQLEEITEKVKKLQFNIKSTQGDTLESLVKLL
SENRKLQGEVIEHGNIKYIDLEKIEELKKQLSKSNTQLSDQTVEFLLREEALIPYEEKVI
AEKERVNQITKVIDGQLVDENCKLISSELELLIDILNSLKIEDTTQTTKIIEKISLIFAS
LNEVRAQLKKKLESLKTGEAIAEFHAQLTLLDQSIVNFLELSTSPEKCDEYFTKVSVQVE
EMESKFADFEEFITQIADKRDEVIKVFDAQKTRLVEQINKKTSSLEQIGSRILKNIENKA
SSFKTKEEIQAFFSTDLMVDKVRKLAEELKQLGDVSKAENLENSIKTSLEDSLRTLRDKT
ELFVDGENIISLGEYKFAVNRQPLDLTIVRRNNLLYYHLTGTGFFHSVKEEKIYQYQSIW
EQDVISENNQVYRAEYLAYQAFQESFKNKNFNLSEYIKNKIEQSYAEAYLKGVHDFDAIQ
IYTALNELHQSLQTLVYSPSLRAVAQLFWNSLLEEEKNKLNKLIISASSVLKIFPDSDNY
QYVVNNLKEQFEQWNTAFSTLEISSEQVAEYLFKEFSTSPNFTKSKQADELKKEFTAYLK
SQKALSIFEEDTQDASLEFSDQFYLVKNWLESFTGLSDHFSAFEKYIDEASCLLLFEHKN
AYTLVESTDETILTQLKGSHPVIEKDSYVLNYHSFIEKLILFSEESVPKFKEFSQTKEQL
LEEYKKSLKVNELQPKVLTSFVRNKLINDVYFPLIGANLAKQIGVAGENKRTARMGMLLL
VSPPGYGKTTLMEYLAKTLGLNFVKINGPTIGHSITSIDPNEATTSGAREELKKINLSFE
MADNVMLYLDDIQHCSAEFLQKFISLADGQRKMDGIFSGESKTYDLRGKRFCVVMAGNPY
TESGEKFQIPDMLANRSDVYNLGDVIGNTENLFKLSLLENSIAENNYLQKLSSRSFDDFY
KLVNYIETGNEELLNLEGNYSNREIEEFISVLKKCIQVREVVMKVNQNYISSAAMDHAYR
TEPAFKLQGSYRDMNKMVGKIVPLMNDEEVQELIRTHYENESQTLTSDAEANMLKLKELM
NELTAEETQRWENIKTTFLKNNKLGGVTQDAQAGQVIAQLMDFNTNLEGIIKVLNNRKN
>EGEFANNL_01759 hypothetical protein
MRKRFFVWILLLFLFNYGNAQKNIPVKDSIFLFDEEHNSSTMRYTDTIRINYNYNKDLFD
ILPQIPDSAIASWIWTKKERQEITNSVKKNNFFSDTDFFYNNIQEIKPNYLSTQVVDGSW
ELALYKIKKEHYIVITNDITGDGKNVMTFEYSKGNLKSIANENIFDQYPEEILKTNSTDC
KEQIEHIIPYMSYDFANKNEVTFYYDLDNKKCFKGNTVTYLFDKNIKKFLLSTIEWY
>EGEFANNL_01760 hypothetical protein
MDRLTFSIQNKKISYLIWFIVLGIIISVLISLKFVKALEFLAISGYSIVVSVSVVLIYLI
VTKKLTAYISKFISTVIFKITIKDQIVSVEEKKSNGILKNYTVDVRDIYTIYYNKHVRNS
KILSLKIKLVDIHNNTKFRIISSYFE
>EGEFANNL_01761 Inner membrane protein YqiK
MSIGIGGIVAIIVGAFLFIALLFLAILASFYKKIPQGKAIVRTGVGGTKVAFNKGIYVIP
VFHKMEIMDISVKKLQIERLEKDGLICKDNIRADIKVAFFIRVNKSVDDVINVAQTLGCE
RASEVETLKNIFEAKFSEALKTVGKKFEFIELYEARREFRDEILNIIGKDLNGYNLDDCA
IDYLEQTNLSYLDPQNILDSEGIKKITELTAAQNINANLIRRDEQKVIKKQDVEAREAIL
ELERQLAEKEEKQKREIDNIKSREEAEIQKVREEERLKSETVRISTEESLAIQEENKLRQ
IIIAAKNKERTDAVETERVEKDRSLEQTERERIVTLAQINKEKVVEEEKKNIQDVIRERV
QLEKGVVEEQQNVKDIEALREVERKKKAGIIAASQEAEQNLIKTVKEAEAQKKAEEEKAQ
RLLIEAEAQKEASLKQAEARKILAEAQAKEDATYGLAEAEVIKAKAEADEQKGIVDAGII
ERTAKAEAQGIEAKAEAKRKEGLAEAEVIKQKALSEAEGITEKAEAMKKLDGVGKDHEEF
KLKLQKEKEVELAHIHVQKDIADAQAQVLGEAMKTAKIDIVGGESTFFENIVNQISRAKG
FDKLVEESKTITEIKESLLGDGNGEGDLHERIRHFAEKFNISSEDIKNLSIASLIFKMQQ
NAGTEDQSTLGNLSNLVKNLGLSNKKLG
>EGEFANNL_01762 hypothetical protein
MPEIIHSLFYPLSNAIMSGFMVVIFIYWIFAFLGVGLDSFDFGLDFDGPVETDLDVNTAV
EPDSDVDANTHASTGKDVAEPHTYHEKSETDTSHETGDHWFVRFLKFMNVGKVPFMLVLS
TLKFFTWAGSLITTQITMVGNWGWKSIIILIPCFLIGIFLTKIVTNPLAKFLKKTGYQGE
DKIEFLGRRGRMFSTIEHEKLGSAEFIIEKNPIKLNVISHSGEKINYGDSVIITDESKDK
KVYFVTREISLEQN
>EGEFANNL_01763 Phage shock protein A 
MSNIFKRLLRIGSAEIHSVIDKMEEPVRMTEQGIREMKADLENSLEALAKIKALAIRTNN
DISKKNKDAEEYEAKAILLMTKAKNGDLDPQQAEKLAKEALTLKARLLSEAEILTAEKTQ
HDRVVENMSNNIDILKFNINKWENELRILKARVKVSKATQEVNKQMAQVDNDGTMNMLER
MRNKVADDEALAEAYGTLANKNISVDEAIDRAIGGDSLKVNQDLEEIKRKLEL
>EGEFANNL_01764 N-isopropylammelide isopropyl amidohydrolase
MNSFTDENTIAQKSSRPEFNKNERKEKDIKLNKQSWKNVRLEVGFEYDEDGEVCNTKTQL
FYIESENGIITKIEENKPEVSAVDVMGKLILPPFKDMHIHLDKTNYTEPWKAAKKRNGGV
REMIKLEQKNMPAILENSTYKAEKIIELLQSHGVAFARNHFNIEPTSGFKSLENLNKALE
NKKGMFFTETVAFPQHGIFYTPTAPLMKEVAQMDIDFIGGLDPHSLDGSIEKTMDFIFQL
ALDYNKGVDIHLHDMDEFGIKTVEYITQKVNENPQLKGKTYISHAYVLANLNNTQLRDLS
DKLAEAQVGIVSTLPIGSIRMPIPALYEHKVKVRTGNDSIIDHWDTFGTGSILQKANLLA
QMYGYRTEFELSRCLRIATTDVLPLNNKGQRAWPKIGDPADWVVVDASCSAEAVSRLSAV
KSLVSKGKMLF
>EGEFANNL_01765 hypothetical protein
MFNKKNSLILLASIGLLSFTISCSNDDNAHASTTTPEIVPPGVPVLSEHIWLSTEAFDNN
KNLFDLNNSPVSTYSGYTYYKPDGTFRVVDANNQTKLFGTWSLIENNTKKQLAIYKSNNT
INPDENIYNIEADKIFDIVALNNSLFTYRINDDTNPGKYYDLVNRVDNHAEPKTPAEVLA
TVNWKTDKAINLNTGVELKLNDYPATVNSGNSYFINLNSNAYFPKNKDGNYVNGNFTISS
FTDKNEIVKYGDWYVSLDGKLLTTYLKNPQGEFEGIRKAVIVELNENKFIFEENINGEII
RFEQVPL
>EGEFANNL_01766 hypothetical protein
MNTILVVFFIVLVIWLLFRLLNFDGNNVDVEKKENGSVLKAKKQSFLARIFSKPLPYDDE
AITWCANFLIIDKNTLISILRNTSAYYSHFKLAKRSGGYRTISAPNEALLNIQRIIYKRT
LLTVNIHPASMGFRKNFSVTHNAKAHLGNNHILKVDLFDFFGSIKKDRVIKTFEKIGYPV
NISQVLAELCTLGGKLPQGAPTSPTLSNIIAFNMDIELASIAQKNSLRYTRYADDLTFSG
TDIAFEPLLTDIDVIIRKENFIIQRKKTRFLTEKKRKIVTGISISSGEKMTIPRAKRREI
RKNMHYILTKGLVEHQRFRGSTDPVYLQRLMGYLNFWLMVEPENEYVKRSIAALKKLKIT
>EGEFANNL_01767 ATP-dependent RecD-like DNA helicase
MENDGNKLNVDFLYLPVVNFAMQQNRVSLIRDLSIENLTEEILKDIKVKLVADPEFTTIT
PISIEGIQPKEKVRLEIPKINLSANYFAPLTEQISGYIALKVYSKEKLLFEEKYSINILA
YDQWGGIGVLPEMLAAFVTPNHPATLPIIRRAAMILEKWTGNPSLDEYQSRNPDRVQKQM
AAIYTAIAEQEIIYSTIPASFEDYGQRIRLVDSVLNQKLGTCLDMALLYASCLEAIGINS
LIIVVNGHAFAGAWLVPETFPDSIVEDVSLIKNRIAEGINEITLVETTGMNMGQNVEFDQ
AVKNANHRISQNGFILAVDIKRARFSGIKPIPQRVLNGQHWEIKEEELSPISDRSEITPQ
NINPYDLSGISSEVVVTKQLLWERKLLDLSLRNNLLNIRLTKNTLQLISTDLDIFEDALS
EGEEFRILQKPTDWEHPLFDFGLYKSVTESDPIMDLVKSELTQKRIRSYLTENELSKALT
HLYRSSRTAMEENGANTLYVALGLLKWYETPSSERPRYAPILLIPVEIIRKSVAHGYVIR
SREEEIMVNITLLEMLRQNFNINISGLDPLPTDGSGVDVKLIYTIFRNRIKNQPKWDVEE
QAILGLFSFNKFIMWNDIHNNAHKLIENQVVSSLLNGKIEWNMEESVVDANTFDHKLLPN
EIILPISADSSQLEAIWEASEDRNFILHGPPGTGKSQTITNLIANALYKGKRVLFVAEKR
AALSVVQRRLEAIGLAPFCLELHSNKAKKGMILSQLKETTEIVKNIPPENFKQEAERIFT
LRTEINEYMEALHKVYPFGHSLYEAIVKYQQIDAEPQFKIPETLFSELDLNREQQWRETL
EQLISVAGACGHPYQHPLTGINIDEYSPTIREEATKILQDLIRLITDIQKNLEQLPDLFN
EFEVNKDKTNLNIVTSLIDKLLSIPELTTELLVSPQLNETLDEYKDVCIHGKNRDILKQS
LLCKFSEGVLLLDANKILFDWNRASNQWFIPRFFGQRTIKKKLKVYATCQLNKNQIASTL
EEIIAFQSEQDYLKKYENDLPLYFKKYGRQGNENWETIEQIIADTYAIHSLLLEHTKDLS
KATNLKRVLSHQLPDGINSFKIMYGSALISITHLKQNLDQKERLLYDKLGVSKDILYQPS
MNWMDSALGQLNIWKKNLDKLKDWFQWLVVYKKMKAIQLGFVADQYKEQNIETVNLLNIF
NKSFYKSSIDYIISKEPNLQLFKGEIFNDKIEKYIKLVSDFEDLTRKELVAKLSANLPSF
TREASQNSEVGILQRNIRNNVRGISIRRLFDLIPTLLPRMCPCMLMSPISVAQYIDVDAD
KFDLIVFDEASQMPTYEAVGAIARGKNVVIVGDPKQMPPTNFFSVNSTDEENIEMEDLES
ILDDCLALSMPSKYLLWHYRSKHESLIAFSNSEYYDNKLLTFPSPDNIESKVKLVPVQGY
YDKGKTRQNKAEAQAIVDEIVRRLKDDKLRTKSIGVVTFSSVQQSLIEDLLSEVFMHDSQ
LESLALECEEPIFIKNLENVQGDERDIILFSVGYGPDIEGRVSMNFGPLNREGGERRLNV
AVSRARYEMIIYSTLRSDQIDLNRTSAVGVAGLKRFLEYAEKGGRIATSTQNIISEYSIN
DIIAGQLEKLGYKVDTNIGCSGYKIDIGIVDKENPSSYILGIICDGENYKRAKMLRDREI
VQNSVLKMLGWRILKIWTLDWRENPNAVLANIEKALIEKEKNTVDIGIKASQKKMEVKNE
IIEDTSSPTELVENKIYSYQTATLMPSPYGSEEFFYSGHKSIILNQIKEVMETEAPISKT
LLSKRVLAAWGISRLGQRLDSYLQELLMSTSFFISQNEDLSFYWLNEEQYQRYDYFRTGL
RDAVNLPPEEVANAMKYILTNEISIPTTDLSRLTAQLLGFARNGSNVDAAMHRGMVKAIK
KNYLKVENGRAVIM
>EGEFANNL_01768 hypothetical protein
MIIFFGIRYTTGRLILTGQECPACKENHSLAVIPQQGYFHIFWIPVFPISRDYIPVCNSC
GSTFIHKRPPIDRELKSQYKTPVWTFSGLIIIGIFLLYIFSMMLISKI
>EGEFANNL_01769 putative ABC transporter ATP-binding protein YheS
MILVQNLGLHFAGRYLFEEVNFRINKNDRIGLAGKNGAGKSTLLKILAKEQPSTEGNVEK
EGEVRIGFLKQDLDFEKGRTVWDEAKQAFKELNQINDKIDKINHELATRTDYESDSYAKL
IHDLTDLTDRFSHLGGYNIDGEIEKILKGLGFKESDFNKLTDDFSGGWRMRIELAKLLLE
ENDVLLLDEPTNHLDIESIIWLEGFLINYKGAVVLVSHDKQFLTNVTNRTIEISNQTIQD
YKANYTKYLILRQERKEKLIQSQKNQEQEIKRTEQLIQKFRAKASKASFAQSLIKKLDKV
ERIEVEDEDVTRFNIKFEPSVTPGKIIFKAEKLGKSFGDHVVFQNADFFIERGEKIAFVG
QNGQGKTTMAKIMEGVIPHEGSLEIGHNVQIGYFAQNQAEVLNPNKTILEEAEDSATEES
RPRVRDLLGSFLFQGDEVQKKVSVLSGGERNRLALCKLLLRPFNTLIMDEPTNHLDLQSK
AILKQALINFQGTLLLVSHDREFLDGLVNKIFEFRNGEVKEFLGGITEYLEYRKKENMRE
VDMEKSTLAKKAFTQENNPSAPKKEDSLKTKEEKALENKLAKLEKDMGEVETKIKRYEEN
FANENPTEELLKKYEELKQTLLNLNKEWEQTFNQLS
>EGEFANNL_01770 hypothetical protein
MKKILGFTLLIAILNLFIISCSNDDNNSNNNLYTDTDTIPEVYEINVTSFTEVNPSSYIF
RAPFTLSNSEHLLIYRQTNVTTSGNPVWELLPSTYADNYGTVSYNYDFSMEDFTIYVDGY
KNIANLNPEYITNQWFRIVVLPGFFPSTQSTTPPVDYNDYNAVINYFHIDEAKTKLLK
>EGEFANNL_01771 Enoyl-[acyl-carrier-protein] reductase [NADH] FabI
MSYGLLKGKKGIIFGALDSNSIAWKVAELAHQEGAEFVLTNAPVALRMGELNGLAEKTGS
DIVPADATSMEDLGKLFDHTLEKFEKIDFILHSIGMSVNVRKGKEYTDINYDWLMKGWDI
SAVSFHKVMKTAWDKDAMNEWGSILALTYIAAQRTFPGYNDMADNKAYLESIARSFGYEW
GNKNKVRVNTISQSPTLTTAGQGIKGFNGFVDFAKEMSPLGNATADDCANYCITLFSDLT
KMVTMQNLFHDGGFSNVGVSEMVMNRFEK
>EGEFANNL_01772 hypothetical protein
MNSPFNLYETYLINLNRSKDRLNFMESEFKKQKMNFLRIPAVDGSLLKGDEYIIKNKYDR
DLVPGEIGCYLSHVKALKTFLVSKYEYALIIEDDAILCTDFKNIIENSILNHKNNLSKKH
QWEILKLINGKRHHIKITDIYKGYFLAACGTSIPITTLAAIWTRNGARKFLKKIMNPIPV
IRRPIDCDLQHPWEFNLLIYNLLPSPVKGAELGTQIQLNKKLRKSNVPKEILYEINRFFP
KYHYLISQHGWKSVYNSFIAKKNERIR
>EGEFANNL_01773 DNA ligase
MDNIFIKIQELRKQINHLNYQYYVLDKSEVSDYEFDQLLNELRQLEQAYPELDDPNSPTH
RVGGEITKNFSTITHEKRMYSLDNSYSFDDIHDWAERIKKSISDEVEFVCELKYDGLSIS
ILYEQGKFKQAITRGDGFQGDDVSTNVKTIRSVPLELSGDYPERFFIRGEIIMPKKSLEK
LNQLRISEGLEPYANPRNTASGSLKLQDSTETAKRGLDCYLYNIISVDDVYATQWESLQY
AKNLGFKIGNFAKLCKNLDEVFQFIDYWNTERFNLPFEIDGIVIKVNSLSEQEELGYTSK
SPRWAIAYKFKAEKVETKLLSIDYQVGRTGAITPVANLMPVLLAGTVVKRASLHNEDFIS
KLDLRINDYVFVEKGGEIIPKIVDINYDKREKNTTKIEFIKNCPVCETPLVRKEGEAAHF
CPNEDLCPPQVIGRLEHFVSRKAMNIDSVGAETVTLLYKNGLIENISDFYELKKEQLIHL
DRMADKSAENIINGIENSKNTPFEKVLYALGIKHIGETIAKKLVKKFKTIENIKNASVEE
LINTDDIGEKIALSLVEYFSNDVHWRIIEKLKMAGLHFEIEDNNSLISNKLEGKTFLFTG
KLTVFTRENAEQMVELNGGKNVSSVSKNLNYLIVGEKAGSKLKKAKELGSVIILDEQEFL
NLINKP
>EGEFANNL_01774 Signal recognition particle protein
MFQSLQDKLDKALHNISGRGKITEINVAETVKEIRRALVDADVSYKVAKDLTKRIQDKAL
GQNVLTSLSPGQLMVKIVHDELAQLMGGENVGINLSSNPSIILIAGLQGSGKTTFSGKLA
NYLKTKKNKKVLLVAGDVYRPAAINQLKVLGEQIGVEVFSELENKNPVEIAQHAIEYANQ
NKFSAIIIDTAGRLAIDQVMMDEIKNVHQAVNPQETLFVVDSMTGQDAVNTAKAFNEVLD
YNGVVLTKLDGDTRGGAALTIRTVVDKPIKFISTGEKMEALDVFYPERMADRILGMGDVV
SLVERAQEQFDEEEARKLHKKIAKNQFGFDDFLKQIKQIKRMGNMKDLMGMIPGVGKALK
DVNIDDDAFKYVEALIYSMTPEERRNPSIINTSRKNRIAKGSGRTIQDINQLLKQFEQMS
KMMKMMQSPQGKMMMQAMAKQMGGAGGKPF
>EGEFANNL_01775 Manganese-dependent inorganic pyrophosphatase
MNKILVIGHLNPDTDSITSAISFSFLQNQLGKNTEAVALGECNEETLFALNYFKFDAPRI
IDRASNDTKDVMLVDHNEFQQAVSDISELNILAVIDHHRIANFQTASPLYYRAEAVGCTQ
TIILKIFKENSIAIPKNIAGLMLSGIISDTLLFKSPTCTEEDVRAAEELSSIAEVDINSY
GLDLLKAGTNLSNKTAEQLIHLDAKSFEVHGKKIVVSQVNAIDFSDILSRKNEILDVLNH
TISESSLDLFVFVITNILEGDSKMISAGGLINECEKAFNTKFIDNEAFLKGVVSRKKQII
PSLMDALS
>EGEFANNL_01776 hypothetical protein
MSSFLAKLEMEGDTYNVLQCKYDFYQNIDNAGKPQGSCKGGKILLTIESSGKPTFIEWML
SSEKTKDAVIVFYRRDAMSKLQEVKFEKGYCIEFSEEFDAINDQPMKIKLLISAKKLSIC
TVGFENSWKIS
>EGEFANNL_01777 hypothetical protein
MSFKAKLEVAGKTYNVLNVNYSLAQETDPTGRPSSQTRGGRIEVTVESTGETDVFEWMTN
SFERKDGKVVFIKRDSDATLKELNFTDGYVVKYRENFDSIGSNPLTETFTISAKTIKMGT
GEHVNEWV
>EGEFANNL_01778 hypothetical protein
MEILNKKERFISFIIFISLFLITTLIIIWALFYNVYLPKRENAQLKKENKALITEFRYQA
RFENQMEDLKKFIDSIDLPKQDLNTSFYFQQKAINKIIEIEQGIPKEDSVRRGLLYKNFL
LTSRSLIDAKKTIKTYGQSKSEIDTLLAQIVTYKKQIELMKRDLDICRMLNKKD
>EGEFANNL_01779 hypothetical protein
MLEKLSKFPVNWVDGMKINKSHFIAMQENFADVTRDAIGSHVTPISYGLLPVQTPLESIK
LSLVIDNHKLLRVKVEECHAITPNGSRIEISSKDNAIDTQMPYPEAVYDIEQGTELVLLA
NIVVNPVEQIPFGELDPEENPPRYPFLHPTYRLHLELEGQSSQQAAHKSFQLTVGKILVN
RDQTRLQPNYIPPCTMTNSHKELIDAHTRIDRFMGQLELLAVQIAQKINRKQQTNELAVM
VLKLSEIIITYLGNEINSLRWMGLYSTPAFMFDKIVRLARIMKNYVDAKSGAGKEELLNY
LAEWCGLSQGDFEVLFTDLVNVGYNHIQIDKTLTQVDKFMQTIEQLFISLNKLDFIGKRN
DTGIFVKERLENDPIEKNKRSRFFDE
>EGEFANNL_01780 hypothetical protein
MNFRTYFKDLIDPTIIVGIIVILIVFTLLTIFFGSKVGDFKQKYKSKYITYLIVLFLGVS
LITFIGSSEIFNNQLDNILVFYQTIFFMVGVTHTYLYRVYFNRFEKRSIKQSWVEGLFTL
LIFVFNIIPFVLVFTIVKGNTYAYTMAGSTVFFIVPSLIFLTFESTISVPPKIYKTWKFP
EDHSFPDPLNSDYRDMLVVTFVFYKNPESDVRTEFRAKAPIRMDFGRLFYHFVNDYNIRN
PDDTIKLNDTDGERQHWVFYLKSKYLGFAKFIRPDYPLYMNSIEENSVIICQRTPPLIDA
EEGLKYMEKEIEGEEKAKSKSKKKENKNI
>EGEFANNL_01781 hypothetical protein
MENTEKHTIQEILKNRINSLTDDLRAEVIVSELIHKIKEEDRNFLVDFKGQFKRPFRKDV
LGAEIVDFNFDTTQFVKINLSRDGIFDTLPQGLFHASEKNRQKISVDEMTQEYKTHKVEE
EYARKFFLPFENEFFLKSIERENKEKEILLELNGSKPIDFFYEFWNLDRDLPEILMSKLI
RILPYTNQIVGNLELTIHCLSYLIEEKVEIAEQTYKEQSSTEQDITLGDCRLGLDMISGS
AYLDYSLYLEFRIGELKKTSFAEYIHEGKMKKFLELFYEFFLPMEIDVKTTILLNKEEEI
FDFNKTAVLGITTRI
>EGEFANNL_01782 Murein DD-endopeptidase MepS/Murein LD-carboxypeptidase
MSCRSRYYKDIPFKLVYNQQDIEKSLNVPKYKYSILDTLNQEYEMNLTDREVYLKEKYSI
VLGVKPQEVKNYKFYDFIDQWLGTKYSGEGFTRDSLNMAPFVSALYQYTYKIKLPSNAMG
MFKSNQVSLFTGRKYLEEGDILFFRYGKDSPVSDVAVYLKNNRVLTTSKRDGLIISDFNN
DYFQLRYISAGRLILPEDKESN
>EGEFANNL_01783 hypothetical protein
MDTQERIKDRILRRAAQTWGYTDSELETSFDPIVSLLLEACSSELEKISAELNNSRSRII
ERLLEIMSPENKTGVIPARSIMHVVPLENNFTISLEHQFQCKKTIQNIYDPLNPTVKEIC
FGPTLPFKLTQASLEYLAYGNSLFSLKRIIHKDPLGKIKSHLSPGELWLGLKCPKDETVI
EKLMFFTDIRNISQREVFYNYLKQAKFYINNKQVSFKEGYNVPNFKIDIDAVVNKNYNKI
NQLYTDVNNFYADKFIHLEEDISLEEEGIFDLPKELEEIFKDKNLNIQESGDIVWIKIQF
PEVVINDILENVMLYVNSIPVLNKKLLNQSQTIDSFINYIPLSSDDTFLDLGIIHDSRGF
KYHIKEFSEGNLEIGDATLRHTGVTRFDERNASELIQYLIELLKDESASFTVIGGDFIDG
TIREVNQLIATLEQHIKEKKFTKTSFPYVIIRPKSPETKGDNDMFTITYWVTSGEDANDL
RVGTRLDGVLAGDFVPNSAMLISTSVGGKTRLSTQEKIISYREALLTRGRVVTFADIKTF
CLNHFKFSISSVEVRKGTKVDSSTNKGFVRTIDIVLTRNDKAEYQVSDFEWQYLCDNLLH
KLDYVSSNVYPYRLIVK
>EGEFANNL_01784 hypothetical protein
MYGIYYKKPLNFKDIIEKKDLEKTNLEKSIMQYIDLIVTTSFGECKFQELFGCKVWEMDF
DLLSDDNSLRDRIKNNIKDALKMHECRLEVTEIIVTIGVGRVAALSNSYRVKKGVVALIN
GFIKKTNRPFVYKSEFYLGPLSYV
>EGEFANNL_01785 hypothetical protein
MPIPQLGLSLSITDNAGSSMYTGNGEREKMAEFDSALRQHTITITISDEKINEVELEVQK
GILNKVKIPTYKMMVTDDKTEEKTYYEVTRDSLLFNKLKNEEIGGFSFLGLNILKKKMYN
IPVLTFEPLTSKIEKFEVSKYRTKKQDYLSYNLLRNKESATLVAGKLPPNFFNTIETNHF
FYIVDHNEGQKFMGDISYREKFVQITPKVEINLIKRSDHIKEYQLDKRGRINKIIYL
>EGEFANNL_01786 hypothetical protein
MFKRIISNIILPILLINFINLHSQEQILDTSDHELITISEDTLVTRVVDCNSLFTLNNRK
IDYLKNRPYIYAEPYYERAYNDKKEYGVFQLGKRKGTKPFLYIKLFKFNTCLKQDEVLEF
ILDNDYRYRINNIYKPNCDGIFIGEITHKDIKKLEQGYVKSLKVLTFDEDFEFHLTDEKS
EKFRDELQCLRYQNFKYK
>EGEFANNL_01787 hypothetical protein
MPKDEIKTQVQTKGVSVVETGRKADVQKGIDKLAKFGGFDLLESAIENVQNMNPERKARR
QIFLGDSSKTNERTALKKTLELWLEVLKGNNNLTDMVAQSEDKSKVAEKTLLKNLATAVK
ETEELEKAYRTIALFYKNTEQDKIKNVSIVNAEMDQLTDLDNTRFIDAIHNELVDNYDRL
DLKNNYGLLVIPGYLGGNKVVEKWAKIAHQNKVMLVTDFAHLDEPDDVMEMFDEAYLTGG
DIYRSNVLMTCNWLVGRGKFDEIEEIDDLYVPPSAALAGKIYKTLMSQVTAGKKFGGINE
VDGVKFDLKKSEIANLENMGLIPMVNEYGKVMAFSGKTLFNGDNLGLQTYSVVRVFDYVT
KVLMDFLNRRAFENFTAKTRKEIMNQIVRFLDGITGPDKLIENFEVRRFEQDPVQKDRIY
LDIHMKPYFPAKNFLIKMDGHKGDDGNEWDTEYEQK
>EGEFANNL_01788 hypothetical protein
MLSNFGIGGNEVPLDANEAILEIAQNRTLIAQKLTGNPPVKPEIVEGLNTVEQVFEHFKP
EVKVNFEDAEGATKFEELKFKNLGDFGIKGITAQSNFLTDLKMEKEQYQKIIKQLKTNKI
LKAALEDPDAKEALMESIEGLINELNQK
>EGEFANNL_01789 Chaperone protein ClpB
MQKEEALFHEELHTALELARKYATENRNAEYGPSHLLKAILHRDLSLLKELESMKKDVFF
IEEWAEVRIDDELKAGRPTQPEPNGDIDKVINEADEIRDILGRSEVDLYCVMVALATPGV
GFTYDQMKSFPVVREELLTEVDHNTTLEATEEKATNSKSIKYLFKYCKDKLVQVRKRPKK
IVAREKEIKEIVEIICRFVNPNVLLQGYPGVGKTALIEGFVNLVANKQVPDKLIKTKIYE
LDLGTLIAGASYKGEIEDRLKKILQELKTYPQAILIIDGIHVLLDKNSDNAGISSILKSE
LSGQEGLTLIVTTTIDEYTKKIEKDESLSGMFEVIKVEEPDEKQAFRIIKSALTSYLVHH
EIKVTDDSIEESIRLSKRYLKEKSLPESALNLLDRTMSVIKTAGISFLKEKEVLQKRLES
IKQKESYTSNKSLEYKWFYEDLKRKSQYLLSQEKELSEDIEKLSEEELYNYLNQILEKLS
EASLAKKEHIEPIDLAAVVAQKTGIPLGKLHSEEKDRLQNMEEILKKRVVGQNYAIQVIT
EAVLESRSGLSKAGQPMGSFFFLGPTGTGKTELAKSLADFLFQDENAIIRFDMSEFKEEH
SAALLYGAPPGYVGYEEGGLLVNKIRQKPYSIVLFDEIEKAHSSVFDVFLQIMDEGKLHD
RLGKEGDFSNALILFTSNIGAQFIVNSVNEGKGLPPSNQLMEIMTNNFRPEFLGRLTEII
PFSPITKENALGIFKIHLKKELLDLVQSLNINLEISDEAQSYLVDNGFNATYGARPLKGI
IRSELRRPMAKKIISGEIKEGDQVEVYLENKQLNWKIK
>EGEFANNL_01790 hypothetical protein
MDYKRKRSLLNYLRKLDIRILLVFIILILFGLFLFLFQLYRHVDCSQIDFEIISERNQVG
EVISFKNKTPNAQTSIWDFGDNTKESKEKDPLHKYEKPGVYTVSLQVNGSCVFQKIIEIK
DLGAIIDESRVPKIIAPESVTVGDPVKFYYNYKGEAFSWEWNFGESGQTDNTFEFPAYTY
SIPGIKRVTLIINGDVKHMGSVDIYVKPRKLVKTKTDTIHSYEPEKDANLFQLPKGSPQK
DPLEEFLRRIPGVPQPNPVQDKIKKANDSIAPNISQYQFELLLLDVAKQVKTQEDFAKYT
CGNYDFPVVKNSKKIMPFTQFCEQISNKKIKIEALRLTKDNKNCIKGIDITYKVKKSLIW
IYD
>EGEFANNL_01791 Beta-phosphoglucomutase
MINTVIFDMDGVIVNTEPMHKASFFKHYKELGLNISEEEHDTFRGLSTKNLYQKIKEKYK
VDASLEELVNRKREIFYKIFETKKDLDLLPGMRNLMESLYKENFQLILATSSAKATLSKV
FTRFNLYPYFTHIVSGEDFPQSKPNPAIFLEAVRLSGNSKQNCIIIEDSTNGIKAANASD
VFCIGYKNEASGDQDLSTADLVIDDFNTLTIDKIRNLVKQD
>EGEFANNL_01792 Inner membrane protein YbaL
MENHLPKLIVDLALILGAGAITTIIFKKIKQPLVLGYIIAGFLVGPHFNLMPNVGDMANI
KTWAEIGVIFLLFSLGLEFSFKKLINVGGAASITAIVEIVVILILGYLVGQWMGWSMMNS
IFLGGLLASSSTTIILRAFDELGVKRKNYARIVFGVLIVEDIVVILLMVLLSTMAVTQQF
NGTDMFMEFLKLIFFLALWFIFGIFLIPTLLRKTKKILDEETLLILSIGLCLGMVVLATN
IGFSAELGAFVMGSILAETTSAEKIEHSLKPVKDLFGAVFFVSIGMLIDPISMYEYRWEI
LIVTLLTIIGKFLFTTMGALLSGQPLKQSVQVGMSMAQIGEFAFIVAALGMSLGVTSDFL
FPIAVGVSAITTFTTPYMIKYSETFYEIISKIVPPRILRLIDKYSAGTQNIQEENKWKKL
SKAYLSLVLTNGVVIIGIVLLVVYVAIPIINEQLLGVRIFNPSLFNIIATIVTIILCTPF
LWAIVVKKPEKEIFTHIWKENIYARGPLIAMEIAKVAVAIILLGFILNLFLSGIIASLIV
IPIVIVGLYFLSTKFDFFYSLITKRFVYNLNERDIKQKELEKSENIKPKKSYLLWDSHIT
DFEVSPNSKFVGKKLSELAWREKFGINIAYIKRGDIKISIPSENDRVFPYDKLGLIGTDE
QIKNFETNIQMECPQDENINSLKQNVSLNKFAILEDSPVLNKDVKFLRELTQGLVVGIER
GDDKIVNPSSHTLLQLYDRVWIVADKENLQGINTTDTENKD
>EGEFANNL_01793 Nicotinamide-nucleotide amidohydrolase PncC
MNAYLIAIGDELLSGRTLDTNSNFIAKQLDRIGISTIKISTIFDDPETIKNELLQATLSK
ADFIFTTGGLGPTKDDKTKQTIADFLSDVLIFNQDCLDHVSKLYTERGRILNELTRNQAL
VPSRSLAIVNRYGTAPILWSKAKNNKILINLPGVPYETRAMMEETIIPKIKSEFKLPFIL
RKSLTVINYPESELAIALTDWENELPKNISLSYLPAGSRIELRLTIKGEDKDLMEKLVSK
EIEKLPEILGDRLISKEDINIIDLISDFLKKEQLSIALAESITGGSLSQCFTSVPGCSSY
YKGGIIAYNTKIKENILNVPRALIDEHTVVSKEVAEAMAINTAKIFQTDIAISTTGVAGP
NTDEYNNPVGLAYVGLFYKGEVFSEKFVYSNLTREEMILRISNKAIEFLYNIIIMNK
>EGEFANNL_01794 Na(+)/H(+) antiporter NhaP
MELYYSFSILIVLAAIFSYINVRFLKFPSTIGIMVIALVMSIILVLLGNLTSKPLNDFAS
LIKEFDFTEILMGSMLNFLLFAGAIHINLSDLKEQRIPVIVFATIGVIISTIFVGVSLYY
ITNYFFPLVNIHLAIPLIYCLLFGALISPTDPIAVLSILNQVKVSKSLETKIAGESLLND
GVAVVLFAILANLAANPVVVETGHMDLSFSHIFDLFVKEAIGGLILGGALGYLAAYGFKT
SRDYKVSVLITLAVVMGGYLIASYLHTSAPLAMVGAGLIIGEAKRKSVSSEKNYVGNFWE
LIDEVMNAILFLFMGFELLLIQDLLNYWSIGLSAIIIVLIARYVSIKIPILIIPFKEKFS
KGTVAMLVWGGLRGGVSIALALSIPESNYKEAIIATTYVVVLFSILVQGMTVGKLAKKI
>EGEFANNL_01795 hypothetical protein
MDLKLAKCCGNCEFFLDGRICSKKEISVTQNQVCDAYEFKAVLHREDDCLKCSKFQTTNC
AHPKVASEGIMCTVWYPRNSAVS
>EGEFANNL_01796 Phosphatase NudJ
MENLEKINVRVYALLINEGNILFLQEKFAGKDIIKLPGGGLELGEGTQETLERELMEELN
LKIEVKEHFYTQDFFLKSEITPKSQLLSIYYFVECKDLSTLKIVDKDIKSILWLPIKTID
IHRIDLPIDRIVIRKLIQNKFFMR
>EGEFANNL_01797 tRNA 5-methylaminomethyl-2-thiouridine biosynthesis bifunctional protein MnmC
MLKRVVVTTKEGSKTLQIPEWNESYHSQHGILQEASHVFIKNGLELINLSKISILEMGFG
TGFNALLTLFKALNYNKKITYYTLEKYPLEINELLELEYWKLIDDSRAKDYYLQLHHCEW
GRIVQIHENFEIVKYPSDFFDLYKLPIHNINLVYYDAFGARVQPHLWEEEIFTQIINTMA
PQSLLTTYSSKGSARRAMQKAGFSVEKLAGPIGKREMVNAWKI
>EGEFANNL_01798 Branched-chain-amino-acid transaminase 1
MEIKKTQHSKLDTIDPNNSPFGVNISDHMLICEYENGQWGKPVIMPYGGMNYSPALMAIH
YGQAIFEGMKAYKDKNNDVFLFRPEKNFERFNKSAERLAMPPITKEIFLEGLYALIDLDR
DWVPTKDGSSLYIRPTMFASEEMFSARISNKYTFAIMTSPADSYYDKPLKIKIENHYTRA
VSGGVGFTKCAGNYGASFYPTLLANQQGFDQIIWTDSQEHKYFEESGTMNVMVRIGDIIY
TPPVSNTILNGVTRDSLVNVARHNKIEVREERIPVDSIVNAYQQGTLKEIFGCGTAVVVN
RYSHVGYNDNIMELPTLKDEESYAVLLKKQLVGIQTNELDDPFGWRIKI
>EGEFANNL_01799 hypothetical protein
MSKINSKNIQYIFLLILLIFNLLHAYTLPLIDDEAYYWVWSNHLDFGYYDHPPMVAVFIK
IGSFFLKNELGVRLISCFSNILFYIIWLKILNPKTINENYLFLGLFGSTAIFNGMSFVAT
PDVPLLLFGSLFLWRWKCFINKYNALNSIFLGLSMALTMYSKYHGAILIIFTLLPSIPIF
YKNKWFYFSILLALILYIPHLVWQYNHNWVSIEYHLFGRNKKEINGFPTAAWLLGLMLIA
NPLLLYFYGKSLLKKYDSLWIKSLQWISIGTIAFFFLFSFKRIIQPQWNLIVYLAIIPLT
YLKYKSLNNKRIILLSYTYLAVLFLLRFLILSPWVIHASPMYKLKEFVVKANKFTNGIAV
FERYQKAALFHFYNQKPSISLQVYRHRSSQYDLWNSENLIQGKPITFFGLGNISDKFITD
ENGDKEYYKFIPSYISYPEIKVEVSPTIIQSKPNQTFDLELNWNHPYKTSIDLNSVANQT
IKVLFLRKKNLEPVVLLPVEDKIRIPNNKTVRSNLRITIPQLEPGEYFIYIVLNPCGISG
KIISNEITTKIY
>EGEFANNL_01800 Lipoprotein-releasing system ATP-binding protein LolD
MVLVKNIYKSFGNLEVLKGISLHIKTGEIVSIIGESGAGKSTLLQIIGTLDKPTHPEKHH
SLLEIDNLPVTQFRDKELSLFRNQNIGFIFQFHQLLPEFTALENVMFPGMIAGKGKNELQ
KKASELLKYLNLSHRLDHKPSELSGGEQQRVSVARALMNDPKVILADEPSGNLDSKNAED
LHQLFLQLRQEFNQTFIIVTHNNQLAEMSDKCLVIKDGVIAE
>EGEFANNL_01801 hypothetical protein
MKKKGYCIILTIILLLGISLWGYLQYQEKQSYKAGIYNHAHTLVKIDTYEILKKAITNQP
NTLDSVTIIKKIIKAVEIPTNIFIYNVEAKDKSTFFGSLKIKDYTFFENYTEPGLERKDI
DSHTKLFMDKDHKWAIMYNQTTAVFAYTYKEEKVIDIMLEIINNKNIIPVEESKFKDIIN
KKGLVVFYDGKNEANLNLEGTKISGTIQIETNKIKIPATIVSPDFNKENILSFWLQADVK
SFIPHKIFTIDKYQINTDSLLSSFQNEIQLEITKPVIQKESIITYDFDDNFEKIEIVKTK
ETLIPGLSLQIKSKTNQLYQYLDKQKIIINNEEVNRKVFPLYQVYVGKSKEALVFSTQKK
PKFAPQVPSNIIFYLKIDFDKMKKEKEYSTLSKYIQKFQNLEMKARSSNNKITCDWQFNF
SNNNEYPLETLIDFIKIVNNPKFENNKD
>EGEFANNL_01802 hypothetical protein
MKLLLSTLCTLLYISIFAQGQLVNKIPQDANAVIHAKGNKFLENISLQELSKTNLGDSIL
NKIFGKKRNGKDFNDLGINFSSDFFYFNQTTDSINYNALLFSISDANKFEELLKTKQGKN
IKIKQQGTIKEFYKNNNLILWDNEKAVFVFGDFKNNFFDDSTNVARYGVNNSDEYVYNSI
DTLAATDVMESASVEESDEVTDYLVATIANPAENDEETTVAETSTEDDDSEYENRQNSYE
REREKQDSLKASVNERWLKEYAYRIYYRNTAPSILDNPNYRKVEDKEAAITFFTDKYDKR
RYYYGWYPENNGLLSIYTKKFLEFTGSPLALGAKSVNVKLYLNNQNVLLKTAVEVNEKDL
EQYKQMYNYKLNKKFYQYIDEDKVPGFISLSLNTEKYMELYPKWMANLIFSKDDKEEAEL
FTEFFNIILDEKAIAKVAKGDALFLLNGLSARESTYKTYEYEEDTYDSKEVEKTKKETLP
EFLFMASSEDTRFQKSLLKYGIKKGIVSLDDGIYTIENKDYKTYKFYLLIKDGIIFIGTS
PNDILNIKNGTYVAKINKKQKELLSKNGSVVYFDSSKILNQLSEEGFNVAKDYKKVSDFL
KEMGIFTAKYTGISDNSINAELTLETKGENNNSVKSFLKMVEILLDF
>EGEFANNL_01803 hypothetical protein
MLIFNGYKLTAIIMDLYKTFLIKNCKFFLLFILSPFLISCFEILEEVDMNADGSGEMTMT
INLSQSKNKIASIMLLDSINGYKVPGKKDIQQDINGLSTKLKNIAGISNVKTTTDFTNYI
VSVSFSFSDVSVLNKASKDIFAAYKMKVEETPVYSYNKTSKTFNYDYKNGNKEAYNKLKA
ADKEVFKNATYTQIYRFTSTIEKSNNAQAKISKSKKAIMQKSLILDLINNKVNISNQIKL
N
>EGEFANNL_01804 Quinolinate synthase A
MPTLNNAIESLKEKGYLNLKVPENLDLVKEIQKLKKEKNAIILAHYYQSKEIQDLSDFLG
DSLQLARAAEKTEADMIVFCGVHFMAETAKILNPTKKVVLPDLHAGCSLADNCSGDGLRK
MKEEHPGATVVSYINCDIGVKAESDIIVTSSNAESIIKSLPENQKIIFAPDRNLGRYINQ
VTGRNMILWDGACIIHEAFSAERIAKQMLEHPGAKLIAHPEAQKNVLALADFIGSTARLL
DYVVNNESQKFIVATEEGILHEMHKRAPHKELIPALIQDETCNCSECFYMKMNTLEKLYL
CMKYELPEILLDENMRVKALKSINKMLELSVQIK
>EGEFANNL_01805 L-aspartate oxidase
MLYTDVLVIGSGISGLSYALKIAQKSPEARITILTKADDEESNTKYAQGGVAVVTNFIQD
SFDKHIEDTLRAGDGLCNREVVEIVVKEGPERIKEIVEWGTIFDKDDKQTYDLGREGGHT
VNRVVHFKDITGAEIERALLEAINKYKNIQLLNYHYVIDLITEHHIPNEPFNKYNQNCFG
AYVLDLKKQRIIKMSSKITLMATGGCGHVYKNTTNPLIATGDGIGLAHRAKAKISHMQYI
QFHPTAFYSRRSGQLSLISEAVRGFGAKLRTASGEKFMHKYDEREELASRDIVARAIDSE
MKLRGDDYVCLDCRHLDHEKFLEHFPNIYQKCKEEGFDMFKDLIPVVPACHYLCGGIDVD
IYGQSTIENMFAVGECSNTGLHGANRLASNSLLEALVFAHRSAMKTTEKLNSDNFQYNKI
DKIPEWDQKGMEVSKEMAILNYLRKDLQILMSDLVGIVRSNRRLEMAKQKEEEIYKAVKE
LYHLSILSPQLSELRNLVSVAWLIINQSLEQKRNNGAFYNKDLN
>EGEFANNL_01806 putative nicotinate-nucleotide pyrophosphorylase [carboxylating]
MNSPPYVTKDRLKHFITEAIKEDIENGDHSTLGSVPAHSKQKAHLIIKEDCLLAGIDLAI
EIFNFYDPSLQIEVLKNDGEQVSKGEIAFIVSGNASSILSMERLVLNCMQRMSGIATLSK
EMSDLVKGTKTKILDTRKTTPNFRMCEKWAVYIGGATNHRYGLFDMVMLKDNHNDFSGGI
IESVTSVRKYLQEKQLDLKIEVETRNLLEVQQAIDVKADIIMLDNMSILDMEKAVLLIDG
CAKTEASGGITKERILEIASIGVDYISSGSIIYRASVKDMSLKAIK
>EGEFANNL_01807 hypothetical protein
MKFNQLSNNKDQTVNHMGALAFRMESEIELYSAVVTFMVDDSYYESGEERLKRIKKLIIE
CDPEFVCKLAVYARTYMNLRSVPILLTVELAKITNGNDLIRKTIASIVRRADEIKEVLAY
YQIANKRKQTKKLNQLSKQIQKGLAEAFNSFDEYQFAKYNSKSEVSLRDALFLVHPQPKD
KNQQEIFNRIATNTLKIPYTWETEMSELGKKNFSSEIEKKNAVAKKWEELVESGSLGYMA
ILRNIRNILVKGTDRSLDTAIQILTDRERIHKSKQMPFRYLSAFIEIDKLSQEDQIFEKI
KEKTVRVRNALEIALLIACENIPYQEGKTAILSDNSGSMYGDYAGKSLVSAMSSRKTADI
ANLFAVLYWEKCRDTYVGLFGDHLVNAKLSRNENVFENFKRIDEAAKECGPGTERGIFAY
MEEIIKEKIIIDRMIIFSDCQIGDGCNWFDDKGNTGKNFNSLFKKYLKINPEVKVYTIDL
KGYGNSMTKSSKNMVYISGWSERIFDMIYFIEQGSTIVEEIMKIKL
>EGEFANNL_01808 hypothetical protein
MPVNRNALIRYKTIDTCLRNKYRRWTLNDLIDACSDALYEYEGIDKGISKRTVQMDIQMM
RSEKLGYNAPIVVYDHKYYKYEDENYSITDTPLTEQDLKTMSEAVEILRQFKGFSYFSEM
DNIVSRLEDHVTSAKKKTFPVIDFEKNENLTGLKYLDPIYHAINNKKVLKITYKSFKATS
TCCYIFHPYLLKEYRNRWFVFGRFNHSLYNLALDRIQEIEISENDKFIDNDLFNIQSFFE
DIVGVTRNANIRAKNIRFWVDKNNAPYVETKPLHKSQQIIESHEDGSKTFQIRVIINQEL
QREFLGFADSIVILSPQSLANFMNKKFYSALKNYTENEI
>EGEFANNL_01809 putative HTH-type transcriptional regulator YybR
MYKRKIPFEIDCGIKITMEVIGGKWKSCILQSLNKEPMRPSELHKEFSDASPRVINQQLK
ELEIHGIIQKKIFAEFPPHSQYSITDIGKTLIPIIDQIEKWGDSFRPTMGKILGIKES
>EGEFANNL_01810 Arginase
MNKEQNTTLRLIYPQWQGGIISPLVPELSPEDSCTGYYLGARLLNFLAPNTNQKTIEVPI
SLNINDRAVKNGINSYQVIYKQTQSALEILKKENPQRIVTLGGECSVSIVPFTYLASKYP
DDVAIIWIDAHPDLNLPYDKYEGYHAMALTASLGMGDEKLINLLPGKVDASKALLVGLRA
WDEEGGTPERQKALGIKHLTGEEVAKNSKQILNWIKATKASKVVIHFDLDVIDPNEMVAA
VGTDPDGMKINEVVRIINDIASSYDLVGLTIAEPMPRVAIKIKNMLEKLPLIQ
>EGEFANNL_01811 Hydroxymethylglutaryl-CoA synthase
MNSSIKVGIDAASFDIPKIYLPIKDLAVARNIEPAKLEKGLGLLRMSFPDVHQDVVVFAA
NALRKLIIQENLKPEDIARIYVGTESGIDSSKPIGSFLLPLLEDYYGAGSMEHCDVVDLT
FACIGGVDALHNCLDFLRVNPEKKAIVICTDFAKYDLNSTGEYTQGAGAIAILLSSNPRI
ISIDNKIGISTQGVFDFFKPKRSLNKKEVTGKENNPEWFGVLENEIDLFKEQPVFEGQYS
NSCYQNRLKGAYFQLKKLLNYEGSLYNAWKNIIVHLPYSFQGRRMFSEIYALDSNLKDSL
PEDLTAYNERIKEIGKSAEYKTLVKEKFSPAEIASSDIGNMYTGSIFMGLLSTLYYHFKN
NSEIKGEKFGLLAYGSGSKSKAFEGIVESEWKSQTEKIKLFETIKDSKPIDLDAYHALHK
KELKKSIISPCNEYILDKIEKNDPNLLGARFYKYI
>EGEFANNL_01812 Formyltetrahydrofolate deformylase
MKNSNAILLIHCPDRPGLIASVTEFICSYGGNIIELEQHVDPKDKIFFMRVEWDLKDFSI
PRNEISEYFKKNYGENLSMNFKLYFNDYVPKMAICVSKMSHCLFDILGRYTAGEWKVQIP
IIISNHEDLRWVADKFGIEYHVFKMNSENKTSIEAKQKELLREKEIDFIVLARYMQILTD
DFILSYPNKIINIHHSFLPAFVGAKPYHAAFERGVKLIGATSHYVTEELDAGPIIEQDIT
RISHKDCVQDLVRKGQDLEKIVLSHAIEHHINRKVLVYKNKTVLFS
>EGEFANNL_01813 Peptide chain release factor 3
MSTTLEKEIHKRKTFGIISHPDAGKTTLTEKLLLFGGAIQEAGAVKSNKVKKGAASDFME
IERQRGISVATSVLAFDYKGKKINILDTPGHKDFAEDTYRTLTAVDSVIVVIDVAKGVEE
QTEKLVQVCRMRNIPMLVFINKLDREGKDAFDLLDEVEQKLNLRVTPLSWPIGMGLDFQG
IYNMWEKNLKFFTEEKKQKVGDRIEIEDINDPIINELIGDKAAENLRTDQELITSVYPEF
SKQEYLDGTLQPVFFGSALNNFGVQELLDAFIDIAPNPLPKMSDIRLVKPEENNFTGFVF
KIHANMDPKHRDRLAFVKIVSGTFKRNTNYLHVRQNKTLKFSSPAAFFADKKEVIEESFP
GDIVGLHDTGNFRIGDTLTEGEKLNFKGIPSFSPEHFRYINNDDPMKTKQLAKGIDQLMD
EGVAQLFTLEINNRKIIGTVGALQYEVIQYRLEHEYSAKCSYEPVSIHKACWVECEDQKS
EEFLEFKRVKQKFLAKDKFGQLVFLADSAFSITMTQEKYPSVKLHFTNEF
>EGEFANNL_01814 2,3-bisphosphoglycerate-independent phosphoglycerate mutase
MILDGWGIATDKSVSAIDQAHTPFMDSNFQKYSHTTLVTYGLDVGLPKGQMGNSEVGHMN
LGAGRVVYQNLTRINLTVENKTLNKEAELQKAFEYAKANNKPVHFIGLVSDGGVHAHIDH
LKSLVEAANNSEVKEVFVHAFTDGRDCDPHSGKGFIKETLDFCNTYNAKLATIVGRYYAM
DRDKRWERLKLAYDAMVNSEGTHTDDPLQVIEQSYKDGITDEFLKPIVITENDTAIAKIQ
EGDVVICFNFRTDRPREIVDVLSQHDHPEVGTKKLDLYFVTMTEYDETFKNIHVIFKEET
IKNTLGEVIANASLNQIRIAETEKYPHVTFFFSGGEEKEFVNEKRIMAQSPKDVPTYDLK
PQMAAYDIRDAIIPELKKQEVDFVCLNFANTDMVGHTGVFEAAIKAAEVVDECAKDICDV
ALDNGYTTIIIADHGNSDKMKNEDGSPNTQHTTNLVPLVIVDKEHYNLKPGKLGDVAPTI
LTLMGLPIPKEMTGDILIQK
>EGEFANNL_01815 Glutamine--fructose-6-phosphate aminotransferase [isomerizing]
MCGITGYIGKKLAYPIIINGLRRLEYRGYDSAGIVLNENKNFKLFKTKGKVSDLEEICKG
LKSDATVGVGHTRWATHGVPNDINSHPHLSNNEKIVLVHNGIIENYDTLKIMLTSKGYTF
KSDTDTEVLVNLIQFMQDTQNIDLSTAVRLALNEVIGAYAIAVMEVDHPEEIVVARLSSP
LAIGIGENEYFIASDASPFIEFTKEALYLEDGEMANISLKGVDVFKIKDNSKVNPIIQEL
KLSLEEIEKGGYEHFMLKEIHEQPKSIMDTMRGRLLVEEGIIQMAGIWDYQEKFLNAERI
IIISCGTSWHAGLVGEYLIEDLARIPVEVEYASEFRYRNPIITDKDIVIAISQSGETADS
LAALKLAKEKGAFIYGICNVVDSSIARLTDAGSYTHAGPEIGVASTKAFTAQLAVLSMIA
IKLAKHKGTISKEKFNSLITELDSIPDKIEKLIKSTEEQIKKISLQYENVHNFLYLGRGY
NYPIALEGALKLKEISYIHAEGYPAAEMKHGPIALIDENMPVVVIAPRTEHYEKIVSNIQ
EINSRKGKVIAIVTEGDTQVKNMVAEAIEIPDVSECFSPILASIPLQLLAYYIAILRGVN
VDQPRNLAKSVTVE
>EGEFANNL_01816 hypothetical protein
MNILKSNIKLLILTGISITFLLSCENDSTDIGAGLIPDQSKGMKTTVDLVAYTVSNNDTI
RADYSTLTNGLIGVYEDNVFGKSKASFNTQIRLAANHEIKGNIQEVDSVVLTINPSFGAS
LGTVSSVLKPGNGTDTLKYTTKYPLTSYLGSTETPMPINVNRINTFLETTSSALYSNKVV
SVGDLLGTANLGGTLTSISIKTSGGAVVTTESKPGYRIRLDPTYFKENFFNKKGAPELSN
DDLFVQYFKGIRISPADDRSHFMFDFSRSTMTLVAYYKYKNTNADNFVNATYEFTMGNEF
NSELGEYTFDNSTASSQLKEQLLNPNITQGESKLFLQGMGGPSAIIKLDETQISAIRDSV
LHKNWAIVNAQLKFNVAETTGTKPIYIYGYNSTKNSFLPDITSFSSLSGYNFNPPYNTEI
NPGYYILNITQYVKSIVEKNASNDLIKVGIGNFEKNSSDQYVSYAKTTRAYQPYRLVFYG
NNETEDKKLKLEITYTKK
>EGEFANNL_01817 Glycogen synthase
MSLQRILHVTSELVPYFNENPISSGVYNAAKQMFAQGKDVRIFMPRFGLINERRYQLHEV
IRLSGMNLIINDLDQPLVIKVASLPGERMQVYFIENQEYFKRKSAYSDDFNQWFEDNDER
SVFFAKGVLETIKKLNWIPDVIHIHGWMASFLPIYLKTNYSNDAFFSDIKIISSVYNHGE
GGVFSENFKNILEYDKIDLNDLKYLNSNSYVNVVKEAMKFSDVVVKGEELLLNELEELFN
ELEQSKFDFIQNEDIQEVYREANGINIQH
>EGEFANNL_01818 Pantothenate synthetase
MVILRNRQDLSDFSSSINDKQLALGFVPTMGALHQGHLSLIQKSIEENQYTLASIYVNPT
QFNDISDFEKYPKTEQEDIKKLESIGCDAVYIPSNQDMYPEGLEIDEFTIGTLGDYMEGH
SRPGHFDGMITIVRRLFLQIKPSKAYFGEKDFQQLQIIRKFVYDEKLPIKIIGMPIFRED
SGLALSSRNSRLSGSFKEEASFIYQSLLKAKKLIENCKPVSEVISEIKELYDSSIFKLDY
FIIAEEENLIPVEKLESNKSYRAFITVYAGEVRLIDNIKLDFNNCI
>EGEFANNL_01819 hypothetical protein
MNKKIKTTLTVLVSIIVAGGLMLLVAKSLGGNFVEKTISVVKRANYLWIGLAACFGLGAY
FLRAIRWNLLLEPMGYKIHNSNALWTLSFGYFLNLGIPRMGEIGRATALQTVENVPFSKS
FGTIVTERVIDLLFMLLFLLLAFIFNYSSLLSAISISISSNDKPIEINYTILYIIGFTTL
LLFSLILILRKKLLQLSVVNKIISLLKGILTGLISIVKVKQKLKFTLLTIGIWVCYFFAS
YLIVFALPETSFISIQTGFYLLAIGSLGMMLPASGGIGAYHGAMMIGFSALFLSLDKSAS
EGKDIGYSYAILSHSLQMVIMIVMGLISVVMLARNKKTKK
>EGEFANNL_01820 General stress protein CTC
MKSITIQGEKRESVGKKSSQALRNAEKVPCVVYGEKEVLHFSADEKSFKNLVYTPEAHTV
TLEVDGRKIDAILQDVQFHPVTDRIIHADFYELNPDKPVSIEVPVITTGRSKGVVRGGVL
RVNLRKLKVRAIPVNLPDEIVIDVTPLNVGHKFEVAKLKNDKFQILHPDNTVVVAVKTSR
TVKAGADDDDEENGESSANENAEGTN
>EGEFANNL_01821 Ribose-phosphate pyrophosphokinase
MSQPVHIFSTRENVTLAEKISQSYGMPLGKMSFFDFSDGEYQPCLEESVRGSRVFIIGST
FPPADNLMEMLLMIDAAKRASADKITAVIPYFGLARQDRKDKPRVPIGAKLVANLLSAAG
ATRIMTMDLHADQIQGFFEIPVDHLFASNIFVNYVRSLNLKNLTIASPDMGGAKRARTYA
SHLNADVVICYKERKKANNIDYMILIGDVKDRNVILIDDMIDTAGTLTKAADIIMESGAL
SVRAMATHPILSGGAYERINNSRLEEVIVTDSIPLKNNLVDKIKVLSCAPLFGEIMNLVH
NRESISKKFLI
>EGEFANNL_01822 hypothetical protein
MKKKYLYLFLLPILVLIVHSCKNSFDEDVSDVAIQKGQADFSRYVALGNSLTSGYRDNAL
YISGQKESYPVMLATQMKYAGGGDFKVPYMNDELGGIPMLKVENKKILAVVNGSLSPVTA
PDNASTTINNLYSEGPFQNMGVPGAKSFHLIVSGYGNPNKLQSQEANPYFVRFASSPESS
VLSDAMLQNPTFFSLWIGNNDVLGYATSGGDGTNPITDISTFDSAYKTLVQTLTSGGAKG
VVANIPDVTSIPFFTTVPFNPLSPQALTASDPNQIDKINTSYSQLNQIFEALGYPERKIV
YSSTQANPVLIKDKSIKDLSQQLSNVLISKGIPSQQANFLGKLYGQSRPANSKDYLLLTV
SSILGKPNQEAIKDGVLAEQSINGVTYPLEDQWVLTEVEVNLIKQATIAFNNIIKNYAEQ
YNLAFVDVNKLMNDLSKKSGITYDGVNYTSKFVTGGAFSLDGVHPSGRGYAFIANEFIES
INKKYLSNLPKVNPNNYKGVDFP
>EGEFANNL_01823 Putative outer membrane protein
MISMVQAGGFRVSLQGVRQAAMAHTSAHVRDASVAFFNPGGIAFIPSKLSISSGGFLVGT
KVNYQNLQTHYKASTDNPISTPMTFNVAYKATNQISVALSITTPFGSTVNWGRDWAGKDL
INKIELQAFYIQPTVAYRFNNWISVGAGVIYATGNVNLQKSLTPVNGHMKLEDKNASGNG
FNVGVYLRPTDKLDISVAYRSKVDMKAKKGKAEFDIPSSLVGKSPFLTSTDQFSATLPLA
SEFTLGLTYRVLPKLSISADWNVSGWNRYENLTFNFKKNQVGNLENDPTVSMAPKKFKNS
NTFRIGGEYLATKDLAVRLGYYYDQSPVRSNYWSPETPSTNNNAVTGGVGYSFYNKKLMV
DLSGIYYVGKSRKFNNEFYNFSGEANLSSFIVGLGLTWNPF
>EGEFANNL_01824 Fe(2+) transport protein A
MNPQSLSLLKPSEKAIVIGFSEEDIPAKILEMGIVPGVSISLIRKAPWNGPLYIEYGNEK
SIIMLRKEEAKCILIEVKS
>EGEFANNL_01825 Fe(2+) transporter FeoB
MEKKTIVLVGNPNSGKTTLFNQLTGLHQKTGNYPGITVEKKEGKFSFKNTNYRIVDLPGT
YSLSPSSADEEVVLNTLLDTKNPFYPDCIVVVGDVHNIKRSLYLYKQIRDLQIPCILAIN
QIDDIEKEGILIREENISTYFDTPVVLVSARKNKGVEELKNKIYELTTSSAVTKEIHFEC
PNEYKAIINEIKESCSINNDYIAWLLITQVKTYNIPLKYKSVISEIEKKYKIIPKRLQVK
ETILRHQQIDNVVEKIVYKDPTYQTLTNKIDEIATHKIWGYLIFFLILFLIFQSLFYLSS
YPQDWIEGIFADSSTWISKFLPKGPLTDLIAQGIIPGVSGVIVFVPQIALLFFFLLLMEE
SGYMARVVYLMDRWFKPVGLNGKSVVPLLSGVACAIPGIMSARNIENTKERLITILVTPF
MTCSARLPVYSIIISLIIPKGEGFFNLQGVAMMVMYLLGVLMAFLGASIANAFIKSKYKS
YLVLDMPNYKVPFWRNVFYGLYEKSLSFITNAGKIIIAVSVVLWALGTFGISKNNSKTNY
FAEVPLADSYLGKFGKTIEPVFRPLGYDWKIDIAILSSFAAREVFVGTLASIYSLEENDS
DSNVKLKELMKNDINPNTGKPSFNFASGVSLLLFYAFAMQCVSTLAVVKKETFSWKWPII
QLLSMTGIAYFTALLAYQILK
>EGEFANNL_01826 hypothetical protein
MQKIIYTYIILIGAINLFEAQENKKVDELDSIIVPKKEKHWKIIGEQSLTINQSSFSNWV
AGGVNSFGASAKINYSFNYEKGKNIFKNKIILGYGQVSNEKEKPKKTDDVIHIESMYGYK
ISKSWYSSIASSLITQMANGYNYDADPDYTVKDRKSAFMSPGYVTLGLGFEYKPYGKLQI
SILPVTAKATLILDKKLQKKGEYGLKKDGDNLFMELGNLVTVKYDFDLMKNVSTNNTLSL
FSNYLEHVERFNIVYGTIINMKINNSLATKLTFDLIYAHNQVQKVQIKQTFGLGMSYKFQ
TE
>EGEFANNL_01827 hypothetical protein
MNFTENAWRIFNQSIEHYHKLDRVDQEIKNPYPNHSIEHLLYLKNWIDTVQWHLEDLIRD
PKIDPIEALELKRKIDASNQERTDRVENLDGWFLEKFKDVNILSEAKINTESPAWALDRF
SILALKIYHMNMEVNREDASTTHIQNCKEKLSILKEQHKDLSIAIEELLEDYKHGRKYMK
VYKQMKMYNDEDLNPILYNKK
>EGEFANNL_01828 Sec-independent protein translocase protein TatAy
MRLFEHPMTIVIILVVVLLLFGGKKIPELMRGLGTGLREFKDATKKDEEVKNKDSNSTKD
EL
>EGEFANNL_01829 Murein hydrolase activator EnvC
MSIKSYFTLFTAVFLGCITYAQQPYKKENLQKESAKLRQEIVELNKALSISKNQSQSSLI
YITNLNKKLAAREALINNTKKESKVLDDEIYLNQLAINKLRRELKDLREDYAEVLIRSYK
NRSVQNKVLFILSSNDISQAFRRIKYLQKYSEYQNEKVAEIEAKQEAILKTIELREKAKK
DKINILAQQQAQIKEINKDKKEKEAAVELYNKQQGDLLTKIKEKQTQRNALDRQVQAIIT
EEMRIAKAKEAEERRKAELAELARRKTIEEERARKAREAELAAKKLAEEKAAAARKAAAE
ALAAKQAAEKEANEKARIEAEKIRVAREKAAEKAAAEKVAADKLAAEKAVKAKEAEKIAD
DKRASLGITKTPITNTETLSKNFEANKGRLPWPAIGTVVATFGTSPHPTMQNIKVDHKGV
EIATSPGSLAKSVFEGTVSKVFAVPGGGKAVLVNHGNYFTLYANLSTAIVSAGDKVKIGQ
PLGKIYTDDANNTLLDFQIWQGQVPVNPANWISGM
>EGEFANNL_01830 hypothetical protein
MKYIIYFALLTILFSCNTQKVSTEQTNKINFESVNEKRVFDNINSSLEFKNLKIKANANI
KVGETSYPSVSLVLYLDKYKEIWGNASLILPLARVSITPEAFKLYEKIGKSYIDTDFKYI
NSLLNVDFLDYSSIENLLTGKIFLTITPKDYKFSIEKNQFILQSIKDIRVGEGKNIRNYK
VKISLDSNYNLKEVKMEDKKYNSLIEVSYGEYLLFENLKFPKNIKIILKDQKEASITLEY
NKFESVKMETPFDIPKGYTQRKIN
>EGEFANNL_01831 UTP--glucose-1-phosphate uridylyltransferase
MKIIVPMAGKGSRLRPHTLTVPKPLIPIAGKPIVQRLVEDIAKVVNEKIDEIAFIIGDFG
QDVENKLIKAAENLGAKASIYYQLEPCGTAHAIHCAKNSMSGPVIIAFADTLFRADFQLD
KYSDGVIWVKKVENPSAFGVVKLDAYGVIQSIVEKPKEFISDLAIIGIYYFKEAEKLMNE
IDYLIDNNIKSGGEYQLTDALDNLKTKGAKFTLGKVDDWMDCGNKDATVETNSKILDYEK
DNAIEYPASAEIKNSLIIPPCYIGENVKITNSKIGPYVSLGNGTKIDSSNIENSLIQENT
LITHGNLNNSMIGSSAKYFGVASALSLGDFSVLETK
>EGEFANNL_01832 Deoxyuridine 5'-triphosphate nucleotidohydrolase
MKINIINKSKHKLPEYKTALAAGMDLRANLDEPITLRSLERKIIPTGLYLEIPPGYEGQI
RARSGLALKHGIGCPNSPGTIDADYRGELGVILVNWSKDDFVINDGDRVAQLVISKHETV
EWVEVSELNNTSRGNGGYGSSGIN
>EGEFANNL_01833 hypothetical protein
MKEQFIKELSTRYTFKGEKIVLGKAMLDREVMTDVEIGVPLKMINRHGLIAGATGTGKTK
SLQTLSEQLSLNGVPTLLMDIKGDLSGLAKPGDHSNAKILERYKSLELTYNAQGFPVELL
TISKEKGVRLRATVKEFGPILLSKILGLNDTQTSIISIIFKYCEDKNLPLINLSDLRKVL
QYVTDNEEGKKDLVTHYGSIASSSLGAILRSIVTLEQQGASCFFGEPSFDPNDLLKFKDN
LGVINIIRLTDIQNNPLFFSTFMLSLLTEIYQKFPEIGDQDKPKLAIFIDEAHLIFNEAS
KVLINQIETMVKLIRSKGVGLYFCTQVPGDVPEGILSQLGLKIQHALRGFTAKDKKEIDK
AVENYPSSSYYKANELIQQLGIGEAFITSLDEKGIPTPLADTFMISPSSRMNILTETEIE
EIVNDSYLVKKYEQNLETKGAFEILSESSNNNSTPKEQSDVSTKKTTPDQKKSTKDTSLF
STILNSAFVRDMGRTIVREGSKALFNALGVNKRRSSRKR
>EGEFANNL_01834 putative ATP-dependent helicase DinG 
MDYAILDIETTGGKFNEEGIIEIAVYRFNGEKVTDTFISMVNPERKIHFYVQKLTGITSK
MVLAAPKFYELAKRLIEITENAIIVAHNANFDYRVIKNEFKRLGYNYQRLTLDTVNLSKK
LIPNMPSYSLGNLCSELGIPVSDRHRAHGDARATVQLFQLLLSKDINKNIITSFIQEETS
IKKEENNKINKLLENLPQLPGVFYLLDVNGTIIYIASSRNIAIKARLILTHNQRKSKIIL
KQTVSITYELTGSAVIAEIKALNEEIAILPKFRAIKENYPFLQGIFIKEDQFTITSITHK
NKKSAWLAFSTVEEAESFLENYTYTETSKNNYFLKEDKLLLLGIGRNKNEHSFLYLEKGL
LKGYGYYKLHSQIKSVDRIQKIMTPATANLNLQLLIRNLVYINKKLIKKTITQE
>EGEFANNL_01835 Chaperone protein DnaK
MSKIIGIDLGTTNSCVAVMEGSDPTVITNAEGKRTTPSVVAFMEDGEIKVGDPAKRQAVT
NPHNTIYSIKRFMGTKFSSDENEVSRVPYKVVKGDGDTPRVDINGRLYTPQEISAMILQK
MKKTAEDFLGETVDRAVITVPAYFNDAQRQATKEAGEIAGLKVERIINEPTAAALAYGLD
KSHKDQKVAVYDLGGGTFDISILDLGDGVFEVLSTNGDTHLGGDDFDDVIINWLADEFKS
AEGVDLKADPIALQRLKEAAEKAKIELSSSTQTEVNLPYITATASGPKHLVKTLSRAKFE
QLAADLVKRSMEPCKKALEDAGLKTSDIDEVLLVGGSTRIPVIQEEVEKFFGKKPSKGVN
PDEVVAVGAAIQGGVLTGDVKDVLLLDVTPLSLGIETYGGVFTKLIEANTTIPTKKSETF
STAADNQPAVTIRVGQGERPMFNDNKEIGKFDLVDIPPAPRGVPQIEVTFDIDANGILSV
SAKDKGTGKEQSIKIQASSGLSEAEIEKMKKEAEANAEADKKRKEEVEKVNAADSLIFQT
EKQLKEFGEKLPADKKQPIEDALAELKKAHEAKDVPAIETSMEKLNTAWTAASEDLYKAG
QNADAGAGAQQGGANPNAGANQQGNDNVEDVDFEEVK
>EGEFANNL_01836 hypothetical protein
MEATTIKGTNHGPNLRRWREWRNINQEVLAEKIGVSQATLSGYEKKDKLEQEVLEKLAKA
LEIPVEAITEIGESTSINIVANTFTDFKDNAVANQNYPTFNTVDKIVELYEKLLETEKEK
VRLLEEVLKGRG
>EGEFANNL_01837 hypothetical protein
MDSFTPYFFIDNIQFNDSTNIDLNYNDIIVFVGANNSGKSASLKEMYSKLENIKNPTKII
KEVRVKKNRPDDEIKKYITENSIIEKSSFNNYKGYGYSFNEHSLDFALRSSDELNFLRSV
FANFIGTEDRLVASNPPDNIDFIKNPYTHPIHFLYRDDTIEAEFSDYFKSAFNKELIVHR
VAGNIIPLYIGEKPILNQGEDRVSTSYIEKLEKLDLLHEQGDGMRSFVGVLLHSFIATQN
ILFIDEPEAFLHPPQAKLLGKMLSNNLPSHKQLFLSTHSEDFLQGLLDSGHERLKIIRIN
RVQNINYINHLENSNIKEIWSDSILRHSNILSGLFHKKVVICESDSDCRFYSAILSSITD
NESIPSPDLLFIHCGGKHRIPVVVKSLQQLNVPTVVISDFDVLNNETPLKDIFLSLGGNW
EAIKNDWKIVKDKIDEKRPELLTEDVKKEIISQLDLATDRIFPKEISNNIQSILKKASPW
SEAKNNGISYIPNGDPTTFYNKIKEKFEEKGLFIVEVGELENFDKSIGNHGPKWVNEVLK
KDLYNDSNLQKARDFVKKII
>EGEFANNL_01838 hypothetical protein
MLFGTKRITNGEFLFLDIIAVLNEQDDYNKVRNYWKYLKSKLKKEKNELVRVTTQLKLRS
LDGKIRLTDTLDSNGVFYLAKNITY
>EGEFANNL_01839 hypothetical protein
MILEGKVTYRKYKEAKDSVKALFKDEFFDYWELSIGNDEIANMSPGKANLALLKLLIELS
ESNCPILIDQPEDNLDNRSIYTDLVQFIRKRKENRQIIIVTHNPNIVVGADSENVIIANQ
NGQDKNRENKSFRFEYVNGALENTYANKNENVESGVLFSMGIRENVTEILEGGREAFKKR
EEKYGF
>EGEFANNL_01840 hypothetical protein
MKKLVLFAAVVFGLSTMNAQKGSILLGGNIGYSHNETKFGDSKTQLDSYNWNPYLGVQIA
DNWTIAADVKFAKEDVDHDTSNKNTRIGGFIRYTQPLSETFSVYANVGAGWQELKTTVSG
TDAGKADGYYIGFTPALFINFKNNFGLNFNIGGIEYSHLKQNKSDLKSSKFDLTFGNAFN
IGISKNFSL
>EGEFANNL_01841 hypothetical protein
MKKIILVAFTIVSVLSVHAQKGSIMLGTDLGYSRVDGFDDVSTNTFSFSPAIAYEVANNF
YLGIKSDLSYSESSEKFYDINGDLAFKDKLNNYTTKIGGFIRYYHPFSETFGIYGDLGAG
YIQGRQNSTVRDYSTASTYSDDLGRQRQYGYYIDFTPALFINFKNNFGLNVSFGGVEWSD
TKTNVAADYKNYTTSKDFDFTFGKAIKVGVMKKFSF
>EGEFANNL_01842 hypothetical protein
MRNMTFKITIYSIFLSLLGFVTSCSSDDDHVVQPEHQHEEVSKIVLHFTNIDKPTEIIEI
PYEVPEGSTEYPLAKINLPVGTYNVEAHLFAHENNQYQEITEEIFKHDADDHFIFYQILN
GKGLTIAYTNNDYVDTAGNKLGYNTVWTVTDEANNLPVYLYLLHQPANKKQDAVSLQELG
GNIDLEAHYQLN
>EGEFANNL_01843 putative TonB-dependent receptor
MKKILGIFFTFFILINISSQTNLCNYIFKGKVIDGQTNQSIKNATILLKSENANNYPEVI
SDSLGNFLLDSVCAGNYRILVSSNNYNSKEVELNISDNIFLDLDLLKLSELSDVIVIGKK
QLKNTQTSVENKLSKDKINAYSDTNLGTLLSTIAGVNTLSTGNNVVKPVIHGMHSSRVPV
MNNGIKQEDQQWGIEHAPDIDLNVANSISIIKGAGALQYSGDAVGGLVLIEPKKLTAQDT
LLGNLLGSYISNGRGGNISANIEKGWGNGLSMRLQGTYKNLGDLSAPHYNLSNTGVKEND
FSFQLGYNKQKYGIEAFYSYYGLESGILKSAHIGNLTNLVNAINSREPSIIEKYTRKISA
PKQKIEHNLAKINTFYRSTLGVFNLAYAFQYNKRQEFDIRRSEFKEKPSLDLELSTQNVN
FDFDHNYWGNLKGKMGISYIFQENKPQAGTGVDPLIPYYKKNSFGIYWLESYELTNKLTL
EGGVRYDYQKINALKFYKKARWRALGYDNKYSSLIKDDVGLSYLVNPKFNFNGYSATLGF
NYKINHANQFTFNYSLSSRAPNPSELFSDGLHHSAAAIELGDLELGNEKSSKWIASFKSK
LLNSKLDLELVLHYNTIKDFINEIPVGAEYTIRGAFPVWKYIQTNAEIYGMDITADYRFT
NNWNLSSNFSYLRGQDTQNHIALINMPPTKWVNSIEYINNNWNNFFVKLSSISVFKQNHY
PDYNFNVDIVENGQIIPTLLDLSSPPSAYQLFDFTTGLAFNVTDKNQIQLSLIIRNIFDT
SYRNYMNRLRYYSDETGRNIILQMQYNF
>EGEFANNL_01844 hypothetical protein
MKVFQLYKIKITLLLFVVLLLFKVVNLQEYLHIHKDHVENSSHKKSCDLCNSIFHYGKTE
VCQNFEFENFRIKVNPLVLKHEESMGLIISLHNKYLTTQLYNRPPPSLS
>EGEFANNL_01845 UTP--glucose-1-phosphate uridylyltransferase
MKKVRKAVIPAAGLGTRFLPATKAMAKEMLPIVDKPTIQFIVEEAINSGIEDILIVTGKG
KRPIEDHFDSNPELEINLREKGKNELLKLVEETTDINLHFIRQSHPRGLGHAVLQAKAFV
GNEPFVVMLGDDLMEDSIPLTRQLIMDYEKTYASTIAVMKVPEEETSKYGIIAPERMIEK
GLYNVLNFVEKPNPKDAPSNLAIIGRYLLTPQIFEILENQAPGAGGEIQLTDAIDNLNKV
QRVFAREFCGTRYDVGDKFGFIKTSIQYGLVHPDVKENLHNYILELAQELQKSKK
>EGEFANNL_01846 Lipoprotein-releasing system transmembrane protein LolE
MKNLSLHIAFRYFISKKSTQAVSIIMYTSLIAIAIATCAMFVILSVFSGLEHFNIKFFSD
VNPSLKISPASGKTLNNIEKLNKILSTNPKVKSFTKVIEEKVYVHYNNKDEIAYLKGVDE
NFLNVIKLDTCFQAGKFPSSASDNEAAFGNALAYRLGLPINDQETASLYMPKPGKGLLKN
TDEAFETTQVHMTGVFALNDQYENYIFVPLQVSQKLLNLSNNSAFSIEIKAQDKDINLLQ
EQLKKDLGSDYIILNRQEQDASFLKMMKIEQLFIYLIFILVIIIASFNLAGAIIIIILDK
KNQSRSLISMGYTIQKLKNMFFVTGLIIAVFGVLIGIILGTLLTWVQSHFHLVMANAYMP
FPIHFEFYNYVVVLGTTIVISTLVSYLSSRRLNFN
>EGEFANNL_01847 Ribosome-binding factor A
MDSNRQRKVNQLLQEELAEIFRQQSADIGKNLLISVTEVKISVDLSTAKVYLSIFPPEKR
SDLIKEIGIVKSQIRKILGLKLAKQLRRIPELIFRLDTTLDDVEKINKALKDGDENNILN
K
>EGEFANNL_01848 Small-conductance mechanosensitive channel
MFLYQIKLENILNTETIKIILDKFWILIFDLGLKIIICTLIYIVGRFLIKWLKKILRHIL
DTRDIDKSVKSFLNNLIHISLNIILILVIVGILGIQTTSFAAILASAGLAIGMAMKDNLS
NFAGGVMILLNKPIKIGDYIAVQNTEGTVKSIGILYTTLVTSDNKTIFIPNGPLSSGNIL
NYSTQTMRKVAITVGVDYGTSMAKIKQILNEIIIENPLVQNTPQPFIGLHKLNDSSIDIL
ISVWANTPDYWTVYYYLNETIYERFEKENINIPFPQLTVHLPK
>EGEFANNL_01849 hypothetical protein
MTSIKFKRITSIDMLRGLVILLMLLDHVRETFFLHLQLSDPIDVSQVSTSLFINRTLAHI
CAPSFVFLAGISAYLFQVSRGGSKKEVFKFLFKRGIFLIVLELTLINYAWTGIFPPKIIY
LQVIWAIGISMVILSVLLWIPRKLLFLIAISIIVGHNLLDSIHFNKDSIFYIPWSILHDR
GWIEFTYLKIRTSYPILPWIGVISLGYSLGWIFNKSTPSPFRRKILLYTGILMFILFMVI
RYLNFYGEKPWEFFTNPTLTWMSFFNITKYPPSFLFLLLTLSLSFILLYIFELISTKHDI
KFLETLGSAPMFFYILHLYVLKILYILCVQIWGYNQGEYFGFKDVWQIWVVTICLAVVLY
PLVQWFSKFKKNHKEIRWLKYL
>EGEFANNL_01850 Phosphoribosylamine--glycine ligase
MKILIIGNGGREHAIGWKIKKDNPEATLYFSKGNAGTETLGENLNLQTISQLTEFAEKTE
IDLTIVGSEELLVDGIVDSFQRNGLKILGPHKAAALLEGSKEFAKNFMHKYGVKTAKYKV
FNNFTEAHEYAKDHEYPLVIKADGLAAGKGVVICEDQYEAEKTLDDILNKKIFGDAGAHV
VIEEYLEGFEASILSIYNGKDIFPFISAKDHKKIGEGETGLNTGGMGVVAPNPYFTNEHF
EAFKKDILQPTLKGLKEEKLFFAGVIFFGLMITKDGVYLLEYNMRMGDPETQAVLPLLKN
NLLEVFNSALHGEPINLDWEEKHSVCVVLTSGGYPLNYEKGFEIRGLDKVNTTWFIAGAT
NKDHKIVTSGGRVLNVVGVGNSLEDARKIAYNDIKNVHFDYEYFRHDIGEI
>EGEFANNL_01851 hypothetical protein
MKKTLATFFLFVSIISLKAQVPDSVKSANTSTEPGIKTVVDYLLKNKELINIKLDTRFDY
QGVFNEKETEQNSLVTQTLKIVADGQITPGIRYMLRQRLNRPQTTLARDNAGYATDFAYL
EFDAGKRWTFRVGRQFVIFGTFEYNYNPADVYIPSMIYNDLESYATGLNVSYKVAKQVFN
VQVVNSTAPQFADKNYSNKALAGLFLWEGDLFDGVVKTRYGLGLFQHDGSKYFGWYTLGN
QLNINKFSTNLDWYIGTRTMDFNSVVPIYNEGDLREVRDQAASVYMKYDLGKFQPILRGT
WSHRKDLQSGGSYSITGIQGGLEYYPFKGNPLLENLRLHAIYGYNNTDYSGDFKSLDSFD
TNYVIVGMRWLFKIM
>EGEFANNL_01852 L-asparaginase
MNLKEFKRFIALAMVVLSVLFIDAQKKPTIYVLATGGTIAGTGESSTSSAYKAGSIGVDQ
LLKAVPDLAKVADIKSEQIANIGSQDMNIDVWLKLVKRINELAKDENVAGFVITHGTDTM
EETSYFLNLTAKTNKPIVLVGAMRPSTAISADGPRNLFNAVACAADPSASDQGVMVVMDD
KILGADDIEKVHTLEVGSFDNPNYGYLGFIYDGKPYFTRKSTKKHTNNSEFDITNLTVLP
RVDIITGYANADRLFVDAAVKANTKGIVYGGVGNGNMSTDVLNALTETAKKGIPVVRSSR
LPVGPTAQWDEIDDDARNFAASWFLTPQKSRILLMLALTKTKDYKEIQRMFTEY
>EGEFANNL_01853 Aspartate ammonia-lyase
MYRIENDLIGDLQVPVDAYYGVQTQRAVNNFHITGIKLSQYPELIKALAYVKWAAAETNF
ELGVLDEKIKDAIVKACKKVIEGKYNNEFPSDVIQGGAGTSTNMNINEVVANIALEIMGH
QKGEYQYCSPHDHVNLSQSTNDAYPTSIKLAAINSNAILIEHLQLLINSFREKGKSFKSV
LKMGRTQLQDAVPMTLGQEFEAFAETLSEDVDRLTQNSNLFLEINMGATAIGTGLNAIPG
YAELCAEKLAKISGHPFVSAKNLVEATPDTGSYVIYSSALKRVAIKLSKICNDLRLLSSG
PRCGLNEINLPAMQPGSSIMPGKVNPVIPEAMNQTCFKVIGNDLTVTMAAESGQLQLNVM
EPVIAYSILESVHILINALDCLRINCIDGITANEQHCKDMVLNSIGIVTALNPYIGYKNS
TKVAKEALEKNKSVYDLVLEYKLLSKEKLDEILNPENMLGPHKYN
>EGEFANNL_01854 Anaerobic C4-dicarboxylate transporter DcuB
MNIISYFFGELNSEILIFMELIVVLAAIFIGAKKGGLSLGIFGGFGLAILVFIFNLKPQS
PPIDVMLMIVAVITAASTLQASGGIDYMVKVAEKLLRAYPPAITLVAPIVSYLFTFIAGT
GHIAYALLPIISEVATEAKVRPERPLSISVIASQQAITASPISAATAALLSVIAIKNPSI
GLSDILMISIPSTLIGVIVASVVQMFIGKDLEKDSAYLKRIKNGILKEKTDLNSFEYKVS
KGAKYSVLIFLLSVLLIVILGSVDNLRPSWNGAYMEMSHIIEIIMLASAGLMILITKTNV
VQIAKGNIFSAGMQAVIAIFGIAWMGDTFFGANIDFFKGLLTHMVTEHPWTFAIALFLMS
IMLFSQAATVRALMPLGVSLGIPIPSLIAMFPAVNGYFFIPNYPTIVAAINFDRTGTTSI
GKYVINHSFQIPGFIATIISVSMGFIIAYLIL
>EGEFANNL_01855 CRP-like cAMP-activated global transcriptional regulator
MLKKSYTIPCYENLPVEQQELIHKNSRIVDFEARECVFKQGSFAVNIYIIIEGYCKLTFQ
SGEKKRILYIPKHNDLIGKDYLLKGNYPYSMQTLTSTKFLIIPKTFFNRICSSNPEYNLK
ITQLFESKLIEEMKWMINLNFKNVEGAVAMFVLKYCNKDYQGIDLSRTEIADLIGYSRES
IIHTLKNFVNENLLETKGKEIQIRDVKKIIEIIKYS
>EGEFANNL_01856 ATP-dependent RNA helicase CshA
MNLFEQYGLSGSILKAINELGYSEPTEIQKQTIPYLLSKEEDLIALAQTGTGKTAAFSLP
ILEQIDENIKKVQALILCPTRELCLQISRDIANYSKYLSNVSSLAVYGGSSISDQIKGLK
KNPQIVIGTPGRVNDMIKRGVLKLNEVQWLVLDEADEMLSMGFKQELETILVETPKDRRT
YLFSATMSKQVESIAKNYMKGAHKISAGGINEVKKNITHKFVLVRDRQKSNGLRRILDAN
PDIYSIIFCRTRVETQSVADFLMQQGYSCDALHGDLSQAQRDTVMKKFRLKNLQILVATD
VAARGLDVNDLTHVIHFSLPDDPEVFVHRSGRTGRAGKNGDSIAIIRPSEMFKFNRIKKE
TSIKVEEMPIPTKETILKAKEIYLSDKLLTENLDSESFTLSNTPDLSIISKEELYKRIMY
LELKSTWNFYKNEKDIAPIDKNERSTDRGNNSRDRGSRRERDRNTKSSSDRSNNRRNKKQ
GNFTRFFFNLGKKDNLNKVTVIDLINKNTKGARADIGDIDIRDKFTFFEVDSNYTTQLLN
KINKLSFNGKSMSLEIAQ
>EGEFANNL_01857 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MKLLEGKTAIITGATRGIGKGIAKVFAEHGANIAFTYASSESKAKELENELSSIVKIKGY
KSDASDFNATQKLIDDVLAEFGNIDTVVNNAGITKDNLILRMSKEEWDEVLRVNLDSVFN
LTKAVTKPMMKQKKGSIINMSSVVGIKGNAGQSNYAASKAGIIGFSKSIALELGSRNIRC
NVVAPGFIETEMTEVLDEKIIQEWRNNIPLKRGGTPEDIANACLYLASDLSNYVTGHVLN
VNGGLITY
>EGEFANNL_01858 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase
MYSTKVSVQLLGEMLYAFGINDIIISPGSRNAPLTIHFTQDTRYKCYSIVDERSAAFFAL
GMAQSKKKPIVICCTSGTASANYYPAIIEAYYQNIPLLILTADRPENFVDIFDGQTIRQK
NIYHNHIYGSYQLSEGNDDQSISDNFLMIKEAITQLYNCSGPIHINIPFSEPLYELTDTL
SINIEKLTLPKLASDNYNWNHLLNKWNSYEKKMILVGMQQPSPELNSLLESLARREDTIV
LTETTSNLKSDLFYSNIDRYISSLTDKNIYEEFNPDLLLTIGQNIVSKKIKVFLRNSNLK
EHWHLDKHWHPDTYFCLTEKIKTNPINFLEKLDSLPSKESLYSTLWLNHKKNKNLKHDEF
LKNSSYSDLKVMEVLDAKIPNFYNLQVSNSSAIRYAQLFNFNAKNKVFCNRGASGIDGSS
STAIGFASVELNPTVLITGDIGFFYDINALWNKYIPNTFRIILMNNGGGDIFNIISGPDQ
ISTALNEFFVTKHNRNAKLISEEFNLIYKEISCIDELENHLPIFFSSSNQPKILEINTKN
TSNAKILRDYFSFLENN
>EGEFANNL_01859 Outer membrane porin F
MNKRCILFVFMLFCLGFKGFSQTVNSENFTADYVPFNNTDRQFNDWSVSIYAGLPWLQSS
DFTSIDNGASGKWRTGYDFQLSINKQISHAFALSLLGQYGKTNQGYGDDDIKAYTDYLGI
SLLGDLNLSSIFRRVDNRSHYRWALHLYAGVGTIQYKAYTKDIAGGWPDYVQMADVKLGV
GSFFGQVGGGLAYKLNNRFDLLLKAMYVITGDNAFDGSGETGPWAHLHPGGDSDNFITTS
LGLNYKIGKHSEFLGWVDPLRDIYTKLQTLEDKQVSEVCVFGDKDDDGVCDDWDRELNTP
KGARVDGSGVALDVDMDGVIDLYDKCPTFPGPASNDGCPLPEQLAKTLNDDIIVKLGGIN
FNFDSDRISLDSQPVLDQVADAIIQYGGGRSFLVEGHTDAVGTHEYNMNLSKRRVASVIK
YLASKGVSPSQLTGRGMGATDLKNPECNPASKCPEWKNKENRRVVFKLLEETN
>EGEFANNL_01860 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase
MNKATLILGSNLGDKITNINVAISHIAINIGIVLKKTIVHKTLPEGFNSTNNFINLGLVI
ETHLSPFSLLREVKYIEEKMGRVYDYESEDRYQDRIIDIDIVYFNNLNFKSNLLIVPHQM
HVKSRQFSTKILYELQ
>EGEFANNL_01861 Rod shape-determining protein MreB
MGLFDFLTQEIAIDLGTANTLIIHNNKVVVDSPSIVALDRRTGKPIAVGDMAKQMQGKTH
DDIKTIRPLKDGVIADFGASEHMIREFIKQIPGIKGKIFTPSLRMVICIPSGITEVEKRA
VKDSATKVNAKDVKLIYEPMAAAIGVGIDVTQPKGNMIIDIGGGTTEIAVIALGGIVCDN
SIKIAGDVFTNDIVYYLRTHHNLFIGEKTAEHIKMEVGSGLEELESPPDDLPVQGRDLIT
GKPKEIMVNYKEMARALDKSILRVEDAIMETLSRTPPELSADIYNTGIYLAGGGALLRGL
DQRISRKTGLPVFIADDPLRAVVRGTGIALKNIEKFENFLIK
>EGEFANNL_01862 Cell shape-determining protein MreC
MSVLSKFLLKNSRFFLFLFLQTLALTFTFSENIYHNSILENKIISFKGSIDSKISNFKYY
FNLKHENDRLLKENNYYRNLFLGKSKKIKPEYIEILDSTKYKQSYHYTPADIVSNSINRV
NNYLIINKGTSQNIKPEMGVITSTGVVGMIVNSTPNFSKVMSILNKNTKVNARLRSNKYY
GTLLWDGEDSRIMKLSDIPKYVNINIGDTIETDGKSRIYPEGILIGRISSKTIDDESGNW
DISVELFQDMGNIQKVYIVNNIDREEIKSLIDTIQ
>EGEFANNL_01863 hypothetical protein
MLNKSFIYNLFIIPLLILVQVFVFNNMYFTISNHKYIPIIYIIWIIFFPYGKSDKFFFLI
FCFLLGFGIDCFLDTGGVNAFASVLIGYLRTPIILYISDLNKELKLLRFSDLNIIQLLLY
ILILIFIHHFSLFLLEVFKLSQIIYVLKETAITTVYSFIYIIIFYIFFKNNFEK
>EGEFANNL_01864 Peptidoglycan D,D-transpeptidase MrdA
MKKKQIIIWILTIFSFIFIIRIAYLQLLTEKYRLNAANTSIKSEYQIPLRGYIMDRNGKI
LVGSTPSYELTFTEIQMEKDFDTLSFCKLVNISKEDFIFKINSLKAKGGKNYSKLVPYTF
IKGLSKEDLARIQEKLFKYNAFSIIRTPERNYFVKSAGNILGFVNEVNQKYIKSDSTYYL
PGNLAGMAGVEKSYEKDLRGIKGIKYIQKDRKSRSIGSYKDGEYDQKMQTGKDITLSIDY
DLQEYAEKLLTNKRGGVVAIDPNNGEILAMASSPVIDPSVFIGRDKNKHIYALQVDSINK
PMYDRAVQAAYPPGSTFKLVNGLVAMQMGVIDENTTFVCKHGFHYGNRKIACHCGYFYTP
IKMDKAIQKSCNNYFAETYVKILSKYPNDIEKSIDEWSDIMKSFGVGDYMNNDLAVGSRG
NIPDANYYNKRYGKDKWNIYTIISNSIGQGEILATPLQIANYTAAIANRGFFFTPHIVKA
INGTPISDPNFTKPKYTKVDRKYFDIVNEGMELVVLSGTGRRIYTKSFSQEGKTGTSQNP
HGRDHSIFVLIAPADKPKIAIAVVVENGGFGGTYAGPIASLVAEKYLTGNVERKSMEESI
IKANFQSEYTRQWNDYLKRIGMYIPPNLPNEAKEKIKEIQQNREISFKERQKLIHTIINS
KMSSFPEINKINLTNE
>EGEFANNL_01865 Peptidoglycan glycosyltransferase MrdB
MSKLFRGLDGPMLFLYLLIAIFGCVNIYSVDSNLGQKQISWLIVSIILGLCTFLVRPKFF
ENFSGLFYILGILLLAGVLVFGSDINGAKAWYRIGGFSLQPVEISKICTALMLANYIGSP
NFNIKSIQSLIVSTIIIGFPIILILLQPDVGSILVFLAYLIALYREGLSGWIFIIGGYFA
IIFLASIAISSWIITLIIVIFIAISILLLRRKINWSQPLHLIYIGTFIVISSAFSFSSSY
IFEKLPQHQKDRIMVLYEGEDIPKYRNNIGYNLYFSKTAIGSGGFWGKGYKQGSVTAGRF
VPEQQTDYIFCTVGEEWGFVGSCILIMLYALLITRIYFLAENQKGIFSRVFGYCLASVLL
MHFLINIGMVIGLFPTVGIPLPFFSYGGSSLLGFSLFVFVFLRLNYSDANRLI
>EGEFANNL_01866 ATP-dependent DNA helicase RecG
MDELSLNTPIEYLNGLGTEKAKLIKSHLNIYTCEDFLNYFPFRYIDKSKIYLVSQINNSS
TIEIQLKGRIIDIKEKVLKKRKTLSAIFEDSSGKIELVWFKYTNWFMDSIPLNVEVLIFG
KINKFNGLLTMAHPEVEKFSEVNFKNVALDPVYSNSLKIQKRGINQRFIKKIIKEILDKL
KSKIFENFSEPIIKNFRLISRVEAYQEIHFPTNYINLQKAEYRIKFEEIFFFQLGLSLQK
LYRKSTIPGTPFPKVGNYFNNFYTNHLPFPLTSAQKKVIKEIRNDLKKNVQMNRLLQGDV
GSGKTIVALLCMLLAMDNNFQACMLAPTEILITQHYNSIVSLLKDFDITIELLTSSTTSA
KRKQIFNDLESGKLNILLGTHAILEDKVKFKKLSLAIVDEQHRFGVEQRSKLWKKNTIPP
HILVMTATPIPRTLAMSYYSDLDVSIIDELPQGRKPIKTFYKMDSDRLAVFGFVKEQIKI
GRQVYFVYPLIEESEVLNYKDLMDGYESITRSFPMPEYQVSIVHGKMNKIDRDYEMNRFL
NGETQIMVATTVIEVGVNVPNATVMVIESAEKFGLSQLHQLRGRVGRGFDQSYCILMIKS
ELSPEAQKRILTMCETNDGFKIAEADLEIRGPGNILGTQQSGNIEFKKINLLQDKDIVSL
SKSYIDHLLLEDPKLQLIKNEPIKNFFIKNYKNKFQWSIIS
>EGEFANNL_01867 Thiol-disulfide oxidoreductase ResA
MKKILIGCLFVSIFANAQFTFKGTINNYPNKRVIIKLNKSLDGIVIGNLTTDANGKFSLP
VKENYTGVVEMSLFDAKKNYSFLADNSNIDFQAEITADGDLEVSNPGNLINYKYKDFINY
EIKNGDILSQLKLIKNWYNPKDEFYKSLDKEITNISSTKKIDIDNYPFLNYYVEAMKLVK
DSEANPTQKSLNSLLNHFKNSGEYFETSGLGKSLIYNYLNISSSLASSSSKTQAEWQEKF
DHSIENLLNEVDTETDRGQNILAVTINFLNTYELKDLLTKYMKKAESLTCKITPELSEVI
YVNNSIKEGGKVPNIKFTRKLNGKYSSLYDLKNKYKLILVWASWCGHCQHEMPRVKEFYE
NFKKSGGEIIGLAVDYDENDWKNAIKELPWLNDSDLLYWDSQFVKELNISGTPTLILVDS
NNKILKISSKISEISKEIK
>EGEFANNL_01868 hypothetical protein
MRKIFALIFIVLLHINSFAYTPLQIVIENSEISAPPTPNEAVGISPFDVGEQDYDKTPID
FVVPFLLLTVLALMIYIVKYRKQKLV
>EGEFANNL_01869 hypothetical protein
MKIKFIPLLLLGSIFVEAQITSTNGASVYVSPNTLVYSTGDVKVSNTSGVFTNEGNIEIS
GGTITSSSADKFVLTYTDTSNYGQLIIKSATAAGSKADAGDTKEITVQKNLLERITDELT
AQKSQINFGVPFVNYTFSQLTKDITGNDNVTPPSLPCAPPWQEGARAYCYNKSQLWNSHP
LFVWNYNNRLRWDPYDKNQSHLELGKRYIVRSEIFKGVNPSSFTGVTNFKGIPYVAGQKE
NIPNSLPYQIVENYNFGNGIRESAYGVRYYTYLEDPFALKELETPGNKFSATTTNEELEK
VGFANNILYATNPYTSNLNLATLTNNFDGMIGAAVSRGVTVYSQANSREDALFYLVTRTV
GGQLTGDIDQVTIIPPMSTFIIKTNPENNKTNLDLFSQNASLAQTFDYPKKPISSTVTAA
SKTKVSSFSSSQVEDLYQLNLIMSVEDKISNTYLATADEFTTGQFNDVEASLPFDGDVFT
SVYTIPESKEGGINPGFENSKLYINTMNVASSKVAIPVGVNISGEDKGKRFTFTSELRLN
QVPLSMNETNYPNPDAKFYFHDKATNIVKEIDQNFTYSVNLEDSTNDRFEIFWSDSGLIS
SEEVTNDDNIINDTVVDDNNNSLNNSNTINSTSVYKSGSDYKVRFNSNWKKADITIFNVV
GQLISNEKNVNTQIDYLLPIFDSYSSVYVVVIVNSITGEKIIKKIVK
>EGEFANNL_01870 ATP-dependent Clp protease ATP-binding subunit ClpX
MDETCTFCGRKKSEVQLLVAGLNGHICNDCIEQAHNILIQDQTQAKKQDFEFKEQKPKEI
KKFLDQYVIGQEEAKKQLSVAVYNHYKRLKHSLELNKEVEIEKSNILMVGQTGTGKTLLA
KSIAKLLEVPFTIVDSTVLTEAGYVGEDVESILTRLLQAADYNVEKAEQGIVFIDEIDKI
SRKSDNPSITRDVSGEGVQQALLKLLEGSVINVPPQGGRKHPDQKYIQVNTQNILFIAGG
AFSGIERIISNRLNKSVIGFTKDKSSNLDNKEILSRINALDLKNYGLIPELLGRFPVVTS
LEPLDSQAMLQILTEPKNAIIKQYKALFALDGIDIKISDDVLREIVAETEILGLGARGLR
SISEKLFSEISYNIDNSEKEIFIDKDKYVNLVKQIKINT
>EGEFANNL_01871 2-oxoisovalerate dehydrogenase subunit beta
MKEVQFRQAVCEAMSEEMRRDSSIFLIGEEVANYNGAYKASKGMLDEFGPKRVIDSPIAE
SGFSGISVGAAMNGCRPIVEYMTFNFSLVAIDQIINNAAKIYQMSGGQWNVPIVFRGPTG
SAGQLGATHSQAFESWFANCPGLKVIVPSNPYDAKGLLKSAIRDNDPVIFMESEQMYGDK
MEIPEDEYLLPIGVADIKKEGSDVTIVSFGKIMKVALQAAEELEKENIHAEVIDLRTIRP
LDYDTIITSVKKTNRLVLLIEEWPFASIAGEIAYMIQQKAFDYLDAPIKRITTADTSAPY
SAPLFNEWYPKASEVVKAVKKSLYK
>EGEFANNL_01872 hypothetical protein
MRKVESSLKIVEELKREIEVYPYNEDVFWSIEVTKYMSDFKIPDYPISLKFAIDRKPKLA
LKLNNNELPFGCHGINKPKVINFWKKKLNF
>EGEFANNL_01873 hypothetical protein
MKVKIIIPIYKTELDSLEKFSLDRCLNVFKNYTIVLIHPISLNLPKYFELKGSNNIEKEG
FDNFYFESVEGYNRLLLSVDFYQRFKYLDYILIYQLDCYVFKDELLNWCNQGYDYIGAPW
IFTSNILAKIKKK
>EGEFANNL_01874 Serine--tRNA ligase
MLKRFILNSMLQISFIKENRDKVLNGLKKRNFNNLSLIDEIIQLDDSRKKIKFNLEAQLA
ELNHISKQIGILIKQQKLDEVESLKSNTLKLKDLTKELQHELNNIEDTILKHLYEIPNIP
NSLVPEGTSEQDNLEIYKHTANYNLIPNCLPHWDLAKNYNLIDFELGVKITGAGFPVYIG
KGARLQRALIQYFLDKNSEAGYTEIVPPFVVNETSAYGTGQLPDKEGQMYFINEDHLYLI
PTSEVPVTNIYRNELLDNTELPIKLTAYSPCFRREAGSYGKDVRGLNRLHQFEKVEIVRI
EKPENSYSALDEMVEHIKTILESLNLTYRILRLCGGDLGFTSAITYDFEVWSAAQERWLE
ISSVSNFETYQANRLKLRYKTEGKNQLCHTLNGSSLALPRVLAAILENFQTHEGIVIPEV
LVPYTGFNIIN
>EGEFANNL_01875 Cysteine desulfuration protein SufE
MIISEIQQEIIDEFNSFDDWQQRYEYIIELGKSLKGMNVEDKTEDKLIQGCQSQVWLDVT
KNDNKLFFVADSDAILPKGILALLVKIYSGQPITDILKSDENFIQKIGLQEFLSPTRANG
LLAMIKKIKYYAIVYSIKHE
>EGEFANNL_01876 hypothetical protein
MYIPLNMSNLKKRLLVFRFSAMGDVAMTVPVLKELALKNLDLELIIISRDLYKPFFESIP
NSVFVGVDFNNYKGVLGLFKLSRILKKYKADAIVDLHNVLRTKILKFFLRPYIKTQITVN
KGRNEKKLLASNKYKILKPLKSMHERYADVFRKLGFNLTLSHKLNSDIIKKNKHIGIAPF
ANYKEKMYTLDRMKKICLYLANKNYKIYLFGGGTNESNILKEWSDTNSYIHSLADNCSIK
EQMEIMKNLEFIITMDSANMHIASIAGTRVISIWGATHPFAGFLGYGQKIEDVIQIDLSC
RPCSIYGNKSCLRKDIACMNYIDEKTILSKILNK
>EGEFANNL_01877 50S ribosomal protein L17
MRHGKKFNHLGRTASHRKAMLSNMAVSLIKYKRINTTLAKAKALRVFIEPILTKSKEDTT
PNRRLAFSYLQDKEAVTELFREIAPKISSRNGGYTRIIKTGFRLGDAADTALIELVDFNE
IYNSGDTSKKTTRRGRRASTTKKVDTETVNEVTSDEQDDLNLENKEVNSTDK
>EGEFANNL_01878 DNA-directed RNA polymerase subunit alpha
MAILNFIKPDKVILIESDDFKGRFEFRPLEPGFGLTVGNALRRVLLSSLEGFALTSIKIE
GVEHEFSTIPGVIEDVTEIILNLKKVRFKNQINKGGNETATASISGKTELTAGDLGKFIS
SYQVLNPDLVICHMDKSVNFNITFTISKGRGYVPAEQNKSNHSPIGTIAIDSIYTPIRNV
SYSIEDYRVEQRTDYEKLVLDIQTDGSIAPQDALTEAAKILINHFMLFSDERITLEADIV
ASSDTYDEEALHMRQLLKTKLVDMDLSVRALNCLKAAEVETLGELVSFTKSDLMKFRNFG
KKSLTELEDLVYSKNLTFGLDVSKYKLDVE
>EGEFANNL_01879 30S ribosomal protein S4
MARYIGPKTKIARKFGQAIYGEDKYFERRKYPPGQHGPNKRRGAKKSEYAIQLAEKQKAK
YTYGILERQFLNLFNKAQRSKGITGEVLLQLCESRLDNVVYRLGLSNTRAGSRQLVSHKH
ITVNGEIVNIPSYLLNPGDVIGVREKSKSLQVIKDALTNNSHKTYDWLVWNDEKLSGEFK
IAPERIQIPEDIKEQLIVELYSK
>EGEFANNL_01880 30S ribosomal protein S11
MAKTASKTTKKRKVKIEAVGEAHIQASFNNIIISLTNKNGEVISWASAGKMGFKGSKKNT
PYAAQMAAENCSQVAFELGLKRVKVFVKGPGAGRESAIRTIHNSGIEVSEIVDVTPIPHN
GCRPPKRRRV
>EGEFANNL_01881 30S ribosomal protein S13
MARISGVDLPKNKRGVIGLTYIYGIGKSTAAKILKDAGISEDKKVSDWNDDEINSIRKFI
SENVKVEGELRSEIQLNIKRLMDIGCQRGIRHRLGLPLRGQRTKNNSRTRKGRRKTVANK
KKATK
>EGEFANNL_01882 50S ribosomal protein L36
MKIRASLKKRSSDDIVVRRKGRLYIINKKNPKLKQRQG
>EGEFANNL_01883 Translation initiation factor IF-1
MAKQKHIEQDGTIIEALSNAMFRVELENGHILTAHISGKMRMHYIKLLPGDKVRLEMSPY
DLSKGRITFRY
>EGEFANNL_01884 Protein translocase subunit SecY
MKGFIQTLKNIWSIKELRDKIVFTFLLILVYRLGTHVTLPAINMVEVGNVLKAYEENGGN
KQATGLLTLLSSFTGGAFSKASILALGIMPYISASIVVQLMGLAIPYIQKLQKEGESGRK
TVNQITRWLTILICLIQAPAYLTSITQVFLPVDSFRSAYLVDPNNILLFWIPSIFILISG
TIFAMWMGEKITDKGIGNGISILIMVGILAGFPTAFVQEIGVQMGNTGKGLIMIFAEVIV
WLFVIVLCIMLTVAVRKVPVQYVSRTKSGSLRSITQAARQYIPLKVNAAGVMPIIFAQAL
MFIPGLLVRSESTTNSFWAGFSQVFSWQYNLLFSILIIVFTFFYTAITIPVNQMADDLKR
NGGLIPKVKPGKETADYLDDVLSKITLPGAIFLALIAILPAIVKIVGLTATDQFALFFGG
TSLLIMVGVMLDTVQQINTYLLNHHYDGLMQSRLSRS
>EGEFANNL_01885 50S ribosomal protein L15
MNLHTLRPAEGSTHNSKRLGRGQGSGKGGTSTKGHKGDKSRSGHKDKIGFEGGQMPLQRR
LPKFGFKNINRKEYVGINLDTIQSLIDNNKISNEITKEILVQNGLASKKDLVKILGRGEL
KSSITISVDKYTKSALEAIEKAGGKANIL
>EGEFANNL_01886 50S ribosomal protein L30
MAATIKITLKRSPIKRVKNQKLTLEALGLTKLNKTVEHNVTPQIMGMVAVVKHLVTVEE
>EGEFANNL_01887 30S ribosomal protein S5
MLGIKNIERVKPGGLELVDRLVGVQRVTKVTKGGRAFGFSAIVVVGDEKGVVGFGLGKSK
EVASAIAKAIEDAKKNLVRVPILNGSLPHEQTARYGGANVFIRPASHGTGLIAGGAVRAV
LESAGIKDVLSKSKGSSNPHNVVKATVKALLNLRSADVIARQRGISISKVFKG
>EGEFANNL_01888 50S ribosomal protein L18
MALTKKEKRIRVKRRVRKNIFGTADKPRLSVYRSNKEIYAQLIDDNTGKTLAFASSREKE
ISGKQGTKTEISTLVGKELAKKAKTAGVNTVVFDRNGFLYHGRVKALADGAREEGLNF
>EGEFANNL_01889 50S ribosomal protein L6
MSRIGKAIINIPTGATLDYKDNVVTVKGKNGELKQELVGGITLKIEDAQVTVERPSDAKE
HRSLHGLYRALINNMVIGVSEGFTKKLELVGVGYRASNQGQRLELALGFSHLVVFDLPTE
IKVETLTEKGKNPIITLSSYDKHLLGMVCAKIRSLRKPEPYKGKGIRFVGEQIRRKAGKS
A
>EGEFANNL_01890 30S ribosomal protein S8
MVTDPIADYLTRVRNATRAGHKVVEIPASKIKKEITKILFDQGYILNYKFEDDKVQGKIK
IALKYDKLTNLSAIKCIERASKPGLRKYSGSKELPRVLNGLGIAIISTSKGVMTDKKARQ
ENVGGEVICYVY
>EGEFANNL_01891 Alternate 30S ribosomal protein S14
MAKESMKARERKREALSTKYADKRKALKEAGDYEALQKLPKNSSPVRLHNRCKLTGRPRG
YMRVFGISRVTFREMANDGLIPGVKKASW
>EGEFANNL_01892 50S ribosomal protein L5
MQYIARPKKKYNETIKSALKEEFGYKSVMQVPKLQKIVISQGLGSATADKKIVDYAVEEI
TLISGQKAVPCISKKDEAGFKLRKGMPIGAMVTLRGDRMYEFLDRLVSSALPRVRDFNGI
KNSGFDGRGNYTLGVTEQIIFPEINIDKVKKIQGMDITFVTSASTDKEAKALLTHFGLPF
KKN
>EGEFANNL_01893 50S ribosomal protein L24
MTKIKIKKGDKVQVLAGAYKGKQGNVLVVYPEKNRAIVEGVNIVKKHKKPSAENPQGSII
EKEATIHISNLALLDPKSGKPTRISYRIEEGKKVRIAVKSGEAI
>EGEFANNL_01894 50S ribosomal protein L14
MLQTESRLKVADNTGAKEALVIRVLGGSKRRYASVGDKIVVTIKDATPSGNAKKGQVSKA
VVVRTKKSVRRKDGSYISFDDNACVLLNTAGEMRGTRVFGPVARELRDKEYMKIISLAPE
VL
>EGEFANNL_01895 30S ribosomal protein S17
MERNLRKERIGVVSSNKMDKTVVISETTRMKHPMYGKFVLKTKKYTAHDEKNECNEGDTV
RIMETRPLSKNKRWRLVEILERAK
>EGEFANNL_01896 50S ribosomal protein L29
MKAKDIKNLSTEELKLKLAEKKAEYAKLKLAHKVSPIENPIQLRDIRKTIARLLTTLK
>EGEFANNL_01897 50S ribosomal protein L16
MKGLSYRGNQLAYGTFGIKALDPVFITGRQIEAARIAATRYMKREGQLWIKIFPDKPITK
KPAEVRMGKGKGAVEYWVARVTPGRIIFEIGGVSYEVAKEALRLAAQKLPVKTKFVVAND
FVKPE
>EGEFANNL_01898 30S ribosomal protein S3
MGQKTNPIGNRLGIIRGWDSNWYGGKKFGDKIAEDFKIRRYLEARLSKAGVSRIYIERTL
KLITITITTARPGIIIGKGGQEVDKLKEELKKITKKEIQINIFEIKRPELDAKLVAESVA
RQIENRISYRRAVKMAIASTMRMNAEGIKIMISGRLNGAEMARSESFKEGRIPLSTFRAD
IDYYIAEAHTTYGRLGVKVWIMKGEVYGKRELSPLVGLQKKTQKRKVKERR
>EGEFANNL_01899 50S ribosomal protein L22
MGKRKKDSALARKESYKDLAIARLNNCPTSPRKMRLVTDIIRGVDVDKALYILKYSKKEA
SIRLEKLLLSAIANWQVKNEGKDIEEAKLFVKEIFVDGGSMLKRLRPAPQGRGYRIRKRS
NHVTIILGNKNEVN
>EGEFANNL_01900 30S ribosomal protein S19
MARSLKKGPYIHYKLNKKVQANVESGKKVVIKTWSRASMISPDFVGQTFAVHNGKQFIPV
YVTENMVGHKLGEFSPTRVFRGHAGNKNKGNR
>EGEFANNL_01901 50S ribosomal protein L2
MSVRKLKPITPGQRFRIVNNFEEITTSKPEKSLLRKISKSGGRNNSGKMTMRYTGGGHKK
RYREIDFKRNKFGIPATVKSVEYDPNRTAFIALLVYADGEKRYIVAPHGIKVDQKVISGD
TVAPEIGNAMKLKNIPLGTVVSCIELRPGQGAKMARSAGTSAQLIARDGKYAVLKMPSGE
TRMILVECLATIGSVSNSDHQLTVSGKAGRSRWLGRRPRTRPVAMNPVDHPMGGGEGRST
GGHPRSRKGMPAKGFKTRSKKKESNRHILQKRK
>EGEFANNL_01902 50S ribosomal protein L23
MSVLIRPIISEKANDIAEKRNRFTFLVNPKANKSEIKYAVQKAYGVTVVGVRTLISPPSV
KSKYTKSGLQVGKTNKVKKAMVDIKDGETIDVFGTI
>EGEFANNL_01903 50S ribosomal protein L4
MELVVLDKNGKETGRKVTLDESIFEVQPNEHAVYLEVKQYLAAQRQGTHKSKERSELSGS
TRKLHRQKGTGGSRKGDIKNPLFKGGARVFGPRPRDYRFKLNKSLKRLAKRSVLSQKLQD
NNLKVLEDLKFEGPKTKEFIQVLSNLGLEGKKTLFVLGEANKFVYLSSRNLQQTKVLTHN
EISSYDILKANEVVLFEGSVEKLQENLRK
>EGEFANNL_01904 50S ribosomal protein L3
MSGIIGKKIGMTSLFDEQGKNIPCTVIEAGPCSVLQVRTKEKDGYFAVQLGFDDRSEKNV
GKAMLGHFKKAGSTPKRKMVEFYHGFENLKLGDSVKVNLFSEGEYVDVTGVSKGKGFQGV
VKRHGFGGVMQATHGQHNRLRAPGSIGAGSDPSRVFKGMRMAGRMGGNQVTVQNLEVIKV
DEEKNLLVVKGAVPGPKNSYIIIRRWN
>EGEFANNL_01905 Lysine--tRNA ligase
MQLSEQEKIRREKLEKLKSAGINPFPASEFKINYTTEEIRNNFKEGEKVYIAGRLMSNRI
QGKAGFSELQDSTGRIQLYFNRDVICPEDDKFKYNDFYKKLLDLGDFIGVEGELFNTKLG
EKTVMVKDFTLLSKALRPLPLPKTDEEGKVHDAFNDPELRYRMRYVDLVVNPKVKDIFIK
RTLLFSSMRNFFNERGYFEVETPVLQSIPGGAAARPFITHHNSLNIPLYLRIANELYLKR
LIVGGFDGVYEFSKNFRNEGMDRTHNPEFTAMEIYVAYKDYHWMMSFTEQLLEHCAIAIN
GTTKATYGEHEIDFKAPYARISMTDAIIKFTGFDITGKSETEIREAARSLGIEVDDSMGK
GKLIDEIFGEKCEGNFIQPTFITDYPVEMSPLTKKHRDNPELTERFELMVCGKEVANAYS
ELNDPIDQRNRFEEQLKLSEKGDDEAMFIDQDFLRALEFGMPPTSGLGIGMDRLIMFLTN
NSSIQEVLFFPQMKPEKKSLSIELTDEEKLILEILEKNDSTMDINTLKSLANLSGKKWDK
SIKNLTKNNILRVNIHGDIKTIDIVK
>EGEFANNL_01906 Regulatory protein AsnC
MREFKKYSFELDGIDKIILNSLMSNAKTSISKIAKEVGVSSTAIHQRIKKLEASEIIKNP
VTPLNYKALGYKTIAYVGIYLEKSVKYQESINEMLKINEIIEAHFTTGNYTVFIKLLCKD
NDHLMDVLRNKIQKINGIVRTETIISLEQSISRQIKP
>EGEFANNL_01907 hypothetical protein
MKKTFLILYSIFFIILSCNKEYKVIDGSSKESFDLSLKSISSKLTILQQDKLEEAIKLIY
KFKTDGDDENQRWEKLYSILNDKSSEQVFEMAEEIAKENKISWSSTSMIPLDPSILRTEE
KKLSEEEKNLQQLESATSINIRFSTINSDPELNEGFYIYPKLVDDSGQEITFNNLPLNFS
ISFINNGTVVYTTNRTLSSSFDLNKGLKFMYNLFDKEKIINSSLDVEVKTSAGDKYLYGK
LAGIPIEVSKTKDSSSSIEDELDNQLAVKNVNNFIQLIGDKKYSEAYKLSKNPKWGDEEK
FSSTSNGFGTIEAVNILSSDLINRNKDEITVFSIYQIKDKSGKIKSLKQNFKLHKINGDW
LITDTQTKEVTNDDSWK
>EGEFANNL_01908 Adenine phosphoribosyltransferase
MNSLTEDIKQHITDVRDFPKEGILYKDISSLFLNTELCHRIVLEFVKFSKNKVDAVCGIE
SRGFLFGPQIAQLLNVPFIMIRKSGKLPPPVVSKNYNLEYNKATIEIKKHFISQGQRILI
HDDILATGGTAKACAELITECGGIATQFSFIAELSFLNGTQTLLPHCKEIHSLVSY
>EGEFANNL_01909 hypothetical protein
MENNQNQQDLNIELPDEIATGVFSNLALINHSPTEFVLDFIQMMPGVQKPKVRSRVILTP
EHAKRLLNALSENLKNFESQFGNVKDDDTFHLNFGQNGQA
>EGEFANNL_01910 DNA-directed RNA polymerase subunit beta'
MAVKQKTSRFNKITIGLASPESILQQSRGEVLKPETINYRTHKPERDGLFCERIFGPIKD
YECACGKYKRIRYKGIVCDRCGVEVTEKKVRRERIGHINLVVPVAHIWYFRSLPNKIGYL
LGIPSKKLDMIIYNERFVVIQAGIAKKLNGEELEPNEFLTEEEYLDILETLPIENQYLDD
SDPNKFVAKMGAECLEELLKRIDLDALSYDLRHKANHETSKQRRTEALKRLHVVESFRDA
NNNGRINRPEWMVMRVIPVIPPDLRPLVPLDGGRFATSDLNDLYRRVIIRNNRLKRLIEI
KAPEVILRNEKRMLQEAVDSLFDNTRKSSAVKSESNRPLKSLSDSLKGKQGRFRQNLLGK
RVDYSARSVIVVGPFLQLHECGLPKDMAAELYKPFIIRKLIERGIVKTVKSAKRIIERKE
PVVYDILENVMKGHPVLLNRAPTLHRLGIQAFQPRMIEGKAIRLHPLVCTAFNADFDGDQ
MAVHLPLGPEAILEAQLLMLASQNILNPANGSPIQVPSQDMVLGLYYMTKPLVPTEEISV
KGHGSIFYSEEEVEIAYNEKAIDLNAIIKVRAKVREGEELVEKLIETTVGRVLFNKIVPE
KVGYINEVLTKKSLRNIIGNILETTDFPTTAKFLDDMKNLGYATAFRGGLSFSLGDIITP
DEKKIMIQDAHEQVDGIRSNYNMGLITNNERYNQVIDVWTNTNARLTDLIMQRMKTDKGG
FNSVYMMLDSGARGSKEQIRQLAGMRGLMAKPQKAGSSGGEIIENPIISNFREGLSILEY
FISTHGARKGLADTALKTADAGYLTRRLVDVAQDVIINDEDCGTLRGIEISALKKNDEIV
EPLSERILGRVSLHDIYHPDTDELLVEADQLITSELAKTIEKSGIEVVEARSPLTCESKR
GICAKCYGVNLATNKLINKGEAVGVIAAQSIGEPGTQLTLRTFHLGGTAGNVADVNSIVA
KREGKVEFDDIRTVESEDENGNPVTIVVSRSTEFKLLNSEGNVLMINNIPYGSNLLVKPG
QEVKKGDIICKWDPYNATILSETAGKIEYEQIEQGITYQLEIDEQTGFEEKVISESRNKK
LIPTLKILDTSGEVIKTINLPVGAHLIVNDGEKIKAGKILVKIPRRSAKAGDITGGLPRV
TELFEARNPSNPAVVSEIDGVVSYGKIKRGNREIVIESKGGEIKRYLVKLSNQILVQEND
FVRAGDPLSDGAITPNDILNIKGPTAVQEYLVNEIQEVYRLQGVKIDDKHFEIIVRQMMT
KVEIVDAGDTKFLEGNLEHKIDFIEENDRIFGMKVIEEPGDSQELKAGQIVTARELRDEN
SKLKREDKKLVEAREALPATASPVLQGITRASLQTKSFISAASFQETTKVLNEAAVAGKI
DTLNGLKENVIVGHRIPAGTGLAEYQNVVVGSNREFEELINEKI
>EGEFANNL_01911 DNA-directed RNA polymerase subunit beta
MSKSLASKTQNPDRISFSHSKGQIEFPDFLDIQVKSFQDFFQLETRPDQRTNEGLFKTFT
ENFPISDTRNQFVLEFLDYFVDPPKYSIDECIERGLTYSVPLKARLKLYCTDPEHEDFET
VVQDVYLGPIPYMTPSGSFIVNGAERVLVSQLHRSPGVFFGQSYHANGAKLYSSRIIPFK
GSWIEFATDINGVMYAYIDRKKKLPMTTLLRAIGYQSDKDILEIFDLAEEVKVNKSNLKK
VLGRTLAARVLNTWFEDFVDEDTGEVVSIERNEIILDRETVLEKEHVDLIVDSGIKTILI
HKENSGEFSIIHNTLQKDSTNSEKEAVEYIYRQLRNAEPPDEETARGIIDKLFFSDARYS
LGEVGRYRINKKLGLNIPEDVQVLTKDDIIEIVKYLIELINSKTEVDDIDHLSNRRVKTV
GEQLAGQFGVGLARMARTIKERMNVRDNEVFTPIDLINAKTLTSVINSFFGTNQLSQFMD
QTNPLSEVTHKRRMSALGPGGLSRERAGFEVRDVHYTHYGRICPIETPEGPNIGLISSLG
CYARINDLGFMETPYRKVVDGKVDLESEPQYFTAEEEEDKIVAQANVNMDDQGNILDERV
IARLEADYPSVEPKEVDLIDVAPNQITGISASLIPFLEHDDANRALMGSNMMRQAVPLLK
PQAPIVGTGLEFQVAKDSRILINAEGEGVVEYVDADKITIKYDRTEEEELISFEPASKTY
KLTKFRKTNQSTSITLKPIVRVGDRVTKGQVLTEGYATEGGELALGRNLLVAFMPWKGYN
FEDAIVINQRAVSEDWFTSIHVDEYSLEVRDTKLGMEELTSDIPNVSEEATKDLDENGMI
RIGAEVMPGDILVGKITPKGESDPTPEEKLLRAIFGDKAGDVKDASLKAEPSLKGVVIDK
KLFTRNIKDKRKRGDEKIKIEQLESEFKTKFKEVKDQLLEKLYVLLNGKTSQGIYNDLNE
EVIPKGIKFTQKLLSSIDDYFNLTGGSWTLDEDKNNAIKELIHNYKIKHNDLLGALNRER
HTISVGDELPTGIVKLAKVYIAKKRKLNVGDKMAGRHGNKGIVAKIVRDEDMPFLEDGTP
VDIVLNPLGVPSRMNIGQIYETILGWCGKKLGKKYATPIFDGATFSQIDELTKEAGVPQW
GTTYLYDGGTGERFEQQATVGVIYMLKLGHMVDDKMHARSIGPYSLITQQPLGGKAQFGG
QRFGEMEVWALEAFGASNILREIITVKSDDVMGRAKTYESIVKGEPMPEPGIPESFNVFL
HELQGLGLDVRLEE
>EGEFANNL_01912 50S ribosomal protein L7/L12
MADLKQLAETLVNLTVKEVSELADILKEEYGIEPAAAAVAVAAGPAAGDAGAAEEKTEFD
VILKSAGANKLAVVKLVKDLTGKGLKEAKDAVDAAPTAVKEGVAKDEAESLKKQLEEAGA
EVELK
>EGEFANNL_01913 50S ribosomal protein L10
MTKQEKTQVIEEIQTLLNEVNVLYIADTDGLNAQQTSDLRRACFKGEISMKVVKNTLLKK
AMDNVEDKDFSELYNTLKGNTTILISEKANAPAKLIQTFRKKTAKPVLKSAWIDSATYIG
DEQLDNLANLKSKEELVGEIIGLLQSPIKNVISSLKSGGNTIAGLVKTLSERE
>EGEFANNL_01914 50S ribosomal protein L1
MAVLTKKQKEVVSKVDKNKLYSLEEASKLVKEISYTKFDASVDIAVRLGVDPRKANQMVR
GVVSLPHGTGKETKVLALVTPDKEQEAKDAGADYVGLDDYLQKIKEGWTDVDVIVTQPQV
MGKLGPLGRILGPRGLMPNPKTGTVTMEIGKAVAEVKAGKIDFKVDKYGIVHAAIGKVSF
EASNIQENAQEIISTLIKLKPQAAKGVYVKSIYLSSTMSPGIAIDPKNVN
>EGEFANNL_01915 50S ribosomal protein L11
MAKKIFKMVKLQVKGGQANPSPPVGPALGAAGVNIMEFCKQFNARTQEKQGQVLPVVITV
YEDKSFDFVVKTPPVTVQLLAASKAKKGSGEPNRDKVASVNWSQIQTIAEDKMPDLNCFT
LQSAMSMVAGTARSMGIKVTGPNPFNN
>EGEFANNL_01916 Transcription termination/antitermination protein NusG
MVEEMKWYVLKAISGQESKVKMYIENEVLRSEHLKNNLGQIIIPVEKVVQIRNGKKIRKD
KVYYPGYIMIEANLVGELPHVIKNIPGVISFLSATKGGDPLPMRKNEVSRMFGKMDELSE
SDDTMNIPFEISETVKVTDGPFNGFNGTIEKINEDKRKLDVMVLIFGRKTPIELNFSQVE
KI
>EGEFANNL_01917 Protein translocase subunit SecE
MSGFINYLKGSIEEFRNHVEWPKWSDLQSSTTVVAIASVILAIFCFGVDWSFAKSLQNIY
SFLIGLKS
>EGEFANNL_01919 Elongation factor Tu
MAKETFQRTKPHLNIGTIGHVDHGKTTLTAAITKVLSDKGLAQSRDFSSIDAAPEEKERG
ITINTSHVEYETANRHYAHVDCPGHADYVKNMVTGAAQMDGGILVVAATDGPMPQTREHI
LLCRQVNVPKIVVFMNKVDMVDDPELLELVEIEVRDLLSSYEYDGDNTPVIQGSALGALN
GEAKWVETVEKLMDAVDSWIEQPQRDQDKPFLMPIEDVFSITGRGTVATGRIESGVINSG
ESVDIVGMGDEKLTSTVTGVEMFRKILDRGEAGDNVGLLLRGIEKTDIRRGMVIAKPGSI
TPHKKFKAEVYILTKEEGGRHTPFHNNYRPQFYVRTTDVTGNISLPEGTEMVMPGDNLTI
TVELHQPIALNQGLRFAIREGGRTVGAGQVTEILD
>EGEFANNL_01924 Tyrosine recombinase XerC
MHNKFISYLKLEKNYSDLTIKSYERDLLDLINYLLEIEGVEDIKKVQTKHLRNFIINLSK
KHLSEKTINRKISTIRSYFKFLLKIELINENPVVHLKNIKSRKIAYLPYTENELLKLNQY
LQTSLENSDNNHKKILEYLIFRIFYETGIRRIELINIKTSQINFNNSSLKILGKRNKERI
VPLSNQLLDLIYLFINKKYELGISKTETLLTDMHGQILKERYVYNLIRNLLNQVTTKENK
SPHMLRHSFATHLLNNGANLNVIKDLLGHSSLAATQIYTHNSIEELKKSFNKAHPLANKN
RD
>EGEFANNL_01925 30S ribosomal protein S21
MLIIPVKDGESIDKALKKYKRKYDKTGVVKELRKRQQFIKPSVIKRQQLIKAAYKQRLQT
QDEI
>EGEFANNL_01926 hypothetical protein
MLHKLNQKIQNLINFFSHEIWRINTSSKSNRKIIIYDIVKAFLLTFRNINSSQINTRAAA
LTYNSLLSIIPLLAVLFAIARGFGFQNIVESQLFEFFTGQKELLTRAMKFIDHSISYAQG
GIFLGIGIILLFYTVITLLSNIEDNFNSIWRIQQGRSLFRKFTDYLALIVITPIFFICNA
GLTIFLNSSLNFDFFNYVLVPIIKFVPFVIIILLFTILYIYIPNTKVKFKSALMGGLVSG
SCFQIFQMLYISGQLGLSKYNAIYGSFAALPLLLFWLQLSWFICLFGVQLSYSYQNINKF
SFERETSNISRRYKDFILLTIATLIIKRFETKTPPYTADEISETFKIPSQLVNDSLYYLL
KSEIIRETPSNDEMVISYIPSIDINKISISFFFNNIDQLGSEDFKIDKSDEKIKNIWEKT
LEIRQLIYRKEGDILLKDI
>EGEFANNL_01927 Lipid-A-disaccharide synthase
MDKEIVKELIQNELTPFNLKKELSKILEPKHRSNLIFQYDQLQKKLGESGASKRTAYLIY
KTLVNN
>EGEFANNL_01928 hypothetical protein
MKVNDGQVIFEELNIGQLTIDPPPEELKNLIVRNCSINSFSYKNRSHILEELLVENNESP
DINTSIDIGAADHIILRNNGELNLVSISASSSKKHDVKMLDFINQKIYQLQIYGLDTINL
KELTLPIIGSFIQFTQCLLTEQFLDSLYNHIIKQSPIAIYFDSCDNVFSKEQQAQLKEKG
YTITIR
>EGEFANNL_01929 hypothetical protein
MILNGFVLINTCNLIKMNNKENFKCFNIKSLNFQHKILDASINIWTENIENPTIYDIVEN
KKYEFQGKYEVFFLEYHDETGNSLKNYSDRIGSAFYGLCIKIEQIELKLLIKGCVLSNYI
IPRLQYSIYTTHLTLGKRIDKEFVRINLFDPEEDVNQIATVQEQKAYYNQWLKSIEGLPY
>EGEFANNL_01930 Cholera enterotoxin subunit A
MYAYTYDSNTMIDLFGLDLITVYRFDRRSPDVINAEGGFNAKSPNANVDLLDYAKNNTPS
QYISTTYDINSAINFGNDYYNGEGYVYKIQVDDSKGVNVNEVLGAKSPYPLEKEFSVINK
IPNENIIGHTPAKDIKNPNDIKWLCPY
>EGEFANNL_01931 hypothetical protein
MNWVYFLFLFNIIFISAQEGIENILKSQLEDGNSVPLGDEYESHEYSEKDLDATIPIIEN
ILKTQGYKTLTSSEFKEKIKSKFNRIIDEKSEKRYLYVDLYDKCSRDIIYTRNPIYNGFF
IIKNKNFITSLYAIPELIDYQKEYPEIAKVENKILIKTDSYWTDNLEVPHWRDTKNLSSQ
RRFIKKLLIARNKYLFNEDQNQFAWLITNDAQFMRSLVTTFGYTEDKKLYKWFFDNTPFD
EKNLDEFGELIWTKYCNNSISIHNNFFNVIDNLLSVDKEKYLNYLLKYLQYVLDYDVKNP
NALIKQISLAQKCELIGRIISFGEKFRYAENINIEDPYKFMGWTFMMDYKELYKKEFERN
NYYNLPEFKERYKMAEDYWVSEVLPFNE
>EGEFANNL_01932 hypothetical protein
MLFQLWSSEIKNFSIEDVENNLWARQAGLDDKSLARSVNEFNLAFTKYGINSCMQKIVFW
LKLLLKLFSLLPLGIIE
>EGEFANNL_01933 hypothetical protein
MYHLLRKAIIYISLKKQTEDFDEIHDSIVQGISFKGTNLWILVCAILIASVGLNTNSTAV
IIGAMLISPLMGPINGMGYSIAIHDFKLLNQSIKNFCFAVLASIVASTIYFAITPVHTAH
SELLARTNPTIYDVLIALFGGFAGIIAISSKQKGNVIPGVAIATALMPPLCTAGYGLATF
QFSFFYGAMYLFTINTVCIAYASVLISQMLKFPIRDSQISEKRKKRIHHGLSLILLIIIL
PSIYLGYQMSQNEKFRSNADKYTRNIEIYKGNYLLNKKINPNKREINLVYGGSLLSEADK
KAIINKAIAYSLADAKIVIEQGLAIDQNLDKEATNAQSEEERLMQQIARLNLEISKYKQK
VDSIKSLPLIGKQLLSELSPIYPQIENCMYTNANIYSKDDSIQELKSSILMISSNQKFSI
IDQEKIESWINKRLNNNKIKVIFNESN
>EGEFANNL_01934 Ktr system potassium uptake protein A
MKYIIVGLGVFGSSLAEKLVSQGNEVIGVDMKMQRVNELKDKITHVVCLNVTDAAAVETL
PLKNTDVVIVCIGEDQGANIMVTALFKNLNVKRLIGRSLNPLHENVLQAIGVHEIVRPEE
ETAERWAKKLTLRGMVDSFELNENYSIVEVLVPEIFIGKSIEEIGFRREFNILVLTVVKN
IERKSIIGKTKIVSEVQGIPKPETILEKDDILVVYGANRDIKKFISDNR
>EGEFANNL_01935 Ktr system potassium uptake protein B
MLTEIKYIGLNPARLFIFSFLGLILIGTILLMLPFATTRGISIINALFTTTSAVCVTGLV
VLDTGKDFTLFGQIVIISLIQAGGLGILTFASYFSYFFKGGASYEDQLAMGTISNIEKID
EIFKTLKRILIITLGIEMVGAIFIFASLDPNLIPSFSQRIYFSVFHSISAFCNAGFSTLP
YGIMENGYVHNYLFQLSLIFLFILGGLGFPIVINVLKYLSHVIIKNFFLAFSKRKDVYKP
RVMKLGSKINILTTLFLVILGTTFIYVNEYCNILASHKGIGKFITALFTATTPRTAGFNT
IDFSQLHLSSIIVIIILMWIGASPASTGGGIKTSTFAIAVLNFLSLGKGQKKIEVYGREI
NDLSIRRAFAVISLSLIFLGIGSLVISYFDKDLQLYEIIFESVSAYSTVGLTLGITSSLS
MGSKIVLIVLMFIGRVTALTLLIAFFKQVKKCDYTYPSEDVLIN
>EGEFANNL_01936 Na(+)/H(+) antiporter NhaA
MPEEKKVPIDIVLKPIQRFILEEKSGGIVLGLSVVIAMFLANGPWSNEYFHFLERKFGFV
FNGNSFFEYSIHHWINDGLMAIFFFVVGLELKREIVGGELSNPRKALLPIAAAIGGMVVP
ALIYIAFNNSGEVHHGWGIPMATDIAFALGVLFLLGSRIPLTIKIFLTALAIVDDLGAVL
VIAFFYTSDISYYNLAIGFVFVLLMYLGNRMGVRSILFYAVLGILGVWTSFLLSGVHATI
ASVIAAFMIPADVKIKENLFFERIRKYLDKFKSKDPNSKIPTLTNDQLHILEKIKIDTNK
AIPPLQILEHAMHPFVTFIIIPIFALANAGVSLDINIDELFSTHVALGVALGLLLGKVLG
VVGFTLLLVKLKVAPFPEGMNIKNLLGIGLLASIGFTMSLFITSLAFTNPEYVVQAKIGI
FVASIIGGILGYIVLSRSTNSKPC
>EGEFANNL_01937 UvrABC system protein B
MKFKVNSSFQPTGDQPKAIQTLAQGIFNQEKYQTLLGVTGSGKTFTIANVVEKIQRPTII
LAHNKTLAAQLYMEFKEFFPDNAVEYFVSYYDYYQPEAFMPTTNTYIEKDLSINENLEKL
RLSATSALLSGRRDVLVVSSVSCLYGIGNPQEFKNNMLSLQVGKKITKTQVLKLLVNALY
SRSEINFARGNFRVKGDVVDVFPAYSDTGIRIQFFGHEIERIENVDYASNNVIDSVESIH
IYPANLFVTSPETLNGAIRNIQIDLGKQVDYYNEIGKHLEAHRLKERTEFDLEMIKELGY
CSGIENYSRYLDGRMPGSRPFCLLDYFPQDYLMVIDESHVTLPQVHAMYGGDRSRKETLV
EYGFRLPAALDNRPLKFEEFEGMQNQVVYVSATPADYELQKSEGVYVEQIIRPTGLLDPV
IEVKPSLNQIDDLMAEIQKRVEEDERVLVTTLTKRMAEELTKYLNKFGIRTRFIHSDIDT
LERVEIMQDLRIGKFDVLVGVNLLREGLDLPEVSLVAILDADKEGFLRSHRSLTQTAGRA
ARNIHGKVIMYADKMTDSMNKTIEETARRREIQNQYNIEHNITPQPLKKKITSITIGNME
TPVIKTYAENSEVLKVAEESANYSKTDVNKLISKKQKEMEKAAKELDFLTAAKIRDEIKE
LKERIKK
>EGEFANNL_01938 hypothetical protein
MELIRLNIRGISYSQTQTGAYALILEEDFGKRKIPIIIGSFEAQSIALALETNIDPPRPI
THDLFATFARSFYITVKAVFIYKLVDGVFYSNILFQNSETDEEKEIDSRTSDAIALAVRF
NAPIYTNKEIMDKAGVYMEMKQQSSDEVNYGNVIDDIDNQLENYEEEDSFHHLSDLEIKE
LMEKSLESEDYETAAKLRDELARRG
>EGEFANNL_01939 Actin cross-linking toxin VgrG1
MSKSKPNPDKNSALNLSDASREISKTKKVNLLDEFDSNEVPPIKNIIPGDIYSLPNGLLT
EEQYAQYKGLNSLIATYGGDPEKNLANSHIVFSKIFIGGERVLADSHFEVKIEQKVAEHD
TFIIRCFSDAIEDPKAYPLEKARNFLGKRATIQFMQFGSATLVYTGIITDIANVRENGES
QLVFTGKSPTILLENGLDCQSFENLDLKEIVTKATTEYPTDLVQLDLQPLLTDRLLYTVQ
YRESDWNFIKRLATRYGEWLYYNGQQIVLGPYRGKTWELVEEQDVYDCTLRMKLMPQKFS
YTAYDAKQAETYTINSQSVRLSRRLVNPFQQHAMDASEGIYSKVASSLYNHSLLEGGPSE
LERAVKKQKQRRQNVFYMEAKTNNPNLKVGDNVKLKAWMPGHSIFKNGEVPLETYRIIEI
KHYQDITEGYYNHIVAIPKDNEVPPYMDEDAFPACEEQSAIVTDNNDPQGMSRIRVQFPW
QRAFNGQTPWIRSITPYAGEGKGMHVIPEIGEEVIVSFENGNAEKPVSLGAMFNGKGKSG
HGGAGNYIKGLQTPTGNKIQFNDKEGSALLTDNGGASMKFDGAGNATTIANLIHSVNAGS
NANTSVGDDASTLKMDASGNITLKGNTNITLKVGGNTIVIDGSGITMTSNSGNIQTISNT
GSITALAANSIMMSSNKTIIQGNRAALKGNQILLEGASSIKCVSPDTDIF
>EGEFANNL_01940 hypothetical protein
MPNPLEYIVSKALIYCTEGTAIDQFQPTSNTHYRIDGIVGVENDLKLGVNLPSDFAFCEA
KGRKKCVPDISGKWQDTYGPLKGEHKDTLVFRCSLKCNNGGIIKFSTSGQKGGGKLDKWD
KLPSIPKMSDFNKSSVVVPKNNEEESMKNYEDLIKQQRNSERSTGEISSFYEEKIAGSID
NFNSFLASGDQAKINRLEFIEGFIPFYGLIDAFMKSNNNFMQGNGEDGLINMASAIPISK
LVGKVSKLSKLDELGELMDNLGDVYDFGYGKGLDAIQTYTDNLNIENSENNELLKLINDK
TLDASVLKSDPSFFIRNDYGSKGACKVMAKYLGAQSDAMKGKKVLACFPAGTLISTEKGH
KVIQNITPGDLVWAKNELNNEVSLKKVLKTFIRETNKLIVLILEDDKIKTTEEHPFYTKK
GWKEANELSTEDYLLAQDNQWHRIKNKQFLYSYEKVYNFEVEEFHTYFVGIEKVLVHNAC
EKPVEGPLPQK
>EGEFANNL_01941 hypothetical protein
MEKNIEKENLNKIYFYMREGYDDYEFYNFKGAISNFEKAIKLIPEPKNSHEFSKRLFTCL
AMSLLPSKEYDKAIENYKLALNCVEDRKDPQLQFMIGKYLYESNKKDDAFFYFYKSYELA
EEKYFKNHDNKYLLFFLKCKNKNNLKEEHINKTINYKGKTYTQEEWEEFEKKQFKDYAQK
HNIPLDDGKPKKSFGFFLDEKDCKY
>EGEFANNL_01942 hypothetical protein
MMENLKNPLDSFWMRKIVNTNLYSLIKRVRFINVKYKSLLINKLLLSYSVTVFIF
>EGEFANNL_01943 hypothetical protein
MKKKFTLFVCIFLYSLLQAQQYEVDTNYGTQGMALHQLKGDKQFATDYVQLHNGKILISG
TTGVIRINEDYTQDFSFGKKGRIRVPLDRIFERADHKIIGIKKSINPNLLTIHCFLADGS
YDRSFGNQGTLEVDLEDNDSIDFSNNSLGMAIQGDQLLLALYSGKVIRLTSNGNLDTTFG
NQGVINIPLPKKVEGIVSSNNDIRLVVDIIVESDGRLIFGTNVFPKQGLSENHIAYILKY
SSEGILETTFGENKDGSYIIKYLNGSIVYPLTARLHKIQMGHNRTILALTEVQSNDSNYE
PSMIFSKISYDGKNKLNENVLHSGFTNPSYPPTIGSSTLVYKNILELSENNYVVTAYCNS
SQAPKKFYYDQGALALIKPDGTFDANFGNNGAFYITDSKTGFASNAIGTLELKDGSLLTI
GSYLLYSFSGEENYGITLYKFDQRGNPILTFGKGGKMIYSIPSEKQSIFTMGVQPDNKLL
LGSSTIWRLLENGSFDSEFNPIKNEYSVSGTGGADYYFNGYLKINSMDGSIKTVGKDINS
YTNNGILLHRTSSMDRGSNHSDVLAIQPDGKYIFMRNKYSSNGVGAPAEQNIYRNNPDGT
LDNTFTFDKDFLTYSSDANQIQSIALQGDQLLVEGNFIMVGPPNPMQTQKSIRRFNSDGS
YDYTFTPLKPRPIKLQSDKKIILKDGTYLERYLPDGDLDLSYGTNGKVDLNSILEISTFT
YQILPDDKVLIHAKTTQGENQLLQLTPEGKLDSNFANQGIYTIDPSLDAQIVQVQPDSKI
LIGGTKTLDGEEYMAVLRLKKQENQQQTNKNQSIEAPKTKTEPHEPLHFTPKFQEQPETY
YWEVKIGTEKRTYTDPELNLTLEKEGIYTITLFATYSDGTEQKTEQTIEIKKINILENQP
ENYEQEVTITPNPATSYIHIKGTKEGKKITIEIIDTNGRLLHKQEGITTMNIQSLAPGVY
FIKIKQEGKTTVKKIIKI
>EGEFANNL_01944 hypothetical protein
MKEKFTLFVCIFLFSFFQAQQYEVDTNYGTQGMALHQLKGDKQFATDYVQLHNGKILISG
TTGVIRINEDYTQDFSFGKNGRIRVPLDRIFERADHKIIGIKKSTNPNLLTIHCFLADGS
YDTSFGNQGILSVSNDYNFSKEIDANYIGASMQGNQLILALNGGKVVRITSEGKIDQSFG
NNGAINIPLPQEVKYTPDYDIVYRTIEDILVLPDGKIIIGATVSGYDNLNQAASYLIKYT
SEGILDTNFGESSQGISVIKYVSVVPGSNINAHLQKIQICKDGSILGLNEFDDGLTFPSM
IFTKTSSDGKLKYIDTIFYPNTDGSTGSLTEPEIGSVYMNYNRVLELSGGGFLISASSLG
GIKLNFPNQVMYKGALSLLKSDGTVDTDFGNQGKINLTNFQETLSESNVIGTIQLKDGNI
LAIGGYNGEETYGLTLYKFDQRGNPILTFGKGGKMIYPIPSEKQSIFTMGVQPDNKLLLG
SSTIWRLLENGSFDSGFNPIKNEYSPLSLGQNIFYSNGFLKINSMDGSIKTVGTYINSYT
NNGLLLNSTPSMDRGSNHSDVLAIQPDGKYIFIRKKYFPSAVGLLVAEQNIYRNNPDGTL
DNTFTFDKDFLINAQDENQIQSIALQGDQLLVEGKFFSDGSLNSMLIPDYIRRFNSNGSI
DQTFIPFKGGTIKVQSDHKILSKSMTQLERYLPDGDPDLSYGTHGKVDLNSILEISTFTY
QILPDDKVLIHAKTTQGENQLLQLTPEGKLDINFANQGIYIIDPSLDAQIVQVQSDDKIL
IGGTKTLDGEEYMAVLRLKKQENQQQTKKNQSIEAPKTKAEPHEPLHFTPKFQEQPETYY
WEVKIGTEKRTYTDPELNLTLEKEGIYTITLFATYSDGTEQKTEQTIEIKKINILENQLE
NYEQEVTITPNPATSYIHIKGTKEGKKIIIEIIDTNGRILQKQEGITTMNIQSLAPGVYF
IKIKQEGKTTVKKIIKI
>EGEFANNL_01945 Threonylcarbamoyladenosine tRNA methylthiotransferase MtaB
MLEKNKSVAFYTLGCKLNFAETSTIARQLLKEGFQKVFFEEAADVYIINTCSVTENADKE
CKTIVKRALQINPKAFVCIIGCYAQLKPEEIAKIEGVDLVLGAKEKFNIHKYLQEIHKES
ETQIHSCEIDQADFFIGSYSIGDRTRAFLKVQDGCDYKCTYCTIPLARGISRSSTLENVL
SQAQEISDKNIKEIVLTGVNIGDYGKGEYGNKKHEHTFLDLVQGLDKISGIERIRISSIE
PNLLKNETIEFVSKSKKFVPHFHIPLQSGSDDILKKMKRRYLTNLYEDRVYKIRELLPDA
CIGVDVIVGFPGETEQKFMETYTFLQNLPVSYLHVFTYSERDHTEAIEMEGIVPISERKK
RNKMLKILSEKKRQAFYESQLGKVKMALWEHENKNGKMYGYTENYVRVTKNYQEQSINQL
EKVSLNTIDHLGNFEIDI
>EGEFANNL_01946 Carbonic anhydrase
MKKLVILVGILSFSFSNSQEHHWGYEGSESPEHWGEIKGNEQCGKGKYQSPIDIYKSTKN
KKLPKLKFQYGSGEIEKIEDNGHSLQFDFKEGSSINFNGQDFTLAQFHAHEESEHTIDGV
RYPLELHFVHRSMDGKVLVIGVMVKEGDENSYFERLKVFKNLGKEQNQEVHVSFNPEKLY
PKDKTFYTYIGSLTTPPCAENVTWIIFKNPILMSEHEIEDIAKHLPKSNNRPIQPLNGRR
VENN
>EGEFANNL_01947 hypothetical protein
MLGINLFANYFPLKWIVLSAKPEVMYNWYKKEYSNSNIKTTKNHFIPAFSVGGGLYLKPF
LLQLNYELIQDKYSPYGHDIFFTLGFMF
>EGEFANNL_01948 hypothetical protein
MVYGGDFSFSVSNNYWSLGISPQVGYRFTDNFIVGAGIGY
>EGEFANNL_01949 DNA gyrase subunit B
MSEQKYTADSIQALEGIEHVRMRPSMYIGDVGIRGLHHLVYEVVDNSIDEALAGYCNTIN
VIIGKDNSITVKDNGRGIPVDINTQTGLSALELVMTKIGAGGKFDKDSYKVSGGLHGVGV
SCVNALSTQLIATVNRNGKKYQQTYSKGVAQSSVEEIGTSEHTGTKVNFIPDSTIFSQTI
FNYDTLATRLRELSFLNKGITITLTDERELEEDGTEKSETFFSDRGLEEFVEFVDGNREP
LMEEIIHMEGEIDEVPVEVAMRYNTSYTENIHSYVNNINTHEGGTHLTGFRRALTRTLKK
YADENINLAKEKVEITGDDFREGLTAVISVKVMEPQFEGQTKTKLGNSEVSSAVDKIVSE
MLTNYLEEHPNEAKQIVQKVLLAAKARQAAKKARELVQRKTPLGGSGLPGKLADCSSRKP
EESELFLVEGDSAGGTAKQGRDRNFQAILPLRGKILNVEKAMTYKVFESEEIKNIYTALG
VSVGTEEDSKELNLTKLRYHKVVIMTDADVDGSHITTLILTFFFRYMKEMIEKGYIYIAT
PPLYLLKKGNKEYYAWDDKHREEIAAEIGNSQGKGFTVQRYKGLGEMNAEQLWDTTMNPQ
QRTLRQVTINNASEADRIFSMLMGDDVPPRREFIEKNAVYANIDV
>EGEFANNL_01950 hypothetical protein
MAKLKIKNIFTKILKGALYSLGFFFVIAISLLIILNIPSVKEKIAQKALSFLNDKFKTEI
SVQRIEVDYLGNIILHDAMVKDHHQKEFIQIKELKAYANTISLLKNILIKKVNDIEIDQI
TLNEPVVQVITYKGENTDNFNKFITKFKSDEPSNKDFKLRLKVNLIDGKLSIVNQNLPTN
DQYWLDASHLYLKAPSVSVFNSDVQVTVDELRFKGIRRNESYDVSKIKGKVHYSDTKLAF
EDLFFQTDTSFLLGKLIFSYTKENGMTNFSDHVNWDLDLKPGSKISGKDIRYFVKDWDSN
SIMVASSKAEGTLNNLKLINPIISSENTIYSAPYLFIKDMASSDKEKSISLLTEKAHLQT
SYTSLTKWLPKFLSVKIPEVFSNVGIANYKGDFSLDKQEILAKGTVVSSIGEVIADVQLY
NYSGNVPIYKGTLNTHHLNLAPFTKTSALGPITSKISFDGKGFDMNHLDTKFDAYLSNLQ
MNNREIHGISVVGKINNKIFKGNINTNDQHVDFNFEGNLDFSQKTIKTTFDAEINKLDIS
YFTNVVDKNTIFRGDVNADVKFSTIDDVLGKINITSITITKDSISIPYNDINIQTSMDNG
LRNLDIFSPNMLTANIYGNYKLNEVPAMLQEGVGSLLVNYKPKKAFKGKEFSFILDVQKD
LFDLLMIKANISPGTTLTGRYIGDKNQLQVQMISEYVYYDNIKLKNPNIFINTADSLKQF
MGNLSSLSIGNNSINDLNFSGFKRNDSLFASTKFNYGKTKDNKTNFDLNLYQTRKGNDVI
FGFKPSDIKMPQTVWTLNPEFKSNEAIAIYNTITGKLSLQKIGLRSTDSEIMLSGEYSSN
DNYNFDLDLNNVLLEKVIPANLLKDMTFEGVASGTVEILKTSKEFKPIVDFEIKGLKFNK
EALGNLNVDAVYNSLENKYEIDAQLEDSKGKHFLANGYIQNKKGLPAQLDINLIANEMNV
APIGSFLQSILSRFRGTATGEVHITGDITNPKYQGILTMSKVGFKLNFTGVDYELTKDQD
LQISDGIFLLDNIELRDTKDGTIGNVFGPLMTKNFSEWGMDLEFSTNRLLVLNTTITDND
LFFGTVYASGNFSLTGSTASGIQLSAKATALNGSSLTINSSSTTNATDISYIKFLPEQKD
EDAPISNQKPPTGFSINAEVTAHSNSVVKIIISDETGDNIEVRGNTENLQFKMNQSGVIT
MDGTYTIAENSKYYYKMFLNKDFNITPGSTIRWENQAPTAAIMDIKATYSKSVSNIGAYL
GIGTVPASNVTVTALLTGNLAKPEISFDINADVSSSIAEQLKTKLNNNEGEKFNQVAGIV
LFGNFIASNMGGSSYASSAYDVVLKQLTSVINNINNSFSLNASYNAGSKVDNTSDRISLD
PTLHLNKRLSIIGSVNMPLEQKSAADVWTYGAKINYDVSTDADGSLIISGFSKPSTFGLE
TSLLSNSGADNQAYGGSIIYKRSFNSFKELFKKKDTKKDKDKDKSKKEENSAKKDTLSYL
KFMK
>EGEFANNL_01951 tRNA N6-adenosine threonylcarbamoyltransferase
MKTPIILGIESSCDDTSAAIIRGRKILSNVVSTQKVHQNYGGVVPELASRAHLQNIVPVI
DQAIQLANITKKDINAIAFTRGPGLLGSLLVGTSFAKSLAMALNIPLLEVNHMQGHIFAH
FIEEDNLDSPNFPFLCLTVSGGHTQIVKVNDYFSFEVLGETLDDAAGEAFDKIGKLMGLN
YPAGAMIDQLAQLGDPEKFKFPIPKLEDLNFSFSGIKTSVMYFLKKNQNNPSFISENLED
LCASVQNTIIKALLIKVEKAVEITGIKNIAIAGGVSANSELRKRFKNLEITHNCKTYIPK
LEYTSDNAAMIAVVGSLKYERSLFTNLNVSASARYNL
>EGEFANNL_01952 hypothetical protein
MSNKIIACLFSILTLFILTSCNKKTKIFEENFSNNFNRWDTLTSVYISNEIKNNQLVMSN
QLDNILNSSLIRLDFLKTEEKYSISSNLIFDKFYGNHGLGGLILFSDSKDNPKNFIFFGV
NSQNEIVISEENASPNLSKVYYKQKNQAYKQGETNLFKLKYLGNHWQFLVNNKPIVTIQN
QLKNNYYMGFGVINCQLTSNHIIIESE
>EGEFANNL_01953 Beta-barrel assembly-enhancing protease
MKVKKILVSTWIALTLASCATNPLTGRKSLSFVSNSQILPSSFQQYSQVLTSSKIIKGTK
DAKEVSEVGNRIKAAAEAYYASIGKSSALEGYEWQFVLIEDPKNINAWCMPGGKVAVYSG
ILPVCKDDTGLAVVLGHEIAHALAGHGAEKISQTYVSQLGGQLLGGVTNNQLLNGVIGEL
YPVASGVTLLKYGRKQESDADEMGLYIMAMAGYDPRQAPIFWERMVEATGGSSTPEFLST
HPDPKNRIEDLNRIMPKALEYYYASNKK
>EGEFANNL_01954 S-adenosylmethionine synthase
MSYLFTSESVSEGHPDKIADQISDSILDNFLAFDSESKVACETLVTTGQVVLAGEIKSNT
YIDVQKITRDIIKKIGYTKSEYKFEADSCGILSALHEQSQDINRGVDKEKKEDQGAGDQG
MMFGYATNETKNYMPLALDISHNILKVLAKVRKDGSEMTYLRPDAKSQVTIEYDDHNKPI
RIDTIVLSTQHDMFDEDEKVVLNQIEKDVKNIIIPKVKALASKEIQDLFDDNIIYHINPT
GKFEIGGPHGDTGLTGRKIIVDTYGGKGAHGGGAFSGKDPSKVDRSAAYATRHIAKNLVA
AGVADEVLVQVSYAIGVTEPCGVYINTFGTSKVELTDGEIALKVEKIFDLRPYSIEKRLK
LRNPIYAETAAYGHMGRENETVIKRFERSGENGKIEVKEIEVELFTWEKLNYVNEIKSSF
NIN
>EGEFANNL_01955 Putative pre-16S rRNA nuclease
MPKILAIDFGEKRTGLAETDDLQIIASGLAGILTKDLIPFLSKYMKDNSVQKIIIGLPTR
LDGTMSIIENSIQECIKKINCLFPSIPIERIDERFTSKIAAHAISLSGKNKKQRENKHLL
DEVSATLILQTYLDKNIKL
>EGEFANNL_01956 Peptide deformylase
MILPIYAYGEPILRKKTTDIDKDFPELDNLITNMFETMYKANGIGLAAPQIGLNKRLFII
DAAPLAEDEEYSDLKNELLNCKKVFINPKIIHTEGEPWKFNEGCLSIPDIREDIARPEKI
TIEYYDENWEFHTETFGDIRARIIQHEYDHIEGILFTDLLSPLKKKLLKSKLTQISKGKI
KVDYRIKFPSN
>EGEFANNL_01957 hypothetical protein
MDLTKVISITGKPGLFELLSQTRGGFIVKDLDAQKKSSINANSQVSLIQNISIYTQESEV
SLISVFISIAQKHNFQELKFEKNNSEALHTLMKEVQPDYAQDRVYNSDLKKLFSWYNILI
KNKILTEEGVKTYLANMAQVESENNQEVSENNQAPLDIEVTEKNASKKAEKKESKPKTKS
EEKSKTSKKKIDQ
>EGEFANNL_01958 Nucleoside triphosphate pyrophosphohydrolase
MSTREKQLESFNKLLDIMDQLRVECPWDKKQTFQSLSVLTLEETYELLEAIENKDYKEIK
EELGDLMLHLVFYSKIASESDKFDIVDVLNSICDKLIYRHPHIYGSVNVKDENDVKQNWE
KLKLKEGRNSVLEGVPSSLPSMIKAYRILDKVKGIGFDFKNESEDINKIKEEIEEFENEN
NLENKEQEFGDILFSLINFAHRQNINPENALEKTNRKFITRFQTMEYLIKNKNLEIENLS
LNELKYFWDEAKSIHNK
>EGEFANNL_01961 hypothetical protein
MKKIIAYPLSIIYYLLFGSTLLIFHIIQWLCLNLFGYGAHKKSVDIMCFFLVANTYVLGT
RYKVLGLDKIPSNEPLIIAANHQSLYDTTSIGWFFRKFHPKFISKIELGKGIPSISYNLT
HGDSVLIDRKDPKQSLSAIKTMAEYIEEHNRAAVIFPEGTRSKTGKPGTFAKAGFKILCK
NSPSAYVVPVTINNSWKMTLWGAFPMGIGNCIELLVHEPIKVSSTSLDELFIETENQIVK
HINKDHIV
>EGEFANNL_01962 hypothetical protein
MKLSFKKLNNLVGLLVFIIAAITYLLTIEPNFSFWDCGEYISSAVKLEVTHSPGAIFFQL
LGAVWAILAMGDGTKYSLVINAMSAIMSALTILFLFWTITHLTRKLLFSKIELDDLTAYQ
KATLILSGAVGALSFTFTDTFWFSAVEGEVYAAASCFTALLLWLMCKWENDDSSRSDRWI
VLISLIIGLSVGVHLMVILIVPTLGYIYYIKKYTFTWKSFIIASAVIGFVFILVFKVIFP
YTMSFFGKSEIFFVNKLQMPFNTGSIFAFIVIVLVFYFGLKYTHKHKLSLVHTIILSILF
MLIGFSSWLALPIRAQANTPINLNDPDNAIGMLDYYNRAQYGDWPVFYGANYTAYLDPNG
IIGTEDNGPIYEKNEEEGRYIETGRRFNYKFNPEHISLLPRMYSPDAGAMENYGLMEGYP
KFSLNPSYYQNPEAQKIYEDLNSKLENGSIRIRDYQVAKQNDLLKVQKPTLGQNLDFMMT
YQMGYMFIRYLLWNFVGKQNDIQGNYESTKGNWISGINFIDKMHLGDQSKLPATYINKAT
NKYYFLPLILGLIGFFFQLNRDPRRNFALIAIFLLSSVGIILYTSIKAFEPRERDYALVT
SFFTFAIWIGLGVSAIMHQFKKNNQKKIGLVLGILTLGVPLLMGFQNWDDHDRSRRYTAY
DFSKSYLEGLDKNNPILFVYGDNDTYPLWALQETEEFRPDAKVINYTLLGTAWYIDQTHR
KTYTAPSLPHSLSHEEYRDGVNDQIMLLNKNFWSQLFQQIPAKDLPEEFIKFKKFATQDS
LSAKEAINFLKNKDDQKSLKNLLATVYDDRDLNKDDIGLLPVNKFYIPVNKENALKYGIV
KPEDADLIVNDIVLTIGRSSLGKDGLAMLDLLANYNWDRSIYFSSGGTYSPSNLMYANNY
LEYQGLVSKLSPIYTPNDELGNLGRVNPNTLYQLVKNYKFGNLKDPKAYFDETCRSNIIN
YRISLGRTAKELANIGENKKSNEILELINTEIPLSMYPATPSYNSIITSYLQIGKEEEGL
KLADIYKNQLLDELNYYLSLSPKSQTFVIDDMDNLSNSYTYLISEIANTYLKMNQKEKAV
KYIDNSMKPLDKRLQEFKTLGKNSKNNYSASFNNLKFSYGQMFQLLHSIDSVYGKQKAEE
ILNVYEELK
>EGEFANNL_01964 hypothetical protein
MEKLIKLSSFRTNFRTNKIFVLMNTRFVPRTQPNKQGEHRMYLHISSQGKQ
>EGEFANNL_01965 hypothetical protein
MKKILFIFSCLLLLFSSCSDDLTDGITTGEVQPTSHQIRWYGTQTPIGVQSLGVSDGSKR
WNQDAGIYIKFINTPTDPIIIQKIKDIASEWEQYAGIQFHYVESGQKADVRIAFDWNGND
WLTWSYTGNDAKKISDPNQPTAVFGGLQYQDEQQFKGDVLRVFGQILGLDYEQRHQQWTE
NGYWRNPEKLQTYWEDFFEGYTMDWAEIRQYVFDPLTSENSLQLLETKELDESSIMAWPY
YIRSQTLKLLANYELSEGDKAFIAKLYPKKGSENGSGNESGNGSENGSENGLENGSENHL
PTIQEAWIDTGYFRWVNDSKTAVVITAKGLSMQYLPDVSDGEQLTTAKSMFFGAVLLIKA
PKFNTKNIIDFGNMFENCSSLSEIPLYDSSKAINFSYMFNNCISLKTIPLLDTSKGLYFR
GMFNGAMTLTYVPNLDTSRGVTLYRMFYNCRYLQSKPDLVIPPSAIVDEMYTATPFG
>EGEFANNL_01966 hypothetical protein
MKNIFLLSIVLLITGITISCSSDDDIPKGLSANQFPQYQATLIASKNEPINTNGELKYDV
YYTCMVVNTTDQPVDAFLVVDFYINNNQFSYSNKVYHFPAKDTLLIEGVAEDVPAMYAES
GIKRIRLDPKALAENPFK
>EGEFANNL_01967 ATP-dependent Clp protease ATP-binding subunit ClpC
MNENFSQQVKDVISFSNEEVLRLGSDHLGTEHLILGMLREGNSKALTVLRSLNIDLRELR
HQIEGLNVVNPNSKVDRNQIPFTKAAERVLKTSFLEAKLFKSQEIETIHLLICILRMESD
PVTHIFSKYDVDVKTIRDEYKLQFQDDFPAQVVNEFSEDEKEGEDRSYEAPKSAPNTSKS
RTPVLDNFGRDLTLAAEEGRLDPVIGREKEIERVSQILSRRKKNNPLLIGEPGVGKSAIA
EGLALRIVQKKVSRVLYKKRVVTLDVASLVAGTKYRGQFEERMKAIMNELEKNSDIILFI
DEIHTIVGAGGATGSLDASNMFKPALARGEIQCIGATTLDEYRQYIEKDGALERRFQKVI
VEQTSPEETEEILKQIKNKYEEHHNVVYTDEAIKACVALTVRYITDRYLPDKAIDALDEA
GSRVHIKNIKVPQEILNYEKELEDARENKTTAIKQQRYEEAARLRDLEKETEAKLAQAQR
NWENASKEKREIVTEDNVAEVVSMMSGIPVQRVAEGELKKLAQMKDLMKGKIIGQDEAVD
KVVKAIQRNRAGLKDPNRPIGTFIFLGSTGVGKTQLAKVMAKELFDSTDALIRIDMSEYM
EKFAVSRLVGAPPGYIGYEEGGQLTEAVRRKPYAVILLDEIEKAHPDVFNILLQILDDGH
VTDSLGRKIDFRNTIVILTSNIGTRELKEFGDGVGFGTSAKKSNSEVRAKSTLENALKRT
FAPEFLNRIDDVVIFNNLDKEDISKIIDIELGKVYERIEKLGYKIELSQEAKEFIIEKGW
DKNFGARPLKRAIQKYIEDVIAEEIINTSIHEGDFIQIDLNEDKNGTKVCILSK
>EGEFANNL_01968 Bifunctional protein FolD protein
MANILDGLKLSKQIKVEIKQEVEGYKDNGLRPPHLAAVLVGNNGASMTYVDNKIKDCEAV
GFKSTLVKLSDQTSEKELLNEIDKLNKDDSLDGFIVQLPLPKHINEEKIIMAINPDKDVD
GFHPENFGKMALDMETFLPATPFGIMVMLERYKISTVGKDVVVIGRSHIVGRPMSILMSR
KGNPGDATVTLLHSKSENLEEYTKKADIVITALGSPHFLKAEMIKDGAVIIDVGITRIED
SSKDRGFYLAGDVDFESVSQKASWITPVPGGVGPMTRAMLLKNTMLSYKRKNKVNN
>EGEFANNL_01969 Isocitrate dehydrogenase [NADP]
MRKIKVINPVVEMDGDEMTRIIWKFIKDKLILPYLDIDIKYFDLSIENRDKTNDQVTVDS
AEATKKYNVAIKCATITPDEARVKEFNLKKMWKSPNGTIRNIVGGTVFREPIIMKNVPRY
VQGWTQPIVIGRHAFGDQYKATDIITKGAGKLTMTFTPNDGSESESWEVYDFKGDGVALS
MYNTDESIKGFAHSSFQMALTKKWPLYLSTKNTILKAYDGRFKDIFQEIYENTYKTEFEK
IGITYEHRLIDDMVASAMKWNGGFVWACKNYDGDVQSDTVAQGFGSLGLMTSVLVTPDGK
TVESEAAHGTVTRHFRLHQEGKETSTNPIASIFAWTRGLMHRGKLDNTPELVSFAEALEK
VCIETVESGKMTKDLALLVKGKNMTKEDYLNTEDFLDAIDKGLKQKLN
>EGEFANNL_01970 Transcriptional regulatory protein ZraR
MAKILIVEDEESIRRVLKNILIDENKKFEIDEADDGVKAKEFIDKNDYDLVICDIKMPKM
DGEELLNLVMADKPNLPFIMISGHGTIDIAVDCIKKGAFDYISKPPDLGRLLSAVRNALD
KKLLIHENQKLSNQNKILKKKISKKYEMIGDSKSLEEIKNIIDKVAPTDVRVFISGPNGT
GKELVAHSIHEKSERSNKPMIEVNCAAIPSELIESELFGHMKGSFTGAIKDKPGKFELAD
QGTLFLDEIGDMSLSAQAKVLRALQEGKVSRVGSDKETSVDVRVLAATNKNLKEEIKEGR
FREDLYHRISVIELKVPALKERKEDIPLLISHFSKLIAEEHGSKIKEFTQEAIQLLQSFE
WTGNIRELRNVVERLIILGNDPITIENINSFC
>EGEFANNL_01971 GMP synthase [glutamine-hydrolyzing]
MKNGIIILDFGSQYNQLIGRRIREFGVYSEILPYYTPIEDILIHEPKGIILSGGPSSVNA
EDAHLIERKIYELGIPILGICYGMQLTSKLLGGEVTEGKKGEYGKSEFNIIKDNAIIKDV
PKNSTVWMSHFDEVSTLPDGFELIGKSTNSIACIANDEKKIYAVQFHPEVSHTEHGSSLI
KNFVFEICNCEKNWELTDFIQTEIKRIQKVVGNKKVILGLSGGVDSSVAAVLINKAIGNQ
LTCIFVDTGLLRKDEGDKVMEIYGEHFNMNIKRVNAQERFFFKLKDIEDPERKRKIIGNE
FVYVFDEEARKIENVDFLAQGTIYPDVIESQSVKGPSAVIKSHHNVGGLPKEMNLQLLEP
LRELFKDEVRKIGVELGIPEKLVYRHPFPGPGLGIRVLGAVDEEKVSILQEADSIFIEEL
YKNNLYDKVSQAFVVLLPVKSVGVMGDERTYEYTAVIRSANTIDFMTATWSKFSYEFLEL
VSNRIINEVKGINRVAYDISSKPPATIEWE
>EGEFANNL_01972 hypothetical protein
MTNQMQVAILYQAHEPPCIHGIQKPMKKGGYSDSGADIAYALKLSQISVVTPIQNPDLYL
DTD
>EGEFANNL_01973 D-alanine--D-alanine ligase
MYKDHPIVKYLHRVNLVGQIPENVEKYDDKFQTNALLKLNNLPVPHSILISSNDINYSNL
KKLNFPIVIKPIRGRGSQGVTKVNNFEELLINLKLIFDKKVYGTSVYLEEYLSGNELTIT
VMPPGNYPLKNEIKTFSDFWCLPPVNRFNHENGIAPYNGTVAVVNNSKVLNNEDRSNKSI
QQLMNRCEKAAKLVQAKAPIRIDCRANDEGNYYLFDLNMKPNMTGASRPHRFDQDSLSAL
AARQIGWSYSELLINMLGQNWKL
>EGEFANNL_01974 Putative cysteine protease YraA
MSKKVLIFAGDFVEDYELMVPYQALLSLGIEVDVICPGKKSGETIATAIHDFVGFQTYQE
LRGHNFTINKSFDEVDVHSYDGLFITGGRAPEYIRLNPKIIEITQYFFKVNKPVAAICHG
IQVLTAAQVIKGRTLTCYEAVAPDVELSGGNYKKVGPSETVVDGNLATSPAWPGNVSILK
EFYKMLGINVSF
>EGEFANNL_01975 Phosphoenolpyruvate carboxykinase (ATP)
MGHLIKSLEKHGIKGIKEIIHNPTYEQLFQAEIDPMNQGFEKGEVTSTGAISVKTGVFTG
RSPKDRYIVKDEITEDTIWWDGNINRPTTNEIYKGLKKIVSDQLSNKKLYVVDTFCGTNN
DTRMKVRFVMEVAWQAHFVTNMFIRPSLYELENYGEPDFIVMNGSKVTNPHWKEQGLNSE
NFVMFNLTEKVQIIGGTWYGGEMKKGMFSMMNYYLPLRGMASMHCSANVGEDGDVAVYFG
LSGTGKTTLSADPKRYLIGDDEHGWDDNGVFNYEGGCYAKVIDLTEEKEPDIWRAIRRDA
LLENVVVKPDGSVDYTDKSITENTRVSYPIYFINKIVLPSKAGHAKKIIYLSADAFGVLP
PVSILDEEQAQYHFLCGYTSKLAGTERGITEPQPSFSPAFGEAFLSLHPTMYSKTLVSKM
KKHGAKAYLVNTGWNGTGKRISLKDTRAIIDAIIDGSIENAPQDKIPYLNLVFPTQLEQV
SDILDPRTSYSNVSDWEVKAKDLASKYIKNFEQYTDTEDGKKLVSAGPQL
>EGEFANNL_01976 Inner membrane transport permease YhhJ
MLKKIFEYLATIGNSFTTELKLIFSDSAAYTTYIITPLIVGFVYTYVYSNEIITKVPIAV
VDQNQSQLSHKVIRMLDASQQVEVTHNSTSIDQAKELYNQGKIDGILFIPSNFSSKIQQG
QVATISAYYDASYMLYYKQMKKAVVTAVGTLSAQVEVSKLMSSGLTQTEATAVRRSVQPI
SISLFNINSGYATFLMPVVFIIALQLVQLTTIGVLGGTQREKGNFEKTYPFISKPLGSLF
IVLGRSGAYALISTLIIILQMGLVVPIFDLPHRGNPWEAILFLLPFFLAVCFLGIFLTNL
FKKREDAVMVITLSSIPALFLCGLSWPKESFPKWIEIISIFSPSTLGSRGFIAINQYGAT
LSEIKPIWFNLWGVALFYFILAVLSMKRIYYYSKKR
>EGEFANNL_01977 Inner membrane transport permease YbhR
MFKGFLSILKQEFIRLFTSPRLLLFIFIVPVAIFFYYSKLMYSGVPRDLPVVLCDQDNTQ
TSRKIIRMFDASPTLKFTSTVNNYKEGEKKIKSENSYALIVIPRDFEKKLFKGNSVNVIC
YYNGQYILAGSLINSAFQTVASTFSAGVHLQTLNKKGQMPSQAMANTVPIKIDEHILFNP
YTNYSYYLNIALMPMALQIVIMVVSIYVLGNVLKYNNGNQLLEQGCQNIWVVYWGKILPY
TLVFTIIGFFMNSLLFYYIKIPLQGSFFAINLFFLCFIVVCQFMSIFFVSISKDLRSALT
FGGGFAALSFSFTGYTFPAMGMPIVVQYINYIFPFTSYLRLIVDYAIRGISFNHLELNYY
LAFGIFIIIGFLSIYKYRILLKKGGYHA
>EGEFANNL_01978 Multidrug resistance protein MdtN
MKKSKYITAILSIIVIATLIGTSIWFMSEPEESYIQGQADATQINVAPKIPGRLEEIKVK
EGDQVKKGQLLAVLSTPELNAKLIQAKAGRAAALAMDEKAKKGARAEQIQAAYNVWQQAK
AASELAQKTYMRMQNLYNEKVVSAQKRDEAYAQSLATKDQADAAHSNYKLLLSGASVEDK
EAAAAKLNQAQGAVDEVEAYIKEAELVSPANAEVLKIIPNRGELVNTGYTIINLVDLNDV
WVVFNIKEDLMPYFRQGTTFEAKIPALNNQMVKLQVQYIAAEGDFATWNATKTQGDFDMK
TFEIKAYPVEPIKGLRPGMTALVNQKSLKK
>EGEFANNL_01979 Outer membrane protein TolC
MIKRSLLFLSLTSFLLLPRLGFSQLSMLTFSDAQSIMNNHNHLIKAVEKKEEVHEFELKA
TKGLRYPKIGLNASALYFDKGISANLNNLRNGVSGILSIPNPNLLGDWNFNLMKRDVLFG
GAYFLWPVFTGGKINAGIEAAKINAHIGEKELISTKNQLITELAQRYFQVKLADEAVLVR
KQILEGMNRHLYNAKKLEDNGIIAPVERLQADVAVAEADRQYKASLKDASLARVALSNTL
NSEEEIGDLITDFFTTPFLQPLEYYQESAIANYPELQKVRLQIELAEQGVKAKKSSYYPT
VLALGQTVLVHNTPLGFGDKNDKPWVLGVGLTYPLFEGLQSKNEIRAAKATKESAELYEK
KAHADIKTMIEKIYNDLQKQEEQIQSFNVQVNQAEELLRARSLSFSEGLATSLDVVDAEM
NLSGILLQKLQARYNYVIDLASLLEYSGLSQEFIQYMNQ
>EGEFANNL_01980 NADPH dehydrogenase
MPKLLSPLNLNQISLKNRIVMSPMCQYSSDDGFANDWHFVHYSSRAVGGVSAIIQEATAI
SPKGRISYKDLGLWKDEHMHNLNKIVDFLHKQNCLAGIQLSHAGRKASTPVPWNPKENLK
LNNNYWESVAPSPIPFNSDSDIPKELTIQGINKIIQEFKEAAHRADKIGYDIVEIHAAHG
YLIHQFLSPLSNKRTDDYGGNFNNRIRFLLEIISEVKNVLSKKVSLWVRISATDWIEEGW
SNEDSIQLSILLKNMGVDVIDVSTGGLVNAKIPVQPNYQVPYAKNIKKETGIITGAVGLI
TNAIQAEEILENNEADFILLGRELLRNPYFPMEAASILGINPLIPPPYERAKIVF
>EGEFANNL_01981 hypothetical protein
MKFKDKLIYVVIFIVLIGNIPLKANINYEKLDRKVINLNKQNFPSDCSSYKEEDRKIVIA
TYRTSLNIIQFRKNKLGDIYVYSLFPNQEKLLLIINNQSDPLNLTNDEKYYFFIYNLIFI
KSEILLTFGSLKGQEFEIFIDKELQAKAIYTGKPENFIKVYLKNNNSPVKTFQDFEELYK
SQFLVLLYK
>EGEFANNL_01982 Peptidase T
MFTFLDAEWQNKIQTRFLKYVSFHSTSKEDVNKIPSTERQWKIANFIFNELINIGLTEVT
LDENGYIMASLPATSKIDLPTIGFIAHYDTSPDFSGENVKPIIWNNYEGNDLLLNEETKF
YLRVKDFPELKDYIGQTLITTDGSTLLGADDKAGIAEIVTAMEYLINHPEIEHGKISIGF
TPDEEVGKGADLFDVKKFGAQWAYTMDGGEIGELEFENFNAGSVSIHINGKSVHPGYAKN
KMINAGLLASEFNQALPKEEIPSLTSGYEGFFHLTQIQGNVESSFLQYIIRDHDLNLYNN
RKKILLKLIEDFNSKYGKETFTIEIVDQYFNMKEKIEKCMFIIDLAKNAMQEVGVKPKIK
PIRGGTDGAQLSYKGLPCPNIFAGGLNFHGPYEFIPVESMVKATEVIISIAKNIGKFPSA
QKLIS
>EGEFANNL_01983 Succinyl-diaminopimelate desuccinylase
MDKVYEFQKKNKDRFLNELLEILKIPSISADSNYSKEIIKCANAISDNCVLSGLDNVEIC
STNGNPIVYGEKIIPKDLPTVLVYGHYDVQPPDPLNLWENDPFQPIIKKNNIHPEGAIFA
RGSADDKGQVFMHLKALESLIKTSSLPCNVKLLIEGEEEIGSPNLGEFIKNNKDKFSCDV
ILVSDTHLFSLKVPTITTGLRGLCYLEVEIQGADRDLHSGLYGGAVPNPIYILSKMIASL
IDSEGKITIPGFYDQVDELSNKDREELNKIPFDEEIFKNSIGIKGLDGENGYNTLERTSI
RPTLDINGIWGGYTGEGAKTIIPSKAYAKISMRLVPNQDPDKISQLFIQHLKKIAPPNVT
VNVTSFQGGKAYVLPSEHIGYKAAKKAMEKGFNLETLPYRTGGSIPIISLMEDVLKVKSV
LLGFGLDTDAIHSPNEHYGIFNFYKGIEVIPYFYKYYQQMKNDKSHG
>EGEFANNL_01984 hypothetical protein
MKKIKINFILVFLITIVNFSFAQKQNRELRAVWIASVLNIDWPSQSGLSTNRQKEEFISI
LDNVEKWNMNAIIIQVKPTADALYKSKLSPWSKYLTGKQGGDPGYDPLEFIIEEAHKRNI
EVHAWFNPYRLTLGSANWETLSPDNIAFKHKDWVVKYGNQLLLNPGIPEVTDYVVDGIME
VVKNYNVDGIHLDDYFYPYKIGTLEYPDYKEYAKYGITYASKEDWRRANINNLVKKLHDK
IKAENKNLEFGISPFGVWRNKKSDPRGSETRALQNYDDLYADVLYWMEKGWIDYVAPQLY
WHRGNSSADYTTLVEWWNEAAKNNNTDLYIGLGVYRVKNWKLENELIEQINMNKEFSSIK
GNIFFSYKSLLENPKDIINQLTSGPFSEKVNSKLVK
>EGEFANNL_01985 Quinone oxidoreductase 1
MLKFTAKAWEWKRKGEPNELSLKDFIIEDLKDDEVIVQNHYIGLNPVDWKLIGGEHPSWK
TGIIPGVDGAGIIIKTGKNMNHLRVGSRVCYHADLTKNGSFSTHTIVNGKRMIYIPEKVS
DIIAASFPCPALTAWQSLKKIPEIKNKYVFVNGAGGSVGYFLTQLLLEKGARVFLTSSEK
HHQEFLNMGVIKTLDYRDPSWKDIMSESLNGNLFDVIFDTTNNSNTKELLNLIGYNGHII
SIQGRIKENLLSAFTTCISLHEIALGAYHQFASEKQVIELMMDAEHLLNQIGSGKYKLRN
YKLSSFDDLPEHLMEMKKNNSELKYIVKI
>EGEFANNL_01986 tRNA (guanine-N(7)-)-methyltransferase
MGKDKLRKFAETKTFTNVIQPTRDEIVNNFSYKGNWNKLFFKNSNPIVLELGCGKGEYSV
GLAKFFPNKNFLGIDIKGARFWRGAKTALENGITNVGFLRTQIELIEHAFSPNEVSEIWI
TFPDPQIKYKRTKHRLINEEFLKKYKNIMSSDGNIHLKTDSEFLHGYANGLIHGLGLNII
SSHHDIYGAPEYELPSYVRDIKTHYEKLFLGEGKPITYLNFKF
>EGEFANNL_01987 ATP synthase epsilon chain
MKLQILTPEEIVFDGEVTSLVLPGSKGEFQMLKDHAGIVSTLEKGKIKLKDPVSSLNDHL
EEEGDYKVYNIDGGILEFNKNKGIIFCH
>EGEFANNL_01988 ATP synthase subunit beta
MATQKKGKISQVIGPVIDVIFDEVEQLPNIYDAIEVVRDNEEGNLVLEVEQHIGQDTVRC
IAMDATDGLSRGQEVISTEKPITMPIGEEVNGRLFNVIGKAIDGIGEVSKASELPIHRSA
PKFEDLSTSAEVLYTGIKVIDLIEPYSKGGKIGLFGGAGVGKTVLIQELINNIAKGHGGL
SVFAGVGERTREGNDLLREMLESKIISYGDDFLKSMEEGGWDLSKVNHEALKTSKVAFVF
GQMNEPPGARARVALSGLTLAEYYRDGLGEGKGRDVLFFIDNIFRFTQAGSEVSALLGRM
PSAVGYQPTLASEMGALQERITSTKNGSITSVQAVYVPADDLTDPAPATTFAYLDATTVL
DRKIASLGIYPAVDPLQSTSRILTPEILGEEHYNCAQSVKEILQRYKGLQDIIAILGMEE
LSEEDKLVVHRARRVQRFLSQPFHVAEQFTGTPGVLVDIKDTIKGFNMIINGELDQYPEA
AFNLKGTIEEVIEHGEKMLAEFNNK
>EGEFANNL_01989 Riboflavin biosynthesis protein RibF
MEIYRGNYNIPKNEKLVFTLGMFDGVHLGHQSVLNYIKNIAKEEKGKTAVMTFSPHPRLV
LNPEADFRLLTILDEKISLFEKFSVDYLFIQEFSKEFSQLSSEEFIQNILVNQLNILALV
IGYDQHFGKNRELNYENLKIQSKKLGFKLYQLPAVSENQEIISSTKIRNKLLKGSISEAN
EWLGYPFILSGKVIEGDKIGRTLGFPTANLEIDPHKIHPTHGVYFVKVKIDNNQFYGMMN
IGMRPTVNGVKKQVEVHILNFDQDIYGKIIEVSFYERVRNEIKFSSLEELKNRLSIDKME
TIKFFNL
>EGEFANNL_01990 hypothetical protein
MKKLLVSVFVFLFTSAALFSQKSNSQIGREYGEKYRQIGQDRSLSGYEKGQRKKQLSLKK
KQEMIRNNQNHNHNNHGVTSNSNEKERLEKKIDRLEEKYDREKKNIENNYNLSKSEKKSR
KKLLEKKYKAEKEILKKRKDDL
>EGEFANNL_01991 Aminopeptidase YwaD
MRILNILCLIILISFNSALYSQTPKEYALQVINKLTSPEFSGRGYVDDGMKKAANEIVNQ
FEKIGVLKLGDSYFQTFTYPVNIIEDCSLKINDKQLTLGIDYLVGSGSPSLKGTFKPLPF
NTAVIDSLFEWGDRSYFDLEMQRLNHKPVVFPDVRFIENLSTRENTANQFYREIPQLISN
GELEEINIPLAIEQTSSRFIHSLSPVQTSTVNLFINSQSVPENIDEVDIDLKTNFDPKFE
SQNLVGYIPGERSDSLVVLTAHYDHLGKIGNTIFPGANDNASGIAFLLSMAKIYTKEKPK
FTTFFIAFGGEEAGLKGSQYFVAHPLIDLNKIKFLINFDMVGTGEEGIQVVNGKEFPKQF
NLLESINYKYNYLKEVKTRGSACNSDHCPFYNKQVPSFYIYTLGGKSGYHDIYDNSVSLY
GYNQLIALIRKFLDNL
>EGEFANNL_01992 hypothetical protein
MKSKNFKILIFFFIILTNIKAQVGINTDQPLANLDVQGNLEIPEVRLNIKDRRTKEYTQI
DYSKGVNVMIDPNGYLYKANSTGGIYYTTFDQQILIPVNSKNAFPIVSLSDKYAIARFTF
STNISLAAQSQATLFGTIAFGNASGFVLSNLASGANDLTQVGAPNIRYSADKMQVTIDFP
QANVITSNVGLIFKYNNATGEITVEPTDSNPKTNIVVNILESLRTRVL
>EGEFANNL_01993 Murein DD-endopeptidase MepM
MKKIALITFFLSKLLISQDFPKDFRSPVQIPISLSGNFGELRNNHFHAGIDIRTQQRIGL
KVLAPKDGYVSRIKISPYGYGKAVYIDHPNGYTTVYGHLSELIGDINTKAREEQYKKQNY
SIDLYLKPNELPVTEGDLIALTGNTGGSGGPHLHFEVRDTKTEEILNPFLFGFDIADNVP
PQINGTWIYPIDGIVNGSKEKIMVSQGGNYLAVGKIGFGIKTYDKQNASNNLNGIYFIKT
YVNDELISEYKANRHSFDESRAINATIDYKERLNKNSWIYRTYLLPGNTLQMYEQTKNKG
IVEIESGKNYSIKLVAGDFAGNTTTKSFTVQGIGNITTSAKPVQGKYVVEILKPLEIKEN
GIHIKFNQGSFYENIDFDFQPLEINKFKIHNSSVPLHKAFELIIKPNWSTLDKNKAEHYV
IFRQSNYGPAKKQYLPTTYKNGFFTAFPKDLGEFSLVLDDIPPTITSPMLTKSKQVGKKL
SFIIKDAESGIKSYDVWIDGKWILAEYEYKQNSLFIPDLSKEGIDKGFHEVEVRVMDEAN
NLKIYKNNFEKL
>EGEFANNL_01994 hypothetical protein
MRSFKKKLTLCFSIITVCLWSQSITLSGKIIDKEGKPLIGAKISITDSTIQYSDSLGLYS
IAIPKDRSFTISIQKNNFEPVEKIIESTSINLTQNFSLASLVNNDKIEYHSSLEPVIFVG
KKQPSDLTSVELDVSHLNYMPSLGSGVEGLLNTFAVSTASELSSNYRVRGGNYDENLVYI
NGVEIYRPLTLRSGQQEGMSIINPNMVSTINFSAGGFESRYGDKMSSVLDITYKLPKKFE
TSLEASLLGGGITLGFVDNKDQNKQKLTGIVGARYRNTNLILNTFDGDTNFNPEYFDVQT
FVQYKISSLWKLSFLGNYSSNHFKMEPKSREVEFGTLNNPIHLNVTYQGDEKDKYQTMNG
TLALQFNPNAKWAFNLDTYAFHSKEKESFDITSAYRLYENDTETGSSIPTFGIGGQVDHG
RNNLDLLVAGLHLKTKYKISLNSNLEAGIQYQREDTRNLKNEWQVLDSLGYSIPRKFFPP
GEIDNSDLVLNYHTTSNNHLKANRITGYLQYTTKFLLKDDTRVLINTGIRGTYWDFNGET
NLSPRAQIAIKPSWNLDMLFRFATGFYYQPPFYKEAMRLDGTLNKNIKSQRSLHFIVGND
FEFKMFKNRPFKLTTEIYYKKMDNLIPYFIDNVRVIYTGENNSKGYAYGIDARLNGEFVP
GAESWFSISYGRTEENIDGRGYIPRPTDPRLKLGLFFQDYMKIYPQLKASVNLVYASGLP
NGAPLFTDPYQYQTKLSDYKRADIGLTYVFVDQFLNKAKKGSTWEKFKDFSIGLEIFNVF
DIKNTISNQWIRDINSPQTIYYAVPNKLTGRFFNLKLNARF
>EGEFANNL_01995 hypothetical protein
MFKNNNYQIVVRDNHYQCYYKGKYVIENNILKLQNLNDAINTDRQVSNKYIINNQLDTLK
PLIRAIRI
>EGEFANNL_01996 hypothetical protein
MILLKIILKYFTLILLFSIIFLLTKRFGDYCSDIYVNIFVIPLIGILTIINLIILYITDT
FKSDYSITNKIVLTLLSILIISLIIGYLATNQKPLYRFDTISKLSTYKKKL
>EGEFANNL_01997 hypothetical protein
MNDINKIGRNIALISFILGTILFAVFTLTLSDNWAFFSYFLVLIMLIINLSFLILLLYKL
FVRKDGRKKIVITILIIFLNIPIAKIYEIGFLILLNTIQLTIINKSQETIENIKIQGCDE
KYIKQLEPNESKTVWIFIPYDCSIDAIYNIHEERKKVVIMGYVTTMMGERVIYEINNNSL
IL
>EGEFANNL_01998 hypothetical protein
MKITGLLTKMVTELDNPIHYYLNFEEEIISVNQLLNKNIKVKFNHCQCLECENYVEIFAM
GFCEKCYFSSPHTGEWVVRPELSKAHLGEEDRNLSYESKVQLQPHVVYLANTGGMKVGVT
RKSQIPTRWIDQGAEYAIPLAETENRYEAGLIEVALKEKISDKTNYRKMLQSEASFFDLE
KKKDELKDNIPDFLQKYYLEESELIHLKYPIVQYPLKITSVNLKKVPEFEGKLIGIKGQY
WLFENHLAFNIRSHEGFAIDLEF
>EGEFANNL_01999 hypothetical protein
MFSKDRLEQAIKDGWIQVQKHPEYPWYIYNYTQKTQYEKHWNELTLSCRGLILNENYEIV
ARPLPKFFNFEELNEHQIPKLGFEVFEKLDGSLGILYWVDNKPYIATRGSFTSLQAKKAN
ELLHTKYKNFIKNLNPRNTYLFEIIYPENRIVVNYGSREELVLLVVIETSTGKELSMDDL
GFARAKRIFGINSMEDINKHYDLLNEGFVIKFSNGFRIKAKFPEYIRLHKIITEVSSISL
WEDLKNGKPLEDLLKNIPDEIFQWVKEKRNQLIDHYLEIENQCKKDFKILNSRKETASYF
LTCSYPKVLFSMLDRRDYSPIIWKIIKPDFEKPLTNKF
>EGEFANNL_02000 Formate--tetrahydrofolate ligase
MNPSKDFSNKIPSDIEIARSTTLESIDKIAKKIDIPQDELIPYGKFMAKIPWNLQSPEKQ
KKSNLILVTSITPTKAGIGKTTVSIGLALGLNKIGKKASVALREPSLGPCFGMKGGAAGG
GYAQVLPMENINLHFTGDFHAITSAHNMLAALLDNYNYQNRGTDNVVTEVLWKRVLDVND
RALRNIVSGLGGTANGVPQESGFDITPASEIMAILCLAEDPKDLKRRIENILLGYKADGS
MFTVKELGVAGAITVLLKDAIHPNLVQTTENTPAFIHGGPFANIAHGCNSVLATRMAMSF
SDYVITEAGFGADLGAEKFFDIKCRKTGLCPKLTLIVATAQGLKMHGGVPLNAIKDENIP
GLIQGLENLKKHIENIKSYGQSVMVVFNRYNSDTEEEISILKEFCLKRNIPLAENNSFGL
GGEGAVEFANLVVKTIEENPSQDPIQFAYSEADGLEEKIAKVAKNIYGASSVNFSKKAKS
KLKKLKDTEMDKFPICIAKTQYSFSSDPKAYGVSKNFDFQINDIVINRGAEFIVAIAGDI
MRMPGLPKQPQAMNIDIVDGQIEGLS
>EGEFANNL_02001 hypothetical protein
MKLKIQLIIGIIFIQINLFSQVGIGIDNPNPHSLLEVYSQNAGILIPRLTEQQRNSLTSS
NSTEINLTDTDNSLLIYNTTENCFNYWNSSETEWKSLCGVKGKAKFTINCKDIVINGVYI
EGNNLTDSDYISVPVNITKPGTYNIKIITDNNYSFQAEGVFDYIGSYTIKVMGMGTPLKK
GENLLTIKSQDLDISCDTAKTISVLPALANVNIQCSTVIVDGVYVVKKPLTETNTIALNV
STTNEGSWEITSNTVNGISFSGSGNFSAAGTYPVTLQGNGTPIESGEYTFKLNASGNGSI
TNCDFKVKIAVRSMKVLGLGNNTTDGVWNIAGNQKFGGVTNFTYGSLMETDKHFGNNQQA
TFPVESITMLPLYGESPDLAGTIQSFNPDVIVAEYNFLSGASTSAATVNNIQALVNFVNS
GGALVLCMDGDGPTAVRNQNALSITKSIFNDENITVNGLTTARQFLFASANNKIIDGYFF
NLLNHNLGSDGGNNFSFTNLPPEKTDYIAYAGSTASNDYISFKHKNKGYLFVGDGAPFSN
RYGNIAPYNYPLKFDSSFNPLVNVYSTPPSVNSYFYLNVMAWAFNWAQKHKIQ
>EGEFANNL_02002 Deoxyguanosinetriphosphate triphosphohydrolase
MDLNSLFSDKRTGTQYKSNSKKADPRSEYQRDFDRVIFSTAFRRLQNKTQVFPLPGSVFV
HNRLTHSLEVASVGRSLGNEIGNYISTKYENHLTPETKDLYKHSLYNVISTGCLCHDIGN
PAFGHSGEDAIASYFYRNESALKDRFTEKQWSDFINFEGNANAIRVLTQQQNGKSEGGIM
LTYSTLASIAKYPCESIAKNKKILQQKKFGFFQTEKSTFLDIAKETSMLQKHEDPLIFAR
HPFVWLVETADDICYNIIDLEDAQRLGFISASVCEELLQQIITEIQGAKKWQRVGKKLGG
IEDKNDRISFLRAVSIGTLTGRSIELYKQNFEKILSGSLQLSIFDEIKQECKAIQEIESF
SIEHIYNHRSVVEIENAGYNVMYELLDHFIPPIIKTKEERKEYEKKAIKLIPKQYLYEDL
TEYERVLGVLDFVSGMTDNYATDLYRKIKGIDIGMTL
>EGEFANNL_02003 O-acetyltransferase OatA
MDNKQFRFDLSFLRAFSVLVVLFYHYNFFLFSGGFVGVDVFFVISGYLMTSIILSGIQSN
TFNLITFYKKRIIRIIPALLFMLIFFLIILYFFIPTQFIIYLKSAYSSCLFFSNFIFYLN
SGYFDYYSQFNFLLHTWSLSVEWQLYMVYPLLLLLLKKIYLRNIEIFKIIYIFLIALSFL
LMNIYSRSNPSYAFYMFYLRAWEMMFGGLAFIYSYNLIKINNNIKKYIFIISLVILFGFV
LIANRTLTWPSYLTLVPVFAVSIIIFINVDIKLFHNKIITYLGNISYSLYLWHWPIYVLS
AYFSLNINILNRIFLILVSLLFAIISYHFIEKTKFIKVKFVLFISIVFSLFTIILTEIDI
RTIYPTRYKSNLVYYATNYPSSTQCKAQYSYNNHHFQPKKQNFLDFYLNKVEVDTSKKNV
ILLGDSHAGMFIKTFKNIFKNSDYNLIQITTNGAYPMIYPNPGKEQEKFFFNYFFKEFFP
KNSNHIDLVIISSSYIYYAVSNEDLLEKIDNTESYFKQFNVKTLFLGQNMIYDIDFPTKY
YLKNCYSITRKQDETLKENVLKINALLKDKLNDKYLDLLKLPIKEVSNVGIPYVHDTGHF
TFYGAEQYAPYIKNKLIECGVSLK
>EGEFANNL_02004 hypothetical protein
MKIINEYKRFLISGIEFNTQQVIDITNYIKQEFSFKI
>EGEFANNL_02005 hypothetical protein
MQIKVKEYYNKKIKVATEPSKYDIELNFFTQRQEVELQKPYTFPRGARFDISLECLSCKD
KISILSEQFRKNKGLPYVYNLGLLSTANKNRTFIDSIHTVFPYIEMNYLNDYWILISPPE
NRSSIFDLLYFKCPHCNEKYLSINLYIPPNITEINNGNEIVHSLGKNCLYDIARVDFDEP
EFFKESGLLHA
>EGEFANNL_02006 hypothetical protein
MLVRNNSYAIFLGIECRFWSISDNFYRLQTEKNYISLSNNFKSYNNNELDSKVFLDVERS
DIQSAYYVITLCNYKGYRCQIIKVIQPNKIVLNPPIDLQVILKNYAHHGYDPIYEIEENE
VDEIWEERTPIEDFKFEIEPIYYIKKK
>EGEFANNL_02007 hypothetical protein
MKTPFYIDKGSCGVIRFKSLKVPKEIIIPTGGTYDMFDYPFTATGFTAGKRGVLGVPEWH
LPNRVRFSEGDEIWEVHNDGMEILKAIYNKDLEKFINVK
>EGEFANNL_02008 hypothetical protein
MEPNNKKQIIAPLEVRLYLRSAEVLKKRLPNFNKDYQTDFECLETTPHSKNIVYTIFSIK
KQPRLEHCLLKVSQYQWQNFFSLGIILAIIENKLRKEGVKEWQDFYNLSPKAPRNKNLWE
EQELVVGWFDIHLLQKKMEDYNATYGTDFQIKDCANDERGLYTLTASHFLPEDLFYLAYN
TEIALNKVEKLNAFFVSYVDNRIKENMPSLSPLLVVSQELDRDNEYMRLLKEEVLDVPNF
STLREIPKKYINGNYNEVGGFMSRASDAKHLKSY
>EGEFANNL_02009 hypothetical protein
MVKKVINVREIYIYIVRKREKRPLICPLAEYEYSEIYEKLDISKKLKQEIKDKIFFKKNF
IIEIPILKILVHALEVKIEELLKHPDFDPFKEELRSRFPAQYSSYPFEYKGVIYYLYYIG
RNFYIDNLISEYSKRSLIMKELIQLNEPLEYTFKYSYIK
>EGEFANNL_02010 hypothetical protein
MTSKYKYYKIKHQRIFDTPQEVLGHANGEYVPRGREYFNRIGDGEIVEDAPIFDYFHLQS
FGEEKDWEWRLQDIHGFIGVGSIMTGWYISNDFKLLLENFKIAPKYHFYETRLKYREEKL
KYWIFQFPIDHYQNINFKKSQFESYPDQNIYSFNTSEEFIFFAEKHYLETRKDLKTKKVC
FKSTFDIAETTENETIVSEKLKKAIETMELKGFLFTEIDYEITVE
>EGEFANNL_02011 hypothetical protein
MITKVETLDNIEVYLKQGSLGIYFQRQEQLYYLNGIVPELIQDKIFGFHVQDQWVYYAEK
EETSNIYRVDVQRGITQKLEGEYYYNGIHKGKDFDYIFGEEEGEEYLYTFNKETFQIENK
FTDQIVGLPKGELVPYQLIIKTRTKPFLYDIIKNKSIWEFPLEIKTAGDVFLYGDILIVP
LENFNLLGIDAHSGKMLWQLEKCFPYHNLDQEKGLLYGFGGQHLQVIDIRQGKKIKEHLF
QESKELGITTSSHMNALCGEYLWFTSWRYGQKFGKINLNTYQIEFVYDMKEDGIQGTLDD
PKVYQGYIYIRDSEGYLHIYKEE
>EGEFANNL_02012 hypothetical protein
MITKVETLDKIEVYLKQGSLGVYFQRQEQLYYLNGIVPELIQDQIYQFRVQDQWVYYQKK
VMSDLYRVDVQRGITQKQEGEFYPSIYKGKDFDYIYGEEEGEEYLYTVNPETFQIENKLI
VEIEAASKGELKPYQRIYKTRNKLFLYDLIKKETLWEFPLEIKTAGDVFLYQDILLVPLE
NFNLLGLDAHSGKMLWQLEKCFPYHNLDQEKGLLYGFGGQHLQVIDIRQGKKIKEHLFQE
SKELGITTSSHMNALCGEYLWFTSWRYGQKFGKINLNTYQIEFVYEMKKGEVVQAALDRP
KVYQGYIYIRDSEGYLHIYKEE
>EGEFANNL_02013 hypothetical protein
MSELNQLRWIFDGKKVSSLEKKAFVEELLKRQDFLENKKIQGLFKNYYDLEEITPSKLKK
LLENNDNWFNEIFKIN
>EGEFANNL_02014 hypothetical protein
MITKVETLDNIEVYLEQGSLGVYFQREKQLYYLNGIVPELIHDQIYQFRVLDQWVYYQED
EISDKYRVDVQRGITQKLEGNFYMSIYKGKDFDYIYGEEEGEEYLYTVNPETFEIENKLK
FEIRSLSRGELAPYQRIYETRNKLFLYDLIKKETLWEFPLEIKTGGDVFLYGDILIVPLE
NFNLLGLDAHSGKMLWQLEKCFPYHNLDQEKGLLYGFGGQHLQVIDIRQGKKIKEHLFQE
SKELGITTSSHMNALCGEYLWFTSWRYGQKFGKINLNTYQIEFVYEMKKGEAVQAALDRP
KVYQGYIYIRDSEGYLHIYKEE
>EGEFANNL_02015 hypothetical protein
MSKLKITTLILGLLLTTLTLAQSCNFNKLVDDLSESSVEFNKIIDKEEGFSAWLILAEEA
PSLRTQIEELNLVSKHLAEIKKAGGYKIWKAKLAQSTTTDKLPEFIEKIVGNLKADESTQ
ALLRKDLNTQPELLTLFEKADNVKKIELAEAWKVVNSYPGLRVSEAILEDTRKLLTHTKL
AESGLNKELLEQLVKGNRGAGATELQSLIQGYDNLITNGVKFENIDRLISDLNKGGNFAE
GAQWVQRYMVKNTQEFAGKTVAFEQTLSVSGNLRRRIDLITQIDGELKSTYYEFKSVQKV
PPANFAEQFIKDLNLDGVSELNQLRWIFDGKKVSSLEKKAFVEELLKRQDFLENKKIQGL
FKSYYRLDEITQNQLKKLLENNHEWFNEIFKIN
>EGEFANNL_02016 hypothetical protein
MSLALETSHTFQSKFHNIKLVATEFDEPLNGLTLWRFRLYRNNTIFHHKYLDYENKFCGL
PSNLENFELESAKGNYLYIPYGLLLLNTETLELEKYNIETGANNHFLMNTFISNHLVVLH
ERAIYIVDIEKKELFQKIYPYQQRKFHKIISDQQEIKFLYKDKTTDQTGILRYTIQTKTL
NNEQA
>EGEFANNL_02017 hypothetical protein
MKIIDEYKKFSISGIEYNVQQIIDITNYIRQEFPFKFVIKIIDDEEISVDLIGNSEKTIV
KGLYWEYFSNSDLIEIQNKFNIQLRKIHNIENRDSNMIAYYDDFENLEIAMKTVKNRTYL
IIFNIKLPDMYRGAGKFEGQLYIHNICKVELTED
>EGEFANNL_02018 hypothetical protein
MDLPTMNTLYKENKKKQSQRKNILFFLFFLYGFIQAQVYPVQVNHYYVPPYSPQLSDYAL
STENKFTLRLLMQDIHVVNRKVKLKLYIEGSGFKAVSQDYVVGAPDIYLTGGVMQEFSSI
DLRAYFEFQNLQGINSAQYSRPLNEGMYLFSWEVYDFLTNEKLSQKSTVPLYIVQNEPPL
LNLPVNGENIQERTPQNLIFQWMPRHINAPNTRYLFQLRELWDNQIDPRAAFLSSPDYYT
QETYGTTLLYTMANPSLIPGKTYAWRVQAVSSNGLSENHVFKNNGYSEIYYFTYSTGCET
PTFLLSEALSSQRVKLYWQGRPQHHKYHVQYRKKGNPRAEWFDVYTQNNQVQVSELEPGA
TYEFRVGGTCEPLTGLTQHYTYSGLQQFTLPEKKGSKDSSYNCGIQPEIKITNKNPLLNL
AVNESFSAGDFTVKVKQVSGQNGVYNGTGYITVPYFADTRIAVEFRGIQINTDYQLFSGV
INTTYDPSWGGMSDVGTLTGEGRDGKNDIEVNFPVKEIIVQGDKILIIGENGETVEYPLG
KDYQLVDSNGKVYTIDEKGNVTEGGILSEAGASNPKTTEGVDAKGSITQLTAQGIRVSFT
QASDSRYAFDAVEKNDPEEVRKNYKKIDPNYYLPYKAVKNGNTDYLLANVVLEDTSVNAD
SLIFRTQDGVAIKSEKISSGQYKLTLEGRFNNAEEEVQAIIKQKGKYQTAGAFILVHITD
QEPARVVLVKLDKKAQLPASQELEKYLNQVYHPAGGIFTVGESLDLSEVLSLEGNTITTD
KSGALAQYTEQQQQINQKVRELPEFDPSTYYLLITEKSASSGEIGFMPLGRQFGYVFKNS
NLRTYAHELGHGVYSLKHPQEVPQGKTDLLMDYGQGTKLSRQDWTAIQNPQLHIGWFDDK
NEGAAYVSHWISIPYLEKGIRYIYYFSYYDFKSEKYSQLLIEVWDEDGKRIEEFKHNSSA
KTQYEKKYGKNGKWIFTEGPSDQLPSKATKAINFIIERNKEYRKKSQQNKEELVKKVEEV
SLKEKLSTEDITKLIKVVNATDLNELKQLNYTTIIAAFNNIQSQKTLKENSENALLKLIK
AITLEKSQLKFLSYLEENNNKVLLHLLDELNDRSINPWDNNNFTHFINLLIKIYNSNPNF
YKDRFGEIGSSKLQGQIINLNPKPFSDIETVKVEGKIPYLIKFNSFRFRGELTNNKIKIY
QQQLISPNVVGHINIASYNTVEDITELNLLDPVLITGDKELPLVAAALDGNFSAGKENYL
VPAVFLAYQKEKEFQDLLSKYVMTTLDVATIATSGGTALATKVHWVKRSWALLEVAGAIG
NIGVNTTAIDPNSNAGRAVQIYNSAMVLIAVKNTTQGVVSFTKSISPDIRKLLESNLSLR
KSMDGYFEKWLLEYEKAIKEGKFVTNEKKLLEEQAQAWKILGYIGKLENTIYKNVKYEDF
ILTVSDFAKGQNANLAKQSYKLWGEEKWEELYKLFKENNLNDGWPPFNGTKSILKIEKGN
QLSEKVFDRFQGPGKITGTFASPVYGKEGISDLYFTYDSRALKWNISEGTNYIKFKFKSN
VPESISFEYGDVIPWFGKQGLGEQVKSSQELSKLFENGIIEIVERMEYRNGKWINIK
>EGEFANNL_02019 hypothetical protein
MKITTTKNKQRIRRISTYFLRIQYVLSGIGLFLGGCLQAQDLDFEAMSQATDLKINGAVT
ANSVFYNSNQRSSREPFTYYLQGNINLSWLTFSMPISYSLTNQGNELNYQVPYKFNRLSI
HPKWKWITAHIGDASMSFSPYTLDGHQFTGAGLELTPEGPLNISVMGGQLLKAVKPDEFQ
PQTLPTFRRMGYGVKTSWEKEIYKIQFSGFYGRDEKNSLPYIPDDRGVTPKENLALSLGG
ELAITKDIKLSAEYGSSAITRDTRDASSSYRRGLSGLFIGNPKNSTQYYSAYKAGLEFRV
EKMQWGVGYERVDPGYETLGAYYFTNDFENITVHGSRPFLNDRLNIAFNLGYQRDNLENT
KEQNTRRIVGAVNASLQLSEKLNFTGSYSNFTTYTNQRLNQFDQINHYYDPEQEYLQTFR
YEQLSQNANINANWNISAKDKLSQNFNFNYSLAASANKTDGVIRRGQASNFHNFSTAYNL
TFPQKNLSISTLLNYTYVDITDNDSRSWGPSVTLNKKLLNQTLNTNIGVSYNTSESKQAN
SQIINLRGGATYTLFKKHNFNLTGIYLIKSGGTTADLNELTVTFGYGYSFDLGSPKGKPN
NN
>EGEFANNL_02020 hypothetical protein
MKLKKYLFCLLGIMITLQSCYKDSIIEAKAAFELEYVQENYSIPVQIHLLDKSEGAENWE
WSFEGAIPSSSHKKNPGTITYETPGEYTISLTVTNKDGGKDTYTETIRIYDAIKIDFSAQ
IINNQANYPPVQVELQNNTEGIGFTYLWEFEGGMPSISTEKIPPVVIFSTPGEHKITLTV
DNGNKKERSSKIITVADNISSLFHWEVSLFDNDYQAPVRLQLKNQSKNATAYLWTFEGAT
PSVSTEKEPAVVYQNPGTYTIKLETDNGSSQSVSEQTITIYKDTNLRLFKNIKLGTHSAH
TQNTQGAFFSTVMQRSYTAQEVNETNSNQIDLVFFGLSPAFTYNKFVSPNKVSSEGFPTL
PNAQPTIFVNSQELCNCGTLLSPEQFEGMSDDHLLQSLTPQENPAGLQRFGNTTPRVILF
QTQDGRKGAIKINQMVNQGEESFIICDIKVQKTAK
>EGEFANNL_02021 hypothetical protein
MKKLLLFFCLLIFKIIWSQQDIGQYILTTTIDGINYVRYGDEGGEFYIRVYHQNGEEYEF
LWLQVGDGSSPLGIPNQLRFSSQNRIVTLTAFGIDRNQSKNDGICGPYAPKRRRSCGIRY
WSVYYPSGRGATGQPSYNNNQVGTTISYGDMKTGRSLLRNSNNIVWNEQYPVLMDFVKNI
YSPAYRNGYCTGVIDILPDLVLKRENSLSTLLPIIDKIKIYAPKGFDAEEYNWEYSLDAK
SWISLPQYAGRSLLDISATDILGNQVENYINKKVYFRTTAYKYGNLPPLVQSNVLEYSIR
LSSPHITKTNVANTSCFDQTDGSVKLTFDRQLQENETINLTLQKKSLAGNFYEFYASHEN
LRELNEENTAFDNLPPGDYRVQLVGFYKGFPTYTDGSNHSVLLTIQKPAPVTFQTKITPV
YCKGGQDGVIEIIAQGGQGSYLYQIEYPDGTISEWIPFLTGVKTQISHLLPGEYKIQVKD
THECYARELIKNTQGNIIGLGQIILQTAIITEPEKPVNIAYVDYKEPSAFGFTNGTITAQ
ITGGTPYNNSKLYNYTWTYQDGTVWTHVESATYEGNEGWFITLKGAPAGKYTLTVTDANY
EGATDQASCTVFESEFILSQPDPIVAKITLNTPISCNVGNEYGDETDNDPRDGQRDESQN
GRLQAKVSGGVKPYTYTWKKQTENQWQIITTQSDQEETSVAYYLSDGNYAFNVKDANGII
LGEYINNELAEQKDEIFYLHQPEPLTLSFEKEDITCYPGNNGFIKAIPLGGVAPYSYEWT
TGSTEPQINHLIAGVYKVIITDAAGCRVEGSIVLQQPGEIVIEESIENPTCYGGNNGSIH
VQVTGGVAPYQYLWNTGDTHASIDHLSQGIYTLTVTDARGCIAIKPIEIQNPEEYKINLG
GNKVLCNGQSLDLDATLEGIPATYSWESSNGFSSPSAQVTLTDPGNYRVTAITEQGCIVT
DEINIYRSNVDIDAEFLLATQAYVGEEVILVNVSRPQGETTQWWVPNTVKINNQEDQQIS
LNFPKEGNYIIGLTSTQGECSQYFEKNIIVEQSKSLPNPGTTQNPLIKEFTLTPNPNQGE
FKILVKLSEESPVVLRVFNTNGQLFDERKIQGKSEYEEMYHLLNLGSSVYIIVLETSKGT
LVKRMITY
>EGEFANNL_02022 hypothetical protein
MKKIIFSILAILSVILISAQEKKEASLRMIVREQSDQILLRWAVDQPMAWQKANEFGYIL
EKYLFSKEGKILSKPKFIQEKLIKAEPLSSWEKMVMEDDNAAIIAQGLYGESFLVEAGSS
GKLADIVNLSEELEQRYSFSLLAADMNFAAAVKAGWGYIDKEIKKGEVYIYKIKTAVPED
VARIKGNSVIGNPSNYHPLPAPTDIAILGQDKSVLLTWEYQMYKDIYTTYNIQKSEDGIN
FKDLSETPLVNVYDTSDSPAKRMYYIDTLAQNDRKYYYRVYGISPFGEKGENSKIVSGSG
VSSLQNTPAITSYEFTTNENEAVIEWEFPKESEKDIEKFQLNRSSTDQGPYIVIADNIPV
YQRKITYSDLQPTNYLTITAVGKAPNQKATSYSTFIQPIDSIPPVSPIGLKGTIDSLGVV
KITWEPNQEKDVLGYRIFRANIEGEEFSQITVSPIKENLFIDSVQVASLNPKVYYRLVAV
DQRFNNSDYSETLVVEKPKLIPPTSPVFSSYKIEDGKVNLSWITPTEDGITLLLERRKEE
EINWDIIFQTKDTLQNFIDEKAQPNKQYVYRLKAVNNQKLEAVSPELTLKVINLLPENII
NEITPIVNREKKYIELFWSIENNKKVEIVEFTLYKKDEATEPTTWKVLPGKFTRVVDTQI
YPGKTYTYYIRAILSNGAFSNVKTIEITY
>EGEFANNL_02023 hypothetical protein
MKKKIIYLIANLLFLQFFYAQNLNSNSEAKNTFSLVEKNDSWINNFSSEDIQELPVGIKY
TFGDKGSNMQAALGIINATVYSEYAEVTLFARVRLPQTDAKGKPYELFFGADKVKISHDG
GIMGDVKLVLLGDINIPFTGNKWLINLRGGLDYKKGYIQGLTYLTVNCDGIKELGVSGTV
EFSRDLILPIESNGEVDENKKEITISQTNELGTYKKSVPNRVKGEFQTVVSDWNDMLLEV
SIQPFVLKEKRNKYNYDGNFQFYVNRAVLDLSDVRNSPSVKFPDYYYNNNLLIPSTNSWR
GVYVETVEVRMPKEFMTTQTVKDKKRVAFGSHNLIIDNYGVSGDFYADNLIPLKEGITNK
EKAWAYSVDHIGINLAANSLVGAEFNGKILLPVSKQEKDSSKVSLSYVGIISQKEYLISV
KNDTIVDFSIWKAKGHLEPNSYVELKVKEGEFRPKAVLHGDLVIKELKENSNKEKISFEG
IVFQNLQLQTEAPLFAVDYMGYKHIGDRKFMNFPITISEMGITTNKDEANLYFGIRINLM
GDTQKSEFSGFTRLSILGEFEEYNRKQKWSFKGIEVGTIALKADMGALKLTGNLEIMEND
RIYGDGFKSSLQATFGSFGPITSNAIFGSTSYRYWMVDAAIENLNLGVGAINLSGFAGGA
SYKMKRSVDNTTSLDSGLTYIPDENIGLGVKAAVALNIASKKAIQGSAGFEILFNNNGGV
KEIGFYGSASAMNFDKYDYKLSKLKSNLHTLVKDKTGISKVENSKIVNQMVGNQKIRNLL
DIAKNDYPNDDKSSSSIQIKFGMQQDFVNNTFHAELETYVNVAGMLTGRGSNHRAGLGVM
HISPNEWYAYLGRPSDRLGIKLGVGPVSINTGGYLMIGDRLEESPPPPPMVSRILGTDTE
RLRYMRDENALSLGRGFAFGTDFSLDTGDMRFLAFYARFVAGGGFDIMLRDYGDAQCINT
GKQAGINGWYANGQAYAYLQGELGIRIKLFFIKKKIPIIKAGAAALFQAKAPNPVWMRGY
LGGQYNLLGGLIKGKFRFKITLGEDCEFAEKYPIGGIKMIADLSPDNNSETDVFAIPQAT
FAMKVGEELLIPEEDGDKTYKIFLDQFKVFNAGQEIEGKIEWSDYKDKVNFISKEILPPN
TLLTAKVQVSFMEKKNGIFQPLIVDGKKAVEMEERTFTTGGAPEIIPLQNIQYSYPVIDQ
KYFFTDEYKQGYIQLKRGQSYLFDDKQWQSTLRLVDSEGNQLKTDFEYMVGDNRINYTLP
KMKQSQTYQFLLVSNLKKSSKNANEKEVVYKQESMEDEDNTVEIKQNQAESKSKEGEIER
LSYKFSTSQYKTLKSKINSLTVTSYNWDKIYSDVIYLTNKIKDHENFDWVELTGSEYTEN
IPTLLAEAILEDEYYKKDIYPYLYQGYPLANKYFIKNRDTHELGVPPSKSLPIYSDYLTY
IEYGINSEWTRSTFPYKYNLPYQYKLDWVDLLGQIVNDYVDGKLPENSSILNLMKADYKF
IREGNYRIILKYRLPGGILGTQETINFKNRIKSN
>EGEFANNL_02024 hypothetical protein
MVKVKFLLRNPKAGRELPIHIRLTDGRKVDIWGKTKESTTQDNWDANTGFLLEEIKDDRG
RIKRSAEVKNQIIKNKEVNRRLLELKNLIEDSYKSNKTEKINSDWLKNIINPKIELNPTN
DIPNELVKYIDYYVKQKGLGISKALTTKSNAVKKILERFKKVNKISELLIEDINNNFKVE
FEKFCQNEKYAQNYTARNIKFIKTICYDAESNGLKVHFQLKKINSKIEKSEIIYLNFNEL
EQIEKYKQPHEYLDNARDWLIISCYTGQRVSDFMNFRKEMLRKEKEMIFIDFTQQKTGKI
MSLALHPKVLQILKKRNGNFPRKISDQKYNEYIKLVCKNAEITEEIKGSKEINKRKVKGN
YPKYELVTSHIGRRSFASNFFGEIPTPLIMVATGHSTERMLLNYIGKTNTQQSIALAEYF
EKLS
>EGEFANNL_02025 hypothetical protein
MNYFNNDTTIQNFYIRDLFSLEEFILVNGNGSFLDNNIRIERHCRIYLGSDDQGDYYDEI
PVESFDKDDESHQSFLNYSEFIDYFNIYDFEQSNLVSFSENESYFFEYCCNYIEKYTDNQ
LKPLLLKDLLTIHASSVRFLKETKNPPKIRIWKSTSSKEFRIEEPQKPNKVIIEVIDFLL
SMYQCVYKRFSDRYIDIYPTIFPTKDLEETNIQINPTIEENQNPEPRIFTSARAFKIFER
LLEKFNILEDKNILGTQKNKHFRDFSFIYRKMVYDKYIYKDYLMINFLGWFSEKYEIEYE
RPKTLDAIGGKEKRNSIYNKVIQSFQ
>EGEFANNL_02026 hypothetical protein
MKNEIKFIQITSEELENLIDKGIKNGLEGIKKDLSEQREQEKIMTREQTAQLLDIDLSTL
WRWTKKGRIKAHSIGDRVYYFLSDINRALLPIN
>EGEFANNL_02027 hypothetical protein
MFQIIPAITNRRIIKKIPDLKALVDYVKSTEREEYPLIEQARESGKGSKEYDQIKKHQLP
CVAINFNYTNNYIKGDNIDNPTGYLYIDIDNYETININKTYVCACWKSLSNNGYHIIVKV
KGLTKDNYKEATKIIAESLDCPYDSAAISIDRITVLPYDPEAYYNNNTEVFDISYLNTTV
AQEKVKEEKSIESIEKKFHSTNKEESLSLGYNYNGKNIINHKIRYDNLEEKKSTISIVYD
EEGVCDLGENKLSYIQVFIPVKGKIPKGNRNSILSAITQTLIALNKNSPRNIIEKKIFTI
NEQKMQEPLPAQEVKQIIDKAYKNKDKLKLSPNNSKRFFFDESLHLTKEQKLSLVGIRMG
RCRKEATREMILKVLEKWDEKEFGKITLIKMEPLVGKKKSCISNHLKEMGIDLKNPETYF
KAI
>EGEFANNL_02028 hypothetical protein
MKKVIFILSIAFGVISCASTKQTATIKLTPKQPDVYTKPILSEFLSKNKKPAVIIRVPEQ
NSVIANSNIISLSSTYNTIEKEFVKEGYIVRDRAIFEKVANQNQSIDYSKLQSITGVDLL
IELVSVSDFTIITNKYYDKKGREKTMNTDASFTGKKIEFKIVKLKENEIAGNYTFFFTPC
IGGCTYAYYPQWGLFDQKYTINKMNVQVFKNMPYEAVFSSDSWELFIKQATDTMIQQMKN
N
>EGEFANNL_02029 hypothetical protein
MKKILLFLLFLLSYFSFSQSNKDLTINKIKTFISKNGVLPGTDKLAGNTPVIYFDKSTKE
INIDNFSFSLSEVNIIYEYKYQYGNHSMTFECKYSKCISDINGHKSDGFGIPISSKQKCY
ELIGLFNQLKY
>EGEFANNL_02030 hypothetical protein
MKKLLVLLFLSIQAVLYSQNSFRLDYSKFATYEDGKWTSIQQGNHTFVFNSDSNSDIKWY
NSVGVKASYRRISGTSTSSIDGYTYQITKFIDSAGNEAYIQLFDNVGWLVLIYPSSEFKI
QFYP
>EGEFANNL_02031 DNA primase
MSIPEIKQKLSIQEVLEHYQIPVKNQMCRCPFHEDQTPSMQVFYDSNTVRCYSGNCPQSN
KVIDVIDFIMYKEQISKAQAIAKASQWIGLATKSSYKEYQELPMDRLEEIFYKMKQNLRQ
SKKANEYTLSRNLTPEQLEIGYNGRTYKGIMNCIVFPLKDHHNKIVSFYGRSIKDKNHYY
LKNRSGLYPGYPPKETKNLILTESIIDSASLLQIEKIREKYSVLACYGVNGFTQEHKQAI
QELKQLEEIIIIFDNDRAGKQATEKLAKQIQELNPQLQLTTLELPNKDINETLQLHSPEI
FTELINNRTKKEEQSNNNNLEERSKKIEDPPNLSLNQINQLIEQSGIIGEENTRLLLFII
ASSYKTPKPLHAIVQGSSGSGKTHLISKIADLMPPEDVLRFTRITESSLYNWGEWDLVGK
SMVIEDLDGLKEEALYSLRELISSQKLSSSVSIKDKKGNIKSTQKKVRGIFSSLSATTKG
EIYEDNMSRSFVLAVDESIEQSQKIIAYQNKKYAGEIRKETENKARKHLQEYVRSLQNLE
VINPYATRLQLPQEVHKIRRLNQMYQSIINQVTYLNQKNRKINQGKIITEKEDLQQATEV
LFESIILKIDELDGSLRQFFERLKNHLKTKDKEFTQREIRQAFNLSKAQCSRYITHLLEL
EYLTARNKQNLRKITYQIDYWDNFEKLRKQIKEQLQNQIKDL
>EGEFANNL_02032 HTH-type transcriptional regulator ImmR
MGLGNRIISLRKVQKLSQGDLASKIGVHQNVLGRYERGEAKPSIEMASKIADCLGVSIDY
LVGKIDVEIDKVILDKIIAIQKLPEEDKSHIMYSLDGLIQHAKNRLAYK
>EGEFANNL_02033 hypothetical protein
MKNTDFSNLNNNLNPESLKVFLTALDNFSFIEDYQQLGFSIQALIKALKVAILDPGNSLN
RDEFFLLLSLLLELIPKSEWELLDKLNKN
>EGEFANNL_02034 hypothetical protein
MVFLLYLYLMKEREIRAVFDEETITVYQAYRKEIALPAVKAQTFVSPFKIERMTWIKPSF
LWMMYRSGWAKKVGQEHILAIKIKREGFEWALKNACLSTFKEHIYKTHENWKEKLNNTPV
RIQWDPEKDLLLNKLQYKSIQIGLKEEAVKKFVNDWIVEIKDITDFSKDIHHLILNDELE
KAKDKLPKEEIYPLPDNIKMIINAD
>EGEFANNL_02035 hypothetical protein
MLGKLDIIEQNGKIVTLTKVNENYSWFVSDKEYWVLDRIKWINDFKNAGYDLPEGHEERF
NIGILNKENSSKFIKCLQKEGDEITQQELSDEFYLRFEISKDWWDFSELLPQLFIDFDNQ
IFYQEGLSETIDYKLYLPDGWKFHEDKYFENIPESLKFWVKDGIDYLKKIAEFINSNQH
>EGEFANNL_02036 putative deoxyribonuclease RhsA
MKDHKSYKLKPVKAEKFDAAMGKSSASSSTETQAGAEASQNSADSSAAASSQEEEAHTLT
TIPQLNKKEYTWSGNASQHASKHFDVVVALDVHYTQIPPPPSFRTIPIPLPHPFVGIIFD
PMDYLPGDISIPSAVQGALGMFMSNPPQSIPLGSSVYVHGRHKATTTTSVMGLGIPSPPK
KMMKNPIKSPLVHITGSLPVYKIALGEMEAPHDGEVYVGSETVIVQGSEMSGDKPQQVLT
CWGMGLGHQYFPPAWAALYNHISTLYIQFNTGNPVLIGGPFVPHKYSLSDILMRAATVLL
MKGISKGVGAGFTKLNHFLASKFGKDNPISKALCKLGLEPVNFVTGAMSFEWEDFEILGS
HTLQWKNVWESDNPYLGMLGRGVSNSYDLFLVPQEADGVVAFKHPLENQVVPLPCPALEG
EFEYDRTWKIWQKRPDVNTWVIKIGEDVYTYQAFPHKEFGKIYRVKTLESAQGGVLNFHY
NSRGEILTYIRDQAYRTLKFSATPDGTKIAFVHMVYQNQEDLLVSYEYDERGNLTRVFDA
QGKSIDFYYDNDDRVVRRVNRNGMEYLWRYDSQGRVIYTTGKNQLQEGKIFYFPEEGFNE
VRYTQKEGKIERYYYDEDFLVYKQVDAEGGETWYDYTPHHELTMVSSPEGKITGYQYDER
GNRKAVQAPDGEEIQYMYDEFNRLVYRKEPTGKSESWQYDTLGRLTNWQRLDESTVEYLY
HEQEKQPYASKDSQGLETYWEYNAFGQMVKATNNRGAVQEFQYDKYGRLISQNRENEAPT
YWRRDHLGRVSEFQTPGQKKLRIKYDAYDLPVHVSNGSEEWFMEYTPMGSLKKQSRRSAK
TMEALSTLVYDYNAYEQLFRITNEKNEFYTFTRNRNDQIIKERDFDGQTQEYIRNLDGEI
VKTLAPGGKEIYHQYDGAGRLTYNRYNTGYWESFEYDPLGRLVKAQNLMSEVEFIRNPFG
QVTQERQGEHWLDYLYDERGQLQKLKSSLGAEIEYRYTAEGRLEELKAQTPITVQNPRNP
YWHLSLQVDPDRRKVQRSMSGGVNQQMQYDDLGRPLAQTVTSDAGKTLDTAYRWKENFKL
VETLNRLTGANIRYDYDAFGSLAQAHHSDGTTEYKNPDEVGNLYNSTHRKDRVYDAGGKL
RKDTEWWYHYDEYGNLRFKTRTPRGSEVEASSGSDFSTSFLLPDGEVYDNIFDQKAEIRK
YSRREMREYDKIRNRRQQAWEEKKEQKLKWESGDWEYLWYSNGMLQKVIKPDGSTLSFEY
DALGRRTAKIVGNKIYRYLWDGNVLLHEWDYPLEDRPRLITDAEGEVKYNREEPVTEVTT
WVYERGSFTPCAKIVGEEKYSLVSDYLGRPVQAYDRFGKLVWEAEYNLYGGFKELKGSPT
LIPFRQAGQYEDVETGLYYNRFRYYNPETGQYISKDPIGLAGNNPNMYAYVDDSNTMVDL
FGLMPEETVTVFRVQGGEPFPSGNRSKDIIKIDSSGKIKISNETLNISMGSSTDLAHAEY
FAAKRGGDAKVYSFEVPKWMGDMIEDYSIPQANSTKNPLNQGGMAPKRVDPNQPGAKKFE
LPPIWAKWLEENAISGSGKVKDPQSTPRVKCPT
>EGEFANNL_02037 hypothetical protein
MNSVQLEVLKLDKQWYREIKNSPQSPLYVCLGEKHELRLLEGYFKSQSSDQAKTKDLFLI
LYHPFEGKNQYGTFMVERWHELHQAGLQTRVENLREWQEVQFPEGKYKTDAYQLLQTLES
YYHTYPEMEGRKIFLLLQPPNLKEDNAQEWEEWIGEWCRINRKKKDIKLVIKEYKHLRTF
KNLPPNTHEVVLNIDGGKLMQNAAQQTQREKGNPEMNFQQQILNAYTLLGEGKYEPALHS
LDRALFIAKKDGSQESEATARFIRATVFTALEDKKNAKAEFEKLFQTVEKDTLFAAQIHF
HYAGFLLSQSETTAAIQELEKALTIGEKIEDYFIQLESHRMLGQFKDGMFNSSQALAHYE
KCLEIGAQLPLQERKASTFPYTMRQLLKKYGKSSEKGKKLDQKMKQLVGENWQEKVNDPE
PQPTN
>EGEFANNL_02038 Actin cross-linking toxin VgrG1
MSIIDPNLGKGAGKASSSLSTGKIVENAADLSGLTDKLSNLEDQLADKISDLTAPVQEAV
DKAQKAVDTAKNIANQAQEIKKIIPGDITSLPNGLITPEQYAEYKGLNSLIATYGGDPET
NLANSHIVYSKITIGGERVLADSHFVVEIQQKAAEHDTFTIKCSAEAIDGPKAYPMEKAR
NYLGKRTTIQMIQFGAPAFIFTGIITDITNERENGESRLIFTGKAPTILLENGLDSQSFE
NLDLAGIIKNATAEYPQDLVQWDIRPIMKEKLLYTVQYRESDWDFVKRLATRYGEWLGYN
GQQIVFGGYGGKTVEMVEEQDVYDCKLRMQLVPQKFNYMAYDASQAEPHMVDSDSVPITH
RLVNPFQQHAIKASEDIYSKVPTSLYNHSLLEGGRPELKDAVKRQKLKRQNVFFMEAKTN
NPNVRLGDIIKLKAWMPGHKIFKNGEVPLESYKIIEIKHFHDITEGYINEVVAIPMDNEV
PPYMDEDAIPLCEEQSAIVTDNNDPQGMSRIRVQFPWQKPTGGQSPWIRSITPYAGNGKG
MHVIPEIGEEVIVAFESGNAEKPVSLGAMFNGKGKSGHGGAGNYKKGLQTASGSHITFND
QVGDMTLSDQGGTVMNFDGAGNSVISSKEHITLVCGESRIDMLKDGTILINGKDIGILGS
TTVNFGVGAGENINSGMGIKADEVNICTQNLIQTGTTEVSINSPGKVTVGSKEETTIVGG
KVKIN
>EGEFANNL_02039 NADH-quinone oxidoreductase subunit M
MLTILLLLLPLLGSLLLFIVKSNHSKFIALGFSLISLFLALGVGMQFSVEHTSTFEIGQK
LYFSPIRSAFHFGIGGLSLLMLFLTNALIPIIIFSSFKDSRPNQFYALILLMQFGLIGLF
LALDGLMFYIFWELTLIPIWFICGIYGTGENKTRINLKFFIYTFFGSLFMLVALIYAYTQ
AGSFDFKDLYAAEIDPKAQIYLFWMFFIAFAIKLPIFPFHTWQADTYTMAPTQGSMLLSG
IMLKMGVFGMLVLLVPLTPYALGGISGSIALVLSIVGIVYASLIAVVQKDIKRLIAFSSM
AHVGLIAAGILASSIVTAQCGTSVTGFEGASFQMLAHGINVVGLFYAADLLIRRFGTRDL
SQMGGLASKAPIFAVLFMIVSLGSMGLPLTNAFIGEFLLLKAVFTLSTWATIFAGLTLIL
GAVYVTKMYGMAMFGQGNKEFLSNQKDISCADQLGLGILAVLVFVLGIFPQPLLNLVVSY
TSQIAHIFNS
>EGEFANNL_02040 NADH-quinone oxidoreductase subunit L
MDKIIYLIPILPLVGFIINGLLGKKLPKNIVGTIATLVVFVPFLMSVVLFCNFQSMEKAV
LFNWFTVDDLKVNFSFQIDQLSLVMMMIVTGIGTLIHLYSIGYMHDDEGFSKFFSYLNLF
IFSMLLLVMGSNFLILFIGWEGVGFCSYLLIGFWYKNQEYGYAARKAFVMNRIGDLGLLI
GIFLLAYYMGSIEFTDIATQAHKFSVNDPILITATLFLFIGAMGKSAQIPLYTWLPDAMA
GPTPVSALIHAATMVTAGIYMIVRTNAIYTLVPCTLDFIMYIGLATSILAAFIGLRQNDI
KKVLAYSTVSQLGLMFIALGAGAYTTALFHVTTHAFFKALLFLGAGSVIHAMGGEQDMRY
MGGLRKKIPVTYVTFLIATLAICGVPPLAGMFSKDEILIAIWEKNKWVWGLTLFSAALTC
IYMFRLLFLTFFGDFRGNEKQKSHLHESPKVMTIPLIVLAILTIFGGVLNLPHYLGKAIS
HKFAHWLSPIYIGNIPHEEPTFVVEMILLILTLSVIVLVAVFTYRCYVVKKAHPQMVENL
TGWEKASARAAYVNELYNEIVVNPVLHLSNFLKNIVDKYIINGTVVGITKIIQCIGQWLK
SVQNGNAEFYVLAMSLAIAVILLALRFISH
>EGEFANNL_02041 NADH-quinone oxidoreductase subunit K
MEVNSLIKIVPIDYFIYLATLLFCIGVTGVLVRRNAIIILGCVELMLNSVNLLLAAFSAY
KGDADGQILVFFIMVVAAAEVAVGLAIIALMYRNTRSVDISLFNRLKG
>EGEFANNL_02042 NADH-quinone oxidoreductase subunit J
MEAILLYVISTCAVLSALFVVFSKNAMHSIIALILTFFSISGLYILLNAQFLGAVQVIVY
SGAIMVLFLYVLMMLNLKRKDEPLKGNSFRILATLCGGLVFIAFLGALKGFEKIPFPADP
DSQIGLTKNLGILLFSKYVLPFELAGILFLAALVGSVMLGKRDL
>EGEFANNL_02043 NADH-quinone oxidoreductase subunit 9
MQRLTNRSKVVSNKEMSLKERIYLPAILGGMKITFSHFFKKPVTTAYPEKKREFSPVYRG
RHVLKRDEEGRERCTACGLCALACPAEAITMIAAERKPGEENLYREEKYAENYEINMLRC
IFCGMCEEACPKEAIFLTDRLVLPEQERRDFVYGKDRLVESVENRIDISKRQIKKYTIEK
>EGEFANNL_02044 NADH-quinone oxidoreductase subunit H
MWFTLVLVVILFLLCLGAAAYETLMERKVAAFLQDRIGPNRAGKFGLLQPLCDGGKLFFK
EDFVPRNAEKWLFIISPAILMIIALSTSAVIPWGKSLLIGGETYLVQVANIDIGVLYIMG
IVSIGVYGIMLGGWASNNKYSLLGAIRASSQMISYELAMGLSLLSIIMMTGTLDLRTMVE
GQAGNLYGLTFLNGMSWNVFYQPLAFILFVTCSFAELNRAPFDLAECESELVGGYHTEYG
SMKFGTFLFAEYINMFISSALISTLFFGGYSFPFMNELAENGTLGVNAIGIISIVVFLIK
IIFCIFCFMWVRWTLPRFRYDQLMKLGWQIMIPLAILNLLITAVVVVFK
>EGEFANNL_02045 NADH-quinone oxidoreductase chain 3
MSEEVINKIKVTIDGVTIDVNPGISIVEAAREIGGPSVPPTMCYYSKLEGSGGRCRTCLV
EVSKGSEKDPRPMPKLVPACRTQVMDGMEVKVITSPKVVEAVQGVTELLLINHPLDCPVC
DQAGECKLQDLAYEHGLERTRSEFPRRTFQPDDLGPYIKLNMNRCILCARCILVANQLTD
QRNQGILFRGDHAEISTYLNKAITNDFSGNVIDVCPVGALTDRTARFKSRVWFTEPVNAT
CKCEKCSGKAVLWVKGNEIIRVTARKDQYNEVEEFICNECRFERKDLNDWTIEGPTPINK
HSVISVNHYELPLPKNDPHYKLKNNNIKTIE
>EGEFANNL_02046 hypothetical protein
MHAYKRIRLLLCIWIGLIATQFYGQEKKIAHKKGEVYAYWGWNRAVYGRSSVHFTGDNYN
FTLHSVKADDKPLNFNFHDYLNPGRVTIPQTNYRIGYFFKDNWALSLGVDHMKYVVRPGQ
WVKATGEINVPGYENAIQDGQYIYLDDNFLHLEHTDGLNYLNLDLEYYHNFLEAGFFKFN
GIAGGGIGLVIPKTNSTLMGNPRHDKFHLAGWGIDAKIGAELLFWKLFFLRTELKEGLIA
LPDIRTTSNKSDKASQTILFLQWNYTFGFSWHF
>EGEFANNL_02047 NADH-quinone oxidoreductase subunit 1
MNNKLLLTHINVEGIRGFDVYRNHGGYTSVDKALKMTPEEILEEVKASGLRGRGGAGFPT
GMKWSFLAKPEGVPRYLVVNADESEPGTFKDRFLMEYIPHKLIEGIIISSYCLGTNTSYI
YIRGEYSWIPDILEQAIQEAKDNGFLGKNIKNTGYDLEIYVQRGAGAYVCGEETALIESL
EGKRGNPRLKPPFPAVKGLYQCPTVVNNVETISSVPSIIEISGAEYAKIGVGRSTGTKLI
SACGNINKPGVYEIDFNLSVEEFIYSEEYCGGIPNGKKLKACIPGGSSVPIVPAKLLLKT
ADGETRYMNYESLSLGGFESGTMLGSGGFIVLDEDQCVVRHTMTLARFYNHESCGQCTPC
REGTGWLYRILKKIEEGKGTYEDIDLLWDVQSKIEGKTICPLGDAAAWPVAAAIRHFRDE
FEWHINNPECLTKNYGIANYACV
>EGEFANNL_02048 NADH-quinone oxidoreductase chain 2
MQPNEKLEMTENNTNNLEKIVFSDQSLKKVHEIIARYPEGKQKSALIPVLHLAQKEFGGW
LDVPVMDYVASLLNITSIEVYEVATFYTMFNMRPVGKYVLEVCRTGPCMLNGSDGIIEYI
KEKLQIKEGETTKDGLFTLKPAECLGACGYAPMMQMGKFYHEHLTKEKVDEIIELCKLGN
IAID
>EGEFANNL_02049 hypothetical protein
MIIDNENTYTSNASGNSFTVKEQGIYFIALNFLIQNTVQNTLPVIGIWDDTDGKWIARIN
DVFVVESGFSTRNQSFTLITSTELLPSHIYSFRVSNTSPLTIASTSSGSTGSGAVSTALV
QRLR
>EGEFANNL_02050 hypothetical protein
MKNFILFFLNILSSVEICAYGQVGIETSTPQAMLHINGSLQITGDLSVGGDAKTSGNPGN
PGDILVSNGPEKSPSWSKFELPEISLNNTGTVIAVDGNFVIAQQIAVQLSKDFNYTGNSP
MAIPNLNTIILDNENTYISDASGNSFTVKDNGTYQIIMNFMLENTVKGTAPVIGLWDNTD
NLWVARINDTFNVSETGVSARNQTYTLFTTQKLVNNHSYSFRISHKSPVTIKSLSSGTTG
SGNVSMAIVMRLK
>EGEFANNL_02051 hypothetical protein
MKYITSIFFFTITRLFVYGQFGINTETPQNTLHVNGSIQITKELNFGGDEKTSGNSGLNE
QTLVSNGAGKPPIWSEFKLDNISPSNSGTIIALDGNFEVAQEITVLLSSDFNYSNVNTPV
AIPNFNTIIIDNENSFTSGPSGNSFTVNKDGIYMVILNYLIQDAKTNSNPVVGIWDDTEN
KWIARINDAFNAPNTNVSQSNQTYTLITANPLYKDHVYSLRVGNTSPFILKSTSSGKTGS
GQVSMISIKRLK
>EGEFANNL_02052 Dipeptide permease D
MKNKSSSNFFDSQVLGHPSGLFVLFFTEMWERFSFYGMRVLLINFLTMAIIGSNPGWAWS
AVNAGALFGTYAMLLYLTPIMGGLIADRYIGYRWAIVIGAFIMTLGHISMTFESESSLYL
GLALLIIGNGLFKPNITSIVSEIYKEVPDKKDGAYTIFYMGVNAGAFFGMMLCGYLAEKV
GWSWGFGLAGVFMLLGTLQFWLAKPLFGTIGNIPKKVLTNSNVVANPPQSLNPFTFLDKI
LIVLSSIIGLVYAINDPLSKIKGINILPQEFIFNKDLIEGPLVIAILGLLMFLYLIITRI
IRYEKIVRNRMIVVVIFAFLTMFFFASFEQGATSLVIFARDFTNRLVEGKAATIYLIFNT
LLTIVPLVIISWVLYLLFKKTHHKILSSNLVLGISFAIIWGLVIWLLNSDRKSHAYEVEY
LAIKDPKVNIENTEKSSENIYTPLSESYQIKPSDSIVTKKMTIASQTEYNINDSILLHEE
IGIMVPLSKNQEERIREDYKTHGLESKIIKAKISDIRDNKIEITTSWFSILNSFFIITFA
SLFTQWWDSKYNPSAAIKFGLGLIIMAIGFGVLAYGSLDIPKSSAPGIFRVSMLWLILAY
LFHTLGELCISPVGLSYVSKLVPGRMIAFMFGMWYLAIAIGSKLAASLGGMVEEISKEYS
MSYFFLVFTFIPALAGIICITLNPLIKKLMHGVK
>EGEFANNL_02053 hypothetical protein
MLNKIIFTFFLLYFYNSWGQNIQDLNRNSFSDRENIRTKEKAISNFENLLDTDHDDISDS
EDRCPNETGTPYFKGCPDTDGDGILDVDDACPTISGLKEDDGCPKAIPLHPQKKSNGIQF
SENNYHLSSEVIESLKYVAILINDINDEFLIKGSAICTESKKIAKKRVRNVRTELIKNGV
KKNKLKLEAFYSSDCENTNVEKDVIIKLLNS
>EGEFANNL_02054 hypothetical protein
MKELLIFIIFLCPFISYGQTTIDTDGDGIPDTDDICPMTLGTIEMKGCQEPTYCSFSPLE
FLFDKNSYSLTSKSSHNLKSITIFMKEKNAKFYVKGFATCDESKKLAKKRAKNVRNELIK
NGVNKHKLKIKIIYSSNCNNTEIKPEVNFQIINYKKVSL
>EGEFANNL_02055 hypothetical protein
MVFLFENEPKKIAKERAKNSGNELVRNVIDIKKRLNLKTNHLINCEEAKNKVVFCIRN
>EGEFANNL_02056 hypothetical protein
MKRNLLFYLLLYFSSFYGQTSIDTDGDGIPDSEDRCPNETGTHYFQGCPDTDGDGITDID
DTCPNEFGPKENMGCPWNFDEINRESQCHFVKIIFDLNSIDLTEKSKKGISCFSYNINKY
FKEKKFIVRSYPDLKESKKIGRKRAIIVKKQLIKGGINPNKLKIKVSYENTPHFLRRVFI
FFDDTNPRNNKIQFK
>EGEFANNL_02057 D-cysteine desulfhydrase
MTIPIQPFQFLDLKTNHQLFIKREDLIHPIISGNKFWKMKYNLLRAKDLNCKTLITFGGA
MSNHIVATAGAGKENNFKTIGIIRGEEIENCWKDNLTLQEAHQLGMEFYFVPRSEYRLKE
HSTQIQNFLQTIPNHYLVPEGGTNELAVLGASEILSKETEIFDIITTAVGTGGTISGLLK
GSTNHQHILGFPALKNAEFLRSEILKLTDKTNFDLILDYHFGGYAKVKTNLIQFINDFFR
LNKILLDPIYTGKMMYGLYEMLKNGLISDKKKILAIHTGGLQGIHEMNKILMKNEKPLIL
TKL
>EGEFANNL_02058 Exo-glucosaminidase LytG
MKKLLLIVAFTIVGKFSFTQESVKKDELYIQTHAKTAVKEMILYKIPASITIAQGILETG
NGQSTLAQVGNNHFGIKCKGEWTGDRMYHDDDLKGECFRKYTSAEESYRDHSLFLAERPY
YKKLFTLDIKDYKGWAFGLKKAGYATNPKYAYSLISIIERYNLNRFDNINEEQTDLVLAE
LFPNSYTPALPASEKNETVQLATNTNQKKEVNKQLISSTLTNKKTLKTKTNNFEFPSRRV
RIHPNGKIKYIVWKEGDRLEDVAKAYHVNLQNLKSYNDLAFKEEISINQKIYLEPKKSKG
ISKIYITKNGERMYDIAQNNAISLIELYKRNTMLPGQEPEKGDKIFLKGRKS
>EGEFANNL_02059 Glutamate-1-semialdehyde 2,1-aminomutase
MKYERSSALFKNAQKYIPGGVNSPVRAFKSVGGTPIFIKSAKGAYLTDEDGNSYIDYINS
WGPMILGHNPSEVLEAVTEQLKNGFSFGTPTELETEIAKIITESVPYIDQVRMVNSGTEA
CMSAIRLARGYTSRNKIIKFEGCYHGHSDSFLIKAGSGLATFGSPSSPGVTPGTAQDTLL
AKYNDIESVKILFEQNPEEIAAIILEPVAGNMGCIPPEKNFLEGLRDLCNKHDSLLIFDE
VMTGFRLKMGGAQEYFSVKADLVTYGKVIGGGMPVGAFAGSHKIMKFLSPEGPVYQAGTL
SGNPIAMRAGYTTLSILKDNPSIFHNINNTTRKLSTELSIIFKDFGIPVCFKQCGSMMSL
FFTAEDILNFDDVTKANHENFNKYFHFMLENGIYLPPSGYETWFISSCILGNEINKTLEL
TRKFLSKI
>EGEFANNL_02060 Outer membrane lipoprotein Blc
MKLTKVILGGLIFSCLGTATTLYLLNKRKTTPKGIIPIRPFNINKFLGKWYEIARIDFFF
EKNMENVIAEYSLNFDGSLRVLNSGHNFKKKKYKISAGKAIYNYNNEGKLLISFFGKFYS
GFNVISIDDEYKYALVTGNSRKYLWILSREKEMPLEIIEDFLIKAHNLNYDISKLVWTNH
S
>EGEFANNL_02061 hypothetical protein
MNTSNILSKIKDYYGFKKDIELANFLGISPQALYNWKKRNSYDLQLIYSKCPEINPEWLL
AGTGAILKRRYNENEFKSSVANEFTETYSTNHSSHIPIFDLDNSEGLSNLLKNKNSSSFL
NIPNISNSDGACYVKGDSMEPLFKSGDIVIFKVLPIESIFFGGIYLLEIDLGNNSSFTSI
RHINKSDLGDEYIKLTSANSVYEPKDVSLKTVKLVATINSSVRFH
>EGEFANNL_02062 hypothetical protein
MDKIRTFFEANGFEVISRISEKFGVRASKLRLLFIYLSFITLGGIFAIYLVGAFFLWVKD
CFFIKRPSVFDL
>EGEFANNL_02063 hypothetical protein
MAVSLLVVFLYGSLVWGMLPGSVLGIYDTTSISWESHLAGGITGMFLAYILRNIGNSKHN
FSKHEEHFEIENEKLWEEYKEQFPEDFSDKNQLKHNVSKELESIKGRINYKETEIRDIEK
Y
>EGEFANNL_02064 hypothetical protein
MMYETILGNVNDVIPLSKEEKYYLKSILKFKKLKKKEFLLQQGEVEENYYYVLSGCLRSF
FIDNKGVEQVVQFSSSGWWLADNESILLNQPSKFNILAALDSEILVLSKYDKEESVKKIP
KLETYYHESLERSVIFLRYRLYEILSLPAEEKYKNFCKSFPELINSIPQKHIASYIGVTP
EFFSSMKRKIKE
>EGEFANNL_02065 Elongation factor 4
MKNIRNFCIIAHIDHGKSTLADRLLQQTKTISDRELQEQTLDDMDLERERGITIKSHAIQ
MEHEYKGEKYILNLIDTPGHVDFSYEVSRSIAACEGALLIVDAAQSIQAQTISNLYLALE
HDLEIIPVLNKIDLPSANPEEVTDEIVNLLGCKPEDVLRVSGKTGVGVAELLEEIIERIP
SPTGDPEAPLQALIFDSVFNPFRGIEAYFKVVNGSIKKGQKVKFMATNKTYDADEIGTLK
LKQFPKTTIQCGDVGYIISGIKEAKEVKVGDTITSTEKPALNPIEGFEEVKPMVYAGIYP
VDTEEYELLRSALEKLQLNDASLVFEPESSAALGFGFRCGFLGMLHMEIIQERLDREFKM
TVITTVPNVSYNAYLNKNPDKAVPVHNPSELPEPTMLDRVEEPYIKASIITKSDFIGSVM
TLCIEKRGELTNQSYLTTDRVELFFEMPLAEVVFDFYDRLKTISKGYASFDYAPHGMKAS
KLVKVDILINGEPVDALSALIHQDNAYTIGKKMCEKLKELIPRQQFDIPIQAAIGAKIIA
RETIKALRKDVTAKCYGGDISRKRKLLEKQKEGKKRMRQIGRVEVPQSAFLAVLKIND
>EGEFANNL_02066 Limonene 1,2-monooxygenase
MNMDLKLSVLDQSPIIKGQTSSKTLQNTLDLACYAEGLGYHRFWLSEHHNTNGVIGSAPE
IMIAHIANHTKKIKVGAGGIMLLNYSPLKVAEIFHVLESLHPSRIDLGMAKSSGANKKTA
NILNPHLQDPKKEFIDKLNAINKFLDSTPKLSTEIKAMPIVESSPERWLLVSSIESAIIA
AEFGMGVSFAHFINPTKGKEALEIYRNNFKPSENLKNPKASFGIFVFCSLDKDKIHRQQA
MMDHRFIQLQETGNILPINFEDIKDIDYSDKDKLSIKYNRQLYICGTPEKVKKQLDSLIE
DYKVDEIMLATYAESIEDKKESYKLIADLYNS
>EGEFANNL_02067 Carbonic anhydrase 2
MFLDKIFTHNEEWIKSKLVVDKNYFKELAKGQSPEILYIGCSDSRVATEELLGADPGEVF
VHRNIANMVISIDLNVMSVITYAVEHLKVKHIVICGHYYCGGVKAAMEAKDLGLLNPWLR
NIRDVYRIHKDELDNIEDTVVKYNRLTELNVEEQCINLIKTAAVQKAFIERGLSVHGWIF
DIRSGKLIDLKINFKKKLKEIMEIYNLNEGKDII
>EGEFANNL_02068 hypothetical protein
MINRSQEINSNLGKLFLRISIGGLMIFHGISKFIYGHDFIKQVLVEKGLPESMWLGVPVG
EVIAPLCIILGVFTRVSSLILAFTMLMTLYLVHGWEGFLLTETGGPAVELNLFYLLTSIS
LFLLGPGNYRIYKGNNPILV
>EGEFANNL_02069 Inner membrane protein YiaA
MKNNKTSLAFVAASWIGLILGIGGYLIGLWRAEMQLNEKGYYLLIILYGLFSAVSIQKSV
RDKLENIPVTDVYYGLCWASLIISISLLVIGLINADLLPSEKGFYAFGFILSLFGAICVQ
KNTRDLEDEKKKLNS
>EGEFANNL_02070 hypothetical protein
MKKKIFTTLFVAFSLLLAKAQNPIDSTEVSLSIINTEKSDLEIVKDFHRTASPYFKDPKA
PRFLLYDRQKKVAFGIGGIIRVRTAYNFSGISNSSSGFVPYSISVPTNSAEKNDFKINAN
KSTLFFKLMGDNSKIGKYMAYVSGNFSGNNNNFTLKDAYVSFLGFTIGQTWSTFNDIAAV
PPTVDYQGPNGAAMMRTGQIRYTHKLNDQISFAVAVEQSQSTGTYENSLNEKTTQSIPDI
PLYIQYSWGKDFASHIRVSGVMKNINYRNLVKDKTETETALGVQLSTKVGITPLIEFYGQ
INYGNGIAPYINDLSGHGLSIVNNPNHDGRMYALEAMGWFSQVKFNLSKNVFTSLGYSQA
KIFPKSGTFSDQEYRYGQYLVGNVFYNITNNIQLGAEYLWGNRVNMGGQSSAANCIQTLV
KFNF
>EGEFANNL_02071 Urease subunit gamma 2
MYLTPREIDKLMLLSLGAIAERRLKKGLKLNYPEAVAYITSAALEGAREGKTLEEVMNEA
ANVLKKEDVMEGVADMIPLLQVEAVFTDGSRLVSIHTPIK
>EGEFANNL_02072 Urease subunit beta
MSKENQINDNQIAPGFTPKNKIPVGGIIFADQPIEYNTDRPTLTVTVRNTGDRPIQVGSH
FHFFEVNRYLEFDRVASLGYHLNIPASTAIRFEPGEEKEVSLITFGGKRRIIGFNNLVDG
YTGDEGAPTFFPATIRAIKKLEEYGYKTISEKDAQAEYKTNVNKK
>EGEFANNL_02073 Urease subunit alpha
MATISRQENYNLFGPTVGDKIRLGNTDLYIEIEKDLKGYGDENVYGGGKTLRDGMGLANT
ITEDEGSLDLVITNVTIIDAKLGIIKADVGIKDGKIAGIGKSGNPNTMDGVDPDLVTGAS
TDAISGEHLILTAGGIDGHVHYIAPQQIDHALSNGITTLFGGGIGPSDGTNGTTVTSGKW
NTEKMFQAIEGLPVNIGLLGKGNCSTERPIEDQIIAGVAGLKIHEDWGSTMASIRASMNV
ADRMDVQVAIHSDTLNEAGFVEDTIAAIDGRTIHTYHTEGAGGGHAPDLLKVASMSNVLP
SSTNPTLPFGINSQAELFDMIMVCHNLNPKIPSDVAFAESRVRPETQAAENILHDLGVLS
MVSSDSQAMGRIGESFLRTFQMASYMKNAKGKLKEDSADNDNFRVLRYIAKITLNPAITF
GISDVVGSIEKGKFADLVLWSPSMFAAKPKMVIKGGFITWSEMGDPNASLPTPQPIIYRP
MFGAYGKAMPQTSMTFVSKAAYDLGIKEKLGLEKIVHPVSHTRQLTKNDMIYNGGTPNIE
VNPETFEVLIDGQPAHVAPAKEFSLGQLYFFS
>EGEFANNL_02074 Urease accessory protein UreE
MEVYSEILGNVNNSDDWNHKLQNVEIEHIFLDQWAAQKSRLLAKGDQGNEYPIALKRGSQ
VTDGDIIYYSPEDNKAVVIKIELNPVLVIDLSDLVTKSPEDIIRITVELAHAIGNQHWPA
VVKGTTVYVPLTVTEKVMLTVIDTHHIEGIKYQFKKGQEVISNLEPQEIRKLFGGASHEI
HGFEHGHAHSHNHSHSTSHTHTHYDENGNPHTHTH
>EGEFANNL_02075 Urease accessory protein UreF
MSINILSLMRLIQLSDSAFPIGTFSFSNGLETAIHEKIVYDAQTLEDFTRSIALQAAYSD
GIATLLAYRAALEKDYQEIVNIDNQLFMFKMNDEARLMQKRMGRKMAEISIDLLDNELLV
KWLKDIKDEKTPGTFPIAQALAFASENLSEVELFTSHQYGAINMILGAALRAVKVSHFDT
QRILYKLSEQTQELYEEVRLLSLEDMNSFVPQIDILASLHEKGKMRMFMN
>EGEFANNL_02076 Urease accessory protein UreG
MSNNICRIGVGGPVGSGKTALIEALTPKLLEKGLKVIIITNDIVTTEDAKHVRKTLSGIL
PEEQIVGVETGACPHTAVREDPSMNIAAAEELEAKFPDSDVLFIESGGDNLTLTFSPALV
DFFMYVIDVAAGDKIPRKNGPGVAQADIMVINKTDLAPYVNASLEVMDRDSKTLRGDKPF
VFTNCMTGEGLDELVDLICRIALFDKVKK
>EGEFANNL_02077 Urease accessory protein UreD
MAISKVDFSSAKEMAPYLEQPKAMYVGAPGKTGYLFMGFELDKSGKSIMRDLDRRSPIIV
QQELYFDEEMPEMPCVYILSAGGPNIDGDRYEQNITVRKDAFAFVSTGAATKLSEMKYNY
SGLKQEFVLEDHAYLEFLPEPLIPCRHTRFISDTKLVIAPTATLFYSEVFMGGRKHYGDG
ELFEYDILSVCCHGERPDGEQLFREKFIIDPNKYSPRNLGVMHNYDVFANVIVMTPKEHA
DKIYEQITPFIDNDKQIAAGITYLPNQSGLLFKVLGMEPGPVKKVIRDFCSKVRLQVKGK
PVPAEFPWR
>EGEFANNL_02078 Urea transporter
METITTKPSTKFCHLFSMDFIKIIFKGSGQVMFQNNIWTGVLFLLGIFVGAYQEGQGLVA
WGALVGLLTSTITAYFLPLSSDDNENGLWGFNGILVGCAFLTFLGNTPYTWIALIVCAML
TSSVRLAFNNVMASWGINSLTFPFVFLTWIFLFSARVLQGIPPTHMSEPVLSSAINPSLD
LSISHLLIYWLKGISQVFLINSWVTGIIFLIALFISNKWAAIWAALASAIALFAAIMFKA
PGSDIANGLYGFSAVLTGIALGMTFYKVSHKTAAWAFLGIIATVFVQAGMNGMLEPFGLP
SLTAPFCLTTWLFLLPRFKF
>EGEFANNL_02079 Inner membrane metabolite transport protein YgcS
MLQKKMVDMDHMPLRWGHVKIFFISSLGQALGAGLATLIGIIIPMIQMLIHPELTSFSQG
IISCMSLLGIVVGSSLIGDLSDKHGYLKLFRICPLLILGASLIGYFFDHVWILAFCLFLM
GIGIGGEYSLGSDYISEIMPDRWKLFMVGAAKSTSAIGSIVVATISYFLLIKWQNPMHWN
FLLLLISALSLLMFLLRIRFAQSPGWLIAHGQIEKAEIAVKYFLGNDVKIGDIKNKPVDI
KDPNLKDFLSKDNLKKVIFSGVPWACEGLGVYGLGIFLPILVLALGLEPSKQDPFDKIIS
SVKITTFINIFVLIGFILGLFIVNKINHLKIQVWGFTLSSLGLILLLVGYKLGLSTWVFV
LGFLIFELFLNAGPHLMTFIIPPQIYSIEERGTGVGLAASIGKIGAVIAVFFIPNLLKWG
GIELVLIVSILVNLLGAFITQYYGRKIPEINKN
>EGEFANNL_02080 Fe(3+) dicitrate transport ATP-binding protein FecE
MKNAIEINNLEFSYSDKPVLKKLNVSFIENKFSVLLGINGGGKSTLFKIIAGLLKGYRGE
IKIFNKNMETISFKERAHLIGFLPQFHQFVFSFTVNEVLLTGRTAFSGFSVKDSDQEMAE
EIMKDLSIYHLKDKPINQLSGGEQQITMIGRLLMQNPKILLLDEPTNHLDVYYQHHLMEK
LKKYSTQGFTVVSIMHNPTLAFQYADHYYYLHDGHVHTAEDPSVPDLNLLEAVYNMSFVV
INKNEKDFILPFGEKLD
>EGEFANNL_02081 putative ABC transporter permease protein
MNNKLAKILCYGLPIPVLIVSLFIGSSDQVNAIQFFKSLINQLQGQTLVGRDQGSYELTK
NILVNVRLPRILLTFMVGAALSVSGSVLQALFRNPLVDSYILGISSGAAFGASLAIVYTL
SFINIYAFVGGILAVILTYFIATVNKQTSTVTIVLSGMIISGVFIALLTLVQYISDPYKL
QAIIQWTMGNLHSASWIEVKQSFIPIILTILICYRYRWRLNLLSLGDDAARAVGVNPVPD
KFILITCATLMTTTTVAVAGVISFYGLFLPHIVRMLLGADNSKSIAGNILLGGTFLLIID
DLSRTLFVFEIPIGVFTTILGGGFFVYLLKKNKLNWN
>EGEFANNL_02082 Ubiquinone biosynthesis O-methyltransferase
MEIKYIENYWDKQATIWREEKEDAWDLPETKYWLQYFKQLLPTLSGKKVLEVGTASGYFA
NLLSLAGYQVTAVDLSSKMIEEAKEVTQKLKLSIDYQVMDAQNLDFESNTFDLVFTRLMT
WTLPDVNKFYQLSYNILKPQGKLINFDGDMGKIQFSSEEGHERYPSEIMEEANKIKANLE
ISKNDRPTYDLELLKKIGFINVVSDNKIQNEILHKDISVKSLFQISAQKP
>EGEFANNL_02083 Vitamin B12-binding protein
MKNFFLILFALILLNGCNSNQEKLENQDKNFITLTDTQGNHVTLPKPAQKVVCLFDPSVD
VIYMLQKEETLVGIPAELYFDKELYNYFKLLDKRIEAKQLSTPGSNDLANIESIVALKPD
LVIAKNLTASTIQTLKSMQIPVYLSSSDTNKNLIKEMRDISIMLGNEKRGEELIAYAKSK
AKELQSKADQLSEGKRKTAYFSWANGRIFTTTGVESMMNNCLELAGVNNVCSTKIDKMNV
NPETLIQWNPDMIVMWNDSPNLFYEKPELASITAIKDKQVYNLMPMFFYSPHTFKALCAA
TAINNWAYTHDKNLELKDLKEIILKLYGEKNGTELMKYL
>EGEFANNL_02084 FhuE receptor
MKKINNLIFPSLTLLIVPSFFSQKINAQTTTDSIRGVTLEEVKIQAPKNRHYNTNNISKS
LRLDGDILDISQNIQSIDQSVIKDQLSLNVNESVTRNVSGTFREELHNGISSDIYSRGGY
INAQRNGVDLRPLLKGPLGDDIAVIDRVEFVKGPSAFMNALGDPAGSYNIVTKSADGKKR
TDFTLSQGSFNLLRGEADISGKYKEDNKLYYRLNLVGMHKKGFMKYDDNSRIVIAPSIQY
NFDENTSISAQYIYQHLSYNMLSEAQISPYGFGTLPYDFTITDPSSRPYRADANDIFVNF
DKTFNKNWSLHTQVSNVNSKSVGAMYWVNGINKVDPDILDRVYVYDAMKYNTFSAQAYAK
GHFVTGIFTHNLLTGVDYNYKTNKTQDTWNTATTIYPLSISNPIYSNVINNNSMGGSYNS
ENDINGVDNLSTGRLSYISPYLMEEISILDGKLKMNVGLRYTYAQGFFNQYGARNKNSDN
NLSPRVGINYKINETFSAYGLFDNTFTPLVGKSFEDKPLDPVKGQSFEIGLKKEWMNAFT
TTVSIYQIERSHTVTKDPITNNIYQNGQNKAKGIEVDVRGELFPGMYATINYAYTDSKIT
KDDLNPSLVGKATPDRIRHIQNTWLTYKLPGNFLKGFSISTGYQWLVGRAPRFTTIDPVE
MKNIFRMDAGISYEAKRYTFSVMVNNVLDSKQYSTAWKKNDMYYWVQLAPINYRCSLTVK
L
>EGEFANNL_02085 Carbamoyl-phosphate synthase large chain
MPKRTDIKKILVIGSGPIIIGQAAEFDYAGTQACLALKEEGYHVVLVNSNPATIMTDKEI
ADTVYMEPLTLDFLQQIIALERPDALLPSLGGQTGLNLAVELAKSGTLNQYDVEVLGTKL
TSIEQAEDRDLFKQLMESINEPIAESVIVNDIEAALDFANQIGYPIIVRPAFTLGGTGGG
IAENELELREITESGLKYSPVHQCLIEKSIAGYKEIEYEVMRDANDNAIVVCNMENFDPV
GIHTGDSIVFAPSQTLADQEYQLLRNSALKIIRALEIEGGCNVQFALDPYSRDYIVIEVN
PRVSRSSALASKATGYPIAKLAAKIAIGLTLDEMKNPVTNTTYACFEPALDYVVAKIPRW
PFDKFQSANRQLGTQMKATGEVMAIGTSIEESLLKAVQSLEIGCLHIRKKDIQPYDPSTL
EEKLKKADDERLFLIADALRNGESIERIQEASKIDKFFLAKLQHIIEIEKELEAQPENIE
ILKKAKKYGFSDFEIAQLWKADEKSIYKLRKEKNIVPVFKMVDTCAAEFTSSTPYFYSTY
GIENESLRTDKKKIVVLGSGPIRIGQGVEFDYATVHSVFALKQSGYEAIIINSNPETVST
DFSISDKLYFEPLTRESITTILDLEKPDGILVQFGGQTAINLAEAAREAGVKILGTSIED
IDRAEDRKKFEAQLNELDIARPKGDTVFNLDEALKVASSIGYPVVIRPSYVLGGRAMQIV
YSDRELERYMKEAVNVHEKQPILIDKYLVGKEIEVDAICDGTNVFIPGVMEHIEKAGVHS
GDSIAVYPTQTISQEEKEEIIRQTKALAKGFKIVGLMNIQFVLMKGKVYVLEVNPRSSRT
IPFMSKVTGIPLAQVATKAVLGSSLIDQGLSMEYYPEPKNIYVKAPVFSFAKLRSVDITL
GPEMKSTGEVIGKDTTYERALYKALLASHINIPILGNAIFTVADKDKPEALPIAKRFYDI
GYTIMATKGTAKYLRDNEIPVIEIDKLENEDYNIIKIMQKGKAQFVINTLSNDGLTQEDG
YLIRRNAVENSVACLTSLDTASAVVQVLESIGFDIKSF
>EGEFANNL_02086 Carbamoyl-phosphate synthase small chain
MKRKLVLENGMEFIGEGFGSDQFTVGEVVFTTGMTGYQETMSDPSFHKQIIVFTYPLIGN
YGINPSDFESLNPFVGGVVVHEFAHTESHWQSQMNIDYFLKKQNIPGLSGIDTRALVKMI
RTKGSMKGKFCDLSEDTAQVAQKLQNTILEHHVPEVSTPRAYSAPGEGYRIVLIDYGMKK
SILKELCLRKCDVVVVPYNTNARSILELNPDGIMLSNGPGDPQELNDSIEIIKQISGKVP
IFGICLGHQLFAIAHGAKTYKMLFGHRGANHPVKELKTNRVHITSQNHGYAVEEDSLKNT
PLEITHRALNDGTIEGLCHKENYAFTVQYHPESSPGPNDNEYLFNQFMNLIRDFKNTH
>EGEFANNL_02087 Aspartate carbamoyltransferase
MQHFISLENLNIEVIRELIEDAISFKKRNAYPNLSNHYISNLFFENSTRTKLSFEMAEKK
TGMEIIYFDAESSSIKKGETLYDTVKTLNSIGVECFVIRHWEDRFYENLISKFDVPIINA
GDGCGDHPTQSLLDLITIQEEFGEFRDLNVVIVGDVVHSRVAHSDAKILQRLGANISFAT
PEFWRDSTMTMGRYTTIDEAIPKADVVMLLRNQNERHSQQYDEGNFLSLYGLTKERASNM
KAHSIIMHPAPINRGVEIDEDLIESPKSRIFTQMTNGVFARISVLNYVFNS
>EGEFANNL_02088 Lipoyl synthase
MENSLTTKPKWIRVKLPTGKNYKSLINIVDKYKLNTICQSGSCPNMGECWGEGTATFMIL
GNICTRSCGFCGVKTGRPSEIDWEEPEKVARSIKLMKIKHAVLTSVDRDDLKDMGSILWA
ETINAIRRICPETTMETLIPDFQGITKHLDRLINASPEVISHNMETVSRLTREVRIQAKY
SRSLDVLRYLKEQGQRRTKTGIMLGLGEKVSEVYETIKDIHDAKVDIITIGQYLQPSKKH
LPVKEYISLELFKEYEDFAKSLGNFRHVECGPLVRSSYHAEKHIH
>EGEFANNL_02089 Macrolide export protein MacA
MKKKILKISLIVIFIALLIFCISYIIKANSNKSEKFLTETPLIKTIEIKSIATGKINPKE
KIEIKPNISGIIKEIYVKEGDQVEVGQLIATIKVVPVVATVNSTMQSINSAKIQLSNQKR
IFEREKLLFTQGVISKQEYENAETQYKLAKQTLNQAEKEYDIATKGVASGLENLASIQIR
STTKGMILALPIEVGNQVIEANTFNAGTTIATIADINKMIFEGKVDESDAGMMKIGMPMN
IVIGALQDEKLQGNLSFIAPQGYDENGAVKYNIKADLKIPNGVLIRAGYSANAEIVLNER
KDVLSVREALVQFDEQNKPFVEILQPNGEYKKQDITLGLSDGLYVEVHGININDKIKIWN
ASEEDNK
>EGEFANNL_02090 ATP-dependent DNA helicase RecQ
MSLPNQVLEYYWGYKDFRYPQKEIILSILNNNDTVALLPTGAGKSICYQVPALLKEGVCI
IISPLLALIKDQVFQLKRRYIPSDFISSEQTADQHHIIYNKLKNNELKLLYISPERLLNK
QFLEIISDIKVSFIAIDEAHCISEWGNDFRPSYQQIHSFREFIGSHIPCIALTATATEKV
LSEIIIKLKLKDVEVFKKSYKRENLSLQVVKAEDKISQIVRILNKYRGSGIIYCRTRSET
KNLCSILRGKGYLVDFFHAGLSPSEKIKKQKNWTESDSLVLISTNAFGMGIDKENVRCII
HFSPPYSLENYYQEVGRAGRDGNLSHAFLLWNDYEFSNLSSFLLQTICSYNDYNKIIKYL
YTLYGIAPSETPEHIFDFDLNYFQKYTKIPSTRIIPILEFLNNSSIINWRYEPGDSIIQL
KFPIERLDYQSFGKDTWIFDEISRKITGVFSYQIKFNESKLANVLRISLEELRKFLTKYS
QSGDIFYVDGNKQKIQFLTARNDSDLLNEFWKKFNQIQNNKLLKYKELEFFIQNKKFCRM
RLILGYFGEKEKESCGKCDICLSKQTYNSLTNSENLFQFIKVSPRTRQDIYDEFYCHTSD
EIHDLLQELIGENKIKVLNYNTYCVNN
>EGEFANNL_02091 Uracil-DNA glycosylase
MDIKIEKSWKKVLDQEFEKPYFKSLIEFVKSEYKNHVCFPKGKDIFKAFELTPFNDVKVV
ILGQDPYHNFNQAMGLCFSVPEGTVYPPSLKNIITELKDDMGTVLKSGDLSYWANQGVFM
LNATLTVRAHIAGSHQKKGWEIFTDKVIEKISELKNNVVFILWGSYAQQKTSLINTDQHC
IIKSVHPSPLSAYRGFFGSKPFSNANKYLASKNLSPIQW
>EGEFANNL_02092 hypothetical protein
MKKIYTLPIILLSITSYAQLEEVQEETSSQQGYILKQEGSVIDVEKKEAIMTQQQILLAE
NSGKKAENPANPTIFRTTDANGNELWVLSNGVVVRNVTQESNYSKEPMSVLRSKEGVKVK
NVPISKPSEVYEENITTTTKNIELEEVVIPKLESQQENIVTQDNISNKQESYVTEEAAVP
NKQEKKESFTDNKDIKLEKSTNSDISSQTNITKPVDQTNASELKSTINLSETTAVSQPGD
IIITAEDLKDQDISELFSPDVNSMSPKDRKQYEKNQKKIKKQLEKDLKKESSYK
>EGEFANNL_02093 Lipopolysaccharide export system protein LptC
MFKISRKLSFIILIIYLLFYFNSCTDDESKKLEKKNLEFPSRQILNANLTLHDSVYIKVK
LKSPLIEEYEFTKTPFTLFPKGLKVEFIERDKDEPIYLMANYAKIIESEGWYEAKNNVVV
INSDKDTLKTNHLFWDKKLRKIYSDDTVKIYRADGVTTNISSNGIEATEDFKNFKLKNNK
GTLPYNNEVDKE
>EGEFANNL_02094 Pyruvate kinase
MNLYNKKTKIVATIGPASEDKETLINMFKSGVNVIRVNFSHAEESIAEKWVTLVREINEE
HGFSVALLADLQGPKLRLGIVKPGVVVNQGDIITFTNEKIEGDAQQVYMSYNEFAKDVKV
GERILLDDGKLIFEVIETNLIDKVKARVIQGGPLLSKKGVNLPNTKISLPALTEKDIKDA
EIAIKLDFDWIALSFVRHEVDVNDLKKLIQKHCNHKIPIIAKIEKPEAVKNIEEIVSAVD
GIMVARGDLGIEIPMEQVPLIQKNLVKRCKIACKPVIIATQMMESMIDGLTPTRAEVNDV
ANSVLDGADAVMLSGETSVGKHPVEVIQNMSKIINSVEEDECIRIPQHKPVQGSERYITD
TICYNAADMVGQVNAKAIITLTQSGYTAFQISSHRPLADIIVFTSNKRIITMLNLLWGVQ
AFLYEGLKSTDETVVEVNRMVKERGIIKSKDYVINLNAMPSFGNGLTNTLRLTQIS
>EGEFANNL_02095 hypothetical protein
MKLYSLTWEDDDPIFDFKLLGIKTNVSKDYRFVFLLNEFFSFSFKRIRDHKIYKDEHEYS
FSAYKFYDIKTKQNIELISNASYPLFKEEKNELFDHSEIIEILVPEYKFFNYFLKYDFLL
SEEFYVTLKKFNFISNYEVVDLNRIKKNNLENLILIEE
>EGEFANNL_02096 Ribonuclease 3
MNFWKKNIFHSIISKKKNFSIQEKTFQKQIEVLIGYKPISIEIFHECFTHTSLNSDDKNF
ERLEFLGDSIISTVVSDFLFHKAPNKDEGYLTQMRSKMVNRSALNLLGKKLNLSTYLSKR
KNTNLGKNIEGNLYESLVGAIYVDKGFIFSKKFIERTLINNDDLINLENKITSYKSYILE
WAQKNKFNITFETSQEDNAENILIFDSVIKLNDQIISKGRASSKKSAEEIASKRAYYKLS
NKIK
>EGEFANNL_02097 3-oxoacyl-[acyl-carrier-protein] synthase 2
MALKRVVVTGLGAITPLGNTFQEYWEALLNGVSGAGPITLFDATNFKTRFACEVKNYNPE
DYFGKKDIRKYDRCAQLGIISSREAIEDSRLLEYSDLDKAKVGVIWGSGIGGLFTFQHEV
SEFALGNGMPRFNPFFIPKMIADMTPGLISMEYRFMGPNYATVSACASSSNAIIDSLMLI
RLGKADVIVTGGSEAAICESGIGGFNALHAMSTRNEDPSTASRPFDKDRDGFVLGEGAGT
LVLEEYEHAIRRGATIYAELVAGGLSADAYHMTAPHPEGLGAYNVMKNALDDANISITDI
DHINLHGTSTPLGDLAEIKAIKKLFGEHSYNIQINSTKSMTGHLLGGAGAIEALACVGAI
RNDIVPPTINHFTDDEEIDEKLDLTFNKAKKKNITYALSNTFGFGGHNACVIFKKI
>EGEFANNL_02098 Acyl carrier protein
MSDITSRVKAIIVDKLGVDESEVTPEASFTNDLGADSLDTVELIMEFEKEFDIQIPDDQA
EKISTVGQAISYIEEVNKQ
>EGEFANNL_02099 hypothetical protein
MVFFYKNRNSFFILLGLSIFYVFPLILANVYFIDDMSRVNKFQYWSYIGRPFADVLYTII
SLGAPVDLFPLTTILSCIFITIALMILIKRMNMKFNIISYLIVLPVLCSPLFLENLSYRF
DSVFMAFSILLAILSSEIKGKKYIVIKILMVFVALGMYQASINIYFSVCFLFYISDYKNS
HPNSAKNLLQSILIAIIAYILYYVLVIKLYLNGGENFYIKGMKENIPFNLDGLILFFKNI
ITILANFYFHFSFLYLIVLIVLFLISYIFIFKNIRLNKNKLNKIIFILSPLAIALCVPGI
LLFMKNIAYMPRMLIATSIFIVFLFYYINAFLKGYWKFLLVLPYLYFFSLSYSYGASLSI
MKTYNEYLFTQISYDLNNLNIKDDDNVYLLNGAPMPSQVIQFTEKNKFMEAPFILNSFGN
DAGANIMTAGLFEFHNLNINIPSIFEGQKYIDKVKDNPTIKKNLYNIYKENNDYVIWFNK
KELKTNQ
>EGEFANNL_02100 hypothetical protein
MISTLPLKNILFIDLETVPEHENWNELSDRTKKLWEVKTQFQRKEEISAEEYYYDRAGIL
SEFGKIICLSCGLITDDNKIKIKSFYGSNEKNILNSFNEMLKAKYFKSTLLLCAHNGKEF
DFPFIARRMLIHQIKLPNILKIQGKKPWEIPHLDTMELWKFGDYKHYTSLDLLAHIFNLP
SPKNEMDGSEVSNVFYKEKNIDKIKNYCENDVVTLINIFRKMRYETPLNRE
>EGEFANNL_02101 hypothetical protein
MHNSYLLTLLKYLKMTISKARESTDIIERLYITMRHLFNRGGFKPSGTSGIELRNYLLKL
NPEIYGTLAEPEKVELNGLIYVLDRLPKGIEECSYIYLSSNEGLDKSTFEPIYPKKRRRT
CYRIDDHQMNIEVLLGRSEIYDILTHLTFLYNEADKIRKKTHDFKGKAGRIWKSIEKIAL
NQEPLERIEREIVLAHLSTILGRSFNEIVQTYNSFSENNDPDRFIKVIYHLGNVSKNDFN
NTRKREIFFSSILKERVGHHLFGERWALNLKKTLISNNFINKKIHIISSNMHSVCNMLYA
HEALNKKYDLSNELKLYEELSKNFNLVSKVNEHAKEHGMIYIHDDSGSNIDVQIFDLSKI
NLDNSPFKNLKNINSDDLLIVFDYAFGEQAFEIMDELLRPLEINNEKKNLNVESISILGK
AGILVGNKGDIMIPNAHIFEGTADNYPLHNELSISDFDGYNVQTYKGAMITVLGTSLQNK
DVLTYFMDTSWKAIGLEMEGAHYQKAIQVASKIRNHINKNVKLRYAYYASDNPLETGSTL
ASGGLGLTGVKPTYLITQKILEQIFSDKNQ
>EGEFANNL_02102 Antiholin-like protein LrgA
MKLLSQLGIILFFFFIGEFIVFILKLKIPGSIVGMLLLLISLQLKIIKVESIKEVSTFFI
NNMLILFIPLGVGLAAQWDLISKEWLTIIVSIFISTFIVLSVVALIINKKK
>EGEFANNL_02103 Inner membrane protein YohK
MNELLNTPLFHILITLIVFGLSNLLYNQFKYKILHPGIISILSLIIYLKISETSFENYNK
NTYLISFWLGPSVVALGLPLYLYIKHLKGSYLRVLLAMLAGSILGIVSVVIISKLLGASD
VIAYSLSPKSVTTPIAMEISKSLGGIPSLTIAIVFITGFTGALFGWSFLQFLGIKDQKAI
GIAMGTAAHAIGTAEVVKKGQEFGAYGAIGIALNGIFTAIFAPLIIPPLLHLLNFL
>EGEFANNL_02104 Ribonuclease R
MTNKKKRIPAKHQEKLRDLKKEILTLFTKNPNKQYNYKQVASSLDKKNPRQRELVIQALQ
QLTSEKQLLEIKLGKYQINFKEDTLEGKIDFNSSGNAYLIVEGLEKDLFIPKGKTGKALQ
NDLVKVIVHQFKNKKSEAQVIEVVERYKNQFVGKLEYTKGKNFGFVIVNKNAIHTDIFVS
KDQLNHAENGQIVLVELLSWDEKSESPSGKIIDVLGEPGENETEMHAILADYGLPYDFPE
EIEEEAKKLDLSISEVEIAKRRDMRKITTFTIDPADAKDFDDALSIQKLDNGNWEIGIHI
ADVSHYVKPGSPLDQEAYSRATSVYLVDRVVPMLPEILSNNVCSLRPHEDKYTFSAVFEL
DENADIKHQWFGRTATHSDRRFSYEEAQQIIEGKEGDFKEELLVLNKLAKTLREKRLKAG
AISFDKVEVKFNLDEDKNPTGVFFKVSKDSNHLIEEFMLLANKKVSEFVSLRKGKPTDRT
FIYRIHDDPDPTKLLTFKQFVNTLGYDINITEKKQTYLSINQLLMEVKGKGEANMIETLA
VRTMSKAKYSTDNVGHYGLAFDYYSHFTSPIRRYPDIIAHRLLQDFLDKKPSAKKEEIEG
MAKHSSEMEKLAADAERDSIKYMQVKFMEQHVGECFEGVISGTTDFGIYVEIREFGAEGL
IRLRDIRDDDYRYDEKTYSITGQRTGNQYRLGDTILVKVIKANLERKQLDFELVQE
>EGEFANNL_02105 Phosphoethanolamine transferase EptA
MLKNSLKISNFALLVSLLNFLLYHLPFFKFVFKNIDYKSLSGIILIASLVVVMLVANYFV
FYLLTFLSRYIGKTLIILTFIINSIAVYFILTYGVIIDESMIGNIFNTNYEESSSFFSIK
LLLFILILGILPSIYIARIKILKATTKKFLVRSSLSLLFLIILSFANASNWLWIDKNSKT
LGGLAMPWSYSVNIPLYFIHKNQENQKEILLPEAKIKDNEKSIFVLVIGESARRENFSLY
GYTKNTNPLLSKIENIHPFKANSCGTYTTAGVKCILEHINSNKLYEILPNYLYRNNVEVI
WRSTNWGQPPLHIKNYLDKDALRTTCEGENCQYDEILLNGLKEQILASDKNKILVVLHTS
TSHGPTYSKKYPSKFEVFKPVCNSVELGKCSQEELINAYDNTIVYTDYLLASVINDLKDL
KDYHSTLLFVSDHGESLGEKNLYMHGVPMSIAPKEQYEIPFIVWTSDNYRQLKPNDMLSQ
NHVFHSVLNFLNIESPIYNEQMNIFK
>EGEFANNL_02106 hypothetical protein
MNLTIIKNFSSLNSKILFIPIVLLLGMTVFFISENLLIDNYYSFIQKDYFQWINKELSNY
PNLIYNLTQFGDVLIILSFLAVFIVYAPELWKGLIPSILISGILTPLFKNCFKVPRPAAI
YDLSDFTIIGKTLKGYNSFPSGHSTTIFTVLTVIMIAFMPQRTINKIVWCVGVLLMAYIL
AFTRVGVGAHYPLDVISGSILGFICGILGILSYQKYKFWHWINNKKYYPIFISLFLISII
ILGVKIYHTQLLIFYISIVSLLISLYTIINAYVKK
>EGEFANNL_02107 putative succinyl-diaminopimelate desuccinylase
MEKEKIDWLKDILKIDSTLDNEKEVADYIEKLFKEEGIETEQIEYSEGRNQLIATLKGKK
SDKILGFTGHMDVVPVGEQEWEHKPFDADEKDGKIYACGASDMKGGLMAAVVAMIELKRN
NVELNGDIQLLATVGEETSAIGAGQLVEKGYAKDLDALIIGEPTRNYVVIAHKGAIWLRL
KTKGKTAHGSAPSEGINAVEHMLNFIEAFNKKFNFSQYKDDMVGPSTSTINVFKGGNATN
VIPDQCIVEIDIRTIESQDHQEFLKELEQLNKEMSEKIKNFCLEIEVINDLDPVKTDENT
EIVKLVTSIVSKKKGEEVKPLGVSGYTDGSQFVKAQKNLPIIVLGPGEPIMAHQPDEYIE
IENYLEGIEIYKEIAKEFLK
>EGEFANNL_02108 Tryptophan synthase alpha chain
MNRINQLFKNKPKNILSIYFTAGYPNLDSTVEIIKKLESNGIDLIEIGIPFSDPMADGPT
IQASGTQALKNGMTLKILFEQLENIRKEANLPLIMMGYLNPIMQYGFGNFCKKCKEIGLD
GAIIPDLPFDDYIKEYKPIADQYDIKIIMLITPETSEERIRLIDEHTDGFIYMVSSASTT
GAQKSFDEKKQEYFQKINAMNLKNPRLIGFGISNKETLDAAQKNSNGAIIGSKFISLLED
TNSIDKAIQKLINGLKE
>EGEFANNL_02109 N-(5'-phosphoribosyl)anthranilate isomerase
MKHPENIQQLIQLPIDFMGLIFYSKSPRYVVELNPKHLSNLPSNIKKVGVFVNAELQEVE
NRVKEYFLDYVQLHGKETVEYIKELRIKIPNLRIIKAFSIAEIEDIEKTEEYEEVCDYLL
FDTKTPQHGGSGKKFDWTILNNYKGETPFFLSGGISLEDTEEIQKIQHKKLYALDLNSKF
ELKPGLKDIKQLDKFLNKIKRYNQ
>EGEFANNL_02110 Indole-3-glycerol phosphate synthase
MSTILDKIIANKKIEISKHKEEISLQELENKVKEVTQKFSFKESLQKSSTGIISEFKRRS
PSKDWIFKEAKIEEVIPYYSKGGASAISVLTDFDFFGGNLNDLKEASLLTNTPLLRKDFM
VDEYQIYQAKLYGASAILLIAAALTIEETKNLAKKAKELGLDVLLEIHNEQELDHINEYV
DVVGVNNRNLKTFVTDVQVSFQLVEKIPNEFVKISESGISSSQTVKELQQVGYQGFLMGE
NFMKTSNPGEALEQFIKELR
>EGEFANNL_02111 Anthranilate phosphoribosyltransferase
MIRNQSMKDILNRLFEHQYLNREEASRILTQMAEGIYNESQIAAFISVFLMRNISIEEFL
GFRDALLNLCKDVSPLQKYNTIDIVGTGGDNKNTFNISTLSSFVVASAGYKVAKHGNYGA
TSVSGASNVMEQHGVKFTSDLDRLERSLEEANIAYLHAPLFNDALKVVAPIRKSLGVRTF
FNMLGPVVNPIRPKRNVLGVFNLKMARLYYYIYQNMDCDYTIVHSLDGYDEISLTDKFKT
ISKLGEYLYSPEDLGFDFYKPMDLDGGQTAEEASRIFDNVLNNTATLAQKNVVIANSAFA
IQTVKPNLRLEDCLAQAKEALESGKTKKTFQKFLELNN
>EGEFANNL_02112 Anthranilate synthase component 2
MKILLFDNYDSFTYNLAYLVKDLGYAELDVIRNDKISISEIEKYDKIILSPGPGIPSESG
ILLPLIKEYASTKPILGICLGEQAIGEAFGAQLKNLEEVYHGVATQAKIIEKDYIFEGLN
SSFEIGRYHSWIVSQEDFPHENMIITAVDENNQIMALKHRLYDVHGLQFHPESILTPHGK
IMIKNFLEG
>EGEFANNL_02113 Streptothricin hydrolase
MKALIVIDVQKDYFENGNFPLEGALQASEQTKKILENFRSLHLPVIHIQHISLQEEAIFF
KPYTEGAEIHPNVKPIDGEIVITKYSPNSFIKTNLQKHLQKYEVNELVICGMMTHMCVDA
TVRAAKDFGYQCTLIEDACATRELEFSGKKATAQEVQTAFLSALSYYYAEIKTTEEYLQA
NNK
>EGEFANNL_02114 Anthranilate synthase component 1
MNIRLITKKLLADLQTPVGLYLKIRDLFPESALLESSDFHGGEDSSSFIALEPLAKFKVQ
DHEVITEINGVENKQKLEISLPIAFDNFMKSFKIEGDNPTNVNGFFGYTSYDSIRYFETV
QPKNQKLNNADIPEFYYIFYRFIFVINHLKNELIIVENIPEGENSKMEQLEALLQNNNYA
SYNFKQIGDENSFTTGEEYLDAVKKGIAHCKRGDVFQIVLSRCFSQAFAGDDFKVYRALR
SVNPSPYLFYFDFGVFRIFGSSPETHCKITQGHAYIDPIAGTYKRTGEDEKDKILSEKLL
KDEKENAEHVMLVDLARNDLSRNCSQVRVDFYKNVQYFSHVIHLVSRVSGKVEEGKNNIA
VFADTFPAGTLSGAPKVRAMQLIYDIEKHTRGAYGGCIGYIGINGDLNQAITIRSFMSRN
NTLYYQAGAGVVSKSNPEEELQEVNNKLGALKRAVNLAETLKN
>EGEFANNL_02115 Tryptophan synthase beta chain
MQKYNVDQKGFYGEFGGAYIPEILYDNVEELKKNYLQFLESPDFKKEYYDLLKDYVGRPS
PLYLAKRLSKKYGCKIYLKREDLNHTGAHKINNTIGQILLAKKMGKTRIIAETGAGQHGV
ATATVCALMNMECIVYMGATDVERQRLNVEKMHMLGATVVPVESGNKTLKDATNEAIRDW
CSNPSNTYYIIGSTVGPHPYPDMVARLQSVISEEIKKQLLEKEGREAPDYLIACIGGGSN
AAGTIYHYLDDEKVNIILAEAAGKGVNSGESAATIHLGKLGIVHGSKTLLMQTDDGQIQE
PYSISAGLDYPGIGPMHAHLATVGRSEVLAVTDEEAMKAAFELTRMEGIIPAIESAHALG
VLEQKKFKPEDIVVLCLSGRGDKDMETYVSYREKN
>EGEFANNL_02116 Folylpolyglutamate synthase
MQTYDEILEWLYSQVSNFQNVGQSAYKPGFDNILKLCEILDNPHKKIKTIHIAGTNGKGS
TSNMVASILKEAGYSVGLFTSPHLKNFTERIRVNGEECENDYVFNFLTNIRTYFTKDFNP
SFFELTTAMAFDYFTKKKVDIAVIEVGLGGRLDSTNIISPQVCAITSISLDHTELLGDTL
EKIAWEKAGIIKTKIPVVIGEEKENIKNYLIDICKERNAPYIDATSINKEYISDITGIYQ
SQNKRTVLGIIHFLNEQGCSIKEEHIKNGFLSVKKNMHLRGRWDILQEKNPLIICDTAHN
EDGFKKVTDQLSKMSFNELHMVLGFVKGKNLDKVFPLLPENANYYFVKPSIARGLPPNEY
EEKIKKFFSKYKILSSAHDGLNYSKSIANENDLIFIGGSNFIISEII
>EGEFANNL_02119 30S ribosomal protein S20
MANHKSALKRVRQAQVKRLRNRYYHKSARTAIKELRAETEKSVASEKLPTVFSKIDKLAK
RNIIHKNKASNLKSKLNKFVNTLA
>EGEFANNL_02121 Copper-containing nitrite reductase
MLKKIYRCFIGLFMITNCILCHKNNPGSSLSNTLKSEEIETQGSVEEAEITSPPNVPKPT
GNRAAKKIIVRLETIETVKELAHGVTYDFWTFDGTVPGSFVRAKVGDEIELHLKNNENST
FPHNIDLHAVNGPGGGAAATLVPPGKEATFTFKALNPGLYVYHCATAPVGMHIANGMYGL
ILIEPEEGLPKVDKEFYIMQGDFYTSGSFGEKGFQKFDINKAIAEHPDYVVFNGHTNSLI
GENELKVNVGETVRIFVGNGGPNLTSSFHIIGEIFDKVYMEGGNQINENVQTTLIPPGGS
AIVEFKATVPGEYVIVDHAIFRAFNKGALGKIKVSGKENPKVFSAN
>EGEFANNL_02122 Serine/threonine-protein kinase pkn1
MNIQGSSILIVFFIIISCFPNSNHESLKENKQLVPNKTFSSKKMKIIEEGYLHSFFSKDS
TNKIYIQSFLLDEAPVTLKEYLRFVKENPAWARSRVIELYADKDYLKNWKSDFELPEHIS
PEAPVTYVSWFAAKAYAKSLDQRLPTTDEWEYVSSADEYTANATDKEEFTNYILASYQKK
FRNKLPVKQNHPNFYGIYDLYGVVWEWTEDFNSVMISGESRNDNTINNENLFCAGAALTT
SDLKNYAAFIRYAMRGGTKANYCIQNMGFRCAKNL
>EGEFANNL_02123 SCO1 protein 
MKKIIYVILSLLTFFSCTKENNLAILPNSIYNLTSKWENQNGDTIALSDLKGKVVVLTMI
YTSCKTACPRLTAEMREIYKNVNIKNSQDIRYVLVSIDPENDNPQIMMEYLSNNKFNDIE
WLFLRSDEESTKELANTLSVKYKQIDPVEFSHSNIISVLSKQGELVHQKNGLNTDIDPIV
MKIKNELKK
>EGEFANNL_02124 Cytochrome c-551
MKKVLIVIFNVLLMVSCSNDEESKILTSSSSQVNHEVKAVENTPPEHKGKLAIENSDCLS
CHKENAKLIGPSFKEIADRYSNKDIDVLSDRIINGGKGNWGDIPMQEHPNLSKEEAKIMI
EYILSLKKI
>EGEFANNL_02125 Uridylate kinase
MKYKRILLKLSGEALMGDQQYGIDPSILQNYSQQIKELVDMRVEVAIVIGGGNIFRGVSG
AATGIDRVQGDYMGMLATVINGMALQSALESAGVKTRLQTAIRMEQVAEPFIKRKADRHL
EKGRVVIFGAGTGNPYFTTDTAATLKAIEINAEVILKGTRVDGIYNSDPEKDKNAVKFNS
ISFEEVYKKGLKIMDMTAFTLSQENKLPIIVFDMNKKGNLKKIIEGEDVGTLVTI
>EGEFANNL_02126 Ribosome-recycling factor
MEELSLIVDTTKESMESAINHLQISFNKIRAGRANPAMLQSIMVEYYGAPTPLSQVANIS
VPDGMTLSIQPWEKSVLGAIEKAIFQSNLGFTPNNNGETIIINIPPLTEERRRDLVKQAK
AETENSKIGIRKARQEANADIKKIENLSEDLKKDGEDQIQTLTDNYIKIAEDYLSQKEKE
IMTV
>EGEFANNL_02127 Prephenate dehydrogenase
MSKNITIIGLGLIGGSIALDLKKVGFAKQITGVDQSKEHENEALELGITDKIESLENAVM
FADIVILATPVNVSIALLPKILDLINPNTVVMDVGSTKTSIIEAIKDHPKRKSFVPTHPM
AGTEYSGPSAAFHGLFKDRVGIICNSEESSPTAVQLISELYFHLGSRLILMNAESHDEHV
GYVSHLSHAISYALAVTVLEKEQNDAAIFNLAAGGFSSTARLAKSSVDMWLPIFEENSKY
VLPILDLYLENLNKFKSYLENKDSQKLFDFIKTANAIKDKLQK
>EGEFANNL_02128 Murein DD-endopeptidase MepS/Murein LD-carboxypeptidase
MRYTSFFNILTIIFGLTFITSCVSYETTRSTKNRKPSSSHIYTSNQSNKNSSALPKVVNN
KKKETKGSILSSKNSSASNKEVKTVIKEAEKYKGTPYKFGGNTSSGIDCSGLVCNAYQKI
DVKLPRRSIDMSKEGKEIRISNVKEGDLIFFATGGGAINHVGIVQNVSKSGEIFFIHAST
SKGVMISSLEEKYWKGKVKKIRRII
>EGEFANNL_02129 Ribonuclease HI
MIEVFTDGASSGNPGKGGYGILMRLKGTSYEKTFSEGFRLTTNNRMELLAVIVALENITK
PNQQVIIYSDSKYVVDAINLKWIFGWEKKSFSKVKNSDLWLRFLKVYRKHKVNFIWVKGH
NGHPENERVDFLATSAIKKDHLKIDSEYERTTHSEGLL
>EGEFANNL_02130 Putative HAD-hydrolase YfnB
MLKEIKHLFFDLDNTLWDTDRNSKLTLQKMYHEKNIEEKYSLNFSDFYRNYYHRNENLWA
LYRENKITKQNILDRRFTLTFKEYGIEDRDIQDYFNENFLKKMTENNYLIDGAEETLKYL
KEKNYSLHIVSNGFKEQTYRKVNDTAIKNFVSTITSGEEINKRKPAPEVFHLGLSKANAK
AEESVFIGDDWESDIIGSSKIGMQAIYFDYNHKNENLNKGFQVIQKLNELISIL
>EGEFANNL_02131 1,4-dihydroxy-2-naphthoate octaprenyltransferase
MKAWIEAARPRTLPLSLSGIILGGLLAKWKGDFNGIIFILSCSTTILFQVLSNFANDYGD
GVKGTDNEHRIGPQRAIQSGAISRKTMFRGIIITTILSLISAIALLWYAFIPGDWKDFFI
FIGLGIACILAAIFYTMGKKPYGYMGLGDLFVFIFFGWVAVLGSEYLYTHTLNWSILLPA
SAVGLFSVAVLNLNNMRDIESDRMSGKNTFALRIGFQNAKYYQLLLMNLPFILCLVFLLI
NKETISIQLENLESLKPFIFFLLFIPTTIIRRKILYTKEPQKLDLYMKPVAFIALLFSVL
FGMGLSL
>EGEFANNL_02132 hypothetical protein
MYIYAESFHVEFSIENDWIHWVKENFIAELHQTNLFTKAIFCKVLSHQDESGNTYSIQCF
TNEKENLSLFQTQYSDRIHQLIFKKFGAKVLFFTSEIELLETFEF
>EGEFANNL_02133 hypothetical protein
MFNTRPVLAPKQKALQINLDKDIYGTFSEIGAGQETVRYFFRVGAASNTIAKAISAYDKD
FSDALYGKEPNNRYVSQSRLLKILDYEIKVIEDRISRESCPGRKFFSYANTVTTINFDKT
SKGHGWVGIRFQLNELEPYNEIILHVRFHENDAKLQQETLGILGVNLIYGAFYYAENPKV
IIESLYDELNTDQIEIDMINFSGPRYAYLDNRLMSLQLVKNGMTDAVVFEPNGKNVLAAD
ELYKKNILALRGSFRPVTNVNIDIYKRGLKMFMEEDQVTEQNTKILFEITLSNLRAKGEI
NERDFLDRADILGKLGHTVLISNFSEYYRLVDYFSRFTSEKIRISMGVNNLLDVFQEEYY
TNLSGGIMEAFGKLFKKQLKIYLYPYIDQETNKILTSDTLRVSEELKDLYKYFKKNNWIV
DMLEYDESYLKIYGKQILAQIIMGEPDWENQVPKEVAEMIKERGMFGFSRRLK
>EGEFANNL_02134 Phosphoribosyl 1,2-cyclic phosphate phosphodiesterase
MKPNYNSITFLGTGTSQGIPIIGCTDPVCLSNNPKDKRLRCSALINYNGLDILLDCGTDF
RTQMLRENKANVDAVLLTHEHTDHVGGLDDLRPINFIKKQDIPIYGLNRTLDDIKIRYSY
AFSKNKYPGAPGFQLFPVKDVFNIKNIKITPIHVLHGKLPILGYKIGNLSYITDASFIDE
KEMDKIFNSEILVLNSLRLEEHHSHFNLDQALQVIDKVKPKKSYLTHISYQLGFHEEIEK
NLPSNVFLAYDGLELNF
>EGEFANNL_02135 Phosphate acetyltransferase
MNRSVYVTTTSTNSGKSLVSLGIMQMVIRRTPNVAYFRPIIDNLDEGAKDNHIATMISYF
NLDQNYDEAYAFTKNEIIDYQNNCKLDDAYDLIIQKYKNLESKFDFVLIDGTDLSSESNS
LDYDLNVVIAKSLNIPVVLVIKDSFKSTHDLCKNIRLEVNNLLSKDNKIISVIVNKTSKS
IEDITSEYKKTVLNNNSIVFSAIPKDQYLGFPTLKEVADSLRAKVLYGNENLDRPIKKFI
VGGMLLSNFMNHVEEDCVAVIPGDRADLVAGVLLSNLSNFKRVSGLILTAGISLDPMIEK
LIGNSNLNIPTMVVEAGTFETASATANIRSRIYPEATAKIKRNLDLFEEYVNISELDKQI
SSFKIEGITPRMFLYNLFKSAKQAQKHIVLPEGGDDRILQAASMLAEDEIVKVTILGKNE
DIKQRANQLGLSWNDNYISVLDNTVSDKIEDYAQTLFELRKSKGMEFAQAKDLILDPSYF
GTMMVYKGDADGMVSGAQNTTAHTIRPALQFVKTKPGIKTVSSVFFMLLKDHVLVYGDCA
VVPSPTSEQLADIAISSAQTAKAFGIEPKVAMLSYSSGNSGSGEEVDKVRLATELVKKAE
PNLLIEGPIQYDAAVVPSVGNSKMPGSLVAGQANVLIFPDLNTGNNTYKAVQRESGGLAL
GPVLQGLKKPINDLSRGAKIEDIYNTVVITAIQAANNF
>EGEFANNL_02136 Elongation factor Ts
MSYSPKAADVAKLRNATGAGMMDSKKALVEAEGDFDKAVELLRKKGQKVAANRADRENLE
GAAIAAVNSDNTKAAIIKLSCETDFVAKNEDFVKLATEFANLALNFSNKEDLLASDFHGI
PVSEKLIEQTGVIGEKIEISEFKIIEAPFVGAYIHAGNKIAAAVGLSKVIDNAAEVAKNV
SMQVAAMNPIALDESKVDSSVIEKELEIAKDQLRQEGKPENMLENIAKGKLNKFFKDNTL
VKQDYIMGEKISVEDYVKSIDPEVKITEFIRI
>EGEFANNL_02137 30S ribosomal protein S2
MFAQTAERKLKENMAKVDVKQLLDAGVHFGHLTRKWNPQMAPYIFMEKNGIHIIDLHKTS
VKLDEASRALEKIATSGRKILFVATKKQAKDIVAKHAEAVNMPYITERWPGGMLTNFVTI
RKAVKKMNSIDRMKKDGTFETLSKKEKLQIDRLRAKLEKNLGSIADMTRLPSALFVVDIL
REHIAVTEAKKLGIPVFAIVDTNSNPQLVDFPIPGNDDASKSVDLILETVTNSIKDGLSV
RKAEKVKAKEENSEDSDDDFIVEEEVVLENTEENTKED
>EGEFANNL_02138 30S ribosomal protein S9
MAVTHKIGRRKTSVARIYLTEGNGEILINGKDYKTYFPTEVLQYKVLQPFQLTETLNQYN
VKVNVYGGGVTGQVEAVRLAISRALVSIDAENRAHLKPEGLLTRDPRMVERKKFGQKKAR
KRFQFSKR
>EGEFANNL_02139 50S ribosomal protein L13
MNTLSYKTISANKETSNKEWLLVDAEGQKLGRLASKLAKILRGKHKTNFTPHADCGDNVI
VVNAEKVILSGAKAEQKEYVRHTGYPGGQKFSSVDDVKEKDPKRILEYAVKGMLPKNKLG
RAVLKNLYLYEGVEHKQEAQKPKTLDINAFI
>EGEFANNL_02140 DNA repair protein RecO
MIESTKALILSHLKYSDNSLIIKCFTDSFGFKTFILKGAFSKGKKKNNKVFLLNEVEISF
YKKLNNNSSTLELIKDMHQGYVFQSLHTNVVKSSMITFIGEILNQVLKNEDAYNLSLYFF
LKNKLIELDNRKASFADFHLYFLLELTKYLGITPLAVNSNFPYFNLREGIFSLKSHNLSK
SENGNLWNQLLTYDFNNEINCFNSSQRKMMIEEIISYYEFHIDNFKKPISLEILKEIFN
>EGEFANNL_02141 tRNA-specific 2-thiouridylase MnmA
MKVVVGLSGGVDSSVAAYLLKQQGHEVIGLFMRNWNDAEYTLEDECPWIEDSNDALLVSQ
KLDIPYQVIDLSAIYKEKIVDYMFYEYENGRTPNPDVLCNREIKFDIFLKAALSLGADKV
ATGHYARIDSFQKGKETIYRLLEGKDKNKDQSYFLCQLNQYQLSKSLLPLGGLTKPEVRE
IARSLKLITAEKKDSQGLCFIGKVSLPDFLQQQLKPQKGKIIEISSEFKGFKKLKNSIPF
NSKKEELIHLSKSITYNEQDGKIIGEHNGAHFYTIGQRKGLGIGGHVEPCFVIDTNVRNN
IIFVGEGKNHPGLFKRALFIKENESHWVREDLKLKIGDSLEAQVRIRYRQALQMAKIYQY
EEGIFIEFNQAQSAISRGQFAAWYINDELVGSGVIS
>EGEFANNL_02142 hypothetical protein
MNNMLTIILDSKGGLMEQIGGFAPIVLLFIVFYFFFIRPQTKRQKQEKTFQQEIGKGTRV
VTTSGIHGRILEVTDDGVVIETMAGKIKFEKSAISRELTMARYPENAPEKK
>EGEFANNL_02143 hypothetical protein
MKKIILYSTIISLSFINCSKKDTENSSDKNLNAIDQHQNPVVDTSETEIKFEEEMYDFKD
IKKGENATHIFSFTNVGSKPLIITEVKPACGCTTPEYTNTPVAPGQKGSITVTFNSSNFE
GPVKKNVIVSGNFEKKDLQFQANVK
>EGEFANNL_02144 N utilization substance protein B 
MLGRRQLREKILQALYAYNIGGNDLSFVEQKMFQAIDEIYHLYIYELNLLLAVRDYAQEV
IEKKRNKRFATEEEKNPNLKFVNNKIFQIIENCKARKELSDKHSELLWYLDTNYPAMIFK
KFQNSTAYLDYMKDETLDFEKDKKIILKLFFNFIADNPTLYEWFEEIKLFWADDIHVANN
MTLKTLKSLEENKPLNNLIQVLKPDDSIPFAKNLLRTTISYYPECMNLIKERSNNWELDR
IAEIDKIILSMGFTELNHSHQIPAKVVINECIELAKVYSSNKSNIFINGILDKYARDINK
V
>EGEFANNL_02145 putative protein-export membrane protein SecG
MVIFSIIMIFIIIACVLMVCVVLLQNPKGGGLSSTFGGGGTQMFGVQKTNDFMEKATWTL
ASVIVILTILASVLIAKPKVYPTPSNSNLPVEEKAIQQEPINASSETSSQTPATNSAPAK
>EGEFANNL_02146 hypothetical protein
MNNRIIQLLEDSSKIKFSDKIIIEQEYEKHPSVASFKMLYLKWKLLYHRENLDQSIQEAA
IYISNRELIKQMVDETKFQNEDNIHIEPSKELEENIVDTMTNQDKDISLEHEEATHAHQQ
SRDEQQNHLTINDKVNENIEIGQSDISNYSYIKQLGLSHLFDTTDKEEISSKTQPTKNDE
VVENENKVFVDKDQKEPIKEIKQEKLTFNQWLSLSQKGTKKTEKQEEIIHKFIENNPKIT
PPKKADKNIKSFEFKNEEIKDIANLMTITLAQLYVEQGKYDTAITAFKILSLKYPEKSSY
FVSEIKKIKKLKNIK
>EGEFANNL_02147 hypothetical protein
MTLKNKVTFLLVSLMLLSLSSCYSFTGSSLDPTIKTIQIKSFPNYSPYQSPDLSVDFTVA
LQNKFNRSTKLIETDDNPDIILEGEITNFTTVPVNIQSGSDQATQNRLTITVSVRYINKV
NPEKSFEKTFSDYQDYDSNQLLINVQNQLSQSINQRIVDQIFIAVVADW
>EGEFANNL_02148 Transcriptional regulatory protein ZraR
MDSLQIVKQRFGIIGNNLELNRALEKSMQVAPTDISVLVIGESGVGKEFIPKIIHNLSPR
KHKQYIAVNCGAIPEGTIDSELFGHEKGAFTGADKVRKGYFEVADGGTIFLDEVGELPLQ
TQVRLLRVLESGEFMKVGSSNIQKTNVRIVAATNVNLLSAIKKGDFREDLYYRLNTIQID
IPALRNRRDDIPLLLRKFAVDFSEKYRMPTIAFSDEAMAYIQQYYWPGNIRQLRNFAEQV
TVVETKRELTLEKVKEYLKDIQTNTSLVNISNTKDTTSDFSTEREILYKILFDMKKDLND
LKTLTLDLIKNKGEYHLTPNEQDLFHKVYKNYDSPKENESLVYYEENNIPALNAATISNY
HEDIDVYEDIPSNNSESLSLQKKEEELIKKALEKYNGKRKLAAQELGISERTLYRKIKQY
DIEE
>EGEFANNL_02149 tRNA-2-methylthio-N(6)-dimethylallyladenosine synthase
MEKEIIERRQGEVLLRQSANQNSKKLFLESYGCQMNFSDSEIVASILQQEGYDTTNQLEE
ADLILLNTCSIREKAEQTVRKRLSQFNSLKKRNPKLTIGVLGCMAERLKTKFLDEEHLVD
LVVGPDAYRDLPNLLQDTDDGRNAINVLLSKEETYADISPVRLGGNGVTAFVTITRGCDN
MCTFCVVPFTRGRERSRDPHSILKECEELAKNNYKEITLLGQNIDSYLWYGGGPKKDFNK
ASELQKATAINFAKLLDLVASSNPKIRIRFSTSNPQDMSEDVLHIMAKHKNICKYIHLPV
QSGSTTVLQRMNRQHTREEYIELVDKIRKIVPECAISHDMIAGFCGETEEEHKETLSLME
YANYDFGYMFSYSERPGTPAHKKMADDVPLETKKRRLAEIIELQQKLSLQRMKTYVGKSH
EVLIEGTSKKREDQWYGRISQNAVVVFPKKDNTKIGDFVKVKAIQCTSATLIGEQE
>EGEFANNL_02150 hypothetical protein
MNILLFDSNDIGESISVSLKLLLHLIRSTKFFIMDYFKVWIYQSNRILSSSEEEYIIKYL
SNFLNTWAAHGDALKSELKILDHKFMIVQVDESQAKASGCSIDKLNQCIRDIDNHLNLDL
LNRLLVSYQNTKDSQIQTVPLHIFKELIKNSEIDSQTLVYNLSVDNSLDFKTKFKLPLKD
SWASIYLK
>EGEFANNL_02151 hypothetical protein
MKTLILTILTTINIVFSLHGQTADQIINKHLEVTGGLTAWKTFNSVILNGEIVLGKEESY
KIKILQQRPNLNKTRMYIQDRGIILNGYNGKKAIKFNFTTNQIEEDLEYIPESFDSDLLE
YNSKGFQAILIGTEKIGNSDCFKVKLIKNTNTITYFFDKNTYQLIRESNPQEIKTYSDFT
KVSTLTFPMKTEVQIIGDNSNFTLVIDKVQVNPVISPKEFNF
>EGEFANNL_02152 3-deoxy-alpha-D-manno-octulosonate 8-oxidase
MKFRNFPMVPRVVYGRGSFDQTSEIIEEKRNKERPFIFLVDKVFKDKELSKNIPLQGKDI
IIYIDTTDEPKTKGIDEIRDNLKEEFGIVSGIIGIGGGSVMDAAKAVAIMMNNEGSSTQY
QGWDLVKNPAVYHVGIPTISGTGAEVSRTCILTGPERKLGINSDFTPFDQVILDPALTKG
VEKNQAFFTGMDCYIHCIESLTGTYLNAFSKSYGEKALDLCQKVYVQKSEWDDESDEDLM
MASWHGGMSIAYSQVGIAHAVSYGLSYLLGTHHGVGNCIVFDRLEKYYPEGVKEFKYMVE
KNKIEIPQGICKGLSDEQFDIMINVSYGMVPLWENALGKDWQKIMTKEKLRALYEEM
>EGEFANNL_02153 8-amino-3,8-dideoxy-manno-octulosonate cytidylyltransferase
MNLKIIAVIPARYAASRFPAKLMGMLGGKTVIRSTYENARETGLFHDVFVVTDSEIIYNE
ISRNGGKAIMSIQEHETGSDRIAEAVKDLDCDIVINIQGDEPFVKRDPLEKLIQVFRQDD
KNEVDVATLIREINDPKIIEDPNYVKVVKDKNNYALYFSRSVIPYPREKTLLANYYEHVG
VYAFRKQALLSFYELPMLQNETAEKIECIRYLEYGMRIKVIETTFVGVEIDTPEDLELAN
KIIKEQENKIF
>EGEFANNL_02154 Outer membrane porin F
MIFKFGKKDVPPPPPPPIVISDRDGDGIPDDQDRCPDTPGLAQFQGCPDTDGDGIPDIDD
RCPNEAGLAEFQGCPDTDGDGIPDVDDQCPTQYGPKENNGCPYTFEIVTEKLKNINFQFN
SAKLTEESLPLVKDAADMLNDRSFEGQKFYVDGYTDRVGSAAVNLRISKQRAQAVLDELV
KDGVAKDRLTARGFGKTNYLCTEADINTKRNDQGNIMYPDQAACDKANRRVVIISQETGK
KPVIEKEVKVKK
>EGEFANNL_02155 SsrA-binding protein
MKFENRVNILNRKARFNYELLDKYEAGLVLKGTEIKSLRLGKASIAESFCQFINDELYVI
NMTIDEYFFGNIYNHSIKRERKLLLNKKEINKLLRKTKESGLTIVPTRLYLNNKGLAKIE
IYLAKGKKIYDKRETIKERETQRNINRLVKKY
>EGEFANNL_02156 putative ABC transporter ATP-binding protein YbiT
MLTVSNLSLQFGKRVLFDEVNIKFTKGNCYGIIGANGAGKSTFLKILSGDIDPTTGHVTL
ETDKRMSVLEQDHFAYDSYSVLETVMRGNQKLFQIKEEMDALYAKPDFSDEDGVKAGELG
VIFEEMGGWNAEADAGTLLSNLGIKDDLHYKMMSELENVDKVRVLLAQALFGSPDVLILD
EPTNDLDIDTISWLEDFLAEYENTVIVVSHDRHFLDAVCTHTCDLDFSKLNLYTGNYSFW
YQASQLATRQRAQQNKKAEEKKKELQEFISRFSSNVAKAKQATARKKMLEKLNVEDIKPS
SRRYPAIIFEQEREAGDQILEVKGLEKTKDSELLFSNIDLNLKKGDKIAVLSKNSLAINE
FFQIISGEVDADKGTYTWGVTTKQSYLPLDNTKYFQTDDNLVDWLRQYVNTDEERHEEYI
RGFLGKMLFSGDEALKSCKVLSGGEKMRCMFSRMMLFRANVLMLDEPTNHLDLESITALN
NSLVNFKGTLLLSSHDHELVSTVCNRIIELTPKGIIDRYMTYDEYLNDPKVKELKAQYYS
>EGEFANNL_02157 NADH pyrophosphatase
MLNLNVKKQAFMKSSFQYCPNCKKPKLRIENESKITCSSCNFEYYHNVAGAVAVIIQNKD
KILFTVRNKNPQAGMLDLPGGFIDPKETAENACKRELNEELNISIDESKLKYLNSNPNTY
LYKEILYNTIDLFYLYRDDKLEITDFDSLELKGFVWKSLDEIKLEELAFESQKKSLSLII
KNK
>EGEFANNL_02158 Thiol peroxidase
MATVTLKGSEVHTSGDLPKVGDKAPDFTLVSSDLSEKKLSDFVGKKIVLNIFPSIDTGTC
AMSVRTFNKDASSLDNTVVLCISKDLPFAQSRFCAAEGLNGVINLSAFRSDFGKDYGLEF
TDGPLKGLLSRVVIVLDEAGKIIYQEQVSEISQEPNYEKAIASLK
>EGEFANNL_02159 Antilisterial bacteriocin subtilosin biosynthesis protein AlbA
MANPVRKYTYYDYTISLCPTCLKRIGAKIVFEKENVYMIKKCPEHGTHKVLLATDIDYYK
NIRNYNKASEMPLKFNTPIEYGCPYDCGLCTDHEQHSCLSIIEITDRCNLTCPTCYAMSS
PHYGNHRTVEEVEKMLNIMVENEGEPDVLQISGGEPTIHPEFFKILDIAKSKPIKHLMLN
TNGIRIAQDPGFAEKLATYMPDFEIYLQFDSFKPEVLQKMRGKDLTEVREKALKKLNELN
LSTTLVVTMEKGLNDDEAGKIIDFALKQKCVRGVTFQPVQIAGRNTPESLKNRLTLTEVR
SNILTQTDVFQPNDIIPVPCNPDALAMGYVLKLGGEKFPLTRYIDPKELLNTETQNTIIY
EQSEVMRDKLIKIFSTGISVDKAEGEFNQLLCCLPQISAPGLKYENLFRIIIMNFMDAYD
FDVRAVKKSCVHIVNKDGKIIPFENMNLFYRDEKKEYLKDLRKKASLTF
>EGEFANNL_02160 hypothetical protein
MNDLGIVFFYAMIAFFVLFIICGLITMVLSEIGNKAKQTWLKITLISLLLSGVSLLLTSI
LCGWLR
>EGEFANNL_02161 Prolipoprotein diacylglyceryl transferase
MFEFPVSTTIFGYPILYHTIFESLGIFLGSRYYWYLRKKQKVEKMDIISVLIILIGATFG
AYFGSHVLGAMENVPKWRETQYPVLFFLTNKTLVGGLLGGLIGVELAKKIVKEKRSTGDL
FVYPLLLAMIIGRLGCFSAGIYEETYGIPTSLPWGMDLGDHIYRHPVTLYEIIYLIAIWI
ILRQIQKKYELKSGDLFKLFMIFYLLFRFLLDFIKPGWRYFLGLGSIQIACLIGFLYYNR
FILNLKN
>EGEFANNL_02162 Aconitate hydratase A
MIFDIDMIKAVYSRYQSRVEKARKILGKPLTYTEKVLYSHLYSGEPQEAFSRGESYVDFA
PDRVAMQDATAQMALLQFMQAGKKNVAVPSTVHADHLVQARIGADKDLQEAINKNNEVYN
FLASVSNKYGIGFWKPGAGIIHQVLFENYAFPGGMMIGTDSHTPTAGGLGMIAIGVGGAD
AVDVMAGMPWELKFPKLIGIKLKGKLNGWTSAKDIILQVAGLLTVKGGTGCIVEYFGEGA
ESLSATGKGTICNMGAEIGATTSLFAYDKNAADYLIATGRSELVTLADNIKEDLRADQEV
YANPEQYFDQVIEIDLNILEPHLNGPFSPDIATPISKMKEVAEKNGWPLKVEVGLIGSCT
NSSYEDISRAASIAKQAVEKGIKSKAEYTVTPGSEMVRYTVERDGYLETFEKIGGKVFAN
ACGPCIGQWAREGADKQEKNTIVHSFNRNFAKRSDGNPNTYAFVGSPELITAIAIAGDLT
FDPRKDKLLNEKGEEVMLNAPEGNELPPKGFEVDDPGYQAPAQDGSEVKIEVEPTSERLQ
LLESFPAWDGKNITGARLLIKAYGKCTTDHISMAGPWLRFRGHLDNISNNTLIGAINAFN
MEANKVKNEISGEYLSVPDSARKYKSEGISTIIVGDNNYGEGSSREHAAMQPRHLGVRVV
LVKSFARIHETNLKKQGMLALTFVNPEDYDKIKEDDVINFLDLDQFSPGRSINIELIHSD
GGKDIITTNHTYNQGQIEWFKAGSALNLIKQNEAKNK
>EGEFANNL_02163 UDP-N-acetylglucosamine 4-epimerase
MKILITGSAGFIGYHLTKVLAIRKDEIFGLDSLNDYYDVNLKYGRLEDLGIHRSNISYNK
INKSSCLSNISFIQLNLEDKENLDLLFKQEQFDYVIHLAAQAGVRYSLVNPHAYIDSNII
GFINILECCRNYKIKHLTYASSSSVYGLNGKQPFSTQDNVDHPVSLYAASKKSNELMAHT
YSHLFNLPTTGLRFFTVYGPWGRPDMALFLFTKAIIENQPIDVYNFGNMHRDFTYISDIV
EGIVKVNDHPSKGNELWNCKKPDPSYSTAPYKVYNIGNSKPIKLLYFIECIEKELGKEAL
KNLLPIQPGDVPSTYADISDLVRDFNYKPKVSVEEGVKNFITWYNDFYKAK
>EGEFANNL_02164 UDP-N-acetyl-D-glucosamine 6-dehydrogenase
MDFNPNKINITIIGLGYVGMPLALEFSKKYKVIGFDISCKRINELKECRDITLEVSVEEL
SKVIITDIEDLKNKNGFYPTNNIEEIKNSTIYIVTVPTPIDVYNKPDLTPLISASSTVGS
VIKKGDIVIYESTTYPGCTEDDCIPIIEKISGLKYNIDFFAGYSPERINPSDKINTLTKI
KKITSGSSPKIAEFVNYLYSSIITAGTYKASCIKVAEAAKAIENAQRDINIAFVNELAKI
FNLLNIDTTEVLEAAGTKWNFLPFKPGLVGGHCIGVDPYYLAQKAIEVGYHSEIILAGRK
LNDSMGEYIASTVIKLMIKKQIHIYNSSVLILGITFKENCPDVRNTKVIDIIRYLQDYSI
NISVYDPLANAEEVKNKYNIDVFNKIPDHTNNFDAAILAVAHNEFKTFNIKKFLNKDSVI
YDCKSFLEKDIVDSRL
>EGEFANNL_02165 Putative glycosyltransferase EpsH
MPLSNQSLPLITVSIPIYNCEKYIERCISSVLNQTYPNIEIILVNDKSSDGSLEIIKQIQ
EKHPESIEIINFIENKGPSAARNAGIDRANGEYLFFIDSDDEITETCIEKLYVKSIETGA
TISMGKSLAKNTFKRTEYEIFPFKKDLNYLEGNDIILKNFCEGNWSITCWNKLVKLDFLK
KNQLYFVEGIFSQDELWSFHCALELDSITFLDEYTYYYYLHGESIIFNKTKRNFENHQTI
VEYFTKAYYEQNSIRKKYILNHIIKFKEITLTMQYQIMGRDIKYWKINYSRLKKSPSLSV
VDYFSNSFSKDMKKKNIFQNLPSSLGYKLYKWRIERT
>EGEFANNL_02166 hypothetical protein
MQKLAIIIPYYKIDFFERTLQSLNKQTNKEFTVYIGNDNSPDDPQLIIDKFSTNNNIIYK
KFDNNLGGIDLVKQWDRCIQLSNEEPWIMILGDDDTLSENCIEEFYKSLPEIQKDNISVV
KFSTIEIDENDNPISEKYEHPTKELSTSAYVRKIKGETRSSLIEYIFSREKYLKYGFKNF
PLAFGSDNLAWIEFSECGDIYSINDAVVYFRMSKSSISGNKNIGMKEKTKAMYLTKKYII
KNYFSYFTKDQRRDILKRAYKELVWSDNKNYVERMWIILLMIKHISIQEIKEYL
>EGEFANNL_02167 hypothetical protein
MYKNIDIDFEIFFMNKLNSYIKLYEHKLKNKSLQTQKKYVRDLFKRVFDSINKNIVIQSQ
KRFKKNICNYYFPIFLFII
>EGEFANNL_02168 putative glycosyltransferase EpsJ
MDDIPLVSVIITFYNSGNLVHSAIKEVQKQTYKKIEIICVNDGFQDETLSLLKKYQQEDN
RIIIINKNNEGGAHNALAAGQKVVKGKYILTFDHDDKLGEDAFEQAVVSMEQNPDWGISL
FKVKIMDEDGDLLESRPQPKNILTAKEAVKATVIRFKYAFRCLYKREVFQSFSYYKKEP
>EGEFANNL_02169 Putative glycosyltransferase EpsE
MKTSVALCTYNGAKYIAEQIESILAQTISPNEIIICDDGSIDNTIEILKRYKEKYPDIIK
LYRNDQNLKVIKNFEKAISLCTGDIIFLSDQDDIWFPNKIKEVINFFEKHPNIGACFHNL
QLIKLGELSEDTVWDAILLKKNILDFIFEKNKLVEYILKYNNILTGAALAIKKEIVNHIL
PLDERLIHDYQIALKLGIRNEITFIPKILGAYRIHENQQIGVGKLLSKKDKEKSIKEYIE
GIEDIELEIKYLLTALEKAQEYSCFIPELSDYVDFFKSKIKNSKIDFFKKTTYIQKKKTL
FRWYRYKFLNTSLLDVLIK
>EGEFANNL_02170 Putative glycosyltransferase EpsE
MNQPLVSIVAINYNNEKYVIETLDSIANQTYQNTELIIVDDCSTDESLHIIEKWLKNYNK
PYKLIKHAKNLGVCKTINDGYGIAKGKYISSIATDDIMLSKKIEKQVCCLENTDNTVGMV
YSNAYLIDDNSNVIEGNFIAKYRGDLSNPFTGNVYQELFKGNFIPAMSIMIKKNILLDIG
YFDERLKYEDFDMWLRIAEKYKIIYSEYISVKYRIRENSLSNRISKIEWILDNIRIYKKH
KNRDIILRKEYNIIRKKWYLRLSEEKLPFIDKIKFVFNIGVGSGSRRSLLKFLFS
>EGEFANNL_02171 dTDP-3-amino-3,6-dideoxy-alpha-D-galactopyranose transaminase
MIKFLDLQKINLQYQQEIEKKIIQVYRSGWYLLGEEVNNFEKNLAQYIGVSNAIGVANGL
DALRLILRAYKELGAIKDGDEIIVPSNTYIASVLAITENNLVPVFVEPDLNTFNIDISKI
EEKITIKTKAIMIVHLYGQIVFSQELKDLAEKYKLKIIEDNAQAIGAEYQGIKSGAIGDA
AGFSFYPGKNLGAIGDAGAVTTNDKELVQTIRAIANYGSAEKYVNKYQGLNSRLDEIQAA
VLNIKLKYIDKENQKRREVANYYLKNINNPNIELPSIEDCKHNKQHVWHLFVVESKRRDD
LQKYLTDNNIQILIHYPIPPHKQVAYSQYNMLSFPIAESLSNQVLSLPISSILEKKELEK
IVEVINKF
>EGEFANNL_02172 hypothetical protein
MINKKNFYCTSLGILIFIYLAILLIYNIDFIDSGFIISYVQRIKEGQIIYKDFDYVRPFG
SIVFWDIILTPFWNFKSYLGIISRLLVLIEILIITQNFFKGFKNVGVKIKNYILSIFICS
ILIIHTFNIMPWHTIDGVFFLSFAFLFFTKEKFILSIAFASIAATMKQSFYLDFFIIFFI
NTICIYYKFRKNEVKLKSLKIEFFFIVLILIALLLVTFKYQLEKNIDLFLEQTHVNNSIN
SFFKAGFKDYIFSEYIFRVILFLAILLFVVIQRMNRKGSIKLYNCIIILALFILYLLPML
KHLLFGSNIEFEGSKTIYLLLLSFFLKDIRSYIAYDIKKFLALIILFFITWSVSISWGYS
NVLLMLPILVFAFDDKFRFSEKINNLVVIVVIALFIIYRLLSPYFSKSILETKFIFIKEN
IPIYSGMLISENNYDYIKEAQALQKKFENSIFLPGSPIFEVMFNKNLNRSPWEMDVEYPS
WKKDYEQLSKKNIYYILDKKEIINSETGFFKSSFTQMVKHKKTLIDSTNFYYIYN
>EGEFANNL_02173 dTDP-3-amino-3,6-dideoxy-alpha-D-galactopyranose 3-N-acetyltransferase
MIKIHPTAEVQTESIGDGTQVWQYCVILSKARIGKNCNINFNVFIENEVEIGNNVTIKSG
VQIWDGITILDDVFIGPNVTFTNDLIPRSKKYPERFEKTVIQKGASIGANATIIAGHTIG
EYALVGAGSVVTKDIPPYTVWYGNPARQRGKIDKKGMIIREL
>EGEFANNL_02174 TDP-4-oxo-6-deoxy-alpha-D-glucose-3,4-oxoisomerase
MELVKEQIINFEKIGSSQLGFITVAEVQKNIPFEIKRVYWTYYTPQDVIRGGHAHKELKQ
FIFAVSGTIEFNTENLKGYKNTFILDSPEKGLYIPELVWRDIKFTHSAVLLCLASEIYDE
NDYFRDYNDFKSYRK
>EGEFANNL_02175 putative glycosyltransferase EpsJ
MVKGLITVVIPCYNSSKFIKKTLDSLLKQTYQKLQILCINDGSKDDTYKILKEYSNKYKY
IQIINKENGGIESVLKASLSLIEGEYTFLHGHDDYLSYNAFERAIGSFTEDLDAIRLDLF
FVDEHKTIYKMQDRRILEGRQALIETIGWNIHTFCVWRTNKFKDIVHVDTKGMMNFDELA
TRFLYSKSRKVGYCEGIYYYYQHSESVSKKKTYRFYDRVYTNVLLRKLLIDVGVYNEIST
KFENEIYEELISMHLIYNENKLNYATEFKKRIKAILKDGFTSLNGSVLVNESKIFKRRHR
LVYLIGRLSLYNYSLFKLLVNRKILR
>EGEFANNL_02176 Teichoic acids export ATP-binding protein TagH
MNKILAVKAENISKQYRLGQVGTGTISHDLNRWWAKIRGKEDPYLKIGESNDRSVKGNSD
YVWSLKDVNFEIEQGTAVGIIGRNGAGKSTLLKLLSKVTQPTTGSFKVKGRIASLLEVGT
GFNPEMTGRENVYLNGAILGMTRSEIRRKFDEIVDFSGCERYIDTPVKRYSSGMYVRLAF
AVAAHLESEILIVDEVLAVGDSEFQKKCLGKMGDVSKGEGRTVLFVSHNMAAVKQLCNKG
IVLEKGSVVYLGGALESVLEYQKRQNEANKLIASRFIGNDKIEIIKFEVKPRFEKLLSVG
SGLEIELEFLNKVSDVVLDTSFILMTQDEINVFGASCILTPLKNSKTGVYKVKFDLPKNL
LNAGNYYFKLIFGANSTDLLFYYDNFSFEVLNEGVNGNFNLSPGIIRPNINFISEYHG
>EGEFANNL_02177 Teichoic acid translocation permease protein TagG
MNESSPQTWTEVISSKHSLLDLNLKEVWKYRDLVYMLVKRDFITSFKQTILGPMWFFVNP
ILTTLMYIVIFGNVAGLSTDGAPMLVFYLAGVTLWNFFSSSLTSTSNVFVGNASVFGKVY
FPRLVMPLSIIASNLMRFIVQYLLFIIVIIYYLLKGEIEPNLWILSTPILLLLMAMFSMG
VGMIFSSMTTKYKDLSMLLGFGISLSMYVTPVIIPISSFPKKYKWIIDINPLSGIFECFK
YGYLGVGDFSLNMLIYSTIFISITLFLGIIIFNKVQKTFMDTV
>EGEFANNL_02178 Glucose-1-phosphate thymidylyltransferase
MKGIILAGGSGTRLYPLTIAVSKQLMPIYDKPMVYYPLSVLMEADINDILIITTPHDQNC
FKKLLGDGSDFGCNLTYEIQHEPNGLAQAFIIGEKFIGDDSVALILGDNIFYGAGLGDLL
RQKTNPKGAIVFAYHVNDPERYGVVEFDEHMRAISIEEKPLNPKSNYAVPGLYFYDNKVV
EIAKNLQPSARGEYEITDINQAYLLKQKLEVGVMDRGTAWLDTGTFESLHDASEYIRVIE
KRQGIKIGCIEETAYKRGFINQEKLSTIADKYGKSGYGEYLKNIL
>EGEFANNL_02179 dTDP-glucose 4,6-dehydratase
MKKIIITGGAGFIGSHVVRQFVNKYLEYQIINLDALTYAGNLENLKDIESKSNYTFIKAD
ITNEKQINNIFNDIQPDGVIHLAAESHVDRSISSPLEFVKTNVIGTVNLLNASKNIWKDS
YEGKRFHHVSTDEVFGALGQTGFFKEETKYDPHSPYSASKASSDHFVRAYADTYGLPVVI
TNCSNNYGPNHFPEKLIPLMIHNIINNKPLPVYGDGNYTRDWLYVIDHAIAIDLVFHEAK
NNDNYNIGGFNEWKNIDLVNLLCDLMDRKLERQRGESAKLITFVKDRPGHDLRYAIDATK
INRELGWKPSVTFEEGLEKTIDWYLENQEWLNNVTSGEYQKYYEAQYK
>EGEFANNL_02180 UDP-glucose 6-dehydrogenase TuaD
MNITIVGTGYVGLVSGTCLADLGHSVHCVDINEEKVQMMKKGEVPIYEPQLEEVFLRNIK
GNRLFFTTDLAEAVKKSNVIFLALPTPPGGDGSADLSYVLEVAGQIATLITQYTVIVNKS
TVPVGTAKKVGELIKLKTSVPFDVVSNPEFLREGYAVEDFMRPERVIVGASSKKAFEIME
KIYLPLTNAGVNLIKMDEKSSELTKYAANSFLATKITFMNEIANYCEKVGADVDKVRMGM
GADDRIGHRFLFPGIGYGGSCFPKDVKALIKSGNEIGYDFKILESVEQINEKQKTILVPD
IEKHLGTLKNKCIAVWGLAFKENTDDIREASSLEIINKLLEKGASIKAYDPIAIENVQRL
LGDRISYAKDMYECVENVDALVISTEWGEFRNPHFEWLEKRMKNKAIFDGRNLYNLEELE
AHGFYYKSIGRKIIIN
>EGEFANNL_02181 hypothetical protein
MNLKIFILLISYCFGFLVQAQQSSKDSVSIDEKQFFVGVDLLNPIASFFSSKKNYNGFVS
YKFKNRWIAVAEVGYEKNDYKENDWNVDAKGIYLEAGVNYILTNYYEKTGQGFYIGGRLA
FTPYEQTIINYPIKEMNTSNQVQTIGNSSLPKANVSAGWLEAVLGAKVQLGESPLYLDFI
IKPKFLVYSKKQDHVDNLVIPGFGKNKGDVNISFLWGVSYRIF
>EGEFANNL_02182 hypothetical protein
MILKKIFLVSLFISFIFAVQACVDDDVCDKQVTPNLTIAFVDSISKPLTLDSLYVDKLSS
DGKLLQMGIFSKVDSIRVPLNSFSNETKFYFYTNKNADSLQKDILAVTYNTSQSFVSKAC
GFKVSYNDVKYQLLQTYKIKNLSPITNKIENESKDLYITY
>EGEFANNL_02183 23S rRNA (uracil-C(5))-methyltransferase RlmCD
MKKKKNIQISNLKLQTAGAKGVAVGKNVEGKTVFVSGAVPGDVVNAQVIKSKKNYIEAEA
VEFLEYSPYRVEPRCQHFGVCGGCKWQNLSYQKQLEFKEEEVMNNLTRIGKIEGFKKINI
LPSEEQYFYRNKLEFSFSNSRWLTFNEIKSGEEIEDRNALGFHIPKQWSKVLDIKECYLQ
KEPSNQIRLFVKELAQKYKMEFYDLKQQLGFLRTLMIRSNSKNELLVFVQFFKENKGKRE
ILLSSIQEKFPEVKTILYAINPKGNDSIYDLSIETFSGEGYLEEEIEGFKFKIGAKSFFQ
TNYKQAVRLYEITREFADLKGDEIVYDLYTGTGTIAQFISKKAKKVIGVESVPEAIIAAK
ENVKYNQIENCTFYCGDMKDIFTDEFITENGHADVIITDPPRDGMHKKVVETILNIRAEK
IVYVSCNSATQARDLELMKDQYQVVKVQAVDMFPQTHHVESVALLKLKAL
>EGEFANNL_02184 Aspartate aminotransferase
MIVNNTTNLVKMNILSERINRLSYSQTFVMSNKARELKAQGINVISLTLGEPDFEIPEFV
RESAIKAINNGVKSYTPVPGYLELRKAIANKFKRDNNLDYKPEQIIVSNGGKQSIINVLL
SVLNDGDEVIVPAPYWVSYFEMVKLAGGENVIVETNIDTDFKITPEQLENAITSKTKAFL
FSSPCNPSGTVYTKDELQSLAKVLSKRPNIVIISDEIYEYINYESKHESIAQFPEVFEQT
VTINGVSKSYAMTGWRIGYLGGPKWLTEACDKIQGQMTSGANCIAQMASITAVEADPSNI
NYMIEGFKSRRDLVYNLLKNIPGFKVNKPAGAFYFFPDISYYFGKTIQGTEIKNSDDFAL
MLLEKAHVATVGGVSFGDSNCIRLSYAASEQELIEAMKRIKEILS
>EGEFANNL_02185 hypothetical protein
MFEIFKDKSGAFRFRLKAKNGEVILASEGYTQKTNCQKGVSSVKRNAKNEDRFELKQSSN
SKWFFNLKAGNGQVVGTSEMFENETNVKNGVKSVMSTAAVAETVDLSK
>EGEFANNL_02186 23S rRNA (uridine(2479)-2'-O)-methyltransferase
MTIESDKNPKIKKLLKLIEKSRERKIQNKIIVEGVQENFFALQNNYDPIEFFIQTSIFQN
NINIPKNIQIYEVSKQVYSKIAYRQSTEGIVGVYRQKEEELKKIKLKKDPFLVIIESIEK
PGNLGAICRSVDAFGVDYLFVCDEKVDIYNPNVIRSSVGSVFNVPIIHVANQELYEFLKD
RKINTYATFMNMDFKEIQEISLDQSTAIIFGTEHSGVSNFWKDKITENILIPMQGKVDSL
NISNAVSISCYEVRRQRGINKK
>EGEFANNL_02187 Ribonuclease
MSIKKGFKLPYLLLLVVIISIGFVLSYNSSIKKLNYNQFNVKELSAENVVIPYIKSKHRL
PDYYITKNKAREMGWNANQGNLCSKIPGKIIGGDLFKNRENLLPNKKGRVWFEADLNYNC
GSRGKDRVIFSNDGLIFVTYNHYKSFEKR
>EGEFANNL_02188 Barstar
MKTVIFDFNDIENLSIFYRRFQKEFKLNSTMANNLDSLWDALTGYIEIPVKIEFINLTLF
KLDKFSRLITLFEEAEEETDHKISFTYFISNSNI
>EGEFANNL_02189 Polyprenol monophosphomannose synthase
MQDKKIVVIPTYNEAENIKDLLLCVIHLKQDFDILVVDDSSPDGTSNIVQEMQKEYPNQI
FLTIRKQKEGLGKAYIHGFQWALKYKYDYIFEMDADFSHNPKDLSRLYEACKAGADLAVG
SRYSQGVNVVNWPMNRVLLSFFASKYVRFITGLPIHDSTAGFVCYSKRVLENLPLDQIKL
VGYGFQIEMKFRTYCKKFKIVEVPIIFTDRTKGESKMSGAIINEAVFGVIKMKLMALLGK
L
>EGEFANNL_02190 hypothetical protein
MRRFFFLILFCLVILSCQQTVKKPKNLLSKEEMISILTDIYLYKQNINSSVPLDKDKTFE
TYVSIFKINNTSKEQFQESYQYYYVNSTTLQNIYEEVLKNLKNKLDKNQQSLLKY
>EGEFANNL_02191 General stress protein 69
MEYRKIGNSDLQLSVITFGAWAAGGWMWGGTERNDAVNAIKAGYEVGITSIDTAPIYGQG
TSEEIVGEAIKDIPREKIQILTKFGMRWDLAKGDFAMHSQDNSGKNIDIYKYAGKESIIY
ECEQSLKRLGTDYIDLYQIHWPESSTPIEESFEAVARLIEQGKVRYAGVCNYTAQQMEEA
NKACKIISNQAPYSMLNRKIEAEVVPYCLKNNFGILAYSPLERGLLTGKIQPNHVFAKGD
ARSEMKVYQPESIKKVNDFLLKIKPIADDLGATLGQLVLKWTLEQPAITIALAGARNVEQ
TLQNAKASNLQLSQEQIQFINSELSSI
>EGEFANNL_02192 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MEKLQGKKALITGGSRGLGKAVALALSKEGVQVAITGRNESSLQETVKEIGNHATYSVFD
ISNQQDVKNSLEKLQVDFGPIDILINNAGISAFGGFLEMTEKEWLDIIHTNLLGVYYVSK
AILPSMVERKCGDIINVSSTAGLKGGASTSAYSVSKAGLISLSESLMFEMRKHNVRVTTL
TPSTIASDMSVKDLKITDGNPEKVLQPEYNRKIKKY
>EGEFANNL_02193 hypothetical protein
METKKNLLKLAFSGSKVGRIKEIEELIKDRNYKRVIEPFGGSCCISNNLKYHDLIKEAVA
NDYDQYFKDFDKHLTYKEQLVKKLIDLGFVKSKNYLPKDKQVSLQRLIVDIQDNKSMLKY
LAKNFVFSAKRSSGVLNIKDFKYFTNELSTEQDRFFYENLNNIQLDSLDYKDFIKKYVQP
EDRNTLIVLDPPYLNSAQKQYNNETFFGLCETIQLLNLMKQLQNDFIFFNMVEKDSIELL
NLFGFSYVYQTKRVSVSGKNHREDFMAYVTFDDQNKIFNPCLN
>EGEFANNL_02194 hypothetical protein
MAEITDKSTLKNWFKNNEKPTQEQFWAWMDSYWHKDEKIPIDIIEDINNILANKADTEQV
NTLLEELESKADRTIVDALQSYIEALIDDREASSTTTYSSEKIEELINQVKPSELIDDEL
EEGSVNTYSIDKIKELVENSAGGDLQSVTDQGNTTDKEITVQGATLGADSALKNTKFGQG
ALENNKSSYQNVALGHQAFNKLETGDTNLAVGYLAAQKAVSSMNSTLVGPYAGANAIYLN
RDTFIGLSGYSHTGEDFTDGKGIVKKGGNNVYIGDSCALYTINGYGNTFVGAACGQNWKY
SGSYNTLLGHGIASMTKASNGDCNVLIGAFAPCNGSFSDTLIIHSQRKASEGGSYAITPL
IKGHFTQRTFSLGGTYILNFTYTPDADKLVAEGEKAFEPNKMLVVDAEGKVGVKSLQNST
ENNDIIYYSFSDFLCEMPSDNSLNEDNFQIFPELFLNGKTATLILKGCFKFSDKPPLNKT
IKLELPRGLKFSKVIEYMDIACYGDKNGKLDMAWLSFKNTADSGLFELTTPPDGASAGMS
TPVGALYNFHQTIIFEIG
>EGEFANNL_02195 hypothetical protein
MNKLEYNNAGGYPLTTNRLDDIQQAFASLLNGLGAMTGNLSIISGCQEKGSQITDGVVQI
ENEIFEFKAGIKQENVTLFEEKIAKEFENGEAKAVLNKRYISFGTGATSYKWADFKRVPV
LNKLEDTFKTLLEQLTIRVATLEKKNAVFQTGGAMVFWNKPANEIPMGWREVTDWRGRIP
IGLNPNDADFYPLGKTGGLKKKSLSIAEMPAHTHEGTSGDPIYSDGKAKYLSGYNKTGGY
TGYTGGSQPFSIMNPYRVVYFIEFVG
>EGEFANNL_02196 hypothetical protein
MWYNPNLKKLAVLTMPPGLRNNFSISYLISLLKPLETTLYNWQKLRNNSLYKLQHTGQVC
YLRKVLNDRFDPIQRRIIITGSQRYKSQYIYTEAEKKEKYLGTMYLRRDVDFEDNGADFL
VLAPAELLDENNYEMNALIDYYKLASKRYRIEPLEYL
>EGEFANNL_02197 hypothetical protein
MARTITEIQNSILEEKEKHEALKVLNSNSKASIWRLFTYVVAYVIFNLELLFDAHTEEIN
TTIAEQKKGSLKWYRNKALAFQLGFDLLPDSEDFNNENYTEEEIENSKIIKYSAVTEATT
QSRLIIKIATETGDKLTPINEAELEAFTYYLEEIKYAGVAVTVINYLPDELSLYITIRRD
PLVLDAQGNAIAPVNGIIRPVEATIRQFLKELPFNGELQLSKLTDQLQLTTGVTDIKITY
AASAWLDPTTGKYNTPQIIEMSVIPESGYFTTEDTEGKNLININYVV
>EGEFANNL_02198 hypothetical protein
MTVTVLNNQSFLDLAVQYLGTTEAAFAIAFTNQRSLTDELTAGEKLILPEKSKYKNSDIA
SYYQQKGLFPATSVTDDFMLPFDQDGIGEMIININFMAKAKS
>EGEFANNL_02199 hypothetical protein
MKEFLTSYLGEFLSVVIAGIGGWLFGRRKQNVELKSAEIDNEIKFADYYKSLLDDLSARY
EKKYLDIEQLYTGKEKLLQDEIAMLKSKITMLERENSELKKRIKELENQLKDDSNRTK
>EGEFANNL_02200 hypothetical protein
MKDILLDETRRIQVLNGDFRIGESEMQEIALLLESNQGEWKEHPIIGANLYQLVNSKASK
LDIEKRVKLQLSLDNKEYAELKNKIQTTIKTTI
>EGEFANNL_02201 hypothetical protein
MLDKAGLIEDLKALMNLNNEGKSNTEEAVQKLADAIEKYVKSGKVQGICPPNGGALQNGK
VV
>EGEFANNL_02202 hypothetical protein
MKIENRQNPKAELRSLLKIQAGALVPIQTYWAITQEVDWENKTMTAIGVSNELPFYKVLL
GLGSLQVKPKVGSPVLLGVIENQTPLTFLLDSEQVEEVVYTSGSSQWVINPEGFQLSSQG
ENLYQILGDYIEQFGKLADEINKIKVAIGTSPNTPVIAKIKQEVTGTIKQRLNTLLK
>EGEFANNL_02203 hypothetical protein
MTLAMNCKLIFFPNDSRREKLTLYTVSEVQIETSYTNLTQNSEIIIARKVKYFDRNKIKE
VFRKGDKVEIYLGYNGALTLEFIGYITQVSADFPISIKLEDEMYNLKKKEVNFSSPGITL
KKLIEKLLPNPEYIVNITYDAQLGQVMFSKTNLGAVLDKLKTDWNIHSYFRLVDGKPVLE
VGSIYQTQTNTKPVLFHLERNCVDQQLNYRRKEDIRIKIKGVCNLGKGKKIEVEYGDYDG
TVNTLTYYNPGITKKDLEILVKKDYDRFKQDGMEGSFTALGIPSVQFGQKVKLVSNLYEE
RNGTFGIEGVNKSFSKSGYRQDIKLGFQIGEKK
>EGEFANNL_02204 hypothetical protein
MDARYYVSKALQKLFGYNLPIYFPYRLNKQLPAEIIFPDVTLKEEEEILKLSYLGTPIVA
PTTFKAGEYRKYKANGELTSISLPDFQLPLVTLIEFRRAKNIIKTDMLGANGTVKEIYGM
DDWVISFRGYAMDEPNKKAQDQIENLLKFEELADSIEVDGILFTSKNIHRLAIESIELGQ
LEAEPGTIPFTITASSDEALELVLTEKTLSE
>EGEFANNL_02205 hypothetical protein
MSDKETSWILSIIDRASKPVKEIMASVKECAQVVDKSNERIVMSEKQTQQALTNTKKHHK
ELEKQIKENEKQVKELEKAYEKAAPGTQKLNASKPLAESKRALQSLQEQLKETLEDAQTL
EKDLENITNSKKSPTSLTGMMTGVNQTMEIIDKVSSMLDFTQPIVATRTEIERMTGISGK
GLDDLTGKVHKLGVVFNENDEDIARAAHSMQTTWGGSYEEMLALMQKGYEKGGNINKEML
DSLKEYPKQLKEAGLSASESIALIAQANKQGVYSDKAIDSIKEMNLALREMDKPQVEALQ
GIGISGKDLKGKTTMDVAKLISEKMKGASSQAQQKVLADIFKAAGEDAGKEFILGLSTMD
LNLENLPSVKQAGAGIKGIIADIQSKVATSVGTFAPYLQTLGSFSTQTMGVISLVQTLGR
VTVVQTIATKSAALAQRAWNLVMVANPIGAVIASIAALGAMVYKIRKDTIESTEAFKQQA
SVMRVNEELNKYAIQTTNERITKLKNLTRVATDERISLVERKKALGELIKEDARYQSSLQ
NGIILTDQLRRTTEQLTQEIYNNALTEGRKKLIAKTAEEVELAKLEEKKWSDEIDRKSKI
AQAGHVVLDIVNLGVFSKYDAAKETKENKERDLQNLIRQDIQADRLKNGLRPQKGIVEKI
TADPLTPTLDDYSSSFSGGGNKKGDKKGSNSKNGLRISGGSGGGKTITQNLTINNYFTRG
NSSDDRSFADKVITQINDGLRDGLATI
>EGEFANNL_02206 hypothetical protein
MPEDKGFEFRKWNAILRLKYGIKDPDNLPLKDWAKLVEEYRYIYELEAEDRKAELETLEI
NIKNTLYHIVNTLYGKN
>EGEFANNL_02207 hypothetical protein
MITEAEIQDLKARHGDFLTQVNIEVEGNKKTYIIKPPTRTVIDIISDEKTNTAEVSKVLI
NNCVVYGDLELIEKNGKVYTTLLAHIKDEVGNYKSEAKKL
>EGEFANNL_02208 hypothetical protein
MANADHLVNNFGVMTGWNNVTVNLLGRDVVGITSLTYKDNHEKVNAYGAGRMPVGRGYKK
YSAEASITLYKEEVDALKAALVPGARIQDIAMFDITVEYARPSGYIQRDRVYNAEFTNDG
VEITNEDGTISIQYTLIITHIGWDIVI
>EGEFANNL_02209 hypothetical protein
MAQLTGVNVNKLQGGLGRGNGTTDSYVGLVGYISAETLALLPEIKENKALQLLQIEDLEA
QGFNESFDANNKLLVHYHISEIFRLAPEAVVYFIPTTSESIEKAIEVIIPAIRENSEIKG
LGFCGFSETLETLNVDAIQKTLVDEFTKENRDLDFVLLEGKPKAGETFKVNDLPNLREKA
APNITVIIGQDPAVASLEEAYKNYSAIGSALGMLAIRKISENMGSVNIENKPANSRATTS
YPLTDSASSRWLSSALSDGTPLSELSKTHLKTIQQKGYVFIAGYEGFAGLFFSASTTCIE
KASDFSTIENNRVWNAAKRAIRQSLLPYVKGKVKKDPSTGYIKSTTIATWHGAASKALEQ
MVINNDISGYQVRIDNNQVVNEDNPVKIRAVVVTDDIAHEFDVDLGLTNNIE
>EGEFANNL_02210 hypothetical protein
MKSKEELNREAQSFLEQYKQKEVYGTSDGQFFLDKNRAELHARSKKELSVYVFPKDGSTT
AEANEDWAEKLKATEDVNTLIYPELKNMVKGLGLEVENQKQATLIEALEKHKETLNN
>EGEFANNL_02211 hypothetical protein
MKVLIPLVALFSFIFLGCGSRKPQPSHKTETNTLIVEKTTTYRDTVFVTEKAKASVTTPV
ENLNEKPQVSKNKNATQSLYKDKDGNIVADCECDSLQIAAKIKQELQKETLETVITETQI
QKVPYVPFLVKCLAWIGGGAVVFLIGVLLIKMKI
>EGEFANNL_02212 hypothetical protein
MKAVITRTKFEKVQTLGELELYNNQNQLIYKCKTLELPWKNNQLRVSCIPEGIYQVNPRT
SAKFKKHFHVVPTEPRSYILIHAGNYYTDIQGCILVGTAYSDINKDGYLDVVNSKVALNR
LLGLAPKGFELIIKKG
>EGEFANNL_02213 hypothetical protein
MKNKTLIFSLAFLLVAVLLFALPSHKETAITAMSLPLAGKQLKNEVAEKELIKKFRHENT
WLQEIKSKQKWLENDVIRIPKQGTAPNVIINNQVYPIVSNKREDDYVSLSLNKYETENTE
VTADELYALSYEKLSDVQVQHREELEDKTASHALYSISPDKKTTQTPILETTGDADENGR
KKLTSKDVINLKKALDKLGVPKKGRVLVLCTDHVGDLLEEDRNFQTRYQNAIDGVISKSY
YGFTTYESLDTPEYNDNLEKLPFESLNTGRTASIAFFKNNAAKATGSVKRFMRAEEEDPE
YRKNTLGFRLYFICVAIKDEGQAALVSGKDA
>EGEFANNL_02214 ATP-dependent Clp protease proteolytic subunit
MKSTLQITASVEKSIGQIRITDRISEYSETSSSSVVRKIVEDLIKQGVKKAEVYINSQGG
STFEETEIENALDQLEEVNLTVGALAASAATKLVAKYPTSAFSNSQFMIHKPMLGTYGNV
TQIQADLKLLINTTADYKKAYASKMKKTEEEIEALWKDGDYWMTAQEALALGLIDRIIEE
PEKVTAESLAILEACGAPHIPHLIKEKPNKTTMDRKQLIASLGLATDATDAEIAEKIADN
RQKAEQAEQTKAQAEALKKTNAEALVNQAILDKKITAEQKATYQILAEADFNATQAVISS
LPTPQALSSQLNPQQQQKINAARASWTLDDYIEKDPKALAEMEVKDPQNFLRLNQEYYGY
>EGEFANNL_02215 hypothetical protein
MAKEAEKKRAYDYYVNQGKTAKETAGLSGVTEKTIGEWIKKGNWKGLRHTKANSKAERLT
NIQQIIDSLAEDRIQVQRDISSELEKEEPNKTYINDLRRQAVSISDEISKWNKTLTNFDK
ENKISLSVYIEVMNDIFDNLKKYDPKLFASTVDFQEEHLNTISIKY
>EGEFANNL_02216 hypothetical protein
MFKLILNLLWNRANKRRWQMELGTYLLRQGVQWKIGDPVQVPNGRNKVCTMWISNLFYDF
QKNHIQHSLTSKKPFRKESEKRG
>EGEFANNL_02217 hypothetical protein
MRKEDKKALERYRKKLELSKQSVHINPFETDKERKEAIERSKKDILYCVERYFPHYAKYP
CADFHLQWAKLVKKDKNFVGFCKWGRGLAKSVWNNIFIPFWLWLNGENMYFVLVAVNEKK
ARQLLEDLRAEFEINPQIIADFGEQVKLGSWEEELWITKGGFIGQAMGFGQSCRGLRVGA
QRPTYYNLDDLETRQTIKSEKRQDEMVEWVEEELLPSMDSPEDTERLLFSNNWFAPVMFL
KKLAKKHPDWKVHEVKAYDSTTFKPTWAGKYTADYYRAKAKKMGITSADSEYNHKAVLRG
GKVFKAEYIQWAKLPRIDHFKAICAHWDIAYAGNETSDYNAVRIWGLYKNDFYYIDSFVK
QTKMKPAVKYMIAIDREMKAKGIEIIWRAEAQFWNDEVERTIKEACKEEGNYQLSITLVY
DKNHKYTKIIARLEARYQNGRIYYNDKKQSHNDTQIGLQQLYGISPGYSSHDDAPDADSE
AVEYLSKYITNNSDSDDNAYLQGSYQPKHERI
>EGEFANNL_02218 hypothetical protein
MIYLTRDYLNTFAFEKLIDESINDYEPILDNIEASSIELIKTYLSGIFDIDKIFDPEAPI
QNELLKTILAKLVLYGIVRRNAARKVPTDYKEEYEWAIKQLENINSGKLNPGGLPPLTDE
NGNTVESTTLIGNLSNSNFYI
>EGEFANNL_02219 hypothetical protein
MSKKRRHNRRPAIQQPQAQAEKKSNYLSSLLVPQEISIHAKSINDYKIAVALALDNSNPD
RSPLAALYDNLLLDNHVASVIDSRILYSQRSPFKMIDDKGNENEELSWLLERSWFEELIR
LVLFSKFQGTTLLELYETNAEGELATTTEIPQSHFNATKGLILKEPGATNGWQYKEGIFK
NYYVQIGKDRDLGILERLAPMILAKKIGWGAWMDFIDKYGVPPLFITTDREDNSRLQQLY
SSAMAFKSNSFLIGRGNEKFEVGSTHTGNSKDTFDVFIERANDEISKRILGGSSLTDQKT
FVGSAQIQYRLAEDRYNADKIFFKNIFNSFIRPRLINLSPIYAPLQNHYFEWDNSEVRTA
DGVADLVVKLSQAGYVPDPEFVEQETGIKLLGLKENTIVKPQPEAEKKK
>EGEFANNL_02220 hypothetical protein
MLANYLPKENCCPSEVVAVDLSDYEELIRQLAEDIKSGKIDKNNLSVDLVKKTYKDLSKG
ATKGWGNDFNELTGDNPPGDKTVQHLHQNIYRFSGAKTAAQAYEISQLLYTEDGKIRPKK
EFMELVLKLNERYNRHYLETEYNTAIKAATMARQWVDFQQDAELFPNLKYKTAGDSRVRP
EHQKLNGTIRPLNDPFWNKYYPPNGWNCRCYVVQTAETVTEGREDDSVPKEFYGHVGKEE
VVFSKNQTYFKVVKELGEGEFNKHFETAKLDAPYLNLKGVKVNIWADLEDYKENLDAALV
LKKAGYEVKLRPHVNSSILLNTPNPEYEINGQLAERKAPKGVNLRNVLSKANKQGCKIVV
IDMVDSKASLEEIQKEAEARLNDPEKFPRIEEILIVNEGKTFSVKRKKQSK
>EGEFANNL_02221 hypothetical protein
MSETNKLPDLESMVTRLLKEAESYAAVSGLNFFKESFEKQGWTGTAFEPWQARTNDLRPG
GAILMDSGQLRDSLQILERGDLKIKYGTFSPYASIHNHGGVMMIPITKKSRKYFWYMYYR
TKKELYRGLALTKKKSVRVQMPKRQFIGHSDTLMIQLDDWILNRIITRFKEI
>EGEFANNL_02222 hypothetical protein
MQNWKDLYIEIAEKIDNGLEAIRWVDLWHNQVYFLEEEHPFPTPAVFLAFRGRQFKDLGD
KVQDVSLQMDVFLFYETFKDTYLKGVNQETALEFLDLLDGLNALLHGSGGKNYSSMRRIG
LAPVDSGGSGNLYQLVYECTLMDFSAQKVMEEGIIEGFEVEKLRDKENDFFIP
>EGEFANNL_02223 hypothetical protein
MMQNLIETRQRQATRRMYEDIQKEHARLMAITEHGVQKYHDKWIIGELAHKFYKSPATIE
KIIYNRNNLNLF
>EGEFANNL_02224 hypothetical protein
MRVVSIILLTLTTILSCNKKTDKSVNDSMVIDSLPIEFQHSEEAKKQIDSLNSWLYEDEV
DKMGDSIYYAQLKSAENLNLDFPYENSYASLNIRNKQGKNDVIFSVTEGQIKGYVYDGGT
ARIRFDNEKPFNIGYVGSSDGSSEVIFLQTPNKIIDKLKKSKRMVIEVEFYNNGNKQIEF
NTEGLVWKH
>EGEFANNL_02225 hypothetical protein
MSNLIKHKQTIHSIECLNKETEAAMELVLLESDLTVRKCMDTTLVINIEKAIHKKQIISA
VRFAIINCSKVFKFSEKMDIETATFMAADLVDVFKYESFEDIILMLKMARQGKLGSNKGR
FDNDTLFNIFVPTYLDMKAEEREKEKQNEKAELKRREEQPYKISPENKKKLDELIERLDK
KKEKTEVPSSVLSNHQIFISRLPELCKNLSDKELKEQIQKAQSYKLSDAYEIYKTELEKR
NEHKKTLSEKRKVGNPTKSRKQSD
>EGEFANNL_02226 hypothetical protein
MNTQTILPEIEILNYLNEIAGKRFKPIKSNLKPISARFKDGYTLEEMKEVVMVKTLEWKN
NEVMAVHLCPTTLFRPSNFEKYLNQVLTIKQNPEKYKKHYEQLNKTQADDPLDRMFK
>EGEFANNL_02227 hypothetical protein
MKTITSKSKLLDKLKKNNLLTNGVIFYLSDFHRTKVGKSVANKIICENLVIPTRAMCSWF
EREWKLNKEL
>EGEFANNL_02228 hypothetical protein
MKIQYSQKQQIFRLLPEEIKKDKDLRSDFISDFTDGRITSTKELTNDEANNLIVSLKGDY
SYFGYFDKDNKQHAQIRRICYDLGWTTYSKKAGKSVADVNKLGIFIVSKKSPVRKPLKQM
TSKETSKLIIALEGVLNSTYKK
>EGEFANNL_02229 hypothetical protein
MNQFKDFKIKPEINHFTGDKIKIDKILNVPIVIIDYKIEQSKAKVGTQLLTLQIEKSGTR
HVVFTGSTVLLQMIQKVDKEKFPFISTIVKENEYLEFT
>EGEFANNL_02230 hypothetical protein
MKRIGKLYPKIYNMENLILADEKAQKGKSKQYGVQIHNKNKDTNLLKLHEMLKDKTYSTS
KYDIFKVYEPKEREVYRLPYFPDRITHHAIMNVLEPLFVASFTADTYSCIKHRGIHACVK
KLKQALTNKEETIYCLKLDITKFYPSINHGVLKNLLRRKFKDTNLLWLLDEIINSAPGLP
IGNYLSQYLANFYLTYFDHWLKEEKKVKYYFRYADDLVILSDNKLYLHSLLHDIKQYLNT
HLKLLVKSNYQIFPVQARGIDFLGYRFYHTHILLRKRIKKNFARMLKQNRNPASIASYKG
WTIHCNSKNLLKKLLKDEPV
>EGEFANNL_02231 hypothetical protein
MSTIIEKIKTFEDACKELNLNPKDFTITIPNEFSKHSEALTAHLKLVVITQALNEGWEPD
WSNWDEYKYYPWFDMEDSASGGFSYYGYVFWLTTSGVGSRLCFKSRELAEYAGKQFEGLY
ETYFVIKK
>EGEFANNL_02232 hypothetical protein
MKTLKIEIPEGFKVDSFDDKTGELKFIPIPKTVIERIKTFDDVLNETGFDKEEFKQSLKG
LDKDEKAYRKLKLLAAALNEDWVPDWNNSSEYKYYPWFRMGSASGGFSCDDYDFWYSRSS
VGSRLCFKSRELAEYAGKQFETIYKDFLTL
>EGEFANNL_02233 hypothetical protein
METKIITAAESYQELDRQIKDLQSKQKQFKDTLLKYAEENKSDFDAAFQLKFPNGTYVSQ
RVKDVIEGSKDAKKQLLDEIEYEFIKTELDEKLIINEAPKDTRLRKLLTKLGIKITQKET
FAIYAG
>EGEFANNL_02234 hypothetical protein
MEIDIHDLRDLLSYDSEEVRFLTFDQRCEIQRNISNIVNKKPLKFSEELEQKIIENLAKI
RINEWTRPSIRYVEEDGTLIKRYYKK
>EGEFANNL_02235 hypothetical protein
MIMTTTQSNFCRLTGMPEEIYQTILFECGCEFAENYCKYLPEEARENHIRVMLSLSQYWN
WWKTQWNIRTQEAFGLTGIKENEPQLCPFEIEALKEAFYDTHCENSYRNIYPNNLVMKVL
RQKIYGSRNNTLKSNSIKGMERNRTRKSSVSVEL
>EGEFANNL_02236 hypothetical protein
MTVKELKEYIADLPDNMDVMIMQVNDDFQYNLLQNSEVKEAKFIDPSNKEVYAFEDCLIL
SDEIIDINDYDNNSI
>EGEFANNL_02237 hypothetical protein
MARALSANELSNKKYQLFDFKGDWMEAFGNPEMSGVWFIWGNSGSGKTTFTLQLVKYLSQ
FDKVLYNSLEEATSYTMKLAFGRVNMGEVGTHVQLLPAEPIKELITRLDKRQSRRIVVID
SIQYARLNYPKYQDFVERYPNKLFIFTSQAKGMNPVGRTAEQVMFDADLKIWVEGHKAFS
KGRYIGTSGEYTIWDEGAEKYWGKLENQ
>EGEFANNL_02238 hypothetical protein
MKTEVKNQIITELENYLSVHKLSANEFSKKAGINSGYISALRNGKETASVSGKEVLISDK
WYKKIAEYIGLELEQTYWEPVPTEQFLRTIATLEDAKKYGYTNVIIGSTGSGKSFTADIF
VKQNPVDTFKITVGSSDTIGDLIDKVIEALKIPTAKTKSKKIREIVKKLKQLKYEGFTPV
ILFDEAEYMKQPALCAMKELYDNLFGICSIILIGTDQLTKNLDKLRKKNKDGIPQLYRRI
KFGIRVLPSIDKTFKQFLNGIEDKGLIQFLKQNCDNYGELHDVLVPAMREADRTGEPLTE
NFVRTIIGIPNI
>EGEFANNL_02239 hypothetical protein
MYEFHNNILSIPAKVLYEDLEVVSYDTYRQWCVRGKLIKTRTARGLDSYALLDFEKLPQN
LKDLIIKEYGNPPSENKSLLEKQLKSDPEAVEFFANWQLPDYRFLEESVQKEYHAHAQIF
NAVHALINIRQTSRKKLNRPKQNSEELWKEISGHIQKLNKTEYPHSLPTNPTSLKRKYTR
YIKEGYSSLIHANFCNQHSAKVKDTEQEASLRQLLRKHNNLDNEQISAIYNIIADKCNWK
HISTSTVGNYREKWDLITFAGRRGQQTFDNVKAMTVKRKAPVYPLYYWTIDGWDVELLYQ
KTDVTPRGKEVTTYHNRLNVVVVLDPCGKYPIGYAIGTHETPELIQQAIRNAVNHTAELF
GQRHRVLQLQSDRYATKKLTPFYEAVSNNYIPAKAHNAKAKIIEPYFLRLNKKYCQLMPN
WSGFGVTSRKENQPNSEILNKIRHTFPDEQLCRLQIERILEAEREAGKAKYLSAYADMPS
EDKHYMSDDEYLYYLGERTGYTNKLNHEGIKVTLNGTIQHYDCFNPDFRLYGHLDWTIAY
DSDNTDKILAYNEGGTLRFMLDKKYVQPMALKDRTTGDAAELKKIQQFNKYINGKIAEQT
YQDAEIVEDLFQKVPELGNTLAKLVLTDSTGNHKNNRNKARINALNEVKKVAYKQDRKKE
KENVSNWKAQQDAYLREKVDINKYLQ
>EGEFANNL_02240 hypothetical protein
MRPGDLLTASEMLNITSDAARMRLNRGKEDMLYVMEKIFENRKILINEYQNSLIDKI
>EGEFANNL_02241 hypothetical protein
MNKALILNRIKEYNDFKTDKELASFLGISKSTLSNWYNRNSIDYDLVFSKCVQIDKNWLL
TGKGKMLKEEKESDIIINPIVINRKTKDSLKEIQEIPLYNLHATAGLVELFKGSNQDAII
DNIKIPGIASCDGAVYVSGDSMYPLLKSGDIVLYKEVDISRLFWGEMYLLSIQLDDWSEY
ITIKYIQKSELGEDYIKLVSQNQHHQPKDEPIKNIQALALIRASIRIQSS
>EGEFANNL_02242 hypothetical protein
MKKHFLLLNLILLLAVCITSCSSDDNLNEEEILSSDKLLPVSILGDNGDKVLYTYNDKNQ
ITELRQEEHYKDYTELYIAKINYDAQGNPVQLITAYEDLETPENEYLWETHNFTYEGNNI
VNDTDGDTGLLKYRFTLNNGFIVKLEDFEENNLTLTTDIAYDEFFNAISDIFTVKGLTTG
KKIYQYDYSHHSYLKNVSTPDWMLSFIYEDFGRYNQLISTMEESNSKLYETVKFNWDNYQ
DGFPTYLKKERIDRDGISTITENTITYTKAK
>EGEFANNL_02243 hypothetical protein
MKKHFLLLNLFFFLAICITSCSSDDNFNEENTISSDKLLPVSILGDNGDKILYTYNDKNQ
ITEIRQEEQHKDYIWLHLRMITYDEQGKPIQVKIAEEEPDTPLVDYIWYKYNFTYEGDSI
VNIIDADTNILRYKYTINNNLLVKEDEISNGKVNRTTEFKYDQNFNIISEVTSFAGKISS
RYDFQYDYNQRSILRNVSTPEWLLSFVNENFAKNNQLISTLEEDYFETSNTQSPNYVQMD
TYTWDSYIDSFPTYVKTEREINGNPFVSNSTITYTKAK
>EGEFANNL_02244 Glyoxylate/hydroxypyruvate reductase B
MKKVFISGIIPRVGIDMLNEEGYTVEEWSNSKPITEKELISKCQKAEAYLCIMSQVSENF
LKQCSHLKVIATYSVGFNHIDIATATKLKIPIGNTPDVLSNATADLAFLLMINVSRKAFF
NYRRILEGKWESSFSATRYLGQELEGKTLGIFGMGRIGLKMAEKCRNAYGMKILYHNRNK
IINDEKELNASYVSFEELLLQSDVLSIHAPLNSENSGIFDKSAFNKMKPSAILINTARGS
IVNEIDLITALENKQIWGAGLDVTDPEPIQLDNPLLQMENVAITPHIGSATAETRNAMAV
LCAKNIIAGLKGEKLPGIVNPDVYK
>EGEFANNL_02245 Ribonuclease HII
MKKKYSTYQFEAALDEVGRGCLAGPVVAAAVILPADFYHKDINDSKKLSPKKRKELGAII
KDNCLSYSIAEVPSKKIDEINILNASFLAMHIAIEKLSIVPEFLLVDGNRFNPYKNIPHF
CAIKGDANFLNIASASILAKNYRDSLMEKLHEKFPNYYWNKNMGYPTIQHRKAIQEFGIT
NFHRKSFNLFPIQLSLEL
>EGEFANNL_02246 Decaprenyl-phosphate phosphoribosyltransferase
MNFLKLIRIHQWVKNIFVFLPIFFAGKLLDLNLVINSFFGFLAFSFIASSIYIINDYVDI
ESDKKHPEKKNRPLASGKIKKSEAIIILLFLLLFSFSICLYLKSWTLSLFIIAYFLMNLA
YSFRLKHVAIIDVIIIALGFLFRVFVGGAATGLPISIWAILLTFFLALVMGIGKRRGELI
NANLTGKTRKALDGYNLQFTDTVMTVISTCAILCYIMYTLDPTVMHNIHKDIVYTSLFVV
IGILRYLQLTFVFNKTESPTKVVYKDLFLQVDLILWIISIFILKYSI
>EGEFANNL_02247 Decaprenylphosphoryl-beta-D-ribose oxidase
MEKKSKPDTIEITNWGKYPLVKTNFHQTSNISEIQKIIKESHSIIPRGNGRSYGDNSLNK
ENILSTLRLNKFLSFDRENGIFECESGVILSDILDTIVPEGFFLPVTPGTKLISIGGAIG
SDVHGKNNHSEGCFGDYVLDFKIITEDGEIKKCSPTENSELFWNTIGGMGLTGIIISARF
SLKRIETAYIKQKILKADNLEEIFKYFDESENWTYSVAWIDCLQKGKQMGKSILMIGEHA
KLDELPTKWKNQPLHVEKKPLLNVPIDFPSFVLNTLTVKAFNFLYYFKQRKKIVNNFVDY
NTFFYPLDAINNWNRIYGKNGFIQYQFIIPRESGKKGMTEILQTIAKSGQGSFLAVLKLY
KKSNPKAHNSFPIDGYSLALDFKINSKLPLLVKELDEIVEHYGGRIYLAKDAMSKKELTD
YVKVPETNKFNSVQHTRIANGI
>EGEFANNL_02248 hypothetical protein
MKKNIYLLPAITAIIYLVINLVYVYFRNFDEDAYILFRYVEMAVDGNGIVFYPGGEHTEG
ATDFLWLILLIILGKIGINVGVGAIILNSFGVYIINYIFFKTLCKGFNYKISYFIAFPIA
TFWILFYPIIAALGGFSVILYSSLIVLLSYFLYNQKFINLIPYLGLTISLFRPDGAIIAV
TSTILGFLISYKKYFFHSLIALTLSIIYFIWRFNYFEEILPLPIYVKSNGGILQNILSNL
KILLFNKQTLIFTFLFLLSLIFIKKIRFRLLFAFFPVLIHFLTFTLMHQSQNVGFRFQAP
FFLVLYYLLILITIFIALSYRNIYIVLILPLLMLITSIKTYKHYYYTLNTLDYINQFTFF
LSRDILKGNETLYITEAGRFAYWNTKPNKIIDVVGLNNRYYAKKEAPLDNSKDKIDILMC
YWGGNSKPFSFFQNNIIYKFTNINQFQNIIHDYITQNKHSSEKTVLATMNILSFLSKNFN
DYDIIFVKMGGETSAHVYGINKKINISNDILKLLIWSNNHENYKSYINLIQLRKHLK
>EGEFANNL_02249 Decaprenylphosphoryl-2-keto-beta-D-erythro-pentose reductase
MIILGTTSDISQAFIDKFLFENSTKYKKIYLVTSNEEETKRFAQHILVKFKQESEIISFD
LMKDIDYSVFNHIDSDLLFCASGYLGKNTEDGLYNLSNTKQIININYAKLVPLINYFAQK
FEQNNNGTIIGLSSVAGLRGRQSNFIYGSAKAGFLTYLDGLRNYLYSKNVHVMSVIPGFM
DTKMTAGMPLPKPLTATPSKAASIIYKAYKKKKNKIYVTSIWWAIMTIIKNIPEFIFKKL
KM
>EGEFANNL_02250 hypothetical protein
MNNRLYLFDFDGTLTNKDTLFDFLQISFPHIYKSRFIKFIPLFLLSKFKLVNTEFVKQTF
ISSFLKGKSKEEINVLSQNYFNKRINSLIHPKALQYLKNIENTNDKYIVTASLDIWVEPF
ANFFGFRLISTKAEFKNQIFTGKFATPNCNGKEKVKRIVCEIQLSQFKEIYAFGDTKGDK
YMLELSTNPHYKYFNS
>EGEFANNL_02251 hypothetical protein
MVKKIILLVLFIGFVSFTNAQAYNGQGDQKVQIGINAFGYGTGITGSYDYGVLDWLSVGA
GGNFYWSNDNDNFFIFGRVNFHLNDVLDLPYNMDLYPTVRVGGRNDGFGIGAGLGYRYFF
TDKIGAYAELGSYGSLGVSINL
>EGEFANNL_02252 hypothetical protein
MKGLIKFYHPDETLEYHIRKCFCKVVFLNKKNTLVVEVESDDDLDHVEEDSYQNEYPQVS
FSLEDFEIPVNTVQQLLGKSFQVPSFEEIETDSGEIEEVYYTNLNINDEEYLDTGDNELK
FGKDENGNLKLIWIGYCEDFLTGNKEPLKFKISCSFTQDKLEIVE
>EGEFANNL_02253 Tyrosine--tRNA ligase 1
MNSFIEELTWRGLIHNVIPGTEEQLDKEMTLGYIGFDPTADSLHVGSLVPILLLVHFQRH
GHKPIALIGGSTGMIGDPSGKSSERNLQDDETLQKHLAGIKSQLERFLDFESNSPNSAVL
VNNYDWMKNISFLEFARDIGKFITVNYMMAKDSVKKRLNGEFQEGMSFTEFTYQLLQGFD
FYHLFSKEGVKLQMGGSDQWGNLTTGTELIRKKIGQEAFALTCPLITKADGTKFGKSEGG
ENIWLDVNRTSVFKFYQFWLNVADEDSEKYIKIYTFLSKQEIDELIIQHKEDPSKRILQK
KLAEEITSWVHGKEETDKVIQASSILFGKSTKEDFLALDESTFLSLFEGVPQKEVSLADL
KNGVLILEALSDFSGFLASKGEARRALKENSISVNQQKINEEYKIGEGDLIQGKYILLQR
GKKSYFILKGV
>EGEFANNL_02254 3-hydroxy-3-methylglutaryl-coenzyme A reductase
MEGLIVNGFSRLSKEDRINWLVKNFTNNSLKTKEILSQYWLDNKDLQKLHDEFSENTISN
FFLPWGIAPNFLIDGEMYALPMVTEESSVVAAAANAAKFWLNKGGFSTQVLGTTKLGHIH
FFYKGNKEKFTNWFQNFLKIKLEDATAEITQNMRSRGGGITSIILQDNTAKLEGYYFIEV
SFDTRDSMGANFINSCLEEMTKILKEEMNQSESFQSNEKESLQITMSILSNYVPDCRVRA
EVCCEVDELDVKVMSPYEFAVKFKQAIDIATVETFRASTHNKGIMNGIDAVVIATGNDFR
AVESCAHTYASRSGQYRGLTNCSIEDNIFRFWLEIPLALGVVGGLTKLHPLVRASLEILK
NPTSEKLMKIVAVSGLAQNFAAIRSLITTGIQKGHMKMHLLNILNQLGATNSEKELLSNL
FKYQIVSHHRVVKEFNKLRRNS
>EGEFANNL_02255 Lipoate-protein ligase LplJ
MIFIDNLQIYNPQINLAIEEYILKNLSLENDSYLLFYINNPSIIVGKNQNTIEEINTEYV
EKNNIKVVRRLSGGGAVYHDRGNLNFSFITKDDGSSFSNYQKFLNPVIKALNDMEIMAEL
RGRNDVVVNGKKINGNAQFATKGKMLTHGTLLFDSNINEVVNSLKVRKDKIESKGIKSIR
SRVGNISDYLSFPMSIEEFKKKILLSIFKVDSISKINSYTLTKFDWEKINQISKEKYANW
DWNYGKSPKFLMERTQRFPIGSIDLKLDVEEGVIKAIKIYGDFFGIGEISEIESKLVGIK
YSRQQVEIALKDVDLKHYFGAISLDEFLSLIY
>EGEFANNL_02256 hypothetical protein
MLLINNNGKSMKICFLFIVLLGLTLGAQKPIVATAKVEAATVYFNSVEISQSVNINLPNG
TSEIIVKNVSDYVNEETVLVGVPKQVSVLSVQYTTNYISEYDKNENSSQLKEVKDSILWV
TNKYSQIKNEKESTQKTIELLDANQKIVGSNGINSGDLIKVVEYYQTKRTELNNSLFVLE
RKEKELSEKLTNLKNKLSYSQANEENISQGKLVLQLMNSGNLQNIPLQISYISGGASWQP
FYDLRAESISQPIQFLYKAQVVQQTGVDWKNVKLTLSSGMPSQNNRVPELNPWFLYFQPV
AKLYRSNALSISMPEYANEEQVFNKKGMALENRQKQAYEVSTVSSTINENQLNTSFDIPV
LYNILSNGKQHSVVLNEIEIPASYKYFAVPKLDKDAYLLAQISNYSQYNLLKGEANIIFE
GLYVGKTVIDPNQTQDTLSLGMGRDKRVTITREKIADKSGTRFLSSSKEQTFTYDIVIKN
NKKNRINLTIEDQYPLSTDENIKIELMDKGGAKVDADLGKLTWDLVLAANEIRKIRISYK
VKSPKNQSISNL
>EGEFANNL_02257 Putative fluoride ion transporter CrcB
MFIQFLFIFLGGGLGSISRYAVSYITPNYYKGNFPLGTFLVNIIGCFLIGLFSIVLHKNL
TLNEFLITGFCGGFTTFSSFSKEAFLLFNKEKIKLAFIYVFSSCVVGLLSLFLGYITGGG
NC
>EGEFANNL_02258 Putative fluoride ion transporter CrcB
MKKILLVFIGGGFGSLCRHSISLLSATSNPPLFPFATFVANLLGCFIIGLLAGKVNLKNN
LNLLLVTGFCGGFTTFSTFSKETFFLIKEGYISIAFLYLTISFLAGITLVWLGFLISRKT
SKD
>EGEFANNL_02259 NAD-specific glutamate dehydrogenase
MKQDLNEFMKVVEMKNPHEPEFLQAVKEFAETIIPFISEQPRYNNKNILMRMTEPERSII
FRVPWVDDRGHIQVNRGFRVQMNSAIGPYKGGLRFHPSVNLSTMKFLAFEQVFKNSLTTL
PMGGGKGGADFDPKGKSENEIMRFCQSFMTELSKHIGAETDVPAGDIGVGTREIGFLFGQ
YKRLQNEFTGVLTGKGLSYGGSLIRPEATGYGVVYFCEKMLETIDEKIAGKTVLVSGFGN
VAWGVIKKVNQLGGKVVTISGPDGYIYDQDGITEEKVEYLLEMRMSGNDEVKDYLHKYPS
AAFYAGKRPWEQKGDIAIPAATQNELDLEDAKLLIANGVICITEAANMPCTLEAVHEFIS
NKILYSPGKASNAGGVATSGLEMSQNAMRMHWSSEEVDKKLKEIMTGIHDNCRKYGLEED
GSINYVKGANIAGFIKVADAMIAQGVI
>EGEFANNL_02260 UvrABC system protein A
MNTQTSSLKTNQDSEDILIKNAHLHNLKNINVSIPKNKLTVITGVSGSGKSTLAFDTLYA
EGQRRYVESLSSYARQFLGKLEKPQVDDIVGLAPAIAIQQKVISDNPRSTVGTTTEIYDY
LRLLFSRVGKTYSPISGKEVKKDEVSDVVRYVESLPEGGKYLLLSPLEVQGKDFSELLKL
LKGQGYVRLEIGGKVVTMEDLESFGFTPEPEVDILLVVERFSVEHNEEALQRFADSVQIA
FYEGKGDCFIKNTETGVTQKFSNAFELDGMQFLEPTIHFFSFNNPYGACPTCEGYGRVLG
IDEELVIPNKNLSIYEDAVFAWKGEKMSEWKEHFIKETAQAKFPIHKPYFELTSEQKKLL
WRGNGSKKFPCLDNFFKMLEENTYKIQYRVMLSRYRGKTTCPDCNGKRLRPETYFVKIDE
SSINDWIDLPLDQLSERIKQLKLSDYQKQIAKRLLFEINSRISFLLDVGLGYLTLNRASN
TLSGGESQRINLATSLGSSLVGSIYILDEPSIGLHGRDTDRLISVLKKLRDLGNTVVVVE
HDEDIMKTADYLVDIGPNAGTLGGEVVFAGTYKQMMKKQTLTSDYLNGAKKIEVPKTRRK
TKEYIEITGARQNNLKGIDVKLPMYCLTVVTGVSGSGKSTLMKGIVAPALQRKLGISGDR
PGAFSELKGNWKEIEHLELVDQNPIGKSSRSNPATYVKAFDDIRDLFAKQKLSKLNDYKP
KHFSFNVEGGRCETCQGEGRIKVEMQFMADIELECESCHGKRFKQEILEVTFEGKNIADI
LEMTVEESIQFFNTHKQAKIVNKLQPLEEVGLGYLQLGQSSGTLSGGEAQRIKLASFLIK
GNTTNKTLFIFDEPSTGLHFDDINKLLKSFYALIEKGHSVMVIEHHPDIIKCADYLVDIG
PEAGVHGGEVIFTGTPEEIIKCKKSYTGKYLKEKLSV
>EGEFANNL_02261 hypothetical protein
MFYTFAFVDFVFMSNYKYKVQKGDTLHKVALKFGISCDELRQYHNQYCPLEDLLPGTDKL
PRHLKEILLPEGQLTYQEKLEKSLNTNFSLGKNNSYKIEIENSFFLKNELMSENQTMNLW
KISEDLHAQRAEILVQEVQVIKCSSPLKALIDLVQQINKSSDHLMVSLLTDGTLGEVLNK
KEIFEKWEAIKFEELKSAELQDDFAKVLIEEYNQAFKRITPYIKQNMLYQVLFCPKKPLV
FPVNSPRVINKEFLVNSLIFPELLIPYTLSYTSKEQAEEIEILLTSKSPSSHWELFKERY
EKAYSLMLEDPFLPHFSLEGKYFYDKDSGTLNRAVVYAKEQMSKQLFYTLQYKINRIDQE
EGETPNDAFEPQEEIVLHEKKKLPPSPFLFDE
>EGEFANNL_02262 hypothetical protein
MKRKNYLLVLFCLMSSLFLLSCLDPIKSKNRKKYTPEFCFEEPLLPLAEAIYQGNAREIE
KLVHDNQIDLNTWSSKSGFTPLYYACLLEDVSVVKKLLDLGADPNLVSFDIIKDKKYPRT
ELCLTFVVARGNMSLTRLLLEKGANPNNPIDILPLNYAMAHKNSQEYIDLLMKYGADANF
LEAGSIDNAAQIAFTGRHFELINYFLDQGADPRSVNRLGYSLALLVQEELEEPGRTKEAR
ETLENIKKRLEKEYGIRFPVQLQRRQGMINEINQYEKIPEYIRKLPLMESSNKYIIRVKD
SLAAGKTISGRPLES
>EGEFANNL_02263 hypothetical protein
MKRIKIILVLLISMAFLTSCLDPIKSKNRKKYTPEFCFEKSLLPLAEAIYQGKAREIEKL
VHDNQIDLNTWSSKSGFTPLYYACLMEDVSVVKKLLELGADPNLVTLDVSDGSKYPRKIT
NISFVVARGNMSLTRVLLEKGANANTPIGLLPLNVAMAHKNSQEYIDLLMKYGADANFLE
YGSIDNAAQIAFTGRHFELINYFLDQGADPRSVNRLGFSLAYYIQEELKEPGRTKQARET
LENIKKRLEKEYGIRFPVQLQRRQGMINEIQRYEEVPESIRNLPLMKGDEEYNQKEVQYL
KAGKTIFGKPLND
>EGEFANNL_02264 hypothetical protein
MSQLYVPHGAITTCLEGKKNSQIKVSSQKTVFINQKLKATEEDRFQDNFYCQKMVGGTSS
LVGWISGAMGALGGPLGAFVGYYAGRFVGGFLGNQLSSQLLPSLCSTLCQSSQWSSVHPK
VKISGRRALLEKATLQCKMGGVVHIVLPQMHKALTHARMAAASYEDVDFQNPEDNKVIDG
FTPVNEDRAKDILGKDWKDLLNQNADNGFYAALYEDREGNVVIAYRGTEPSKTADLKEDY
LQAMGIRSDQYDAAVELAQKVKDAKNSGGILGEVSITGHSLGGGLATIAGAATGYETYTY
NAAAVHNSSYQRNGVEKNTEHIQAYIGTRDILNTLQDQREMVLSGAVLGAPAVMPVLGGV
AGGATGTVVGGSLGAVSTLPSLNPSIIGSGTLVGANVGGTTGTVAGLLGGGLLGTLLSAS
GIWGLATGGMPRQEGVQRIVVPQSDSDAMHAMEPLIVAMEKMFAKMGGGKPVKALLKN
>EGEFANNL_02265 hypothetical protein
MIEIIIFLLPAIFATSIFDFFTKQKSSPFTFLKKSLLFMLAINLFVWLSMIIVFDSDILQ
VQLDNYHSMFFSLSYLVTTLVYAFILSFLSFIFKTYVKTFLVYKKNKK
>EGEFANNL_02266 Phosphoglycerol transferase I
MKFSKKIILFILIFLSITIFFILLWLNSNFAHATFEQILFHINIPDNNPTFDYKTNLILL
TLLPASIITLCFIVLSMDFSKNESLFLYIKLFTKIKFRIQIYPIQLFRKYLFIFTIFLIL
LSSYLVYQKFKSYNVYGYFFEKTALYDQEYINPKKIKITFPEKPNNLIVIYLESMETTMQ
SKEEGGLFNQNIIPELTKLAKDNINFSQSDHVGGSVQVSFTGWTMAAVVASTSGIPLKLS
NKKENDMERYKVFLPNALTLGDILEKEGYNNILMEGSDSKFSGLKTFFQSHGKFQIKDYN
YFKENGLIHKDYLVWWGIEDAKLFNFAKQELTDLSKDQRPFAFVMNTMDTHFPNGYLDPN
ADIKFDNQYANVNANSSKQLYEFIEWLKSQSFFKNTTIIILGDHLSMDNFYKSYDLNQRF
PYNCIINSVVQPKHMKNRNFTTFDWFPTIIESIGGKIDAPGLGLGRSLFGNDQTLLEKMG
KDSLNNELSKNSDTFNHFWNN
>EGEFANNL_02267 hypothetical protein
MNESIRLTDTLNTLTENVSLVAVSKTRSIEEIAGMYKAGQKDFGENKVQEMMQKEEALPK
DIRWHQIGHLQKNKVKYIAPFVHLIHSVDSEELLHIVEKEAIKNDRILSILLQVKIAQEE
TKYGLTFNEALQILTQKKLEAFPHVNIIGLMGMASFTDNIQQITEEFLSLNSFFIKHQKE
FELQTLSMGMSNDYPIAIQCGSNMVRIGTKLFGARDYNK
>EGEFANNL_02268 hypothetical protein
MRKFFLPIILNLFTMTDAQPYNTEIKTDINGYKYETVIQDPSQTRIYTLKNGLKVYLAQN
IDEPKIQTFIAVRTGSANDPSDQTGLAHYLEHMMFKGTSKIGTLNWEEESKLLSQISDLY
EAHKVESDPDKKIQIYSKIDALSQEASQYAVANEYDQLLSQIGASGTNAHTWLDETIYKN
VIPSNELERWLLVEKERFSTLVLRLFHTELETVYEEFNRAQDNDARLVNYQLMDALFPNH
PYGQQTTLGTSEHLKNPSMKAIHSYFENYYVPNNMAMVLVGDLDFENAIQWIDQNFGNFK
YRELPVFNKIIEKPLTSVVKRTVKSPSSEKLQLAFRTQGANSEDLLKVKMVDMILNNSGA
GLIDININQKQKAQGAGSYTSFFNDYGMHILFGAPREGQDLKQIEKLLLDQIEEVKKGNF
PDWLIPAIVNNFKTQRIQNWDTASGLATQMYTSFIQKKSWESILKEFDELDKITKPSIVE
FANKFYKDNYVVVYKETGTNDHLIRVESPRITPITINRKAHSIFYKEFIQIPEKEIEPQF
VDYKDSIHFDKINATPFSFIKNKNNALGRLYYIFDFGLDHNQELGLALGYLNVIGTNQYK
KSELEQEFYKMGVKYSLQVQNEKIVLSLHGLEENLPQGIRLVEHLLKNPQVDDKAYHDYV
QTILKARKDAQRNKQYIFNALTQYAKYGQNNRIKNIIKEEELRNKNPEDLIQIIKGLTTY
KHEIFYFGPNEEPIKKAIIENHNTLGKNIYTQSLNYEKLVSDGTIYFTPYDMVQTEVLAQ
SKGEIFDVSKISFAYIFSEYFGSGLSSIVFQEIRESKSLAYSAYAFYSIAADQHKHDAVS
LYLGTQAEKLPLAMETMYKLMNDMPEIEEQFENAKKSALKQIASQRITKMNLFWSYLSAK
KKGLDDDIRKKVYSEVQAIALNDLKNFFNKNIKNKKYNVALMGNSDIIDWKEIKKFGNVV
ELSTSDLFSPTN
>EGEFANNL_02269 Na(+)/H(+) antiporter NhaA
MKRINKLFNDFLEDEKTAGIILIICTIISLIIANSIFQNSYLEFWKTPIRLQFGDFNFFN
HHGEPLSLDTFINDALMTVFFLMVGLELAREIYIGELSNVKQALLPIMAALGGILIPAGI
YAYFNYNTETASGTGIPMATDIAFALGVLSLLGKRIPLALRVFLTALAVIDDLGAIIVIA
LFYTQDLSMFSLGTALGIWAILLILNLLKVKSLIPYIIGGIIMWYFMLNSGVHATITGVL
LAFVIPFGDGGKNTKSYQLLSALHHPVSFLILPVFALANTAIVIDSGFPELFSQPYTLGI
FLGLVVGKPLGIFLFTFIACKSKLCVLPSQIGWKQLMGVGFLGGIGFTMSIFITLLAFDP
VMHYDYINNAKFMILISSLCAAILGFTYLNFIYRKKNI
>EGEFANNL_02270 DNA base-flipping protein
MKEFYEKVYKIVSKIPYGKVTTYGLIGEYIGVKSSARMVGYAMSHSHQLNIPAHRVVNRK
GLLTGKHHFATPSLMKELLENEGLEIENDQIVNFKNHLWDPKSLDNKNLSSI
>EGEFANNL_02271 Divalent metal cation transporter MntH
MNKKSLQEVHESINTDSPKRWRRIFAFFGPAYLVAVGYLDPGNWATDIAGGSKFGYALIW
VLLMSNLMALLLQSLSARLGIVRGLDLAQTNREYYPKWMNYILYAFAEIAIAATDLAEVL
GMAIGLQLLFGLDLIWGVWIAALDTFLLLVLQRFGMRKMEAFIIALVSIIGGCFLVEMFL
AKPELGEVVQGFKPSLPNNEALYIAIGIIGATVMPHNLYLHSALVQTRKIKRDFQSVKRA
IKYNFFDSLIALNLAFFVNASILILAAATFYKAGLHDIAGLHDAYRMLSNILGPMAPFLF
AIALIAAGQSSTVTGTLAGQIVMEGYLHFRMNPALRRLLTRMLAIIPAVIVISILGDNSV
DEMLIFSQVLLSMQLGFAVIPLIHFVSDKEKMGKFAIKLPIKILSWLVCIIIVILNIKLV
YDEEILIFKNPEISLGIKIFLGCISFSLLLFLLNIIIYPWLVRARKLKFNIHDNLVKNKL
LQIKNFNTVGIALDFSKNDARVLNYLSLVSDKTTRVILIHITESASANYYGKIADDFETK
FDHEKLDSYKRFLEKEGYENIETKLGYGLPAVNLRNLTEENQIEILLIAKHGHKGLINLI
FGTTSTKIHSKIDIPILIV
>EGEFANNL_02272 Oxygen-insensitive NAD(P)H nitroreductase
MDIAEISKKRFTTKHYNKEKKISSQDIQKLYEVLKNAPSSVNSQPWHFIIAESDDAKKKI
LPAILEFNHARIEGASHVVIFCAKLRFTEERFQELIEKEDNDHRFSSEELKKQNDEGRRY
FVGLNNTSEEKLVNWESKQIYIALGQLLLAAASLKIDSTPIEGFIPEKLDEILNLKEKGL
TSVVIASLGYHDENDYNASLPKSRLPEDKLFTFL
>EGEFANNL_02273 1,4-dihydroxy-2-naphthoyl-CoA synthase
MARNWKTIKEYSDILFQYWEGIAKITINRPQVYNAFRPETNFQMLEAMDYCREHSEIDVI
ILTGAGDKAFCSGGDQNVKGVGGYMGEDGIPRLNVLDLHKKIREIPKPVIAMVNGYAIGG
GHVLHVVCDLTIASENAKFGQTGPKVGSFDGGFGSSYLARSVGQKKAREIWFLCQQYTAH
EAMEMGMVNKVVPFSELEDATIEWCQIMQERSPLALRMIKRCLNAELDGQHGLMQLAGDA
TLMYYLMDEAQEGKNAFLEKRKPDFKKFPKFP
>EGEFANNL_02274 hypothetical protein
MNYINNFFRKIPDWLSSKLSIFIYLFLLFYLVIFALLCIIIPSWKDFMPSDNAQLIFGNY
TNVISALGASIAAGSGVSAHNSSQISRRNHRELLDTIKKLNNRLDELNKSISDNKKI
>EGEFANNL_02275 D-serine/D-alanine/glycine transporter
MLISLKSELNYKMNQPGKKLQRNLTNRHIQLIAIGGAIGTGLFMGSGKTISLAGPSILLV
YAIIGFVLFFVMRAMGELLLSNLQYKSFVDFVTDLLGPTAGFFMGWTYWFCWIVTGSADL
IAISGYIEYLFPGAVDPWVPAFICILIFLCLNLLTVKLFGEAEFWFSIIKILAIVALVII
GAVFIIYKFKTPVGIVASLSNIWSDGGFFPTGFAGFVAGFQIAVFAFVGVELVGTTAAET
KDPEKTLPKAINAIPVRVIFFYVLALAVIMSVMPWRMINPNASPFIVLFNFAGIAAAFSI
TYFVVLTSAASSANSGIFSTSRMLYGLALSQKAPTIFKKLSKVSVPAYGLLFSCLCLLPA
VILLYFGNENIMLAFTLVSTASTILFVFVWSMILISYIVYRSKRKELHKKSKFKVPGGLF
SVYGALTFFVLLIIALWFKDDTRQALIFTPVWFIILAVGHFLIPSKVRKQWLNDRFDLNE
NDSFK
>EGEFANNL_02276 Esterase YbfF
MNKQILHSKIYENKNKPSLLIFHGLFGLLDNWGSLGKKFGENYDTHLIDLRNHGKSFHSD
EMSYESMVEDIADYIDFYNLNKPILLGHSLGGRAVMSFSIEKPNLVHKLIVVDMAPKAYE
PHHVKIFEALNTIDFSNVRDRKDVENMLSKEIDNKAIVQFLVKNVYRKDDNSFDFRFNLK
GLEKNYIHIISKAIETGIFLGSSLFISGEKSNYILEDDKIEIIKQFPNSEFISISNAGHW
VQAENPTDFYNSVVSFIES
>EGEFANNL_02277 hypothetical protein
MARNIIRYENKENLEENGIITVVKYYRNRFQKSENKEFICSNCGNSHNHQHIYELQDKRI
VGICYHCNKKIHNLNSSNPKFNKPNQK
>EGEFANNL_02278 hypothetical protein
MPEKSTQGEIVVEGAQLFCSKGVTSSFLKVSHAEDDKYLINNKKIATWNEDSIQHMNFGA
CTRSSPPPQCTPKIQWTKYYENAEFGKRKILIDSSVGNCTCGGGKVEIKRSGQKLQPSRV
MYKKVNQNTYDLYVLNAKVASSKGKIAPAVTQVLIKSPLDLPIPENREVKVEMGGLVTKI
VLEAQVKSGGDPGLVHWVVYEGDTQKKRRMTWLEHGKEFVVDVNLYPEGKTTFYAYGKTP
TGNATKVVMHRLKNQLEGISGNSTVPKHNVNTFSPQYTFKRSLFSFIKPIWRIKQGEHVI
FSSVWPLLLNNQKHINVAINPNSQALSVSFANSGDYTLELEDSDFKTTRTLSVKVKNRSI
DSIENLGKSKIRKTEKIHLKCTGIHYSYTGLGNRGFWYARKDNGTVVELGLLESLQYTIP
QLQSVLASKVSNEVEKNKILSSPFGMYNFSVFGEKQTHVSKISFGSSADVAHIEVGKNRV
ESIEGPSVLPLKAKAKFKVRTFLPLIPEERVEWQLLDPALVQTSTPGVDEVFIQALQPTE
AEINVYLRGAEVSQAPLPTPWKIKASHLLFNQALWCYANGKRRTETGWDEENYIHLSLEG
FPLLPVKFKVFIKFPNVPLENSLSNSYCFLKEIEATLNDKGSCQVSFTADEEIKKKVEDY
GSFYGFTDARLFFTVELGKNDSLDLTEVGLYHKDNPEQALPSAQVEGKTLFFVLDPNEDL
LLPAPERITAINFSNEAQDDIQVGVTRYGITHRIWVNTVGMPKAKLTVKVYKTLLPVDMK
ETYHPESQAFQTAQEVKTYEEEVVGTDGLLNLEFTPKKEDADGDPQLFFVKVFKTITLED
SSTRLEPIGSQLDINLSLPFAEEISKDCDRLGISLPTLEEGQDPTEEQLKEIIGKFMHFK
NPLYVSETGTITDRDIISPVLVERGESTKTRTCYCDRDFTEEEVKSLVKTIKGKEIIWEG
LTESCLIEDKSFKSLTFELNKMFRKYKINKCIQKITFLAQVNAETGFFTLSHEEKSKFKS
SQSIYKGRGLIQLTGNLNKSKTAYDEPGVYETYGSYLGDKNKFIKNPDLIATNLHYTVDS
AGWEWEVSKKVPNWNDDPNKDTKVTKEIKKWKRKNFSKGLGKSLNGLALVMEETAEEEKY
FWLQSKMLNGYTLTHKDKPDPHGWDKRKEALQKLKTWFKYDKKVCNEEKSLIFNNIEGDM
PPWLKIAINEEKKNIREKTHCQYIIDTYHASTDNAKMSQCSGSRNGAAWCAAFVNYCIKT
SGYTSQQDPGATWYKDIYRVKRNKTGPYLTQEIWANKYTTMYIGGIIVWANNGHTAFIVG
IDKSNKNNYIILGGNQDDGVRFWTAPKTKIHSFCLFPIDYKGNLLPLKEIEPSDISPNAI
KYKEGGTA
>EGEFANNL_02279 hypothetical protein
MEVKDWKHTRLYKVSHTVEVKERSTLLKSETAYDLGIHCSTHPELKRRIFSKENLHLNGA
WPKDPTVRLYAQLELATYPLEIEVDEEENFLTLPTYRLWLTHWKKKADALLSEQYHGDFA
ESLKENFLVTMDTEEKLKQKLQQEAFWNLFFFNCNEEDTHRLRWNFLKLGNAAFSGSSKE
ESAKETYGFRFQGQLEEINEDFTKTLNEKLKFPWLSKNYIHAADLQGECTILSLREKENG
RLEHKSAEIILKSKNNQYFYNEKIEIKHQGISLRKIEPSHAFTFFLSEKEEETN
>EGEFANNL_02280 hypothetical protein
MKIKFLDTNNRTSNKSIIFPFFPFYQSDIEAIPDNINKNTY
>EGEFANNL_02281 hypothetical protein
MKKIYLFKLIFSILLLCLTFFLIIDTFYLQKLFLTGLMPYLLFITIIWIFLLIIVFIIKF
FIKKNKKLYFISILISIIALFVQYVFLFILSGIASISDW
>EGEFANNL_02282 hypothetical protein
MDEDEPNKITDPTKYFKSIHEALKDYFEKKGDKRTYYFMAMLGEVIKKDTIYYFKEKLIE
KCANKFENFATPSLTLRDAKNLPEAINFFNPASKEIASIFIEGLIHVIKNPKNMITAYTD
PDPKPKVITVKSKISDKSKEYYKKLKNMEKI
>EGEFANNL_02283 hypothetical protein
MNNKNSKKIILIILLFFSFIISVIASLLIIYNWNSFFNKENNIGEESMGIIFFQQGILLF
FIDFTLILFLTFLYRKIRKKEKKE
>EGEFANNL_02284 hypothetical protein
MKFYKNILLFIYLYGLLCFTTYLSMYAYSSEISSSCLKCSYERDILLSSFYVSFLFIPLI
IFHKKINKWYHRLVIVIVFILLVLLNNYKIFADRVSSWSSYSFLDELLSIWSISYPYLTI
GSLLVFFFNEII
>EGEFANNL_02285 hypothetical protein
MYLIRKIFILFIFISILISCHSKKQSQIPSDKEMIDSFLLRENEFNSFKEYIFNDSGFKN
YPLVRNFKDSLKIKNLDYVKKVKENLNIIRVYKIDDYIEITTFEKGNSTWGIEKGYYYKK
GKMDDFQHKYNSEKVVEGDLWEECRKIGENNFTVYKNIKGNWYLFLRYDK
>EGEFANNL_02286 hypothetical protein
MHKGNIIRTIGGESIKKAKKSITLTATHGDLTFNSPTQVIMTGKQGGVQYLSDYTPPLPL
RVMKLDGPYDENGKKVTILEKEKWYKYKVIQFNRAPKGSEIKNLRWANQYDDNKIDTYFP
TVIGKKEVSFRIPNKAIVSKFTVYAYFKQPTISVSVSTYVEKHSCNYIDANIIAEYMAKE
MNTNIKSSHCDLIKMFNNKYSNTYNLKKKYDYFRKACVLWKSLVKKGAIWDHKITLLDMQ
NKKNWSCDKKSSKALLYNYDIWSNIHYGFVGKYVGFSEFTLINGAGYAQIGDNNKPLDEW
KTWKEYLKNRIEDFGDSDILGGFDDPSDQQAIKIGFRLFDKHIENIQAKDLLDEIQITLE
KNKPLSVKLCI
>EGEFANNL_02287 Actin cross-linking toxin VgrG1
MAKKPVFGDGNRMLTEEEADLLRHISHKIPTYGGSKSNLFENSSLVSVKVLINGKECFND
THIELELKQSIGHPHSFELICDPDEFQENEAYLLENSRLVLGKRISFMFYQYGKVQQMFT
GIISRVQTKVVESVRHVILKGSCPSVLMENGPHCESFEEVTFEQLLAGIATKYPQNLVQF
KVNPNFKGSIPYLSQYHESDYGFIQRLAKQFGEYFYYNGEQFVFSAWGSKIIEMMEGEDI
YDFELGMEMGTQGFSYTAYDPKHGEEIQVDSKSHPVQKSVNPFEQYADNVSEDWFNRVSP
QQHLYPSLLPKGKNGMVEAAEREQRRNQGLVRMKARGNNPSLRVGDVAKMFVWMPGHKIF
KNGRVPAESYKVIEIVHKFIDGHGYEHHFVGVPKDAIVPLNYNPTAYPKAELQHAKVMDH
KDPLKMGRLRVQFSWQKAKNSQTPWIQVIQPHAGSGKGTYFTPEIGETVLVAFQGGNPDA
PVVLGTAYNGGEIARYYTEGNDIKVIETRSGTRIVFNDAEGKGSILVEDPSGNRVFLDGK
GNIKSVAPETIFMEAKNIVLSASQNISISAGENISTLAAEDYNLAAGNIYESAGETREST
ALNFSETSKKSAYTSKEDVIHLESGTLVKSNSANQTSLH
>EGEFANNL_02288 ABC transporter ATP-binding protein NatA
MSVKIQNLKKRYKDQWALEDINLDIKKGEIVGLLGPNGAGKTTMMRAITGSLSIDGGKIW
IQGLDNQEEAFKIKSLIGYLPENNPLYTDMYVKEYLTFVANIHRIDPKEIEGVIEKVGLS
PEKGKKISQLSKGYKQRVGLAQAIIFNPEILILDEPTNGLDPNQIIEIRQLIQELGKEKT
VILSTHIMQEVEALCSRVILLNHGKIIQDKSIEEFQSKFTNLEEAFFEYTR
>EGEFANNL_02289 P-protein
MKSVSIQGIKGSFHHEAVVKFFKEEEVEIVDSPSFNTLVKDIIQGTADYGMMAIENSIAG
SILPNYTLITKNNLYIVGEVVIPIHHHLLALESETLETIREVQTHPMALLQCQNFLEKHE
DWKQLAKDDTATCAKNISENHWKGVAGIGSQLAAERYNLKVLAKNIHDVADNYTRFYLLS
KHKEKIEHFNKASLYFATNHKMGSLAQVLNLLAEHEMNITKIQSVPLPEAVFQYSFHVDV
VSDKKGYDHYYKALEEIKKVTGFLHVLGEYKQFKI
>EGEFANNL_02290 hypothetical protein
MGVTELVFIGFVIFGGILGYSKGLLRQISTLAGLFLGYFAAGLFLSPVHKYLVEKKILSS
DFSTTLTFILLILVIYLSVKFLSKGIENMLKAIGLNFTNRIAGFLLGGFKFLLIGLFVSY
LLIMVGIISEKNTSQNFMDGVGLFRSILWSYLK
>EGEFANNL_02291 Peptide chain release factor 1
MSDLVPKLEAIKQRFDEVADLIIQPNIISDQKRYAQLNKEYKDLGKLVDVYKEYKTLLNT
ISDADEIIKEGADAEMVELAKEEKNSALGLIPSMEENIKFMLIPKDPEDDKNITVELRAG
TGGDESAIFVEDVFRMYSMYWRQKGWNFEVVDATEGSVKGYKEMIVNVSGEGAFGTMKFE
SGVHRVQRVPETESQGRVHTSAITVAVLPEAEEVDVEINPADLEFQTARSSGAGGQNVNK
VETKVQLFHKPTGIMIQCQVARSQHANREMALQMLRNKLYDIKLQEHLDKISSQRKTMVS
TGDRSAKIRTYNYPQGRVTDHRINKSIYNLDNFMNGDIEEMIDSLKIAENAEKLKGEEE
>EGEFANNL_02292 zeta-carotene-forming phytoene desaturase
MKKVAIIGSGISGLSASAYAARQGYEVHVFEKHSQPGGRARQFKSKEGYIFDMGPSWYWM
PDLIEDFFTDFNCKTSDFFTLISLDPQFEIIFSDQTVQVPKSIKELEDLFESHEPGGAAQ
LRKFMREAKFKYEVGMKEFVNKPCLSWLEFLSFRILKSTLKINLLENFRSYVSKFFKDKK
LRTLMEFPVIFLGASPEKIPALYSLMNYGGYALGTKYPIGGFYKLILAMKDIAEKQGVKF
YFNHNVEAIHAKDDLVKSLIIDGKIHEFDAVIASSDYHHTETLLNPRYNNYTENFWKKKT
FAPSCLIYYLGISQKIPKLQHHTLFFENDLDEHIDTIYNEKRWPEKPLFYVSCPSKTDNL
VAPEGKENLFLLMPLAIGLEDNEAVREKYLEIMLQRIEKYTGVSHLQNKIEFKKSYCVSD
FITDYHAYGGNAYGLANTLEQTAVLKPKIKNKILKNLFYAGQLTVPGPGVPPCILSGKIA
AHELSKLKF
>EGEFANNL_02293 All-trans-phytoene synthase
MKHLFDELSFSISKLTTRKYSTSFSMGILALKPSIRSAIYAIYGYVRLVDEIVDSFHDFN
KEKMLQNVKRETEEALNEKISLNPILNSFQQTVHKYDIDKNLIDEFLQSMEMDLKKINYD
SNLYKTYIHGSAEVVGLMCLKVFTEGNQKIYEDLKPYAMKLGSAFQKINFLRDLKNDYWE
LGRTYFPNLNVKAFNNQVKVLIENEIENEFKEALIGIKKLPHSSLFGVYLAYKYYFSLFK
KIKSKSSNEILIQRIRVPNTEKAWVAFKSYLRHKTTFY
>EGEFANNL_02294 hypothetical protein
MNYQLYREQHLNCNIKEAWEFFSSPKNLSLITPKDLGLTVLTNFEDDEIYEGMIINYKVS
PLLNIPLKWQTRIIQVDYQRSFTDFQEKGPYKYWNHFHEFIPKSQGVLMKDTVDYELPLG
VLGVFAHNIFIKNKLKSIFEYRFNILEKIFNSNLN
>EGEFANNL_02295 hypothetical protein
MEGFTWVVHKYIMHGFLWVLHKDHHDHSSPGNLEKNDYFFVIFALPTIALMYFGSLNNFN
ILFYIGLGIMLYGLAYFFVHDIFIHQRIKIFKHTKNPYFLALRRAHKQHHKYIGKYEGEC
FGFLFVPIKYFKMYSKSDTQ
>EGEFANNL_02296 hypothetical protein
MIAYTYITVLFFTIIICLIASFNPLIKFNKYFGVFIKSAICASIPFILWDVYFTHLGVWW
FDTRYTLGITIAGLPIEEWLFFICIPFSCIFTYYCIDKFFNIRWLRGFNNMIVFFSIVTC
SLIALLYSPKIYTLITTLATILTLIFLHFIARAYWISQASFVFTILMLGFFPVNGILTGF
GLDHPIVNYNPKGYMGVRMGTIPIEDAIYGYTQFLWVLYFFKKYSSKKNLKMRKIEPNE
>EGEFANNL_02297 hypothetical protein
MYLDEWKFFKYKYLVNKYLNNLKIYRYQLNWLRKFYL
>EGEFANNL_02298 hypothetical protein
MNLKYIKSLLCVAFASSCYGMVAIFVRLAYQQHYNTAEIIISQALIGFLGLLLIYFISQN
KYKNYLYTKKDIIKLMICGCSFAFTNTFFYQAVRLGIPVAICTVLLMQAVWMGSVVDFIV
NKKKPSIVEIIAILTILVGTFLATNILEHKKEQLNFLGLTFGFLAAVSYTFSLFSTNKIS
VNVPPTLRPACLLFGASLMVSLIWSHELVNEPFHPSIFYKWGLIIAFFGTILATSLFSSH
MPVVGIGVGSIVASIELPTSVIAAKIILSENINYIQWVGILLILLSVVFLNIPLLRSNKT
SN
>EGEFANNL_02299 DNA polymerase III subunit alpha
MNFLVFDTETTGLPANASAPVSDSDNWPRMVQIAWQLHDENGNLIENYDYIIKPEGYDIP
FNAQKIHGISTEKALAEGYDLKEILDKFNKVLEKNPILVGQNIAFDIPIVGAEFYRKSID
NHIADLDLVDTAKEGTNFCAIPGGIGGGFKYPKLSELYEKLFGYSFDEAHNAAADVNATA
QAFWELVRLNQIEPKKLGFTPEQLVNFINNHPNPFQPFDIVVRQQVKDFNEKLKESRKDH
KRSIDEIDYSQYFHFHNHSVFSILTSTSKHSDLIQKTLEFNMPALGVTDTGNLMGAFAFL
NEIKKVNGKIKDQNAKINAGDIHKPLQREILPIVGCELYISENYLQNKFTKDNPDRRYTQ
VLLAKNYQGFKNLSKLSTLGYQLGYYAGFPRIGKDLIEKYKENLIATTGGLSSEIPSLIL
NVGEKQAEEAFVYWHQLFGEDFYVELLRHHLAEEDHLNQVLLKFAEKYQVKVLAQNDTYY
INKEEAETQDILLCIKDGEKQSTPKGKGFGKRYGLPNEEYNFKSQEEMATLFADIPDAIE
NFKDFIKKFEPYQLAREVLLPKFDIPEEFKDPKDDEDGGKRGENAYLAHLTWEGAKKRYG
ENIQESTKERLQFELEIIAKTGYPGYFLIVQDFTSQARKMGVAVGPGRGSAAGSAVAYCI
GITNIDPVKYDLLFERFLNPDRVSLPDIDIDFDDRGREKIIQWVVEKYGQNQVAQIITYG
TLAGRSAIRDAGRVLELPLSDTDRLSKNLPATLNLTKLKNKSEADIQKDFGKEEAQPVLE
LKHKFKSNDLEGKVIQNASLLEGSIRNTGVHACGVIITPEDITNLIPVAVAKDSSLLVSQ
FDNSVVESAGLLKMDFLGLRTLTIIGDAVEIIKKRTGNKIDPDEFPLDDEKTYEIFKNGN
TVGIFQYESPGMQKHLKALQPDKFEDLIAMNALYRPGPLQYIPNFINRKHGKEPITYDLP
DMEEYLADTYGITVYQEQVMLLSQKLAGFTKGEADVLRKAMGKKMIDVLNKMEAKFVDGA
KSKGHPEEVLKKIWEDWKAFAQYAFNKSHSTCYAFIAFQTAYLKAHYPAEFMAALLSNNL
NNLSTLTFFMEECKNMGLEVLGPDVNESDYEFTVNEKGAIRFGMGAIKGIGENAVEAVVN
ERNTKGKYKNLFDFFERVDLKNINKKVLENFVLAGAFDDLADGNRAQFFTEENGSITLEK
LVRYGIAYQGDKNSAQNSLFGDLGDEGLEIMKPNIPQTEEWTTMYKLGKEKEVVGIYISA
HPMDNYKYELDLVKPMDIVEINENKDKYVGKELFIAGMISRFEHKEINDGRDRIAYFDVE
DKTGTLSLKLKKNYLDLQKYLIKNLFVLVKITVGMIKDNGFIYINVLNIEELSGIIDKHT
KKLTIKINLEDLDEKTLIALNKICDENSGTKDIHFEILDKKNNLFLESASMNKRINISKE
VLDQLKDELYLDFRLN
>EGEFANNL_02300 Methylated-DNA--protein-cysteine methyltransferase
MHLKLNLKHLVSNIKIQYYKSPVGKLVIGAYKEKICLCDWLYRKKREVIDSRIKGYLEAD
YIFSKSEVIDQTIIQLKEYFNKERKTFNIPILLCGSEFQKLVWTELMNVPYGRTTSYLEL
SKNIKNINAIRAVANANGANGISIIIPCHRIIGVNGGLTGYSGGLKAKKKLLELEAPFIQ
TTLF
>EGEFANNL_02301 hypothetical protein
MKIPAYIQLQFIVLMWGFTGVIGKLITLSSIPLVWGRTLIATVFLYIYLRFIVKENFIIK
KKLILQFIGCGFVIGIHWILFYGAIKISNISIATSTLSTGTLFAALLEPIFLKRKIKISE
IFISIIIILCIFLIFKTEFQYWKGILMGVSCALLSALFSVINGKLHSKSNATVLTFYEMI
GGFLILNLFIGLGNNLDQIIHIKFMDIFWLIILSCILTCLPMIHTIKLMKFLTPFTIMLS
INLEPVYAILIAFLIWGDAEKMSLTFYIATAIMILAICTNGYLKNRNSLR
>EGEFANNL_02302 Ribonuclease BN
MKLTILGFNSAIPTINSHPSAQLLDIQENLFLIDCGEGTQVQLRRAKAKFSKINHIFISH
LHGDHVFGLIGLISTFLLLGRENILNIYGPKGIKMFIENQLSLTESYQIFKLNFIELSST
DSQLIYEDNKLTVHTIPLDHRVYTNGFIFKEKAKPKRLNIESINQYPQIEVCDYHNLKLG
KDWVSEDGKTIISNEKLTYEAKHSYSYAYCSDTSYKPDIIDLIKDVDVLYHESTFLNDLE
DLARKTKHSTALEAAKIAKEAKVKHLILGHFSNRYSDFSVFKEEAETIFASTLLPSELET
IDFEKM
>EGEFANNL_02303 Aerobic C4-dicarboxylate transport protein
MKLLKSLYVQVIIAIIVGILIGHFYPSHSEVVDGVNKNIPGFAEKLKPLGDGFIKLIKMI
VGPLIFCTIVIGIAGMEDTKKVGKVGVTAIVYFEIMTTIALIIGLLFVNILKPGNGMNVD
PKELDSSSVSGYIDKANHEDGNALVDFIMGMIPDNVIASLSSNNLLQVLVFAVLFGFAMT
KIGPKASKPVLTVLQSFLDGLFAIIKMIMYLAPIGAFGAMAYTIGRYGISSLSNLGMLIL
CFYLTCIIFIFGVIGAVLYYNKINVFKFIKYIKEELLIVLGTSSSESALPGIMKKMEDIG
CAKSVVGLVIPTGYSFNLDGTSIYLTMAAVFISQALNSHLTIGQEITLLLVLLLTSKGAA
GVTGSGFITLAATLPVVGDLPVESVALIFGIDKFMSEARALTNIIGNAAATIVVARRENE
FDTSMAKEILISSEVAKAS
>EGEFANNL_02304 Inosine-5'-monophosphate dehydrogenase
MSLSKKIIEEAITFDDVLLVPAYSEILPSQVSLKTNLTQKIELNIPIVSAAMDTVTESSL
AITLAREGGLGFIHKNMPIEQQASEVNRVKRSENGMISNPITLSRKHSLKEALSLMQEYR
ISGLPVIEEDDTLVGIITNRDIKYQSNLEQRVDEVMTKNNIITSTKDTSLEQAKQILLDN
RIEKLPITDKNNKLIGLITIKDIDNLLEYPSACKDSNGRLRVGAGVGVGVDTLDRVDALV
KAGVDIIAVDSAHGHSINVINKIKEIKNSFPELDVIGGNIVTAEAAKDLIDAGANALKVG
VGPGSICTTRVVAGVGVPQLSAINNVFEYASQHNIPVIADGGIKLSGDIVKAIASGASCV
MLGSLFAGTEEAPGDEIIFQGRKFKSYQGMGSLSAMKRGSKDRYFQSEAKKLVPEGIEGR
VPYKGKISDVVYQLCGGIRAGMGYCGTKNLEELKRDSKMVKISSAGLKESHPHDVIITQE
APNYTN
>EGEFANNL_02305 Cytidylate kinase
MIYTIAIDGHSSTGKSTYAKSLAKDLGWTHIDTGAMYRAITLYGLINFNEGHSINEKKVI
AALKNIHLKFIYNPITNTNDIYLNDENFEPKIRDLKVSESVSTIAKIPEVRSFLVEKQRE
LGKSESIVMDGRDIGTVVFPNADLKFFITASIDIRAQRRYLELKNKSSIITYEEVKENLI
KRDYIDEHRILSPLKMAENAYLIDNTFLDKEQTYRKIKQIVISKINL
>EGEFANNL_02306 Biosynthetic arginine decarboxylase
MKIKYYDLIQQTFDFPQPEFKVNNGNLLFHDIPLMDLIEKFGTPFKFNYLPKISENILQT
KEWFKKSFKENDYKGDYKYCYCTKSSHFSFVVEEALKNNISLETSFSNDIEIIKKLYEKG
SVDKNIEVICNGFKTEEYLKNIAEMINGGFSNIIPVLDNFKELERLSDSIDSNFNVGIRI
ASEEEPKFEFYTSRLGIGYKDIIPYYAQRIQNHPFARLKMLHFFINTGIKDTSYYWNELY
KCLRVYARLKKIAPEVDSLNIGGGFPVKTSLSFDYDYYYMINEITYQIKKFCEGEGVEEP
TIYTEFGSFTVGESGGVVYKILSQKRQNDREKWNMIDSSFMTTLPDSWAISRRFVMLPIN
RWEDSYERVFLGGLTCDSDDYYNSEQHVNAIYLPIFNEEKPLYIGFFNTGAYQDSISGFG
GVHHCLVPGPKHILIDKDKDGKLNYKVFREEQSHKEILDLLGY
>EGEFANNL_02307 IMPACT family member YigZ
MSEIFQYRTIDKPITNFLLRIKGSKFYGLLLYMENENDLNIFLQKSKDLYPQATHYCYAY
RIGVKGEKFRVNDDGEPSGTAGLPIYNQLLSADIVNVLLIVVRYYGGTKLGVSGLIKAYK
ECSLQTISQSNIIEKEIYECYELIFNYDKQSLVMNFLKKLQIEPISFNFLENCSVKIKVP
VKKRDSFLDKFNPLFLQKFVSYKLLA
>EGEFANNL_02308 Chromosomal replication initiator protein DnaA
MSKTSISVWDSCLQYIRDNISEKSYLTWFEPVKAVKLQENVLTIQVPSKFYYEYLEENYI
KIIKSALTKNLGKDAKLVYSIMMEKKQMTEEPYTVNIPSSQKAKIQVQEVDAPLFVERGV
KNPFIIPGLQKLKIDSQLNTNYTFDNFIEGESNRLARSAGKQIAKRPGGTSFNPFFIYSG
VGLGKTHLAHAIGLEVKRLQSGKTVLYVSMEKFCQQFQEATKSNNRNDFIHFYQMIDVLI
VDDIHFISGKKGTQEVFFHIFNHLHQSGKQIILTSDKSPVDIQDVEQRLISRFKWGLSTE
IQVPDYTTRLAILKQKMEFDGIELSEEVLEYIAQNIKTNIRELEGSLNSIIAQATFNKKE
ITLELVQKTLDSLITNSKKDITIDFIQKLVCDYFKVPIDLLQSKTRKRDIVQARQIAMYF
AKKYTNASLTSIGNQIGKRDHATVLHACKTVDNLFETDRMFKTYVDDLNKKLASNI
>EGEFANNL_02309 Low molecular weight protein-tyrosine-phosphatase YfkJ
MVCLGNICRSPMAEGILRSKLPENFIVDSAGIADYHVNDKPDKRAIEICKEHNIDISHLK
GRQFLPSDFDDFDLIYVMDHANFGDIIFKARKEADKRKVRMILSDVYENPKQQSIPDPYY
GDENDFKKVFQQLDLACTSIAEKLLSAN
>EGEFANNL_02310 Fe/S biogenesis protein NfuA
MELKIENTPNKDIIKFVAPHTLVEGSFEISNFDEAKNIPLAQELLKFSFITKILITANFI
ALQKNESIDWELVQNEIKEIIIDELLANPSIIIKPQKNPITVYAESTPNQEVMKFVTSRI
LVEGIIEIKDVHEAKDVPLALYLLSFPYVKEIFICDNFISITKNKDFDWQEIAMEIRTNI
SEYLKDNKDISYLNELIVKESIENSDRKEYTPIEEKIKKILDEYVLPAVSGDGGNIDLVS
FDETTKTAKMILQGACSGCPSSIITLKNGIENLLKQMLPNEVENVEAING
>EGEFANNL_02311 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-acetyltransferase
MAIIKKILDKTPLWGKDCFLAENSVLVGDVILGDECSVWFGAVIRGDVNFIKIGNRVNIQ
DHAIIHCTYNKYSTTIGNNVSLGHRAIVHGCTIKSQVLVGMGSIVMDDVLVESNSIIAAG
AVVTQGKHIKSGEIWAGVPAKKIGEVSTELKDNEINRIAANYVEYSSWYK
>EGEFANNL_02312 Asparagine synthetase B [glutamine-hydrolyzing]
MCGLVGIFNIIENKQLLRYKAINMSKKLRHRGPDSSGIYFNDKAIMVHERLSIVDVSSGH
QPLYDEKKNLILIANGEIYNYKELKYDLKDKYSFQTNSDCEVILALYKEKGLKLFDYISG
IYAFALYDKEKNTFLIGRDHLGIIPLYIGYDEYKQLYIASELKVLEGICNDIKEFEPGSY
YYSPEPIIKKWYFKDWDQYKNVKDNISDIQKIRKGLEDAVLKQTMSEVPYGVLLSGGLDS
SIISAIAKKIFDEKSNDKHSPAKTNQLHSFAIGLKGAPDLIAAKKVADYIGTNHHEIHFT
IEEAMDALEDVIYHIETYDVTTVRASTPMYLLARYIKSLGIKMVLSGEGSDELFGGYLYF
HKAPNAKEFHEETVRKLESLHLYDCLRANKSLMAWGVEGRVPFLDQEFIDIAMNINPKDK
MCGNGNIEKYILRKAFEQYLPKDILWRQKEQFSDGVGYSWIDSLKATADKKISDNQMKFA
KEQFPINTPKSKEEYWFRTIFEKHFPSQAAAKTVPSIPSIACSSATALKWDKSFQNNLDP
SGRAIKSIHVNAI
>EGEFANNL_02313 hypothetical protein
MKHLIIIGGGASGFFLSSNIKTSNWNISLLEQSKNPLQKLKISGGGRCNVTNACYKPKDL
IKNYPRGNKELLSLFSKFQPLDTFQWFEKRGIHLKIENDSRVFPDTNSSQTIIDTLLSET
KKNNVVIHYETTVLEINYTNNKFEILTNKDIYYADAVVIATGSSKKIWNIIEKLGHKIIP
PVPSLFTFNCNHPLIKNLQGISLAETDLNILNTPFKERGPLLITHWGLSGPAILKLSSWA
ARYLADLDYKFQLRINWITENFDDARELLTNYKNAHPKMDIYNIKIYNLPQRFWLNLLNH
LNIIKKPLFEISKKEINRIAESLTNSKLDIIGKSTFKNEFVTCGGVDLKEIDFNNMQSKL
IPNLFFTGEVLNIDAITGGFNFQACWSESYILSKQFN
>EGEFANNL_02314 Putative tyrosine-protein kinase YveL
MDSTKDSQNVLQNKLNQKKNSDILDNNFFSIERFIRRLIKNWYWFVIAFIIGWVIAFLVN
RFSDRFYQTSATVSISSGTSSVLAPSQSINFIWGGGGGATQGIYYKKLLTSRTHNENLVK
SLNLYINYYRKGKIKTTEIDYVDLPYKIVIDTSYAQALNTNVNVQLLPNQKFKLIFPEEL
NENCFYFNSEKYIHRKDQYKNELIAPLNTWIKTNNLKFKFIKNEDYQDKFGKNPINLDYY
FYLSDINSAVSKIQSSISINFDQDLPSIMIITKTGLSLHGTINFLNKSIDELIKRRIEDK
NQVNLNTIKFIKDQIKITKTKLDSASASFKKVQLENKVFSKNDVSTDILLSKIQGLDQQK
EELKSKQLVFNRLRGSVYNSNELIDGEFMGIENSTFNSAIQTIESLEKERKEKLLLYREN
SEPIKELNYQINNAKNKAISSLNSSSKELNNKLLNINEQIKNLELDIDALPEKEQLFINA
QRGYLLNNSIYNTLLDKLSEVEMRKATTISDITVLDKAKNIGQGPITPDIRKNKLTYIGG
SLIIPFIILVLIELLDNKLKLISDLKSATKIPLIGAIGAKNTENNLAVFQRPKSSIAESF
RAIRFNMRFLFNEKSIQGGKVFLITSSIGGEGKTFISINIASVLALSGKKTVLVGMDLRK
PRIFDDFKISNKIGLSGYLAGNNTLEEIIKKTEYDNLDIISAGPIPPNPGELLISDENEQ
LIQILREKYDYIIIDSPPVGLVIDAYDLMKFSDARLYVTRCNYTYKQLLKSINEKYNNDE
IDHIGIIFNDYVNPGGYGYGYGYGYGYGYGYGYGYFEEDEKYDNSLLSRIKRIIKKN
>EGEFANNL_02315 hypothetical protein
MKISHISVTLFILLFFNSCIGIKDLKYLQPSEDLQLNEYGLIPVVYENYRIKKDDILAMT
LITTDQNAAKFLASENTTRFKGGITGNDNSLRMTGLIVDPNGYISIYGLGEFYVYGLTLR
EVTELVQNKLNEVLYNEGKAEVRMNLGAIRYYMIGEIGAPGEKLEQSNRVDLLQAIAKSG
DLTRFADRRHIRIIREYPEGKKNIVLDVTREDIMNSPYFYLQSGDQIIIDPLKEKISGLG
GGTTIGDVTQFLSVGIQAITTYLFFKTL
>EGEFANNL_02316 UDP-N-acetyl-alpha-D-glucosamine C6 dehydratase
MFDFKKEDSIIINNKTVFFDELFKKKIDYSILNYSFFENKIILVTGGGTIGSSLIKYLLL
QNVKKIILVDHSEYAIFNLHLDLKQNINLNKIKFLLGDIRNTSFIDEIFKKFTINIVYHT
AAYKHINILEDNMTEAITNNIDGTINLLNISLINNIDQFIYISTDKAVNPINKMGITKRI
AELKLLDKIIYTNNSFIKIIRFGNVFNSSGSVFPIFKYQIENNKNLTITDSNMKRYFISK
FQAARGLMEISNPSNPSGIYLLNMQESHKILIILLELLKKLDLEYLTKDIYITSNTKDHE
KLEEELYYPYELIENCNNLFSKLKLELELNSKNEINAELINLYGILKK
>EGEFANNL_02317 Putative pyridoxal phosphate-dependent aminotransferase EpsN
MDEKIYLSPPNIDYRVYNNIKKALDSGWISPVGSFIDDFTNKLNSYFNKKILLTNSGTSS
LHLALKIVNIQKDDYVLCSNFTFAASAFPILYEKAIPIFIGSEEQTWNLSPDYLNLAIEQ
LNKKKIKPKALILAHIYGMPAQLDEIIKICNLNKIVLIEDSAEAFGSKYNDQPLGALGKI
GILSFNGNKIITCSTGGAIILSDIESLEYAKKLSNQSKENTDYYLHNELGYNYALSNVLA
AIGDSQIEKLNLKVNKRREIYKHYFKFLKEKFDIQHQYESYKSFSNRWLSSFIFPTNINH
KIKNSLAFNNIETRYLWNPLHNQKAFANSLYFGNKILDNFLFENGLSLPSGDNLTLDNLE
KIINIIKKL
>EGEFANNL_02318 putative undecaprenyl-phosphate N-acetylglucosaminyl 1-phosphate transferase
MEEFDIRHIKYLFGINSFYLRCVIGFLGTFFLTYISVPKIIRVSYKKNLMVTPGQRSSHI
RKTPNLGGIAIFYSIVVMASICAYELFTSYIFLFAAIVILFFIGLMDDILVVAPNKKFYA
QIITAIMISVGSNVRIGHFFGIMGINLIPYWLSIIFTVFVFIFLINAFNLIDGIDGLASG
IAILACCAFIFTFWRLSTNINYAMIVLALTIIGSLLAFLKFNFSVKYKIFMGDTGSMIVG
FLLSFMAVKFLNLFLLKNAEGGPMYNLQSAPAIAMAILIIPIIDTLCVFLIRLYYRTPPF
KADKNHMHHRYLKLGLTHKQVSMILVIENAFIIIVAYFLRHLNVNILLVIILFLGFVFSF
LPLILKKDYKNYG
>EGEFANNL_02319 hypothetical protein
MKNCLLFLTRYPYPPIGGDKVKSKNMVKILSKNFNLTIVIITDEPYNENSEDFLKKYCTK
YFVYRYPKYRFLFNSIKGIIKKEPIQVSYYYFKNIKKKLYLEIENSDFIINNLIRTVKYV
EDTEKIKFLDIVDSIGLHYLEAQKKSTSFLWNLVYKLEGKRVSNYEKNCIANFNNTFFVN
KNESEFYSKYGNTSWIPNGVNPNLLNYKYTINNKSNKIVFFGKMNYQPNIEAVLWYIKNV
HPLVKTDYEFIILGAYPSKEITKYSNKYNNIQVTGYVDDPYKIIASSTMVVSPMQIGGGI
QNKVLESMALGQINILTQKVAKPITFGVSNQHFLVEDNPYKMSLLIDDILLNRDKYFRIG
LNARKLIKEKYTWDNYELKLLRLINSY
>EGEFANNL_02320 hypothetical protein
MIHPLYYTLMVIMTILSYNEFIFRKKNKVGIALLTLILIILAGIRVGQGADYWPYLRLYH
AINKYVAWNNIFGPDAGVEPTYVFFSKFLGSLSLPFTLLLLLFASMSLTLKANSFFKYSP
LPILSLLYYFMPSYFIADSGQIRQGLAISICLFSFKYIEQKNLLKYLLCMLICYWTHKTS
IAFFPAYWIANAKISTTKAFIIITISLILWPLKPYLIIGETLNSISSDGFATGSFNSYGG
IEEAELGLSEIVKILFLIVVFVNDKYIIKTNVDENYMKVRNLMIFYFFIYYSFHGNAIFS
IRLPGAYGAFDSILISMIVCYSRYKNFYYLYFTIYIYLLSYRFWNNAQSVGFDKIRTIFN
DPRFNIYYFTPQEFYKDINDVHPLK
>EGEFANNL_02321 putative glycosyltransferase EpsJ
MHIKISIIVPVYNVESYLSKCLSSIVNQTLKEIEIIAVNDGSTDNSLSILKKYSSIHKNI
IIINKDNGGLSDARNVGIKNALGEYIAFVDSDDWIDKEMMFDMYYLAKNNDADIVFCSLQ
KVDEYDNVIKNIPQFHNLPEKINFKDNLKIFGEIENFACNKIFRKSLFKNIKFPKGLNFE
DNATIPRIILNSKILAKSNNYYYKYFVRDNSISNSYNDKGLDMLNAICLVKKDYLSSCYA
NQNNVWKKFVIFQGFYCFLAYSAYVKDKEIKKIMLLHLKNLLASEKISKKEILMYNRFGE
NYLNSLNYKKKLYYLIQLIRI
>EGEFANNL_02322 hypothetical protein
MSNKKINFILYIILLPIIISFVIYFGYSSRYNNYFFTDQMPENYFENIYKYRFLSRDLIV
YFQNFFEQRIFLNLNYFNKILTRLNTTNFYLIIFTYNTFFYVLTCIVIYKIIFYINIDNI
KNFLLIIIIESLIGFSQFVVTPYDMSSLFLLTLTFLISIKLTENFTKKKYILLILIIIIS
TLNRETSALSLSFYAALIFNNWSIKDFIISANKLILPIIAFLIPYIILRIHFNSEGYSNS
LIMDNFILTNLFEFRNLLGIFFYIIFTRFSLILCNHTYQKIFIKKYIAFSLPYIFIIFYG
GILWEIRLFIPLIIGQLILANIKNLNNFNNYIRA
>EGEFANNL_02323 3-phosphoshikimate 1-carboxyvinyltransferase
MKNISINLSGSKSITNRLLVLNSLYNNSIILKNLSLSQDSKLMAEALASNQEIIDIHHAG
TAMRFLTAYYSIFSDKKTILTGSSRMKERPIEILVNALIDLGADISYLEKKGYPPLLING
RELYKNTVKLSASISSQYLTALCLIGAKLKNGLNIEIIGKITSFPYLNMTLQILKDLGIS
ACFENNIIKISYFDHLEKQEYTIESDWSSASYHYSLCALGNELTINMKYLFENSLQADRR
IESIFKEFFGVNTIFNNGEIKIYKNTDFKYPNNIEIDMNDCPDIAQTVAVTAFGLKIPIK
ITGLETLIIKETDRLQALKNELEKCGGEVEISSSSIELKNNFNFNKNQSIKTYNDHRMAM
SFTPLKLVFPLNIENPEVVEKSYTEFWNDMTLYGLY
>EGEFANNL_02324 hypothetical protein
MGLNDTQLKVNEWIEEYGIRYFNELTNLAQLTEEVGEVARIISRRYGEQSEKESDKNKDL
GEELADVIFVVCCLANQTGIDLEEAFNKKISIKSLRDKDRHSNNKKLK
>EGEFANNL_02325 Tyrosine recombinase XerD
MNWEELITLYNEYLFLEKGLSKNTQLAYIRDLKKIKYYFNKDNSITPNTINKENVQDFIY
DYSKKSKSSKSQARLISSIKSFFKFLQLEDIRKDNPAELLESPKIGLYLPDTLEHDEVMK
LIESIDLSTSEGERNRTIIETLYGCGLRVSELVNLKLSDLFFNENLIRVTGKGDKQRLVP
ISDWTIKYINIYINKIRLHQTINPKFKDILFLNRRGGQLTREMVFIIVKKLSRNAGINKN
ISPHTFRHSFATVLLKNGADLRSIQLMLGHESITTTEIYTHLDREQLREAIEKYHPFNIN
KDFKTDENKI
>EGEFANNL_02326 N-acetylmuramoyl-L-alanine amidase AmiC
MRVLTIFNLKYILIFFSFFFINSIHSQNKDFVLVLDAGHGGHDSGARGPYANEKDVTLSL
VKKIGALIENNNKDVKVIYTRTTDEFIPLMTRANIANKNKANLFISIHCNSSSKSAPYGT
ETFVLGTHRNQDNFDVAKRENEVVYMEKDYKTTYEDFDPSSPESMIGLTLMQNTYLENSL
KIASYVENNFIKENRLSRGVKQAGFLVLVQTAMPAILIETGFISNYQEGQYLASEDGQNT
IAKNIYDAFISYKKAFDEKSGKENSAKETINIAENLPVDTDTFYKVQFLSSFSKYTPNSS
QLRGLKDIEIIKYKGKYIYYSGSSNLKSDAELNQNLAKEAGFNNATIVKHIEKENLNDEY
YTIELFLSPKKYKEKDSIFKGLNNIVRQKSNNIYIYTTGKVNNYVSAKRLLENIKKLGFS
DAVISRVSA
>EGEFANNL_02327 hypothetical protein
MINFETEFFLNLYILMNSKSKYNILCLLFLIFNILLAQEGRKQVIDSITPPTDTLVRVNK
ESLQDIVDTQGDEIRNIFSKNTTYLIHNAKVKYEDMIIEGDYIVMDWNSGDIFARGKVDS
LGKIIENITFTQGGKKFEYTEAVFNMNTKQGTAFNVRTEEEEMVIIAEKAKRMNDSEYYM
RRGLMTPDEYFKAKKDSLADVEFHTNKLKLINKPQGGKDLIAGPTTMYIEQIPTPFILPF
LYLPASGKKRSAGILIGSFGERQNKGFYLERWGFYVPIGEYLDLETRFGVYTKGSWMIDN
KLRYNKRYRYNGNLEYIYEKNISGTKGLSDYSESNNYRFIWNHIQDPKANPNLSFNSTVN
FLSQNYYNNSIYNYNAINGNVTNNQTSSSISLVKRFNNNPFTISLNASASQNISTGLVSM
VLPNLSVTMPQIYPFKPKNGAKRTIFHNLYLDYKMNLQNSITTTTEDMFSSKMFDNSNNG
MSNSSSFGTTSTIFNYFQFGINGNYKEVWTTKTIRKDFDPTTKTVVSNDKNDFSAYRTFG
GALSLTTTLYGIAQFKKGALIQAVRHMMTPTISYQYAPDFSTDTWGYYGSYTNEEGKKIK
YSYYEGNVMGSPSNFENSSLNLSIANNLEMKVRSKKEDNGVKKIKIFETFNVNTSYNFAA
DSLKLNPINITASTPLFNSRMKINYAMRINPYKIQFDSPTSTVGYAVDKFNFSVASFTMG
LNLGLDSSIFGGEKASDKYKRRGTIRYENYYFDNEGYAHFDIPWRLDIGFNYTSTKEFNR
VSNVSATVNLNGEISPAPYWKLTASTNYDLESKEFGFTRLGFSRDLRSFNINFNWVPISA
GFNKTWNFYIGLKAAILKDALKYEAKNFNDQTNF
>EGEFANNL_02328 2-iminobutanoate/2-iminopropanoate deaminase
MAKQIIKTEQAPKAIGPYSQAVKVDNLLFISGQIPVHPTTNSIPITIEEQTHQVMINIEA
ILLEAQLNWDNVIKSTIYLTDMNDFTKVNDIYASYFSSFYPARECVQVVALPKNVSVEIS
VIASEEK
>EGEFANNL_02329 hypothetical protein
MLRNTLAVLLGLLVALAIITFSLMINSYWIPYDYRGVPIEAWRSVVKTAKEEFFVALLIS
SGVASLLGGVVCALIVKRAKKAYAMFIGFILLLTAIANVLIFKGFPTWYILSSFFVFFPS
SWLGAQIVESLQKKSNKEKKKL
>EGEFANNL_02330 hypothetical protein
MNLEKYKQEAINKTNEHKKYLNKLKNKKPKKLDETLFEIHEEVFNNINCLNCANCCKTTG
PLFTEKDIDRISKHLRLKSTTFIDQYLYMDEDNDWILKNLPCPFLDNENYCLIYEVRPKA
CKEYPHTDRKKFYQINKLTEKNIIICPATYEIVNSLMNKLPL
>EGEFANNL_02331 ATP-dependent 6-phosphofructokinase 1
MPENNNKYKKIGVLTSGGDSPGMNAALRAVVRTCNYYDINCYGIRMGYDGLINDHIVELG
PRSVKNLINKGGTELKSARSEEFRTVEGRKKAAETIKKHGIEALVVIGGDGSFTGAMKLY
EEQGVPFIGIPGTIDNDIFGTDYTVGYDTALNTVAEAIDKIRDTATSHNRVFFIEVMGRD
AGFIALNTGIATGALDILIPEEKDSIEDLFQSFDNAKKKGKTSSIIVVAEGDKLGGVYDL
AKFTKMKYPEFDVRVTVLGHIQRGGSPTVADRVLASRLGVAAVEGLIDGRCCVMAGMQSS
KIVFTPIEEAIKKHNEIDKELIKVSNILSMQ
>EGEFANNL_02332 Glyceraldehyde-3-phosphate dehydrogenase A
MSKIKVGINGFGRIGRLVFRAAQHNDAIEVVGINDLIDVEYMAYMLKYDTIHGKFNGTVE
VQDGKLVVNGKSIRVTAERNPADLKWGDIGAEYIVESTGLFLTKEKAQGHIDAGAKYVVM
SAPSKDDTPMFVCGVNDSTYAKGTQFVSNASCTTNCLAPIAKVLNDKFGILEGLMTTVHA
TTATQKTVDGPSVKDWRGGRAAAGNIIPSSTGAAKAVGKVIPELNGKLTGMAFRVPTLDV
SVVDLTVRLAKETSYDEICKAMKDASEGELKGVLGYTDEEVVSSDFISDPRTSIFDVKAG
IQLSPTFVKVVSWYDNEWGYSNKVVELITRMAKINA
>EGEFANNL_02333 Putative glycosyltransferase EpsH
MFSDFNLRLSIIIAVYNRKEELKELLNSLANQTDKDFEVIVVDDGSTDNLEVIALEYLDK
LDIKYFYQKNTGAGYARNMGVSKSSRNYLIFLDSDCIAPKNYIYNVKKELKVNFVDAFGG
ADSASSDFNNLQKAISYSMTSYLTTGGIRGNKNAVSRFQPRSFNMGISKIAFNTIGGFSE
LRIGEDPDLSLCLWENNFETRFFPSCTVYHKRRTSLLKFAKQVYKFGIARPILNQRHPKF
KKLTFWFPSIFLIYTIISILLLLFVLFYYIFNSKFSLFSILCLFPFIGLILYCVVLFVDS
SNKNKSLKIGYLSLITTFTQFFSYGFGFLQSYFALNILKRKAEKSFPSHYY
>EGEFANNL_02334 UDP-N-acetylglucosamine 1-carboxyvinyltransferase
MNTFRIKGGQTLRGDFYPQGAKNEALQVICAVLLTSKPVRIKNIPEIQDVLKLIEILETL
GVKITKNAKGDYTFCSEHIDFDYLKSNEFRRDGAKLRGTIMILGPLLGRFKEGYIPIPGG
DKIGRRRLDTHFQGFKNLGAVFTYKEEEKFYSVVAKELKGCYMLLEEASVTGTANIIMAA
VLAEGQTQIYNAACEPYIQQLCKMLCSMGAKINGIGSNLLTIEGVSQLDGTEHTVLPDMI
EIGSIIGLAAMTQSEITIKNVSWDNLGNIPDTFKRLGIRIERKNDDMFIPSQKHYKIQNF
IDGSILTISDAPWPGFTPDLISIILVVATQAKGSLLIHQKMFESRLFFVDKLIDMGAQII
LCDPHRATVIGMNQEVPLRATNMASPDIRAGIALLIAAMSAKGESLISNIYQIDRGYENI
DVRLRALGAEIERITT
>EGEFANNL_02335 hypothetical protein
MEYNTQRTKLIIPEYGRYIQALVNHCLNIENNEDRNKFARSIIKVMGDLNPHLRDIPDFQ
HKLWDQLFIMSEFKLKVDSPYPIISKAEIQIPPKKMEYPKNESKFRYYGTNIKKMIEVAK
TWEEGDRKEGLKYVIANQMKKNYLKWNKDQVEDSVIFSHLEEMSEGNLKSTEGDPLMTVV
NSSNANTISNNSKNRNRNSRNNNFKNKVNYSKKNSK
>EGEFANNL_02336 Miniconductance mechanosensitive channel YbdG
MQEYSPIRFFTLKIYSFLRSLGVSEEWINITAIIVIIAVAIILVTVFKKVTNYSLEKIYS
VTKFSIFDHLIKNKISNYLAYILSYVLFVNIVPDLIFKKHISRIILKFADIFFVFVMIWI
IMSIIKSFLNVLAERSTLKNRPMKSYIQIIEIILYIFGAVAIFSIVTGKSATVFFTAMGA
ASAILMLMFKDTIMGFVGSIQISTNRIVLIGDWITMNKYGADGTVEEINLSTVKVRNFDK
TITTIPTYSLISDSFQNWRGMQESGGRRVKRSFYVKQRDIKLLSESELDEYEKELILSEF
IKEKRKHYAKINNHLKVNETSKLRGYHITNCDLFLSYINSLLKCNPEIRQDYTCMARQMA
PTSSGIPIELYFFTNTVQWIEYERISAEVLNQVYYSLDYFKLEIFEVTAGNDSLNVNLST
TKN
>EGEFANNL_02337 hypothetical protein
MKKISSIILLISLFIIVGCKSNKTTAVNKKYINSDSLPTLIGRTTPDALLHKDFSDWYLD
EYNSYIPDSKIIKKLKNRIDLYTIEVFYGTWSEESKVLIPDLLKIIKLSHYPEKKLKMYA
VNEKKQSFYGEDVQKKIIEIPTIIIYRNYDDKNGIRREVGRIIKEPSKKLEEDIYNYIDN
FGAKHKKSKKKHKKFKKLNY
>EGEFANNL_02338 hypothetical protein
MFKIWKKISFVLSIIIVILALYFIINVRSDSNDNIVADTRIINHEIERLNKMIVIEQNYS
AFRTKDFNKFNSKYLDFLNKNIVLYITAKAQVVYDMKKMIVEVDSINKRIHILSIPEPQV
EVFPNVEIYSMEDGMFNRFSKSDLNLVMEEGKRDIYKEVEKSNIKSLAKKQLISNLQDLY
SMAKLYRWQIQDDTPYAKDLIPLND
>EGEFANNL_02339 hypothetical protein
MLIFKPFKGIHMKDTSLSNFPMYSPDKYTEEQIKAKLRNKNPSYIDIIKPTFFKGESPLE
NRFKKVRKRYEEYINENLLESDPSSIYIYEQTKRNGLTFRGVIGLVDVENFKNNDIKVSE
RANEQKQEIFSKFLDLTYLQTNPVILSYNSNSKLEVMIDLEIKSKPLINIEDELGITHKL
WNVENRLKIAQFKETIENLPSLYLIDGCYRMAGAIAHSDKIKAKNKSKDLLFDNNHYIMS
LIVSSQSIKISEYNYLIKSLNGLTKKDFFDKLETHFTINRKGNNPYYPSHKHHISMYYNG
EFYGLYIKHEFRNIPEGLGCMDNYLFRKFIVESIFNIQTLKQEKELITYLQGSGDIKGIM
DLKAAVDNREYAVGFGFYPANFQDLQTVSDLGKKIPFKSAYIEPNLLLGLLMFDMK
>EGEFANNL_02340 Hydroxypyruvate reductase
MKILPNDGISSNAIEALEKAGHEVLNQKVAQEQLVKYINENEIDVLLVRSATKVRKELID
ECPSIKIIGRGGVGMDNIDVTYAKEKGIHVINTPAASSRSVAELVFGHMLSLYRYLQDSN
RNMPLEGDKNFSALKKSYAGAMELGGKTLGVIGFGRIGIEVVKLGLAFGMKVLVADAVEI
TKTVTLDFYDGQKVNFEITTVPMDELLKNSDAISVHVPKQPKYVIGKDEISKMKPNAIIV
NAARGGVIDEVALVDALKENKLFGAALDVFENEPNPEITLLMDPKLSLSPHIGGNTKEAQ
ERVGLELAEQIIELAKK
>EGEFANNL_02341 Phosphoserine aminotransferase
MKKYNFSAGPSTLPEEVLQQAAEAVLNLNNSGTSLIEISHRSKDFIAIMDEARSLVKKLM
KLDDNHEVLYLQGGASLQFSMIPYNLLKNKAAYIDSGNFASSAIKEAKKIGSIEVLASSK
DDKYTYIPKNFEIPKDVDYLHLTSNNTVYGTELKEFPETDVPLVCDMSSDILSRDIDFNK
FGLIYAGAQKNIGPAGVTLVIVNKNLLGKTDRNLPSYLDYQIHIEKESMANTPPVFAVYA
TLLNLRWLDKQGGVSEIEKKNREKAALLYGEIDRNPLFRGVCVEEDRSLMNACFFLNDEA
TYKAKFDELVKQANIIGINGYRTVGGYRASIYNAMPLEGVQTLVNVMKELEKIA
>EGEFANNL_02342 Ferredoxin
MSIIITDECINCGACEPECPNNAIYEGAVDWKMSDGTDLSGHVITPSGLSIDADALQKPI
SDDVYFIVSDKCTECHGFHEEPQCAAVCPVDCCIPDDNHKETDEQLLSKKNFLHS
>EGEFANNL_02343 hypothetical protein
MSLESRIKSISEIRNFLNQFLNHLNTGNPRFQDFDRVISMAEQKNSWFTQENIFNALNYW
NKVLEESNVNQWLSRYSLNENKNKTIGLVLAGNIPMVGFHDCLCCLLLGYKTKIKLSSKD
NVLIPFFLNLWKETCNDLDFSFVEIIKDCDAVITTGSNNTARYFEYYFKDIPHIIRKNRT
SIAVINGNEKQEDLEKLAKDVFTYFGLGCRNVTQLLVPADYNLNQLFESFLSYKDLIRHN
KYANNYDYNKAIYLLNKDKFWDNNLILLKESDNLYSAIGSLNVKFYKDQKEINTYISENI
NDIQCIVSLNNEINGLETVPFGYTQKPELYNYSDGVDTIKFLLKI
>EGEFANNL_02344 Ribonuclease G
MSKELILSYEEDRVRIVILENGRIQELHEENVDDHFSVGDIVYGKVKKLAPSLNACFVNI
GYEKDAFLHYHDLGPQIKSSLKYCKGVSQGKINSPKLNSFSFEEDIDKDGVIQDILSPNQ
EILVQVSKEPISTKGPRISSEVSLAGRYLVLIPFSSKTSISRSISTQEEKNRLKSIGEQI
RPNGFGLIIRTVAENKTVAELQSDLRYLLNKWNNICFKNIKKGKPPVKILSELDKASSIL
RDNFNEDFVNIVCDNQDLVDEIKDYLEIIAPEKVKLVQYYDSHIPIFEHYNIDKQIKQLF
GKHVNIYQAKGAYLIIEHTEALHVIDVNSGNVTASLKSQEDSALHINKLAAAEIARQLRL
RDIGGIIVVDFIDMTSSQHKKELYEYLKEVMSIDKAKHKILPPSKFGLVQITRQRVRPQK
QVNTLENNPNPDGKIESPIVLVDKIQDQIQSLVHSKNKLFLHAHPFVCAYLTKGVKSIRN
QWFLKYKKWIRVIPRDGFKYLEFQVQNDKKEILYQHSN
>EGEFANNL_02345 DNA-binding protein HU
MTKADIVNSISNKIGLEKSEIQKVVEVFMDDIKTAMAKGDNVYLRGFGTFLIKKRAAKTG
RNISKNTAIKIPAHNVPAFKPSKSFVDNIKTNVKVTN
>EGEFANNL_02346 Adenine DNA glycosylase
MNFISLLDKWYQTNKRQLPWRKTTHPYNIWISEIILQQTRVNQGIDYYNNFISTFPDIES
LANASEDQVLNQWKGLGYYSRAHNIHLSAKYIFKDLNNIFPNTFQEILKLKGVGKYTAAA
IASISFHEKIPAIDGNAFRVYSRIFNSNKDISKQTTFNYFFNLLKAVMPNNPGDFNQSIM
DFGSLICIPKKPNCEICPIYMECLAFKNSNQNILPINKSMIKRTEKIINYVHITCNDQLL
VIKRDNSSIWKGLYEFPIYKKNLFENFDSDGIYSIKHQLSHIDLYIYIHMHRVSENDFFK
LSKILKAKIIYKNEINSLAFPKPLENYLFFN
>EGEFANNL_02347 Plasmid-derived single-stranded DNA-binding protein
MSTSVNKVILVGNLGTDVKSHKFNDGNMVVNFPVATSESYINRDTGEKVDVTDWHNITAR
NKLAELCEKFLKKGSKVYIEGKLKTRKFDDNGVTKHVTEVIADNVLFLSNLIGKPLENSM
DLDD
>EGEFANNL_02348 hypothetical protein
MFLSKKSKFNLVVLFAIVFVLNGCKDHDYIPKPIGQVRLEYPNPKYKLFSPPNCPFEFEY
SDLLVIKDRKEPCWFNFYYPNMKATVYITYSSVNNDLNSLIKEAQRLVYEHTIKANSINT
KSFMYPEKKVYGNLYKIGGESASNIQFYVTDSIHNFISGNLYFRVQPKPDSLSPAIDYVE
RDIIKMIETTTWK
>EGEFANNL_02349 Aminopeptidase N
MKKIFLLLLILPSIIYGQNISHSYTKIDTLIGSNTEYRDWWDVKKYILTVEPDIISKSLQ
GTNEIIFDSKAVGTMQLDLQEPMQIDEIFTDNNTKLSFTKDGDIYLIDLKGHIKDYSSNN
KILIKFSGKPKLANNPPWDGGWIFTNDNDNNPWVTVACEGIGASVWFPCKEYLGDKIDGG
MELSIITNQKGVGNGKLISNSSINKTKNIYTWNISNPISNYNIIPYIGNYVNFLDTYNGL
KGKLTLNYWVLPSNLEKAKDHFSQVKKMLKAFEYWLGPYPFYEDGYKLVETPYLGMEHQS
GIAYGNQYLNGYLGNDLSNTDVGLNWDYIIVHESGHEWFGNSITCKDLADMWIHEAFTTY
TETLFTEYFYGKDKANEYIIGQRNLIENEHPIIGNYGVREKGSVDMYFKGANMIHTIRQV
INNDSIFRDILIGLNKEFYHQTVSSKQIENYISEKSGIDFSKVFDQYLRTTNIPTLEYYQ
KGNELIYRWNYVVPEFTMNIKTSLGNLKPSSNWKRMRMPKNSSLYDFKVDKNYYINTINT
TR
>EGEFANNL_02350 hypothetical protein
MGTELDSLQNAEDNVSKDLNSNTSTNENLDNLNYVRESNNDKECTISEEEYETFPLEKLI
DKFQELINKFPIHKIGEPVNIIKEIFLKKYEEEEKDRKEKFILAGGDELNYQPNTILKSR
FNSIYNDYKTTLNSFYKDQEKIEQVNLDKRLEIIENLKDLYTQPIESIGTFFRKFKSIKE
EWHNAGRISKLKAGDTFKTYFHHLENVHEFIRMNKELEELNYAHNLEQRNAIINRAKELV
TEPSIQKALNELQYLHKLWKEQAEPVSEEFRESTWIEFKDITQIIHNRKSELFEKIKLEQ
ESNLKIKQSIIKELEKIISNDSNNLTFWNNNATKIEELRENFFSTGRVPKENSTEIWQQF
KKIIQEINHKKNIFYRNLKKVQQENLLKKNELLEIAMANKDIEDWETGLNLFKKIQEDWK
KIGHVPRKNSDQIWKDFRENCNYFFERYKQRNIKVNEEWIENLEKKKLLLNELNELNNNT
DSENILSKINEFSIKWNSIGKVPKENININSEFNQTVKSIIKKFDIEKNKVDEMFLNIKI
EEYKNTNNSKQFDDNLKSLKKEIQDLEQEVVQLENNLSFFSNAKADNPLLKNVLGNINSK
KDKIKELKLVYTKLLHTNPEDN
>EGEFANNL_02351 Octanoyltransferase
MNVIKNHEVCFKDLEYISYSDALLQQENYLNSIIDKKIIRKKENLVNLITPNYFLFAMHP
HVYTLGKNGDISNLLINHQQLENIQAEFYRTSRGGDITYHGPGQIVGYPILDLDNFFNDL
HKYMRLLEEIIIKTIKVYGIKGERSSGETGVWIDAGKPFARKICAIGVRISRWVTMHGFA
LNVNPDLSYFTNIVPCGIINKGVTSIEQELNKTLDLQEVKNNIKKNFSEVFDVEWI
>EGEFANNL_02352 Thioredoxin
MALEINDQTFKNEVIDSNEPVLVDFWAEWCGPCRSLSPVIDELSEEFKGKLKVVKIDIDA
NQNTPVEYGIRNIPTLLFFKDGQLVEKVVGAQPKEALVEKIQNIIK
>EGEFANNL_02353 GTP-binding protein TypA/BipA
MQSIRNVAIIAHVDHGKTTLVDKIIQACHVVEKNDGDLILDNNDLERERGITILSKNVSV
NYNGVKINIIDTPGHADFGGEVERVLKMADGVLLLVDAFEGPMPQTRFVLGKAIELGLKP
IVVINKVDKENCQPEHVHDQVFELMFNLDATEDQLDFQTVYGSSKQGWMSGDYKQPTDNI
TYLLDKIIELIPEAPYVEGTPQMQITSLDFSSFVGKIAIGRVYRGDLVAGKDYILCQDNN
QNKKIRIKELQVFEGLGRKAVENVRSGDLCAIVGIESFDIGDTIADLNNPEALPRISIDE
PTMSMLFTINTSPFFGKEGKYVTSRHLRDRLMKETEINLALRVEETDSEDKFNVYGRGIL
HLSVLIETMRREGYELQVGRPRVTIKEIDGVKQEPYEHLVIDVPSEVSGKAIELVTQRKG
ELKVMEPKGDLQHLEFDISSRGLIGLRNLILTATSGEAIINHRFKDYQPMKDIIPQRQNG
SLVSSETGQALAYAIDRLQDRGKFFIEPGDQIYKGQIVGEHSRDNDLEVNLIKGKKLTNV
RASGTDQAAKIFPKVEFSLEESMEYIKDDEYLEITPKSLRMRKINS
>EGEFANNL_02354 hypothetical protein
MKIFYAYLLTVFFFLFFNCEKKTNIKENKVEKLSENKDSSELNISDSEIALDPIISEVPQ
FSNAEVNKFINKTKAYYEEVYKAAKDKNLDKEIELQHKSIEIDTEFLQIKSKLSNSEQKQ
LENWYMKLVESAAY
>EGEFANNL_02355 hypothetical protein
MQIYSVLGILLLLGILIFFLFKRTKKKNSSQLNNEFTKEGINIPLKEKSFVEIEEHQFRL
EGSLEGAKKTSRNRQMLLMDMNSYSEVSFELEKRGNSNTILVLNEEGYDIGFLKKEDQEK
IINYLNNVDYKLESGVEKFARTSEGESLTIYVTVFHYQ
>EGEFANNL_02356 Dihydroorotate dehydrogenase A (fumarate)
MINLESKISERIFTNCLMNASGVKCMTFDELEVLGASESGTFITKSCTLQPREGNPSPRY
IDLKLGSINSMGLPNLGFDFYLDYVLNENNRNNKNVFFSLAGLSLEENMEMLKQIQNSDF
KGLVELNLSCPNIPGKPQTAYDFDRTKVVLEDVFSLYKKPLGVKLPPYFDMVHFEMMAEI
LNKFPLKFVTCINSIGNALFIDNETVVIKPKGGFGGIGGAYVKPTALANVRMFYKLLRND
IAIIGCGGVENGRDVFEHLLCGASMVQVGTQLMKEGTDAFQRLILELKEIMQTKGYKNIE
DFRGSLKEL
>EGEFANNL_02357 hypothetical protein
MKKIRHKLYRRYVSGSQKWYSSIYIILLSIFIVWMIFFDTNSYLTHRELNKELSKIKHEK
SYYKSKLDSEHAQYTNLKYNKDARERYARENYFFKRKNEDIFIIIQDSNTIKK
>EGEFANNL_02358 hypothetical protein
MNYKEISKGILSAFTVIVISTLLVFLLWKVRYIVGYIFISFAFSLMGRPLMNFLNEKLHI
SKTISAFTTMFVMLGILTIFFSLFIPLAINQAGNLSLLDTNQLQDTITKQIKLIDEALKS
KHIYLFDGNYRQLFMPQYAFKIHKETLQSGFSFIAEIGVSIFSIIFITFFFLREKDLFNR
IIIGAAPTNDTDKVVEAITNIKTLLTRYFLGLSLQTFSMFILYIIILGIFKVENMIIIAL
FCATLNLIPYLGPLIGFFVINLLSISSMFSLGMDFNTQITTNIFWISILYFIAQLMDNAI
FQPLIYAKSIKSHPLEIFLVMLIFGVLFGILGVIFAIPGYTVLRVILKSFFSKFKIVQAI
TKNL
>EGEFANNL_02359 hypothetical protein
MEKKIKKKRIFRDAFGYWFIFKRLLIFVFGTISYNRFNGFNKLKIKGTENLVNLPDRNVL
FVSNHQTYFADVFAMYHVFCAVKHGYIDTLKNPIYLLDPKVDLYYVAAKETMNKGILSKL
FALAGAITVKRTWRDAGKSVNRMVDMSEIDNILKALDSGWVITFPQGTTKPWSPGRKGSA
KIIQKNKPIVIPVVIDGFRRAFDKKGLIVKKRGVEPKMTFKAPIEIDYENEDANMILDKI
MNAIEQDPKYLKVKTVEELEAEREEEKTRPFFEF
>EGEFANNL_02360 UDP-N-acetylmuramate--L-alanyl-gamma-D-glutamyl-meso-2,6-diaminoheptandioate ligase
MKIHFIAIGGSAMHNLALALAQKGYEISGSDDAIFEPSFSRLKNHGILPKELGWYPDKIT
SDLDAIILGMHAHPDNPELKKAKEIGLKIYSYPEFIFEQTKNKTRVVIAGSHGKTTITSM
ILHVLKYHDKNVDYMVGAQLEGFDTMVKLTKENDFVLLEGDEYLSSPIDRRSKFLHYKPN
IALLSGIAWDHINVFPTFDIYKQQFIEFVNSISDGGVLIYNEEDSEVLEVVEKTDKYIKK
FPYKTPDFCIKNEKVYLQTHEGEVQLSIFGKHNLINLEGARLICNQLGIQDIEFYEAIMS
FKGASRRLEKIYENENFLVFKDFAHAPSKVSATVQAVKENYKNRRLVACLELHTYSSLNP
EFLNQYSGALDDADEAIVFYSQEAVEIKRLQPISEELIKKSFQNNKLKIFTDPKGLSNYL
SSLNTTNTVFLMMSSGSYAGMDLDNIFKCK
>EGEFANNL_02361 GTPase Obg
MQSNFVDYVKIYCKSGHGGAGSAHLHRAKYIPKGGPDGGDGGRGGHIILRGNAQLWTLLP
LKYSKHIRAENGKPGGKQELTGAGGEDVYVDVPVGTIAKDELGNVLAEIEEDKQEIILLH
GGKGGLGNSHFKSPTNQTPRYAQPGLPGEEATILLELKLLGDVGLVGFPNAGKSTLLSAL
TSAKPKIANYAFTTLVPNLGIVEYRNFQSFVLADIPGIIEGASEGKGLGYRFLRHIERNS
VLLFLIPADTEDYYKEYQILLNELEKYNPELVDKDRLIAISKSDLLDEELENEIRKTFPE
NFKLLFISAVSQKNLVVLKDELWDLLHK
>EGEFANNL_02362 Adenylate kinase
MDIIVLFGPPGSGKGTQAEILSKKFNLKHISTGDLFRYNIKNETSLGIQVKSYMDKGNLV
PDELTTEMLKDELKRNSDQKGFILDGYPRTTSQAEALDFLLKELFETNVSLTLALYVEDE
ILVQRILKRSIDSGRTDDADESIIRNRIKEYYDKTAIVSEYYKNQNKLREIAGEGTIEEI
TNSLSTEIEKVI
>EGEFANNL_02363 Hypoxanthine-guanine phosphoribosyltransferase
MAEIKIHDKTFVPFIESKDIEQSIERMANTLYQEYENKVPVFIGVLNGVIMFFSDFLKYY
KGDCEIGFLQLSSYKGIQSTGDINLLKDISVDITNRDIVILEDIIDTGNTLEYLYKLLEA
KPVNSIKIITLFFKPEVYTKNLNIDLIGMNIPNKFVIGYGLDYDGLGRNLKDLYQLKENI
>EGEFANNL_02364 Universal stress protein/MSMEI_3859
MNTILVPIDFSNLTDHLLNEAIDYAKDTRSKVYLLHVASLDLGFVIGDLGFQYLPELEDA
GMKEEISELKKYESKLKAESIDVEIIIKQGIPSEIILQEAEKLNVRMIVMGSHGKGFFMD
VLLGSVSNEIIKKSKIPVLIIPSKILNK
>EGEFANNL_02365 Putative zinc metalloprotease
MELFIQISQLLLCLSILVILHEAGHFFAAKYFKCRVEKFYLFFDPWFSLFKRKIGETEYG
IGWLPLGGYVKISGMIDESLDTEQLKKDPQPWEFRSKPAWQRLIIMLAGIIVNIILAIVI
YTGILYTTGEETINTQELKDGYVFSEAGKKLGFQDGDVILEVDHKPIPTLNYLPVSILFG
DQVSVNRNGKIIHLDLLPEAKKYVLSSEGKSFISPRIISDVDSITPKSVASKHFKKGDII
VSINGMPIQYLDQLKKDLLTYKKDTVSLGIVRGEKQIIQKIYVPDSAILGFTPSATILKN
ATTYKKYSFFQALQRAPSLSWDMLLMQIKQFKIVLNPKTEAYKHVSGPLRLYQAFSPEWD
WLHFWSFTAMFSIWLAFLNILPIPGLDGGHALFTIAEMITGRKLSDKAMEKVQMVGVIIL
LSLMILVFGNDIWNIIQNIIKK
>EGEFANNL_02367 hypothetical protein
MIKVREEAYKYYFHFMEKRMDIFWKKYNNEKYPWTNDSILIRHKFTNVYRANDRVSQYLI
HNVIYGDNAKSFKEEDTLLRILIFKVFNRIDTWEYIQGNLGELTLKTFDASAMSELLAQR
IENRPIFNSAYLMTGSHRDYIQYISKHERWLQMIDNKFIKGKLFTKIIKAKSLEEIYELL
CSCPFIGEFLGYQYAIDFNYSDVVNFDENSFVKAGIGAIRGLKKCFIDADGYSNEDLIRF
TQDNLFKYREKYGCSNFKNLFGREPTLIDLQNCFCETDKYLRVKMPELKVDNVRIKQKYK
KNGNNINYFFPPKWGLNNKIKDVCLQQNTKELTLF
>EGEFANNL_02368 Thymidylate synthase
MFTAEYEGINSFLVGMAKVLLDHGVERTTREQKCWELPTPVMIKIKNPLARWVTIPERKW
NLSLPYAESLWLALGRNDLEFIKYYLSSMEEFSDDREYLRGGYGPRLRCYNGNSNDYKKA
WNENEVIFQNQEIDQFYYVAESFKRDPFTRQGIITIGDPPKDCFDANNIIKQTKDLPCTR
LLQFMRSPVDQKLNLTVYMRSNDFIWGASAVNMFNYMFMQEYFASILGLKVGEYYHIANN
FHYYDNRHRELVEQLASIDQVSDTSYCYNKKFQSLTEFDTLLKELGQWEQDLRMQQSTEI
RDFGDDFFNDWAKVLFQKIKKETVVFANPILNELSIY
>EGEFANNL_02369 hypothetical protein
MKNYKYKIDHDYGLAPNPFGGFCTLAVCKSDIRKSSNLEIGSWIFGIGAKSVGEQYFQKL
IFCMKVEEKLTFNEYWNDSRFQYKKPIINGSLVQMYGDNFYHQDENNNWIQENSAHSLVN
GIPNETHLKRDTSGEFVLISKENFYYWGDKAIIVPDEYKSAICTDTRNRAFAEPKEIVDE
FIMWLEDRHEKGVLLGDPISWSVHLNK
>EGEFANNL_02370 hypothetical protein
MSKKKNVFISHYNEDDKYVHKLIDRLNDKGYEIRNGSIDRAKYRPYRVTDALIARFLRVR
INWSGTFICLIGKDTHTRPWVNYEIQQAHKLGKPIVGIYAHGCANNVELPEAFKKYGGSP
IGWNSLDKLGDILDGKIAPPENPDGTSSQPIYNIVRVDC
>EGEFANNL_02371 hypothetical protein
MEEKQLKKITDDIIKILLKKNSDYGGASFDLGLNGNMVHLWDKIKRYRTLVENNNKGIEP
NFESIQDTLKDIMGYAIIGLLILDEESNNK
>EGEFANNL_02372 hypothetical protein
MVDNNKIKHLEFIQNVIARMCSNSFLIKGWAITLVSALFALAAKDSNMHFVLVSYIVIPV
FWALDGFFISRERQFRDLYNDVIKKTEDQIDFNMNTSVYNIGDRTWCAGILSKTLCPFYG
VSLFTTVIVMFLIKYL
>EGEFANNL_02373 Putative transposon Tn552 DNA-invertase bin3
MKARYIRVSTANQNTQRQLEKQHPEEKLYIDIISGAIPFKEREKGKELLEDIETGSINYI
SVHSIDRLGRNLFDILSTLEILNKKRIILKVDNLGIESLVNNKPNSAFKLIISVMANIAE
MERETMLERQKEGIRIAIAKGVYKGRVKGSKETDQQVLDKYKNVVKYLKKGQSLRNTAKL
CNVSLGTVQKVKGILKRKIIYNCT
>EGEFANNL_02374 hypothetical protein
MVAHNKADVNKCSTVKLKLINMTKVRNCLYETKIYVGTYKKYNEGSLFGQWLNLSDYNDF
EELIQAMKELHQDEEDPEFMFQDYECSTIIKSMGLIGESYISSEIYEVLEVIEDSYYSEE
IIEAYVDCYGTEDNIHNLIRKVEESYTGEYNTDQEFVQELLEQTGDIPENLPSYIHIDWE
STARNIMYDYSTSNNYYFRDI
>EGEFANNL_02375 hypothetical protein
MNTDTAPKKVHQGRNIKRLREMLGIKQESLALDLGVTQSTVSDYEQKEQLEDKILEKVSQ
ALKVPMEAIKNMNDEATINYINTFNDKVDNSCFGSSDTNNFNCIFNPIEKIVELYTEKEE
LYERMIKDRDELIEKLSKK
>EGEFANNL_02376 hypothetical protein
MKRKEIDLLENSKDYFTSLSKMDIESYKELGFILKSIVRVSQSAILAKESNIHLHRDWDI
YNLLSLVEKLIPDSELEFLDKVYSSGY
>EGEFANNL_02377 hypothetical protein
MSHPIIQDTQLECSQGTKPTPIQITSQSFVCIAGKLQATEADKEATTNIIPFGLCKLKPI
PGGFLPCQPALIKWQNTSVFTIDGKQELTTDSFCICSTGGKITPKIDANSSFENIK
>EGEFANNL_02378 hypothetical protein
MKNIFIFFSILFFIGSCSSPSKSNLHINDNIKDTLISEINYAFVEDPIQNIETKNIIKEY
NKHKEYIYTYGIDENSHSIISKYRNFNIGNTLISTYIIDVKYEDAECKTLLGLILDKKNN
ILDSFIFYQKGFSPDIEKNNVSTVISGNKIKFINELDDIYSKSKKIETHFFYLLNNSFVK
SDKF
>EGEFANNL_02379 hypothetical protein
MGLKRDKCIEIGINCPPKMDGGIKAQYDNNQRNSEDAEEKVEKWQYKGAVRFKAIDEDGD
TTETIITGVDKELADIEYYIYQNGNIEYKINNKEKREKAQYYYYDSSNNIHDLGVIKLKK
ISQSRITKPKQLPKRSFYNNPIGGEYIYLVDVRDINSSYNNGDIKYKLSLNTTRYFINDI
TTAAFLGAMLNCGYEDFVFNGASDETGYSAGPSNSHWNGMHLDFRYLRKDKSGKNLHLNL
SSETGDPCGWKGLDEVRQNKFNDELYLFGWTSMLSYYYNNKKLLNHTINYANHNHHLHVQ
IFKPKLKNITK
>EGEFANNL_02380 hypothetical protein
MEIDIQENLTTKVGNNISTTAGQEISQYSGKKTLLHSSQSMEVEAMNYLDLYGKQKLITY
TKGNAEMGALGQMHVHGTNALYSAKGNLDYKAPNMGRLAQSEKFLYGKTKTILEIYVMDK
NMENRLEEVPYGEESHVFVQTRNYEEGEIITIIGEPLNTETEETYTFKGIVNKEGIAKME
KTFSLKKNVAKQKENILSEDMEIDENAIYKTYKGKDYTYQQWKDFEQKQWEYYQSKQKRK
RFWD
